data_1g3g_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1g3g _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.742 0.305 . . . . 0.0 111.071 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 13.8 m-20 -109.15 -13.42 14.68 Favored 'General case' 0 CA--C 1.514 -0.422 0 CA-C-O 121.983 0.897 . . . . 0.0 108.742 178.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.58 ' CG2' ' O ' ' A' ' 32' ' ' ILE . 0.1 OUTLIER -70.23 97.32 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.577 0 CA-C-N 114.0 -1.455 . . . . 0.0 110.731 -179.317 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.53 ' CG1' ' N ' ' A' ' 34' ' ' CYS . 0.9 OUTLIER -36.99 -61.94 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 114.839 -1.073 . . . . 0.0 112.169 -179.245 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.53 ' N ' ' CG1' ' A' ' 33' ' ' VAL . 28.0 p -163.9 164.85 23.23 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.116 0.484 . . . . 0.0 112.027 -179.621 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 4.1 ttm180 -122.45 127.46 49.65 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.634 179.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 11.7 p -99.29 128.62 50.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.271 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.442 ' CG2' HG12 ' A' ' 45' ' ' ILE . 25.0 mt -127.08 108.31 18.44 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.601 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.443 ' HB2' ' O ' ' A' ' 43' ' ' ILE . 0.1 OUTLIER -86.43 100.2 12.18 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 178.617 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 8.9 t -65.55 -40.66 93.12 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.416 0.524 . . . . 0.0 112.416 -178.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -55.75 -33.97 64.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.867 0.365 . . . . 0.0 111.172 -179.345 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 114.36 0.21 23.6 Favored Glycine 0 CA--C 1.518 0.222 0 C-N-CA 120.553 -0.832 . . . . 0.0 113.575 179.217 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.421 ' HG3' ' CG ' ' A' ' 141' ' ' LEU . 0.0 OUTLIER -61.39 -45.63 93.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.066 0.46 . . . . 0.0 110.86 179.904 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.481 HG22 ' CD2' ' A' ' 76' ' ' TYR . 4.3 mp -131.04 141.54 42.33 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.1 -179.644 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.463 ' CD ' ' CZ ' ' A' ' 76' ' ' TYR . 96.3 Cg_endo -81.12 147.08 16.28 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 122.512 2.141 . . . . 0.0 111.591 179.451 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.442 HG12 ' CG2' ' A' ' 37' ' ' ILE . 40.4 mt -42.19 109.59 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.034 0.445 . . . . 0.0 111.78 -179.473 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.01 132.34 56.63 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.843 179.513 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -85.99 119.6 26.46 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.108 0.48 . . . . 0.0 111.609 -179.276 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.533 ' HB3' ' CE2' ' A' ' 66' ' ' TRP . 2.9 mt -96.43 125.85 41.22 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 178.615 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.529 ' O ' ' HZ2' ' A' ' 66' ' ' TRP . 0.0 OUTLIER -132.64 161.86 32.85 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 113.874 1.064 . . . . 0.0 113.874 -178.045 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.472 ' HB2' HG22 ' A' ' 33' ' ' VAL . . . -151.52 164.98 35.62 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.02 -1.445 . . . . 0.0 110.806 178.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -87.41 123.87 32.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.957 0.408 . . . . 0.0 111.325 -179.547 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 18.0 mt . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.338 179.751 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 52.3 mttt . . . . . 0 N--CA 1.457 -0.102 0 CA-C-O 120.897 0.379 . . . . 0.0 111.579 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 4.9 ttpt -140.36 131.37 26.2 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.262 179.228 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.476 ' CG1' ' O ' ' A' ' 91' ' ' ILE . 18.4 t -137.46 137.95 45.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.174 0.511 . . . . 0.0 112.232 -178.752 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . 0.64 ' HB2' ' HB ' ' A' ' 91' ' ' ILE . 14.5 m-90 -99.78 140.48 33.93 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.372 178.719 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.57 ' N ' ' HB2' ' A' ' 75' ' ' ASP . 33.6 m -128.44 137.18 51.71 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.554 0.692 . . . . 0.0 112.084 179.237 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.506 ' CE1' ' CG ' ' A' ' 75' ' ' ASP . 13.0 m-85 -109.07 119.01 38.26 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.124 -0.944 . . . . 0.0 109.203 178.222 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.631 ' HA2' ' O ' ' A' ' 85' ' ' SER . . . 156.82 -152.81 24.16 Favored Glycine 0 CA--C 1.503 -0.66 0 C-N-CA 118.71 -1.71 . . . . 0.0 113.412 179.16 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.462 ' CG ' ' HA ' ' A' ' 80' ' ' ASN . 62.1 mtp180 -75.06 91.44 2.55 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-O 122.513 1.149 . . . . 0.0 108.615 -179.629 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.477 ' O ' ' CD2' ' A' ' 77' ' ' HIS . 13.8 m120 -150.54 159.27 34.87 Favored Pre-proline 0 C--N 1.309 -1.183 0 CA-C-N 112.744 -2.026 . . . . 0.0 108.153 179.004 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.551 ' O ' ' HB2' ' A' ' 77' ' ' HIS . 34.7 Cg_endo -66.04 -7.08 15.98 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 120.79 0.993 . . . . 0.0 110.683 177.689 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.598 ' HB2' ' HB2' ' A' ' 77' ' ' HIS . . . 136.91 54.22 0.0 OUTLIER 'General case' 0 CA--C 1.488 -1.41 0 CA-C-N 114.338 -1.301 . . . . 0.0 108.887 178.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . 0.498 ' HB3' ' HB ' ' A' ' 67' ' ' THR . 0.1 OUTLIER -52.46 -69.9 0.1 Allowed 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 105.58 -2.007 . . . . 0.0 105.58 179.826 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.57 ' HB2' ' N ' ' A' ' 67' ' ' THR . 62.0 t0 -96.04 -47.18 6.2 Favored 'General case' 0 N--CA 1.437 -1.103 0 N-CA-C 105.383 -2.08 . . . . 0.0 105.383 168.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.498 ' C ' ' HA ' ' A' ' 73' ' ' ALA . 57.2 t80 -142.75 142.22 31.9 Favored 'General case' 0 C--N 1.35 0.599 0 CA-C-N 112.767 -2.015 . . . . 0.0 111.347 179.565 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . 0.598 ' HB2' ' HB2' ' A' ' 73' ' ' ALA . 23.7 t-160 -93.11 112.54 24.52 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 177.194 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.49 ' HB3' ' CE2' ' A' ' 76' ' ' TYR . 1.4 pp -129.02 173.5 10.38 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.03 0.443 . . . . 0.0 111.525 -179.524 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -60.53 178.7 3.04 Favored Glycine 0 C--N 1.333 0.376 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.465 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.462 ' HA ' ' CG ' ' A' ' 70' ' ' ARG . 0.8 OUTLIER -111.84 99.39 8.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.848 0.356 . . . . 0.0 111.487 -179.762 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.549 ' HB ' ' HB2' ' A' ' 85' ' ' SER . 0.5 OUTLIER -114.83 121.27 66.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.163 -0.471 . . . . 0.0 109.835 178.871 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.4 t -53.81 -24.54 15.76 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -178.15 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.94 -103.72 0.09 Allowed 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -179.071 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.431 ' O ' ' CB ' ' A' ' 85' ' ' SER . 0.0 OUTLIER -109.0 113.56 26.55 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-O 121.336 0.589 . . . . 0.0 109.432 179.681 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.631 ' O ' ' HA2' ' A' ' 69' ' ' GLY . 0.4 OUTLIER 162.02 -48.98 0.0 OUTLIER 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 114.769 -1.105 . . . . 0.0 109.317 -179.276 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.907 ' O ' ' N ' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -59.79 -162.84 0.01 OUTLIER 'General case' 0 CA--C 1.513 -0.465 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 177.717 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.493 ' HA ' ' HA3' ' A' ' 69' ' ' GLY . 13.3 mtmt -44.99 71.08 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 178.547 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 1.013 ' O ' ' O ' ' A' ' 104' ' ' ILE . 39.6 t60 -86.87 -15.92 37.62 Favored 'General case' 0 CA--C 1.513 -0.459 0 N-CA-C 113.956 1.095 . . . . 0.0 113.956 -176.466 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.557 ' CE1' HG13 ' A' ' 91' ' ' ILE . 0.0 OUTLIER -175.97 159.53 2.19 Favored 'General case' 0 C--N 1.311 -1.07 0 C-N-CA 119.165 -1.014 . . . . 0.0 112.8 178.145 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.503 ' O ' ' O ' ' A' ' 102' ' ' ASN . 42.3 mt-30 -138.73 160.23 40.16 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 113.734 1.013 . . . . 0.0 113.734 -178.336 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.64 ' HB ' ' HB2' ' A' ' 66' ' ' TRP . 4.8 mt -125.08 129.21 73.34 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.019 177.825 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.418 ' HG ' ' HB2' ' A' ' 100' ' ' LEU . 0.3 OUTLIER -109.43 140.17 43.49 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.115 0.483 . . . . 0.0 111.82 -179.203 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.437 ' CD1' ' CG2' ' A' ' 33' ' ' VAL . 6.6 tp -120.16 128.25 53.24 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.409 179.231 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.436 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.55 179.74 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 6.3 mp . . . . . 0 C--O 1.23 0.06 0 CA-C-O 120.763 0.316 . . . . 0.0 110.826 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.646 ' HA ' ' O ' ' A' ' 122' ' ' GLN . 2.5 mp -133.47 148.86 51.75 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.487 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.472 ' O ' ' N ' ' A' ' 122' ' ' GLN . 9.5 mp -112.66 129.02 56.54 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.503 ' O ' ' O ' ' A' ' 90' ' ' GLN . 28.7 t30 -110.39 111.94 23.55 Favored 'General case' 0 CA--C 1.508 -0.638 0 C-N-CA 119.735 -0.786 . . . . 0.0 109.838 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.556 ' HB3' ' CG2' ' A' ' 109' ' ' THR . 88.5 m-20 -84.04 111.22 19.1 Favored 'General case' 0 N--CA 1.439 -0.99 0 C-N-CA 119.572 -0.851 . . . . 0.0 109.564 179.755 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 1.013 ' O ' ' O ' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -123.07 107.9 20.17 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.968 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 177.22 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.441 ' HB3' ' CE1' ' A' ' 88' ' ' HIS . 50.8 m -135.23 167.32 21.22 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.485 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 18.4 m -69.5 -63.26 1.1 Allowed 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 119.109 -1.036 . . . . 0.0 111.749 -178.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -112.45 -32.64 6.42 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 115.065 1.506 . . . . 0.0 115.065 179.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -146.05 128.66 3.13 Favored Glycine 0 C--N 1.34 0.788 0 N-CA-C 117.216 1.646 . . . . 0.0 117.216 -177.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.556 ' CG2' ' HB3' ' A' ' 103' ' ' ASP . 6.1 m -121.35 138.14 54.39 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 174.353 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . 0.722 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.8 m-90 -121.27 149.04 43.49 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 113.466 0.913 . . . . 0.0 113.466 -178.47 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -123.24 112.27 17.45 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 114.98 -1.009 . . . . 0.0 108.709 177.479 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 71.5 m-20 45.42 43.88 9.01 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.104 -0.498 . . . . 0.0 112.061 -179.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 79.19 23.67 62.9 Favored Glycine 0 N--CA 1.444 -0.82 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.699 179.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 7.8 mt-30 -136.19 96.41 3.38 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.038 0.447 . . . . 0.0 110.828 179.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.722 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.0 OUTLIER -44.84 136.2 4.7 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.812 179.762 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 3.2 m -127.4 -179.89 3.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 121.023 0.44 . . . . 0.0 112.043 -178.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -83.51 142.36 30.96 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.439 -179.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.413 ' O ' ' C ' ' A' ' 119' ' ' ASN . 82.3 tttt -64.86 164.88 11.6 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.108 179.362 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.413 ' C ' ' O ' ' A' ' 118' ' ' LYS . 21.0 m-80 33.9 39.54 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 121.209 0.528 . . . . 0.0 111.193 -179.446 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 2.5 p -110.91 106.29 15.37 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.989 -179.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 22.7 m120 -57.7 144.18 38.95 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.506 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . 0.646 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 76.9 mm-40 -129.39 149.27 51.24 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-O 121.063 0.458 . . . . 0.0 112.003 -179.473 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 62.9 tp -72.92 124.38 25.31 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.71 179.104 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.401 ' HG ' ' N ' ' A' ' 125' ' ' SER . 4.9 tp -50.73 141.48 12.88 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-O 122.026 0.917 . . . . 0.0 111.78 -178.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' SER . . . . . 0.406 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.0 OUTLIER -127.14 153.06 46.51 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 113.836 -1.529 . . . . 0.0 109.936 179.421 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 1.7 mm-40 -71.14 113.64 8.38 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 179.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 64.84 30.96 79.37 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.516 -179.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.406 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 27.0 t70 -55.71 159.53 2.98 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 120.906 0.384 . . . . 0.0 111.109 -179.763 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.461 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 13.0 tt0 -146.49 135.6 22.61 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.699 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.466 ' CG2' ' O ' ' A' ' 110' ' ' TRP . 8.2 mm -114.23 128.72 71.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 116.145 -0.48 . . . . 0.0 109.915 178.644 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.461 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 88.9 m -103.43 145.2 30.35 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.873 -179.431 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.476 ' HB ' ' NE2' ' A' ' 88' ' ' HIS . 6.0 m -141.2 158.38 22.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 -179.193 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 69.49 44.23 65.39 Favored Glycine 0 N--CA 1.447 -0.595 0 CA-C-N 115.897 -0.592 . . . . 0.0 112.287 179.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.453 ' HA ' HG12 ' A' ' 140' ' ' ILE . 90.5 t -79.72 155.46 4.62 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.569 0 CA-C-O 121.373 0.606 . . . . 0.0 112.236 -179.166 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 145.62 -46.5 0.77 Allowed Glycine 0 N--CA 1.441 -1.0 0 CA-C-N 114.908 -1.042 . . . . 0.0 110.571 -179.01 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 45.7 t -126.81 128.56 71.01 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 CA-C-N 115.241 -0.48 . . . . 0.0 109.795 178.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -51.06 -26.52 6.43 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.692 0.282 . . . . 0.0 111.376 -179.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -94.66 6.05 50.05 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 -179.268 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -131.29 23.4 4.82 Favored 'General case' 0 CA--C 1.523 -0.093 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 -179.449 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.461 ' CG2' ' CG2' ' A' ' 131' ' ' THR . 23.6 mt -97.65 141.16 16.37 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.249 179.06 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.421 ' CG ' ' HG3' ' A' ' 42' ' ' GLN . 3.8 mm? -119.21 135.54 54.63 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 114.821 -1.081 . . . . 0.0 109.793 179.514 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 46.3 t -116.46 151.73 35.46 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.749 0.785 . . . . 0.0 113.011 -178.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.461 ' O ' ' HA ' ' A' ' 129' ' ' GLU . 0.9 OUTLIER -134.0 132.24 39.87 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 114.554 -1.203 . . . . 0.0 109.679 179.2 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 25.1 t -128.11 140.46 49.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.914 0.387 . . . . 0.0 111.518 -178.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -117.3 124.99 73.72 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.763 179.795 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 49.3 t80 -106.62 105.69 15.84 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.393 179.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 1.3 mp -84.97 133.39 29.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.483 -179.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -79.9 113.93 18.43 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.835 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -58.59 -21.03 52.0 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.256 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 32.1 mtmm -57.49 -42.67 83.16 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.957 0.408 . . . . 0.0 110.638 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 5.7 t80 . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.75 179.873 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.612 0.244 . . . . 0.0 111.271 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -109.0 -14.65 14.51 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-O 121.911 0.863 . . . . 0.0 108.906 178.409 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.515 ' CG2' ' O ' ' A' ' 32' ' ' ILE . 0.1 OUTLIER -73.3 106.36 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.58 0 CA-C-N 113.968 -1.469 . . . . 0.0 111.094 -179.442 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.602 ' CG1' ' N ' ' A' ' 34' ' ' CYS . 0.5 OUTLIER -38.87 -62.21 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.384 -0.826 . . . . 0.0 111.403 -179.664 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.602 ' N ' ' CG1' ' A' ' 33' ' ' VAL . 28.4 p -165.77 165.95 18.12 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.482 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 2.2 ttp180 -120.77 127.38 51.91 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.542 179.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.423 ' CG2' ' CD2' ' A' ' 48' ' ' LEU . 39.1 t -97.23 121.92 48.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.504 179.285 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.417 ' CG2' HG12 ' A' ' 45' ' ' ILE . 20.3 mt -125.29 109.02 20.96 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.824 -179.355 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 43.4 t -78.2 99.92 6.42 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 178.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 9.7 t -69.73 -33.27 72.24 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -178.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.415 ' OG1' ' O ' ' A' ' 142' ' ' SER . 0.0 OUTLIER -52.38 -29.32 23.46 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.914 0.388 . . . . 0.0 110.9 -179.658 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 90.46 49.78 3.13 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.866 -0.683 . . . . 0.0 113.003 179.205 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 2.3 mm-40 -126.55 -31.77 2.7 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.663 0.268 . . . . 0.0 111.368 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.444 HG22 ' CE2' ' A' ' 76' ' ' TYR . 19.0 mt -127.37 131.15 23.7 Favored Pre-proline 0 N--CA 1.452 -0.329 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.98 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.436 ' HD2' ' CE2' ' A' ' 76' ' ' TYR . 27.8 Cg_exo -59.85 146.82 94.73 Favored 'Trans proline' 0 C--N 1.343 0.263 0 C-N-CA 122.655 2.236 . . . . 0.0 112.046 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.417 HG12 ' CG2' ' A' ' 37' ' ' ILE . 78.8 mt -51.59 133.12 13.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.327 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -126.16 131.23 52.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.371 179.669 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -96.17 119.95 35.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.043 0.449 . . . . 0.0 111.511 -179.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.558 ' HG ' ' CG ' ' A' ' 66' ' ' TRP . 1.8 mp -96.37 117.0 29.95 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 178.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.525 ' O ' ' HZ2' ' A' ' 66' ' ' TRP . 0.1 OUTLIER -112.24 162.17 15.78 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 122.077 0.942 . . . . 0.0 113.121 -178.715 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.466 ' CB ' ' CG2' ' A' ' 33' ' ' VAL . . . -125.97 165.9 17.93 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 114.718 -1.128 . . . . 0.0 111.4 179.401 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -108.22 78.56 1.18 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.42 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 88.4 mt . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.571 -179.581 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 27.9 tttt . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.827 0.346 . . . . 0.0 111.08 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -115.0 138.88 50.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.563 179.597 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.447 ' CG1' ' O ' ' A' ' 91' ' ' ILE . 13.9 t -136.73 136.92 47.89 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 CA-C-O 121.116 0.484 . . . . 0.0 112.003 -179.289 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . 0.626 ' HB2' ' HB ' ' A' ' 91' ' ' ILE . 15.2 m-90 -100.19 140.61 34.18 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.666 179.205 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.555 ' HB ' ' HB3' ' A' ' 74' ' ' CYS . 7.1 m -129.21 129.47 45.08 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.455 0.645 . . . . 0.0 112.337 179.653 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.504 ' CE1' ' CG ' ' A' ' 75' ' ' ASP . 3.4 m-85 -103.43 118.69 37.34 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.051 -0.977 . . . . 0.0 108.716 177.578 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.63 ' HA2' ' O ' ' A' ' 85' ' ' SER . . . 157.06 -154.86 25.89 Favored Glycine 0 CA--C 1.505 -0.548 0 C-N-CA 118.58 -1.772 . . . . 0.0 113.468 179.346 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 4.1 mtp180 -75.27 91.83 2.7 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-O 122.543 1.163 . . . . 0.0 108.826 -179.416 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.518 ' O ' ' CD2' ' A' ' 77' ' ' HIS . 16.1 m120 -150.05 159.41 35.52 Favored Pre-proline 0 C--N 1.307 -1.262 0 CA-C-N 112.782 -2.008 . . . . 0.0 107.85 178.786 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.548 ' O ' ' HB2' ' A' ' 77' ' ' HIS . 30.9 Cg_endo -64.4 -7.09 13.19 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 120.7 0.933 . . . . 0.0 110.758 177.714 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.591 ' HB2' ' HB2' ' A' ' 77' ' ' HIS . . . 136.71 53.62 0.0 OUTLIER 'General case' 0 CA--C 1.488 -1.406 0 CA-C-N 114.367 -1.288 . . . . 0.0 109.0 178.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . 0.555 ' HB3' ' HB ' ' A' ' 67' ' ' THR . 0.1 OUTLIER -52.56 -70.07 0.1 Allowed 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 105.409 -2.071 . . . . 0.0 105.409 179.719 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.504 ' CG ' ' CE1' ' A' ' 68' ' ' PHE . 16.8 t70 -95.58 -47.56 6.18 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 105.781 -1.933 . . . . 0.0 105.781 169.114 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.473 ' C ' ' HA ' ' A' ' 73' ' ' ALA . 19.4 t80 -143.08 141.95 31.4 Favored 'General case' 0 C--N 1.348 0.507 0 CA-C-N 112.775 -2.011 . . . . 0.0 111.458 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . 0.591 ' HB2' ' HB2' ' A' ' 73' ' ' ALA . 23.7 t-160 -96.1 107.28 19.58 Favored 'General case' 0 C--N 1.33 -0.261 0 O-C-N 122.114 -0.366 . . . . 0.0 110.222 177.26 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.465 ' HB3' ' CE2' ' A' ' 76' ' ' TYR . 0.6 OUTLIER -121.19 173.77 7.1 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.916 0.388 . . . . 0.0 111.506 -179.895 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -56.91 -173.39 0.21 Allowed Glycine 0 C--N 1.332 0.343 0 C-N-CA 121.014 -0.612 . . . . 0.0 112.475 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.404 ' HA ' ' OD1' ' A' ' 86' ' ' ASN . 9.2 p30 -111.81 98.34 7.32 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.82 0.343 . . . . 0.0 111.758 -179.671 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.655 ' HB ' ' HB2' ' A' ' 85' ' ' SER . 11.2 mt -114.91 113.79 44.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.436 178.574 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -55.65 -24.37 33.35 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 -179.352 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 1.4 mtt180 -88.21 -106.11 0.08 Allowed 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -179.047 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.402 ' O ' ' CB ' ' A' ' 85' ' ' SER . 0.0 OUTLIER -109.26 111.17 22.61 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-O 121.568 0.699 . . . . 0.0 110.158 179.976 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.655 ' HB2' ' HB ' ' A' ' 81' ' ' ILE . 0.5 OUTLIER 162.11 -48.94 0.0 OUTLIER 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 114.378 -1.283 . . . . 0.0 109.261 -179.817 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.846 ' O ' ' N ' ' A' ' 88' ' ' HIS . 89.0 m-20 -63.32 -152.57 0.01 OUTLIER 'General case' 0 CA--C 1.522 -0.122 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 177.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 12.9 mttt -48.54 72.8 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 179.303 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.996 ' O ' ' O ' ' A' ' 104' ' ' ILE . 36.3 t60 -93.93 -17.76 22.64 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 114.103 1.149 . . . . 0.0 114.103 -176.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.498 ' HA ' ' H ' ' A' ' 104' ' ' ILE . 0.1 OUTLIER -175.83 155.69 1.7 Allowed 'General case' 0 C--N 1.313 -1.002 0 C-N-CA 118.96 -1.096 . . . . 0.0 113.073 177.982 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.515 ' O ' ' O ' ' A' ' 102' ' ' ASN . 21.2 mt-30 -137.46 160.97 37.62 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.308 -1.314 . . . . 0.0 113.574 -177.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.626 ' HB ' ' HB2' ' A' ' 66' ' ' TRP . 2.7 mt -128.42 132.33 68.17 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.784 178.746 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.427 ' N ' ' O ' ' A' ' 100' ' ' LEU . 0.3 OUTLIER -109.52 146.12 35.15 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.142 0.496 . . . . 0.0 112.017 -179.126 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.475 ' HG ' HG23 ' A' ' 33' ' ' VAL . 1.1 tm? -125.97 124.52 40.92 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.445 179.195 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.337 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.617 179.857 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 4.9 mp . . . . . 0 N--CA 1.457 -0.094 0 CA-C-O 120.842 0.353 . . . . 0.0 110.943 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.671 ' HA ' ' O ' ' A' ' 122' ' ' GLN . 4.6 mp -131.58 148.35 52.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.389 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.462 ' O ' ' N ' ' A' ' 122' ' ' GLN . 6.0 mt -118.23 128.78 55.02 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 179.823 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.515 ' O ' ' O ' ' A' ' 90' ' ' GLN . 29.4 t30 -111.21 111.38 22.41 Favored 'General case' 0 CA--C 1.507 -0.675 0 C-N-CA 119.907 -0.717 . . . . 0.0 109.685 179.606 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.562 ' HB3' ' CG2' ' A' ' 109' ' ' THR . 84.0 m-20 -85.8 111.56 20.28 Favored 'General case' 0 N--CA 1.44 -0.932 0 C-N-CA 119.596 -0.842 . . . . 0.0 109.535 179.697 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.996 ' O ' ' O ' ' A' ' 88' ' ' HIS . 0.1 OUTLIER -122.91 107.57 19.59 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.953 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 177.563 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.406 ' OG ' ' NE2' ' A' ' 88' ' ' HIS . 70.9 m -134.17 166.89 21.72 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-N 114.982 -1.008 . . . . 0.0 109.398 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 20.8 m -69.24 -62.81 1.23 Allowed 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 119.226 -0.99 . . . . 0.0 111.581 -179.074 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -112.12 -32.82 6.43 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 114.984 1.476 . . . . 0.0 114.984 179.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -146.35 127.95 2.9 Favored Glycine 0 C--N 1.339 0.749 0 N-CA-C 117.388 1.715 . . . . 0.0 117.388 -177.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.562 ' CG2' ' HB3' ' A' ' 103' ' ' ASP . 5.4 m -121.37 138.3 54.32 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 174.18 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . 0.739 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.9 m-90 -121.24 148.91 43.65 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 113.318 0.859 . . . . 0.0 113.318 -178.506 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -121.6 112.05 17.98 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 115.12 -0.946 . . . . 0.0 108.509 177.424 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 43.97 44.44 6.02 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.038 -0.528 . . . . 0.0 112.126 -179.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 80.06 25.12 58.36 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.744 179.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 58.0 mt-30 -137.74 95.98 3.15 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.077 0.465 . . . . 0.0 110.841 179.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.739 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.0 OUTLIER -45.61 134.54 7.17 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.891 179.77 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 27.3 m -126.05 -178.19 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.916 -179.029 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -85.84 142.1 29.15 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.229 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.429 ' HG3' ' HA ' ' A' ' 104' ' ' ILE . 71.4 tttt -64.49 163.21 13.82 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.155 179.28 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.404 ' N ' ' O ' ' A' ' 103' ' ' ASP . 4.2 p30 35.41 39.5 0.06 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.287 0.565 . . . . 0.0 111.17 -179.796 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 4.9 p -110.87 106.76 16.02 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.024 -179.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -57.26 140.8 48.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.506 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . 0.671 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 59.9 mm-40 -129.63 147.86 51.47 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-O 121.109 0.481 . . . . 0.0 111.965 -179.542 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.3 tp -73.77 116.89 14.9 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.628 -0.715 . . . . 0.0 109.491 178.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.4 tt -47.54 144.53 3.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.85 0.833 . . . . 0.0 111.892 -178.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' SER . . . . . 0.429 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.6 OUTLIER -126.83 153.18 45.99 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 114.04 -1.436 . . . . 0.0 110.291 179.535 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 24.6 mm100 -71.67 113.93 9.22 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.002 0.429 . . . . 0.0 110.152 179.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 69.24 25.66 75.27 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.645 -179.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.429 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 27.0 t70 -58.5 159.99 5.85 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.045 0.45 . . . . 0.0 111.136 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.412 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 1.7 tt0 -146.56 135.37 22.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.411 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.466 ' CG2' ' O ' ' A' ' 110' ' ' TRP . 1.2 mp -110.46 128.5 66.7 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.157 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 178.685 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.454 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 23.3 m -103.13 144.79 30.84 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.451 -179.571 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.468 ' HB ' ' NE2' ' A' ' 88' ' ' HIS . 10.2 m -141.29 158.14 22.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -178.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 67.38 43.16 88.59 Favored Glycine 0 N--CA 1.447 -0.582 0 CA-C-N 115.667 -0.697 . . . . 0.0 112.281 179.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.448 ' HA ' HG12 ' A' ' 140' ' ' ILE . 85.2 t -77.84 156.48 5.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 121.406 0.622 . . . . 0.0 112.133 -179.245 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 147.79 -42.06 0.89 Allowed Glycine 0 N--CA 1.441 -0.99 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.635 -179.061 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 43.8 t -126.65 130.14 71.63 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.684 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 178.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.29 -34.0 31.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.724 0.297 . . . . 0.0 111.405 -179.181 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 4.0 p -94.28 6.39 48.81 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 -179.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -128.14 30.25 5.25 Favored 'General case' 0 CA--C 1.52 -0.197 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -179.274 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.454 ' CG2' ' CG2' ' A' ' 131' ' ' THR . 20.9 mt -103.66 141.12 20.03 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.361 179.183 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 3.4 mp -111.51 135.67 51.76 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.021 -0.991 . . . . 0.0 110.048 179.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.415 ' O ' ' OG1' ' A' ' 40' ' ' THR . 47.3 t -116.82 152.02 35.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.865 0.841 . . . . 0.0 112.94 -178.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.412 ' O ' ' HA ' ' A' ' 129' ' ' GLU . 3.9 mm? -136.24 127.06 27.45 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.526 -1.215 . . . . 0.0 109.166 178.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 18.7 t -120.2 140.61 43.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.017 0.437 . . . . 0.0 111.978 -178.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . 0.402 ' CG1' HG23 ' A' ' 36' ' ' VAL . 0.2 OUTLIER -114.19 127.17 71.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.575 179.639 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 15.6 t80 -110.65 107.19 16.68 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.753 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 1.4 mp -99.76 133.41 42.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.393 -179.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 14.7 p30 -82.05 134.79 35.37 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.926 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -64.63 -23.03 67.13 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.154 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 16.7 mtmt -57.31 -42.22 81.37 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.94 0.4 . . . . 0.0 110.687 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 37.3 t80 . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.75 179.766 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.701 0.286 . . . . 0.0 111.317 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -109.06 -14.37 14.54 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-O 121.949 0.881 . . . . 0.0 108.746 178.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.541 ' CG2' ' O ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -74.31 101.53 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.522 0 CA-C-N 114.011 -1.449 . . . . 0.0 110.558 -179.769 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.585 ' CG1' ' N ' ' A' ' 34' ' ' CYS . 0.5 OUTLIER -34.93 -61.73 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.249 -0.887 . . . . 0.0 112.297 -179.059 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.585 ' N ' ' CG1' ' A' ' 33' ' ' VAL . 41.2 m -159.36 165.46 33.25 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.677 -179.178 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.46 115.12 17.68 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.828 179.367 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 9.9 p -89.18 134.38 28.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.812 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.463 ' CG2' HG12 ' A' ' 45' ' ' ILE . 21.6 mt -132.68 107.86 12.55 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -179.373 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -89.23 106.56 18.52 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 177.604 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 10.1 t -99.11 -22.4 15.7 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 -177.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.554 HG22 ' OG ' ' A' ' 142' ' ' SER . 56.7 p -57.74 -20.7 36.51 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.656 0.265 . . . . 0.0 111.583 -179.556 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 104.86 71.75 0.84 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.561 -0.828 . . . . 0.0 112.627 179.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -159.35 -66.95 0.08 Allowed 'General case' 0 C--N 1.328 -0.37 0 CA-C-O 120.893 0.377 . . . . 0.0 110.925 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.478 HG21 ' CD2' ' A' ' 76' ' ' TYR . 34.3 mt -103.5 138.97 19.69 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.257 -179.714 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.464 ' CG ' ' CE1' ' A' ' 76' ' ' TYR . 91.2 Cg_endo -81.73 146.79 15.09 Favored 'Trans proline' 0 N--CA 1.46 -0.458 0 C-N-CA 122.71 2.273 . . . . 0.0 111.706 179.51 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.463 HG12 ' CG2' ' A' ' 37' ' ' ILE . 55.8 mt -43.82 116.07 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.072 0.463 . . . . 0.0 111.622 -179.665 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 8.9 mmm180 -114.69 131.48 56.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.928 179.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.405 ' HB3' HD13 ' A' ' 32' ' ' ILE . 5.0 m-20 -88.11 119.6 28.64 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.063 0.459 . . . . 0.0 111.604 -179.306 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.498 ' HB3' ' CE2' ' A' ' 66' ' ' TRP . 1.0 OUTLIER -98.34 121.57 40.43 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 178.741 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.517 ' O ' ' HZ2' ' A' ' 66' ' ' TRP . 0.0 OUTLIER -120.81 162.05 20.44 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 122.133 0.968 . . . . 0.0 113.46 -178.371 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.473 ' CB ' ' CG2' ' A' ' 33' ' ' VAL . . . -116.96 166.28 12.36 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 114.343 -1.299 . . . . 0.0 110.958 179.685 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -105.47 63.44 0.69 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.029 0.442 . . . . 0.0 110.837 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.42 HD13 ' CE2' ' A' ' 151' ' ' PHE . 53.6 mt . . . . . 0 C--N 1.326 -0.428 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.04 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.461 0.078 0 CA-C-O 120.868 0.366 . . . . 0.0 110.852 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.438 ' O ' ' HB3' ' A' ' 93' ' ' LEU . 13.2 ttpt -130.41 136.68 49.3 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.625 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.475 ' CG1' ' O ' ' A' ' 91' ' ' ILE . 17.6 t -137.41 137.3 46.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.969 0.414 . . . . 0.0 112.008 -179.124 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . 0.634 ' HB2' ' HB ' ' A' ' 91' ' ' ILE . 13.8 m-90 -100.26 139.29 36.15 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.09 178.636 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.587 ' O ' ' N ' ' A' ' 75' ' ' ASP . 4.4 m -131.3 130.49 42.83 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.458 0.647 . . . . 0.0 112.57 179.747 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.521 ' CD2' ' CD2' ' A' ' 89' ' ' PHE . 93.7 m-85 -101.73 118.57 37.2 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.303 178.006 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.602 ' HA2' ' O ' ' A' ' 85' ' ' SER . . . 157.34 -157.2 27.9 Favored Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 118.899 -1.619 . . . . 0.0 112.812 179.291 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.47 92.34 2.85 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-O 122.71 1.243 . . . . 0.0 108.738 -179.763 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.536 ' O ' ' CD2' ' A' ' 77' ' ' HIS . 19.3 m120 -149.16 159.43 37.09 Favored Pre-proline 0 C--N 1.309 -1.169 0 CA-C-N 112.515 -2.129 . . . . 0.0 107.921 179.224 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.545 ' O ' ' CB ' ' A' ' 73' ' ' ALA . 28.8 Cg_endo -63.64 -7.43 12.75 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 120.842 1.028 . . . . 0.0 111.118 178.255 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.617 ' HB1' ' HB2' ' A' ' 77' ' ' HIS . . . 135.99 51.6 0.0 OUTLIER 'General case' 0 CA--C 1.49 -1.362 0 CA-C-N 114.527 -1.215 . . . . 0.0 109.455 178.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . 0.541 ' HB3' ' HB ' ' A' ' 67' ' ' THR . 0.1 OUTLIER -52.88 -69.9 0.1 Allowed 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 105.63 -1.989 . . . . 0.0 105.63 179.491 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.587 ' N ' ' O ' ' A' ' 67' ' ' THR . 7.6 t0 -95.26 -47.14 6.45 Favored 'General case' 0 N--CA 1.435 -1.182 0 N-CA-C 106.0 -1.852 . . . . 0.0 106.0 169.594 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.491 ' C ' ' HA ' ' A' ' 73' ' ' ALA . 29.8 t80 -144.33 142.6 30.5 Favored 'General case' 0 C--N 1.347 0.465 0 CA-C-N 112.624 -2.08 . . . . 0.0 111.476 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . 0.617 ' HB2' ' HB1' ' A' ' 73' ' ' ALA . 23.7 t-160 -96.33 107.3 19.64 Favored 'General case' 0 C--N 1.33 -0.249 0 O-C-N 121.997 -0.439 . . . . 0.0 110.322 177.073 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -124.24 175.22 7.19 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 120.916 0.388 . . . . 0.0 111.375 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -59.02 -174.18 0.57 Allowed Glycine 0 C--N 1.332 0.342 0 C-N-CA 120.981 -0.628 . . . . 0.0 112.704 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.418 ' HA ' ' OD1' ' A' ' 86' ' ' ASN . 8.0 p30 -111.48 98.24 7.32 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.933 0.397 . . . . 0.0 111.634 -179.797 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.556 ' HB ' ' HB2' ' A' ' 85' ' ' SER . 4.0 mp -114.92 114.03 45.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.356 178.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 53.3 p -55.7 -24.62 35.54 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 -178.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -85.32 -110.13 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 -178.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.474 ' HB3' ' CE1' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -108.98 112.07 24.08 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-O 121.453 0.644 . . . . 0.0 109.573 179.679 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.602 ' O ' ' HA2' ' A' ' 69' ' ' GLY . 0.6 OUTLIER 161.86 -45.63 0.0 OUTLIER 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 114.671 -1.15 . . . . 0.0 109.433 -179.562 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.858 ' O ' ' N ' ' A' ' 88' ' ' HIS . 95.7 m-20 -64.68 -149.65 0.01 OUTLIER 'General case' 0 N--CA 1.456 -0.148 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 177.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 28.1 mttm -49.58 72.02 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 179.065 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.983 ' C ' ' O ' ' A' ' 104' ' ' ILE . 31.8 t60 -91.35 -15.93 28.26 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 113.846 1.054 . . . . 0.0 113.846 -176.853 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.521 ' CD2' ' CD2' ' A' ' 68' ' ' PHE . 0.9 OUTLIER -175.31 152.83 1.45 Allowed 'General case' 0 C--N 1.31 -1.131 0 C-N-CA 119.436 -0.906 . . . . 0.0 112.291 177.972 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.474 ' N ' ' CD1' ' A' ' 89' ' ' PHE . 20.5 tt0 -136.82 153.38 50.81 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 114.514 -1.221 . . . . 0.0 113.338 -177.664 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.634 ' HB ' ' HB2' ' A' ' 66' ' ' TRP . 32.4 mt -123.53 131.98 72.17 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.196 178.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -108.64 144.05 36.89 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.055 0.455 . . . . 0.0 111.824 -179.56 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.438 ' HB3' ' O ' ' A' ' 64' ' ' LYS . 0.2 OUTLIER -125.77 122.66 36.86 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.28 179.26 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.287 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.375 -179.99 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.805 0.336 . . . . 0.0 110.893 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.523 ' HA ' ' O ' ' A' ' 122' ' ' GLN . 20.5 mt -133.61 147.98 51.53 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.432 179.758 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.451 ' O ' ' N ' ' A' ' 122' ' ' GLN . 4.8 mp -116.58 131.85 56.84 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.463 ' O ' ' O ' ' A' ' 90' ' ' GLN . 23.1 t30 -114.42 110.87 20.54 Favored 'General case' 0 CA--C 1.508 -0.661 0 C-N-CA 119.714 -0.795 . . . . 0.0 109.839 179.704 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.565 ' HB3' ' CG2' ' A' ' 109' ' ' THR . 70.1 m-20 -81.68 111.88 18.36 Favored 'General case' 0 N--CA 1.442 -0.865 0 C-N-CA 119.726 -0.79 . . . . 0.0 109.37 179.557 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.983 ' O ' ' C ' ' A' ' 88' ' ' HIS . 0.1 OUTLIER -123.45 107.98 20.1 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.937 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 177.71 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.429 ' OG ' ' NE2' ' A' ' 88' ' ' HIS . 69.8 m -130.91 169.83 15.25 Favored 'General case' 0 C--N 1.296 -1.742 0 CA-C-N 114.926 -1.034 . . . . 0.0 109.304 179.694 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 24.0 m -69.56 -62.68 1.28 Allowed 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 119.089 -1.044 . . . . 0.0 111.325 -179.302 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -111.75 -33.52 6.3 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 114.66 1.356 . . . . 0.0 114.66 179.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -146.99 130.37 3.58 Favored Glycine 0 C--N 1.34 0.786 0 N-CA-C 116.764 1.466 . . . . 0.0 116.764 -178.158 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.565 ' CG2' ' HB3' ' A' ' 103' ' ' ASP . 4.3 m -120.85 137.87 54.34 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 174.47 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . 0.747 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.5 m-90 -120.37 148.96 43.08 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 -178.543 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -122.49 112.09 17.62 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 114.931 -1.031 . . . . 0.0 108.514 177.421 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 67.4 m-20 48.02 42.82 17.34 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.08 -0.509 . . . . 0.0 112.12 -179.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 82.22 3.44 90.56 Favored Glycine 0 N--CA 1.445 -0.754 0 C-N-CA 120.785 -0.721 . . . . 0.0 113.134 179.125 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.07 100.07 7.3 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.062 0.458 . . . . 0.0 110.829 179.78 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.747 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.0 OUTLIER -44.86 139.17 3.17 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.018 179.919 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 28.1 m -126.98 178.92 3.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.103 0.478 . . . . 0.0 111.756 -179.103 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -84.01 139.09 32.75 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.755 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.451 ' O ' ' N ' ' A' ' 120' ' ' SER . 0.5 OUTLIER -61.94 169.46 2.6 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 179.348 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.444 ' C ' ' O ' ' A' ' 118' ' ' LYS . 6.7 p30 28.63 41.42 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.534 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.451 ' N ' ' O ' ' A' ' 118' ' ' LYS . 4.0 p -111.22 111.52 22.64 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.154 -179.113 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -62.95 133.77 55.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.124 179.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . 0.523 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 49.6 mm-40 -129.56 147.04 51.32 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 -179.425 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.8 tt -72.62 113.71 9.95 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.351 178.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -45.51 155.41 0.15 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.852 0.834 . . . . 0.0 112.362 -178.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' SER . . . . . 0.439 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.0 OUTLIER -127.44 153.38 46.35 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 114.069 -1.423 . . . . 0.0 109.855 179.142 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 5.6 tp-100 -70.72 113.82 8.18 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 179.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 69.13 27.93 73.34 Favored Glycine 0 N--CA 1.445 -0.7 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.131 -179.093 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.439 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 27.5 t70 -58.96 159.62 6.88 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.099 0.476 . . . . 0.0 111.53 -179.567 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.415 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 2.0 tt0 -146.54 135.35 22.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.941 179.704 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.439 ' CG2' ' O ' ' A' ' 110' ' ' TRP . 1.0 OUTLIER -108.74 129.17 63.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.13 179.157 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.469 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 32.0 m -102.77 143.16 32.75 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.86 0.362 . . . . 0.0 110.454 -179.665 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.466 ' HB ' ' NE2' ' A' ' 88' ' ' HIS . 5.3 m -141.13 158.26 22.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 -178.669 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 68.64 43.98 73.47 Favored Glycine 0 N--CA 1.447 -0.575 0 CA-C-N 115.705 -0.68 . . . . 0.0 112.219 179.351 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.463 ' HA ' HG12 ' A' ' 140' ' ' ILE . 93.0 t -79.35 154.22 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 CA-C-O 121.467 0.651 . . . . 0.0 112.242 -179.093 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 151.39 -42.79 0.71 Allowed Glycine 0 N--CA 1.44 -1.04 0 CA-C-N 114.93 -1.032 . . . . 0.0 110.648 -179.068 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 44.8 t -126.66 132.19 70.42 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.751 0 CA-C-N 115.196 -0.502 . . . . 0.0 109.844 178.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 46.5 tp10 -51.42 -34.74 36.13 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.798 0.332 . . . . 0.0 111.405 -179.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 40.9 t -94.31 6.45 48.65 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -179.318 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -126.94 30.16 5.51 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 -179.3 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.469 ' CG2' ' CG2' ' A' ' 131' ' ' THR . 13.3 mt -107.33 140.95 23.81 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.305 179.15 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -117.3 135.01 54.14 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 114.974 -1.012 . . . . 0.0 109.834 179.409 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.554 ' OG ' HG22 ' A' ' 40' ' ' THR . 0.9 OUTLIER -120.65 147.4 45.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.537 0.684 . . . . 0.0 112.701 -178.943 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.415 ' O ' ' HA ' ' A' ' 129' ' ' GLU . 3.5 mp -122.93 147.38 46.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 114.861 -1.063 . . . . 0.0 109.369 179.534 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.407 HG11 ' N ' ' A' ' 145' ' ' ILE . 23.5 t -131.76 140.28 48.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 C-N-CA 120.769 -0.372 . . . . 0.0 111.657 -179.314 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . 0.407 ' N ' HG11 ' A' ' 144' ' ' VAL . 0.0 OUTLIER -115.4 139.85 39.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.809 179.64 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 39.2 t80 -117.51 105.06 11.69 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.904 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . 0.401 ' CD1' ' O ' ' A' ' 125' ' ' SER . 3.5 mp -98.96 130.57 47.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.298 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . 0.413 ' ND2' ' O ' ' A' ' 32' ' ' ILE . 11.1 p30 -89.06 133.43 34.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.81 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -67.71 -20.06 65.23 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.264 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.46 -42.93 83.48 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.895 0.379 . . . . 0.0 110.591 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . 0.42 ' CE2' HD13 ' A' ' 52' ' ' ILE . 31.2 t80 . . . . . 0 C--N 1.327 -0.383 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.754 179.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 . . . . . 0 C--O 1.232 0.152 0 CA-C-O 120.787 0.327 . . . . 0.0 110.96 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 11.2 m-20 -108.23 -13.11 14.97 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-O 121.933 0.873 . . . . 0.0 108.979 178.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.539 ' CG2' ' O ' ' A' ' 32' ' ' ILE . 0.1 OUTLIER -70.78 103.46 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.518 0 CA-C-N 113.94 -1.482 . . . . 0.0 111.268 -179.274 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.631 ' CG1' ' N ' ' A' ' 34' ' ' CYS . 0.4 OUTLIER -33.37 -62.8 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 CA-C-N 115.25 -0.886 . . . . 0.0 112.065 -179.297 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.631 ' N ' ' CG1' ' A' ' 33' ' ' VAL . 67.2 m -162.42 165.26 26.57 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.401 -179.299 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.39 114.96 18.23 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.669 179.125 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 1.8 t -89.16 129.08 40.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.427 179.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.443 ' CG2' HG12 ' A' ' 45' ' ' ILE . 26.0 mt -122.6 108.45 21.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -178.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -102.5 107.86 18.97 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 177.783 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.6 t -113.92 -24.49 9.05 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 -178.143 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.435 ' CG2' ' HB3' ' A' ' 142' ' ' SER . 17.1 p -56.01 -26.16 47.5 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.765 0.316 . . . . 0.0 111.348 -179.489 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 124.53 66.84 0.19 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.642 -0.789 . . . . 0.0 112.674 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 21.9 mt-30 -141.13 -71.92 0.35 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.765 0.317 . . . . 0.0 110.666 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.455 ' CG2' ' CG ' ' A' ' 76' ' ' TYR . 3.9 mp -135.33 136.65 24.76 Favored Pre-proline 0 N--CA 1.452 -0.37 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.084 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.465 ' HD2' ' CE2' ' A' ' 76' ' ' TYR . 31.3 Cg_exo -58.8 147.29 89.3 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.576 2.184 . . . . 0.0 111.739 179.508 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.443 HG12 ' CG2' ' A' ' 37' ' ' ILE . 48.8 mt -38.04 140.19 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 CA-C-O 121.004 0.43 . . . . 0.0 111.83 -179.503 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.405 ' HG2' ' O ' ' A' ' 75' ' ' ASP . 0.0 OUTLIER -137.26 130.42 30.86 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.318 179.864 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -94.7 120.27 34.66 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.028 0.442 . . . . 0.0 111.538 -179.339 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.522 ' HB3' ' CE2' ' A' ' 66' ' ' TRP . 1.2 mt -100.35 129.84 46.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.821 179.295 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.483 ' HB3' HG12 ' A' ' 32' ' ' ILE . 0.1 OUTLIER -120.91 162.92 19.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 122.091 0.948 . . . . 0.0 113.364 -179.118 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.475 ' CB ' ' CG2' ' A' ' 33' ' ' VAL . . . -127.34 166.59 17.55 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.456 -1.247 . . . . 0.0 111.064 179.73 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -104.8 92.37 4.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.365 179.607 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.438 HG22 HD13 ' A' ' 52' ' ' ILE . 45.6 mt . . . . . 0 C--N 1.33 -0.242 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.929 -179.363 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 4.3 tptm . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.888 0.375 . . . . 0.0 110.77 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 16.6 ttpt -117.06 133.49 55.94 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.687 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.446 HG11 ' HG ' ' A' ' 92' ' ' LEU . 23.9 t -136.9 139.25 44.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.181 0.515 . . . . 0.0 111.856 -179.497 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . 0.634 ' HB2' ' HB ' ' A' ' 91' ' ' ILE . 13.1 m-90 -100.36 137.73 38.38 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.472 179.03 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.562 ' O ' ' N ' ' A' ' 75' ' ' ASP . 17.6 m -132.38 129.09 38.92 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.586 0.707 . . . . 0.0 112.712 179.835 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.414 ' CE1' ' CE2' ' A' ' 89' ' ' PHE . 18.4 m-85 -101.32 118.87 37.85 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.02 -0.991 . . . . 0.0 108.76 177.399 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.579 ' HA2' ' O ' ' A' ' 85' ' ' SER . . . 157.99 -156.53 27.44 Favored Glycine 0 CA--C 1.503 -0.698 0 C-N-CA 118.723 -1.703 . . . . 0.0 113.261 179.491 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 2.1 mtp180 -74.97 91.84 2.53 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-O 122.496 1.141 . . . . 0.0 108.561 -179.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.52 ' O ' ' CD2' ' A' ' 77' ' ' HIS . 17.5 m120 -149.76 159.31 36.25 Favored Pre-proline 0 C--N 1.308 -1.226 0 CA-C-N 112.764 -2.016 . . . . 0.0 108.036 179.148 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.544 ' O ' ' HB2' ' A' ' 77' ' ' HIS . 28.9 Cg_endo -64.33 -7.03 12.92 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 120.79 0.994 . . . . 0.0 110.845 178.006 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.576 ' HB2' ' HB2' ' A' ' 77' ' ' HIS . . . 136.43 52.38 0.0 OUTLIER 'General case' 0 CA--C 1.49 -1.36 0 CA-C-N 114.542 -1.208 . . . . 0.0 109.281 178.738 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . 0.538 ' HB3' ' HB ' ' A' ' 67' ' ' THR . 0.1 OUTLIER -52.85 -69.48 0.11 Allowed 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 105.823 -1.918 . . . . 0.0 105.823 179.57 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.562 ' N ' ' O ' ' A' ' 67' ' ' THR . 6.1 t70 -95.06 -48.27 6.03 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 105.544 -2.021 . . . . 0.0 105.544 169.649 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.466 ' C ' ' HA ' ' A' ' 73' ' ' ALA . 29.0 t80 -144.74 142.61 30.16 Favored 'General case' 0 C--N 1.345 0.402 0 CA-C-N 112.527 -2.124 . . . . 0.0 111.779 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . 0.576 ' HB2' ' HB2' ' A' ' 73' ' ' ALA . 23.4 t-160 -97.82 106.96 19.34 Favored 'General case' 0 C--N 1.33 -0.244 0 O-C-N 122.091 -0.381 . . . . 0.0 110.043 176.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.416 ' HB3' ' CE1' ' A' ' 76' ' ' TYR . 0.7 OUTLIER -121.57 -176.48 3.32 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.899 0.38 . . . . 0.0 111.569 -179.841 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -62.21 -174.41 1.98 Allowed Glycine 0 C--N 1.332 0.344 0 C-N-CA 120.953 -0.642 . . . . 0.0 112.445 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -111.89 98.38 7.34 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.926 0.393 . . . . 0.0 111.772 -179.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.585 ' HB ' ' HB2' ' A' ' 85' ' ' SER . 1.4 mp -114.85 115.18 48.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.252 178.737 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -56.43 -24.26 43.99 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 -179.077 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -90.07 -105.34 0.09 Allowed 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -178.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.43 ' HB3' ' CE1' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -109.11 111.96 23.87 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-O 121.466 0.65 . . . . 0.0 110.132 -179.522 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.585 ' HB2' ' HB ' ' A' ' 81' ' ' ILE . 0.6 OUTLIER 160.17 -48.02 0.0 OUTLIER 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 114.396 -1.275 . . . . 0.0 109.209 -179.753 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.846 ' O ' ' N ' ' A' ' 88' ' ' HIS . 91.6 m-20 -64.92 -151.19 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.247 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 177.546 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 2.1 pttp -46.82 74.42 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.975 ' O ' ' O ' ' A' ' 104' ' ' ILE . 32.7 t60 -95.45 -18.76 20.42 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 114.047 1.129 . . . . 0.0 114.047 -176.763 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.531 ' CZ ' HG13 ' A' ' 91' ' ' ILE . 0.1 OUTLIER -174.57 154.79 2.1 Favored 'General case' 0 C--N 1.312 -1.046 0 C-N-CA 118.912 -1.115 . . . . 0.0 113.089 178.125 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.482 ' O ' ' O ' ' A' ' 102' ' ' ASN . 31.7 mt-30 -137.05 158.4 44.55 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.397 -1.274 . . . . 0.0 113.858 -177.726 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.634 ' HB ' ' HB2' ' A' ' 66' ' ' TRP . 13.4 mt -129.92 127.67 64.08 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.204 178.708 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.446 ' HG ' HG11 ' A' ' 65' ' ' VAL . 0.3 OUTLIER -102.99 142.05 34.74 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.103 0.478 . . . . 0.0 111.874 -179.56 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.442 ' HG ' HG23 ' A' ' 33' ' ' VAL . 0.4 OUTLIER -125.74 130.36 51.33 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.481 179.32 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.384 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.621 179.639 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.18 0 CA-C-O 120.713 0.292 . . . . 0.0 110.742 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.522 ' HA ' ' O ' ' A' ' 122' ' ' GLN . 14.8 mt -133.61 148.38 51.56 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.523 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.43 ' O ' ' N ' ' A' ' 122' ' ' GLN . 5.5 mp -112.68 132.18 55.3 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 179.292 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.482 ' O ' ' O ' ' A' ' 90' ' ' GLN . 20.4 t30 -113.33 111.8 22.61 Favored 'General case' 0 CA--C 1.509 -0.607 0 C-N-CA 119.868 -0.733 . . . . 0.0 110.046 -179.773 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.563 ' HB3' ' CG2' ' A' ' 109' ' ' THR . 72.8 m-20 -84.81 112.26 20.36 Favored 'General case' 0 N--CA 1.442 -0.87 0 C-N-CA 119.835 -0.746 . . . . 0.0 109.452 179.476 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.975 ' O ' ' O ' ' A' ' 88' ' ' HIS . 0.1 OUTLIER -123.16 107.56 19.42 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.018 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 177.875 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.415 ' OG ' ' NE2' ' A' ' 88' ' ' HIS . 75.8 m -130.81 170.74 13.98 Favored 'General case' 0 C--N 1.294 -1.833 0 CA-C-N 114.95 -1.023 . . . . 0.0 109.372 179.646 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 25.1 m -69.39 -63.02 1.15 Allowed 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 118.965 -1.094 . . . . 0.0 111.234 -179.334 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -112.27 -33.21 6.28 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 114.551 1.315 . . . . 0.0 114.551 178.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -146.63 130.26 3.59 Favored Glycine 0 C--N 1.34 0.775 0 N-CA-C 116.976 1.55 . . . . 0.0 116.976 -177.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.563 ' CG2' ' HB3' ' A' ' 103' ' ' ASP . 6.3 m -121.06 138.23 54.28 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 174.262 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . 0.671 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.4 m-90 -119.6 149.28 42.21 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 113.407 0.892 . . . . 0.0 113.407 -178.461 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -120.96 112.03 18.25 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 115.162 -0.926 . . . . 0.0 108.638 177.495 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 66.9 m-20 44.7 43.17 6.49 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.126 -0.488 . . . . 0.0 112.085 -179.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 79.74 26.81 55.56 Favored Glycine 0 N--CA 1.444 -0.813 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.743 179.349 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 38.6 tt0 -138.11 98.18 3.57 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.073 0.464 . . . . 0.0 110.929 179.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.671 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.0 OUTLIER -45.29 128.76 7.91 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.97 179.725 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 28.3 m -121.12 -179.31 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.845 -179.329 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -85.65 141.83 29.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.921 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.411 ' O ' ' C ' ' A' ' 119' ' ' ASN . 86.7 tttt -66.38 163.14 18.86 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.226 179.471 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.411 ' C ' ' O ' ' A' ' 118' ' ' LYS . 8.1 m-80 34.24 39.05 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 121.203 0.525 . . . . 0.0 111.13 -179.4 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.409 ' OG ' ' NE2' ' A' ' 122' ' ' GLN . 14.8 p -111.13 115.25 29.09 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.991 -179.443 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 11.9 m-80 -59.63 138.52 57.71 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.534 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . 0.522 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 31.5 mm-40 -129.07 144.91 51.35 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.163 0.506 . . . . 0.0 111.829 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.4 tp -72.39 127.03 31.31 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.976 179.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.432 ' HG ' ' N ' ' A' ' 125' ' ' SER . 4.7 tp -55.7 143.33 30.94 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.899 0.856 . . . . 0.0 111.763 -179.145 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' SER . . . . . 0.432 ' N ' ' HG ' ' A' ' 124' ' ' LEU . 0.6 OUTLIER -126.87 151.98 47.66 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 114.049 -1.432 . . . . 0.0 109.92 179.133 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.44 114.13 9.19 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.962 0.411 . . . . 0.0 109.988 179.752 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 69.66 25.83 75.1 Favored Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.333 -179.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -54.97 159.62 2.3 Favored 'General case' 0 C--N 1.334 -0.103 0 CA-C-O 121.001 0.429 . . . . 0.0 111.068 -179.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.455 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 1.1 tt0 -146.56 135.26 22.21 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.559 -179.823 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.473 ' CD1' ' CE1' ' A' ' 89' ' ' PHE . 3.5 mt -111.37 127.94 68.19 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.184 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 178.53 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.465 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 29.4 m -103.39 144.31 31.55 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.505 -179.531 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.469 ' HB ' ' NE2' ' A' ' 88' ' ' HIS . 5.4 m -140.91 156.31 22.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -179.042 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 72.42 40.05 55.52 Favored Glycine 0 N--CA 1.446 -0.682 0 CA-C-N 115.891 -0.595 . . . . 0.0 112.366 179.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.414 ' HA ' HG12 ' A' ' 140' ' ' ILE . 95.1 t -75.7 156.64 5.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 121.38 0.61 . . . . 0.0 112.06 -179.256 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . 0.413 ' N ' ' CG1' ' A' ' 134' ' ' VAL . . . 153.74 -47.35 0.54 Allowed Glycine 0 N--CA 1.441 -0.971 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.8 -179.281 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 49.3 t -126.66 134.49 66.17 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 CA-C-N 115.216 -0.492 . . . . 0.0 109.908 178.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -51.29 -31.66 22.14 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.835 0.35 . . . . 0.0 111.263 -179.419 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -94.05 6.34 48.84 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.119 -0.491 . . . . 0.0 112.118 -179.538 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -129.79 29.62 4.98 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 112.543 0.571 . . . . 0.0 112.543 -179.343 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.465 ' CG2' ' CG2' ' A' ' 131' ' ' THR . 28.3 mt -104.99 141.24 20.8 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.073 179.22 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 1.6 mp -118.63 134.94 54.74 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.492 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.435 ' HB3' ' CG2' ' A' ' 40' ' ' THR . 42.4 t -115.04 152.23 32.85 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.761 0.791 . . . . 0.0 112.686 -179.089 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.455 ' O ' ' HA ' ' A' ' 129' ' ' GLU . 1.3 tm? -135.85 129.44 32.38 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 114.488 -1.233 . . . . 0.0 108.96 179.169 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.419 ' N ' HD23 ' A' ' 143' ' ' LEU . 21.4 t -119.78 140.21 44.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.934 0.397 . . . . 0.0 111.83 -178.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -110.56 139.67 33.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.851 179.558 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -115.23 118.71 34.08 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.586 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . 0.432 ' CD1' ' O ' ' A' ' 125' ' ' SER . 1.7 mt -98.26 133.56 40.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.986 0.422 . . . . 0.0 111.775 -179.602 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 18.5 p-10 -77.94 124.39 27.95 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.738 179.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -66.16 -24.87 66.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.313 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 3.2 mptt -59.22 -44.33 92.31 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.991 0.424 . . . . 0.0 110.844 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 20.3 t80 . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.093 -179.855 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 . . . . . 0 C--O 1.23 0.07 0 CA-C-O 120.737 0.303 . . . . 0.0 111.275 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -109.43 -13.81 14.52 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-O 121.856 0.836 . . . . 0.0 109.043 178.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.609 ' CG2' ' O ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -70.97 95.46 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.534 0 CA-C-N 114.032 -1.44 . . . . 0.0 111.166 -179.08 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.604 ' CG1' ' N ' ' A' ' 34' ' ' CYS . 0.4 OUTLIER -32.58 -62.13 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 CA-C-N 115.081 -0.963 . . . . 0.0 111.647 -179.946 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.604 ' N ' ' CG1' ' A' ' 33' ' ' VAL . 23.2 p -165.85 163.44 18.69 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.962 179.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 6.7 ttm180 -122.58 125.99 46.81 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.096 179.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.454 HG12 ' CD1' ' A' ' 48' ' ' LEU . 12.3 m -93.67 137.0 23.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.993 -0.548 . . . . 0.0 111.169 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.419 ' CG2' HG12 ' A' ' 45' ' ' ILE . 19.0 mt -130.74 106.88 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 CA-C-O 120.954 0.406 . . . . 0.0 111.787 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -99.78 99.73 10.58 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 177.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 9.5 t -108.62 26.7 10.22 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -178.322 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.451 ' CG2' ' HB2' ' A' ' 142' ' ' SER . 77.4 p -111.39 -6.35 14.49 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 111.679 0.252 . . . . 0.0 111.679 179.764 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 101.59 61.64 0.76 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.425 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 -141.66 -69.5 0.37 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.708 0.29 . . . . 0.0 110.904 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.45 ' CG2' ' CG ' ' A' ' 76' ' ' TYR . 3.5 mp -135.06 129.92 19.19 Favored Pre-proline 0 N--CA 1.452 -0.36 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.091 179.764 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.431 ' HD2' ' CZ ' ' A' ' 76' ' ' TYR . 35.5 Cg_exo -59.36 147.0 93.12 Favored 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 122.702 2.268 . . . . 0.0 111.848 179.743 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.419 HG12 ' CG2' ' A' ' 37' ' ' ILE . 40.8 mt -44.73 127.5 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.076 -0.511 . . . . 0.0 112.044 -179.416 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.36 130.25 44.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.92 179.124 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -86.86 119.54 27.19 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.079 0.466 . . . . 0.0 111.629 -179.19 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.496 ' HB3' ' CE2' ' A' ' 66' ' ' TRP . 9.1 mt -99.5 138.89 35.96 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.054 178.621 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.588 ' OG ' ' N ' ' A' ' 50' ' ' ALA . 45.5 t -131.49 -171.55 2.63 Favored 'General case' 0 CA--C 1.511 -0.536 0 CA-C-O 123.09 1.424 . . . . 0.0 113.971 -179.173 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.588 ' N ' ' OG ' ' A' ' 49' ' ' SER . . . -157.16 165.27 36.47 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 112.537 -2.119 . . . . 0.0 110.941 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -106.59 121.76 44.95 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.043 0.449 . . . . 0.0 110.785 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 7.5 mt . . . . . 0 C--N 1.326 -0.432 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.889 -179.581 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.902 0.382 . . . . 0.0 110.938 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 18.9 ttpt -117.43 131.11 56.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.472 179.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.478 ' CG1' ' O ' ' A' ' 91' ' ' ILE . 9.0 t -130.49 136.94 57.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.99 0.424 . . . . 0.0 111.654 -179.191 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . 0.619 ' HB2' ' HB ' ' A' ' 91' ' ' ILE . 16.0 m-90 -99.8 138.89 36.25 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.536 179.218 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.56 ' N ' ' HB2' ' A' ' 75' ' ' ASP . 2.2 m -131.86 128.33 38.42 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.511 ' CE1' ' CE2' ' A' ' 89' ' ' PHE . 81.4 m-85 -96.74 118.09 32.44 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 177.374 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.526 ' HA3' ' C ' ' A' ' 86' ' ' ASN . . . 157.73 -154.87 25.92 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 118.56 -1.781 . . . . 0.0 113.263 179.547 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.497 ' HG2' ' HA ' ' A' ' 80' ' ' ASN . 61.9 mtp180 -75.87 91.09 2.97 Favored 'General case' 0 N--CA 1.44 -0.931 0 CA-C-O 122.481 1.134 . . . . 0.0 108.196 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.465 ' O ' ' CD2' ' A' ' 77' ' ' HIS . 29.2 m-80 -150.12 160.1 34.06 Favored Pre-proline 0 C--N 1.31 -1.143 0 CA-C-N 112.897 -1.956 . . . . 0.0 108.658 179.503 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.528 ' O ' ' CB ' ' A' ' 73' ' ' ALA . 35.6 Cg_endo -65.22 -9.66 22.81 Favored 'Trans proline' 0 N--CA 1.452 -0.931 0 C-N-CA 120.73 0.954 . . . . 0.0 110.564 177.257 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.651 ' HB3' ' HB2' ' A' ' 77' ' ' HIS . . . 138.92 52.47 0.0 OUTLIER 'General case' 0 CA--C 1.492 -1.288 0 CA-C-N 114.537 -1.211 . . . . 0.0 109.405 178.785 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . 0.533 ' HB3' ' HB ' ' A' ' 67' ' ' THR . 0.1 OUTLIER -53.07 -69.87 0.1 Allowed 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 106.135 -1.802 . . . . 0.0 106.135 179.539 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.56 ' HB2' ' N ' ' A' ' 67' ' ' THR . 5.5 t70 -94.14 -47.49 6.63 Favored 'General case' 0 N--CA 1.436 -1.144 0 N-CA-C 105.577 -2.008 . . . . 0.0 105.577 169.837 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.533 ' C ' ' HA ' ' A' ' 73' ' ' ALA . 14.4 t80 -144.0 142.78 30.89 Favored 'General case' 0 C--N 1.343 0.315 0 CA-C-N 112.37 -2.195 . . . . 0.0 110.91 179.664 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . 0.651 ' HB2' ' HB3' ' A' ' 73' ' ' ALA . 18.7 t-160 -84.83 107.12 16.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 118.41 0.55 . . . . 0.0 110.014 177.589 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.419 HD21 ' CD1' ' A' ' 76' ' ' TYR . 29.9 mt -111.96 156.63 21.81 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.849 0.357 . . . . 0.0 111.114 -179.662 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -60.26 -160.25 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.586 -0.816 . . . . 0.0 111.792 179.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.497 ' HA ' ' HG2' ' A' ' 70' ' ' ARG . 9.4 p30 -109.42 98.9 8.21 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 117.001 0.4 . . . . 0.0 111.112 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.462 ' HB ' ' HB2' ' A' ' 85' ' ' SER . 37.9 mm -113.72 154.61 15.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.567 179.387 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -67.48 -44.83 77.57 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 -178.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 1.6 mpp_? -122.81 -92.09 0.54 Allowed 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 113.658 0.985 . . . . 0.0 113.658 -177.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.487 ' O ' ' CB ' ' A' ' 85' ' ' SER . 0.0 OUTLIER -79.05 101.85 8.07 Favored 'General case' 0 CA--C 1.506 -0.724 0 CA-C-O 121.973 0.892 . . . . 0.0 110.961 -178.546 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.516 ' O ' ' HA2' ' A' ' 69' ' ' GLY . 0.4 OUTLIER 150.03 -28.59 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 113.155 -1.839 . . . . 0.0 108.834 -179.793 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.826 ' O ' ' N ' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -85.47 -164.66 1.04 Allowed 'General case' 0 CA--C 1.51 -0.589 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 177.465 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.409 ' HA ' ' HA3' ' A' ' 69' ' ' GLY . 2.5 ptmt -47.74 73.85 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 178.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.99 ' O ' ' O ' ' A' ' 104' ' ' ILE . 25.1 t60 -91.66 -17.35 25.63 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 114.243 1.201 . . . . 0.0 114.243 -176.779 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.511 ' CE2' ' CE1' ' A' ' 68' ' ' PHE . 0.2 OUTLIER -173.56 155.3 2.73 Favored 'General case' 0 C--N 1.314 -0.938 0 C-N-CA 118.946 -1.102 . . . . 0.0 112.775 177.845 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.507 ' O ' ' O ' ' A' ' 102' ' ' ASN . 0.5 OUTLIER -135.18 154.43 51.62 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.579 -1.191 . . . . 0.0 113.868 -177.67 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.619 ' HB ' ' HB2' ' A' ' 66' ' ' TRP . 49.3 mt -124.91 132.14 71.7 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.734 178.435 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.424 ' N ' ' O ' ' A' ' 100' ' ' LEU . 0.3 OUTLIER -108.6 140.57 41.78 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.139 0.495 . . . . 0.0 112.249 -179.168 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.496 ' HG ' HG22 ' A' ' 33' ' ' VAL . 0.6 OUTLIER -125.54 135.07 51.87 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.173 179.129 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.413 0 C-N-CA 120.605 -0.807 . . . . 0.0 112.693 179.691 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 8.1 mp . . . . . 0 C--O 1.23 0.076 0 CA-C-O 120.914 0.388 . . . . 0.0 110.878 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.632 ' HA ' ' O ' ' A' ' 122' ' ' GLN . 7.9 mp -123.72 148.29 46.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.171 179.735 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.457 ' O ' ' N ' ' A' ' 122' ' ' GLN . 12.3 mt -118.1 130.5 56.17 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.813 -0.355 . . . . 0.0 110.263 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.507 ' O ' ' O ' ' A' ' 90' ' ' GLN . 24.8 t30 -113.32 111.58 22.25 Favored 'General case' 0 CA--C 1.512 -0.516 0 C-N-CA 120.017 -0.673 . . . . 0.0 109.686 179.611 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.591 ' HB3' ' CG2' ' A' ' 109' ' ' THR . 72.3 m-20 -84.96 111.93 20.13 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 119.826 -0.749 . . . . 0.0 110.13 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.99 ' O ' ' O ' ' A' ' 88' ' ' HIS . 0.1 OUTLIER -124.47 108.18 19.89 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.91 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 177.393 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.411 ' OG ' ' NE2' ' A' ' 88' ' ' HIS . 67.1 m -129.77 174.16 9.98 Favored 'General case' 0 C--N 1.296 -1.737 0 CA-C-N 115.285 -0.871 . . . . 0.0 109.312 179.353 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 23.3 m -69.25 -63.85 0.99 Allowed 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 118.998 -1.081 . . . . 0.0 111.435 -179.271 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 5.5 p30 -112.48 -32.91 6.33 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 114.181 1.178 . . . . 0.0 114.181 178.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -145.98 131.47 4.13 Favored Glycine 0 C--N 1.339 0.695 0 N-CA-C 116.558 1.383 . . . . 0.0 116.558 -178.133 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.591 ' CG2' ' HB3' ' A' ' 103' ' ' ASP . 5.8 m -121.19 138.29 54.28 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 174.697 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . 0.744 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.4 m-90 -119.78 149.18 42.47 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 113.503 0.927 . . . . 0.0 113.503 -178.542 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -122.84 112.25 17.64 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 114.997 -1.001 . . . . 0.0 108.644 177.603 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 46.25 43.73 11.63 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.091 -0.504 . . . . 0.0 112.18 -179.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 79.49 17.41 75.91 Favored Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.913 179.257 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -130.39 97.85 4.53 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.053 0.454 . . . . 0.0 110.713 179.634 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.744 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.0 OUTLIER -44.75 134.3 5.62 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.059 179.886 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 14.7 p -127.57 164.2 29.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.45 -179.163 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -70.13 141.83 52.63 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.975 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.438 ' HG3' ' HA ' ' A' ' 104' ' ' ILE . 36.3 tttm -65.23 163.69 14.76 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.217 179.552 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 36.16 39.13 0.08 Allowed 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 121.255 0.55 . . . . 0.0 110.747 -179.438 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 4.7 p -110.82 108.94 18.94 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.034 -179.305 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -58.77 139.37 56.38 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.798 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . 0.632 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 44.0 mm-40 -129.85 147.42 51.62 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-O 120.964 0.412 . . . . 0.0 111.919 -179.651 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.1 tp -72.3 112.01 8.0 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 178.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.418 ' CD1' HG12 ' A' ' 147' ' ' ILE . 3.7 tt -44.0 145.91 0.68 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.726 0.774 . . . . 0.0 112.143 -178.716 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -126.4 153.15 45.38 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 114.225 -1.352 . . . . 0.0 110.33 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.56 113.78 8.95 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 179.51 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 70.33 26.5 74.1 Favored Glycine 0 N--CA 1.444 -0.787 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.338 -179.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -56.54 159.89 3.52 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.02 0.438 . . . . 0.0 111.198 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.434 ' CG ' ' O ' ' A' ' 143' ' ' LEU . 5.1 tt0 -146.53 135.07 22.07 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.415 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.428 ' CG2' ' O ' ' A' ' 110' ' ' TRP . 7.8 mm -111.68 128.31 68.3 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.119 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 178.761 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.544 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 3.4 m -103.66 144.74 31.04 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.81 -179.493 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.409 ' CG1' ' HE2' ' A' ' 88' ' ' HIS . 4.4 m -141.28 158.39 22.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 112.462 0.542 . . . . 0.0 112.462 -178.801 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 70.26 43.99 61.23 Favored Glycine 0 N--CA 1.447 -0.586 0 CA-C-N 115.75 -0.659 . . . . 0.0 112.398 179.269 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.459 ' HA ' HG12 ' A' ' 140' ' ' ILE . 93.6 t -79.26 155.73 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 CA-C-O 121.436 0.636 . . . . 0.0 112.234 -179.13 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . 0.401 ' N ' ' CG1' ' A' ' 134' ' ' VAL . . . 150.07 -43.88 0.72 Allowed Glycine 0 N--CA 1.442 -0.939 0 CA-C-N 114.908 -1.042 . . . . 0.0 110.529 -178.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 46.3 t -126.6 130.87 71.7 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.687 0 CA-C-N 115.08 -0.56 . . . . 0.0 109.753 178.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -51.07 -33.9 27.73 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.731 0.3 . . . . 0.0 111.493 -179.198 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 83.0 p -94.14 6.25 49.17 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.243 0.461 . . . . 0.0 112.243 -179.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -127.54 30.15 5.39 Favored 'General case' 0 CA--C 1.52 -0.206 0 N-CA-C 112.408 0.521 . . . . 0.0 112.408 -179.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.544 ' CG2' ' CG2' ' A' ' 131' ' ' THR . 14.9 mt -106.0 141.28 21.65 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.935 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.392 179.213 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -115.64 135.67 53.83 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.052 -0.977 . . . . 0.0 110.51 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.451 ' HB2' ' CG2' ' A' ' 40' ' ' THR . 4.2 m -120.01 153.67 35.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.814 0.816 . . . . 0.0 112.669 -179.273 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.434 ' O ' ' CG ' ' A' ' 129' ' ' GLU . 1.2 tm? -135.45 135.38 40.49 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 114.49 -1.232 . . . . 0.0 108.835 179.451 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.409 ' N ' HD22 ' A' ' 143' ' ' LEU . 21.2 t -122.67 140.46 46.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 112.217 0.451 . . . . 0.0 112.217 -178.717 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -108.45 138.79 33.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.43 179.378 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 18.3 t80 -121.23 104.17 9.54 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.783 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . 0.418 HG12 ' CD1' ' A' ' 124' ' ' LEU . 1.6 mp -102.39 130.67 51.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.281 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 11.3 p30 -78.33 141.16 38.64 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.929 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -73.27 -22.62 60.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.182 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 28.0 mmtt -58.26 -43.87 88.12 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-O 120.898 0.38 . . . . 0.0 110.712 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 11.4 t80 . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.831 179.827 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.733 0.301 . . . . 0.0 110.995 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -108.72 -13.82 14.72 Favored 'General case' 0 CA--C 1.516 -0.347 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 178.333 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.595 ' CG2' ' O ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -70.77 96.33 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.635 0 CA-C-N 113.928 -1.487 . . . . 0.0 110.689 -179.48 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.567 ' CG1' ' N ' ' A' ' 34' ' ' CYS . 0.8 OUTLIER -33.46 -62.51 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 114.996 -1.002 . . . . 0.0 112.244 -179.157 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.567 ' N ' ' CG1' ' A' ' 33' ' ' VAL . 22.4 m -160.7 164.85 31.36 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.092 0.472 . . . . 0.0 111.637 -179.487 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 3.1 tmm_? -132.72 114.34 14.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.445 179.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.436 ' CG2' HD13 ' A' ' 91' ' ' ILE . 40.0 t -90.27 136.08 24.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.612 179.767 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.425 ' CG2' HG12 ' A' ' 45' ' ' ILE . 21.5 mt -124.09 107.97 19.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -179.248 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.471 ' HB2' ' O ' ' A' ' 43' ' ' ILE . 70.3 m -99.82 102.91 14.47 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 177.565 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.4 p -108.86 -21.54 12.61 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 113.509 0.929 . . . . 0.0 113.509 -176.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.444 ' CG2' ' HB2' ' A' ' 142' ' ' SER . 34.0 p -55.67 -20.67 14.92 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.745 0.307 . . . . 0.0 111.525 -179.428 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 113.53 62.87 0.43 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.285 179.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -144.18 -54.16 0.34 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.703 0.287 . . . . 0.0 111.361 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.492 ' CG2' ' CD2' ' A' ' 76' ' ' TYR . 0.0 OUTLIER -134.76 154.62 79.54 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.33 -178.961 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.477 ' CG ' ' CZ ' ' A' ' 76' ' ' TYR . 90.1 Cg_endo -83.78 146.86 11.94 Favored 'Trans proline' 0 N--CA 1.459 -0.511 0 C-N-CA 122.648 2.232 . . . . 0.0 111.569 179.402 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.425 HG12 ' CG2' ' A' ' 37' ' ' ILE . 40.8 mt -47.85 112.0 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 120.926 0.393 . . . . 0.0 111.728 -179.5 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 7.4 mmm180 -114.91 130.05 56.83 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.684 178.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -97.98 120.08 37.74 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.094 0.473 . . . . 0.0 111.928 -178.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.542 ' HB3' ' CE2' ' A' ' 66' ' ' TRP . 0.2 OUTLIER -92.59 137.21 32.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.238 178.641 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.523 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -135.79 163.16 30.83 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 113.258 0.836 . . . . 0.0 113.258 -178.601 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.478 ' HB2' HG22 ' A' ' 33' ' ' VAL . . . -157.48 142.16 16.58 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.626 -1.17 . . . . 0.0 111.195 179.111 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -64.31 137.19 57.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.227 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 12.4 mt . . . . . 0 C--N 1.33 -0.271 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.994 179.804 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.232 0.152 0 CA-C-O 120.809 0.337 . . . . 0.0 110.916 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 12.4 ttpt -134.32 134.44 41.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.585 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.485 ' CG1' ' O ' ' A' ' 91' ' ' ILE . 11.8 t -132.88 137.36 54.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.052 0.453 . . . . 0.0 111.763 -179.125 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . 0.611 ' HB2' ' HB ' ' A' ' 91' ' ' ILE . 14.9 m-90 -99.6 139.7 34.87 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.431 179.081 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.595 ' O ' ' N ' ' A' ' 75' ' ' ASP . 4.8 m -129.56 131.39 46.54 Favored 'General case' 0 CA--C 1.52 -0.194 0 CA-C-O 121.416 0.626 . . . . 0.0 112.46 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.503 ' CE2' ' CE2' ' A' ' 89' ' ' PHE . 90.1 m-85 -103.03 118.35 36.62 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.12 177.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.559 ' HA2' ' O ' ' A' ' 85' ' ' SER . . . 158.2 -156.12 27.09 Favored Glycine 0 CA--C 1.504 -0.656 0 C-N-CA 118.883 -1.627 . . . . 0.0 112.432 179.468 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.448 ' CD ' ' HB3' ' A' ' 86' ' ' ASN . 7.5 ptm180 -75.74 92.09 2.98 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-O 122.549 1.166 . . . . 0.0 108.377 179.703 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.513 ' O ' ' CD2' ' A' ' 77' ' ' HIS . 17.1 m120 -149.18 159.81 36.21 Favored Pre-proline 0 C--N 1.311 -1.089 0 CA-C-N 112.783 -2.008 . . . . 0.0 108.46 179.511 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.557 ' O ' ' HB2' ' A' ' 77' ' ' HIS . 32.7 Cg_endo -64.96 -7.85 16.39 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 121.025 1.15 . . . . 0.0 111.095 178.295 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.636 ' HB3' ' HB2' ' A' ' 77' ' ' HIS . . . 136.18 50.89 0.0 OUTLIER 'General case' 0 CA--C 1.49 -1.331 0 CA-C-N 114.661 -1.154 . . . . 0.0 109.656 178.704 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . 0.542 ' HB3' ' HB ' ' A' ' 67' ' ' THR . 0.1 OUTLIER -53.24 -69.74 0.11 Allowed 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 105.863 -1.903 . . . . 0.0 105.863 179.438 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.595 ' N ' ' O ' ' A' ' 67' ' ' THR . 11.2 t0 -95.33 -46.92 6.52 Favored 'General case' 0 N--CA 1.435 -1.196 0 N-CA-C 105.915 -1.883 . . . . 0.0 105.915 169.766 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.506 ' C ' ' HA ' ' A' ' 73' ' ' ALA . 61.4 t80 -143.77 142.73 31.05 Favored 'General case' 0 C--N 1.346 0.453 0 CA-C-N 112.62 -2.082 . . . . 0.0 111.113 179.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . 0.636 ' HB2' ' HB3' ' A' ' 73' ' ' ALA . 23.1 t-160 -94.23 108.91 20.75 Favored 'General case' 0 C--N 1.328 -0.329 0 O-C-N 121.984 -0.447 . . . . 0.0 110.413 177.125 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.9 pp -126.17 170.92 11.33 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.82 0.343 . . . . 0.0 110.735 179.48 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -53.16 -176.3 0.06 OUTLIER Glycine 0 CA--C 1.518 0.245 0 C-N-CA 120.897 -0.668 . . . . 0.0 112.745 -179.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -108.25 102.25 11.39 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.85 0.357 . . . . 0.0 110.881 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.453 ' CD1' ' N ' ' A' ' 81' ' ' ILE . 2.0 mp -110.11 153.99 11.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.919 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 10.0 t -68.19 -45.31 73.76 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 113.72 1.007 . . . . 0.0 113.72 -178.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 3.1 mpt_? -120.4 -90.1 0.59 Allowed 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 113.74 1.015 . . . . 0.0 113.74 -177.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.497 ' O ' ' CB ' ' A' ' 85' ' ' SER . 0.0 OUTLIER -84.72 103.51 13.88 Favored 'General case' 0 CA--C 1.506 -0.741 0 CA-C-O 122.014 0.912 . . . . 0.0 110.836 -178.622 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.559 ' O ' ' HA2' ' A' ' 69' ' ' GLY . 0.4 OUTLIER 148.13 -35.8 0.01 OUTLIER 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 113.072 -1.876 . . . . 0.0 108.607 -179.812 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.8 ' O ' ' N ' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -70.42 -161.55 0.05 Allowed 'General case' 0 CA--C 1.513 -0.477 0 N-CA-C 107.586 -1.265 . . . . 0.0 107.586 177.492 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.502 ' HA ' ' HA3' ' A' ' 69' ' ' GLY . 9.6 pttt -51.54 72.82 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 178.129 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.93 ' O ' ' O ' ' A' ' 104' ' ' ILE . 32.9 t60 -84.51 -17.09 40.09 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 114.389 1.255 . . . . 0.0 114.389 -176.374 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.55 ' HA ' ' H ' ' A' ' 104' ' ' ILE . 0.1 OUTLIER -172.09 154.18 3.34 Favored 'General case' 0 C--N 1.31 -1.124 0 C-N-CA 119.124 -1.03 . . . . 0.0 112.48 177.867 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.492 ' N ' ' CD1' ' A' ' 89' ' ' PHE . 32.9 mt-30 -136.04 159.05 42.88 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 114.52 -1.218 . . . . 0.0 113.902 -177.294 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.611 ' HB ' ' HB2' ' A' ' 66' ' ' TRP . 7.1 mt -125.25 131.85 71.86 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 CA-C-N 114.949 -1.023 . . . . 0.0 109.703 178.607 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.421 ' CD1' ' HB2' ' A' ' 102' ' ' ASN . 0.3 OUTLIER -108.05 143.78 36.29 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.083 0.468 . . . . 0.0 112.111 -179.421 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.404 ' CD1' ' CG2' ' A' ' 33' ' ' VAL . 14.3 tp -125.6 122.68 37.15 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.349 179.038 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.353 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.401 179.951 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.2 mt . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.708 0.29 . . . . 0.0 110.854 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.553 ' HA ' ' O ' ' A' ' 122' ' ' GLN . 5.6 mt -133.79 148.46 51.35 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.434 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.447 ' O ' ' N ' ' A' ' 122' ' ' GLN . 38.0 mt -117.27 130.99 56.91 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 179.777 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.491 ' O ' ' O ' ' A' ' 90' ' ' GLN . 23.8 t30 -113.25 111.31 21.83 Favored 'General case' 0 CA--C 1.51 -0.581 0 C-N-CA 119.847 -0.741 . . . . 0.0 109.944 179.684 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.557 ' HB3' ' CG2' ' A' ' 109' ' ' THR . 70.7 m-20 -84.43 112.52 20.44 Favored 'General case' 0 N--CA 1.444 -0.773 0 C-N-CA 119.669 -0.812 . . . . 0.0 109.381 179.4 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.93 ' O ' ' O ' ' A' ' 88' ' ' HIS . 0.1 OUTLIER -122.91 107.61 19.67 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.876 0 CA-C-O 121.756 0.789 . . . . 0.0 108.96 178.136 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.456 ' OG ' ' NE2' ' A' ' 88' ' ' HIS . 66.8 m -132.39 171.49 13.67 Favored 'General case' 0 C--N 1.295 -1.77 0 CA-C-N 114.757 -1.11 . . . . 0.0 109.36 179.551 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 22.6 m -69.5 -63.8 1.0 Allowed 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 118.998 -1.081 . . . . 0.0 111.706 -178.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 5.5 p30 -112.6 -32.76 6.35 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 114.63 1.344 . . . . 0.0 114.63 179.203 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -146.13 129.17 3.28 Favored Glycine 0 C--N 1.339 0.719 0 N-CA-C 116.931 1.532 . . . . 0.0 116.931 -177.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.557 ' CG2' ' HB3' ' A' ' 103' ' ' ASP . 6.5 m -121.15 138.36 54.24 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 174.411 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . 0.622 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.7 m-90 -120.45 149.2 42.76 Favored 'General case' 0 CA--C 1.515 -0.374 0 N-CA-C 113.283 0.846 . . . . 0.0 113.283 -178.447 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -121.64 111.85 17.71 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 115.001 -0.999 . . . . 0.0 108.563 177.44 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 44.74 43.79 7.06 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.125 -0.489 . . . . 0.0 112.114 -179.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 78.88 31.4 44.0 Favored Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.891 179.238 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -141.95 98.93 3.42 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.999 0.428 . . . . 0.0 110.832 179.648 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.622 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.2 OUTLIER -45.22 122.59 3.49 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.786 179.727 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 8.1 m -112.35 179.56 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.902 -179.047 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -88.13 136.96 32.73 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.809 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 63.7 tttm -62.73 162.39 10.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.534 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 4.0 p30 34.46 38.54 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.364 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 9.0 p -111.28 114.23 27.28 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.055 -179.334 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . 0.409 ' ND2' HD13 ' A' ' 92' ' ' LEU . 1.6 m120 -61.76 136.26 57.92 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.616 179.777 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . 0.553 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 32.0 mm-40 -129.53 145.37 51.47 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.119 0.485 . . . . 0.0 112.161 -179.613 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.6 tp -72.62 120.03 17.67 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.562 178.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.463 ' O ' HD11 ' A' ' 124' ' ' LEU . 0.0 OUTLIER -47.6 149.22 1.23 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 122.026 0.917 . . . . 0.0 112.346 -178.661 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' SER . . . . . 0.435 ' O ' ' CD1' ' A' ' 147' ' ' ILE . 0.0 OUTLIER -126.42 152.56 46.2 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 114.102 -1.408 . . . . 0.0 109.661 179.195 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.62 113.75 8.03 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.07 0.462 . . . . 0.0 110.136 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 66.49 29.96 75.69 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.375 -179.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.42 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 9.8 t70 -58.31 161.05 4.61 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.98 0.419 . . . . 0.0 111.343 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -146.28 135.35 22.63 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.044 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.464 ' CD1' ' CE1' ' A' ' 89' ' ' PHE . 3.9 mt -109.91 128.53 65.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 120.831 0.348 . . . . 0.0 110.258 179.213 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.443 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 16.8 m -103.19 142.66 33.79 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.634 -179.57 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.463 ' HB ' ' NE2' ' A' ' 88' ' ' HIS . 4.4 m -140.72 154.09 21.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.298 -0.41 . . . . 0.0 112.008 -179.11 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 75.16 37.03 43.86 Favored Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 121.127 -0.559 . . . . 0.0 112.402 179.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.452 ' HA ' HG12 ' A' ' 140' ' ' ILE . 91.5 t -72.89 156.75 6.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 121.44 0.638 . . . . 0.0 112.081 -179.174 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . 0.417 ' N ' ' CG1' ' A' ' 134' ' ' VAL . . . 153.59 -47.86 0.53 Allowed Glycine 0 N--CA 1.442 -0.957 0 N-CA-C 110.665 -0.974 . . . . 0.0 110.665 -179.297 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 56.1 t -126.71 134.61 65.87 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.682 0 CA-C-N 115.295 -0.453 . . . . 0.0 109.877 178.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -51.19 -32.06 22.3 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.841 0.353 . . . . 0.0 111.19 -179.36 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 90.2 p -94.09 6.26 49.13 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 116.159 -0.473 . . . . 0.0 112.088 -179.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -129.31 29.14 5.16 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 112.376 0.51 . . . . 0.0 112.376 -179.487 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.452 HG12 ' HA ' ' A' ' 134' ' ' VAL . 23.6 mt -104.88 140.95 21.37 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 CA-C-N 115.668 -0.697 . . . . 0.0 111.154 179.157 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -117.23 135.22 53.96 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 114.925 -1.034 . . . . 0.0 110.06 179.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.444 ' HB2' ' CG2' ' A' ' 40' ' ' THR . 4.1 m -119.13 152.79 35.92 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.833 0.825 . . . . 0.0 112.581 -179.144 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -132.11 153.88 50.04 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 114.401 -1.272 . . . . 0.0 109.174 179.25 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 22.1 t -128.08 140.55 48.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 120.946 0.403 . . . . 0.0 111.777 -179.348 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -113.88 126.58 71.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.333 179.61 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 7.7 t80 -108.84 119.52 39.79 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.054 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . 0.435 ' CD1' ' O ' ' A' ' 125' ' ' SER . 2.7 mp -112.1 123.0 67.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.881 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . 0.409 ' ND2' ' O ' ' A' ' 32' ' ' ILE . 3.1 p30 -76.31 122.88 25.07 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.923 0.392 . . . . 0.0 111.087 -179.74 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -73.82 -19.44 60.75 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.078 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.82 -42.98 85.46 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 120.962 0.411 . . . . 0.0 110.732 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 4.7 t80 . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.64 179.861 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 . . . . . 0 CA--C 1.527 0.094 0 CA-C-O 120.642 0.258 . . . . 0.0 111.369 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -109.42 -14.45 14.42 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-O 121.936 0.874 . . . . 0.0 108.681 178.463 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.609 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 0.1 OUTLIER -71.08 108.99 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.662 0 CA-C-N 113.949 -1.478 . . . . 0.0 111.121 -179.464 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.496 ' CG2' ' N ' ' A' ' 50' ' ' ALA . 2.2 t -53.35 -67.19 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.834 0 CA-C-N 114.946 -1.025 . . . . 0.0 111.459 -179.576 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 18.3 p -155.23 165.08 37.79 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.022 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 1.5 ttm180 -129.33 115.48 17.63 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.402 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.427 ' CG2' ' CD2' ' A' ' 48' ' ' LEU . 66.6 t -89.05 130.09 38.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.149 -0.478 . . . . 0.0 109.901 179.183 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.456 ' CG2' HG12 ' A' ' 45' ' ' ILE . 28.0 mt -122.23 108.54 22.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -178.802 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -95.92 101.65 13.35 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 177.599 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -111.47 2.32 17.42 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -178.049 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.466 ' CG2' ' HB2' ' A' ' 142' ' ' SER . 67.8 p -83.76 -16.35 45.1 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.784 -0.366 . . . . 0.0 111.402 179.646 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 113.71 58.83 0.4 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.587 179.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 6.1 mt-30 -134.6 -69.42 0.52 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.641 0.258 . . . . 0.0 111.134 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.411 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 3.7 mp -135.09 139.07 30.83 Favored Pre-proline 0 N--CA 1.452 -0.336 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.185 -179.88 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.527 ' HD2' ' CZ ' ' A' ' 76' ' ' TYR . 28.2 Cg_exo -59.26 147.32 91.38 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.718 2.278 . . . . 0.0 111.68 179.607 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.456 HG12 ' CG2' ' A' ' 37' ' ' ILE . 32.0 mt -46.33 148.72 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 121.008 0.432 . . . . 0.0 111.689 -179.633 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.1 130.28 13.61 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.187 179.445 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -91.58 119.77 31.78 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.086 0.469 . . . . 0.0 111.168 -179.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.609 ' HB3' ' CE2' ' A' ' 66' ' ' TRP . 0.1 OUTLIER -92.5 123.34 35.74 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.479 179.129 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.609 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -132.99 155.98 48.16 Favored 'General case' 0 CA--C 1.515 -0.398 0 N-CA-C 114.04 1.126 . . . . 0.0 114.04 -178.979 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.496 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -149.9 142.24 24.24 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 113.698 -1.592 . . . . 0.0 110.824 179.028 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -66.46 110.22 3.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.982 0.42 . . . . 0.0 110.89 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 10.7 mt . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.1 179.956 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.1 pttp . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.851 0.358 . . . . 0.0 111.084 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.433 ' HG2' ' CH2' ' A' ' 66' ' ' TRP . 29.2 ttmt -99.69 123.55 44.07 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.237 179.478 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.468 ' CG1' ' O ' ' A' ' 91' ' ' ILE . 4.7 t -126.11 133.32 69.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.141 0.496 . . . . 0.0 112.09 -178.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . 0.609 ' CE2' ' HB3' ' A' ' 48' ' ' LEU . 13.3 m-90 -99.34 139.9 34.3 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.229 178.827 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.547 ' N ' ' HB2' ' A' ' 75' ' ' ASP . 2.8 m -131.37 129.34 41.23 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.447 0.642 . . . . 0.0 112.436 179.678 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.509 ' CD2' ' CD2' ' A' ' 89' ' ' PHE . 94.2 m-85 -100.13 117.6 34.71 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.415 -0.812 . . . . 0.0 109.091 177.832 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.545 ' HA2' ' O ' ' A' ' 85' ' ' SER . . . 158.19 -157.83 28.64 Favored Glycine 0 CA--C 1.503 -0.695 0 C-N-CA 119.061 -1.542 . . . . 0.0 113.061 179.456 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -75.46 91.49 2.77 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-O 122.726 1.25 . . . . 0.0 108.43 -179.7 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.485 ' O ' ' CD2' ' A' ' 77' ' ' HIS . 0.2 OUTLIER -150.39 155.26 36.61 Favored Pre-proline 0 C--N 1.309 -1.162 0 CA-C-N 112.617 -2.083 . . . . 0.0 108.44 179.34 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.558 ' O ' ' HB2' ' A' ' 77' ' ' HIS . 23.9 Cg_exo -56.9 -11.11 6.62 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 121.406 1.404 . . . . 0.0 111.606 178.254 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.617 ' HB2' ' HB2' ' A' ' 77' ' ' HIS . . . 136.16 51.78 0.0 OUTLIER 'General case' 0 CA--C 1.491 -1.315 0 CA-C-N 115.001 -1.0 . . . . 0.0 109.535 178.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . 0.54 ' CB ' ' HB ' ' A' ' 67' ' ' THR . 0.1 OUTLIER -52.91 -69.55 0.11 Allowed 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 105.919 -1.882 . . . . 0.0 105.919 179.387 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.547 ' HB2' ' N ' ' A' ' 67' ' ' THR . 8.2 t0 -94.48 -47.73 6.43 Favored 'General case' 0 N--CA 1.434 -1.258 0 N-CA-C 105.772 -1.936 . . . . 0.0 105.772 169.784 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.527 ' CZ ' ' HD2' ' A' ' 44' ' ' PRO . 39.0 t80 -145.04 142.37 29.69 Favored 'General case' 0 C--N 1.347 0.473 0 CA-C-N 112.655 -2.066 . . . . 0.0 111.54 179.485 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . 0.617 ' HB2' ' HB2' ' A' ' 73' ' ' ALA . 23.8 t-160 -92.06 107.43 19.21 Favored 'General case' 0 C--N 1.331 -0.196 0 O-C-N 121.846 -0.534 . . . . 0.0 109.906 176.779 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.6 pp -119.99 176.29 5.5 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.949 0.404 . . . . 0.0 111.48 -179.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -64.1 -169.98 1.82 Allowed Glycine 0 C--N 1.332 0.324 0 C-N-CA 121.044 -0.598 . . . . 0.0 112.572 -179.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 10.1 p-10 -111.71 98.82 7.68 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.957 0.408 . . . . 0.0 111.604 -179.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.553 ' HB ' ' HB2' ' A' ' 85' ' ' SER . 13.4 mm -113.72 112.1 38.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.302 179.018 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 8.0 t -55.01 -24.24 23.4 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.238 0.458 . . . . 0.0 112.238 -179.236 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -91.49 -109.51 0.1 Allowed 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 -179.027 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.44 ' HB3' ' CE1' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -108.01 112.41 24.96 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 121.619 0.723 . . . . 0.0 109.87 -179.915 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.553 ' HB2' ' HB ' ' A' ' 81' ' ' ILE . 0.4 OUTLIER 162.16 -43.93 0.0 OUTLIER 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 114.285 -1.325 . . . . 0.0 108.932 -179.422 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.843 ' O ' ' N ' ' A' ' 88' ' ' HIS . 96.9 m-20 -65.43 -149.46 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 177.522 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.79 72.33 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 179.063 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.962 ' C ' ' O ' ' A' ' 104' ' ' ILE . 30.7 t60 -90.58 -16.17 29.23 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 113.813 1.042 . . . . 0.0 113.813 -176.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.511 ' HA ' ' H ' ' A' ' 104' ' ' ILE . 1.0 OUTLIER -174.8 152.66 1.61 Allowed 'General case' 0 C--N 1.311 -1.092 0 C-N-CA 119.484 -0.886 . . . . 0.0 112.257 178.052 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.482 ' O ' ' O ' ' A' ' 102' ' ' ASN . 3.2 tt0 -136.42 154.14 50.88 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 114.656 -1.156 . . . . 0.0 113.638 -177.422 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.609 ' HB ' ' HB2' ' A' ' 66' ' ' TRP . 16.4 mt -124.65 131.96 71.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.261 -0.882 . . . . 0.0 109.842 178.623 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -113.32 140.23 48.18 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.975 0.417 . . . . 0.0 111.99 -179.378 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.409 ' CD2' HG21 ' A' ' 33' ' ' VAL . 27.1 tp -125.9 130.66 51.75 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.602 179.116 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.344 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.415 -179.959 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 67.8 tp . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.744 0.307 . . . . 0.0 110.836 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.488 ' HA ' ' O ' ' A' ' 122' ' ' GLN . 3.8 mm? -133.48 147.84 51.68 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.547 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.43 ' O ' ' N ' ' A' ' 122' ' ' GLN . 8.0 mp -117.03 130.67 56.83 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 179.647 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.482 ' O ' ' O ' ' A' ' 90' ' ' GLN . 25.0 t30 -114.84 110.93 20.42 Favored 'General case' 0 CA--C 1.508 -0.64 0 C-N-CA 119.87 -0.732 . . . . 0.0 109.881 179.729 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.57 ' HB3' ' CG2' ' A' ' 109' ' ' THR . 63.0 m-20 -82.9 111.85 19.15 Favored 'General case' 0 N--CA 1.442 -0.841 0 C-N-CA 119.63 -0.828 . . . . 0.0 109.326 179.5 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.962 ' O ' ' C ' ' A' ' 88' ' ' HIS . 0.1 OUTLIER -123.55 108.03 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.997 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 178.028 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.441 ' OG ' ' NE2' ' A' ' 88' ' ' HIS . 75.6 m -128.09 171.34 11.98 Favored 'General case' 0 C--N 1.297 -1.702 0 CA-C-N 114.914 -1.039 . . . . 0.0 109.275 179.673 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 26.6 m -69.24 -62.96 1.17 Allowed 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 119.099 -1.04 . . . . 0.0 111.074 -179.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 5.7 p30 -111.97 -33.66 6.21 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 114.216 1.191 . . . . 0.0 114.216 178.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -147.02 133.09 4.62 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 116.667 1.427 . . . . 0.0 116.667 -178.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.57 ' CG2' ' HB3' ' A' ' 103' ' ' ASP . 8.3 m -121.01 138.29 54.24 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 174.164 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . 0.734 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.4 m-90 -119.3 149.15 42.27 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 -178.387 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.404 ' O ' ' HG ' ' A' ' 111' ' ' LEU . 0.2 OUTLIER -123.74 112.44 17.35 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 114.842 -1.072 . . . . 0.0 108.647 177.66 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 7.1 m-80 46.46 42.93 11.5 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.951 -0.568 . . . . 0.0 112.34 -179.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.04 -6.5 83.19 Favored Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 120.69 -0.767 . . . . 0.0 113.437 178.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 1.8 mm-40 -110.55 104.77 13.53 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.892 0.377 . . . . 0.0 110.963 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.734 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.0 OUTLIER -44.22 127.85 5.78 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.908 179.721 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 12.3 p -111.95 159.45 11.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.779 -179.049 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 14.1 mp0 -70.7 136.86 49.29 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.95 179.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.408 ' O ' ' C ' ' A' ' 119' ' ' ASN . 78.7 tttt -63.09 163.86 9.34 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.296 179.594 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.408 ' C ' ' O ' ' A' ' 118' ' ' LYS . 10.5 m-80 34.43 40.61 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.24 -179.537 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 4.9 p -110.99 110.6 21.23 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.86 -179.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -62.69 133.97 55.63 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.554 179.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . 0.488 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 32.7 mm-40 -129.62 145.62 51.48 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.312 0.577 . . . . 0.0 112.357 -179.602 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.7 tt -72.61 122.77 21.94 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.634 179.018 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.458 ' O ' HD12 ' A' ' 124' ' ' LEU . 0.0 OUTLIER -48.71 148.82 1.96 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 122.067 0.937 . . . . 0.0 112.041 -178.887 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -126.79 153.08 46.07 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 114.195 -1.366 . . . . 0.0 110.153 179.703 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 1.3 mm100 -70.98 113.49 8.08 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 179.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 68.33 28.1 73.44 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.227 -179.096 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -53.86 160.09 1.51 Allowed 'General case' 0 C--O 1.231 0.123 0 CA-C-O 120.963 0.411 . . . . 0.0 111.224 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.49 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 29.0 tt0 -146.66 134.9 21.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.587 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.427 HD12 HG22 ' A' ' 130' ' ' ILE . 7.1 mm -117.56 128.3 74.82 Favored 'Isoleucine or valine' 0 C--O 1.231 0.131 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 178.542 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.504 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 94.6 m -103.49 145.47 29.97 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.632 -179.658 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.499 ' HB ' ' NE2' ' A' ' 88' ' ' HIS . 6.2 m -140.9 157.97 23.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -178.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . 0.403 ' O ' ' O ' ' A' ' 139' ' ' ASP . . . 70.72 40.86 65.02 Favored Glycine 0 N--CA 1.446 -0.637 0 CA-C-N 115.728 -0.669 . . . . 0.0 112.648 179.292 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.422 ' HA ' HG12 ' A' ' 140' ' ' ILE . 94.8 t -76.76 157.17 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 CA-C-O 121.409 0.624 . . . . 0.0 112.005 -179.297 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . 0.407 ' N ' ' CG1' ' A' ' 134' ' ' VAL . . . 152.63 -44.68 0.61 Allowed Glycine 0 N--CA 1.44 -1.037 0 N-CA-C 110.652 -0.979 . . . . 0.0 110.652 -179.271 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 45.3 t -126.75 134.22 66.76 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.739 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 178.66 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 26.9 tp10 -50.87 -34.51 28.4 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.827 0.346 . . . . 0.0 111.464 -179.182 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 37.7 t -93.78 6.23 49.05 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 116.204 -0.453 . . . . 0.0 112.141 -179.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . 0.403 ' O ' ' O ' ' A' ' 133' ' ' GLY . 2.3 t70 -125.77 29.25 5.98 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-O 121.124 0.488 . . . . 0.0 112.169 -179.484 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.504 ' CG2' ' CG2' ' A' ' 131' ' ' THR . 25.7 mt -107.17 141.45 22.34 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.328 179.394 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 12.1 mt -123.41 134.79 53.93 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.037 -0.983 . . . . 0.0 110.633 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.466 ' HB2' ' CG2' ' A' ' 40' ' ' THR . 4.8 m -114.94 153.5 30.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.756 0.788 . . . . 0.0 112.462 -179.352 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.49 ' O ' ' HA ' ' A' ' 129' ' ' GLU . 1.8 tm? -133.83 136.84 44.7 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 114.55 -1.205 . . . . 0.0 109.396 179.701 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 15.0 t -118.04 140.3 41.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.903 0.382 . . . . 0.0 111.801 -179.13 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -108.01 140.3 26.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.776 179.592 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 37.5 t80 -118.4 122.87 43.86 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.96 -179.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 3.0 mp -115.32 130.23 70.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.11 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 23.6 p-10 -75.28 138.0 41.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.993 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -73.64 -30.24 62.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.934 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -57.44 -40.16 77.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.777 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 6.2 t80 . . . . . 0 N--CA 1.451 -0.393 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.917 -179.942 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.757 0.313 . . . . 0.0 110.936 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -109.02 -13.5 14.71 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-O 121.997 0.903 . . . . 0.0 108.626 178.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.598 ' CG2' ' O ' ' A' ' 32' ' ' ILE . 0.1 OUTLIER -70.7 95.57 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.556 0 CA-C-N 113.911 -1.495 . . . . 0.0 110.711 -179.41 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.572 ' CG1' ' N ' ' A' ' 34' ' ' CYS . 0.5 OUTLIER -32.45 -59.94 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 114.874 -1.057 . . . . 0.0 112.379 -179.127 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.572 ' N ' ' CG1' ' A' ' 33' ' ' VAL . 31.7 p -164.29 164.88 22.26 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.529 -179.757 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 5.2 ttm180 -127.11 122.62 34.76 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.077 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.432 HG12 ' CZ ' ' A' ' 68' ' ' PHE . 24.8 t -93.81 131.74 39.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.669 179.536 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.496 ' CG2' HG12 ' A' ' 45' ' ' ILE . 32.9 mt -121.18 108.38 22.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 N-CA-C 112.362 0.505 . . . . 0.0 112.362 -179.326 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -98.6 105.66 17.83 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 177.374 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 8.9 t -113.71 -21.22 10.84 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 113.328 0.862 . . . . 0.0 113.328 -177.496 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.541 HG23 ' HB2' ' A' ' 142' ' ' SER . 44.5 p -55.59 -22.22 21.14 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.874 0.369 . . . . 0.0 111.467 -179.475 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 120.73 64.76 0.25 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.353 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.2 mt-30 -141.75 -70.32 0.36 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.773 0.32 . . . . 0.0 111.205 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.462 HG22 ' CZ ' ' A' ' 76' ' ' TYR . 0.7 OUTLIER -135.16 139.24 31.2 Favored Pre-proline 0 N--CA 1.453 -0.325 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.113 -179.566 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.421 ' O ' ' CE2' ' A' ' 76' ' ' TYR . 26.6 Cg_exo -59.41 147.76 89.83 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.506 2.137 . . . . 0.0 111.379 179.223 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.496 HG12 ' CG2' ' A' ' 37' ' ' ILE . 43.1 mt -36.33 136.04 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 -179.398 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.48 ' CG ' ' CE2' ' A' ' 76' ' ' TYR . 0.0 OUTLIER -123.26 144.87 49.12 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.337 179.306 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -110.11 119.61 39.82 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.977 0.418 . . . . 0.0 111.259 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.554 ' HB3' ' CE2' ' A' ' 66' ' ' TRP . 5.4 mt -98.53 137.88 36.55 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 178.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.57 ' O ' ' HZ2' ' A' ' 66' ' ' TRP . 0.0 OUTLIER -137.8 163.31 31.69 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 113.55 0.944 . . . . 0.0 113.55 -178.646 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.459 ' HB1' HG22 ' A' ' 33' ' ' VAL . . . -138.27 166.03 25.23 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 114.41 -1.268 . . . . 0.0 110.888 179.292 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -92.28 100.52 13.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.943 0.401 . . . . 0.0 111.187 -179.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.3 mt . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.528 -179.962 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 4.5 tttt . . . . . 0 C--O 1.232 0.169 0 CA-C-O 120.922 0.392 . . . . 0.0 110.707 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.448 ' O ' ' CZ3' ' A' ' 66' ' ' TRP . 29.9 ttpt -132.55 118.79 19.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.916 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.442 ' CG2' ' O ' ' A' ' 91' ' ' ILE . 7.9 p -108.61 140.13 28.39 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 CA-C-O 121.37 0.605 . . . . 0.0 112.428 -179.07 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . 0.664 ' HB2' ' HB ' ' A' ' 91' ' ' ILE . 14.3 m-90 -99.93 139.31 35.78 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.099 -0.955 . . . . 0.0 111.325 179.099 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.62 ' N ' ' HB2' ' A' ' 75' ' ' ASP . 10.6 m -127.36 130.07 48.76 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.547 0.689 . . . . 0.0 111.951 179.113 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.559 ' CE1' ' CG ' ' A' ' 75' ' ' ASP . 11.2 m-85 -102.86 118.33 36.59 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.054 -0.976 . . . . 0.0 108.98 178.099 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.634 ' HA2' ' O ' ' A' ' 85' ' ' SER . . . 157.16 -153.95 25.12 Favored Glycine 0 CA--C 1.505 -0.561 0 C-N-CA 118.765 -1.683 . . . . 0.0 113.317 179.32 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 1.6 mtp180 -75.58 91.94 2.88 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-O 122.593 1.187 . . . . 0.0 108.873 -179.299 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.519 ' O ' ' CD2' ' A' ' 77' ' ' HIS . 33.8 m-80 -150.07 159.62 35.06 Favored Pre-proline 0 C--N 1.308 -1.197 0 CA-C-N 112.761 -2.018 . . . . 0.0 108.102 178.708 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.543 ' O ' ' HB2' ' A' ' 77' ' ' HIS . 31.7 Cg_endo -64.85 -6.78 13.28 Favored 'Trans proline' 0 N--CA 1.453 -0.91 0 C-N-CA 120.637 0.891 . . . . 0.0 110.576 177.33 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.601 ' HB1' ' HB2' ' A' ' 77' ' ' HIS . . . 136.36 52.99 0.0 OUTLIER 'General case' 0 CA--C 1.49 -1.337 0 CA-C-N 114.359 -1.292 . . . . 0.0 109.052 178.856 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . 0.551 ' HB3' ' HB ' ' A' ' 67' ' ' THR . 0.1 OUTLIER -52.7 -69.93 0.1 Allowed 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 105.497 -2.038 . . . . 0.0 105.497 179.491 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.62 ' HB2' ' N ' ' A' ' 67' ' ' THR . 60.7 t0 -95.85 -47.0 6.33 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 105.834 -1.913 . . . . 0.0 105.834 169.259 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.48 ' CE2' ' CG ' ' A' ' 46' ' ' ARG . 0.1 OUTLIER -143.63 141.33 30.55 Favored 'General case' 0 C--N 1.348 0.531 0 CA-C-N 112.77 -2.014 . . . . 0.0 111.855 -179.712 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . 0.601 ' HB2' ' HB1' ' A' ' 73' ' ' ALA . 23.7 t-160 -97.21 106.15 18.42 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 176.306 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.1 pp -123.11 175.52 6.59 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.919 0.39 . . . . 0.0 111.512 -179.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -53.54 -179.76 0.12 Allowed Glycine 0 C--N 1.333 0.369 0 C-N-CA 121.015 -0.612 . . . . 0.0 112.573 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.432 ' HA ' ' OD1' ' A' ' 86' ' ' ASN . 5.0 p30 -111.61 98.47 7.45 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.785 0.326 . . . . 0.0 111.582 -179.708 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.652 ' HB ' ' HB2' ' A' ' 85' ' ' SER . 15.0 mm -114.7 117.52 55.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.701 178.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 43.4 t -54.97 -24.18 22.7 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 111.82 0.304 . . . . 0.0 111.82 -179.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 3.3 mpt_? -92.44 -102.25 0.12 Allowed 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -179.095 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.439 ' O ' ' HB2' ' A' ' 85' ' ' SER . 0.0 OUTLIER -108.96 109.76 20.9 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-O 121.631 0.729 . . . . 0.0 110.512 -179.702 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.652 ' HB2' ' HB ' ' A' ' 81' ' ' ILE . 0.3 OUTLIER 161.38 -46.0 0.0 OUTLIER 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 114.128 -1.397 . . . . 0.0 109.201 -179.92 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.814 ' O ' ' N ' ' A' ' 88' ' ' HIS . 88.3 m-20 -66.44 -153.44 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 177.658 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 17.2 pttm -49.37 73.64 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 179.095 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 1.053 ' O ' ' O ' ' A' ' 104' ' ' ILE . 36.9 t60 -95.0 -16.5 22.7 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 114.307 1.225 . . . . 0.0 114.307 -176.854 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.51 ' HA ' ' H ' ' A' ' 104' ' ' ILE . 0.2 OUTLIER -177.39 157.04 1.26 Allowed 'General case' 0 C--N 1.316 -0.881 0 C-N-CA 119.127 -1.029 . . . . 0.0 112.529 178.264 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.47 ' O ' ' O ' ' A' ' 102' ' ' ASN . 17.4 mt-30 -137.74 161.81 35.54 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 -177.348 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.664 ' HB ' ' HB2' ' A' ' 66' ' ' TRP . 4.7 mt -128.33 132.66 67.99 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 CA-C-N 114.913 -1.039 . . . . 0.0 110.041 178.754 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.425 ' O ' ' O ' ' A' ' 100' ' ' LEU . 0.0 OUTLIER -120.52 128.92 53.55 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.851 0.358 . . . . 0.0 111.963 -179.414 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.475 ' HG ' ' CG1' ' A' ' 33' ' ' VAL . 4.2 mm? -125.71 133.63 52.06 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.842 179.171 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.269 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.425 179.965 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.403 ' HA ' ' CD1' ' A' ' 93' ' ' LEU . 2.1 mp . . . . . 0 N--CA 1.456 -0.13 0 CA-C-O 120.655 0.264 . . . . 0.0 110.807 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.616 ' HA ' ' O ' ' A' ' 122' ' ' GLN . 3.6 mm? -133.97 148.05 51.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.784 0.326 . . . . 0.0 111.029 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.416 ' O ' ' N ' ' A' ' 122' ' ' GLN . 3.0 mm? -112.79 131.71 55.57 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 179.203 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.47 ' O ' ' O ' ' A' ' 90' ' ' GLN . 9.7 t30 -109.06 111.96 23.88 Favored 'General case' 0 CA--C 1.508 -0.665 0 C-N-CA 119.742 -0.783 . . . . 0.0 109.963 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.574 ' HB3' ' CG2' ' A' ' 109' ' ' THR . 31.2 m-20 -86.24 110.65 19.77 Favored 'General case' 0 N--CA 1.44 -0.928 0 C-N-CA 119.319 -0.952 . . . . 0.0 109.231 179.274 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 1.053 ' O ' ' O ' ' A' ' 88' ' ' HIS . 0.1 OUTLIER -123.84 108.5 20.91 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.07 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 177.44 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.431 ' OG ' ' NE2' ' A' ' 88' ' ' HIS . 73.8 m -133.37 169.32 17.1 Favored 'General case' 0 C--N 1.293 -1.858 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.59 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 21.4 m -69.29 -63.05 1.14 Allowed 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 119.061 -1.056 . . . . 0.0 111.328 -179.149 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -112.12 -33.38 6.26 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 114.576 1.324 . . . . 0.0 114.576 179.078 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -146.94 132.64 4.45 Favored Glycine 0 C--N 1.34 0.795 0 N-CA-C 116.875 1.51 . . . . 0.0 116.875 -178.078 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.574 ' CG2' ' HB3' ' A' ' 103' ' ' ASP . 13.3 m -121.28 137.94 54.46 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 174.386 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . 0.695 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 3.0 m-90 -121.61 148.82 44.04 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 113.599 0.963 . . . . 0.0 113.599 -178.506 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.403 ' O ' ' HG ' ' A' ' 111' ' ' LEU . 0.2 OUTLIER -123.26 112.33 17.51 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 114.969 -1.014 . . . . 0.0 108.637 177.61 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 71.6 m-20 44.71 44.28 7.38 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.032 -0.531 . . . . 0.0 112.213 -179.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 79.75 24.18 60.73 Favored Glycine 0 N--CA 1.445 -0.763 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.739 179.295 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -136.43 97.9 3.69 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.113 0.483 . . . . 0.0 110.819 179.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.695 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.0 OUTLIER -44.63 129.03 6.87 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.969 179.826 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 15.0 p -118.82 162.07 17.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.671 -178.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -70.47 142.05 51.97 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.068 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 49.2 tttm -65.42 162.93 16.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.396 179.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 4.1 p30 35.55 37.44 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.313 0.578 . . . . 0.0 111.354 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 5.0 p -111.27 109.49 19.54 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.953 -179.488 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -59.76 139.5 57.24 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.808 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . 0.616 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 29.9 mm-40 -129.25 148.23 51.16 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.878 0.37 . . . . 0.0 111.925 -179.677 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -71.61 131.78 43.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.026 -0.534 . . . . 0.0 109.933 179.463 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.483 ' O ' HD13 ' A' ' 124' ' ' LEU . 0.0 OUTLIER -55.18 147.2 16.88 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 122.258 1.028 . . . . 0.0 112.248 -178.747 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' SER . . . . . 0.426 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.5 OUTLIER -127.16 153.38 46.12 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 113.79 -1.55 . . . . 0.0 109.898 179.143 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 4.8 mm-40 -70.81 113.12 7.56 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 179.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 63.05 31.87 82.19 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.019 -179.207 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.426 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 30.2 t70 -51.71 160.51 0.64 Allowed 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 121.015 0.436 . . . . 0.0 111.584 -179.571 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -146.47 135.43 22.48 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.17 179.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.428 ' CG2' ' O ' ' A' ' 110' ' ' TRP . 2.6 mp -114.61 128.76 71.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-O 120.802 0.334 . . . . 0.0 110.396 179.151 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.464 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 59.9 m -102.93 145.05 30.42 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.341 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.475 ' HB ' ' NE2' ' A' ' 88' ' ' HIS . 4.8 m -141.01 158.3 23.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -178.582 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 67.11 43.21 90.79 Favored Glycine 0 N--CA 1.447 -0.59 0 CA-C-N 115.621 -0.718 . . . . 0.0 112.334 179.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.476 ' HA ' HG12 ' A' ' 140' ' ' ILE . 90.8 t -78.85 156.43 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 CA-C-O 121.49 0.662 . . . . 0.0 112.275 -179.163 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 147.4 -42.89 0.87 Allowed Glycine 0 N--CA 1.441 -0.984 0 CA-C-N 114.843 -1.072 . . . . 0.0 110.553 -178.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 47.4 t -126.77 128.13 70.66 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.723 0 CA-C-N 115.157 -0.522 . . . . 0.0 109.796 178.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 8.6 tt0 -51.13 -30.14 15.59 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.802 0.334 . . . . 0.0 111.279 -179.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 28.2 t -94.2 6.46 48.55 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -179.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -131.03 29.27 4.71 Favored 'General case' 0 CA--C 1.52 -0.182 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -179.346 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.476 HG12 ' HA ' ' A' ' 134' ' ' VAL . 18.9 mt -105.55 140.97 21.95 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.33 179.103 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 5.4 mp -121.49 134.67 55.07 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 114.971 -1.013 . . . . 0.0 109.846 179.297 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.541 ' HB2' HG23 ' A' ' 40' ' ' THR . 0.9 OUTLIER -119.1 149.73 41.2 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.676 0.751 . . . . 0.0 112.757 -178.721 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 4.7 mp -125.34 150.68 46.94 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 114.843 -1.071 . . . . 0.0 109.193 179.372 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 12.1 t -126.87 141.09 47.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 120.904 0.383 . . . . 0.0 111.842 -179.276 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -122.72 125.92 73.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.069 179.436 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -115.58 121.38 42.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.961 0.41 . . . . 0.0 111.248 -179.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 3.0 mm -104.04 130.03 55.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.788 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . 0.42 ' ND2' ' O ' ' A' ' 32' ' ' ILE . 6.2 p30 -77.42 130.75 37.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.85 0.357 . . . . 0.0 110.78 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -73.02 -22.96 60.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.398 -179.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 1.3 mptp? -57.34 -40.62 78.36 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.913 0.387 . . . . 0.0 110.699 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 4.1 t80 . . . . . 0 N--CA 1.452 -0.345 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.724 179.801 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 8.3 pm0 . . . . . 0 CA--C 1.529 0.142 0 N-CA-C 111.687 0.254 . . . . 0.0 111.687 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 11.3 m-80 -108.75 -14.56 14.58 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-O 121.918 0.866 . . . . 0.0 109.017 178.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.508 ' CG2' ' O ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -74.08 105.91 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.533 0 CA-C-N 113.919 -1.491 . . . . 0.0 110.664 -179.6 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.577 ' CG1' ' N ' ' A' ' 34' ' ' CYS . 0.5 OUTLIER -40.26 -62.65 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.712 -179.105 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.577 ' N ' ' CG1' ' A' ' 33' ' ' VAL . 31.1 p -164.92 164.96 20.67 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.505 -179.78 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 12.0 ttm180 -126.78 122.4 34.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.842 0.353 . . . . 0.0 111.176 179.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.401 HG11 ' CZ ' ' A' ' 68' ' ' PHE . 18.8 t -93.12 124.34 45.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.616 179.643 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.483 ' CG2' HG12 ' A' ' 45' ' ' ILE . 35.6 mt -121.51 108.49 22.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 112.254 0.464 . . . . 0.0 112.254 -179.178 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 14.6 t -80.28 103.92 10.48 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 177.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.9 p -99.34 22.18 10.98 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 112.454 0.538 . . . . 0.0 112.454 -178.347 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.401 ' CG2' ' HB2' ' A' ' 142' ' ' SER . 45.5 p -114.21 -13.14 12.4 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 111.657 0.244 . . . . 0.0 111.657 179.78 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 95.63 75.54 1.27 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.602 -0.808 . . . . 0.0 112.616 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 -150.97 -55.68 0.15 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.774 0.321 . . . . 0.0 110.983 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.427 HG22 ' CD2' ' A' ' 76' ' ' TYR . 2.0 mt -134.71 131.14 20.04 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.833 -179.697 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.427 ' HD2' ' CZ ' ' A' ' 76' ' ' TYR . 37.3 Cg_exo -58.87 147.1 90.79 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.569 2.18 . . . . 0.0 111.682 179.721 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.483 HG12 ' CG2' ' A' ' 37' ' ' ILE . 51.9 mt -42.39 128.97 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 121.03 0.443 . . . . 0.0 112.064 -179.363 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.41 ' HG2' ' O ' ' A' ' 75' ' ' ASP . 0.9 OUTLIER -123.54 130.13 52.22 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.935 179.295 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -95.14 120.16 34.89 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.095 0.474 . . . . 0.0 111.664 -179.13 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.598 ' HB3' ' CE2' ' A' ' 66' ' ' TRP . 1.6 mt -94.63 126.73 40.12 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.387 178.821 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.499 ' O ' ' HZ2' ' A' ' 66' ' ' TRP . 0.0 OUTLIER -119.62 162.08 19.58 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 122.102 0.953 . . . . 0.0 113.171 -178.731 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.477 ' CB ' ' CG2' ' A' ' 33' ' ' VAL . . . -116.47 166.17 12.39 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 114.47 -1.241 . . . . 0.0 111.011 179.596 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -103.99 57.97 0.72 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.098 0.475 . . . . 0.0 110.755 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.446 HG22 HD12 ' A' ' 52' ' ' ILE . 46.2 mt . . . . . 0 C--N 1.327 -0.395 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.9 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 10.1 ttmt . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.837 0.351 . . . . 0.0 111.201 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 3.7 ttpt -136.79 134.03 36.6 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.183 179.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.44 ' CG1' ' O ' ' A' ' 91' ' ' ILE . 3.4 t -123.29 134.6 65.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.214 0.531 . . . . 0.0 112.01 -178.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . 0.606 ' HB2' ' HB ' ' A' ' 91' ' ' ILE . 12.3 m-90 -100.95 138.86 37.43 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.727 179.2 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.589 ' N ' ' HB2' ' A' ' 75' ' ' ASP . 1.3 m -131.75 127.71 37.36 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.31 0.576 . . . . 0.0 112.315 179.436 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.513 ' CE1' ' CE2' ' A' ' 89' ' ' PHE . 96.2 m-85 -98.32 117.83 33.61 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.423 178.011 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.652 ' HA2' ' O ' ' A' ' 85' ' ' SER . . . 158.9 -157.95 28.94 Favored Glycine 0 CA--C 1.503 -0.716 0 C-N-CA 119.001 -1.571 . . . . 0.0 112.683 179.1 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 7.8 ptm180 -76.13 91.92 3.18 Favored 'General case' 0 N--CA 1.441 -0.911 0 CA-C-O 122.614 1.197 . . . . 0.0 108.302 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.483 ' O ' ' CD2' ' A' ' 77' ' ' HIS . 0.1 OUTLIER -149.71 160.4 34.09 Favored Pre-proline 0 C--N 1.309 -1.188 0 CA-C-N 112.787 -2.006 . . . . 0.0 108.261 179.608 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.544 ' O ' ' CB ' ' A' ' 73' ' ' ALA . 29.3 Cg_endo -63.0 -11.04 22.75 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 120.869 1.046 . . . . 0.0 111.03 178.479 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.633 ' HB1' ' HB2' ' A' ' 77' ' ' HIS . . . 137.82 52.32 0.0 OUTLIER 'General case' 0 CA--C 1.491 -1.297 0 CA-C-N 114.743 -1.117 . . . . 0.0 109.685 178.548 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . 0.539 ' CB ' ' HB ' ' A' ' 67' ' ' THR . 0.1 OUTLIER -53.12 -69.92 0.1 Allowed 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 105.957 -1.868 . . . . 0.0 105.957 179.347 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.589 ' HB2' ' N ' ' A' ' 67' ' ' THR . 5.8 t0 -94.26 -47.45 6.62 Favored 'General case' 0 N--CA 1.436 -1.153 0 N-CA-C 105.743 -1.947 . . . . 0.0 105.743 169.754 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.536 ' C ' ' HA ' ' A' ' 73' ' ' ALA . 10.6 t80 -143.37 143.12 31.52 Favored 'General case' 0 C--N 1.344 0.356 0 CA-C-N 112.386 -2.188 . . . . 0.0 110.728 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . 0.633 ' HB2' ' HB1' ' A' ' 73' ' ' ALA . 19.4 t-160 -84.54 114.1 21.71 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.33 -0.548 . . . . 0.0 110.309 177.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 87.2 mt -126.58 166.19 17.76 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.869 0.366 . . . . 0.0 111.099 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -66.02 -166.71 2.06 Favored Glycine 0 C--N 1.33 0.228 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.212 179.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -111.35 99.1 7.96 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.932 0.396 . . . . 0.0 111.245 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.49 ' HB ' ' HB2' ' A' ' 85' ' ' SER . 29.7 mm -113.84 133.63 59.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.811 179.34 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 5.7 p -66.6 -41.91 87.7 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.794 0.665 . . . . 0.0 112.794 -179.449 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -83.12 -105.76 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 113.11 0.781 . . . . 0.0 113.11 -177.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.467 ' CD1' ' N ' ' A' ' 84' ' ' LEU . 0.0 OUTLIER -107.69 114.6 28.67 Favored 'General case' 0 CA--C 1.511 -0.554 0 CA-C-O 121.637 0.732 . . . . 0.0 109.179 -179.8 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.652 ' O ' ' HA2' ' A' ' 69' ' ' GLY . 0.5 OUTLIER 156.34 -36.25 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 114.054 -1.43 . . . . 0.0 107.885 -178.839 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.802 ' O ' ' N ' ' A' ' 88' ' ' HIS . 0.1 OUTLIER -61.85 -161.56 0.01 OUTLIER 'General case' 0 CA--C 1.51 -0.566 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 176.743 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.505 ' HA ' ' HA3' ' A' ' 69' ' ' GLY . 0.0 OUTLIER -53.63 72.53 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 177.091 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.928 ' O ' ' O ' ' A' ' 104' ' ' ILE . 28.3 t60 -77.66 -16.32 58.6 Favored 'General case' 0 CA--C 1.515 -0.376 0 N-CA-C 113.858 1.059 . . . . 0.0 113.858 -176.406 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.513 ' CE2' ' CE1' ' A' ' 68' ' ' PHE . 0.2 OUTLIER -173.47 154.84 2.67 Favored 'General case' 0 C--N 1.308 -1.232 0 C-N-CA 119.307 -0.957 . . . . 0.0 112.549 177.914 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.482 ' O ' ' O ' ' A' ' 102' ' ' ASN . 2.8 tt0 -136.28 155.66 49.77 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.732 -1.122 . . . . 0.0 113.533 -177.448 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.606 ' HB ' ' HB2' ' A' ' 66' ' ' TRP . 25.4 mt -127.42 132.46 69.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 115.256 -0.883 . . . . 0.0 110.224 179.231 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.404 ' O ' ' O ' ' A' ' 100' ' ' LEU . 0.1 OUTLIER -117.29 125.35 50.94 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.946 0.403 . . . . 0.0 111.365 179.792 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -127.19 140.11 52.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.599 179.265 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.31 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.529 -179.98 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.703 0.287 . . . . 0.0 110.552 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.627 ' HA ' ' O ' ' A' ' 122' ' ' GLN . 6.5 mt -133.76 148.5 51.4 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.028 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.455 ' O ' ' N ' ' A' ' 122' ' ' GLN . 41.3 mt -116.31 129.77 56.43 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 179.205 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.482 ' O ' ' O ' ' A' ' 90' ' ' GLN . 18.1 t30 -110.56 110.78 21.63 Favored 'General case' 0 CA--C 1.508 -0.637 0 C-N-CA 119.611 -0.836 . . . . 0.0 110.105 -179.793 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.597 ' HB3' ' CG2' ' A' ' 109' ' ' THR . 58.4 m-20 -83.57 111.11 18.8 Favored 'General case' 0 N--CA 1.441 -0.888 0 C-N-CA 119.647 -0.821 . . . . 0.0 108.883 179.157 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.928 ' O ' ' O ' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -124.08 107.69 19.16 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.9 0 CA-C-O 121.6 0.714 . . . . 0.0 109.188 178.203 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.428 ' OG ' ' NE2' ' A' ' 88' ' ' HIS . 43.4 m -131.33 172.28 12.36 Favored 'General case' 0 C--N 1.297 -1.706 0 CA-C-N 114.867 -1.061 . . . . 0.0 109.142 179.504 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 19.6 m -69.62 -63.63 1.03 Allowed 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 119.092 -1.043 . . . . 0.0 111.906 -178.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -112.41 -32.26 6.55 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 114.755 1.391 . . . . 0.0 114.755 179.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -145.57 126.55 2.59 Favored Glycine 0 C--N 1.338 0.685 0 N-CA-C 116.849 1.5 . . . . 0.0 116.849 -177.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.597 ' CG2' ' HB3' ' A' ' 103' ' ' ASP . 3.3 m -121.12 138.16 54.32 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 174.522 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . 0.683 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 3.1 m-90 -121.76 149.37 43.39 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 113.393 0.886 . . . . 0.0 113.393 -178.231 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.2 mt -124.06 112.1 16.75 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.068 -0.969 . . . . 0.0 109.021 177.157 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 10.1 m-80 50.13 35.72 10.76 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.541 -179.223 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 82.57 26.09 48.01 Favored Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.64 179.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -133.08 96.83 3.85 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.009 0.433 . . . . 0.0 110.743 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.683 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.0 OUTLIER -46.52 134.61 9.18 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.01 179.82 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 12.6 p -135.14 165.45 30.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.227 -179.254 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.407 ' O ' ' HB3' ' A' ' 120' ' ' SER . 0.3 OUTLIER -69.6 142.69 53.48 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.256 179.746 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.47 ' HG3' ' ND2' ' A' ' 119' ' ' ASN . 12.8 ptmt -68.42 169.68 10.32 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.792 0.329 . . . . 0.0 110.92 -179.65 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.47 ' ND2' ' HG3' ' A' ' 118' ' ' LYS . 21.8 p30 33.86 37.58 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.192 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.407 ' HB3' ' O ' ' A' ' 117' ' ' GLU . 0.1 OUTLIER -111.8 107.9 17.12 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.671 179.406 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -47.67 138.45 8.22 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 120.598 0.237 . . . . 0.0 110.951 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . 0.627 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 71.9 mm-40 -126.84 148.5 49.97 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-O 121.144 0.497 . . . . 0.0 111.857 -179.684 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -73.98 112.08 9.75 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.585 178.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.409 ' CD1' HG12 ' A' ' 147' ' ' ILE . 6.6 tt -46.99 145.75 1.95 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.789 0.804 . . . . 0.0 112.06 -178.693 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -126.67 153.23 45.68 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 114.185 -1.37 . . . . 0.0 110.272 179.638 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 8.0 mm100 -71.24 113.68 8.52 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 179.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 68.47 28.38 73.25 Favored Glycine 0 N--CA 1.445 -0.72 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.18 -179.145 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -55.1 160.56 2.04 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.987 0.422 . . . . 0.0 111.434 -179.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.436 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 1.3 tm-20 -146.4 135.58 22.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.249 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.423 ' CG2' ' O ' ' A' ' 110' ' ' TRP . 1.3 mp -112.38 129.05 68.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.415 179.047 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.454 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 16.0 m -103.02 142.26 34.4 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.835 -179.513 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.425 ' HB ' ' NE2' ' A' ' 88' ' ' HIS . 4.3 m -140.85 153.26 20.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.187 -0.461 . . . . 0.0 112.004 -179.021 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 75.52 35.8 45.9 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 121.111 -0.566 . . . . 0.0 112.367 179.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.42 ' HA ' HG12 ' A' ' 140' ' ' ILE . 78.9 t -71.68 155.61 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 CA-C-O 121.468 0.651 . . . . 0.0 112.127 -179.306 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 153.44 -45.77 0.57 Allowed Glycine 0 N--CA 1.443 -0.863 0 CA-C-N 115.003 -0.998 . . . . 0.0 110.707 -179.164 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 62.0 t -126.71 134.85 65.32 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 CA-C-N 115.258 -0.471 . . . . 0.0 109.744 178.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 16.3 tm-20 -51.28 -34.38 32.72 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.83 0.347 . . . . 0.0 111.26 -179.293 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 76.7 p -94.11 6.4 48.67 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 116.246 -0.434 . . . . 0.0 112.06 -179.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -126.38 30.66 5.54 Favored 'General case' 0 CA--C 1.518 -0.257 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -179.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.454 ' CG2' ' CG2' ' A' ' 131' ' ' THR . 20.9 mt -107.23 140.91 23.82 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.304 179.213 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -120.43 135.43 55.05 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 114.874 -1.057 . . . . 0.0 110.005 179.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.41 ' HA ' ' HA ' ' A' ' 131' ' ' THR . 4.2 m -125.13 152.35 44.53 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.848 0.833 . . . . 0.0 113.094 -178.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.436 ' O ' ' HA ' ' A' ' 129' ' ' GLU . 6.5 mp -125.82 146.21 49.89 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.323 -1.308 . . . . 0.0 109.033 178.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 21.7 t -131.16 140.28 48.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 120.838 0.351 . . . . 0.0 111.793 -179.083 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -111.04 139.64 34.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.743 179.552 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 47.4 t80 -119.14 104.24 10.26 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.689 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . 0.409 HG12 ' CD1' ' A' ' 124' ' ' LEU . 1.2 mp -98.15 129.72 47.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.241 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 14.7 p30 -83.37 133.1 34.96 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.953 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -67.83 -20.65 65.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.13 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.71 -43.1 84.98 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.935 0.398 . . . . 0.0 110.61 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . 0.428 ' CE2' HD13 ' A' ' 52' ' ' ILE . 13.2 t80 . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.816 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 . . . . . 0 CA--C 1.527 0.088 0 CA-C-O 120.617 0.246 . . . . 0.0 111.39 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 43.6 m-20 -108.74 -14.53 14.58 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-O 121.904 0.859 . . . . 0.0 108.95 178.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.457 ' O ' ' CG2' ' A' ' 32' ' ' ILE . 0.1 OUTLIER -75.07 110.62 10.09 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.636 0 CA-C-N 113.991 -1.459 . . . . 0.0 111.088 -179.557 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.626 ' CG1' ' N ' ' A' ' 34' ' ' CYS . 0.5 OUTLIER -41.18 -63.66 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.406 -179.49 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.626 ' N ' ' CG1' ' A' ' 33' ' ' VAL . 23.4 p -166.21 165.05 17.77 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.519 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 3.6 ttm180 -121.95 120.39 34.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.877 179.491 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.408 HG21 HD11 ' A' ' 48' ' ' LEU . 40.1 t -89.13 124.75 42.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.95 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.463 ' CG2' HG12 ' A' ' 45' ' ' ILE . 30.0 mt -124.58 108.12 19.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.65 -179.741 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 3.4 m -90.48 100.96 13.7 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 178.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 7.0 t -80.21 -27.19 38.85 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 -178.184 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.417 ' OG1' ' O ' ' A' ' 142' ' ' SER . 0.1 OUTLIER -51.54 -27.17 10.09 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.997 0.427 . . . . 0.0 111.023 -179.679 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 97.41 36.94 4.7 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.384 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 18.9 pt20 -106.0 -46.85 3.99 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.853 0.358 . . . . 0.0 110.908 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.422 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 7.1 mt -133.53 132.53 21.9 Favored Pre-proline 0 N--CA 1.451 -0.414 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.19 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.507 ' HD2' ' CZ ' ' A' ' 76' ' ' TYR . 27.3 Cg_exo -59.63 147.37 92.19 Favored 'Trans proline' 0 C--O 1.232 0.214 0 C-N-CA 122.763 2.309 . . . . 0.0 111.904 179.535 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.463 HG12 ' CG2' ' A' ' 37' ' ' ILE . 44.2 mt -43.6 139.0 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.83 -179.702 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.1 140.81 46.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.37 179.67 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -108.34 120.23 41.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.112 0.482 . . . . 0.0 111.632 -179.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.546 ' HG ' ' CD1' ' A' ' 66' ' ' TRP . 3.0 mp -98.82 125.2 44.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.156 178.796 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.518 ' O ' ' CZ2' ' A' ' 66' ' ' TRP . 0.0 OUTLIER -111.26 163.11 14.28 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 122.041 0.924 . . . . 0.0 113.338 -178.545 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.486 ' CB ' ' CG2' ' A' ' 33' ' ' VAL . . . -123.45 166.19 15.8 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 114.632 -1.167 . . . . 0.0 111.22 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -111.21 71.69 0.75 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.287 179.477 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 92.3 mt . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.401 -179.56 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 11.0 tttm . . . . . 0 C--O 1.23 0.036 0 CA-C-O 120.902 0.382 . . . . 0.0 111.013 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.408 ' O ' ' HB3' ' A' ' 93' ' ' LEU . 17.0 ttpt -136.1 130.64 33.67 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.635 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.44 ' CG1' ' O ' ' A' ' 91' ' ' ILE . 15.3 t -135.2 137.93 49.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.113 0.482 . . . . 0.0 111.894 -179.29 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . 0.608 ' HB2' ' HB ' ' A' ' 91' ' ' ILE . 15.5 m-90 -100.61 140.15 35.28 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.607 179.175 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.571 ' N ' ' HB2' ' A' ' 75' ' ' ASP . 7.8 m -125.78 127.41 46.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.544 0.687 . . . . 0.0 112.329 179.46 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.513 ' HD2' ' CD2' ' A' ' 89' ' ' PHE . 44.7 m-85 -101.03 118.57 37.25 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.114 -0.948 . . . . 0.0 108.927 177.808 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.591 ' HA2' ' O ' ' A' ' 85' ' ' SER . . . 160.0 -157.66 28.95 Favored Glycine 0 CA--C 1.503 -0.665 0 C-N-CA 119.117 -1.516 . . . . 0.0 112.419 179.499 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.409 ' N ' ' HA ' ' A' ' 86' ' ' ASN . 0.5 OUTLIER -76.74 92.17 3.54 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-O 122.554 1.168 . . . . 0.0 108.912 -179.712 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.524 ' O ' ' CD2' ' A' ' 77' ' ' HIS . 6.1 m-80 -149.59 155.19 38.76 Favored Pre-proline 0 C--N 1.308 -1.197 0 CA-C-N 112.809 -1.996 . . . . 0.0 108.259 178.72 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.551 ' O ' ' CB ' ' A' ' 73' ' ' ALA . 24.5 Cg_exo -55.79 -10.23 3.72 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 121.277 1.318 . . . . 0.0 111.278 177.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.603 ' HB1' ' HB2' ' A' ' 77' ' ' HIS . . . 135.99 52.23 0.0 OUTLIER 'General case' 0 CA--C 1.49 -1.336 0 CA-C-N 114.999 -1.0 . . . . 0.0 109.375 178.792 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . 0.545 ' HB3' ' HB ' ' A' ' 67' ' ' THR . 0.1 OUTLIER -52.97 -69.62 0.11 Allowed 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 105.867 -1.901 . . . . 0.0 105.867 179.524 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.571 ' HB2' ' N ' ' A' ' 67' ' ' THR . 40.1 t0 -94.93 -47.74 6.3 Favored 'General case' 0 N--CA 1.435 -1.211 0 N-CA-C 105.687 -1.968 . . . . 0.0 105.687 169.755 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.507 ' CZ ' ' HD2' ' A' ' 44' ' ' PRO . 33.0 t80 -145.01 142.7 30.01 Favored 'General case' 0 C--N 1.347 0.485 0 CA-C-N 112.573 -2.103 . . . . 0.0 111.473 179.366 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . 0.603 ' HB2' ' HB1' ' A' ' 73' ' ' ALA . 23.7 t-160 -93.79 107.28 19.19 Favored 'General case' 0 C--N 1.33 -0.249 0 O-C-N 122.014 -0.429 . . . . 0.0 109.968 176.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.426 ' HB3' ' CE1' ' A' ' 76' ' ' TYR . 3.8 pp -121.82 172.61 8.04 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 120.96 0.409 . . . . 0.0 111.645 -179.691 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -57.86 -172.65 0.3 Allowed Glycine 0 C--N 1.333 0.383 0 CA-C-N 115.916 -0.584 . . . . 0.0 112.595 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.425 ' HA ' ' OD1' ' A' ' 86' ' ' ASN . 0.3 OUTLIER -111.94 98.11 7.15 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -179.64 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.649 ' HB ' ' HB2' ' A' ' 85' ' ' SER . 16.7 mt -114.79 113.96 45.18 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.252 178.41 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 5.8 m -54.7 -24.12 20.6 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 112.587 0.588 . . . . 0.0 112.587 -178.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.58 -102.22 0.13 Allowed 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 -178.743 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.416 ' O ' ' CB ' ' A' ' 85' ' ' SER . 0.0 OUTLIER -109.23 110.45 21.66 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-O 121.682 0.753 . . . . 0.0 110.537 -179.391 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.649 ' HB2' ' HB ' ' A' ' 81' ' ' ILE . 0.5 OUTLIER 160.43 -46.84 0.0 OUTLIER 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 114.205 -1.362 . . . . 0.0 109.489 179.875 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.817 ' O ' ' N ' ' A' ' 88' ' ' HIS . 93.9 m-20 -64.8 -153.99 0.01 OUTLIER 'General case' 0 CA--C 1.521 -0.165 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 178.128 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.416 ' HA ' ' HA3' ' A' ' 69' ' ' GLY . 7.9 ptmt -49.31 73.44 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 179.099 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.971 ' O ' ' O ' ' A' ' 104' ' ' ILE . 31.2 t60 -95.67 -18.64 20.35 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 114.299 1.222 . . . . 0.0 114.299 -176.517 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.54 ' HA ' ' H ' ' A' ' 104' ' ' ILE . 0.2 OUTLIER -172.98 153.24 2.53 Favored 'General case' 0 C--N 1.31 -1.115 0 C-N-CA 119.014 -1.074 . . . . 0.0 112.489 178.063 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.49 ' O ' ' O ' ' A' ' 102' ' ' ASN . 20.1 mt-30 -134.1 159.23 41.48 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 114.38 -1.282 . . . . 0.0 113.483 -177.322 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.608 ' HB ' ' HB2' ' A' ' 66' ' ' TRP . 2.8 mt -124.71 131.88 72.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.113 -0.948 . . . . 0.0 110.213 179.013 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.45 ' N ' ' O ' ' A' ' 100' ' ' LEU . 0.3 OUTLIER -107.38 145.09 33.34 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.036 0.446 . . . . 0.0 111.935 -179.623 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.408 ' HB3' ' O ' ' A' ' 64' ' ' LYS . 0.3 OUTLIER -125.73 128.73 48.21 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.47 179.324 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.299 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.46 179.872 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 9.7 tt . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.839 0.352 . . . . 0.0 110.893 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.615 ' HA ' ' O ' ' A' ' 122' ' ' GLN . 4.5 mp -133.4 149.25 51.82 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.53 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.472 ' O ' ' N ' ' A' ' 122' ' ' GLN . 4.9 mp -114.81 128.92 56.58 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.756 -0.378 . . . . 0.0 110.101 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.49 ' O ' ' O ' ' A' ' 90' ' ' GLN . 27.9 t30 -110.47 111.21 22.31 Favored 'General case' 0 CA--C 1.509 -0.619 0 C-N-CA 119.76 -0.776 . . . . 0.0 109.766 179.47 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.557 ' HB3' ' CG2' ' A' ' 109' ' ' THR . 83.7 m-20 -84.74 112.65 20.68 Favored 'General case' 0 N--CA 1.444 -0.772 0 C-N-CA 119.865 -0.734 . . . . 0.0 109.887 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.971 ' O ' ' O ' ' A' ' 88' ' ' HIS . 0.1 OUTLIER -122.91 107.5 19.44 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.925 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 177.473 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.413 ' OG ' ' NE2' ' A' ' 88' ' ' HIS . 55.7 m -134.79 164.53 27.34 Favored 'General case' 0 C--N 1.295 -1.797 0 CA-C-N 115.011 -0.995 . . . . 0.0 109.432 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 19.9 m -69.4 -62.69 1.28 Allowed 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 119.207 -0.997 . . . . 0.0 111.789 -178.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -111.79 -32.64 6.56 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 115.218 1.562 . . . . 0.0 115.218 179.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -146.18 127.64 2.83 Favored Glycine 0 C--N 1.339 0.747 0 N-CA-C 117.36 1.704 . . . . 0.0 117.36 -177.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.557 ' CG2' ' HB3' ' A' ' 103' ' ' ASP . 7.5 m -121.36 138.12 54.4 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 174.289 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . 0.694 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 3.4 m-90 -122.89 149.21 44.51 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 113.532 0.938 . . . . 0.0 113.532 -178.552 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -123.95 112.18 16.91 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 114.917 -1.038 . . . . 0.0 108.451 177.5 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 15.9 m-20 44.37 44.46 6.84 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.065 -0.516 . . . . 0.0 112.109 -179.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 79.89 26.4 56.02 Favored Glycine 0 N--CA 1.444 -0.792 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.779 179.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -138.62 96.8 3.21 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.079 0.466 . . . . 0.0 110.78 179.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.694 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.0 OUTLIER -44.37 129.08 6.48 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.964 179.806 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 27.6 m -115.91 -178.74 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.133 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.971 -178.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -91.61 142.23 27.86 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.086 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.428 ' HG3' ' HA ' ' A' ' 104' ' ' ILE . 49.1 tttm -63.72 162.35 13.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.27 179.381 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.406 ' N ' ' HG2' ' A' ' 118' ' ' LYS . 4.3 p30 34.58 39.13 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.268 0.556 . . . . 0.0 111.264 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 9.5 p -111.24 106.58 15.62 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.07 -179.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -54.68 143.6 24.53 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.64 179.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . 0.615 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 30.9 mm-40 -129.74 145.62 51.54 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.98 0.419 . . . . 0.0 112.005 -179.467 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.8 tt -72.87 121.33 19.82 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.526 178.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 12.1 tp -47.76 142.39 4.74 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-O 122.027 0.918 . . . . 0.0 112.186 -178.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' SER . . . . . 0.436 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.3 OUTLIER -127.51 152.62 47.35 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 113.895 -1.502 . . . . 0.0 110.05 179.191 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 11.3 mm100 -71.61 113.82 9.04 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.898 0.38 . . . . 0.0 110.024 179.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 64.61 31.67 81.67 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.512 -179.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.436 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 17.2 t70 -58.31 159.42 6.13 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.959 0.409 . . . . 0.0 111.195 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.47 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 3.0 tt0 -146.6 135.71 22.59 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.531 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.447 ' CG2' ' O ' ' A' ' 110' ' ' TRP . 1.3 mp -111.84 128.69 68.25 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.168 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.117 178.851 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.46 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 95.2 m -103.24 145.05 30.52 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.512 -179.687 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.459 ' HB ' ' NE2' ' A' ' 88' ' ' HIS . 4.3 m -141.09 158.27 22.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 -178.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 68.8 41.26 83.67 Favored Glycine 0 N--CA 1.448 -0.533 0 CA-C-N 115.776 -0.647 . . . . 0.0 112.553 179.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.47 ' HA ' HG12 ' A' ' 140' ' ' ILE . 98.6 t -76.45 157.33 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.625 0 CA-C-O 121.38 0.609 . . . . 0.0 112.012 -179.343 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 138.21 -43.46 1.19 Allowed Glycine 0 N--CA 1.441 -1.017 0 N-CA-C 110.36 -1.096 . . . . 0.0 110.36 -178.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 46.4 t -126.8 123.93 63.81 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.708 0 CA-C-N 115.022 -0.589 . . . . 0.0 109.63 178.423 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -51.05 -26.17 5.92 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.711 0.291 . . . . 0.0 111.355 -179.121 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 6.4 t -94.4 6.4 48.85 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 112.3 0.481 . . . . 0.0 112.3 -179.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -131.54 24.31 4.75 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 -179.243 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.47 HG12 ' HA ' ' A' ' 134' ' ' VAL . 23.6 mt -98.89 141.1 17.05 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.305 179.04 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 8.7 mp -119.98 135.07 55.05 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.83 -1.077 . . . . 0.0 109.805 179.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.417 ' O ' ' OG1' ' A' ' 40' ' ' THR . 46.6 t -114.54 151.84 32.72 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.836 0.827 . . . . 0.0 112.765 -178.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.47 ' O ' ' HA ' ' A' ' 129' ' ' GLU . 8.2 mt -136.18 129.76 32.17 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.554 -1.203 . . . . 0.0 109.251 178.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 21.4 t -124.09 140.95 45.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.917 0.389 . . . . 0.0 111.923 -178.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -112.31 140.23 33.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.832 179.558 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -118.99 108.64 15.0 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.704 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 1.9 mp -101.21 128.66 53.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.436 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 10.7 p30 -79.16 132.02 36.41 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.909 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -63.64 -21.36 66.33 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.128 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 2.1 mptm? -58.37 -44.35 88.82 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.967 0.413 . . . . 0.0 110.716 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 17.9 t80 . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.82 179.777 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 . . . . . 0 C--O 1.232 0.157 0 CA-C-O 120.656 0.265 . . . . 0.0 111.403 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 68.0 m-20 -108.83 -13.29 14.79 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-O 121.886 0.851 . . . . 0.0 109.117 178.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.575 ' CG2' ' O ' ' A' ' 32' ' ' ILE . 0.1 OUTLIER -70.41 96.77 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.618 0 CA-C-N 114.11 -1.405 . . . . 0.0 110.844 -179.145 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.524 ' CG1' ' N ' ' A' ' 34' ' ' CYS . 0.9 OUTLIER -39.21 -61.5 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 114.54 -1.209 . . . . 0.0 112.651 -178.896 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.524 ' N ' ' CG1' ' A' ' 33' ' ' VAL . 49.6 t -162.93 162.85 26.38 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.853 0.359 . . . . 0.0 111.743 -178.795 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.425 ' HD3' ' CG2' ' A' ' 45' ' ' ILE . 1.8 ttm180 -128.93 115.37 17.73 Favored 'General case' 0 C--N 1.334 -0.104 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.678 179.817 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.458 ' CG2' ' CD2' ' A' ' 48' ' ' LEU . 92.4 t -89.07 129.64 39.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.559 179.858 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.49 ' CG2' HG12 ' A' ' 45' ' ' ILE . 29.0 mt -118.48 107.77 22.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 116.056 -0.52 . . . . 0.0 112.026 -179.309 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.494 ' HB2' ' O ' ' A' ' 43' ' ' ILE . 3.7 m -97.38 99.93 11.37 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 177.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 8.7 t -107.27 27.17 9.33 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 -178.097 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.464 ' CG2' ' HB2' ' A' ' 142' ' ' SER . 40.3 p -108.96 -3.31 17.61 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.761 0.315 . . . . 0.0 111.566 179.664 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 95.67 60.2 1.04 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.467 179.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -141.12 -60.58 0.49 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.762 0.315 . . . . 0.0 111.242 -179.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.494 ' O ' ' HB2' ' A' ' 38' ' ' CYS . 3.5 mp -135.24 132.36 20.04 Favored Pre-proline 0 N--CA 1.452 -0.339 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.371 -179.639 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.423 ' HD2' ' CZ ' ' A' ' 76' ' ' TYR . 24.1 Cg_exo -60.14 146.8 95.43 Favored 'Trans proline' 0 N--CA 1.463 -0.307 0 C-N-CA 122.214 1.943 . . . . 0.0 111.054 178.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.49 HG12 ' CG2' ' A' ' 37' ' ' ILE . 29.9 mt -50.72 122.55 2.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.948 0.404 . . . . 0.0 111.791 -179.165 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.421 ' HG3' ' CE2' ' A' ' 76' ' ' TYR . 0.0 OUTLIER -124.85 141.76 51.9 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.032 179.241 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -99.55 119.58 38.27 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.975 0.417 . . . . 0.0 111.689 -179.241 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.552 ' HB3' ' CE2' ' A' ' 66' ' ' TRP . 0.3 OUTLIER -89.63 136.47 33.02 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 178.48 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.603 ' O ' ' HZ2' ' A' ' 66' ' ' TRP . 0.0 OUTLIER -137.23 162.25 33.99 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 122.034 0.921 . . . . 0.0 113.398 -178.564 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.438 ' HB1' HG23 ' A' ' 33' ' ' VAL . . . -149.62 152.65 35.79 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 114.418 -1.265 . . . . 0.0 111.174 179.24 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -80.27 111.26 16.48 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.121 -179.617 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.484 HG23 HD11 ' A' ' 52' ' ' ILE . 11.6 mt . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.733 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.915 0.388 . . . . 0.0 111.153 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.431 ' O ' ' HB3' ' A' ' 93' ' ' LEU . 2.1 ttpt -118.65 136.29 53.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.178 179.573 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.481 ' CG1' ' O ' ' A' ' 91' ' ' ILE . 14.1 t -136.26 135.91 49.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.143 0.497 . . . . 0.0 111.946 -179.215 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . 0.608 ' HB2' ' HB ' ' A' ' 91' ' ' ILE . 13.8 m-90 -99.74 140.06 34.49 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.59 179.052 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.604 ' N ' ' HB2' ' A' ' 75' ' ' ASP . 4.3 m -130.3 126.79 38.08 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.404 0.621 . . . . 0.0 112.403 179.504 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.471 ' CD2' ' CD2' ' A' ' 89' ' ' PHE . 88.5 m-85 -98.01 118.39 34.51 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.171 177.89 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.621 ' HA3' ' N ' ' A' ' 87' ' ' LYS . . . 160.33 -158.97 30.4 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 118.978 -1.582 . . . . 0.0 112.936 179.473 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.492 ' CD ' ' HB3' ' A' ' 86' ' ' ASN . 0.4 OUTLIER -76.84 91.75 3.56 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-O 122.55 1.167 . . . . 0.0 108.456 -179.888 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.493 ' O ' ' CD2' ' A' ' 77' ' ' HIS . 0.2 OUTLIER -149.83 160.78 33.16 Favored Pre-proline 0 C--N 1.308 -1.205 0 CA-C-N 112.755 -2.021 . . . . 0.0 108.027 179.326 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.559 ' O ' ' CB ' ' A' ' 73' ' ' ALA . 28.1 Cg_endo -63.14 -8.73 14.94 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 120.99 1.127 . . . . 0.0 111.439 178.697 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.621 ' HB2' ' HB2' ' A' ' 77' ' ' HIS . . . 135.98 51.85 0.0 OUTLIER 'General case' 0 CA--C 1.491 -1.309 0 CA-C-N 114.806 -1.088 . . . . 0.0 109.788 178.602 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . 0.536 ' HB3' ' HB ' ' A' ' 67' ' ' THR . 0.1 OUTLIER -52.88 -69.45 0.11 Allowed 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 105.838 -1.912 . . . . 0.0 105.838 179.328 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.604 ' HB2' ' N ' ' A' ' 67' ' ' THR . 7.5 t0 -94.63 -47.76 6.38 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 105.734 -1.951 . . . . 0.0 105.734 169.732 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.476 ' C ' ' HA ' ' A' ' 73' ' ' ALA . 1.7 t80 -145.37 141.65 28.66 Favored 'General case' 0 C--N 1.346 0.454 0 CA-C-N 112.717 -2.038 . . . . 0.0 112.35 -179.76 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . 0.621 ' HB2' ' HB2' ' A' ' 73' ' ' ALA . 23.5 t-160 -94.91 107.2 19.23 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 176.276 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -135.67 -176.24 4.22 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.001 0.429 . . . . 0.0 111.7 -179.386 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -60.92 163.31 20.39 Favored Glycine 0 N--CA 1.451 -0.339 0 CA-C-N 115.819 -0.628 . . . . 0.0 112.582 -179.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 12.8 p-10 -111.97 100.57 8.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.823 0.345 . . . . 0.0 111.553 -179.649 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.627 ' HB ' ' HB2' ' A' ' 85' ' ' SER . 12.4 mm -112.76 120.48 62.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 178.67 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 3.5 m -51.09 -23.92 3.54 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -177.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -83.66 -106.7 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 120.971 -0.291 . . . . 0.0 111.084 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -109.86 113.32 25.96 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-O 121.341 0.591 . . . . 0.0 109.598 179.236 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.627 ' HB2' ' HB ' ' A' ' 81' ' ' ILE . 1.5 m 166.6 -66.55 0.0 OUTLIER 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.041 -179.708 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.977 ' O ' ' N ' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -60.04 -166.18 0.01 OUTLIER 'General case' 0 CA--C 1.51 -0.575 0 N-CA-C 109.333 -0.618 . . . . 0.0 109.333 178.954 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.621 ' N ' ' HA3' ' A' ' 69' ' ' GLY . 2.8 mtmt -28.7 69.44 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 121.279 0.562 . . . . 0.0 109.704 -179.685 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.986 ' C ' ' O ' ' A' ' 104' ' ' ILE . 32.3 t60 -98.03 -17.44 19.15 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 113.559 0.948 . . . . 0.0 113.559 -176.765 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.56 ' HA ' ' H ' ' A' ' 104' ' ' ILE . 0.3 OUTLIER -173.08 153.33 2.5 Favored 'General case' 0 C--N 1.31 -1.135 0 C-N-CA 119.422 -0.911 . . . . 0.0 112.379 177.73 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.488 ' O ' ' O ' ' A' ' 102' ' ' ASN . 31.9 mt-30 -135.83 157.92 45.67 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.455 -1.248 . . . . 0.0 113.674 -177.42 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.608 ' HB ' ' HB2' ' A' ' 66' ' ' TRP . 9.9 mt -125.14 131.62 72.22 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 CA-C-N 114.955 -1.021 . . . . 0.0 109.711 178.496 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.404 ' N ' ' O ' ' A' ' 100' ' ' LEU . 0.2 OUTLIER -109.37 141.45 41.72 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.098 0.475 . . . . 0.0 112.154 -179.298 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.431 ' HB3' ' O ' ' A' ' 64' ' ' LYS . 6.4 tp -125.8 141.52 51.96 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.355 178.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.305 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.542 179.787 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.428 ' CD2' ' N ' ' A' ' 99' ' ' LEU . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.845 0.355 . . . . 0.0 110.751 . . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.578 ' HA ' ' O ' ' A' ' 122' ' ' GLN . 0.4 OUTLIER -133.73 148.31 51.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.399 179.969 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.458 ' O ' ' N ' ' A' ' 122' ' ' GLN . 3.2 mp -114.82 131.33 56.86 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.978 -0.378 . . . . 0.0 109.978 179.855 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.488 ' O ' ' O ' ' A' ' 90' ' ' GLN . 23.4 t30 -113.16 111.32 21.89 Favored 'General case' 0 CA--C 1.511 -0.529 0 C-N-CA 119.851 -0.74 . . . . 0.0 110.032 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.573 ' HB3' ' CG2' ' A' ' 109' ' ' THR . 73.2 m-20 -84.37 112.17 20.1 Favored 'General case' 0 N--CA 1.444 -0.752 0 C-N-CA 119.738 -0.785 . . . . 0.0 109.641 179.519 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.986 ' O ' ' C ' ' A' ' 88' ' ' HIS . 0.1 OUTLIER -123.54 107.29 18.66 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.886 0 N-CA-C 108.752 -0.832 . . . . 0.0 108.752 177.614 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.421 ' OG ' ' NE2' ' A' ' 88' ' ' HIS . 67.3 m -129.72 169.14 15.48 Favored 'General case' 0 C--N 1.296 -1.74 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.435 179.617 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 23.7 m -69.35 -62.88 1.2 Allowed 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 119.121 -1.031 . . . . 0.0 111.281 -179.228 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -112.11 -33.09 6.35 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 114.658 1.355 . . . . 0.0 114.658 179.011 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -146.67 130.2 3.56 Favored Glycine 0 C--N 1.341 0.813 0 N-CA-C 116.97 1.548 . . . . 0.0 116.97 -177.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.573 ' CG2' ' HB3' ' A' ' 103' ' ' ASP . 5.6 m -121.18 138.32 54.26 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 174.396 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . 0.65 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.6 m-90 -120.48 149.22 42.74 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 -178.639 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -122.17 112.04 17.7 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 114.915 -1.039 . . . . 0.0 108.601 177.579 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 44.9 44.36 7.84 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.983 -0.553 . . . . 0.0 112.155 -179.524 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 79.79 21.62 65.7 Favored Glycine 0 N--CA 1.444 -0.794 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.786 179.345 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -133.4 98.75 4.32 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.928 0.394 . . . . 0.0 110.664 179.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.65 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.1 OUTLIER -43.23 122.43 2.53 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.034 179.804 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 12.6 p -113.78 160.49 13.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.688 -178.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -70.96 141.61 51.06 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.104 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.407 ' O ' ' C ' ' A' ' 119' ' ' ASN . 88.6 tttt -65.39 164.24 14.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.076 179.325 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.407 ' C ' ' O ' ' A' ' 118' ' ' LYS . 4.3 m-80 35.47 39.01 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.249 0.547 . . . . 0.0 110.938 -179.402 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.403 ' OG ' ' NE2' ' A' ' 122' ' ' GLN . 5.3 p -111.04 108.46 18.18 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.997 -179.365 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . 0.4 ' HB3' ' CD2' ' A' ' 100' ' ' LEU . 1.4 m-20 -58.59 140.59 54.11 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.737 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . 0.578 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 22.4 mm-40 -129.82 145.21 51.58 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-O 121.039 0.447 . . . . 0.0 112.137 -179.567 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 22.3 tp -72.58 117.94 14.88 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.44 178.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.442 ' CD2' HG12 ' A' ' 147' ' ' ILE . 29.9 tp -45.24 144.05 1.49 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.875 0.845 . . . . 0.0 112.081 -178.713 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -127.02 152.79 46.78 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 114.037 -1.438 . . . . 0.0 110.252 179.585 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.72 113.88 9.22 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 179.414 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 67.06 29.12 74.12 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.281 -179.379 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -54.57 160.53 1.76 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.925 0.393 . . . . 0.0 111.203 -179.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.459 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 2.4 tt0 -146.05 135.32 22.87 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.529 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.476 ' CD1' ' CE1' ' A' ' 89' ' ' PHE . 5.4 mt -115.05 128.61 72.15 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 116.285 -0.416 . . . . 0.0 109.976 179.007 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.447 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 7.7 m -103.21 143.74 32.24 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.83 -179.374 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.45 ' HB ' ' NE2' ' A' ' 88' ' ' HIS . 4.6 m -141.21 155.26 21.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.317 -0.401 . . . . 0.0 112.039 -179.013 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 72.14 38.1 59.46 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 121.126 -0.559 . . . . 0.0 112.4 179.282 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.445 ' HA ' HG12 ' A' ' 140' ' ' ILE . 96.1 t -72.88 156.26 6.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 121.499 0.666 . . . . 0.0 112.129 -179.276 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . 0.404 ' N ' ' CG1' ' A' ' 134' ' ' VAL . . . 153.26 -46.5 0.56 Allowed Glycine 0 N--CA 1.442 -0.96 0 CA-C-N 114.939 -1.028 . . . . 0.0 110.606 -179.234 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 46.7 t -126.78 135.83 62.56 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.65 0 CA-C-N 115.239 -0.48 . . . . 0.0 109.832 178.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.1 -35.13 33.6 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.818 0.342 . . . . 0.0 111.269 -179.337 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -94.04 6.14 49.47 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 116.273 -0.421 . . . . 0.0 112.13 -179.513 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -125.6 28.72 6.16 Favored 'General case' 0 CA--C 1.518 -0.261 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -179.398 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.447 ' CG2' ' CG2' ' A' ' 131' ' ' THR . 22.0 mt -105.29 141.28 20.99 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.373 179.342 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -114.85 135.0 54.67 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 114.906 -1.043 . . . . 0.0 109.92 179.344 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.464 ' HB2' ' CG2' ' A' ' 40' ' ' THR . 3.9 m -119.2 153.7 34.53 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.845 0.831 . . . . 0.0 112.48 -179.03 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.459 ' O ' ' HA ' ' A' ' 129' ' ' GLU . 13.7 mt -135.4 141.5 45.48 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.36 -1.291 . . . . 0.0 109.216 179.325 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 17.3 t -124.02 140.85 46.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.014 0.435 . . . . 0.0 112.123 -178.636 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -108.63 125.99 65.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.105 179.257 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 8.5 t80 -111.98 118.36 35.24 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.277 -179.419 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . 0.459 ' CD1' ' N ' ' A' ' 147' ' ' ILE . 2.4 mp -95.34 134.57 32.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.655 179.628 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -73.87 122.66 22.85 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.994 -179.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -60.38 -41.7 94.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.798 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.17 -43.28 87.36 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.677 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 24.1 t80 . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.761 179.784 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.648 0.261 . . . . 0.0 111.414 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 26.6 m120 -109.23 -13.56 14.63 Favored 'General case' 0 CA--C 1.514 -0.422 0 CA-C-O 121.933 0.873 . . . . 0.0 109.131 178.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.585 ' CG2' ' O ' ' A' ' 32' ' ' ILE . 0.1 OUTLIER -70.47 96.83 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.619 0 CA-C-N 114.103 -1.408 . . . . 0.0 111.183 -178.983 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.517 ' CG1' ' N ' ' A' ' 34' ' ' CYS . 0.9 OUTLIER -36.55 -60.77 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 CA-C-N 114.643 -1.162 . . . . 0.0 112.246 -179.403 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.517 ' N ' ' CG1' ' A' ' 33' ' ' VAL . 1.7 m -163.19 165.42 24.45 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.742 -179.466 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 2.3 tmm_? -134.27 114.78 13.39 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.159 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.435 ' CG2' ' CD2' ' A' ' 48' ' ' LEU . 48.2 t -91.38 122.0 42.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.508 179.313 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.472 ' N ' ' O ' ' A' ' 144' ' ' VAL . 34.1 mt -109.55 108.06 24.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.636 -179.847 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.527 ' HB2' ' O ' ' A' ' 43' ' ' ILE . 60.1 m -102.04 101.75 12.16 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 178.098 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 7.6 t -118.69 32.63 6.03 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -177.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.445 HG22 ' CB ' ' A' ' 142' ' ' SER . 34.8 p -112.45 15.89 20.05 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.976 0.417 . . . . 0.0 111.285 179.325 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 88.71 38.87 6.82 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.133 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -117.23 -76.21 0.57 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.663 0.268 . . . . 0.0 111.465 -179.591 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.527 ' O ' ' HB2' ' A' ' 38' ' ' CYS . 3.7 mp -135.18 141.59 38.55 Favored Pre-proline 0 N--CA 1.452 -0.348 0 CA-C-O 120.859 0.361 . . . . 0.0 111.527 -179.072 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.464 ' HD2' ' CZ ' ' A' ' 76' ' ' TYR . 25.6 Cg_exo -59.25 147.08 92.5 Favored 'Trans proline' 0 N--CA 1.465 -0.186 0 C-N-CA 122.338 2.025 . . . . 0.0 111.202 178.832 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.441 HG12 ' CG2' ' A' ' 37' ' ' ILE . 44.2 mt -43.38 128.6 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-O 121.046 0.451 . . . . 0.0 111.852 -179.401 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.27 130.38 52.66 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.255 179.58 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -100.83 119.72 39.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.021 0.439 . . . . 0.0 111.444 -179.54 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.577 ' HB3' ' CE2' ' A' ' 66' ' ' TRP . 0.2 OUTLIER -93.9 130.73 39.85 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.353 178.763 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.535 ' O ' ' HZ2' ' A' ' 66' ' ' TRP . 0.0 OUTLIER -133.41 161.66 33.93 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.972 0.891 . . . . 0.0 113.221 -178.809 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.468 ' HB1' HG23 ' A' ' 33' ' ' VAL . . . -156.87 141.94 17.17 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 114.441 -1.254 . . . . 0.0 110.937 179.017 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -70.02 124.14 23.31 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.091 0.472 . . . . 0.0 111.231 -179.613 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 14.7 mt . . . . . 0 C--N 1.33 -0.283 0 CA-C-N 115.824 -0.626 . . . . 0.0 111.104 179.92 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 3.0 mttp . . . . . 0 CA--C 1.528 0.097 0 CA-C-O 120.947 0.403 . . . . 0.0 110.999 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -108.16 132.73 53.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.35 179.587 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.47 ' CG1' ' O ' ' A' ' 91' ' ' ILE . 6.9 t -127.35 135.47 63.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.182 0.515 . . . . 0.0 111.959 -179.058 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . 0.611 ' HB2' ' HB ' ' A' ' 91' ' ' ILE . 14.7 m-90 -99.25 139.97 34.11 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.786 179.179 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.579 ' O ' ' N ' ' A' ' 75' ' ' ASP . 32.0 m -131.43 131.42 43.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.571 0.7 . . . . 0.0 112.048 179.491 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.49 ' CD2' ' CD2' ' A' ' 89' ' ' PHE . 94.0 m-85 -102.68 118.98 38.03 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.023 -0.99 . . . . 0.0 109.148 177.851 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.56 ' HA2' ' O ' ' A' ' 85' ' ' SER . . . 158.64 -156.87 27.87 Favored Glycine 0 CA--C 1.501 -0.804 0 C-N-CA 118.962 -1.59 . . . . 0.0 112.709 179.638 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -75.62 91.65 2.88 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-O 122.615 1.198 . . . . 0.0 108.679 -179.669 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.511 ' O ' ' CD2' ' A' ' 77' ' ' HIS . 10.3 m120 -149.9 153.37 35.84 Favored Pre-proline 0 C--N 1.31 -1.119 0 CA-C-N 112.693 -2.049 . . . . 0.0 108.187 178.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.558 ' O ' ' HB2' ' A' ' 77' ' ' HIS . 26.6 Cg_exo -55.92 -10.84 4.57 Favored 'Trans proline' 0 N--CA 1.459 -0.525 0 C-N-CA 121.239 1.293 . . . . 0.0 111.318 178.101 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.591 ' HB3' ' HB2' ' A' ' 77' ' ' HIS . . . 137.99 52.03 0.0 OUTLIER 'General case' 0 CA--C 1.49 -1.365 0 CA-C-N 114.761 -1.109 . . . . 0.0 109.212 178.871 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . 0.504 ' HB3' ' HB ' ' A' ' 67' ' ' THR . 0.1 OUTLIER -52.55 -69.45 0.11 Allowed 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 105.783 -1.932 . . . . 0.0 105.783 179.689 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.579 ' N ' ' O ' ' A' ' 67' ' ' THR . 9.2 t0 -95.38 -47.73 6.17 Favored 'General case' 0 N--CA 1.435 -1.21 0 N-CA-C 105.671 -1.974 . . . . 0.0 105.671 169.513 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.497 ' C ' ' HA ' ' A' ' 73' ' ' ALA . 33.7 t80 -144.07 142.61 30.73 Favored 'General case' 0 C--N 1.347 0.5 0 CA-C-N 112.544 -2.116 . . . . 0.0 111.316 179.713 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . 0.591 ' HB2' ' HB3' ' A' ' 73' ' ' ALA . 23.6 t-160 -92.77 109.32 20.75 Favored 'General case' 0 C--N 1.33 -0.279 0 O-C-N 121.999 -0.438 . . . . 0.0 110.177 177.209 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.3 pp -123.45 175.28 6.85 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.911 0.386 . . . . 0.0 111.538 -179.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -62.92 -170.85 1.35 Allowed Glycine 0 C--N 1.332 0.313 0 C-N-CA 120.985 -0.626 . . . . 0.0 112.525 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -111.76 98.64 7.54 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 121.025 0.44 . . . . 0.0 111.68 -179.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.577 ' HB ' ' HB2' ' A' ' 85' ' ' SER . 3.2 mp -114.13 111.77 37.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.404 178.775 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 46.9 t -55.35 -24.25 28.33 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 -179.247 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.75 -109.53 0.07 Allowed 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 112.249 0.463 . . . . 0.0 112.249 -178.845 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.47 ' HB3' ' CE1' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -108.89 112.22 24.34 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-O 121.437 0.637 . . . . 0.0 109.666 179.87 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.577 ' HB2' ' HB ' ' A' ' 81' ' ' ILE . 0.6 OUTLIER 161.88 -45.11 0.0 OUTLIER 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 114.686 -1.143 . . . . 0.0 109.335 -179.628 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.858 ' O ' ' N ' ' A' ' 88' ' ' HIS . 97.1 m-20 -64.31 -149.47 0.01 OUTLIER 'General case' 0 CA--C 1.521 -0.138 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 177.726 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 9.3 mttt -49.47 72.34 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.073 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.977 ' C ' ' O ' ' A' ' 104' ' ' ILE . 32.8 t60 -90.89 -17.34 26.64 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 114.02 1.118 . . . . 0.0 114.02 -176.727 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.538 ' HA ' ' H ' ' A' ' 104' ' ' ILE . 0.5 OUTLIER -174.43 153.56 1.93 Allowed 'General case' 0 C--N 1.311 -1.089 0 C-N-CA 119.257 -0.977 . . . . 0.0 112.673 178.061 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.489 ' O ' ' O ' ' A' ' 102' ' ' ASN . 34.9 mt-30 -136.64 158.49 44.33 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.523 -1.217 . . . . 0.0 113.72 -177.624 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.611 ' HB ' ' HB2' ' A' ' 66' ' ' TRP . 10.6 mt -127.72 131.7 69.68 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 CA-C-N 114.868 -1.06 . . . . 0.0 109.896 178.725 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.507 ' HG ' ' HB2' ' A' ' 100' ' ' LEU . 0.5 OUTLIER -111.42 137.68 48.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.86 0.362 . . . . 0.0 110.945 -179.94 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.456 ' HG ' HG23 ' A' ' 33' ' ' VAL . 1.0 OUTLIER -124.06 129.14 50.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.779 179.789 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.306 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.399 179.922 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.4 mm? . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.826 0.346 . . . . 0.0 110.809 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.568 ' HA ' ' O ' ' A' ' 122' ' ' GLN . 3.8 mm? -127.39 148.05 50.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.284 179.845 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.47 ' O ' ' N ' ' A' ' 122' ' ' GLN . 52.5 mt -115.93 129.66 56.49 Favored 'General case' 0 CA--C 1.518 -0.287 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.11 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.489 ' O ' ' O ' ' A' ' 90' ' ' GLN . 26.7 t30 -113.26 111.25 21.72 Favored 'General case' 0 CA--C 1.509 -0.598 0 C-N-CA 119.804 -0.758 . . . . 0.0 109.877 179.803 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.575 ' HB3' ' CG2' ' A' ' 109' ' ' THR . 72.6 m-20 -83.57 112.24 19.82 Favored 'General case' 0 N--CA 1.442 -0.853 0 C-N-CA 119.827 -0.749 . . . . 0.0 109.619 179.664 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.977 ' O ' ' C ' ' A' ' 88' ' ' HIS . 0.1 OUTLIER -123.13 107.84 20.0 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.949 0 N-CA-C 108.928 -0.768 . . . . 0.0 108.928 177.745 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.417 ' OG ' ' NE2' ' A' ' 88' ' ' HIS . 71.9 m -128.93 169.6 14.44 Favored 'General case' 0 C--N 1.295 -1.793 0 CA-C-N 114.974 -1.012 . . . . 0.0 109.286 179.473 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 29.2 m -69.11 -62.68 1.28 Allowed 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 119.074 -1.05 . . . . 0.0 111.061 -179.356 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -111.86 -33.42 6.31 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 114.326 1.232 . . . . 0.0 114.326 178.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -147.05 131.69 4.05 Favored Glycine 0 C--N 1.341 0.813 0 N-CA-C 116.886 1.514 . . . . 0.0 116.886 -178.181 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.575 ' CG2' ' HB3' ' A' ' 103' ' ' ASP . 7.2 m -121.08 138.18 54.31 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 174.259 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . 0.727 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.4 m-90 -119.78 149.36 42.17 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 113.543 0.942 . . . . 0.0 113.543 -178.58 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -123.4 112.2 17.27 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 114.82 -1.082 . . . . 0.0 108.546 177.556 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 73.3 m-20 47.3 43.11 14.7 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.079 -0.509 . . . . 0.0 112.204 -179.496 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 84.06 -4.11 84.01 Favored Glycine 0 N--CA 1.445 -0.732 0 C-N-CA 120.759 -0.734 . . . . 0.0 113.25 179.168 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -111.47 102.3 10.67 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.917 0.389 . . . . 0.0 110.817 179.688 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.727 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.0 OUTLIER -44.01 136.49 3.72 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.939 179.846 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 14.9 p -124.35 163.39 24.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.693 -179.082 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 29.7 tp10 -70.1 141.84 52.69 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.019 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 63.4 tttm -68.59 162.7 25.3 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.407 179.654 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 4.1 p30 35.21 38.04 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.349 0.595 . . . . 0.0 111.404 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 6.7 p -111.39 109.79 19.94 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.018 -179.453 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 29.5 m120 -59.33 139.47 56.98 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.502 179.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . 0.568 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 48.9 mm-40 -129.7 148.53 51.6 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-O 121.072 0.463 . . . . 0.0 112.121 -179.357 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -72.31 112.08 8.07 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.456 179.172 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.434 ' CD2' HG12 ' A' ' 147' ' ' ILE . 7.8 tt -43.23 147.22 0.38 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.728 0.775 . . . . 0.0 112.246 -178.645 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -126.64 153.15 45.74 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 114.322 -1.308 . . . . 0.0 110.43 179.752 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.61 113.86 9.08 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 179.414 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 68.25 27.32 73.78 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.201 -179.153 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -53.41 161.22 1.01 Allowed 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.928 0.394 . . . . 0.0 111.319 -179.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -146.21 134.85 22.2 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.204 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.41 ' CG2' ' O ' ' A' ' 110' ' ' TRP . 3.7 mt -115.8 128.44 73.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 178.854 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.483 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 36.7 m -103.02 143.31 32.74 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.61 -179.742 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.47 ' HB ' ' NE2' ' A' ' 88' ' ' HIS . 6.3 m -140.75 158.21 23.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 -178.549 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 72.88 44.09 38.94 Favored Glycine 0 N--CA 1.445 -0.717 0 CA-C-N 115.679 -0.692 . . . . 0.0 112.275 179.39 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.469 ' HA ' HG12 ' A' ' 140' ' ' ILE . 85.4 t -81.64 153.94 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.616 0 CA-C-O 121.438 0.637 . . . . 0.0 112.161 -179.212 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 152.68 -43.48 0.65 Allowed Glycine 0 N--CA 1.441 -1.0 0 CA-C-N 114.932 -1.031 . . . . 0.0 110.564 -179.113 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 44.0 t -126.71 132.82 69.74 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.675 0 CA-C-N 115.137 -0.531 . . . . 0.0 109.714 178.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 37.3 tp10 -51.28 -34.59 33.59 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.761 0.315 . . . . 0.0 111.449 -179.169 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 48.2 t -94.34 6.52 48.46 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -179.413 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -126.13 29.64 5.81 Favored 'General case' 0 CA--C 1.52 -0.201 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -179.239 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.483 ' CG2' ' CG2' ' A' ' 131' ' ' THR . 11.8 mt -107.6 141.14 23.58 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.367 179.162 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 1.2 mp -123.07 134.79 54.24 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.164 -0.926 . . . . 0.0 110.315 179.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.445 ' CB ' HG22 ' A' ' 40' ' ' THR . 0.8 OUTLIER -112.73 154.67 25.81 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.958 0.885 . . . . 0.0 112.758 -179.087 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -130.12 144.05 51.13 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 114.047 -1.433 . . . . 0.0 109.192 179.34 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.472 ' O ' ' N ' ' A' ' 37' ' ' ILE . 21.9 t -124.31 140.97 46.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.933 0.396 . . . . 0.0 111.939 -178.903 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -109.86 132.2 58.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.712 179.538 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -118.2 125.27 49.84 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.69 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . 0.434 HG12 ' CD2' ' A' ' 124' ' ' LEU . 3.9 mp -109.58 133.61 54.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.472 -179.647 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -78.62 117.95 20.27 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.957 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -65.15 -27.58 68.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.95 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.74 -46.01 90.44 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-O 121.065 0.459 . . . . 0.0 110.68 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 10.5 t80 . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.008 179.897 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 . . . . . 0 C--O 1.231 0.111 0 N-CA-C 111.795 0.295 . . . . 0.0 111.795 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 18.2 m-80 -107.99 -12.92 15.07 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-O 121.883 0.849 . . . . 0.0 109.107 179.345 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.616 ' CG2' ' O ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -70.71 95.08 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.572 0 CA-C-N 113.961 -1.472 . . . . 0.0 111.198 -179.241 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.62 ' CG1' ' N ' ' A' ' 34' ' ' CYS . 0.4 OUTLIER -32.81 -61.13 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-N 114.706 -1.134 . . . . 0.0 112.286 -179.567 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.62 ' N ' ' CG1' ' A' ' 33' ' ' VAL . 20.9 p -165.11 164.83 20.25 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 112.516 0.561 . . . . 0.0 112.516 -179.47 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 2.8 ttm180 -119.44 125.15 48.26 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.62 179.47 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.5 m -92.96 124.39 45.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.896 0.379 . . . . 0.0 111.088 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.463 ' CG2' HG12 ' A' ' 45' ' ' ILE . 19.8 mt -132.27 108.6 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.911 -179.487 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.421 ' HB3' ' O ' ' A' ' 43' ' ' ILE . 38.9 t -78.9 127.77 32.45 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 178.291 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 48.4 p -110.77 28.65 8.49 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 112.576 0.584 . . . . 0.0 112.576 -178.442 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.435 ' OG1' ' O ' ' A' ' 142' ' ' SER . 0.0 OUTLIER -116.41 -37.41 3.75 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.778 0.323 . . . . 0.0 110.983 179.333 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 116.92 53.08 0.33 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.861 179.492 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -142.58 -42.71 0.32 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.612 0.244 . . . . 0.0 111.479 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.462 HG21 ' CD2' ' A' ' 76' ' ' TYR . 4.0 mp -115.04 138.96 23.74 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 120.779 0.323 . . . . 0.0 111.493 -179.385 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.489 ' CD ' ' CZ ' ' A' ' 76' ' ' TYR . 86.9 Cg_endo -82.43 146.79 13.92 Favored 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 122.76 2.307 . . . . 0.0 111.732 179.494 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.463 HG12 ' CG2' ' A' ' 37' ' ' ILE . 35.7 mt -53.2 111.86 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.995 0.426 . . . . 0.0 111.528 -179.688 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.17 144.0 44.36 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.84 179.297 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -103.36 119.65 39.28 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.052 0.453 . . . . 0.0 111.599 -179.409 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.486 ' HB3' ' CE2' ' A' ' 66' ' ' TRP . 0.3 OUTLIER -100.47 138.65 37.25 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 178.504 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.617 ' C ' ' HB ' ' A' ' 33' ' ' VAL . 42.5 t -127.48 -170.82 2.29 Favored 'General case' 0 CA--C 1.511 -0.538 0 CA-C-O 122.941 1.353 . . . . 0.0 113.916 -178.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.577 ' N ' ' OG ' ' A' ' 49' ' ' SER . . . -157.52 145.02 18.61 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 112.699 -2.046 . . . . 0.0 110.809 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -84.7 86.6 7.31 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.116 0.484 . . . . 0.0 110.705 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.419 HD12 ' CE2' ' A' ' 151' ' ' PHE . 5.8 mt . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.687 -179.67 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.88 0.371 . . . . 0.0 110.951 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 15.9 ttpt -113.29 131.48 55.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.693 179.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.478 ' CG1' ' O ' ' A' ' 91' ' ' ILE . 13.9 t -132.29 139.21 50.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.989 0.423 . . . . 0.0 111.696 -179.284 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . 0.609 ' HB2' ' HB ' ' A' ' 91' ' ' ILE . 17.3 m-90 -100.62 139.63 36.04 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.286 179.069 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.586 ' O ' ' N ' ' A' ' 75' ' ' ASP . 15.6 m -122.4 133.03 54.64 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.594 0.712 . . . . 0.0 112.286 179.829 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.518 ' CE1' ' CG ' ' A' ' 75' ' ' ASP . 10.8 m-85 -102.8 118.21 36.34 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.051 -0.977 . . . . 0.0 108.792 177.887 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.639 ' HA2' ' O ' ' A' ' 85' ' ' SER . . . 157.21 -153.92 25.09 Favored Glycine 0 CA--C 1.503 -0.663 0 C-N-CA 118.812 -1.661 . . . . 0.0 113.148 179.573 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.528 ' HB3' ' HA ' ' A' ' 80' ' ' ASN . 6.5 ptm180 -76.55 92.08 3.43 Favored 'General case' 0 N--CA 1.442 -0.861 0 CA-C-O 122.551 1.167 . . . . 0.0 108.985 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.491 ' O ' ' CD2' ' A' ' 77' ' ' HIS . 25.3 m-80 -149.72 159.99 34.93 Favored Pre-proline 0 C--N 1.308 -1.225 0 CA-C-N 112.806 -1.997 . . . . 0.0 108.261 178.857 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.545 ' O ' ' HB2' ' A' ' 77' ' ' HIS . 30.2 Cg_endo -63.89 -8.37 15.69 Favored 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 120.606 0.87 . . . . 0.0 110.434 177.407 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.574 ' HB1' ' HB2' ' A' ' 77' ' ' HIS . . . 137.28 53.32 0.0 OUTLIER 'General case' 0 CA--C 1.49 -1.345 0 CA-C-N 114.482 -1.235 . . . . 0.0 109.14 178.814 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . 0.536 ' HB3' ' HB ' ' A' ' 67' ' ' THR . 0.1 OUTLIER -52.96 -69.75 0.11 Allowed 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 105.859 -1.904 . . . . 0.0 105.859 179.713 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.586 ' N ' ' O ' ' A' ' 67' ' ' THR . 55.5 t0 -95.09 -47.73 6.25 Favored 'General case' 0 N--CA 1.435 -1.197 0 N-CA-C 105.526 -2.027 . . . . 0.0 105.526 169.59 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.5 ' C ' ' HA ' ' A' ' 73' ' ' ALA . 13.9 t80 -144.05 142.38 30.62 Favored 'General case' 0 C--N 1.346 0.441 0 CA-C-N 112.603 -2.089 . . . . 0.0 110.984 179.262 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . 0.574 ' HB2' ' HB1' ' A' ' 73' ' ' ALA . 23.8 t-160 -89.33 108.51 19.67 Favored 'General case' 0 C--N 1.328 -0.338 0 O-C-N 121.961 -0.462 . . . . 0.0 109.902 177.038 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.446 ' HB3' ' CE2' ' A' ' 76' ' ' TYR . 0.5 OUTLIER -132.8 175.43 9.35 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.931 0.396 . . . . 0.0 111.546 -179.615 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -57.06 161.56 8.0 Favored Glycine 0 C--N 1.332 0.309 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.406 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.528 ' HA ' ' HB3' ' A' ' 70' ' ' ARG . 3.6 p-10 -112.02 100.07 8.58 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.857 0.36 . . . . 0.0 111.79 -179.499 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.606 ' HB ' ' HB2' ' A' ' 85' ' ' SER . 14.2 mt -113.41 147.28 17.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.177 178.738 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.07 -24.27 67.41 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 -179.45 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.409 ' HB3' HD11 ' A' ' 84' ' ' LEU . 41.8 mtp180 -95.78 -98.31 0.17 Allowed 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 112.077 0.399 . . . . 0.0 112.077 -178.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.439 ' O ' ' CB ' ' A' ' 85' ' ' SER . 0.0 OUTLIER -108.46 110.71 22.3 Favored 'General case' 0 CA--C 1.512 -0.491 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 179.268 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.639 ' O ' ' HA2' ' A' ' 69' ' ' GLY . 0.5 OUTLIER 158.56 -35.95 0.0 OUTLIER 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 114.415 -1.266 . . . . 0.0 108.514 -179.068 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.783 ' O ' ' N ' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -66.17 -164.9 0.03 OUTLIER 'General case' 0 CA--C 1.507 -0.688 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 176.86 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.442 ' HA ' ' HA3' ' A' ' 69' ' ' GLY . 0.5 OUTLIER -55.52 70.39 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 177.411 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 1.061 ' O ' ' O ' ' A' ' 104' ' ' ILE . 44.6 t60 -73.3 -14.46 61.31 Favored 'General case' 0 CA--C 1.513 -0.449 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 -176.708 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.542 ' CD2' ' HA ' ' A' ' 103' ' ' ASP . 0.1 OUTLIER -177.67 159.81 1.49 Allowed 'General case' 0 C--N 1.313 -1.007 0 C-N-CA 119.577 -0.849 . . . . 0.0 112.101 178.423 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.492 ' N ' ' CD1' ' A' ' 89' ' ' PHE . 23.4 mt-30 -137.92 160.79 38.37 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 113.791 1.034 . . . . 0.0 113.791 -177.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.609 ' HB ' ' HB2' ' A' ' 66' ' ' TRP . 2.9 mt -122.81 132.02 72.12 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 CA-C-N 115.333 -0.848 . . . . 0.0 109.643 178.058 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.45 ' N ' ' O ' ' A' ' 100' ' ' LEU . 0.5 OUTLIER -106.69 142.79 35.76 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -179.391 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.426 ' HG ' HG23 ' A' ' 33' ' ' VAL . 0.2 OUTLIER -126.36 127.78 46.03 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.389 179.04 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.31 0 C-N-CA 120.6 -0.81 . . . . 0.0 112.801 179.647 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.23 0.065 0 CA-C-O 120.875 0.369 . . . . 0.0 110.909 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.66 ' HA ' ' O ' ' A' ' 122' ' ' GLN . 4.2 mp -133.8 149.06 51.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.294 179.819 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.452 ' O ' ' N ' ' A' ' 122' ' ' GLN . 1.1 mt -115.27 129.97 56.77 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 179.723 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.477 ' O ' ' O ' ' A' ' 90' ' ' GLN . 29.6 t30 -108.54 112.49 24.89 Favored 'General case' 0 CA--C 1.508 -0.636 0 C-N-CA 119.832 -0.747 . . . . 0.0 109.854 179.739 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.635 ' HB3' ' CG2' ' A' ' 109' ' ' THR . 44.3 m-20 -83.92 109.7 17.81 Favored 'General case' 0 N--CA 1.44 -0.926 0 C-N-CA 119.198 -1.001 . . . . 0.0 109.627 179.871 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 1.061 ' O ' ' O ' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -125.05 109.38 22.04 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.041 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 177.168 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.447 ' HB3' ' CE1' ' A' ' 88' ' ' HIS . 65.0 m -136.09 169.39 17.69 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.359 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 19.1 m -69.38 -63.34 1.09 Allowed 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 119.005 -1.078 . . . . 0.0 111.709 -179.009 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -112.29 -32.88 6.38 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 114.904 1.446 . . . . 0.0 114.904 179.301 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -146.03 131.49 4.13 Favored Glycine 0 C--N 1.34 0.759 0 N-CA-C 117.033 1.573 . . . . 0.0 117.033 -177.725 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.635 ' CG2' ' HB3' ' A' ' 103' ' ' ASP . 11.9 m -121.33 138.2 54.36 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 174.451 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . 0.699 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 3.1 m-90 -121.69 149.27 43.48 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 113.648 0.981 . . . . 0.0 113.648 -178.411 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -123.85 112.22 17.02 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 114.979 -1.009 . . . . 0.0 108.711 177.512 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 44.66 43.94 7.03 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.013 -0.54 . . . . 0.0 112.127 -179.566 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 80.8 22.81 60.95 Favored Glycine 0 N--CA 1.445 -0.732 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.801 179.308 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.46 97.77 3.77 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.013 0.435 . . . . 0.0 110.661 179.749 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.699 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.0 OUTLIER -43.99 127.04 5.19 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.98 179.919 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 6.1 m -112.41 179.96 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.907 -179.008 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -90.66 142.2 28.0 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.143 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.415 ' O ' ' C ' ' A' ' 119' ' ' ASN . 54.4 tttm -63.51 163.78 10.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.113 179.429 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.415 ' C ' ' O ' ' A' ' 118' ' ' LYS . 19.4 m-80 33.72 39.85 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 121.28 0.562 . . . . 0.0 111.167 -179.39 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 7.1 p -111.04 105.05 13.68 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.038 -179.429 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -53.58 144.59 17.06 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.571 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . 0.66 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 35.4 mm-40 -129.5 146.02 51.38 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-O 120.976 0.417 . . . . 0.0 111.754 -179.625 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -74.08 129.5 37.98 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.677 179.216 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -52.28 138.46 26.45 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-O 122.045 0.926 . . . . 0.0 111.587 -179.102 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' SER . . . . . 0.404 ' O ' ' CD1' ' A' ' 147' ' ' ILE . 0.6 OUTLIER -127.36 152.13 47.88 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 113.762 -1.563 . . . . 0.0 110.395 179.686 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 14.0 mm100 -71.33 113.9 8.85 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.911 0.386 . . . . 0.0 109.973 179.412 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 62.95 32.12 82.93 Favored Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.336 -179.399 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.403 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 9.3 t70 -53.78 159.24 1.7 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.97 0.414 . . . . 0.0 111.011 -179.837 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.49 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 30.4 tt0 -146.66 135.1 21.94 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.883 -0.598 . . . . 0.0 111.642 -179.838 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.435 ' CG2' ' O ' ' A' ' 110' ' ' TRP . 2.7 mp -116.03 129.0 73.14 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.045 178.597 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.456 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 12.9 m -102.75 145.41 29.78 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.884 0.373 . . . . 0.0 110.852 -179.266 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.494 ' HB ' ' NE2' ' A' ' 88' ' ' HIS . 5.8 m -141.2 158.39 22.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 112.327 0.491 . . . . 0.0 112.327 -179.113 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 67.17 43.03 90.75 Favored Glycine 0 N--CA 1.447 -0.601 0 CA-C-N 115.797 -0.638 . . . . 0.0 112.31 179.356 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.411 ' HA ' HG12 ' A' ' 140' ' ' ILE . 93.6 t -78.44 157.25 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.613 0 CA-C-O 121.36 0.6 . . . . 0.0 112.076 -179.146 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . 0.401 ' N ' ' CG1' ' A' ' 134' ' ' VAL . . . 149.0 -42.02 0.84 Allowed Glycine 0 N--CA 1.441 -1.012 0 N-CA-C 110.691 -0.964 . . . . 0.0 110.691 -179.193 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 48.1 t -126.6 131.33 71.36 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.715 0 CA-C-N 115.256 -0.472 . . . . 0.0 109.883 178.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.24 -33.9 30.04 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.772 0.32 . . . . 0.0 111.432 -179.247 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -94.31 6.5 48.48 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.214 0.45 . . . . 0.0 112.214 -179.397 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 12.0 t0 -127.74 30.92 5.23 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 112.648 0.61 . . . . 0.0 112.648 -179.259 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.456 ' CG2' ' CG2' ' A' ' 131' ' ' THR . 24.2 mt -105.53 141.11 21.6 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.978 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.353 179.238 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.4 ' HB2' ' CG2' ' A' ' 132' ' ' VAL . 2.8 mm? -116.49 135.92 53.42 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 114.938 -1.028 . . . . 0.0 110.358 179.822 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.435 ' O ' ' OG1' ' A' ' 40' ' ' THR . 43.5 t -120.96 152.59 38.35 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 -178.758 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.49 ' O ' ' HA ' ' A' ' 129' ' ' GLU . 3.3 tm? -135.41 136.99 41.83 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 114.841 -1.072 . . . . 0.0 109.21 179.04 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 43.0 t -130.12 140.21 49.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 120.955 0.407 . . . . 0.0 111.842 -178.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -111.41 126.44 68.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.612 179.493 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 15.5 t80 -106.08 108.63 20.24 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.687 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . 0.404 ' CD1' ' O ' ' A' ' 125' ' ' SER . 1.7 mp -85.24 133.42 29.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.26 -179.797 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . 0.414 ' ND2' ' HB2' ' A' ' 151' ' ' PHE . 0.9 OUTLIER -83.77 116.52 22.74 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.798 179.841 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -58.08 -21.67 46.97 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.326 -179.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 4.7 mptt -57.54 -41.07 80.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.891 0.377 . . . . 0.0 110.717 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . 0.419 ' CE2' HD12 ' A' ' 52' ' ' ILE . 4.0 t80 . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.76 179.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.528 0.122 0 CA-C-O 120.668 0.27 . . . . 0.0 111.631 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 27.3 m120 -108.54 -13.27 14.86 Favored 'General case' 0 CA--C 1.513 -0.476 0 CA-C-O 121.913 0.863 . . . . 0.0 109.35 179.282 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.529 ' CG2' ' O ' ' A' ' 32' ' ' ILE . 0.1 OUTLIER -70.6 104.13 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.54 0 CA-C-N 114.085 -1.416 . . . . 0.0 111.035 -179.353 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.603 ' CG1' ' N ' ' A' ' 34' ' ' CYS . 0.5 OUTLIER -37.5 -63.42 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 CA-C-N 115.133 -0.94 . . . . 0.0 112.037 -179.197 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.603 ' N ' ' CG1' ' A' ' 33' ' ' VAL . 18.8 p -164.83 164.73 20.94 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.363 -179.406 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.4 ' HD3' ' CG2' ' A' ' 45' ' ' ILE . 0.9 OUTLIER -127.38 123.64 36.68 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.858 0.361 . . . . 0.0 111.245 179.629 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.422 ' CG2' ' CD1' ' A' ' 48' ' ' LEU . 2.4 t -93.75 122.22 45.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.478 179.531 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.481 ' CG2' HG12 ' A' ' 45' ' ' ILE . 22.4 mt -121.86 107.94 21.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -179.231 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 8.4 m -85.02 100.64 11.81 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 177.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.6 t -85.81 -27.43 25.14 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -178.398 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.45 ' OG1' ' O ' ' A' ' 142' ' ' SER . 0.1 OUTLIER -52.08 -26.43 11.04 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.986 0.422 . . . . 0.0 111.016 -179.899 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 97.08 68.42 0.96 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.28 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 16.9 pt20 -142.42 -46.87 0.33 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.825 0.345 . . . . 0.0 111.204 -179.622 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.444 HG21 ' CE2' ' A' ' 76' ' ' TYR . 10.7 mt -132.31 133.84 24.24 Favored Pre-proline 0 N--CA 1.452 -0.351 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.161 -179.684 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.475 ' HD2' ' CZ ' ' A' ' 76' ' ' TYR . 29.4 Cg_exo -59.36 147.14 92.5 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.754 2.303 . . . . 0.0 111.728 179.501 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.481 HG12 ' CG2' ' A' ' 37' ' ' ILE . 52.6 mt -47.24 143.5 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.994 0.426 . . . . 0.0 111.851 -179.607 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.06 130.38 33.38 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.123 179.422 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -97.76 120.27 37.85 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.11 0.481 . . . . 0.0 111.512 -179.341 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.542 ' HB3' ' CE2' ' A' ' 66' ' ' TRP . 0.5 OUTLIER -96.78 125.18 41.05 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.393 179.032 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.499 ' O ' ' HZ2' ' A' ' 66' ' ' TRP . 0.0 OUTLIER -118.49 162.21 18.73 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 122.065 0.936 . . . . 0.0 113.274 -178.861 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.477 ' CB ' ' CG2' ' A' ' 33' ' ' VAL . . . -119.07 164.78 15.01 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.531 -1.213 . . . . 0.0 111.026 179.644 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -116.06 71.24 0.77 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.021 0.439 . . . . 0.0 110.679 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.408 HD11 ' CE2' ' A' ' 151' ' ' PHE . 96.6 mt . . . . . 0 C--N 1.328 -0.356 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.416 -179.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.2 tptm . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.822 0.344 . . . . 0.0 111.166 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 17.7 ttpt -124.83 131.57 53.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.599 179.385 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.469 ' CG1' ' O ' ' A' ' 91' ' ' ILE . 19.2 t -136.0 139.26 46.2 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 CA-C-O 121.211 0.529 . . . . 0.0 111.94 -179.172 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . 0.638 ' HB2' ' HB ' ' A' ' 91' ' ' ILE . 15.0 m-90 -100.11 139.97 35.02 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.443 179.138 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.529 ' HB ' ' HB3' ' A' ' 74' ' ' CYS . 26.1 m -130.79 132.54 45.33 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.527 0.68 . . . . 0.0 112.149 179.719 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.486 ' CE1' ' CG ' ' A' ' 75' ' ' ASP . 3.6 m-85 -105.96 119.04 38.18 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 114.873 -1.058 . . . . 0.0 109.348 178.298 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.629 ' HA2' ' O ' ' A' ' 85' ' ' SER . . . 160.71 -157.85 29.32 Favored Glycine 0 CA--C 1.505 -0.538 0 C-N-CA 118.658 -1.734 . . . . 0.0 113.286 178.802 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.609 ' HD2' ' ND2' ' A' ' 86' ' ' ASN . 5.1 ptm180 -75.94 91.76 3.07 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-O 122.629 1.204 . . . . 0.0 108.165 179.887 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.506 ' O ' ' CD2' ' A' ' 77' ' ' HIS . 0.2 OUTLIER -149.72 160.35 34.18 Favored Pre-proline 0 C--N 1.307 -1.263 0 CA-C-N 112.606 -2.088 . . . . 0.0 108.085 179.681 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.547 ' O ' ' CB ' ' A' ' 73' ' ' ALA . 30.1 Cg_endo -63.91 -8.74 16.69 Favored 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 120.84 1.027 . . . . 0.0 111.12 178.268 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.608 ' HB3' ' HB2' ' A' ' 77' ' ' HIS . . . 135.69 54.21 0.0 OUTLIER 'General case' 0 CA--C 1.49 -1.358 0 CA-C-N 114.706 -1.134 . . . . 0.0 109.361 178.724 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . 0.529 ' HB3' ' HB ' ' A' ' 67' ' ' THR . 0.1 OUTLIER -52.59 -69.73 0.11 Allowed 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 105.546 -2.02 . . . . 0.0 105.546 179.46 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.504 ' N ' ' O ' ' A' ' 67' ' ' THR . 13.8 t70 -95.51 -47.74 6.12 Favored 'General case' 0 N--CA 1.435 -1.202 0 N-CA-C 105.446 -2.057 . . . . 0.0 105.446 169.137 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.508 ' C ' ' HA ' ' A' ' 73' ' ' ALA . 67.3 t80 -142.96 142.21 31.6 Favored 'General case' 0 C--N 1.347 0.492 0 CA-C-N 112.627 -2.079 . . . . 0.0 111.465 179.756 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . 0.608 ' HB2' ' HB3' ' A' ' 73' ' ' ALA . 23.6 t-160 -91.65 111.64 23.24 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 177.079 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.477 ' HB3' ' CE2' ' A' ' 76' ' ' TYR . 0.5 OUTLIER -135.47 175.89 9.17 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.925 0.393 . . . . 0.0 111.604 -179.666 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -59.39 165.63 9.68 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.257 179.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -112.01 100.07 8.58 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.829 0.347 . . . . 0.0 111.76 -179.493 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.647 ' HB ' ' HB2' ' A' ' 85' ' ' SER . 19.1 mt -115.02 131.77 66.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 177.903 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.435 ' HA ' ' OD1' ' A' ' 86' ' ' ASN . 1.6 m -52.79 -24.01 8.03 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 111.789 0.292 . . . . 0.0 111.789 -178.779 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.409 ' HB3' HD12 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -93.05 -94.85 0.15 Allowed 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 120.428 0.156 . . . . 0.0 111.419 -179.943 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.435 ' O ' ' CB ' ' A' ' 85' ' ' SER . 0.0 OUTLIER -109.43 108.77 19.4 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 121.388 0.613 . . . . 0.0 109.402 178.918 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.647 ' HB2' ' HB ' ' A' ' 81' ' ' ILE . 1.8 m 158.7 -39.67 0.0 OUTLIER 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 114.589 -1.187 . . . . 0.0 109.369 -179.684 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.695 ' O ' ' N ' ' A' ' 88' ' ' HIS . 6.7 m120 -65.76 -163.01 0.02 OUTLIER 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 177.188 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.418 ' HA ' ' HA3' ' A' ' 69' ' ' GLY . 4.1 pttp -58.08 72.82 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 177.435 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.976 ' O ' ' O ' ' A' ' 104' ' ' ILE . 31.2 t60 -77.79 -19.5 54.92 Favored 'General case' 0 CA--C 1.515 -0.382 0 N-CA-C 114.315 1.228 . . . . 0.0 114.315 -176.437 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.478 ' CZ ' HD11 ' A' ' 91' ' ' ILE . 0.0 OUTLIER -173.7 156.86 2.99 Favored 'General case' 0 C--N 1.314 -0.97 0 C-N-CA 118.834 -1.146 . . . . 0.0 113.012 177.944 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.491 ' O ' ' O ' ' A' ' 102' ' ' ASN . 33.4 mt-30 -137.55 160.75 38.27 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 114.587 -1.188 . . . . 0.0 113.751 -177.861 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.638 ' HB ' ' HB2' ' A' ' 66' ' ' TRP . 3.5 mt -128.37 132.18 68.36 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 CA-C-N 115.076 -0.966 . . . . 0.0 109.49 178.486 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.439 ' N ' ' O ' ' A' ' 100' ' ' LEU . 0.3 OUTLIER -108.95 144.11 37.33 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.118 0.485 . . . . 0.0 112.219 -178.988 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.45 ' HG ' HG23 ' A' ' 33' ' ' VAL . 0.3 OUTLIER -125.88 129.95 50.36 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.477 179.409 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.312 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.509 179.733 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 6.6 mp . . . . . 0 CA--C 1.523 -0.092 0 CA-C-O 120.762 0.315 . . . . 0.0 110.769 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.633 ' HA ' ' O ' ' A' ' 122' ' ' GLN . 3.6 mm? -122.54 147.96 45.76 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.336 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.46 ' O ' ' N ' ' A' ' 122' ' ' GLN . 3.5 mp -118.79 127.44 53.53 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 179.502 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.491 ' O ' ' O ' ' A' ' 90' ' ' GLN . 26.1 t30 -111.98 111.48 22.44 Favored 'General case' 0 CA--C 1.506 -0.736 0 C-N-CA 119.641 -0.824 . . . . 0.0 109.944 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.572 ' HB3' ' CG2' ' A' ' 109' ' ' THR . 81.6 m-20 -83.83 111.36 19.14 Favored 'General case' 0 N--CA 1.439 -1.016 0 C-N-CA 119.645 -0.822 . . . . 0.0 109.098 179.354 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.976 ' O ' ' O ' ' A' ' 88' ' ' HIS . 0.1 OUTLIER -122.8 107.74 20.0 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.073 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 177.964 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.437 ' OG ' ' NE2' ' A' ' 88' ' ' HIS . 59.1 m -133.89 169.12 17.56 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-N 114.86 -1.064 . . . . 0.0 109.187 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 20.0 m -69.44 -63.58 1.04 Allowed 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 119.04 -1.064 . . . . 0.0 111.689 -179.045 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -112.5 -32.45 6.47 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 114.858 1.429 . . . . 0.0 114.858 179.271 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -145.66 129.25 3.37 Favored Glycine 0 C--N 1.34 0.761 0 N-CA-C 117.151 1.62 . . . . 0.0 117.151 -177.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.572 ' CG2' ' HB3' ' A' ' 103' ' ' ASP . 6.8 m -121.61 138.54 54.28 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 174.392 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . 0.738 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.4 m-90 -119.46 149.23 42.22 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 -178.393 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -122.61 112.2 17.7 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 115.158 -0.928 . . . . 0.0 108.692 177.594 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 57.8 m-20 44.93 44.06 7.65 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.075 -0.511 . . . . 0.0 112.171 -179.595 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 79.02 23.71 63.19 Favored Glycine 0 N--CA 1.445 -0.745 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.787 179.362 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 -136.76 96.09 3.26 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.105 0.478 . . . . 0.0 110.752 179.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.738 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.0 OUTLIER -44.12 132.87 5.45 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.071 179.888 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 4.1 m -123.61 179.29 2.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.761 -179.184 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -82.95 139.34 33.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.971 180.0 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.437 ' O ' ' C ' ' A' ' 119' ' ' ASN . 9.3 tmtt? -63.03 167.78 4.58 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 179.312 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.437 ' C ' ' O ' ' A' ' 118' ' ' LYS . 3.7 p30 31.22 40.74 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.331 -179.664 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 5.2 p -110.97 107.66 17.15 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.059 -179.187 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . 0.415 ' ND2' ' CD1' ' A' ' 92' ' ' LEU . 1.5 m120 -56.54 140.46 46.3 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.436 179.741 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . 0.633 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 68.6 mm-40 -129.63 147.07 51.38 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-O 121.115 0.483 . . . . 0.0 112.042 -179.714 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 7.3 tp -72.62 119.92 17.52 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.384 -0.825 . . . . 0.0 109.759 179.147 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.4 ' CD1' HD13 ' A' ' 147' ' ' ILE . 2.3 tp -48.06 142.41 5.18 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-O 121.854 0.835 . . . . 0.0 111.825 -178.881 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' SER . . . . . 0.416 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.0 OUTLIER -127.19 152.62 47.13 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 114.146 -1.388 . . . . 0.0 110.557 179.739 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 1.2 tp60 -72.34 113.71 9.66 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 179.162 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 68.75 27.24 74.01 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.466 -179.486 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.416 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 8.3 t70 -56.03 159.96 3.05 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-O 120.895 0.378 . . . . 0.0 111.232 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.413 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 2.0 tt0 -146.74 135.4 22.13 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.756 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.457 ' CD1' ' CE1' ' A' ' 89' ' ' PHE . 7.0 mt -116.27 128.14 73.67 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 178.586 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.498 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 98.6 m -103.2 145.82 29.35 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.856 0.36 . . . . 0.0 110.788 -179.404 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.533 ' HB ' ' NE2' ' A' ' 88' ' ' HIS . 7.8 m -141.12 158.42 22.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -178.786 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 69.94 44.13 62.87 Favored Glycine 0 N--CA 1.448 -0.567 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.451 179.2 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.438 ' HA ' HG12 ' A' ' 140' ' ' ILE . 93.8 t -80.43 156.49 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 CA-C-O 121.434 0.635 . . . . 0.0 112.192 -179.242 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . 0.402 ' N ' ' CG1' ' A' ' 134' ' ' VAL . . . 149.62 -42.56 0.79 Allowed Glycine 0 N--CA 1.441 -0.972 0 N-CA-C 110.552 -1.019 . . . . 0.0 110.552 -179.129 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 51.9 t -126.85 131.95 70.53 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.69 0 CA-C-N 115.205 -0.497 . . . . 0.0 109.769 178.563 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -51.34 -34.52 34.05 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.725 0.298 . . . . 0.0 111.472 -179.266 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 13.9 m -94.3 6.51 48.44 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.416 0.524 . . . . 0.0 112.416 -179.36 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 18.2 t0 -126.51 30.37 5.57 Favored 'General case' 0 CA--C 1.519 -0.249 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -179.313 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.498 ' CG2' ' CG2' ' A' ' 131' ' ' THR . 14.7 mt -107.29 141.23 23.01 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.437 179.348 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 28.3 mt -119.82 135.23 54.95 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 114.902 -1.045 . . . . 0.0 109.916 179.554 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.45 ' O ' ' OG1' ' A' ' 40' ' ' THR . 47.3 t -116.92 151.89 35.69 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.912 0.863 . . . . 0.0 113.053 -178.806 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.413 ' O ' ' HA ' ' A' ' 129' ' ' GLU . 5.5 mp -128.42 129.54 46.31 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.547 -1.206 . . . . 0.0 109.312 179.145 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 10.6 t -115.37 140.45 36.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 120.892 0.377 . . . . 0.0 111.641 -179.179 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . 0.419 HG13 HG22 ' A' ' 36' ' ' VAL . 0.1 OUTLIER -116.23 126.26 73.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.766 179.957 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 9.8 t80 -109.62 121.89 46.22 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.782 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . 0.4 HD13 ' CD1' ' A' ' 124' ' ' LEU . 5.9 mm -100.79 133.54 43.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.275 -179.835 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 7.9 p-10 -82.44 125.57 31.23 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.002 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -67.82 -22.66 65.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.024 179.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 9.8 mtmt -57.19 -40.23 76.95 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-O 120.939 0.399 . . . . 0.0 110.649 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . 0.408 ' CE2' HD11 ' A' ' 52' ' ' ILE . 19.5 t80 . . . . . 0 C--N 1.328 -0.348 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.563 179.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.727 0.299 . . . . 0.0 110.888 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 10.7 m-20 -109.0 -13.95 14.63 Favored 'General case' 0 CA--C 1.516 -0.345 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 178.244 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.594 ' CG2' ' O ' ' A' ' 32' ' ' ILE . 0.1 OUTLIER -70.74 95.46 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.581 0 CA-C-N 113.908 -1.497 . . . . 0.0 110.473 -179.685 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.564 ' CG1' ' N ' ' A' ' 34' ' ' CYS . 0.8 OUTLIER -36.02 -63.08 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 114.813 -1.085 . . . . 0.0 112.593 -178.939 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.564 ' N ' ' CG1' ' A' ' 33' ' ' VAL . 98.3 m -154.31 164.8 38.03 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.152 0.501 . . . . 0.0 112.141 -179.009 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.19 114.84 20.82 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.264 179.241 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.7 m -88.98 126.93 42.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.663 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.446 ' CG2' HG12 ' A' ' 45' ' ' ILE . 26.3 mt -126.07 108.82 20.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 112.464 0.542 . . . . 0.0 112.464 -179.035 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -108.73 108.88 19.88 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 177.822 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.6 t -110.69 -23.22 11.19 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 -177.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.2 p -53.13 -25.21 12.5 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.917 0.389 . . . . 0.0 111.286 -179.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 119.98 47.74 0.34 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.494 179.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -120.06 -67.77 0.96 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.837 0.351 . . . . 0.0 110.886 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.475 ' CG2' ' CD1' ' A' ' 76' ' ' TYR . 0.6 OUTLIER -135.02 135.1 22.33 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.953 -179.804 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.44 ' HD2' ' CZ ' ' A' ' 76' ' ' TYR . 24.0 Cg_exo -59.37 147.69 89.99 Favored 'Trans proline' 0 C--N 1.342 0.234 0 C-N-CA 122.469 2.112 . . . . 0.0 111.563 179.451 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.446 HG12 ' CG2' ' A' ' 37' ' ' ILE . 32.8 mt -44.28 129.02 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.056 0.455 . . . . 0.0 111.99 -179.32 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.419 ' HB2' ' CD2' ' A' ' 76' ' ' TYR . 4.8 tpt180 -128.05 148.16 50.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.738 -0.664 . . . . 0.0 109.765 179.151 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -106.05 120.03 40.73 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.972 0.415 . . . . 0.0 111.797 -179.159 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.522 ' HB3' ' CE2' ' A' ' 66' ' ' TRP . 3.5 mt -93.64 131.84 38.56 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.282 178.716 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.527 ' O ' ' HZ2' ' A' ' 66' ' ' TRP . 0.0 OUTLIER -136.59 162.27 33.59 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 122.03 0.919 . . . . 0.0 113.406 -178.641 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.465 ' HB3' HG21 ' A' ' 33' ' ' VAL . . . -149.17 165.57 31.43 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.24 -1.346 . . . . 0.0 111.035 179.057 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 32.3 m-20 -91.57 121.16 33.0 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.051 0.453 . . . . 0.0 111.303 -179.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 72.0 mt . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 115.788 -0.642 . . . . 0.0 112.077 -179.759 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 60.3 tttt . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.842 0.353 . . . . 0.0 110.961 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.424 ' O ' ' HB3' ' A' ' 93' ' ' LEU . 6.3 ttpt -115.18 134.1 55.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.462 179.791 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.469 ' CG1' ' O ' ' A' ' 91' ' ' ILE . 16.8 t -137.1 137.72 46.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.116 0.484 . . . . 0.0 111.647 -179.292 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . 0.655 ' HB2' ' HB ' ' A' ' 91' ' ' ILE . 14.5 m-90 -99.89 139.67 35.21 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.199 179.128 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.678 ' N ' ' HB2' ' A' ' 75' ' ' ASP . 8.8 m -127.57 129.63 47.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.505 0.669 . . . . 0.0 112.489 179.301 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.571 ' CE1' ' CG ' ' A' ' 75' ' ' ASP . 12.9 m-85 -100.91 118.49 37.05 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.14 -0.936 . . . . 0.0 108.961 177.735 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.622 ' HA2' ' O ' ' A' ' 85' ' ' SER . . . 160.46 -157.03 28.4 Favored Glycine 0 CA--C 1.505 -0.546 0 C-N-CA 119.045 -1.55 . . . . 0.0 113.057 179.236 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.41 ' O ' ' HG3' ' A' ' 70' ' ' ARG . 0.0 OUTLIER -76.78 92.42 3.59 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-O 122.663 1.22 . . . . 0.0 108.719 -179.685 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.502 ' O ' ' CD2' ' A' ' 77' ' ' HIS . 17.7 m-80 -149.42 159.45 36.58 Favored Pre-proline 0 C--N 1.306 -1.289 0 CA-C-N 112.68 -2.055 . . . . 0.0 108.06 179.15 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.544 ' O ' ' CB ' ' A' ' 73' ' ' ALA . 27.8 Cg_endo -63.61 -6.66 10.95 Favored 'Trans proline' 0 N--CA 1.452 -0.956 0 C-N-CA 120.64 0.893 . . . . 0.0 110.695 177.648 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.591 ' HB1' ' HB2' ' A' ' 77' ' ' HIS . . . 135.32 53.47 0.0 OUTLIER 'General case' 0 CA--C 1.491 -1.316 0 CA-C-N 114.447 -1.252 . . . . 0.0 109.227 178.814 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . 0.551 ' HB3' ' HB ' ' A' ' 67' ' ' THR . 0.1 OUTLIER -52.48 -69.88 0.1 Allowed 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 105.443 -2.058 . . . . 0.0 105.443 179.617 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.678 ' HB2' ' N ' ' A' ' 67' ' ' THR . 57.0 t0 -95.45 -47.47 6.26 Favored 'General case' 0 N--CA 1.434 -1.232 0 N-CA-C 105.504 -2.036 . . . . 0.0 105.504 169.05 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.491 ' C ' ' HA ' ' A' ' 73' ' ' ALA . 1.7 t80 -143.72 142.72 31.08 Favored 'General case' 0 C--N 1.348 0.512 0 CA-C-N 112.602 -2.09 . . . . 0.0 112.019 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . 0.591 ' HB2' ' HB1' ' A' ' 73' ' ' ALA . 23.3 t-160 -96.43 108.02 20.5 Favored 'General case' 0 C--N 1.331 -0.218 0 O-C-N 122.166 -0.334 . . . . 0.0 110.101 176.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.452 ' CD1' ' N ' ' A' ' 78' ' ' LEU . 0.0 OUTLIER -136.94 179.93 6.08 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.891 0.377 . . . . 0.0 111.677 -179.754 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -52.23 157.75 3.54 Favored Glycine 0 C--N 1.333 0.383 0 CA-C-N 115.983 -0.553 . . . . 0.0 112.854 -179.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 5.9 p-10 -111.93 99.9 8.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.811 0.339 . . . . 0.0 111.814 -179.561 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.627 ' HB ' ' HB2' ' A' ' 85' ' ' SER . 14.1 mm -114.26 129.97 69.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.237 -0.438 . . . . 0.0 109.845 178.336 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.448 ' HA ' ' ND2' ' A' ' 86' ' ' ASN . 80.3 p -53.02 -23.7 8.07 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.788 -179.082 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.408 ' HB3' HD12 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -93.97 -96.38 0.15 Allowed 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 111.669 0.248 . . . . 0.0 111.669 -179.509 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.463 ' O ' ' CB ' ' A' ' 85' ' ' SER . 0.0 OUTLIER -109.82 109.93 20.74 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-O 121.295 0.569 . . . . 0.0 109.84 179.324 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.627 ' HB2' ' HB ' ' A' ' 81' ' ' ILE . 0.4 OUTLIER 157.24 -41.26 0.0 OUTLIER 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 114.781 -1.099 . . . . 0.0 109.469 -179.942 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.761 ' O ' ' N ' ' A' ' 88' ' ' HIS . 91.1 m-20 -67.71 -156.19 0.02 OUTLIER 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 177.69 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.408 ' HB2' ' CD1' ' A' ' 104' ' ' ILE . 8.7 pttp -54.03 72.23 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 178.397 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 1.023 ' O ' ' O ' ' A' ' 104' ' ' ILE . 42.8 t60 -81.92 -16.13 51.59 Favored 'General case' 0 CA--C 1.514 -0.419 0 N-CA-C 113.888 1.07 . . . . 0.0 113.888 -176.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.583 ' CE1' HG13 ' A' ' 91' ' ' ILE . 0.0 OUTLIER -177.54 159.99 1.55 Allowed 'General case' 0 C--N 1.314 -0.95 0 C-N-CA 119.301 -0.96 . . . . 0.0 112.457 178.161 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.485 ' O ' ' O ' ' A' ' 102' ' ' ASN . 38.3 mt-30 -138.89 160.35 39.93 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 113.761 1.022 . . . . 0.0 113.761 -178.442 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.655 ' HB ' ' HB2' ' A' ' 66' ' ' TRP . 5.6 mt -124.57 131.54 72.58 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.345 177.714 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.447 ' N ' ' O ' ' A' ' 100' ' ' LEU . 0.2 OUTLIER -107.61 140.24 40.93 Favored 'General case' 0 N--CA 1.463 0.176 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 -179.129 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.519 ' HG ' HG21 ' A' ' 33' ' ' VAL . 0.3 OUTLIER -126.34 131.18 51.87 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.445 179.068 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.402 ' N ' ' CD2' ' A' ' 93' ' ' LEU . . . . . . . . 0 N--CA 1.451 -0.328 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.661 179.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 4.0 mm? . . . . . 0 C--O 1.23 0.072 0 CA-C-O 120.836 0.351 . . . . 0.0 110.763 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.645 ' HA ' ' O ' ' A' ' 122' ' ' GLN . 3.8 mp -133.58 149.02 51.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.538 -179.794 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.458 ' O ' ' N ' ' A' ' 122' ' ' GLN . 0.5 OUTLIER -115.21 129.9 56.77 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 179.506 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.485 ' O ' ' O ' ' A' ' 90' ' ' GLN . 20.6 t30 -110.26 112.35 24.25 Favored 'General case' 0 CA--C 1.51 -0.588 0 C-N-CA 119.796 -0.762 . . . . 0.0 109.893 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.58 ' HB3' ' CG2' ' A' ' 109' ' ' THR . 87.0 m-20 -83.93 110.49 18.44 Favored 'General case' 0 N--CA 1.442 -0.848 0 C-N-CA 119.355 -0.938 . . . . 0.0 109.495 179.593 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 1.023 ' O ' ' O ' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -124.27 108.5 20.62 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.026 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 177.08 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.424 ' OG ' ' NE2' ' A' ' 88' ' ' HIS . 64.0 m -134.56 168.97 17.99 Favored 'General case' 0 C--N 1.296 -1.754 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.227 179.808 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 19.9 m -69.33 -63.14 1.12 Allowed 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 119.006 -1.078 . . . . 0.0 111.542 -179.042 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 63.9 m-80 -112.27 -32.39 6.54 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 114.934 1.457 . . . . 0.0 114.934 179.323 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -145.89 127.82 2.91 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 117.105 1.602 . . . . 0.0 117.105 -177.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.58 ' CG2' ' HB3' ' A' ' 103' ' ' ASP . 5.7 m -121.18 138.11 54.36 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 174.337 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . 0.716 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.8 m-90 -120.7 148.98 43.21 Favored 'General case' 0 CA--C 1.515 -0.384 0 N-CA-C 113.462 0.912 . . . . 0.0 113.462 -178.515 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -122.65 112.08 17.53 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 115.026 -0.988 . . . . 0.0 108.621 177.532 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 39.7 m-20 45.57 43.76 9.42 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.085 -0.507 . . . . 0.0 112.118 -179.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 78.88 25.05 60.82 Favored Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.784 179.425 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 31.2 mt-30 -136.98 97.51 3.53 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.102 0.477 . . . . 0.0 110.802 179.69 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.716 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.0 OUTLIER -45.66 132.61 8.44 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.911 179.755 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 27.7 m -124.07 -178.84 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 121.069 0.461 . . . . 0.0 111.916 -179.041 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -85.5 142.29 29.3 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.111 -179.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.409 ' HG2' ' N ' ' A' ' 119' ' ' ASN . 33.7 tttm -64.26 163.73 12.34 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.197 179.422 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.409 ' N ' ' HG2' ' A' ' 118' ' ' LYS . 8.2 m-80 34.56 39.91 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 121.182 0.515 . . . . 0.0 111.062 -179.374 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 3.5 p -110.74 107.2 16.66 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.901 -179.537 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -53.12 146.75 10.87 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.771 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . 0.645 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 80.7 mm-40 -129.28 152.11 49.2 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-O 121.149 0.499 . . . . 0.0 111.925 -179.514 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -81.02 122.52 27.41 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.571 -0.741 . . . . 0.0 109.531 179.031 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.529 ' O ' HD12 ' A' ' 124' ' ' LEU . 0.0 OUTLIER -48.45 139.44 9.05 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-O 122.365 1.078 . . . . 0.0 112.241 -178.672 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' SER . . . . . 0.411 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.3 OUTLIER -127.68 152.56 47.55 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 113.593 -1.64 . . . . 0.0 110.196 179.485 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 7.2 tp-100 -71.86 113.44 8.9 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 179.27 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 64.8 30.79 78.92 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.366 -179.564 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.411 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 29.8 t70 -53.74 160.5 1.34 Allowed 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.884 0.373 . . . . 0.0 111.077 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.485 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 0.1 OUTLIER -146.6 135.48 22.37 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.755 -179.898 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.447 ' CG2' ' O ' ' A' ' 110' ' ' TRP . 7.3 mm -113.68 128.72 70.43 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.124 0 CA-C-N 116.167 -0.47 . . . . 0.0 109.922 178.659 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.458 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 18.7 m -103.42 144.31 31.55 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.785 -179.392 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.471 ' HB ' ' NE2' ' A' ' 88' ' ' HIS . 5.6 m -141.19 156.1 21.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.005 0.431 . . . . 0.0 112.159 -179.068 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . 0.405 ' O ' ' O ' ' A' ' 139' ' ' ASP . . . 70.34 39.54 70.45 Favored Glycine 0 N--CA 1.448 -0.562 0 CA-C-N 115.914 -0.585 . . . . 0.0 112.463 179.396 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.421 ' HA ' HG12 ' A' ' 140' ' ' ILE . 90.2 t -74.39 156.86 6.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 121.447 0.641 . . . . 0.0 112.123 -179.247 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . 0.41 ' N ' ' CG1' ' A' ' 134' ' ' VAL . . . 152.99 -46.21 0.57 Allowed Glycine 0 N--CA 1.441 -1.0 0 CA-C-N 114.981 -1.008 . . . . 0.0 110.749 -179.285 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 42.7 t -126.59 133.9 67.55 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.722 0 CA-C-N 115.222 -0.489 . . . . 0.0 109.904 178.597 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -51.01 -32.44 21.27 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.89 0.376 . . . . 0.0 111.207 -179.353 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 46.7 m -94.39 6.22 49.39 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 116.164 -0.471 . . . . 0.0 112.132 -179.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . 0.405 ' O ' ' O ' ' A' ' 133' ' ' GLY . 25.4 t0 -128.34 30.26 5.21 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 -179.378 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.458 ' CG2' ' CG2' ' A' ' 131' ' ' THR . 27.5 mt -105.89 141.19 21.76 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.287 179.373 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 4.5 mt -116.79 135.27 53.88 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.869 -1.059 . . . . 0.0 110.291 179.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 29.8 t -120.31 152.42 37.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.694 0.759 . . . . 0.0 112.359 -179.17 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.485 ' O ' ' HA ' ' A' ' 129' ' ' GLU . 0.8 OUTLIER -135.7 131.28 35.44 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.625 -1.17 . . . . 0.0 108.992 179.357 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.453 ' N ' HD22 ' A' ' 143' ' ' LEU . 12.2 t -111.67 140.17 32.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.975 0.416 . . . . 0.0 111.908 -179.079 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -116.91 126.63 74.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.215 179.575 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 16.0 t80 -106.97 125.48 51.06 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.057 -179.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . 0.47 HD13 HG22 ' A' ' 147' ' ' ILE . 4.1 mm -103.53 133.3 47.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.999 -179.931 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 35.5 p-10 -84.77 111.25 19.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.861 0.362 . . . . 0.0 110.718 179.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -56.28 -27.34 54.96 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.153 -179.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 2.2 tptt -57.2 -36.34 70.72 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.807 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 4.2 t80 . . . . . 0 N--CA 1.451 -0.381 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.777 179.998 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.643 0.258 . . . . 0.0 111.508 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 26.0 m-80 -109.56 -14.69 14.34 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-O 121.909 0.862 . . . . 0.0 109.28 178.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.449 ' O ' ' CG2' ' A' ' 32' ' ' ILE . 0.1 OUTLIER -74.1 111.14 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.571 0 CA-C-N 114.129 -1.396 . . . . 0.0 111.23 -179.168 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.589 ' CG1' ' N ' ' A' ' 34' ' ' CYS . 0.5 OUTLIER -45.02 -64.12 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.211 -0.904 . . . . 0.0 111.381 -179.488 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.589 ' N ' ' CG1' ' A' ' 33' ' ' VAL . 30.2 p -165.4 164.93 19.61 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.039 0.447 . . . . 0.0 112.046 -179.644 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -124.39 117.63 24.89 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.598 179.38 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.428 ' CG2' ' CD2' ' A' ' 48' ' ' LEU . 89.3 t -89.16 132.57 33.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.112 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.47 ' CG2' HG12 ' A' ' 45' ' ' ILE . 22.6 mt -129.86 108.14 15.84 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.693 -179.745 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.406 ' HB3' ' O ' ' A' ' 43' ' ' ILE . 2.5 t -86.66 105.98 17.29 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 178.18 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 11.4 t -90.71 -26.76 19.38 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 -178.41 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.406 HG21 ' HB3' ' A' ' 142' ' ' SER . 26.1 p -59.64 -21.99 61.24 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 121.047 -0.261 . . . . 0.0 111.422 -179.429 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 103.65 72.39 0.9 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.571 -0.823 . . . . 0.0 113.033 179.384 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.411 ' NE2' ' HB3' ' A' ' 141' ' ' LEU . 0.0 OUTLIER -151.1 -70.62 0.17 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.859 0.361 . . . . 0.0 110.941 179.534 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.486 HG21 ' CD2' ' A' ' 76' ' ' TYR . 16.7 mt -102.56 140.33 21.0 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.2 -179.565 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.478 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 74.3 Cg_endo -77.6 146.76 24.41 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 122.337 2.025 . . . . 0.0 111.724 179.566 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.47 HG12 ' CG2' ' A' ' 37' ' ' ILE . 35.5 mt -44.12 108.67 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.056 0.455 . . . . 0.0 111.779 -179.499 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.24 129.8 56.73 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.761 179.132 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -96.4 119.38 34.78 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.986 0.422 . . . . 0.0 111.429 -179.305 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.503 ' HB3' ' CE2' ' A' ' 66' ' ' TRP . 0.2 OUTLIER -96.36 131.98 42.34 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 178.543 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.559 ' O ' ' CZ2' ' A' ' 66' ' ' TRP . 0.1 OUTLIER -113.15 164.02 14.03 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.84 0.828 . . . . 0.0 112.608 -178.598 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.514 ' CB ' ' CG2' ' A' ' 33' ' ' VAL . . . -111.46 166.42 11.14 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 114.915 -1.039 . . . . 0.0 110.864 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -93.56 46.13 1.18 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.946 0.403 . . . . 0.0 110.942 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 14.1 mm . . . . . 0 C--N 1.328 -0.368 0 CA-C-O 121.099 0.476 . . . . 0.0 110.664 179.614 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.5 ttpt . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.99 0.424 . . . . 0.0 110.776 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.415 ' O ' ' HB3' ' A' ' 93' ' ' LEU . 7.9 ttpt -126.92 131.21 51.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.685 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.427 ' CG1' ' O ' ' A' ' 91' ' ' ILE . 10.7 t -134.86 136.33 52.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 121.037 0.446 . . . . 0.0 111.588 -179.494 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . 0.611 ' HB2' ' HB ' ' A' ' 91' ' ' ILE . 16.0 m-90 -102.07 140.06 36.86 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.057 179.599 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.595 ' O ' ' N ' ' A' ' 75' ' ' ASP . 3.1 m -127.58 129.81 47.95 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.435 0.635 . . . . 0.0 112.14 179.51 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.477 ' CD2' ' CE2' ' A' ' 89' ' ' PHE . 64.7 m-85 -101.77 118.38 36.81 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.322 178.192 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.591 ' HA2' ' O ' ' A' ' 85' ' ' SER . . . 159.33 -157.6 28.72 Favored Glycine 0 CA--C 1.502 -0.755 0 C-N-CA 119.034 -1.555 . . . . 0.0 112.192 179.328 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.425 ' CD ' ' HB3' ' A' ' 86' ' ' ASN . 11.7 ptm180 -76.75 91.81 3.52 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-O 122.424 1.106 . . . . 0.0 108.297 179.538 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.542 ' O ' ' CD2' ' A' ' 77' ' ' HIS . 6.3 m120 -149.08 154.63 39.63 Favored Pre-proline 0 C--N 1.311 -1.068 0 CA-C-N 112.985 -1.916 . . . . 0.0 108.506 179.269 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.572 ' O ' ' HB2' ' A' ' 77' ' ' HIS . 25.7 Cg_exo -56.1 -11.56 5.97 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 121.507 1.472 . . . . 0.0 111.571 178.45 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.637 ' HB2' ' HB2' ' A' ' 77' ' ' HIS . . . 137.27 50.97 0.0 OUTLIER 'General case' 0 CA--C 1.49 -1.336 0 CA-C-N 114.96 -1.018 . . . . 0.0 109.605 178.791 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . 0.556 ' HB3' ' HB ' ' A' ' 67' ' ' THR . 0.1 OUTLIER -52.92 -69.9 0.1 Allowed 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 105.858 -1.904 . . . . 0.0 105.858 179.485 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.595 ' N ' ' O ' ' A' ' 67' ' ' THR . 12.2 t0 -94.78 -47.4 6.49 Favored 'General case' 0 N--CA 1.437 -1.112 0 N-CA-C 105.89 -1.893 . . . . 0.0 105.89 169.806 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.505 ' C ' ' HA ' ' A' ' 73' ' ' ALA . 35.6 t80 -144.21 142.56 30.59 Favored 'General case' 0 C--N 1.347 0.473 0 CA-C-N 112.576 -2.102 . . . . 0.0 110.951 179.658 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . 0.637 ' HB2' ' HB2' ' A' ' 73' ' ' ALA . 23.3 t-160 -93.0 108.38 19.96 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 118.12 0.418 . . . . 0.0 110.442 177.323 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.495 ' HB3' ' CE2' ' A' ' 76' ' ' TYR . 2.2 pp -125.66 168.48 13.67 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.784 0.326 . . . . 0.0 111.103 179.698 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -53.91 173.05 0.63 Allowed Glycine 0 C--N 1.33 0.209 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.777 -179.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 12.8 p-10 -96.05 105.36 17.39 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.725 0.298 . . . . 0.0 110.965 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.469 ' CB ' ' HB2' ' A' ' 85' ' ' SER . 2.0 mp -111.53 152.65 13.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.772 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.23 -45.27 73.74 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 113.61 0.967 . . . . 0.0 113.61 -178.767 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 17.9 mtt180 -119.72 -91.16 0.56 Allowed 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 113.692 0.997 . . . . 0.0 113.692 -177.328 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.493 ' O ' ' CB ' ' A' ' 85' ' ' SER . 0.0 OUTLIER -84.9 103.26 13.8 Favored 'General case' 0 CA--C 1.507 -0.704 0 CA-C-O 121.948 0.88 . . . . 0.0 110.74 -178.606 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.591 ' O ' ' HA2' ' A' ' 69' ' ' GLY . 0.4 OUTLIER 148.62 -35.42 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 113.113 -1.858 . . . . 0.0 108.718 -179.745 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.792 ' O ' ' N ' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -68.44 -162.39 0.03 OUTLIER 'General case' 0 CA--C 1.514 -0.43 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 177.6 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.527 ' HA ' ' HA3' ' A' ' 69' ' ' GLY . 1.0 OUTLIER -53.14 72.18 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 177.822 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.959 ' O ' ' O ' ' A' ' 104' ' ' ILE . 29.6 t60 -83.73 -18.91 36.26 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 114.642 1.349 . . . . 0.0 114.642 -175.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.53 ' HA ' ' H ' ' A' ' 104' ' ' ILE . 0.0 OUTLIER -171.06 156.98 5.02 Favored 'General case' 0 C--N 1.31 -1.113 0 C-N-CA 118.824 -1.15 . . . . 0.0 112.632 177.864 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.497 ' O ' ' O ' ' A' ' 102' ' ' ASN . 34.4 mt-30 -135.37 158.8 43.45 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.587 -1.188 . . . . 0.0 113.825 -177.197 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.611 ' HB ' ' HB2' ' A' ' 66' ' ' TRP . 7.9 mt -124.16 132.82 70.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 114.908 -1.042 . . . . 0.0 109.785 178.499 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.428 ' HB2' ' CB ' ' A' ' 100' ' ' LEU . 0.3 OUTLIER -108.99 144.03 37.5 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.01 0.433 . . . . 0.0 111.807 -179.557 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.465 ' HG ' HG23 ' A' ' 33' ' ' VAL . 0.8 OUTLIER -125.58 122.69 37.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.485 179.442 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.379 0 C-N-CA 120.594 -0.812 . . . . 0.0 112.678 179.806 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.797 0.332 . . . . 0.0 110.783 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.593 ' HA ' ' O ' ' A' ' 122' ' ' GLN . 4.1 mm? -131.35 148.24 52.65 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.263 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.466 ' O ' ' N ' ' A' ' 122' ' ' GLN . 0.3 OUTLIER -117.03 129.99 56.38 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 179.869 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.497 ' O ' ' O ' ' A' ' 90' ' ' GLN . 28.0 t30 -111.35 111.41 22.43 Favored 'General case' 0 CA--C 1.508 -0.64 0 C-N-CA 119.79 -0.764 . . . . 0.0 109.781 179.611 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.571 ' HB3' ' CG2' ' A' ' 109' ' ' THR . 76.2 m-20 -85.54 112.01 20.55 Favored 'General case' 0 N--CA 1.442 -0.838 0 C-N-CA 119.643 -0.823 . . . . 0.0 109.543 179.507 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.959 ' O ' ' O ' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -123.0 107.63 19.66 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.975 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 177.849 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.446 ' OG ' ' NE2' ' A' ' 88' ' ' HIS . 50.1 m -134.49 168.95 18.02 Favored 'General case' 0 C--N 1.296 -1.732 0 CA-C-N 114.906 -1.043 . . . . 0.0 109.221 179.672 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 19.5 m -69.59 -63.34 1.09 Allowed 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 119.055 -1.058 . . . . 0.0 111.76 -178.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -112.26 -32.33 6.56 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 114.976 1.473 . . . . 0.0 114.976 179.436 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -145.72 126.46 2.55 Favored Glycine 0 C--N 1.339 0.725 0 N-CA-C 117.346 1.698 . . . . 0.0 117.346 -177.531 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.571 ' CG2' ' HB3' ' A' ' 103' ' ' ASP . 4.3 m -121.26 138.11 54.38 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 174.389 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . 0.682 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.6 m-90 -120.67 148.94 43.25 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 -178.539 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -121.77 112.2 18.08 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 115.152 -0.931 . . . . 0.0 108.698 177.437 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 33.5 m-20 45.48 43.4 8.81 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.073 -0.512 . . . . 0.0 112.099 -179.439 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 78.83 27.87 55.78 Favored Glycine 0 N--CA 1.444 -0.798 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.761 179.247 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -139.19 96.73 3.15 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.099 0.476 . . . . 0.0 110.774 179.776 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.682 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.3 OUTLIER -44.57 128.96 6.76 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.019 179.775 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 3.7 m -121.99 -179.84 2.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.743 -179.208 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -85.57 142.1 29.37 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.186 -179.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.412 ' HG2' ' N ' ' A' ' 119' ' ' ASN . 62.3 tttm -65.0 162.55 16.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.129 179.358 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.412 ' N ' ' HG2' ' A' ' 118' ' ' LYS . 4.4 p30 35.88 38.19 0.05 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.215 0.531 . . . . 0.0 111.142 -179.799 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 9.6 p -111.18 110.95 21.69 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.929 -179.394 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -57.39 141.04 48.62 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.683 179.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . 0.593 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 33.6 mm-40 -129.52 145.89 51.4 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-O 121.009 0.433 . . . . 0.0 111.861 -179.666 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -72.28 117.7 14.25 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.671 179.184 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.441 ' HG ' ' N ' ' A' ' 125' ' ' SER . 0.7 OUTLIER -47.42 143.79 3.34 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.9 0.857 . . . . 0.0 112.029 -178.943 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' SER . . . . . 0.441 ' N ' ' HG ' ' A' ' 124' ' ' LEU . 0.3 OUTLIER -126.84 152.78 46.53 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 114.045 -1.434 . . . . 0.0 110.124 179.263 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.59 113.99 9.21 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.981 -0.378 . . . . 0.0 109.981 179.633 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 67.99 27.62 73.62 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.852 -0.689 . . . . 0.0 112.266 -179.411 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -55.04 160.42 2.05 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.01 0.433 . . . . 0.0 111.185 -179.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -146.01 135.38 22.98 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.447 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.44 ' CG2' ' O ' ' A' ' 110' ' ' TRP . 7.0 mm -111.51 128.22 68.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 178.908 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.455 ' HB ' ' CB ' ' A' ' 110' ' ' TRP . 41.9 m -103.73 144.94 30.81 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.73 -179.538 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.462 ' HB ' ' NE2' ' A' ' 88' ' ' HIS . 4.1 m -141.46 158.42 21.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -178.781 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 66.17 42.17 94.49 Favored Glycine 0 N--CA 1.447 -0.574 0 CA-C-N 115.83 -0.623 . . . . 0.0 112.355 179.359 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.42 ' HA ' HG12 ' A' ' 140' ' ' ILE . 88.9 t -76.89 157.04 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 CA-C-O 121.467 0.651 . . . . 0.0 112.193 -179.125 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 144.65 -43.08 0.98 Allowed Glycine 0 N--CA 1.44 -1.062 0 N-CA-C 110.447 -1.061 . . . . 0.0 110.447 -178.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 47.5 t -126.87 126.09 67.88 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 CA-C-N 114.984 -0.608 . . . . 0.0 109.705 178.589 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -51.17 -28.23 10.66 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.774 0.321 . . . . 0.0 111.186 -179.342 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -94.36 6.49 48.56 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 116.224 -0.443 . . . . 0.0 112.114 -179.598 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -130.94 27.55 4.88 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 -179.427 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.446 ' CG2' ' CG2' ' A' ' 131' ' ' THR . 23.9 mt -102.73 140.86 19.94 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.312 179.169 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.411 ' HB3' ' NE2' ' A' ' 42' ' ' GLN . 4.9 mp -124.07 135.39 53.53 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 114.808 -1.087 . . . . 0.0 109.734 179.511 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.406 ' HB3' HG21 ' A' ' 40' ' ' THR . 38.9 t -127.65 151.92 48.33 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -178.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.405 ' CD2' ' CG1' ' A' ' 36' ' ' VAL . 3.2 tm? -122.96 138.09 54.77 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 114.424 -1.262 . . . . 0.0 109.155 179.184 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 3.8 t -119.17 141.03 41.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.8 0.333 . . . . 0.0 111.724 -178.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -111.02 140.34 30.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.161 179.564 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -119.76 106.57 12.25 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.556 179.79 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . 0.427 HG12 ' CD2' ' A' ' 124' ' ' LEU . 2.0 mp -99.38 133.38 42.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.483 -179.781 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 -78.82 140.23 38.24 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.236 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -73.8 -18.44 60.95 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.196 178.771 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.5 -45.21 84.44 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.648 179.779 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 26.1 t80 . . . . . 0 C--N 1.331 -0.227 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.681 179.844 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 . . . . . 0 CA--C 1.528 0.109 0 CA-C-O 120.73 0.3 . . . . 0.0 111.326 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 73.2 m-20 -110.1 -13.34 14.39 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-O 121.829 0.823 . . . . 0.0 109.07 178.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.589 ' CG2' ' O ' ' A' ' 32' ' ' ILE . 0.1 OUTLIER -70.07 97.32 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.605 0 CA-C-N 114.216 -1.356 . . . . 0.0 111.266 -178.839 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.55 ' CG1' ' N ' ' A' ' 34' ' ' CYS . 0.6 OUTLIER -34.15 -59.06 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 114.795 -1.093 . . . . 0.0 112.159 -179.578 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.55 ' N ' ' CG1' ' A' ' 33' ' ' VAL . 3.2 t -163.5 164.98 24.18 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.747 -179.27 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 1.8 ttm180 -125.47 115.17 19.81 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.026 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 14.4 p -89.92 137.17 22.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.076 179.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.491 ' CG2' HG12 ' A' ' 45' ' ' ILE . 23.6 mt -129.51 107.42 15.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -179.673 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.423 ' HB2' ' O ' ' A' ' 43' ' ' ILE . 67.1 m -92.74 101.03 13.41 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 177.211 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.2 t -105.82 -18.21 14.13 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 113.469 0.915 . . . . 0.0 113.469 -177.256 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.542 HG22 ' HB2' ' A' ' 142' ' ' SER . 26.1 p -57.81 -19.35 27.95 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.924 -0.31 . . . . 0.0 111.534 -179.564 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 111.12 67.64 0.55 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.558 -0.83 . . . . 0.0 112.425 179.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -151.15 -54.49 0.14 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.737 0.303 . . . . 0.0 111.138 -179.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.446 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 0.0 OUTLIER -134.63 151.5 76.02 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.158 -179.299 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.446 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 87.0 Cg_endo -80.42 147.3 17.86 Favored 'Trans proline' 0 N--CA 1.461 -0.433 0 C-N-CA 122.403 2.069 . . . . 0.0 111.562 179.352 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.491 HG12 ' CG2' ' A' ' 37' ' ' ILE . 23.2 mt -37.73 124.58 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 CA-C-O 121.043 0.449 . . . . 0.0 111.844 -179.517 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.544 ' HD2' ' HB3' ' A' ' 76' ' ' TYR . 0.0 OUTLIER -115.28 153.94 30.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.266 179.698 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 15.9 p-10 -116.22 119.83 37.03 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.187 0.517 . . . . 0.0 111.674 -179.605 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.522 ' HB3' ' CE2' ' A' ' 66' ' ' TRP . 6.9 mt -96.72 123.25 40.36 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.251 178.829 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.532 ' O ' ' HZ2' ' A' ' 66' ' ' TRP . 0.0 OUTLIER -127.52 160.88 30.17 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 -178.76 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.451 ' HB3' HG22 ' A' ' 33' ' ' VAL . . . -157.71 142.31 16.4 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 114.287 -1.324 . . . . 0.0 110.998 178.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -68.87 129.89 41.22 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.969 0.414 . . . . 0.0 111.083 -179.771 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 33.9 mt . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.197 -179.992 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 34.0 mtmt . . . . . 0 C--O 1.232 0.16 0 CA-C-O 120.807 0.337 . . . . 0.0 111.128 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.416 ' O ' ' HB3' ' A' ' 93' ' ' LEU . 5.5 ttpt -112.96 130.78 56.0 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.409 179.557 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.439 ' CG1' ' O ' ' A' ' 91' ' ' ILE . 21.4 t -137.47 139.45 43.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.164 0.507 . . . . 0.0 112.176 -179.098 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . 0.635 ' HB2' ' HB ' ' A' ' 91' ' ' ILE . 12.5 m-90 -100.08 139.23 36.04 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.06 178.607 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.559 ' O ' ' N ' ' A' ' 75' ' ' ASP . 33.9 m -131.68 130.64 42.29 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.554 0.692 . . . . 0.0 111.793 179.329 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.593 ' CD2' ' CE2' ' A' ' 76' ' ' TYR . 1.3 m-85 -102.26 119.36 38.67 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 114.886 -1.052 . . . . 0.0 109.093 178.462 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.638 ' HA2' ' O ' ' A' ' 85' ' ' SER . . . 156.35 -160.7 30.37 Favored Glycine 0 CA--C 1.505 -0.542 0 C-N-CA 118.537 -1.792 . . . . 0.0 113.225 179.041 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.403 ' HD2' ' OD1' ' A' ' 86' ' ' ASN . 12.5 ptm180 -76.84 93.15 3.69 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-O 122.686 1.231 . . . . 0.0 108.918 -179.874 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.591 ' O ' ' CD2' ' A' ' 77' ' ' HIS . 6.7 m120 -148.45 156.53 42.37 Favored Pre-proline 0 C--N 1.307 -1.275 0 CA-C-N 112.857 -1.974 . . . . 0.0 107.936 178.812 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.546 ' O ' ' CB ' ' A' ' 73' ' ' ALA . 47.0 Cg_exo -50.37 -13.76 0.83 Allowed 'Trans proline' 0 N--CA 1.459 -0.553 0 C-N-CA 121.384 1.389 . . . . 0.0 111.315 178.276 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.546 ' CB ' ' O ' ' A' ' 72' ' ' PRO . . . 135.85 53.63 0.0 OUTLIER 'General case' 0 CA--C 1.489 -1.385 0 CA-C-N 114.504 -1.226 . . . . 0.0 108.582 178.731 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . 0.53 ' HB3' ' HB ' ' A' ' 67' ' ' THR . 0.0 OUTLIER -52.07 -69.28 0.12 Allowed 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 -179.846 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.559 ' N ' ' O ' ' A' ' 67' ' ' THR . 29.9 t70 -92.76 -51.2 5.2 Favored 'General case' 0 N--CA 1.433 -1.29 0 N-CA-C 104.388 -2.449 . . . . 0.0 104.388 169.861 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.593 ' CE2' ' CD2' ' A' ' 68' ' ' PHE . 1.3 p90 -148.26 143.87 27.25 Favored 'General case' 0 C--N 1.345 0.389 0 CA-C-N 112.815 -1.993 . . . . 0.0 111.011 176.227 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . 0.591 ' CD2' ' O ' ' A' ' 71' ' ' ASN . 15.4 t-160 -90.09 105.81 18.06 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 177.454 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -127.63 178.78 5.89 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.922 0.391 . . . . 0.0 111.336 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -51.1 158.43 2.24 Favored Glycine 0 C--N 1.333 0.373 0 C-N-CA 120.991 -0.623 . . . . 0.0 112.694 -179.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 5.0 p30 -111.71 99.38 8.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.762 0.315 . . . . 0.0 111.579 -179.697 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.614 ' HB ' ' HB2' ' A' ' 85' ' ' SER . 17.3 mt -114.93 131.66 66.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 178.175 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.416 ' HA ' ' ND2' ' A' ' 86' ' ' ASN . 0.5 OUTLIER -52.81 -24.09 8.24 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 111.697 0.258 . . . . 0.0 111.697 -179.016 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 2.2 mtt-85 -92.3 -95.05 0.14 Allowed 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 116.841 -0.163 . . . . 0.0 111.256 179.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.452 ' O ' ' CB ' ' A' ' 85' ' ' SER . 0.0 OUTLIER -109.48 109.45 20.28 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-O 121.359 0.599 . . . . 0.0 109.761 179.191 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.638 ' O ' ' HA2' ' A' ' 69' ' ' GLY . 1.5 m 157.19 -42.37 0.0 OUTLIER 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 114.592 -1.186 . . . . 0.0 109.55 -179.698 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.669 ' O ' ' N ' ' A' ' 88' ' ' HIS . 30.3 m-20 -65.41 -160.71 0.02 OUTLIER 'General case' 0 CA--C 1.516 -0.354 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 177.514 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.407 ' O ' ' CG1' ' A' ' 104' ' ' ILE . 0.0 OUTLIER -58.64 75.18 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 177.791 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.969 ' O ' ' O ' ' A' ' 104' ' ' ILE . 30.6 t60 -79.53 -18.64 51.4 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 114.182 1.179 . . . . 0.0 114.182 -176.685 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.484 ' CZ ' HG13 ' A' ' 91' ' ' ILE . 0.0 OUTLIER -174.98 156.84 2.25 Favored 'General case' 0 C--N 1.312 -1.052 0 C-N-CA 119.038 -1.065 . . . . 0.0 112.88 177.961 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.484 ' O ' ' O ' ' A' ' 102' ' ' ASN . 35.2 mt-30 -138.09 160.75 38.57 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 114.677 -1.147 . . . . 0.0 113.758 -177.779 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.635 ' HB ' ' HB2' ' A' ' 66' ' ' TRP . 3.4 mt -130.24 129.81 65.31 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.004 178.617 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.446 ' N ' ' O ' ' A' ' 100' ' ' LEU . 0.4 OUTLIER -103.93 143.86 32.3 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -179.22 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.449 ' HG ' HG21 ' A' ' 33' ' ' VAL . 0.2 OUTLIER -126.43 122.81 36.36 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.188 178.965 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.247 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.563 179.935 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.796 0.332 . . . . 0.0 110.936 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.559 ' HA ' ' O ' ' A' ' 122' ' ' GLN . 0.8 OUTLIER -121.07 148.01 44.74 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.083 179.625 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.441 ' O ' ' N ' ' A' ' 122' ' ' GLN . 4.4 mp -116.94 127.38 54.17 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 179.614 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.484 ' O ' ' O ' ' A' ' 90' ' ' GLN . 27.8 t30 -113.9 111.49 21.8 Favored 'General case' 0 CA--C 1.507 -0.706 0 C-N-CA 119.74 -0.784 . . . . 0.0 109.928 -179.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.57 ' HB3' ' CG2' ' A' ' 109' ' ' THR . 74.8 m-20 -84.11 111.51 19.39 Favored 'General case' 0 N--CA 1.44 -0.972 0 C-N-CA 119.647 -0.821 . . . . 0.0 109.227 179.57 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.969 ' O ' ' O ' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -123.38 107.76 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.007 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 177.837 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.436 ' OG ' ' NE2' ' A' ' 88' ' ' HIS . 71.1 m -132.96 171.48 13.9 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-N 114.939 -1.028 . . . . 0.0 109.328 179.754 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 23.4 m -69.58 -63.56 1.05 Allowed 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 119.093 -1.043 . . . . 0.0 111.545 -179.156 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -112.65 -32.85 6.31 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 114.687 1.366 . . . . 0.0 114.687 179.162 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -145.97 129.08 3.27 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 116.996 1.558 . . . . 0.0 116.996 -177.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.57 ' CG2' ' HB3' ' A' ' 103' ' ' ASP . 5.8 m -121.17 138.15 54.34 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 174.478 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . 0.751 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.5 m-90 -120.09 148.85 43.09 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 113.14 0.793 . . . . 0.0 113.14 -178.653 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -123.59 112.3 17.27 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 115.123 -0.944 . . . . 0.0 108.755 177.714 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 13.4 m-80 45.23 44.68 9.08 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.933 -0.576 . . . . 0.0 112.116 -179.531 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 77.53 26.14 61.75 Favored Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.75 179.249 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -138.74 95.3 2.95 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.077 0.465 . . . . 0.0 110.739 179.703 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.751 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.1 OUTLIER -44.98 133.64 6.25 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.931 179.763 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 31.2 m -124.44 -179.66 2.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.83 -179.113 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 29.3 mm-40 -84.9 141.57 30.31 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.005 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.421 ' O ' ' C ' ' A' ' 119' ' ' ASN . 88.4 tttt -65.31 163.2 15.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.056 179.443 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.421 ' C ' ' O ' ' A' ' 118' ' ' LYS . 13.5 m-80 33.63 40.04 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.164 0.507 . . . . 0.0 111.152 -179.461 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.402 ' OG ' ' NE2' ' A' ' 122' ' ' GLN . 19.5 p -110.48 117.08 32.59 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.967 -179.397 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . 0.427 ' ND2' ' CD1' ' A' ' 92' ' ' LEU . 15.8 m120 -57.97 138.98 55.38 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.778 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . 0.559 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 45.0 mm-40 -129.49 146.33 51.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.117 0.484 . . . . 0.0 111.787 -179.849 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 12.3 tp -78.74 120.24 23.1 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.545 178.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.404 ' CD2' HG12 ' A' ' 147' ' ' ILE . 13.3 tp -46.88 144.33 2.48 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.773 0.797 . . . . 0.0 111.965 -178.905 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' SER . . . . . 0.428 ' O ' ' CD1' ' A' ' 147' ' ' ILE . 0.6 OUTLIER -126.83 152.34 47.11 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 114.22 -1.354 . . . . 0.0 110.26 179.542 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 4.1 mm100 -71.41 114.15 9.18 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 179.584 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 65.67 30.29 77.01 Favored Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.172 -179.364 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 18.6 t0 -55.76 160.24 2.7 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.987 0.423 . . . . 0.0 111.39 -179.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.409 ' CG ' ' O ' ' A' ' 143' ' ' LEU . 1.2 tt0 -146.15 134.94 22.38 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.004 179.925 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.446 ' CG2' ' O ' ' A' ' 110' ' ' TRP . 1.1 mp -113.41 127.15 70.86 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.202 0 CA-C-O 120.799 0.333 . . . . 0.0 110.112 178.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.484 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 18.3 m -104.04 145.6 29.93 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.52 -179.754 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.468 ' HB ' ' NE2' ' A' ' 88' ' ' HIS . 5.5 m -141.21 158.09 22.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -178.669 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . 0.404 ' O ' ' O ' ' A' ' 139' ' ' ASP . . . 69.06 41.33 81.61 Favored Glycine 0 N--CA 1.447 -0.612 0 CA-C-N 115.682 -0.69 . . . . 0.0 112.509 179.25 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.437 ' HA ' HG12 ' A' ' 140' ' ' ILE . 85.9 t -77.55 153.87 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.636 0 CA-C-O 121.398 0.618 . . . . 0.0 112.14 -179.284 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 145.13 -39.61 1.17 Allowed Glycine 0 N--CA 1.441 -0.999 0 CA-C-N 115.015 -0.993 . . . . 0.0 110.7 -179.004 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 48.3 t -126.67 129.35 71.59 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.65 0 CA-C-N 115.231 -0.485 . . . . 0.0 109.837 178.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -51.25 -34.43 32.54 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.784 0.326 . . . . 0.0 111.618 -179.235 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 2.6 t -94.06 6.48 48.41 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 -179.326 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . 0.404 ' O ' ' O ' ' A' ' 133' ' ' GLY . 14.6 t0 -126.77 26.94 6.13 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -179.319 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.484 ' CG2' ' CG2' ' A' ' 131' ' ' THR . 26.6 mt -102.52 141.35 18.77 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.34 179.194 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -121.26 135.45 55.12 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 114.885 -1.052 . . . . 0.0 110.176 179.594 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.542 ' HB2' HG22 ' A' ' 40' ' ' THR . 0.9 OUTLIER -122.27 147.39 46.28 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.551 0.691 . . . . 0.0 112.648 -178.898 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.413 ' N ' ' CD1' ' A' ' 143' ' ' LEU . 5.7 mp -127.14 146.27 50.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.028 -0.987 . . . . 0.0 109.086 179.399 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 21.5 t -129.42 141.01 47.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.918 0.39 . . . . 0.0 112.009 -178.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -116.08 127.88 73.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.786 179.771 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 9.7 t80 -111.27 120.21 41.48 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.49 179.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . 0.428 ' CD1' ' O ' ' A' ' 125' ' ' SER . 1.3 mt -100.47 133.8 42.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.998 0.427 . . . . 0.0 111.86 -179.458 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . 0.414 ' ND2' ' O ' ' A' ' 32' ' ' ILE . 0.7 OUTLIER -84.37 114.99 22.27 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.558 179.423 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -59.97 -19.28 51.39 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.442 -179.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 9.4 mtmm -57.9 -43.29 86.07 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.947 0.403 . . . . 0.0 110.801 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 32.4 t80 . . . . . 0 C--N 1.328 -0.36 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.968 179.987 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.527 0.09 0 CA-C-O 120.596 0.236 . . . . 0.0 111.474 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 10.4 m120 -108.55 -14.02 14.72 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-O 121.843 0.83 . . . . 0.0 109.048 178.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.468 HG12 ' HB3' ' A' ' 49' ' ' SER . 0.1 OUTLIER -73.58 111.6 8.8 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.568 0 CA-C-N 114.066 -1.424 . . . . 0.0 111.433 -179.355 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.631 ' CG1' ' N ' ' A' ' 34' ' ' CYS . 0.5 OUTLIER -42.27 -64.57 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.47 -179.653 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.631 ' N ' ' CG1' ' A' ' 33' ' ' VAL . 22.6 p -166.31 165.85 17.05 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.712 -179.686 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 11.7 ttm180 -119.21 126.27 51.15 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.385 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.474 ' CG2' HD12 ' A' ' 48' ' ' LEU . 14.8 t -95.59 137.09 24.6 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.19 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.349 179.226 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.466 ' CG2' HG12 ' A' ' 45' ' ' ILE . 21.8 mt -129.3 108.6 17.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 -178.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -103.38 102.02 11.94 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 177.413 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.7 p -112.42 -23.16 10.48 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 113.664 0.987 . . . . 0.0 113.664 -177.112 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.41 ' CG2' ' HB3' ' A' ' 142' ' ' SER . 5.3 p -54.16 -23.33 13.9 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.874 -0.33 . . . . 0.0 111.452 -179.241 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 124.26 70.64 0.22 Allowed Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.642 -0.79 . . . . 0.0 112.402 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -151.05 -70.77 0.17 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.74 0.305 . . . . 0.0 110.944 -179.893 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.447 HG21 ' CG ' ' A' ' 76' ' ' TYR . 2.1 mp -134.64 133.13 21.07 Favored Pre-proline 0 N--CA 1.453 -0.319 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.15 -179.826 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.476 ' HD2' ' CZ ' ' A' ' 76' ' ' TYR . 35.6 Cg_exo -58.58 147.44 86.84 Favored 'Trans proline' 0 C--N 1.342 0.236 0 C-N-CA 122.474 2.116 . . . . 0.0 111.611 179.497 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.466 HG12 ' CG2' ' A' ' 37' ' ' ILE . 45.7 mt -33.68 145.57 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -179.24 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.418 ' HD3' ' CD2' ' A' ' 76' ' ' TYR . 9.8 tpt180 -139.88 149.46 43.42 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.045 179.47 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -120.54 119.91 34.31 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.888 0.375 . . . . 0.0 111.635 -179.441 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.497 ' HB3' ' CE2' ' A' ' 66' ' ' TRP . 0.3 OUTLIER -99.26 133.39 43.62 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 178.367 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.567 ' O ' ' CZ2' ' A' ' 66' ' ' TRP . 0.1 OUTLIER -113.42 164.73 13.23 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.794 0.807 . . . . 0.0 112.658 -179.131 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.496 ' CB ' ' CG2' ' A' ' 33' ' ' VAL . . . -119.77 166.16 13.61 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.116 -0.947 . . . . 0.0 111.428 -179.895 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -105.72 76.02 1.17 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.384 179.642 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 19.0 mt . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.484 -179.53 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.6 ptpt . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.806 0.336 . . . . 0.0 110.995 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.444 ' O ' ' HB3' ' A' ' 93' ' ' LEU . 14.0 ttpt -115.19 130.84 57.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.532 179.8 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.415 ' CG1' ' O ' ' A' ' 91' ' ' ILE . 5.5 t -133.36 134.08 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 CA-C-O 121.028 0.442 . . . . 0.0 111.554 -179.503 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . 0.627 ' HB2' ' HB ' ' A' ' 91' ' ' ILE . 17.2 m-90 -100.61 140.27 35.12 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.854 179.395 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.633 ' N ' ' HB2' ' A' ' 75' ' ' ASP . 21.6 m -127.34 130.44 49.46 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.53 0.681 . . . . 0.0 112.262 179.515 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.424 ' CE1' ' CG ' ' A' ' 75' ' ' ASP . 43.6 m-85 -101.66 118.04 36.12 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.089 -0.959 . . . . 0.0 108.739 177.768 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.679 ' HA2' ' O ' ' A' ' 85' ' ' SER . . . 158.29 -151.93 23.06 Favored Glycine 0 CA--C 1.505 -0.558 0 C-N-CA 119.054 -1.546 . . . . 0.0 113.055 179.828 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.418 ' HD2' ' HB2' ' A' ' 80' ' ' ASN . 35.5 mtp180 -75.49 91.08 2.76 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-O 122.348 1.071 . . . . 0.0 108.49 -179.853 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.505 ' O ' ' CD2' ' A' ' 77' ' ' HIS . 20.6 m120 -150.82 159.32 34.26 Favored Pre-proline 0 C--N 1.308 -1.212 0 CA-C-N 113.18 -1.827 . . . . 0.0 108.688 178.917 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.552 ' O ' ' HB2' ' A' ' 77' ' ' HIS . 36.3 Cg_endo -66.73 -6.22 15.04 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 120.874 1.05 . . . . 0.0 110.777 177.591 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.594 ' HB1' ' HB2' ' A' ' 77' ' ' HIS . . . 137.03 51.57 0.0 OUTLIER 'General case' 0 CA--C 1.491 -1.32 0 CA-C-N 114.452 -1.249 . . . . 0.0 109.269 178.867 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . 0.521 ' HB3' ' HB ' ' A' ' 67' ' ' THR . 0.1 OUTLIER -52.78 -69.43 0.11 Allowed 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 105.709 -1.959 . . . . 0.0 105.709 179.537 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.633 ' HB2' ' N ' ' A' ' 67' ' ' THR . 36.9 t0 -95.56 -47.56 6.19 Favored 'General case' 0 N--CA 1.433 -1.319 0 N-CA-C 105.872 -1.899 . . . . 0.0 105.872 169.638 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.476 ' CZ ' ' HD2' ' A' ' 44' ' ' PRO . 7.5 t80 -145.12 142.14 29.4 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 112.501 -2.136 . . . . 0.0 112.102 -179.609 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . 0.594 ' HB2' ' HB1' ' A' ' 73' ' ' ALA . 23.6 t-160 -100.89 106.7 18.07 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 176.392 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -133.07 -174.65 3.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.057 0.456 . . . . 0.0 111.773 -179.282 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -56.73 170.71 2.73 Favored Glycine 0 C--N 1.332 0.355 0 CA-C-N 115.75 -0.659 . . . . 0.0 112.471 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.418 ' HB2' ' HD2' ' A' ' 70' ' ' ARG . 3.4 p30 -112.12 98.49 7.37 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 -179.438 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.632 ' HB ' ' HB2' ' A' ' 85' ' ' SER . 15.3 mm -115.3 129.81 70.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 177.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.409 ' HA ' ' ND2' ' A' ' 86' ' ' ASN . 18.8 m -53.09 -23.86 8.81 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 111.617 0.229 . . . . 0.0 111.617 -179.267 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 3.1 mpt_? -98.01 -88.6 0.31 Allowed 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 111.608 0.225 . . . . 0.0 111.608 -179.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.441 ' O ' ' CB ' ' A' ' 85' ' ' SER . 0.0 OUTLIER -109.41 108.8 19.46 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 121.455 0.645 . . . . 0.0 110.541 179.812 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.679 ' O ' ' HA2' ' A' ' 69' ' ' GLY . 3.1 m 155.23 -42.93 0.01 OUTLIER 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 114.247 -1.342 . . . . 0.0 109.437 179.793 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.655 ' O ' ' N ' ' A' ' 88' ' ' HIS . 38.0 m-20 -77.21 -164.5 0.47 Allowed 'General case' 0 CA--C 1.512 -0.498 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 177.679 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.51 83.12 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 178.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 1.071 ' O ' ' O ' ' A' ' 104' ' ' ILE . 36.3 t60 -102.74 -19.32 14.78 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 114.624 1.342 . . . . 0.0 114.624 -177.002 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.554 ' CD2' ' HA ' ' A' ' 103' ' ' ASP . 0.1 OUTLIER -176.55 159.44 1.9 Allowed 'General case' 0 C--N 1.317 -0.811 0 C-N-CA 119.332 -0.947 . . . . 0.0 111.869 178.338 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.493 ' N ' ' CD1' ' A' ' 89' ' ' PHE . 27.4 mt-30 -137.89 161.09 37.56 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 113.767 1.025 . . . . 0.0 113.767 -177.673 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.627 ' HB ' ' HB2' ' A' ' 66' ' ' TRP . 2.9 mt -124.97 133.11 70.31 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 CA-C-N 115.092 -0.958 . . . . 0.0 109.588 178.267 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.451 ' N ' ' O ' ' A' ' 100' ' ' LEU . 0.2 OUTLIER -110.47 141.92 42.93 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 121.01 0.434 . . . . 0.0 112.166 -179.168 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.444 ' HB3' ' O ' ' A' ' 64' ' ' LYS . 19.0 tp -125.65 137.96 53.89 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.298 178.843 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.322 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.416 179.777 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 10.5 mp . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.794 0.33 . . . . 0.0 110.658 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.632 ' HA ' ' O ' ' A' ' 122' ' ' GLN . 1.0 OUTLIER -133.68 148.72 51.5 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.627 -179.965 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.459 ' O ' ' N ' ' A' ' 122' ' ' GLN . 5.4 mp -116.22 129.69 56.42 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.681 -0.488 . . . . 0.0 109.681 179.638 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.464 ' O ' ' O ' ' A' ' 90' ' ' GLN . 24.5 t30 -110.31 112.39 24.31 Favored 'General case' 0 CA--C 1.508 -0.652 0 C-N-CA 119.706 -0.798 . . . . 0.0 110.031 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.59 ' HB3' ' CG2' ' A' ' 109' ' ' THR . 33.5 m-20 -83.78 110.23 18.16 Favored 'General case' 0 N--CA 1.441 -0.924 0 C-N-CA 119.428 -0.909 . . . . 0.0 109.662 179.846 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 1.071 ' O ' ' O ' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -125.04 108.91 20.9 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.061 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 177.07 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.426 ' OG ' ' NE2' ' A' ' 88' ' ' HIS . 68.7 m -131.48 173.5 11.03 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.452 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 25.8 m -69.34 -63.86 0.98 Allowed 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 119.038 -1.065 . . . . 0.0 111.084 -179.358 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 6.1 m-80 -112.68 -33.23 6.18 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 114.234 1.198 . . . . 0.0 114.234 178.629 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -146.71 133.94 5.06 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 116.536 1.374 . . . . 0.0 116.536 -178.093 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.59 ' CG2' ' HB3' ' A' ' 103' ' ' ASP . 16.7 m -121.06 138.01 54.38 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 174.417 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . 0.7 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.9 m-90 -120.89 149.14 43.07 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 113.65 0.981 . . . . 0.0 113.65 -178.357 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -122.92 111.99 17.3 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 115.004 -0.998 . . . . 0.0 108.66 177.536 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 44.21 44.6 6.61 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.998 -0.546 . . . . 0.0 112.191 -179.457 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 80.72 21.77 63.16 Favored Glycine 0 N--CA 1.445 -0.765 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.837 179.437 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -134.29 98.34 4.08 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.968 0.413 . . . . 0.0 110.7 179.608 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.7 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.3 OUTLIER -44.06 124.93 4.12 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.084 179.936 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 14.7 p -112.15 160.22 11.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.722 -179.074 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -71.01 142.05 50.95 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.995 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.407 ' O ' ' C ' ' A' ' 119' ' ' ASN . 81.6 tttt -65.17 162.55 16.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.293 179.432 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.407 ' C ' ' O ' ' A' ' 118' ' ' LYS . 12.1 p30 34.67 39.09 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.265 0.555 . . . . 0.0 111.305 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 8.6 p -111.09 109.5 19.61 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.9 -179.473 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -57.69 140.91 50.16 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.771 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . 0.632 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 18.4 mm-40 -129.64 143.43 50.82 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-O 121.055 0.455 . . . . 0.0 111.844 -179.707 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -72.57 122.83 22.02 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.512 178.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.43 ' HG ' ' N ' ' A' ' 125' ' ' SER . 0.9 OUTLIER -47.71 143.53 3.85 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-O 121.854 0.835 . . . . 0.0 111.941 -178.799 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' SER . . . . . 0.43 ' N ' ' HG ' ' A' ' 124' ' ' LEU . 0.3 OUTLIER -126.72 152.84 46.27 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 114.166 -1.379 . . . . 0.0 110.242 179.535 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -71.72 113.99 9.33 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.882 0.372 . . . . 0.0 110.058 179.615 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 65.9 30.3 76.82 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.917 -0.658 . . . . 0.0 112.577 -179.588 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.409 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 29.2 t70 -57.87 159.5 5.41 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.96 0.41 . . . . 0.0 111.142 -179.851 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.458 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 0.6 OUTLIER -146.55 135.79 22.72 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.377 -179.932 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.452 HD12 HG23 ' A' ' 130' ' ' ILE . 10.4 mm -113.31 128.86 69.91 Favored 'Isoleucine or valine' 0 C--O 1.232 0.132 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.3 178.815 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.49 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 53.8 m -103.17 144.65 31.04 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.477 -179.804 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.474 ' HB ' ' NE2' ' A' ' 88' ' ' HIS . 9.7 m -140.57 157.7 24.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.039 0.447 . . . . 0.0 112.18 -178.927 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 70.43 42.19 65.16 Favored Glycine 0 N--CA 1.446 -0.65 0 CA-C-N 115.725 -0.67 . . . . 0.0 112.404 179.436 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.417 ' HA ' HG12 ' A' ' 140' ' ' ILE . 94.6 t -78.13 156.81 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 CA-C-O 121.394 0.616 . . . . 0.0 112.032 -179.256 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . 0.408 ' N ' ' CG1' ' A' ' 134' ' ' VAL . . . 149.82 -42.68 0.78 Allowed Glycine 0 N--CA 1.443 -0.896 0 N-CA-C 110.627 -0.989 . . . . 0.0 110.627 -179.248 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 48.0 t -126.66 131.3 71.34 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 CA-C-N 115.271 -0.464 . . . . 0.0 109.89 178.791 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.07 -33.67 26.81 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.769 0.319 . . . . 0.0 111.257 -179.425 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 2.0 p -94.16 6.24 49.22 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 112.251 0.464 . . . . 0.0 112.251 -179.535 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -128.1 29.91 5.31 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-O 121.137 0.494 . . . . 0.0 112.265 -179.467 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.49 ' CG2' ' CG2' ' A' ' 131' ' ' THR . 26.9 mt -104.71 141.34 20.38 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.268 179.22 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 5.8 mp -118.88 135.19 54.69 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.015 -0.993 . . . . 0.0 110.633 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.41 ' HB3' ' CG2' ' A' ' 40' ' ' THR . 46.9 t -118.76 152.4 36.25 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.691 0.758 . . . . 0.0 112.547 -179.178 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.458 ' O ' ' HA ' ' A' ' 129' ' ' GLU . 1.5 tm? -134.72 137.55 43.6 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 114.589 -1.187 . . . . 0.0 109.019 179.427 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 25.5 t -128.4 140.01 50.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 C-N-CA 120.75 -0.38 . . . . 0.0 111.858 -179.062 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 1.1 tt -109.08 139.84 30.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.725 179.461 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 16.8 t80 -118.1 103.85 10.28 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.777 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 2.5 mp -92.56 129.37 43.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.175 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 12.2 p30 -78.6 132.08 36.97 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.017 -179.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 50.2 m-20 -64.49 -21.38 66.65 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.095 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 3.1 mmpt? -57.49 -43.66 84.33 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-O 120.953 0.406 . . . . 0.0 110.564 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 19.0 t80 . . . . . 0 C--N 1.328 -0.354 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.67 179.731 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 . . . . . 0 CA--C 1.528 0.098 0 CA-C-O 120.695 0.283 . . . . 0.0 111.484 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 38.1 m-80 -109.39 -14.27 14.46 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-O 121.946 0.879 . . . . 0.0 109.018 178.767 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.592 ' CG2' ' O ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -71.06 98.41 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.581 0 CA-C-N 113.935 -1.484 . . . . 0.0 110.922 -179.285 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.598 ' CG1' ' N ' ' A' ' 34' ' ' CYS . 0.5 OUTLIER -34.39 -60.62 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 114.96 -1.018 . . . . 0.0 112.058 -179.432 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.598 ' N ' ' CG1' ' A' ' 33' ' ' VAL . 19.7 m -159.81 149.36 18.12 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.454 -179.434 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.0 114.62 24.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.763 179.506 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.422 HG13 ' CZ ' ' A' ' 68' ' ' PHE . 26.7 t -90.29 124.64 43.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.686 179.712 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.487 ' CG2' HG12 ' A' ' 45' ' ' ILE . 31.2 mt -123.12 108.33 21.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.138 -0.483 . . . . 0.0 112.033 -179.35 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.457 ' SG ' ' HG ' ' A' ' 143' ' ' LEU . 0.8 OUTLIER -78.81 99.73 6.84 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 177.984 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 9.6 t -87.34 -28.65 22.1 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 -178.007 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.528 HG22 ' OG ' ' A' ' 142' ' ' SER . 66.0 p -58.72 -18.27 29.96 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.678 0.275 . . . . 0.0 111.655 -179.552 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 90.88 71.46 1.22 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.554 -0.831 . . . . 0.0 112.555 179.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 16.8 pt20 -142.99 -48.08 0.32 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.69 0.281 . . . . 0.0 111.151 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 14.8 mt -134.53 138.05 29.13 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.04 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.478 ' HD2' ' CZ ' ' A' ' 76' ' ' TYR . 33.4 Cg_exo -58.46 146.69 89.43 Favored 'Trans proline' 0 N--CA 1.465 -0.186 0 C-N-CA 122.445 2.097 . . . . 0.0 111.5 179.53 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.487 HG12 ' CG2' ' A' ' 37' ' ' ILE . 45.6 mt -45.46 129.93 2.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 112.376 0.51 . . . . 0.0 112.376 -179.096 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 6.3 tpt180 -120.31 130.61 54.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.646 178.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 8.7 p30 -105.83 122.27 45.76 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.346 0.499 . . . . 0.0 112.346 -178.798 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.444 ' HB3' ' CE2' ' A' ' 66' ' ' TRP . 0.3 OUTLIER -97.52 133.63 41.84 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 178.384 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.517 ' HB3' HG12 ' A' ' 32' ' ' ILE . 0.0 OUTLIER -134.27 164.44 27.39 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 113.67 0.989 . . . . 0.0 113.67 -178.333 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.502 ' HB2' HG22 ' A' ' 33' ' ' VAL . . . -151.33 166.23 31.61 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 114.484 -1.234 . . . . 0.0 110.667 179.041 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -106.04 136.34 45.89 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.08 0.467 . . . . 0.0 111.29 -179.679 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 18.5 mm . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.483 -179.915 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.528 0.111 0 CA-C-O 120.853 0.359 . . . . 0.0 111.236 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.409 ' O ' ' HB3' ' A' ' 93' ' ' LEU . 22.9 ttpt -104.09 131.66 51.13 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.19 179.335 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.473 ' CG1' ' O ' ' A' ' 91' ' ' ILE . 5.8 t -131.1 135.92 58.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.044 0.45 . . . . 0.0 111.916 -179.036 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . 0.62 ' HB2' ' HB ' ' A' ' 91' ' ' ILE . 14.6 m-90 -99.7 139.85 34.76 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.692 -0.686 . . . . 0.0 111.25 178.932 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.59 ' N ' ' HB2' ' A' ' 75' ' ' ASP . 12.0 m -123.57 129.07 50.63 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.541 0.686 . . . . 0.0 112.162 179.445 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.499 ' CE1' ' CG ' ' A' ' 75' ' ' ASP . 13.8 m-85 -100.37 118.1 35.92 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.069 -0.969 . . . . 0.0 109.104 178.077 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.596 ' HA2' ' O ' ' A' ' 85' ' ' SER . . . 159.21 -159.6 30.55 Favored Glycine 0 N--CA 1.444 -0.793 0 C-N-CA 119.287 -1.435 . . . . 0.0 112.708 179.459 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.407 ' HD3' ' HB3' ' A' ' 86' ' ' ASN . 0.0 OUTLIER -76.13 92.27 3.21 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-O 122.612 1.196 . . . . 0.0 109.05 -179.402 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.54 ' O ' ' CD2' ' A' ' 77' ' ' HIS . 6.0 m-80 -149.19 155.38 39.86 Favored Pre-proline 0 C--N 1.309 -1.175 0 CA-C-N 112.681 -2.054 . . . . 0.0 107.989 178.646 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.564 ' O ' ' CB ' ' A' ' 73' ' ' ALA . 25.2 Cg_exo -55.76 -7.87 1.79 Allowed 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 121.271 1.314 . . . . 0.0 111.32 177.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.615 ' HB3' ' HB2' ' A' ' 77' ' ' HIS . . . 132.99 52.7 0.0 OUTLIER 'General case' 0 CA--C 1.489 -1.379 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.223 178.765 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . 0.543 ' HB3' ' HB ' ' A' ' 67' ' ' THR . 0.1 OUTLIER -52.81 -69.52 0.11 Allowed 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 105.565 -2.013 . . . . 0.0 105.565 179.499 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.59 ' HB2' ' N ' ' A' ' 67' ' ' THR . 51.3 t0 -95.32 -47.81 6.15 Favored 'General case' 0 N--CA 1.433 -1.302 0 N-CA-C 105.776 -1.935 . . . . 0.0 105.776 169.65 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.493 ' C ' ' HA ' ' A' ' 73' ' ' ALA . 9.4 t80 -144.52 142.68 30.4 Favored 'General case' 0 C--N 1.346 0.424 0 CA-C-N 112.51 -2.132 . . . . 0.0 111.354 179.66 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . 0.615 ' HB2' ' HB3' ' A' ' 73' ' ' ALA . 22.4 t-160 -97.16 106.91 19.32 Favored 'General case' 0 CA--C 1.531 0.238 0 O-C-N 121.921 -0.487 . . . . 0.0 110.157 176.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.483 HD23 ' O ' ' A' ' 79' ' ' GLY . 0.0 OUTLIER -120.67 171.83 8.31 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 120.824 0.345 . . . . 0.0 111.692 179.749 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.483 ' O ' HD23 ' A' ' 78' ' ' LEU . . . -55.03 -167.86 0.04 OUTLIER Glycine 0 C--N 1.333 0.405 0 CA-C-N 116.022 -0.535 . . . . 0.0 113.126 -179.499 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -112.06 97.77 6.89 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.927 0.394 . . . . 0.0 111.768 -179.752 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.611 ' HB ' ' HB2' ' A' ' 85' ' ' SER . 3.2 mp -114.86 112.72 41.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.104 178.542 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 68.5 m -56.69 -24.16 47.05 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 -179.002 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 3.7 mtt180 -93.47 -102.15 0.13 Allowed 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 -178.487 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.434 ' O ' ' CB ' ' A' ' 85' ' ' SER . 0.0 OUTLIER -109.02 110.83 22.21 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-O 121.52 0.676 . . . . 0.0 110.691 -179.262 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.611 ' HB2' ' HB ' ' A' ' 81' ' ' ILE . 0.6 OUTLIER 158.99 -48.39 0.0 OUTLIER 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 114.247 -1.342 . . . . 0.0 109.478 179.796 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.792 ' O ' ' N ' ' A' ' 88' ' ' HIS . 94.1 m-20 -65.34 -153.45 0.01 OUTLIER 'General case' 0 CA--C 1.521 -0.151 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 177.779 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.55 76.71 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 179.105 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 1.071 ' O ' ' O ' ' A' ' 104' ' ' ILE . 36.3 t60 -101.58 -15.89 16.93 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 114.622 1.341 . . . . 0.0 114.622 -176.346 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.512 ' CD1' ' N ' ' A' ' 90' ' ' GLN . 0.1 OUTLIER -178.1 160.37 1.39 Allowed 'General case' 0 C--N 1.317 -0.848 0 C-N-CA 119.333 -0.947 . . . . 0.0 112.125 178.334 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.512 ' N ' ' CD1' ' A' ' 89' ' ' PHE . 14.7 mt-30 -137.45 160.82 38.03 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 113.694 0.998 . . . . 0.0 113.694 -178.031 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.62 ' HB ' ' HB2' ' A' ' 66' ' ' TRP . 2.5 mt -122.27 132.14 71.7 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 CA-C-N 115.109 -0.95 . . . . 0.0 108.998 177.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.443 ' N ' ' O ' ' A' ' 100' ' ' LEU . 1.9 mt -110.06 135.31 51.07 Favored 'General case' 0 N--CA 1.464 0.233 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 -178.732 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.503 ' HG ' HG22 ' A' ' 33' ' ' VAL . 1.2 tm? -126.42 136.64 52.92 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.245 178.752 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.294 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.601 179.819 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.569 0.224 . . . . 0.0 110.653 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.56 ' HA ' ' O ' ' A' ' 122' ' ' GLN . 4.4 mt -133.66 148.62 51.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.81 -179.813 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.44 ' O ' ' N ' ' A' ' 122' ' ' GLN . 1.6 mt -113.38 130.87 56.18 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 179.529 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.491 ' O ' ' O ' ' A' ' 90' ' ' GLN . 7.4 t30 -107.18 112.56 25.5 Favored 'General case' 0 CA--C 1.51 -0.59 0 C-N-CA 119.976 -0.69 . . . . 0.0 109.776 179.863 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.568 ' HB3' ' CG2' ' A' ' 109' ' ' THR . 29.1 m-20 -87.4 108.94 19.23 Favored 'General case' 0 N--CA 1.442 -0.872 0 C-N-CA 119.076 -1.05 . . . . 0.0 109.789 179.691 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 1.071 ' O ' ' O ' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -126.48 109.32 20.83 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.164 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 176.854 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.406 ' HB3' ' CE1' ' A' ' 88' ' ' HIS . 70.5 m -129.38 174.66 9.42 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.868 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 28.0 m -69.76 -63.29 1.1 Allowed 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 118.98 -1.088 . . . . 0.0 110.862 -179.557 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -112.52 -33.46 6.15 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 114.253 1.205 . . . . 0.0 114.253 178.593 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -147.1 136.71 6.26 Favored Glycine 0 C--N 1.34 0.795 0 N-CA-C 116.422 1.329 . . . . 0.0 116.422 -178.339 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.568 ' CG2' ' HB3' ' A' ' 103' ' ' ASP . 14.8 m -121.06 137.96 54.41 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 174.738 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . 0.718 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 3.0 m-90 -122.36 149.25 44.04 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 113.436 0.902 . . . . 0.0 113.436 -178.517 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -122.46 112.07 17.61 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 115.182 -0.917 . . . . 0.0 108.62 177.24 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 46.14 43.93 11.46 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.104 -0.498 . . . . 0.0 112.167 -179.573 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 79.91 20.92 66.89 Favored Glycine 0 N--CA 1.445 -0.76 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.93 179.153 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 13.6 mt-30 -133.82 97.79 4.0 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.039 0.447 . . . . 0.0 110.624 179.674 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.718 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.3 OUTLIER -44.92 134.17 5.89 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.843 179.856 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 15.0 m -121.25 177.25 3.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.141 0.496 . . . . 0.0 111.969 -178.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.404 ' HB3' ' HB3' ' A' ' 120' ' ' SER . 0.0 OUTLIER -82.83 141.13 32.51 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.676 179.799 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.401 ' O ' ' C ' ' A' ' 119' ' ' ASN . 0.0 OUTLIER -66.25 163.75 17.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.731 0.3 . . . . 0.0 110.537 179.711 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.401 ' C ' ' O ' ' A' ' 118' ' ' LYS . 0.5 OUTLIER 34.88 37.52 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.995 -179.639 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.426 ' OG ' ' NE2' ' A' ' 122' ' ' GLN . 10.1 p -111.3 105.16 13.73 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.858 -179.281 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -50.22 142.46 9.87 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.803 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . 0.56 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 30.1 mm-40 -128.75 144.15 51.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.207 0.527 . . . . 0.0 112.057 -179.662 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 16.6 tp -74.36 120.62 20.17 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.718 178.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.502 ' O ' HD11 ' A' ' 124' ' ' LEU . 0.0 OUTLIER -51.73 144.65 10.67 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 122.193 0.997 . . . . 0.0 112.202 -178.857 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' SER . . . . . 0.434 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.6 OUTLIER -127.15 153.15 46.41 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 113.871 -1.513 . . . . 0.0 110.022 179.499 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 5.7 tp-100 -70.62 113.5 7.79 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 179.647 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 68.35 28.6 73.19 Favored Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.394 -179.359 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.434 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 9.7 t70 -58.85 158.86 7.61 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.984 0.421 . . . . 0.0 111.308 -179.719 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.414 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 0.4 OUTLIER -147.12 135.71 21.96 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.565 179.871 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.424 ' CG2' ' O ' ' A' ' 110' ' ' TRP . 2.0 mp -108.86 129.12 64.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.299 -0.41 . . . . 0.0 109.994 178.559 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.492 ' O ' ' HB2' ' A' ' 110' ' ' TRP . 69.5 m -102.31 142.37 33.64 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.0 0.428 . . . . 0.0 110.519 -179.53 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.47 ' HB ' ' NE2' ' A' ' 88' ' ' HIS . 5.2 m -141.24 158.37 22.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.132 -0.485 . . . . 0.0 112.21 -178.592 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 69.87 44.43 62.1 Favored Glycine 0 N--CA 1.446 -0.645 0 CA-C-N 115.911 -0.586 . . . . 0.0 112.086 179.545 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.461 ' HA ' HG12 ' A' ' 140' ' ' ILE . 81.8 t -80.18 153.1 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 CA-C-O 121.526 0.679 . . . . 0.0 112.261 -178.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 148.14 -44.52 0.77 Allowed Glycine 0 N--CA 1.44 -1.075 0 N-CA-C 110.374 -1.09 . . . . 0.0 110.374 -178.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 41.3 t -126.8 127.83 70.35 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.764 0 CA-C-N 115.103 -0.549 . . . . 0.0 109.641 178.499 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -51.07 -29.61 13.47 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.789 0.328 . . . . 0.0 111.308 -179.202 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -94.31 6.48 48.56 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -179.56 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -128.77 25.61 5.64 Favored 'General case' 0 CA--C 1.519 -0.223 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 -179.402 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.461 ' CG2' ' CG2' ' A' ' 131' ' ' THR . 13.4 mt -103.13 140.67 20.74 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.003 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.447 179.233 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -124.24 134.53 53.22 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.017 -0.992 . . . . 0.0 109.798 179.196 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.528 ' OG ' HG22 ' A' ' 40' ' ' THR . 0.9 OUTLIER -119.33 150.95 39.29 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.408 0.623 . . . . 0.0 112.504 -178.78 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.457 ' HG ' ' SG ' ' A' ' 38' ' ' CYS . 5.7 mp -122.77 132.99 54.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.325 179.342 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 4.7 t -114.15 140.28 35.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 120.872 0.368 . . . . 0.0 111.426 -179.432 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . 0.45 HD13 HG23 ' A' ' 145' ' ' ILE . 0.2 OUTLIER -120.66 127.68 75.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.821 179.893 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 18.6 t80 -105.08 103.78 13.39 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.54 179.786 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 2.7 mp -87.91 128.45 40.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.053 -179.776 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 25.9 p-10 -78.3 120.7 23.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.003 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -71.35 -24.67 62.14 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.957 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 4.2 mttt -57.38 -40.53 78.35 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.947 0.403 . . . . 0.0 110.595 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 19.9 t80 . . . . . 0 C--N 1.328 -0.364 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.613 179.746 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.716 0.293 . . . . 0.0 111.119 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -109.17 -14.08 14.56 Favored 'General case' 0 CA--C 1.514 -0.409 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 178.405 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.55 HG12 ' HB3' ' A' ' 49' ' ' SER . 0.1 OUTLIER -71.15 108.44 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.66 0 CA-C-N 113.888 -1.505 . . . . 0.0 110.933 -179.499 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.51 HG22 ' C ' ' A' ' 49' ' ' SER . 2.3 t -48.21 -66.3 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.769 0 CA-C-N 115.19 -0.914 . . . . 0.0 111.364 -179.498 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 31.9 p -162.98 164.59 25.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.676 179.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 8.1 ttm180 -122.98 123.76 41.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.189 -179.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.41 ' CG2' ' CD1' ' A' ' 48' ' ' LEU . 3.3 t -91.58 122.13 42.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.754 179.666 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.461 ' CG2' HG12 ' A' ' 45' ' ' ILE . 26.7 mt -121.61 107.81 20.9 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 CA-C-N 116.263 -0.426 . . . . 0.0 112.006 -179.547 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 88.8 m -81.86 102.2 10.7 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 178.076 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.0 p -89.79 2.96 54.26 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 -178.076 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.607 HG22 ' HB2' ' A' ' 142' ' ' SER . 77.2 p -94.59 -6.78 42.75 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.038 0.384 . . . . 0.0 112.038 -179.769 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 85.91 91.58 0.88 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.606 179.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 16.3 pt20 -172.41 -45.86 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.108 0.48 . . . . 0.0 110.516 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.484 HG21 ' CD2' ' A' ' 76' ' ' TYR . 5.1 mt -131.87 140.43 38.17 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.718 179.899 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.48 ' CG ' ' CE1' ' A' ' 76' ' ' TYR . 74.2 Cg_endo -78.46 147.01 22.28 Favored 'Trans proline' 0 N--CA 1.462 -0.377 0 C-N-CA 122.324 2.016 . . . . 0.0 112.141 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.461 HG12 ' CG2' ' A' ' 37' ' ' ILE . 27.3 mt -43.12 122.21 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 121.222 0.534 . . . . 0.0 111.827 -179.493 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.408 ' HG2' ' O ' ' A' ' 75' ' ' ASP . 0.0 OUTLIER -121.49 130.21 53.41 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.099 179.463 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.435 ' HB2' ' CD1' ' A' ' 32' ' ' ILE . 3.8 p30 -93.14 120.11 33.07 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.06 0.457 . . . . 0.0 111.413 -179.302 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.603 ' HB3' ' CE2' ' A' ' 66' ' ' TRP . 0.8 OUTLIER -94.36 121.73 36.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.642 179.249 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.55 ' HB3' HG12 ' A' ' 32' ' ' ILE . 0.0 OUTLIER -130.98 154.56 48.03 Favored 'General case' 0 CA--C 1.517 -0.323 0 N-CA-C 114.295 1.22 . . . . 0.0 114.295 -179.205 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.492 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -133.22 166.07 23.32 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 113.587 -1.642 . . . . 0.0 110.832 178.753 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 60.6 m-20 -91.08 97.26 11.05 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.065 0.46 . . . . 0.0 111.014 -179.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.408 HD11 ' CD2' ' A' ' 151' ' ' PHE . 4.4 mt . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.704 -179.701 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.528 0.114 0 CA-C-O 121.012 0.435 . . . . 0.0 111.058 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 7.8 ttpt -138.01 132.09 31.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.667 179.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.485 ' CG1' ' O ' ' A' ' 91' ' ' ILE . 21.5 t -135.35 138.82 47.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.14 0.495 . . . . 0.0 111.707 -179.407 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . 0.62 ' HB2' ' HB ' ' A' ' 91' ' ' ILE . 14.7 m-90 -99.91 139.95 34.83 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.6 179.297 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.539 ' O ' ' N ' ' A' ' 75' ' ' ASP . 30.5 m -131.39 131.85 43.95 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.53 0.681 . . . . 0.0 112.162 179.744 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.474 ' CE1' ' CG ' ' A' ' 75' ' ' ASP . 7.3 m-85 -103.24 119.06 38.16 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 114.897 -1.047 . . . . 0.0 109.086 177.873 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.632 ' HA2' ' O ' ' A' ' 85' ' ' SER . . . 158.7 -155.96 26.99 Favored Glycine 0 CA--C 1.503 -0.706 0 C-N-CA 118.832 -1.652 . . . . 0.0 113.098 179.389 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.41 ' O ' ' HG3' ' A' ' 70' ' ' ARG . 3.1 ptm180 -76.37 91.77 3.3 Favored 'General case' 0 N--CA 1.441 -0.888 0 CA-C-O 122.587 1.184 . . . . 0.0 108.747 -179.614 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.502 ' O ' ' CD2' ' A' ' 77' ' ' HIS . 15.7 m-80 -149.98 154.53 37.09 Favored Pre-proline 0 C--N 1.308 -1.218 0 CA-C-N 112.857 -1.974 . . . . 0.0 108.337 178.758 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.548 ' O ' ' CB ' ' A' ' 73' ' ' ALA . 21.8 Cg_exo -57.18 -8.25 3.35 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 121.115 1.21 . . . . 0.0 110.934 177.679 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.611 ' HB3' ' HB2' ' A' ' 77' ' ' HIS . . . 135.04 53.45 0.0 OUTLIER 'General case' 0 CA--C 1.489 -1.402 0 CA-C-N 114.901 -1.045 . . . . 0.0 109.08 179.041 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . 0.508 ' HB3' ' HB ' ' A' ' 67' ' ' THR . 0.1 OUTLIER -52.28 -69.6 0.11 Allowed 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 105.599 -2.0 . . . . 0.0 105.599 179.708 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.539 ' N ' ' O ' ' A' ' 67' ' ' THR . 4.9 t70 -95.45 -47.87 6.09 Favored 'General case' 0 N--CA 1.436 -1.174 0 N-CA-C 105.426 -2.064 . . . . 0.0 105.426 169.085 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.51 ' C ' ' HA ' ' A' ' 73' ' ' ALA . 73.3 t80 -143.26 142.1 31.26 Favored 'General case' 0 C--N 1.347 0.493 0 CA-C-N 112.512 -2.131 . . . . 0.0 111.334 179.825 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . 0.611 ' HB2' ' HB3' ' A' ' 73' ' ' ALA . 23.8 t-160 -91.78 110.23 21.57 Favored 'General case' 0 C--N 1.33 -0.247 0 O-C-N 122.027 -0.421 . . . . 0.0 110.013 177.327 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.451 ' HB3' ' CE2' ' A' ' 76' ' ' TYR . 1.1 pp -129.57 174.6 9.51 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.969 0.414 . . . . 0.0 111.494 -179.642 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -58.6 175.33 2.63 Favored Glycine 0 C--N 1.333 0.41 0 C-N-CA 120.939 -0.648 . . . . 0.0 112.311 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 15.5 p-10 -112.04 99.28 7.95 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.902 0.382 . . . . 0.0 111.847 -179.628 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.671 ' HB ' ' HB2' ' A' ' 85' ' ' SER . 16.5 mm -113.91 118.39 58.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.036 178.45 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -53.46 -24.03 11.76 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 111.807 0.299 . . . . 0.0 111.807 -179.056 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 6.2 mpt_? -86.72 -106.85 0.06 Allowed 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 121.222 -0.191 . . . . 0.0 111.378 -179.661 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.466 ' CD1' ' N ' ' A' ' 84' ' ' LEU . 0.0 OUTLIER -109.36 110.22 21.31 Favored 'General case' 0 CA--C 1.512 -0.482 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 179.036 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.671 ' HB2' ' HB ' ' A' ' 81' ' ' ILE . 0.4 OUTLIER 162.25 -40.66 0.0 OUTLIER 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 114.709 -1.132 . . . . 0.0 109.427 -179.525 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.802 ' O ' ' N ' ' A' ' 88' ' ' HIS . 95.1 m-20 -64.25 -153.81 0.01 OUTLIER 'General case' 0 CA--C 1.52 -0.191 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 177.597 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.413 ' HA ' ' HA3' ' A' ' 69' ' ' GLY . 0.0 OUTLIER -54.05 71.28 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 178.313 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.964 ' O ' ' O ' ' A' ' 104' ' ' ILE . 36.2 t60 -80.82 -17.6 50.28 Favored 'General case' 0 CA--C 1.514 -0.412 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 -176.789 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.484 ' HA ' ' H ' ' A' ' 104' ' ' ILE . 0.0 OUTLIER -174.57 156.3 2.38 Favored 'General case' 0 C--N 1.31 -1.111 0 C-N-CA 119.23 -0.988 . . . . 0.0 112.981 178.024 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.497 ' O ' ' O ' ' A' ' 102' ' ' ASN . 36.6 mt-30 -138.1 161.02 37.86 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.502 -1.226 . . . . 0.0 113.958 -177.829 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.62 ' HB ' ' HB2' ' A' ' 66' ' ' TRP . 6.2 mt -127.84 126.6 67.01 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-N 115.006 -0.997 . . . . 0.0 109.13 178.037 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.419 ' O ' ' N ' ' A' ' 100' ' ' LEU . 0.3 OUTLIER -107.4 142.41 37.28 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.961 0.41 . . . . 0.0 111.974 -178.781 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.405 ' N ' ' CD1' ' A' ' 92' ' ' LEU . 0.5 OUTLIER -125.78 125.41 42.9 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.693 179.356 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.382 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.59 179.923 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.449 ' HB2' ' HB2' ' A' ' 124' ' ' LEU . 2.3 mp . . . . . 0 CA--C 1.528 0.122 0 CA-C-O 120.765 0.317 . . . . 0.0 110.761 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.591 ' HA ' ' O ' ' A' ' 122' ' ' GLN . 0.8 OUTLIER -132.47 147.96 52.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.107 179.987 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.468 ' O ' ' N ' ' A' ' 122' ' ' GLN . 1.0 OUTLIER -116.04 126.28 53.57 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 120.623 -0.431 . . . . 0.0 110.363 -179.81 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.497 ' O ' ' O ' ' A' ' 90' ' ' GLN . 33.5 t30 -111.57 111.47 22.49 Favored 'General case' 0 CA--C 1.51 -0.58 0 C-N-CA 119.988 -0.685 . . . . 0.0 109.448 179.539 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.587 ' HB3' ' CG2' ' A' ' 109' ' ' THR . 74.4 m-20 -83.37 111.5 19.06 Favored 'General case' 0 N--CA 1.442 -0.857 0 C-N-CA 119.623 -0.831 . . . . 0.0 109.603 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.964 ' O ' ' O ' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -123.35 107.95 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.969 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 177.533 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.419 ' OG ' ' NE2' ' A' ' 88' ' ' HIS . 63.7 m -132.17 171.12 14.06 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 115.05 -0.977 . . . . 0.0 109.331 179.778 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 25.1 m -69.52 -63.36 1.08 Allowed 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 119.143 -1.023 . . . . 0.0 111.541 -179.157 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -112.5 -32.75 6.37 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 114.63 1.345 . . . . 0.0 114.63 179.015 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -146.04 128.16 2.99 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 116.988 1.555 . . . . 0.0 116.988 -177.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.587 ' CG2' ' HB3' ' A' ' 103' ' ' ASP . 3.4 m -121.1 138.29 54.26 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 174.483 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . 0.667 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.3 m-90 -119.35 149.24 42.15 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 -178.535 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -120.9 112.08 18.33 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 115.177 -0.92 . . . . 0.0 108.691 177.483 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 39.7 m-20 45.24 43.29 7.93 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.074 -0.512 . . . . 0.0 112.24 -179.522 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 80.35 23.37 60.94 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.947 179.13 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 42.3 mt-30 -135.61 99.07 4.1 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.017 0.437 . . . . 0.0 110.861 179.647 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.667 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.0 OUTLIER -43.98 123.64 3.41 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.08 179.87 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 5.4 m -114.92 -179.74 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.7 -179.218 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -87.29 140.13 29.85 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.824 -0.626 . . . . 0.0 111.011 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.41 ' HG2' ' N ' ' A' ' 119' ' ' ASN . 54.2 tttm -63.63 162.69 12.58 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.25 179.518 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.41 ' N ' ' HG2' ' A' ' 118' ' ' LYS . 4.1 p30 34.85 38.87 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.228 0.537 . . . . 0.0 111.372 -179.865 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 6.9 p -111.04 108.71 18.52 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.973 -179.533 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . 0.415 ' ND2' ' CD2' ' A' ' 92' ' ' LEU . 27.9 m120 -54.91 144.66 22.21 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.633 179.882 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . 0.591 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 65.8 mm-40 -129.88 149.39 51.63 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.04 0.448 . . . . 0.0 112.084 -179.346 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 9.8 tt -77.27 120.5 22.4 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.357 178.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.449 ' HB2' ' HB2' ' A' ' 99' ' ' LEU . 8.2 tp -46.39 141.98 3.26 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 122.06 0.933 . . . . 0.0 112.022 -178.549 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -127.29 152.85 46.89 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 113.811 -1.541 . . . . 0.0 110.215 179.567 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 9.6 tp60 -71.79 113.67 9.07 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 179.301 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 64.87 31.58 81.39 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.323 -179.351 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -54.9 160.13 2.07 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.978 0.418 . . . . 0.0 111.207 -179.758 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.475 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 13.8 tt0 -146.48 135.35 22.39 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.642 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.418 ' CG2' ' O ' ' A' ' 110' ' ' TRP . 1.1 mp -112.94 128.47 69.66 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.121 0 CA-C-N 116.363 -0.38 . . . . 0.0 109.986 178.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.464 ' HB ' ' CB ' ' A' ' 110' ' ' TRP . 16.0 m -103.16 144.77 30.88 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.478 -179.748 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.47 ' HB ' ' NE2' ' A' ' 88' ' ' HIS . 5.4 m -141.37 158.16 22.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 112.581 0.586 . . . . 0.0 112.581 -178.715 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 67.04 42.81 92.06 Favored Glycine 0 N--CA 1.449 -0.494 0 CA-C-N 115.595 -0.729 . . . . 0.0 112.312 179.253 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.51 ' HA ' HG12 ' A' ' 140' ' ' ILE . 89.8 t -76.79 153.3 5.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-O 121.479 0.656 . . . . 0.0 112.268 -179.176 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 148.65 -42.03 0.85 Allowed Glycine 0 N--CA 1.441 -0.99 0 CA-C-N 114.888 -1.051 . . . . 0.0 110.655 -178.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 47.6 t -126.62 131.4 71.28 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 CA-C-N 115.172 -0.514 . . . . 0.0 109.743 178.698 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -51.3 -34.61 34.01 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.737 0.303 . . . . 0.0 111.445 -179.229 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -94.17 6.32 48.96 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 112.343 0.497 . . . . 0.0 112.343 -179.288 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -125.65 26.72 6.64 Favored 'General case' 0 CA--C 1.518 -0.252 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 -179.367 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.51 HG12 ' HA ' ' A' ' 134' ' ' VAL . 14.9 mt -105.5 140.81 22.4 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.967 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.267 179.069 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -117.73 130.01 56.06 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.901 179.327 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.607 ' HB2' HG22 ' A' ' 40' ' ' THR . 0.8 OUTLIER -116.37 139.06 50.81 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.417 0.627 . . . . 0.0 112.397 -178.845 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.475 ' O ' ' HA ' ' A' ' 129' ' ' GLU . 4.8 mp -118.25 138.98 51.98 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.14 -0.937 . . . . 0.0 109.331 179.083 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 21.7 t -123.41 140.5 46.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 120.809 0.338 . . . . 0.0 111.816 -179.034 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -113.63 126.7 71.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.554 179.657 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 80.0 t80 -111.27 123.78 50.89 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.948 -179.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 2.8 mp -106.27 132.24 53.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.111 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . 0.408 ' ND2' HG23 ' A' ' 32' ' ' ILE . 8.9 p30 -81.65 141.7 33.41 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.104 -179.795 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -73.93 -19.45 60.68 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.375 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 12.7 mptt -58.19 -44.83 88.28 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.958 0.408 . . . . 0.0 110.815 -179.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . 0.408 ' CD2' HD11 ' A' ' 52' ' ' ILE . 14.0 t80 . . . . . 0 C--N 1.328 -0.355 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.886 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.377 0 N-CA-C 112.582 -0.207 . . . . 0.0 112.582 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 -106.65 -39.61 5.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.785 0.326 . . . . 0.0 110.803 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -88.71 -174.17 4.43 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.775 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 11.5 mt -118.07 137.11 53.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.139 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.6 t -166.45 134.75 2.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.112 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 59.52 69.91 1.2 Allowed Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.925 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -72.18 139.93 33.27 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.568 2.179 . . . . 0.0 112.298 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 41.1 p -97.59 162.64 13.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.202 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.53 113.33 2.62 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.856 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -146.19 -73.7 0.22 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.854 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.8 p -142.32 131.61 23.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.903 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 6.8 m -117.84 138.8 51.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.078 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -170.6 147.8 2.94 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.915 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -133.62 31.99 3.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.057 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.75 -65.96 0.97 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.149 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 21.8 mm-40 -63.01 -35.68 81.04 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.925 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 8.1 tmm_? -64.62 -36.65 84.92 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.922 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 15.6 t80 -60.8 -42.17 97.1 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.86 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 57.0 mt -60.2 -39.4 86.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.011 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 43.1 mm -65.32 -40.76 89.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.177 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -57.64 -43.58 84.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.086 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 2.0 ttpt -64.35 -37.57 87.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.999 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -60.98 -47.57 85.83 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.19 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 31.2 t -71.19 -28.69 64.41 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.016 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.36 95.22 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.984 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -81.4 124.09 29.12 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.833 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 41.9 mt-30 -101.36 142.65 32.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.995 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.411 HG21 ' N ' ' A' ' 29' ' ' GLY . 20.7 mm -82.47 139.35 17.98 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.333 0 CA-C-O 121.512 0.672 . . . . 0.0 111.427 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.411 ' N ' HG21 ' A' ' 28' ' ' ILE . . . -123.9 67.11 0.5 Allowed Glycine 0 C--N 1.318 -0.427 0 CA-C-N 114.907 -1.042 . . . . 0.0 112.72 -179.751 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -88.96 -23.79 22.58 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.742 0.305 . . . . 0.0 111.071 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 13.8 m-20 -109.15 -13.42 14.68 Favored 'General case' 0 CA--C 1.514 -0.422 0 CA-C-O 121.983 0.897 . . . . 0.0 108.742 178.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.58 ' CG2' ' O ' ' A' ' 32' ' ' ILE . 0.1 OUTLIER -70.23 97.32 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.577 0 CA-C-N 114.0 -1.455 . . . . 0.0 110.731 -179.317 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.53 ' CG1' ' N ' ' A' ' 34' ' ' CYS . 0.9 OUTLIER -36.99 -61.94 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 114.839 -1.073 . . . . 0.0 112.169 -179.245 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.53 ' N ' ' CG1' ' A' ' 33' ' ' VAL . 28.0 p -163.9 164.85 23.23 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.116 0.484 . . . . 0.0 112.027 -179.621 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 4.1 ttm180 -122.45 127.46 49.65 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.634 179.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 11.7 p -99.29 128.62 50.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.271 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.442 ' CG2' HG12 ' A' ' 45' ' ' ILE . 25.0 mt -127.08 108.31 18.44 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.601 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.443 ' HB2' ' O ' ' A' ' 43' ' ' ILE . 0.1 OUTLIER -86.43 100.2 12.18 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 178.617 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 8.9 t -65.55 -40.66 93.12 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.416 0.524 . . . . 0.0 112.416 -178.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -55.75 -33.97 64.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.867 0.365 . . . . 0.0 111.172 -179.345 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 114.36 0.21 23.6 Favored Glycine 0 CA--C 1.518 0.222 0 C-N-CA 120.553 -0.832 . . . . 0.0 113.575 179.217 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.421 ' HG3' ' CG ' ' A' ' 141' ' ' LEU . 0.0 OUTLIER -61.39 -45.63 93.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.066 0.46 . . . . 0.0 110.86 179.904 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.481 HG22 ' CD2' ' A' ' 76' ' ' TYR . 4.3 mp -131.04 141.54 42.33 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.1 -179.644 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.463 ' CD ' ' CZ ' ' A' ' 76' ' ' TYR . 96.3 Cg_endo -81.12 147.08 16.28 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 122.512 2.141 . . . . 0.0 111.591 179.451 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.442 HG12 ' CG2' ' A' ' 37' ' ' ILE . 40.4 mt -42.19 109.59 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.034 0.445 . . . . 0.0 111.78 -179.473 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.01 132.34 56.63 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.843 179.513 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -85.99 119.6 26.46 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.108 0.48 . . . . 0.0 111.609 -179.276 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.533 ' HB3' ' CE2' ' A' ' 66' ' ' TRP . 2.9 mt -96.43 125.85 41.22 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 178.615 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.529 ' O ' ' HZ2' ' A' ' 66' ' ' TRP . 0.0 OUTLIER -132.64 161.86 32.85 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 113.874 1.064 . . . . 0.0 113.874 -178.045 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.472 ' HB2' HG22 ' A' ' 33' ' ' VAL . . . -151.52 164.98 35.62 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.02 -1.445 . . . . 0.0 110.806 178.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.415 ' CB ' ' HG3' ' A' ' 54' ' ' GLN . 0.5 OUTLIER -87.41 123.87 32.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.957 0.408 . . . . 0.0 111.325 -179.547 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 18.0 mt -63.75 -36.88 78.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.338 179.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -56.18 -34.16 65.96 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.838 -179.267 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.415 ' HG3' ' CB ' ' A' ' 51' ' ' ASP . 0.1 OUTLIER -63.45 -37.15 86.19 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.564 179.974 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 13.7 t -66.92 -38.01 80.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.097 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.7 mp -61.5 -41.29 97.07 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.886 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.404 ' O ' ' HG2' ' A' ' 58' ' ' GLU . 0.0 OUTLIER -81.09 -43.76 18.99 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.713 179.835 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.404 ' HG2' ' O ' ' A' ' 57' ' ' LYS . 0.9 OUTLIER 57.14 164.91 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.227 179.846 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 2.5 tmtp? 65.47 -72.92 0.07 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.316 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.52 -41.38 93.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.383 -179.592 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.409 ' O ' ' HB ' ' A' ' 62' ' ' ILE . 4.7 m -124.54 99.34 6.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.242 -179.556 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.415 ' CG2' ' O ' ' A' ' 62' ' ' ILE . 8.7 tp 178.26 61.89 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.063 179.776 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 52.3 mttt -144.53 89.29 1.99 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.579 -179.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 4.9 ttpt -140.36 131.37 26.2 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.262 179.228 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.476 ' CG1' ' O ' ' A' ' 91' ' ' ILE . 18.4 t -137.46 137.95 45.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.174 0.511 . . . . 0.0 112.232 -178.752 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . 0.64 ' HB2' ' HB ' ' A' ' 91' ' ' ILE . 14.5 m-90 -99.78 140.48 33.93 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.372 178.719 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.57 ' N ' ' HB2' ' A' ' 75' ' ' ASP . 33.6 m -128.44 137.18 51.71 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.554 0.692 . . . . 0.0 112.084 179.237 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.506 ' CE1' ' CG ' ' A' ' 75' ' ' ASP . 13.0 m-85 -109.07 119.01 38.26 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.124 -0.944 . . . . 0.0 109.203 178.222 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.631 ' HA2' ' O ' ' A' ' 85' ' ' SER . . . 156.82 -152.81 24.16 Favored Glycine 0 CA--C 1.503 -0.66 0 C-N-CA 118.71 -1.71 . . . . 0.0 113.412 179.16 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.462 ' CG ' ' HA ' ' A' ' 80' ' ' ASN . 62.1 mtp180 -75.06 91.44 2.55 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-O 122.513 1.149 . . . . 0.0 108.615 -179.629 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.477 ' O ' ' CD2' ' A' ' 77' ' ' HIS . 13.8 m120 -150.54 159.27 34.87 Favored Pre-proline 0 C--N 1.309 -1.183 0 CA-C-N 112.744 -2.026 . . . . 0.0 108.153 179.004 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.551 ' O ' ' HB2' ' A' ' 77' ' ' HIS . 34.7 Cg_endo -66.04 -7.08 15.98 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 120.79 0.993 . . . . 0.0 110.683 177.689 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.598 ' HB2' ' HB2' ' A' ' 77' ' ' HIS . . . 136.91 54.22 0.0 OUTLIER 'General case' 0 CA--C 1.488 -1.41 0 CA-C-N 114.338 -1.301 . . . . 0.0 108.887 178.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . 0.498 ' HB3' ' HB ' ' A' ' 67' ' ' THR . 0.1 OUTLIER -52.46 -69.9 0.1 Allowed 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 105.58 -2.007 . . . . 0.0 105.58 179.826 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.57 ' HB2' ' N ' ' A' ' 67' ' ' THR . 62.0 t0 -96.04 -47.18 6.2 Favored 'General case' 0 N--CA 1.437 -1.103 0 N-CA-C 105.383 -2.08 . . . . 0.0 105.383 168.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.498 ' C ' ' HA ' ' A' ' 73' ' ' ALA . 57.2 t80 -142.75 142.22 31.9 Favored 'General case' 0 C--N 1.35 0.599 0 CA-C-N 112.767 -2.015 . . . . 0.0 111.347 179.565 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . 0.598 ' HB2' ' HB2' ' A' ' 73' ' ' ALA . 23.7 t-160 -93.11 112.54 24.52 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 177.194 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.49 ' HB3' ' CE2' ' A' ' 76' ' ' TYR . 1.4 pp -129.02 173.5 10.38 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.03 0.443 . . . . 0.0 111.525 -179.524 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -60.53 178.7 3.04 Favored Glycine 0 C--N 1.333 0.376 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.465 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.462 ' HA ' ' CG ' ' A' ' 70' ' ' ARG . 0.8 OUTLIER -111.84 99.39 8.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.848 0.356 . . . . 0.0 111.487 -179.762 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.549 ' HB ' ' HB2' ' A' ' 85' ' ' SER . 0.5 OUTLIER -114.83 121.27 66.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.163 -0.471 . . . . 0.0 109.835 178.871 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.4 t -53.81 -24.54 15.76 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -178.15 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.94 -103.72 0.09 Allowed 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -179.071 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.431 ' O ' ' CB ' ' A' ' 85' ' ' SER . 0.0 OUTLIER -109.0 113.56 26.55 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-O 121.336 0.589 . . . . 0.0 109.432 179.681 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.631 ' O ' ' HA2' ' A' ' 69' ' ' GLY . 0.4 OUTLIER 162.02 -48.98 0.0 OUTLIER 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 114.769 -1.105 . . . . 0.0 109.317 -179.276 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.907 ' O ' ' N ' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -59.79 -162.84 0.01 OUTLIER 'General case' 0 CA--C 1.513 -0.465 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 177.717 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.493 ' HA ' ' HA3' ' A' ' 69' ' ' GLY . 13.3 mtmt -44.99 71.08 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 178.547 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 1.013 ' O ' ' O ' ' A' ' 104' ' ' ILE . 39.6 t60 -86.87 -15.92 37.62 Favored 'General case' 0 CA--C 1.513 -0.459 0 N-CA-C 113.956 1.095 . . . . 0.0 113.956 -176.466 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.557 ' CE1' HG13 ' A' ' 91' ' ' ILE . 0.0 OUTLIER -175.97 159.53 2.19 Favored 'General case' 0 C--N 1.311 -1.07 0 C-N-CA 119.165 -1.014 . . . . 0.0 112.8 178.145 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.503 ' O ' ' O ' ' A' ' 102' ' ' ASN . 42.3 mt-30 -138.73 160.23 40.16 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 113.734 1.013 . . . . 0.0 113.734 -178.336 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.64 ' HB ' ' HB2' ' A' ' 66' ' ' TRP . 4.8 mt -125.08 129.21 73.34 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.019 177.825 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.418 ' HG ' ' HB2' ' A' ' 100' ' ' LEU . 0.3 OUTLIER -109.43 140.17 43.49 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.115 0.483 . . . . 0.0 111.82 -179.203 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.437 ' CD1' ' CG2' ' A' ' 33' ' ' VAL . 6.6 tp -120.16 128.25 53.24 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.409 179.231 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 146.85 -155.17 26.41 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.55 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 63.18 78.85 0.28 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.879 0.371 . . . . 0.0 110.743 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 2.4 t70 69.01 17.82 8.52 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.331 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 93.58 -26.98 13.33 Favored Glycine 0 C--N 1.331 0.28 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.846 179.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -56.74 178.33 0.06 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.844 0.354 . . . . 0.0 111.107 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 6.3 mp -116.97 148.91 41.01 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.826 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.646 ' HA ' ' O ' ' A' ' 122' ' ' GLN . 2.5 mp -133.47 148.86 51.75 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.487 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.472 ' O ' ' N ' ' A' ' 122' ' ' GLN . 9.5 mp -112.66 129.02 56.54 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.503 ' O ' ' O ' ' A' ' 90' ' ' GLN . 28.7 t30 -110.39 111.94 23.55 Favored 'General case' 0 CA--C 1.508 -0.638 0 C-N-CA 119.735 -0.786 . . . . 0.0 109.838 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.556 ' HB3' ' CG2' ' A' ' 109' ' ' THR . 88.5 m-20 -84.04 111.22 19.1 Favored 'General case' 0 N--CA 1.439 -0.99 0 C-N-CA 119.572 -0.851 . . . . 0.0 109.564 179.755 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 1.013 ' O ' ' O ' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -123.07 107.9 20.17 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.968 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 177.22 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.441 ' HB3' ' CE1' ' A' ' 88' ' ' HIS . 50.8 m -135.23 167.32 21.22 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.485 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 18.4 m -69.5 -63.26 1.1 Allowed 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 119.109 -1.036 . . . . 0.0 111.749 -178.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -112.45 -32.64 6.42 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 115.065 1.506 . . . . 0.0 115.065 179.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -146.05 128.66 3.13 Favored Glycine 0 C--N 1.34 0.788 0 N-CA-C 117.216 1.646 . . . . 0.0 117.216 -177.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.556 ' CG2' ' HB3' ' A' ' 103' ' ' ASP . 6.1 m -121.35 138.14 54.39 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 174.353 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . 0.722 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.8 m-90 -121.27 149.04 43.49 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 113.466 0.913 . . . . 0.0 113.466 -178.47 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -123.24 112.27 17.45 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 114.98 -1.009 . . . . 0.0 108.709 177.479 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 71.5 m-20 45.42 43.88 9.01 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.104 -0.498 . . . . 0.0 112.061 -179.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 79.19 23.67 62.9 Favored Glycine 0 N--CA 1.444 -0.82 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.699 179.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 7.8 mt-30 -136.19 96.41 3.38 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.038 0.447 . . . . 0.0 110.828 179.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.722 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.0 OUTLIER -44.84 136.2 4.7 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.812 179.762 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 3.2 m -127.4 -179.89 3.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 121.023 0.44 . . . . 0.0 112.043 -178.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -83.51 142.36 30.96 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.439 -179.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.413 ' O ' ' C ' ' A' ' 119' ' ' ASN . 82.3 tttt -64.86 164.88 11.6 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.108 179.362 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.413 ' C ' ' O ' ' A' ' 118' ' ' LYS . 21.0 m-80 33.9 39.54 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 121.209 0.528 . . . . 0.0 111.193 -179.446 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 2.5 p -110.91 106.29 15.37 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.989 -179.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 22.7 m120 -57.7 144.18 38.95 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.506 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . 0.646 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 76.9 mm-40 -129.39 149.27 51.24 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-O 121.063 0.458 . . . . 0.0 112.003 -179.473 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 62.9 tp -72.92 124.38 25.31 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.71 179.104 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.401 ' HG ' ' N ' ' A' ' 125' ' ' SER . 4.9 tp -50.73 141.48 12.88 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-O 122.026 0.917 . . . . 0.0 111.78 -178.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' SER . . . . . 0.406 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.0 OUTLIER -127.14 153.06 46.51 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 113.836 -1.529 . . . . 0.0 109.936 179.421 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 1.7 mm-40 -71.14 113.64 8.38 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 179.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 64.84 30.96 79.37 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.516 -179.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.406 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 27.0 t70 -55.71 159.53 2.98 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 120.906 0.384 . . . . 0.0 111.109 -179.763 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.461 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 13.0 tt0 -146.49 135.6 22.61 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.699 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.466 ' CG2' ' O ' ' A' ' 110' ' ' TRP . 8.2 mm -114.23 128.72 71.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 116.145 -0.48 . . . . 0.0 109.915 178.644 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.461 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 88.9 m -103.43 145.2 30.35 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.873 -179.431 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.476 ' HB ' ' NE2' ' A' ' 88' ' ' HIS . 6.0 m -141.2 158.38 22.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 -179.193 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 69.49 44.23 65.39 Favored Glycine 0 N--CA 1.447 -0.595 0 CA-C-N 115.897 -0.592 . . . . 0.0 112.287 179.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.453 ' HA ' HG12 ' A' ' 140' ' ' ILE . 90.5 t -79.72 155.46 4.62 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.569 0 CA-C-O 121.373 0.606 . . . . 0.0 112.236 -179.166 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 145.62 -46.5 0.77 Allowed Glycine 0 N--CA 1.441 -1.0 0 CA-C-N 114.908 -1.042 . . . . 0.0 110.571 -179.01 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 45.7 t -126.81 128.56 71.01 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 CA-C-N 115.241 -0.48 . . . . 0.0 109.795 178.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -51.06 -26.52 6.43 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.692 0.282 . . . . 0.0 111.376 -179.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -94.66 6.05 50.05 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 -179.268 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -131.29 23.4 4.82 Favored 'General case' 0 CA--C 1.523 -0.093 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 -179.449 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.461 ' CG2' ' CG2' ' A' ' 131' ' ' THR . 23.6 mt -97.65 141.16 16.37 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.249 179.06 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.421 ' CG ' ' HG3' ' A' ' 42' ' ' GLN . 3.8 mm? -119.21 135.54 54.63 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 114.821 -1.081 . . . . 0.0 109.793 179.514 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 46.3 t -116.46 151.73 35.46 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.749 0.785 . . . . 0.0 113.011 -178.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.461 ' O ' ' HA ' ' A' ' 129' ' ' GLU . 0.9 OUTLIER -134.0 132.24 39.87 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 114.554 -1.203 . . . . 0.0 109.679 179.2 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 25.1 t -128.11 140.46 49.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.914 0.387 . . . . 0.0 111.518 -178.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -117.3 124.99 73.72 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.763 179.795 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 49.3 t80 -106.62 105.69 15.84 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.393 179.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 1.3 mp -84.97 133.39 29.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.483 -179.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -79.9 113.93 18.43 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.835 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -58.59 -21.03 52.0 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.256 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 32.1 mtmm -57.49 -42.67 83.16 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.957 0.408 . . . . 0.0 110.638 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -60.4 -44.31 95.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.75 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 1.3 mttt -64.26 -36.0 82.68 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.809 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 5.5 tt0 -63.28 -37.91 89.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.852 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 10.9 t -63.92 -45.26 90.07 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.939 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -58.87 -39.65 82.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.892 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -65.2 -41.0 94.92 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.833 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -66.41 -22.45 66.23 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.147 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -116.0 63.09 0.7 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.854 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.26 161.71 30.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.97 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 11.5 m -92.28 132.39 36.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.017 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -172.61 157.39 3.86 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.881 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 20.0 mtp180 -141.96 38.56 1.62 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.837 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 21.4 mt -98.44 124.64 51.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.081 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 2.1 mmt85 . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.148 -0.929 . . . . 0.0 110.842 -179.968 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.265 0 N-CA-C 112.485 -0.246 . . . . 0.0 112.485 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -155.17 114.35 3.62 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.853 0.358 . . . . 0.0 110.929 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -129.39 151.59 49.86 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.907 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.43 ' N ' ' CD1' ' A' ' 4' ' ' ILE . 0.1 OUTLIER -136.77 134.69 48.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.06 -179.998 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 22.1 p -69.41 127.02 31.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.105 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -132.86 62.74 64.05 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.847 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -71.61 -35.16 8.24 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.605 2.203 . . . . 0.0 112.231 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 31.1 p -103.65 -22.31 13.6 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.273 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 61.69 -172.98 0.14 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.815 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 3.1 pm0 -123.74 23.01 8.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.138 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 52.72 -168.5 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.843 0.354 . . . . 0.0 111.061 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -73.49 -36.87 65.84 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.032 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 11.8 mp0 -106.31 120.18 41.2 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.805 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -130.88 102.57 6.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.148 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -161.62 -55.26 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.13 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.9 -47.06 79.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.965 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 3.5 ttt85 -63.81 -37.37 87.13 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.078 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -67.01 -35.9 80.95 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.036 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.2 mp -63.42 -45.25 91.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.994 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 41.1 mm -62.15 -40.77 88.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.302 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -57.64 -47.14 83.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.108 -179.776 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -67.18 -28.67 68.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.044 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -59.25 -47.26 86.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.443 -179.726 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 78.6 p -65.33 -48.05 74.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.205 -179.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 42.66 34.61 0.58 Allowed 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.365 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -62.57 131.21 48.32 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.223 -179.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -110.45 140.95 44.2 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.832 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 23.9 mm -86.62 139.61 17.08 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.347 0 CA-C-O 121.474 0.654 . . . . 0.0 111.789 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 102.3 -24.45 31.01 Favored Glycine 0 C--N 1.318 -0.443 0 CA-C-N 114.937 -1.029 . . . . 0.0 112.679 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -80.56 -23.93 39.59 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.612 0.244 . . . . 0.0 111.271 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -109.0 -14.65 14.51 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-O 121.911 0.863 . . . . 0.0 108.906 178.409 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.515 ' CG2' ' O ' ' A' ' 32' ' ' ILE . 0.1 OUTLIER -73.3 106.36 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.58 0 CA-C-N 113.968 -1.469 . . . . 0.0 111.094 -179.442 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.602 ' CG1' ' N ' ' A' ' 34' ' ' CYS . 0.5 OUTLIER -38.87 -62.21 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.384 -0.826 . . . . 0.0 111.403 -179.664 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.602 ' N ' ' CG1' ' A' ' 33' ' ' VAL . 28.4 p -165.77 165.95 18.12 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.482 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 2.2 ttp180 -120.77 127.38 51.91 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.542 179.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.423 ' CG2' ' CD2' ' A' ' 48' ' ' LEU . 39.1 t -97.23 121.92 48.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.504 179.285 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.417 ' CG2' HG12 ' A' ' 45' ' ' ILE . 20.3 mt -125.29 109.02 20.96 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.824 -179.355 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 43.4 t -78.2 99.92 6.42 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 178.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 9.7 t -69.73 -33.27 72.24 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -178.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.415 ' OG1' ' O ' ' A' ' 142' ' ' SER . 0.0 OUTLIER -52.38 -29.32 23.46 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.914 0.388 . . . . 0.0 110.9 -179.658 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 90.46 49.78 3.13 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.866 -0.683 . . . . 0.0 113.003 179.205 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 2.3 mm-40 -126.55 -31.77 2.7 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.663 0.268 . . . . 0.0 111.368 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.444 HG22 ' CE2' ' A' ' 76' ' ' TYR . 19.0 mt -127.37 131.15 23.7 Favored Pre-proline 0 N--CA 1.452 -0.329 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.98 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.436 ' HD2' ' CE2' ' A' ' 76' ' ' TYR . 27.8 Cg_exo -59.85 146.82 94.73 Favored 'Trans proline' 0 C--N 1.343 0.263 0 C-N-CA 122.655 2.236 . . . . 0.0 112.046 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.417 HG12 ' CG2' ' A' ' 37' ' ' ILE . 78.8 mt -51.59 133.12 13.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.327 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -126.16 131.23 52.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.371 179.669 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -96.17 119.95 35.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.043 0.449 . . . . 0.0 111.511 -179.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.558 ' HG ' ' CG ' ' A' ' 66' ' ' TRP . 1.8 mp -96.37 117.0 29.95 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 178.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.525 ' O ' ' HZ2' ' A' ' 66' ' ' TRP . 0.1 OUTLIER -112.24 162.17 15.78 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 122.077 0.942 . . . . 0.0 113.121 -178.715 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.466 ' CB ' ' CG2' ' A' ' 33' ' ' VAL . . . -125.97 165.9 17.93 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 114.718 -1.128 . . . . 0.0 111.4 179.401 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.4 ' CB ' ' CG ' ' A' ' 54' ' ' GLN . 0.0 OUTLIER -108.22 78.56 1.18 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.42 179.879 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 88.4 mt -64.06 -45.52 96.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.571 -179.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 37.8 t -61.27 -37.08 81.86 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.018 0.437 . . . . 0.0 110.812 -179.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.4 ' CG ' ' CB ' ' A' ' 51' ' ' ASP . 11.7 mm-40 -68.53 -40.41 80.76 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.033 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 23.7 t -74.03 -38.45 49.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.24 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.99 -41.29 95.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.152 -179.608 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -90.73 -43.71 9.93 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.096 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -114.66 163.56 15.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.816 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.43 30.62 3.2 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.785 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -94.5 -36.18 11.97 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.994 -179.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.7 p -81.15 -97.24 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.918 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER 41.37 42.76 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.162 0 CA-C-O 121.064 0.459 . . . . 0.0 111.578 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 27.9 tttt -159.03 77.67 0.74 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.08 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -115.0 138.88 50.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.563 179.597 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.447 ' CG1' ' O ' ' A' ' 91' ' ' ILE . 13.9 t -136.73 136.92 47.89 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 CA-C-O 121.116 0.484 . . . . 0.0 112.003 -179.289 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . 0.626 ' HB2' ' HB ' ' A' ' 91' ' ' ILE . 15.2 m-90 -100.19 140.61 34.18 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.666 179.205 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.555 ' HB ' ' HB3' ' A' ' 74' ' ' CYS . 7.1 m -129.21 129.47 45.08 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.455 0.645 . . . . 0.0 112.337 179.653 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.504 ' CE1' ' CG ' ' A' ' 75' ' ' ASP . 3.4 m-85 -103.43 118.69 37.34 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.051 -0.977 . . . . 0.0 108.716 177.578 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.63 ' HA2' ' O ' ' A' ' 85' ' ' SER . . . 157.06 -154.86 25.89 Favored Glycine 0 CA--C 1.505 -0.548 0 C-N-CA 118.58 -1.772 . . . . 0.0 113.468 179.346 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 4.1 mtp180 -75.27 91.83 2.7 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-O 122.543 1.163 . . . . 0.0 108.826 -179.416 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.518 ' O ' ' CD2' ' A' ' 77' ' ' HIS . 16.1 m120 -150.05 159.41 35.52 Favored Pre-proline 0 C--N 1.307 -1.262 0 CA-C-N 112.782 -2.008 . . . . 0.0 107.85 178.786 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.548 ' O ' ' HB2' ' A' ' 77' ' ' HIS . 30.9 Cg_endo -64.4 -7.09 13.19 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 120.7 0.933 . . . . 0.0 110.758 177.714 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.591 ' HB2' ' HB2' ' A' ' 77' ' ' HIS . . . 136.71 53.62 0.0 OUTLIER 'General case' 0 CA--C 1.488 -1.406 0 CA-C-N 114.367 -1.288 . . . . 0.0 109.0 178.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . 0.555 ' HB3' ' HB ' ' A' ' 67' ' ' THR . 0.1 OUTLIER -52.56 -70.07 0.1 Allowed 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 105.409 -2.071 . . . . 0.0 105.409 179.719 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.504 ' CG ' ' CE1' ' A' ' 68' ' ' PHE . 16.8 t70 -95.58 -47.56 6.18 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 105.781 -1.933 . . . . 0.0 105.781 169.114 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.473 ' C ' ' HA ' ' A' ' 73' ' ' ALA . 19.4 t80 -143.08 141.95 31.4 Favored 'General case' 0 C--N 1.348 0.507 0 CA-C-N 112.775 -2.011 . . . . 0.0 111.458 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . 0.591 ' HB2' ' HB2' ' A' ' 73' ' ' ALA . 23.7 t-160 -96.1 107.28 19.58 Favored 'General case' 0 C--N 1.33 -0.261 0 O-C-N 122.114 -0.366 . . . . 0.0 110.222 177.26 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.465 ' HB3' ' CE2' ' A' ' 76' ' ' TYR . 0.6 OUTLIER -121.19 173.77 7.1 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.916 0.388 . . . . 0.0 111.506 -179.895 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -56.91 -173.39 0.21 Allowed Glycine 0 C--N 1.332 0.343 0 C-N-CA 121.014 -0.612 . . . . 0.0 112.475 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.404 ' HA ' ' OD1' ' A' ' 86' ' ' ASN . 9.2 p30 -111.81 98.34 7.32 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.82 0.343 . . . . 0.0 111.758 -179.671 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.655 ' HB ' ' HB2' ' A' ' 85' ' ' SER . 11.2 mt -114.91 113.79 44.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.436 178.574 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -55.65 -24.37 33.35 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 -179.352 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 1.4 mtt180 -88.21 -106.11 0.08 Allowed 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -179.047 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.402 ' O ' ' CB ' ' A' ' 85' ' ' SER . 0.0 OUTLIER -109.26 111.17 22.61 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-O 121.568 0.699 . . . . 0.0 110.158 179.976 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.655 ' HB2' ' HB ' ' A' ' 81' ' ' ILE . 0.5 OUTLIER 162.11 -48.94 0.0 OUTLIER 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 114.378 -1.283 . . . . 0.0 109.261 -179.817 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.846 ' O ' ' N ' ' A' ' 88' ' ' HIS . 89.0 m-20 -63.32 -152.57 0.01 OUTLIER 'General case' 0 CA--C 1.522 -0.122 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 177.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 12.9 mttt -48.54 72.8 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 179.303 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.996 ' O ' ' O ' ' A' ' 104' ' ' ILE . 36.3 t60 -93.93 -17.76 22.64 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 114.103 1.149 . . . . 0.0 114.103 -176.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.498 ' HA ' ' H ' ' A' ' 104' ' ' ILE . 0.1 OUTLIER -175.83 155.69 1.7 Allowed 'General case' 0 C--N 1.313 -1.002 0 C-N-CA 118.96 -1.096 . . . . 0.0 113.073 177.982 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.515 ' O ' ' O ' ' A' ' 102' ' ' ASN . 21.2 mt-30 -137.46 160.97 37.62 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.308 -1.314 . . . . 0.0 113.574 -177.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.626 ' HB ' ' HB2' ' A' ' 66' ' ' TRP . 2.7 mt -128.42 132.33 68.17 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.784 178.746 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.427 ' N ' ' O ' ' A' ' 100' ' ' LEU . 0.3 OUTLIER -109.52 146.12 35.15 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.142 0.496 . . . . 0.0 112.017 -179.126 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.475 ' HG ' HG23 ' A' ' 33' ' ' VAL . 1.1 tm? -125.97 124.52 40.92 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.445 179.195 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 128.21 -129.55 6.33 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.617 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 67.76 -70.4 0.12 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.779 0.323 . . . . 0.0 111.023 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -143.15 52.86 1.36 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.01 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 77.93 -60.18 3.82 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.562 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -57.67 -170.27 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.901 0.382 . . . . 0.0 110.991 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 4.9 mp -106.95 159.92 15.91 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.943 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.671 ' HA ' ' O ' ' A' ' 122' ' ' GLN . 4.6 mp -131.58 148.35 52.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.389 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.462 ' O ' ' N ' ' A' ' 122' ' ' GLN . 6.0 mt -118.23 128.78 55.02 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 179.823 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.515 ' O ' ' O ' ' A' ' 90' ' ' GLN . 29.4 t30 -111.21 111.38 22.41 Favored 'General case' 0 CA--C 1.507 -0.675 0 C-N-CA 119.907 -0.717 . . . . 0.0 109.685 179.606 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.562 ' HB3' ' CG2' ' A' ' 109' ' ' THR . 84.0 m-20 -85.8 111.56 20.28 Favored 'General case' 0 N--CA 1.44 -0.932 0 C-N-CA 119.596 -0.842 . . . . 0.0 109.535 179.697 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.996 ' O ' ' O ' ' A' ' 88' ' ' HIS . 0.1 OUTLIER -122.91 107.57 19.59 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.953 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 177.563 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.406 ' OG ' ' NE2' ' A' ' 88' ' ' HIS . 70.9 m -134.17 166.89 21.72 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-N 114.982 -1.008 . . . . 0.0 109.398 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 20.8 m -69.24 -62.81 1.23 Allowed 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 119.226 -0.99 . . . . 0.0 111.581 -179.074 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -112.12 -32.82 6.43 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 114.984 1.476 . . . . 0.0 114.984 179.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -146.35 127.95 2.9 Favored Glycine 0 C--N 1.339 0.749 0 N-CA-C 117.388 1.715 . . . . 0.0 117.388 -177.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.562 ' CG2' ' HB3' ' A' ' 103' ' ' ASP . 5.4 m -121.37 138.3 54.32 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 174.18 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . 0.739 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.9 m-90 -121.24 148.91 43.65 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 113.318 0.859 . . . . 0.0 113.318 -178.506 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -121.6 112.05 17.98 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 115.12 -0.946 . . . . 0.0 108.509 177.424 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 43.97 44.44 6.02 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.038 -0.528 . . . . 0.0 112.126 -179.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 80.06 25.12 58.36 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.744 179.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 58.0 mt-30 -137.74 95.98 3.15 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.077 0.465 . . . . 0.0 110.841 179.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.739 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.0 OUTLIER -45.61 134.54 7.17 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.891 179.77 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 27.3 m -126.05 -178.19 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.916 -179.029 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -85.84 142.1 29.15 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.229 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.429 ' HG3' ' HA ' ' A' ' 104' ' ' ILE . 71.4 tttt -64.49 163.21 13.82 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.155 179.28 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.404 ' N ' ' O ' ' A' ' 103' ' ' ASP . 4.2 p30 35.41 39.5 0.06 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.287 0.565 . . . . 0.0 111.17 -179.796 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 4.9 p -110.87 106.76 16.02 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.024 -179.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -57.26 140.8 48.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.506 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . 0.671 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 59.9 mm-40 -129.63 147.86 51.47 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-O 121.109 0.481 . . . . 0.0 111.965 -179.542 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.3 tp -73.77 116.89 14.9 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.628 -0.715 . . . . 0.0 109.491 178.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.4 tt -47.54 144.53 3.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.85 0.833 . . . . 0.0 111.892 -178.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' SER . . . . . 0.429 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.6 OUTLIER -126.83 153.18 45.99 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 114.04 -1.436 . . . . 0.0 110.291 179.535 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 24.6 mm100 -71.67 113.93 9.22 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.002 0.429 . . . . 0.0 110.152 179.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 69.24 25.66 75.27 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.645 -179.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.429 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 27.0 t70 -58.5 159.99 5.85 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.045 0.45 . . . . 0.0 111.136 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.412 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 1.7 tt0 -146.56 135.37 22.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.411 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.466 ' CG2' ' O ' ' A' ' 110' ' ' TRP . 1.2 mp -110.46 128.5 66.7 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.157 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 178.685 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.454 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 23.3 m -103.13 144.79 30.84 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.451 -179.571 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.468 ' HB ' ' NE2' ' A' ' 88' ' ' HIS . 10.2 m -141.29 158.14 22.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -178.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 67.38 43.16 88.59 Favored Glycine 0 N--CA 1.447 -0.582 0 CA-C-N 115.667 -0.697 . . . . 0.0 112.281 179.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.448 ' HA ' HG12 ' A' ' 140' ' ' ILE . 85.2 t -77.84 156.48 5.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 121.406 0.622 . . . . 0.0 112.133 -179.245 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 147.79 -42.06 0.89 Allowed Glycine 0 N--CA 1.441 -0.99 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.635 -179.061 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 43.8 t -126.65 130.14 71.63 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.684 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 178.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.29 -34.0 31.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.724 0.297 . . . . 0.0 111.405 -179.181 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 4.0 p -94.28 6.39 48.81 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 -179.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -128.14 30.25 5.25 Favored 'General case' 0 CA--C 1.52 -0.197 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -179.274 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.454 ' CG2' ' CG2' ' A' ' 131' ' ' THR . 20.9 mt -103.66 141.12 20.03 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.361 179.183 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 3.4 mp -111.51 135.67 51.76 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.021 -0.991 . . . . 0.0 110.048 179.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.415 ' O ' ' OG1' ' A' ' 40' ' ' THR . 47.3 t -116.82 152.02 35.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.865 0.841 . . . . 0.0 112.94 -178.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.412 ' O ' ' HA ' ' A' ' 129' ' ' GLU . 3.9 mm? -136.24 127.06 27.45 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.526 -1.215 . . . . 0.0 109.166 178.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 18.7 t -120.2 140.61 43.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.017 0.437 . . . . 0.0 111.978 -178.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . 0.402 ' CG1' HG23 ' A' ' 36' ' ' VAL . 0.2 OUTLIER -114.19 127.17 71.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.575 179.639 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 15.6 t80 -110.65 107.19 16.68 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.753 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 1.4 mp -99.76 133.41 42.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.393 -179.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 14.7 p30 -82.05 134.79 35.37 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.926 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -64.63 -23.03 67.13 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.154 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 16.7 mtmt -57.31 -42.22 81.37 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.94 0.4 . . . . 0.0 110.687 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 37.3 t80 -59.38 -43.88 92.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.75 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 16.4 mttm -59.55 -42.8 93.19 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.95 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 72.5 mt-30 -63.75 -40.22 96.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.956 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 10.5 t -63.29 -45.07 93.09 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.949 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -68.51 -37.84 80.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.915 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -60.28 -39.32 86.47 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.983 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -88.85 -35.52 16.52 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.909 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 4.6 p30 42.51 42.28 2.68 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.465 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 1.9 mttm -90.87 150.2 21.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.917 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 21.5 t -66.16 141.1 18.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.13 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -57.59 92.77 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.939 -179.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 5.6 ptm180 -138.13 -175.52 4.13 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.902 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 3.6 mt -77.92 113.77 17.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.025 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 48.0 ttp85 . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.282 -0.866 . . . . 0.0 110.91 -179.925 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.353 0 N-CA-C 112.546 -0.221 . . . . 0.0 112.546 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -64.36 130.82 45.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.843 0.354 . . . . 0.0 110.95 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -158.28 51.41 0.42 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.82 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 4.8 mt -121.33 -65.51 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.061 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 10.9 p -148.4 102.18 3.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.193 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . 0.419 ' N ' ' CD ' ' A' ' 7' ' ' PRO . 0.0 OUTLIER -61.08 -52.24 73.21 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.968 179.91 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.419 ' CD ' ' N ' ' A' ' 6' ' ' GLN . 74.0 Cg_exo -48.49 113.89 1.0 Allowed 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.634 2.223 . . . . 0.0 112.41 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 12.9 m -61.04 126.91 29.09 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.144 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -134.95 85.79 2.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.895 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.19 -38.07 82.16 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.85 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -151.98 176.12 11.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.916 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -145.8 89.27 1.89 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.131 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -103.91 34.96 2.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.883 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -145.33 64.31 1.26 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.105 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -140.84 -48.69 0.42 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.147 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 10.1 tm0? -66.24 -37.29 85.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.868 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 2.5 mtt180 -61.68 -41.74 97.98 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.899 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -64.41 -36.01 82.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.869 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.7 tt -59.8 -42.22 92.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.931 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 34.5 mm -62.14 -40.57 88.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.108 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -57.68 -35.94 71.25 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.039 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.35 -33.51 74.85 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.942 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -61.73 -47.58 84.6 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.142 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 6.8 t -59.95 -46.98 87.64 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.824 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 22.4 mt-30 -146.15 154.62 41.99 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.838 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -98.02 155.52 17.07 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.869 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 21.1 tt0 -96.74 131.1 43.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.828 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 22.6 mm -82.04 139.5 17.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 121.463 0.649 . . . . 0.0 111.59 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -172.86 -37.95 0.04 OUTLIER Glycine 0 C--N 1.317 -0.521 0 CA-C-N 114.884 -1.053 . . . . 0.0 112.644 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -73.89 -23.69 59.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.701 0.286 . . . . 0.0 111.317 -179.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -109.06 -14.37 14.54 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-O 121.949 0.881 . . . . 0.0 108.746 178.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.541 ' CG2' ' O ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -74.31 101.53 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.522 0 CA-C-N 114.011 -1.449 . . . . 0.0 110.558 -179.769 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.585 ' CG1' ' N ' ' A' ' 34' ' ' CYS . 0.5 OUTLIER -34.93 -61.73 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.249 -0.887 . . . . 0.0 112.297 -179.059 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.585 ' N ' ' CG1' ' A' ' 33' ' ' VAL . 41.2 m -159.36 165.46 33.25 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.677 -179.178 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.46 115.12 17.68 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.828 179.367 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 9.9 p -89.18 134.38 28.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.812 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.463 ' CG2' HG12 ' A' ' 45' ' ' ILE . 21.6 mt -132.68 107.86 12.55 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -179.373 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -89.23 106.56 18.52 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 177.604 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 10.1 t -99.11 -22.4 15.7 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 -177.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.554 HG22 ' OG ' ' A' ' 142' ' ' SER . 56.7 p -57.74 -20.7 36.51 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.656 0.265 . . . . 0.0 111.583 -179.556 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 104.86 71.75 0.84 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.561 -0.828 . . . . 0.0 112.627 179.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -159.35 -66.95 0.08 Allowed 'General case' 0 C--N 1.328 -0.37 0 CA-C-O 120.893 0.377 . . . . 0.0 110.925 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.478 HG21 ' CD2' ' A' ' 76' ' ' TYR . 34.3 mt -103.5 138.97 19.69 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.257 -179.714 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.464 ' CG ' ' CE1' ' A' ' 76' ' ' TYR . 91.2 Cg_endo -81.73 146.79 15.09 Favored 'Trans proline' 0 N--CA 1.46 -0.458 0 C-N-CA 122.71 2.273 . . . . 0.0 111.706 179.51 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.463 HG12 ' CG2' ' A' ' 37' ' ' ILE . 55.8 mt -43.82 116.07 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.072 0.463 . . . . 0.0 111.622 -179.665 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 8.9 mmm180 -114.69 131.48 56.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.928 179.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.405 ' HB3' HD13 ' A' ' 32' ' ' ILE . 5.0 m-20 -88.11 119.6 28.64 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.063 0.459 . . . . 0.0 111.604 -179.306 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.498 ' HB3' ' CE2' ' A' ' 66' ' ' TRP . 1.0 OUTLIER -98.34 121.57 40.43 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 178.741 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.517 ' O ' ' HZ2' ' A' ' 66' ' ' TRP . 0.0 OUTLIER -120.81 162.05 20.44 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 122.133 0.968 . . . . 0.0 113.46 -178.371 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.473 ' CB ' ' CG2' ' A' ' 33' ' ' VAL . . . -116.96 166.28 12.36 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 114.343 -1.299 . . . . 0.0 110.958 179.685 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -105.47 63.44 0.69 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.029 0.442 . . . . 0.0 110.837 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.42 HD13 ' CE2' ' A' ' 151' ' ' PHE . 53.6 mt -63.18 -44.05 99.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.04 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.54 -39.23 88.47 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.04 0.448 . . . . 0.0 111.1 -179.497 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 16.8 mt-30 -65.79 -40.76 92.25 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.198 -179.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 41.4 t -63.28 -40.37 88.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.136 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -61.63 -32.36 72.5 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.959 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.95 -27.74 16.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.079 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.59 -175.98 3.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.919 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.42 -48.88 4.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.833 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 6.6 mmt85 -115.87 -67.93 0.96 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.894 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.8 t 61.5 -163.44 0.26 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.827 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 22.0 mm 71.93 86.62 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.176 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 179.83 71.24 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.852 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.438 ' O ' ' HB3' ' A' ' 93' ' ' LEU . 13.2 ttpt -130.41 136.68 49.3 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.625 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.475 ' CG1' ' O ' ' A' ' 91' ' ' ILE . 17.6 t -137.41 137.3 46.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.969 0.414 . . . . 0.0 112.008 -179.124 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . 0.634 ' HB2' ' HB ' ' A' ' 91' ' ' ILE . 13.8 m-90 -100.26 139.29 36.15 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.09 178.636 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.587 ' O ' ' N ' ' A' ' 75' ' ' ASP . 4.4 m -131.3 130.49 42.83 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.458 0.647 . . . . 0.0 112.57 179.747 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.521 ' CD2' ' CD2' ' A' ' 89' ' ' PHE . 93.7 m-85 -101.73 118.57 37.2 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.303 178.006 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.602 ' HA2' ' O ' ' A' ' 85' ' ' SER . . . 157.34 -157.2 27.9 Favored Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 118.899 -1.619 . . . . 0.0 112.812 179.291 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.47 92.34 2.85 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-O 122.71 1.243 . . . . 0.0 108.738 -179.763 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.536 ' O ' ' CD2' ' A' ' 77' ' ' HIS . 19.3 m120 -149.16 159.43 37.09 Favored Pre-proline 0 C--N 1.309 -1.169 0 CA-C-N 112.515 -2.129 . . . . 0.0 107.921 179.224 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.545 ' O ' ' CB ' ' A' ' 73' ' ' ALA . 28.8 Cg_endo -63.64 -7.43 12.75 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 120.842 1.028 . . . . 0.0 111.118 178.255 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.617 ' HB1' ' HB2' ' A' ' 77' ' ' HIS . . . 135.99 51.6 0.0 OUTLIER 'General case' 0 CA--C 1.49 -1.362 0 CA-C-N 114.527 -1.215 . . . . 0.0 109.455 178.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . 0.541 ' HB3' ' HB ' ' A' ' 67' ' ' THR . 0.1 OUTLIER -52.88 -69.9 0.1 Allowed 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 105.63 -1.989 . . . . 0.0 105.63 179.491 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.587 ' N ' ' O ' ' A' ' 67' ' ' THR . 7.6 t0 -95.26 -47.14 6.45 Favored 'General case' 0 N--CA 1.435 -1.182 0 N-CA-C 106.0 -1.852 . . . . 0.0 106.0 169.594 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.491 ' C ' ' HA ' ' A' ' 73' ' ' ALA . 29.8 t80 -144.33 142.6 30.5 Favored 'General case' 0 C--N 1.347 0.465 0 CA-C-N 112.624 -2.08 . . . . 0.0 111.476 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . 0.617 ' HB2' ' HB1' ' A' ' 73' ' ' ALA . 23.7 t-160 -96.33 107.3 19.64 Favored 'General case' 0 C--N 1.33 -0.249 0 O-C-N 121.997 -0.439 . . . . 0.0 110.322 177.073 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -124.24 175.22 7.19 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 120.916 0.388 . . . . 0.0 111.375 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -59.02 -174.18 0.57 Allowed Glycine 0 C--N 1.332 0.342 0 C-N-CA 120.981 -0.628 . . . . 0.0 112.704 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.418 ' HA ' ' OD1' ' A' ' 86' ' ' ASN . 8.0 p30 -111.48 98.24 7.32 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.933 0.397 . . . . 0.0 111.634 -179.797 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.556 ' HB ' ' HB2' ' A' ' 85' ' ' SER . 4.0 mp -114.92 114.03 45.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.356 178.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 53.3 p -55.7 -24.62 35.54 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 -178.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -85.32 -110.13 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 -178.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.474 ' HB3' ' CE1' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -108.98 112.07 24.08 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-O 121.453 0.644 . . . . 0.0 109.573 179.679 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.602 ' O ' ' HA2' ' A' ' 69' ' ' GLY . 0.6 OUTLIER 161.86 -45.63 0.0 OUTLIER 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 114.671 -1.15 . . . . 0.0 109.433 -179.562 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.858 ' O ' ' N ' ' A' ' 88' ' ' HIS . 95.7 m-20 -64.68 -149.65 0.01 OUTLIER 'General case' 0 N--CA 1.456 -0.148 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 177.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 28.1 mttm -49.58 72.02 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 179.065 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.983 ' C ' ' O ' ' A' ' 104' ' ' ILE . 31.8 t60 -91.35 -15.93 28.26 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 113.846 1.054 . . . . 0.0 113.846 -176.853 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.521 ' CD2' ' CD2' ' A' ' 68' ' ' PHE . 0.9 OUTLIER -175.31 152.83 1.45 Allowed 'General case' 0 C--N 1.31 -1.131 0 C-N-CA 119.436 -0.906 . . . . 0.0 112.291 177.972 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.474 ' N ' ' CD1' ' A' ' 89' ' ' PHE . 20.5 tt0 -136.82 153.38 50.81 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 114.514 -1.221 . . . . 0.0 113.338 -177.664 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.634 ' HB ' ' HB2' ' A' ' 66' ' ' TRP . 32.4 mt -123.53 131.98 72.17 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.196 178.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -108.64 144.05 36.89 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.055 0.455 . . . . 0.0 111.824 -179.56 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.438 ' HB3' ' O ' ' A' ' 64' ' ' LYS . 0.2 OUTLIER -125.77 122.66 36.86 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.28 179.26 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 113.0 -136.27 13.32 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.375 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 57.75 88.59 0.06 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.788 0.328 . . . . 0.0 110.871 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 1.6 t70 60.93 29.9 19.29 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.851 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 80.55 174.82 48.52 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.593 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 34.0 m-80 61.66 176.6 0.12 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.843 0.354 . . . . 0.0 110.932 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -107.08 155.58 19.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.893 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.523 ' HA ' ' O ' ' A' ' 122' ' ' GLN . 20.5 mt -133.61 147.98 51.53 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.432 179.758 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.451 ' O ' ' N ' ' A' ' 122' ' ' GLN . 4.8 mp -116.58 131.85 56.84 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.463 ' O ' ' O ' ' A' ' 90' ' ' GLN . 23.1 t30 -114.42 110.87 20.54 Favored 'General case' 0 CA--C 1.508 -0.661 0 C-N-CA 119.714 -0.795 . . . . 0.0 109.839 179.704 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.565 ' HB3' ' CG2' ' A' ' 109' ' ' THR . 70.1 m-20 -81.68 111.88 18.36 Favored 'General case' 0 N--CA 1.442 -0.865 0 C-N-CA 119.726 -0.79 . . . . 0.0 109.37 179.557 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.983 ' O ' ' C ' ' A' ' 88' ' ' HIS . 0.1 OUTLIER -123.45 107.98 20.1 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.937 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 177.71 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.429 ' OG ' ' NE2' ' A' ' 88' ' ' HIS . 69.8 m -130.91 169.83 15.25 Favored 'General case' 0 C--N 1.296 -1.742 0 CA-C-N 114.926 -1.034 . . . . 0.0 109.304 179.694 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 24.0 m -69.56 -62.68 1.28 Allowed 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 119.089 -1.044 . . . . 0.0 111.325 -179.302 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -111.75 -33.52 6.3 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 114.66 1.356 . . . . 0.0 114.66 179.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -146.99 130.37 3.58 Favored Glycine 0 C--N 1.34 0.786 0 N-CA-C 116.764 1.466 . . . . 0.0 116.764 -178.158 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.565 ' CG2' ' HB3' ' A' ' 103' ' ' ASP . 4.3 m -120.85 137.87 54.34 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 174.47 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . 0.747 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.5 m-90 -120.37 148.96 43.08 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 -178.543 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -122.49 112.09 17.62 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 114.931 -1.031 . . . . 0.0 108.514 177.421 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 67.4 m-20 48.02 42.82 17.34 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.08 -0.509 . . . . 0.0 112.12 -179.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 82.22 3.44 90.56 Favored Glycine 0 N--CA 1.445 -0.754 0 C-N-CA 120.785 -0.721 . . . . 0.0 113.134 179.125 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.07 100.07 7.3 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.062 0.458 . . . . 0.0 110.829 179.78 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.747 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.0 OUTLIER -44.86 139.17 3.17 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.018 179.919 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 28.1 m -126.98 178.92 3.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.103 0.478 . . . . 0.0 111.756 -179.103 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -84.01 139.09 32.75 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.755 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.451 ' O ' ' N ' ' A' ' 120' ' ' SER . 0.5 OUTLIER -61.94 169.46 2.6 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 179.348 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.444 ' C ' ' O ' ' A' ' 118' ' ' LYS . 6.7 p30 28.63 41.42 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.534 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.451 ' N ' ' O ' ' A' ' 118' ' ' LYS . 4.0 p -111.22 111.52 22.64 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.154 -179.113 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -62.95 133.77 55.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.124 179.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . 0.523 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 49.6 mm-40 -129.56 147.04 51.32 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 -179.425 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.8 tt -72.62 113.71 9.95 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.351 178.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -45.51 155.41 0.15 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.852 0.834 . . . . 0.0 112.362 -178.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' SER . . . . . 0.439 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.0 OUTLIER -127.44 153.38 46.35 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 114.069 -1.423 . . . . 0.0 109.855 179.142 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 5.6 tp-100 -70.72 113.82 8.18 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 179.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 69.13 27.93 73.34 Favored Glycine 0 N--CA 1.445 -0.7 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.131 -179.093 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.439 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 27.5 t70 -58.96 159.62 6.88 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.099 0.476 . . . . 0.0 111.53 -179.567 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.415 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 2.0 tt0 -146.54 135.35 22.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.941 179.704 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.439 ' CG2' ' O ' ' A' ' 110' ' ' TRP . 1.0 OUTLIER -108.74 129.17 63.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.13 179.157 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.469 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 32.0 m -102.77 143.16 32.75 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.86 0.362 . . . . 0.0 110.454 -179.665 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.466 ' HB ' ' NE2' ' A' ' 88' ' ' HIS . 5.3 m -141.13 158.26 22.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 -178.669 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 68.64 43.98 73.47 Favored Glycine 0 N--CA 1.447 -0.575 0 CA-C-N 115.705 -0.68 . . . . 0.0 112.219 179.351 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.463 ' HA ' HG12 ' A' ' 140' ' ' ILE . 93.0 t -79.35 154.22 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 CA-C-O 121.467 0.651 . . . . 0.0 112.242 -179.093 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 151.39 -42.79 0.71 Allowed Glycine 0 N--CA 1.44 -1.04 0 CA-C-N 114.93 -1.032 . . . . 0.0 110.648 -179.068 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 44.8 t -126.66 132.19 70.42 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.751 0 CA-C-N 115.196 -0.502 . . . . 0.0 109.844 178.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 46.5 tp10 -51.42 -34.74 36.13 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.798 0.332 . . . . 0.0 111.405 -179.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 40.9 t -94.31 6.45 48.65 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -179.318 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -126.94 30.16 5.51 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 -179.3 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.469 ' CG2' ' CG2' ' A' ' 131' ' ' THR . 13.3 mt -107.33 140.95 23.81 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.305 179.15 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -117.3 135.01 54.14 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 114.974 -1.012 . . . . 0.0 109.834 179.409 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.554 ' OG ' HG22 ' A' ' 40' ' ' THR . 0.9 OUTLIER -120.65 147.4 45.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.537 0.684 . . . . 0.0 112.701 -178.943 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.415 ' O ' ' HA ' ' A' ' 129' ' ' GLU . 3.5 mp -122.93 147.38 46.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 114.861 -1.063 . . . . 0.0 109.369 179.534 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.407 HG11 ' N ' ' A' ' 145' ' ' ILE . 23.5 t -131.76 140.28 48.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 C-N-CA 120.769 -0.372 . . . . 0.0 111.657 -179.314 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . 0.407 ' N ' HG11 ' A' ' 144' ' ' VAL . 0.0 OUTLIER -115.4 139.85 39.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.809 179.64 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 39.2 t80 -117.51 105.06 11.69 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.904 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.401 ' CD1' ' O ' ' A' ' 125' ' ' SER . 3.5 mp -98.96 130.57 47.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.298 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . 0.413 ' ND2' ' O ' ' A' ' 32' ' ' ILE . 11.1 p30 -89.06 133.43 34.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.81 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -67.71 -20.06 65.23 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.264 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.46 -42.93 83.48 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.895 0.379 . . . . 0.0 110.591 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . 0.42 ' CE2' HD13 ' A' ' 52' ' ' ILE . 31.2 t80 -59.05 -43.23 91.68 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.754 179.804 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -60.59 -34.35 74.07 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.859 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 56.5 tt0 -62.91 -41.64 99.52 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.941 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 12.6 t -60.47 -45.54 93.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.909 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.92 -42.13 94.97 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.92 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -60.35 -41.0 92.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.839 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -67.91 -28.89 67.89 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.937 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -124.03 46.62 2.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.869 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 4.4 ttpt -70.12 131.73 44.73 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.971 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 25.8 t -66.29 121.9 16.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.079 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 33.8 m-20 -107.31 -30.47 8.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.843 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 1.3 ppt_? -164.33 150.64 10.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.894 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 3.1 mp -100.77 131.98 47.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.088 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 1.8 mmt85 . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.173 -0.918 . . . . 0.0 111.048 -179.987 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.322 0 N-CA-C 112.463 -0.255 . . . . 0.0 112.463 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 60.04 62.95 1.53 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.066 0.46 . . . . 0.0 110.853 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 43.0 t-20 58.36 99.19 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.026 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 5.6 pt -120.86 51.15 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.053 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 64.75 131.84 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.222 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -112.32 78.07 2.42 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.809 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 147.8 63.62 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.657 2.238 . . . . 0.0 112.269 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -59.89 -40.06 87.47 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.058 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -178.05 93.12 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.88 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 -61.62 84.67 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.768 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 18.9 p -149.58 130.54 14.32 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.898 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.68 88.63 3.95 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.992 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -170.98 -64.42 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.816 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.74 112.6 3.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.228 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 2.0 t -148.4 -51.21 0.17 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.103 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 28.0 pt20 -73.07 -35.41 66.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.92 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 5.5 ttm-85 -65.93 -36.8 84.36 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.974 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 64.5 t80 -57.45 -47.0 82.98 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.083 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 8.4 tt -59.59 -43.49 93.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.876 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 42.4 mm -71.26 -46.46 65.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.099 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -57.6 -44.72 85.64 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.077 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -59.24 -34.04 71.74 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.847 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -59.73 -47.63 84.89 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.211 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 19.5 p -66.96 -30.73 70.93 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.901 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 3.0 tt0 -77.51 116.58 18.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.874 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 13.9 pm0 -96.86 127.36 42.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.991 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.6 mm100 -76.49 120.98 22.46 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.706 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 21.3 mm -83.46 139.52 17.58 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.368 0 CA-C-O 121.502 0.668 . . . . 0.0 111.695 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -90.23 62.11 3.22 Favored Glycine 0 C--N 1.317 -0.474 0 CA-C-N 114.851 -1.068 . . . . 0.0 112.49 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -87.09 -23.13 25.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.787 0.327 . . . . 0.0 110.96 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 11.2 m-20 -108.23 -13.11 14.97 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-O 121.933 0.873 . . . . 0.0 108.979 178.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.539 ' CG2' ' O ' ' A' ' 32' ' ' ILE . 0.1 OUTLIER -70.78 103.46 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.518 0 CA-C-N 113.94 -1.482 . . . . 0.0 111.268 -179.274 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.631 ' CG1' ' N ' ' A' ' 34' ' ' CYS . 0.4 OUTLIER -33.37 -62.8 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 CA-C-N 115.25 -0.886 . . . . 0.0 112.065 -179.297 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.631 ' N ' ' CG1' ' A' ' 33' ' ' VAL . 67.2 m -162.42 165.26 26.57 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.401 -179.299 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.39 114.96 18.23 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.669 179.125 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 1.8 t -89.16 129.08 40.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.427 179.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.443 ' CG2' HG12 ' A' ' 45' ' ' ILE . 26.0 mt -122.6 108.45 21.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -178.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -102.5 107.86 18.97 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 177.783 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.6 t -113.92 -24.49 9.05 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 -178.143 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.435 ' CG2' ' HB3' ' A' ' 142' ' ' SER . 17.1 p -56.01 -26.16 47.5 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.765 0.316 . . . . 0.0 111.348 -179.489 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 124.53 66.84 0.19 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.642 -0.789 . . . . 0.0 112.674 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 21.9 mt-30 -141.13 -71.92 0.35 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.765 0.317 . . . . 0.0 110.666 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.455 ' CG2' ' CG ' ' A' ' 76' ' ' TYR . 3.9 mp -135.33 136.65 24.76 Favored Pre-proline 0 N--CA 1.452 -0.37 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.084 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.465 ' HD2' ' CE2' ' A' ' 76' ' ' TYR . 31.3 Cg_exo -58.8 147.29 89.3 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.576 2.184 . . . . 0.0 111.739 179.508 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.443 HG12 ' CG2' ' A' ' 37' ' ' ILE . 48.8 mt -38.04 140.19 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 CA-C-O 121.004 0.43 . . . . 0.0 111.83 -179.503 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.405 ' HG2' ' O ' ' A' ' 75' ' ' ASP . 0.0 OUTLIER -137.26 130.42 30.86 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.318 179.864 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -94.7 120.27 34.66 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.028 0.442 . . . . 0.0 111.538 -179.339 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.522 ' HB3' ' CE2' ' A' ' 66' ' ' TRP . 1.2 mt -100.35 129.84 46.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.821 179.295 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.483 ' HB3' HG12 ' A' ' 32' ' ' ILE . 0.1 OUTLIER -120.91 162.92 19.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 122.091 0.948 . . . . 0.0 113.364 -179.118 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.475 ' CB ' ' CG2' ' A' ' 33' ' ' VAL . . . -127.34 166.59 17.55 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.456 -1.247 . . . . 0.0 111.064 179.73 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.426 ' CB ' ' CG ' ' A' ' 54' ' ' GLN . 0.3 OUTLIER -104.8 92.37 4.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.365 179.607 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.438 HG22 HD13 ' A' ' 52' ' ' ILE . 45.6 mt -64.07 -44.96 97.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.929 -179.363 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 11.4 m -58.44 -38.7 78.04 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.189 0.519 . . . . 0.0 110.76 -179.357 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.426 ' CG ' ' CB ' ' A' ' 51' ' ' ASP . 18.0 mm-40 -68.81 -37.31 79.15 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.485 -0.779 . . . . 0.0 111.032 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 36.0 t -73.68 -37.7 49.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.12 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.7 tp -57.15 -39.11 74.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.729 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 8.0 mttm -95.61 -29.35 14.38 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.66 179.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 59.26 46.64 12.56 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.961 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.2 mtpt -112.26 -36.78 5.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.697 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -129.51 174.54 9.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.663 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.44 ' O ' ' CB ' ' A' ' 62' ' ' ILE . 3.5 m 61.38 -151.59 0.38 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.546 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.44 ' CB ' ' O ' ' A' ' 61' ' ' SER . 0.4 OUTLIER 87.92 14.89 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 C-N-CA 122.552 0.341 . . . . 0.0 111.359 -179.89 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 4.3 tptm -148.15 67.38 1.09 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.888 0.375 . . . . 0.0 110.77 179.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 16.6 ttpt -117.06 133.49 55.94 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.687 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.446 HG11 ' HG ' ' A' ' 92' ' ' LEU . 23.9 t -136.9 139.25 44.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.181 0.515 . . . . 0.0 111.856 -179.497 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . 0.634 ' HB2' ' HB ' ' A' ' 91' ' ' ILE . 13.1 m-90 -100.36 137.73 38.38 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.472 179.03 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.562 ' O ' ' N ' ' A' ' 75' ' ' ASP . 17.6 m -132.38 129.09 38.92 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.586 0.707 . . . . 0.0 112.712 179.835 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.414 ' CE1' ' CE2' ' A' ' 89' ' ' PHE . 18.4 m-85 -101.32 118.87 37.85 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.02 -0.991 . . . . 0.0 108.76 177.399 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.579 ' HA2' ' O ' ' A' ' 85' ' ' SER . . . 157.99 -156.53 27.44 Favored Glycine 0 CA--C 1.503 -0.698 0 C-N-CA 118.723 -1.703 . . . . 0.0 113.261 179.491 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 2.1 mtp180 -74.97 91.84 2.53 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-O 122.496 1.141 . . . . 0.0 108.561 -179.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.52 ' O ' ' CD2' ' A' ' 77' ' ' HIS . 17.5 m120 -149.76 159.31 36.25 Favored Pre-proline 0 C--N 1.308 -1.226 0 CA-C-N 112.764 -2.016 . . . . 0.0 108.036 179.148 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.544 ' O ' ' HB2' ' A' ' 77' ' ' HIS . 28.9 Cg_endo -64.33 -7.03 12.92 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 120.79 0.994 . . . . 0.0 110.845 178.006 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.576 ' HB2' ' HB2' ' A' ' 77' ' ' HIS . . . 136.43 52.38 0.0 OUTLIER 'General case' 0 CA--C 1.49 -1.36 0 CA-C-N 114.542 -1.208 . . . . 0.0 109.281 178.738 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . 0.538 ' HB3' ' HB ' ' A' ' 67' ' ' THR . 0.1 OUTLIER -52.85 -69.48 0.11 Allowed 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 105.823 -1.918 . . . . 0.0 105.823 179.57 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.562 ' N ' ' O ' ' A' ' 67' ' ' THR . 6.1 t70 -95.06 -48.27 6.03 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 105.544 -2.021 . . . . 0.0 105.544 169.649 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.466 ' C ' ' HA ' ' A' ' 73' ' ' ALA . 29.0 t80 -144.74 142.61 30.16 Favored 'General case' 0 C--N 1.345 0.402 0 CA-C-N 112.527 -2.124 . . . . 0.0 111.779 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . 0.576 ' HB2' ' HB2' ' A' ' 73' ' ' ALA . 23.4 t-160 -97.82 106.96 19.34 Favored 'General case' 0 C--N 1.33 -0.244 0 O-C-N 122.091 -0.381 . . . . 0.0 110.043 176.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.416 ' HB3' ' CE1' ' A' ' 76' ' ' TYR . 0.7 OUTLIER -121.57 -176.48 3.32 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.899 0.38 . . . . 0.0 111.569 -179.841 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -62.21 -174.41 1.98 Allowed Glycine 0 C--N 1.332 0.344 0 C-N-CA 120.953 -0.642 . . . . 0.0 112.445 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -111.89 98.38 7.34 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.926 0.393 . . . . 0.0 111.772 -179.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.585 ' HB ' ' HB2' ' A' ' 85' ' ' SER . 1.4 mp -114.85 115.18 48.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.252 178.737 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -56.43 -24.26 43.99 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 -179.077 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -90.07 -105.34 0.09 Allowed 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -178.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.43 ' HB3' ' CE1' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -109.11 111.96 23.87 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-O 121.466 0.65 . . . . 0.0 110.132 -179.522 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.585 ' HB2' ' HB ' ' A' ' 81' ' ' ILE . 0.6 OUTLIER 160.17 -48.02 0.0 OUTLIER 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 114.396 -1.275 . . . . 0.0 109.209 -179.753 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.846 ' O ' ' N ' ' A' ' 88' ' ' HIS . 91.6 m-20 -64.92 -151.19 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.247 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 177.546 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 2.1 pttp -46.82 74.42 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.975 ' O ' ' O ' ' A' ' 104' ' ' ILE . 32.7 t60 -95.45 -18.76 20.42 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 114.047 1.129 . . . . 0.0 114.047 -176.763 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.531 ' CZ ' HG13 ' A' ' 91' ' ' ILE . 0.1 OUTLIER -174.57 154.79 2.1 Favored 'General case' 0 C--N 1.312 -1.046 0 C-N-CA 118.912 -1.115 . . . . 0.0 113.089 178.125 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.482 ' O ' ' O ' ' A' ' 102' ' ' ASN . 31.7 mt-30 -137.05 158.4 44.55 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.397 -1.274 . . . . 0.0 113.858 -177.726 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.634 ' HB ' ' HB2' ' A' ' 66' ' ' TRP . 13.4 mt -129.92 127.67 64.08 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.204 178.708 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.446 ' HG ' HG11 ' A' ' 65' ' ' VAL . 0.3 OUTLIER -102.99 142.05 34.74 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.103 0.478 . . . . 0.0 111.874 -179.56 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.442 ' HG ' HG23 ' A' ' 33' ' ' VAL . 0.4 OUTLIER -125.74 130.36 51.33 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.481 179.32 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 88.34 -114.76 4.28 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.621 179.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 69.82 -64.94 0.33 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.784 0.326 . . . . 0.0 110.851 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -130.38 32.54 4.43 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.889 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 78.42 31.27 46.75 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.477 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 25.0 p-10 -155.36 -178.76 7.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.867 0.365 . . . . 0.0 111.037 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -106.87 138.06 43.75 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.742 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.522 ' HA ' ' O ' ' A' ' 122' ' ' GLN . 14.8 mt -133.61 148.38 51.56 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.523 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.43 ' O ' ' N ' ' A' ' 122' ' ' GLN . 5.5 mp -112.68 132.18 55.3 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 179.292 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.482 ' O ' ' O ' ' A' ' 90' ' ' GLN . 20.4 t30 -113.33 111.8 22.61 Favored 'General case' 0 CA--C 1.509 -0.607 0 C-N-CA 119.868 -0.733 . . . . 0.0 110.046 -179.773 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.563 ' HB3' ' CG2' ' A' ' 109' ' ' THR . 72.8 m-20 -84.81 112.26 20.36 Favored 'General case' 0 N--CA 1.442 -0.87 0 C-N-CA 119.835 -0.746 . . . . 0.0 109.452 179.476 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.975 ' O ' ' O ' ' A' ' 88' ' ' HIS . 0.1 OUTLIER -123.16 107.56 19.42 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.018 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 177.875 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.415 ' OG ' ' NE2' ' A' ' 88' ' ' HIS . 75.8 m -130.81 170.74 13.98 Favored 'General case' 0 C--N 1.294 -1.833 0 CA-C-N 114.95 -1.023 . . . . 0.0 109.372 179.646 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 25.1 m -69.39 -63.02 1.15 Allowed 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 118.965 -1.094 . . . . 0.0 111.234 -179.334 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -112.27 -33.21 6.28 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 114.551 1.315 . . . . 0.0 114.551 178.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -146.63 130.26 3.59 Favored Glycine 0 C--N 1.34 0.775 0 N-CA-C 116.976 1.55 . . . . 0.0 116.976 -177.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.563 ' CG2' ' HB3' ' A' ' 103' ' ' ASP . 6.3 m -121.06 138.23 54.28 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 174.262 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . 0.671 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.4 m-90 -119.6 149.28 42.21 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 113.407 0.892 . . . . 0.0 113.407 -178.461 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -120.96 112.03 18.25 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 115.162 -0.926 . . . . 0.0 108.638 177.495 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 66.9 m-20 44.7 43.17 6.49 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.126 -0.488 . . . . 0.0 112.085 -179.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 79.74 26.81 55.56 Favored Glycine 0 N--CA 1.444 -0.813 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.743 179.349 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 38.6 tt0 -138.11 98.18 3.57 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.073 0.464 . . . . 0.0 110.929 179.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.671 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.0 OUTLIER -45.29 128.76 7.91 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.97 179.725 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 28.3 m -121.12 -179.31 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.845 -179.329 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -85.65 141.83 29.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.921 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.411 ' O ' ' C ' ' A' ' 119' ' ' ASN . 86.7 tttt -66.38 163.14 18.86 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.226 179.471 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.411 ' C ' ' O ' ' A' ' 118' ' ' LYS . 8.1 m-80 34.24 39.05 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 121.203 0.525 . . . . 0.0 111.13 -179.4 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.409 ' OG ' ' NE2' ' A' ' 122' ' ' GLN . 14.8 p -111.13 115.25 29.09 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.991 -179.443 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 11.9 m-80 -59.63 138.52 57.71 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.534 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . 0.522 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 31.5 mm-40 -129.07 144.91 51.35 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.163 0.506 . . . . 0.0 111.829 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.4 tp -72.39 127.03 31.31 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.976 179.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.432 ' HG ' ' N ' ' A' ' 125' ' ' SER . 4.7 tp -55.7 143.33 30.94 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.899 0.856 . . . . 0.0 111.763 -179.145 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' SER . . . . . 0.432 ' N ' ' HG ' ' A' ' 124' ' ' LEU . 0.6 OUTLIER -126.87 151.98 47.66 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 114.049 -1.432 . . . . 0.0 109.92 179.133 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.44 114.13 9.19 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.962 0.411 . . . . 0.0 109.988 179.752 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 69.66 25.83 75.1 Favored Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.333 -179.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -54.97 159.62 2.3 Favored 'General case' 0 C--N 1.334 -0.103 0 CA-C-O 121.001 0.429 . . . . 0.0 111.068 -179.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.455 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 1.1 tt0 -146.56 135.26 22.21 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.559 -179.823 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.473 ' CD1' ' CE1' ' A' ' 89' ' ' PHE . 3.5 mt -111.37 127.94 68.19 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.184 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 178.53 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.465 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 29.4 m -103.39 144.31 31.55 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.505 -179.531 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.469 ' HB ' ' NE2' ' A' ' 88' ' ' HIS . 5.4 m -140.91 156.31 22.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -179.042 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 72.42 40.05 55.52 Favored Glycine 0 N--CA 1.446 -0.682 0 CA-C-N 115.891 -0.595 . . . . 0.0 112.366 179.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.414 ' HA ' HG12 ' A' ' 140' ' ' ILE . 95.1 t -75.7 156.64 5.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 121.38 0.61 . . . . 0.0 112.06 -179.256 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . 0.413 ' N ' ' CG1' ' A' ' 134' ' ' VAL . . . 153.74 -47.35 0.54 Allowed Glycine 0 N--CA 1.441 -0.971 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.8 -179.281 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 49.3 t -126.66 134.49 66.17 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 CA-C-N 115.216 -0.492 . . . . 0.0 109.908 178.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -51.29 -31.66 22.14 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.835 0.35 . . . . 0.0 111.263 -179.419 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -94.05 6.34 48.84 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.119 -0.491 . . . . 0.0 112.118 -179.538 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -129.79 29.62 4.98 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 112.543 0.571 . . . . 0.0 112.543 -179.343 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.465 ' CG2' ' CG2' ' A' ' 131' ' ' THR . 28.3 mt -104.99 141.24 20.8 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.073 179.22 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 1.6 mp -118.63 134.94 54.74 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.492 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.435 ' HB3' ' CG2' ' A' ' 40' ' ' THR . 42.4 t -115.04 152.23 32.85 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.761 0.791 . . . . 0.0 112.686 -179.089 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.455 ' O ' ' HA ' ' A' ' 129' ' ' GLU . 1.3 tm? -135.85 129.44 32.38 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 114.488 -1.233 . . . . 0.0 108.96 179.169 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.419 ' N ' HD23 ' A' ' 143' ' ' LEU . 21.4 t -119.78 140.21 44.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.934 0.397 . . . . 0.0 111.83 -178.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -110.56 139.67 33.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.851 179.558 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -115.23 118.71 34.08 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.586 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.432 ' CD1' ' O ' ' A' ' 125' ' ' SER . 1.7 mt -98.26 133.56 40.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.986 0.422 . . . . 0.0 111.775 -179.602 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 18.5 p-10 -77.94 124.39 27.95 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.738 179.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -66.16 -24.87 66.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.313 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 3.2 mptt -59.22 -44.33 92.31 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.991 0.424 . . . . 0.0 110.844 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 20.3 t80 -62.75 -44.35 96.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.093 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 46.1 tttp -58.94 -47.57 84.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.847 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -61.61 -36.94 82.16 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.888 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 11.6 t -62.34 -45.59 92.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.959 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.99 -46.73 67.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.037 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 72.4 mm-40 -58.88 -48.49 81.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.23 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -78.75 -37.07 42.12 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.13 -179.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 3.9 p30 42.47 45.26 3.79 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.511 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.65 148.12 42.26 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.869 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 38.5 t -99.09 137.19 27.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.132 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 68.5 m-20 -116.47 141.57 48.0 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.791 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 23.2 tpp180 -105.03 106.82 17.49 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.944 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 14.2 tt -92.95 123.09 44.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.998 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 2.1 ttt-85 . . . . . 0 C--O 1.25 1.086 0 CA-C-O 118.276 -0.868 . . . . 0.0 110.927 179.922 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.307 0 N-CA-C 112.542 -0.223 . . . . 0.0 112.542 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -124.05 31.74 5.74 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.826 0.346 . . . . 0.0 110.899 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -109.8 94.68 5.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.888 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 4.7 mt -140.38 164.44 22.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.003 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 72.4 54.5 0.16 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.176 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 57.59 79.08 0.34 Allowed Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.994 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -66.88 101.22 0.56 Allowed 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.577 2.185 . . . . 0.0 112.301 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.6 t -149.81 36.74 0.71 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.119 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -166.04 109.62 0.79 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.887 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -132.53 -70.16 0.56 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.883 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 63.0 p -127.71 179.53 5.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.872 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -131.23 -53.48 1.03 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.054 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 25.1 mm-40 -122.75 165.77 16.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.933 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -75.4 162.85 28.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.059 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 40.5 p -112.47 20.55 16.55 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.427 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -64.23 -47.6 79.07 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.932 0.396 . . . . 0.0 110.474 179.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 2.0 ptt85 -72.02 -36.35 69.66 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.406 179.363 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 4.1 m-30 -56.86 -39.28 74.0 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.619 179.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 14.9 tp -61.9 -32.28 72.65 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.453 179.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 7.9 mt -69.15 -42.33 81.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.725 179.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -57.69 -35.48 70.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.996 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.58 -36.92 84.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.878 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -58.94 -47.5 84.84 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.065 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 5.9 m -62.99 -35.92 81.83 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.861 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -157.62 89.93 1.06 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.904 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 63.7 tt0 -87.48 137.82 32.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.966 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -88.36 101.96 14.4 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.892 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 19.5 mm -93.12 139.32 18.31 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.308 0 CA-C-O 121.475 0.655 . . . . 0.0 112.048 -179.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 46.51 64.99 2.33 Favored Glycine 0 C--N 1.319 -0.398 0 CA-C-N 114.775 -1.102 . . . . 0.0 113.114 179.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -89.02 -32.03 17.79 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.737 0.303 . . . . 0.0 111.275 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -109.43 -13.81 14.52 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-O 121.856 0.836 . . . . 0.0 109.043 178.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.609 ' CG2' ' O ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -70.97 95.46 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.534 0 CA-C-N 114.032 -1.44 . . . . 0.0 111.166 -179.08 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.604 ' CG1' ' N ' ' A' ' 34' ' ' CYS . 0.4 OUTLIER -32.58 -62.13 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 CA-C-N 115.081 -0.963 . . . . 0.0 111.647 -179.946 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.604 ' N ' ' CG1' ' A' ' 33' ' ' VAL . 23.2 p -165.85 163.44 18.69 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.962 179.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 6.7 ttm180 -122.58 125.99 46.81 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.096 179.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.454 HG12 ' CD1' ' A' ' 48' ' ' LEU . 12.3 m -93.67 137.0 23.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.993 -0.548 . . . . 0.0 111.169 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.419 ' CG2' HG12 ' A' ' 45' ' ' ILE . 19.0 mt -130.74 106.88 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 CA-C-O 120.954 0.406 . . . . 0.0 111.787 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -99.78 99.73 10.58 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 177.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 9.5 t -108.62 26.7 10.22 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -178.322 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.451 ' CG2' ' HB2' ' A' ' 142' ' ' SER . 77.4 p -111.39 -6.35 14.49 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 111.679 0.252 . . . . 0.0 111.679 179.764 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 101.59 61.64 0.76 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.425 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 -141.66 -69.5 0.37 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.708 0.29 . . . . 0.0 110.904 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.45 ' CG2' ' CG ' ' A' ' 76' ' ' TYR . 3.5 mp -135.06 129.92 19.19 Favored Pre-proline 0 N--CA 1.452 -0.36 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.091 179.764 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.431 ' HD2' ' CZ ' ' A' ' 76' ' ' TYR . 35.5 Cg_exo -59.36 147.0 93.12 Favored 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 122.702 2.268 . . . . 0.0 111.848 179.743 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.419 HG12 ' CG2' ' A' ' 37' ' ' ILE . 40.8 mt -44.73 127.5 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.076 -0.511 . . . . 0.0 112.044 -179.416 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.36 130.25 44.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.92 179.124 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -86.86 119.54 27.19 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.079 0.466 . . . . 0.0 111.629 -179.19 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.496 ' HB3' ' CE2' ' A' ' 66' ' ' TRP . 9.1 mt -99.5 138.89 35.96 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.054 178.621 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.588 ' OG ' ' N ' ' A' ' 50' ' ' ALA . 45.5 t -131.49 -171.55 2.63 Favored 'General case' 0 CA--C 1.511 -0.536 0 CA-C-O 123.09 1.424 . . . . 0.0 113.971 -179.173 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.588 ' N ' ' OG ' ' A' ' 49' ' ' SER . . . -157.16 165.27 36.47 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 112.537 -2.119 . . . . 0.0 110.941 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.436 ' CB ' ' HG2' ' A' ' 54' ' ' GLN . 3.3 m-20 -106.59 121.76 44.95 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.043 0.449 . . . . 0.0 110.785 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 7.5 mt -64.63 -34.65 71.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.889 -179.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.1 m -60.24 -43.74 95.84 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.606 -178.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.436 ' HG2' ' CB ' ' A' ' 51' ' ' ASP . 9.9 pt20 -68.58 -37.56 79.95 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.702 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 23.9 t -74.09 -37.87 47.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.06 179.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.3 tt -56.74 -36.26 69.55 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.749 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -99.88 -29.82 12.37 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.693 179.606 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 56.6 57.49 4.78 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.878 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.95 -47.32 0.16 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.771 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.73 120.21 24.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.847 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 62.5 -83.66 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.927 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.432 ' O ' HG13 ' A' ' 62' ' ' ILE . 6.8 tp 43.54 34.61 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.173 0 CA-C-O 121.07 0.462 . . . . 0.0 111.322 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.65 79.12 1.15 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.938 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 18.9 ttpt -117.43 131.11 56.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.472 179.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.478 ' CG1' ' O ' ' A' ' 91' ' ' ILE . 9.0 t -130.49 136.94 57.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.99 0.424 . . . . 0.0 111.654 -179.191 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . 0.619 ' HB2' ' HB ' ' A' ' 91' ' ' ILE . 16.0 m-90 -99.8 138.89 36.25 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.536 179.218 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.56 ' N ' ' HB2' ' A' ' 75' ' ' ASP . 2.2 m -131.86 128.33 38.42 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.511 ' CE1' ' CE2' ' A' ' 89' ' ' PHE . 81.4 m-85 -96.74 118.09 32.44 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 177.374 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.526 ' HA3' ' C ' ' A' ' 86' ' ' ASN . . . 157.73 -154.87 25.92 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 118.56 -1.781 . . . . 0.0 113.263 179.547 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.497 ' HG2' ' HA ' ' A' ' 80' ' ' ASN . 61.9 mtp180 -75.87 91.09 2.97 Favored 'General case' 0 N--CA 1.44 -0.931 0 CA-C-O 122.481 1.134 . . . . 0.0 108.196 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.465 ' O ' ' CD2' ' A' ' 77' ' ' HIS . 29.2 m-80 -150.12 160.1 34.06 Favored Pre-proline 0 C--N 1.31 -1.143 0 CA-C-N 112.897 -1.956 . . . . 0.0 108.658 179.503 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.528 ' O ' ' CB ' ' A' ' 73' ' ' ALA . 35.6 Cg_endo -65.22 -9.66 22.81 Favored 'Trans proline' 0 N--CA 1.452 -0.931 0 C-N-CA 120.73 0.954 . . . . 0.0 110.564 177.257 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.651 ' HB3' ' HB2' ' A' ' 77' ' ' HIS . . . 138.92 52.47 0.0 OUTLIER 'General case' 0 CA--C 1.492 -1.288 0 CA-C-N 114.537 -1.211 . . . . 0.0 109.405 178.785 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . 0.533 ' HB3' ' HB ' ' A' ' 67' ' ' THR . 0.1 OUTLIER -53.07 -69.87 0.1 Allowed 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 106.135 -1.802 . . . . 0.0 106.135 179.539 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.56 ' HB2' ' N ' ' A' ' 67' ' ' THR . 5.5 t70 -94.14 -47.49 6.63 Favored 'General case' 0 N--CA 1.436 -1.144 0 N-CA-C 105.577 -2.008 . . . . 0.0 105.577 169.837 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.533 ' C ' ' HA ' ' A' ' 73' ' ' ALA . 14.4 t80 -144.0 142.78 30.89 Favored 'General case' 0 C--N 1.343 0.315 0 CA-C-N 112.37 -2.195 . . . . 0.0 110.91 179.664 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . 0.651 ' HB2' ' HB3' ' A' ' 73' ' ' ALA . 18.7 t-160 -84.83 107.12 16.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 118.41 0.55 . . . . 0.0 110.014 177.589 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.419 HD21 ' CD1' ' A' ' 76' ' ' TYR . 29.9 mt -111.96 156.63 21.81 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.849 0.357 . . . . 0.0 111.114 -179.662 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -60.26 -160.25 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.586 -0.816 . . . . 0.0 111.792 179.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.497 ' HA ' ' HG2' ' A' ' 70' ' ' ARG . 9.4 p30 -109.42 98.9 8.21 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 117.001 0.4 . . . . 0.0 111.112 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.462 ' HB ' ' HB2' ' A' ' 85' ' ' SER . 37.9 mm -113.72 154.61 15.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.567 179.387 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -67.48 -44.83 77.57 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 -178.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 1.6 mpp_? -122.81 -92.09 0.54 Allowed 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 113.658 0.985 . . . . 0.0 113.658 -177.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.487 ' O ' ' CB ' ' A' ' 85' ' ' SER . 0.0 OUTLIER -79.05 101.85 8.07 Favored 'General case' 0 CA--C 1.506 -0.724 0 CA-C-O 121.973 0.892 . . . . 0.0 110.961 -178.546 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.516 ' O ' ' HA2' ' A' ' 69' ' ' GLY . 0.4 OUTLIER 150.03 -28.59 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 113.155 -1.839 . . . . 0.0 108.834 -179.793 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.826 ' O ' ' N ' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -85.47 -164.66 1.04 Allowed 'General case' 0 CA--C 1.51 -0.589 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 177.465 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.409 ' HA ' ' HA3' ' A' ' 69' ' ' GLY . 2.5 ptmt -47.74 73.85 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 178.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.99 ' O ' ' O ' ' A' ' 104' ' ' ILE . 25.1 t60 -91.66 -17.35 25.63 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 114.243 1.201 . . . . 0.0 114.243 -176.779 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.511 ' CE2' ' CE1' ' A' ' 68' ' ' PHE . 0.2 OUTLIER -173.56 155.3 2.73 Favored 'General case' 0 C--N 1.314 -0.938 0 C-N-CA 118.946 -1.102 . . . . 0.0 112.775 177.845 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.507 ' O ' ' O ' ' A' ' 102' ' ' ASN . 0.5 OUTLIER -135.18 154.43 51.62 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.579 -1.191 . . . . 0.0 113.868 -177.67 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.619 ' HB ' ' HB2' ' A' ' 66' ' ' TRP . 49.3 mt -124.91 132.14 71.7 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.734 178.435 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.424 ' N ' ' O ' ' A' ' 100' ' ' LEU . 0.3 OUTLIER -108.6 140.57 41.78 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.139 0.495 . . . . 0.0 112.249 -179.168 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.496 ' HG ' HG22 ' A' ' 33' ' ' VAL . 0.6 OUTLIER -125.54 135.07 51.87 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.173 179.129 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 97.17 108.99 2.63 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.605 -0.807 . . . . 0.0 112.693 179.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 178.51 68.73 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.959 0.409 . . . . 0.0 110.574 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 60.73 31.03 20.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.659 -179.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 101.58 162.95 27.14 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.31 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 65.12 -173.35 0.18 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.841 0.353 . . . . 0.0 110.972 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 8.1 mp -123.99 160.77 26.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.878 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.632 ' HA ' ' O ' ' A' ' 122' ' ' GLN . 7.9 mp -123.72 148.29 46.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.171 179.735 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.457 ' O ' ' N ' ' A' ' 122' ' ' GLN . 12.3 mt -118.1 130.5 56.17 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.813 -0.355 . . . . 0.0 110.263 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.507 ' O ' ' O ' ' A' ' 90' ' ' GLN . 24.8 t30 -113.32 111.58 22.25 Favored 'General case' 0 CA--C 1.512 -0.516 0 C-N-CA 120.017 -0.673 . . . . 0.0 109.686 179.611 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.591 ' HB3' ' CG2' ' A' ' 109' ' ' THR . 72.3 m-20 -84.96 111.93 20.13 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 119.826 -0.749 . . . . 0.0 110.13 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.99 ' O ' ' O ' ' A' ' 88' ' ' HIS . 0.1 OUTLIER -124.47 108.18 19.89 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.91 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 177.393 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.411 ' OG ' ' NE2' ' A' ' 88' ' ' HIS . 67.1 m -129.77 174.16 9.98 Favored 'General case' 0 C--N 1.296 -1.737 0 CA-C-N 115.285 -0.871 . . . . 0.0 109.312 179.353 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 23.3 m -69.25 -63.85 0.99 Allowed 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 118.998 -1.081 . . . . 0.0 111.435 -179.271 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 5.5 p30 -112.48 -32.91 6.33 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 114.181 1.178 . . . . 0.0 114.181 178.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -145.98 131.47 4.13 Favored Glycine 0 C--N 1.339 0.695 0 N-CA-C 116.558 1.383 . . . . 0.0 116.558 -178.133 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.591 ' CG2' ' HB3' ' A' ' 103' ' ' ASP . 5.8 m -121.19 138.29 54.28 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 174.697 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . 0.744 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.4 m-90 -119.78 149.18 42.47 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 113.503 0.927 . . . . 0.0 113.503 -178.542 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -122.84 112.25 17.64 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 114.997 -1.001 . . . . 0.0 108.644 177.603 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 46.25 43.73 11.63 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.091 -0.504 . . . . 0.0 112.18 -179.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 79.49 17.41 75.91 Favored Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.913 179.257 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -130.39 97.85 4.53 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.053 0.454 . . . . 0.0 110.713 179.634 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.744 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.0 OUTLIER -44.75 134.3 5.62 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.059 179.886 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 14.7 p -127.57 164.2 29.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.45 -179.163 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -70.13 141.83 52.63 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.975 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.438 ' HG3' ' HA ' ' A' ' 104' ' ' ILE . 36.3 tttm -65.23 163.69 14.76 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.217 179.552 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 36.16 39.13 0.08 Allowed 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 121.255 0.55 . . . . 0.0 110.747 -179.438 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 4.7 p -110.82 108.94 18.94 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.034 -179.305 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -58.77 139.37 56.38 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.798 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . 0.632 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 44.0 mm-40 -129.85 147.42 51.62 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-O 120.964 0.412 . . . . 0.0 111.919 -179.651 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.1 tp -72.3 112.01 8.0 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 178.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.418 ' CD1' HG12 ' A' ' 147' ' ' ILE . 3.7 tt -44.0 145.91 0.68 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.726 0.774 . . . . 0.0 112.143 -178.716 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -126.4 153.15 45.38 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 114.225 -1.352 . . . . 0.0 110.33 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.56 113.78 8.95 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 179.51 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 70.33 26.5 74.1 Favored Glycine 0 N--CA 1.444 -0.787 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.338 -179.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -56.54 159.89 3.52 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.02 0.438 . . . . 0.0 111.198 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.434 ' CG ' ' O ' ' A' ' 143' ' ' LEU . 5.1 tt0 -146.53 135.07 22.07 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.415 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.428 ' CG2' ' O ' ' A' ' 110' ' ' TRP . 7.8 mm -111.68 128.31 68.3 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.119 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 178.761 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.544 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 3.4 m -103.66 144.74 31.04 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.81 -179.493 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.409 ' CG1' ' HE2' ' A' ' 88' ' ' HIS . 4.4 m -141.28 158.39 22.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 112.462 0.542 . . . . 0.0 112.462 -178.801 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 70.26 43.99 61.23 Favored Glycine 0 N--CA 1.447 -0.586 0 CA-C-N 115.75 -0.659 . . . . 0.0 112.398 179.269 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.459 ' HA ' HG12 ' A' ' 140' ' ' ILE . 93.6 t -79.26 155.73 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 CA-C-O 121.436 0.636 . . . . 0.0 112.234 -179.13 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . 0.401 ' N ' ' CG1' ' A' ' 134' ' ' VAL . . . 150.07 -43.88 0.72 Allowed Glycine 0 N--CA 1.442 -0.939 0 CA-C-N 114.908 -1.042 . . . . 0.0 110.529 -178.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 46.3 t -126.6 130.87 71.7 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.687 0 CA-C-N 115.08 -0.56 . . . . 0.0 109.753 178.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -51.07 -33.9 27.73 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.731 0.3 . . . . 0.0 111.493 -179.198 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 83.0 p -94.14 6.25 49.17 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.243 0.461 . . . . 0.0 112.243 -179.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -127.54 30.15 5.39 Favored 'General case' 0 CA--C 1.52 -0.206 0 N-CA-C 112.408 0.521 . . . . 0.0 112.408 -179.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.544 ' CG2' ' CG2' ' A' ' 131' ' ' THR . 14.9 mt -106.0 141.28 21.65 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.935 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.392 179.213 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -115.64 135.67 53.83 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.052 -0.977 . . . . 0.0 110.51 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.451 ' HB2' ' CG2' ' A' ' 40' ' ' THR . 4.2 m -120.01 153.67 35.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.814 0.816 . . . . 0.0 112.669 -179.273 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.434 ' O ' ' CG ' ' A' ' 129' ' ' GLU . 1.2 tm? -135.45 135.38 40.49 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 114.49 -1.232 . . . . 0.0 108.835 179.451 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.409 ' N ' HD22 ' A' ' 143' ' ' LEU . 21.2 t -122.67 140.46 46.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 112.217 0.451 . . . . 0.0 112.217 -178.717 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -108.45 138.79 33.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.43 179.378 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 18.3 t80 -121.23 104.17 9.54 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.783 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.418 HG12 ' CD1' ' A' ' 124' ' ' LEU . 1.6 mp -102.39 130.67 51.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.281 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 11.3 p30 -78.33 141.16 38.64 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.929 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -73.27 -22.62 60.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.182 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 28.0 mmtt -58.26 -43.87 88.12 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-O 120.898 0.38 . . . . 0.0 110.712 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 11.4 t80 -58.99 -44.58 91.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.831 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.53 -34.34 73.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.002 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -59.68 -46.22 89.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.913 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 12.0 t -59.65 -43.67 93.82 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.866 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.06 -37.72 84.54 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.011 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -60.35 -48.01 83.61 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.887 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.417 ' O ' ' N ' ' A' ' 159' ' ' LYS . 0.7 OUTLIER -83.42 -28.76 28.61 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.056 -179.919 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 43.68 -90.73 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.658 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . 0.417 ' N ' ' O ' ' A' ' 157' ' ' GLN . 4.8 tptt -108.33 149.93 28.02 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.839 0.352 . . . . 0.0 110.904 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 12.0 p -70.23 118.08 14.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.104 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -165.75 148.88 7.7 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.764 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -174.37 99.45 0.1 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.903 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 3.3 pt -79.25 134.81 27.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.113 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.096 0 CA-C-O 118.277 -0.868 . . . . 0.0 110.938 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.29 0 N-CA-C 112.438 -0.265 . . . . 0.0 112.438 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -77.93 -38.89 44.42 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.775 0.321 . . . . 0.0 110.91 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -160.7 -57.15 0.05 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.88 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 52.6 mt 62.12 85.39 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.953 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.6 t -59.53 141.16 55.44 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.123 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -142.64 154.37 62.89 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.931 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -67.91 75.12 0.65 Allowed 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.517 2.145 . . . . 0.0 112.178 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.1 t -95.18 154.34 17.23 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.175 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 17.4 mt-30 -115.78 78.91 1.23 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.838 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -80.94 170.87 15.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.846 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -153.15 78.59 1.17 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.959 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.88 153.57 41.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.115 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 21.6 pt20 -76.55 113.08 13.78 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.909 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -173.43 115.64 0.25 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.063 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -143.6 -59.1 0.41 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.141 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -59.94 -31.93 70.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.895 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.09 -40.27 71.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.84 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -61.08 -35.76 77.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.874 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.8 mt -57.36 -37.31 72.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.024 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 35.7 mm -68.43 -41.39 83.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.171 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -57.67 -39.49 77.21 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.126 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -64.26 -40.43 95.98 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.075 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -68.32 -47.5 67.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.182 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 13.4 p -62.72 -36.41 82.89 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.975 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 4.7 tp60 69.19 -66.2 0.26 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.985 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -62.97 124.04 20.08 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.872 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 3.2 tt0 -85.7 115.63 23.49 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.924 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 23.0 mm -82.33 139.45 17.85 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.347 0 CA-C-O 121.459 0.647 . . . . 0.0 111.737 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -100.94 72.07 0.4 Allowed Glycine 0 C--N 1.318 -0.465 0 CA-C-N 114.904 -1.044 . . . . 0.0 112.595 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -84.92 -24.95 28.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.733 0.301 . . . . 0.0 110.995 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -108.72 -13.82 14.72 Favored 'General case' 0 CA--C 1.516 -0.347 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 178.333 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.595 ' CG2' ' O ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -70.77 96.33 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.635 0 CA-C-N 113.928 -1.487 . . . . 0.0 110.689 -179.48 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.567 ' CG1' ' N ' ' A' ' 34' ' ' CYS . 0.8 OUTLIER -33.46 -62.51 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 114.996 -1.002 . . . . 0.0 112.244 -179.157 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.567 ' N ' ' CG1' ' A' ' 33' ' ' VAL . 22.4 m -160.7 164.85 31.36 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.092 0.472 . . . . 0.0 111.637 -179.487 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 3.1 tmm_? -132.72 114.34 14.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.445 179.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.436 ' CG2' HD13 ' A' ' 91' ' ' ILE . 40.0 t -90.27 136.08 24.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.612 179.767 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.425 ' CG2' HG12 ' A' ' 45' ' ' ILE . 21.5 mt -124.09 107.97 19.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -179.248 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.471 ' HB2' ' O ' ' A' ' 43' ' ' ILE . 70.3 m -99.82 102.91 14.47 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 177.565 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.4 p -108.86 -21.54 12.61 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 113.509 0.929 . . . . 0.0 113.509 -176.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.444 ' CG2' ' HB2' ' A' ' 142' ' ' SER . 34.0 p -55.67 -20.67 14.92 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.745 0.307 . . . . 0.0 111.525 -179.428 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 113.53 62.87 0.43 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.285 179.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -144.18 -54.16 0.34 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.703 0.287 . . . . 0.0 111.361 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.492 ' CG2' ' CD2' ' A' ' 76' ' ' TYR . 0.0 OUTLIER -134.76 154.62 79.54 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.33 -178.961 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.477 ' CG ' ' CZ ' ' A' ' 76' ' ' TYR . 90.1 Cg_endo -83.78 146.86 11.94 Favored 'Trans proline' 0 N--CA 1.459 -0.511 0 C-N-CA 122.648 2.232 . . . . 0.0 111.569 179.402 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.425 HG12 ' CG2' ' A' ' 37' ' ' ILE . 40.8 mt -47.85 112.0 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 120.926 0.393 . . . . 0.0 111.728 -179.5 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 7.4 mmm180 -114.91 130.05 56.83 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.684 178.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -97.98 120.08 37.74 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.094 0.473 . . . . 0.0 111.928 -178.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.542 ' HB3' ' CE2' ' A' ' 66' ' ' TRP . 0.2 OUTLIER -92.59 137.21 32.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.238 178.641 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.523 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -135.79 163.16 30.83 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 113.258 0.836 . . . . 0.0 113.258 -178.601 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.478 ' HB2' HG22 ' A' ' 33' ' ' VAL . . . -157.48 142.16 16.58 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.626 -1.17 . . . . 0.0 111.195 179.111 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -64.31 137.19 57.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.227 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 12.4 mt -63.87 -38.19 81.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.994 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -56.42 -34.46 66.8 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.929 -179.565 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -63.64 -43.61 96.28 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.613 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 20.2 t -74.07 -38.17 48.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.206 179.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.3 mt -57.99 -37.38 74.14 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.856 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 8.4 mttm -88.64 -51.82 5.48 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.799 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 57.55 51.11 10.04 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.952 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -175.9 39.54 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.974 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 2.2 ttt-85 -163.65 -75.54 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.048 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 4.9 m -106.83 20.9 18.36 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.178 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -86.88 60.38 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.939 0.399 . . . . 0.0 111.107 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -154.32 80.97 1.12 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.916 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 12.4 ttpt -134.32 134.44 41.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.585 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.485 ' CG1' ' O ' ' A' ' 91' ' ' ILE . 11.8 t -132.88 137.36 54.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.052 0.453 . . . . 0.0 111.763 -179.125 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . 0.611 ' HB2' ' HB ' ' A' ' 91' ' ' ILE . 14.9 m-90 -99.6 139.7 34.87 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.431 179.081 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.595 ' O ' ' N ' ' A' ' 75' ' ' ASP . 4.8 m -129.56 131.39 46.54 Favored 'General case' 0 CA--C 1.52 -0.194 0 CA-C-O 121.416 0.626 . . . . 0.0 112.46 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.503 ' CE2' ' CE2' ' A' ' 89' ' ' PHE . 90.1 m-85 -103.03 118.35 36.62 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.12 177.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.559 ' HA2' ' O ' ' A' ' 85' ' ' SER . . . 158.2 -156.12 27.09 Favored Glycine 0 CA--C 1.504 -0.656 0 C-N-CA 118.883 -1.627 . . . . 0.0 112.432 179.468 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.448 ' CD ' ' HB3' ' A' ' 86' ' ' ASN . 7.5 ptm180 -75.74 92.09 2.98 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-O 122.549 1.166 . . . . 0.0 108.377 179.703 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.513 ' O ' ' CD2' ' A' ' 77' ' ' HIS . 17.1 m120 -149.18 159.81 36.21 Favored Pre-proline 0 C--N 1.311 -1.089 0 CA-C-N 112.783 -2.008 . . . . 0.0 108.46 179.511 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.557 ' O ' ' HB2' ' A' ' 77' ' ' HIS . 32.7 Cg_endo -64.96 -7.85 16.39 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 121.025 1.15 . . . . 0.0 111.095 178.295 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.636 ' HB3' ' HB2' ' A' ' 77' ' ' HIS . . . 136.18 50.89 0.0 OUTLIER 'General case' 0 CA--C 1.49 -1.331 0 CA-C-N 114.661 -1.154 . . . . 0.0 109.656 178.704 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . 0.542 ' HB3' ' HB ' ' A' ' 67' ' ' THR . 0.1 OUTLIER -53.24 -69.74 0.11 Allowed 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 105.863 -1.903 . . . . 0.0 105.863 179.438 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.595 ' N ' ' O ' ' A' ' 67' ' ' THR . 11.2 t0 -95.33 -46.92 6.52 Favored 'General case' 0 N--CA 1.435 -1.196 0 N-CA-C 105.915 -1.883 . . . . 0.0 105.915 169.766 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.506 ' C ' ' HA ' ' A' ' 73' ' ' ALA . 61.4 t80 -143.77 142.73 31.05 Favored 'General case' 0 C--N 1.346 0.453 0 CA-C-N 112.62 -2.082 . . . . 0.0 111.113 179.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . 0.636 ' HB2' ' HB3' ' A' ' 73' ' ' ALA . 23.1 t-160 -94.23 108.91 20.75 Favored 'General case' 0 C--N 1.328 -0.329 0 O-C-N 121.984 -0.447 . . . . 0.0 110.413 177.125 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.9 pp -126.17 170.92 11.33 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.82 0.343 . . . . 0.0 110.735 179.48 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -53.16 -176.3 0.06 OUTLIER Glycine 0 CA--C 1.518 0.245 0 C-N-CA 120.897 -0.668 . . . . 0.0 112.745 -179.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -108.25 102.25 11.39 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.85 0.357 . . . . 0.0 110.881 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.453 ' CD1' ' N ' ' A' ' 81' ' ' ILE . 2.0 mp -110.11 153.99 11.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.919 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 10.0 t -68.19 -45.31 73.76 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 113.72 1.007 . . . . 0.0 113.72 -178.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 3.1 mpt_? -120.4 -90.1 0.59 Allowed 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 113.74 1.015 . . . . 0.0 113.74 -177.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.497 ' O ' ' CB ' ' A' ' 85' ' ' SER . 0.0 OUTLIER -84.72 103.51 13.88 Favored 'General case' 0 CA--C 1.506 -0.741 0 CA-C-O 122.014 0.912 . . . . 0.0 110.836 -178.622 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.559 ' O ' ' HA2' ' A' ' 69' ' ' GLY . 0.4 OUTLIER 148.13 -35.8 0.01 OUTLIER 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 113.072 -1.876 . . . . 0.0 108.607 -179.812 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.8 ' O ' ' N ' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -70.42 -161.55 0.05 Allowed 'General case' 0 CA--C 1.513 -0.477 0 N-CA-C 107.586 -1.265 . . . . 0.0 107.586 177.492 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.502 ' HA ' ' HA3' ' A' ' 69' ' ' GLY . 9.6 pttt -51.54 72.82 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 178.129 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.93 ' O ' ' O ' ' A' ' 104' ' ' ILE . 32.9 t60 -84.51 -17.09 40.09 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 114.389 1.255 . . . . 0.0 114.389 -176.374 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.55 ' HA ' ' H ' ' A' ' 104' ' ' ILE . 0.1 OUTLIER -172.09 154.18 3.34 Favored 'General case' 0 C--N 1.31 -1.124 0 C-N-CA 119.124 -1.03 . . . . 0.0 112.48 177.867 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.492 ' N ' ' CD1' ' A' ' 89' ' ' PHE . 32.9 mt-30 -136.04 159.05 42.88 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 114.52 -1.218 . . . . 0.0 113.902 -177.294 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.611 ' HB ' ' HB2' ' A' ' 66' ' ' TRP . 7.1 mt -125.25 131.85 71.86 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 CA-C-N 114.949 -1.023 . . . . 0.0 109.703 178.607 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.421 ' CD1' ' HB2' ' A' ' 102' ' ' ASN . 0.3 OUTLIER -108.05 143.78 36.29 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.083 0.468 . . . . 0.0 112.111 -179.421 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.404 ' CD1' ' CG2' ' A' ' 33' ' ' VAL . 14.3 tp -125.6 122.68 37.15 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.349 179.038 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 120.44 -136.62 11.6 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.401 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 57.69 81.43 0.15 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.835 0.35 . . . . 0.0 110.862 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 61.15 28.76 18.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.894 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 84.2 -177.94 51.85 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.55 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 22.1 m120 63.35 177.76 0.16 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.848 0.356 . . . . 0.0 110.984 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.2 mt -106.76 153.09 22.96 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.854 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.553 ' HA ' ' O ' ' A' ' 122' ' ' GLN . 5.6 mt -133.79 148.46 51.35 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.434 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.447 ' O ' ' N ' ' A' ' 122' ' ' GLN . 38.0 mt -117.27 130.99 56.91 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 179.777 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.491 ' O ' ' O ' ' A' ' 90' ' ' GLN . 23.8 t30 -113.25 111.31 21.83 Favored 'General case' 0 CA--C 1.51 -0.581 0 C-N-CA 119.847 -0.741 . . . . 0.0 109.944 179.684 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.557 ' HB3' ' CG2' ' A' ' 109' ' ' THR . 70.7 m-20 -84.43 112.52 20.44 Favored 'General case' 0 N--CA 1.444 -0.773 0 C-N-CA 119.669 -0.812 . . . . 0.0 109.381 179.4 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.93 ' O ' ' O ' ' A' ' 88' ' ' HIS . 0.1 OUTLIER -122.91 107.61 19.67 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.876 0 CA-C-O 121.756 0.789 . . . . 0.0 108.96 178.136 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.456 ' OG ' ' NE2' ' A' ' 88' ' ' HIS . 66.8 m -132.39 171.49 13.67 Favored 'General case' 0 C--N 1.295 -1.77 0 CA-C-N 114.757 -1.11 . . . . 0.0 109.36 179.551 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 22.6 m -69.5 -63.8 1.0 Allowed 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 118.998 -1.081 . . . . 0.0 111.706 -178.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 5.5 p30 -112.6 -32.76 6.35 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 114.63 1.344 . . . . 0.0 114.63 179.203 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -146.13 129.17 3.28 Favored Glycine 0 C--N 1.339 0.719 0 N-CA-C 116.931 1.532 . . . . 0.0 116.931 -177.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.557 ' CG2' ' HB3' ' A' ' 103' ' ' ASP . 6.5 m -121.15 138.36 54.24 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 174.411 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . 0.622 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.7 m-90 -120.45 149.2 42.76 Favored 'General case' 0 CA--C 1.515 -0.374 0 N-CA-C 113.283 0.846 . . . . 0.0 113.283 -178.447 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -121.64 111.85 17.71 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 115.001 -0.999 . . . . 0.0 108.563 177.44 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 44.74 43.79 7.06 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.125 -0.489 . . . . 0.0 112.114 -179.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 78.88 31.4 44.0 Favored Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.891 179.238 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -141.95 98.93 3.42 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.999 0.428 . . . . 0.0 110.832 179.648 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.622 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.2 OUTLIER -45.22 122.59 3.49 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.786 179.727 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 8.1 m -112.35 179.56 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.902 -179.047 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -88.13 136.96 32.73 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.809 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 63.7 tttm -62.73 162.39 10.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.534 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 4.0 p30 34.46 38.54 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.364 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 9.0 p -111.28 114.23 27.28 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.055 -179.334 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . 0.409 ' ND2' HD13 ' A' ' 92' ' ' LEU . 1.6 m120 -61.76 136.26 57.92 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.616 179.777 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . 0.553 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 32.0 mm-40 -129.53 145.37 51.47 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.119 0.485 . . . . 0.0 112.161 -179.613 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.6 tp -72.62 120.03 17.67 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.562 178.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.463 ' O ' HD11 ' A' ' 124' ' ' LEU . 0.0 OUTLIER -47.6 149.22 1.23 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 122.026 0.917 . . . . 0.0 112.346 -178.661 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' SER . . . . . 0.435 ' O ' ' CD1' ' A' ' 147' ' ' ILE . 0.0 OUTLIER -126.42 152.56 46.2 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 114.102 -1.408 . . . . 0.0 109.661 179.195 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.62 113.75 8.03 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.07 0.462 . . . . 0.0 110.136 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 66.49 29.96 75.69 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.375 -179.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.42 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 9.8 t70 -58.31 161.05 4.61 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.98 0.419 . . . . 0.0 111.343 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -146.28 135.35 22.63 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.044 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.464 ' CD1' ' CE1' ' A' ' 89' ' ' PHE . 3.9 mt -109.91 128.53 65.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 120.831 0.348 . . . . 0.0 110.258 179.213 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.443 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 16.8 m -103.19 142.66 33.79 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.634 -179.57 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.463 ' HB ' ' NE2' ' A' ' 88' ' ' HIS . 4.4 m -140.72 154.09 21.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.298 -0.41 . . . . 0.0 112.008 -179.11 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 75.16 37.03 43.86 Favored Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 121.127 -0.559 . . . . 0.0 112.402 179.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.452 ' HA ' HG12 ' A' ' 140' ' ' ILE . 91.5 t -72.89 156.75 6.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 121.44 0.638 . . . . 0.0 112.081 -179.174 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . 0.417 ' N ' ' CG1' ' A' ' 134' ' ' VAL . . . 153.59 -47.86 0.53 Allowed Glycine 0 N--CA 1.442 -0.957 0 N-CA-C 110.665 -0.974 . . . . 0.0 110.665 -179.297 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 56.1 t -126.71 134.61 65.87 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.682 0 CA-C-N 115.295 -0.453 . . . . 0.0 109.877 178.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -51.19 -32.06 22.3 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.841 0.353 . . . . 0.0 111.19 -179.36 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 90.2 p -94.09 6.26 49.13 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 116.159 -0.473 . . . . 0.0 112.088 -179.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -129.31 29.14 5.16 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 112.376 0.51 . . . . 0.0 112.376 -179.487 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.452 HG12 ' HA ' ' A' ' 134' ' ' VAL . 23.6 mt -104.88 140.95 21.37 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 CA-C-N 115.668 -0.697 . . . . 0.0 111.154 179.157 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -117.23 135.22 53.96 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 114.925 -1.034 . . . . 0.0 110.06 179.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.444 ' HB2' ' CG2' ' A' ' 40' ' ' THR . 4.1 m -119.13 152.79 35.92 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.833 0.825 . . . . 0.0 112.581 -179.144 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -132.11 153.88 50.04 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 114.401 -1.272 . . . . 0.0 109.174 179.25 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 22.1 t -128.08 140.55 48.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 120.946 0.403 . . . . 0.0 111.777 -179.348 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -113.88 126.58 71.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.333 179.61 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 7.7 t80 -108.84 119.52 39.79 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.054 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.435 ' CD1' ' O ' ' A' ' 125' ' ' SER . 2.7 mp -112.1 123.0 67.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.881 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . 0.409 ' ND2' ' O ' ' A' ' 32' ' ' ILE . 3.1 p30 -76.31 122.88 25.07 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.923 0.392 . . . . 0.0 111.087 -179.74 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -73.82 -19.44 60.75 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.078 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.82 -42.98 85.46 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 120.962 0.411 . . . . 0.0 110.732 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -59.5 -41.54 90.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.64 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 3.3 tptm -63.18 -34.16 77.04 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.807 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -68.14 -38.47 82.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.962 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 12.2 t -60.17 -45.53 92.81 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.823 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -68.95 -48.18 63.84 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.951 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -57.77 -46.9 83.91 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.177 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 15.2 tt0 -79.3 -37.01 38.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.046 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 3.7 p30 44.36 -171.4 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.541 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 15.3 pttt -57.08 146.65 26.79 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.027 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 12.8 p -91.92 130.0 41.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.068 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -171.38 35.02 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.786 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 30.6 ttt180 -58.94 136.32 57.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.996 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 34.5 pt -105.86 135.68 43.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.141 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 3.6 tmt_? . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.231 -0.89 . . . . 0.0 110.88 179.974 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.353 0 N-CA-C 112.466 -0.253 . . . . 0.0 112.466 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -109.32 58.77 0.6 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.92 0.391 . . . . 0.0 110.936 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 43.8 p30 -121.13 32.57 5.89 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.872 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 6.1 pt -156.73 106.44 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.197 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 13.7 p -90.17 -43.02 10.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.224 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -141.56 79.21 17.4 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.874 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -71.17 63.57 2.65 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.59 2.194 . . . . 0.0 112.24 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.4 -40.09 6.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.099 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -98.69 41.65 1.13 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.831 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 2.3 mm-40 -122.39 37.52 4.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.832 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 7.9 p 62.4 122.39 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.873 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 9.6 t -122.01 -42.15 2.4 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.252 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 62.85 101.32 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.792 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -97.62 -169.88 1.91 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.153 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -124.56 -58.6 1.5 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.067 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -64.56 -46.12 84.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.943 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.82 -38.75 82.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.876 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -60.82 -41.3 95.44 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.975 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 91.8 mt -59.71 -39.03 83.28 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.098 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 45.6 mm -69.88 -37.34 72.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.217 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -57.56 -36.15 71.29 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.246 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -59.18 -29.76 67.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.049 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -65.68 -47.26 76.06 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.173 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.3 m -58.03 -47.19 83.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.95 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -90.93 172.34 8.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.88 179.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -80.24 128.97 34.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.992 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -81.18 110.74 16.96 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.767 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.416 HG22 ' N ' ' A' ' 29' ' ' GLY . 20.3 mm -86.15 139.26 17.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.483 0.659 . . . . 0.0 111.761 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.416 ' N ' HG22 ' A' ' 28' ' ' ILE . . . -123.63 72.15 0.42 Allowed Glycine 0 C--N 1.317 -0.481 0 CA-C-N 114.773 -1.103 . . . . 0.0 112.287 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -78.07 -24.81 47.52 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.642 0.258 . . . . 0.0 111.369 -179.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -109.42 -14.45 14.42 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-O 121.936 0.874 . . . . 0.0 108.681 178.463 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.609 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 0.1 OUTLIER -71.08 108.99 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.662 0 CA-C-N 113.949 -1.478 . . . . 0.0 111.121 -179.464 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.496 ' CG2' ' N ' ' A' ' 50' ' ' ALA . 2.2 t -53.35 -67.19 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.834 0 CA-C-N 114.946 -1.025 . . . . 0.0 111.459 -179.576 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 18.3 p -155.23 165.08 37.79 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.022 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 1.5 ttm180 -129.33 115.48 17.63 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.402 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.427 ' CG2' ' CD2' ' A' ' 48' ' ' LEU . 66.6 t -89.05 130.09 38.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.149 -0.478 . . . . 0.0 109.901 179.183 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.456 ' CG2' HG12 ' A' ' 45' ' ' ILE . 28.0 mt -122.23 108.54 22.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -178.802 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -95.92 101.65 13.35 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 177.599 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -111.47 2.32 17.42 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -178.049 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.466 ' CG2' ' HB2' ' A' ' 142' ' ' SER . 67.8 p -83.76 -16.35 45.1 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.784 -0.366 . . . . 0.0 111.402 179.646 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 113.71 58.83 0.4 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.587 179.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 6.1 mt-30 -134.6 -69.42 0.52 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.641 0.258 . . . . 0.0 111.134 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.411 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 3.7 mp -135.09 139.07 30.83 Favored Pre-proline 0 N--CA 1.452 -0.336 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.185 -179.88 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.527 ' HD2' ' CZ ' ' A' ' 76' ' ' TYR . 28.2 Cg_exo -59.26 147.32 91.38 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.718 2.278 . . . . 0.0 111.68 179.607 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.456 HG12 ' CG2' ' A' ' 37' ' ' ILE . 32.0 mt -46.33 148.72 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 121.008 0.432 . . . . 0.0 111.689 -179.633 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.1 130.28 13.61 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.187 179.445 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -91.58 119.77 31.78 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.086 0.469 . . . . 0.0 111.168 -179.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.609 ' HB3' ' CE2' ' A' ' 66' ' ' TRP . 0.1 OUTLIER -92.5 123.34 35.74 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.479 179.129 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.609 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -132.99 155.98 48.16 Favored 'General case' 0 CA--C 1.515 -0.398 0 N-CA-C 114.04 1.126 . . . . 0.0 114.04 -178.979 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.496 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -149.9 142.24 24.24 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 113.698 -1.592 . . . . 0.0 110.824 179.028 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.446 ' CB ' ' HG3' ' A' ' 54' ' ' GLN . 0.4 OUTLIER -66.46 110.22 3.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.982 0.42 . . . . 0.0 110.89 -179.845 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 10.7 mt -56.16 -34.53 39.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.1 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 9.6 t -56.86 -34.66 68.04 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.899 -179.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.446 ' HG3' ' CB ' ' A' ' 51' ' ' ASP . 0.0 OUTLIER -66.22 -44.74 82.97 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.768 -179.974 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 7.8 t -74.01 -40.66 52.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.208 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -59.38 -37.97 79.3 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.973 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 5.3 mmtm -92.81 -50.06 5.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.764 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 60.54 79.96 0.23 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.959 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 19.0 tttt -126.27 -64.66 1.02 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.819 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 23.9 mtp180 -136.57 38.53 2.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.785 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -175.01 103.22 0.09 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.986 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -168.75 53.56 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.917 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.1 pttp -160.4 70.0 0.4 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.084 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.433 ' HG2' ' CH2' ' A' ' 66' ' ' TRP . 29.2 ttmt -99.69 123.55 44.07 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.237 179.478 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.468 ' CG1' ' O ' ' A' ' 91' ' ' ILE . 4.7 t -126.11 133.32 69.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.141 0.496 . . . . 0.0 112.09 -178.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . 0.609 ' CE2' ' HB3' ' A' ' 48' ' ' LEU . 13.3 m-90 -99.34 139.9 34.3 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.229 178.827 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.547 ' N ' ' HB2' ' A' ' 75' ' ' ASP . 2.8 m -131.37 129.34 41.23 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.447 0.642 . . . . 0.0 112.436 179.678 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.509 ' CD2' ' CD2' ' A' ' 89' ' ' PHE . 94.2 m-85 -100.13 117.6 34.71 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.415 -0.812 . . . . 0.0 109.091 177.832 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.545 ' HA2' ' O ' ' A' ' 85' ' ' SER . . . 158.19 -157.83 28.64 Favored Glycine 0 CA--C 1.503 -0.695 0 C-N-CA 119.061 -1.542 . . . . 0.0 113.061 179.456 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -75.46 91.49 2.77 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-O 122.726 1.25 . . . . 0.0 108.43 -179.7 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.485 ' O ' ' CD2' ' A' ' 77' ' ' HIS . 0.2 OUTLIER -150.39 155.26 36.61 Favored Pre-proline 0 C--N 1.309 -1.162 0 CA-C-N 112.617 -2.083 . . . . 0.0 108.44 179.34 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.558 ' O ' ' HB2' ' A' ' 77' ' ' HIS . 23.9 Cg_exo -56.9 -11.11 6.62 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 121.406 1.404 . . . . 0.0 111.606 178.254 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.617 ' HB2' ' HB2' ' A' ' 77' ' ' HIS . . . 136.16 51.78 0.0 OUTLIER 'General case' 0 CA--C 1.491 -1.315 0 CA-C-N 115.001 -1.0 . . . . 0.0 109.535 178.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . 0.54 ' CB ' ' HB ' ' A' ' 67' ' ' THR . 0.1 OUTLIER -52.91 -69.55 0.11 Allowed 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 105.919 -1.882 . . . . 0.0 105.919 179.387 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.547 ' HB2' ' N ' ' A' ' 67' ' ' THR . 8.2 t0 -94.48 -47.73 6.43 Favored 'General case' 0 N--CA 1.434 -1.258 0 N-CA-C 105.772 -1.936 . . . . 0.0 105.772 169.784 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.527 ' CZ ' ' HD2' ' A' ' 44' ' ' PRO . 39.0 t80 -145.04 142.37 29.69 Favored 'General case' 0 C--N 1.347 0.473 0 CA-C-N 112.655 -2.066 . . . . 0.0 111.54 179.485 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . 0.617 ' HB2' ' HB2' ' A' ' 73' ' ' ALA . 23.8 t-160 -92.06 107.43 19.21 Favored 'General case' 0 C--N 1.331 -0.196 0 O-C-N 121.846 -0.534 . . . . 0.0 109.906 176.779 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.6 pp -119.99 176.29 5.5 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.949 0.404 . . . . 0.0 111.48 -179.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -64.1 -169.98 1.82 Allowed Glycine 0 C--N 1.332 0.324 0 C-N-CA 121.044 -0.598 . . . . 0.0 112.572 -179.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 10.1 p-10 -111.71 98.82 7.68 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.957 0.408 . . . . 0.0 111.604 -179.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.553 ' HB ' ' HB2' ' A' ' 85' ' ' SER . 13.4 mm -113.72 112.1 38.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.302 179.018 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 8.0 t -55.01 -24.24 23.4 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.238 0.458 . . . . 0.0 112.238 -179.236 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -91.49 -109.51 0.1 Allowed 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 -179.027 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.44 ' HB3' ' CE1' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -108.01 112.41 24.96 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 121.619 0.723 . . . . 0.0 109.87 -179.915 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.553 ' HB2' ' HB ' ' A' ' 81' ' ' ILE . 0.4 OUTLIER 162.16 -43.93 0.0 OUTLIER 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 114.285 -1.325 . . . . 0.0 108.932 -179.422 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.843 ' O ' ' N ' ' A' ' 88' ' ' HIS . 96.9 m-20 -65.43 -149.46 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 177.522 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.79 72.33 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 179.063 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.962 ' C ' ' O ' ' A' ' 104' ' ' ILE . 30.7 t60 -90.58 -16.17 29.23 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 113.813 1.042 . . . . 0.0 113.813 -176.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.511 ' HA ' ' H ' ' A' ' 104' ' ' ILE . 1.0 OUTLIER -174.8 152.66 1.61 Allowed 'General case' 0 C--N 1.311 -1.092 0 C-N-CA 119.484 -0.886 . . . . 0.0 112.257 178.052 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.482 ' O ' ' O ' ' A' ' 102' ' ' ASN . 3.2 tt0 -136.42 154.14 50.88 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 114.656 -1.156 . . . . 0.0 113.638 -177.422 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.609 ' HB ' ' HB2' ' A' ' 66' ' ' TRP . 16.4 mt -124.65 131.96 71.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.261 -0.882 . . . . 0.0 109.842 178.623 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -113.32 140.23 48.18 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.975 0.417 . . . . 0.0 111.99 -179.378 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.409 ' CD2' HG21 ' A' ' 33' ' ' VAL . 27.1 tp -125.9 130.66 51.75 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.602 179.116 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 123.29 -167.26 15.56 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.415 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 62.39 118.76 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.93 0.395 . . . . 0.0 110.916 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 19.5 t0 59.98 20.23 9.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.117 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 54.13 60.03 9.07 Favored Glycine 0 C--N 1.332 0.314 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.691 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 -158.99 -179.21 7.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.84 0.352 . . . . 0.0 110.876 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 67.8 tp -108.04 145.4 34.04 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.836 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.488 ' HA ' ' O ' ' A' ' 122' ' ' GLN . 3.8 mm? -133.48 147.84 51.68 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.547 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.43 ' O ' ' N ' ' A' ' 122' ' ' GLN . 8.0 mp -117.03 130.67 56.83 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 179.647 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.482 ' O ' ' O ' ' A' ' 90' ' ' GLN . 25.0 t30 -114.84 110.93 20.42 Favored 'General case' 0 CA--C 1.508 -0.64 0 C-N-CA 119.87 -0.732 . . . . 0.0 109.881 179.729 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.57 ' HB3' ' CG2' ' A' ' 109' ' ' THR . 63.0 m-20 -82.9 111.85 19.15 Favored 'General case' 0 N--CA 1.442 -0.841 0 C-N-CA 119.63 -0.828 . . . . 0.0 109.326 179.5 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.962 ' O ' ' C ' ' A' ' 88' ' ' HIS . 0.1 OUTLIER -123.55 108.03 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.997 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 178.028 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.441 ' OG ' ' NE2' ' A' ' 88' ' ' HIS . 75.6 m -128.09 171.34 11.98 Favored 'General case' 0 C--N 1.297 -1.702 0 CA-C-N 114.914 -1.039 . . . . 0.0 109.275 179.673 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 26.6 m -69.24 -62.96 1.17 Allowed 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 119.099 -1.04 . . . . 0.0 111.074 -179.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 5.7 p30 -111.97 -33.66 6.21 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 114.216 1.191 . . . . 0.0 114.216 178.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -147.02 133.09 4.62 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 116.667 1.427 . . . . 0.0 116.667 -178.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.57 ' CG2' ' HB3' ' A' ' 103' ' ' ASP . 8.3 m -121.01 138.29 54.24 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 174.164 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . 0.734 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.4 m-90 -119.3 149.15 42.27 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 -178.387 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.404 ' O ' ' HG ' ' A' ' 111' ' ' LEU . 0.2 OUTLIER -123.74 112.44 17.35 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 114.842 -1.072 . . . . 0.0 108.647 177.66 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 7.1 m-80 46.46 42.93 11.5 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.951 -0.568 . . . . 0.0 112.34 -179.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.04 -6.5 83.19 Favored Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 120.69 -0.767 . . . . 0.0 113.437 178.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 1.8 mm-40 -110.55 104.77 13.53 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.892 0.377 . . . . 0.0 110.963 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.734 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.0 OUTLIER -44.22 127.85 5.78 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.908 179.721 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 12.3 p -111.95 159.45 11.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.779 -179.049 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 14.1 mp0 -70.7 136.86 49.29 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.95 179.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.408 ' O ' ' C ' ' A' ' 119' ' ' ASN . 78.7 tttt -63.09 163.86 9.34 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.296 179.594 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.408 ' C ' ' O ' ' A' ' 118' ' ' LYS . 10.5 m-80 34.43 40.61 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.24 -179.537 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 4.9 p -110.99 110.6 21.23 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.86 -179.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -62.69 133.97 55.63 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.554 179.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . 0.488 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 32.7 mm-40 -129.62 145.62 51.48 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.312 0.577 . . . . 0.0 112.357 -179.602 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.7 tt -72.61 122.77 21.94 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.634 179.018 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.458 ' O ' HD12 ' A' ' 124' ' ' LEU . 0.0 OUTLIER -48.71 148.82 1.96 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 122.067 0.937 . . . . 0.0 112.041 -178.887 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -126.79 153.08 46.07 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 114.195 -1.366 . . . . 0.0 110.153 179.703 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 1.3 mm100 -70.98 113.49 8.08 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 179.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 68.33 28.1 73.44 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.227 -179.096 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -53.86 160.09 1.51 Allowed 'General case' 0 C--O 1.231 0.123 0 CA-C-O 120.963 0.411 . . . . 0.0 111.224 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.49 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 29.0 tt0 -146.66 134.9 21.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.587 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.427 HD12 HG22 ' A' ' 130' ' ' ILE . 7.1 mm -117.56 128.3 74.82 Favored 'Isoleucine or valine' 0 C--O 1.231 0.131 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 178.542 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.504 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 94.6 m -103.49 145.47 29.97 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.632 -179.658 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.499 ' HB ' ' NE2' ' A' ' 88' ' ' HIS . 6.2 m -140.9 157.97 23.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -178.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . 0.403 ' O ' ' O ' ' A' ' 139' ' ' ASP . . . 70.72 40.86 65.02 Favored Glycine 0 N--CA 1.446 -0.637 0 CA-C-N 115.728 -0.669 . . . . 0.0 112.648 179.292 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.422 ' HA ' HG12 ' A' ' 140' ' ' ILE . 94.8 t -76.76 157.17 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 CA-C-O 121.409 0.624 . . . . 0.0 112.005 -179.297 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . 0.407 ' N ' ' CG1' ' A' ' 134' ' ' VAL . . . 152.63 -44.68 0.61 Allowed Glycine 0 N--CA 1.44 -1.037 0 N-CA-C 110.652 -0.979 . . . . 0.0 110.652 -179.271 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 45.3 t -126.75 134.22 66.76 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.739 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 178.66 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 26.9 tp10 -50.87 -34.51 28.4 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.827 0.346 . . . . 0.0 111.464 -179.182 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 37.7 t -93.78 6.23 49.05 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 116.204 -0.453 . . . . 0.0 112.141 -179.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . 0.403 ' O ' ' O ' ' A' ' 133' ' ' GLY . 2.3 t70 -125.77 29.25 5.98 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-O 121.124 0.488 . . . . 0.0 112.169 -179.484 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.504 ' CG2' ' CG2' ' A' ' 131' ' ' THR . 25.7 mt -107.17 141.45 22.34 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.328 179.394 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 12.1 mt -123.41 134.79 53.93 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.037 -0.983 . . . . 0.0 110.633 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.466 ' HB2' ' CG2' ' A' ' 40' ' ' THR . 4.8 m -114.94 153.5 30.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.756 0.788 . . . . 0.0 112.462 -179.352 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.49 ' O ' ' HA ' ' A' ' 129' ' ' GLU . 1.8 tm? -133.83 136.84 44.7 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 114.55 -1.205 . . . . 0.0 109.396 179.701 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 15.0 t -118.04 140.3 41.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.903 0.382 . . . . 0.0 111.801 -179.13 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -108.01 140.3 26.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.776 179.592 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 37.5 t80 -118.4 122.87 43.86 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.96 -179.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 3.0 mp -115.32 130.23 70.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.11 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 23.6 p-10 -75.28 138.0 41.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.993 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -73.64 -30.24 62.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.934 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -57.44 -40.16 77.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.777 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 6.2 t80 -63.72 -38.73 92.22 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.917 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 19.7 tttm -64.86 -44.4 89.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.036 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 17.3 tt0 -58.99 -36.84 75.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.055 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 9.0 t -64.97 -43.46 92.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.737 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.35 -35.67 80.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.822 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 59.5 tt0 -56.83 -41.08 77.21 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.807 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 3.4 tt0 -89.35 -34.08 16.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.838 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 4.9 p30 44.62 -171.54 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.55 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 4.1 pttp -88.13 140.32 29.61 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.954 -179.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 29.3 m -67.36 125.48 24.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.167 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 28.9 p30 -114.16 -173.47 2.29 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.86 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -58.72 -26.82 64.31 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.963 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 27.8 mt -76.84 132.64 32.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.023 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.241 -0.885 . . . . 0.0 110.945 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.36 0 N-CA-C 112.521 -0.231 . . . . 0.0 112.521 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 59.52 36.98 23.01 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.769 0.319 . . . . 0.0 110.944 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -165.61 -73.68 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.81 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 5.9 pt -162.72 158.5 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.148 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.4 m -135.29 112.01 10.07 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.175 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 5.9 mm-40 -152.46 73.97 7.39 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.857 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -67.36 -165.51 0.11 Allowed 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.632 2.221 . . . . 0.0 112.304 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.8 p 62.68 158.59 0.07 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.174 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER 61.57 63.44 1.17 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.882 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -161.32 32.94 0.14 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.82 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -59.41 158.55 9.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.871 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -69.48 143.51 53.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.151 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.59 158.81 14.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.871 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -131.7 174.94 9.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.228 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 1.6 t -164.69 -42.05 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.021 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -71.67 -39.29 70.38 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.86 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 41.7 mtp85 -66.31 -46.34 77.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.906 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 -58.53 -35.71 72.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.973 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.07 -37.74 80.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.784 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 37.2 mm -65.1 -39.16 84.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.029 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.7 -37.54 73.67 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.984 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.69 -43.54 97.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.871 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -61.06 -47.65 85.38 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.042 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.9 m -65.29 -45.24 85.2 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.939 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -80.39 160.72 25.29 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.882 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -73.86 142.9 46.04 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.822 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 64.9 mt-30 -98.03 116.74 30.87 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.916 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 25.1 mm -82.03 139.73 17.49 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.345 0 CA-C-O 121.458 0.647 . . . . 0.0 111.574 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -140.55 80.95 0.26 Allowed Glycine 0 C--N 1.318 -0.443 0 CA-C-N 114.95 -1.023 . . . . 0.0 112.633 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -87.51 -25.58 23.61 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.757 0.313 . . . . 0.0 110.936 179.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -109.02 -13.5 14.71 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-O 121.997 0.903 . . . . 0.0 108.626 178.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.598 ' CG2' ' O ' ' A' ' 32' ' ' ILE . 0.1 OUTLIER -70.7 95.57 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.556 0 CA-C-N 113.911 -1.495 . . . . 0.0 110.711 -179.41 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.572 ' CG1' ' N ' ' A' ' 34' ' ' CYS . 0.5 OUTLIER -32.45 -59.94 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 114.874 -1.057 . . . . 0.0 112.379 -179.127 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.572 ' N ' ' CG1' ' A' ' 33' ' ' VAL . 31.7 p -164.29 164.88 22.26 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.529 -179.757 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 5.2 ttm180 -127.11 122.62 34.76 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.077 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.432 HG12 ' CZ ' ' A' ' 68' ' ' PHE . 24.8 t -93.81 131.74 39.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.669 179.536 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.496 ' CG2' HG12 ' A' ' 45' ' ' ILE . 32.9 mt -121.18 108.38 22.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 N-CA-C 112.362 0.505 . . . . 0.0 112.362 -179.326 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -98.6 105.66 17.83 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 177.374 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 8.9 t -113.71 -21.22 10.84 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 113.328 0.862 . . . . 0.0 113.328 -177.496 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.541 HG23 ' HB2' ' A' ' 142' ' ' SER . 44.5 p -55.59 -22.22 21.14 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.874 0.369 . . . . 0.0 111.467 -179.475 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 120.73 64.76 0.25 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.353 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.2 mt-30 -141.75 -70.32 0.36 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.773 0.32 . . . . 0.0 111.205 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.462 HG22 ' CZ ' ' A' ' 76' ' ' TYR . 0.7 OUTLIER -135.16 139.24 31.2 Favored Pre-proline 0 N--CA 1.453 -0.325 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.113 -179.566 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.421 ' O ' ' CE2' ' A' ' 76' ' ' TYR . 26.6 Cg_exo -59.41 147.76 89.83 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.506 2.137 . . . . 0.0 111.379 179.223 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.496 HG12 ' CG2' ' A' ' 37' ' ' ILE . 43.1 mt -36.33 136.04 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 -179.398 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.48 ' CG ' ' CE2' ' A' ' 76' ' ' TYR . 0.0 OUTLIER -123.26 144.87 49.12 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.337 179.306 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -110.11 119.61 39.82 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.977 0.418 . . . . 0.0 111.259 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.554 ' HB3' ' CE2' ' A' ' 66' ' ' TRP . 5.4 mt -98.53 137.88 36.55 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 178.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.57 ' O ' ' HZ2' ' A' ' 66' ' ' TRP . 0.0 OUTLIER -137.8 163.31 31.69 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 113.55 0.944 . . . . 0.0 113.55 -178.646 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.459 ' HB1' HG22 ' A' ' 33' ' ' VAL . . . -138.27 166.03 25.23 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 114.41 -1.268 . . . . 0.0 110.888 179.292 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.404 ' CB ' ' HG3' ' A' ' 54' ' ' GLN . 1.4 m-20 -92.28 100.52 13.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.943 0.401 . . . . 0.0 111.187 -179.71 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.3 mt -63.76 -29.7 47.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.528 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -56.47 -34.84 67.28 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.017 -179.186 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.404 ' HG3' ' CB ' ' A' ' 51' ' ' ASP . 0.6 OUTLIER -66.07 -36.99 84.67 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.822 179.992 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 16.4 t -73.77 -42.21 54.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.242 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -61.57 -27.07 68.37 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.308 -179.678 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.5 tppp? -99.47 -32.4 11.15 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.784 0.326 . . . . 0.0 111.221 -179.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -135.14 117.97 16.18 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.031 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -58.02 -56.29 23.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.906 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -82.98 71.19 10.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.793 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 51.4 p -128.2 -161.48 1.1 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.847 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 23.9 mm 73.54 128.95 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-O 120.912 0.386 . . . . 0.0 111.335 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 4.5 tttt -169.51 64.02 0.05 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.707 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.448 ' O ' ' CZ3' ' A' ' 66' ' ' TRP . 29.9 ttpt -132.55 118.79 19.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.916 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.442 ' CG2' ' O ' ' A' ' 91' ' ' ILE . 7.9 p -108.61 140.13 28.39 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 CA-C-O 121.37 0.605 . . . . 0.0 112.428 -179.07 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . 0.664 ' HB2' ' HB ' ' A' ' 91' ' ' ILE . 14.3 m-90 -99.93 139.31 35.78 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.099 -0.955 . . . . 0.0 111.325 179.099 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.62 ' N ' ' HB2' ' A' ' 75' ' ' ASP . 10.6 m -127.36 130.07 48.76 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.547 0.689 . . . . 0.0 111.951 179.113 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.559 ' CE1' ' CG ' ' A' ' 75' ' ' ASP . 11.2 m-85 -102.86 118.33 36.59 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.054 -0.976 . . . . 0.0 108.98 178.099 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.634 ' HA2' ' O ' ' A' ' 85' ' ' SER . . . 157.16 -153.95 25.12 Favored Glycine 0 CA--C 1.505 -0.561 0 C-N-CA 118.765 -1.683 . . . . 0.0 113.317 179.32 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 1.6 mtp180 -75.58 91.94 2.88 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-O 122.593 1.187 . . . . 0.0 108.873 -179.299 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.519 ' O ' ' CD2' ' A' ' 77' ' ' HIS . 33.8 m-80 -150.07 159.62 35.06 Favored Pre-proline 0 C--N 1.308 -1.197 0 CA-C-N 112.761 -2.018 . . . . 0.0 108.102 178.708 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.543 ' O ' ' HB2' ' A' ' 77' ' ' HIS . 31.7 Cg_endo -64.85 -6.78 13.28 Favored 'Trans proline' 0 N--CA 1.453 -0.91 0 C-N-CA 120.637 0.891 . . . . 0.0 110.576 177.33 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.601 ' HB1' ' HB2' ' A' ' 77' ' ' HIS . . . 136.36 52.99 0.0 OUTLIER 'General case' 0 CA--C 1.49 -1.337 0 CA-C-N 114.359 -1.292 . . . . 0.0 109.052 178.856 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . 0.551 ' HB3' ' HB ' ' A' ' 67' ' ' THR . 0.1 OUTLIER -52.7 -69.93 0.1 Allowed 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 105.497 -2.038 . . . . 0.0 105.497 179.491 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.62 ' HB2' ' N ' ' A' ' 67' ' ' THR . 60.7 t0 -95.85 -47.0 6.33 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 105.834 -1.913 . . . . 0.0 105.834 169.259 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.48 ' CE2' ' CG ' ' A' ' 46' ' ' ARG . 0.1 OUTLIER -143.63 141.33 30.55 Favored 'General case' 0 C--N 1.348 0.531 0 CA-C-N 112.77 -2.014 . . . . 0.0 111.855 -179.712 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . 0.601 ' HB2' ' HB1' ' A' ' 73' ' ' ALA . 23.7 t-160 -97.21 106.15 18.42 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 176.306 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.1 pp -123.11 175.52 6.59 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.919 0.39 . . . . 0.0 111.512 -179.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -53.54 -179.76 0.12 Allowed Glycine 0 C--N 1.333 0.369 0 C-N-CA 121.015 -0.612 . . . . 0.0 112.573 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.432 ' HA ' ' OD1' ' A' ' 86' ' ' ASN . 5.0 p30 -111.61 98.47 7.45 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.785 0.326 . . . . 0.0 111.582 -179.708 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.652 ' HB ' ' HB2' ' A' ' 85' ' ' SER . 15.0 mm -114.7 117.52 55.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.701 178.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 43.4 t -54.97 -24.18 22.7 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 111.82 0.304 . . . . 0.0 111.82 -179.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 3.3 mpt_? -92.44 -102.25 0.12 Allowed 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -179.095 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.439 ' O ' ' HB2' ' A' ' 85' ' ' SER . 0.0 OUTLIER -108.96 109.76 20.9 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-O 121.631 0.729 . . . . 0.0 110.512 -179.702 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.652 ' HB2' ' HB ' ' A' ' 81' ' ' ILE . 0.3 OUTLIER 161.38 -46.0 0.0 OUTLIER 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 114.128 -1.397 . . . . 0.0 109.201 -179.92 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.814 ' O ' ' N ' ' A' ' 88' ' ' HIS . 88.3 m-20 -66.44 -153.44 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 177.658 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 17.2 pttm -49.37 73.64 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 179.095 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 1.053 ' O ' ' O ' ' A' ' 104' ' ' ILE . 36.9 t60 -95.0 -16.5 22.7 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 114.307 1.225 . . . . 0.0 114.307 -176.854 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.51 ' HA ' ' H ' ' A' ' 104' ' ' ILE . 0.2 OUTLIER -177.39 157.04 1.26 Allowed 'General case' 0 C--N 1.316 -0.881 0 C-N-CA 119.127 -1.029 . . . . 0.0 112.529 178.264 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.47 ' O ' ' O ' ' A' ' 102' ' ' ASN . 17.4 mt-30 -137.74 161.81 35.54 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 -177.348 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.664 ' HB ' ' HB2' ' A' ' 66' ' ' TRP . 4.7 mt -128.33 132.66 67.99 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 CA-C-N 114.913 -1.039 . . . . 0.0 110.041 178.754 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.425 ' O ' ' O ' ' A' ' 100' ' ' LEU . 0.0 OUTLIER -120.52 128.92 53.55 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.851 0.358 . . . . 0.0 111.963 -179.414 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.475 ' HG ' ' CG1' ' A' ' 33' ' ' VAL . 4.2 mm? -125.71 133.63 52.06 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.842 179.171 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 126.43 -139.31 11.26 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.425 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 58.23 84.33 0.1 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.844 0.354 . . . . 0.0 110.894 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 50.2 m-20 62.06 30.78 17.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.0 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 66.46 94.33 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.567 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -178.07 -175.24 0.47 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.872 0.368 . . . . 0.0 110.942 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.403 ' HA ' ' CD1' ' A' ' 93' ' ' LEU . 2.1 mp -132.94 130.86 40.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.807 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.616 ' HA ' ' O ' ' A' ' 122' ' ' GLN . 3.6 mm? -133.97 148.05 51.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.784 0.326 . . . . 0.0 111.029 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.416 ' O ' ' N ' ' A' ' 122' ' ' GLN . 3.0 mm? -112.79 131.71 55.57 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 179.203 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.47 ' O ' ' O ' ' A' ' 90' ' ' GLN . 9.7 t30 -109.06 111.96 23.88 Favored 'General case' 0 CA--C 1.508 -0.665 0 C-N-CA 119.742 -0.783 . . . . 0.0 109.963 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.574 ' HB3' ' CG2' ' A' ' 109' ' ' THR . 31.2 m-20 -86.24 110.65 19.77 Favored 'General case' 0 N--CA 1.44 -0.928 0 C-N-CA 119.319 -0.952 . . . . 0.0 109.231 179.274 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 1.053 ' O ' ' O ' ' A' ' 88' ' ' HIS . 0.1 OUTLIER -123.84 108.5 20.91 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.07 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 177.44 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.431 ' OG ' ' NE2' ' A' ' 88' ' ' HIS . 73.8 m -133.37 169.32 17.1 Favored 'General case' 0 C--N 1.293 -1.858 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.59 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 21.4 m -69.29 -63.05 1.14 Allowed 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 119.061 -1.056 . . . . 0.0 111.328 -179.149 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -112.12 -33.38 6.26 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 114.576 1.324 . . . . 0.0 114.576 179.078 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -146.94 132.64 4.45 Favored Glycine 0 C--N 1.34 0.795 0 N-CA-C 116.875 1.51 . . . . 0.0 116.875 -178.078 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.574 ' CG2' ' HB3' ' A' ' 103' ' ' ASP . 13.3 m -121.28 137.94 54.46 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 174.386 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . 0.695 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 3.0 m-90 -121.61 148.82 44.04 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 113.599 0.963 . . . . 0.0 113.599 -178.506 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.403 ' O ' ' HG ' ' A' ' 111' ' ' LEU . 0.2 OUTLIER -123.26 112.33 17.51 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 114.969 -1.014 . . . . 0.0 108.637 177.61 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 71.6 m-20 44.71 44.28 7.38 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.032 -0.531 . . . . 0.0 112.213 -179.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 79.75 24.18 60.73 Favored Glycine 0 N--CA 1.445 -0.763 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.739 179.295 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -136.43 97.9 3.69 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.113 0.483 . . . . 0.0 110.819 179.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.695 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.0 OUTLIER -44.63 129.03 6.87 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.969 179.826 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 15.0 p -118.82 162.07 17.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.671 -178.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -70.47 142.05 51.97 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.068 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 49.2 tttm -65.42 162.93 16.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.396 179.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 4.1 p30 35.55 37.44 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.313 0.578 . . . . 0.0 111.354 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 5.0 p -111.27 109.49 19.54 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.953 -179.488 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -59.76 139.5 57.24 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.808 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . 0.616 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 29.9 mm-40 -129.25 148.23 51.16 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.878 0.37 . . . . 0.0 111.925 -179.677 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -71.61 131.78 43.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.026 -0.534 . . . . 0.0 109.933 179.463 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.483 ' O ' HD13 ' A' ' 124' ' ' LEU . 0.0 OUTLIER -55.18 147.2 16.88 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 122.258 1.028 . . . . 0.0 112.248 -178.747 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' SER . . . . . 0.426 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.5 OUTLIER -127.16 153.38 46.12 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 113.79 -1.55 . . . . 0.0 109.898 179.143 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 4.8 mm-40 -70.81 113.12 7.56 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 179.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 63.05 31.87 82.19 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.019 -179.207 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.426 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 30.2 t70 -51.71 160.51 0.64 Allowed 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 121.015 0.436 . . . . 0.0 111.584 -179.571 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -146.47 135.43 22.48 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.17 179.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.428 ' CG2' ' O ' ' A' ' 110' ' ' TRP . 2.6 mp -114.61 128.76 71.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-O 120.802 0.334 . . . . 0.0 110.396 179.151 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.464 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 59.9 m -102.93 145.05 30.42 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.341 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.475 ' HB ' ' NE2' ' A' ' 88' ' ' HIS . 4.8 m -141.01 158.3 23.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -178.582 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 67.11 43.21 90.79 Favored Glycine 0 N--CA 1.447 -0.59 0 CA-C-N 115.621 -0.718 . . . . 0.0 112.334 179.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.476 ' HA ' HG12 ' A' ' 140' ' ' ILE . 90.8 t -78.85 156.43 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 CA-C-O 121.49 0.662 . . . . 0.0 112.275 -179.163 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 147.4 -42.89 0.87 Allowed Glycine 0 N--CA 1.441 -0.984 0 CA-C-N 114.843 -1.072 . . . . 0.0 110.553 -178.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 47.4 t -126.77 128.13 70.66 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.723 0 CA-C-N 115.157 -0.522 . . . . 0.0 109.796 178.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 8.6 tt0 -51.13 -30.14 15.59 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.802 0.334 . . . . 0.0 111.279 -179.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 28.2 t -94.2 6.46 48.55 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -179.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -131.03 29.27 4.71 Favored 'General case' 0 CA--C 1.52 -0.182 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -179.346 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.476 HG12 ' HA ' ' A' ' 134' ' ' VAL . 18.9 mt -105.55 140.97 21.95 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.33 179.103 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 5.4 mp -121.49 134.67 55.07 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 114.971 -1.013 . . . . 0.0 109.846 179.297 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.541 ' HB2' HG23 ' A' ' 40' ' ' THR . 0.9 OUTLIER -119.1 149.73 41.2 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.676 0.751 . . . . 0.0 112.757 -178.721 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 4.7 mp -125.34 150.68 46.94 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 114.843 -1.071 . . . . 0.0 109.193 179.372 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 12.1 t -126.87 141.09 47.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 120.904 0.383 . . . . 0.0 111.842 -179.276 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -122.72 125.92 73.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.069 179.436 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -115.58 121.38 42.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.961 0.41 . . . . 0.0 111.248 -179.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 3.0 mm -104.04 130.03 55.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.788 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . 0.42 ' ND2' ' O ' ' A' ' 32' ' ' ILE . 6.2 p30 -77.42 130.75 37.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.85 0.357 . . . . 0.0 110.78 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -73.02 -22.96 60.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.398 -179.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 1.3 mptp? -57.34 -40.62 78.36 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.913 0.387 . . . . 0.0 110.699 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -60.65 -41.31 94.72 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.724 179.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.3 -34.38 73.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.745 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -62.48 -41.95 99.15 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.794 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 13.0 t -58.73 -45.44 89.6 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.954 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -68.06 -35.83 78.86 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.825 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -63.52 -41.19 98.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.884 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -80.92 -37.06 30.25 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.871 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 2.9 p30 42.41 89.3 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.451 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 10.5 tptm -60.05 120.75 10.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.948 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 28.7 m -66.17 138.86 22.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.076 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -158.36 44.06 0.29 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.88 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 6.9 mtt180 -106.55 -62.65 1.36 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.885 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 19.2 pt -100.01 133.64 42.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.197 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.232 -0.889 . . . . 0.0 110.911 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.303 0 N-CA-C 112.683 -0.167 . . . . 0.0 112.683 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 62.45 47.86 4.9 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.956 0.408 . . . . 0.0 110.844 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 36.4 m-80 -109.17 -26.4 10.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.112 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 20.6 mm 71.2 -66.89 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.229 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.8 m 61.91 151.05 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.189 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 56.97 84.7 0.2 Allowed Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.955 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -53.94 136.05 65.35 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.634 2.223 . . . . 0.0 112.345 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -126.3 179.9 5.06 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.964 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -122.39 -57.41 1.76 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.928 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -59.96 136.38 57.99 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.03 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -146.64 54.74 1.12 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.73 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.9 p -106.29 -17.59 14.25 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.482 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.83 147.27 7.05 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.882 0.372 . . . . 0.0 111.053 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -56.94 164.92 1.39 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.204 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 18.8 p -95.12 -46.57 6.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.051 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -59.69 -36.57 76.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.004 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.61 -38.43 70.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.898 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -59.08 -40.3 84.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.968 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 7.4 mp -60.34 -40.26 90.06 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.855 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 34.3 mm -68.34 -47.2 78.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.055 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -57.71 -35.37 70.56 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.002 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -60.31 -37.94 82.13 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.86 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -59.66 -47.53 85.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.093 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 35.4 p -76.95 -31.33 56.52 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.941 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -59.77 92.99 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.929 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -91.35 146.23 23.98 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.933 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -64.88 128.71 36.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.831 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.409 HG23 ' N ' ' A' ' 29' ' ' GLY . 19.0 mm -87.26 139.16 17.76 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.327 0 CA-C-O 121.589 0.709 . . . . 0.0 111.709 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.447 ' HA2' ' HB ' ' A' ' 32' ' ' ILE . . . -152.19 18.13 0.81 Allowed Glycine 0 C--N 1.318 -0.428 0 CA-C-N 114.773 -1.103 . . . . 0.0 112.885 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 8.3 pm0 -89.19 -23.62 22.36 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 111.687 0.254 . . . . 0.0 111.687 -179.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 11.3 m-80 -108.75 -14.56 14.58 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-O 121.918 0.866 . . . . 0.0 109.017 178.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.508 ' CG2' ' O ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -74.08 105.91 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.533 0 CA-C-N 113.919 -1.491 . . . . 0.0 110.664 -179.6 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.577 ' CG1' ' N ' ' A' ' 34' ' ' CYS . 0.5 OUTLIER -40.26 -62.65 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.712 -179.105 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.577 ' N ' ' CG1' ' A' ' 33' ' ' VAL . 31.1 p -164.92 164.96 20.67 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.505 -179.78 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 12.0 ttm180 -126.78 122.4 34.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.842 0.353 . . . . 0.0 111.176 179.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.401 HG11 ' CZ ' ' A' ' 68' ' ' PHE . 18.8 t -93.12 124.34 45.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.616 179.643 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.483 ' CG2' HG12 ' A' ' 45' ' ' ILE . 35.6 mt -121.51 108.49 22.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 112.254 0.464 . . . . 0.0 112.254 -179.178 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 14.6 t -80.28 103.92 10.48 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 177.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.9 p -99.34 22.18 10.98 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 112.454 0.538 . . . . 0.0 112.454 -178.347 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.401 ' CG2' ' HB2' ' A' ' 142' ' ' SER . 45.5 p -114.21 -13.14 12.4 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 111.657 0.244 . . . . 0.0 111.657 179.78 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 95.63 75.54 1.27 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.602 -0.808 . . . . 0.0 112.616 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 -150.97 -55.68 0.15 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.774 0.321 . . . . 0.0 110.983 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.427 HG22 ' CD2' ' A' ' 76' ' ' TYR . 2.0 mt -134.71 131.14 20.04 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.833 -179.697 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.427 ' HD2' ' CZ ' ' A' ' 76' ' ' TYR . 37.3 Cg_exo -58.87 147.1 90.79 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.569 2.18 . . . . 0.0 111.682 179.721 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.483 HG12 ' CG2' ' A' ' 37' ' ' ILE . 51.9 mt -42.39 128.97 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 121.03 0.443 . . . . 0.0 112.064 -179.363 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.41 ' HG2' ' O ' ' A' ' 75' ' ' ASP . 0.9 OUTLIER -123.54 130.13 52.22 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.935 179.295 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -95.14 120.16 34.89 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.095 0.474 . . . . 0.0 111.664 -179.13 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.598 ' HB3' ' CE2' ' A' ' 66' ' ' TRP . 1.6 mt -94.63 126.73 40.12 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.387 178.821 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.499 ' O ' ' HZ2' ' A' ' 66' ' ' TRP . 0.0 OUTLIER -119.62 162.08 19.58 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 122.102 0.953 . . . . 0.0 113.171 -178.731 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.477 ' CB ' ' CG2' ' A' ' 33' ' ' VAL . . . -116.47 166.17 12.39 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 114.47 -1.241 . . . . 0.0 111.011 179.596 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -103.99 57.97 0.72 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.098 0.475 . . . . 0.0 110.755 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.446 HG22 HD12 ' A' ' 52' ' ' ILE . 46.2 mt -60.08 -43.49 92.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.9 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 5.0 m -66.76 -38.73 87.17 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.112 -179.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 2.4 mm100 -68.11 -41.71 81.34 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.036 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 37.7 t -65.04 -41.96 93.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.034 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.4 mt -70.77 -41.13 72.13 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.913 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.2 mtpt -100.1 21.6 12.59 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.109 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 177.99 96.66 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.87 0.366 . . . . 0.0 110.834 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.07 105.03 0.36 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.02 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.13 15.53 2.07 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.273 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.2 t 53.33 101.27 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.769 0.319 . . . . 0.0 111.071 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -49.54 116.43 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.06 179.789 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 10.1 ttmt -154.5 99.69 2.2 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.201 -179.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 3.7 ttpt -136.79 134.03 36.6 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.183 179.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.44 ' CG1' ' O ' ' A' ' 91' ' ' ILE . 3.4 t -123.29 134.6 65.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.214 0.531 . . . . 0.0 112.01 -178.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . 0.606 ' HB2' ' HB ' ' A' ' 91' ' ' ILE . 12.3 m-90 -100.95 138.86 37.43 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.727 179.2 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.589 ' N ' ' HB2' ' A' ' 75' ' ' ASP . 1.3 m -131.75 127.71 37.36 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.31 0.576 . . . . 0.0 112.315 179.436 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.513 ' CE1' ' CE2' ' A' ' 89' ' ' PHE . 96.2 m-85 -98.32 117.83 33.61 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.423 178.011 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.652 ' HA2' ' O ' ' A' ' 85' ' ' SER . . . 158.9 -157.95 28.94 Favored Glycine 0 CA--C 1.503 -0.716 0 C-N-CA 119.001 -1.571 . . . . 0.0 112.683 179.1 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 7.8 ptm180 -76.13 91.92 3.18 Favored 'General case' 0 N--CA 1.441 -0.911 0 CA-C-O 122.614 1.197 . . . . 0.0 108.302 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.483 ' O ' ' CD2' ' A' ' 77' ' ' HIS . 0.1 OUTLIER -149.71 160.4 34.09 Favored Pre-proline 0 C--N 1.309 -1.188 0 CA-C-N 112.787 -2.006 . . . . 0.0 108.261 179.608 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.544 ' O ' ' CB ' ' A' ' 73' ' ' ALA . 29.3 Cg_endo -63.0 -11.04 22.75 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 120.869 1.046 . . . . 0.0 111.03 178.479 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.633 ' HB1' ' HB2' ' A' ' 77' ' ' HIS . . . 137.82 52.32 0.0 OUTLIER 'General case' 0 CA--C 1.491 -1.297 0 CA-C-N 114.743 -1.117 . . . . 0.0 109.685 178.548 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . 0.539 ' CB ' ' HB ' ' A' ' 67' ' ' THR . 0.1 OUTLIER -53.12 -69.92 0.1 Allowed 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 105.957 -1.868 . . . . 0.0 105.957 179.347 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.589 ' HB2' ' N ' ' A' ' 67' ' ' THR . 5.8 t0 -94.26 -47.45 6.62 Favored 'General case' 0 N--CA 1.436 -1.153 0 N-CA-C 105.743 -1.947 . . . . 0.0 105.743 169.754 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.536 ' C ' ' HA ' ' A' ' 73' ' ' ALA . 10.6 t80 -143.37 143.12 31.52 Favored 'General case' 0 C--N 1.344 0.356 0 CA-C-N 112.386 -2.188 . . . . 0.0 110.728 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . 0.633 ' HB2' ' HB1' ' A' ' 73' ' ' ALA . 19.4 t-160 -84.54 114.1 21.71 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.33 -0.548 . . . . 0.0 110.309 177.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 87.2 mt -126.58 166.19 17.76 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.869 0.366 . . . . 0.0 111.099 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -66.02 -166.71 2.06 Favored Glycine 0 C--N 1.33 0.228 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.212 179.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -111.35 99.1 7.96 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.932 0.396 . . . . 0.0 111.245 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.49 ' HB ' ' HB2' ' A' ' 85' ' ' SER . 29.7 mm -113.84 133.63 59.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.811 179.34 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 5.7 p -66.6 -41.91 87.7 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.794 0.665 . . . . 0.0 112.794 -179.449 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -83.12 -105.76 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 113.11 0.781 . . . . 0.0 113.11 -177.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.467 ' CD1' ' N ' ' A' ' 84' ' ' LEU . 0.0 OUTLIER -107.69 114.6 28.67 Favored 'General case' 0 CA--C 1.511 -0.554 0 CA-C-O 121.637 0.732 . . . . 0.0 109.179 -179.8 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.652 ' O ' ' HA2' ' A' ' 69' ' ' GLY . 0.5 OUTLIER 156.34 -36.25 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 114.054 -1.43 . . . . 0.0 107.885 -178.839 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.802 ' O ' ' N ' ' A' ' 88' ' ' HIS . 0.1 OUTLIER -61.85 -161.56 0.01 OUTLIER 'General case' 0 CA--C 1.51 -0.566 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 176.743 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.505 ' HA ' ' HA3' ' A' ' 69' ' ' GLY . 0.0 OUTLIER -53.63 72.53 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 177.091 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.928 ' O ' ' O ' ' A' ' 104' ' ' ILE . 28.3 t60 -77.66 -16.32 58.6 Favored 'General case' 0 CA--C 1.515 -0.376 0 N-CA-C 113.858 1.059 . . . . 0.0 113.858 -176.406 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.513 ' CE2' ' CE1' ' A' ' 68' ' ' PHE . 0.2 OUTLIER -173.47 154.84 2.67 Favored 'General case' 0 C--N 1.308 -1.232 0 C-N-CA 119.307 -0.957 . . . . 0.0 112.549 177.914 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.482 ' O ' ' O ' ' A' ' 102' ' ' ASN . 2.8 tt0 -136.28 155.66 49.77 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.732 -1.122 . . . . 0.0 113.533 -177.448 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.606 ' HB ' ' HB2' ' A' ' 66' ' ' TRP . 25.4 mt -127.42 132.46 69.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 115.256 -0.883 . . . . 0.0 110.224 179.231 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.404 ' O ' ' O ' ' A' ' 100' ' ' LEU . 0.1 OUTLIER -117.29 125.35 50.94 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.946 0.403 . . . . 0.0 111.365 179.792 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -127.19 140.11 52.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.599 179.265 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 128.5 -124.27 4.62 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.529 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 62.93 43.06 7.05 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.892 0.377 . . . . 0.0 110.971 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 60.18 30.79 20.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.936 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 106.96 75.8 0.96 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.456 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -178.37 136.19 0.16 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.763 0.316 . . . . 0.0 110.758 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -108.1 130.84 55.08 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.552 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.627 ' HA ' ' O ' ' A' ' 122' ' ' GLN . 6.5 mt -133.76 148.5 51.4 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.028 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.455 ' O ' ' N ' ' A' ' 122' ' ' GLN . 41.3 mt -116.31 129.77 56.43 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 179.205 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.482 ' O ' ' O ' ' A' ' 90' ' ' GLN . 18.1 t30 -110.56 110.78 21.63 Favored 'General case' 0 CA--C 1.508 -0.637 0 C-N-CA 119.611 -0.836 . . . . 0.0 110.105 -179.793 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.597 ' HB3' ' CG2' ' A' ' 109' ' ' THR . 58.4 m-20 -83.57 111.11 18.8 Favored 'General case' 0 N--CA 1.441 -0.888 0 C-N-CA 119.647 -0.821 . . . . 0.0 108.883 179.157 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.928 ' O ' ' O ' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -124.08 107.69 19.16 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.9 0 CA-C-O 121.6 0.714 . . . . 0.0 109.188 178.203 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.428 ' OG ' ' NE2' ' A' ' 88' ' ' HIS . 43.4 m -131.33 172.28 12.36 Favored 'General case' 0 C--N 1.297 -1.706 0 CA-C-N 114.867 -1.061 . . . . 0.0 109.142 179.504 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 19.6 m -69.62 -63.63 1.03 Allowed 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 119.092 -1.043 . . . . 0.0 111.906 -178.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -112.41 -32.26 6.55 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 114.755 1.391 . . . . 0.0 114.755 179.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -145.57 126.55 2.59 Favored Glycine 0 C--N 1.338 0.685 0 N-CA-C 116.849 1.5 . . . . 0.0 116.849 -177.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.597 ' CG2' ' HB3' ' A' ' 103' ' ' ASP . 3.3 m -121.12 138.16 54.32 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 174.522 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . 0.683 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 3.1 m-90 -121.76 149.37 43.39 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 113.393 0.886 . . . . 0.0 113.393 -178.231 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.2 mt -124.06 112.1 16.75 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.068 -0.969 . . . . 0.0 109.021 177.157 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 10.1 m-80 50.13 35.72 10.76 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.541 -179.223 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 82.57 26.09 48.01 Favored Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.64 179.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -133.08 96.83 3.85 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.009 0.433 . . . . 0.0 110.743 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.683 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.0 OUTLIER -46.52 134.61 9.18 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.01 179.82 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 12.6 p -135.14 165.45 30.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.227 -179.254 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.407 ' O ' ' HB3' ' A' ' 120' ' ' SER . 0.3 OUTLIER -69.6 142.69 53.48 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.256 179.746 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.47 ' HG3' ' ND2' ' A' ' 119' ' ' ASN . 12.8 ptmt -68.42 169.68 10.32 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.792 0.329 . . . . 0.0 110.92 -179.65 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.47 ' ND2' ' HG3' ' A' ' 118' ' ' LYS . 21.8 p30 33.86 37.58 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.192 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.407 ' HB3' ' O ' ' A' ' 117' ' ' GLU . 0.1 OUTLIER -111.8 107.9 17.12 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.671 179.406 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -47.67 138.45 8.22 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 120.598 0.237 . . . . 0.0 110.951 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . 0.627 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 71.9 mm-40 -126.84 148.5 49.97 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-O 121.144 0.497 . . . . 0.0 111.857 -179.684 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -73.98 112.08 9.75 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.585 178.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.409 ' CD1' HG12 ' A' ' 147' ' ' ILE . 6.6 tt -46.99 145.75 1.95 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.789 0.804 . . . . 0.0 112.06 -178.693 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -126.67 153.23 45.68 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 114.185 -1.37 . . . . 0.0 110.272 179.638 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 8.0 mm100 -71.24 113.68 8.52 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 179.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 68.47 28.38 73.25 Favored Glycine 0 N--CA 1.445 -0.72 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.18 -179.145 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -55.1 160.56 2.04 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.987 0.422 . . . . 0.0 111.434 -179.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.436 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 1.3 tm-20 -146.4 135.58 22.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.249 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.423 ' CG2' ' O ' ' A' ' 110' ' ' TRP . 1.3 mp -112.38 129.05 68.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.415 179.047 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.454 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 16.0 m -103.02 142.26 34.4 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.835 -179.513 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.425 ' HB ' ' NE2' ' A' ' 88' ' ' HIS . 4.3 m -140.85 153.26 20.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.187 -0.461 . . . . 0.0 112.004 -179.021 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 75.52 35.8 45.9 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 121.111 -0.566 . . . . 0.0 112.367 179.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.42 ' HA ' HG12 ' A' ' 140' ' ' ILE . 78.9 t -71.68 155.61 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 CA-C-O 121.468 0.651 . . . . 0.0 112.127 -179.306 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 153.44 -45.77 0.57 Allowed Glycine 0 N--CA 1.443 -0.863 0 CA-C-N 115.003 -0.998 . . . . 0.0 110.707 -179.164 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 62.0 t -126.71 134.85 65.32 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 CA-C-N 115.258 -0.471 . . . . 0.0 109.744 178.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 16.3 tm-20 -51.28 -34.38 32.72 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.83 0.347 . . . . 0.0 111.26 -179.293 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 76.7 p -94.11 6.4 48.67 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 116.246 -0.434 . . . . 0.0 112.06 -179.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -126.38 30.66 5.54 Favored 'General case' 0 CA--C 1.518 -0.257 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -179.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.454 ' CG2' ' CG2' ' A' ' 131' ' ' THR . 20.9 mt -107.23 140.91 23.82 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.304 179.213 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -120.43 135.43 55.05 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 114.874 -1.057 . . . . 0.0 110.005 179.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.41 ' HA ' ' HA ' ' A' ' 131' ' ' THR . 4.2 m -125.13 152.35 44.53 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.848 0.833 . . . . 0.0 113.094 -178.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.436 ' O ' ' HA ' ' A' ' 129' ' ' GLU . 6.5 mp -125.82 146.21 49.89 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.323 -1.308 . . . . 0.0 109.033 178.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 21.7 t -131.16 140.28 48.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 120.838 0.351 . . . . 0.0 111.793 -179.083 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -111.04 139.64 34.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.743 179.552 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 47.4 t80 -119.14 104.24 10.26 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.689 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.409 HG12 ' CD1' ' A' ' 124' ' ' LEU . 1.2 mp -98.15 129.72 47.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.241 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 14.7 p30 -83.37 133.1 34.96 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.953 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -67.83 -20.65 65.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.13 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.71 -43.1 84.98 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.935 0.398 . . . . 0.0 110.61 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . 0.428 ' CE2' HD13 ' A' ' 52' ' ' ILE . 13.2 t80 -59.57 -44.51 93.29 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.816 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 50.0 tttm -59.43 -36.86 76.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.857 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 3.0 tp60 -66.09 -37.26 85.33 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.9 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 13.0 t -59.82 -45.6 91.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.863 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.0 -39.31 79.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.922 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -60.71 -48.46 81.68 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.096 -179.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -82.84 -32.5 27.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.996 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 3.6 p30 42.5 65.03 0.98 Allowed 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.432 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 16.4 mmtm -85.01 120.36 26.44 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.941 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 18.8 t -85.0 124.04 39.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.025 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -49.97 -64.75 0.71 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.15 -179.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 3.1 tpt180 52.23 99.51 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.271 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . 0.403 HG22 HD12 ' A' ' 163' ' ' ILE . 30.8 mm -103.57 114.46 43.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.119 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 20.7 mmt180 . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.254 -0.879 . . . . 0.0 110.877 -179.918 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.266 0 N-CA-C 112.49 -0.244 . . . . 0.0 112.49 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 57.2 31.87 20.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.821 0.343 . . . . 0.0 110.977 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 22.4 m-20 -107.21 41.61 1.45 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.908 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.8 tt -58.43 -22.37 20.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.316 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 69.72 140.86 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.086 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 9.2 tp60 -126.41 93.79 42.21 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.959 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -49.76 97.74 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.564 2.176 . . . . 0.0 112.326 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.9 t -101.13 -26.61 13.62 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.29 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 62.86 30.58 16.58 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.871 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 60.76 158.49 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.89 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -125.05 176.19 6.85 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.847 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.3 m -144.44 114.93 7.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.188 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -102.14 70.21 1.19 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.7 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -109.3 106.11 15.8 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.069 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 32.8 p -107.53 59.81 0.62 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.106 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -60.48 -34.22 73.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.688 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.99 -35.76 77.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.714 179.727 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -56.83 -41.43 77.86 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.981 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.74 -34.6 78.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.867 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 40.2 mm -73.48 -43.68 55.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.015 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -57.78 -33.96 69.1 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.048 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.12 -28.63 66.72 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.072 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -56.89 -47.59 80.15 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.032 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.28 -21.71 66.76 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.979 179.763 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 71.21 47.86 0.38 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.939 0.4 . . . . 0.0 110.86 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -75.03 153.21 38.56 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.892 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -110.39 110.64 21.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.024 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 22.3 mm -86.84 139.61 17.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.404 0.621 . . . . 0.0 111.716 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.12 -36.31 0.06 OUTLIER Glycine 0 C--N 1.319 -0.408 0 CA-C-N 114.914 -1.039 . . . . 0.0 112.616 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -72.7 -23.45 60.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.617 0.246 . . . . 0.0 111.39 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 43.6 m-20 -108.74 -14.53 14.58 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-O 121.904 0.859 . . . . 0.0 108.95 178.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.457 ' O ' ' CG2' ' A' ' 32' ' ' ILE . 0.1 OUTLIER -75.07 110.62 10.09 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.636 0 CA-C-N 113.991 -1.459 . . . . 0.0 111.088 -179.557 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.626 ' CG1' ' N ' ' A' ' 34' ' ' CYS . 0.5 OUTLIER -41.18 -63.66 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.406 -179.49 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.626 ' N ' ' CG1' ' A' ' 33' ' ' VAL . 23.4 p -166.21 165.05 17.77 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.519 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 3.6 ttm180 -121.95 120.39 34.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.877 179.491 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.408 HG21 HD11 ' A' ' 48' ' ' LEU . 40.1 t -89.13 124.75 42.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.95 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.463 ' CG2' HG12 ' A' ' 45' ' ' ILE . 30.0 mt -124.58 108.12 19.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.65 -179.741 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 3.4 m -90.48 100.96 13.7 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 178.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 7.0 t -80.21 -27.19 38.85 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 -178.184 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.417 ' OG1' ' O ' ' A' ' 142' ' ' SER . 0.1 OUTLIER -51.54 -27.17 10.09 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.997 0.427 . . . . 0.0 111.023 -179.679 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 97.41 36.94 4.7 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.384 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 18.9 pt20 -106.0 -46.85 3.99 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.853 0.358 . . . . 0.0 110.908 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.422 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 7.1 mt -133.53 132.53 21.9 Favored Pre-proline 0 N--CA 1.451 -0.414 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.19 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.507 ' HD2' ' CZ ' ' A' ' 76' ' ' TYR . 27.3 Cg_exo -59.63 147.37 92.19 Favored 'Trans proline' 0 C--O 1.232 0.214 0 C-N-CA 122.763 2.309 . . . . 0.0 111.904 179.535 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.463 HG12 ' CG2' ' A' ' 37' ' ' ILE . 44.2 mt -43.6 139.0 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.83 -179.702 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.1 140.81 46.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.37 179.67 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -108.34 120.23 41.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.112 0.482 . . . . 0.0 111.632 -179.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.546 ' HG ' ' CD1' ' A' ' 66' ' ' TRP . 3.0 mp -98.82 125.2 44.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.156 178.796 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.518 ' O ' ' CZ2' ' A' ' 66' ' ' TRP . 0.0 OUTLIER -111.26 163.11 14.28 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 122.041 0.924 . . . . 0.0 113.338 -178.545 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.486 ' CB ' ' CG2' ' A' ' 33' ' ' VAL . . . -123.45 166.19 15.8 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 114.632 -1.167 . . . . 0.0 111.22 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -111.21 71.69 0.75 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.287 179.477 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 92.3 mt -63.59 -45.77 96.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.401 -179.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -60.49 -36.89 79.39 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.083 0.468 . . . . 0.0 110.672 -179.762 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 37.7 mm-40 -68.55 -44.78 73.8 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.973 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 23.7 t -62.18 -45.14 99.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.204 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.5 tp -58.73 -33.13 69.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.991 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.04 -46.13 10.78 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.954 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -118.35 134.57 54.94 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.865 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.65 -31.41 52.67 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.824 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 13.5 ptm180 -68.3 -34.0 75.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.9 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 5.8 m -61.22 95.88 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.947 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -178.28 65.56 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.119 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 11.0 tttm -157.78 84.59 0.89 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.013 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.408 ' O ' ' HB3' ' A' ' 93' ' ' LEU . 17.0 ttpt -136.1 130.64 33.67 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.635 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.44 ' CG1' ' O ' ' A' ' 91' ' ' ILE . 15.3 t -135.2 137.93 49.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.113 0.482 . . . . 0.0 111.894 -179.29 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . 0.608 ' HB2' ' HB ' ' A' ' 91' ' ' ILE . 15.5 m-90 -100.61 140.15 35.28 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.607 179.175 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.571 ' N ' ' HB2' ' A' ' 75' ' ' ASP . 7.8 m -125.78 127.41 46.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.544 0.687 . . . . 0.0 112.329 179.46 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.513 ' HD2' ' CD2' ' A' ' 89' ' ' PHE . 44.7 m-85 -101.03 118.57 37.25 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.114 -0.948 . . . . 0.0 108.927 177.808 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.591 ' HA2' ' O ' ' A' ' 85' ' ' SER . . . 160.0 -157.66 28.95 Favored Glycine 0 CA--C 1.503 -0.665 0 C-N-CA 119.117 -1.516 . . . . 0.0 112.419 179.499 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.409 ' N ' ' HA ' ' A' ' 86' ' ' ASN . 0.5 OUTLIER -76.74 92.17 3.54 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-O 122.554 1.168 . . . . 0.0 108.912 -179.712 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.524 ' O ' ' CD2' ' A' ' 77' ' ' HIS . 6.1 m-80 -149.59 155.19 38.76 Favored Pre-proline 0 C--N 1.308 -1.197 0 CA-C-N 112.809 -1.996 . . . . 0.0 108.259 178.72 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.551 ' O ' ' CB ' ' A' ' 73' ' ' ALA . 24.5 Cg_exo -55.79 -10.23 3.72 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 121.277 1.318 . . . . 0.0 111.278 177.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.603 ' HB1' ' HB2' ' A' ' 77' ' ' HIS . . . 135.99 52.23 0.0 OUTLIER 'General case' 0 CA--C 1.49 -1.336 0 CA-C-N 114.999 -1.0 . . . . 0.0 109.375 178.792 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . 0.545 ' HB3' ' HB ' ' A' ' 67' ' ' THR . 0.1 OUTLIER -52.97 -69.62 0.11 Allowed 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 105.867 -1.901 . . . . 0.0 105.867 179.524 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.571 ' HB2' ' N ' ' A' ' 67' ' ' THR . 40.1 t0 -94.93 -47.74 6.3 Favored 'General case' 0 N--CA 1.435 -1.211 0 N-CA-C 105.687 -1.968 . . . . 0.0 105.687 169.755 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.507 ' CZ ' ' HD2' ' A' ' 44' ' ' PRO . 33.0 t80 -145.01 142.7 30.01 Favored 'General case' 0 C--N 1.347 0.485 0 CA-C-N 112.573 -2.103 . . . . 0.0 111.473 179.366 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . 0.603 ' HB2' ' HB1' ' A' ' 73' ' ' ALA . 23.7 t-160 -93.79 107.28 19.19 Favored 'General case' 0 C--N 1.33 -0.249 0 O-C-N 122.014 -0.429 . . . . 0.0 109.968 176.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.426 ' HB3' ' CE1' ' A' ' 76' ' ' TYR . 3.8 pp -121.82 172.61 8.04 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 120.96 0.409 . . . . 0.0 111.645 -179.691 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -57.86 -172.65 0.3 Allowed Glycine 0 C--N 1.333 0.383 0 CA-C-N 115.916 -0.584 . . . . 0.0 112.595 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.425 ' HA ' ' OD1' ' A' ' 86' ' ' ASN . 0.3 OUTLIER -111.94 98.11 7.15 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -179.64 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.649 ' HB ' ' HB2' ' A' ' 85' ' ' SER . 16.7 mt -114.79 113.96 45.18 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.252 178.41 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 5.8 m -54.7 -24.12 20.6 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 112.587 0.588 . . . . 0.0 112.587 -178.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.58 -102.22 0.13 Allowed 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 -178.743 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.416 ' O ' ' CB ' ' A' ' 85' ' ' SER . 0.0 OUTLIER -109.23 110.45 21.66 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-O 121.682 0.753 . . . . 0.0 110.537 -179.391 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.649 ' HB2' ' HB ' ' A' ' 81' ' ' ILE . 0.5 OUTLIER 160.43 -46.84 0.0 OUTLIER 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 114.205 -1.362 . . . . 0.0 109.489 179.875 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.817 ' O ' ' N ' ' A' ' 88' ' ' HIS . 93.9 m-20 -64.8 -153.99 0.01 OUTLIER 'General case' 0 CA--C 1.521 -0.165 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 178.128 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.416 ' HA ' ' HA3' ' A' ' 69' ' ' GLY . 7.9 ptmt -49.31 73.44 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 179.099 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.971 ' O ' ' O ' ' A' ' 104' ' ' ILE . 31.2 t60 -95.67 -18.64 20.35 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 114.299 1.222 . . . . 0.0 114.299 -176.517 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.54 ' HA ' ' H ' ' A' ' 104' ' ' ILE . 0.2 OUTLIER -172.98 153.24 2.53 Favored 'General case' 0 C--N 1.31 -1.115 0 C-N-CA 119.014 -1.074 . . . . 0.0 112.489 178.063 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.49 ' O ' ' O ' ' A' ' 102' ' ' ASN . 20.1 mt-30 -134.1 159.23 41.48 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 114.38 -1.282 . . . . 0.0 113.483 -177.322 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.608 ' HB ' ' HB2' ' A' ' 66' ' ' TRP . 2.8 mt -124.71 131.88 72.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.113 -0.948 . . . . 0.0 110.213 179.013 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.45 ' N ' ' O ' ' A' ' 100' ' ' LEU . 0.3 OUTLIER -107.38 145.09 33.34 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.036 0.446 . . . . 0.0 111.935 -179.623 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.408 ' HB3' ' O ' ' A' ' 64' ' ' LYS . 0.3 OUTLIER -125.73 128.73 48.21 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.47 179.324 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 158.32 -146.94 14.06 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.46 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 62.67 71.68 0.52 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.909 0.385 . . . . 0.0 110.936 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 63.47 -80.41 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.028 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -150.02 29.27 1.12 Allowed Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.593 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -114.68 -170.8 1.81 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.715 0.293 . . . . 0.0 110.897 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 9.7 tt -131.0 156.69 44.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.893 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.615 ' HA ' ' O ' ' A' ' 122' ' ' GLN . 4.5 mp -133.4 149.25 51.82 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.53 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.472 ' O ' ' N ' ' A' ' 122' ' ' GLN . 4.9 mp -114.81 128.92 56.58 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.756 -0.378 . . . . 0.0 110.101 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.49 ' O ' ' O ' ' A' ' 90' ' ' GLN . 27.9 t30 -110.47 111.21 22.31 Favored 'General case' 0 CA--C 1.509 -0.619 0 C-N-CA 119.76 -0.776 . . . . 0.0 109.766 179.47 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.557 ' HB3' ' CG2' ' A' ' 109' ' ' THR . 83.7 m-20 -84.74 112.65 20.68 Favored 'General case' 0 N--CA 1.444 -0.772 0 C-N-CA 119.865 -0.734 . . . . 0.0 109.887 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.971 ' O ' ' O ' ' A' ' 88' ' ' HIS . 0.1 OUTLIER -122.91 107.5 19.44 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.925 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 177.473 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.413 ' OG ' ' NE2' ' A' ' 88' ' ' HIS . 55.7 m -134.79 164.53 27.34 Favored 'General case' 0 C--N 1.295 -1.797 0 CA-C-N 115.011 -0.995 . . . . 0.0 109.432 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 19.9 m -69.4 -62.69 1.28 Allowed 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 119.207 -0.997 . . . . 0.0 111.789 -178.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -111.79 -32.64 6.56 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 115.218 1.562 . . . . 0.0 115.218 179.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -146.18 127.64 2.83 Favored Glycine 0 C--N 1.339 0.747 0 N-CA-C 117.36 1.704 . . . . 0.0 117.36 -177.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.557 ' CG2' ' HB3' ' A' ' 103' ' ' ASP . 7.5 m -121.36 138.12 54.4 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 174.289 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . 0.694 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 3.4 m-90 -122.89 149.21 44.51 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 113.532 0.938 . . . . 0.0 113.532 -178.552 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -123.95 112.18 16.91 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 114.917 -1.038 . . . . 0.0 108.451 177.5 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 15.9 m-20 44.37 44.46 6.84 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.065 -0.516 . . . . 0.0 112.109 -179.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 79.89 26.4 56.02 Favored Glycine 0 N--CA 1.444 -0.792 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.779 179.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -138.62 96.8 3.21 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.079 0.466 . . . . 0.0 110.78 179.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.694 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.0 OUTLIER -44.37 129.08 6.48 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.964 179.806 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 27.6 m -115.91 -178.74 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.133 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.971 -178.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -91.61 142.23 27.86 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.086 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.428 ' HG3' ' HA ' ' A' ' 104' ' ' ILE . 49.1 tttm -63.72 162.35 13.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.27 179.381 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.406 ' N ' ' HG2' ' A' ' 118' ' ' LYS . 4.3 p30 34.58 39.13 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.268 0.556 . . . . 0.0 111.264 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 9.5 p -111.24 106.58 15.62 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.07 -179.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -54.68 143.6 24.53 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.64 179.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . 0.615 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 30.9 mm-40 -129.74 145.62 51.54 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.98 0.419 . . . . 0.0 112.005 -179.467 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.8 tt -72.87 121.33 19.82 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.526 178.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 12.1 tp -47.76 142.39 4.74 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-O 122.027 0.918 . . . . 0.0 112.186 -178.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' SER . . . . . 0.436 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.3 OUTLIER -127.51 152.62 47.35 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 113.895 -1.502 . . . . 0.0 110.05 179.191 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 11.3 mm100 -71.61 113.82 9.04 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.898 0.38 . . . . 0.0 110.024 179.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 64.61 31.67 81.67 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.512 -179.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.436 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 17.2 t70 -58.31 159.42 6.13 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.959 0.409 . . . . 0.0 111.195 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.47 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 3.0 tt0 -146.6 135.71 22.59 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.531 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.447 ' CG2' ' O ' ' A' ' 110' ' ' TRP . 1.3 mp -111.84 128.69 68.25 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.168 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.117 178.851 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.46 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 95.2 m -103.24 145.05 30.52 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.512 -179.687 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.459 ' HB ' ' NE2' ' A' ' 88' ' ' HIS . 4.3 m -141.09 158.27 22.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 -178.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 68.8 41.26 83.67 Favored Glycine 0 N--CA 1.448 -0.533 0 CA-C-N 115.776 -0.647 . . . . 0.0 112.553 179.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.47 ' HA ' HG12 ' A' ' 140' ' ' ILE . 98.6 t -76.45 157.33 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.625 0 CA-C-O 121.38 0.609 . . . . 0.0 112.012 -179.343 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 138.21 -43.46 1.19 Allowed Glycine 0 N--CA 1.441 -1.017 0 N-CA-C 110.36 -1.096 . . . . 0.0 110.36 -178.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 46.4 t -126.8 123.93 63.81 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.708 0 CA-C-N 115.022 -0.589 . . . . 0.0 109.63 178.423 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -51.05 -26.17 5.92 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.711 0.291 . . . . 0.0 111.355 -179.121 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 6.4 t -94.4 6.4 48.85 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 112.3 0.481 . . . . 0.0 112.3 -179.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -131.54 24.31 4.75 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 -179.243 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.47 HG12 ' HA ' ' A' ' 134' ' ' VAL . 23.6 mt -98.89 141.1 17.05 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.305 179.04 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 8.7 mp -119.98 135.07 55.05 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.83 -1.077 . . . . 0.0 109.805 179.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.417 ' O ' ' OG1' ' A' ' 40' ' ' THR . 46.6 t -114.54 151.84 32.72 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.836 0.827 . . . . 0.0 112.765 -178.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.47 ' O ' ' HA ' ' A' ' 129' ' ' GLU . 8.2 mt -136.18 129.76 32.17 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.554 -1.203 . . . . 0.0 109.251 178.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 21.4 t -124.09 140.95 45.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.917 0.389 . . . . 0.0 111.923 -178.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -112.31 140.23 33.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.832 179.558 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -118.99 108.64 15.0 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.704 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 1.9 mp -101.21 128.66 53.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.436 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 10.7 p30 -79.16 132.02 36.41 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.909 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -63.64 -21.36 66.33 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.128 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 2.1 mptm? -58.37 -44.35 88.82 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.967 0.413 . . . . 0.0 110.716 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 17.9 t80 -58.9 -44.49 91.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.82 179.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 4.0 mttt -63.94 -36.85 85.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.784 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -62.76 -37.43 86.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.82 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 11.4 t -60.97 -44.02 97.95 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.893 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -57.22 -38.9 74.45 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.93 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 12.9 tm-20 -59.69 -41.0 89.76 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.84 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 32.9 tt0 -72.59 -27.94 62.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.006 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -122.08 44.59 2.55 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.867 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.79 120.85 27.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.85 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 21.5 t -93.21 129.51 43.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.12 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -124.54 86.65 2.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.959 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.67 157.57 9.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.864 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 2.7 tt -78.63 127.58 38.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.142 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.248 1.003 0 CA-C-O 118.292 -0.861 . . . . 0.0 110.934 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.367 0 N-CA-C 112.519 -0.232 . . . . 0.0 112.519 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -100.34 -165.48 1.22 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.763 0.316 . . . . 0.0 110.808 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 7.4 m120 70.6 67.64 0.19 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.926 0.393 . . . . 0.0 110.86 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 6.0 pt -95.55 116.28 36.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.934 179.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 4.0 m 69.9 -66.91 0.25 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.926 -179.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 3.3 tp60 49.06 80.11 0.31 Allowed Pre-proline 0 C--N 1.331 -0.223 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.238 179.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -53.99 121.7 10.08 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.545 2.164 . . . . 0.0 112.314 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 5.5 t -99.04 151.37 21.02 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.064 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 8.8 mt-30 -100.32 69.56 1.47 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.945 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 36.4 tp60 -128.95 32.22 4.79 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.876 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.9 m -139.48 -64.19 0.5 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.967 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 73.6 p -74.52 77.75 1.95 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.112 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 61.7 mt-30 -102.3 38.2 1.73 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.94 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -124.76 113.39 17.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.03 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 4.9 m -124.93 -47.54 1.79 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.144 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -59.82 -41.94 92.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.998 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 19.0 mtt85 -71.48 -39.0 71.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.931 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 87.0 t80 -59.45 -39.8 84.75 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.929 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.95 -41.47 96.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.99 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 39.6 mm -64.77 -40.14 88.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.251 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -57.65 -46.93 83.56 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.992 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 10.6 ttpp -67.04 -35.63 80.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.86 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -65.78 -47.73 74.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.201 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -70.16 -43.8 70.1 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.999 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -142.38 137.12 30.24 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.085 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -95.6 158.64 15.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.758 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 12.0 mt-30 -106.25 101.59 11.06 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.898 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 22.7 mm -90.77 139.69 17.22 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.343 0 CA-C-O 121.458 0.647 . . . . 0.0 111.526 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.421 ' HA2' ' ND2' ' A' ' 148' ' ' ASN . . . -150.95 -43.47 0.02 OUTLIER Glycine 0 C--N 1.317 -0.483 0 CA-C-N 114.882 -1.054 . . . . 0.0 112.681 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -71.82 -22.83 61.5 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.656 0.265 . . . . 0.0 111.403 -179.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 68.0 m-20 -108.83 -13.29 14.79 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-O 121.886 0.851 . . . . 0.0 109.117 178.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.575 ' CG2' ' O ' ' A' ' 32' ' ' ILE . 0.1 OUTLIER -70.41 96.77 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.618 0 CA-C-N 114.11 -1.405 . . . . 0.0 110.844 -179.145 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.524 ' CG1' ' N ' ' A' ' 34' ' ' CYS . 0.9 OUTLIER -39.21 -61.5 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 114.54 -1.209 . . . . 0.0 112.651 -178.896 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.524 ' N ' ' CG1' ' A' ' 33' ' ' VAL . 49.6 t -162.93 162.85 26.38 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.853 0.359 . . . . 0.0 111.743 -178.795 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.425 ' HD3' ' CG2' ' A' ' 45' ' ' ILE . 1.8 ttm180 -128.93 115.37 17.73 Favored 'General case' 0 C--N 1.334 -0.104 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.678 179.817 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.458 ' CG2' ' CD2' ' A' ' 48' ' ' LEU . 92.4 t -89.07 129.64 39.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.559 179.858 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.49 ' CG2' HG12 ' A' ' 45' ' ' ILE . 29.0 mt -118.48 107.77 22.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 116.056 -0.52 . . . . 0.0 112.026 -179.309 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.494 ' HB2' ' O ' ' A' ' 43' ' ' ILE . 3.7 m -97.38 99.93 11.37 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 177.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 8.7 t -107.27 27.17 9.33 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 -178.097 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.464 ' CG2' ' HB2' ' A' ' 142' ' ' SER . 40.3 p -108.96 -3.31 17.61 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.761 0.315 . . . . 0.0 111.566 179.664 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 95.67 60.2 1.04 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.467 179.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -141.12 -60.58 0.49 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.762 0.315 . . . . 0.0 111.242 -179.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.494 ' O ' ' HB2' ' A' ' 38' ' ' CYS . 3.5 mp -135.24 132.36 20.04 Favored Pre-proline 0 N--CA 1.452 -0.339 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.371 -179.639 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.423 ' HD2' ' CZ ' ' A' ' 76' ' ' TYR . 24.1 Cg_exo -60.14 146.8 95.43 Favored 'Trans proline' 0 N--CA 1.463 -0.307 0 C-N-CA 122.214 1.943 . . . . 0.0 111.054 178.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.49 HG12 ' CG2' ' A' ' 37' ' ' ILE . 29.9 mt -50.72 122.55 2.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.948 0.404 . . . . 0.0 111.791 -179.165 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.421 ' HG3' ' CE2' ' A' ' 76' ' ' TYR . 0.0 OUTLIER -124.85 141.76 51.9 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.032 179.241 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -99.55 119.58 38.27 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.975 0.417 . . . . 0.0 111.689 -179.241 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.552 ' HB3' ' CE2' ' A' ' 66' ' ' TRP . 0.3 OUTLIER -89.63 136.47 33.02 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 178.48 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.603 ' O ' ' HZ2' ' A' ' 66' ' ' TRP . 0.0 OUTLIER -137.23 162.25 33.99 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 122.034 0.921 . . . . 0.0 113.398 -178.564 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.438 ' HB1' HG23 ' A' ' 33' ' ' VAL . . . -149.62 152.65 35.79 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 114.418 -1.265 . . . . 0.0 111.174 179.24 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.422 ' CB ' ' HG2' ' A' ' 54' ' ' GLN . 95.6 m-20 -80.27 111.26 16.48 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.121 -179.617 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.484 HG23 HD11 ' A' ' 52' ' ' ILE . 11.6 mt -64.01 -35.36 73.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.733 -179.826 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 7.3 t -56.78 -34.48 67.68 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.994 -179.121 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.422 ' HG2' ' CB ' ' A' ' 51' ' ' ASP . 10.3 mm-40 -65.76 -36.85 84.74 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.93 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 10.1 t -72.03 -37.94 62.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.149 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.2 tt -58.97 -37.52 76.97 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.8 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 5.7 mttt -91.23 -55.63 3.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.849 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 57.3 72.65 0.5 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.948 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.6 18.58 1.67 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.267 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 174.64 -55.92 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.859 0.361 . . . . 0.0 110.774 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -97.73 117.75 32.73 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.863 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -178.08 46.85 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.947 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -161.92 87.99 0.67 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.153 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.431 ' O ' ' HB3' ' A' ' 93' ' ' LEU . 2.1 ttpt -118.65 136.29 53.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.178 179.573 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.481 ' CG1' ' O ' ' A' ' 91' ' ' ILE . 14.1 t -136.26 135.91 49.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.143 0.497 . . . . 0.0 111.946 -179.215 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . 0.608 ' HB2' ' HB ' ' A' ' 91' ' ' ILE . 13.8 m-90 -99.74 140.06 34.49 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.59 179.052 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.604 ' N ' ' HB2' ' A' ' 75' ' ' ASP . 4.3 m -130.3 126.79 38.08 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.404 0.621 . . . . 0.0 112.403 179.504 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.471 ' CD2' ' CD2' ' A' ' 89' ' ' PHE . 88.5 m-85 -98.01 118.39 34.51 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.171 177.89 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.621 ' HA3' ' N ' ' A' ' 87' ' ' LYS . . . 160.33 -158.97 30.4 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 118.978 -1.582 . . . . 0.0 112.936 179.473 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.492 ' CD ' ' HB3' ' A' ' 86' ' ' ASN . 0.4 OUTLIER -76.84 91.75 3.56 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-O 122.55 1.167 . . . . 0.0 108.456 -179.888 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.493 ' O ' ' CD2' ' A' ' 77' ' ' HIS . 0.2 OUTLIER -149.83 160.78 33.16 Favored Pre-proline 0 C--N 1.308 -1.205 0 CA-C-N 112.755 -2.021 . . . . 0.0 108.027 179.326 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.559 ' O ' ' CB ' ' A' ' 73' ' ' ALA . 28.1 Cg_endo -63.14 -8.73 14.94 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 120.99 1.127 . . . . 0.0 111.439 178.697 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.621 ' HB2' ' HB2' ' A' ' 77' ' ' HIS . . . 135.98 51.85 0.0 OUTLIER 'General case' 0 CA--C 1.491 -1.309 0 CA-C-N 114.806 -1.088 . . . . 0.0 109.788 178.602 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . 0.536 ' HB3' ' HB ' ' A' ' 67' ' ' THR . 0.1 OUTLIER -52.88 -69.45 0.11 Allowed 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 105.838 -1.912 . . . . 0.0 105.838 179.328 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.604 ' HB2' ' N ' ' A' ' 67' ' ' THR . 7.5 t0 -94.63 -47.76 6.38 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 105.734 -1.951 . . . . 0.0 105.734 169.732 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.476 ' C ' ' HA ' ' A' ' 73' ' ' ALA . 1.7 t80 -145.37 141.65 28.66 Favored 'General case' 0 C--N 1.346 0.454 0 CA-C-N 112.717 -2.038 . . . . 0.0 112.35 -179.76 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . 0.621 ' HB2' ' HB2' ' A' ' 73' ' ' ALA . 23.5 t-160 -94.91 107.2 19.23 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 176.276 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -135.67 -176.24 4.22 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.001 0.429 . . . . 0.0 111.7 -179.386 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -60.92 163.31 20.39 Favored Glycine 0 N--CA 1.451 -0.339 0 CA-C-N 115.819 -0.628 . . . . 0.0 112.582 -179.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 12.8 p-10 -111.97 100.57 8.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.823 0.345 . . . . 0.0 111.553 -179.649 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.627 ' HB ' ' HB2' ' A' ' 85' ' ' SER . 12.4 mm -112.76 120.48 62.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 178.67 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 3.5 m -51.09 -23.92 3.54 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -177.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -83.66 -106.7 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 120.971 -0.291 . . . . 0.0 111.084 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -109.86 113.32 25.96 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-O 121.341 0.591 . . . . 0.0 109.598 179.236 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.627 ' HB2' ' HB ' ' A' ' 81' ' ' ILE . 1.5 m 166.6 -66.55 0.0 OUTLIER 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.041 -179.708 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.977 ' O ' ' N ' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -60.04 -166.18 0.01 OUTLIER 'General case' 0 CA--C 1.51 -0.575 0 N-CA-C 109.333 -0.618 . . . . 0.0 109.333 178.954 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.621 ' N ' ' HA3' ' A' ' 69' ' ' GLY . 2.8 mtmt -28.7 69.44 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 121.279 0.562 . . . . 0.0 109.704 -179.685 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.986 ' C ' ' O ' ' A' ' 104' ' ' ILE . 32.3 t60 -98.03 -17.44 19.15 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 113.559 0.948 . . . . 0.0 113.559 -176.765 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.56 ' HA ' ' H ' ' A' ' 104' ' ' ILE . 0.3 OUTLIER -173.08 153.33 2.5 Favored 'General case' 0 C--N 1.31 -1.135 0 C-N-CA 119.422 -0.911 . . . . 0.0 112.379 177.73 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.488 ' O ' ' O ' ' A' ' 102' ' ' ASN . 31.9 mt-30 -135.83 157.92 45.67 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.455 -1.248 . . . . 0.0 113.674 -177.42 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.608 ' HB ' ' HB2' ' A' ' 66' ' ' TRP . 9.9 mt -125.14 131.62 72.22 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 CA-C-N 114.955 -1.021 . . . . 0.0 109.711 178.496 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.404 ' N ' ' O ' ' A' ' 100' ' ' LEU . 0.2 OUTLIER -109.37 141.45 41.72 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.098 0.475 . . . . 0.0 112.154 -179.298 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.431 ' HB3' ' O ' ' A' ' 64' ' ' LYS . 6.4 tp -125.8 141.52 51.96 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.355 178.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 127.37 -135.89 9.01 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.542 179.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 58.74 80.09 0.2 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.815 0.341 . . . . 0.0 110.855 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 67.27 -72.68 0.09 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.956 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -172.94 54.52 0.16 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.421 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 32.1 m-20 -148.81 -174.88 4.74 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.825 0.345 . . . . 0.0 110.953 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.428 ' CD2' ' N ' ' A' ' 99' ' ' LEU . 0.3 OUTLIER -119.47 148.32 43.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.751 179.918 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.578 ' HA ' ' O ' ' A' ' 122' ' ' GLN . 0.4 OUTLIER -133.73 148.31 51.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.399 179.969 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.458 ' O ' ' N ' ' A' ' 122' ' ' GLN . 3.2 mp -114.82 131.33 56.86 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.978 -0.378 . . . . 0.0 109.978 179.855 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.488 ' O ' ' O ' ' A' ' 90' ' ' GLN . 23.4 t30 -113.16 111.32 21.89 Favored 'General case' 0 CA--C 1.511 -0.529 0 C-N-CA 119.851 -0.74 . . . . 0.0 110.032 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.573 ' HB3' ' CG2' ' A' ' 109' ' ' THR . 73.2 m-20 -84.37 112.17 20.1 Favored 'General case' 0 N--CA 1.444 -0.752 0 C-N-CA 119.738 -0.785 . . . . 0.0 109.641 179.519 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.986 ' O ' ' C ' ' A' ' 88' ' ' HIS . 0.1 OUTLIER -123.54 107.29 18.66 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.886 0 N-CA-C 108.752 -0.832 . . . . 0.0 108.752 177.614 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.421 ' OG ' ' NE2' ' A' ' 88' ' ' HIS . 67.3 m -129.72 169.14 15.48 Favored 'General case' 0 C--N 1.296 -1.74 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.435 179.617 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 23.7 m -69.35 -62.88 1.2 Allowed 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 119.121 -1.031 . . . . 0.0 111.281 -179.228 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -112.11 -33.09 6.35 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 114.658 1.355 . . . . 0.0 114.658 179.011 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -146.67 130.2 3.56 Favored Glycine 0 C--N 1.341 0.813 0 N-CA-C 116.97 1.548 . . . . 0.0 116.97 -177.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.573 ' CG2' ' HB3' ' A' ' 103' ' ' ASP . 5.6 m -121.18 138.32 54.26 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 174.396 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . 0.65 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.6 m-90 -120.48 149.22 42.74 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 -178.639 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -122.17 112.04 17.7 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 114.915 -1.039 . . . . 0.0 108.601 177.579 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 44.9 44.36 7.84 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.983 -0.553 . . . . 0.0 112.155 -179.524 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 79.79 21.62 65.7 Favored Glycine 0 N--CA 1.444 -0.794 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.786 179.345 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -133.4 98.75 4.32 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.928 0.394 . . . . 0.0 110.664 179.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.65 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.1 OUTLIER -43.23 122.43 2.53 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.034 179.804 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 12.6 p -113.78 160.49 13.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.688 -178.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -70.96 141.61 51.06 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.104 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.407 ' O ' ' C ' ' A' ' 119' ' ' ASN . 88.6 tttt -65.39 164.24 14.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.076 179.325 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.407 ' C ' ' O ' ' A' ' 118' ' ' LYS . 4.3 m-80 35.47 39.01 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.249 0.547 . . . . 0.0 110.938 -179.402 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.403 ' OG ' ' NE2' ' A' ' 122' ' ' GLN . 5.3 p -111.04 108.46 18.18 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.997 -179.365 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . 0.4 ' HB3' ' CD2' ' A' ' 100' ' ' LEU . 1.4 m-20 -58.59 140.59 54.11 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.737 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . 0.578 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 22.4 mm-40 -129.82 145.21 51.58 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-O 121.039 0.447 . . . . 0.0 112.137 -179.567 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 22.3 tp -72.58 117.94 14.88 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.44 178.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.442 ' CD2' HG12 ' A' ' 147' ' ' ILE . 29.9 tp -45.24 144.05 1.49 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.875 0.845 . . . . 0.0 112.081 -178.713 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -127.02 152.79 46.78 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 114.037 -1.438 . . . . 0.0 110.252 179.585 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.72 113.88 9.22 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 179.414 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 67.06 29.12 74.12 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.281 -179.379 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -54.57 160.53 1.76 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.925 0.393 . . . . 0.0 111.203 -179.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.459 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 2.4 tt0 -146.05 135.32 22.87 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.529 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.476 ' CD1' ' CE1' ' A' ' 89' ' ' PHE . 5.4 mt -115.05 128.61 72.15 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 116.285 -0.416 . . . . 0.0 109.976 179.007 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.447 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 7.7 m -103.21 143.74 32.24 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.83 -179.374 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.45 ' HB ' ' NE2' ' A' ' 88' ' ' HIS . 4.6 m -141.21 155.26 21.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.317 -0.401 . . . . 0.0 112.039 -179.013 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 72.14 38.1 59.46 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 121.126 -0.559 . . . . 0.0 112.4 179.282 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.445 ' HA ' HG12 ' A' ' 140' ' ' ILE . 96.1 t -72.88 156.26 6.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 121.499 0.666 . . . . 0.0 112.129 -179.276 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . 0.404 ' N ' ' CG1' ' A' ' 134' ' ' VAL . . . 153.26 -46.5 0.56 Allowed Glycine 0 N--CA 1.442 -0.96 0 CA-C-N 114.939 -1.028 . . . . 0.0 110.606 -179.234 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 46.7 t -126.78 135.83 62.56 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.65 0 CA-C-N 115.239 -0.48 . . . . 0.0 109.832 178.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.1 -35.13 33.6 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.818 0.342 . . . . 0.0 111.269 -179.337 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -94.04 6.14 49.47 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 116.273 -0.421 . . . . 0.0 112.13 -179.513 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -125.6 28.72 6.16 Favored 'General case' 0 CA--C 1.518 -0.261 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -179.398 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.447 ' CG2' ' CG2' ' A' ' 131' ' ' THR . 22.0 mt -105.29 141.28 20.99 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.373 179.342 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -114.85 135.0 54.67 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 114.906 -1.043 . . . . 0.0 109.92 179.344 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.464 ' HB2' ' CG2' ' A' ' 40' ' ' THR . 3.9 m -119.2 153.7 34.53 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.845 0.831 . . . . 0.0 112.48 -179.03 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.459 ' O ' ' HA ' ' A' ' 129' ' ' GLU . 13.7 mt -135.4 141.5 45.48 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.36 -1.291 . . . . 0.0 109.216 179.325 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 17.3 t -124.02 140.85 46.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.014 0.435 . . . . 0.0 112.123 -178.636 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -108.63 125.99 65.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.105 179.257 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 8.5 t80 -111.98 118.36 35.24 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.277 -179.419 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.459 ' CD1' ' N ' ' A' ' 147' ' ' ILE . 2.4 mp -95.34 134.57 32.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.655 179.628 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . 0.421 ' ND2' ' HA2' ' A' ' 29' ' ' GLY . 2.7 m120 -73.87 122.66 22.85 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.994 -179.765 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -60.38 -41.7 94.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.798 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.17 -43.28 87.36 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.677 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 24.1 t80 -60.84 -44.41 96.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.761 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 54.7 tttm -60.24 -34.6 73.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.833 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 15.3 tt0 -58.98 -45.3 90.93 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.792 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 9.7 t -64.33 -44.31 91.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.83 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -68.73 -38.44 80.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.806 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -58.38 -40.17 81.6 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.938 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -91.65 -28.55 17.41 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.894 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 2.7 p30 42.6 88.23 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.484 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 20.3 mtmm -61.24 136.2 57.98 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.894 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 27.6 m -102.9 123.34 56.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.151 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -66.6 139.75 57.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.892 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 1.3 mmm180 -98.4 -36.94 9.8 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.926 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 3.7 mp -92.75 120.47 42.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.114 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.201 -0.904 . . . . 0.0 110.918 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.319 0 N-CA-C 112.485 -0.246 . . . . 0.0 112.485 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -108.55 -174.61 2.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.906 0.384 . . . . 0.0 110.85 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -150.7 87.58 1.44 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.76 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 26.3 mt -144.36 47.82 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.151 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -93.76 -37.99 11.5 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.041 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -145.84 89.78 6.04 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.898 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -50.68 -53.45 7.12 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.579 2.186 . . . . 0.0 112.429 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 9.3 t -177.22 -176.24 0.63 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.246 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 14.6 mt-30 62.19 -89.99 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.045 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 45.43 32.44 1.07 Allowed 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 120.881 0.372 . . . . 0.0 111.329 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 59.7 p -62.13 -47.22 85.53 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.11 -179.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER 51.7 77.19 0.15 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.132 -179.849 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -86.63 -164.61 1.09 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.901 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 65.82 175.93 0.22 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.099 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 3.2 t -172.95 -45.25 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.078 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 15.3 mt-30 -65.89 -47.09 75.98 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.902 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -71.65 -37.58 70.8 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.81 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -61.66 -38.19 86.85 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.865 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -60.64 -42.99 98.07 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.897 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 33.0 mm -63.03 -42.63 97.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.163 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -57.68 -34.12 69.08 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.018 -179.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -63.65 -31.01 72.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.868 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -59.18 -47.64 84.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.158 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 2.4 m -56.55 -32.12 64.83 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.103 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -110.11 81.03 1.37 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.926 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -70.89 149.87 46.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.933 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -68.53 123.61 21.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.894 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 22.4 mm -82.69 139.61 17.56 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.358 0 CA-C-O 121.507 0.67 . . . . 0.0 111.648 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.433 ' CA ' ' HB ' ' A' ' 32' ' ' ILE . . . -87.93 66.85 3.27 Favored Glycine 0 C--N 1.318 -0.453 0 CA-C-N 114.875 -1.057 . . . . 0.0 112.578 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -67.95 -22.75 65.02 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.648 0.261 . . . . 0.0 111.414 -179.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 26.6 m120 -109.23 -13.56 14.63 Favored 'General case' 0 CA--C 1.514 -0.422 0 CA-C-O 121.933 0.873 . . . . 0.0 109.131 178.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.585 ' CG2' ' O ' ' A' ' 32' ' ' ILE . 0.1 OUTLIER -70.47 96.83 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.619 0 CA-C-N 114.103 -1.408 . . . . 0.0 111.183 -178.983 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.517 ' CG1' ' N ' ' A' ' 34' ' ' CYS . 0.9 OUTLIER -36.55 -60.77 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 CA-C-N 114.643 -1.162 . . . . 0.0 112.246 -179.403 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.517 ' N ' ' CG1' ' A' ' 33' ' ' VAL . 1.7 m -163.19 165.42 24.45 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.742 -179.466 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 2.3 tmm_? -134.27 114.78 13.39 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.159 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.435 ' CG2' ' CD2' ' A' ' 48' ' ' LEU . 48.2 t -91.38 122.0 42.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.508 179.313 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.472 ' N ' ' O ' ' A' ' 144' ' ' VAL . 34.1 mt -109.55 108.06 24.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.636 -179.847 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.527 ' HB2' ' O ' ' A' ' 43' ' ' ILE . 60.1 m -102.04 101.75 12.16 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 178.098 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 7.6 t -118.69 32.63 6.03 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -177.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.445 HG22 ' CB ' ' A' ' 142' ' ' SER . 34.8 p -112.45 15.89 20.05 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.976 0.417 . . . . 0.0 111.285 179.325 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 88.71 38.87 6.82 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.133 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -117.23 -76.21 0.57 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.663 0.268 . . . . 0.0 111.465 -179.591 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.527 ' O ' ' HB2' ' A' ' 38' ' ' CYS . 3.7 mp -135.18 141.59 38.55 Favored Pre-proline 0 N--CA 1.452 -0.348 0 CA-C-O 120.859 0.361 . . . . 0.0 111.527 -179.072 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.464 ' HD2' ' CZ ' ' A' ' 76' ' ' TYR . 25.6 Cg_exo -59.25 147.08 92.5 Favored 'Trans proline' 0 N--CA 1.465 -0.186 0 C-N-CA 122.338 2.025 . . . . 0.0 111.202 178.832 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.441 HG12 ' CG2' ' A' ' 37' ' ' ILE . 44.2 mt -43.38 128.6 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-O 121.046 0.451 . . . . 0.0 111.852 -179.401 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.27 130.38 52.66 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.255 179.58 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -100.83 119.72 39.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.021 0.439 . . . . 0.0 111.444 -179.54 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.577 ' HB3' ' CE2' ' A' ' 66' ' ' TRP . 0.2 OUTLIER -93.9 130.73 39.85 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.353 178.763 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.535 ' O ' ' HZ2' ' A' ' 66' ' ' TRP . 0.0 OUTLIER -133.41 161.66 33.93 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.972 0.891 . . . . 0.0 113.221 -178.809 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.468 ' HB1' HG23 ' A' ' 33' ' ' VAL . . . -156.87 141.94 17.17 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 114.441 -1.254 . . . . 0.0 110.937 179.017 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.418 ' CB ' ' HG3' ' A' ' 54' ' ' GLN . 0.2 OUTLIER -70.02 124.14 23.31 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.091 0.472 . . . . 0.0 111.231 -179.613 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 14.7 mt -63.69 -36.34 76.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 115.824 -0.626 . . . . 0.0 111.104 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.6 t -56.62 -34.28 67.08 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.899 -179.537 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.418 ' HG3' ' CB ' ' A' ' 51' ' ' ASP . 1.9 mt-30 -63.76 -37.72 88.42 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.67 -179.888 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 37.4 t -73.73 -46.6 46.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.149 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -59.45 -34.02 72.0 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.921 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.8 mmtp -89.54 -36.15 15.52 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.881 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 43.82 47.1 6.78 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.396 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 3.2 tmtm? -84.56 -67.72 0.77 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.009 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 6.2 ttp180 -160.42 51.12 0.29 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.884 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -158.43 29.46 0.24 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.96 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.3 tp -110.64 61.62 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.876 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 3.0 mttp -165.65 71.45 0.15 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.999 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -108.16 132.73 53.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.35 179.587 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.47 ' CG1' ' O ' ' A' ' 91' ' ' ILE . 6.9 t -127.35 135.47 63.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.182 0.515 . . . . 0.0 111.959 -179.058 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . 0.611 ' HB2' ' HB ' ' A' ' 91' ' ' ILE . 14.7 m-90 -99.25 139.97 34.11 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.786 179.179 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.579 ' O ' ' N ' ' A' ' 75' ' ' ASP . 32.0 m -131.43 131.42 43.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.571 0.7 . . . . 0.0 112.048 179.491 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.49 ' CD2' ' CD2' ' A' ' 89' ' ' PHE . 94.0 m-85 -102.68 118.98 38.03 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.023 -0.99 . . . . 0.0 109.148 177.851 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.56 ' HA2' ' O ' ' A' ' 85' ' ' SER . . . 158.64 -156.87 27.87 Favored Glycine 0 CA--C 1.501 -0.804 0 C-N-CA 118.962 -1.59 . . . . 0.0 112.709 179.638 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -75.62 91.65 2.88 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-O 122.615 1.198 . . . . 0.0 108.679 -179.669 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.511 ' O ' ' CD2' ' A' ' 77' ' ' HIS . 10.3 m120 -149.9 153.37 35.84 Favored Pre-proline 0 C--N 1.31 -1.119 0 CA-C-N 112.693 -2.049 . . . . 0.0 108.187 178.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.558 ' O ' ' HB2' ' A' ' 77' ' ' HIS . 26.6 Cg_exo -55.92 -10.84 4.57 Favored 'Trans proline' 0 N--CA 1.459 -0.525 0 C-N-CA 121.239 1.293 . . . . 0.0 111.318 178.101 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.591 ' HB3' ' HB2' ' A' ' 77' ' ' HIS . . . 137.99 52.03 0.0 OUTLIER 'General case' 0 CA--C 1.49 -1.365 0 CA-C-N 114.761 -1.109 . . . . 0.0 109.212 178.871 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . 0.504 ' HB3' ' HB ' ' A' ' 67' ' ' THR . 0.1 OUTLIER -52.55 -69.45 0.11 Allowed 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 105.783 -1.932 . . . . 0.0 105.783 179.689 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.579 ' N ' ' O ' ' A' ' 67' ' ' THR . 9.2 t0 -95.38 -47.73 6.17 Favored 'General case' 0 N--CA 1.435 -1.21 0 N-CA-C 105.671 -1.974 . . . . 0.0 105.671 169.513 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.497 ' C ' ' HA ' ' A' ' 73' ' ' ALA . 33.7 t80 -144.07 142.61 30.73 Favored 'General case' 0 C--N 1.347 0.5 0 CA-C-N 112.544 -2.116 . . . . 0.0 111.316 179.713 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . 0.591 ' HB2' ' HB3' ' A' ' 73' ' ' ALA . 23.6 t-160 -92.77 109.32 20.75 Favored 'General case' 0 C--N 1.33 -0.279 0 O-C-N 121.999 -0.438 . . . . 0.0 110.177 177.209 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.3 pp -123.45 175.28 6.85 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.911 0.386 . . . . 0.0 111.538 -179.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -62.92 -170.85 1.35 Allowed Glycine 0 C--N 1.332 0.313 0 C-N-CA 120.985 -0.626 . . . . 0.0 112.525 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -111.76 98.64 7.54 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 121.025 0.44 . . . . 0.0 111.68 -179.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.577 ' HB ' ' HB2' ' A' ' 85' ' ' SER . 3.2 mp -114.13 111.77 37.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.404 178.775 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 46.9 t -55.35 -24.25 28.33 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 -179.247 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.75 -109.53 0.07 Allowed 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 112.249 0.463 . . . . 0.0 112.249 -178.845 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.47 ' HB3' ' CE1' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -108.89 112.22 24.34 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-O 121.437 0.637 . . . . 0.0 109.666 179.87 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.577 ' HB2' ' HB ' ' A' ' 81' ' ' ILE . 0.6 OUTLIER 161.88 -45.11 0.0 OUTLIER 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 114.686 -1.143 . . . . 0.0 109.335 -179.628 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.858 ' O ' ' N ' ' A' ' 88' ' ' HIS . 97.1 m-20 -64.31 -149.47 0.01 OUTLIER 'General case' 0 CA--C 1.521 -0.138 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 177.726 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 9.3 mttt -49.47 72.34 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.073 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.977 ' C ' ' O ' ' A' ' 104' ' ' ILE . 32.8 t60 -90.89 -17.34 26.64 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 114.02 1.118 . . . . 0.0 114.02 -176.727 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.538 ' HA ' ' H ' ' A' ' 104' ' ' ILE . 0.5 OUTLIER -174.43 153.56 1.93 Allowed 'General case' 0 C--N 1.311 -1.089 0 C-N-CA 119.257 -0.977 . . . . 0.0 112.673 178.061 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.489 ' O ' ' O ' ' A' ' 102' ' ' ASN . 34.9 mt-30 -136.64 158.49 44.33 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.523 -1.217 . . . . 0.0 113.72 -177.624 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.611 ' HB ' ' HB2' ' A' ' 66' ' ' TRP . 10.6 mt -127.72 131.7 69.68 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 CA-C-N 114.868 -1.06 . . . . 0.0 109.896 178.725 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.507 ' HG ' ' HB2' ' A' ' 100' ' ' LEU . 0.5 OUTLIER -111.42 137.68 48.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.86 0.362 . . . . 0.0 110.945 -179.94 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.456 ' HG ' HG23 ' A' ' 33' ' ' VAL . 1.0 OUTLIER -124.06 129.14 50.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.779 179.789 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 136.63 -128.61 4.52 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.399 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 60.17 66.71 0.93 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.825 0.345 . . . . 0.0 110.775 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 49.1 m-20 62.6 32.39 16.41 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.848 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 79.55 78.1 0.89 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.497 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -167.82 177.92 5.49 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.795 0.331 . . . . 0.0 110.897 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -119.85 130.76 55.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.809 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.568 ' HA ' ' O ' ' A' ' 122' ' ' GLN . 3.8 mm? -127.39 148.05 50.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.284 179.845 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.47 ' O ' ' N ' ' A' ' 122' ' ' GLN . 52.5 mt -115.93 129.66 56.49 Favored 'General case' 0 CA--C 1.518 -0.287 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.11 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.489 ' O ' ' O ' ' A' ' 90' ' ' GLN . 26.7 t30 -113.26 111.25 21.72 Favored 'General case' 0 CA--C 1.509 -0.598 0 C-N-CA 119.804 -0.758 . . . . 0.0 109.877 179.803 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.575 ' HB3' ' CG2' ' A' ' 109' ' ' THR . 72.6 m-20 -83.57 112.24 19.82 Favored 'General case' 0 N--CA 1.442 -0.853 0 C-N-CA 119.827 -0.749 . . . . 0.0 109.619 179.664 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.977 ' O ' ' C ' ' A' ' 88' ' ' HIS . 0.1 OUTLIER -123.13 107.84 20.0 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.949 0 N-CA-C 108.928 -0.768 . . . . 0.0 108.928 177.745 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.417 ' OG ' ' NE2' ' A' ' 88' ' ' HIS . 71.9 m -128.93 169.6 14.44 Favored 'General case' 0 C--N 1.295 -1.793 0 CA-C-N 114.974 -1.012 . . . . 0.0 109.286 179.473 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 29.2 m -69.11 -62.68 1.28 Allowed 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 119.074 -1.05 . . . . 0.0 111.061 -179.356 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -111.86 -33.42 6.31 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 114.326 1.232 . . . . 0.0 114.326 178.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -147.05 131.69 4.05 Favored Glycine 0 C--N 1.341 0.813 0 N-CA-C 116.886 1.514 . . . . 0.0 116.886 -178.181 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.575 ' CG2' ' HB3' ' A' ' 103' ' ' ASP . 7.2 m -121.08 138.18 54.31 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 174.259 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . 0.727 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.4 m-90 -119.78 149.36 42.17 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 113.543 0.942 . . . . 0.0 113.543 -178.58 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -123.4 112.2 17.27 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 114.82 -1.082 . . . . 0.0 108.546 177.556 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 73.3 m-20 47.3 43.11 14.7 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.079 -0.509 . . . . 0.0 112.204 -179.496 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 84.06 -4.11 84.01 Favored Glycine 0 N--CA 1.445 -0.732 0 C-N-CA 120.759 -0.734 . . . . 0.0 113.25 179.168 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -111.47 102.3 10.67 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.917 0.389 . . . . 0.0 110.817 179.688 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.727 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.0 OUTLIER -44.01 136.49 3.72 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.939 179.846 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 14.9 p -124.35 163.39 24.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.693 -179.082 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 29.7 tp10 -70.1 141.84 52.69 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.019 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 63.4 tttm -68.59 162.7 25.3 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.407 179.654 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 4.1 p30 35.21 38.04 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.349 0.595 . . . . 0.0 111.404 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 6.7 p -111.39 109.79 19.94 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.018 -179.453 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 29.5 m120 -59.33 139.47 56.98 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.502 179.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . 0.568 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 48.9 mm-40 -129.7 148.53 51.6 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-O 121.072 0.463 . . . . 0.0 112.121 -179.357 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -72.31 112.08 8.07 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.456 179.172 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.434 ' CD2' HG12 ' A' ' 147' ' ' ILE . 7.8 tt -43.23 147.22 0.38 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.728 0.775 . . . . 0.0 112.246 -178.645 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -126.64 153.15 45.74 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 114.322 -1.308 . . . . 0.0 110.43 179.752 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.61 113.86 9.08 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 179.414 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 68.25 27.32 73.78 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.201 -179.153 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -53.41 161.22 1.01 Allowed 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.928 0.394 . . . . 0.0 111.319 -179.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -146.21 134.85 22.2 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.204 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.41 ' CG2' ' O ' ' A' ' 110' ' ' TRP . 3.7 mt -115.8 128.44 73.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 178.854 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.483 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 36.7 m -103.02 143.31 32.74 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.61 -179.742 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.47 ' HB ' ' NE2' ' A' ' 88' ' ' HIS . 6.3 m -140.75 158.21 23.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 -178.549 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 72.88 44.09 38.94 Favored Glycine 0 N--CA 1.445 -0.717 0 CA-C-N 115.679 -0.692 . . . . 0.0 112.275 179.39 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.469 ' HA ' HG12 ' A' ' 140' ' ' ILE . 85.4 t -81.64 153.94 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.616 0 CA-C-O 121.438 0.637 . . . . 0.0 112.161 -179.212 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 152.68 -43.48 0.65 Allowed Glycine 0 N--CA 1.441 -1.0 0 CA-C-N 114.932 -1.031 . . . . 0.0 110.564 -179.113 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 44.0 t -126.71 132.82 69.74 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.675 0 CA-C-N 115.137 -0.531 . . . . 0.0 109.714 178.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 37.3 tp10 -51.28 -34.59 33.59 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.761 0.315 . . . . 0.0 111.449 -179.169 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 48.2 t -94.34 6.52 48.46 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -179.413 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -126.13 29.64 5.81 Favored 'General case' 0 CA--C 1.52 -0.201 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -179.239 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.483 ' CG2' ' CG2' ' A' ' 131' ' ' THR . 11.8 mt -107.6 141.14 23.58 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.367 179.162 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 1.2 mp -123.07 134.79 54.24 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.164 -0.926 . . . . 0.0 110.315 179.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.445 ' CB ' HG22 ' A' ' 40' ' ' THR . 0.8 OUTLIER -112.73 154.67 25.81 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.958 0.885 . . . . 0.0 112.758 -179.087 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -130.12 144.05 51.13 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 114.047 -1.433 . . . . 0.0 109.192 179.34 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.472 ' O ' ' N ' ' A' ' 37' ' ' ILE . 21.9 t -124.31 140.97 46.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.933 0.396 . . . . 0.0 111.939 -178.903 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -109.86 132.2 58.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.712 179.538 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -118.2 125.27 49.84 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.69 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.434 HG12 ' CD2' ' A' ' 124' ' ' LEU . 3.9 mp -109.58 133.61 54.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.472 -179.647 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -78.62 117.95 20.27 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.957 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -65.15 -27.58 68.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.95 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.74 -46.01 90.44 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-O 121.065 0.459 . . . . 0.0 110.68 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 10.5 t80 -57.61 -44.48 85.51 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.008 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 4.8 mttm -61.38 -47.68 84.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.12 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 1.1 mm100 -58.96 -36.92 75.62 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.938 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 12.2 t -58.29 -44.67 88.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.963 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.26 -35.9 82.45 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.038 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -57.91 -48.39 80.03 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.0 -179.877 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 17.7 mm-40 -85.84 -30.5 22.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.933 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 4.1 p30 42.64 68.54 0.47 Allowed 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.416 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.06 134.07 47.85 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.816 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 6.3 m -71.69 120.39 19.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.032 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -126.77 -67.51 0.85 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.184 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 17.2 ttm180 61.23 119.49 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.884 0.373 . . . . 0.0 111.052 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 17.8 mt -104.66 128.46 58.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.044 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.239 -0.886 . . . . 0.0 110.934 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.355 0 N-CA-C 112.552 -0.219 . . . . 0.0 112.552 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -107.92 121.42 44.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.769 0.319 . . . . 0.0 110.95 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -107.0 -168.89 1.46 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.847 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.7 tt -106.59 17.04 6.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.397 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER 48.13 92.73 0.01 OUTLIER 'General case' 0 C--O 1.231 0.106 0 CA-C-O 120.834 0.349 . . . . 0.0 111.344 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -87.04 119.95 71.26 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.868 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -52.3 101.29 0.06 OUTLIER 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.406 2.071 . . . . 0.0 112.331 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.18 138.32 36.45 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.137 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 11.2 tm0? -83.15 -32.22 26.76 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.874 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 7.6 mt-30 -61.19 -27.59 68.53 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.04 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.2 m -55.9 105.77 0.21 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.993 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 69.5 p -108.16 76.16 1.03 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.167 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 2.6 tt0 -152.01 -176.75 5.78 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.816 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -75.96 105.75 7.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.183 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 6.0 t -148.46 -46.52 0.15 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.03 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 31.9 tt0 -72.78 -47.06 49.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.92 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.4 ttt85 -63.36 -40.12 96.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.945 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -60.52 -35.86 76.98 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.889 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -62.75 -37.22 85.74 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.991 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 32.5 mm -70.49 -42.57 78.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.164 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -57.6 -43.83 84.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.987 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.58 -35.34 80.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.895 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -59.24 -47.58 84.83 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.115 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.3 p -64.65 -44.14 91.37 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.897 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 12.8 tt0 -150.66 150.86 31.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.06 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 -97.77 159.39 14.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.811 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 2.0 mm-40 -64.41 101.8 0.47 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.956 0.408 . . . . 0.0 110.774 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.405 HG23 ' N ' ' A' ' 29' ' ' GLY . 17.9 mm -92.78 140.04 16.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.438 0.637 . . . . 0.0 111.861 -179.785 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.456 ' HA2' ' HB ' ' A' ' 32' ' ' ILE . . . -85.16 13.73 53.23 Favored Glycine 0 C--N 1.318 -0.427 0 CA-C-N 114.893 -1.049 . . . . 0.0 112.817 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -88.96 -21.76 23.39 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 111.795 0.295 . . . . 0.0 111.795 -179.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 18.2 m-80 -107.99 -12.92 15.07 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-O 121.883 0.849 . . . . 0.0 109.107 179.345 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.616 ' CG2' ' O ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -70.71 95.08 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.572 0 CA-C-N 113.961 -1.472 . . . . 0.0 111.198 -179.241 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.62 ' CG1' ' N ' ' A' ' 34' ' ' CYS . 0.4 OUTLIER -32.81 -61.13 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-N 114.706 -1.134 . . . . 0.0 112.286 -179.567 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.62 ' N ' ' CG1' ' A' ' 33' ' ' VAL . 20.9 p -165.11 164.83 20.25 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 112.516 0.561 . . . . 0.0 112.516 -179.47 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 2.8 ttm180 -119.44 125.15 48.26 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.62 179.47 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.5 m -92.96 124.39 45.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.896 0.379 . . . . 0.0 111.088 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.463 ' CG2' HG12 ' A' ' 45' ' ' ILE . 19.8 mt -132.27 108.6 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.911 -179.487 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.421 ' HB3' ' O ' ' A' ' 43' ' ' ILE . 38.9 t -78.9 127.77 32.45 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 178.291 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 48.4 p -110.77 28.65 8.49 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 112.576 0.584 . . . . 0.0 112.576 -178.442 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.435 ' OG1' ' O ' ' A' ' 142' ' ' SER . 0.0 OUTLIER -116.41 -37.41 3.75 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.778 0.323 . . . . 0.0 110.983 179.333 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 116.92 53.08 0.33 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.861 179.492 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -142.58 -42.71 0.32 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.612 0.244 . . . . 0.0 111.479 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.462 HG21 ' CD2' ' A' ' 76' ' ' TYR . 4.0 mp -115.04 138.96 23.74 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 120.779 0.323 . . . . 0.0 111.493 -179.385 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.489 ' CD ' ' CZ ' ' A' ' 76' ' ' TYR . 86.9 Cg_endo -82.43 146.79 13.92 Favored 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 122.76 2.307 . . . . 0.0 111.732 179.494 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.463 HG12 ' CG2' ' A' ' 37' ' ' ILE . 35.7 mt -53.2 111.86 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.995 0.426 . . . . 0.0 111.528 -179.688 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.17 144.0 44.36 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.84 179.297 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -103.36 119.65 39.28 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.052 0.453 . . . . 0.0 111.599 -179.409 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.486 ' HB3' ' CE2' ' A' ' 66' ' ' TRP . 0.3 OUTLIER -100.47 138.65 37.25 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 178.504 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.617 ' C ' ' HB ' ' A' ' 33' ' ' VAL . 42.5 t -127.48 -170.82 2.29 Favored 'General case' 0 CA--C 1.511 -0.538 0 CA-C-O 122.941 1.353 . . . . 0.0 113.916 -178.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.577 ' N ' ' OG ' ' A' ' 49' ' ' SER . . . -157.52 145.02 18.61 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 112.699 -2.046 . . . . 0.0 110.809 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.458 ' CB ' ' HG3' ' A' ' 54' ' ' GLN . 13.2 m-20 -84.7 86.6 7.31 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.116 0.484 . . . . 0.0 110.705 179.826 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.419 HD12 ' CE2' ' A' ' 151' ' ' PHE . 5.8 mt -57.98 -31.55 41.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.687 -179.67 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -57.01 -34.84 68.56 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.982 -179.195 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.458 ' HG3' ' CB ' ' A' ' 51' ' ' ASP . 2.7 mm-40 -67.6 -42.93 81.64 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.961 -179.746 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 22.4 t -74.27 -37.75 46.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.238 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -56.47 -33.26 65.76 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.967 0.413 . . . . 0.0 110.682 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 25.5 mmtt -105.81 -24.76 12.41 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.603 179.48 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.437 ' N ' ' O ' ' A' ' 54' ' ' GLN . 15.9 tp10 60.09 95.86 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.873 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 26.1 mtpp -150.68 -60.02 0.18 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.832 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.94 -175.58 4.56 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.914 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.8 t 57.33 84.06 0.1 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.951 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.5 tt -145.98 47.5 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.996 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -174.42 73.62 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.951 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 15.9 ttpt -113.29 131.48 55.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.693 179.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.478 ' CG1' ' O ' ' A' ' 91' ' ' ILE . 13.9 t -132.29 139.21 50.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.989 0.423 . . . . 0.0 111.696 -179.284 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . 0.609 ' HB2' ' HB ' ' A' ' 91' ' ' ILE . 17.3 m-90 -100.62 139.63 36.04 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.286 179.069 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.586 ' O ' ' N ' ' A' ' 75' ' ' ASP . 15.6 m -122.4 133.03 54.64 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.594 0.712 . . . . 0.0 112.286 179.829 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.518 ' CE1' ' CG ' ' A' ' 75' ' ' ASP . 10.8 m-85 -102.8 118.21 36.34 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.051 -0.977 . . . . 0.0 108.792 177.887 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.639 ' HA2' ' O ' ' A' ' 85' ' ' SER . . . 157.21 -153.92 25.09 Favored Glycine 0 CA--C 1.503 -0.663 0 C-N-CA 118.812 -1.661 . . . . 0.0 113.148 179.573 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.528 ' HB3' ' HA ' ' A' ' 80' ' ' ASN . 6.5 ptm180 -76.55 92.08 3.43 Favored 'General case' 0 N--CA 1.442 -0.861 0 CA-C-O 122.551 1.167 . . . . 0.0 108.985 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.491 ' O ' ' CD2' ' A' ' 77' ' ' HIS . 25.3 m-80 -149.72 159.99 34.93 Favored Pre-proline 0 C--N 1.308 -1.225 0 CA-C-N 112.806 -1.997 . . . . 0.0 108.261 178.857 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.545 ' O ' ' HB2' ' A' ' 77' ' ' HIS . 30.2 Cg_endo -63.89 -8.37 15.69 Favored 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 120.606 0.87 . . . . 0.0 110.434 177.407 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.574 ' HB1' ' HB2' ' A' ' 77' ' ' HIS . . . 137.28 53.32 0.0 OUTLIER 'General case' 0 CA--C 1.49 -1.345 0 CA-C-N 114.482 -1.235 . . . . 0.0 109.14 178.814 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . 0.536 ' HB3' ' HB ' ' A' ' 67' ' ' THR . 0.1 OUTLIER -52.96 -69.75 0.11 Allowed 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 105.859 -1.904 . . . . 0.0 105.859 179.713 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.586 ' N ' ' O ' ' A' ' 67' ' ' THR . 55.5 t0 -95.09 -47.73 6.25 Favored 'General case' 0 N--CA 1.435 -1.197 0 N-CA-C 105.526 -2.027 . . . . 0.0 105.526 169.59 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.5 ' C ' ' HA ' ' A' ' 73' ' ' ALA . 13.9 t80 -144.05 142.38 30.62 Favored 'General case' 0 C--N 1.346 0.441 0 CA-C-N 112.603 -2.089 . . . . 0.0 110.984 179.262 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . 0.574 ' HB2' ' HB1' ' A' ' 73' ' ' ALA . 23.8 t-160 -89.33 108.51 19.67 Favored 'General case' 0 C--N 1.328 -0.338 0 O-C-N 121.961 -0.462 . . . . 0.0 109.902 177.038 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.446 ' HB3' ' CE2' ' A' ' 76' ' ' TYR . 0.5 OUTLIER -132.8 175.43 9.35 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.931 0.396 . . . . 0.0 111.546 -179.615 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -57.06 161.56 8.0 Favored Glycine 0 C--N 1.332 0.309 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.406 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.528 ' HA ' ' HB3' ' A' ' 70' ' ' ARG . 3.6 p-10 -112.02 100.07 8.58 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.857 0.36 . . . . 0.0 111.79 -179.499 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.606 ' HB ' ' HB2' ' A' ' 85' ' ' SER . 14.2 mt -113.41 147.28 17.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.177 178.738 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.07 -24.27 67.41 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 -179.45 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.409 ' HB3' HD11 ' A' ' 84' ' ' LEU . 41.8 mtp180 -95.78 -98.31 0.17 Allowed 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 112.077 0.399 . . . . 0.0 112.077 -178.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.439 ' O ' ' CB ' ' A' ' 85' ' ' SER . 0.0 OUTLIER -108.46 110.71 22.3 Favored 'General case' 0 CA--C 1.512 -0.491 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 179.268 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.639 ' O ' ' HA2' ' A' ' 69' ' ' GLY . 0.5 OUTLIER 158.56 -35.95 0.0 OUTLIER 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 114.415 -1.266 . . . . 0.0 108.514 -179.068 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.783 ' O ' ' N ' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -66.17 -164.9 0.03 OUTLIER 'General case' 0 CA--C 1.507 -0.688 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 176.86 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.442 ' HA ' ' HA3' ' A' ' 69' ' ' GLY . 0.5 OUTLIER -55.52 70.39 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 177.411 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 1.061 ' O ' ' O ' ' A' ' 104' ' ' ILE . 44.6 t60 -73.3 -14.46 61.31 Favored 'General case' 0 CA--C 1.513 -0.449 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 -176.708 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.542 ' CD2' ' HA ' ' A' ' 103' ' ' ASP . 0.1 OUTLIER -177.67 159.81 1.49 Allowed 'General case' 0 C--N 1.313 -1.007 0 C-N-CA 119.577 -0.849 . . . . 0.0 112.101 178.423 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.492 ' N ' ' CD1' ' A' ' 89' ' ' PHE . 23.4 mt-30 -137.92 160.79 38.37 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 113.791 1.034 . . . . 0.0 113.791 -177.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.609 ' HB ' ' HB2' ' A' ' 66' ' ' TRP . 2.9 mt -122.81 132.02 72.12 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 CA-C-N 115.333 -0.848 . . . . 0.0 109.643 178.058 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.45 ' N ' ' O ' ' A' ' 100' ' ' LEU . 0.5 OUTLIER -106.69 142.79 35.76 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -179.391 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.426 ' HG ' HG23 ' A' ' 33' ' ' VAL . 0.2 OUTLIER -126.36 127.78 46.03 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.389 179.04 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 132.39 -121.56 3.02 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.6 -0.81 . . . . 0.0 112.801 179.647 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 70.55 -65.2 0.34 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.762 0.315 . . . . 0.0 110.868 -179.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 21.5 p-10 -167.74 54.98 0.07 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.909 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 72.45 27.21 70.06 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.508 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -135.42 -174.6 3.68 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.799 0.333 . . . . 0.0 110.954 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -113.73 146.95 39.1 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.909 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.66 ' HA ' ' O ' ' A' ' 122' ' ' GLN . 4.2 mp -133.8 149.06 51.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.294 179.819 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.452 ' O ' ' N ' ' A' ' 122' ' ' GLN . 1.1 mt -115.27 129.97 56.77 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 179.723 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.477 ' O ' ' O ' ' A' ' 90' ' ' GLN . 29.6 t30 -108.54 112.49 24.89 Favored 'General case' 0 CA--C 1.508 -0.636 0 C-N-CA 119.832 -0.747 . . . . 0.0 109.854 179.739 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.635 ' HB3' ' CG2' ' A' ' 109' ' ' THR . 44.3 m-20 -83.92 109.7 17.81 Favored 'General case' 0 N--CA 1.44 -0.926 0 C-N-CA 119.198 -1.001 . . . . 0.0 109.627 179.871 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 1.061 ' O ' ' O ' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -125.05 109.38 22.04 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.041 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 177.168 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.447 ' HB3' ' CE1' ' A' ' 88' ' ' HIS . 65.0 m -136.09 169.39 17.69 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.359 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 19.1 m -69.38 -63.34 1.09 Allowed 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 119.005 -1.078 . . . . 0.0 111.709 -179.009 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -112.29 -32.88 6.38 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 114.904 1.446 . . . . 0.0 114.904 179.301 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -146.03 131.49 4.13 Favored Glycine 0 C--N 1.34 0.759 0 N-CA-C 117.033 1.573 . . . . 0.0 117.033 -177.725 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.635 ' CG2' ' HB3' ' A' ' 103' ' ' ASP . 11.9 m -121.33 138.2 54.36 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 174.451 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . 0.699 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 3.1 m-90 -121.69 149.27 43.48 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 113.648 0.981 . . . . 0.0 113.648 -178.411 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -123.85 112.22 17.02 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 114.979 -1.009 . . . . 0.0 108.711 177.512 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 44.66 43.94 7.03 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.013 -0.54 . . . . 0.0 112.127 -179.566 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 80.8 22.81 60.95 Favored Glycine 0 N--CA 1.445 -0.732 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.801 179.308 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.46 97.77 3.77 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.013 0.435 . . . . 0.0 110.661 179.749 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.699 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.0 OUTLIER -43.99 127.04 5.19 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.98 179.919 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 6.1 m -112.41 179.96 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.907 -179.008 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -90.66 142.2 28.0 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.143 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.415 ' O ' ' C ' ' A' ' 119' ' ' ASN . 54.4 tttm -63.51 163.78 10.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.113 179.429 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.415 ' C ' ' O ' ' A' ' 118' ' ' LYS . 19.4 m-80 33.72 39.85 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 121.28 0.562 . . . . 0.0 111.167 -179.39 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 7.1 p -111.04 105.05 13.68 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.038 -179.429 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -53.58 144.59 17.06 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.571 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . 0.66 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 35.4 mm-40 -129.5 146.02 51.38 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-O 120.976 0.417 . . . . 0.0 111.754 -179.625 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -74.08 129.5 37.98 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.677 179.216 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -52.28 138.46 26.45 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-O 122.045 0.926 . . . . 0.0 111.587 -179.102 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' SER . . . . . 0.404 ' O ' ' CD1' ' A' ' 147' ' ' ILE . 0.6 OUTLIER -127.36 152.13 47.88 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 113.762 -1.563 . . . . 0.0 110.395 179.686 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 14.0 mm100 -71.33 113.9 8.85 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.911 0.386 . . . . 0.0 109.973 179.412 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 62.95 32.12 82.93 Favored Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.336 -179.399 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.403 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 9.3 t70 -53.78 159.24 1.7 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.97 0.414 . . . . 0.0 111.011 -179.837 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.49 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 30.4 tt0 -146.66 135.1 21.94 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.883 -0.598 . . . . 0.0 111.642 -179.838 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.435 ' CG2' ' O ' ' A' ' 110' ' ' TRP . 2.7 mp -116.03 129.0 73.14 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.045 178.597 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.456 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 12.9 m -102.75 145.41 29.78 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.884 0.373 . . . . 0.0 110.852 -179.266 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.494 ' HB ' ' NE2' ' A' ' 88' ' ' HIS . 5.8 m -141.2 158.39 22.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 112.327 0.491 . . . . 0.0 112.327 -179.113 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 67.17 43.03 90.75 Favored Glycine 0 N--CA 1.447 -0.601 0 CA-C-N 115.797 -0.638 . . . . 0.0 112.31 179.356 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.411 ' HA ' HG12 ' A' ' 140' ' ' ILE . 93.6 t -78.44 157.25 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.613 0 CA-C-O 121.36 0.6 . . . . 0.0 112.076 -179.146 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . 0.401 ' N ' ' CG1' ' A' ' 134' ' ' VAL . . . 149.0 -42.02 0.84 Allowed Glycine 0 N--CA 1.441 -1.012 0 N-CA-C 110.691 -0.964 . . . . 0.0 110.691 -179.193 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 48.1 t -126.6 131.33 71.36 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.715 0 CA-C-N 115.256 -0.472 . . . . 0.0 109.883 178.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.24 -33.9 30.04 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.772 0.32 . . . . 0.0 111.432 -179.247 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -94.31 6.5 48.48 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.214 0.45 . . . . 0.0 112.214 -179.397 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 12.0 t0 -127.74 30.92 5.23 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 112.648 0.61 . . . . 0.0 112.648 -179.259 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.456 ' CG2' ' CG2' ' A' ' 131' ' ' THR . 24.2 mt -105.53 141.11 21.6 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.978 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.353 179.238 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.4 ' HB2' ' CG2' ' A' ' 132' ' ' VAL . 2.8 mm? -116.49 135.92 53.42 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 114.938 -1.028 . . . . 0.0 110.358 179.822 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.435 ' O ' ' OG1' ' A' ' 40' ' ' THR . 43.5 t -120.96 152.59 38.35 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 -178.758 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.49 ' O ' ' HA ' ' A' ' 129' ' ' GLU . 3.3 tm? -135.41 136.99 41.83 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 114.841 -1.072 . . . . 0.0 109.21 179.04 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 43.0 t -130.12 140.21 49.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 120.955 0.407 . . . . 0.0 111.842 -178.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -111.41 126.44 68.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.612 179.493 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 15.5 t80 -106.08 108.63 20.24 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.687 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.404 ' CD1' ' O ' ' A' ' 125' ' ' SER . 1.7 mp -85.24 133.42 29.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.26 -179.797 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . 0.414 ' ND2' ' HB2' ' A' ' 151' ' ' PHE . 0.9 OUTLIER -83.77 116.52 22.74 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.798 179.841 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -58.08 -21.67 46.97 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.326 -179.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 4.7 mptt -57.54 -41.07 80.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.891 0.377 . . . . 0.0 110.717 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . 0.419 ' CE2' HD12 ' A' ' 52' ' ' ILE . 4.0 t80 -61.22 -44.56 97.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.76 179.781 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 8.0 tttt -59.48 -34.29 72.39 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.788 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -60.5 -43.73 96.72 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.918 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 10.6 t -62.46 -44.92 95.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.865 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.67 -38.13 83.87 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.81 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -59.37 -40.89 87.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.937 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 1.5 tp-100 -78.64 -31.79 47.02 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.871 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -124.99 68.97 1.12 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.896 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.29 134.31 42.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.858 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 14.0 p -77.55 133.65 30.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.171 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -175.95 149.6 0.93 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.951 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -89.7 99.69 12.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.889 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 38.5 mt -93.11 119.53 40.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.104 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.237 -0.887 . . . . 0.0 110.906 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.336 0 N-CA-C 112.513 -0.235 . . . . 0.0 112.513 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -122.23 -173.56 2.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.805 0.336 . . . . 0.0 110.832 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -97.08 27.52 4.04 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.022 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 21.4 mm -143.12 122.69 8.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.121 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 7.5 m -150.4 133.91 16.49 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.108 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -80.21 165.98 43.19 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.857 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -52.25 179.03 0.04 OUTLIER 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.588 2.192 . . . . 0.0 112.237 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -64.54 104.75 0.84 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.05 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -72.83 -35.63 67.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.918 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 62.24 149.43 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.824 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -97.65 -172.79 2.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.972 -179.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 16.2 p -107.89 -167.24 1.22 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.134 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 69.6 144.44 0.05 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.897 0.379 . . . . 0.0 111.013 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.51 -23.98 67.24 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.298 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER 77.83 -58.54 0.47 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.272 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 4.5 tp-100 -59.44 -33.35 71.16 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.901 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 6.3 mtt85 -62.55 -37.61 86.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.846 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 17.3 t80 -68.0 -35.84 78.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.838 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -61.18 -39.24 89.43 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.949 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 34.2 mm -67.88 -39.45 81.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.118 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -57.73 -39.92 78.4 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.036 -179.868 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.69 -32.73 73.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.903 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -60.49 -47.52 85.79 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.084 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 44.4 t -59.03 -38.89 80.38 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.94 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER 60.52 62.69 1.48 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.856 -179.924 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -101.05 128.61 47.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.952 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -81.25 115.18 20.52 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.888 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 23.7 mm -82.76 139.5 17.71 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.359 0 CA-C-O 121.482 0.658 . . . . 0.0 111.703 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.411 ' O ' ' ND2' ' A' ' 148' ' ' ASN . . . 152.84 41.95 0.02 OUTLIER Glycine 0 C--N 1.318 -0.436 0 CA-C-N 114.841 -1.072 . . . . 0.0 112.514 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -89.46 -22.72 22.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.668 0.27 . . . . 0.0 111.631 -179.73 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 27.3 m120 -108.54 -13.27 14.86 Favored 'General case' 0 CA--C 1.513 -0.476 0 CA-C-O 121.913 0.863 . . . . 0.0 109.35 179.282 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.529 ' CG2' ' O ' ' A' ' 32' ' ' ILE . 0.1 OUTLIER -70.6 104.13 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.54 0 CA-C-N 114.085 -1.416 . . . . 0.0 111.035 -179.353 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.603 ' CG1' ' N ' ' A' ' 34' ' ' CYS . 0.5 OUTLIER -37.5 -63.42 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 CA-C-N 115.133 -0.94 . . . . 0.0 112.037 -179.197 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.603 ' N ' ' CG1' ' A' ' 33' ' ' VAL . 18.8 p -164.83 164.73 20.94 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.363 -179.406 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.4 ' HD3' ' CG2' ' A' ' 45' ' ' ILE . 0.9 OUTLIER -127.38 123.64 36.68 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.858 0.361 . . . . 0.0 111.245 179.629 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.422 ' CG2' ' CD1' ' A' ' 48' ' ' LEU . 2.4 t -93.75 122.22 45.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.478 179.531 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.481 ' CG2' HG12 ' A' ' 45' ' ' ILE . 22.4 mt -121.86 107.94 21.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -179.231 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 8.4 m -85.02 100.64 11.81 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 177.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.6 t -85.81 -27.43 25.14 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -178.398 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.45 ' OG1' ' O ' ' A' ' 142' ' ' SER . 0.1 OUTLIER -52.08 -26.43 11.04 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.986 0.422 . . . . 0.0 111.016 -179.899 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 97.08 68.42 0.96 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.28 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 16.9 pt20 -142.42 -46.87 0.33 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.825 0.345 . . . . 0.0 111.204 -179.622 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.444 HG21 ' CE2' ' A' ' 76' ' ' TYR . 10.7 mt -132.31 133.84 24.24 Favored Pre-proline 0 N--CA 1.452 -0.351 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.161 -179.684 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.475 ' HD2' ' CZ ' ' A' ' 76' ' ' TYR . 29.4 Cg_exo -59.36 147.14 92.5 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.754 2.303 . . . . 0.0 111.728 179.501 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.481 HG12 ' CG2' ' A' ' 37' ' ' ILE . 52.6 mt -47.24 143.5 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.994 0.426 . . . . 0.0 111.851 -179.607 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.06 130.38 33.38 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.123 179.422 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -97.76 120.27 37.85 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.11 0.481 . . . . 0.0 111.512 -179.341 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.542 ' HB3' ' CE2' ' A' ' 66' ' ' TRP . 0.5 OUTLIER -96.78 125.18 41.05 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.393 179.032 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.499 ' O ' ' HZ2' ' A' ' 66' ' ' TRP . 0.0 OUTLIER -118.49 162.21 18.73 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 122.065 0.936 . . . . 0.0 113.274 -178.861 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.477 ' CB ' ' CG2' ' A' ' 33' ' ' VAL . . . -119.07 164.78 15.01 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.531 -1.213 . . . . 0.0 111.026 179.644 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.4 ' HB3' ' CG ' ' A' ' 54' ' ' GLN . 0.0 OUTLIER -116.06 71.24 0.77 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.021 0.439 . . . . 0.0 110.679 179.932 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.408 HD11 ' CE2' ' A' ' 151' ' ' PHE . 96.6 mt -63.83 -45.63 96.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.416 -179.803 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 11.2 t -66.17 -35.55 80.76 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.475 -179.274 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.4 ' CG ' ' HB3' ' A' ' 51' ' ' ASP . 42.6 mm-40 -67.94 -38.88 83.38 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.189 -179.535 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 21.8 t -66.38 -38.02 80.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.381 -179.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.2 tp -68.74 -29.82 68.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.266 -179.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.5 -34.05 13.54 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.064 -179.76 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 11.9 mm-40 -72.82 166.65 22.51 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.931 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -89.71 77.23 7.14 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.861 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 63.27 88.21 0.1 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.854 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 25.2 p -139.0 137.66 36.54 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.919 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -179.37 69.95 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.882 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.2 tptm -142.36 79.74 1.67 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.166 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 17.7 ttpt -124.83 131.57 53.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.599 179.385 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.469 ' CG1' ' O ' ' A' ' 91' ' ' ILE . 19.2 t -136.0 139.26 46.2 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 CA-C-O 121.211 0.529 . . . . 0.0 111.94 -179.172 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . 0.638 ' HB2' ' HB ' ' A' ' 91' ' ' ILE . 15.0 m-90 -100.11 139.97 35.02 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.443 179.138 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.529 ' HB ' ' HB3' ' A' ' 74' ' ' CYS . 26.1 m -130.79 132.54 45.33 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.527 0.68 . . . . 0.0 112.149 179.719 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.486 ' CE1' ' CG ' ' A' ' 75' ' ' ASP . 3.6 m-85 -105.96 119.04 38.18 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 114.873 -1.058 . . . . 0.0 109.348 178.298 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.629 ' HA2' ' O ' ' A' ' 85' ' ' SER . . . 160.71 -157.85 29.32 Favored Glycine 0 CA--C 1.505 -0.538 0 C-N-CA 118.658 -1.734 . . . . 0.0 113.286 178.802 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.609 ' HD2' ' ND2' ' A' ' 86' ' ' ASN . 5.1 ptm180 -75.94 91.76 3.07 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-O 122.629 1.204 . . . . 0.0 108.165 179.887 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.506 ' O ' ' CD2' ' A' ' 77' ' ' HIS . 0.2 OUTLIER -149.72 160.35 34.18 Favored Pre-proline 0 C--N 1.307 -1.263 0 CA-C-N 112.606 -2.088 . . . . 0.0 108.085 179.681 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.547 ' O ' ' CB ' ' A' ' 73' ' ' ALA . 30.1 Cg_endo -63.91 -8.74 16.69 Favored 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 120.84 1.027 . . . . 0.0 111.12 178.268 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.608 ' HB3' ' HB2' ' A' ' 77' ' ' HIS . . . 135.69 54.21 0.0 OUTLIER 'General case' 0 CA--C 1.49 -1.358 0 CA-C-N 114.706 -1.134 . . . . 0.0 109.361 178.724 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . 0.529 ' HB3' ' HB ' ' A' ' 67' ' ' THR . 0.1 OUTLIER -52.59 -69.73 0.11 Allowed 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 105.546 -2.02 . . . . 0.0 105.546 179.46 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.504 ' N ' ' O ' ' A' ' 67' ' ' THR . 13.8 t70 -95.51 -47.74 6.12 Favored 'General case' 0 N--CA 1.435 -1.202 0 N-CA-C 105.446 -2.057 . . . . 0.0 105.446 169.137 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.508 ' C ' ' HA ' ' A' ' 73' ' ' ALA . 67.3 t80 -142.96 142.21 31.6 Favored 'General case' 0 C--N 1.347 0.492 0 CA-C-N 112.627 -2.079 . . . . 0.0 111.465 179.756 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . 0.608 ' HB2' ' HB3' ' A' ' 73' ' ' ALA . 23.6 t-160 -91.65 111.64 23.24 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 177.079 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.477 ' HB3' ' CE2' ' A' ' 76' ' ' TYR . 0.5 OUTLIER -135.47 175.89 9.17 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.925 0.393 . . . . 0.0 111.604 -179.666 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -59.39 165.63 9.68 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.257 179.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -112.01 100.07 8.58 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.829 0.347 . . . . 0.0 111.76 -179.493 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.647 ' HB ' ' HB2' ' A' ' 85' ' ' SER . 19.1 mt -115.02 131.77 66.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 177.903 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.435 ' HA ' ' OD1' ' A' ' 86' ' ' ASN . 1.6 m -52.79 -24.01 8.03 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 111.789 0.292 . . . . 0.0 111.789 -178.779 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.409 ' HB3' HD12 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -93.05 -94.85 0.15 Allowed 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 120.428 0.156 . . . . 0.0 111.419 -179.943 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.435 ' O ' ' CB ' ' A' ' 85' ' ' SER . 0.0 OUTLIER -109.43 108.77 19.4 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 121.388 0.613 . . . . 0.0 109.402 178.918 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.647 ' HB2' ' HB ' ' A' ' 81' ' ' ILE . 1.8 m 158.7 -39.67 0.0 OUTLIER 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 114.589 -1.187 . . . . 0.0 109.369 -179.684 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.695 ' O ' ' N ' ' A' ' 88' ' ' HIS . 6.7 m120 -65.76 -163.01 0.02 OUTLIER 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 177.188 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.418 ' HA ' ' HA3' ' A' ' 69' ' ' GLY . 4.1 pttp -58.08 72.82 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 177.435 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.976 ' O ' ' O ' ' A' ' 104' ' ' ILE . 31.2 t60 -77.79 -19.5 54.92 Favored 'General case' 0 CA--C 1.515 -0.382 0 N-CA-C 114.315 1.228 . . . . 0.0 114.315 -176.437 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.478 ' CZ ' HD11 ' A' ' 91' ' ' ILE . 0.0 OUTLIER -173.7 156.86 2.99 Favored 'General case' 0 C--N 1.314 -0.97 0 C-N-CA 118.834 -1.146 . . . . 0.0 113.012 177.944 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.491 ' O ' ' O ' ' A' ' 102' ' ' ASN . 33.4 mt-30 -137.55 160.75 38.27 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 114.587 -1.188 . . . . 0.0 113.751 -177.861 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.638 ' HB ' ' HB2' ' A' ' 66' ' ' TRP . 3.5 mt -128.37 132.18 68.36 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 CA-C-N 115.076 -0.966 . . . . 0.0 109.49 178.486 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.439 ' N ' ' O ' ' A' ' 100' ' ' LEU . 0.3 OUTLIER -108.95 144.11 37.33 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.118 0.485 . . . . 0.0 112.219 -178.988 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.45 ' HG ' HG23 ' A' ' 33' ' ' VAL . 0.3 OUTLIER -125.88 129.95 50.36 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.477 179.409 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 136.47 100.68 0.59 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.509 179.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -176.88 -169.06 0.24 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.806 0.336 . . . . 0.0 110.768 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -68.4 73.05 0.22 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.716 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 60.23 29.92 69.73 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.327 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 -138.27 165.65 26.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.891 0.377 . . . . 0.0 111.051 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 6.6 mp -112.16 160.69 17.32 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.769 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.633 ' HA ' ' O ' ' A' ' 122' ' ' GLN . 3.6 mm? -122.54 147.96 45.76 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.336 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.46 ' O ' ' N ' ' A' ' 122' ' ' GLN . 3.5 mp -118.79 127.44 53.53 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 179.502 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.491 ' O ' ' O ' ' A' ' 90' ' ' GLN . 26.1 t30 -111.98 111.48 22.44 Favored 'General case' 0 CA--C 1.506 -0.736 0 C-N-CA 119.641 -0.824 . . . . 0.0 109.944 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.572 ' HB3' ' CG2' ' A' ' 109' ' ' THR . 81.6 m-20 -83.83 111.36 19.14 Favored 'General case' 0 N--CA 1.439 -1.016 0 C-N-CA 119.645 -0.822 . . . . 0.0 109.098 179.354 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.976 ' O ' ' O ' ' A' ' 88' ' ' HIS . 0.1 OUTLIER -122.8 107.74 20.0 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.073 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 177.964 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.437 ' OG ' ' NE2' ' A' ' 88' ' ' HIS . 59.1 m -133.89 169.12 17.56 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-N 114.86 -1.064 . . . . 0.0 109.187 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 20.0 m -69.44 -63.58 1.04 Allowed 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 119.04 -1.064 . . . . 0.0 111.689 -179.045 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -112.5 -32.45 6.47 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 114.858 1.429 . . . . 0.0 114.858 179.271 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -145.66 129.25 3.37 Favored Glycine 0 C--N 1.34 0.761 0 N-CA-C 117.151 1.62 . . . . 0.0 117.151 -177.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.572 ' CG2' ' HB3' ' A' ' 103' ' ' ASP . 6.8 m -121.61 138.54 54.28 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 174.392 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . 0.738 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.4 m-90 -119.46 149.23 42.22 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 -178.393 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -122.61 112.2 17.7 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 115.158 -0.928 . . . . 0.0 108.692 177.594 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 57.8 m-20 44.93 44.06 7.65 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.075 -0.511 . . . . 0.0 112.171 -179.595 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 79.02 23.71 63.19 Favored Glycine 0 N--CA 1.445 -0.745 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.787 179.362 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 -136.76 96.09 3.26 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.105 0.478 . . . . 0.0 110.752 179.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.738 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.0 OUTLIER -44.12 132.87 5.45 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.071 179.888 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 4.1 m -123.61 179.29 2.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.761 -179.184 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -82.95 139.34 33.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.971 180.0 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.437 ' O ' ' C ' ' A' ' 119' ' ' ASN . 9.3 tmtt? -63.03 167.78 4.58 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 179.312 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.437 ' C ' ' O ' ' A' ' 118' ' ' LYS . 3.7 p30 31.22 40.74 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.331 -179.664 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 5.2 p -110.97 107.66 17.15 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.059 -179.187 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . 0.415 ' ND2' ' CD1' ' A' ' 92' ' ' LEU . 1.5 m120 -56.54 140.46 46.3 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.436 179.741 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . 0.633 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 68.6 mm-40 -129.63 147.07 51.38 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-O 121.115 0.483 . . . . 0.0 112.042 -179.714 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 7.3 tp -72.62 119.92 17.52 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.384 -0.825 . . . . 0.0 109.759 179.147 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.4 ' CD1' HD13 ' A' ' 147' ' ' ILE . 2.3 tp -48.06 142.41 5.18 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-O 121.854 0.835 . . . . 0.0 111.825 -178.881 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' SER . . . . . 0.416 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.0 OUTLIER -127.19 152.62 47.13 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 114.146 -1.388 . . . . 0.0 110.557 179.739 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 1.2 tp60 -72.34 113.71 9.66 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 179.162 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 68.75 27.24 74.01 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.466 -179.486 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.416 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 8.3 t70 -56.03 159.96 3.05 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-O 120.895 0.378 . . . . 0.0 111.232 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.413 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 2.0 tt0 -146.74 135.4 22.13 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.756 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.457 ' CD1' ' CE1' ' A' ' 89' ' ' PHE . 7.0 mt -116.27 128.14 73.67 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 178.586 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.498 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 98.6 m -103.2 145.82 29.35 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.856 0.36 . . . . 0.0 110.788 -179.404 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.533 ' HB ' ' NE2' ' A' ' 88' ' ' HIS . 7.8 m -141.12 158.42 22.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -178.786 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 69.94 44.13 62.87 Favored Glycine 0 N--CA 1.448 -0.567 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.451 179.2 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.438 ' HA ' HG12 ' A' ' 140' ' ' ILE . 93.8 t -80.43 156.49 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 CA-C-O 121.434 0.635 . . . . 0.0 112.192 -179.242 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . 0.402 ' N ' ' CG1' ' A' ' 134' ' ' VAL . . . 149.62 -42.56 0.79 Allowed Glycine 0 N--CA 1.441 -0.972 0 N-CA-C 110.552 -1.019 . . . . 0.0 110.552 -179.129 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 51.9 t -126.85 131.95 70.53 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.69 0 CA-C-N 115.205 -0.497 . . . . 0.0 109.769 178.563 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -51.34 -34.52 34.05 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.725 0.298 . . . . 0.0 111.472 -179.266 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 13.9 m -94.3 6.51 48.44 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.416 0.524 . . . . 0.0 112.416 -179.36 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 18.2 t0 -126.51 30.37 5.57 Favored 'General case' 0 CA--C 1.519 -0.249 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -179.313 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.498 ' CG2' ' CG2' ' A' ' 131' ' ' THR . 14.7 mt -107.29 141.23 23.01 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.437 179.348 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 28.3 mt -119.82 135.23 54.95 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 114.902 -1.045 . . . . 0.0 109.916 179.554 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.45 ' O ' ' OG1' ' A' ' 40' ' ' THR . 47.3 t -116.92 151.89 35.69 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.912 0.863 . . . . 0.0 113.053 -178.806 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.413 ' O ' ' HA ' ' A' ' 129' ' ' GLU . 5.5 mp -128.42 129.54 46.31 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.547 -1.206 . . . . 0.0 109.312 179.145 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 10.6 t -115.37 140.45 36.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 120.892 0.377 . . . . 0.0 111.641 -179.179 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . 0.419 HG13 HG22 ' A' ' 36' ' ' VAL . 0.1 OUTLIER -116.23 126.26 73.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.766 179.957 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 9.8 t80 -109.62 121.89 46.22 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.782 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.4 HD13 ' CD1' ' A' ' 124' ' ' LEU . 5.9 mm -100.79 133.54 43.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.275 -179.835 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . 0.411 ' ND2' ' O ' ' A' ' 29' ' ' GLY . 7.9 p-10 -82.44 125.57 31.23 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.002 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -67.82 -22.66 65.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.024 179.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 9.8 mtmt -57.19 -40.23 76.95 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-O 120.939 0.399 . . . . 0.0 110.649 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . 0.408 ' CE2' HD11 ' A' ' 52' ' ' ILE . 19.5 t80 -60.57 -41.29 94.34 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.563 179.732 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 5.6 mttm -58.88 -35.48 73.08 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.717 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 5.0 mt-30 -68.45 -40.43 81.09 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.895 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 13.7 t -58.77 -45.73 89.12 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.824 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -68.44 -35.65 77.92 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.861 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -62.41 -36.87 83.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.992 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -92.13 -36.51 13.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.881 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 5.0 p30 42.71 32.82 0.41 Allowed 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.501 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -124.8 156.09 38.34 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.85 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 4.3 m -102.63 124.18 56.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.174 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -168.0 -169.4 1.13 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.791 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.58 36.46 3.55 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.901 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 24.3 mm -95.57 131.69 41.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.093 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.206 -0.902 . . . . 0.0 110.939 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.352 0 N-CA-C 112.486 -0.245 . . . . 0.0 112.486 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -69.76 121.19 16.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.745 0.307 . . . . 0.0 110.845 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -158.68 -70.43 0.09 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.867 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 18.7 pt -114.53 157.92 15.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.084 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 5.5 m -87.68 -21.61 25.14 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.359 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 64.5 mt-30 -52.88 157.33 2.82 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.02 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -65.75 173.03 7.33 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.567 2.178 . . . . 0.0 112.234 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -127.03 131.89 50.85 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.203 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -131.09 122.24 26.35 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.739 179.893 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 4.5 mm100 64.54 69.01 0.52 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.765 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -102.98 36.85 2.1 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.951 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 3.3 t -165.21 128.59 2.27 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.155 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 38.3 tt0 -72.41 114.45 10.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.963 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -169.71 44.82 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.096 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.3 -57.94 2.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.23 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 7.2 mt-30 -68.21 -41.72 80.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.86 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.2 mtp180 -70.54 -35.88 73.38 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.954 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 15.7 t80 -56.84 -44.72 82.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.27 -179.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.1 pp -58.61 -32.39 68.95 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.881 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 33.3 mm -72.76 -41.27 61.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.04 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -57.77 -46.77 84.09 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.051 -179.865 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.81 -34.3 77.51 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.769 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -65.37 -47.48 76.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.063 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.9 t -59.9 -30.95 69.37 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.907 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER 60.49 163.16 0.06 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.845 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -68.72 135.63 51.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.807 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 9.9 mt-30 -76.69 135.05 39.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.913 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 23.8 mm -82.22 139.61 17.64 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.316 0 CA-C-O 121.426 0.632 . . . . 0.0 111.509 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -103.84 73.14 0.27 Allowed Glycine 0 C--N 1.316 -0.56 0 CA-C-N 114.884 -1.053 . . . . 0.0 112.585 -179.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -84.31 -27.49 27.76 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.727 0.299 . . . . 0.0 110.888 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 10.7 m-20 -109.0 -13.95 14.63 Favored 'General case' 0 CA--C 1.516 -0.345 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 178.244 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.594 ' CG2' ' O ' ' A' ' 32' ' ' ILE . 0.1 OUTLIER -70.74 95.46 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.581 0 CA-C-N 113.908 -1.497 . . . . 0.0 110.473 -179.685 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.564 ' CG1' ' N ' ' A' ' 34' ' ' CYS . 0.8 OUTLIER -36.02 -63.08 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 114.813 -1.085 . . . . 0.0 112.593 -178.939 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.564 ' N ' ' CG1' ' A' ' 33' ' ' VAL . 98.3 m -154.31 164.8 38.03 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.152 0.501 . . . . 0.0 112.141 -179.009 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.19 114.84 20.82 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.264 179.241 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.7 m -88.98 126.93 42.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.663 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.446 ' CG2' HG12 ' A' ' 45' ' ' ILE . 26.3 mt -126.07 108.82 20.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 112.464 0.542 . . . . 0.0 112.464 -179.035 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -108.73 108.88 19.88 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 177.822 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.6 t -110.69 -23.22 11.19 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 -177.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.2 p -53.13 -25.21 12.5 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.917 0.389 . . . . 0.0 111.286 -179.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 119.98 47.74 0.34 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.494 179.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -120.06 -67.77 0.96 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.837 0.351 . . . . 0.0 110.886 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.475 ' CG2' ' CD1' ' A' ' 76' ' ' TYR . 0.6 OUTLIER -135.02 135.1 22.33 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.953 -179.804 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.44 ' HD2' ' CZ ' ' A' ' 76' ' ' TYR . 24.0 Cg_exo -59.37 147.69 89.99 Favored 'Trans proline' 0 C--N 1.342 0.234 0 C-N-CA 122.469 2.112 . . . . 0.0 111.563 179.451 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.446 HG12 ' CG2' ' A' ' 37' ' ' ILE . 32.8 mt -44.28 129.02 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.056 0.455 . . . . 0.0 111.99 -179.32 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.419 ' HB2' ' CD2' ' A' ' 76' ' ' TYR . 4.8 tpt180 -128.05 148.16 50.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.738 -0.664 . . . . 0.0 109.765 179.151 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -106.05 120.03 40.73 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.972 0.415 . . . . 0.0 111.797 -179.159 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.522 ' HB3' ' CE2' ' A' ' 66' ' ' TRP . 3.5 mt -93.64 131.84 38.56 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.282 178.716 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.527 ' O ' ' HZ2' ' A' ' 66' ' ' TRP . 0.0 OUTLIER -136.59 162.27 33.59 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 122.03 0.919 . . . . 0.0 113.406 -178.641 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.465 ' HB3' HG21 ' A' ' 33' ' ' VAL . . . -149.17 165.57 31.43 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.24 -1.346 . . . . 0.0 111.035 179.057 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.416 ' CB ' ' CG ' ' A' ' 54' ' ' GLN . 32.3 m-20 -91.57 121.16 33.0 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.051 0.453 . . . . 0.0 111.303 -179.678 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 72.0 mt -64.65 -45.18 96.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.788 -0.642 . . . . 0.0 112.077 -179.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -63.93 -38.06 89.7 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.093 0.473 . . . . 0.0 111.135 -178.806 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.416 ' CG ' ' CB ' ' A' ' 51' ' ' ASP . 55.2 mm-40 -68.55 -38.37 80.72 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.042 -179.751 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 32.6 t -73.63 -40.64 54.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.029 179.695 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 5.6 tp -59.06 -37.82 77.96 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.945 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 3.7 tttt -78.07 -38.83 43.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.786 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 44.54 44.92 7.53 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.346 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.3 -60.51 1.51 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.763 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 4.2 ptm180 -143.2 36.53 1.37 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.922 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 68.6 m -163.23 54.51 0.18 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.822 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 7.3 tp -139.43 71.92 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.915 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 60.3 tttt -172.85 75.71 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.961 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.424 ' O ' ' HB3' ' A' ' 93' ' ' LEU . 6.3 ttpt -115.18 134.1 55.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.462 179.791 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.469 ' CG1' ' O ' ' A' ' 91' ' ' ILE . 16.8 t -137.1 137.72 46.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.116 0.484 . . . . 0.0 111.647 -179.292 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . 0.655 ' HB2' ' HB ' ' A' ' 91' ' ' ILE . 14.5 m-90 -99.89 139.67 35.21 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.199 179.128 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.678 ' N ' ' HB2' ' A' ' 75' ' ' ASP . 8.8 m -127.57 129.63 47.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.505 0.669 . . . . 0.0 112.489 179.301 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.571 ' CE1' ' CG ' ' A' ' 75' ' ' ASP . 12.9 m-85 -100.91 118.49 37.05 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.14 -0.936 . . . . 0.0 108.961 177.735 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.622 ' HA2' ' O ' ' A' ' 85' ' ' SER . . . 160.46 -157.03 28.4 Favored Glycine 0 CA--C 1.505 -0.546 0 C-N-CA 119.045 -1.55 . . . . 0.0 113.057 179.236 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.41 ' O ' ' HG3' ' A' ' 70' ' ' ARG . 0.0 OUTLIER -76.78 92.42 3.59 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-O 122.663 1.22 . . . . 0.0 108.719 -179.685 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.502 ' O ' ' CD2' ' A' ' 77' ' ' HIS . 17.7 m-80 -149.42 159.45 36.58 Favored Pre-proline 0 C--N 1.306 -1.289 0 CA-C-N 112.68 -2.055 . . . . 0.0 108.06 179.15 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.544 ' O ' ' CB ' ' A' ' 73' ' ' ALA . 27.8 Cg_endo -63.61 -6.66 10.95 Favored 'Trans proline' 0 N--CA 1.452 -0.956 0 C-N-CA 120.64 0.893 . . . . 0.0 110.695 177.648 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.591 ' HB1' ' HB2' ' A' ' 77' ' ' HIS . . . 135.32 53.47 0.0 OUTLIER 'General case' 0 CA--C 1.491 -1.316 0 CA-C-N 114.447 -1.252 . . . . 0.0 109.227 178.814 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . 0.551 ' HB3' ' HB ' ' A' ' 67' ' ' THR . 0.1 OUTLIER -52.48 -69.88 0.1 Allowed 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 105.443 -2.058 . . . . 0.0 105.443 179.617 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.678 ' HB2' ' N ' ' A' ' 67' ' ' THR . 57.0 t0 -95.45 -47.47 6.26 Favored 'General case' 0 N--CA 1.434 -1.232 0 N-CA-C 105.504 -2.036 . . . . 0.0 105.504 169.05 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.491 ' C ' ' HA ' ' A' ' 73' ' ' ALA . 1.7 t80 -143.72 142.72 31.08 Favored 'General case' 0 C--N 1.348 0.512 0 CA-C-N 112.602 -2.09 . . . . 0.0 112.019 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . 0.591 ' HB2' ' HB1' ' A' ' 73' ' ' ALA . 23.3 t-160 -96.43 108.02 20.5 Favored 'General case' 0 C--N 1.331 -0.218 0 O-C-N 122.166 -0.334 . . . . 0.0 110.101 176.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.452 ' CD1' ' N ' ' A' ' 78' ' ' LEU . 0.0 OUTLIER -136.94 179.93 6.08 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.891 0.377 . . . . 0.0 111.677 -179.754 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -52.23 157.75 3.54 Favored Glycine 0 C--N 1.333 0.383 0 CA-C-N 115.983 -0.553 . . . . 0.0 112.854 -179.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 5.9 p-10 -111.93 99.9 8.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.811 0.339 . . . . 0.0 111.814 -179.561 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.627 ' HB ' ' HB2' ' A' ' 85' ' ' SER . 14.1 mm -114.26 129.97 69.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.237 -0.438 . . . . 0.0 109.845 178.336 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.448 ' HA ' ' ND2' ' A' ' 86' ' ' ASN . 80.3 p -53.02 -23.7 8.07 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.788 -179.082 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.408 ' HB3' HD12 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -93.97 -96.38 0.15 Allowed 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 111.669 0.248 . . . . 0.0 111.669 -179.509 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.463 ' O ' ' CB ' ' A' ' 85' ' ' SER . 0.0 OUTLIER -109.82 109.93 20.74 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-O 121.295 0.569 . . . . 0.0 109.84 179.324 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.627 ' HB2' ' HB ' ' A' ' 81' ' ' ILE . 0.4 OUTLIER 157.24 -41.26 0.0 OUTLIER 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 114.781 -1.099 . . . . 0.0 109.469 -179.942 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.761 ' O ' ' N ' ' A' ' 88' ' ' HIS . 91.1 m-20 -67.71 -156.19 0.02 OUTLIER 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 177.69 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.408 ' HB2' ' CD1' ' A' ' 104' ' ' ILE . 8.7 pttp -54.03 72.23 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 178.397 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 1.023 ' O ' ' O ' ' A' ' 104' ' ' ILE . 42.8 t60 -81.92 -16.13 51.59 Favored 'General case' 0 CA--C 1.514 -0.419 0 N-CA-C 113.888 1.07 . . . . 0.0 113.888 -176.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.583 ' CE1' HG13 ' A' ' 91' ' ' ILE . 0.0 OUTLIER -177.54 159.99 1.55 Allowed 'General case' 0 C--N 1.314 -0.95 0 C-N-CA 119.301 -0.96 . . . . 0.0 112.457 178.161 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.485 ' O ' ' O ' ' A' ' 102' ' ' ASN . 38.3 mt-30 -138.89 160.35 39.93 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 113.761 1.022 . . . . 0.0 113.761 -178.442 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.655 ' HB ' ' HB2' ' A' ' 66' ' ' TRP . 5.6 mt -124.57 131.54 72.58 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.345 177.714 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.447 ' N ' ' O ' ' A' ' 100' ' ' LEU . 0.2 OUTLIER -107.61 140.24 40.93 Favored 'General case' 0 N--CA 1.463 0.176 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 -179.129 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.519 ' HG ' HG21 ' A' ' 33' ' ' VAL . 0.3 OUTLIER -126.34 131.18 51.87 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.445 179.068 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.402 ' N ' ' CD2' ' A' ' 93' ' ' LEU . . . 133.41 -142.49 14.0 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.661 179.694 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 63.15 75.08 0.41 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.903 0.382 . . . . 0.0 110.77 -179.852 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 7.5 t0 59.04 39.88 22.82 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.912 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 65.06 71.46 0.87 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.442 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -156.56 165.75 35.39 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.778 0.323 . . . . 0.0 110.864 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -106.74 137.07 45.47 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.763 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.645 ' HA ' ' O ' ' A' ' 122' ' ' GLN . 3.8 mp -133.58 149.02 51.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.538 -179.794 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.458 ' O ' ' N ' ' A' ' 122' ' ' GLN . 0.5 OUTLIER -115.21 129.9 56.77 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 179.506 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.485 ' O ' ' O ' ' A' ' 90' ' ' GLN . 20.6 t30 -110.26 112.35 24.25 Favored 'General case' 0 CA--C 1.51 -0.588 0 C-N-CA 119.796 -0.762 . . . . 0.0 109.893 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.58 ' HB3' ' CG2' ' A' ' 109' ' ' THR . 87.0 m-20 -83.93 110.49 18.44 Favored 'General case' 0 N--CA 1.442 -0.848 0 C-N-CA 119.355 -0.938 . . . . 0.0 109.495 179.593 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 1.023 ' O ' ' O ' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -124.27 108.5 20.62 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.026 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 177.08 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.424 ' OG ' ' NE2' ' A' ' 88' ' ' HIS . 64.0 m -134.56 168.97 17.99 Favored 'General case' 0 C--N 1.296 -1.754 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.227 179.808 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 19.9 m -69.33 -63.14 1.12 Allowed 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 119.006 -1.078 . . . . 0.0 111.542 -179.042 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 63.9 m-80 -112.27 -32.39 6.54 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 114.934 1.457 . . . . 0.0 114.934 179.323 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -145.89 127.82 2.91 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 117.105 1.602 . . . . 0.0 117.105 -177.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.58 ' CG2' ' HB3' ' A' ' 103' ' ' ASP . 5.7 m -121.18 138.11 54.36 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 174.337 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . 0.716 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.8 m-90 -120.7 148.98 43.21 Favored 'General case' 0 CA--C 1.515 -0.384 0 N-CA-C 113.462 0.912 . . . . 0.0 113.462 -178.515 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -122.65 112.08 17.53 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 115.026 -0.988 . . . . 0.0 108.621 177.532 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 39.7 m-20 45.57 43.76 9.42 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.085 -0.507 . . . . 0.0 112.118 -179.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 78.88 25.05 60.82 Favored Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.784 179.425 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 31.2 mt-30 -136.98 97.51 3.53 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.102 0.477 . . . . 0.0 110.802 179.69 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.716 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.0 OUTLIER -45.66 132.61 8.44 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.911 179.755 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 27.7 m -124.07 -178.84 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 121.069 0.461 . . . . 0.0 111.916 -179.041 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -85.5 142.29 29.3 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.111 -179.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.409 ' HG2' ' N ' ' A' ' 119' ' ' ASN . 33.7 tttm -64.26 163.73 12.34 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.197 179.422 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.409 ' N ' ' HG2' ' A' ' 118' ' ' LYS . 8.2 m-80 34.56 39.91 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 121.182 0.515 . . . . 0.0 111.062 -179.374 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 3.5 p -110.74 107.2 16.66 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.901 -179.537 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -53.12 146.75 10.87 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.771 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . 0.645 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 80.7 mm-40 -129.28 152.11 49.2 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-O 121.149 0.499 . . . . 0.0 111.925 -179.514 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -81.02 122.52 27.41 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.571 -0.741 . . . . 0.0 109.531 179.031 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.529 ' O ' HD12 ' A' ' 124' ' ' LEU . 0.0 OUTLIER -48.45 139.44 9.05 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-O 122.365 1.078 . . . . 0.0 112.241 -178.672 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' SER . . . . . 0.411 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.3 OUTLIER -127.68 152.56 47.55 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 113.593 -1.64 . . . . 0.0 110.196 179.485 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 7.2 tp-100 -71.86 113.44 8.9 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 179.27 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 64.8 30.79 78.92 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.366 -179.564 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.411 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 29.8 t70 -53.74 160.5 1.34 Allowed 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.884 0.373 . . . . 0.0 111.077 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.485 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 0.1 OUTLIER -146.6 135.48 22.37 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.755 -179.898 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.447 ' CG2' ' O ' ' A' ' 110' ' ' TRP . 7.3 mm -113.68 128.72 70.43 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.124 0 CA-C-N 116.167 -0.47 . . . . 0.0 109.922 178.659 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.458 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 18.7 m -103.42 144.31 31.55 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.785 -179.392 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.471 ' HB ' ' NE2' ' A' ' 88' ' ' HIS . 5.6 m -141.19 156.1 21.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.005 0.431 . . . . 0.0 112.159 -179.068 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . 0.405 ' O ' ' O ' ' A' ' 139' ' ' ASP . . . 70.34 39.54 70.45 Favored Glycine 0 N--CA 1.448 -0.562 0 CA-C-N 115.914 -0.585 . . . . 0.0 112.463 179.396 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.421 ' HA ' HG12 ' A' ' 140' ' ' ILE . 90.2 t -74.39 156.86 6.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 121.447 0.641 . . . . 0.0 112.123 -179.247 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . 0.41 ' N ' ' CG1' ' A' ' 134' ' ' VAL . . . 152.99 -46.21 0.57 Allowed Glycine 0 N--CA 1.441 -1.0 0 CA-C-N 114.981 -1.008 . . . . 0.0 110.749 -179.285 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 42.7 t -126.59 133.9 67.55 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.722 0 CA-C-N 115.222 -0.489 . . . . 0.0 109.904 178.597 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -51.01 -32.44 21.27 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.89 0.376 . . . . 0.0 111.207 -179.353 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 46.7 m -94.39 6.22 49.39 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 116.164 -0.471 . . . . 0.0 112.132 -179.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . 0.405 ' O ' ' O ' ' A' ' 133' ' ' GLY . 25.4 t0 -128.34 30.26 5.21 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 -179.378 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.458 ' CG2' ' CG2' ' A' ' 131' ' ' THR . 27.5 mt -105.89 141.19 21.76 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.287 179.373 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 4.5 mt -116.79 135.27 53.88 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.869 -1.059 . . . . 0.0 110.291 179.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 29.8 t -120.31 152.42 37.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.694 0.759 . . . . 0.0 112.359 -179.17 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.485 ' O ' ' HA ' ' A' ' 129' ' ' GLU . 0.8 OUTLIER -135.7 131.28 35.44 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.625 -1.17 . . . . 0.0 108.992 179.357 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.453 ' N ' HD22 ' A' ' 143' ' ' LEU . 12.2 t -111.67 140.17 32.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.975 0.416 . . . . 0.0 111.908 -179.079 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -116.91 126.63 74.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.215 179.575 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 16.0 t80 -106.97 125.48 51.06 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.057 -179.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.47 HD13 HG22 ' A' ' 147' ' ' ILE . 4.1 mm -103.53 133.3 47.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.999 -179.931 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 35.5 p-10 -84.77 111.25 19.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.861 0.362 . . . . 0.0 110.718 179.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -56.28 -27.34 54.96 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.153 -179.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 2.2 tptt -57.2 -36.34 70.72 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.807 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -66.32 -41.88 89.05 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.777 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -62.05 -49.81 74.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.948 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 6.5 tm0? -59.22 -38.29 79.59 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.885 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 10.2 t -65.88 -45.15 83.15 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.886 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -68.64 -37.69 79.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.768 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -60.05 -39.83 87.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.876 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -86.43 -36.13 19.29 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.791 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 3.9 p30 42.6 90.76 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.466 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 13.8 pttp -75.37 117.72 17.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.975 -179.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 14.3 t -91.53 132.49 35.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.01 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 24.0 p-10 -91.48 -31.8 15.83 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.043 -179.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 33.3 ttm180 -70.47 -77.96 0.08 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.942 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 16.9 pt -106.01 136.05 41.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.136 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 4.0 ppt_? . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.189 -0.91 . . . . 0.0 111.015 179.946 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.325 0 N-CA-C 112.502 -0.239 . . . . 0.0 112.502 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 6.2 pm0 -60.35 143.49 52.93 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.851 0.357 . . . . 0.0 110.936 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -124.52 42.32 3.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.748 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.0 mp 63.12 83.19 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.099 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -115.68 178.64 4.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.115 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 2.3 pm0 -112.38 90.84 15.09 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.835 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -68.01 122.94 10.08 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.511 2.14 . . . . 0.0 112.329 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.6 m 64.27 139.03 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.059 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 2.8 tp60 -122.57 33.7 5.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.943 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -145.47 141.79 28.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.924 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -171.47 86.23 0.09 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.907 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 23.4 m -161.33 -61.38 0.05 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.132 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -165.55 175.34 9.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.896 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 61.66 71.07 0.56 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.14 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 27.6 m -159.05 -70.0 0.08 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.097 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 4.3 mp0 -72.79 -45.4 58.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.878 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 23.1 ttt180 -61.3 -42.63 98.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.858 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 15.4 t80 -58.53 -38.91 78.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.997 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -62.37 -34.5 76.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.833 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 41.6 mm -73.05 -39.47 57.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.173 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.5 tm-20 -57.72 -46.49 84.33 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.139 -179.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 16.9 mmtm -60.68 -29.06 69.08 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.987 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -63.4 -47.65 81.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.208 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 85.7 p -58.44 -33.78 70.09 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.054 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -58.99 -31.54 68.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.922 -179.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -97.74 136.51 37.98 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.88 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -95.96 103.49 15.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.862 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 19.7 mm -83.47 139.27 17.94 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.333 0 CA-C-O 121.521 0.677 . . . . 0.0 111.624 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.402 ' HA2' ' HB ' ' A' ' 32' ' ' ILE . . . -97.21 12.64 65.21 Favored Glycine 0 C--N 1.318 -0.469 0 CA-C-N 114.845 -1.07 . . . . 0.0 112.759 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -88.98 -23.78 22.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.643 0.258 . . . . 0.0 111.508 -179.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 26.0 m-80 -109.56 -14.69 14.34 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-O 121.909 0.862 . . . . 0.0 109.28 178.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.449 ' O ' ' CG2' ' A' ' 32' ' ' ILE . 0.1 OUTLIER -74.1 111.14 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.571 0 CA-C-N 114.129 -1.396 . . . . 0.0 111.23 -179.168 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.589 ' CG1' ' N ' ' A' ' 34' ' ' CYS . 0.5 OUTLIER -45.02 -64.12 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.211 -0.904 . . . . 0.0 111.381 -179.488 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.589 ' N ' ' CG1' ' A' ' 33' ' ' VAL . 30.2 p -165.4 164.93 19.61 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.039 0.447 . . . . 0.0 112.046 -179.644 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -124.39 117.63 24.89 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.598 179.38 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.428 ' CG2' ' CD2' ' A' ' 48' ' ' LEU . 89.3 t -89.16 132.57 33.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.112 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.47 ' CG2' HG12 ' A' ' 45' ' ' ILE . 22.6 mt -129.86 108.14 15.84 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.693 -179.745 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.406 ' HB3' ' O ' ' A' ' 43' ' ' ILE . 2.5 t -86.66 105.98 17.29 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 178.18 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 11.4 t -90.71 -26.76 19.38 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 -178.41 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.406 HG21 ' HB3' ' A' ' 142' ' ' SER . 26.1 p -59.64 -21.99 61.24 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 121.047 -0.261 . . . . 0.0 111.422 -179.429 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 103.65 72.39 0.9 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.571 -0.823 . . . . 0.0 113.033 179.384 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.411 ' NE2' ' HB3' ' A' ' 141' ' ' LEU . 0.0 OUTLIER -151.1 -70.62 0.17 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.859 0.361 . . . . 0.0 110.941 179.534 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.486 HG21 ' CD2' ' A' ' 76' ' ' TYR . 16.7 mt -102.56 140.33 21.0 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.2 -179.565 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.478 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 74.3 Cg_endo -77.6 146.76 24.41 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 122.337 2.025 . . . . 0.0 111.724 179.566 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.47 HG12 ' CG2' ' A' ' 37' ' ' ILE . 35.5 mt -44.12 108.67 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.056 0.455 . . . . 0.0 111.779 -179.499 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.24 129.8 56.73 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.761 179.132 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -96.4 119.38 34.78 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.986 0.422 . . . . 0.0 111.429 -179.305 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.503 ' HB3' ' CE2' ' A' ' 66' ' ' TRP . 0.2 OUTLIER -96.36 131.98 42.34 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 178.543 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.559 ' O ' ' CZ2' ' A' ' 66' ' ' TRP . 0.1 OUTLIER -113.15 164.02 14.03 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.84 0.828 . . . . 0.0 112.608 -178.598 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.514 ' CB ' ' CG2' ' A' ' 33' ' ' VAL . . . -111.46 166.42 11.14 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 114.915 -1.039 . . . . 0.0 110.864 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.4 ' HB3' ' CG ' ' A' ' 54' ' ' GLN . 0.0 OUTLIER -93.56 46.13 1.18 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.946 0.403 . . . . 0.0 110.942 179.919 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 14.1 mm -57.02 -40.59 73.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.099 0.476 . . . . 0.0 110.664 179.614 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -67.25 -38.45 85.17 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.968 -179.763 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.4 ' CG ' ' HB3' ' A' ' 51' ' ' ASP . 1.4 mm-40 -67.99 -41.71 81.89 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.92 -179.765 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 39.1 t -64.08 -38.02 81.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.85 179.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.11 -25.82 64.59 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.936 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -93.45 -54.14 3.79 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.15 -179.795 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.58 -178.42 3.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.077 -179.763 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 8.9 pttt -100.11 -31.89 11.19 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.88 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 16.0 mtm180 -111.39 112.36 24.06 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.834 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -166.83 33.03 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.788 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 39.7 mm -117.47 91.07 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.017 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.5 ttpt -179.27 68.49 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.776 179.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.415 ' O ' ' HB3' ' A' ' 93' ' ' LEU . 7.9 ttpt -126.92 131.21 51.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.685 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.427 ' CG1' ' O ' ' A' ' 91' ' ' ILE . 10.7 t -134.86 136.33 52.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 121.037 0.446 . . . . 0.0 111.588 -179.494 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . 0.611 ' HB2' ' HB ' ' A' ' 91' ' ' ILE . 16.0 m-90 -102.07 140.06 36.86 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.057 179.599 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.595 ' O ' ' N ' ' A' ' 75' ' ' ASP . 3.1 m -127.58 129.81 47.95 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.435 0.635 . . . . 0.0 112.14 179.51 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.477 ' CD2' ' CE2' ' A' ' 89' ' ' PHE . 64.7 m-85 -101.77 118.38 36.81 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.322 178.192 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.591 ' HA2' ' O ' ' A' ' 85' ' ' SER . . . 159.33 -157.6 28.72 Favored Glycine 0 CA--C 1.502 -0.755 0 C-N-CA 119.034 -1.555 . . . . 0.0 112.192 179.328 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.425 ' CD ' ' HB3' ' A' ' 86' ' ' ASN . 11.7 ptm180 -76.75 91.81 3.52 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-O 122.424 1.106 . . . . 0.0 108.297 179.538 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.542 ' O ' ' CD2' ' A' ' 77' ' ' HIS . 6.3 m120 -149.08 154.63 39.63 Favored Pre-proline 0 C--N 1.311 -1.068 0 CA-C-N 112.985 -1.916 . . . . 0.0 108.506 179.269 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.572 ' O ' ' HB2' ' A' ' 77' ' ' HIS . 25.7 Cg_exo -56.1 -11.56 5.97 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 121.507 1.472 . . . . 0.0 111.571 178.45 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.637 ' HB2' ' HB2' ' A' ' 77' ' ' HIS . . . 137.27 50.97 0.0 OUTLIER 'General case' 0 CA--C 1.49 -1.336 0 CA-C-N 114.96 -1.018 . . . . 0.0 109.605 178.791 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . 0.556 ' HB3' ' HB ' ' A' ' 67' ' ' THR . 0.1 OUTLIER -52.92 -69.9 0.1 Allowed 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 105.858 -1.904 . . . . 0.0 105.858 179.485 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.595 ' N ' ' O ' ' A' ' 67' ' ' THR . 12.2 t0 -94.78 -47.4 6.49 Favored 'General case' 0 N--CA 1.437 -1.112 0 N-CA-C 105.89 -1.893 . . . . 0.0 105.89 169.806 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.505 ' C ' ' HA ' ' A' ' 73' ' ' ALA . 35.6 t80 -144.21 142.56 30.59 Favored 'General case' 0 C--N 1.347 0.473 0 CA-C-N 112.576 -2.102 . . . . 0.0 110.951 179.658 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . 0.637 ' HB2' ' HB2' ' A' ' 73' ' ' ALA . 23.3 t-160 -93.0 108.38 19.96 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 118.12 0.418 . . . . 0.0 110.442 177.323 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.495 ' HB3' ' CE2' ' A' ' 76' ' ' TYR . 2.2 pp -125.66 168.48 13.67 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.784 0.326 . . . . 0.0 111.103 179.698 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -53.91 173.05 0.63 Allowed Glycine 0 C--N 1.33 0.209 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.777 -179.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 12.8 p-10 -96.05 105.36 17.39 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.725 0.298 . . . . 0.0 110.965 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.469 ' CB ' ' HB2' ' A' ' 85' ' ' SER . 2.0 mp -111.53 152.65 13.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.772 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.23 -45.27 73.74 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 113.61 0.967 . . . . 0.0 113.61 -178.767 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 17.9 mtt180 -119.72 -91.16 0.56 Allowed 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 113.692 0.997 . . . . 0.0 113.692 -177.328 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.493 ' O ' ' CB ' ' A' ' 85' ' ' SER . 0.0 OUTLIER -84.9 103.26 13.8 Favored 'General case' 0 CA--C 1.507 -0.704 0 CA-C-O 121.948 0.88 . . . . 0.0 110.74 -178.606 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.591 ' O ' ' HA2' ' A' ' 69' ' ' GLY . 0.4 OUTLIER 148.62 -35.42 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 113.113 -1.858 . . . . 0.0 108.718 -179.745 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.792 ' O ' ' N ' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -68.44 -162.39 0.03 OUTLIER 'General case' 0 CA--C 1.514 -0.43 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 177.6 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.527 ' HA ' ' HA3' ' A' ' 69' ' ' GLY . 1.0 OUTLIER -53.14 72.18 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 177.822 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.959 ' O ' ' O ' ' A' ' 104' ' ' ILE . 29.6 t60 -83.73 -18.91 36.26 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 114.642 1.349 . . . . 0.0 114.642 -175.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.53 ' HA ' ' H ' ' A' ' 104' ' ' ILE . 0.0 OUTLIER -171.06 156.98 5.02 Favored 'General case' 0 C--N 1.31 -1.113 0 C-N-CA 118.824 -1.15 . . . . 0.0 112.632 177.864 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.497 ' O ' ' O ' ' A' ' 102' ' ' ASN . 34.4 mt-30 -135.37 158.8 43.45 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.587 -1.188 . . . . 0.0 113.825 -177.197 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.611 ' HB ' ' HB2' ' A' ' 66' ' ' TRP . 7.9 mt -124.16 132.82 70.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 114.908 -1.042 . . . . 0.0 109.785 178.499 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.428 ' HB2' ' CB ' ' A' ' 100' ' ' LEU . 0.3 OUTLIER -108.99 144.03 37.5 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.01 0.433 . . . . 0.0 111.807 -179.557 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.465 ' HG ' HG23 ' A' ' 33' ' ' VAL . 0.8 OUTLIER -125.58 122.69 37.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.485 179.442 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 157.53 -125.71 1.61 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.594 -0.812 . . . . 0.0 112.678 179.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 61.68 -176.06 0.13 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.793 0.33 . . . . 0.0 110.786 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -76.73 67.86 2.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.944 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 71.4 68.47 1.61 Allowed Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.553 179.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -178.26 179.39 0.81 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.821 0.343 . . . . 0.0 110.782 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -113.26 154.78 26.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.783 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.593 ' HA ' ' O ' ' A' ' 122' ' ' GLN . 4.1 mm? -131.35 148.24 52.65 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.263 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.466 ' O ' ' N ' ' A' ' 122' ' ' GLN . 0.3 OUTLIER -117.03 129.99 56.38 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 179.869 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.497 ' O ' ' O ' ' A' ' 90' ' ' GLN . 28.0 t30 -111.35 111.41 22.43 Favored 'General case' 0 CA--C 1.508 -0.64 0 C-N-CA 119.79 -0.764 . . . . 0.0 109.781 179.611 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.571 ' HB3' ' CG2' ' A' ' 109' ' ' THR . 76.2 m-20 -85.54 112.01 20.55 Favored 'General case' 0 N--CA 1.442 -0.838 0 C-N-CA 119.643 -0.823 . . . . 0.0 109.543 179.507 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.959 ' O ' ' O ' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -123.0 107.63 19.66 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.975 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 177.849 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.446 ' OG ' ' NE2' ' A' ' 88' ' ' HIS . 50.1 m -134.49 168.95 18.02 Favored 'General case' 0 C--N 1.296 -1.732 0 CA-C-N 114.906 -1.043 . . . . 0.0 109.221 179.672 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 19.5 m -69.59 -63.34 1.09 Allowed 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 119.055 -1.058 . . . . 0.0 111.76 -178.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -112.26 -32.33 6.56 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 114.976 1.473 . . . . 0.0 114.976 179.436 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -145.72 126.46 2.55 Favored Glycine 0 C--N 1.339 0.725 0 N-CA-C 117.346 1.698 . . . . 0.0 117.346 -177.531 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.571 ' CG2' ' HB3' ' A' ' 103' ' ' ASP . 4.3 m -121.26 138.11 54.38 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 174.389 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . 0.682 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.6 m-90 -120.67 148.94 43.25 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 -178.539 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -121.77 112.2 18.08 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 115.152 -0.931 . . . . 0.0 108.698 177.437 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 33.5 m-20 45.48 43.4 8.81 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.073 -0.512 . . . . 0.0 112.099 -179.439 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 78.83 27.87 55.78 Favored Glycine 0 N--CA 1.444 -0.798 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.761 179.247 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -139.19 96.73 3.15 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.099 0.476 . . . . 0.0 110.774 179.776 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.682 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.3 OUTLIER -44.57 128.96 6.76 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.019 179.775 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 3.7 m -121.99 -179.84 2.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.743 -179.208 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -85.57 142.1 29.37 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.186 -179.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.412 ' HG2' ' N ' ' A' ' 119' ' ' ASN . 62.3 tttm -65.0 162.55 16.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.129 179.358 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.412 ' N ' ' HG2' ' A' ' 118' ' ' LYS . 4.4 p30 35.88 38.19 0.05 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.215 0.531 . . . . 0.0 111.142 -179.799 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 9.6 p -111.18 110.95 21.69 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.929 -179.394 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -57.39 141.04 48.62 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.683 179.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . 0.593 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 33.6 mm-40 -129.52 145.89 51.4 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-O 121.009 0.433 . . . . 0.0 111.861 -179.666 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -72.28 117.7 14.25 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.671 179.184 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.441 ' HG ' ' N ' ' A' ' 125' ' ' SER . 0.7 OUTLIER -47.42 143.79 3.34 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.9 0.857 . . . . 0.0 112.029 -178.943 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' SER . . . . . 0.441 ' N ' ' HG ' ' A' ' 124' ' ' LEU . 0.3 OUTLIER -126.84 152.78 46.53 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 114.045 -1.434 . . . . 0.0 110.124 179.263 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.59 113.99 9.21 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.981 -0.378 . . . . 0.0 109.981 179.633 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 67.99 27.62 73.62 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.852 -0.689 . . . . 0.0 112.266 -179.411 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -55.04 160.42 2.05 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.01 0.433 . . . . 0.0 111.185 -179.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -146.01 135.38 22.98 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.447 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.44 ' CG2' ' O ' ' A' ' 110' ' ' TRP . 7.0 mm -111.51 128.22 68.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 178.908 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.455 ' HB ' ' CB ' ' A' ' 110' ' ' TRP . 41.9 m -103.73 144.94 30.81 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.73 -179.538 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.462 ' HB ' ' NE2' ' A' ' 88' ' ' HIS . 4.1 m -141.46 158.42 21.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -178.781 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 66.17 42.17 94.49 Favored Glycine 0 N--CA 1.447 -0.574 0 CA-C-N 115.83 -0.623 . . . . 0.0 112.355 179.359 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.42 ' HA ' HG12 ' A' ' 140' ' ' ILE . 88.9 t -76.89 157.04 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 CA-C-O 121.467 0.651 . . . . 0.0 112.193 -179.125 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 144.65 -43.08 0.98 Allowed Glycine 0 N--CA 1.44 -1.062 0 N-CA-C 110.447 -1.061 . . . . 0.0 110.447 -178.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 47.5 t -126.87 126.09 67.88 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 CA-C-N 114.984 -0.608 . . . . 0.0 109.705 178.589 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -51.17 -28.23 10.66 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.774 0.321 . . . . 0.0 111.186 -179.342 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -94.36 6.49 48.56 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 116.224 -0.443 . . . . 0.0 112.114 -179.598 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -130.94 27.55 4.88 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 -179.427 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.446 ' CG2' ' CG2' ' A' ' 131' ' ' THR . 23.9 mt -102.73 140.86 19.94 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.312 179.169 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.411 ' HB3' ' NE2' ' A' ' 42' ' ' GLN . 4.9 mp -124.07 135.39 53.53 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 114.808 -1.087 . . . . 0.0 109.734 179.511 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.406 ' HB3' HG21 ' A' ' 40' ' ' THR . 38.9 t -127.65 151.92 48.33 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -178.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.405 ' CD2' ' CG1' ' A' ' 36' ' ' VAL . 3.2 tm? -122.96 138.09 54.77 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 114.424 -1.262 . . . . 0.0 109.155 179.184 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 3.8 t -119.17 141.03 41.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.8 0.333 . . . . 0.0 111.724 -178.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -111.02 140.34 30.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.161 179.564 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -119.76 106.57 12.25 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.556 179.79 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.427 HG12 ' CD2' ' A' ' 124' ' ' LEU . 2.0 mp -99.38 133.38 42.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.483 -179.781 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 -78.82 140.23 38.24 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.236 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -73.8 -18.44 60.95 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.196 178.771 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.5 -45.21 84.44 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.648 179.779 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 26.1 t80 -57.25 -42.41 81.44 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.681 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.78 -38.14 72.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.73 179.749 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 7.8 mm100 -64.61 -36.54 84.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.882 179.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 13.0 t -58.0 -45.13 87.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.958 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.47 -38.15 86.67 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.905 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -60.42 -40.7 91.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.901 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 6.5 mt-30 -86.75 -36.62 18.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.899 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 4.9 p30 44.83 -172.76 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.635 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 4.8 ttpp -82.54 145.92 29.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.013 -179.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 13.7 t -97.43 129.63 47.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.017 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -79.43 157.54 27.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.007 -179.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 6.2 ptm180 -133.35 27.06 4.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.901 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 2.1 mt -105.85 130.01 58.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.051 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.252 -0.88 . . . . 0.0 110.895 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.344 0 N-CA-C 112.487 -0.245 . . . . 0.0 112.487 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 -142.69 156.12 44.99 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.844 0.354 . . . . 0.0 110.92 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -62.82 -177.05 0.13 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.88 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.431 ' N ' ' CD1' ' A' ' 4' ' ' ILE . 0.1 OUTLIER -125.53 129.08 72.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.026 179.963 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -156.89 135.31 11.38 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.1 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -171.94 136.23 0.91 Allowed Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.811 179.873 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -74.91 83.73 1.76 Allowed 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.499 2.133 . . . . 0.0 112.33 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 11.0 m -62.36 -50.71 70.52 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.108 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -175.34 116.7 0.16 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.893 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -74.57 141.69 44.74 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.914 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 13.4 m -127.3 88.09 2.74 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.835 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -124.82 30.98 5.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.033 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -58.8 -32.11 69.04 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.923 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.8 81.13 0.19 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.157 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 18.2 m -152.52 -48.03 0.1 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.224 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -62.74 -42.45 99.67 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.965 -179.87 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.8 mtm-85 -60.03 -39.9 87.5 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.995 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -65.24 -36.55 84.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.964 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 6.9 mp -62.2 -43.17 99.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.016 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 37.5 mm -62.87 -44.04 99.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.167 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -57.66 -40.96 80.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.019 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -65.23 -29.51 70.31 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.014 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -57.92 -47.5 82.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.282 -179.894 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -57.5 -41.06 80.0 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.98 -179.892 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 8.4 mm-40 -86.51 -174.07 4.83 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.968 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -62.52 140.52 58.62 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.876 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -80.22 114.93 19.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.893 -179.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 21.7 mm -82.12 139.67 17.56 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.329 0 CA-C-O 121.388 0.613 . . . . 0.0 111.476 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.419 ' O ' ' ND2' ' A' ' 148' ' ' ASN . . . -91.6 36.57 3.6 Favored Glycine 0 C--N 1.317 -0.506 0 CA-C-N 114.978 -1.01 . . . . 0.0 112.755 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -89.79 -39.23 13.25 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.73 0.3 . . . . 0.0 111.326 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 73.2 m-20 -110.1 -13.34 14.39 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-O 121.829 0.823 . . . . 0.0 109.07 178.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.589 ' CG2' ' O ' ' A' ' 32' ' ' ILE . 0.1 OUTLIER -70.07 97.32 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.605 0 CA-C-N 114.216 -1.356 . . . . 0.0 111.266 -178.839 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.55 ' CG1' ' N ' ' A' ' 34' ' ' CYS . 0.6 OUTLIER -34.15 -59.06 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 114.795 -1.093 . . . . 0.0 112.159 -179.578 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.55 ' N ' ' CG1' ' A' ' 33' ' ' VAL . 3.2 t -163.5 164.98 24.18 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.747 -179.27 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 1.8 ttm180 -125.47 115.17 19.81 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.026 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 14.4 p -89.92 137.17 22.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.076 179.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.491 ' CG2' HG12 ' A' ' 45' ' ' ILE . 23.6 mt -129.51 107.42 15.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -179.673 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.423 ' HB2' ' O ' ' A' ' 43' ' ' ILE . 67.1 m -92.74 101.03 13.41 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 177.211 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.2 t -105.82 -18.21 14.13 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 113.469 0.915 . . . . 0.0 113.469 -177.256 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.542 HG22 ' HB2' ' A' ' 142' ' ' SER . 26.1 p -57.81 -19.35 27.95 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.924 -0.31 . . . . 0.0 111.534 -179.564 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 111.12 67.64 0.55 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.558 -0.83 . . . . 0.0 112.425 179.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -151.15 -54.49 0.14 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.737 0.303 . . . . 0.0 111.138 -179.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.446 ' CG2' ' HD2' ' A' ' 44' ' ' PRO . 0.0 OUTLIER -134.63 151.5 76.02 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.158 -179.299 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.446 ' HD2' ' CG2' ' A' ' 43' ' ' ILE . 87.0 Cg_endo -80.42 147.3 17.86 Favored 'Trans proline' 0 N--CA 1.461 -0.433 0 C-N-CA 122.403 2.069 . . . . 0.0 111.562 179.352 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.491 HG12 ' CG2' ' A' ' 37' ' ' ILE . 23.2 mt -37.73 124.58 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 CA-C-O 121.043 0.449 . . . . 0.0 111.844 -179.517 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.544 ' HD2' ' HB3' ' A' ' 76' ' ' TYR . 0.0 OUTLIER -115.28 153.94 30.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.266 179.698 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 15.9 p-10 -116.22 119.83 37.03 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.187 0.517 . . . . 0.0 111.674 -179.605 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.522 ' HB3' ' CE2' ' A' ' 66' ' ' TRP . 6.9 mt -96.72 123.25 40.36 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.251 178.829 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.532 ' O ' ' HZ2' ' A' ' 66' ' ' TRP . 0.0 OUTLIER -127.52 160.88 30.17 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 -178.76 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.451 ' HB3' HG22 ' A' ' 33' ' ' VAL . . . -157.71 142.31 16.4 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 114.287 -1.324 . . . . 0.0 110.998 178.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.435 ' CB ' ' HG3' ' A' ' 54' ' ' GLN . 0.5 OUTLIER -68.87 129.89 41.22 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.969 0.414 . . . . 0.0 111.083 -179.771 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 33.9 mt -62.15 -38.84 81.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.197 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 31.4 p -56.74 -34.08 67.18 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.031 -179.43 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.435 ' HG3' ' CB ' ' A' ' 51' ' ' ASP . 0.3 OUTLIER -63.5 -44.77 93.37 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.934 -179.66 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 16.8 t -74.04 -42.62 52.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.24 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -58.75 -35.54 72.9 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.996 -179.896 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 14.2 tptp -93.93 -44.62 7.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.823 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 57.66 69.69 0.72 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.841 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -175.02 -40.64 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.828 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 7.2 tpp180 -62.85 -71.66 0.16 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.833 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 58.1 m -144.04 68.27 1.27 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.903 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.2 tt -95.22 42.39 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.974 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 34.0 mtmt -139.23 71.11 1.38 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.128 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.416 ' O ' ' HB3' ' A' ' 93' ' ' LEU . 5.5 ttpt -112.96 130.78 56.0 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.409 179.557 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.439 ' CG1' ' O ' ' A' ' 91' ' ' ILE . 21.4 t -137.47 139.45 43.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.164 0.507 . . . . 0.0 112.176 -179.098 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . 0.635 ' HB2' ' HB ' ' A' ' 91' ' ' ILE . 12.5 m-90 -100.08 139.23 36.04 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.06 178.607 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.559 ' O ' ' N ' ' A' ' 75' ' ' ASP . 33.9 m -131.68 130.64 42.29 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.554 0.692 . . . . 0.0 111.793 179.329 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.593 ' CD2' ' CE2' ' A' ' 76' ' ' TYR . 1.3 m-85 -102.26 119.36 38.67 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 114.886 -1.052 . . . . 0.0 109.093 178.462 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.638 ' HA2' ' O ' ' A' ' 85' ' ' SER . . . 156.35 -160.7 30.37 Favored Glycine 0 CA--C 1.505 -0.542 0 C-N-CA 118.537 -1.792 . . . . 0.0 113.225 179.041 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.403 ' HD2' ' OD1' ' A' ' 86' ' ' ASN . 12.5 ptm180 -76.84 93.15 3.69 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-O 122.686 1.231 . . . . 0.0 108.918 -179.874 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.591 ' O ' ' CD2' ' A' ' 77' ' ' HIS . 6.7 m120 -148.45 156.53 42.37 Favored Pre-proline 0 C--N 1.307 -1.275 0 CA-C-N 112.857 -1.974 . . . . 0.0 107.936 178.812 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.546 ' O ' ' CB ' ' A' ' 73' ' ' ALA . 47.0 Cg_exo -50.37 -13.76 0.83 Allowed 'Trans proline' 0 N--CA 1.459 -0.553 0 C-N-CA 121.384 1.389 . . . . 0.0 111.315 178.276 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.546 ' CB ' ' O ' ' A' ' 72' ' ' PRO . . . 135.85 53.63 0.0 OUTLIER 'General case' 0 CA--C 1.489 -1.385 0 CA-C-N 114.504 -1.226 . . . . 0.0 108.582 178.731 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . 0.53 ' HB3' ' HB ' ' A' ' 67' ' ' THR . 0.0 OUTLIER -52.07 -69.28 0.12 Allowed 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 -179.846 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.559 ' N ' ' O ' ' A' ' 67' ' ' THR . 29.9 t70 -92.76 -51.2 5.2 Favored 'General case' 0 N--CA 1.433 -1.29 0 N-CA-C 104.388 -2.449 . . . . 0.0 104.388 169.861 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.593 ' CE2' ' CD2' ' A' ' 68' ' ' PHE . 1.3 p90 -148.26 143.87 27.25 Favored 'General case' 0 C--N 1.345 0.389 0 CA-C-N 112.815 -1.993 . . . . 0.0 111.011 176.227 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . 0.591 ' CD2' ' O ' ' A' ' 71' ' ' ASN . 15.4 t-160 -90.09 105.81 18.06 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 177.454 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -127.63 178.78 5.89 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.922 0.391 . . . . 0.0 111.336 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -51.1 158.43 2.24 Favored Glycine 0 C--N 1.333 0.373 0 C-N-CA 120.991 -0.623 . . . . 0.0 112.694 -179.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 5.0 p30 -111.71 99.38 8.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.762 0.315 . . . . 0.0 111.579 -179.697 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.614 ' HB ' ' HB2' ' A' ' 85' ' ' SER . 17.3 mt -114.93 131.66 66.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 178.175 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.416 ' HA ' ' ND2' ' A' ' 86' ' ' ASN . 0.5 OUTLIER -52.81 -24.09 8.24 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 111.697 0.258 . . . . 0.0 111.697 -179.016 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 2.2 mtt-85 -92.3 -95.05 0.14 Allowed 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 116.841 -0.163 . . . . 0.0 111.256 179.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.452 ' O ' ' CB ' ' A' ' 85' ' ' SER . 0.0 OUTLIER -109.48 109.45 20.28 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-O 121.359 0.599 . . . . 0.0 109.761 179.191 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.638 ' O ' ' HA2' ' A' ' 69' ' ' GLY . 1.5 m 157.19 -42.37 0.0 OUTLIER 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 114.592 -1.186 . . . . 0.0 109.55 -179.698 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.669 ' O ' ' N ' ' A' ' 88' ' ' HIS . 30.3 m-20 -65.41 -160.71 0.02 OUTLIER 'General case' 0 CA--C 1.516 -0.354 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 177.514 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.407 ' O ' ' CG1' ' A' ' 104' ' ' ILE . 0.0 OUTLIER -58.64 75.18 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 177.791 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.969 ' O ' ' O ' ' A' ' 104' ' ' ILE . 30.6 t60 -79.53 -18.64 51.4 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 114.182 1.179 . . . . 0.0 114.182 -176.685 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.484 ' CZ ' HG13 ' A' ' 91' ' ' ILE . 0.0 OUTLIER -174.98 156.84 2.25 Favored 'General case' 0 C--N 1.312 -1.052 0 C-N-CA 119.038 -1.065 . . . . 0.0 112.88 177.961 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.484 ' O ' ' O ' ' A' ' 102' ' ' ASN . 35.2 mt-30 -138.09 160.75 38.57 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 114.677 -1.147 . . . . 0.0 113.758 -177.779 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.635 ' HB ' ' HB2' ' A' ' 66' ' ' TRP . 3.4 mt -130.24 129.81 65.31 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.004 178.617 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.446 ' N ' ' O ' ' A' ' 100' ' ' LEU . 0.4 OUTLIER -103.93 143.86 32.3 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -179.22 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.449 ' HG ' HG21 ' A' ' 33' ' ' VAL . 0.2 OUTLIER -126.43 122.81 36.36 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.188 178.965 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 119.11 -114.8 2.89 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.563 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 17.5 tp10 66.07 -72.98 0.07 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.843 0.354 . . . . 0.0 111.033 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -175.88 65.15 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.841 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 93.26 136.8 8.0 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.4 -179.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 6.2 m-20 63.74 -173.36 0.16 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.766 0.317 . . . . 0.0 110.803 -179.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -106.85 160.11 15.75 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.936 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.559 ' HA ' ' O ' ' A' ' 122' ' ' GLN . 0.8 OUTLIER -121.07 148.01 44.74 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.083 179.625 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.441 ' O ' ' N ' ' A' ' 122' ' ' GLN . 4.4 mp -116.94 127.38 54.17 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 179.614 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.484 ' O ' ' O ' ' A' ' 90' ' ' GLN . 27.8 t30 -113.9 111.49 21.8 Favored 'General case' 0 CA--C 1.507 -0.706 0 C-N-CA 119.74 -0.784 . . . . 0.0 109.928 -179.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.57 ' HB3' ' CG2' ' A' ' 109' ' ' THR . 74.8 m-20 -84.11 111.51 19.39 Favored 'General case' 0 N--CA 1.44 -0.972 0 C-N-CA 119.647 -0.821 . . . . 0.0 109.227 179.57 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.969 ' O ' ' O ' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -123.38 107.76 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.007 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 177.837 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.436 ' OG ' ' NE2' ' A' ' 88' ' ' HIS . 71.1 m -132.96 171.48 13.9 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-N 114.939 -1.028 . . . . 0.0 109.328 179.754 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 23.4 m -69.58 -63.56 1.05 Allowed 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 119.093 -1.043 . . . . 0.0 111.545 -179.156 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -112.65 -32.85 6.31 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 114.687 1.366 . . . . 0.0 114.687 179.162 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -145.97 129.08 3.27 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 116.996 1.558 . . . . 0.0 116.996 -177.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.57 ' CG2' ' HB3' ' A' ' 103' ' ' ASP . 5.8 m -121.17 138.15 54.34 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 174.478 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . 0.751 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.5 m-90 -120.09 148.85 43.09 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 113.14 0.793 . . . . 0.0 113.14 -178.653 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -123.59 112.3 17.27 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 115.123 -0.944 . . . . 0.0 108.755 177.714 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 13.4 m-80 45.23 44.68 9.08 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.933 -0.576 . . . . 0.0 112.116 -179.531 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 77.53 26.14 61.75 Favored Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.75 179.249 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -138.74 95.3 2.95 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.077 0.465 . . . . 0.0 110.739 179.703 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.751 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.1 OUTLIER -44.98 133.64 6.25 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.931 179.763 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 31.2 m -124.44 -179.66 2.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.83 -179.113 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 29.3 mm-40 -84.9 141.57 30.31 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.005 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.421 ' O ' ' C ' ' A' ' 119' ' ' ASN . 88.4 tttt -65.31 163.2 15.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.056 179.443 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.421 ' C ' ' O ' ' A' ' 118' ' ' LYS . 13.5 m-80 33.63 40.04 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.164 0.507 . . . . 0.0 111.152 -179.461 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.402 ' OG ' ' NE2' ' A' ' 122' ' ' GLN . 19.5 p -110.48 117.08 32.59 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.967 -179.397 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . 0.427 ' ND2' ' CD1' ' A' ' 92' ' ' LEU . 15.8 m120 -57.97 138.98 55.38 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.778 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . 0.559 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 45.0 mm-40 -129.49 146.33 51.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.117 0.484 . . . . 0.0 111.787 -179.849 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 12.3 tp -78.74 120.24 23.1 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.545 178.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.404 ' CD2' HG12 ' A' ' 147' ' ' ILE . 13.3 tp -46.88 144.33 2.48 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.773 0.797 . . . . 0.0 111.965 -178.905 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' SER . . . . . 0.428 ' O ' ' CD1' ' A' ' 147' ' ' ILE . 0.6 OUTLIER -126.83 152.34 47.11 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 114.22 -1.354 . . . . 0.0 110.26 179.542 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 4.1 mm100 -71.41 114.15 9.18 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 179.584 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 65.67 30.29 77.01 Favored Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.172 -179.364 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 18.6 t0 -55.76 160.24 2.7 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.987 0.423 . . . . 0.0 111.39 -179.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.409 ' CG ' ' O ' ' A' ' 143' ' ' LEU . 1.2 tt0 -146.15 134.94 22.38 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.004 179.925 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.446 ' CG2' ' O ' ' A' ' 110' ' ' TRP . 1.1 mp -113.41 127.15 70.86 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.202 0 CA-C-O 120.799 0.333 . . . . 0.0 110.112 178.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.484 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 18.3 m -104.04 145.6 29.93 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.52 -179.754 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.468 ' HB ' ' NE2' ' A' ' 88' ' ' HIS . 5.5 m -141.21 158.09 22.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -178.669 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . 0.404 ' O ' ' O ' ' A' ' 139' ' ' ASP . . . 69.06 41.33 81.61 Favored Glycine 0 N--CA 1.447 -0.612 0 CA-C-N 115.682 -0.69 . . . . 0.0 112.509 179.25 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.437 ' HA ' HG12 ' A' ' 140' ' ' ILE . 85.9 t -77.55 153.87 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.636 0 CA-C-O 121.398 0.618 . . . . 0.0 112.14 -179.284 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 145.13 -39.61 1.17 Allowed Glycine 0 N--CA 1.441 -0.999 0 CA-C-N 115.015 -0.993 . . . . 0.0 110.7 -179.004 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 48.3 t -126.67 129.35 71.59 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.65 0 CA-C-N 115.231 -0.485 . . . . 0.0 109.837 178.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -51.25 -34.43 32.54 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.784 0.326 . . . . 0.0 111.618 -179.235 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 2.6 t -94.06 6.48 48.41 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 -179.326 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . 0.404 ' O ' ' O ' ' A' ' 133' ' ' GLY . 14.6 t0 -126.77 26.94 6.13 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -179.319 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.484 ' CG2' ' CG2' ' A' ' 131' ' ' THR . 26.6 mt -102.52 141.35 18.77 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.34 179.194 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -121.26 135.45 55.12 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 114.885 -1.052 . . . . 0.0 110.176 179.594 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.542 ' HB2' HG22 ' A' ' 40' ' ' THR . 0.9 OUTLIER -122.27 147.39 46.28 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.551 0.691 . . . . 0.0 112.648 -178.898 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.413 ' N ' ' CD1' ' A' ' 143' ' ' LEU . 5.7 mp -127.14 146.27 50.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.028 -0.987 . . . . 0.0 109.086 179.399 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 21.5 t -129.42 141.01 47.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.918 0.39 . . . . 0.0 112.009 -178.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -116.08 127.88 73.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.786 179.771 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 9.7 t80 -111.27 120.21 41.48 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.49 179.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.428 ' CD1' ' O ' ' A' ' 125' ' ' SER . 1.3 mt -100.47 133.8 42.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.998 0.427 . . . . 0.0 111.86 -179.458 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . 0.419 ' ND2' ' O ' ' A' ' 29' ' ' GLY . 0.7 OUTLIER -84.37 114.99 22.27 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.558 179.423 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -59.97 -19.28 51.39 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.442 -179.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 9.4 mtmm -57.9 -43.29 86.07 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.947 0.403 . . . . 0.0 110.801 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 32.4 t80 -61.27 -44.66 96.87 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.968 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.11 -39.97 88.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.926 -179.844 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -59.86 -39.5 85.43 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.943 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 9.3 t -66.68 -45.55 78.48 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.885 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -67.41 -40.4 85.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.902 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -57.27 -38.89 74.58 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.928 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 3.3 mm-40 -89.58 -32.21 17.22 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.766 179.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 3.6 p30 42.33 79.62 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.497 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -120.49 115.87 24.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.885 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 22.2 t -84.08 133.05 30.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.1 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -117.43 123.97 47.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.932 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -99.1 126.14 44.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.798 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 2.9 tt -105.51 129.77 57.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.101 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 35.8 ptt180 . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.259 -0.877 . . . . 0.0 110.91 179.937 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.323 0 N-CA-C 112.397 -0.281 . . . . 0.0 112.397 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -165.69 111.96 0.9 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.764 0.316 . . . . 0.0 110.969 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 31.3 m120 -90.11 123.64 34.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.863 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 8.6 pt -131.98 101.05 4.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.205 -179.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.4 t 175.38 -35.36 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.278 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . 0.4 ' CB ' ' HD3' ' A' ' 7' ' ' PRO . 0.0 OUTLIER -52.69 -53.26 56.09 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.155 -179.803 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.4 ' HD3' ' CB ' ' A' ' 6' ' ' GLN . 50.5 Cg_exo -53.56 99.1 0.05 OUTLIER 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.515 2.143 . . . . 0.0 112.282 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.86 -68.36 0.78 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.126 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 56.15 37.24 28.64 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.103 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -153.08 144.73 23.45 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.885 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 72.1 p -126.46 84.81 2.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.865 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 37.1 p -65.02 80.56 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.111 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 1.7 tm0? -131.64 108.55 9.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.939 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 59.1 80.46 0.19 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.087 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -139.03 -49.96 0.52 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.049 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.2 mm-40 -66.33 -36.53 83.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.896 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -61.56 -37.72 84.84 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.89 179.909 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -63.8 -36.97 85.65 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.87 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.6 mt -59.4 -38.74 81.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.891 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 31.3 mm -64.24 -40.56 89.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.025 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -57.85 -43.92 86.22 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.959 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -64.79 -37.32 87.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.991 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -64.29 -47.47 79.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.086 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 2.3 m -64.62 -38.15 90.02 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.951 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 10.8 tp60 -62.1 120.03 10.09 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.934 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.85 129.48 39.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.834 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 20.9 mt-30 -89.37 102.07 14.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.996 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 21.4 mm -88.15 139.27 17.62 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.345 0 CA-C-O 121.421 0.629 . . . . 0.0 111.58 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 90.94 -24.4 18.42 Favored Glycine 0 C--N 1.317 -0.48 0 CA-C-N 114.938 -1.028 . . . . 0.0 112.868 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -78.03 -23.22 48.27 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.596 0.236 . . . . 0.0 111.474 -179.698 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 10.4 m120 -108.55 -14.02 14.72 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-O 121.843 0.83 . . . . 0.0 109.048 178.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.468 HG12 ' HB3' ' A' ' 49' ' ' SER . 0.1 OUTLIER -73.58 111.6 8.8 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.568 0 CA-C-N 114.066 -1.424 . . . . 0.0 111.433 -179.355 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.631 ' CG1' ' N ' ' A' ' 34' ' ' CYS . 0.5 OUTLIER -42.27 -64.57 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.47 -179.653 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.631 ' N ' ' CG1' ' A' ' 33' ' ' VAL . 22.6 p -166.31 165.85 17.05 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.712 -179.686 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 11.7 ttm180 -119.21 126.27 51.15 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.385 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.474 ' CG2' HD12 ' A' ' 48' ' ' LEU . 14.8 t -95.59 137.09 24.6 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.19 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.349 179.226 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.466 ' CG2' HG12 ' A' ' 45' ' ' ILE . 21.8 mt -129.3 108.6 17.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 -178.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -103.38 102.02 11.94 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 177.413 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.7 p -112.42 -23.16 10.48 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 113.664 0.987 . . . . 0.0 113.664 -177.112 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.41 ' CG2' ' HB3' ' A' ' 142' ' ' SER . 5.3 p -54.16 -23.33 13.9 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.874 -0.33 . . . . 0.0 111.452 -179.241 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 124.26 70.64 0.22 Allowed Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.642 -0.79 . . . . 0.0 112.402 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -151.05 -70.77 0.17 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.74 0.305 . . . . 0.0 110.944 -179.893 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.447 HG21 ' CG ' ' A' ' 76' ' ' TYR . 2.1 mp -134.64 133.13 21.07 Favored Pre-proline 0 N--CA 1.453 -0.319 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.15 -179.826 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.476 ' HD2' ' CZ ' ' A' ' 76' ' ' TYR . 35.6 Cg_exo -58.58 147.44 86.84 Favored 'Trans proline' 0 C--N 1.342 0.236 0 C-N-CA 122.474 2.116 . . . . 0.0 111.611 179.497 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.466 HG12 ' CG2' ' A' ' 37' ' ' ILE . 45.7 mt -33.68 145.57 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -179.24 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.418 ' HD3' ' CD2' ' A' ' 76' ' ' TYR . 9.8 tpt180 -139.88 149.46 43.42 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.045 179.47 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -120.54 119.91 34.31 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.888 0.375 . . . . 0.0 111.635 -179.441 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.497 ' HB3' ' CE2' ' A' ' 66' ' ' TRP . 0.3 OUTLIER -99.26 133.39 43.62 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 178.367 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.567 ' O ' ' CZ2' ' A' ' 66' ' ' TRP . 0.1 OUTLIER -113.42 164.73 13.23 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.794 0.807 . . . . 0.0 112.658 -179.131 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.496 ' CB ' ' CG2' ' A' ' 33' ' ' VAL . . . -119.77 166.16 13.61 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.116 -0.947 . . . . 0.0 111.428 -179.895 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.429 ' CB ' ' CG ' ' A' ' 54' ' ' GLN . 0.0 OUTLIER -105.72 76.02 1.17 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.384 179.642 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 19.0 mt -61.55 -41.24 89.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.484 -179.53 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 19.3 t -57.51 -36.61 71.77 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.174 0.511 . . . . 0.0 110.506 -179.525 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.429 ' CG ' ' CB ' ' A' ' 51' ' ' ASP . 3.3 mm-40 -68.75 -40.48 79.8 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.742 179.736 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 39.6 t -72.66 -37.65 56.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.748 179.728 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 22.0 mt -56.67 -35.29 68.25 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.49 179.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.45 -30.09 13.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.526 179.513 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER 59.6 111.76 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.01 179.783 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.8 tttt -176.68 -53.55 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.908 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 12.2 mtt180 -152.67 -176.95 5.95 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.814 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 62.15 30.0 17.65 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.874 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -103.06 42.26 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 121.018 0.437 . . . . 0.0 111.044 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.6 ptpt -160.62 82.89 0.67 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.995 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.444 ' O ' ' HB3' ' A' ' 93' ' ' LEU . 14.0 ttpt -115.19 130.84 57.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.532 179.8 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.415 ' CG1' ' O ' ' A' ' 91' ' ' ILE . 5.5 t -133.36 134.08 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 CA-C-O 121.028 0.442 . . . . 0.0 111.554 -179.503 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . 0.627 ' HB2' ' HB ' ' A' ' 91' ' ' ILE . 17.2 m-90 -100.61 140.27 35.12 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.854 179.395 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.633 ' N ' ' HB2' ' A' ' 75' ' ' ASP . 21.6 m -127.34 130.44 49.46 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.53 0.681 . . . . 0.0 112.262 179.515 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.424 ' CE1' ' CG ' ' A' ' 75' ' ' ASP . 43.6 m-85 -101.66 118.04 36.12 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.089 -0.959 . . . . 0.0 108.739 177.768 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.679 ' HA2' ' O ' ' A' ' 85' ' ' SER . . . 158.29 -151.93 23.06 Favored Glycine 0 CA--C 1.505 -0.558 0 C-N-CA 119.054 -1.546 . . . . 0.0 113.055 179.828 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.418 ' HD2' ' HB2' ' A' ' 80' ' ' ASN . 35.5 mtp180 -75.49 91.08 2.76 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-O 122.348 1.071 . . . . 0.0 108.49 -179.853 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.505 ' O ' ' CD2' ' A' ' 77' ' ' HIS . 20.6 m120 -150.82 159.32 34.26 Favored Pre-proline 0 C--N 1.308 -1.212 0 CA-C-N 113.18 -1.827 . . . . 0.0 108.688 178.917 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.552 ' O ' ' HB2' ' A' ' 77' ' ' HIS . 36.3 Cg_endo -66.73 -6.22 15.04 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 120.874 1.05 . . . . 0.0 110.777 177.591 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.594 ' HB1' ' HB2' ' A' ' 77' ' ' HIS . . . 137.03 51.57 0.0 OUTLIER 'General case' 0 CA--C 1.491 -1.32 0 CA-C-N 114.452 -1.249 . . . . 0.0 109.269 178.867 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . 0.521 ' HB3' ' HB ' ' A' ' 67' ' ' THR . 0.1 OUTLIER -52.78 -69.43 0.11 Allowed 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 105.709 -1.959 . . . . 0.0 105.709 179.537 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.633 ' HB2' ' N ' ' A' ' 67' ' ' THR . 36.9 t0 -95.56 -47.56 6.19 Favored 'General case' 0 N--CA 1.433 -1.319 0 N-CA-C 105.872 -1.899 . . . . 0.0 105.872 169.638 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.476 ' CZ ' ' HD2' ' A' ' 44' ' ' PRO . 7.5 t80 -145.12 142.14 29.4 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 112.501 -2.136 . . . . 0.0 112.102 -179.609 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . 0.594 ' HB2' ' HB1' ' A' ' 73' ' ' ALA . 23.6 t-160 -100.89 106.7 18.07 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 176.392 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -133.07 -174.65 3.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.057 0.456 . . . . 0.0 111.773 -179.282 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -56.73 170.71 2.73 Favored Glycine 0 C--N 1.332 0.355 0 CA-C-N 115.75 -0.659 . . . . 0.0 112.471 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.418 ' HB2' ' HD2' ' A' ' 70' ' ' ARG . 3.4 p30 -112.12 98.49 7.37 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 -179.438 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.632 ' HB ' ' HB2' ' A' ' 85' ' ' SER . 15.3 mm -115.3 129.81 70.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 177.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.409 ' HA ' ' ND2' ' A' ' 86' ' ' ASN . 18.8 m -53.09 -23.86 8.81 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 111.617 0.229 . . . . 0.0 111.617 -179.267 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 3.1 mpt_? -98.01 -88.6 0.31 Allowed 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 111.608 0.225 . . . . 0.0 111.608 -179.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.441 ' O ' ' CB ' ' A' ' 85' ' ' SER . 0.0 OUTLIER -109.41 108.8 19.46 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 121.455 0.645 . . . . 0.0 110.541 179.812 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.679 ' O ' ' HA2' ' A' ' 69' ' ' GLY . 3.1 m 155.23 -42.93 0.01 OUTLIER 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 114.247 -1.342 . . . . 0.0 109.437 179.793 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.655 ' O ' ' N ' ' A' ' 88' ' ' HIS . 38.0 m-20 -77.21 -164.5 0.47 Allowed 'General case' 0 CA--C 1.512 -0.498 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 177.679 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.51 83.12 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 178.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 1.071 ' O ' ' O ' ' A' ' 104' ' ' ILE . 36.3 t60 -102.74 -19.32 14.78 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 114.624 1.342 . . . . 0.0 114.624 -177.002 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.554 ' CD2' ' HA ' ' A' ' 103' ' ' ASP . 0.1 OUTLIER -176.55 159.44 1.9 Allowed 'General case' 0 C--N 1.317 -0.811 0 C-N-CA 119.332 -0.947 . . . . 0.0 111.869 178.338 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.493 ' N ' ' CD1' ' A' ' 89' ' ' PHE . 27.4 mt-30 -137.89 161.09 37.56 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 113.767 1.025 . . . . 0.0 113.767 -177.673 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.627 ' HB ' ' HB2' ' A' ' 66' ' ' TRP . 2.9 mt -124.97 133.11 70.31 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 CA-C-N 115.092 -0.958 . . . . 0.0 109.588 178.267 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.451 ' N ' ' O ' ' A' ' 100' ' ' LEU . 0.2 OUTLIER -110.47 141.92 42.93 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 121.01 0.434 . . . . 0.0 112.166 -179.168 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.444 ' HB3' ' O ' ' A' ' 64' ' ' LYS . 19.0 tp -125.65 137.96 53.89 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.298 178.843 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 132.0 -145.09 16.88 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.416 179.777 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 57.01 74.18 0.42 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.913 0.387 . . . . 0.0 110.84 -179.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 2.9 t0 71.07 17.45 6.13 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.218 -179.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 94.37 -23.61 31.15 Favored Glycine 0 C--N 1.331 0.288 0 C-N-CA 120.69 -0.766 . . . . 0.0 112.804 179.711 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 58.0 m-20 -58.96 -178.8 0.06 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.968 0.413 . . . . 0.0 111.02 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 10.5 mp -119.56 147.32 44.61 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.658 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.632 ' HA ' ' O ' ' A' ' 122' ' ' GLN . 1.0 OUTLIER -133.68 148.72 51.5 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.627 -179.965 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.459 ' O ' ' N ' ' A' ' 122' ' ' GLN . 5.4 mp -116.22 129.69 56.42 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.681 -0.488 . . . . 0.0 109.681 179.638 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.464 ' O ' ' O ' ' A' ' 90' ' ' GLN . 24.5 t30 -110.31 112.39 24.31 Favored 'General case' 0 CA--C 1.508 -0.652 0 C-N-CA 119.706 -0.798 . . . . 0.0 110.031 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.59 ' HB3' ' CG2' ' A' ' 109' ' ' THR . 33.5 m-20 -83.78 110.23 18.16 Favored 'General case' 0 N--CA 1.441 -0.924 0 C-N-CA 119.428 -0.909 . . . . 0.0 109.662 179.846 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 1.071 ' O ' ' O ' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -125.04 108.91 20.9 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.061 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 177.07 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.426 ' OG ' ' NE2' ' A' ' 88' ' ' HIS . 68.7 m -131.48 173.5 11.03 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.452 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 25.8 m -69.34 -63.86 0.98 Allowed 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 119.038 -1.065 . . . . 0.0 111.084 -179.358 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 6.1 m-80 -112.68 -33.23 6.18 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 114.234 1.198 . . . . 0.0 114.234 178.629 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -146.71 133.94 5.06 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 116.536 1.374 . . . . 0.0 116.536 -178.093 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.59 ' CG2' ' HB3' ' A' ' 103' ' ' ASP . 16.7 m -121.06 138.01 54.38 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 174.417 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . 0.7 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.9 m-90 -120.89 149.14 43.07 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 113.65 0.981 . . . . 0.0 113.65 -178.357 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -122.92 111.99 17.3 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 115.004 -0.998 . . . . 0.0 108.66 177.536 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 44.21 44.6 6.61 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.998 -0.546 . . . . 0.0 112.191 -179.457 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 80.72 21.77 63.16 Favored Glycine 0 N--CA 1.445 -0.765 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.837 179.437 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -134.29 98.34 4.08 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.968 0.413 . . . . 0.0 110.7 179.608 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.7 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.3 OUTLIER -44.06 124.93 4.12 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.084 179.936 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 14.7 p -112.15 160.22 11.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.722 -179.074 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -71.01 142.05 50.95 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.995 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.407 ' O ' ' C ' ' A' ' 119' ' ' ASN . 81.6 tttt -65.17 162.55 16.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.293 179.432 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.407 ' C ' ' O ' ' A' ' 118' ' ' LYS . 12.1 p30 34.67 39.09 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.265 0.555 . . . . 0.0 111.305 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 8.6 p -111.09 109.5 19.61 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.9 -179.473 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -57.69 140.91 50.16 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.771 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . 0.632 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 18.4 mm-40 -129.64 143.43 50.82 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-O 121.055 0.455 . . . . 0.0 111.844 -179.707 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -72.57 122.83 22.02 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.512 178.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.43 ' HG ' ' N ' ' A' ' 125' ' ' SER . 0.9 OUTLIER -47.71 143.53 3.85 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-O 121.854 0.835 . . . . 0.0 111.941 -178.799 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' SER . . . . . 0.43 ' N ' ' HG ' ' A' ' 124' ' ' LEU . 0.3 OUTLIER -126.72 152.84 46.27 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 114.166 -1.379 . . . . 0.0 110.242 179.535 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -71.72 113.99 9.33 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.882 0.372 . . . . 0.0 110.058 179.615 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 65.9 30.3 76.82 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.917 -0.658 . . . . 0.0 112.577 -179.588 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.409 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 29.2 t70 -57.87 159.5 5.41 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.96 0.41 . . . . 0.0 111.142 -179.851 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.458 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 0.6 OUTLIER -146.55 135.79 22.72 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.377 -179.932 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.452 HD12 HG23 ' A' ' 130' ' ' ILE . 10.4 mm -113.31 128.86 69.91 Favored 'Isoleucine or valine' 0 C--O 1.232 0.132 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.3 178.815 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.49 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 53.8 m -103.17 144.65 31.04 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.477 -179.804 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.474 ' HB ' ' NE2' ' A' ' 88' ' ' HIS . 9.7 m -140.57 157.7 24.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.039 0.447 . . . . 0.0 112.18 -178.927 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 70.43 42.19 65.16 Favored Glycine 0 N--CA 1.446 -0.65 0 CA-C-N 115.725 -0.67 . . . . 0.0 112.404 179.436 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.417 ' HA ' HG12 ' A' ' 140' ' ' ILE . 94.6 t -78.13 156.81 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 CA-C-O 121.394 0.616 . . . . 0.0 112.032 -179.256 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . 0.408 ' N ' ' CG1' ' A' ' 134' ' ' VAL . . . 149.82 -42.68 0.78 Allowed Glycine 0 N--CA 1.443 -0.896 0 N-CA-C 110.627 -0.989 . . . . 0.0 110.627 -179.248 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 48.0 t -126.66 131.3 71.34 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 CA-C-N 115.271 -0.464 . . . . 0.0 109.89 178.791 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.07 -33.67 26.81 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.769 0.319 . . . . 0.0 111.257 -179.425 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 2.0 p -94.16 6.24 49.22 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 112.251 0.464 . . . . 0.0 112.251 -179.535 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -128.1 29.91 5.31 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-O 121.137 0.494 . . . . 0.0 112.265 -179.467 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.49 ' CG2' ' CG2' ' A' ' 131' ' ' THR . 26.9 mt -104.71 141.34 20.38 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.268 179.22 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 5.8 mp -118.88 135.19 54.69 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.015 -0.993 . . . . 0.0 110.633 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.41 ' HB3' ' CG2' ' A' ' 40' ' ' THR . 46.9 t -118.76 152.4 36.25 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.691 0.758 . . . . 0.0 112.547 -179.178 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.458 ' O ' ' HA ' ' A' ' 129' ' ' GLU . 1.5 tm? -134.72 137.55 43.6 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 114.589 -1.187 . . . . 0.0 109.019 179.427 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 25.5 t -128.4 140.01 50.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 C-N-CA 120.75 -0.38 . . . . 0.0 111.858 -179.062 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 1.1 tt -109.08 139.84 30.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.725 179.461 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 16.8 t80 -118.1 103.85 10.28 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.777 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 2.5 mp -92.56 129.37 43.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.175 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 12.2 p30 -78.6 132.08 36.97 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.017 -179.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 50.2 m-20 -64.49 -21.38 66.65 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.095 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 3.1 mmpt? -57.49 -43.66 84.33 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-O 120.953 0.406 . . . . 0.0 110.564 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 19.0 t80 -58.96 -44.62 91.5 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.67 179.731 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 1.7 mttt -65.0 -35.55 81.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.807 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 11.7 tt0 -63.14 -39.98 96.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.907 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 11.8 t -61.22 -44.96 96.43 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.94 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -58.82 -45.45 89.92 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.872 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -60.87 -40.74 94.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.832 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -66.94 -25.76 66.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.992 179.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -115.16 31.61 6.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.9 -179.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.97 115.41 20.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.872 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 25.2 m -77.82 120.16 27.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.143 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -111.76 -164.84 0.94 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.805 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 31.8 mtm180 -49.3 132.7 20.04 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.194 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 20.5 mm -78.56 110.04 13.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.137 -179.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.196 -0.907 . . . . 0.0 111.07 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.356 0 N-CA-C 112.479 -0.248 . . . . 0.0 112.479 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -117.85 81.43 1.66 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.915 0.388 . . . . 0.0 110.884 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -171.7 151.73 2.95 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.843 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 21.9 mm -102.9 136.15 36.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.122 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 18.8 p -135.7 157.64 46.38 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.239 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -114.67 115.31 44.14 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.849 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_exo -51.01 108.92 0.26 Allowed 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.446 2.097 . . . . 0.0 112.372 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -115.34 -9.01 12.23 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.541 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 69.53 -66.93 0.24 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.74 0.305 . . . . 0.0 111.035 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -168.95 107.36 0.44 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.981 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 32.3 t -148.61 161.77 41.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.953 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 9.5 t -125.59 176.24 7.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.075 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 72.0 mt-30 -106.04 101.58 11.06 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.887 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -168.14 -53.81 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.089 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 10.8 p 55.78 29.99 14.91 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.264 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 5.7 tp60 -62.06 -46.91 87.05 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.832 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 2.9 ttm180 -67.08 -36.78 82.74 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.876 179.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -61.55 -35.76 78.69 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.762 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 36.6 mt -64.84 -42.22 95.1 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.864 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 31.6 mm -62.51 -42.0 94.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.977 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -57.84 -46.63 84.46 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.155 -179.874 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.72 -33.66 76.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.013 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -59.01 -47.81 83.85 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.126 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 20.5 p -57.16 -31.37 65.32 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.905 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 22.1 tm0? -88.41 -31.86 18.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.803 179.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -84.46 121.28 27.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.807 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -98.87 142.58 30.2 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.934 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 24.8 mm -82.0 139.51 17.82 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.337 0 CA-C-O 121.393 0.616 . . . . 0.0 111.707 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.416 ' HA2' ' CG2' ' A' ' 32' ' ' ILE . . . 111.89 17.88 8.19 Favored Glycine 0 C--N 1.316 -0.528 0 CA-C-N 114.936 -1.029 . . . . 0.0 112.733 179.907 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -89.36 -32.64 17.21 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.695 0.283 . . . . 0.0 111.484 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 38.1 m-80 -109.39 -14.27 14.46 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-O 121.946 0.879 . . . . 0.0 109.018 178.767 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.592 ' CG2' ' O ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -71.06 98.41 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.581 0 CA-C-N 113.935 -1.484 . . . . 0.0 110.922 -179.285 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.598 ' CG1' ' N ' ' A' ' 34' ' ' CYS . 0.5 OUTLIER -34.39 -60.62 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 114.96 -1.018 . . . . 0.0 112.058 -179.432 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.598 ' N ' ' CG1' ' A' ' 33' ' ' VAL . 19.7 m -159.81 149.36 18.12 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.454 -179.434 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.0 114.62 24.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.763 179.506 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.422 HG13 ' CZ ' ' A' ' 68' ' ' PHE . 26.7 t -90.29 124.64 43.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.686 179.712 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.487 ' CG2' HG12 ' A' ' 45' ' ' ILE . 31.2 mt -123.12 108.33 21.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.138 -0.483 . . . . 0.0 112.033 -179.35 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.457 ' SG ' ' HG ' ' A' ' 143' ' ' LEU . 0.8 OUTLIER -78.81 99.73 6.84 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 177.984 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 9.6 t -87.34 -28.65 22.1 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 -178.007 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.528 HG22 ' OG ' ' A' ' 142' ' ' SER . 66.0 p -58.72 -18.27 29.96 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.678 0.275 . . . . 0.0 111.655 -179.552 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 90.88 71.46 1.22 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.554 -0.831 . . . . 0.0 112.555 179.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 16.8 pt20 -142.99 -48.08 0.32 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.69 0.281 . . . . 0.0 111.151 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 14.8 mt -134.53 138.05 29.13 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.04 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.478 ' HD2' ' CZ ' ' A' ' 76' ' ' TYR . 33.4 Cg_exo -58.46 146.69 89.43 Favored 'Trans proline' 0 N--CA 1.465 -0.186 0 C-N-CA 122.445 2.097 . . . . 0.0 111.5 179.53 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.487 HG12 ' CG2' ' A' ' 37' ' ' ILE . 45.6 mt -45.46 129.93 2.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 112.376 0.51 . . . . 0.0 112.376 -179.096 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 6.3 tpt180 -120.31 130.61 54.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.646 178.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 8.7 p30 -105.83 122.27 45.76 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.346 0.499 . . . . 0.0 112.346 -178.798 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.444 ' HB3' ' CE2' ' A' ' 66' ' ' TRP . 0.3 OUTLIER -97.52 133.63 41.84 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 178.384 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.517 ' HB3' HG12 ' A' ' 32' ' ' ILE . 0.0 OUTLIER -134.27 164.44 27.39 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 113.67 0.989 . . . . 0.0 113.67 -178.333 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.502 ' HB2' HG22 ' A' ' 33' ' ' VAL . . . -151.33 166.23 31.61 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 114.484 -1.234 . . . . 0.0 110.667 179.041 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.436 ' CB ' ' HG2' ' A' ' 54' ' ' GLN . 1.4 m-20 -106.04 136.34 45.89 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.08 0.467 . . . . 0.0 111.29 -179.679 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 18.5 mm -63.86 -38.93 83.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.483 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.7 t -56.09 -33.48 65.1 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.14 -179.244 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.436 ' HG2' ' CB ' ' A' ' 51' ' ' ASP . 9.8 mm100 -62.62 -36.79 83.91 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.025 -179.581 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 40.9 t -68.53 -48.67 71.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.997 179.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.0 tt -57.71 -33.37 68.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.876 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 24.2 ttmt -84.9 -59.02 2.47 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.777 179.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 52.52 89.68 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.274 179.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.8 mtmm -164.02 -76.84 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.75 179.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 7.0 mtt180 -85.29 -73.94 0.42 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.704 179.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -84.78 97.01 9.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.612 179.737 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -145.62 -42.73 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.386 -179.679 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.82 84.69 6.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.236 -179.659 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.409 ' O ' ' HB3' ' A' ' 93' ' ' LEU . 22.9 ttpt -104.09 131.66 51.13 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.19 179.335 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.473 ' CG1' ' O ' ' A' ' 91' ' ' ILE . 5.8 t -131.1 135.92 58.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.044 0.45 . . . . 0.0 111.916 -179.036 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . 0.62 ' HB2' ' HB ' ' A' ' 91' ' ' ILE . 14.6 m-90 -99.7 139.85 34.76 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.692 -0.686 . . . . 0.0 111.25 178.932 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.59 ' N ' ' HB2' ' A' ' 75' ' ' ASP . 12.0 m -123.57 129.07 50.63 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.541 0.686 . . . . 0.0 112.162 179.445 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.499 ' CE1' ' CG ' ' A' ' 75' ' ' ASP . 13.8 m-85 -100.37 118.1 35.92 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.069 -0.969 . . . . 0.0 109.104 178.077 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.596 ' HA2' ' O ' ' A' ' 85' ' ' SER . . . 159.21 -159.6 30.55 Favored Glycine 0 N--CA 1.444 -0.793 0 C-N-CA 119.287 -1.435 . . . . 0.0 112.708 179.459 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.407 ' HD3' ' HB3' ' A' ' 86' ' ' ASN . 0.0 OUTLIER -76.13 92.27 3.21 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-O 122.612 1.196 . . . . 0.0 109.05 -179.402 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.54 ' O ' ' CD2' ' A' ' 77' ' ' HIS . 6.0 m-80 -149.19 155.38 39.86 Favored Pre-proline 0 C--N 1.309 -1.175 0 CA-C-N 112.681 -2.054 . . . . 0.0 107.989 178.646 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.564 ' O ' ' CB ' ' A' ' 73' ' ' ALA . 25.2 Cg_exo -55.76 -7.87 1.79 Allowed 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 121.271 1.314 . . . . 0.0 111.32 177.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.615 ' HB3' ' HB2' ' A' ' 77' ' ' HIS . . . 132.99 52.7 0.0 OUTLIER 'General case' 0 CA--C 1.489 -1.379 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.223 178.765 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . 0.543 ' HB3' ' HB ' ' A' ' 67' ' ' THR . 0.1 OUTLIER -52.81 -69.52 0.11 Allowed 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 105.565 -2.013 . . . . 0.0 105.565 179.499 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.59 ' HB2' ' N ' ' A' ' 67' ' ' THR . 51.3 t0 -95.32 -47.81 6.15 Favored 'General case' 0 N--CA 1.433 -1.302 0 N-CA-C 105.776 -1.935 . . . . 0.0 105.776 169.65 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.493 ' C ' ' HA ' ' A' ' 73' ' ' ALA . 9.4 t80 -144.52 142.68 30.4 Favored 'General case' 0 C--N 1.346 0.424 0 CA-C-N 112.51 -2.132 . . . . 0.0 111.354 179.66 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . 0.615 ' HB2' ' HB3' ' A' ' 73' ' ' ALA . 22.4 t-160 -97.16 106.91 19.32 Favored 'General case' 0 CA--C 1.531 0.238 0 O-C-N 121.921 -0.487 . . . . 0.0 110.157 176.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.483 HD23 ' O ' ' A' ' 79' ' ' GLY . 0.0 OUTLIER -120.67 171.83 8.31 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 120.824 0.345 . . . . 0.0 111.692 179.749 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.483 ' O ' HD23 ' A' ' 78' ' ' LEU . . . -55.03 -167.86 0.04 OUTLIER Glycine 0 C--N 1.333 0.405 0 CA-C-N 116.022 -0.535 . . . . 0.0 113.126 -179.499 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -112.06 97.77 6.89 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.927 0.394 . . . . 0.0 111.768 -179.752 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.611 ' HB ' ' HB2' ' A' ' 85' ' ' SER . 3.2 mp -114.86 112.72 41.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.104 178.542 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 68.5 m -56.69 -24.16 47.05 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 -179.002 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 3.7 mtt180 -93.47 -102.15 0.13 Allowed 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 -178.487 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.434 ' O ' ' CB ' ' A' ' 85' ' ' SER . 0.0 OUTLIER -109.02 110.83 22.21 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-O 121.52 0.676 . . . . 0.0 110.691 -179.262 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.611 ' HB2' ' HB ' ' A' ' 81' ' ' ILE . 0.6 OUTLIER 158.99 -48.39 0.0 OUTLIER 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 114.247 -1.342 . . . . 0.0 109.478 179.796 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.792 ' O ' ' N ' ' A' ' 88' ' ' HIS . 94.1 m-20 -65.34 -153.45 0.01 OUTLIER 'General case' 0 CA--C 1.521 -0.151 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 177.779 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.55 76.71 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 179.105 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 1.071 ' O ' ' O ' ' A' ' 104' ' ' ILE . 36.3 t60 -101.58 -15.89 16.93 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 114.622 1.341 . . . . 0.0 114.622 -176.346 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.512 ' CD1' ' N ' ' A' ' 90' ' ' GLN . 0.1 OUTLIER -178.1 160.37 1.39 Allowed 'General case' 0 C--N 1.317 -0.848 0 C-N-CA 119.333 -0.947 . . . . 0.0 112.125 178.334 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.512 ' N ' ' CD1' ' A' ' 89' ' ' PHE . 14.7 mt-30 -137.45 160.82 38.03 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 113.694 0.998 . . . . 0.0 113.694 -178.031 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.62 ' HB ' ' HB2' ' A' ' 66' ' ' TRP . 2.5 mt -122.27 132.14 71.7 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 CA-C-N 115.109 -0.95 . . . . 0.0 108.998 177.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.443 ' N ' ' O ' ' A' ' 100' ' ' LEU . 1.9 mt -110.06 135.31 51.07 Favored 'General case' 0 N--CA 1.464 0.233 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 -178.732 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.503 ' HG ' HG22 ' A' ' 33' ' ' VAL . 1.2 tm? -126.42 136.64 52.92 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.245 178.752 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 125.7 -161.75 20.07 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.601 179.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 57.27 76.61 0.31 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.808 0.337 . . . . 0.0 110.506 -179.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 67.87 163.6 0.21 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.617 -179.545 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -59.48 86.41 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.488 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -179.59 159.42 0.88 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.822 0.344 . . . . 0.0 111.061 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -109.98 155.04 22.31 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.653 179.769 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.56 ' HA ' ' O ' ' A' ' 122' ' ' GLN . 4.4 mt -133.66 148.62 51.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.81 -179.813 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.44 ' O ' ' N ' ' A' ' 122' ' ' GLN . 1.6 mt -113.38 130.87 56.18 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 179.529 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.491 ' O ' ' O ' ' A' ' 90' ' ' GLN . 7.4 t30 -107.18 112.56 25.5 Favored 'General case' 0 CA--C 1.51 -0.59 0 C-N-CA 119.976 -0.69 . . . . 0.0 109.776 179.863 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.568 ' HB3' ' CG2' ' A' ' 109' ' ' THR . 29.1 m-20 -87.4 108.94 19.23 Favored 'General case' 0 N--CA 1.442 -0.872 0 C-N-CA 119.076 -1.05 . . . . 0.0 109.789 179.691 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 1.071 ' O ' ' O ' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -126.48 109.32 20.83 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.164 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 176.854 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.406 ' HB3' ' CE1' ' A' ' 88' ' ' HIS . 70.5 m -129.38 174.66 9.42 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.868 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 28.0 m -69.76 -63.29 1.1 Allowed 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 118.98 -1.088 . . . . 0.0 110.862 -179.557 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -112.52 -33.46 6.15 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 114.253 1.205 . . . . 0.0 114.253 178.593 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -147.1 136.71 6.26 Favored Glycine 0 C--N 1.34 0.795 0 N-CA-C 116.422 1.329 . . . . 0.0 116.422 -178.339 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.568 ' CG2' ' HB3' ' A' ' 103' ' ' ASP . 14.8 m -121.06 137.96 54.41 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 174.738 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . 0.718 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 3.0 m-90 -122.36 149.25 44.04 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 113.436 0.902 . . . . 0.0 113.436 -178.517 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -122.46 112.07 17.61 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 115.182 -0.917 . . . . 0.0 108.62 177.24 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 46.14 43.93 11.46 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.104 -0.498 . . . . 0.0 112.167 -179.573 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 79.91 20.92 66.89 Favored Glycine 0 N--CA 1.445 -0.76 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.93 179.153 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 13.6 mt-30 -133.82 97.79 4.0 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.039 0.447 . . . . 0.0 110.624 179.674 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.718 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.3 OUTLIER -44.92 134.17 5.89 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.843 179.856 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 15.0 m -121.25 177.25 3.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.141 0.496 . . . . 0.0 111.969 -178.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.404 ' HB3' ' HB3' ' A' ' 120' ' ' SER . 0.0 OUTLIER -82.83 141.13 32.51 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.676 179.799 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.401 ' O ' ' C ' ' A' ' 119' ' ' ASN . 0.0 OUTLIER -66.25 163.75 17.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.731 0.3 . . . . 0.0 110.537 179.711 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.401 ' C ' ' O ' ' A' ' 118' ' ' LYS . 0.5 OUTLIER 34.88 37.52 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.995 -179.639 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.426 ' OG ' ' NE2' ' A' ' 122' ' ' GLN . 10.1 p -111.3 105.16 13.73 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.858 -179.281 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -50.22 142.46 9.87 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.803 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . 0.56 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 30.1 mm-40 -128.75 144.15 51.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.207 0.527 . . . . 0.0 112.057 -179.662 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 16.6 tp -74.36 120.62 20.17 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.718 178.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.502 ' O ' HD11 ' A' ' 124' ' ' LEU . 0.0 OUTLIER -51.73 144.65 10.67 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 122.193 0.997 . . . . 0.0 112.202 -178.857 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' SER . . . . . 0.434 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.6 OUTLIER -127.15 153.15 46.41 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 113.871 -1.513 . . . . 0.0 110.022 179.499 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 5.7 tp-100 -70.62 113.5 7.79 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 179.647 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 68.35 28.6 73.19 Favored Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.394 -179.359 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.434 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 9.7 t70 -58.85 158.86 7.61 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.984 0.421 . . . . 0.0 111.308 -179.719 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.414 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 0.4 OUTLIER -147.12 135.71 21.96 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.565 179.871 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.424 ' CG2' ' O ' ' A' ' 110' ' ' TRP . 2.0 mp -108.86 129.12 64.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.299 -0.41 . . . . 0.0 109.994 178.559 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.492 ' O ' ' HB2' ' A' ' 110' ' ' TRP . 69.5 m -102.31 142.37 33.64 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.0 0.428 . . . . 0.0 110.519 -179.53 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.47 ' HB ' ' NE2' ' A' ' 88' ' ' HIS . 5.2 m -141.24 158.37 22.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.132 -0.485 . . . . 0.0 112.21 -178.592 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 69.87 44.43 62.1 Favored Glycine 0 N--CA 1.446 -0.645 0 CA-C-N 115.911 -0.586 . . . . 0.0 112.086 179.545 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.461 ' HA ' HG12 ' A' ' 140' ' ' ILE . 81.8 t -80.18 153.1 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 CA-C-O 121.526 0.679 . . . . 0.0 112.261 -178.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 148.14 -44.52 0.77 Allowed Glycine 0 N--CA 1.44 -1.075 0 N-CA-C 110.374 -1.09 . . . . 0.0 110.374 -178.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 41.3 t -126.8 127.83 70.35 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.764 0 CA-C-N 115.103 -0.549 . . . . 0.0 109.641 178.499 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -51.07 -29.61 13.47 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.789 0.328 . . . . 0.0 111.308 -179.202 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -94.31 6.48 48.56 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -179.56 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -128.77 25.61 5.64 Favored 'General case' 0 CA--C 1.519 -0.223 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 -179.402 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.461 ' CG2' ' CG2' ' A' ' 131' ' ' THR . 13.4 mt -103.13 140.67 20.74 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.003 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.447 179.233 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -124.24 134.53 53.22 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.017 -0.992 . . . . 0.0 109.798 179.196 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.528 ' OG ' HG22 ' A' ' 40' ' ' THR . 0.9 OUTLIER -119.33 150.95 39.29 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.408 0.623 . . . . 0.0 112.504 -178.78 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.457 ' HG ' ' SG ' ' A' ' 38' ' ' CYS . 5.7 mp -122.77 132.99 54.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.325 179.342 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 4.7 t -114.15 140.28 35.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 120.872 0.368 . . . . 0.0 111.426 -179.432 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . 0.45 HD13 HG23 ' A' ' 145' ' ' ILE . 0.2 OUTLIER -120.66 127.68 75.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.821 179.893 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 18.6 t80 -105.08 103.78 13.39 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.54 179.786 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 2.7 mp -87.91 128.45 40.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.053 -179.776 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 25.9 p-10 -78.3 120.7 23.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.003 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -71.35 -24.67 62.14 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.957 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 4.2 mttt -57.38 -40.53 78.35 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.947 0.403 . . . . 0.0 110.595 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 19.9 t80 -59.99 -40.17 88.27 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.613 179.746 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.17 -37.91 87.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.885 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -61.02 -38.4 85.98 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.842 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 9.8 t -65.88 -43.82 87.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.827 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -58.0 -44.17 87.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.9 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -60.75 -34.08 73.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.847 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.81 -22.71 62.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.141 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -109.64 27.81 9.19 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.057 -179.718 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 1.1 mtmm -125.63 121.4 33.43 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.909 179.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 31.5 t -90.23 124.05 42.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.079 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -88.55 -29.94 19.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.796 179.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 11.3 ttt180 -172.36 155.65 3.57 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.738 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 23.1 pt -76.89 138.01 21.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.161 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.023 0 CA-C-O 118.198 -0.906 . . . . 0.0 110.843 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.375 0 N-CA-C 112.529 -0.228 . . . . 0.0 112.529 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -84.46 -45.93 12.17 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.754 0.311 . . . . 0.0 110.847 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 5.0 p30 -102.96 169.19 8.73 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.853 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 8.4 tp -78.65 110.73 14.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.101 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.9 t -147.2 166.61 26.48 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.926 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 59.23 64.89 2.91 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.823 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_exo -51.86 177.6 0.05 OUTLIER 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.607 2.205 . . . . 0.0 112.389 -179.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 25.8 p -119.42 -176.37 3.13 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.087 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 69.0 tp60 -115.18 151.78 33.81 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.936 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -62.75 109.19 1.35 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.855 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 60.6 p -75.84 -168.68 0.93 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.983 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -57.63 138.69 55.06 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.189 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -135.87 152.22 50.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.944 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -162.12 -168.3 1.86 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.968 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 56.6 p -73.84 64.26 0.95 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.073 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -62.3 -44.42 96.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.918 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.68 -36.57 81.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.918 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 57.5 t80 -57.45 -35.83 70.62 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.912 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 10.7 mt -61.26 -40.43 94.05 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.79 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 34.7 mm -70.45 -36.74 67.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.044 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -57.66 -43.0 84.66 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.075 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 2.6 mtpt -62.03 -41.97 98.67 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.917 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -63.5 -47.76 80.4 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.021 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -66.02 -21.52 66.4 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.133 179.826 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 76.2 161.13 0.23 Allowed 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.839 -179.875 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -62.31 131.33 48.98 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.965 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 11.7 pm0 -101.36 135.22 43.21 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.85 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 24.6 mm -83.14 139.61 17.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.457 0.646 . . . . 0.0 111.581 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -102.6 63.36 0.45 Allowed Glycine 0 C--N 1.317 -0.477 0 CA-C-N 114.952 -1.022 . . . . 0.0 112.617 -179.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -88.45 -23.82 23.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.716 0.293 . . . . 0.0 111.119 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -109.17 -14.08 14.56 Favored 'General case' 0 CA--C 1.514 -0.409 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 178.405 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.55 HG12 ' HB3' ' A' ' 49' ' ' SER . 0.1 OUTLIER -71.15 108.44 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.66 0 CA-C-N 113.888 -1.505 . . . . 0.0 110.933 -179.499 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.51 HG22 ' C ' ' A' ' 49' ' ' SER . 2.3 t -48.21 -66.3 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.769 0 CA-C-N 115.19 -0.914 . . . . 0.0 111.364 -179.498 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 31.9 p -162.98 164.59 25.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.676 179.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 8.1 ttm180 -122.98 123.76 41.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.189 -179.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.41 ' CG2' ' CD1' ' A' ' 48' ' ' LEU . 3.3 t -91.58 122.13 42.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.754 179.666 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.461 ' CG2' HG12 ' A' ' 45' ' ' ILE . 26.7 mt -121.61 107.81 20.9 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 CA-C-N 116.263 -0.426 . . . . 0.0 112.006 -179.547 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 88.8 m -81.86 102.2 10.7 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 178.076 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.0 p -89.79 2.96 54.26 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 -178.076 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.607 HG22 ' HB2' ' A' ' 142' ' ' SER . 77.2 p -94.59 -6.78 42.75 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.038 0.384 . . . . 0.0 112.038 -179.769 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 85.91 91.58 0.88 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.606 179.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 16.3 pt20 -172.41 -45.86 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.108 0.48 . . . . 0.0 110.516 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.484 HG21 ' CD2' ' A' ' 76' ' ' TYR . 5.1 mt -131.87 140.43 38.17 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.718 179.899 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.48 ' CG ' ' CE1' ' A' ' 76' ' ' TYR . 74.2 Cg_endo -78.46 147.01 22.28 Favored 'Trans proline' 0 N--CA 1.462 -0.377 0 C-N-CA 122.324 2.016 . . . . 0.0 112.141 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.461 HG12 ' CG2' ' A' ' 37' ' ' ILE . 27.3 mt -43.12 122.21 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 121.222 0.534 . . . . 0.0 111.827 -179.493 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.408 ' HG2' ' O ' ' A' ' 75' ' ' ASP . 0.0 OUTLIER -121.49 130.21 53.41 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.099 179.463 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.435 ' HB2' ' CD1' ' A' ' 32' ' ' ILE . 3.8 p30 -93.14 120.11 33.07 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.06 0.457 . . . . 0.0 111.413 -179.302 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.603 ' HB3' ' CE2' ' A' ' 66' ' ' TRP . 0.8 OUTLIER -94.36 121.73 36.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.642 179.249 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.55 ' HB3' HG12 ' A' ' 32' ' ' ILE . 0.0 OUTLIER -130.98 154.56 48.03 Favored 'General case' 0 CA--C 1.517 -0.323 0 N-CA-C 114.295 1.22 . . . . 0.0 114.295 -179.205 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.492 ' N ' ' CG2' ' A' ' 33' ' ' VAL . . . -133.22 166.07 23.32 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 113.587 -1.642 . . . . 0.0 110.832 178.753 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.456 ' CB ' ' HG3' ' A' ' 54' ' ' GLN . 60.6 m-20 -91.08 97.26 11.05 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.065 0.46 . . . . 0.0 111.014 -179.815 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.408 HD11 ' CD2' ' A' ' 151' ' ' PHE . 4.4 mt -63.81 -31.15 52.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.704 -179.701 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 27.8 t -56.44 -35.01 67.38 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.218 -179.027 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.456 ' HG3' ' CB ' ' A' ' 51' ' ' ASP . 6.7 mt-30 -68.12 -36.96 80.56 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.806 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 6.0 t -67.37 -44.88 86.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.082 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -69.16 -28.9 66.83 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.002 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.89 -50.96 8.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.979 -179.919 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -104.61 141.83 35.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.003 -179.861 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 3.0 ttpm? -58.94 -30.92 68.23 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.988 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 41.6 ttt-85 -159.38 107.63 1.8 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.928 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 21.1 t -152.7 51.35 0.76 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.894 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 7.1 mm -106.03 134.27 48.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.011 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.6 68.29 0.07 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.012 0.435 . . . . 0.0 111.058 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 7.8 ttpt -138.01 132.09 31.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.667 179.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.485 ' CG1' ' O ' ' A' ' 91' ' ' ILE . 21.5 t -135.35 138.82 47.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.14 0.495 . . . . 0.0 111.707 -179.407 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . 0.62 ' HB2' ' HB ' ' A' ' 91' ' ' ILE . 14.7 m-90 -99.91 139.95 34.83 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.6 179.297 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.539 ' O ' ' N ' ' A' ' 75' ' ' ASP . 30.5 m -131.39 131.85 43.95 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.53 0.681 . . . . 0.0 112.162 179.744 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.474 ' CE1' ' CG ' ' A' ' 75' ' ' ASP . 7.3 m-85 -103.24 119.06 38.16 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 114.897 -1.047 . . . . 0.0 109.086 177.873 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.632 ' HA2' ' O ' ' A' ' 85' ' ' SER . . . 158.7 -155.96 26.99 Favored Glycine 0 CA--C 1.503 -0.706 0 C-N-CA 118.832 -1.652 . . . . 0.0 113.098 179.389 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.41 ' O ' ' HG3' ' A' ' 70' ' ' ARG . 3.1 ptm180 -76.37 91.77 3.3 Favored 'General case' 0 N--CA 1.441 -0.888 0 CA-C-O 122.587 1.184 . . . . 0.0 108.747 -179.614 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.502 ' O ' ' CD2' ' A' ' 77' ' ' HIS . 15.7 m-80 -149.98 154.53 37.09 Favored Pre-proline 0 C--N 1.308 -1.218 0 CA-C-N 112.857 -1.974 . . . . 0.0 108.337 178.758 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.548 ' O ' ' CB ' ' A' ' 73' ' ' ALA . 21.8 Cg_exo -57.18 -8.25 3.35 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 121.115 1.21 . . . . 0.0 110.934 177.679 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.611 ' HB3' ' HB2' ' A' ' 77' ' ' HIS . . . 135.04 53.45 0.0 OUTLIER 'General case' 0 CA--C 1.489 -1.402 0 CA-C-N 114.901 -1.045 . . . . 0.0 109.08 179.041 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . 0.508 ' HB3' ' HB ' ' A' ' 67' ' ' THR . 0.1 OUTLIER -52.28 -69.6 0.11 Allowed 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 105.599 -2.0 . . . . 0.0 105.599 179.708 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.539 ' N ' ' O ' ' A' ' 67' ' ' THR . 4.9 t70 -95.45 -47.87 6.09 Favored 'General case' 0 N--CA 1.436 -1.174 0 N-CA-C 105.426 -2.064 . . . . 0.0 105.426 169.085 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.51 ' C ' ' HA ' ' A' ' 73' ' ' ALA . 73.3 t80 -143.26 142.1 31.26 Favored 'General case' 0 C--N 1.347 0.493 0 CA-C-N 112.512 -2.131 . . . . 0.0 111.334 179.825 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . 0.611 ' HB2' ' HB3' ' A' ' 73' ' ' ALA . 23.8 t-160 -91.78 110.23 21.57 Favored 'General case' 0 C--N 1.33 -0.247 0 O-C-N 122.027 -0.421 . . . . 0.0 110.013 177.327 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.451 ' HB3' ' CE2' ' A' ' 76' ' ' TYR . 1.1 pp -129.57 174.6 9.51 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.969 0.414 . . . . 0.0 111.494 -179.642 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -58.6 175.33 2.63 Favored Glycine 0 C--N 1.333 0.41 0 C-N-CA 120.939 -0.648 . . . . 0.0 112.311 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 15.5 p-10 -112.04 99.28 7.95 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.902 0.382 . . . . 0.0 111.847 -179.628 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.671 ' HB ' ' HB2' ' A' ' 85' ' ' SER . 16.5 mm -113.91 118.39 58.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.036 178.45 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -53.46 -24.03 11.76 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 111.807 0.299 . . . . 0.0 111.807 -179.056 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 6.2 mpt_? -86.72 -106.85 0.06 Allowed 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 121.222 -0.191 . . . . 0.0 111.378 -179.661 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.466 ' CD1' ' N ' ' A' ' 84' ' ' LEU . 0.0 OUTLIER -109.36 110.22 21.31 Favored 'General case' 0 CA--C 1.512 -0.482 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 179.036 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.671 ' HB2' ' HB ' ' A' ' 81' ' ' ILE . 0.4 OUTLIER 162.25 -40.66 0.0 OUTLIER 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 114.709 -1.132 . . . . 0.0 109.427 -179.525 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.802 ' O ' ' N ' ' A' ' 88' ' ' HIS . 95.1 m-20 -64.25 -153.81 0.01 OUTLIER 'General case' 0 CA--C 1.52 -0.191 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 177.597 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.413 ' HA ' ' HA3' ' A' ' 69' ' ' GLY . 0.0 OUTLIER -54.05 71.28 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 178.313 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.964 ' O ' ' O ' ' A' ' 104' ' ' ILE . 36.2 t60 -80.82 -17.6 50.28 Favored 'General case' 0 CA--C 1.514 -0.412 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 -176.789 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.484 ' HA ' ' H ' ' A' ' 104' ' ' ILE . 0.0 OUTLIER -174.57 156.3 2.38 Favored 'General case' 0 C--N 1.31 -1.111 0 C-N-CA 119.23 -0.988 . . . . 0.0 112.981 178.024 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.497 ' O ' ' O ' ' A' ' 102' ' ' ASN . 36.6 mt-30 -138.1 161.02 37.86 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.502 -1.226 . . . . 0.0 113.958 -177.829 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.62 ' HB ' ' HB2' ' A' ' 66' ' ' TRP . 6.2 mt -127.84 126.6 67.01 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-N 115.006 -0.997 . . . . 0.0 109.13 178.037 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.419 ' O ' ' N ' ' A' ' 100' ' ' LEU . 0.3 OUTLIER -107.4 142.41 37.28 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.961 0.41 . . . . 0.0 111.974 -178.781 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.405 ' N ' ' CD1' ' A' ' 92' ' ' LEU . 0.5 OUTLIER -125.78 125.41 42.9 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.693 179.356 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 137.61 89.06 0.22 Allowed Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.59 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -176.98 84.93 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.868 0.366 . . . . 0.0 110.904 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 50.5 m-20 58.66 44.46 17.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.899 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 59.97 59.51 10.33 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.418 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -152.09 178.54 9.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.802 0.334 . . . . 0.0 110.864 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.449 ' HB2' ' HB2' ' A' ' 124' ' ' LEU . 2.3 mp -112.09 151.65 29.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.761 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.591 ' HA ' ' O ' ' A' ' 122' ' ' GLN . 0.8 OUTLIER -132.47 147.96 52.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.107 179.987 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.468 ' O ' ' N ' ' A' ' 122' ' ' GLN . 1.0 OUTLIER -116.04 126.28 53.57 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 120.623 -0.431 . . . . 0.0 110.363 -179.81 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.497 ' O ' ' O ' ' A' ' 90' ' ' GLN . 33.5 t30 -111.57 111.47 22.49 Favored 'General case' 0 CA--C 1.51 -0.58 0 C-N-CA 119.988 -0.685 . . . . 0.0 109.448 179.539 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.587 ' HB3' ' CG2' ' A' ' 109' ' ' THR . 74.4 m-20 -83.37 111.5 19.06 Favored 'General case' 0 N--CA 1.442 -0.857 0 C-N-CA 119.623 -0.831 . . . . 0.0 109.603 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.964 ' O ' ' O ' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -123.35 107.95 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.969 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 177.533 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.419 ' OG ' ' NE2' ' A' ' 88' ' ' HIS . 63.7 m -132.17 171.12 14.06 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 115.05 -0.977 . . . . 0.0 109.331 179.778 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 25.1 m -69.52 -63.36 1.08 Allowed 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 119.143 -1.023 . . . . 0.0 111.541 -179.157 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -112.5 -32.75 6.37 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 114.63 1.345 . . . . 0.0 114.63 179.015 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -146.04 128.16 2.99 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 116.988 1.555 . . . . 0.0 116.988 -177.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.587 ' CG2' ' HB3' ' A' ' 103' ' ' ASP . 3.4 m -121.1 138.29 54.26 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 174.483 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . 0.667 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.3 m-90 -119.35 149.24 42.15 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 -178.535 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -120.9 112.08 18.33 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 115.177 -0.92 . . . . 0.0 108.691 177.483 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 39.7 m-20 45.24 43.29 7.93 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.074 -0.512 . . . . 0.0 112.24 -179.522 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 80.35 23.37 60.94 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.947 179.13 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 42.3 mt-30 -135.61 99.07 4.1 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.017 0.437 . . . . 0.0 110.861 179.647 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.667 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.0 OUTLIER -43.98 123.64 3.41 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.08 179.87 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 5.4 m -114.92 -179.74 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.7 -179.218 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -87.29 140.13 29.85 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.824 -0.626 . . . . 0.0 111.011 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.41 ' HG2' ' N ' ' A' ' 119' ' ' ASN . 54.2 tttm -63.63 162.69 12.58 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.25 179.518 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.41 ' N ' ' HG2' ' A' ' 118' ' ' LYS . 4.1 p30 34.85 38.87 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.228 0.537 . . . . 0.0 111.372 -179.865 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 6.9 p -111.04 108.71 18.52 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.973 -179.533 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . 0.415 ' ND2' ' CD2' ' A' ' 92' ' ' LEU . 27.9 m120 -54.91 144.66 22.21 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.633 179.882 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . 0.591 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 65.8 mm-40 -129.88 149.39 51.63 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.04 0.448 . . . . 0.0 112.084 -179.346 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 9.8 tt -77.27 120.5 22.4 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.357 178.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.449 ' HB2' ' HB2' ' A' ' 99' ' ' LEU . 8.2 tp -46.39 141.98 3.26 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 122.06 0.933 . . . . 0.0 112.022 -178.549 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -127.29 152.85 46.89 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 113.811 -1.541 . . . . 0.0 110.215 179.567 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 9.6 tp60 -71.79 113.67 9.07 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 179.301 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 64.87 31.58 81.39 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.323 -179.351 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -54.9 160.13 2.07 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.978 0.418 . . . . 0.0 111.207 -179.758 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.475 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 13.8 tt0 -146.48 135.35 22.39 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.642 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.418 ' CG2' ' O ' ' A' ' 110' ' ' TRP . 1.1 mp -112.94 128.47 69.66 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.121 0 CA-C-N 116.363 -0.38 . . . . 0.0 109.986 178.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.464 ' HB ' ' CB ' ' A' ' 110' ' ' TRP . 16.0 m -103.16 144.77 30.88 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.478 -179.748 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.47 ' HB ' ' NE2' ' A' ' 88' ' ' HIS . 5.4 m -141.37 158.16 22.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 112.581 0.586 . . . . 0.0 112.581 -178.715 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 67.04 42.81 92.06 Favored Glycine 0 N--CA 1.449 -0.494 0 CA-C-N 115.595 -0.729 . . . . 0.0 112.312 179.253 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.51 ' HA ' HG12 ' A' ' 140' ' ' ILE . 89.8 t -76.79 153.3 5.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-O 121.479 0.656 . . . . 0.0 112.268 -179.176 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 148.65 -42.03 0.85 Allowed Glycine 0 N--CA 1.441 -0.99 0 CA-C-N 114.888 -1.051 . . . . 0.0 110.655 -178.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 47.6 t -126.62 131.4 71.28 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 CA-C-N 115.172 -0.514 . . . . 0.0 109.743 178.698 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -51.3 -34.61 34.01 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.737 0.303 . . . . 0.0 111.445 -179.229 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -94.17 6.32 48.96 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 112.343 0.497 . . . . 0.0 112.343 -179.288 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -125.65 26.72 6.64 Favored 'General case' 0 CA--C 1.518 -0.252 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 -179.367 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.51 HG12 ' HA ' ' A' ' 134' ' ' VAL . 14.9 mt -105.5 140.81 22.4 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.967 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.267 179.069 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -117.73 130.01 56.06 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.901 179.327 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.607 ' HB2' HG22 ' A' ' 40' ' ' THR . 0.8 OUTLIER -116.37 139.06 50.81 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.417 0.627 . . . . 0.0 112.397 -178.845 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.475 ' O ' ' HA ' ' A' ' 129' ' ' GLU . 4.8 mp -118.25 138.98 51.98 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.14 -0.937 . . . . 0.0 109.331 179.083 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 21.7 t -123.41 140.5 46.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 120.809 0.338 . . . . 0.0 111.816 -179.034 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -113.63 126.7 71.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.554 179.657 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 80.0 t80 -111.27 123.78 50.89 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.948 -179.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 2.8 mp -106.27 132.24 53.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.111 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . 0.408 ' ND2' HG23 ' A' ' 32' ' ' ILE . 8.9 p30 -81.65 141.7 33.41 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.104 -179.795 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -73.93 -19.45 60.68 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.375 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 12.7 mptt -58.19 -44.83 88.28 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.958 0.408 . . . . 0.0 110.815 -179.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . 0.408 ' CD2' HD11 ' A' ' 52' ' ' ILE . 14.0 t80 -59.58 -43.61 93.58 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.886 -179.933 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 14.8 tttt -64.57 -34.24 77.79 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.953 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -59.1 -46.05 89.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.917 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 12.1 t -61.16 -45.42 94.7 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.78 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -66.39 -35.78 81.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.835 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 79.8 tt0 -59.44 -36.44 75.92 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.916 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 13.6 mm-40 -76.31 -32.12 58.56 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.875 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -122.4 80.22 1.7 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.899 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 2.3 tttt -125.19 136.59 53.73 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.931 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 12.4 p -96.44 134.57 33.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.109 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -110.48 -69.18 0.88 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.881 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 6.4 ttt180 68.48 -68.28 0.18 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.032 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 10.3 mt -86.18 130.26 36.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.059 -179.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.148 -0.93 . . . . 0.0 110.936 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.611 ' O ' HD11 ' A' ' 52' ' ' ILE . 0.7 OUTLIER . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.742 0.305 . . . . 0.0 111.071 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 13.8 m-20 -109.15 -13.42 14.68 Favored 'General case' 0 CA--C 1.514 -0.422 0 CA-C-O 121.983 0.897 . . . . 0.0 108.742 178.631 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.58 ' O ' ' CG2' ' A' ' 32' ' ' ILE . 0.1 OUTLIER -70.23 97.32 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.577 0 CA-C-N 114.0 -1.455 . . . . 0.0 110.731 -179.317 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.857 HG23 ' HB3' ' A' ' 50' ' ' ALA . 0.9 OUTLIER -36.99 -61.94 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 114.839 -1.073 . . . . 0.0 112.169 -179.245 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.765 ' SG ' HD12 ' A' ' 48' ' ' LEU . 28.0 p -163.9 164.85 23.23 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.116 0.484 . . . . 0.0 112.027 -179.621 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 4.1 ttm180 -122.45 127.46 49.65 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.634 179.804 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.623 HG11 ' HZ ' ' A' ' 68' ' ' PHE . 11.7 p -99.29 128.62 50.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.271 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.829 HG23 HG12 ' A' ' 45' ' ' ILE . 25.0 mt -127.08 108.31 18.44 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.601 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.735 ' SG ' HD23 ' A' ' 143' ' ' LEU . 0.1 OUTLIER -86.43 100.2 12.18 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 178.617 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.404 HG23 ' N ' ' A' ' 40' ' ' THR . 8.9 t -65.55 -40.66 93.12 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.416 0.524 . . . . 0.0 112.416 -178.637 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.404 ' N ' HG23 ' A' ' 39' ' ' THR . 0.2 OUTLIER -55.75 -33.97 64.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.867 0.365 . . . . 0.0 111.172 -179.345 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 114.36 0.21 23.6 Favored Glycine 0 CA--C 1.518 0.222 0 C-N-CA 120.553 -0.832 . . . . 0.0 113.575 179.217 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.76 ' HB3' HD12 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -61.39 -45.63 93.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.066 0.46 . . . . 0.0 110.86 179.904 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.76 HD12 ' HB3' ' A' ' 42' ' ' GLN . 4.3 mp -131.04 141.54 42.33 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.1 -179.644 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.628 ' HD2' HG23 ' A' ' 43' ' ' ILE . 96.3 Cg_endo -81.12 147.08 16.28 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 122.512 2.141 . . . . 0.0 111.591 179.451 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.829 HG12 HG23 ' A' ' 37' ' ' ILE . 40.4 mt -42.19 109.59 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.034 0.445 . . . . 0.0 111.78 -179.473 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.401 ' O ' HG12 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -115.01 132.34 56.63 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.843 179.513 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.4 ' HB3' ' CD1' ' A' ' 32' ' ' ILE . 3.7 m-20 -85.99 119.6 26.46 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.108 0.48 . . . . 0.0 111.609 -179.276 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.765 HD12 ' SG ' ' A' ' 34' ' ' CYS . 2.9 mt -96.43 125.85 41.22 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 178.615 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.527 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -132.64 161.86 32.85 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 113.874 1.064 . . . . 0.0 113.874 -178.045 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.857 ' HB3' HG23 ' A' ' 33' ' ' VAL . . . -151.52 164.98 35.62 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.02 -1.445 . . . . 0.0 110.806 178.867 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -87.41 123.87 32.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.957 0.408 . . . . 0.0 111.325 -179.547 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.611 HD11 ' O ' ' A' ' 30' ' ' GLU . 18.0 mt . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.338 179.751 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 52.3 mttt . . . . . 0 N--CA 1.457 -0.102 0 CA-C-O 120.897 0.379 . . . . 0.0 111.579 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 4.9 ttpt -140.36 131.37 26.2 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.262 179.228 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.647 HG13 ' O ' ' A' ' 91' ' ' ILE . 18.4 t -137.46 137.95 45.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.174 0.511 . . . . 0.0 112.232 -178.752 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' TRP . . . . . 0.683 ' HB2' ' HB ' ' A' ' 91' ' ' ILE . 14.5 m-90 -99.78 140.48 33.93 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.372 178.719 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.627 HG23 ' HG2' ' A' ' 90' ' ' GLN . 33.6 m -128.44 137.18 51.71 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.554 0.692 . . . . 0.0 112.084 179.237 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.623 ' HZ ' HG11 ' A' ' 36' ' ' VAL . 13.0 m-85 -109.07 119.01 38.26 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.124 -0.944 . . . . 0.0 109.203 178.222 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.648 ' HA2' ' O ' ' A' ' 85' ' ' SER . . . 156.82 -152.81 24.16 Favored Glycine 0 CA--C 1.503 -0.66 0 C-N-CA 118.71 -1.71 . . . . 0.0 113.412 179.16 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.462 ' CG ' ' HA ' ' A' ' 80' ' ' ASN . 62.1 mtp180 -75.06 91.44 2.55 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-O 122.513 1.149 . . . . 0.0 108.615 -179.629 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -150.54 159.27 34.87 Favored Pre-proline 0 C--N 1.309 -1.183 0 CA-C-N 112.744 -2.026 . . . . 0.0 108.153 179.004 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.553 ' O ' ' HB2' ' A' ' 77' ' ' HIS . 34.7 Cg_endo -66.04 -7.08 15.98 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 120.79 0.993 . . . . 0.0 110.683 177.689 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.751 ' HB2' ' HB2' ' A' ' 77' ' ' HIS . . . 136.91 54.22 0.0 OUTLIER 'General case' 0 CA--C 1.488 -1.41 0 CA-C-N 114.338 -1.301 . . . . 0.0 108.887 178.999 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.528 ' HB3' ' HB ' ' A' ' 67' ' ' THR . 0.1 OUTLIER -52.46 -69.9 0.1 Allowed 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 105.58 -2.007 . . . . 0.0 105.58 179.826 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.592 ' HB2' ' N ' ' A' ' 67' ' ' THR . 62.0 t0 -96.04 -47.18 6.2 Favored 'General case' 0 N--CA 1.437 -1.103 0 N-CA-C 105.383 -2.08 . . . . 0.0 105.383 168.895 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.505 ' CE2' ' HB3' ' A' ' 78' ' ' LEU . 57.2 t80 -142.75 142.22 31.9 Favored 'General case' 0 C--N 1.35 0.599 0 CA-C-N 112.767 -2.015 . . . . 0.0 111.347 179.565 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' HIS . . . . . 0.751 ' HB2' ' HB2' ' A' ' 73' ' ' ALA . 1.6 t60 -93.11 112.54 24.52 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 177.194 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.796 HD11 ' O ' ' A' ' 85' ' ' SER . 1.4 pp -129.02 173.5 10.38 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.03 0.443 . . . . 0.0 111.525 -179.524 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.562 ' O ' HD12 ' A' ' 78' ' ' LEU . . . -60.53 178.7 3.04 Favored Glycine 0 C--N 1.333 0.376 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.465 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.462 ' HA ' ' CG ' ' A' ' 70' ' ' ARG . 2.6 p-10 -111.84 99.39 8.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.848 0.356 . . . . 0.0 111.487 -179.762 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.596 ' HB ' ' HB2' ' A' ' 85' ' ' SER . 0.5 OUTLIER -114.83 121.27 66.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.163 -0.471 . . . . 0.0 109.835 178.871 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.4 t -53.81 -24.54 15.76 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -178.15 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.425 ' H ' HG23 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -89.94 -103.72 0.09 Allowed 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -179.071 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.431 ' O ' ' CB ' ' A' ' 85' ' ' SER . 0.0 OUTLIER -109.0 113.56 26.55 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-O 121.336 0.589 . . . . 0.0 109.432 179.681 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.796 ' O ' HD11 ' A' ' 78' ' ' LEU . 0.4 OUTLIER 162.02 -48.98 0.0 OUTLIER 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 114.769 -1.105 . . . . 0.0 109.317 -179.276 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.907 ' O ' ' N ' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -59.79 -162.84 0.01 OUTLIER 'General case' 0 CA--C 1.513 -0.465 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 177.717 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.69 ' HB3' HD11 ' A' ' 104' ' ' ILE . 13.3 mtmt -44.99 71.08 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 178.547 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 1.013 ' O ' ' O ' ' A' ' 104' ' ' ILE . 39.6 t60 -86.87 -15.92 37.62 Favored 'General case' 0 CA--C 1.513 -0.459 0 N-CA-C 113.956 1.095 . . . . 0.0 113.956 -176.466 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.592 ' HA ' ' H ' ' A' ' 104' ' ' ILE . 0.0 OUTLIER -175.97 159.53 2.19 Favored 'General case' 0 C--N 1.311 -1.07 0 C-N-CA 119.165 -1.014 . . . . 0.0 112.8 178.145 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.627 ' HG2' HG23 ' A' ' 67' ' ' THR . 42.3 mt-30 -138.73 160.23 40.16 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 113.734 1.013 . . . . 0.0 113.734 -178.336 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.683 ' HB ' ' HB2' ' A' ' 66' ' ' TRP . 4.8 mt -125.08 129.21 73.34 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.019 177.825 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.807 HD12 ' N ' ' A' ' 93' ' ' LEU . 0.3 OUTLIER -109.43 140.17 43.49 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.115 0.483 . . . . 0.0 111.82 -179.203 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.807 ' N ' HD12 ' A' ' 92' ' ' LEU . 6.6 tp -120.16 128.25 53.24 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.409 179.231 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.436 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.55 179.74 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.611 ' O ' HD12 ' A' ' 100' ' ' LEU . 6.3 mp . . . . . 0 C--O 1.23 0.06 0 CA-C-O 120.763 0.316 . . . . 0.0 110.826 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.718 HD23 ' HB3' ' A' ' 121' ' ' ASN . 2.5 mp -133.47 148.86 51.75 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.487 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.472 ' O ' ' N ' ' A' ' 122' ' ' GLN . 9.5 mp -112.66 129.02 56.54 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.503 ' O ' ' O ' ' A' ' 90' ' ' GLN . 28.7 t30 -110.39 111.94 23.55 Favored 'General case' 0 CA--C 1.508 -0.638 0 C-N-CA 119.735 -0.786 . . . . 0.0 109.838 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.773 ' HB3' HG21 ' A' ' 109' ' ' THR . 88.5 m-20 -84.04 111.22 19.1 Favored 'General case' 0 N--CA 1.439 -0.99 0 C-N-CA 119.572 -0.851 . . . . 0.0 109.564 179.755 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 1.013 ' O ' ' O ' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -123.07 107.9 20.17 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.968 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 177.22 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.435 ' HB3' ' CE1' ' A' ' 88' ' ' HIS . 50.8 m -135.23 167.32 21.22 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.485 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 18.4 m -69.5 -63.26 1.1 Allowed 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 119.109 -1.036 . . . . 0.0 111.749 -178.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -112.45 -32.64 6.42 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 115.065 1.506 . . . . 0.0 115.065 179.433 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -146.05 128.66 3.13 Favored Glycine 0 C--N 1.34 0.788 0 N-CA-C 117.216 1.646 . . . . 0.0 117.216 -177.692 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.773 HG21 ' HB3' ' A' ' 103' ' ' ASP . 6.1 m -121.35 138.14 54.39 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 174.353 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' TRP . . . . . 0.74 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.8 m-90 -121.27 149.04 43.49 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 113.466 0.913 . . . . 0.0 113.466 -178.47 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.48 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -123.24 112.27 17.45 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 114.98 -1.009 . . . . 0.0 108.709 177.479 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 112' ' ' ASN . . . . . 0.402 ' N ' HD12 ' A' ' 111' ' ' LEU . 71.5 m-20 45.42 43.88 9.01 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.104 -0.498 . . . . 0.0 112.061 -179.601 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 79.19 23.67 62.9 Favored Glycine 0 N--CA 1.444 -0.82 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.699 179.298 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 7.8 mt-30 -136.19 96.41 3.38 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.038 0.447 . . . . 0.0 110.828 179.69 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.74 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.0 OUTLIER -44.84 136.2 4.7 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.812 179.762 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.452 HG21 ' OD2' ' A' ' 103' ' ' ASP . 3.2 m -127.4 -179.89 3.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 121.023 0.44 . . . . 0.0 112.043 -178.983 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -83.51 142.36 30.96 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.439 -179.669 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.413 ' O ' ' C ' ' A' ' 119' ' ' ASN . 82.3 tttt -64.86 164.88 11.6 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.108 179.362 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.413 ' C ' ' O ' ' A' ' 118' ' ' LYS . 21.0 m-80 33.9 39.54 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 121.209 0.528 . . . . 0.0 111.193 -179.446 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 2.5 p -110.91 106.29 15.37 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.989 -179.489 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.718 ' HB3' HD23 ' A' ' 100' ' ' LEU . 72.9 m-20 -57.7 144.18 38.95 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.506 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' GLN . . . . . 0.667 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 76.9 mm-40 -129.39 149.27 51.24 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-O 121.063 0.458 . . . . 0.0 112.003 -179.473 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 62.9 tp -72.92 124.38 25.31 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.71 179.104 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.702 HD21 HG12 ' A' ' 147' ' ' ILE . 4.9 tp -50.73 141.48 12.88 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-O 122.026 0.917 . . . . 0.0 111.78 -178.88 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.617 ' O ' HD11 ' A' ' 147' ' ' ILE . 0.0 OUTLIER -127.14 153.06 46.51 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 113.836 -1.529 . . . . 0.0 109.936 179.421 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 1.8 mm100 -71.14 113.64 8.38 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 179.566 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 64.84 30.96 79.37 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.516 -179.481 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.411 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 27.0 t70 -55.71 159.53 2.98 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 120.906 0.384 . . . . 0.0 111.109 -179.763 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.656 ' HG3' HG22 ' A' ' 144' ' ' VAL . 13.0 tt0 -146.49 135.6 22.61 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.699 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.665 ' O ' HD12 ' A' ' 143' ' ' LEU . 8.2 mm -114.23 128.72 71.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 116.145 -0.48 . . . . 0.0 109.915 178.644 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.461 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 88.9 m -103.43 145.2 30.35 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.873 -179.431 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.513 HG11 ' CD2' ' A' ' 88' ' ' HIS . 6.0 m -141.2 158.38 22.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 -179.193 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 133' ' ' GLY . . . . . 0.429 ' CA ' HD13 ' A' ' 84' ' ' LEU . . . 69.49 44.23 65.39 Favored Glycine 0 N--CA 1.447 -0.595 0 CA-C-N 115.897 -0.592 . . . . 0.0 112.287 179.583 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.486 ' HA ' HG12 ' A' ' 140' ' ' ILE . 90.5 t -79.72 155.46 4.62 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.569 0 CA-C-O 121.373 0.606 . . . . 0.0 112.236 -179.166 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 135' ' ' GLY . . . . . 0.43 ' N ' HG12 ' A' ' 134' ' ' VAL . . . 145.62 -46.5 0.77 Allowed Glycine 0 N--CA 1.441 -1.0 0 CA-C-N 114.908 -1.042 . . . . 0.0 110.571 -179.01 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.657 HG12 ' H ' ' A' ' 138' ' ' SER . 45.7 t -126.81 128.56 71.01 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 CA-C-N 115.241 -0.48 . . . . 0.0 109.795 178.54 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.488 ' HA ' HD12 ' A' ' 140' ' ' ILE . 7.3 mt-10 -51.06 -26.52 6.43 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.692 0.282 . . . . 0.0 111.376 -179.294 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 138' ' ' SER . . . . . 0.657 ' H ' HG12 ' A' ' 136' ' ' VAL . 0.1 OUTLIER -94.66 6.05 50.05 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 -179.268 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -131.29 23.4 4.82 Favored 'General case' 0 CA--C 1.523 -0.093 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 -179.449 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.603 ' C ' HD22 ' A' ' 141' ' ' LEU . 23.6 mt -97.65 141.16 16.37 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.249 179.06 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.603 HD22 ' C ' ' A' ' 140' ' ' ILE . 3.8 mm? -119.21 135.54 54.63 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 114.821 -1.081 . . . . 0.0 109.793 179.514 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 46.3 t -116.46 151.73 35.46 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.749 0.785 . . . . 0.0 113.011 -178.529 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.735 HD23 ' SG ' ' A' ' 38' ' ' CYS . 0.9 OUTLIER -134.0 132.24 39.87 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 114.554 -1.203 . . . . 0.0 109.679 179.2 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.656 HG22 ' HG3' ' A' ' 129' ' ' GLU . 25.1 t -128.11 140.46 49.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.914 0.387 . . . . 0.0 111.518 -178.975 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.483 HD11 HD11 ' A' ' 91' ' ' ILE . 0.0 OUTLIER -117.3 124.99 73.72 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.763 179.795 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 49.3 t80 -106.62 105.69 15.84 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.393 179.622 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.702 HG12 HD21 ' A' ' 124' ' ' LEU . 1.3 mp -84.97 133.39 29.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.483 -179.478 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -79.9 113.93 18.43 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.835 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -58.59 -21.03 52.0 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.256 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 32.1 mtmm -57.49 -42.67 83.16 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.957 0.408 . . . . 0.0 110.638 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 5.7 t80 . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.75 179.873 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.612 0.244 . . . . 0.0 111.271 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.474 ' HA ' HD12 ' A' ' 52' ' ' ILE . 13.2 m120 -109.0 -14.65 14.51 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-O 121.911 0.863 . . . . 0.0 108.906 178.409 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.521 ' O ' HG22 ' A' ' 32' ' ' ILE . 0.1 OUTLIER -73.3 106.36 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.58 0 CA-C-N 113.968 -1.469 . . . . 0.0 111.094 -179.442 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 1.008 HG23 ' HB2' ' A' ' 50' ' ' ALA . 0.5 OUTLIER -38.87 -62.21 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.384 -0.826 . . . . 0.0 111.403 -179.664 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.602 ' N ' ' CG1' ' A' ' 33' ' ' VAL . 28.4 p -165.77 165.95 18.12 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.482 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 2.2 ttp180 -120.77 127.38 51.91 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.542 179.517 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.693 HG23 ' CD1' ' A' ' 48' ' ' LEU . 39.1 t -97.23 121.92 48.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.504 179.285 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.927 HG23 HG12 ' A' ' 45' ' ' ILE . 20.3 mt -125.29 109.02 20.96 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.824 -179.355 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 43.4 t -78.2 99.92 6.42 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 178.683 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 9.7 t -69.73 -33.27 72.24 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -178.667 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.415 ' OG1' ' O ' ' A' ' 142' ' ' SER . 0.0 OUTLIER -52.38 -29.32 23.46 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.914 0.388 . . . . 0.0 110.9 -179.658 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 90.46 49.78 3.13 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.866 -0.683 . . . . 0.0 113.003 179.205 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.887 ' OE1' HD21 ' A' ' 141' ' ' LEU . 2.3 mm-40 -126.55 -31.77 2.7 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.663 0.268 . . . . 0.0 111.368 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.537 HD12 HD11 ' A' ' 143' ' ' LEU . 19.0 mt -127.37 131.15 23.7 Favored Pre-proline 0 N--CA 1.452 -0.329 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.98 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.462 ' HD2' ' CE2' ' A' ' 76' ' ' TYR . 27.8 Cg_exo -59.85 146.82 94.73 Favored 'Trans proline' 0 C--N 1.343 0.263 0 C-N-CA 122.655 2.236 . . . . 0.0 112.046 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.927 HG12 HG23 ' A' ' 37' ' ' ILE . 78.8 mt -51.59 133.12 13.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.327 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -126.16 131.23 52.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.371 179.669 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.411 ' HB3' HD11 ' A' ' 32' ' ' ILE . 1.1 m-20 -96.17 119.95 35.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.043 0.449 . . . . 0.0 111.511 -179.525 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.944 HD21 HD13 ' A' ' 91' ' ' ILE . 1.8 mp -96.37 117.0 29.95 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 178.985 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.524 ' O ' ' CZ2' ' A' ' 66' ' ' TRP . 0.1 OUTLIER -112.24 162.17 15.78 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 122.077 0.942 . . . . 0.0 113.121 -178.715 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 1.008 ' HB2' HG23 ' A' ' 33' ' ' VAL . . . -125.97 165.9 17.93 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 114.718 -1.128 . . . . 0.0 111.4 179.401 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -108.22 78.56 1.18 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.42 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.474 HD12 ' HA ' ' A' ' 31' ' ' ASN . 88.4 mt . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.571 -179.581 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 27.9 tttt . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.827 0.346 . . . . 0.0 111.08 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.403 ' O ' ' HB3' ' A' ' 93' ' ' LEU . 0.8 OUTLIER -115.0 138.88 50.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.563 179.597 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.598 HG13 ' O ' ' A' ' 91' ' ' ILE . 13.9 t -136.73 136.92 47.89 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 CA-C-O 121.116 0.484 . . . . 0.0 112.003 -179.289 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' TRP . . . . . 0.661 ' HB2' ' HB ' ' A' ' 91' ' ' ILE . 15.2 m-90 -100.19 140.61 34.18 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.666 179.205 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.874 HG23 ' HG3' ' A' ' 90' ' ' GLN . 7.1 m -129.21 129.47 45.08 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.455 0.645 . . . . 0.0 112.337 179.653 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.578 ' CZ ' HG11 ' A' ' 36' ' ' VAL . 3.4 m-85 -103.43 118.69 37.34 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.051 -0.977 . . . . 0.0 108.716 177.578 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.647 ' HA2' ' O ' ' A' ' 85' ' ' SER . . . 157.06 -154.86 25.89 Favored Glycine 0 CA--C 1.505 -0.548 0 C-N-CA 118.58 -1.772 . . . . 0.0 113.468 179.346 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 4.1 mtp180 -75.27 91.83 2.7 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-O 122.543 1.163 . . . . 0.0 108.826 -179.416 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -150.05 159.41 35.52 Favored Pre-proline 0 C--N 1.307 -1.262 0 CA-C-N 112.782 -2.008 . . . . 0.0 107.85 178.786 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.552 ' O ' ' HB2' ' A' ' 77' ' ' HIS . 30.9 Cg_endo -64.4 -7.09 13.19 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 120.7 0.933 . . . . 0.0 110.758 177.714 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.742 ' HB2' ' HB2' ' A' ' 77' ' ' HIS . . . 136.71 53.62 0.0 OUTLIER 'General case' 0 CA--C 1.488 -1.406 0 CA-C-N 114.367 -1.288 . . . . 0.0 109.0 178.874 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.579 ' HB3' ' HB ' ' A' ' 67' ' ' THR . 0.1 OUTLIER -52.56 -70.07 0.1 Allowed 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 105.409 -2.071 . . . . 0.0 105.409 179.719 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.504 ' CG ' ' CE1' ' A' ' 68' ' ' PHE . 16.8 t70 -95.58 -47.56 6.18 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 105.781 -1.933 . . . . 0.0 105.781 169.114 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.499 ' CD2' HG23 ' A' ' 43' ' ' ILE . 19.4 t80 -143.08 141.95 31.4 Favored 'General case' 0 C--N 1.348 0.507 0 CA-C-N 112.775 -2.011 . . . . 0.0 111.458 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' HIS . . . . . 0.742 ' HB2' ' HB2' ' A' ' 73' ' ' ALA . 1.7 t60 -96.1 107.28 19.58 Favored 'General case' 0 C--N 1.33 -0.261 0 O-C-N 122.114 -0.366 . . . . 0.0 110.222 177.26 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.817 HD11 ' O ' ' A' ' 85' ' ' SER . 0.6 OUTLIER -121.19 173.77 7.1 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.916 0.388 . . . . 0.0 111.506 -179.895 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -56.91 -173.39 0.21 Allowed Glycine 0 C--N 1.332 0.343 0 C-N-CA 121.014 -0.612 . . . . 0.0 112.475 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.421 ' HA ' ' OD1' ' A' ' 86' ' ' ASN . 9.2 p30 -111.81 98.34 7.32 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.82 0.343 . . . . 0.0 111.758 -179.671 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.79 HD12 ' OG ' ' A' ' 85' ' ' SER . 11.2 mt -114.91 113.79 44.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.436 178.574 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -55.65 -24.37 33.35 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 -179.352 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.441 ' H ' HG22 ' A' ' 81' ' ' ILE . 1.4 mtt180 -88.21 -106.11 0.08 Allowed 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -179.047 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.408 ' HB3' ' CE1' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -109.26 111.17 22.61 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-O 121.568 0.699 . . . . 0.0 110.158 179.976 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.817 ' O ' HD11 ' A' ' 78' ' ' LEU . 0.5 OUTLIER 162.11 -48.94 0.0 OUTLIER 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 114.378 -1.283 . . . . 0.0 109.261 -179.817 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.846 ' O ' ' N ' ' A' ' 88' ' ' HIS . 89.0 m-20 -63.32 -152.57 0.01 OUTLIER 'General case' 0 CA--C 1.522 -0.122 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 177.809 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.848 ' HB3' HD11 ' A' ' 104' ' ' ILE . 12.9 mttt -48.54 72.8 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 179.303 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.996 ' O ' ' O ' ' A' ' 104' ' ' ILE . 36.3 t60 -93.93 -17.76 22.64 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 114.103 1.149 . . . . 0.0 114.103 -176.86 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.62 ' HA ' ' H ' ' A' ' 104' ' ' ILE . 0.1 OUTLIER -175.83 155.69 1.7 Allowed 'General case' 0 C--N 1.313 -1.002 0 C-N-CA 118.96 -1.096 . . . . 0.0 113.073 177.982 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.874 ' HG3' HG23 ' A' ' 67' ' ' THR . 21.2 mt-30 -137.46 160.97 37.62 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.308 -1.314 . . . . 0.0 113.574 -177.898 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.944 HD13 HD21 ' A' ' 48' ' ' LEU . 2.7 mt -128.42 132.33 68.17 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.784 178.746 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.571 HD13 ' ND2' ' A' ' 121' ' ' ASN . 0.3 OUTLIER -109.52 146.12 35.15 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.142 0.496 . . . . 0.0 112.017 -179.126 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.637 HD22 ' N ' ' A' ' 94' ' ' GLY . 1.1 tm? -125.97 124.52 40.92 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.445 179.195 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.637 ' N ' HD22 ' A' ' 93' ' ' LEU . . . . . . . . 0 N--CA 1.451 -0.337 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.617 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.956 HD21 HG13 ' A' ' 33' ' ' VAL . 4.9 mp . . . . . 0 N--CA 1.457 -0.094 0 CA-C-O 120.842 0.353 . . . . 0.0 110.943 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.938 HD23 ' HB3' ' A' ' 121' ' ' ASN . 4.6 mp -131.58 148.35 52.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.389 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.462 ' O ' ' N ' ' A' ' 122' ' ' GLN . 6.0 mt -118.23 128.78 55.02 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 179.823 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.515 ' O ' ' O ' ' A' ' 90' ' ' GLN . 29.4 t30 -111.21 111.38 22.41 Favored 'General case' 0 CA--C 1.507 -0.675 0 C-N-CA 119.907 -0.717 . . . . 0.0 109.685 179.606 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.758 ' HB3' HG21 ' A' ' 109' ' ' THR . 84.0 m-20 -85.8 111.56 20.28 Favored 'General case' 0 N--CA 1.44 -0.932 0 C-N-CA 119.596 -0.842 . . . . 0.0 109.535 179.697 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.996 ' O ' ' O ' ' A' ' 88' ' ' HIS . 0.1 OUTLIER -122.91 107.57 19.59 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.953 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 177.563 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.415 ' HG ' ' CE1' ' A' ' 88' ' ' HIS . 70.9 m -134.17 166.89 21.72 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-N 114.982 -1.008 . . . . 0.0 109.398 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 20.8 m -69.24 -62.81 1.23 Allowed 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 119.226 -0.99 . . . . 0.0 111.581 -179.074 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -112.12 -32.82 6.43 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 114.984 1.476 . . . . 0.0 114.984 179.443 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -146.35 127.95 2.9 Favored Glycine 0 C--N 1.339 0.749 0 N-CA-C 117.388 1.715 . . . . 0.0 117.388 -177.718 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.758 HG21 ' HB3' ' A' ' 103' ' ' ASP . 5.4 m -121.37 138.3 54.32 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 174.18 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' TRP . . . . . 0.761 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.9 m-90 -121.24 148.91 43.65 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 113.318 0.859 . . . . 0.0 113.318 -178.506 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.463 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -121.6 112.05 17.98 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 115.12 -0.946 . . . . 0.0 108.509 177.424 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 43.97 44.44 6.02 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.038 -0.528 . . . . 0.0 112.126 -179.462 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 80.06 25.12 58.36 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.744 179.336 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' GLN . . . . . 0.434 ' O ' HG13 ' A' ' 116' ' ' VAL . 58.0 mt-30 -137.74 95.98 3.15 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.077 0.465 . . . . 0.0 110.841 179.677 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.761 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.0 OUTLIER -45.61 134.54 7.17 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.891 179.77 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.434 HG13 ' O ' ' A' ' 114' ' ' GLN . 27.3 m -126.05 -178.19 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.916 -179.029 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -85.84 142.1 29.15 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.229 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.457 ' HG3' ' HA ' ' A' ' 104' ' ' ILE . 71.4 tttt -64.49 163.21 13.82 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.155 179.28 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.42 ' N ' ' HG2' ' A' ' 118' ' ' LYS . 4.9 p-10 35.41 39.5 0.06 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.287 0.565 . . . . 0.0 111.17 -179.796 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 4.9 p -110.87 106.76 16.02 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.024 -179.448 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.938 ' HB3' HD23 ' A' ' 100' ' ' LEU . 1.6 m-20 -57.26 140.8 48.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.506 179.86 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' GLN . . . . . 0.691 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 59.9 mm-40 -129.63 147.86 51.47 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-O 121.109 0.481 . . . . 0.0 111.965 -179.542 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.3 tp -73.77 116.89 14.9 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.628 -0.715 . . . . 0.0 109.491 178.931 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.801 HD21 HD13 ' A' ' 147' ' ' ILE . 2.4 tt -47.54 144.53 3.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.85 0.833 . . . . 0.0 111.892 -178.759 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.441 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.6 OUTLIER -126.83 153.18 45.99 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 114.04 -1.436 . . . . 0.0 110.291 179.535 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 24.6 mm100 -71.67 113.93 9.22 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.002 0.429 . . . . 0.0 110.152 179.73 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 69.24 25.66 75.27 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.645 -179.711 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.441 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 27.0 t70 -58.5 159.99 5.85 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.045 0.45 . . . . 0.0 111.136 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.597 ' HG3' HG22 ' A' ' 144' ' ' VAL . 1.7 tt0 -146.56 135.37 22.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.411 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.466 ' CG2' ' O ' ' A' ' 110' ' ' TRP . 1.2 mp -110.46 128.5 66.7 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.157 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 178.685 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.577 HG23 ' CG2' ' A' ' 140' ' ' ILE . 23.3 m -103.13 144.79 30.84 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.451 -179.571 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.474 ' HB ' ' NE2' ' A' ' 88' ' ' HIS . 10.2 m -141.29 158.14 22.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -178.926 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 67.38 43.16 88.59 Favored Glycine 0 N--CA 1.447 -0.582 0 CA-C-N 115.667 -0.697 . . . . 0.0 112.281 179.477 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.485 ' HA ' HG12 ' A' ' 140' ' ' ILE . 85.2 t -77.84 156.48 5.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 121.406 0.622 . . . . 0.0 112.133 -179.245 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' GLY . . . . . 0.448 ' N ' HG12 ' A' ' 134' ' ' VAL . . . 147.79 -42.06 0.89 Allowed Glycine 0 N--CA 1.441 -0.99 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.635 -179.061 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.528 HG12 ' H ' ' A' ' 138' ' ' SER . 43.8 t -126.65 130.14 71.63 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.684 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 178.73 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.29 -34.0 31.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.724 0.297 . . . . 0.0 111.405 -179.181 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 138' ' ' SER . . . . . 0.528 ' H ' HG12 ' A' ' 136' ' ' VAL . 4.0 p -94.28 6.39 48.81 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 -179.441 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -128.14 30.25 5.25 Favored 'General case' 0 CA--C 1.52 -0.197 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -179.274 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.577 ' CG2' HG23 ' A' ' 131' ' ' THR . 20.9 mt -103.66 141.12 20.03 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.361 179.183 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.887 HD21 ' OE1' ' A' ' 42' ' ' GLN . 3.4 mp -111.51 135.67 51.76 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.021 -0.991 . . . . 0.0 110.048 179.506 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 142' ' ' SER . . . . . 0.764 ' C ' HD22 ' A' ' 143' ' ' LEU . 47.3 t -116.82 152.02 35.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.865 0.841 . . . . 0.0 112.94 -178.916 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.764 HD22 ' C ' ' A' ' 142' ' ' SER . 3.9 mm? -136.24 127.06 27.45 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.526 -1.215 . . . . 0.0 109.166 178.906 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.597 HG22 ' HG3' ' A' ' 129' ' ' GLU . 18.7 t -120.2 140.61 43.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.017 0.437 . . . . 0.0 111.978 -178.879 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.499 ' CG1' HG22 ' A' ' 36' ' ' VAL . 0.2 OUTLIER -114.19 127.17 71.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.575 179.639 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 15.6 t80 -110.65 107.19 16.68 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.753 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.801 HD13 HD21 ' A' ' 124' ' ' LEU . 1.4 mp -99.76 133.41 42.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.393 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 14.7 p30 -82.05 134.79 35.37 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.926 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -64.63 -23.03 67.13 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.154 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 16.7 mtmt -57.31 -42.22 81.37 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.94 0.4 . . . . 0.0 110.687 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 37.3 t80 . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.75 179.766 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.701 0.286 . . . . 0.0 111.317 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.417 ' HA ' HD12 ' A' ' 52' ' ' ILE . 12.2 m120 -109.06 -14.37 14.54 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-O 121.949 0.881 . . . . 0.0 108.746 178.574 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.555 ' O ' HG22 ' A' ' 32' ' ' ILE . 0.0 OUTLIER -74.31 101.53 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.522 0 CA-C-N 114.011 -1.449 . . . . 0.0 110.558 -179.769 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 1.022 HG23 ' HB2' ' A' ' 50' ' ' ALA . 0.5 OUTLIER -34.93 -61.73 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.249 -0.887 . . . . 0.0 112.297 -179.059 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.725 ' SG ' HG23 ' A' ' 147' ' ' ILE . 41.2 m -159.36 165.46 33.25 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.677 -179.178 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.513 HH11 HD11 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -128.46 115.12 17.68 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.828 179.367 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.629 HG11 ' HZ ' ' A' ' 68' ' ' PHE . 9.9 p -89.18 134.38 28.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.812 179.799 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.964 HG23 HG12 ' A' ' 45' ' ' ILE . 21.6 mt -132.68 107.86 12.55 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -179.373 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -89.23 106.56 18.52 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 177.604 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 10.1 t -99.11 -22.4 15.7 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 -177.855 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.772 HG21 ' CB ' ' A' ' 142' ' ' SER . 56.7 p -57.74 -20.7 36.51 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.656 0.265 . . . . 0.0 111.583 -179.556 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 104.86 71.75 0.84 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.561 -0.828 . . . . 0.0 112.627 179.658 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.788 ' HG2' HD12 ' A' ' 141' ' ' LEU . 0.0 OUTLIER -159.35 -66.95 0.08 Allowed 'General case' 0 C--N 1.328 -0.37 0 CA-C-O 120.893 0.377 . . . . 0.0 110.925 179.925 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.514 HG23 ' HD2' ' A' ' 44' ' ' PRO . 34.3 mt -103.5 138.97 19.69 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.257 -179.714 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.514 ' HD2' HG23 ' A' ' 43' ' ' ILE . 91.2 Cg_endo -81.73 146.79 15.09 Favored 'Trans proline' 0 N--CA 1.46 -0.458 0 C-N-CA 122.71 2.273 . . . . 0.0 111.706 179.51 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.964 HG12 HG23 ' A' ' 37' ' ' ILE . 55.8 mt -43.82 116.07 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.072 0.463 . . . . 0.0 111.622 -179.665 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.404 ' NE ' ' HA ' ' A' ' 46' ' ' ARG . 8.9 mmm180 -114.69 131.48 56.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.928 179.49 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.424 ' HB3' HD11 ' A' ' 32' ' ' ILE . 5.0 m-20 -88.11 119.6 28.64 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.063 0.459 . . . . 0.0 111.604 -179.306 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.592 HD22 ' CD1' ' A' ' 66' ' ' TRP . 1.0 OUTLIER -98.34 121.57 40.43 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 178.741 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.513 ' O ' ' HZ2' ' A' ' 66' ' ' TRP . 0.0 OUTLIER -120.81 162.05 20.44 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 122.133 0.968 . . . . 0.0 113.46 -178.371 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 1.022 ' HB2' HG23 ' A' ' 33' ' ' VAL . . . -116.96 166.28 12.36 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 114.343 -1.299 . . . . 0.0 110.958 179.685 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -105.47 63.44 0.69 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.029 0.442 . . . . 0.0 110.837 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.417 HD12 ' HA ' ' A' ' 31' ' ' ASN . 53.6 mt . . . . . 0 C--N 1.326 -0.428 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.04 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.461 0.078 0 CA-C-O 120.868 0.366 . . . . 0.0 110.852 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.469 ' HB3' HD12 ' A' ' 93' ' ' LEU . 13.2 ttpt -130.41 136.68 49.3 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.625 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.635 HG13 ' O ' ' A' ' 91' ' ' ILE . 17.6 t -137.41 137.3 46.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.969 0.414 . . . . 0.0 112.008 -179.124 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' TRP . . . . . 0.675 ' HB2' ' HB ' ' A' ' 91' ' ' ILE . 13.8 m-90 -100.26 139.29 36.15 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.09 178.636 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.574 ' HB ' ' HB3' ' A' ' 74' ' ' CYS . 4.4 m -131.3 130.49 42.83 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.458 0.647 . . . . 0.0 112.57 179.747 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.629 ' HZ ' HG11 ' A' ' 36' ' ' VAL . 93.7 m-85 -101.73 118.57 37.2 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.303 178.006 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.62 ' HA2' ' O ' ' A' ' 85' ' ' SER . . . 157.34 -157.2 27.9 Favored Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 118.899 -1.619 . . . . 0.0 112.812 179.291 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.47 92.34 2.85 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-O 122.71 1.243 . . . . 0.0 108.738 -179.763 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -149.16 159.43 37.09 Favored Pre-proline 0 C--N 1.309 -1.169 0 CA-C-N 112.515 -2.129 . . . . 0.0 107.921 179.224 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.545 ' O ' ' CB ' ' A' ' 73' ' ' ALA . 28.8 Cg_endo -63.64 -7.43 12.75 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 120.842 1.028 . . . . 0.0 111.118 178.255 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.735 ' HB2' ' HB2' ' A' ' 77' ' ' HIS . . . 135.99 51.6 0.0 OUTLIER 'General case' 0 CA--C 1.49 -1.362 0 CA-C-N 114.527 -1.215 . . . . 0.0 109.455 178.84 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.574 ' HB3' ' HB ' ' A' ' 67' ' ' THR . 0.1 OUTLIER -52.88 -69.9 0.1 Allowed 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 105.63 -1.989 . . . . 0.0 105.63 179.491 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.551 ' N ' ' O ' ' A' ' 67' ' ' THR . 7.6 t0 -95.26 -47.14 6.45 Favored 'General case' 0 N--CA 1.435 -1.182 0 N-CA-C 106.0 -1.852 . . . . 0.0 106.0 169.594 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.496 ' C ' ' HA ' ' A' ' 73' ' ' ALA . 29.8 t80 -144.33 142.6 30.5 Favored 'General case' 0 C--N 1.347 0.465 0 CA-C-N 112.624 -2.08 . . . . 0.0 111.476 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' HIS . . . . . 0.735 ' HB2' ' HB2' ' A' ' 73' ' ' ALA . 1.6 t60 -96.33 107.3 19.64 Favored 'General case' 0 C--N 1.33 -0.249 0 O-C-N 121.997 -0.439 . . . . 0.0 110.322 177.073 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.811 HD11 ' O ' ' A' ' 85' ' ' SER . 0.7 OUTLIER -124.24 175.22 7.19 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 120.916 0.388 . . . . 0.0 111.375 179.969 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -59.02 -174.18 0.57 Allowed Glycine 0 C--N 1.332 0.342 0 C-N-CA 120.981 -0.628 . . . . 0.0 112.704 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.436 ' HA ' ' OD1' ' A' ' 86' ' ' ASN . 0.4 OUTLIER -111.48 98.24 7.32 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.933 0.397 . . . . 0.0 111.634 -179.797 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.594 ' HB ' ' HB2' ' A' ' 85' ' ' SER . 4.0 mp -114.92 114.03 45.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.356 178.868 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 53.3 p -55.7 -24.62 35.54 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 -178.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.523 ' C ' HD13 ' A' ' 84' ' ' LEU . 0.6 OUTLIER -85.32 -110.13 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 -178.931 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.847 HD22 ' H ' ' A' ' 84' ' ' LEU . 0.0 OUTLIER -108.98 112.07 24.08 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-O 121.453 0.644 . . . . 0.0 109.573 179.679 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.811 ' O ' HD11 ' A' ' 78' ' ' LEU . 0.6 OUTLIER 161.86 -45.63 0.0 OUTLIER 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 114.671 -1.15 . . . . 0.0 109.433 -179.562 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.858 ' O ' ' N ' ' A' ' 88' ' ' HIS . 95.7 m-20 -64.68 -149.65 0.01 OUTLIER 'General case' 0 N--CA 1.456 -0.148 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 177.9 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.925 ' HB3' HD11 ' A' ' 104' ' ' ILE . 28.1 mttm -49.58 72.02 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 179.065 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.983 ' C ' ' O ' ' A' ' 104' ' ' ILE . 31.8 t60 -91.35 -15.93 28.26 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 113.846 1.054 . . . . 0.0 113.846 -176.853 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.631 ' HA ' ' H ' ' A' ' 104' ' ' ILE . 0.9 OUTLIER -175.31 152.83 1.45 Allowed 'General case' 0 C--N 1.31 -1.131 0 C-N-CA 119.436 -0.906 . . . . 0.0 112.291 177.972 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.508 ' HG2' HG12 ' A' ' 65' ' ' VAL . 20.5 tt0 -136.82 153.38 50.81 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 114.514 -1.221 . . . . 0.0 113.338 -177.664 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.675 ' HB ' ' HB2' ' A' ' 66' ' ' TRP . 32.4 mt -123.53 131.98 72.17 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.196 178.972 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.697 HD13 ' ND2' ' A' ' 121' ' ' ASN . 0.3 OUTLIER -108.64 144.05 36.89 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.055 0.455 . . . . 0.0 111.824 -179.56 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.797 HD22 ' N ' ' A' ' 94' ' ' GLY . 0.2 OUTLIER -125.77 122.66 36.86 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.28 179.26 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.797 ' N ' HD22 ' A' ' 93' ' ' LEU . . . . . . . . 0 N--CA 1.452 -0.287 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.375 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.867 ' HB2' HD13 ' A' ' 124' ' ' LEU . 0.5 OUTLIER . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.805 0.336 . . . . 0.0 110.893 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.54 ' HA ' ' O ' ' A' ' 122' ' ' GLN . 20.5 mt -133.61 147.98 51.53 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.432 179.758 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.516 HD13 ' HA ' ' A' ' 124' ' ' LEU . 4.8 mp -116.58 131.85 56.84 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.615 ' HB2' HD11 ' A' ' 92' ' ' LEU . 23.1 t30 -114.42 110.87 20.54 Favored 'General case' 0 CA--C 1.508 -0.661 0 C-N-CA 119.714 -0.795 . . . . 0.0 109.839 179.704 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.69 ' HB3' HG21 ' A' ' 109' ' ' THR . 70.1 m-20 -81.68 111.88 18.36 Favored 'General case' 0 N--CA 1.442 -0.865 0 C-N-CA 119.726 -0.79 . . . . 0.0 109.37 179.557 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.983 ' O ' ' C ' ' A' ' 88' ' ' HIS . 0.1 OUTLIER -123.45 107.98 20.1 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.937 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 177.71 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.456 ' HG ' ' CE1' ' A' ' 88' ' ' HIS . 69.8 m -130.91 169.83 15.25 Favored 'General case' 0 C--N 1.296 -1.742 0 CA-C-N 114.926 -1.034 . . . . 0.0 109.304 179.694 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 24.0 m -69.56 -62.68 1.28 Allowed 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 119.089 -1.044 . . . . 0.0 111.325 -179.302 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -111.75 -33.52 6.3 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 114.66 1.356 . . . . 0.0 114.66 179.195 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -146.99 130.37 3.58 Favored Glycine 0 C--N 1.34 0.786 0 N-CA-C 116.764 1.466 . . . . 0.0 116.764 -178.158 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.69 HG21 ' HB3' ' A' ' 103' ' ' ASP . 4.3 m -120.85 137.87 54.34 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 174.47 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' TRP . . . . . 0.771 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.5 m-90 -120.37 148.96 43.08 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 -178.543 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.432 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.3 OUTLIER -122.49 112.09 17.62 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 114.931 -1.031 . . . . 0.0 108.514 177.421 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 67.4 m-20 48.02 42.82 17.34 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.08 -0.509 . . . . 0.0 112.12 -179.458 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 82.22 3.44 90.56 Favored Glycine 0 N--CA 1.445 -0.754 0 C-N-CA 120.785 -0.721 . . . . 0.0 113.134 179.125 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.07 100.07 7.3 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.062 0.458 . . . . 0.0 110.829 179.78 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.771 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.0 OUTLIER -44.86 139.17 3.17 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.018 179.919 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.456 HG21 ' OD2' ' A' ' 103' ' ' ASP . 28.1 m -126.98 178.92 3.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.103 0.478 . . . . 0.0 111.756 -179.103 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -84.01 139.09 32.75 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.755 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.451 ' O ' ' N ' ' A' ' 120' ' ' SER . 0.5 OUTLIER -61.94 169.46 2.6 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 179.348 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.444 ' C ' ' O ' ' A' ' 118' ' ' LYS . 6.7 p30 28.63 41.42 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.534 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.451 ' N ' ' O ' ' A' ' 118' ' ' LYS . 4.0 p -111.22 111.52 22.64 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.154 -179.113 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.697 ' ND2' HD13 ' A' ' 92' ' ' LEU . 1.9 m120 -62.95 133.77 55.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.124 179.51 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' GLN . . . . . 0.54 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 49.6 mm-40 -129.56 147.04 51.32 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 -179.425 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.8 tt -72.62 113.71 9.95 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.351 178.738 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.895 HD12 HG12 ' A' ' 147' ' ' ILE . 1.6 pt? -45.51 155.41 0.15 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.852 0.834 . . . . 0.0 112.362 -178.462 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.476 ' O ' HD13 ' A' ' 147' ' ' ILE . 0.0 OUTLIER -127.44 153.38 46.35 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 114.069 -1.423 . . . . 0.0 109.855 179.142 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 32.8 tp60 -70.72 113.82 8.18 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 179.659 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 69.13 27.93 73.34 Favored Glycine 0 N--CA 1.445 -0.7 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.131 -179.093 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.449 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 27.5 t70 -58.96 159.62 6.88 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.099 0.476 . . . . 0.0 111.53 -179.567 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.505 ' HB2' HG22 ' A' ' 144' ' ' VAL . 2.0 tt0 -146.54 135.35 22.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.941 179.704 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.692 ' O ' HD12 ' A' ' 143' ' ' LEU . 1.0 OUTLIER -108.74 129.17 63.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.13 179.157 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.529 HG23 ' CG2' ' A' ' 140' ' ' ILE . 32.0 m -102.77 143.16 32.75 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.86 0.362 . . . . 0.0 110.454 -179.665 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.47 ' HB ' ' NE2' ' A' ' 88' ' ' HIS . 5.3 m -141.13 158.26 22.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 -178.669 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 68.64 43.98 73.47 Favored Glycine 0 N--CA 1.447 -0.575 0 CA-C-N 115.705 -0.68 . . . . 0.0 112.219 179.351 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.497 ' HA ' HG12 ' A' ' 140' ' ' ILE . 93.0 t -79.35 154.22 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 CA-C-O 121.467 0.651 . . . . 0.0 112.242 -179.093 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 135' ' ' GLY . . . . . 0.406 ' N ' HG12 ' A' ' 134' ' ' VAL . . . 151.39 -42.79 0.71 Allowed Glycine 0 N--CA 1.44 -1.04 0 CA-C-N 114.93 -1.032 . . . . 0.0 110.648 -179.068 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.547 HG12 ' H ' ' A' ' 138' ' ' SER . 44.8 t -126.66 132.19 70.42 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.751 0 CA-C-N 115.196 -0.502 . . . . 0.0 109.844 178.65 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 46.5 tp10 -51.42 -34.74 36.13 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.798 0.332 . . . . 0.0 111.405 -179.292 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' SER . . . . . 0.547 ' H ' HG12 ' A' ' 136' ' ' VAL . 40.9 t -94.31 6.45 48.65 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -179.318 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -126.94 30.16 5.51 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 -179.3 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.529 ' CG2' HG23 ' A' ' 131' ' ' THR . 13.3 mt -107.33 140.95 23.81 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.305 179.15 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.788 HD12 ' HG2' ' A' ' 42' ' ' GLN . 3.6 mm? -117.3 135.01 54.14 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 114.974 -1.012 . . . . 0.0 109.834 179.409 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 142' ' ' SER . . . . . 0.772 ' CB ' HG21 ' A' ' 40' ' ' THR . 0.9 OUTLIER -120.65 147.4 45.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.537 0.684 . . . . 0.0 112.701 -178.943 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.692 HD12 ' O ' ' A' ' 130' ' ' ILE . 3.5 mp -122.93 147.38 46.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 114.861 -1.063 . . . . 0.0 109.369 179.534 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.505 HG22 ' HB2' ' A' ' 129' ' ' GLU . 23.5 t -131.76 140.28 48.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 C-N-CA 120.769 -0.372 . . . . 0.0 111.657 -179.314 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.63 ' CG2' HD11 ' A' ' 147' ' ' ILE . 0.0 OUTLIER -115.4 139.85 39.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.809 179.64 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 39.2 t80 -117.51 105.06 11.69 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.904 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.895 HG12 HD12 ' A' ' 124' ' ' LEU . 3.5 mp -98.96 130.57 47.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.298 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 148' ' ' ASN . . . . . 0.413 ' ND2' ' O ' ' A' ' 32' ' ' ILE . 11.1 p30 -89.06 133.43 34.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.81 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -67.71 -20.06 65.23 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.264 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.46 -42.93 83.48 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.895 0.379 . . . . 0.0 110.591 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 151' ' ' PHE . . . . . 0.544 ' HE2' ' HB3' ' A' ' 50' ' ' ALA . 31.2 t80 . . . . . 0 C--N 1.327 -0.383 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.754 179.804 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 . . . . . 0 C--O 1.232 0.152 0 CA-C-O 120.787 0.327 . . . . 0.0 110.96 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.572 ' HA ' HD11 ' A' ' 52' ' ' ILE . 11.2 m-20 -108.23 -13.11 14.97 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-O 121.933 0.873 . . . . 0.0 108.979 178.626 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.835 HD13 ' O ' ' A' ' 48' ' ' LEU . 0.1 OUTLIER -70.78 103.46 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.518 0 CA-C-N 113.94 -1.482 . . . . 0.0 111.268 -179.274 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 1.076 HG23 ' HB2' ' A' ' 50' ' ' ALA . 0.4 OUTLIER -33.37 -62.8 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 CA-C-N 115.25 -0.886 . . . . 0.0 112.065 -179.297 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.631 ' N ' ' CG1' ' A' ' 33' ' ' VAL . 67.2 m -162.42 165.26 26.57 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.401 -179.299 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.39 114.96 18.23 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.669 179.125 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 1.035 HG12 HD21 ' A' ' 143' ' ' LEU . 1.8 t -89.16 129.08 40.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.427 179.711 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.928 HG23 HG12 ' A' ' 45' ' ' ILE . 26.0 mt -122.6 108.45 21.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -178.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.537 ' SG ' HD23 ' A' ' 143' ' ' LEU . 0.0 OUTLIER -102.5 107.86 18.97 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 177.783 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.6 t -113.92 -24.49 9.05 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 -178.143 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.592 HG21 ' HB3' ' A' ' 142' ' ' SER . 17.1 p -56.01 -26.16 47.5 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.765 0.316 . . . . 0.0 111.348 -179.489 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 124.53 66.84 0.19 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.642 -0.789 . . . . 0.0 112.674 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.648 ' CB ' HD12 ' A' ' 43' ' ' ILE . 21.9 mt-30 -141.13 -71.92 0.35 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.765 0.317 . . . . 0.0 110.666 179.752 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.648 HD12 ' CB ' ' A' ' 42' ' ' GLN . 3.9 mp -135.33 136.65 24.76 Favored Pre-proline 0 N--CA 1.452 -0.37 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.084 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.48 ' HD2' ' CZ ' ' A' ' 76' ' ' TYR . 31.3 Cg_exo -58.8 147.29 89.3 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.576 2.184 . . . . 0.0 111.739 179.508 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.928 HG12 HG23 ' A' ' 37' ' ' ILE . 48.8 mt -38.04 140.19 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 CA-C-O 121.004 0.43 . . . . 0.0 111.83 -179.503 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.435 ' HG2' ' O ' ' A' ' 75' ' ' ASP . 0.0 OUTLIER -137.26 130.42 30.86 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.318 179.864 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.548 ' C ' HD23 ' A' ' 48' ' ' LEU . 0.7 OUTLIER -94.7 120.27 34.66 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.028 0.442 . . . . 0.0 111.538 -179.339 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.835 ' O ' HD13 ' A' ' 32' ' ' ILE . 1.2 mt -100.35 129.84 46.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.821 179.295 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.479 ' HB3' HG12 ' A' ' 32' ' ' ILE . 0.1 OUTLIER -120.91 162.92 19.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 122.091 0.948 . . . . 0.0 113.364 -179.118 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 1.076 ' HB2' HG23 ' A' ' 33' ' ' VAL . . . -127.34 166.59 17.55 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.456 -1.247 . . . . 0.0 111.064 179.73 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -104.8 92.37 4.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.365 179.607 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.572 HD11 ' HA ' ' A' ' 31' ' ' ASN . 45.6 mt . . . . . 0 C--N 1.33 -0.242 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.929 -179.363 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 4.3 tptm . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.888 0.375 . . . . 0.0 110.77 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 16.6 ttpt -117.06 133.49 55.94 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.687 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.611 HG13 ' O ' ' A' ' 91' ' ' ILE . 23.9 t -136.9 139.25 44.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.181 0.515 . . . . 0.0 111.856 -179.497 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' TRP . . . . . 0.739 ' CD1' HD22 ' A' ' 48' ' ' LEU . 13.1 m-90 -100.36 137.73 38.38 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.472 179.03 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.615 HG23 ' CG ' ' A' ' 90' ' ' GLN . 17.6 m -132.38 129.09 38.92 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.586 0.707 . . . . 0.0 112.712 179.835 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.499 ' HE1' HD12 ' A' ' 91' ' ' ILE . 18.4 m-85 -101.32 118.87 37.85 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.02 -0.991 . . . . 0.0 108.76 177.399 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.594 ' HA2' ' O ' ' A' ' 85' ' ' SER . . . 157.99 -156.53 27.44 Favored Glycine 0 CA--C 1.503 -0.698 0 C-N-CA 118.723 -1.703 . . . . 0.0 113.261 179.491 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 2.1 mtp180 -74.97 91.84 2.53 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-O 122.496 1.141 . . . . 0.0 108.561 -179.686 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -149.76 159.31 36.25 Favored Pre-proline 0 C--N 1.308 -1.226 0 CA-C-N 112.764 -2.016 . . . . 0.0 108.036 179.148 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.549 ' O ' ' HB2' ' A' ' 77' ' ' HIS . 28.9 Cg_endo -64.33 -7.03 12.92 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 120.79 0.994 . . . . 0.0 110.845 178.006 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.71 ' HB2' ' HB2' ' A' ' 77' ' ' HIS . . . 136.43 52.38 0.0 OUTLIER 'General case' 0 CA--C 1.49 -1.36 0 CA-C-N 114.542 -1.208 . . . . 0.0 109.281 178.738 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.559 ' HB3' ' HB ' ' A' ' 67' ' ' THR . 0.1 OUTLIER -52.85 -69.48 0.11 Allowed 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 105.823 -1.918 . . . . 0.0 105.823 179.57 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.515 ' N ' ' O ' ' A' ' 67' ' ' THR . 6.1 t70 -95.06 -48.27 6.03 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 105.544 -2.021 . . . . 0.0 105.544 169.649 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.48 ' CZ ' ' HD2' ' A' ' 44' ' ' PRO . 29.0 t80 -144.74 142.61 30.16 Favored 'General case' 0 C--N 1.345 0.402 0 CA-C-N 112.527 -2.124 . . . . 0.0 111.779 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' HIS . . . . . 0.71 ' HB2' ' HB2' ' A' ' 73' ' ' ALA . 2.0 t60 -97.82 106.96 19.34 Favored 'General case' 0 C--N 1.33 -0.244 0 O-C-N 122.091 -0.381 . . . . 0.0 110.043 176.863 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.445 HD21 ' HA2' ' A' ' 69' ' ' GLY . 0.7 OUTLIER -121.57 -176.48 3.32 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.899 0.38 . . . . 0.0 111.569 -179.841 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -62.21 -174.41 1.98 Allowed Glycine 0 C--N 1.332 0.344 0 C-N-CA 120.953 -0.642 . . . . 0.0 112.445 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -111.89 98.38 7.34 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.926 0.393 . . . . 0.0 111.772 -179.699 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.625 ' HB ' ' HB2' ' A' ' 85' ' ' SER . 1.4 mp -114.85 115.18 48.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.252 178.737 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -56.43 -24.26 43.99 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 -179.077 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -90.07 -105.34 0.09 Allowed 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -178.736 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.444 ' HB3' ' CE1' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -109.11 111.96 23.87 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-O 121.466 0.65 . . . . 0.0 110.132 -179.522 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.625 ' HB2' ' HB ' ' A' ' 81' ' ' ILE . 0.6 OUTLIER 160.17 -48.02 0.0 OUTLIER 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 114.396 -1.275 . . . . 0.0 109.209 -179.753 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.846 ' O ' ' N ' ' A' ' 88' ' ' HIS . 91.6 m-20 -64.92 -151.19 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.247 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 177.546 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.904 ' HB2' HD11 ' A' ' 104' ' ' ILE . 2.1 pttp -46.82 74.42 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.352 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.975 ' O ' ' O ' ' A' ' 104' ' ' ILE . 32.7 t60 -95.45 -18.76 20.42 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 114.047 1.129 . . . . 0.0 114.047 -176.763 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.638 ' HA ' ' H ' ' A' ' 104' ' ' ILE . 0.1 OUTLIER -174.57 154.79 2.1 Favored 'General case' 0 C--N 1.312 -1.046 0 C-N-CA 118.912 -1.115 . . . . 0.0 113.089 178.125 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.615 ' CG ' HG23 ' A' ' 67' ' ' THR . 31.7 mt-30 -137.05 158.4 44.55 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.397 -1.274 . . . . 0.0 113.858 -177.726 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.669 ' HB ' ' HB2' ' A' ' 66' ' ' TRP . 13.4 mt -129.92 127.67 64.08 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.204 178.708 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.891 HD13 ' OD1' ' A' ' 121' ' ' ASN . 0.3 OUTLIER -102.99 142.05 34.74 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.103 0.478 . . . . 0.0 111.874 -179.56 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.851 HD22 ' N ' ' A' ' 94' ' ' GLY . 0.4 OUTLIER -125.74 130.36 51.33 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.481 179.32 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.851 ' N ' HD22 ' A' ' 93' ' ' LEU . . . . . . . . 0 N--CA 1.45 -0.384 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.621 179.639 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 1.006 HD12 HD22 ' A' ' 124' ' ' LEU . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.18 0 CA-C-O 120.713 0.292 . . . . 0.0 110.742 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.571 HD23 ' O ' ' A' ' 122' ' ' GLN . 14.8 mt -133.61 148.38 51.56 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.523 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.43 ' O ' ' N ' ' A' ' 122' ' ' GLN . 5.5 mp -112.68 132.18 55.3 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 179.292 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.723 ' HB2' HD12 ' A' ' 92' ' ' LEU . 20.4 t30 -113.33 111.8 22.61 Favored 'General case' 0 CA--C 1.509 -0.607 0 C-N-CA 119.868 -0.733 . . . . 0.0 110.046 -179.773 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.703 ' HB3' HG21 ' A' ' 109' ' ' THR . 72.8 m-20 -84.81 112.26 20.36 Favored 'General case' 0 N--CA 1.442 -0.87 0 C-N-CA 119.835 -0.746 . . . . 0.0 109.452 179.476 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.975 ' O ' ' O ' ' A' ' 88' ' ' HIS . 0.1 OUTLIER -123.16 107.56 19.42 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.018 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 177.875 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.415 ' OG ' ' NE2' ' A' ' 88' ' ' HIS . 75.8 m -130.81 170.74 13.98 Favored 'General case' 0 C--N 1.294 -1.833 0 CA-C-N 114.95 -1.023 . . . . 0.0 109.372 179.646 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 25.1 m -69.39 -63.02 1.15 Allowed 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 118.965 -1.094 . . . . 0.0 111.234 -179.334 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -112.27 -33.21 6.28 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 114.551 1.315 . . . . 0.0 114.551 178.899 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -146.63 130.26 3.59 Favored Glycine 0 C--N 1.34 0.775 0 N-CA-C 116.976 1.55 . . . . 0.0 116.976 -177.941 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.703 HG21 ' HB3' ' A' ' 103' ' ' ASP . 6.3 m -121.06 138.23 54.28 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 174.262 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' TRP . . . . . 0.688 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.4 m-90 -119.6 149.28 42.21 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 113.407 0.892 . . . . 0.0 113.407 -178.461 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.475 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -120.96 112.03 18.25 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 115.162 -0.926 . . . . 0.0 108.638 177.495 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 66.9 m-20 44.7 43.17 6.49 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.126 -0.488 . . . . 0.0 112.085 -179.484 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 79.74 26.81 55.56 Favored Glycine 0 N--CA 1.444 -0.813 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.743 179.349 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' GLN . . . . . 0.45 ' O ' HG13 ' A' ' 116' ' ' VAL . 38.6 tt0 -138.11 98.18 3.57 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.073 0.464 . . . . 0.0 110.929 179.728 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.688 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.0 OUTLIER -45.29 128.76 7.91 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.97 179.725 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.45 HG13 ' O ' ' A' ' 114' ' ' GLN . 28.3 m -121.12 -179.31 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.845 -179.329 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -85.65 141.83 29.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.921 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.431 ' HG3' ' HA ' ' A' ' 104' ' ' ILE . 86.7 tttt -66.38 163.14 18.86 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.226 179.471 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.411 ' C ' ' O ' ' A' ' 118' ' ' LYS . 8.1 m-80 34.24 39.05 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 121.203 0.525 . . . . 0.0 111.13 -179.4 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.409 ' OG ' ' NE2' ' A' ' 122' ' ' GLN . 14.8 p -111.13 115.25 29.09 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.991 -179.443 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.891 ' OD1' HD13 ' A' ' 92' ' ' LEU . 11.9 m-80 -59.63 138.52 57.71 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.534 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' GLN . . . . . 0.571 ' O ' HD23 ' A' ' 100' ' ' LEU . 31.5 mm-40 -129.07 144.91 51.35 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.163 0.506 . . . . 0.0 111.829 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.4 tp -72.39 127.03 31.31 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.976 179.503 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 1.006 HD22 HD12 ' A' ' 99' ' ' LEU . 4.7 tp -55.7 143.33 30.94 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.899 0.856 . . . . 0.0 111.763 -179.145 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.746 ' O ' HD11 ' A' ' 147' ' ' ILE . 0.6 OUTLIER -126.87 151.98 47.66 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 114.049 -1.432 . . . . 0.0 109.92 179.133 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 126' ' ' GLN . . . . . 0.473 ' HA ' HD12 ' A' ' 147' ' ' ILE . 0.0 OUTLIER -71.44 114.13 9.19 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.962 0.411 . . . . 0.0 109.988 179.752 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 69.66 25.83 75.1 Favored Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.333 -179.374 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -54.97 159.62 2.3 Favored 'General case' 0 C--N 1.334 -0.103 0 CA-C-O 121.001 0.429 . . . . 0.0 111.068 -179.796 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.471 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 1.1 tt0 -146.56 135.26 22.21 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.559 -179.823 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.698 HD13 ' OD1' ' A' ' 103' ' ' ASP . 3.5 mt -111.37 127.94 68.19 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.184 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 178.53 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.465 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 29.4 m -103.39 144.31 31.55 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.505 -179.531 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.488 ' O ' HD12 ' A' ' 141' ' ' LEU . 5.4 m -140.91 156.31 22.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -179.042 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 72.42 40.05 55.52 Favored Glycine 0 N--CA 1.446 -0.682 0 CA-C-N 115.891 -0.595 . . . . 0.0 112.366 179.599 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.462 HG12 ' N ' ' A' ' 135' ' ' GLY . 95.1 t -75.7 156.64 5.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 121.38 0.61 . . . . 0.0 112.06 -179.256 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 135' ' ' GLY . . . . . 0.462 ' N ' HG12 ' A' ' 134' ' ' VAL . . . 153.74 -47.35 0.54 Allowed Glycine 0 N--CA 1.441 -0.971 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.8 -179.281 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.646 HG12 ' H ' ' A' ' 138' ' ' SER . 49.3 t -126.66 134.49 66.17 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 CA-C-N 115.216 -0.492 . . . . 0.0 109.908 178.714 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.418 ' HA ' HD12 ' A' ' 140' ' ' ILE . 14.2 pt-20 -51.29 -31.66 22.14 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.835 0.35 . . . . 0.0 111.263 -179.419 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 138' ' ' SER . . . . . 0.646 ' H ' HG12 ' A' ' 136' ' ' VAL . 0.6 OUTLIER -94.05 6.34 48.84 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.119 -0.491 . . . . 0.0 112.118 -179.538 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -129.79 29.62 4.98 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 112.543 0.571 . . . . 0.0 112.543 -179.343 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.465 ' CG2' ' CG2' ' A' ' 131' ' ' THR . 28.3 mt -104.99 141.24 20.8 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.073 179.22 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.488 HD12 ' O ' ' A' ' 132' ' ' VAL . 1.6 mp -118.63 134.94 54.74 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.492 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 142' ' ' SER . . . . . 0.592 ' HB3' HG21 ' A' ' 40' ' ' THR . 42.4 t -115.04 152.23 32.85 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.761 0.791 . . . . 0.0 112.686 -179.089 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 1.035 HD21 HG12 ' A' ' 36' ' ' VAL . 1.3 tm? -135.85 129.44 32.38 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 114.488 -1.233 . . . . 0.0 108.96 179.169 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.765 ' N ' HD22 ' A' ' 143' ' ' LEU . 21.4 t -119.78 140.21 44.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.934 0.397 . . . . 0.0 111.83 -178.992 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -110.56 139.67 33.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.851 179.558 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -115.23 118.71 34.08 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.586 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.762 HG12 HD21 ' A' ' 124' ' ' LEU . 1.7 mt -98.26 133.56 40.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.986 0.422 . . . . 0.0 111.775 -179.602 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 18.5 p-10 -77.94 124.39 27.95 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.738 179.516 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -66.16 -24.87 66.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.313 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 3.2 mptt -59.22 -44.33 92.31 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.991 0.424 . . . . 0.0 110.844 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 20.3 t80 . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.093 -179.855 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 . . . . . 0 C--O 1.23 0.07 0 CA-C-O 120.737 0.303 . . . . 0.0 111.275 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -109.43 -13.81 14.52 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-O 121.856 0.836 . . . . 0.0 109.043 178.77 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.609 ' O ' ' CG2' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -70.97 95.46 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.534 0 CA-C-N 114.032 -1.44 . . . . 0.0 111.166 -179.08 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.62 ' CG2' ' HB2' ' A' ' 50' ' ' ALA . 0.4 OUTLIER -32.58 -62.13 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 CA-C-N 115.081 -0.963 . . . . 0.0 111.647 -179.946 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.604 ' N ' ' CG1' ' A' ' 33' ' ' VAL . 23.2 p -165.85 163.44 18.69 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.962 179.757 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 6.7 ttm180 -122.58 125.99 46.81 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.096 179.563 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.676 HG21 ' CZ ' ' A' ' 68' ' ' PHE . 12.3 m -93.67 137.0 23.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.993 -0.548 . . . . 0.0 111.169 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.857 HG23 HG12 ' A' ' 45' ' ' ILE . 19.0 mt -130.74 106.88 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 CA-C-O 120.954 0.406 . . . . 0.0 111.787 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.535 ' SG ' HD23 ' A' ' 143' ' ' LEU . 0.1 OUTLIER -99.78 99.73 10.58 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 177.949 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 9.5 t -108.62 26.7 10.22 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -178.322 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.885 HG21 ' HB2' ' A' ' 142' ' ' SER . 77.4 p -111.39 -6.35 14.49 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 111.679 0.252 . . . . 0.0 111.679 179.764 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 101.59 61.64 0.76 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.425 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.575 ' HB3' HD12 ' A' ' 43' ' ' ILE . 3.8 mt-30 -141.66 -69.5 0.37 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.708 0.29 . . . . 0.0 110.904 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.765 HG23 HD21 ' A' ' 78' ' ' LEU . 3.5 mp -135.06 129.92 19.19 Favored Pre-proline 0 N--CA 1.452 -0.36 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.091 179.764 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.435 ' HD2' ' CZ ' ' A' ' 76' ' ' TYR . 35.5 Cg_exo -59.36 147.0 93.12 Favored 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 122.702 2.268 . . . . 0.0 111.848 179.743 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.857 HG12 HG23 ' A' ' 37' ' ' ILE . 40.8 mt -44.73 127.5 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.076 -0.511 . . . . 0.0 112.044 -179.416 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.597 ' O ' HG22 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -130.36 130.25 44.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.92 179.124 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -86.86 119.54 27.19 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.079 0.466 . . . . 0.0 111.629 -179.19 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.987 HD22 ' CD1' ' A' ' 66' ' ' TRP . 9.1 mt -99.5 138.89 35.96 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.054 178.621 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.609 ' OG ' ' N ' ' A' ' 50' ' ' ALA . 45.5 t -131.49 -171.55 2.63 Favored 'General case' 0 CA--C 1.511 -0.536 0 CA-C-O 123.09 1.424 . . . . 0.0 113.971 -179.173 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.62 ' HB2' ' CG2' ' A' ' 33' ' ' VAL . . . -157.16 165.27 36.47 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 112.537 -2.119 . . . . 0.0 110.941 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -106.59 121.76 44.95 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.043 0.449 . . . . 0.0 110.785 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 7.5 mt . . . . . 0 C--N 1.326 -0.432 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.889 -179.581 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.902 0.382 . . . . 0.0 110.938 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.403 ' O ' ' HB3' ' A' ' 93' ' ' LEU . 18.9 ttpt -117.43 131.11 56.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.472 179.609 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.593 HG13 ' O ' ' A' ' 91' ' ' ILE . 9.0 t -130.49 136.94 57.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.99 0.424 . . . . 0.0 111.654 -179.191 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' TRP . . . . . 0.987 ' CD1' HD22 ' A' ' 48' ' ' LEU . 16.0 m-90 -99.8 138.89 36.25 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.536 179.218 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.837 HG23 ' HG3' ' A' ' 90' ' ' GLN . 2.2 m -131.86 128.33 38.42 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.676 ' CZ ' HG21 ' A' ' 36' ' ' VAL . 81.4 m-85 -96.74 118.09 32.44 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 177.374 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.547 ' HA3' ' C ' ' A' ' 86' ' ' ASN . . . 157.73 -154.87 25.92 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 118.56 -1.781 . . . . 0.0 113.263 179.547 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.515 ' HG2' ' HA ' ' A' ' 80' ' ' ASN . 61.9 mtp180 -75.87 91.09 2.97 Favored 'General case' 0 N--CA 1.44 -0.931 0 CA-C-O 122.481 1.134 . . . . 0.0 108.196 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 29.2 m-80 -150.12 160.1 34.06 Favored Pre-proline 0 C--N 1.31 -1.143 0 CA-C-N 112.897 -1.956 . . . . 0.0 108.658 179.503 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.528 ' O ' ' CB ' ' A' ' 73' ' ' ALA . 35.6 Cg_endo -65.22 -9.66 22.81 Favored 'Trans proline' 0 N--CA 1.452 -0.931 0 C-N-CA 120.73 0.954 . . . . 0.0 110.564 177.257 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.792 ' HB2' ' HB2' ' A' ' 77' ' ' HIS . . . 138.92 52.47 0.0 OUTLIER 'General case' 0 CA--C 1.492 -1.288 0 CA-C-N 114.537 -1.211 . . . . 0.0 109.405 178.785 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.563 ' HB3' ' HB ' ' A' ' 67' ' ' THR . 0.1 OUTLIER -53.07 -69.87 0.1 Allowed 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 106.135 -1.802 . . . . 0.0 106.135 179.539 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.583 ' HB2' ' N ' ' A' ' 67' ' ' THR . 5.5 t70 -94.14 -47.49 6.63 Favored 'General case' 0 N--CA 1.436 -1.144 0 N-CA-C 105.577 -2.008 . . . . 0.0 105.577 169.837 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.543 ' C ' ' HA ' ' A' ' 73' ' ' ALA . 14.4 t80 -144.0 142.78 30.89 Favored 'General case' 0 C--N 1.343 0.315 0 CA-C-N 112.37 -2.195 . . . . 0.0 110.91 179.664 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' HIS . . . . . 0.792 ' HB2' ' HB2' ' A' ' 73' ' ' ALA . 0.8 OUTLIER -84.83 107.12 16.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 118.41 0.55 . . . . 0.0 110.014 177.589 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.765 HD21 HG23 ' A' ' 43' ' ' ILE . 29.9 mt -111.96 156.63 21.81 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.849 0.357 . . . . 0.0 111.114 -179.662 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -60.26 -160.25 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.586 -0.816 . . . . 0.0 111.792 179.436 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.515 ' HA ' ' HG2' ' A' ' 70' ' ' ARG . 9.4 p30 -109.42 98.9 8.21 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 117.001 0.4 . . . . 0.0 111.112 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.499 ' HB ' ' HB2' ' A' ' 85' ' ' SER . 37.9 mm -113.72 154.61 15.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.567 179.387 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.417 ' N ' HG22 ' A' ' 81' ' ' ILE . 0.8 OUTLIER -67.48 -44.83 77.57 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 -178.922 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 1.6 mpp_? -122.81 -92.09 0.54 Allowed 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 113.658 0.985 . . . . 0.0 113.658 -177.753 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.487 ' O ' ' CB ' ' A' ' 85' ' ' SER . 0.0 OUTLIER -79.05 101.85 8.07 Favored 'General case' 0 CA--C 1.506 -0.724 0 CA-C-O 121.973 0.892 . . . . 0.0 110.961 -178.546 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.521 ' O ' ' HA2' ' A' ' 69' ' ' GLY . 0.4 OUTLIER 150.03 -28.59 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 113.155 -1.839 . . . . 0.0 108.834 -179.793 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.826 ' O ' ' N ' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -85.47 -164.66 1.04 Allowed 'General case' 0 CA--C 1.51 -0.589 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 177.465 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.923 ' HB2' HD11 ' A' ' 104' ' ' ILE . 2.5 ptmt -47.74 73.85 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 178.98 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.99 ' O ' ' O ' ' A' ' 104' ' ' ILE . 25.1 t60 -91.66 -17.35 25.63 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 114.243 1.201 . . . . 0.0 114.243 -176.779 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.624 ' HA ' ' H ' ' A' ' 104' ' ' ILE . 0.2 OUTLIER -173.56 155.3 2.73 Favored 'General case' 0 C--N 1.314 -0.938 0 C-N-CA 118.946 -1.102 . . . . 0.0 112.775 177.845 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.837 ' HG3' HG23 ' A' ' 67' ' ' THR . 0.5 OUTLIER -135.18 154.43 51.62 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.579 -1.191 . . . . 0.0 113.868 -177.67 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.666 ' HB ' ' HB2' ' A' ' 66' ' ' TRP . 49.3 mt -124.91 132.14 71.7 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.734 178.435 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.667 HD13 ' ND2' ' A' ' 121' ' ' ASN . 0.3 OUTLIER -108.6 140.57 41.78 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.139 0.495 . . . . 0.0 112.249 -179.168 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.87 HD22 ' N ' ' A' ' 94' ' ' GLY . 0.6 OUTLIER -125.54 135.07 51.87 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.173 179.129 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.87 ' N ' HD22 ' A' ' 93' ' ' LEU . . . . . . . . 0 N--CA 1.45 -0.413 0 C-N-CA 120.605 -0.807 . . . . 0.0 112.693 179.691 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.769 ' HB2' HD13 ' A' ' 124' ' ' LEU . 8.1 mp . . . . . 0 C--O 1.23 0.076 0 CA-C-O 120.914 0.388 . . . . 0.0 110.878 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.654 HD23 ' HB3' ' A' ' 121' ' ' ASN . 7.9 mp -123.72 148.29 46.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.171 179.735 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.457 ' O ' ' N ' ' A' ' 122' ' ' GLN . 12.3 mt -118.1 130.5 56.17 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.813 -0.355 . . . . 0.0 110.263 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.517 ' HB2' HD11 ' A' ' 92' ' ' LEU . 24.8 t30 -113.32 111.58 22.25 Favored 'General case' 0 CA--C 1.512 -0.516 0 C-N-CA 120.017 -0.673 . . . . 0.0 109.686 179.611 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.687 ' HB3' HG21 ' A' ' 109' ' ' THR . 72.3 m-20 -84.96 111.93 20.13 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 119.826 -0.749 . . . . 0.0 110.13 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.99 ' O ' ' O ' ' A' ' 88' ' ' HIS . 0.1 OUTLIER -124.47 108.18 19.89 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.91 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 177.393 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 67.1 m -129.77 174.16 9.98 Favored 'General case' 0 C--N 1.296 -1.737 0 CA-C-N 115.285 -0.871 . . . . 0.0 109.312 179.353 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 23.3 m -69.25 -63.85 0.99 Allowed 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 118.998 -1.081 . . . . 0.0 111.435 -179.271 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 5.5 p30 -112.48 -32.91 6.33 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 114.181 1.178 . . . . 0.0 114.181 178.781 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -145.98 131.47 4.13 Favored Glycine 0 C--N 1.339 0.695 0 N-CA-C 116.558 1.383 . . . . 0.0 116.558 -178.133 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.687 HG21 ' HB3' ' A' ' 103' ' ' ASP . 5.8 m -121.19 138.29 54.28 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 174.697 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' TRP . . . . . 0.769 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.4 m-90 -119.78 149.18 42.47 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 113.503 0.927 . . . . 0.0 113.503 -178.542 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.474 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -122.84 112.25 17.64 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 114.997 -1.001 . . . . 0.0 108.644 177.603 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 46.25 43.73 11.63 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.091 -0.504 . . . . 0.0 112.18 -179.546 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 79.49 17.41 75.91 Favored Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.913 179.257 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -130.39 97.85 4.53 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.053 0.454 . . . . 0.0 110.713 179.634 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.769 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.0 OUTLIER -44.75 134.3 5.62 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.059 179.886 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.552 HG22 ' N ' ' A' ' 117' ' ' GLU . 14.7 p -127.57 164.2 29.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.45 -179.163 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.552 ' N ' HG22 ' A' ' 116' ' ' VAL . 19.1 tt0 -70.13 141.83 52.63 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.975 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.469 ' HG3' ' HA ' ' A' ' 104' ' ' ILE . 36.3 tttm -65.23 163.69 14.76 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.217 179.552 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.4 ' N ' ' HG2' ' A' ' 118' ' ' LYS . 0.8 OUTLIER 36.16 39.13 0.08 Allowed 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 121.255 0.55 . . . . 0.0 110.747 -179.438 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 4.7 p -110.82 108.94 18.94 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.034 -179.305 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.667 ' ND2' HD13 ' A' ' 92' ' ' LEU . 1.6 m-20 -58.77 139.37 56.38 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.798 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' GLN . . . . . 0.651 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 44.0 mm-40 -129.85 147.42 51.62 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-O 120.964 0.412 . . . . 0.0 111.919 -179.651 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.1 tp -72.3 112.01 8.0 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 178.832 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.983 HD21 HD13 ' A' ' 147' ' ' ILE . 3.7 tt -44.0 145.91 0.68 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.726 0.774 . . . . 0.0 112.143 -178.716 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -126.4 153.15 45.38 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 114.225 -1.352 . . . . 0.0 110.33 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -71.56 113.78 8.95 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 179.51 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 70.33 26.5 74.1 Favored Glycine 0 N--CA 1.444 -0.787 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.338 -179.32 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -56.54 159.89 3.52 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.02 0.438 . . . . 0.0 111.198 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.623 ' HG3' HG22 ' A' ' 144' ' ' VAL . 5.1 tt0 -146.53 135.07 22.07 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.415 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.428 ' CG2' ' O ' ' A' ' 110' ' ' TRP . 7.8 mm -111.68 128.31 68.3 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.119 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 178.761 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.544 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 3.4 m -103.66 144.74 31.04 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.81 -179.493 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.467 HG11 ' NE2' ' A' ' 88' ' ' HIS . 4.4 m -141.28 158.39 22.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 112.462 0.542 . . . . 0.0 112.462 -178.801 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 70.26 43.99 61.23 Favored Glycine 0 N--CA 1.447 -0.586 0 CA-C-N 115.75 -0.659 . . . . 0.0 112.398 179.269 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.499 ' HA ' HG12 ' A' ' 140' ' ' ILE . 93.6 t -79.26 155.73 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 CA-C-O 121.436 0.636 . . . . 0.0 112.234 -179.13 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 135' ' ' GLY . . . . . 0.436 ' N ' HG12 ' A' ' 134' ' ' VAL . . . 150.07 -43.88 0.72 Allowed Glycine 0 N--CA 1.442 -0.939 0 CA-C-N 114.908 -1.042 . . . . 0.0 110.529 -178.992 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.55 HG12 ' H ' ' A' ' 138' ' ' SER . 46.3 t -126.6 130.87 71.7 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.687 0 CA-C-N 115.08 -0.56 . . . . 0.0 109.753 178.583 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.442 ' HA ' HD12 ' A' ' 140' ' ' ILE . 7.5 tt0 -51.07 -33.9 27.73 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.731 0.3 . . . . 0.0 111.493 -179.198 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 138' ' ' SER . . . . . 0.55 ' H ' HG12 ' A' ' 136' ' ' VAL . 83.0 p -94.14 6.25 49.17 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.243 0.461 . . . . 0.0 112.243 -179.464 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -127.54 30.15 5.39 Favored 'General case' 0 CA--C 1.52 -0.206 0 N-CA-C 112.408 0.521 . . . . 0.0 112.408 -179.373 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.544 ' CG2' ' CG2' ' A' ' 131' ' ' THR . 14.9 mt -106.0 141.28 21.65 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.935 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.392 179.213 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.494 HD22 ' C ' ' A' ' 140' ' ' ILE . 3.6 mm? -115.64 135.67 53.83 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.052 -0.977 . . . . 0.0 110.51 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 142' ' ' SER . . . . . 0.885 ' HB2' HG21 ' A' ' 40' ' ' THR . 4.2 m -120.01 153.67 35.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.814 0.816 . . . . 0.0 112.669 -179.273 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.824 HD22 ' N ' ' A' ' 144' ' ' VAL . 1.2 tm? -135.45 135.38 40.49 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 114.49 -1.232 . . . . 0.0 108.835 179.451 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.824 ' N ' HD22 ' A' ' 143' ' ' LEU . 21.2 t -122.67 140.46 46.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 112.217 0.451 . . . . 0.0 112.217 -178.717 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.559 HG13 HG12 ' A' ' 36' ' ' VAL . 0.6 OUTLIER -108.45 138.79 33.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.43 179.378 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 18.3 t80 -121.23 104.17 9.54 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.783 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.983 HD13 HD21 ' A' ' 124' ' ' LEU . 1.6 mp -102.39 130.67 51.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.281 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 11.3 p30 -78.33 141.16 38.64 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.929 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -73.27 -22.62 60.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.182 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 28.0 mmtt -58.26 -43.87 88.12 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-O 120.898 0.38 . . . . 0.0 110.712 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 11.4 t80 . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.831 179.827 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.733 0.301 . . . . 0.0 110.995 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -108.72 -13.82 14.72 Favored 'General case' 0 CA--C 1.516 -0.347 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 178.333 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.595 ' O ' ' CG2' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -70.77 96.33 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.635 0 CA-C-N 113.928 -1.487 . . . . 0.0 110.689 -179.48 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.906 HG23 ' HB3' ' A' ' 50' ' ' ALA . 0.8 OUTLIER -33.46 -62.51 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 114.996 -1.002 . . . . 0.0 112.244 -179.157 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.64 ' N ' HG12 ' A' ' 33' ' ' VAL . 22.4 m -160.7 164.85 31.36 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.092 0.472 . . . . 0.0 111.637 -179.487 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 3.1 tmm_? -132.72 114.34 14.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.445 179.469 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.923 HG23 ' CD2' ' A' ' 48' ' ' LEU . 40.0 t -90.27 136.08 24.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.612 179.767 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.932 HG23 HG12 ' A' ' 45' ' ' ILE . 21.5 mt -124.09 107.97 19.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -179.248 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.799 ' SG ' HD12 ' A' ' 143' ' ' LEU . 70.3 m -99.82 102.91 14.47 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 177.565 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.492 ' CG2' HG22 ' A' ' 37' ' ' ILE . 1.4 p -108.86 -21.54 12.61 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 113.509 0.929 . . . . 0.0 113.509 -176.866 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.73 HG21 ' HB2' ' A' ' 142' ' ' SER . 34.0 p -55.67 -20.67 14.92 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.745 0.307 . . . . 0.0 111.525 -179.428 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 113.53 62.87 0.43 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.285 179.705 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.666 ' HG3' HD12 ' A' ' 141' ' ' LEU . 3.2 mt-30 -144.18 -54.16 0.34 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.703 0.287 . . . . 0.0 111.361 -179.718 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.926 HG22 ' HD2' ' A' ' 44' ' ' PRO . 0.0 OUTLIER -134.76 154.62 79.54 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.33 -178.961 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.926 ' HD2' HG22 ' A' ' 43' ' ' ILE . 90.1 Cg_endo -83.78 146.86 11.94 Favored 'Trans proline' 0 N--CA 1.459 -0.511 0 C-N-CA 122.648 2.232 . . . . 0.0 111.569 179.402 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.932 HG12 HG23 ' A' ' 37' ' ' ILE . 40.8 mt -47.85 112.0 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 120.926 0.393 . . . . 0.0 111.728 -179.5 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 7.4 mmm180 -114.91 130.05 56.83 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.684 178.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -97.98 120.08 37.74 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.094 0.473 . . . . 0.0 111.928 -178.83 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.923 ' CD2' HG23 ' A' ' 36' ' ' VAL . 0.2 OUTLIER -92.59 137.21 32.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.238 178.641 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.534 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -135.79 163.16 30.83 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 113.258 0.836 . . . . 0.0 113.258 -178.601 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.906 ' HB3' HG23 ' A' ' 33' ' ' VAL . . . -157.48 142.16 16.58 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.626 -1.17 . . . . 0.0 111.195 179.111 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -64.31 137.19 57.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.227 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 12.4 mt . . . . . 0 C--N 1.33 -0.271 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.994 179.804 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.232 0.152 0 CA-C-O 120.809 0.337 . . . . 0.0 110.916 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.41 ' O ' ' HB3' ' A' ' 93' ' ' LEU . 12.4 ttpt -134.32 134.44 41.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.585 179.813 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.621 HG13 ' O ' ' A' ' 91' ' ' ILE . 11.8 t -132.88 137.36 54.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.052 0.453 . . . . 0.0 111.763 -179.125 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' TRP . . . . . 0.839 ' CD1' HD12 ' A' ' 48' ' ' LEU . 14.9 m-90 -99.6 139.7 34.87 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.431 179.081 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.843 HG23 ' CG ' ' A' ' 90' ' ' GLN . 4.8 m -129.56 131.39 46.54 Favored 'General case' 0 CA--C 1.52 -0.194 0 CA-C-O 121.416 0.626 . . . . 0.0 112.46 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.503 ' CE2' ' CE2' ' A' ' 89' ' ' PHE . 90.1 m-85 -103.03 118.35 36.62 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.12 177.833 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.574 ' HA2' ' O ' ' A' ' 85' ' ' SER . . . 158.2 -156.12 27.09 Favored Glycine 0 CA--C 1.504 -0.656 0 C-N-CA 118.883 -1.627 . . . . 0.0 112.432 179.468 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.465 ' CD ' ' HB3' ' A' ' 86' ' ' ASN . 7.5 ptm180 -75.74 92.09 2.98 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-O 122.549 1.166 . . . . 0.0 108.377 179.703 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -149.18 159.81 36.21 Favored Pre-proline 0 C--N 1.311 -1.089 0 CA-C-N 112.783 -2.008 . . . . 0.0 108.46 179.511 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.556 ' O ' ' HB2' ' A' ' 77' ' ' HIS . 32.7 Cg_endo -64.96 -7.85 16.39 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 121.025 1.15 . . . . 0.0 111.095 178.295 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.774 ' HB2' ' HB2' ' A' ' 77' ' ' HIS . . . 136.18 50.89 0.0 OUTLIER 'General case' 0 CA--C 1.49 -1.331 0 CA-C-N 114.661 -1.154 . . . . 0.0 109.656 178.704 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.564 ' HB3' ' HB ' ' A' ' 67' ' ' THR . 0.1 OUTLIER -53.24 -69.74 0.11 Allowed 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 105.863 -1.903 . . . . 0.0 105.863 179.438 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.576 ' N ' ' O ' ' A' ' 67' ' ' THR . 11.2 t0 -95.33 -46.92 6.52 Favored 'General case' 0 N--CA 1.435 -1.196 0 N-CA-C 105.915 -1.883 . . . . 0.0 105.915 169.766 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.55 ' CD2' HG22 ' A' ' 43' ' ' ILE . 61.4 t80 -143.77 142.73 31.05 Favored 'General case' 0 C--N 1.346 0.453 0 CA-C-N 112.62 -2.082 . . . . 0.0 111.113 179.832 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' HIS . . . . . 0.774 ' HB2' ' HB2' ' A' ' 73' ' ' ALA . 1.3 t60 -94.23 108.91 20.75 Favored 'General case' 0 C--N 1.328 -0.329 0 O-C-N 121.984 -0.447 . . . . 0.0 110.413 177.125 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.804 HD12 ' O ' ' A' ' 79' ' ' GLY . 3.9 pp -126.17 170.92 11.33 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.82 0.343 . . . . 0.0 110.735 179.48 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.804 ' O ' HD12 ' A' ' 78' ' ' LEU . . . -53.16 -176.3 0.06 OUTLIER Glycine 0 CA--C 1.518 0.245 0 C-N-CA 120.897 -0.668 . . . . 0.0 112.745 -179.754 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.541 ' C ' HD12 ' A' ' 81' ' ' ILE . 0.5 OUTLIER -108.25 102.25 11.39 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.85 0.357 . . . . 0.0 110.881 179.859 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.741 HD13 ' HB3' ' A' ' 85' ' ' SER . 2.0 mp -110.11 153.99 11.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.919 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 10.0 t -68.19 -45.31 73.76 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 113.72 1.007 . . . . 0.0 113.72 -178.717 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.778 ' HB3' HD13 ' A' ' 84' ' ' LEU . 3.1 mpt_? -120.4 -90.1 0.59 Allowed 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 113.74 1.015 . . . . 0.0 113.74 -177.338 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.778 HD13 ' HB3' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -84.72 103.51 13.88 Favored 'General case' 0 CA--C 1.506 -0.741 0 CA-C-O 122.014 0.912 . . . . 0.0 110.836 -178.622 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.741 ' HB3' HD13 ' A' ' 81' ' ' ILE . 0.4 OUTLIER 148.13 -35.8 0.01 OUTLIER 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 113.072 -1.876 . . . . 0.0 108.607 -179.812 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.809 ' O ' ' N ' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -70.42 -161.55 0.05 Allowed 'General case' 0 CA--C 1.513 -0.477 0 N-CA-C 107.586 -1.265 . . . . 0.0 107.586 177.492 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.831 ' HB2' HD11 ' A' ' 104' ' ' ILE . 9.6 pttt -51.54 72.82 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 178.129 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.93 ' O ' ' O ' ' A' ' 104' ' ' ILE . 32.9 t60 -84.51 -17.09 40.09 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 114.389 1.255 . . . . 0.0 114.389 -176.374 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.665 ' HA ' ' H ' ' A' ' 104' ' ' ILE . 0.1 OUTLIER -172.09 154.18 3.34 Favored 'General case' 0 C--N 1.31 -1.124 0 C-N-CA 119.124 -1.03 . . . . 0.0 112.48 177.867 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.843 ' CG ' HG23 ' A' ' 67' ' ' THR . 32.9 mt-30 -136.04 159.05 42.88 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 114.52 -1.218 . . . . 0.0 113.902 -177.294 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.733 HD11 HG21 ' A' ' 36' ' ' VAL . 7.1 mt -125.25 131.85 71.86 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 CA-C-N 114.949 -1.023 . . . . 0.0 109.703 178.607 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.662 HD22 ' ND2' ' A' ' 121' ' ' ASN . 0.3 OUTLIER -108.05 143.78 36.29 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.083 0.468 . . . . 0.0 112.111 -179.421 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.71 HD13 ' CG2' ' A' ' 33' ' ' VAL . 14.3 tp -125.6 122.68 37.15 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.349 179.038 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.353 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.401 179.951 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.412 HD22 ' SG ' ' A' ' 34' ' ' CYS . 1.2 mt . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.708 0.29 . . . . 0.0 110.854 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.614 HD22 ' HB3' ' A' ' 121' ' ' ASN . 5.6 mt -133.79 148.46 51.35 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.434 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.447 ' O ' ' N ' ' A' ' 122' ' ' GLN . 38.0 mt -117.27 130.99 56.91 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 179.777 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.512 ' HB2' HD11 ' A' ' 92' ' ' LEU . 23.8 t30 -113.25 111.31 21.83 Favored 'General case' 0 CA--C 1.51 -0.581 0 C-N-CA 119.847 -0.741 . . . . 0.0 109.944 179.684 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.724 ' HB3' HG21 ' A' ' 109' ' ' THR . 70.7 m-20 -84.43 112.52 20.44 Favored 'General case' 0 N--CA 1.444 -0.773 0 C-N-CA 119.669 -0.812 . . . . 0.0 109.381 179.4 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.93 ' O ' ' O ' ' A' ' 88' ' ' HIS . 0.1 OUTLIER -122.91 107.61 19.67 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.876 0 CA-C-O 121.756 0.789 . . . . 0.0 108.96 178.136 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.439 ' OG ' ' NE2' ' A' ' 88' ' ' HIS . 66.8 m -132.39 171.49 13.67 Favored 'General case' 0 C--N 1.295 -1.77 0 CA-C-N 114.757 -1.11 . . . . 0.0 109.36 179.551 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 22.6 m -69.5 -63.8 1.0 Allowed 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 118.998 -1.081 . . . . 0.0 111.706 -178.946 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 5.5 p30 -112.6 -32.76 6.35 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 114.63 1.344 . . . . 0.0 114.63 179.203 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -146.13 129.17 3.28 Favored Glycine 0 C--N 1.339 0.719 0 N-CA-C 116.931 1.532 . . . . 0.0 116.931 -177.796 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.724 HG21 ' HB3' ' A' ' 103' ' ' ASP . 6.5 m -121.15 138.36 54.24 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 174.411 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' TRP . . . . . 0.639 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.7 m-90 -120.45 149.2 42.76 Favored 'General case' 0 CA--C 1.515 -0.374 0 N-CA-C 113.283 0.846 . . . . 0.0 113.283 -178.447 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.469 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -121.64 111.85 17.71 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 115.001 -0.999 . . . . 0.0 108.563 177.44 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 44.74 43.79 7.06 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.125 -0.489 . . . . 0.0 112.114 -179.511 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 78.88 31.4 44.0 Favored Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.891 179.238 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -141.95 98.93 3.42 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.999 0.428 . . . . 0.0 110.832 179.648 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.639 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.2 OUTLIER -45.22 122.59 3.49 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.786 179.727 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.515 HG21 ' OD2' ' A' ' 103' ' ' ASP . 8.1 m -112.35 179.56 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.902 -179.047 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.431 ' HB3' ' HB3' ' A' ' 120' ' ' SER . 0.5 OUTLIER -88.13 136.96 32.73 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.809 179.89 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.405 ' HG2' ' N ' ' A' ' 119' ' ' ASN . 63.7 tttm -62.73 162.39 10.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.534 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.405 ' N ' ' HG2' ' A' ' 118' ' ' LYS . 4.9 p-10 34.46 38.54 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.364 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.431 ' HB3' ' HB3' ' A' ' 117' ' ' GLU . 9.0 p -111.28 114.23 27.28 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.055 -179.334 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.662 ' ND2' HD22 ' A' ' 92' ' ' LEU . 1.6 m120 -61.76 136.26 57.92 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.616 179.777 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' GLN . . . . . 0.608 ' C ' HD23 ' A' ' 100' ' ' LEU . 32.0 mm-40 -129.53 145.37 51.47 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.119 0.485 . . . . 0.0 112.161 -179.613 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.6 tp -72.62 120.03 17.67 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.562 178.99 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.567 HD22 ' C ' ' A' ' 124' ' ' LEU . 0.0 OUTLIER -47.6 149.22 1.23 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 122.026 0.917 . . . . 0.0 112.346 -178.661 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.435 ' O ' ' CD1' ' A' ' 147' ' ' ILE . 0.0 OUTLIER -126.42 152.56 46.2 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 114.102 -1.408 . . . . 0.0 109.661 179.195 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.62 113.75 8.03 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.07 0.462 . . . . 0.0 110.136 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 66.49 29.96 75.69 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.375 -179.469 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.452 ' OD2' HD13 ' A' ' 111' ' ' LEU . 9.8 t70 -58.31 161.05 4.61 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.98 0.419 . . . . 0.0 111.343 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -146.28 135.35 22.63 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.044 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.464 ' CD1' ' CE1' ' A' ' 89' ' ' PHE . 3.9 mt -109.91 128.53 65.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 120.831 0.348 . . . . 0.0 110.258 179.213 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.482 HG23 ' CG2' ' A' ' 140' ' ' ILE . 16.8 m -103.19 142.66 33.79 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.634 -179.57 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.5 HG11 ' CD2' ' A' ' 88' ' ' HIS . 4.4 m -140.72 154.09 21.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.298 -0.41 . . . . 0.0 112.008 -179.11 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 75.16 37.03 43.86 Favored Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 121.127 -0.559 . . . . 0.0 112.402 179.549 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.489 ' HA ' HG12 ' A' ' 140' ' ' ILE . 91.5 t -72.89 156.75 6.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 121.44 0.638 . . . . 0.0 112.081 -179.174 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 135' ' ' GLY . . . . . 0.461 ' N ' HG12 ' A' ' 134' ' ' VAL . . . 153.59 -47.86 0.53 Allowed Glycine 0 N--CA 1.442 -0.957 0 N-CA-C 110.665 -0.974 . . . . 0.0 110.665 -179.297 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.65 HG12 ' H ' ' A' ' 138' ' ' SER . 56.1 t -126.71 134.61 65.87 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.682 0 CA-C-N 115.295 -0.453 . . . . 0.0 109.877 178.607 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.447 ' HA ' HD12 ' A' ' 140' ' ' ILE . 12.6 pt-20 -51.19 -32.06 22.3 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.841 0.353 . . . . 0.0 111.19 -179.36 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 138' ' ' SER . . . . . 0.65 ' H ' HG12 ' A' ' 136' ' ' VAL . 90.2 p -94.09 6.26 49.13 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 116.159 -0.473 . . . . 0.0 112.088 -179.657 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -129.31 29.14 5.16 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 112.376 0.51 . . . . 0.0 112.376 -179.487 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.489 HG12 ' HA ' ' A' ' 134' ' ' VAL . 23.6 mt -104.88 140.95 21.37 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 CA-C-N 115.668 -0.697 . . . . 0.0 111.154 179.157 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.666 HD12 ' HG3' ' A' ' 42' ' ' GLN . 4.6 mm? -117.23 135.22 53.96 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 114.925 -1.034 . . . . 0.0 110.06 179.489 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 142' ' ' SER . . . . . 0.764 ' O ' HD13 ' A' ' 143' ' ' LEU . 4.1 m -119.13 152.79 35.92 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.833 0.825 . . . . 0.0 112.581 -179.144 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.799 HD12 ' SG ' ' A' ' 38' ' ' CYS . 1.8 mm? -132.11 153.88 50.04 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 114.401 -1.272 . . . . 0.0 109.174 179.25 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 22.1 t -128.08 140.55 48.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 120.946 0.403 . . . . 0.0 111.777 -179.348 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.759 HG13 HG22 ' A' ' 36' ' ' VAL . 0.4 OUTLIER -113.88 126.58 71.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.333 179.61 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 7.7 t80 -108.84 119.52 39.79 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.054 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.454 HD13 HD23 ' A' ' 124' ' ' LEU . 2.7 mp -112.1 123.0 67.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.881 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 148' ' ' ASN . . . . . 0.409 ' ND2' ' O ' ' A' ' 32' ' ' ILE . 3.1 p30 -76.31 122.88 25.07 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.923 0.392 . . . . 0.0 111.087 -179.74 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -73.82 -19.44 60.75 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.078 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.82 -42.98 85.46 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 120.962 0.411 . . . . 0.0 110.732 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 4.7 t80 . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.64 179.861 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 . . . . . 0 CA--C 1.527 0.094 0 CA-C-O 120.642 0.258 . . . . 0.0 111.369 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -109.42 -14.45 14.42 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-O 121.936 0.874 . . . . 0.0 108.681 178.463 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.587 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 0.1 OUTLIER -71.08 108.99 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.662 0 CA-C-N 113.949 -1.478 . . . . 0.0 111.121 -179.464 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.781 HG11 HD13 ' A' ' 93' ' ' LEU . 2.2 t -53.35 -67.19 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.834 0 CA-C-N 114.946 -1.025 . . . . 0.0 111.459 -179.576 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 18.3 p -155.23 165.08 37.79 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.022 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 1.5 ttm180 -129.33 115.48 17.63 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.402 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.913 HG12 HD21 ' A' ' 143' ' ' LEU . 66.6 t -89.05 130.09 38.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.149 -0.478 . . . . 0.0 109.901 179.183 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.976 HG23 HG12 ' A' ' 45' ' ' ILE . 28.0 mt -122.23 108.54 22.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -178.802 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.632 ' SG ' HD23 ' A' ' 143' ' ' LEU . 0.1 OUTLIER -95.92 101.65 13.35 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 177.599 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -111.47 2.32 17.42 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -178.049 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.86 HG21 ' HB2' ' A' ' 142' ' ' SER . 67.8 p -83.76 -16.35 45.1 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.784 -0.366 . . . . 0.0 111.402 179.646 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 113.71 58.83 0.4 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.587 179.768 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.47 ' HB2' HD12 ' A' ' 43' ' ' ILE . 20.9 mt-30 -134.6 -69.42 0.52 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.641 0.258 . . . . 0.0 111.134 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.47 HD12 ' HB2' ' A' ' 42' ' ' GLN . 3.7 mp -135.09 139.07 30.83 Favored Pre-proline 0 N--CA 1.452 -0.336 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.185 -179.88 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.541 ' HD2' ' CZ ' ' A' ' 76' ' ' TYR . 28.2 Cg_exo -59.26 147.32 91.38 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.718 2.278 . . . . 0.0 111.68 179.607 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.976 HG12 HG23 ' A' ' 37' ' ' ILE . 32.0 mt -46.33 148.72 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 121.008 0.432 . . . . 0.0 111.689 -179.633 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.1 130.28 13.61 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.187 179.445 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.421 ' HB3' HD11 ' A' ' 32' ' ' ILE . 1.8 m-20 -91.58 119.77 31.78 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.086 0.469 . . . . 0.0 111.168 -179.649 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.911 ' CD2' HG23 ' A' ' 36' ' ' VAL . 0.1 OUTLIER -92.5 123.34 35.74 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.479 179.129 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.687 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -132.99 155.98 48.16 Favored 'General case' 0 CA--C 1.515 -0.398 0 N-CA-C 114.04 1.126 . . . . 0.0 114.04 -178.979 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.58 ' N ' HG23 ' A' ' 33' ' ' VAL . . . -149.9 142.24 24.24 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 113.698 -1.592 . . . . 0.0 110.824 179.028 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -66.46 110.22 3.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.982 0.42 . . . . 0.0 110.89 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 10.7 mt . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.1 179.956 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.1 pttp . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.851 0.358 . . . . 0.0 111.084 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.503 ' HD2' ' HB2' ' A' ' 50' ' ' ALA . 29.2 ttmt -99.69 123.55 44.07 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.237 179.478 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.523 HG13 ' O ' ' A' ' 91' ' ' ILE . 4.7 t -126.11 133.32 69.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.141 0.496 . . . . 0.0 112.09 -178.96 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' TRP . . . . . 0.703 ' CD1' HD12 ' A' ' 48' ' ' LEU . 13.3 m-90 -99.34 139.9 34.3 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.229 178.827 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.569 ' HB ' ' CB ' ' A' ' 74' ' ' CYS . 2.8 m -131.37 129.34 41.23 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.447 0.642 . . . . 0.0 112.436 179.678 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.509 ' CD2' ' CD2' ' A' ' 89' ' ' PHE . 94.2 m-85 -100.13 117.6 34.71 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.415 -0.812 . . . . 0.0 109.091 177.832 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.608 ' C ' HD11 ' A' ' 78' ' ' LEU . . . 158.19 -157.83 28.64 Favored Glycine 0 CA--C 1.503 -0.695 0 C-N-CA 119.061 -1.542 . . . . 0.0 113.061 179.456 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -75.46 91.49 2.77 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-O 122.726 1.25 . . . . 0.0 108.43 -179.7 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.403 ' CG ' ' HB2' ' A' ' 74' ' ' CYS . 0.2 OUTLIER -150.39 155.26 36.61 Favored Pre-proline 0 C--N 1.309 -1.162 0 CA-C-N 112.617 -2.083 . . . . 0.0 108.44 179.34 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.56 ' O ' ' HB2' ' A' ' 77' ' ' HIS . 23.9 Cg_exo -56.9 -11.11 6.62 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 121.406 1.404 . . . . 0.0 111.606 178.254 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.744 ' HB2' ' HB2' ' A' ' 77' ' ' HIS . . . 136.16 51.78 0.0 OUTLIER 'General case' 0 CA--C 1.491 -1.315 0 CA-C-N 115.001 -1.0 . . . . 0.0 109.535 178.875 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.569 ' CB ' ' HB ' ' A' ' 67' ' ' THR . 0.1 OUTLIER -52.91 -69.55 0.11 Allowed 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 105.919 -1.882 . . . . 0.0 105.919 179.387 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.568 ' HB2' ' N ' ' A' ' 67' ' ' THR . 8.2 t0 -94.48 -47.73 6.43 Favored 'General case' 0 N--CA 1.434 -1.258 0 N-CA-C 105.772 -1.936 . . . . 0.0 105.772 169.784 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.541 ' CZ ' ' HD2' ' A' ' 44' ' ' PRO . 39.0 t80 -145.04 142.37 29.69 Favored 'General case' 0 C--N 1.347 0.473 0 CA-C-N 112.655 -2.066 . . . . 0.0 111.54 179.485 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' HIS . . . . . 0.744 ' HB2' ' HB2' ' A' ' 73' ' ' ALA . 1.8 t60 -92.06 107.43 19.21 Favored 'General case' 0 C--N 1.331 -0.196 0 O-C-N 121.846 -0.534 . . . . 0.0 109.906 176.779 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.608 HD11 ' C ' ' A' ' 69' ' ' GLY . 2.6 pp -119.99 176.29 5.5 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.949 0.404 . . . . 0.0 111.48 -179.763 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.504 ' O ' HD12 ' A' ' 78' ' ' LEU . . . -64.1 -169.98 1.82 Allowed Glycine 0 C--N 1.332 0.324 0 C-N-CA 121.044 -0.598 . . . . 0.0 112.572 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 10.1 p-10 -111.71 98.82 7.68 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.957 0.408 . . . . 0.0 111.604 -179.686 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.602 ' HB ' ' HB2' ' A' ' 85' ' ' SER . 13.4 mm -113.72 112.1 38.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.302 179.018 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 8.0 t -55.01 -24.24 23.4 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.238 0.458 . . . . 0.0 112.238 -179.236 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -91.49 -109.51 0.1 Allowed 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 -179.027 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.455 ' HB3' ' CE1' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -108.01 112.41 24.96 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 121.619 0.723 . . . . 0.0 109.87 -179.915 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.602 ' HB2' ' HB ' ' A' ' 81' ' ' ILE . 0.4 OUTLIER 162.16 -43.93 0.0 OUTLIER 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 114.285 -1.325 . . . . 0.0 108.932 -179.422 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.843 ' O ' ' N ' ' A' ' 88' ' ' HIS . 96.9 m-20 -65.43 -149.46 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 177.522 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.95 ' HB2' HD11 ' A' ' 104' ' ' ILE . 0.0 OUTLIER -49.79 72.33 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 179.063 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.962 ' C ' ' O ' ' A' ' 104' ' ' ILE . 30.7 t60 -90.58 -16.17 29.23 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 113.813 1.042 . . . . 0.0 113.813 -176.983 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.639 ' HA ' ' H ' ' A' ' 104' ' ' ILE . 1.0 OUTLIER -174.8 152.66 1.61 Allowed 'General case' 0 C--N 1.311 -1.092 0 C-N-CA 119.484 -0.886 . . . . 0.0 112.257 178.052 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.482 ' O ' ' O ' ' A' ' 102' ' ' ASN . 3.2 tt0 -136.42 154.14 50.88 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 114.656 -1.156 . . . . 0.0 113.638 -177.422 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.71 HD11 HG21 ' A' ' 36' ' ' VAL . 16.4 mt -124.65 131.96 71.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.261 -0.882 . . . . 0.0 109.842 178.623 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.745 HD13 ' ND2' ' A' ' 121' ' ' ASN . 0.1 OUTLIER -113.32 140.23 48.18 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.975 0.417 . . . . 0.0 111.99 -179.378 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.781 HD13 HG11 ' A' ' 33' ' ' VAL . 27.1 tp -125.9 130.66 51.75 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.602 179.116 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.344 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.415 -179.959 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.601 ' C ' HD22 ' A' ' 100' ' ' LEU . 67.8 tp . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.744 0.307 . . . . 0.0 110.836 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.601 HD22 ' C ' ' A' ' 99' ' ' LEU . 3.8 mm? -133.48 147.84 51.68 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.547 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 1.064 HD21 HD13 ' A' ' 145' ' ' ILE . 8.0 mp -117.03 130.67 56.83 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 179.647 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.636 ' HB2' HD11 ' A' ' 92' ' ' LEU . 25.0 t30 -114.84 110.93 20.42 Favored 'General case' 0 CA--C 1.508 -0.64 0 C-N-CA 119.87 -0.732 . . . . 0.0 109.881 179.729 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.796 ' OD2' HG11 ' A' ' 116' ' ' VAL . 63.0 m-20 -82.9 111.85 19.15 Favored 'General case' 0 N--CA 1.442 -0.841 0 C-N-CA 119.63 -0.828 . . . . 0.0 109.326 179.5 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.962 ' O ' ' C ' ' A' ' 88' ' ' HIS . 0.1 OUTLIER -123.55 108.03 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.997 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 178.028 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.478 ' HG ' ' CE1' ' A' ' 88' ' ' HIS . 75.6 m -128.09 171.34 11.98 Favored 'General case' 0 C--N 1.297 -1.702 0 CA-C-N 114.914 -1.039 . . . . 0.0 109.275 179.673 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 26.6 m -69.24 -62.96 1.17 Allowed 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 119.099 -1.04 . . . . 0.0 111.074 -179.393 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 5.7 p30 -111.97 -33.66 6.21 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 114.216 1.191 . . . . 0.0 114.216 178.839 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -147.02 133.09 4.62 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 116.667 1.427 . . . . 0.0 116.667 -178.253 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.764 HG21 ' HB3' ' A' ' 103' ' ' ASP . 8.3 m -121.01 138.29 54.24 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 174.164 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' TRP . . . . . 0.756 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.4 m-90 -119.3 149.15 42.27 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 -178.387 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.419 ' O ' ' HG ' ' A' ' 111' ' ' LEU . 0.2 OUTLIER -123.74 112.44 17.35 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 114.842 -1.072 . . . . 0.0 108.647 177.66 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 7.1 m-80 46.46 42.93 11.5 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.951 -0.568 . . . . 0.0 112.34 -179.511 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.04 -6.5 83.19 Favored Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 120.69 -0.767 . . . . 0.0 113.437 178.84 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 1.8 mm-40 -110.55 104.77 13.53 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.892 0.377 . . . . 0.0 110.963 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.756 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.0 OUTLIER -44.22 127.85 5.78 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.908 179.721 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.796 HG11 ' OD2' ' A' ' 103' ' ' ASP . 12.3 p -111.95 159.45 11.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.779 -179.049 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.509 ' N ' HG22 ' A' ' 116' ' ' VAL . 14.1 mp0 -70.7 136.86 49.29 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.95 179.773 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.408 ' O ' ' C ' ' A' ' 119' ' ' ASN . 78.7 tttt -63.09 163.86 9.34 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.296 179.594 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.408 ' C ' ' O ' ' A' ' 118' ' ' LYS . 10.5 m-80 34.43 40.61 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.24 -179.537 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 4.9 p -110.99 110.6 21.23 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.86 -179.629 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.745 ' ND2' HD13 ' A' ' 92' ' ' LEU . 1.9 m120 -62.69 133.97 55.63 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.554 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' GLN . . . . . 0.501 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 32.7 mm-40 -129.62 145.62 51.48 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.312 0.577 . . . . 0.0 112.357 -179.602 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.428 HD23 ' O ' ' A' ' 124' ' ' LEU . 2.7 tt -72.61 122.77 21.94 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.634 179.018 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.558 HD22 ' C ' ' A' ' 124' ' ' LEU . 0.0 OUTLIER -48.71 148.82 1.96 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 122.067 0.937 . . . . 0.0 112.041 -178.887 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -126.79 153.08 46.07 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 114.195 -1.366 . . . . 0.0 110.153 179.703 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 2.9 mm-40 -70.98 113.49 8.08 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 179.452 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 68.33 28.1 73.44 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.227 -179.096 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.454 ' HB3' HG22 ' A' ' 145' ' ' ILE . 28.2 t70 -53.86 160.09 1.51 Allowed 'General case' 0 C--O 1.231 0.123 0 CA-C-O 120.963 0.411 . . . . 0.0 111.224 -179.675 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.509 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 29.0 tt0 -146.66 134.9 21.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.587 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.452 HG21 ' OD1' ' A' ' 103' ' ' ASP . 7.1 mm -117.56 128.3 74.82 Favored 'Isoleucine or valine' 0 C--O 1.231 0.131 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 178.542 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.504 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 94.6 m -103.49 145.47 29.97 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.632 -179.658 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.506 ' HB ' ' NE2' ' A' ' 88' ' ' HIS . 6.2 m -140.9 157.97 23.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -178.885 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 133' ' ' GLY . . . . . 0.403 ' O ' ' O ' ' A' ' 139' ' ' ASP . . . 70.72 40.86 65.02 Favored Glycine 0 N--CA 1.446 -0.637 0 CA-C-N 115.728 -0.669 . . . . 0.0 112.648 179.292 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.484 HG12 ' N ' ' A' ' 135' ' ' GLY . 94.8 t -76.76 157.17 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 CA-C-O 121.409 0.624 . . . . 0.0 112.005 -179.297 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 135' ' ' GLY . . . . . 0.484 ' N ' HG12 ' A' ' 134' ' ' VAL . . . 152.63 -44.68 0.61 Allowed Glycine 0 N--CA 1.44 -1.037 0 N-CA-C 110.652 -0.979 . . . . 0.0 110.652 -179.271 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.545 HG12 ' H ' ' A' ' 138' ' ' SER . 45.3 t -126.75 134.22 66.76 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.739 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 178.66 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 26.9 tp10 -50.87 -34.51 28.4 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.827 0.346 . . . . 0.0 111.464 -179.182 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' SER . . . . . 0.545 ' H ' HG12 ' A' ' 136' ' ' VAL . 37.7 t -93.78 6.23 49.05 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 116.204 -0.453 . . . . 0.0 112.141 -179.507 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 139' ' ' ASP . . . . . 0.403 ' O ' ' O ' ' A' ' 133' ' ' GLY . 2.3 t70 -125.77 29.25 5.98 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-O 121.124 0.488 . . . . 0.0 112.169 -179.484 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.504 ' CG2' ' CG2' ' A' ' 131' ' ' THR . 25.7 mt -107.17 141.45 22.34 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.328 179.394 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 12.1 mt -123.41 134.79 53.93 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.037 -0.983 . . . . 0.0 110.633 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' SER . . . . . 0.86 ' HB2' HG21 ' A' ' 40' ' ' THR . 4.8 m -114.94 153.5 30.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.756 0.788 . . . . 0.0 112.462 -179.352 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.913 HD21 HG12 ' A' ' 36' ' ' VAL . 1.8 tm? -133.83 136.84 44.7 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 114.55 -1.205 . . . . 0.0 109.396 179.701 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.73 ' H ' HD22 ' A' ' 143' ' ' LEU . 15.0 t -118.04 140.3 41.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.903 0.382 . . . . 0.0 111.801 -179.13 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 1.064 HD13 HD21 ' A' ' 101' ' ' LEU . 0.1 OUTLIER -108.01 140.3 26.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.776 179.592 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 37.5 t80 -118.4 122.87 43.86 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.96 -179.802 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 3.0 mp -115.32 130.23 70.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.11 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 23.6 p-10 -75.28 138.0 41.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.993 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -73.64 -30.24 62.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.934 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -57.44 -40.16 77.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.777 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 6.2 t80 . . . . . 0 N--CA 1.451 -0.393 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.917 -179.942 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.757 0.313 . . . . 0.0 110.936 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.409 ' HA ' ' CD1' ' A' ' 52' ' ' ILE . 1.6 m-20 -109.02 -13.5 14.71 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-O 121.997 0.903 . . . . 0.0 108.626 178.353 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.783 HD13 ' O ' ' A' ' 48' ' ' LEU . 0.1 OUTLIER -70.7 95.57 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.556 0 CA-C-N 113.911 -1.495 . . . . 0.0 110.711 -179.41 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.572 ' CG1' ' N ' ' A' ' 34' ' ' CYS . 0.5 OUTLIER -32.45 -59.94 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 114.874 -1.057 . . . . 0.0 112.379 -179.127 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.707 ' SG ' HD12 ' A' ' 48' ' ' LEU . 31.7 p -164.29 164.88 22.26 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.529 -179.757 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 5.2 ttm180 -127.11 122.62 34.76 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.077 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.71 ' CG2' HD11 ' A' ' 48' ' ' LEU . 24.8 t -93.81 131.74 39.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.669 179.536 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.976 HG23 HG12 ' A' ' 45' ' ' ILE . 32.9 mt -121.18 108.38 22.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 N-CA-C 112.362 0.505 . . . . 0.0 112.362 -179.326 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -98.6 105.66 17.83 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 177.374 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 8.9 t -113.71 -21.22 10.84 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 113.328 0.862 . . . . 0.0 113.328 -177.496 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.813 HG21 ' CB ' ' A' ' 142' ' ' SER . 44.5 p -55.59 -22.22 21.14 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.874 0.369 . . . . 0.0 111.467 -179.475 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 120.73 64.76 0.25 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.353 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.2 mt-30 -141.75 -70.32 0.36 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.773 0.32 . . . . 0.0 111.205 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.56 HG22 ' HD2' ' A' ' 44' ' ' PRO . 0.7 OUTLIER -135.16 139.24 31.2 Favored Pre-proline 0 N--CA 1.453 -0.325 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.113 -179.566 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.56 ' HD2' HG22 ' A' ' 43' ' ' ILE . 26.6 Cg_exo -59.41 147.76 89.83 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.506 2.137 . . . . 0.0 111.379 179.223 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.976 HG12 HG23 ' A' ' 37' ' ' ILE . 43.1 mt -36.33 136.04 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 -179.398 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.48 ' CG ' ' CE2' ' A' ' 76' ' ' TYR . 0.0 OUTLIER -123.26 144.87 49.12 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.337 179.306 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -110.11 119.61 39.82 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.977 0.418 . . . . 0.0 111.259 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.794 HD11 HD13 ' A' ' 91' ' ' ILE . 5.4 mt -98.53 137.88 36.55 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 178.971 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.566 ' O ' ' HZ2' ' A' ' 66' ' ' TRP . 0.0 OUTLIER -137.8 163.31 31.69 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 113.55 0.944 . . . . 0.0 113.55 -178.646 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.528 ' HB3' HG23 ' A' ' 33' ' ' VAL . . . -138.27 166.03 25.23 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 114.41 -1.268 . . . . 0.0 110.888 179.292 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -92.28 100.52 13.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.943 0.401 . . . . 0.0 111.187 -179.71 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.409 ' CD1' ' HA ' ' A' ' 31' ' ' ASN . 2.3 mt . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.528 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 4.5 tttt . . . . . 0 C--O 1.232 0.169 0 CA-C-O 120.922 0.392 . . . . 0.0 110.707 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.448 ' O ' ' CZ3' ' A' ' 66' ' ' TRP . 29.9 ttpt -132.55 118.79 19.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.916 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.713 HG23 ' O ' ' A' ' 91' ' ' ILE . 7.9 p -108.61 140.13 28.39 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 CA-C-O 121.37 0.605 . . . . 0.0 112.428 -179.07 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' TRP . . . . . 0.713 ' CD1' HD22 ' A' ' 48' ' ' LEU . 14.3 m-90 -99.93 139.31 35.78 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.099 -0.955 . . . . 0.0 111.325 179.099 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.867 HG23 ' HG3' ' A' ' 90' ' ' GLN . 10.6 m -127.36 130.07 48.76 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.547 0.689 . . . . 0.0 111.951 179.113 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.646 ' CE2' HG11 ' A' ' 36' ' ' VAL . 11.2 m-85 -102.86 118.33 36.59 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.054 -0.976 . . . . 0.0 108.98 178.099 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.651 ' HA2' ' O ' ' A' ' 85' ' ' SER . . . 157.16 -153.95 25.12 Favored Glycine 0 CA--C 1.505 -0.561 0 C-N-CA 118.765 -1.683 . . . . 0.0 113.317 179.32 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 1.6 mtp180 -75.58 91.94 2.88 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-O 122.593 1.187 . . . . 0.0 108.873 -179.299 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 33.8 m-80 -150.07 159.62 35.06 Favored Pre-proline 0 C--N 1.308 -1.197 0 CA-C-N 112.761 -2.018 . . . . 0.0 108.102 178.708 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.549 ' O ' ' HB2' ' A' ' 77' ' ' HIS . 31.7 Cg_endo -64.85 -6.78 13.28 Favored 'Trans proline' 0 N--CA 1.453 -0.91 0 C-N-CA 120.637 0.891 . . . . 0.0 110.576 177.33 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.747 ' HB2' ' HB2' ' A' ' 77' ' ' HIS . . . 136.36 52.99 0.0 OUTLIER 'General case' 0 CA--C 1.49 -1.337 0 CA-C-N 114.359 -1.292 . . . . 0.0 109.052 178.856 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.574 ' HB3' ' HB ' ' A' ' 67' ' ' THR . 0.1 OUTLIER -52.7 -69.93 0.1 Allowed 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 105.497 -2.038 . . . . 0.0 105.497 179.491 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.638 ' HB2' ' N ' ' A' ' 67' ' ' THR . 60.7 t0 -95.85 -47.0 6.33 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 105.834 -1.913 . . . . 0.0 105.834 169.259 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.486 ' C ' ' HA ' ' A' ' 73' ' ' ALA . 0.1 OUTLIER -143.63 141.33 30.55 Favored 'General case' 0 C--N 1.348 0.531 0 CA-C-N 112.77 -2.014 . . . . 0.0 111.855 -179.712 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 77' ' ' HIS . . . . . 0.747 ' HB2' ' HB2' ' A' ' 73' ' ' ALA . 1.8 t60 -97.21 106.15 18.42 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 176.306 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.756 HD11 ' O ' ' A' ' 85' ' ' SER . 1.1 pp -123.11 175.52 6.59 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.919 0.39 . . . . 0.0 111.512 -179.583 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -53.54 -179.76 0.12 Allowed Glycine 0 C--N 1.333 0.369 0 C-N-CA 121.015 -0.612 . . . . 0.0 112.573 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.449 ' HA ' ' OD1' ' A' ' 86' ' ' ASN . 5.0 p30 -111.61 98.47 7.45 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.785 0.326 . . . . 0.0 111.582 -179.708 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.703 ' HB ' ' HB2' ' A' ' 85' ' ' SER . 15.0 mm -114.7 117.52 55.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.701 178.886 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 43.4 t -54.97 -24.18 22.7 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 111.82 0.304 . . . . 0.0 111.82 -179.631 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.478 ' H ' HG22 ' A' ' 81' ' ' ILE . 3.3 mpt_? -92.44 -102.25 0.12 Allowed 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -179.095 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.422 ' O ' ' HB2' ' A' ' 85' ' ' SER . 0.0 OUTLIER -108.96 109.76 20.9 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-O 121.631 0.729 . . . . 0.0 110.512 -179.702 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.756 ' O ' HD11 ' A' ' 78' ' ' LEU . 0.3 OUTLIER 161.38 -46.0 0.0 OUTLIER 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 114.128 -1.397 . . . . 0.0 109.201 -179.92 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.814 ' O ' ' N ' ' A' ' 88' ' ' HIS . 88.3 m-20 -66.44 -153.44 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 177.658 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.844 ' HB2' HD11 ' A' ' 104' ' ' ILE . 17.2 pttm -49.37 73.64 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 179.095 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 1.053 ' O ' ' O ' ' A' ' 104' ' ' ILE . 36.9 t60 -95.0 -16.5 22.7 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 114.307 1.225 . . . . 0.0 114.307 -176.854 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.616 ' HA ' ' H ' ' A' ' 104' ' ' ILE . 0.2 OUTLIER -177.39 157.04 1.26 Allowed 'General case' 0 C--N 1.316 -0.881 0 C-N-CA 119.127 -1.029 . . . . 0.0 112.529 178.264 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.867 ' HG3' HG23 ' A' ' 67' ' ' THR . 17.4 mt-30 -137.74 161.81 35.54 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 -177.348 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.794 HD13 HD11 ' A' ' 48' ' ' LEU . 4.7 mt -128.33 132.66 67.99 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 CA-C-N 114.913 -1.039 . . . . 0.0 110.041 178.754 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.66 ' C ' HD22 ' A' ' 93' ' ' LEU . 0.0 OUTLIER -120.52 128.92 53.55 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.851 0.358 . . . . 0.0 111.963 -179.414 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.777 HD13 ' HA ' ' A' ' 99' ' ' LEU . 4.2 mm? -125.71 133.63 52.06 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.842 179.171 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.269 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.425 179.965 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.777 ' HA ' HD13 ' A' ' 93' ' ' LEU . 2.1 mp . . . . . 0 N--CA 1.456 -0.13 0 CA-C-O 120.655 0.264 . . . . 0.0 110.807 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.776 HD22 ' C ' ' A' ' 99' ' ' LEU . 3.6 mm? -133.97 148.05 51.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.784 0.326 . . . . 0.0 111.029 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.556 ' CD1' HD13 ' A' ' 145' ' ' ILE . 3.0 mm? -112.79 131.71 55.57 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 179.203 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.506 ' HB2' HD11 ' A' ' 92' ' ' LEU . 9.7 t30 -109.06 111.96 23.88 Favored 'General case' 0 CA--C 1.508 -0.665 0 C-N-CA 119.742 -0.783 . . . . 0.0 109.963 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.767 ' HB3' HG21 ' A' ' 109' ' ' THR . 31.2 m-20 -86.24 110.65 19.77 Favored 'General case' 0 N--CA 1.44 -0.928 0 C-N-CA 119.319 -0.952 . . . . 0.0 109.231 179.274 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 1.053 ' O ' ' O ' ' A' ' 88' ' ' HIS . 0.1 OUTLIER -123.84 108.5 20.91 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.07 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 177.44 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.474 ' HG ' ' CE1' ' A' ' 88' ' ' HIS . 73.8 m -133.37 169.32 17.1 Favored 'General case' 0 C--N 1.293 -1.858 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.59 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 21.4 m -69.29 -63.05 1.14 Allowed 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 119.061 -1.056 . . . . 0.0 111.328 -179.149 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -112.12 -33.38 6.26 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 114.576 1.324 . . . . 0.0 114.576 179.078 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -146.94 132.64 4.45 Favored Glycine 0 C--N 1.34 0.795 0 N-CA-C 116.875 1.51 . . . . 0.0 116.875 -178.078 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.767 HG21 ' HB3' ' A' ' 103' ' ' ASP . 13.3 m -121.28 137.94 54.46 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 174.386 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' TRP . . . . . 0.715 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 3.0 m-90 -121.61 148.82 44.04 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 113.599 0.963 . . . . 0.0 113.599 -178.506 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.415 ' O ' ' HG ' ' A' ' 111' ' ' LEU . 0.2 OUTLIER -123.26 112.33 17.51 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 114.969 -1.014 . . . . 0.0 108.637 177.61 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 71.6 m-20 44.71 44.28 7.38 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.032 -0.531 . . . . 0.0 112.213 -179.531 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 79.75 24.18 60.73 Favored Glycine 0 N--CA 1.445 -0.763 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.739 179.295 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -136.43 97.9 3.69 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.113 0.483 . . . . 0.0 110.819 179.655 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.715 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.0 OUTLIER -44.63 129.03 6.87 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.969 179.826 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.544 HG11 ' OD2' ' A' ' 103' ' ' ASP . 15.0 p -118.82 162.07 17.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.671 -178.833 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.533 ' N ' HG22 ' A' ' 116' ' ' VAL . 1.5 tp10 -70.47 142.05 51.97 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.068 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 49.2 tttm -65.42 162.93 16.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.396 179.525 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 35.55 37.44 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.313 0.578 . . . . 0.0 111.354 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 5.0 p -111.27 109.49 19.54 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.953 -179.488 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.586 ' ND2' HD22 ' A' ' 92' ' ' LEU . 1.7 m-20 -59.76 139.5 57.24 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.808 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' GLN . . . . . 0.633 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 5.8 mm100 -129.25 148.23 51.16 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.878 0.37 . . . . 0.0 111.925 -179.677 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -71.61 131.78 43.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.026 -0.534 . . . . 0.0 109.933 179.463 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.577 HD22 ' C ' ' A' ' 124' ' ' LEU . 0.0 OUTLIER -55.18 147.2 16.88 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 122.258 1.028 . . . . 0.0 112.248 -178.747 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.43 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.5 OUTLIER -127.16 153.38 46.12 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 113.79 -1.55 . . . . 0.0 109.898 179.143 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 4.8 mm-40 -70.81 113.12 7.56 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 179.623 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 63.05 31.87 82.19 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.019 -179.207 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.43 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 30.2 t70 -51.71 160.51 0.64 Allowed 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 121.015 0.436 . . . . 0.0 111.584 -179.571 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.904 ' HG2' HG22 ' A' ' 144' ' ' VAL . 2.5 mt-10 -146.47 135.43 22.48 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.17 179.779 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.627 HG21 ' OD1' ' A' ' 103' ' ' ASP . 2.6 mp -114.61 128.76 71.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-O 120.802 0.334 . . . . 0.0 110.396 179.151 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.464 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 59.9 m -102.93 145.05 30.42 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.341 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.479 ' HB ' ' NE2' ' A' ' 88' ' ' HIS . 4.8 m -141.01 158.3 23.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -178.582 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 67.11 43.21 90.79 Favored Glycine 0 N--CA 1.447 -0.59 0 CA-C-N 115.621 -0.718 . . . . 0.0 112.334 179.385 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.509 ' HA ' HG12 ' A' ' 140' ' ' ILE . 90.8 t -78.85 156.43 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 CA-C-O 121.49 0.662 . . . . 0.0 112.275 -179.163 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 135' ' ' GLY . . . . . 0.462 ' N ' HG12 ' A' ' 134' ' ' VAL . . . 147.4 -42.89 0.87 Allowed Glycine 0 N--CA 1.441 -0.984 0 CA-C-N 114.843 -1.072 . . . . 0.0 110.553 -178.989 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.623 HG12 ' H ' ' A' ' 138' ' ' SER . 47.4 t -126.77 128.13 70.66 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.723 0 CA-C-N 115.157 -0.522 . . . . 0.0 109.796 178.634 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.515 ' HA ' HD12 ' A' ' 140' ' ' ILE . 8.6 tt0 -51.13 -30.14 15.59 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.802 0.334 . . . . 0.0 111.279 -179.342 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 138' ' ' SER . . . . . 0.623 ' H ' HG12 ' A' ' 136' ' ' VAL . 28.2 t -94.2 6.46 48.55 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -179.497 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -131.03 29.27 4.71 Favored 'General case' 0 CA--C 1.52 -0.182 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -179.346 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.515 HD12 ' HA ' ' A' ' 137' ' ' GLU . 18.9 mt -105.55 140.97 21.95 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.33 179.103 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 5.4 mp -121.49 134.67 55.07 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 114.971 -1.013 . . . . 0.0 109.846 179.297 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' SER . . . . . 0.813 ' CB ' HG21 ' A' ' 40' ' ' THR . 0.9 OUTLIER -119.1 149.73 41.2 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.676 0.751 . . . . 0.0 112.757 -178.721 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.485 HD12 ' N ' ' A' ' 143' ' ' LEU . 4.7 mp -125.34 150.68 46.94 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 114.843 -1.071 . . . . 0.0 109.193 179.372 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.904 HG22 ' HG2' ' A' ' 129' ' ' GLU . 12.1 t -126.87 141.09 47.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 120.904 0.383 . . . . 0.0 111.842 -179.276 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.556 HD13 ' CD1' ' A' ' 101' ' ' LEU . 0.1 OUTLIER -122.72 125.92 73.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.069 179.436 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -115.58 121.38 42.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.961 0.41 . . . . 0.0 111.248 -179.469 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.535 HD11 ' CG2' ' A' ' 145' ' ' ILE . 3.0 mm -104.04 130.03 55.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.788 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 148' ' ' ASN . . . . . 0.42 ' ND2' ' O ' ' A' ' 32' ' ' ILE . 6.2 p30 -77.42 130.75 37.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.85 0.357 . . . . 0.0 110.78 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -73.02 -22.96 60.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.398 -179.723 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 1.3 mptp? -57.34 -40.62 78.36 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.913 0.387 . . . . 0.0 110.699 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 4.1 t80 . . . . . 0 N--CA 1.452 -0.345 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.724 179.801 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 8.3 pm0 . . . . . 0 CA--C 1.529 0.142 0 N-CA-C 111.687 0.254 . . . . 0.0 111.687 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.659 ' HA ' HD12 ' A' ' 52' ' ' ILE . 8.2 m120 -108.75 -14.56 14.58 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-O 121.918 0.866 . . . . 0.0 109.017 178.926 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.542 HD13 ' O ' ' A' ' 48' ' ' LEU . 0.0 OUTLIER -74.08 105.91 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.533 0 CA-C-N 113.919 -1.491 . . . . 0.0 110.664 -179.6 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 1.027 ' CG2' ' HB2' ' A' ' 50' ' ' ALA . 0.5 OUTLIER -40.26 -62.65 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.712 -179.105 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.739 ' SG ' HD12 ' A' ' 48' ' ' LEU . 31.1 p -164.92 164.96 20.67 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.505 -179.78 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 12.0 ttm180 -126.78 122.4 34.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.842 0.353 . . . . 0.0 111.176 179.73 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.831 ' CG2' HD11 ' A' ' 48' ' ' LEU . 18.8 t -93.12 124.34 45.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.616 179.643 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.963 HG23 HG12 ' A' ' 45' ' ' ILE . 35.6 mt -121.51 108.49 22.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 112.254 0.464 . . . . 0.0 112.254 -179.178 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 14.6 t -80.28 103.92 10.48 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 177.793 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.9 p -99.34 22.18 10.98 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 112.454 0.538 . . . . 0.0 112.454 -178.347 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.691 HG21 ' HB2' ' A' ' 142' ' ' SER . 45.5 p -114.21 -13.14 12.4 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 111.657 0.244 . . . . 0.0 111.657 179.78 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 95.63 75.54 1.27 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.602 -0.808 . . . . 0.0 112.616 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.542 ' CG ' HD12 ' A' ' 141' ' ' LEU . 15.3 mt-30 -150.97 -55.68 0.15 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.774 0.321 . . . . 0.0 110.983 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 2.0 mt -134.71 131.14 20.04 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.833 -179.697 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.433 ' HD2' ' CZ ' ' A' ' 76' ' ' TYR . 37.3 Cg_exo -58.87 147.1 90.79 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.569 2.18 . . . . 0.0 111.682 179.721 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.963 HG12 HG23 ' A' ' 37' ' ' ILE . 51.9 mt -42.39 128.97 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 121.03 0.443 . . . . 0.0 112.064 -179.363 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.439 ' HG2' ' O ' ' A' ' 75' ' ' ASP . 0.9 OUTLIER -123.54 130.13 52.22 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.935 179.295 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -95.14 120.16 34.89 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.095 0.474 . . . . 0.0 111.664 -179.13 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.831 HD11 ' CG2' ' A' ' 36' ' ' VAL . 1.6 mt -94.63 126.73 40.12 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.387 178.821 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.494 ' O ' ' HZ2' ' A' ' 66' ' ' TRP . 0.0 OUTLIER -119.62 162.08 19.58 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 122.102 0.953 . . . . 0.0 113.171 -178.731 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 1.027 ' HB2' ' CG2' ' A' ' 33' ' ' VAL . . . -116.47 166.17 12.39 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 114.47 -1.241 . . . . 0.0 111.011 179.596 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -103.99 57.97 0.72 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.098 0.475 . . . . 0.0 110.755 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.736 HD11 ' CE2' ' A' ' 151' ' ' PHE . 46.2 mt . . . . . 0 C--N 1.327 -0.395 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.9 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 10.1 ttmt . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.837 0.351 . . . . 0.0 111.201 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.404 ' HE3' ' O ' ' A' ' 49' ' ' SER . 3.7 ttpt -136.79 134.03 36.6 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.183 179.489 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.508 HG12 ' HG2' ' A' ' 90' ' ' GLN . 3.4 t -123.29 134.6 65.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.214 0.531 . . . . 0.0 112.01 -178.952 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' TRP . . . . . 0.786 ' CD1' HD22 ' A' ' 48' ' ' LEU . 12.3 m-90 -100.95 138.86 37.43 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.727 179.2 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.612 ' N ' ' HB2' ' A' ' 75' ' ' ASP . 1.3 m -131.75 127.71 37.36 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.31 0.576 . . . . 0.0 112.315 179.436 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.513 ' CE1' ' CE2' ' A' ' 89' ' ' PHE . 96.2 m-85 -98.32 117.83 33.61 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.423 178.011 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.67 ' HA2' ' O ' ' A' ' 85' ' ' SER . . . 158.9 -157.95 28.94 Favored Glycine 0 CA--C 1.503 -0.716 0 C-N-CA 119.001 -1.571 . . . . 0.0 112.683 179.1 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.407 ' HB3' ' HA ' ' A' ' 80' ' ' ASN . 7.8 ptm180 -76.13 91.92 3.18 Favored 'General case' 0 N--CA 1.441 -0.911 0 CA-C-O 122.614 1.197 . . . . 0.0 108.302 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -149.71 160.4 34.09 Favored Pre-proline 0 C--N 1.309 -1.188 0 CA-C-N 112.787 -2.006 . . . . 0.0 108.261 179.608 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.544 ' O ' ' CB ' ' A' ' 73' ' ' ALA . 29.3 Cg_endo -63.0 -11.04 22.75 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 120.869 1.046 . . . . 0.0 111.03 178.479 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.769 ' HB2' ' HB2' ' A' ' 77' ' ' HIS . . . 137.82 52.32 0.0 OUTLIER 'General case' 0 CA--C 1.491 -1.297 0 CA-C-N 114.743 -1.117 . . . . 0.0 109.685 178.548 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.566 ' CB ' ' HB ' ' A' ' 67' ' ' THR . 0.1 OUTLIER -53.12 -69.92 0.1 Allowed 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 105.957 -1.868 . . . . 0.0 105.957 179.347 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.612 ' HB2' ' N ' ' A' ' 67' ' ' THR . 5.8 t0 -94.26 -47.45 6.62 Favored 'General case' 0 N--CA 1.436 -1.153 0 N-CA-C 105.743 -1.947 . . . . 0.0 105.743 169.754 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.548 ' C ' ' HA ' ' A' ' 73' ' ' ALA . 10.6 t80 -143.37 143.12 31.52 Favored 'General case' 0 C--N 1.344 0.356 0 CA-C-N 112.386 -2.188 . . . . 0.0 110.728 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' HIS . . . . . 0.769 ' HB2' ' HB2' ' A' ' 73' ' ' ALA . 0.8 OUTLIER -84.54 114.1 21.71 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.33 -0.548 . . . . 0.0 110.309 177.958 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 87.2 mt -126.58 166.19 17.76 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.869 0.366 . . . . 0.0 111.099 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -66.02 -166.71 2.06 Favored Glycine 0 C--N 1.33 0.228 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.212 179.763 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.41 ' O ' ' ND2' ' A' ' 80' ' ' ASN . 0.3 OUTLIER -111.35 99.1 7.96 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.932 0.396 . . . . 0.0 111.245 -179.875 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.535 ' HB ' ' HB2' ' A' ' 85' ' ' SER . 29.7 mm -113.84 133.63 59.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.811 179.34 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 5.7 p -66.6 -41.91 87.7 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.794 0.665 . . . . 0.0 112.794 -179.449 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.573 ' C ' HD13 ' A' ' 84' ' ' LEU . 2.2 mpt_? -83.12 -105.76 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 113.11 0.781 . . . . 0.0 113.11 -177.769 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.742 HD22 ' H ' ' A' ' 84' ' ' LEU . 0.0 OUTLIER -107.69 114.6 28.67 Favored 'General case' 0 CA--C 1.511 -0.554 0 CA-C-O 121.637 0.732 . . . . 0.0 109.179 -179.8 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.67 ' O ' ' HA2' ' A' ' 69' ' ' GLY . 0.5 OUTLIER 156.34 -36.25 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 114.054 -1.43 . . . . 0.0 107.885 -178.839 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.802 ' O ' ' N ' ' A' ' 88' ' ' HIS . 0.1 OUTLIER -61.85 -161.56 0.01 OUTLIER 'General case' 0 CA--C 1.51 -0.566 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 176.743 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.785 ' HB2' HD11 ' A' ' 104' ' ' ILE . 0.0 OUTLIER -53.63 72.53 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 177.091 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.928 ' O ' ' O ' ' A' ' 104' ' ' ILE . 28.3 t60 -77.66 -16.32 58.6 Favored 'General case' 0 CA--C 1.515 -0.376 0 N-CA-C 113.858 1.059 . . . . 0.0 113.858 -176.406 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.623 ' HA ' ' H ' ' A' ' 104' ' ' ILE . 0.2 OUTLIER -173.47 154.84 2.67 Favored 'General case' 0 C--N 1.308 -1.232 0 C-N-CA 119.307 -0.957 . . . . 0.0 112.549 177.914 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.508 ' HG2' HG12 ' A' ' 65' ' ' VAL . 2.8 tt0 -136.28 155.66 49.77 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.732 -1.122 . . . . 0.0 113.533 -177.448 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.644 ' HB ' ' HB2' ' A' ' 66' ' ' TRP . 25.4 mt -127.42 132.46 69.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 115.256 -0.883 . . . . 0.0 110.224 179.231 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.681 HD11 ' HB2' ' A' ' 102' ' ' ASN . 0.1 OUTLIER -117.29 125.35 50.94 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.946 0.403 . . . . 0.0 111.365 179.792 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.768 ' CD1' HD22 ' A' ' 99' ' ' LEU . 1.1 mm? -127.19 140.11 52.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.599 179.265 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.31 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.529 -179.98 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.829 HD12 HD22 ' A' ' 124' ' ' LEU . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.703 0.287 . . . . 0.0 110.552 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.642 ' HA ' ' O ' ' A' ' 122' ' ' GLN . 6.5 mt -133.76 148.5 51.4 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.028 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.455 ' O ' ' N ' ' A' ' 122' ' ' GLN . 41.3 mt -116.31 129.77 56.43 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 179.205 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.681 ' HB2' HD11 ' A' ' 92' ' ' LEU . 18.1 t30 -110.56 110.78 21.63 Favored 'General case' 0 CA--C 1.508 -0.637 0 C-N-CA 119.611 -0.836 . . . . 0.0 110.105 -179.793 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.764 ' HB3' HG21 ' A' ' 109' ' ' THR . 58.4 m-20 -83.57 111.11 18.8 Favored 'General case' 0 N--CA 1.441 -0.888 0 C-N-CA 119.647 -0.821 . . . . 0.0 108.883 179.157 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.928 ' O ' ' O ' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -124.08 107.69 19.16 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.9 0 CA-C-O 121.6 0.714 . . . . 0.0 109.188 178.203 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.426 ' HG ' ' CD2' ' A' ' 88' ' ' HIS . 43.4 m -131.33 172.28 12.36 Favored 'General case' 0 C--N 1.297 -1.706 0 CA-C-N 114.867 -1.061 . . . . 0.0 109.142 179.504 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 19.6 m -69.62 -63.63 1.03 Allowed 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 119.092 -1.043 . . . . 0.0 111.906 -178.899 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -112.41 -32.26 6.55 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 114.755 1.391 . . . . 0.0 114.755 179.421 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -145.57 126.55 2.59 Favored Glycine 0 C--N 1.338 0.685 0 N-CA-C 116.849 1.5 . . . . 0.0 116.849 -177.756 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.764 HG21 ' HB3' ' A' ' 103' ' ' ASP . 3.3 m -121.12 138.16 54.32 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 174.522 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' TRP . . . . . 0.703 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 3.1 m-90 -121.76 149.37 43.39 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 113.393 0.886 . . . . 0.0 113.393 -178.231 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.701 HD12 HG11 ' A' ' 116' ' ' VAL . 1.2 mt -124.06 112.1 16.75 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.068 -0.969 . . . . 0.0 109.021 177.157 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 10.1 m-80 50.13 35.72 10.76 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.541 -179.223 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 82.57 26.09 48.01 Favored Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.64 179.419 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -133.08 96.83 3.85 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.009 0.433 . . . . 0.0 110.743 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.703 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.0 OUTLIER -46.52 134.61 9.18 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.01 179.82 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.701 HG11 HD12 ' A' ' 111' ' ' LEU . 12.6 p -135.14 165.45 30.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.227 -179.254 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.538 ' N ' HG22 ' A' ' 116' ' ' VAL . 0.3 OUTLIER -69.6 142.69 53.48 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.256 179.746 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.469 ' HG3' ' ND2' ' A' ' 119' ' ' ASN . 12.8 ptmt -68.42 169.68 10.32 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.792 0.329 . . . . 0.0 110.92 -179.65 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.469 ' ND2' ' HG3' ' A' ' 118' ' ' LYS . 21.8 p30 33.86 37.58 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.192 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.427 ' HB3' ' O ' ' A' ' 117' ' ' GLU . 0.1 OUTLIER -111.8 107.9 17.12 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.671 179.406 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.591 ' ND2' HD22 ' A' ' 92' ' ' LEU . 5.3 m120 -47.67 138.45 8.22 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 120.598 0.237 . . . . 0.0 110.951 -179.843 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' GLN . . . . . 0.642 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 11.1 mm100 -126.84 148.5 49.97 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-O 121.144 0.497 . . . . 0.0 111.857 -179.684 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.539 HD13 ' O ' ' A' ' 124' ' ' LEU . 3.0 tm? -73.98 112.08 9.75 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.585 178.916 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 1.104 HD21 HD13 ' A' ' 147' ' ' ILE . 6.6 tt -46.99 145.75 1.95 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.789 0.804 . . . . 0.0 112.06 -178.693 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -126.67 153.23 45.68 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 114.185 -1.37 . . . . 0.0 110.272 179.638 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 8.0 mm100 -71.24 113.68 8.52 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 179.35 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 68.47 28.38 73.25 Favored Glycine 0 N--CA 1.445 -0.72 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.18 -179.145 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -55.1 160.56 2.04 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.987 0.422 . . . . 0.0 111.434 -179.735 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.452 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 1.3 tm-20 -146.4 135.58 22.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.249 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.501 HG21 ' OD1' ' A' ' 103' ' ' ASP . 1.3 mp -112.38 129.05 68.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.415 179.047 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.566 HG23 ' CG2' ' A' ' 140' ' ' ILE . 16.0 m -103.02 142.26 34.4 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.835 -179.513 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.447 HG11 ' CD2' ' A' ' 88' ' ' HIS . 4.3 m -140.85 153.26 20.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.187 -0.461 . . . . 0.0 112.004 -179.021 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 75.52 35.8 45.9 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 121.111 -0.566 . . . . 0.0 112.367 179.442 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.45 ' HA ' HG12 ' A' ' 140' ' ' ILE . 78.9 t -71.68 155.61 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 CA-C-O 121.468 0.651 . . . . 0.0 112.127 -179.306 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 135' ' ' GLY . . . . . 0.426 ' N ' HG12 ' A' ' 134' ' ' VAL . . . 153.44 -45.77 0.57 Allowed Glycine 0 N--CA 1.443 -0.863 0 CA-C-N 115.003 -0.998 . . . . 0.0 110.707 -179.164 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.61 HG12 ' H ' ' A' ' 138' ' ' SER . 62.0 t -126.71 134.85 65.32 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 CA-C-N 115.258 -0.471 . . . . 0.0 109.744 178.644 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 16.3 tm-20 -51.28 -34.38 32.72 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.83 0.347 . . . . 0.0 111.26 -179.293 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' SER . . . . . 0.61 ' H ' HG12 ' A' ' 136' ' ' VAL . 76.7 p -94.11 6.4 48.67 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 116.246 -0.434 . . . . 0.0 112.06 -179.595 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -126.38 30.66 5.54 Favored 'General case' 0 CA--C 1.518 -0.257 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -179.439 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.566 ' CG2' HG23 ' A' ' 131' ' ' THR . 20.9 mt -107.23 140.91 23.82 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.304 179.213 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.542 HD12 ' CG ' ' A' ' 42' ' ' GLN . 3.0 mm? -120.43 135.43 55.05 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 114.874 -1.057 . . . . 0.0 110.005 179.737 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 142' ' ' SER . . . . . 0.691 ' HB2' HG21 ' A' ' 40' ' ' THR . 4.2 m -125.13 152.35 44.53 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.848 0.833 . . . . 0.0 113.094 -178.86 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.634 HD12 ' O ' ' A' ' 142' ' ' SER . 6.5 mp -125.82 146.21 49.89 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.323 -1.308 . . . . 0.0 109.033 178.851 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 21.7 t -131.16 140.28 48.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 120.838 0.351 . . . . 0.0 111.793 -179.083 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.824 HG13 HG22 ' A' ' 36' ' ' VAL . 0.6 OUTLIER -111.04 139.64 34.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.743 179.552 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 47.4 t80 -119.14 104.24 10.26 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.689 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 1.104 HD13 HD21 ' A' ' 124' ' ' LEU . 1.2 mp -98.15 129.72 47.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.241 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 14.7 p30 -83.37 133.1 34.96 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.953 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -67.83 -20.65 65.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.13 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.71 -43.1 84.98 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.935 0.398 . . . . 0.0 110.61 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 151' ' ' PHE . . . . . 0.736 ' CE2' HD11 ' A' ' 52' ' ' ILE . 13.2 t80 . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.816 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 . . . . . 0 CA--C 1.527 0.088 0 CA-C-O 120.617 0.246 . . . . 0.0 111.39 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.576 ' HA ' HD12 ' A' ' 52' ' ' ILE . 43.6 m-20 -108.74 -14.53 14.58 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-O 121.904 0.859 . . . . 0.0 108.95 178.611 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.487 ' O ' HG22 ' A' ' 32' ' ' ILE . 0.1 OUTLIER -75.07 110.62 10.09 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.636 0 CA-C-N 113.991 -1.459 . . . . 0.0 111.088 -179.557 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 1.027 ' CG2' ' HB2' ' A' ' 50' ' ' ALA . 0.5 OUTLIER -41.18 -63.66 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.406 -179.49 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.626 ' N ' ' CG1' ' A' ' 33' ' ' VAL . 23.4 p -166.21 165.05 17.77 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.519 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 3.6 ttm180 -121.95 120.39 34.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.877 179.491 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.781 HG23 HD13 ' A' ' 48' ' ' LEU . 40.1 t -89.13 124.75 42.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.95 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.937 HG23 HG12 ' A' ' 45' ' ' ILE . 30.0 mt -124.58 108.12 19.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.65 -179.741 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.517 ' SG ' HD23 ' A' ' 143' ' ' LEU . 3.4 m -90.48 100.96 13.7 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 178.53 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 7.0 t -80.21 -27.19 38.85 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 -178.184 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.417 ' OG1' ' O ' ' A' ' 142' ' ' SER . 0.1 OUTLIER -51.54 -27.17 10.09 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.997 0.427 . . . . 0.0 111.023 -179.679 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 97.41 36.94 4.7 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.384 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 18.9 pt20 -106.0 -46.85 3.99 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.853 0.358 . . . . 0.0 110.908 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.439 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 7.1 mt -133.53 132.53 21.9 Favored Pre-proline 0 N--CA 1.451 -0.414 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.19 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.524 ' HD2' ' CZ ' ' A' ' 76' ' ' TYR . 27.3 Cg_exo -59.63 147.37 92.19 Favored 'Trans proline' 0 C--O 1.232 0.214 0 C-N-CA 122.763 2.309 . . . . 0.0 111.904 179.535 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.937 HG12 HG23 ' A' ' 37' ' ' ILE . 44.2 mt -43.6 139.0 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.83 -179.702 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.1 140.81 46.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.37 179.67 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -108.34 120.23 41.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.112 0.482 . . . . 0.0 111.632 -179.426 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 1.106 HD21 HD13 ' A' ' 91' ' ' ILE . 3.0 mp -98.82 125.2 44.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.156 178.796 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.518 ' O ' ' CZ2' ' A' ' 66' ' ' TRP . 0.0 OUTLIER -111.26 163.11 14.28 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 122.041 0.924 . . . . 0.0 113.338 -178.545 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 1.027 ' HB2' ' CG2' ' A' ' 33' ' ' VAL . . . -123.45 166.19 15.8 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 114.632 -1.167 . . . . 0.0 111.22 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -111.21 71.69 0.75 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.287 179.477 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.637 HD11 ' CE2' ' A' ' 151' ' ' PHE . 92.3 mt . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.401 -179.56 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 11.0 tttm . . . . . 0 C--O 1.23 0.036 0 CA-C-O 120.902 0.382 . . . . 0.0 111.013 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.418 ' O ' ' HB3' ' A' ' 93' ' ' LEU . 17.0 ttpt -136.1 130.64 33.67 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.635 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.6 HG13 ' O ' ' A' ' 91' ' ' ILE . 15.3 t -135.2 137.93 49.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.113 0.482 . . . . 0.0 111.894 -179.29 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' TRP . . . . . 0.641 ' HB2' ' HB ' ' A' ' 91' ' ' ILE . 15.5 m-90 -100.61 140.15 35.28 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.607 179.175 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.86 HG23 ' HG3' ' A' ' 90' ' ' GLN . 7.8 m -125.78 127.41 46.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.544 0.687 . . . . 0.0 112.329 179.46 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.655 ' HE2' HD11 ' A' ' 91' ' ' ILE . 44.7 m-85 -101.03 118.57 37.25 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.114 -0.948 . . . . 0.0 108.927 177.808 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.604 ' HA2' ' O ' ' A' ' 85' ' ' SER . . . 160.0 -157.66 28.95 Favored Glycine 0 CA--C 1.503 -0.665 0 C-N-CA 119.117 -1.516 . . . . 0.0 112.419 179.499 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.423 ' N ' ' HA ' ' A' ' 86' ' ' ASN . 0.5 OUTLIER -76.74 92.17 3.54 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-O 122.554 1.168 . . . . 0.0 108.912 -179.712 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.409 ' C ' ' H ' ' A' ' 73' ' ' ALA . 6.1 m-80 -149.59 155.19 38.76 Favored Pre-proline 0 C--N 1.308 -1.197 0 CA-C-N 112.809 -1.996 . . . . 0.0 108.259 178.72 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.551 ' O ' ' CB ' ' A' ' 73' ' ' ALA . 24.5 Cg_exo -55.79 -10.23 3.72 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 121.277 1.318 . . . . 0.0 111.278 177.972 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.739 ' HB2' ' HB2' ' A' ' 77' ' ' HIS . . . 135.99 52.23 0.0 OUTLIER 'General case' 0 CA--C 1.49 -1.336 0 CA-C-N 114.999 -1.0 . . . . 0.0 109.375 178.792 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.567 ' HB3' ' HB ' ' A' ' 67' ' ' THR . 0.1 OUTLIER -52.97 -69.62 0.11 Allowed 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 105.867 -1.901 . . . . 0.0 105.867 179.524 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.592 ' HB2' ' N ' ' A' ' 67' ' ' THR . 40.1 t0 -94.93 -47.74 6.3 Favored 'General case' 0 N--CA 1.435 -1.211 0 N-CA-C 105.687 -1.968 . . . . 0.0 105.687 169.755 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.524 ' CZ ' ' HD2' ' A' ' 44' ' ' PRO . 33.0 t80 -145.01 142.7 30.01 Favored 'General case' 0 C--N 1.347 0.485 0 CA-C-N 112.573 -2.103 . . . . 0.0 111.473 179.366 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' HIS . . . . . 0.739 ' HB2' ' HB2' ' A' ' 73' ' ' ALA . 1.9 t60 -93.79 107.28 19.19 Favored 'General case' 0 C--N 1.33 -0.249 0 O-C-N 122.014 -0.429 . . . . 0.0 109.968 176.836 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.841 HD12 ' O ' ' A' ' 79' ' ' GLY . 3.8 pp -121.82 172.61 8.04 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 120.96 0.409 . . . . 0.0 111.645 -179.691 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.841 ' O ' HD12 ' A' ' 78' ' ' LEU . . . -57.86 -172.65 0.3 Allowed Glycine 0 C--N 1.333 0.383 0 CA-C-N 115.916 -0.584 . . . . 0.0 112.595 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.456 ' HA ' ' OD1' ' A' ' 86' ' ' ASN . 0.3 OUTLIER -111.94 98.11 7.15 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -179.64 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.809 HD12 ' CB ' ' A' ' 85' ' ' SER . 16.7 mt -114.79 113.96 45.18 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.252 178.41 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 5.8 m -54.7 -24.12 20.6 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 112.587 0.588 . . . . 0.0 112.587 -178.825 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.448 ' H ' HG22 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -93.58 -102.22 0.13 Allowed 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 -178.743 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.416 ' O ' ' CB ' ' A' ' 85' ' ' SER . 0.0 OUTLIER -109.23 110.45 21.66 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-O 121.682 0.753 . . . . 0.0 110.537 -179.391 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.809 ' CB ' HD12 ' A' ' 81' ' ' ILE . 0.5 OUTLIER 160.43 -46.84 0.0 OUTLIER 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 114.205 -1.362 . . . . 0.0 109.489 179.875 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.817 ' O ' ' N ' ' A' ' 88' ' ' HIS . 93.9 m-20 -64.8 -153.99 0.01 OUTLIER 'General case' 0 CA--C 1.521 -0.165 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 178.128 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.89 ' HB2' HD11 ' A' ' 104' ' ' ILE . 7.9 ptmt -49.31 73.44 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 179.099 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.971 ' O ' ' O ' ' A' ' 104' ' ' ILE . 31.2 t60 -95.67 -18.64 20.35 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 114.299 1.222 . . . . 0.0 114.299 -176.517 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.656 ' HA ' ' H ' ' A' ' 104' ' ' ILE . 0.2 OUTLIER -172.98 153.24 2.53 Favored 'General case' 0 C--N 1.31 -1.115 0 C-N-CA 119.014 -1.074 . . . . 0.0 112.489 178.063 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.86 ' HG3' HG23 ' A' ' 67' ' ' THR . 20.1 mt-30 -134.1 159.23 41.48 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 114.38 -1.282 . . . . 0.0 113.483 -177.322 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 1.106 HD13 HD21 ' A' ' 48' ' ' LEU . 2.8 mt -124.71 131.88 72.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.113 -0.948 . . . . 0.0 110.213 179.013 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.652 HD13 ' ND2' ' A' ' 121' ' ' ASN . 0.3 OUTLIER -107.38 145.09 33.34 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.036 0.446 . . . . 0.0 111.935 -179.623 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.881 HD22 ' N ' ' A' ' 94' ' ' GLY . 0.3 OUTLIER -125.73 128.73 48.21 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.47 179.324 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.881 ' N ' HD22 ' A' ' 93' ' ' LEU . . . . . . . . 0 N--CA 1.452 -0.299 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.46 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 1.014 HD22 HD13 ' A' ' 124' ' ' LEU . 9.7 tt . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.839 0.352 . . . . 0.0 110.893 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.689 HD23 ' HB3' ' A' ' 121' ' ' ASN . 4.5 mp -133.4 149.25 51.82 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.53 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.607 HD11 HD13 ' A' ' 145' ' ' ILE . 4.9 mp -114.81 128.92 56.58 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.756 -0.378 . . . . 0.0 110.101 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.49 ' O ' ' O ' ' A' ' 90' ' ' GLN . 27.9 t30 -110.47 111.21 22.31 Favored 'General case' 0 CA--C 1.509 -0.619 0 C-N-CA 119.76 -0.776 . . . . 0.0 109.766 179.47 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.825 ' HB3' HG21 ' A' ' 109' ' ' THR . 83.7 m-20 -84.74 112.65 20.68 Favored 'General case' 0 N--CA 1.444 -0.772 0 C-N-CA 119.865 -0.734 . . . . 0.0 109.887 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.971 ' O ' ' O ' ' A' ' 88' ' ' HIS . 0.1 OUTLIER -122.91 107.5 19.44 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.925 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 177.473 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.44 ' HG ' ' CE1' ' A' ' 88' ' ' HIS . 55.7 m -134.79 164.53 27.34 Favored 'General case' 0 C--N 1.295 -1.797 0 CA-C-N 115.011 -0.995 . . . . 0.0 109.432 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 19.9 m -69.4 -62.69 1.28 Allowed 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 119.207 -0.997 . . . . 0.0 111.789 -178.903 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -111.79 -32.64 6.56 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 115.218 1.562 . . . . 0.0 115.218 179.698 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -146.18 127.64 2.83 Favored Glycine 0 C--N 1.339 0.747 0 N-CA-C 117.36 1.704 . . . . 0.0 117.36 -177.674 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.825 HG21 ' HB3' ' A' ' 103' ' ' ASP . 7.5 m -121.36 138.12 54.4 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 174.289 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' TRP . . . . . 0.712 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 3.4 m-90 -122.89 149.21 44.51 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 113.532 0.938 . . . . 0.0 113.532 -178.552 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.41 ' O ' ' HG ' ' A' ' 111' ' ' LEU . 0.3 OUTLIER -123.95 112.18 16.91 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 114.917 -1.038 . . . . 0.0 108.451 177.5 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 15.9 m-20 44.37 44.46 6.84 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.065 -0.516 . . . . 0.0 112.109 -179.394 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 79.89 26.4 56.02 Favored Glycine 0 N--CA 1.444 -0.792 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.779 179.28 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -138.62 96.8 3.21 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.079 0.466 . . . . 0.0 110.78 179.737 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.712 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.0 OUTLIER -44.37 129.08 6.48 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.964 179.806 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.786 HG21 ' OD2' ' A' ' 103' ' ' ASP . 27.6 m -115.91 -178.74 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.133 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.971 -178.997 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -91.61 142.23 27.86 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.086 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.46 ' HG3' ' HA ' ' A' ' 104' ' ' ILE . 49.1 tttm -63.72 162.35 13.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.27 179.381 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.422 ' N ' ' HG2' ' A' ' 118' ' ' LYS . 4.8 p-10 34.58 39.13 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.268 0.556 . . . . 0.0 111.264 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 9.5 p -111.24 106.58 15.62 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.07 -179.4 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.689 ' HB3' HD23 ' A' ' 100' ' ' LEU . 1.6 m-20 -54.68 143.6 24.53 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.64 179.736 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' GLN . . . . . 0.633 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 30.9 mm-40 -129.74 145.62 51.54 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.98 0.419 . . . . 0.0 112.005 -179.467 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.8 tt -72.87 121.33 19.82 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.526 178.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 1.014 HD13 HD22 ' A' ' 99' ' ' LEU . 12.1 tp -47.76 142.39 4.74 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-O 122.027 0.918 . . . . 0.0 112.186 -178.806 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.444 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.3 OUTLIER -127.51 152.62 47.35 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 113.895 -1.502 . . . . 0.0 110.05 179.191 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 11.3 mm100 -71.61 113.82 9.04 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.898 0.38 . . . . 0.0 110.024 179.549 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 64.61 31.67 81.67 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.512 -179.619 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.444 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 17.2 t70 -58.31 159.42 6.13 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.959 0.409 . . . . 0.0 111.195 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.748 ' HG3' HG22 ' A' ' 144' ' ' VAL . 3.0 tt0 -146.6 135.71 22.59 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.531 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.447 ' CG2' ' O ' ' A' ' 110' ' ' TRP . 1.3 mp -111.84 128.69 68.25 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.168 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.117 178.851 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.472 HG23 ' CG2' ' A' ' 140' ' ' ILE . 95.2 m -103.24 145.05 30.52 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.512 -179.687 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.513 HG11 ' CD2' ' A' ' 88' ' ' HIS . 4.3 m -141.09 158.27 22.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 -178.879 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 68.8 41.26 83.67 Favored Glycine 0 N--CA 1.448 -0.533 0 CA-C-N 115.776 -0.647 . . . . 0.0 112.553 179.406 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.505 ' HA ' HG12 ' A' ' 140' ' ' ILE . 98.6 t -76.45 157.33 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.625 0 CA-C-O 121.38 0.609 . . . . 0.0 112.012 -179.343 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 135' ' ' GLY . . . . . 0.452 ' N ' HG12 ' A' ' 134' ' ' VAL . . . 138.21 -43.46 1.19 Allowed Glycine 0 N--CA 1.441 -1.017 0 N-CA-C 110.36 -1.096 . . . . 0.0 110.36 -178.609 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.624 HG12 ' H ' ' A' ' 138' ' ' SER . 46.4 t -126.8 123.93 63.81 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.708 0 CA-C-N 115.022 -0.589 . . . . 0.0 109.63 178.423 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.506 ' HA ' HD12 ' A' ' 140' ' ' ILE . 6.9 mt-10 -51.05 -26.17 5.92 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.711 0.291 . . . . 0.0 111.355 -179.121 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 138' ' ' SER . . . . . 0.624 ' H ' HG12 ' A' ' 136' ' ' VAL . 6.4 t -94.4 6.4 48.85 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 112.3 0.481 . . . . 0.0 112.3 -179.463 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -131.54 24.31 4.75 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 -179.243 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.506 HD12 ' HA ' ' A' ' 137' ' ' GLU . 23.6 mt -98.89 141.1 17.05 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.305 179.04 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.412 ' HB2' ' CG2' ' A' ' 132' ' ' VAL . 8.7 mp -119.98 135.07 55.05 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.83 -1.077 . . . . 0.0 109.805 179.446 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 142' ' ' SER . . . . . 0.417 ' O ' ' OG1' ' A' ' 40' ' ' THR . 46.6 t -114.54 151.84 32.72 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.836 0.827 . . . . 0.0 112.765 -178.848 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.517 HD23 ' SG ' ' A' ' 38' ' ' CYS . 8.2 mt -136.18 129.76 32.17 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.554 -1.203 . . . . 0.0 109.251 178.97 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.748 HG22 ' HG3' ' A' ' 129' ' ' GLU . 21.4 t -124.09 140.95 45.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.917 0.389 . . . . 0.0 111.923 -178.728 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.67 HG13 HG22 ' A' ' 36' ' ' VAL . 0.3 OUTLIER -112.31 140.23 33.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.832 179.558 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -118.99 108.64 15.0 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.704 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.698 HG12 HD21 ' A' ' 124' ' ' LEU . 1.9 mp -101.21 128.66 53.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.436 -179.854 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 10.7 p30 -79.16 132.02 36.41 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.909 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -63.64 -21.36 66.33 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.128 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 2.1 mptm? -58.37 -44.35 88.82 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.967 0.413 . . . . 0.0 110.716 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 151' ' ' PHE . . . . . 0.637 ' CE2' HD11 ' A' ' 52' ' ' ILE . 17.9 t80 . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.82 179.777 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.479 ' O ' HD11 ' A' ' 52' ' ' ILE . 25.1 mt-10 . . . . . 0 C--O 1.232 0.157 0 CA-C-O 120.656 0.265 . . . . 0.0 111.403 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 68.0 m-20 -108.83 -13.29 14.79 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-O 121.886 0.851 . . . . 0.0 109.117 178.97 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.575 ' O ' ' CG2' ' A' ' 32' ' ' ILE . 0.1 OUTLIER -70.41 96.77 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.618 0 CA-C-N 114.11 -1.405 . . . . 0.0 110.844 -179.145 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.809 HG23 ' HB3' ' A' ' 50' ' ' ALA . 0.9 OUTLIER -39.21 -61.5 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 114.54 -1.209 . . . . 0.0 112.651 -178.896 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.631 ' N ' HG12 ' A' ' 33' ' ' VAL . 49.6 t -162.93 162.85 26.38 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.853 0.359 . . . . 0.0 111.743 -178.795 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.448 ' HD3' ' CG2' ' A' ' 45' ' ' ILE . 1.8 ttm180 -128.93 115.37 17.73 Favored 'General case' 0 C--N 1.334 -0.104 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.678 179.817 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.901 HG23 ' CD2' ' A' ' 48' ' ' LEU . 92.4 t -89.07 129.64 39.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.559 179.858 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.983 HG23 HG12 ' A' ' 45' ' ' ILE . 29.0 mt -118.48 107.77 22.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 116.056 -0.52 . . . . 0.0 112.026 -179.309 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.491 ' HB2' ' O ' ' A' ' 43' ' ' ILE . 3.7 m -97.38 99.93 11.37 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 177.954 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 8.7 t -107.27 27.17 9.33 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 -178.097 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.741 HG21 ' HB2' ' A' ' 142' ' ' SER . 40.3 p -108.96 -3.31 17.61 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.761 0.315 . . . . 0.0 111.566 179.664 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 95.67 60.2 1.04 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.467 179.819 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.562 ' CG ' HD12 ' A' ' 141' ' ' LEU . 27.7 mt-30 -141.12 -60.58 0.49 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.762 0.315 . . . . 0.0 111.242 -179.83 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.491 ' O ' ' HB2' ' A' ' 38' ' ' CYS . 3.5 mp -135.24 132.36 20.04 Favored Pre-proline 0 N--CA 1.452 -0.339 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.371 -179.639 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.415 ' HB2' ' OH ' ' A' ' 76' ' ' TYR . 24.1 Cg_exo -60.14 146.8 95.43 Favored 'Trans proline' 0 N--CA 1.463 -0.307 0 C-N-CA 122.214 1.943 . . . . 0.0 111.054 178.942 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.983 HG12 HG23 ' A' ' 37' ' ' ILE . 29.9 mt -50.72 122.55 2.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.948 0.404 . . . . 0.0 111.791 -179.165 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.422 ' HB2' ' CD2' ' A' ' 76' ' ' TYR . 0.0 OUTLIER -124.85 141.76 51.9 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.032 179.241 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.403 ' HB3' ' CD1' ' A' ' 32' ' ' ILE . 0.7 OUTLIER -99.55 119.58 38.27 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.975 0.417 . . . . 0.0 111.689 -179.241 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.901 ' CD2' HG23 ' A' ' 36' ' ' VAL . 0.3 OUTLIER -89.63 136.47 33.02 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 178.48 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.601 ' O ' ' HZ2' ' A' ' 66' ' ' TRP . 0.0 OUTLIER -137.23 162.25 33.99 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 122.034 0.921 . . . . 0.0 113.398 -178.564 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.809 ' HB3' HG23 ' A' ' 33' ' ' VAL . . . -149.62 152.65 35.79 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 114.418 -1.265 . . . . 0.0 111.174 179.24 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -80.27 111.26 16.48 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.121 -179.617 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.479 HD11 ' O ' ' A' ' 30' ' ' GLU . 11.6 mt . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.733 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.915 0.388 . . . . 0.0 111.153 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.439 ' O ' ' HB3' ' A' ' 93' ' ' LEU . 2.1 ttpt -118.65 136.29 53.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.178 179.573 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.634 HG13 ' O ' ' A' ' 91' ' ' ILE . 14.1 t -136.26 135.91 49.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.143 0.497 . . . . 0.0 111.946 -179.215 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' TRP . . . . . 0.726 ' CD1' HD12 ' A' ' 48' ' ' LEU . 13.8 m-90 -99.74 140.06 34.49 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.59 179.052 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.858 HG23 ' CG ' ' A' ' 90' ' ' GLN . 4.3 m -130.3 126.79 38.08 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.404 0.621 . . . . 0.0 112.403 179.504 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.471 ' CD2' ' CD2' ' A' ' 89' ' ' PHE . 88.5 m-85 -98.01 118.39 34.51 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.171 177.89 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.641 ' HA3' ' N ' ' A' ' 87' ' ' LYS . . . 160.33 -158.97 30.4 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 118.978 -1.582 . . . . 0.0 112.936 179.473 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.508 ' CD ' ' HB3' ' A' ' 86' ' ' ASN . 0.4 OUTLIER -76.84 91.75 3.56 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-O 122.55 1.167 . . . . 0.0 108.456 -179.888 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.453 ' CG ' ' HB2' ' A' ' 74' ' ' CYS . 0.5 OUTLIER -149.83 160.78 33.16 Favored Pre-proline 0 C--N 1.308 -1.205 0 CA-C-N 112.755 -2.021 . . . . 0.0 108.027 179.326 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.559 ' O ' ' CB ' ' A' ' 73' ' ' ALA . 28.1 Cg_endo -63.14 -8.73 14.94 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 120.99 1.127 . . . . 0.0 111.439 178.697 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.739 ' HB2' ' HB2' ' A' ' 77' ' ' HIS . . . 135.98 51.85 0.0 OUTLIER 'General case' 0 CA--C 1.491 -1.309 0 CA-C-N 114.806 -1.088 . . . . 0.0 109.788 178.602 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.575 ' HB3' ' HB ' ' A' ' 67' ' ' THR . 0.1 OUTLIER -52.88 -69.45 0.11 Allowed 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 105.838 -1.912 . . . . 0.0 105.838 179.328 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.628 ' HB2' ' N ' ' A' ' 67' ' ' THR . 7.5 t0 -94.63 -47.76 6.38 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 105.734 -1.951 . . . . 0.0 105.734 169.732 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.487 ' C ' ' HA ' ' A' ' 73' ' ' ALA . 1.7 t80 -145.37 141.65 28.66 Favored 'General case' 0 C--N 1.346 0.454 0 CA-C-N 112.717 -2.038 . . . . 0.0 112.35 -179.76 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' HIS . . . . . 0.739 ' HB2' ' HB2' ' A' ' 73' ' ' ALA . 1.9 t60 -94.91 107.2 19.23 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 176.276 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -135.67 -176.24 4.22 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.001 0.429 . . . . 0.0 111.7 -179.386 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -60.92 163.31 20.39 Favored Glycine 0 N--CA 1.451 -0.339 0 CA-C-N 115.819 -0.628 . . . . 0.0 112.582 -179.82 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 12.8 p-10 -111.97 100.57 8.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.823 0.345 . . . . 0.0 111.553 -179.649 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.654 ' HB ' ' HB2' ' A' ' 85' ' ' SER . 12.4 mm -112.76 120.48 62.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 178.67 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 3.5 m -51.09 -23.92 3.54 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -177.856 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -83.66 -106.7 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 120.971 -0.291 . . . . 0.0 111.084 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.468 ' N ' HD23 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -109.86 113.32 25.96 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-O 121.341 0.591 . . . . 0.0 109.598 179.236 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.654 ' HB2' ' HB ' ' A' ' 81' ' ' ILE . 1.5 m 166.6 -66.55 0.0 OUTLIER 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.041 -179.708 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.977 ' O ' ' N ' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -60.04 -166.18 0.01 OUTLIER 'General case' 0 CA--C 1.51 -0.575 0 N-CA-C 109.333 -0.618 . . . . 0.0 109.333 178.954 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.641 ' N ' ' HA3' ' A' ' 69' ' ' GLY . 2.8 mtmt -28.7 69.44 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 121.279 0.562 . . . . 0.0 109.704 -179.685 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.986 ' C ' ' O ' ' A' ' 104' ' ' ILE . 32.3 t60 -98.03 -17.44 19.15 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 113.559 0.948 . . . . 0.0 113.559 -176.765 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.677 ' HA ' ' H ' ' A' ' 104' ' ' ILE . 0.3 OUTLIER -173.08 153.33 2.5 Favored 'General case' 0 C--N 1.31 -1.135 0 C-N-CA 119.422 -0.911 . . . . 0.0 112.379 177.73 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.858 ' CG ' HG23 ' A' ' 67' ' ' THR . 31.9 mt-30 -135.83 157.92 45.67 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.455 -1.248 . . . . 0.0 113.674 -177.42 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.663 HD11 HG21 ' A' ' 36' ' ' VAL . 9.9 mt -125.14 131.62 72.22 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 CA-C-N 114.955 -1.021 . . . . 0.0 109.711 178.496 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.636 HD13 ' ND2' ' A' ' 121' ' ' ASN . 0.2 OUTLIER -109.37 141.45 41.72 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.098 0.475 . . . . 0.0 112.154 -179.298 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.709 HD13 ' CG2' ' A' ' 33' ' ' VAL . 6.4 tp -125.8 141.52 51.96 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.355 178.923 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.305 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.542 179.787 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.662 HD22 ' N ' ' A' ' 99' ' ' LEU . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.845 0.355 . . . . 0.0 110.751 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.665 HD22 ' HB3' ' A' ' 121' ' ' ASN . 0.4 OUTLIER -133.73 148.31 51.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.399 179.969 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.541 HD23 HD11 ' A' ' 130' ' ' ILE . 3.2 mp -114.82 131.33 56.86 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.978 -0.378 . . . . 0.0 109.978 179.855 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.499 ' HB2' HD11 ' A' ' 92' ' ' LEU . 23.4 t30 -113.16 111.32 21.89 Favored 'General case' 0 CA--C 1.511 -0.529 0 C-N-CA 119.851 -0.74 . . . . 0.0 110.032 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.787 ' HB3' HG21 ' A' ' 109' ' ' THR . 73.2 m-20 -84.37 112.17 20.1 Favored 'General case' 0 N--CA 1.444 -0.752 0 C-N-CA 119.738 -0.785 . . . . 0.0 109.641 179.519 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.986 ' O ' ' C ' ' A' ' 88' ' ' HIS . 0.1 OUTLIER -123.54 107.29 18.66 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.886 0 N-CA-C 108.752 -0.832 . . . . 0.0 108.752 177.614 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 67.3 m -129.72 169.14 15.48 Favored 'General case' 0 C--N 1.296 -1.74 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.435 179.617 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 23.7 m -69.35 -62.88 1.2 Allowed 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 119.121 -1.031 . . . . 0.0 111.281 -179.228 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -112.11 -33.09 6.35 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 114.658 1.355 . . . . 0.0 114.658 179.011 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -146.67 130.2 3.56 Favored Glycine 0 C--N 1.341 0.813 0 N-CA-C 116.97 1.548 . . . . 0.0 116.97 -177.997 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.787 HG21 ' HB3' ' A' ' 103' ' ' ASP . 5.6 m -121.18 138.32 54.26 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 174.396 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' TRP . . . . . 0.666 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.6 m-90 -120.48 149.22 42.74 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 -178.639 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.474 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -122.17 112.04 17.7 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 114.915 -1.039 . . . . 0.0 108.601 177.579 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 44.9 44.36 7.84 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.983 -0.553 . . . . 0.0 112.155 -179.524 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 79.79 21.62 65.7 Favored Glycine 0 N--CA 1.444 -0.794 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.786 179.345 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -133.4 98.75 4.32 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.928 0.394 . . . . 0.0 110.664 179.779 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.666 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.1 OUTLIER -43.23 122.43 2.53 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.034 179.804 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.712 HG11 ' OD2' ' A' ' 103' ' ' ASP . 12.6 p -113.78 160.49 13.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.688 -178.859 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.515 ' N ' HG22 ' A' ' 116' ' ' VAL . 4.8 tt0 -70.96 141.61 51.06 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.104 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.407 ' O ' ' C ' ' A' ' 119' ' ' ASN . 88.6 tttt -65.39 164.24 14.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.076 179.325 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.407 ' C ' ' O ' ' A' ' 118' ' ' LYS . 4.3 m-80 35.47 39.01 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.249 0.547 . . . . 0.0 110.938 -179.402 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 5.3 p -111.04 108.46 18.18 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.997 -179.365 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.665 ' HB3' HD22 ' A' ' 100' ' ' LEU . 1.4 m-20 -58.59 140.59 54.11 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.737 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 122' ' ' GLN . . . . . 0.596 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 4.2 mm100 -129.82 145.21 51.58 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-O 121.039 0.447 . . . . 0.0 112.137 -179.567 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 22.3 tp -72.58 117.94 14.88 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.44 178.958 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.886 HD21 HG12 ' A' ' 147' ' ' ILE . 29.9 tp -45.24 144.05 1.49 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.875 0.845 . . . . 0.0 112.081 -178.713 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -127.02 152.79 46.78 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 114.037 -1.438 . . . . 0.0 110.252 179.585 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.72 113.88 9.22 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 179.414 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 67.06 29.12 74.12 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.281 -179.379 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -54.57 160.53 1.76 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.925 0.393 . . . . 0.0 111.203 -179.828 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.468 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 2.4 tt0 -146.05 135.32 22.87 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.529 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.674 HD13 ' OD1' ' A' ' 103' ' ' ASP . 5.4 mt -115.05 128.61 72.15 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 116.285 -0.416 . . . . 0.0 109.976 179.007 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.585 HG23 ' CG2' ' A' ' 140' ' ' ILE . 7.7 m -103.21 143.74 32.24 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.83 -179.374 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.452 ' HB ' ' NE2' ' A' ' 88' ' ' HIS . 4.6 m -141.21 155.26 21.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.317 -0.401 . . . . 0.0 112.039 -179.013 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 72.14 38.1 59.46 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 121.126 -0.559 . . . . 0.0 112.4 179.282 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.476 ' HA ' HG12 ' A' ' 140' ' ' ILE . 96.1 t -72.88 156.26 6.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 121.499 0.666 . . . . 0.0 112.129 -179.276 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 135' ' ' GLY . . . . . 0.453 ' N ' HG12 ' A' ' 134' ' ' VAL . . . 153.26 -46.5 0.56 Allowed Glycine 0 N--CA 1.442 -0.96 0 CA-C-N 114.939 -1.028 . . . . 0.0 110.606 -179.234 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.567 HG12 ' H ' ' A' ' 138' ' ' SER . 46.7 t -126.78 135.83 62.56 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.65 0 CA-C-N 115.239 -0.48 . . . . 0.0 109.832 178.644 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.1 -35.13 33.6 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.818 0.342 . . . . 0.0 111.269 -179.337 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 138' ' ' SER . . . . . 0.567 ' H ' HG12 ' A' ' 136' ' ' VAL . 0.2 OUTLIER -94.04 6.14 49.47 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 116.273 -0.421 . . . . 0.0 112.13 -179.513 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -125.6 28.72 6.16 Favored 'General case' 0 CA--C 1.518 -0.261 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -179.398 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.585 ' CG2' HG23 ' A' ' 131' ' ' THR . 22.0 mt -105.29 141.28 20.99 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.373 179.342 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.562 HD12 ' CG ' ' A' ' 42' ' ' GLN . 3.1 mm? -114.85 135.0 54.67 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 114.906 -1.043 . . . . 0.0 109.92 179.344 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 142' ' ' SER . . . . . 0.741 ' HB2' HG21 ' A' ' 40' ' ' THR . 3.9 m -119.2 153.7 34.53 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.845 0.831 . . . . 0.0 112.48 -179.03 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.468 ' O ' ' HA ' ' A' ' 129' ' ' GLU . 13.7 mt -135.4 141.5 45.48 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.36 -1.291 . . . . 0.0 109.216 179.325 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 17.3 t -124.02 140.85 46.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.014 0.435 . . . . 0.0 112.123 -178.636 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.725 HG13 HG22 ' A' ' 36' ' ' VAL . 0.8 OUTLIER -108.63 125.99 65.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.105 179.257 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 8.5 t80 -111.98 118.36 35.24 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.277 -179.419 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.886 HG12 HD21 ' A' ' 124' ' ' LEU . 2.4 mp -95.34 134.57 32.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.655 179.628 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -73.87 122.66 22.85 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.994 -179.765 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -60.38 -41.7 94.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.798 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.17 -43.28 87.36 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.677 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 24.1 t80 . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.761 179.784 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.648 0.261 . . . . 0.0 111.414 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 26.6 m120 -109.23 -13.56 14.63 Favored 'General case' 0 CA--C 1.514 -0.422 0 CA-C-O 121.933 0.873 . . . . 0.0 109.131 178.975 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.585 ' O ' ' CG2' ' A' ' 32' ' ' ILE . 0.1 OUTLIER -70.47 96.83 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.619 0 CA-C-N 114.103 -1.408 . . . . 0.0 111.183 -178.983 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.858 HG23 ' HB3' ' A' ' 50' ' ' ALA . 0.9 OUTLIER -36.55 -60.77 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 CA-C-N 114.643 -1.162 . . . . 0.0 112.246 -179.403 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.625 ' N ' HG12 ' A' ' 33' ' ' VAL . 1.7 m -163.19 165.42 24.45 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.742 -179.466 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.429 ' CZ ' HD11 ' A' ' 37' ' ' ILE . 2.3 tmm_? -134.27 114.78 13.39 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.159 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.99 HG23 HD21 ' A' ' 48' ' ' LEU . 48.2 t -91.38 122.0 42.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.508 179.313 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.984 HG23 HG12 ' A' ' 45' ' ' ILE . 34.1 mt -109.55 108.06 24.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.636 -179.847 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.817 ' SG ' HD12 ' A' ' 143' ' ' LEU . 60.1 m -102.04 101.75 12.16 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 178.098 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 7.6 t -118.69 32.63 6.03 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -177.649 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.562 HG21 ' HB2' ' A' ' 142' ' ' SER . 34.8 p -112.45 15.89 20.05 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.976 0.417 . . . . 0.0 111.285 179.325 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 88.71 38.87 6.82 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.133 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.673 ' OE1' HD13 ' A' ' 141' ' ' LEU . 0.0 OUTLIER -117.23 -76.21 0.57 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.663 0.268 . . . . 0.0 111.465 -179.591 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.616 HD12 ' HB3' ' A' ' 42' ' ' GLN . 3.7 mp -135.18 141.59 38.55 Favored Pre-proline 0 N--CA 1.452 -0.348 0 CA-C-O 120.859 0.361 . . . . 0.0 111.527 -179.072 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.481 ' HD2' ' CZ ' ' A' ' 76' ' ' TYR . 25.6 Cg_exo -59.25 147.08 92.5 Favored 'Trans proline' 0 N--CA 1.465 -0.186 0 C-N-CA 122.338 2.025 . . . . 0.0 111.202 178.832 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.984 HG12 HG23 ' A' ' 37' ' ' ILE . 44.2 mt -43.38 128.6 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-O 121.046 0.451 . . . . 0.0 111.852 -179.401 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.424 ' HG2' ' O ' ' A' ' 75' ' ' ASP . 0.0 OUTLIER -123.27 130.38 52.66 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.255 179.58 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.426 ' C ' HD13 ' A' ' 48' ' ' LEU . 4.9 m-20 -100.83 119.72 39.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.021 0.439 . . . . 0.0 111.444 -179.54 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.99 HD21 HG23 ' A' ' 36' ' ' VAL . 0.2 OUTLIER -93.9 130.73 39.85 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.353 178.763 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.532 ' O ' ' HZ2' ' A' ' 66' ' ' TRP . 0.0 OUTLIER -133.41 161.66 33.93 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.972 0.891 . . . . 0.0 113.221 -178.809 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.858 ' HB3' HG23 ' A' ' 33' ' ' VAL . . . -156.87 141.94 17.17 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 114.441 -1.254 . . . . 0.0 110.937 179.017 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -70.02 124.14 23.31 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.091 0.472 . . . . 0.0 111.231 -179.613 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 14.7 mt . . . . . 0 C--N 1.33 -0.283 0 CA-C-N 115.824 -0.626 . . . . 0.0 111.104 179.92 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 3.0 mttp . . . . . 0 CA--C 1.528 0.097 0 CA-C-O 120.947 0.403 . . . . 0.0 110.999 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -108.16 132.73 53.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.35 179.587 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.563 HG13 ' O ' ' A' ' 91' ' ' ILE . 6.9 t -127.35 135.47 63.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.182 0.515 . . . . 0.0 111.959 -179.058 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' TRP . . . . . 0.83 ' CD1' HD12 ' A' ' 48' ' ' LEU . 14.7 m-90 -99.25 139.97 34.11 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.786 179.179 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.661 HG23 ' HG2' ' A' ' 90' ' ' GLN . 32.0 m -131.43 131.42 43.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.571 0.7 . . . . 0.0 112.048 179.491 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.49 ' CD2' ' CD2' ' A' ' 89' ' ' PHE . 94.0 m-85 -102.68 118.98 38.03 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.023 -0.99 . . . . 0.0 109.148 177.851 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.675 ' CA ' HD21 ' A' ' 78' ' ' LEU . . . 158.64 -156.87 27.87 Favored Glycine 0 CA--C 1.501 -0.804 0 C-N-CA 118.962 -1.59 . . . . 0.0 112.709 179.638 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -75.62 91.65 2.88 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-O 122.615 1.198 . . . . 0.0 108.679 -179.669 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.401 ' C ' ' H ' ' A' ' 73' ' ' ALA . 10.3 m120 -149.9 153.37 35.84 Favored Pre-proline 0 C--N 1.31 -1.119 0 CA-C-N 112.693 -2.049 . . . . 0.0 108.187 178.992 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.556 ' O ' ' HB2' ' A' ' 77' ' ' HIS . 26.6 Cg_exo -55.92 -10.84 4.57 Favored 'Trans proline' 0 N--CA 1.459 -0.525 0 C-N-CA 121.239 1.293 . . . . 0.0 111.318 178.101 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.742 ' HB2' ' HB2' ' A' ' 77' ' ' HIS . . . 137.99 52.03 0.0 OUTLIER 'General case' 0 CA--C 1.49 -1.365 0 CA-C-N 114.761 -1.109 . . . . 0.0 109.212 178.871 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.522 ' HB3' ' HB ' ' A' ' 67' ' ' THR . 0.1 OUTLIER -52.55 -69.45 0.11 Allowed 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 105.783 -1.932 . . . . 0.0 105.783 179.689 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.538 ' HB2' ' N ' ' A' ' 67' ' ' THR . 9.2 t0 -95.38 -47.73 6.17 Favored 'General case' 0 N--CA 1.435 -1.21 0 N-CA-C 105.671 -1.974 . . . . 0.0 105.671 169.513 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.508 ' C ' ' HA ' ' A' ' 73' ' ' ALA . 33.7 t80 -144.07 142.61 30.73 Favored 'General case' 0 C--N 1.347 0.5 0 CA-C-N 112.544 -2.116 . . . . 0.0 111.316 179.713 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' HIS . . . . . 0.742 ' HB2' ' HB2' ' A' ' 73' ' ' ALA . 1.5 t60 -92.77 109.32 20.75 Favored 'General case' 0 C--N 1.33 -0.279 0 O-C-N 121.999 -0.438 . . . . 0.0 110.177 177.209 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.675 HD21 ' CA ' ' A' ' 69' ' ' GLY . 1.3 pp -123.45 175.28 6.85 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.911 0.386 . . . . 0.0 111.538 -179.824 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.503 ' O ' HD12 ' A' ' 78' ' ' LEU . . . -62.92 -170.85 1.35 Allowed Glycine 0 C--N 1.332 0.313 0 C-N-CA 120.985 -0.626 . . . . 0.0 112.525 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -111.76 98.64 7.54 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 121.025 0.44 . . . . 0.0 111.68 -179.666 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.875 HD13 ' HB3' ' A' ' 85' ' ' SER . 3.2 mp -114.13 111.77 37.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.404 178.775 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 46.9 t -55.35 -24.25 28.33 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 -179.247 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.514 ' C ' HD13 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -88.75 -109.53 0.07 Allowed 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 112.249 0.463 . . . . 0.0 112.249 -178.845 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.842 HD22 ' H ' ' A' ' 84' ' ' LEU . 0.0 OUTLIER -108.89 112.22 24.34 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-O 121.437 0.637 . . . . 0.0 109.666 179.87 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.875 ' HB3' HD13 ' A' ' 81' ' ' ILE . 0.6 OUTLIER 161.88 -45.11 0.0 OUTLIER 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 114.686 -1.143 . . . . 0.0 109.335 -179.628 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.858 ' O ' ' N ' ' A' ' 88' ' ' HIS . 97.1 m-20 -64.31 -149.47 0.01 OUTLIER 'General case' 0 CA--C 1.521 -0.138 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 177.726 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.815 ' HB3' HD11 ' A' ' 104' ' ' ILE . 9.3 mttt -49.47 72.34 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.073 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.977 ' C ' ' O ' ' A' ' 104' ' ' ILE . 32.8 t60 -90.89 -17.34 26.64 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 114.02 1.118 . . . . 0.0 114.02 -176.727 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.664 ' HA ' ' H ' ' A' ' 104' ' ' ILE . 0.5 OUTLIER -174.43 153.56 1.93 Allowed 'General case' 0 C--N 1.311 -1.089 0 C-N-CA 119.257 -0.977 . . . . 0.0 112.673 178.061 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.661 ' HG2' HG23 ' A' ' 67' ' ' THR . 34.9 mt-30 -136.64 158.49 44.33 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.523 -1.217 . . . . 0.0 113.72 -177.624 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.781 HD11 HG21 ' A' ' 36' ' ' VAL . 10.6 mt -127.72 131.7 69.68 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 CA-C-N 114.868 -1.06 . . . . 0.0 109.896 178.725 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.539 HD12 ' N ' ' A' ' 93' ' ' LEU . 0.5 OUTLIER -111.42 137.68 48.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.86 0.362 . . . . 0.0 110.945 -179.94 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.806 HD23 HD22 ' A' ' 99' ' ' LEU . 1.0 OUTLIER -124.06 129.14 50.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.779 179.789 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.792 ' N ' HD22 ' A' ' 93' ' ' LEU . . . . . . . . 0 N--CA 1.451 -0.306 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.399 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.806 HD22 HD23 ' A' ' 93' ' ' LEU . 2.4 mm? . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.826 0.346 . . . . 0.0 110.809 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.729 HD13 ' O ' ' A' ' 122' ' ' GLN . 3.8 mm? -127.39 148.05 50.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.284 179.845 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.47 ' O ' ' N ' ' A' ' 122' ' ' GLN . 52.5 mt -115.93 129.66 56.49 Favored 'General case' 0 CA--C 1.518 -0.287 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.11 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.489 ' O ' ' O ' ' A' ' 90' ' ' GLN . 26.7 t30 -113.26 111.25 21.72 Favored 'General case' 0 CA--C 1.509 -0.598 0 C-N-CA 119.804 -0.758 . . . . 0.0 109.877 179.803 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.749 ' HB3' HG21 ' A' ' 109' ' ' THR . 72.6 m-20 -83.57 112.24 19.82 Favored 'General case' 0 N--CA 1.442 -0.853 0 C-N-CA 119.827 -0.749 . . . . 0.0 109.619 179.664 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.977 ' O ' ' C ' ' A' ' 88' ' ' HIS . 0.1 OUTLIER -123.13 107.84 20.0 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.949 0 N-CA-C 108.928 -0.768 . . . . 0.0 108.928 177.745 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.502 ' HG ' ' CE1' ' A' ' 88' ' ' HIS . 71.9 m -128.93 169.6 14.44 Favored 'General case' 0 C--N 1.295 -1.793 0 CA-C-N 114.974 -1.012 . . . . 0.0 109.286 179.473 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 29.2 m -69.11 -62.68 1.28 Allowed 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 119.074 -1.05 . . . . 0.0 111.061 -179.356 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -111.86 -33.42 6.31 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 114.326 1.232 . . . . 0.0 114.326 178.882 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -147.05 131.69 4.05 Favored Glycine 0 C--N 1.341 0.813 0 N-CA-C 116.886 1.514 . . . . 0.0 116.886 -178.181 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.749 HG21 ' HB3' ' A' ' 103' ' ' ASP . 7.2 m -121.08 138.18 54.31 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 174.259 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' TRP . . . . . 0.751 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.4 m-90 -119.78 149.36 42.17 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 113.543 0.942 . . . . 0.0 113.543 -178.58 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.452 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -123.4 112.2 17.27 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 114.82 -1.082 . . . . 0.0 108.546 177.556 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 73.3 m-20 47.3 43.11 14.7 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.079 -0.509 . . . . 0.0 112.204 -179.496 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 84.06 -4.11 84.01 Favored Glycine 0 N--CA 1.445 -0.732 0 C-N-CA 120.759 -0.734 . . . . 0.0 113.25 179.168 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -111.47 102.3 10.67 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.917 0.389 . . . . 0.0 110.817 179.688 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.751 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.0 OUTLIER -44.01 136.49 3.72 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.939 179.846 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.63 HG11 ' OD2' ' A' ' 103' ' ' ASP . 14.9 p -124.35 163.39 24.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.693 -179.082 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.548 ' N ' HG22 ' A' ' 116' ' ' VAL . 29.7 tp10 -70.1 141.84 52.69 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.019 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.409 ' HG3' ' HA ' ' A' ' 104' ' ' ILE . 63.4 tttm -68.59 162.7 25.3 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.407 179.654 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.405 ' N ' ' HG2' ' A' ' 118' ' ' LYS . 4.9 p-10 35.21 38.04 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.349 0.595 . . . . 0.0 111.404 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 6.7 p -111.39 109.79 19.94 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.018 -179.453 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.431 ' HB3' HD12 ' A' ' 100' ' ' LEU . 72.1 m-80 -59.33 139.47 56.98 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.502 179.754 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 122' ' ' GLN . . . . . 0.729 ' O ' HD13 ' A' ' 100' ' ' LEU . 48.9 mm-40 -129.7 148.53 51.6 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-O 121.072 0.463 . . . . 0.0 112.121 -179.357 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.686 HD13 ' O ' ' A' ' 124' ' ' LEU . 3.5 tm? -72.31 112.08 8.07 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.456 179.172 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.686 ' O ' HD13 ' A' ' 123' ' ' LEU . 7.8 tt -43.23 147.22 0.38 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.728 0.775 . . . . 0.0 112.246 -178.645 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.43 ' O ' HD11 ' A' ' 147' ' ' ILE . 0.6 OUTLIER -126.64 153.15 45.74 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 114.322 -1.308 . . . . 0.0 110.43 179.752 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 126' ' ' GLN . . . . . 0.437 ' HA ' HD13 ' A' ' 147' ' ' ILE . 0.1 OUTLIER -71.61 113.86 9.08 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 179.414 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 68.25 27.32 73.78 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.201 -179.153 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -53.41 161.22 1.01 Allowed 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.928 0.394 . . . . 0.0 111.319 -179.744 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.403 ' HG2' ' O ' ' A' ' 143' ' ' LEU . 1.1 tt0 -146.21 134.85 22.2 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.204 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.636 HD13 ' OD1' ' A' ' 103' ' ' ASP . 3.7 mt -115.8 128.44 73.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 178.854 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.483 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 36.7 m -103.02 143.31 32.74 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.61 -179.742 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.474 ' HB ' ' NE2' ' A' ' 88' ' ' HIS . 6.3 m -140.75 158.21 23.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 -178.549 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 72.88 44.09 38.94 Favored Glycine 0 N--CA 1.445 -0.717 0 CA-C-N 115.679 -0.692 . . . . 0.0 112.275 179.39 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.504 ' HA ' HG12 ' A' ' 140' ' ' ILE . 85.4 t -81.64 153.94 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.616 0 CA-C-O 121.438 0.637 . . . . 0.0 112.161 -179.212 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 135' ' ' GLY . . . . . 0.403 ' N ' HG12 ' A' ' 134' ' ' VAL . . . 152.68 -43.48 0.65 Allowed Glycine 0 N--CA 1.441 -1.0 0 CA-C-N 114.932 -1.031 . . . . 0.0 110.564 -179.113 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.53 HG12 ' H ' ' A' ' 138' ' ' SER . 44.0 t -126.71 132.82 69.74 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.675 0 CA-C-N 115.137 -0.531 . . . . 0.0 109.714 178.681 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 37.3 tp10 -51.28 -34.59 33.59 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.761 0.315 . . . . 0.0 111.449 -179.169 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' SER . . . . . 0.53 ' H ' HG12 ' A' ' 136' ' ' VAL . 48.2 t -94.34 6.52 48.46 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -179.413 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -126.13 29.64 5.81 Favored 'General case' 0 CA--C 1.52 -0.201 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -179.239 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.504 HG12 ' HA ' ' A' ' 134' ' ' VAL . 11.8 mt -107.6 141.14 23.58 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.367 179.162 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.673 HD13 ' OE1' ' A' ' 42' ' ' GLN . 1.2 mp -123.07 134.79 54.24 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.164 -0.926 . . . . 0.0 110.315 179.768 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 142' ' ' SER . . . . . 0.759 ' O ' HD13 ' A' ' 143' ' ' LEU . 0.8 OUTLIER -112.73 154.67 25.81 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.958 0.885 . . . . 0.0 112.758 -179.087 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.817 HD12 ' SG ' ' A' ' 38' ' ' CYS . 1.6 mm? -130.12 144.05 51.13 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 114.047 -1.433 . . . . 0.0 109.192 179.34 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.472 ' O ' ' N ' ' A' ' 37' ' ' ILE . 21.9 t -124.31 140.97 46.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.933 0.396 . . . . 0.0 111.939 -178.903 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.873 HG13 HG22 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -109.86 132.2 58.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.712 179.538 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -118.2 125.27 49.84 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.69 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.685 HG12 HD21 ' A' ' 124' ' ' LEU . 3.9 mp -109.58 133.61 54.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.472 -179.647 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -78.62 117.95 20.27 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.957 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -65.15 -27.58 68.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.95 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.74 -46.01 90.44 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-O 121.065 0.459 . . . . 0.0 110.68 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 10.5 t80 . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.008 179.897 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 . . . . . 0 C--O 1.231 0.111 0 N-CA-C 111.795 0.295 . . . . 0.0 111.795 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.564 ' HA ' HD12 ' A' ' 52' ' ' ILE . 18.2 m-80 -107.99 -12.92 15.07 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-O 121.883 0.849 . . . . 0.0 109.107 179.345 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.616 ' O ' ' CG2' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -70.71 95.08 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.572 0 CA-C-N 113.961 -1.472 . . . . 0.0 111.198 -179.241 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.665 ' CG2' ' HB2' ' A' ' 50' ' ' ALA . 0.4 OUTLIER -32.81 -61.13 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-N 114.706 -1.134 . . . . 0.0 112.286 -179.567 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.844 ' SG ' HD12 ' A' ' 48' ' ' LEU . 20.9 p -165.11 164.83 20.25 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 112.516 0.561 . . . . 0.0 112.516 -179.47 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 2.8 ttm180 -119.44 125.15 48.26 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.62 179.47 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.947 HG13 HD11 ' A' ' 48' ' ' LEU . 3.5 m -92.96 124.39 45.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.896 0.379 . . . . 0.0 111.088 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.969 HG23 HG12 ' A' ' 45' ' ' ILE . 19.8 mt -132.27 108.6 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.911 -179.487 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.441 ' HB3' ' O ' ' A' ' 43' ' ' ILE . 38.9 t -78.9 127.77 32.45 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 178.291 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 48.4 p -110.77 28.65 8.49 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 112.576 0.584 . . . . 0.0 112.576 -178.442 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.435 ' OG1' ' O ' ' A' ' 142' ' ' SER . 0.0 OUTLIER -116.41 -37.41 3.75 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.778 0.323 . . . . 0.0 110.983 179.333 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 116.92 53.08 0.33 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.861 179.492 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.694 ' HG3' HD12 ' A' ' 141' ' ' LEU . 3.4 mt-30 -142.58 -42.71 0.32 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.612 0.244 . . . . 0.0 111.479 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.598 HD12 ' HB2' ' A' ' 42' ' ' GLN . 4.0 mp -115.04 138.96 23.74 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 120.779 0.323 . . . . 0.0 111.493 -179.385 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.489 ' CD ' ' CZ ' ' A' ' 76' ' ' TYR . 86.9 Cg_endo -82.43 146.79 13.92 Favored 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 122.76 2.307 . . . . 0.0 111.732 179.494 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.969 HG12 HG23 ' A' ' 37' ' ' ILE . 35.7 mt -53.2 111.86 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.995 0.426 . . . . 0.0 111.528 -179.688 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.437 ' O ' HG22 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -115.17 144.0 44.36 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.84 179.297 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -103.36 119.65 39.28 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.052 0.453 . . . . 0.0 111.599 -179.409 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.947 HD11 HG13 ' A' ' 36' ' ' VAL . 0.3 OUTLIER -100.47 138.65 37.25 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 178.504 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.641 ' C ' ' HB ' ' A' ' 33' ' ' VAL . 42.5 t -127.48 -170.82 2.29 Favored 'General case' 0 CA--C 1.511 -0.538 0 CA-C-O 122.941 1.353 . . . . 0.0 113.916 -178.944 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.665 ' HB2' ' CG2' ' A' ' 33' ' ' VAL . . . -157.52 145.02 18.61 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 112.699 -2.046 . . . . 0.0 110.809 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -84.7 86.6 7.31 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.116 0.484 . . . . 0.0 110.705 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.564 HD12 ' HA ' ' A' ' 31' ' ' ASN . 5.8 mt . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.687 -179.67 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.88 0.371 . . . . 0.0 110.951 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 15.9 ttpt -113.29 131.48 55.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.693 179.72 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.622 HG13 ' O ' ' A' ' 91' ' ' ILE . 13.9 t -132.29 139.21 50.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.989 0.423 . . . . 0.0 111.696 -179.284 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' TRP . . . . . 0.64 ' HB2' ' HB ' ' A' ' 91' ' ' ILE . 17.3 m-90 -100.62 139.63 36.04 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.286 179.069 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.74 HG23 ' HG3' ' A' ' 90' ' ' GLN . 15.6 m -122.4 133.03 54.64 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.594 0.712 . . . . 0.0 112.286 179.829 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.518 ' CE1' ' CG ' ' A' ' 75' ' ' ASP . 10.8 m-85 -102.8 118.21 36.34 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.051 -0.977 . . . . 0.0 108.792 177.887 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.652 ' HA2' HD21 ' A' ' 78' ' ' LEU . . . 157.21 -153.92 25.09 Favored Glycine 0 CA--C 1.503 -0.663 0 C-N-CA 118.812 -1.661 . . . . 0.0 113.148 179.573 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.539 ' HB3' ' HA ' ' A' ' 80' ' ' ASN . 6.5 ptm180 -76.55 92.08 3.43 Favored 'General case' 0 N--CA 1.442 -0.861 0 CA-C-O 122.551 1.167 . . . . 0.0 108.985 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 25.3 m-80 -149.72 159.99 34.93 Favored Pre-proline 0 C--N 1.308 -1.225 0 CA-C-N 112.806 -1.997 . . . . 0.0 108.261 178.857 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.545 ' O ' ' HB2' ' A' ' 77' ' ' HIS . 30.2 Cg_endo -63.89 -8.37 15.69 Favored 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 120.606 0.87 . . . . 0.0 110.434 177.407 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.732 ' HB2' ' HB2' ' A' ' 77' ' ' HIS . . . 137.28 53.32 0.0 OUTLIER 'General case' 0 CA--C 1.49 -1.345 0 CA-C-N 114.482 -1.235 . . . . 0.0 109.14 178.814 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.564 ' HB3' ' HB ' ' A' ' 67' ' ' THR . 0.1 OUTLIER -52.96 -69.75 0.11 Allowed 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 105.859 -1.904 . . . . 0.0 105.859 179.713 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.577 ' HB2' ' N ' ' A' ' 67' ' ' THR . 55.5 t0 -95.09 -47.73 6.25 Favored 'General case' 0 N--CA 1.435 -1.197 0 N-CA-C 105.526 -2.027 . . . . 0.0 105.526 169.59 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.506 ' C ' ' HA ' ' A' ' 73' ' ' ALA . 13.9 t80 -144.05 142.38 30.62 Favored 'General case' 0 C--N 1.346 0.441 0 CA-C-N 112.603 -2.089 . . . . 0.0 110.984 179.262 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' HIS . . . . . 0.732 ' HB2' ' HB2' ' A' ' 73' ' ' ALA . 1.6 t60 -89.33 108.51 19.67 Favored 'General case' 0 C--N 1.328 -0.338 0 O-C-N 121.961 -0.462 . . . . 0.0 109.902 177.038 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.652 HD21 ' HA2' ' A' ' 69' ' ' GLY . 0.5 OUTLIER -132.8 175.43 9.35 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.931 0.396 . . . . 0.0 111.546 -179.615 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -57.06 161.56 8.0 Favored Glycine 0 C--N 1.332 0.309 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.406 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.539 ' HA ' ' HB3' ' A' ' 70' ' ' ARG . 3.8 p30 -112.02 100.07 8.58 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.857 0.36 . . . . 0.0 111.79 -179.499 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.651 ' HB ' ' HB2' ' A' ' 85' ' ' SER . 14.2 mt -113.41 147.28 17.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.177 178.738 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.07 -24.27 67.41 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 -179.45 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.541 ' C ' HD13 ' A' ' 84' ' ' LEU . 41.8 mtp180 -95.78 -98.31 0.17 Allowed 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 112.077 0.399 . . . . 0.0 112.077 -178.962 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.793 HD22 ' H ' ' A' ' 84' ' ' LEU . 0.0 OUTLIER -108.46 110.71 22.3 Favored 'General case' 0 CA--C 1.512 -0.491 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 179.268 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.652 ' O ' ' HA2' ' A' ' 69' ' ' GLY . 0.5 OUTLIER 158.56 -35.95 0.0 OUTLIER 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 114.415 -1.266 . . . . 0.0 108.514 -179.068 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.783 ' O ' ' N ' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -66.17 -164.9 0.03 OUTLIER 'General case' 0 CA--C 1.507 -0.688 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 176.86 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.421 ' HA ' ' HA3' ' A' ' 69' ' ' GLY . 0.5 OUTLIER -55.52 70.39 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 177.411 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 1.061 ' O ' ' O ' ' A' ' 104' ' ' ILE . 44.6 t60 -73.3 -14.46 61.31 Favored 'General case' 0 CA--C 1.513 -0.449 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 -176.708 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.559 ' CD2' ' HA ' ' A' ' 103' ' ' ASP . 0.1 OUTLIER -177.67 159.81 1.49 Allowed 'General case' 0 C--N 1.313 -1.007 0 C-N-CA 119.577 -0.849 . . . . 0.0 112.101 178.423 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.74 ' HG3' HG23 ' A' ' 67' ' ' THR . 23.4 mt-30 -137.92 160.79 38.37 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 113.791 1.034 . . . . 0.0 113.791 -177.998 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.64 ' HB ' ' HB2' ' A' ' 66' ' ' TRP . 2.9 mt -122.81 132.02 72.12 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 CA-C-N 115.333 -0.848 . . . . 0.0 109.643 178.058 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.707 HD13 ' ND2' ' A' ' 121' ' ' ASN . 0.5 OUTLIER -106.69 142.79 35.76 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -179.391 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.857 HD22 ' N ' ' A' ' 94' ' ' GLY . 0.2 OUTLIER -126.36 127.78 46.03 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.389 179.04 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.857 ' N ' HD22 ' A' ' 93' ' ' LEU . . . . . . . . 0 N--CA 1.451 -0.31 0 C-N-CA 120.6 -0.81 . . . . 0.0 112.801 179.647 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.642 ' O ' HD12 ' A' ' 100' ' ' LEU . 0.6 OUTLIER . . . . . 0 C--O 1.23 0.065 0 CA-C-O 120.875 0.369 . . . . 0.0 110.909 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.68 ' HA ' ' O ' ' A' ' 122' ' ' GLN . 4.2 mp -133.8 149.06 51.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.294 179.819 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.452 ' O ' ' N ' ' A' ' 122' ' ' GLN . 1.1 mt -115.27 129.97 56.77 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 179.723 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.477 ' O ' ' O ' ' A' ' 90' ' ' GLN . 29.6 t30 -108.54 112.49 24.89 Favored 'General case' 0 CA--C 1.508 -0.636 0 C-N-CA 119.832 -0.747 . . . . 0.0 109.854 179.739 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.871 ' HB3' HG21 ' A' ' 109' ' ' THR . 44.3 m-20 -83.92 109.7 17.81 Favored 'General case' 0 N--CA 1.44 -0.926 0 C-N-CA 119.198 -1.001 . . . . 0.0 109.627 179.871 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 1.061 ' O ' ' O ' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -125.05 109.38 22.04 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.041 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 177.168 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.443 ' HB3' ' CE1' ' A' ' 88' ' ' HIS . 65.0 m -136.09 169.39 17.69 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.359 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 19.1 m -69.38 -63.34 1.09 Allowed 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 119.005 -1.078 . . . . 0.0 111.709 -179.009 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -112.29 -32.88 6.38 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 114.904 1.446 . . . . 0.0 114.904 179.301 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -146.03 131.49 4.13 Favored Glycine 0 C--N 1.34 0.759 0 N-CA-C 117.033 1.573 . . . . 0.0 117.033 -177.725 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.871 HG21 ' HB3' ' A' ' 103' ' ' ASP . 11.9 m -121.33 138.2 54.36 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 174.451 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' TRP . . . . . 0.716 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 3.1 m-90 -121.69 149.27 43.48 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 113.648 0.981 . . . . 0.0 113.648 -178.411 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.487 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -123.85 112.22 17.02 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 114.979 -1.009 . . . . 0.0 108.711 177.512 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 44.66 43.94 7.03 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.013 -0.54 . . . . 0.0 112.127 -179.566 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 80.8 22.81 60.95 Favored Glycine 0 N--CA 1.445 -0.732 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.801 179.308 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.46 97.77 3.77 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.013 0.435 . . . . 0.0 110.661 179.749 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.716 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.0 OUTLIER -43.99 127.04 5.19 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.98 179.919 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.445 HG13 ' HB3' ' A' ' 111' ' ' LEU . 6.1 m -112.41 179.96 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.907 -179.008 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -90.66 142.2 28.0 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.143 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.415 ' O ' ' C ' ' A' ' 119' ' ' ASN . 54.4 tttm -63.51 163.78 10.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.113 179.429 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.415 ' C ' ' O ' ' A' ' 118' ' ' LYS . 19.4 m-80 33.72 39.85 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 121.28 0.562 . . . . 0.0 111.167 -179.39 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 7.1 p -111.04 105.05 13.68 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.038 -179.429 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.707 ' ND2' HD13 ' A' ' 92' ' ' LEU . 1.7 m120 -53.58 144.59 17.06 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.571 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 122' ' ' GLN . . . . . 0.68 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 35.4 mm-40 -129.5 146.02 51.38 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-O 120.976 0.417 . . . . 0.0 111.754 -179.625 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.673 HD13 ' N ' ' A' ' 124' ' ' LEU . 2.1 tm? -74.08 129.5 37.98 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.677 179.216 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.691 HD13 ' N ' ' A' ' 125' ' ' SER . 3.5 tm? -52.28 138.46 26.45 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-O 122.045 0.926 . . . . 0.0 111.587 -179.102 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.735 ' O ' HD11 ' A' ' 147' ' ' ILE . 0.6 OUTLIER -127.36 152.13 47.88 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 113.762 -1.563 . . . . 0.0 110.395 179.686 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 126' ' ' GLN . . . . . 0.437 ' HA ' HD13 ' A' ' 147' ' ' ILE . 14.0 mm100 -71.33 113.9 8.85 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.911 0.386 . . . . 0.0 109.973 179.412 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 62.95 32.12 82.93 Favored Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.336 -179.399 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.407 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 9.3 t70 -53.78 159.24 1.7 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.97 0.414 . . . . 0.0 111.011 -179.837 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.526 ' HB2' HG22 ' A' ' 144' ' ' VAL . 30.4 tt0 -146.66 135.1 21.94 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.883 -0.598 . . . . 0.0 111.642 -179.838 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.62 HG21 ' OD1' ' A' ' 103' ' ' ASP . 2.7 mp -116.03 129.0 73.14 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.045 178.597 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.569 HG23 ' CG2' ' A' ' 140' ' ' ILE . 12.9 m -102.75 145.41 29.78 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.884 0.373 . . . . 0.0 110.852 -179.266 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.499 ' HB ' ' NE2' ' A' ' 88' ' ' HIS . 5.8 m -141.2 158.39 22.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 112.327 0.491 . . . . 0.0 112.327 -179.113 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 67.17 43.03 90.75 Favored Glycine 0 N--CA 1.447 -0.601 0 CA-C-N 115.797 -0.638 . . . . 0.0 112.31 179.356 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.467 HG12 ' N ' ' A' ' 135' ' ' GLY . 93.6 t -78.44 157.25 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.613 0 CA-C-O 121.36 0.6 . . . . 0.0 112.076 -179.146 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 135' ' ' GLY . . . . . 0.467 ' N ' HG12 ' A' ' 134' ' ' VAL . . . 149.0 -42.02 0.84 Allowed Glycine 0 N--CA 1.441 -1.012 0 N-CA-C 110.691 -0.964 . . . . 0.0 110.691 -179.193 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.569 HG12 ' H ' ' A' ' 138' ' ' SER . 48.1 t -126.6 131.33 71.36 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.715 0 CA-C-N 115.256 -0.472 . . . . 0.0 109.883 178.709 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.24 -33.9 30.04 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.772 0.32 . . . . 0.0 111.432 -179.247 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 138' ' ' SER . . . . . 0.569 ' H ' HG12 ' A' ' 136' ' ' VAL . 0.9 OUTLIER -94.31 6.5 48.48 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.214 0.45 . . . . 0.0 112.214 -179.397 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 12.0 t0 -127.74 30.92 5.23 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 112.648 0.61 . . . . 0.0 112.648 -179.259 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.569 ' CG2' HG23 ' A' ' 131' ' ' THR . 24.2 mt -105.53 141.11 21.6 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.978 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.353 179.238 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.694 HD12 ' HG3' ' A' ' 42' ' ' GLN . 2.8 mm? -116.49 135.92 53.42 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 114.938 -1.028 . . . . 0.0 110.358 179.822 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 142' ' ' SER . . . . . 0.435 ' O ' ' OG1' ' A' ' 40' ' ' THR . 43.5 t -120.96 152.59 38.35 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 -178.758 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.713 HD13 ' N ' ' A' ' 144' ' ' VAL . 3.3 tm? -135.41 136.99 41.83 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 114.841 -1.072 . . . . 0.0 109.21 179.04 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.713 ' N ' HD13 ' A' ' 143' ' ' LEU . 43.0 t -130.12 140.21 49.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 120.955 0.407 . . . . 0.0 111.842 -178.996 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.78 HG13 HG12 ' A' ' 36' ' ' VAL . 0.1 OUTLIER -111.41 126.44 68.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.612 179.493 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 15.5 t80 -106.08 108.63 20.24 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.687 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.735 HD11 ' O ' ' A' ' 125' ' ' SER . 1.7 mp -85.24 133.42 29.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.26 -179.797 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 148' ' ' ASN . . . . . 0.433 ' ND2' ' HB2' ' A' ' 151' ' ' PHE . 0.9 OUTLIER -83.77 116.52 22.74 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.798 179.841 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -58.08 -21.67 46.97 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.326 -179.822 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 4.7 mptt -57.54 -41.07 80.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.891 0.377 . . . . 0.0 110.717 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 151' ' ' PHE . . . . . 0.454 ' CE2' HD11 ' A' ' 52' ' ' ILE . 4.0 t80 . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.76 179.781 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.528 0.122 0 CA-C-O 120.668 0.27 . . . . 0.0 111.631 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 27.3 m120 -108.54 -13.27 14.86 Favored 'General case' 0 CA--C 1.513 -0.476 0 CA-C-O 121.913 0.863 . . . . 0.0 109.35 179.282 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.529 ' O ' ' CG2' ' A' ' 32' ' ' ILE . 0.1 OUTLIER -70.6 104.13 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.54 0 CA-C-N 114.085 -1.416 . . . . 0.0 111.035 -179.353 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 1.02 ' CG2' ' HB2' ' A' ' 50' ' ' ALA . 0.5 OUTLIER -37.5 -63.42 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 CA-C-N 115.133 -0.94 . . . . 0.0 112.037 -179.197 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.784 ' SG ' HD12 ' A' ' 48' ' ' LEU . 18.8 p -164.83 164.73 20.94 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.363 -179.406 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.4 ' HD3' ' CG2' ' A' ' 45' ' ' ILE . 0.9 OUTLIER -127.38 123.64 36.68 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.858 0.361 . . . . 0.0 111.245 179.629 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.863 ' CG2' HD11 ' A' ' 48' ' ' LEU . 2.4 t -93.75 122.22 45.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.478 179.531 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 1.044 HG23 HG12 ' A' ' 45' ' ' ILE . 22.4 mt -121.86 107.94 21.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -179.231 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 8.4 m -85.02 100.64 11.81 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 177.958 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.6 t -85.81 -27.43 25.14 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -178.398 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.45 ' OG1' ' O ' ' A' ' 142' ' ' SER . 0.1 OUTLIER -52.08 -26.43 11.04 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.986 0.422 . . . . 0.0 111.016 -179.899 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 97.08 68.42 0.96 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.28 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.732 ' HB3' HD22 ' A' ' 141' ' ' LEU . 16.9 pt20 -142.42 -46.87 0.33 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.825 0.345 . . . . 0.0 111.204 -179.622 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.477 HG23 ' CE2' ' A' ' 76' ' ' TYR . 10.7 mt -132.31 133.84 24.24 Favored Pre-proline 0 N--CA 1.452 -0.351 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.161 -179.684 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.493 ' HD2' ' CZ ' ' A' ' 76' ' ' TYR . 29.4 Cg_exo -59.36 147.14 92.5 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.754 2.303 . . . . 0.0 111.728 179.501 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 1.044 HG12 HG23 ' A' ' 37' ' ' ILE . 52.6 mt -47.24 143.5 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.994 0.426 . . . . 0.0 111.851 -179.607 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.06 130.38 33.38 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.123 179.422 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.453 ' C ' HD23 ' A' ' 48' ' ' LEU . 1.2 p30 -97.76 120.27 37.85 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.11 0.481 . . . . 0.0 111.512 -179.341 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.863 HD11 ' CG2' ' A' ' 36' ' ' VAL . 0.5 OUTLIER -96.78 125.18 41.05 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.393 179.032 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.492 ' O ' ' HZ2' ' A' ' 66' ' ' TRP . 0.0 OUTLIER -118.49 162.21 18.73 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 122.065 0.936 . . . . 0.0 113.274 -178.861 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 1.02 ' HB2' ' CG2' ' A' ' 33' ' ' VAL . . . -119.07 164.78 15.01 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.531 -1.213 . . . . 0.0 111.026 179.644 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -116.06 71.24 0.77 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.021 0.439 . . . . 0.0 110.679 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.836 HD11 ' CE2' ' A' ' 151' ' ' PHE . 96.6 mt . . . . . 0 C--N 1.328 -0.356 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.416 -179.803 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.2 tptm . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.822 0.344 . . . . 0.0 111.166 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.443 ' HB3' HD12 ' A' ' 93' ' ' LEU . 17.7 ttpt -124.83 131.57 53.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.599 179.385 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.637 HG13 ' O ' ' A' ' 91' ' ' ILE . 19.2 t -136.0 139.26 46.2 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 CA-C-O 121.211 0.529 . . . . 0.0 111.94 -179.172 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' TRP . . . . . 0.678 ' HB2' ' HB ' ' A' ' 91' ' ' ILE . 15.0 m-90 -100.11 139.97 35.02 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.443 179.138 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.598 HG23 ' HG2' ' A' ' 90' ' ' GLN . 26.1 m -130.79 132.54 45.33 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.527 0.68 . . . . 0.0 112.149 179.719 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.486 ' CE1' ' CG ' ' A' ' 75' ' ' ASP . 3.6 m-85 -105.96 119.04 38.18 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 114.873 -1.058 . . . . 0.0 109.348 178.298 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.637 ' HA2' ' O ' ' A' ' 85' ' ' SER . . . 160.71 -157.85 29.32 Favored Glycine 0 CA--C 1.505 -0.538 0 C-N-CA 118.658 -1.734 . . . . 0.0 113.286 178.802 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.479 ' HD2' ' OD1' ' A' ' 86' ' ' ASN . 5.1 ptm180 -75.94 91.76 3.07 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-O 122.629 1.204 . . . . 0.0 108.165 179.887 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.414 ' CG ' ' HB2' ' A' ' 74' ' ' CYS . 0.2 OUTLIER -149.72 160.35 34.18 Favored Pre-proline 0 C--N 1.307 -1.263 0 CA-C-N 112.606 -2.088 . . . . 0.0 108.085 179.681 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.547 ' O ' ' CB ' ' A' ' 73' ' ' ALA . 30.1 Cg_endo -63.91 -8.74 16.69 Favored 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 120.84 1.027 . . . . 0.0 111.12 178.268 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.743 ' HB2' ' HB2' ' A' ' 77' ' ' HIS . . . 135.69 54.21 0.0 OUTLIER 'General case' 0 CA--C 1.49 -1.358 0 CA-C-N 114.706 -1.134 . . . . 0.0 109.361 178.724 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.55 ' HB3' ' HB ' ' A' ' 67' ' ' THR . 0.1 OUTLIER -52.59 -69.73 0.11 Allowed 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 105.546 -2.02 . . . . 0.0 105.546 179.46 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.504 ' N ' ' O ' ' A' ' 67' ' ' THR . 13.8 t70 -95.51 -47.74 6.12 Favored 'General case' 0 N--CA 1.435 -1.202 0 N-CA-C 105.446 -2.057 . . . . 0.0 105.446 169.137 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.518 ' C ' ' HA ' ' A' ' 73' ' ' ALA . 67.3 t80 -142.96 142.21 31.6 Favored 'General case' 0 C--N 1.347 0.492 0 CA-C-N 112.627 -2.079 . . . . 0.0 111.465 179.756 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' HIS . . . . . 0.743 ' HB2' ' HB2' ' A' ' 73' ' ' ALA . 1.7 t60 -91.65 111.64 23.24 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 177.079 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.676 HD11 ' HA ' ' A' ' 85' ' ' SER . 0.5 OUTLIER -135.47 175.89 9.17 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.925 0.393 . . . . 0.0 111.604 -179.666 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -59.39 165.63 9.68 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.257 179.802 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.41 ' HB3' ' CB ' ' A' ' 70' ' ' ARG . 3.1 p30 -112.01 100.07 8.58 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.829 0.347 . . . . 0.0 111.76 -179.493 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.669 ' HB ' ' HB2' ' A' ' 85' ' ' SER . 19.1 mt -115.02 131.77 66.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 177.903 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.632 ' HA ' HD22 ' A' ' 86' ' ' ASN . 1.6 m -52.79 -24.01 8.03 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 111.789 0.292 . . . . 0.0 111.789 -178.779 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.503 ' C ' HD13 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -93.05 -94.85 0.15 Allowed 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 120.428 0.156 . . . . 0.0 111.419 -179.943 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.844 HD22 ' H ' ' A' ' 84' ' ' LEU . 0.0 OUTLIER -109.43 108.77 19.4 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 121.388 0.613 . . . . 0.0 109.402 178.918 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.676 ' HA ' HD11 ' A' ' 78' ' ' LEU . 1.8 m 158.7 -39.67 0.0 OUTLIER 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 114.589 -1.187 . . . . 0.0 109.369 -179.684 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.696 ' O ' ' N ' ' A' ' 88' ' ' HIS . 56.6 m-20 -65.76 -163.01 0.02 OUTLIER 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 177.188 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.845 ' HB2' HD11 ' A' ' 104' ' ' ILE . 4.1 pttp -58.08 72.82 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 177.435 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.976 ' O ' ' O ' ' A' ' 104' ' ' ILE . 31.2 t60 -77.79 -19.5 54.92 Favored 'General case' 0 CA--C 1.515 -0.382 0 N-CA-C 114.315 1.228 . . . . 0.0 114.315 -176.437 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.596 ' HA ' ' H ' ' A' ' 104' ' ' ILE . 0.0 OUTLIER -173.7 156.86 2.99 Favored 'General case' 0 C--N 1.314 -0.97 0 C-N-CA 118.834 -1.146 . . . . 0.0 113.012 177.944 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.598 ' HG2' HG23 ' A' ' 67' ' ' THR . 33.4 mt-30 -137.55 160.75 38.27 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 114.587 -1.188 . . . . 0.0 113.751 -177.861 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.68 HD13 HD11 ' A' ' 48' ' ' LEU . 3.5 mt -128.37 132.18 68.36 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 CA-C-N 115.076 -0.966 . . . . 0.0 109.49 178.486 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.771 HD13 ' ND2' ' A' ' 121' ' ' ASN . 0.3 OUTLIER -108.95 144.11 37.33 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.118 0.485 . . . . 0.0 112.219 -178.988 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.882 HD22 ' N ' ' A' ' 94' ' ' GLY . 0.3 OUTLIER -125.88 129.95 50.36 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.477 179.409 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.882 ' N ' HD22 ' A' ' 93' ' ' LEU . . . . . . . . 0 N--CA 1.451 -0.312 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.509 179.733 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.577 HD21 HG13 ' A' ' 33' ' ' VAL . 6.6 mp . . . . . 0 CA--C 1.523 -0.092 0 CA-C-O 120.762 0.315 . . . . 0.0 110.769 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.852 HD13 ' O ' ' A' ' 122' ' ' GLN . 3.6 mm? -122.54 147.96 45.76 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.336 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.758 HD21 HD13 ' A' ' 145' ' ' ILE . 3.5 mp -118.79 127.44 53.53 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 179.502 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.491 ' O ' ' O ' ' A' ' 90' ' ' GLN . 26.1 t30 -111.98 111.48 22.44 Favored 'General case' 0 CA--C 1.506 -0.736 0 C-N-CA 119.641 -0.824 . . . . 0.0 109.944 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.923 ' OD1' HD13 ' A' ' 130' ' ' ILE . 81.6 m-20 -83.83 111.36 19.14 Favored 'General case' 0 N--CA 1.439 -1.016 0 C-N-CA 119.645 -0.822 . . . . 0.0 109.098 179.354 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.976 ' O ' ' O ' ' A' ' 88' ' ' HIS . 0.1 OUTLIER -122.8 107.74 20.0 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.073 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 177.964 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 59.1 m -133.89 169.12 17.56 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-N 114.86 -1.064 . . . . 0.0 109.187 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 20.0 m -69.44 -63.58 1.04 Allowed 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 119.04 -1.064 . . . . 0.0 111.689 -179.045 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -112.5 -32.45 6.47 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 114.858 1.429 . . . . 0.0 114.858 179.271 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -145.66 129.25 3.37 Favored Glycine 0 C--N 1.34 0.761 0 N-CA-C 117.151 1.62 . . . . 0.0 117.151 -177.712 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.772 HG21 ' HB3' ' A' ' 103' ' ' ASP . 6.8 m -121.61 138.54 54.28 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 174.392 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' TRP . . . . . 0.758 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.4 m-90 -119.46 149.23 42.22 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 -178.393 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.468 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.3 OUTLIER -122.61 112.2 17.7 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 115.158 -0.928 . . . . 0.0 108.692 177.594 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 112' ' ' ASN . . . . . 0.406 ' N ' HD12 ' A' ' 111' ' ' LEU . 57.8 m-20 44.93 44.06 7.65 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.075 -0.511 . . . . 0.0 112.171 -179.595 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 79.02 23.71 63.19 Favored Glycine 0 N--CA 1.445 -0.745 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.787 179.362 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 -136.76 96.09 3.26 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.105 0.478 . . . . 0.0 110.752 179.642 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.758 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.0 OUTLIER -44.12 132.87 5.45 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.071 179.888 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 4.1 m -123.61 179.29 2.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.761 -179.184 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -82.95 139.34 33.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.971 180.0 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.437 ' O ' ' C ' ' A' ' 119' ' ' ASN . 9.3 tmtt? -63.03 167.78 4.58 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 179.312 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.437 ' C ' ' O ' ' A' ' 118' ' ' LYS . 6.0 p-10 31.22 40.74 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.331 -179.664 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 5.2 p -110.97 107.66 17.15 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.059 -179.187 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.771 ' ND2' HD13 ' A' ' 92' ' ' LEU . 1.5 m120 -56.54 140.46 46.3 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.436 179.741 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 122' ' ' GLN . . . . . 0.852 ' O ' HD13 ' A' ' 100' ' ' LEU . 68.6 mm-40 -129.63 147.07 51.38 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-O 121.115 0.483 . . . . 0.0 112.042 -179.714 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 7.3 tp -72.62 119.92 17.52 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.384 -0.825 . . . . 0.0 109.759 179.147 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.777 HD11 ' CD1' ' A' ' 147' ' ' ILE . 2.3 tp -48.06 142.41 5.18 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-O 121.854 0.835 . . . . 0.0 111.825 -178.881 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.422 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.0 OUTLIER -127.19 152.62 47.13 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 114.146 -1.388 . . . . 0.0 110.557 179.739 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 1.2 tp60 -72.34 113.71 9.66 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 179.162 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 68.75 27.24 74.01 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.466 -179.486 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.422 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 8.3 t70 -56.03 159.96 3.05 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-O 120.895 0.378 . . . . 0.0 111.232 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.446 ' HG3' HG22 ' A' ' 144' ' ' VAL . 2.0 tt0 -146.74 135.4 22.13 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.756 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.923 HD13 ' OD1' ' A' ' 103' ' ' ASP . 7.0 mt -116.27 128.14 73.67 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 178.586 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.498 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 98.6 m -103.2 145.82 29.35 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.856 0.36 . . . . 0.0 110.788 -179.404 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.54 ' HB ' ' NE2' ' A' ' 88' ' ' HIS . 7.8 m -141.12 158.42 22.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -178.786 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 69.94 44.13 62.87 Favored Glycine 0 N--CA 1.448 -0.567 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.451 179.2 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.473 ' HA ' HG12 ' A' ' 140' ' ' ILE . 93.8 t -80.43 156.49 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 CA-C-O 121.434 0.635 . . . . 0.0 112.192 -179.242 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 135' ' ' GLY . . . . . 0.451 ' N ' HG12 ' A' ' 134' ' ' VAL . . . 149.62 -42.56 0.79 Allowed Glycine 0 N--CA 1.441 -0.972 0 N-CA-C 110.552 -1.019 . . . . 0.0 110.552 -179.129 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.565 HG12 ' H ' ' A' ' 138' ' ' SER . 51.9 t -126.85 131.95 70.53 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.69 0 CA-C-N 115.205 -0.497 . . . . 0.0 109.769 178.563 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -51.34 -34.52 34.05 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.725 0.298 . . . . 0.0 111.472 -179.266 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' SER . . . . . 0.565 ' H ' HG12 ' A' ' 136' ' ' VAL . 13.9 m -94.3 6.51 48.44 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.416 0.524 . . . . 0.0 112.416 -179.36 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 18.2 t0 -126.51 30.37 5.57 Favored 'General case' 0 CA--C 1.519 -0.249 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -179.313 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.498 ' CG2' ' CG2' ' A' ' 131' ' ' THR . 14.7 mt -107.29 141.23 23.01 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.437 179.348 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.732 HD22 ' HB3' ' A' ' 42' ' ' GLN . 28.3 mt -119.82 135.23 54.95 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 114.902 -1.045 . . . . 0.0 109.916 179.554 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 142' ' ' SER . . . . . 0.819 ' C ' HD12 ' A' ' 143' ' ' LEU . 47.3 t -116.92 151.89 35.69 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.912 0.863 . . . . 0.0 113.053 -178.806 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.819 HD12 ' C ' ' A' ' 142' ' ' SER . 5.5 mp -128.42 129.54 46.31 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.547 -1.206 . . . . 0.0 109.312 179.145 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.446 HG22 ' HG3' ' A' ' 129' ' ' GLU . 10.6 t -115.37 140.45 36.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 120.892 0.377 . . . . 0.0 111.641 -179.179 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.758 HD13 HD21 ' A' ' 101' ' ' LEU . 0.1 OUTLIER -116.23 126.26 73.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.766 179.957 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 9.8 t80 -109.62 121.89 46.22 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.782 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.777 ' CD1' HD11 ' A' ' 124' ' ' LEU . 5.9 mm -100.79 133.54 43.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.275 -179.835 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 7.9 p-10 -82.44 125.57 31.23 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.002 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -67.82 -22.66 65.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.024 179.828 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 9.8 mtmt -57.19 -40.23 76.95 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-O 120.939 0.399 . . . . 0.0 110.649 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 151' ' ' PHE . . . . . 0.836 ' CE2' HD11 ' A' ' 52' ' ' ILE . 19.5 t80 . . . . . 0 C--N 1.328 -0.348 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.563 179.732 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.727 0.299 . . . . 0.0 110.888 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.436 ' OD1' HD12 ' A' ' 52' ' ' ILE . 10.7 m-20 -109.0 -13.95 14.63 Favored 'General case' 0 CA--C 1.516 -0.345 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 178.244 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.594 ' O ' ' CG2' ' A' ' 32' ' ' ILE . 0.1 OUTLIER -70.74 95.46 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.581 0 CA-C-N 113.908 -1.497 . . . . 0.0 110.473 -179.685 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.743 HG23 ' HB3' ' A' ' 50' ' ' ALA . 0.8 OUTLIER -36.02 -63.08 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 114.813 -1.085 . . . . 0.0 112.593 -178.939 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.646 ' N ' HG12 ' A' ' 33' ' ' VAL . 98.3 m -154.31 164.8 38.03 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.152 0.501 . . . . 0.0 112.141 -179.009 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.19 114.84 20.82 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.264 179.241 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.601 HG12 HG13 ' A' ' 145' ' ' ILE . 5.7 m -88.98 126.93 42.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.663 -179.917 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.964 HG23 HG12 ' A' ' 45' ' ' ILE . 26.3 mt -126.07 108.82 20.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 112.464 0.542 . . . . 0.0 112.464 -179.035 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.49 ' SG ' HD23 ' A' ' 143' ' ' LEU . 0.0 OUTLIER -108.73 108.88 19.88 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 177.822 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.6 t -110.69 -23.22 11.19 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 -177.864 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.2 p -53.13 -25.21 12.5 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.917 0.389 . . . . 0.0 111.286 -179.433 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 119.98 47.74 0.34 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.494 179.765 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.752 ' HG2' HD22 ' A' ' 141' ' ' LEU . 2.8 mt-30 -120.06 -67.77 0.96 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.837 0.351 . . . . 0.0 110.886 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.486 HG21 ' CG ' ' A' ' 76' ' ' TYR . 0.6 OUTLIER -135.02 135.1 22.33 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.953 -179.804 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.432 ' HD2' ' CZ ' ' A' ' 76' ' ' TYR . 24.0 Cg_exo -59.37 147.69 89.99 Favored 'Trans proline' 0 C--N 1.342 0.234 0 C-N-CA 122.469 2.112 . . . . 0.0 111.563 179.451 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.964 HG12 HG23 ' A' ' 37' ' ' ILE . 32.8 mt -44.28 129.02 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.056 0.455 . . . . 0.0 111.99 -179.32 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.435 ' HB2' ' CD2' ' A' ' 76' ' ' TYR . 4.8 tpt180 -128.05 148.16 50.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.738 -0.664 . . . . 0.0 109.765 179.151 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -106.05 120.03 40.73 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.972 0.415 . . . . 0.0 111.797 -179.159 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.906 HD11 HD13 ' A' ' 91' ' ' ILE . 3.5 mt -93.64 131.84 38.56 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.282 178.716 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.525 ' O ' ' HZ2' ' A' ' 66' ' ' TRP . 0.0 OUTLIER -136.59 162.27 33.59 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 122.03 0.919 . . . . 0.0 113.406 -178.641 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.743 ' HB3' HG23 ' A' ' 33' ' ' VAL . . . -149.17 165.57 31.43 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.24 -1.346 . . . . 0.0 111.035 179.057 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 32.3 m-20 -91.57 121.16 33.0 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.051 0.453 . . . . 0.0 111.303 -179.678 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.436 HD12 ' OD1' ' A' ' 31' ' ' ASN . 72.0 mt . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 115.788 -0.642 . . . . 0.0 112.077 -179.759 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 60.3 tttt . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.842 0.353 . . . . 0.0 110.961 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.433 ' O ' ' HB3' ' A' ' 93' ' ' LEU . 6.3 ttpt -115.18 134.1 55.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.462 179.791 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.645 HG13 ' O ' ' A' ' 91' ' ' ILE . 16.8 t -137.1 137.72 46.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.116 0.484 . . . . 0.0 111.647 -179.292 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' TRP . . . . . 0.695 ' CD1' HD22 ' A' ' 48' ' ' LEU . 14.5 m-90 -99.89 139.67 35.21 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.199 179.128 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.709 HG23 ' CG ' ' A' ' 90' ' ' GLN . 8.8 m -127.57 129.63 47.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.505 0.669 . . . . 0.0 112.489 179.301 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.571 ' CE1' ' CG ' ' A' ' 75' ' ' ASP . 12.9 m-85 -100.91 118.49 37.05 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.14 -0.936 . . . . 0.0 108.961 177.735 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.639 ' HA2' ' O ' ' A' ' 85' ' ' SER . . . 160.46 -157.03 28.4 Favored Glycine 0 CA--C 1.505 -0.546 0 C-N-CA 119.045 -1.55 . . . . 0.0 113.057 179.236 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.442 ' H ' ' HA ' ' A' ' 86' ' ' ASN . 0.0 OUTLIER -76.78 92.42 3.59 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-O 122.663 1.22 . . . . 0.0 108.719 -179.685 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -149.42 159.45 36.58 Favored Pre-proline 0 C--N 1.306 -1.289 0 CA-C-N 112.68 -2.055 . . . . 0.0 108.06 179.15 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.544 ' O ' ' CB ' ' A' ' 73' ' ' ALA . 27.8 Cg_endo -63.61 -6.66 10.95 Favored 'Trans proline' 0 N--CA 1.452 -0.956 0 C-N-CA 120.64 0.893 . . . . 0.0 110.695 177.648 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.707 ' HB2' ' HB2' ' A' ' 77' ' ' HIS . . . 135.32 53.47 0.0 OUTLIER 'General case' 0 CA--C 1.491 -1.316 0 CA-C-N 114.447 -1.252 . . . . 0.0 109.227 178.814 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.579 ' HB3' ' HB ' ' A' ' 67' ' ' THR . 0.1 OUTLIER -52.48 -69.88 0.1 Allowed 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 105.443 -2.058 . . . . 0.0 105.443 179.617 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.701 ' HB2' ' N ' ' A' ' 67' ' ' THR . 57.0 t0 -95.45 -47.47 6.26 Favored 'General case' 0 N--CA 1.434 -1.232 0 N-CA-C 105.504 -2.036 . . . . 0.0 105.504 169.05 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.499 ' C ' ' HA ' ' A' ' 73' ' ' ALA . 1.7 t80 -143.72 142.72 31.08 Favored 'General case' 0 C--N 1.348 0.512 0 CA-C-N 112.602 -2.09 . . . . 0.0 112.019 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' HIS . . . . . 0.707 ' HB2' ' HB2' ' A' ' 73' ' ' ALA . 2.0 t60 -96.43 108.02 20.5 Favored 'General case' 0 C--N 1.331 -0.218 0 O-C-N 122.166 -0.334 . . . . 0.0 110.101 176.977 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.694 ' N ' HD13 ' A' ' 78' ' ' LEU . 0.0 OUTLIER -136.94 179.93 6.08 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.891 0.377 . . . . 0.0 111.677 -179.754 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -52.23 157.75 3.54 Favored Glycine 0 C--N 1.333 0.383 0 CA-C-N 115.983 -0.553 . . . . 0.0 112.854 -179.736 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 5.9 p-10 -111.93 99.9 8.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.811 0.339 . . . . 0.0 111.814 -179.561 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.662 ' HB ' ' HB2' ' A' ' 85' ' ' SER . 14.1 mm -114.26 129.97 69.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.237 -0.438 . . . . 0.0 109.845 178.336 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.458 ' HA ' ' ND2' ' A' ' 86' ' ' ASN . 80.3 p -53.02 -23.7 8.07 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.788 -179.082 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.516 ' C ' HD13 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -93.97 -96.38 0.15 Allowed 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 111.669 0.248 . . . . 0.0 111.669 -179.509 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.816 HD22 ' H ' ' A' ' 84' ' ' LEU . 0.0 OUTLIER -109.82 109.93 20.74 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-O 121.295 0.569 . . . . 0.0 109.84 179.324 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.662 ' HB2' ' HB ' ' A' ' 81' ' ' ILE . 0.4 OUTLIER 157.24 -41.26 0.0 OUTLIER 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 114.781 -1.099 . . . . 0.0 109.469 -179.942 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.761 ' O ' ' N ' ' A' ' 88' ' ' HIS . 91.1 m-20 -67.71 -156.19 0.02 OUTLIER 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 177.69 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.937 ' HB2' HD11 ' A' ' 104' ' ' ILE . 8.7 pttp -54.03 72.23 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 178.397 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 1.023 ' O ' ' O ' ' A' ' 104' ' ' ILE . 42.8 t60 -81.92 -16.13 51.59 Favored 'General case' 0 CA--C 1.514 -0.419 0 N-CA-C 113.888 1.07 . . . . 0.0 113.888 -176.998 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.591 ' CE1' HG13 ' A' ' 91' ' ' ILE . 0.0 OUTLIER -177.54 159.99 1.55 Allowed 'General case' 0 C--N 1.314 -0.95 0 C-N-CA 119.301 -0.96 . . . . 0.0 112.457 178.161 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.709 ' CG ' HG23 ' A' ' 67' ' ' THR . 38.3 mt-30 -138.89 160.35 39.93 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 113.761 1.022 . . . . 0.0 113.761 -178.442 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.906 HD13 HD11 ' A' ' 48' ' ' LEU . 5.6 mt -124.57 131.54 72.58 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.345 177.714 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.642 HD13 ' ND2' ' A' ' 121' ' ' ASN . 0.2 OUTLIER -107.61 140.24 40.93 Favored 'General case' 0 N--CA 1.463 0.176 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 -179.129 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.916 HD22 ' N ' ' A' ' 94' ' ' GLY . 0.3 OUTLIER -126.34 131.18 51.87 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.445 179.068 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.916 ' N ' HD22 ' A' ' 93' ' ' LEU . . . . . . . . 0 N--CA 1.451 -0.328 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.661 179.694 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.699 ' O ' HD12 ' A' ' 100' ' ' LEU . 4.0 mm? . . . . . 0 C--O 1.23 0.072 0 CA-C-O 120.836 0.351 . . . . 0.0 110.763 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.699 HD12 ' O ' ' A' ' 99' ' ' LEU . 3.8 mp -133.58 149.02 51.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.538 -179.794 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 1.028 HD22 HD13 ' A' ' 145' ' ' ILE . 0.5 OUTLIER -115.21 129.9 56.77 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 179.506 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.485 ' O ' ' O ' ' A' ' 90' ' ' GLN . 20.6 t30 -110.26 112.35 24.25 Favored 'General case' 0 CA--C 1.51 -0.588 0 C-N-CA 119.796 -0.762 . . . . 0.0 109.893 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.729 ' HB3' HG21 ' A' ' 109' ' ' THR . 87.0 m-20 -83.93 110.49 18.44 Favored 'General case' 0 N--CA 1.442 -0.848 0 C-N-CA 119.355 -0.938 . . . . 0.0 109.495 179.593 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 1.023 ' O ' ' O ' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -124.27 108.5 20.62 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.026 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 177.08 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.412 ' HG ' ' CE1' ' A' ' 88' ' ' HIS . 64.0 m -134.56 168.97 17.99 Favored 'General case' 0 C--N 1.296 -1.754 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.227 179.808 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 19.9 m -69.33 -63.14 1.12 Allowed 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 119.006 -1.078 . . . . 0.0 111.542 -179.042 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 63.9 m-80 -112.27 -32.39 6.54 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 114.934 1.457 . . . . 0.0 114.934 179.323 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -145.89 127.82 2.91 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 117.105 1.602 . . . . 0.0 117.105 -177.718 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.729 HG21 ' HB3' ' A' ' 103' ' ' ASP . 5.7 m -121.18 138.11 54.36 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 174.337 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' TRP . . . . . 0.736 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.8 m-90 -120.7 148.98 43.21 Favored 'General case' 0 CA--C 1.515 -0.384 0 N-CA-C 113.462 0.912 . . . . 0.0 113.462 -178.515 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.462 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -122.65 112.08 17.53 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 115.026 -0.988 . . . . 0.0 108.621 177.532 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 39.7 m-20 45.57 43.76 9.42 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.085 -0.507 . . . . 0.0 112.118 -179.478 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 78.88 25.05 60.82 Favored Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.784 179.425 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' GLN . . . . . 0.435 ' O ' HG13 ' A' ' 116' ' ' VAL . 31.2 mt-30 -136.98 97.51 3.53 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.102 0.477 . . . . 0.0 110.802 179.69 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.736 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.0 OUTLIER -45.66 132.61 8.44 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.911 179.755 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.606 HG21 ' OD2' ' A' ' 103' ' ' ASP . 27.7 m -124.07 -178.84 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 121.069 0.461 . . . . 0.0 111.916 -179.041 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -85.5 142.29 29.3 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.111 -179.84 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.426 ' HG2' ' N ' ' A' ' 119' ' ' ASN . 33.7 tttm -64.26 163.73 12.34 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.197 179.422 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.426 ' N ' ' HG2' ' A' ' 118' ' ' LYS . 8.2 m-80 34.56 39.91 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 121.182 0.515 . . . . 0.0 111.062 -179.374 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 3.5 p -110.74 107.2 16.66 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.901 -179.537 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.642 ' ND2' HD13 ' A' ' 92' ' ' LEU . 2.0 m120 -53.12 146.75 10.87 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.771 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 122' ' ' GLN . . . . . 0.665 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 13.8 mm100 -129.28 152.11 49.2 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-O 121.149 0.499 . . . . 0.0 111.925 -179.514 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.596 HD13 ' O ' ' A' ' 124' ' ' LEU . 2.6 tm? -81.02 122.52 27.41 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.571 -0.741 . . . . 0.0 109.531 179.031 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.596 ' O ' HD13 ' A' ' 123' ' ' LEU . 0.0 OUTLIER -48.45 139.44 9.05 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-O 122.365 1.078 . . . . 0.0 112.241 -178.672 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.419 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.3 OUTLIER -127.68 152.56 47.55 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 113.593 -1.64 . . . . 0.0 110.196 179.485 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 7.2 tp-100 -71.86 113.44 8.9 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 179.27 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 64.8 30.79 78.92 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.366 -179.564 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.463 ' OD2' HD13 ' A' ' 101' ' ' LEU . 29.8 t70 -53.74 160.5 1.34 Allowed 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.884 0.373 . . . . 0.0 111.077 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.496 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 0.1 OUTLIER -146.6 135.48 22.37 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.755 -179.898 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.454 HG23 ' O ' ' A' ' 110' ' ' TRP . 7.3 mm -113.68 128.72 70.43 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.124 0 CA-C-N 116.167 -0.47 . . . . 0.0 109.922 178.659 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.536 HG23 ' CG2' ' A' ' 140' ' ' ILE . 18.7 m -103.42 144.31 31.55 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.785 -179.392 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.476 ' HB ' ' NE2' ' A' ' 88' ' ' HIS . 5.6 m -141.19 156.1 21.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.005 0.431 . . . . 0.0 112.159 -179.068 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 133' ' ' GLY . . . . . 0.405 ' O ' ' O ' ' A' ' 139' ' ' ASP . . . 70.34 39.54 70.45 Favored Glycine 0 N--CA 1.448 -0.562 0 CA-C-N 115.914 -0.585 . . . . 0.0 112.463 179.396 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.462 HG12 ' N ' ' A' ' 135' ' ' GLY . 90.2 t -74.39 156.86 6.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 121.447 0.641 . . . . 0.0 112.123 -179.247 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 135' ' ' GLY . . . . . 0.462 ' N ' HG12 ' A' ' 134' ' ' VAL . . . 152.99 -46.21 0.57 Allowed Glycine 0 N--CA 1.441 -1.0 0 CA-C-N 114.981 -1.008 . . . . 0.0 110.749 -179.285 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.595 HG12 ' H ' ' A' ' 138' ' ' SER . 42.7 t -126.59 133.9 67.55 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.722 0 CA-C-N 115.222 -0.489 . . . . 0.0 109.904 178.597 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -51.01 -32.44 21.27 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.89 0.376 . . . . 0.0 111.207 -179.353 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' SER . . . . . 0.595 ' H ' HG12 ' A' ' 136' ' ' VAL . 46.7 m -94.39 6.22 49.39 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 116.164 -0.471 . . . . 0.0 112.132 -179.666 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 139' ' ' ASP . . . . . 0.405 ' O ' ' O ' ' A' ' 133' ' ' GLY . 25.4 t0 -128.34 30.26 5.21 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 -179.378 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.536 ' CG2' HG23 ' A' ' 131' ' ' THR . 27.5 mt -105.89 141.19 21.76 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.287 179.373 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.752 HD22 ' HG2' ' A' ' 42' ' ' GLN . 4.5 mt -116.79 135.27 53.88 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.869 -1.059 . . . . 0.0 110.291 179.675 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 29.8 t -120.31 152.42 37.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.694 0.759 . . . . 0.0 112.359 -179.17 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.872 HD22 ' N ' ' A' ' 144' ' ' VAL . 0.8 OUTLIER -135.7 131.28 35.44 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.625 -1.17 . . . . 0.0 108.992 179.357 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.872 ' N ' HD22 ' A' ' 143' ' ' LEU . 12.2 t -111.67 140.17 32.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.975 0.416 . . . . 0.0 111.908 -179.079 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 1.028 HD13 HD22 ' A' ' 101' ' ' LEU . 0.0 OUTLIER -116.91 126.63 74.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.215 179.575 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 16.0 t80 -106.97 125.48 51.06 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.057 -179.724 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 4.1 mm -103.53 133.3 47.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.999 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 35.5 p-10 -84.77 111.25 19.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.861 0.362 . . . . 0.0 110.718 179.796 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -56.28 -27.34 54.96 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.153 -179.861 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 2.2 tptt -57.2 -36.34 70.72 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.807 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 4.2 t80 . . . . . 0 N--CA 1.451 -0.381 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.777 179.998 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.408 ' HA ' ' HB3' ' A' ' 150' ' ' LYS . 6.2 tm-20 . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.643 0.258 . . . . 0.0 111.508 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 26.0 m-80 -109.56 -14.69 14.34 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-O 121.909 0.862 . . . . 0.0 109.28 178.994 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.487 ' O ' HG22 ' A' ' 32' ' ' ILE . 0.1 OUTLIER -74.1 111.14 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.571 0 CA-C-N 114.129 -1.396 . . . . 0.0 111.23 -179.168 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 1.043 ' CG2' ' HB2' ' A' ' 50' ' ' ALA . 0.5 OUTLIER -45.02 -64.12 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.211 -0.904 . . . . 0.0 111.381 -179.488 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.644 ' N ' HG12 ' A' ' 33' ' ' VAL . 30.2 p -165.4 164.93 19.61 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.039 0.447 . . . . 0.0 112.046 -179.644 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.412 ' HD3' HG23 ' A' ' 45' ' ' ILE . 1.0 OUTLIER -124.39 117.63 24.89 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.598 179.38 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.897 HG13 HD11 ' A' ' 143' ' ' LEU . 89.3 t -89.16 132.57 33.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.112 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.937 HG23 HG12 ' A' ' 45' ' ' ILE . 22.6 mt -129.86 108.14 15.84 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.693 -179.745 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.433 ' HB3' ' O ' ' A' ' 43' ' ' ILE . 2.5 t -86.66 105.98 17.29 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 178.18 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 11.4 t -90.71 -26.76 19.38 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 -178.41 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.454 HG21 ' H ' ' A' ' 142' ' ' SER . 26.1 p -59.64 -21.99 61.24 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 121.047 -0.261 . . . . 0.0 111.422 -179.429 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 103.65 72.39 0.9 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.571 -0.823 . . . . 0.0 113.033 179.384 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.508 ' OE1' HD23 ' A' ' 141' ' ' LEU . 1.8 mt-30 -151.1 -70.62 0.17 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.859 0.361 . . . . 0.0 110.941 179.534 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.554 HG23 ' HD2' ' A' ' 44' ' ' PRO . 16.7 mt -102.56 140.33 21.0 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.2 -179.565 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.554 ' HD2' HG23 ' A' ' 43' ' ' ILE . 74.3 Cg_endo -77.6 146.76 24.41 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 122.337 2.025 . . . . 0.0 111.724 179.566 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.937 HG12 HG23 ' A' ' 37' ' ' ILE . 35.5 mt -44.12 108.67 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.056 0.455 . . . . 0.0 111.779 -179.499 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.24 129.8 56.73 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.761 179.132 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.424 ' C ' HD13 ' A' ' 48' ' ' LEU . 3.6 p30 -96.4 119.38 34.78 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.986 0.422 . . . . 0.0 111.429 -179.305 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.876 HD12 ' CD1' ' A' ' 66' ' ' TRP . 0.2 OUTLIER -96.36 131.98 42.34 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 178.543 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.559 ' O ' ' CZ2' ' A' ' 66' ' ' TRP . 0.1 OUTLIER -113.15 164.02 14.03 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.84 0.828 . . . . 0.0 112.608 -178.598 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 1.043 ' HB2' ' CG2' ' A' ' 33' ' ' VAL . . . -111.46 166.42 11.14 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 114.915 -1.039 . . . . 0.0 110.864 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -93.56 46.13 1.18 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.946 0.403 . . . . 0.0 110.942 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 14.1 mm . . . . . 0 C--N 1.328 -0.368 0 CA-C-O 121.099 0.476 . . . . 0.0 110.664 179.614 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.5 ttpt . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.99 0.424 . . . . 0.0 110.776 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.427 ' O ' ' HB3' ' A' ' 93' ' ' LEU . 7.9 ttpt -126.92 131.21 51.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.685 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.561 HG13 ' O ' ' A' ' 91' ' ' ILE . 10.7 t -134.86 136.33 52.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 121.037 0.446 . . . . 0.0 111.588 -179.494 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' TRP . . . . . 0.876 ' CD1' HD12 ' A' ' 48' ' ' LEU . 16.0 m-90 -102.07 140.06 36.86 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.057 179.599 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.932 HG23 ' HG3' ' A' ' 90' ' ' GLN . 3.1 m -127.58 129.81 47.95 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.435 0.635 . . . . 0.0 112.14 179.51 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.54 ' HE2' HD11 ' A' ' 91' ' ' ILE . 64.7 m-85 -101.77 118.38 36.81 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.322 178.192 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.679 ' HA2' HD21 ' A' ' 78' ' ' LEU . . . 159.33 -157.6 28.72 Favored Glycine 0 CA--C 1.502 -0.755 0 C-N-CA 119.034 -1.555 . . . . 0.0 112.192 179.328 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.44 ' CD ' ' HB3' ' A' ' 86' ' ' ASN . 11.7 ptm180 -76.75 91.81 3.52 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-O 122.424 1.106 . . . . 0.0 108.297 179.538 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 6.3 m120 -149.08 154.63 39.63 Favored Pre-proline 0 C--N 1.311 -1.068 0 CA-C-N 112.985 -1.916 . . . . 0.0 108.506 179.269 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.573 ' O ' ' HB2' ' A' ' 77' ' ' HIS . 25.7 Cg_exo -56.1 -11.56 5.97 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 121.507 1.472 . . . . 0.0 111.571 178.45 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.787 ' HB2' ' HB2' ' A' ' 77' ' ' HIS . . . 137.27 50.97 0.0 OUTLIER 'General case' 0 CA--C 1.49 -1.336 0 CA-C-N 114.96 -1.018 . . . . 0.0 109.605 178.791 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.58 ' HB3' ' HB ' ' A' ' 67' ' ' THR . 0.1 OUTLIER -52.92 -69.9 0.1 Allowed 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 105.858 -1.904 . . . . 0.0 105.858 179.485 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.576 ' N ' ' O ' ' A' ' 67' ' ' THR . 12.2 t0 -94.78 -47.4 6.49 Favored 'General case' 0 N--CA 1.437 -1.112 0 N-CA-C 105.89 -1.893 . . . . 0.0 105.89 169.806 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.517 ' CD2' HG23 ' A' ' 43' ' ' ILE . 35.6 t80 -144.21 142.56 30.59 Favored 'General case' 0 C--N 1.347 0.473 0 CA-C-N 112.576 -2.102 . . . . 0.0 110.951 179.658 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' HIS . . . . . 0.787 ' HB2' ' HB2' ' A' ' 73' ' ' ALA . 1.4 t60 -93.0 108.38 19.96 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 118.12 0.418 . . . . 0.0 110.442 177.323 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.781 HD11 ' O ' ' A' ' 85' ' ' SER . 2.2 pp -125.66 168.48 13.67 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.784 0.326 . . . . 0.0 111.103 179.698 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.677 ' O ' HD12 ' A' ' 78' ' ' LEU . . . -53.91 173.05 0.63 Allowed Glycine 0 C--N 1.33 0.209 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.777 -179.791 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.563 ' C ' HD12 ' A' ' 81' ' ' ILE . 12.8 p-10 -96.05 105.36 17.39 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.725 0.298 . . . . 0.0 110.965 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.673 HD13 ' HB3' ' A' ' 85' ' ' SER . 2.0 mp -111.53 152.65 13.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.772 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.23 -45.27 73.74 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 113.61 0.967 . . . . 0.0 113.61 -178.767 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 17.9 mtt180 -119.72 -91.16 0.56 Allowed 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 113.692 0.997 . . . . 0.0 113.692 -177.328 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.493 ' O ' ' CB ' ' A' ' 85' ' ' SER . 0.0 OUTLIER -84.9 103.26 13.8 Favored 'General case' 0 CA--C 1.507 -0.704 0 CA-C-O 121.948 0.88 . . . . 0.0 110.74 -178.606 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.781 ' O ' HD11 ' A' ' 78' ' ' LEU . 0.4 OUTLIER 148.62 -35.42 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 113.113 -1.858 . . . . 0.0 108.718 -179.745 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.803 ' O ' ' N ' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -68.44 -162.39 0.03 OUTLIER 'General case' 0 CA--C 1.514 -0.43 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 177.6 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.911 ' HB3' HD11 ' A' ' 104' ' ' ILE . 1.0 OUTLIER -53.14 72.18 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 177.822 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.959 ' O ' ' O ' ' A' ' 104' ' ' ILE . 29.6 t60 -83.73 -18.91 36.26 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 114.642 1.349 . . . . 0.0 114.642 -175.981 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.651 ' HA ' ' H ' ' A' ' 104' ' ' ILE . 0.0 OUTLIER -171.06 156.98 5.02 Favored 'General case' 0 C--N 1.31 -1.113 0 C-N-CA 118.824 -1.15 . . . . 0.0 112.632 177.864 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.932 ' HG3' HG23 ' A' ' 67' ' ' THR . 34.4 mt-30 -135.37 158.8 43.45 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.587 -1.188 . . . . 0.0 113.825 -177.197 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.646 ' HB ' ' HB2' ' A' ' 66' ' ' TRP . 7.9 mt -124.16 132.82 70.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 114.908 -1.042 . . . . 0.0 109.785 178.499 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.714 HD13 ' ND2' ' A' ' 121' ' ' ASN . 0.3 OUTLIER -108.99 144.03 37.5 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.01 0.433 . . . . 0.0 111.807 -179.557 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.645 HD22 ' N ' ' A' ' 94' ' ' GLY . 0.8 OUTLIER -125.58 122.69 37.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.485 179.442 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.645 ' N ' HD22 ' A' ' 93' ' ' LEU . . . . . . . . 0 N--CA 1.45 -0.379 0 C-N-CA 120.594 -0.812 . . . . 0.0 112.678 179.806 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.74 ' O ' HD22 ' A' ' 100' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.797 0.332 . . . . 0.0 110.783 . . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.777 HD13 ' O ' ' A' ' 122' ' ' GLN . 4.1 mm? -131.35 148.24 52.65 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.263 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.466 ' O ' ' N ' ' A' ' 122' ' ' GLN . 0.3 OUTLIER -117.03 129.99 56.38 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 179.869 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.497 ' O ' ' O ' ' A' ' 90' ' ' GLN . 28.0 t30 -111.35 111.41 22.43 Favored 'General case' 0 CA--C 1.508 -0.64 0 C-N-CA 119.79 -0.764 . . . . 0.0 109.781 179.611 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.745 ' HB3' HG21 ' A' ' 109' ' ' THR . 76.2 m-20 -85.54 112.01 20.55 Favored 'General case' 0 N--CA 1.442 -0.838 0 C-N-CA 119.643 -0.823 . . . . 0.0 109.543 179.507 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.959 ' O ' ' O ' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -123.0 107.63 19.66 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.975 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 177.849 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 50.1 m -134.49 168.95 18.02 Favored 'General case' 0 C--N 1.296 -1.732 0 CA-C-N 114.906 -1.043 . . . . 0.0 109.221 179.672 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 19.5 m -69.59 -63.34 1.09 Allowed 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 119.055 -1.058 . . . . 0.0 111.76 -178.904 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -112.26 -32.33 6.56 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 114.976 1.473 . . . . 0.0 114.976 179.436 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -145.72 126.46 2.55 Favored Glycine 0 C--N 1.339 0.725 0 N-CA-C 117.346 1.698 . . . . 0.0 117.346 -177.531 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.745 HG21 ' HB3' ' A' ' 103' ' ' ASP . 4.3 m -121.26 138.11 54.38 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 174.389 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 110' ' ' TRP . . . . . 0.7 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.6 m-90 -120.67 148.94 43.25 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 -178.539 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.469 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -121.77 112.2 18.08 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 115.152 -0.931 . . . . 0.0 108.698 177.437 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 33.5 m-20 45.48 43.4 8.81 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.073 -0.512 . . . . 0.0 112.099 -179.439 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 78.83 27.87 55.78 Favored Glycine 0 N--CA 1.444 -0.798 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.761 179.247 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -139.19 96.73 3.15 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.099 0.476 . . . . 0.0 110.774 179.776 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.7 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.3 OUTLIER -44.57 128.96 6.76 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.019 179.775 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 3.7 m -121.99 -179.84 2.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.743 -179.208 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -85.57 142.1 29.37 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.186 -179.785 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.436 ' HG3' ' HA ' ' A' ' 104' ' ' ILE . 62.3 tttm -65.0 162.55 16.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.129 179.358 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.431 ' N ' ' HG2' ' A' ' 118' ' ' LYS . 4.9 p-10 35.88 38.19 0.05 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.215 0.531 . . . . 0.0 111.142 -179.799 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 9.6 p -111.18 110.95 21.69 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.929 -179.394 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.714 ' ND2' HD13 ' A' ' 92' ' ' LEU . 1.4 m120 -57.39 141.04 48.62 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.683 179.864 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 122' ' ' GLN . . . . . 0.777 ' O ' HD13 ' A' ' 100' ' ' LEU . 33.6 mm-40 -129.52 145.89 51.4 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-O 121.009 0.433 . . . . 0.0 111.861 -179.666 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -72.28 117.7 14.25 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.671 179.184 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.72 HD21 HG12 ' A' ' 147' ' ' ILE . 0.7 OUTLIER -47.42 143.79 3.34 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.9 0.857 . . . . 0.0 112.029 -178.943 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.46 ' N ' ' HG ' ' A' ' 124' ' ' LEU . 0.3 OUTLIER -126.84 152.78 46.53 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 114.045 -1.434 . . . . 0.0 110.124 179.263 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -71.59 113.99 9.21 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.981 -0.378 . . . . 0.0 109.981 179.633 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 67.99 27.62 73.62 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.852 -0.689 . . . . 0.0 112.266 -179.411 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.402 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 8.3 t70 -55.04 160.42 2.05 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.01 0.433 . . . . 0.0 111.185 -179.82 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.776 ' CG ' HG22 ' A' ' 144' ' ' VAL . 4.2 mt-10 -146.01 135.38 22.98 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.447 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.454 HG23 ' O ' ' A' ' 110' ' ' TRP . 7.0 mm -111.51 128.22 68.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 178.908 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.589 HG23 ' CG2' ' A' ' 140' ' ' ILE . 41.9 m -103.73 144.94 30.81 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.73 -179.538 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.561 HG11 ' CD2' ' A' ' 88' ' ' HIS . 4.1 m -141.46 158.42 21.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -178.781 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 66.17 42.17 94.49 Favored Glycine 0 N--CA 1.447 -0.574 0 CA-C-N 115.83 -0.623 . . . . 0.0 112.355 179.359 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.454 ' HA ' HG12 ' A' ' 140' ' ' ILE . 88.9 t -76.89 157.04 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 CA-C-O 121.467 0.651 . . . . 0.0 112.193 -179.125 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 135' ' ' GLY . . . . . 0.446 ' N ' HG12 ' A' ' 134' ' ' VAL . . . 144.65 -43.08 0.98 Allowed Glycine 0 N--CA 1.44 -1.062 0 N-CA-C 110.447 -1.061 . . . . 0.0 110.447 -178.814 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.632 HG12 ' H ' ' A' ' 138' ' ' SER . 47.5 t -126.87 126.09 67.88 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 CA-C-N 114.984 -0.608 . . . . 0.0 109.705 178.589 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.525 ' HA ' HD12 ' A' ' 140' ' ' ILE . 0.8 OUTLIER -51.17 -28.23 10.66 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.774 0.321 . . . . 0.0 111.186 -179.342 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 138' ' ' SER . . . . . 0.632 ' H ' HG12 ' A' ' 136' ' ' VAL . 0.9 OUTLIER -94.36 6.49 48.56 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 116.224 -0.443 . . . . 0.0 112.114 -179.598 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -130.94 27.55 4.88 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 -179.427 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.589 ' CG2' HG23 ' A' ' 131' ' ' THR . 23.9 mt -102.73 140.86 19.94 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.312 179.169 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.508 HD23 ' OE1' ' A' ' 42' ' ' GLN . 4.9 mp -124.07 135.39 53.53 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 114.808 -1.087 . . . . 0.0 109.734 179.511 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 142' ' ' SER . . . . . 0.454 ' H ' HG21 ' A' ' 40' ' ' THR . 38.9 t -127.65 151.92 48.33 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -178.966 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.897 HD11 HG13 ' A' ' 36' ' ' VAL . 3.2 tm? -122.96 138.09 54.77 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 114.424 -1.262 . . . . 0.0 109.155 179.184 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.776 HG22 ' CG ' ' A' ' 129' ' ' GLU . 3.8 t -119.17 141.03 41.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.8 0.333 . . . . 0.0 111.724 -178.811 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.741 HG13 HG22 ' A' ' 36' ' ' VAL . 0.2 OUTLIER -111.02 140.34 30.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.161 179.564 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -119.76 106.57 12.25 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.556 179.79 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.72 HG12 HD21 ' A' ' 124' ' ' LEU . 2.0 mp -99.38 133.38 42.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.483 -179.781 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 -78.82 140.23 38.24 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.236 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -73.8 -18.44 60.95 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.196 178.771 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 150' ' ' LYS . . . . . 0.408 ' HB3' ' HA ' ' A' ' 30' ' ' GLU . 0.0 OUTLIER -65.5 -45.21 84.44 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.648 179.779 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 151' ' ' PHE . . . . . 0.523 ' HE2' ' HB3' ' A' ' 50' ' ' ALA . 26.1 t80 . . . . . 0 C--N 1.331 -0.227 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.681 179.844 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 . . . . . 0 CA--C 1.528 0.109 0 CA-C-O 120.73 0.3 . . . . 0.0 111.326 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 73.2 m-20 -110.1 -13.34 14.39 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-O 121.829 0.823 . . . . 0.0 109.07 178.965 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.589 ' O ' ' CG2' ' A' ' 32' ' ' ILE . 0.1 OUTLIER -70.07 97.32 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.605 0 CA-C-N 114.216 -1.356 . . . . 0.0 111.266 -178.839 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.88 HG23 ' HB3' ' A' ' 50' ' ' ALA . 0.6 OUTLIER -34.15 -59.06 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 114.795 -1.093 . . . . 0.0 112.159 -179.578 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.617 ' N ' HG12 ' A' ' 33' ' ' VAL . 3.2 t -163.5 164.98 24.18 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.747 -179.27 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 1.8 ttm180 -125.47 115.17 19.81 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.026 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.639 HG21 ' CZ ' ' A' ' 68' ' ' PHE . 14.4 p -89.92 137.17 22.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.076 179.799 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.899 HG23 HG12 ' A' ' 45' ' ' ILE . 23.6 mt -129.51 107.42 15.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -179.673 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.453 ' HB2' ' O ' ' A' ' 43' ' ' ILE . 67.1 m -92.74 101.03 13.41 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 177.211 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.2 t -105.82 -18.21 14.13 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 113.469 0.915 . . . . 0.0 113.469 -177.256 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.768 HG21 ' CB ' ' A' ' 142' ' ' SER . 26.1 p -57.81 -19.35 27.95 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.924 -0.31 . . . . 0.0 111.534 -179.564 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 111.12 67.64 0.55 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.558 -0.83 . . . . 0.0 112.425 179.837 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.735 ' C ' HD13 ' A' ' 43' ' ' ILE . 10.9 mt-30 -151.15 -54.49 0.14 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.737 0.303 . . . . 0.0 111.138 -179.739 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.927 HG22 ' HD2' ' A' ' 44' ' ' PRO . 0.0 OUTLIER -134.63 151.5 76.02 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.158 -179.299 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.927 ' HD2' HG22 ' A' ' 43' ' ' ILE . 87.0 Cg_endo -80.42 147.3 17.86 Favored 'Trans proline' 0 N--CA 1.461 -0.433 0 C-N-CA 122.403 2.069 . . . . 0.0 111.562 179.352 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.899 HG12 HG23 ' A' ' 37' ' ' ILE . 23.2 mt -37.73 124.58 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 CA-C-O 121.043 0.449 . . . . 0.0 111.844 -179.517 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.568 ' HD2' ' HB3' ' A' ' 76' ' ' TYR . 0.0 OUTLIER -115.28 153.94 30.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.266 179.698 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 15.9 p-10 -116.22 119.83 37.03 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.187 0.517 . . . . 0.0 111.674 -179.605 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.934 HD22 ' CD1' ' A' ' 66' ' ' TRP . 6.9 mt -96.72 123.25 40.36 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.251 178.829 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.526 ' O ' ' HZ2' ' A' ' 66' ' ' TRP . 0.0 OUTLIER -127.52 160.88 30.17 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 -178.76 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.88 ' HB3' HG23 ' A' ' 33' ' ' VAL . . . -157.71 142.31 16.4 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 114.287 -1.324 . . . . 0.0 110.998 178.991 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -68.87 129.89 41.22 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.969 0.414 . . . . 0.0 111.083 -179.771 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 33.9 mt . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.197 -179.992 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 34.0 mtmt . . . . . 0 C--O 1.232 0.16 0 CA-C-O 120.807 0.337 . . . . 0.0 111.128 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.569 ' HB3' HD12 ' A' ' 93' ' ' LEU . 5.5 ttpt -112.96 130.78 56.0 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.409 179.557 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.729 HG22 HD23 ' A' ' 92' ' ' LEU . 21.4 t -137.47 139.45 43.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.164 0.507 . . . . 0.0 112.176 -179.098 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' TRP . . . . . 0.934 ' CD1' HD22 ' A' ' 48' ' ' LEU . 12.5 m-90 -100.08 139.23 36.04 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.06 178.607 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.628 HG23 ' HG2' ' A' ' 90' ' ' GLN . 33.9 m -131.68 130.64 42.29 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.554 0.692 . . . . 0.0 111.793 179.329 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.639 ' CZ ' HG21 ' A' ' 36' ' ' VAL . 1.3 m-85 -102.26 119.36 38.67 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 114.886 -1.052 . . . . 0.0 109.093 178.462 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.65 ' HA2' ' O ' ' A' ' 85' ' ' SER . . . 156.35 -160.7 30.37 Favored Glycine 0 CA--C 1.505 -0.542 0 C-N-CA 118.537 -1.792 . . . . 0.0 113.225 179.041 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.421 ' H ' ' HA ' ' A' ' 86' ' ' ASN . 12.5 ptm180 -76.84 93.15 3.69 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-O 122.686 1.231 . . . . 0.0 108.918 -179.874 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.454 ' C ' ' N ' ' A' ' 73' ' ' ALA . 4.7 m-80 -148.45 156.53 42.37 Favored Pre-proline 0 C--N 1.307 -1.275 0 CA-C-N 112.857 -1.974 . . . . 0.0 107.936 178.812 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.546 ' O ' ' CB ' ' A' ' 73' ' ' ALA . 47.0 Cg_exo -50.37 -13.76 0.83 Allowed 'Trans proline' 0 N--CA 1.459 -0.553 0 C-N-CA 121.384 1.389 . . . . 0.0 111.315 178.276 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.557 ' HB2' ' HB2' ' A' ' 77' ' ' HIS . . . 135.85 53.63 0.0 OUTLIER 'General case' 0 CA--C 1.489 -1.385 0 CA-C-N 114.504 -1.226 . . . . 0.0 108.582 178.731 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.555 ' HB3' ' HB ' ' A' ' 67' ' ' THR . 0.0 OUTLIER -52.07 -69.28 0.12 Allowed 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 -179.846 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.559 ' N ' ' O ' ' A' ' 67' ' ' THR . 29.9 t70 -92.76 -51.2 5.2 Favored 'General case' 0 N--CA 1.433 -1.29 0 N-CA-C 104.388 -2.449 . . . . 0.0 104.388 169.861 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.834 ' CE2' HG21 ' A' ' 43' ' ' ILE . 1.3 p90 -148.26 143.87 27.25 Favored 'General case' 0 C--N 1.345 0.389 0 CA-C-N 112.815 -1.993 . . . . 0.0 111.011 176.227 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' HIS . . . . . 0.557 ' HB2' ' HB2' ' A' ' 73' ' ' ALA . 5.8 t60 -90.09 105.81 18.06 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 177.454 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.631 HD21 ' O ' ' A' ' 85' ' ' SER . 1.4 pt? -127.63 178.78 5.89 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.922 0.391 . . . . 0.0 111.336 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -51.1 158.43 2.24 Favored Glycine 0 C--N 1.333 0.373 0 C-N-CA 120.991 -0.623 . . . . 0.0 112.694 -179.792 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.436 ' ND2' ' O ' ' A' ' 80' ' ' ASN . 0.8 OUTLIER -111.71 99.38 8.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.762 0.315 . . . . 0.0 111.579 -179.697 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.64 ' HB ' ' HB2' ' A' ' 85' ' ' SER . 17.3 mt -114.93 131.66 66.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 178.175 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.423 ' HA ' ' ND2' ' A' ' 86' ' ' ASN . 0.5 OUTLIER -52.81 -24.09 8.24 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 111.697 0.258 . . . . 0.0 111.697 -179.016 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.445 ' H ' HG22 ' A' ' 81' ' ' ILE . 2.2 mtt-85 -92.3 -95.05 0.14 Allowed 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 116.841 -0.163 . . . . 0.0 111.256 179.869 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.491 ' N ' HD23 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -109.48 109.45 20.28 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-O 121.359 0.599 . . . . 0.0 109.761 179.191 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.65 ' O ' ' HA2' ' A' ' 69' ' ' GLY . 1.5 m 157.19 -42.37 0.0 OUTLIER 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 114.592 -1.186 . . . . 0.0 109.55 -179.698 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.669 ' O ' ' N ' ' A' ' 88' ' ' HIS . 30.3 m-20 -65.41 -160.71 0.02 OUTLIER 'General case' 0 CA--C 1.516 -0.354 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 177.514 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.845 ' HB3' HD11 ' A' ' 104' ' ' ILE . 0.0 OUTLIER -58.64 75.18 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 177.791 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.969 ' O ' ' O ' ' A' ' 104' ' ' ILE . 30.6 t60 -79.53 -18.64 51.4 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 114.182 1.179 . . . . 0.0 114.182 -176.685 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.611 ' CZ ' HD11 ' A' ' 91' ' ' ILE . 0.0 OUTLIER -174.98 156.84 2.25 Favored 'General case' 0 C--N 1.312 -1.052 0 C-N-CA 119.038 -1.065 . . . . 0.0 112.88 177.961 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.628 ' HG2' HG23 ' A' ' 67' ' ' THR . 35.2 mt-30 -138.09 160.75 38.57 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 114.677 -1.147 . . . . 0.0 113.758 -177.779 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.672 ' HB ' ' HB2' ' A' ' 66' ' ' TRP . 3.4 mt -130.24 129.81 65.31 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.004 178.617 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.729 HD23 HG22 ' A' ' 65' ' ' VAL . 0.4 OUTLIER -103.93 143.86 32.3 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -179.22 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.78 HD22 ' N ' ' A' ' 94' ' ' GLY . 0.2 OUTLIER -126.43 122.81 36.36 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.188 178.965 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.78 ' N ' HD22 ' A' ' 93' ' ' LEU . . . . . . . . 0 N--CA 1.452 -0.247 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.563 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.789 HD11 HG22 ' A' ' 33' ' ' VAL . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.796 0.332 . . . . 0.0 110.936 . . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.577 ' HA ' ' O ' ' A' ' 122' ' ' GLN . 0.8 OUTLIER -121.07 148.01 44.74 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.083 179.625 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.441 ' O ' ' N ' ' A' ' 122' ' ' GLN . 4.4 mp -116.94 127.38 54.17 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 179.614 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.484 ' O ' ' O ' ' A' ' 90' ' ' GLN . 27.8 t30 -113.9 111.49 21.8 Favored 'General case' 0 CA--C 1.507 -0.706 0 C-N-CA 119.74 -0.784 . . . . 0.0 109.928 -179.92 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.698 ' HB3' HG21 ' A' ' 109' ' ' THR . 74.8 m-20 -84.11 111.51 19.39 Favored 'General case' 0 N--CA 1.44 -0.972 0 C-N-CA 119.647 -0.821 . . . . 0.0 109.227 179.57 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.969 ' O ' ' O ' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -123.38 107.76 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.007 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 177.837 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.465 ' HG ' ' CE1' ' A' ' 88' ' ' HIS . 71.1 m -132.96 171.48 13.9 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-N 114.939 -1.028 . . . . 0.0 109.328 179.754 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 23.4 m -69.58 -63.56 1.05 Allowed 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 119.093 -1.043 . . . . 0.0 111.545 -179.156 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -112.65 -32.85 6.31 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 114.687 1.366 . . . . 0.0 114.687 179.162 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -145.97 129.08 3.27 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 116.996 1.558 . . . . 0.0 116.996 -177.84 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.698 HG21 ' HB3' ' A' ' 103' ' ' ASP . 5.8 m -121.17 138.15 54.34 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 174.478 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 110' ' ' TRP . . . . . 0.776 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.5 m-90 -120.09 148.85 43.09 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 113.14 0.793 . . . . 0.0 113.14 -178.653 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -123.59 112.3 17.27 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 115.123 -0.944 . . . . 0.0 108.755 177.714 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 13.4 m-80 45.23 44.68 9.08 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.933 -0.576 . . . . 0.0 112.116 -179.531 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 77.53 26.14 61.75 Favored Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.75 179.249 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' GLN . . . . . 0.413 ' O ' HG13 ' A' ' 116' ' ' VAL . 0.6 OUTLIER -138.74 95.3 2.95 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.077 0.465 . . . . 0.0 110.739 179.703 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.776 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.1 OUTLIER -44.98 133.64 6.25 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.931 179.763 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.495 HG21 ' OD2' ' A' ' 103' ' ' ASP . 31.2 m -124.44 -179.66 2.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.83 -179.113 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 29.3 mm-40 -84.9 141.57 30.31 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.005 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.427 ' HG2' ' N ' ' A' ' 119' ' ' ASN . 88.4 tttt -65.31 163.2 15.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.056 179.443 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.427 ' N ' ' HG2' ' A' ' 118' ' ' LYS . 13.5 m-80 33.63 40.04 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.164 0.507 . . . . 0.0 111.152 -179.461 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 19.5 p -110.48 117.08 32.59 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.967 -179.397 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.403 ' HB3' ' CD2' ' A' ' 100' ' ' LEU . 66.9 m-20 -57.97 138.98 55.38 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.778 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 122' ' ' GLN . . . . . 0.577 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 45.0 mm-40 -129.49 146.33 51.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.117 0.484 . . . . 0.0 111.787 -179.849 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 12.3 tp -78.74 120.24 23.1 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.545 178.995 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.813 HD21 HG12 ' A' ' 147' ' ' ILE . 13.3 tp -46.88 144.33 2.48 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.773 0.797 . . . . 0.0 111.965 -178.905 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.757 ' O ' HD11 ' A' ' 147' ' ' ILE . 0.6 OUTLIER -126.83 152.34 47.11 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 114.22 -1.354 . . . . 0.0 110.26 179.542 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 126' ' ' GLN . . . . . 0.447 ' HA ' HD12 ' A' ' 147' ' ' ILE . 4.1 mm100 -71.41 114.15 9.18 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 179.584 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 65.67 30.29 77.01 Favored Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.172 -179.364 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.405 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 18.6 t0 -55.76 160.24 2.7 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.987 0.423 . . . . 0.0 111.39 -179.705 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.409 ' CG ' ' O ' ' A' ' 143' ' ' LEU . 1.2 tt0 -146.15 134.94 22.38 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.004 179.925 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.446 ' CG2' ' O ' ' A' ' 110' ' ' TRP . 1.1 mp -113.41 127.15 70.86 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.202 0 CA-C-O 120.799 0.333 . . . . 0.0 110.112 178.958 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.492 ' HB ' ' HB2' ' A' ' 110' ' ' TRP . 18.3 m -104.04 145.6 29.93 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.52 -179.754 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.49 HG11 ' CD2' ' A' ' 88' ' ' HIS . 5.5 m -141.21 158.09 22.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -178.669 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 133' ' ' GLY . . . . . 0.404 ' O ' ' O ' ' A' ' 139' ' ' ASP . . . 69.06 41.33 81.61 Favored Glycine 0 N--CA 1.447 -0.612 0 CA-C-N 115.682 -0.69 . . . . 0.0 112.509 179.25 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.465 ' HA ' HG12 ' A' ' 140' ' ' ILE . 85.9 t -77.55 153.87 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.636 0 CA-C-O 121.398 0.618 . . . . 0.0 112.14 -179.284 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 145.13 -39.61 1.17 Allowed Glycine 0 N--CA 1.441 -0.999 0 CA-C-N 115.015 -0.993 . . . . 0.0 110.7 -179.004 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.541 HG12 ' H ' ' A' ' 138' ' ' SER . 48.3 t -126.67 129.35 71.59 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.65 0 CA-C-N 115.231 -0.485 . . . . 0.0 109.837 178.874 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -51.25 -34.43 32.54 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.784 0.326 . . . . 0.0 111.618 -179.235 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 138' ' ' SER . . . . . 0.541 ' H ' HG12 ' A' ' 136' ' ' VAL . 2.6 t -94.06 6.48 48.41 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 -179.326 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 139' ' ' ASP . . . . . 0.404 ' O ' ' O ' ' A' ' 133' ' ' GLY . 14.6 t0 -126.77 26.94 6.13 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -179.319 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.5 ' C ' HD22 ' A' ' 141' ' ' LEU . 26.6 mt -102.52 141.35 18.77 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.34 179.194 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.539 HD12 ' CD ' ' A' ' 42' ' ' GLN . 4.1 mm? -121.26 135.45 55.12 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 114.885 -1.052 . . . . 0.0 110.176 179.594 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 142' ' ' SER . . . . . 0.807 ' C ' HD12 ' A' ' 143' ' ' LEU . 0.9 OUTLIER -122.27 147.39 46.28 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.551 0.691 . . . . 0.0 112.648 -178.898 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.807 HD12 ' C ' ' A' ' 142' ' ' SER . 5.7 mp -127.14 146.27 50.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.028 -0.987 . . . . 0.0 109.086 179.399 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 21.5 t -129.42 141.01 47.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.918 0.39 . . . . 0.0 112.009 -178.974 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.4 HD13 HD11 ' A' ' 101' ' ' LEU . 0.2 OUTLIER -116.08 127.88 73.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.786 179.771 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 9.7 t80 -111.27 120.21 41.48 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.49 179.855 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.813 HG12 HD21 ' A' ' 124' ' ' LEU . 1.3 mt -100.47 133.8 42.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.998 0.427 . . . . 0.0 111.86 -179.458 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 148' ' ' ASN . . . . . 0.414 ' ND2' ' O ' ' A' ' 32' ' ' ILE . 0.7 OUTLIER -84.37 114.99 22.27 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.558 179.423 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -59.97 -19.28 51.39 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.442 -179.694 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 9.4 mtmm -57.9 -43.29 86.07 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.947 0.403 . . . . 0.0 110.801 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 32.4 t80 . . . . . 0 C--N 1.328 -0.36 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.968 179.987 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.527 0.09 0 CA-C-O 120.596 0.236 . . . . 0.0 111.474 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.597 ' HA ' HD12 ' A' ' 52' ' ' ILE . 10.4 m120 -108.55 -14.02 14.72 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-O 121.843 0.83 . . . . 0.0 109.048 178.797 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.528 HD13 ' O ' ' A' ' 48' ' ' LEU . 0.1 OUTLIER -73.58 111.6 8.8 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.568 0 CA-C-N 114.066 -1.424 . . . . 0.0 111.433 -179.355 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 1.05 ' CG2' ' HB2' ' A' ' 50' ' ' ALA . 0.5 OUTLIER -42.27 -64.57 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.47 -179.653 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.631 ' N ' ' CG1' ' A' ' 33' ' ' VAL . 22.6 p -166.31 165.85 17.05 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.712 -179.686 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 11.7 ttm180 -119.21 126.27 51.15 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.385 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 1.011 HG12 HD21 ' A' ' 143' ' ' LEU . 14.8 t -95.59 137.09 24.6 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.19 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.349 179.226 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.936 HG23 HG12 ' A' ' 45' ' ' ILE . 21.8 mt -129.3 108.6 17.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 -178.985 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.757 ' SG ' HD23 ' A' ' 143' ' ' LEU . 0.7 OUTLIER -103.38 102.02 11.94 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 177.413 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.61 ' CG2' HG22 ' A' ' 37' ' ' ILE . 1.7 p -112.42 -23.16 10.48 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 113.664 0.987 . . . . 0.0 113.664 -177.112 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.528 HG21 ' HB3' ' A' ' 142' ' ' SER . 5.3 p -54.16 -23.33 13.9 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.874 -0.33 . . . . 0.0 111.452 -179.241 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 124.26 70.64 0.22 Allowed Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.642 -0.79 . . . . 0.0 112.402 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.497 ' NE2' ' HB3' ' A' ' 141' ' ' LEU . 0.6 OUTLIER -151.05 -70.77 0.17 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.74 0.305 . . . . 0.0 110.944 -179.893 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.762 HG12 HD13 ' A' ' 78' ' ' LEU . 2.1 mp -134.64 133.13 21.07 Favored Pre-proline 0 N--CA 1.453 -0.319 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.15 -179.826 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.476 ' HD2' ' CZ ' ' A' ' 76' ' ' TYR . 35.6 Cg_exo -58.58 147.44 86.84 Favored 'Trans proline' 0 C--N 1.342 0.236 0 C-N-CA 122.474 2.116 . . . . 0.0 111.611 179.497 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.936 HG12 HG23 ' A' ' 37' ' ' ILE . 45.7 mt -33.68 145.57 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -179.24 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.404 ' HD3' ' CD2' ' A' ' 76' ' ' TYR . 9.8 tpt180 -139.88 149.46 43.42 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.045 179.47 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -120.54 119.91 34.31 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.888 0.375 . . . . 0.0 111.635 -179.441 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.864 HD11 HD13 ' A' ' 91' ' ' ILE . 0.3 OUTLIER -99.26 133.39 43.62 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 178.367 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.567 ' O ' ' CZ2' ' A' ' 66' ' ' TRP . 0.1 OUTLIER -113.42 164.73 13.23 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.794 0.807 . . . . 0.0 112.658 -179.131 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 1.05 ' HB2' ' CG2' ' A' ' 33' ' ' VAL . . . -119.77 166.16 13.61 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.116 -0.947 . . . . 0.0 111.428 -179.895 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -105.72 76.02 1.17 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.384 179.642 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.597 HD12 ' HA ' ' A' ' 31' ' ' ASN . 19.0 mt . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.484 -179.53 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.6 ptpt . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.806 0.336 . . . . 0.0 110.995 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.457 ' O ' ' HB3' ' A' ' 93' ' ' LEU . 14.0 ttpt -115.19 130.84 57.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.532 179.8 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.484 HG13 ' O ' ' A' ' 91' ' ' ILE . 5.5 t -133.36 134.08 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 CA-C-O 121.028 0.442 . . . . 0.0 111.554 -179.503 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' TRP . . . . . 0.666 ' HB2' ' HB ' ' A' ' 91' ' ' ILE . 17.2 m-90 -100.61 140.27 35.12 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.854 179.395 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.73 HG23 ' HG2' ' A' ' 90' ' ' GLN . 21.6 m -127.34 130.44 49.46 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.53 0.681 . . . . 0.0 112.262 179.515 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.52 ' HE2' HD11 ' A' ' 91' ' ' ILE . 43.6 m-85 -101.66 118.04 36.12 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.089 -0.959 . . . . 0.0 108.739 177.768 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.686 ' HA2' ' O ' ' A' ' 85' ' ' SER . . . 158.29 -151.93 23.06 Favored Glycine 0 CA--C 1.505 -0.558 0 C-N-CA 119.054 -1.546 . . . . 0.0 113.055 179.828 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.44 ' HD2' ' HB2' ' A' ' 80' ' ' ASN . 35.5 mtp180 -75.49 91.08 2.76 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-O 122.348 1.071 . . . . 0.0 108.49 -179.853 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.427 ' CB ' ' HB2' ' A' ' 74' ' ' CYS . 20.6 m120 -150.82 159.32 34.26 Favored Pre-proline 0 C--N 1.308 -1.212 0 CA-C-N 113.18 -1.827 . . . . 0.0 108.688 178.917 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.558 ' O ' ' HB2' ' A' ' 77' ' ' HIS . 36.3 Cg_endo -66.73 -6.22 15.04 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 120.874 1.05 . . . . 0.0 110.777 177.591 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.73 ' HB2' ' HB2' ' A' ' 77' ' ' HIS . . . 137.03 51.57 0.0 OUTLIER 'General case' 0 CA--C 1.491 -1.32 0 CA-C-N 114.452 -1.249 . . . . 0.0 109.269 178.867 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.548 ' HB3' ' HB ' ' A' ' 67' ' ' THR . 0.1 OUTLIER -52.78 -69.43 0.11 Allowed 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 105.709 -1.959 . . . . 0.0 105.709 179.537 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.655 ' HB2' ' N ' ' A' ' 67' ' ' THR . 36.9 t0 -95.56 -47.56 6.19 Favored 'General case' 0 N--CA 1.433 -1.319 0 N-CA-C 105.872 -1.899 . . . . 0.0 105.872 169.638 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.5 ' CG ' HG21 ' A' ' 43' ' ' ILE . 7.5 t80 -145.12 142.14 29.4 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 112.501 -2.136 . . . . 0.0 112.102 -179.609 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' HIS . . . . . 0.73 ' HB2' ' HB2' ' A' ' 73' ' ' ALA . 1.9 t60 -100.89 106.7 18.07 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 176.392 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.814 HD11 ' HA ' ' A' ' 85' ' ' SER . 0.9 OUTLIER -133.07 -174.65 3.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.057 0.456 . . . . 0.0 111.773 -179.282 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -56.73 170.71 2.73 Favored Glycine 0 C--N 1.332 0.355 0 CA-C-N 115.75 -0.659 . . . . 0.0 112.471 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.44 ' HB2' ' HD2' ' A' ' 70' ' ' ARG . 0.8 OUTLIER -112.12 98.49 7.37 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 -179.438 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.661 ' HB ' ' HB2' ' A' ' 85' ' ' SER . 15.3 mm -115.3 129.81 70.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 177.964 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.42 ' HA ' ' ND2' ' A' ' 86' ' ' ASN . 18.8 m -53.09 -23.86 8.81 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 111.617 0.229 . . . . 0.0 111.617 -179.267 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.54 ' H ' HG22 ' A' ' 81' ' ' ILE . 3.1 mpt_? -98.01 -88.6 0.31 Allowed 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 111.608 0.225 . . . . 0.0 111.608 -179.82 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.462 HD23 ' HB3' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -109.41 108.8 19.46 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 121.455 0.645 . . . . 0.0 110.541 179.812 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.814 ' HA ' HD11 ' A' ' 78' ' ' LEU . 3.1 m 155.23 -42.93 0.01 OUTLIER 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 114.247 -1.342 . . . . 0.0 109.437 179.793 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.655 ' O ' ' N ' ' A' ' 88' ' ' HIS . 38.0 m-20 -77.21 -164.5 0.47 Allowed 'General case' 0 CA--C 1.512 -0.498 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 177.679 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.505 ' HB2' HD11 ' A' ' 104' ' ' ILE . 0.0 OUTLIER -49.51 83.12 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 178.961 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 1.071 ' O ' ' O ' ' A' ' 104' ' ' ILE . 36.3 t60 -102.74 -19.32 14.78 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 114.624 1.342 . . . . 0.0 114.624 -177.002 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.571 ' CD2' ' HA ' ' A' ' 103' ' ' ASP . 0.1 OUTLIER -176.55 159.44 1.9 Allowed 'General case' 0 C--N 1.317 -0.811 0 C-N-CA 119.332 -0.947 . . . . 0.0 111.869 178.338 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.73 ' HG2' HG23 ' A' ' 67' ' ' THR . 27.4 mt-30 -137.89 161.09 37.56 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 113.767 1.025 . . . . 0.0 113.767 -177.673 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.864 HD13 HD11 ' A' ' 48' ' ' LEU . 2.9 mt -124.97 133.11 70.31 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 CA-C-N 115.092 -0.958 . . . . 0.0 109.588 178.267 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.718 HD13 ' ND2' ' A' ' 121' ' ' ASN . 0.2 OUTLIER -110.47 141.92 42.93 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 121.01 0.434 . . . . 0.0 112.166 -179.168 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.853 HD13 ' CG2' ' A' ' 33' ' ' VAL . 19.0 tp -125.65 137.96 53.89 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.298 178.843 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.322 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.416 179.777 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 10.5 mp . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.794 0.33 . . . . 0.0 110.658 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.916 HD22 ' HB3' ' A' ' 121' ' ' ASN . 1.0 OUTLIER -133.68 148.72 51.5 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.627 -179.965 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.459 ' O ' ' N ' ' A' ' 122' ' ' GLN . 5.4 mp -116.22 129.69 56.42 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.681 -0.488 . . . . 0.0 109.681 179.638 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.467 ' HB3' ' HB2' ' A' ' 90' ' ' GLN . 24.5 t30 -110.31 112.39 24.31 Favored 'General case' 0 CA--C 1.508 -0.652 0 C-N-CA 119.706 -0.798 . . . . 0.0 110.031 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.768 ' OD2' HG11 ' A' ' 116' ' ' VAL . 33.5 m-20 -83.78 110.23 18.16 Favored 'General case' 0 N--CA 1.441 -0.924 0 C-N-CA 119.428 -0.909 . . . . 0.0 109.662 179.846 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 1.071 ' O ' ' O ' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -125.04 108.91 20.9 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.061 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 177.07 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 68.7 m -131.48 173.5 11.03 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.452 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 25.8 m -69.34 -63.86 0.98 Allowed 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 119.038 -1.065 . . . . 0.0 111.084 -179.358 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 6.1 m-80 -112.68 -33.23 6.18 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 114.234 1.198 . . . . 0.0 114.234 178.629 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -146.71 133.94 5.06 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 116.536 1.374 . . . . 0.0 116.536 -178.093 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.756 HG21 ' HB3' ' A' ' 103' ' ' ASP . 16.7 m -121.06 138.01 54.38 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 174.417 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 110' ' ' TRP . . . . . 0.719 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.9 m-90 -120.89 149.14 43.07 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 113.65 0.981 . . . . 0.0 113.65 -178.357 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.474 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -122.92 111.99 17.3 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 115.004 -0.998 . . . . 0.0 108.66 177.536 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 44.21 44.6 6.61 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.998 -0.546 . . . . 0.0 112.191 -179.457 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 80.72 21.77 63.16 Favored Glycine 0 N--CA 1.445 -0.765 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.837 179.437 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -134.29 98.34 4.08 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.968 0.413 . . . . 0.0 110.7 179.608 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.719 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.3 OUTLIER -44.06 124.93 4.12 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.084 179.936 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.768 HG11 ' OD2' ' A' ' 103' ' ' ASP . 14.7 p -112.15 160.22 11.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.722 -179.074 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.511 ' N ' HG22 ' A' ' 116' ' ' VAL . 9.8 tt0 -71.01 142.05 50.95 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.995 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.419 ' HG3' ' HA ' ' A' ' 104' ' ' ILE . 81.6 tttt -65.17 162.55 16.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.293 179.432 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.463 ' ND2' ' O ' ' A' ' 119' ' ' ASN . 1.7 p-10 34.67 39.09 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.265 0.555 . . . . 0.0 111.305 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 8.6 p -111.09 109.5 19.61 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.9 -179.473 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.916 ' HB3' HD22 ' A' ' 100' ' ' LEU . 1.6 m120 -57.69 140.91 50.16 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.771 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 122' ' ' GLN . . . . . 0.651 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 3.6 mm100 -129.64 143.43 50.82 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-O 121.055 0.455 . . . . 0.0 111.844 -179.707 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.509 HD13 ' N ' ' A' ' 124' ' ' LEU . 2.7 tm? -72.57 122.83 22.02 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.512 178.942 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.68 HD11 HG12 ' A' ' 147' ' ' ILE . 0.9 OUTLIER -47.71 143.53 3.85 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-O 121.854 0.835 . . . . 0.0 111.941 -178.799 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.448 ' N ' ' HG ' ' A' ' 124' ' ' LEU . 0.3 OUTLIER -126.72 152.84 46.27 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 114.166 -1.379 . . . . 0.0 110.242 179.535 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -71.72 113.99 9.33 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.882 0.372 . . . . 0.0 110.058 179.615 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 65.9 30.3 76.82 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.917 -0.658 . . . . 0.0 112.577 -179.588 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.418 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 29.2 t70 -57.87 159.5 5.41 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.96 0.41 . . . . 0.0 111.142 -179.851 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.638 ' HB2' HG22 ' A' ' 144' ' ' VAL . 0.6 OUTLIER -146.55 135.79 22.72 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.377 -179.932 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.631 HG21 ' OD1' ' A' ' 103' ' ' ASP . 10.4 mm -113.31 128.86 69.91 Favored 'Isoleucine or valine' 0 C--O 1.232 0.132 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.3 178.815 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.49 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 53.8 m -103.17 144.65 31.04 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.477 -179.804 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.476 ' HB ' ' NE2' ' A' ' 88' ' ' HIS . 9.7 m -140.57 157.7 24.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.039 0.447 . . . . 0.0 112.18 -178.927 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 70.43 42.19 65.16 Favored Glycine 0 N--CA 1.446 -0.65 0 CA-C-N 115.725 -0.67 . . . . 0.0 112.404 179.436 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.462 HG12 ' N ' ' A' ' 135' ' ' GLY . 94.6 t -78.13 156.81 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 CA-C-O 121.394 0.616 . . . . 0.0 112.032 -179.256 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 135' ' ' GLY . . . . . 0.462 ' N ' HG12 ' A' ' 134' ' ' VAL . . . 149.82 -42.68 0.78 Allowed Glycine 0 N--CA 1.443 -0.896 0 N-CA-C 110.627 -0.989 . . . . 0.0 110.627 -179.248 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.587 HG12 ' H ' ' A' ' 138' ' ' SER . 48.0 t -126.66 131.3 71.34 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 CA-C-N 115.271 -0.464 . . . . 0.0 109.89 178.791 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.07 -33.67 26.81 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.769 0.319 . . . . 0.0 111.257 -179.425 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 138' ' ' SER . . . . . 0.587 ' H ' HG12 ' A' ' 136' ' ' VAL . 2.0 p -94.16 6.24 49.22 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 112.251 0.464 . . . . 0.0 112.251 -179.535 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -128.1 29.91 5.31 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-O 121.137 0.494 . . . . 0.0 112.265 -179.467 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.49 ' CG2' ' CG2' ' A' ' 131' ' ' THR . 26.9 mt -104.71 141.34 20.38 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.268 179.22 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.497 ' HB3' ' NE2' ' A' ' 42' ' ' GLN . 5.8 mp -118.88 135.19 54.69 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.015 -0.993 . . . . 0.0 110.633 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 142' ' ' SER . . . . . 0.528 ' HB3' HG21 ' A' ' 40' ' ' THR . 46.9 t -118.76 152.4 36.25 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.691 0.758 . . . . 0.0 112.547 -179.178 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 1.011 HD21 HG12 ' A' ' 36' ' ' VAL . 1.5 tm? -134.72 137.55 43.6 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 114.589 -1.187 . . . . 0.0 109.019 179.427 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.756 ' N ' HD22 ' A' ' 143' ' ' LEU . 25.5 t -128.4 140.01 50.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 C-N-CA 120.75 -0.38 . . . . 0.0 111.858 -179.062 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.493 HG13 HG22 ' A' ' 36' ' ' VAL . 1.1 tt -109.08 139.84 30.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.725 179.461 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 16.8 t80 -118.1 103.85 10.28 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.777 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.68 HG12 HD11 ' A' ' 124' ' ' LEU . 2.5 mp -92.56 129.37 43.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.175 179.9 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 12.2 p30 -78.6 132.08 36.97 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.017 -179.738 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 50.2 m-20 -64.49 -21.38 66.65 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.095 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 3.1 mmpt? -57.49 -43.66 84.33 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-O 120.953 0.406 . . . . 0.0 110.564 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 151' ' ' PHE . . . . . 0.575 ' HE2' ' HB3' ' A' ' 50' ' ' ALA . 19.0 t80 . . . . . 0 C--N 1.328 -0.354 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.67 179.731 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 . . . . . 0 CA--C 1.528 0.098 0 CA-C-O 120.695 0.283 . . . . 0.0 111.484 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 23.5 m120 -109.39 -14.27 14.46 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-O 121.946 0.879 . . . . 0.0 109.018 178.767 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.592 ' O ' ' CG2' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -71.06 98.41 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.581 0 CA-C-N 113.935 -1.484 . . . . 0.0 110.922 -179.285 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.778 HG23 ' HB3' ' A' ' 50' ' ' ALA . 0.5 OUTLIER -34.39 -60.62 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 114.96 -1.018 . . . . 0.0 112.058 -179.432 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.601 ' N ' HG12 ' A' ' 33' ' ' VAL . 19.7 m -159.81 149.36 18.12 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.454 -179.434 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.0 114.62 24.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.763 179.506 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.84 ' CG2' HD11 ' A' ' 48' ' ' LEU . 26.7 t -90.29 124.64 43.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.686 179.712 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 1.009 HG23 HG12 ' A' ' 45' ' ' ILE . 31.2 mt -123.12 108.33 21.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.138 -0.483 . . . . 0.0 112.033 -179.35 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.474 ' SG ' ' HG ' ' A' ' 143' ' ' LEU . 0.8 OUTLIER -78.81 99.73 6.84 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 177.984 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.436 HG22 ' CG2' ' A' ' 144' ' ' VAL . 9.6 t -87.34 -28.65 22.1 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 -178.007 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.749 HG21 ' H ' ' A' ' 142' ' ' SER . 66.0 p -58.72 -18.27 29.96 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.678 0.275 . . . . 0.0 111.655 -179.552 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 90.88 71.46 1.22 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.554 -0.831 . . . . 0.0 112.555 179.735 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -142.99 -48.08 0.32 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.69 0.281 . . . . 0.0 111.151 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.41 ' O ' ' HB2' ' A' ' 38' ' ' CYS . 14.8 mt -134.53 138.05 29.13 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.04 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.485 ' HD2' ' CZ ' ' A' ' 76' ' ' TYR . 33.4 Cg_exo -58.46 146.69 89.43 Favored 'Trans proline' 0 N--CA 1.465 -0.186 0 C-N-CA 122.445 2.097 . . . . 0.0 111.5 179.53 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 1.009 HG12 HG23 ' A' ' 37' ' ' ILE . 45.6 mt -45.46 129.93 2.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 112.376 0.51 . . . . 0.0 112.376 -179.096 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 6.3 tpt180 -120.31 130.61 54.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.646 178.949 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 8.7 p30 -105.83 122.27 45.76 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.346 0.499 . . . . 0.0 112.346 -178.798 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.84 HD11 ' CG2' ' A' ' 36' ' ' VAL . 0.3 OUTLIER -97.52 133.63 41.84 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 178.384 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.519 ' HB3' HG12 ' A' ' 32' ' ' ILE . 0.0 OUTLIER -134.27 164.44 27.39 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 113.67 0.989 . . . . 0.0 113.67 -178.333 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.778 ' HB3' HG23 ' A' ' 33' ' ' VAL . . . -151.33 166.23 31.61 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 114.484 -1.234 . . . . 0.0 110.667 179.041 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -106.04 136.34 45.89 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.08 0.467 . . . . 0.0 111.29 -179.679 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 18.5 mm . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.483 -179.915 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.528 0.111 0 CA-C-O 120.853 0.359 . . . . 0.0 111.236 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.419 ' O ' ' HB3' ' A' ' 93' ' ' LEU . 22.9 ttpt -104.09 131.66 51.13 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.19 179.335 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.565 HG13 ' O ' ' A' ' 91' ' ' ILE . 5.8 t -131.1 135.92 58.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.044 0.45 . . . . 0.0 111.916 -179.036 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' TRP . . . . . 0.685 ' CG ' HD22 ' A' ' 48' ' ' LEU . 14.6 m-90 -99.7 139.85 34.76 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.692 -0.686 . . . . 0.0 111.25 178.932 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.815 HG23 ' HG3' ' A' ' 90' ' ' GLN . 12.0 m -123.57 129.07 50.63 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.541 0.686 . . . . 0.0 112.162 179.445 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.6 ' CE2' HG11 ' A' ' 36' ' ' VAL . 13.8 m-85 -100.37 118.1 35.92 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.069 -0.969 . . . . 0.0 109.104 178.077 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.614 ' HA2' ' O ' ' A' ' 85' ' ' SER . . . 159.21 -159.6 30.55 Favored Glycine 0 N--CA 1.444 -0.793 0 C-N-CA 119.287 -1.435 . . . . 0.0 112.708 179.459 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.42 ' N ' ' HA ' ' A' ' 86' ' ' ASN . 0.0 OUTLIER -76.13 92.27 3.21 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-O 122.612 1.196 . . . . 0.0 109.05 -179.402 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.462 ' C ' ' H ' ' A' ' 73' ' ' ALA . 6.0 m-80 -149.19 155.38 39.86 Favored Pre-proline 0 C--N 1.309 -1.175 0 CA-C-N 112.681 -2.054 . . . . 0.0 107.989 178.646 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.564 ' O ' ' CB ' ' A' ' 73' ' ' ALA . 25.2 Cg_exo -55.76 -7.87 1.79 Allowed 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 121.271 1.314 . . . . 0.0 111.32 177.979 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.708 ' HB2' ' HB2' ' A' ' 77' ' ' HIS . . . 132.99 52.7 0.0 OUTLIER 'General case' 0 CA--C 1.489 -1.379 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.223 178.765 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.564 ' HB3' ' HB ' ' A' ' 67' ' ' THR . 0.1 OUTLIER -52.81 -69.52 0.11 Allowed 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 105.565 -2.013 . . . . 0.0 105.565 179.499 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.612 ' HB2' ' N ' ' A' ' 67' ' ' THR . 51.3 t0 -95.32 -47.81 6.15 Favored 'General case' 0 N--CA 1.433 -1.302 0 N-CA-C 105.776 -1.935 . . . . 0.0 105.776 169.65 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.504 ' C ' ' HA ' ' A' ' 73' ' ' ALA . 9.4 t80 -144.52 142.68 30.4 Favored 'General case' 0 C--N 1.346 0.424 0 CA-C-N 112.51 -2.132 . . . . 0.0 111.354 179.66 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' HIS . . . . . 0.708 ' HB2' ' HB2' ' A' ' 73' ' ' ALA . 2.3 t60 -97.16 106.91 19.32 Favored 'General case' 0 CA--C 1.531 0.238 0 O-C-N 121.921 -0.487 . . . . 0.0 110.157 176.971 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.576 HD21 ' C ' ' A' ' 69' ' ' GLY . 0.0 OUTLIER -120.67 171.83 8.31 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 120.824 0.345 . . . . 0.0 111.692 179.749 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -55.03 -167.86 0.04 OUTLIER Glycine 0 C--N 1.333 0.405 0 CA-C-N 116.022 -0.535 . . . . 0.0 113.126 -179.499 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.459 ' C ' HD12 ' A' ' 81' ' ' ILE . 5.4 p30 -112.06 97.77 6.89 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.927 0.394 . . . . 0.0 111.768 -179.752 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.655 ' HB ' ' HB2' ' A' ' 85' ' ' SER . 3.2 mp -114.86 112.72 41.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.104 178.542 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 68.5 m -56.69 -24.16 47.05 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 -179.002 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.407 ' H ' HG22 ' A' ' 81' ' ' ILE . 3.7 mtt180 -93.47 -102.15 0.13 Allowed 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 -178.487 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.434 ' O ' ' CB ' ' A' ' 85' ' ' SER . 0.0 OUTLIER -109.02 110.83 22.21 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-O 121.52 0.676 . . . . 0.0 110.691 -179.262 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.655 ' HB2' ' HB ' ' A' ' 81' ' ' ILE . 0.6 OUTLIER 158.99 -48.39 0.0 OUTLIER 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 114.247 -1.342 . . . . 0.0 109.478 179.796 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.792 ' O ' ' N ' ' A' ' 88' ' ' HIS . 94.1 m-20 -65.34 -153.45 0.01 OUTLIER 'General case' 0 CA--C 1.521 -0.151 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 177.779 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.42 ' HB2' HD11 ' A' ' 104' ' ' ILE . 0.0 OUTLIER -47.55 76.71 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 179.105 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 1.071 ' O ' ' O ' ' A' ' 104' ' ' ILE . 36.3 t60 -101.58 -15.89 16.93 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 114.622 1.341 . . . . 0.0 114.622 -176.346 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.559 ' HA ' ' H ' ' A' ' 104' ' ' ILE . 0.1 OUTLIER -178.1 160.37 1.39 Allowed 'General case' 0 C--N 1.317 -0.848 0 C-N-CA 119.333 -0.947 . . . . 0.0 112.125 178.334 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.815 ' HG3' HG23 ' A' ' 67' ' ' THR . 14.7 mt-30 -137.45 160.82 38.03 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 113.694 0.998 . . . . 0.0 113.694 -178.031 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.732 HG12 HD11 ' A' ' 145' ' ' ILE . 2.5 mt -122.27 132.14 71.7 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 CA-C-N 115.109 -0.95 . . . . 0.0 108.998 177.981 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.773 HD13 ' ND2' ' A' ' 121' ' ' ASN . 1.9 mt -110.06 135.31 51.07 Favored 'General case' 0 N--CA 1.464 0.233 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 -178.732 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.779 HD22 ' N ' ' A' ' 94' ' ' GLY . 1.2 tm? -126.42 136.64 52.92 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.245 178.752 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.779 ' N ' HD22 ' A' ' 93' ' ' LEU . . . . . . . . 0 N--CA 1.452 -0.294 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.601 179.819 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.669 HD23 HD23 ' A' ' 93' ' ' LEU . 0.6 OUTLIER . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.569 0.224 . . . . 0.0 110.653 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.764 HD22 ' HB3' ' A' ' 121' ' ' ASN . 4.4 mt -133.66 148.62 51.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.81 -179.813 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.44 ' O ' ' N ' ' A' ' 122' ' ' GLN . 1.6 mt -113.38 130.87 56.18 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 179.529 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.684 ' CG ' HD11 ' A' ' 92' ' ' LEU . 7.4 t30 -107.18 112.56 25.5 Favored 'General case' 0 CA--C 1.51 -0.59 0 C-N-CA 119.976 -0.69 . . . . 0.0 109.776 179.863 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.758 ' HB3' HG21 ' A' ' 109' ' ' THR . 29.1 m-20 -87.4 108.94 19.23 Favored 'General case' 0 N--CA 1.442 -0.872 0 C-N-CA 119.076 -1.05 . . . . 0.0 109.789 179.691 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 1.071 ' O ' ' O ' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -126.48 109.32 20.83 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.164 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 176.854 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 70.5 m -129.38 174.66 9.42 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.868 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 28.0 m -69.76 -63.29 1.1 Allowed 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 118.98 -1.088 . . . . 0.0 110.862 -179.557 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -112.52 -33.46 6.15 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 114.253 1.205 . . . . 0.0 114.253 178.593 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -147.1 136.71 6.26 Favored Glycine 0 C--N 1.34 0.795 0 N-CA-C 116.422 1.329 . . . . 0.0 116.422 -178.339 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.758 HG21 ' HB3' ' A' ' 103' ' ' ASP . 14.8 m -121.06 137.96 54.41 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 174.738 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 110' ' ' TRP . . . . . 0.74 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 3.0 m-90 -122.36 149.25 44.04 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 113.436 0.902 . . . . 0.0 113.436 -178.517 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.459 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -122.46 112.07 17.61 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 115.182 -0.917 . . . . 0.0 108.62 177.24 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 3.7 m120 46.14 43.93 11.46 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.104 -0.498 . . . . 0.0 112.167 -179.573 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 79.91 20.92 66.89 Favored Glycine 0 N--CA 1.445 -0.76 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.93 179.153 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 13.6 mt-30 -133.82 97.79 4.0 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.039 0.447 . . . . 0.0 110.624 179.674 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.74 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.3 OUTLIER -44.92 134.17 5.89 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.843 179.856 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 15.0 m -121.25 177.25 3.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.141 0.496 . . . . 0.0 111.969 -178.876 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.433 ' HB3' ' HB3' ' A' ' 120' ' ' SER . 0.0 OUTLIER -82.83 141.13 32.51 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.676 179.799 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.401 ' O ' ' C ' ' A' ' 119' ' ' ASN . 0.0 OUTLIER -66.25 163.75 17.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.731 0.3 . . . . 0.0 110.537 179.711 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.401 ' C ' ' O ' ' A' ' 118' ' ' LYS . 0.6 OUTLIER 34.88 37.52 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.995 -179.639 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.433 ' HB3' ' HB3' ' A' ' 117' ' ' GLU . 10.1 p -111.3 105.16 13.73 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.858 -179.281 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.773 ' ND2' HD13 ' A' ' 92' ' ' LEU . 1.3 m120 -50.22 142.46 9.87 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.803 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 122' ' ' GLN . . . . . 0.575 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 30.1 mm-40 -128.75 144.15 51.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.207 0.527 . . . . 0.0 112.057 -179.662 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 16.6 tp -74.36 120.62 20.17 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.718 178.986 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.621 ' HG ' HD12 ' A' ' 99' ' ' LEU . 0.0 OUTLIER -51.73 144.65 10.67 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 122.193 0.997 . . . . 0.0 112.202 -178.857 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.442 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.6 OUTLIER -127.15 153.15 46.41 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 113.871 -1.513 . . . . 0.0 110.022 179.499 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 34.9 tp60 -70.62 113.5 7.79 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 179.647 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 68.35 28.6 73.19 Favored Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.394 -179.359 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.442 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 9.7 t70 -58.85 158.86 7.61 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.984 0.421 . . . . 0.0 111.308 -179.719 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.425 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 0.4 OUTLIER -147.12 135.71 21.96 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.565 179.871 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.669 HG21 ' OD1' ' A' ' 103' ' ' ASP . 2.0 mp -108.86 129.12 64.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.299 -0.41 . . . . 0.0 109.994 178.559 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.524 HG23 ' CG2' ' A' ' 140' ' ' ILE . 69.5 m -102.31 142.37 33.64 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.0 0.428 . . . . 0.0 110.519 -179.53 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.478 HG11 ' NE2' ' A' ' 88' ' ' HIS . 5.2 m -141.24 158.37 22.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.132 -0.485 . . . . 0.0 112.21 -178.592 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 133' ' ' GLY . . . . . 0.403 ' HA3' ' CD2' ' A' ' 84' ' ' LEU . . . 69.87 44.43 62.1 Favored Glycine 0 N--CA 1.446 -0.645 0 CA-C-N 115.911 -0.586 . . . . 0.0 112.086 179.545 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.489 ' HA ' HG12 ' A' ' 140' ' ' ILE . 81.8 t -80.18 153.1 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 CA-C-O 121.526 0.679 . . . . 0.0 112.261 -178.964 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 148.14 -44.52 0.77 Allowed Glycine 0 N--CA 1.44 -1.075 0 N-CA-C 110.374 -1.09 . . . . 0.0 110.374 -178.925 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.593 HG12 ' H ' ' A' ' 138' ' ' SER . 41.3 t -126.8 127.83 70.35 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.764 0 CA-C-N 115.103 -0.549 . . . . 0.0 109.641 178.499 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.536 ' HA ' HD12 ' A' ' 140' ' ' ILE . 3.1 tt0 -51.07 -29.61 13.47 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.789 0.328 . . . . 0.0 111.308 -179.202 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 138' ' ' SER . . . . . 0.593 ' H ' HG12 ' A' ' 136' ' ' VAL . 0.5 OUTLIER -94.31 6.48 48.56 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -179.56 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -128.77 25.61 5.64 Favored 'General case' 0 CA--C 1.519 -0.223 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 -179.402 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.536 HD12 ' HA ' ' A' ' 137' ' ' GLU . 13.4 mt -103.13 140.67 20.74 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.003 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.447 179.233 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.46 HD22 ' C ' ' A' ' 140' ' ' ILE . 3.8 mm? -124.24 134.53 53.22 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.017 -0.992 . . . . 0.0 109.798 179.196 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 142' ' ' SER . . . . . 0.749 ' H ' HG21 ' A' ' 40' ' ' THR . 0.9 OUTLIER -119.33 150.95 39.29 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.408 0.623 . . . . 0.0 112.504 -178.78 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.712 HD12 ' C ' ' A' ' 142' ' ' SER . 5.7 mp -122.77 132.99 54.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.325 179.342 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.436 ' CG2' HG22 ' A' ' 39' ' ' THR . 4.7 t -114.15 140.28 35.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 120.872 0.368 . . . . 0.0 111.426 -179.432 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.749 ' CG1' HG22 ' A' ' 36' ' ' VAL . 0.2 OUTLIER -120.66 127.68 75.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.821 179.893 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 18.6 t80 -105.08 103.78 13.39 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.54 179.786 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 2.7 mp -87.91 128.45 40.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.053 -179.776 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 25.9 p-10 -78.3 120.7 23.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.003 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -71.35 -24.67 62.14 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.957 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 4.2 mttt -57.38 -40.53 78.35 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.947 0.403 . . . . 0.0 110.595 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 19.9 t80 . . . . . 0 C--N 1.328 -0.364 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.613 179.746 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.554 ' O ' HD12 ' A' ' 52' ' ' ILE . 0.8 OUTLIER . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.716 0.293 . . . . 0.0 111.119 . . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.432 ' HA ' HD12 ' A' ' 52' ' ' ILE . 34.8 m-20 -109.17 -14.08 14.56 Favored 'General case' 0 CA--C 1.514 -0.409 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 178.405 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.558 HG12 ' HB3' ' A' ' 49' ' ' SER . 0.1 OUTLIER -71.15 108.44 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.66 0 CA-C-N 113.888 -1.505 . . . . 0.0 110.933 -179.499 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.89 HG12 ' CD2' ' A' ' 99' ' ' LEU . 2.3 t -48.21 -66.3 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.769 0 CA-C-N 115.19 -0.914 . . . . 0.0 111.364 -179.498 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 31.9 p -162.98 164.59 25.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.676 179.856 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.665 HH11 HD11 ' A' ' 37' ' ' ILE . 8.1 ttm180 -122.98 123.76 41.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.189 -179.808 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.867 ' CG2' HD11 ' A' ' 48' ' ' LEU . 3.3 t -91.58 122.13 42.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.754 179.666 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.849 HG23 HG12 ' A' ' 45' ' ' ILE . 26.7 mt -121.61 107.81 20.9 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 CA-C-N 116.263 -0.426 . . . . 0.0 112.006 -179.547 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 88.8 m -81.86 102.2 10.7 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 178.076 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.0 p -89.79 2.96 54.26 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 -178.076 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.736 HG21 ' CB ' ' A' ' 142' ' ' SER . 77.2 p -94.59 -6.78 42.75 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.038 0.384 . . . . 0.0 112.038 -179.769 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 85.91 91.58 0.88 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.606 179.88 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.519 ' HG3' HD12 ' A' ' 43' ' ' ILE . 17.4 pt20 -172.41 -45.86 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.108 0.48 . . . . 0.0 110.516 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.59 HG23 ' HD2' ' A' ' 44' ' ' PRO . 5.1 mt -131.87 140.43 38.17 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.718 179.899 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.59 ' HD2' HG23 ' A' ' 43' ' ' ILE . 74.2 Cg_endo -78.46 147.01 22.28 Favored 'Trans proline' 0 N--CA 1.462 -0.377 0 C-N-CA 122.324 2.016 . . . . 0.0 112.141 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.849 HG12 HG23 ' A' ' 37' ' ' ILE . 27.3 mt -43.12 122.21 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 121.222 0.534 . . . . 0.0 111.827 -179.493 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.438 ' HG2' ' O ' ' A' ' 75' ' ' ASP . 0.0 OUTLIER -121.49 130.21 53.41 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.099 179.463 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.461 ' HB2' HD11 ' A' ' 32' ' ' ILE . 3.8 p30 -93.14 120.11 33.07 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.06 0.457 . . . . 0.0 111.413 -179.302 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.867 HD11 ' CG2' ' A' ' 36' ' ' VAL . 0.8 OUTLIER -94.36 121.73 36.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.642 179.249 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.686 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -130.98 154.56 48.03 Favored 'General case' 0 CA--C 1.517 -0.323 0 N-CA-C 114.295 1.22 . . . . 0.0 114.295 -179.205 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.583 ' N ' HG23 ' A' ' 33' ' ' VAL . . . -133.22 166.07 23.32 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 113.587 -1.642 . . . . 0.0 110.832 178.753 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 60.6 m-20 -91.08 97.26 11.05 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.065 0.46 . . . . 0.0 111.014 -179.815 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.554 HD12 ' O ' ' A' ' 30' ' ' GLU . 4.4 mt . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.704 -179.701 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.528 0.114 0 CA-C-O 121.012 0.435 . . . . 0.0 111.058 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 7.8 ttpt -138.01 132.09 31.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.667 179.752 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.665 HG13 ' O ' ' A' ' 91' ' ' ILE . 21.5 t -135.35 138.82 47.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.14 0.495 . . . . 0.0 111.707 -179.407 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' TRP . . . . . 0.656 ' HB2' ' HB ' ' A' ' 91' ' ' ILE . 14.7 m-90 -99.91 139.95 34.83 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.6 179.297 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.641 HG23 ' HG2' ' A' ' 90' ' ' GLN . 30.5 m -131.39 131.85 43.95 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.53 0.681 . . . . 0.0 112.162 179.744 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.609 ' HE1' HD12 ' A' ' 91' ' ' ILE . 7.3 m-85 -103.24 119.06 38.16 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 114.897 -1.047 . . . . 0.0 109.086 177.873 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.713 ' HA2' HD21 ' A' ' 78' ' ' LEU . . . 158.7 -155.96 26.99 Favored Glycine 0 CA--C 1.503 -0.706 0 C-N-CA 118.832 -1.652 . . . . 0.0 113.098 179.389 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.42 ' HG3' ' O ' ' A' ' 70' ' ' ARG . 3.1 ptm180 -76.37 91.77 3.3 Favored 'General case' 0 N--CA 1.441 -0.888 0 CA-C-O 122.587 1.184 . . . . 0.0 108.747 -179.614 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.442 ' C ' ' H ' ' A' ' 73' ' ' ALA . 13.1 m120 -149.98 154.53 37.09 Favored Pre-proline 0 C--N 1.308 -1.218 0 CA-C-N 112.857 -1.974 . . . . 0.0 108.337 178.758 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.548 ' O ' ' CB ' ' A' ' 73' ' ' ALA . 21.8 Cg_exo -57.18 -8.25 3.35 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 121.115 1.21 . . . . 0.0 110.934 177.679 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.729 ' HB2' ' HB2' ' A' ' 77' ' ' HIS . . . 135.04 53.45 0.0 OUTLIER 'General case' 0 CA--C 1.489 -1.402 0 CA-C-N 114.901 -1.045 . . . . 0.0 109.08 179.041 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.525 ' HB3' ' HB ' ' A' ' 67' ' ' THR . 0.1 OUTLIER -52.28 -69.6 0.11 Allowed 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 105.599 -2.0 . . . . 0.0 105.599 179.708 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.474 ' N ' ' O ' ' A' ' 67' ' ' THR . 4.9 t70 -95.45 -47.87 6.09 Favored 'General case' 0 N--CA 1.436 -1.174 0 N-CA-C 105.426 -2.064 . . . . 0.0 105.426 169.085 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.519 ' C ' ' HA ' ' A' ' 73' ' ' ALA . 73.3 t80 -143.26 142.1 31.26 Favored 'General case' 0 C--N 1.347 0.493 0 CA-C-N 112.512 -2.131 . . . . 0.0 111.334 179.825 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' HIS . . . . . 0.729 ' HB2' ' HB2' ' A' ' 73' ' ' ALA . 1.9 t60 -91.78 110.23 21.57 Favored 'General case' 0 C--N 1.33 -0.247 0 O-C-N 122.027 -0.421 . . . . 0.0 110.013 177.327 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.845 HD11 ' O ' ' A' ' 85' ' ' SER . 1.1 pp -129.57 174.6 9.51 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.969 0.414 . . . . 0.0 111.494 -179.642 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.424 ' O ' HD12 ' A' ' 78' ' ' LEU . . . -58.6 175.33 2.63 Favored Glycine 0 C--N 1.333 0.41 0 C-N-CA 120.939 -0.648 . . . . 0.0 112.311 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 15.5 p-10 -112.04 99.28 7.95 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.902 0.382 . . . . 0.0 111.847 -179.628 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.719 ' HB ' ' HB2' ' A' ' 85' ' ' SER . 16.5 mm -113.91 118.39 58.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.036 178.45 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -53.46 -24.03 11.76 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 111.807 0.299 . . . . 0.0 111.807 -179.056 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.545 ' C ' HD13 ' A' ' 84' ' ' LEU . 6.2 mpt_? -86.72 -106.85 0.06 Allowed 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 121.222 -0.191 . . . . 0.0 111.378 -179.661 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.812 HD22 ' H ' ' A' ' 84' ' ' LEU . 0.0 OUTLIER -109.36 110.22 21.31 Favored 'General case' 0 CA--C 1.512 -0.482 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 179.036 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.845 ' O ' HD11 ' A' ' 78' ' ' LEU . 0.4 OUTLIER 162.25 -40.66 0.0 OUTLIER 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 114.709 -1.132 . . . . 0.0 109.427 -179.525 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.802 ' O ' ' N ' ' A' ' 88' ' ' HIS . 95.1 m-20 -64.25 -153.81 0.01 OUTLIER 'General case' 0 CA--C 1.52 -0.191 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 177.597 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.858 ' HB2' HD11 ' A' ' 104' ' ' ILE . 0.0 OUTLIER -54.05 71.28 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 178.313 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.964 ' O ' ' O ' ' A' ' 104' ' ' ILE . 36.2 t60 -80.82 -17.6 50.28 Favored 'General case' 0 CA--C 1.514 -0.412 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 -176.789 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.605 ' HA ' ' H ' ' A' ' 104' ' ' ILE . 0.0 OUTLIER -174.57 156.3 2.38 Favored 'General case' 0 C--N 1.31 -1.111 0 C-N-CA 119.23 -0.988 . . . . 0.0 112.981 178.024 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.641 ' HG2' HG23 ' A' ' 67' ' ' THR . 36.6 mt-30 -138.1 161.02 37.86 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.502 -1.226 . . . . 0.0 113.958 -177.829 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.759 HD13 ' CD1' ' A' ' 48' ' ' LEU . 6.2 mt -127.84 126.6 67.01 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-N 115.006 -0.997 . . . . 0.0 109.13 178.037 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.85 HD12 ' N ' ' A' ' 93' ' ' LEU . 0.3 OUTLIER -107.4 142.41 37.28 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.961 0.41 . . . . 0.0 111.974 -178.781 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.85 ' N ' HD12 ' A' ' 92' ' ' LEU . 0.5 OUTLIER -125.78 125.41 42.9 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.693 179.356 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.382 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.59 179.923 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.948 HD13 HD22 ' A' ' 124' ' ' LEU . 2.3 mp . . . . . 0 CA--C 1.528 0.122 0 CA-C-O 120.765 0.317 . . . . 0.0 110.761 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.613 ' HA ' ' O ' ' A' ' 122' ' ' GLN . 0.8 OUTLIER -132.47 147.96 52.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.107 179.987 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.512 HD21 HD12 ' A' ' 124' ' ' LEU . 1.0 OUTLIER -116.04 126.28 53.57 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 120.623 -0.431 . . . . 0.0 110.363 -179.81 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.497 ' O ' ' O ' ' A' ' 90' ' ' GLN . 33.5 t30 -111.57 111.47 22.49 Favored 'General case' 0 CA--C 1.51 -0.58 0 C-N-CA 119.988 -0.685 . . . . 0.0 109.448 179.539 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.692 ' HB3' HG21 ' A' ' 109' ' ' THR . 74.4 m-20 -83.37 111.5 19.06 Favored 'General case' 0 N--CA 1.442 -0.857 0 C-N-CA 119.623 -0.831 . . . . 0.0 109.603 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.964 ' O ' ' O ' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -123.35 107.95 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.969 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 177.533 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.417 ' HG ' ' CE1' ' A' ' 88' ' ' HIS . 63.7 m -132.17 171.12 14.06 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 115.05 -0.977 . . . . 0.0 109.331 179.778 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 25.1 m -69.52 -63.36 1.08 Allowed 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 119.143 -1.023 . . . . 0.0 111.541 -179.157 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -112.5 -32.75 6.37 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 114.63 1.345 . . . . 0.0 114.63 179.015 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -146.04 128.16 2.99 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 116.988 1.555 . . . . 0.0 116.988 -177.814 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.692 HG21 ' HB3' ' A' ' 103' ' ' ASP . 3.4 m -121.1 138.29 54.26 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 174.483 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 110' ' ' TRP . . . . . 0.685 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.3 m-90 -119.35 149.24 42.15 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 -178.535 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.459 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -120.9 112.08 18.33 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 115.177 -0.92 . . . . 0.0 108.691 177.483 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 39.7 m-20 45.24 43.29 7.93 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.074 -0.512 . . . . 0.0 112.24 -179.522 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 80.35 23.37 60.94 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.947 179.13 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 42.3 mt-30 -135.61 99.07 4.1 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.017 0.437 . . . . 0.0 110.861 179.647 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.685 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.0 OUTLIER -43.98 123.64 3.41 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.08 179.87 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.495 HG21 ' OD2' ' A' ' 103' ' ' ASP . 5.4 m -114.92 -179.74 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.7 -179.218 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -87.29 140.13 29.85 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.824 -0.626 . . . . 0.0 111.011 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.432 ' HG3' ' HA ' ' A' ' 104' ' ' ILE . 54.2 tttm -63.63 162.69 12.58 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.25 179.518 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.427 ' N ' ' HG2' ' A' ' 118' ' ' LYS . 4.9 p-10 34.85 38.87 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.228 0.537 . . . . 0.0 111.372 -179.865 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 6.9 p -111.04 108.71 18.52 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.973 -179.533 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.461 ' CG ' HD23 ' A' ' 92' ' ' LEU . 81.1 m-20 -54.91 144.66 22.21 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.633 179.882 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 122' ' ' GLN . . . . . 0.613 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 65.8 mm-40 -129.88 149.39 51.63 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.04 0.448 . . . . 0.0 112.084 -179.346 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.636 HD23 ' O ' ' A' ' 124' ' ' LEU . 9.8 tt -77.27 120.5 22.4 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.357 178.849 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.948 HD22 HD13 ' A' ' 99' ' ' LEU . 8.2 tp -46.39 141.98 3.26 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 122.06 0.933 . . . . 0.0 112.022 -178.549 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.43 ' O ' HD11 ' A' ' 147' ' ' ILE . 0.0 OUTLIER -127.29 152.85 46.89 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 113.811 -1.541 . . . . 0.0 110.215 179.567 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 4.7 tp-100 -71.79 113.67 9.07 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 179.301 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 64.87 31.58 81.39 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.323 -179.351 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.402 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 8.4 t70 -54.9 160.13 2.07 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.978 0.418 . . . . 0.0 111.207 -179.758 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.529 ' HG3' HG22 ' A' ' 144' ' ' VAL . 13.8 tt0 -146.48 135.35 22.39 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.642 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.437 HG21 ' OD1' ' A' ' 103' ' ' ASP . 1.1 mp -112.94 128.47 69.66 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.121 0 CA-C-N 116.363 -0.38 . . . . 0.0 109.986 178.987 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.611 HG23 ' CG2' ' A' ' 140' ' ' ILE . 16.0 m -103.16 144.77 30.88 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.478 -179.748 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.474 ' HB ' ' NE2' ' A' ' 88' ' ' HIS . 5.4 m -141.37 158.16 22.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 112.581 0.586 . . . . 0.0 112.581 -178.715 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 67.04 42.81 92.06 Favored Glycine 0 N--CA 1.449 -0.494 0 CA-C-N 115.595 -0.729 . . . . 0.0 112.312 179.253 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.546 ' HA ' HG12 ' A' ' 140' ' ' ILE . 89.8 t -76.79 153.3 5.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-O 121.479 0.656 . . . . 0.0 112.268 -179.176 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 148.65 -42.03 0.85 Allowed Glycine 0 N--CA 1.441 -0.99 0 CA-C-N 114.888 -1.051 . . . . 0.0 110.655 -178.996 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.548 HG12 ' H ' ' A' ' 138' ' ' SER . 47.6 t -126.62 131.4 71.28 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 CA-C-N 115.172 -0.514 . . . . 0.0 109.743 178.698 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -51.3 -34.61 34.01 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.737 0.303 . . . . 0.0 111.445 -179.229 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 138' ' ' SER . . . . . 0.548 ' H ' HG12 ' A' ' 136' ' ' VAL . 0.7 OUTLIER -94.17 6.32 48.96 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 112.343 0.497 . . . . 0.0 112.343 -179.288 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 139' ' ' ASP . . . . . 0.405 ' CB ' ' HB ' ' A' ' 136' ' ' VAL . 10.1 t70 -125.65 26.72 6.64 Favored 'General case' 0 CA--C 1.518 -0.252 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 -179.367 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.611 ' CG2' HG23 ' A' ' 131' ' ' THR . 14.9 mt -105.5 140.81 22.4 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.967 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.267 179.069 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.439 HD23 ' OE1' ' A' ' 42' ' ' GLN . 1.0 OUTLIER -117.73 130.01 56.06 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.901 179.327 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 142' ' ' SER . . . . . 0.736 ' CB ' HG21 ' A' ' 40' ' ' THR . 0.8 OUTLIER -116.37 139.06 50.81 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.417 0.627 . . . . 0.0 112.397 -178.845 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.545 HD12 ' N ' ' A' ' 143' ' ' LEU . 4.8 mp -118.25 138.98 51.98 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.14 -0.937 . . . . 0.0 109.331 179.083 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.529 HG22 ' HG3' ' A' ' 129' ' ' GLU . 21.7 t -123.41 140.5 46.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 120.809 0.338 . . . . 0.0 111.816 -179.034 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.604 HG13 HG13 ' A' ' 36' ' ' VAL . 0.1 OUTLIER -113.63 126.7 71.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.554 179.657 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 80.0 t80 -111.27 123.78 50.89 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.948 -179.846 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.809 HG12 HD21 ' A' ' 124' ' ' LEU . 2.8 mp -106.27 132.24 53.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.111 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 148' ' ' ASN . . . . . 0.456 ' ND2' HG22 ' A' ' 32' ' ' ILE . 8.9 p30 -81.65 141.7 33.41 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.104 -179.795 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -73.93 -19.45 60.68 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.375 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 12.7 mptt -58.19 -44.83 88.28 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.958 0.408 . . . . 0.0 110.815 -179.835 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 151' ' ' PHE . . . . . 0.459 ' CE2' HD11 ' A' ' 52' ' ' ILE . 14.0 t80 . . . . . 0 C--N 1.328 -0.355 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.886 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.377 0 N-CA-C 112.582 -0.207 . . . . 0.0 112.582 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 -106.65 -39.61 5.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.785 0.326 . . . . 0.0 110.803 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -88.71 -174.17 4.43 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.775 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 11.5 mt -118.07 137.11 53.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.139 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.6 t -166.45 134.75 2.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.112 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 59.52 69.91 1.2 Allowed Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.925 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -72.18 139.93 33.27 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.568 2.179 . . . . 0.0 112.298 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 41.1 p -97.59 162.64 13.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.202 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.53 113.33 2.62 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.856 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -146.19 -73.7 0.22 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.854 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.8 p -142.32 131.61 23.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.903 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 6.8 m -117.84 138.8 51.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.078 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -170.6 147.8 2.94 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.915 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -133.62 31.99 3.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.057 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.75 -65.96 0.97 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.149 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 21.8 mm-40 -63.01 -35.68 81.04 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.925 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 8.1 tmm_? -64.62 -36.65 84.92 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.922 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 15.6 t80 -60.8 -42.17 97.1 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.86 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 57.0 mt -60.2 -39.4 86.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.011 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 43.1 mm -65.32 -40.76 89.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.177 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -57.64 -43.58 84.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.086 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 2.0 ttpt -64.35 -37.57 87.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.999 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -60.98 -47.57 85.83 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.19 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 31.2 t -71.19 -28.69 64.41 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.016 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.36 95.22 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.984 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -81.4 124.09 29.12 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.833 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 41.9 mt-30 -101.36 142.65 32.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.995 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.7 mm -82.47 139.35 17.98 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.333 0 CA-C-O 121.512 0.672 . . . . 0.0 111.427 179.812 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -123.9 67.11 0.5 Allowed Glycine 0 C--N 1.318 -0.427 0 CA-C-N 114.907 -1.042 . . . . 0.0 112.72 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.611 ' O ' HD11 ' A' ' 52' ' ' ILE . 0.7 OUTLIER -88.96 -23.79 22.58 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.742 0.305 . . . . 0.0 111.071 179.855 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 13.8 m-20 -109.15 -13.42 14.68 Favored 'General case' 0 CA--C 1.514 -0.422 0 CA-C-O 121.983 0.897 . . . . 0.0 108.742 178.631 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.58 ' O ' ' CG2' ' A' ' 32' ' ' ILE . 0.1 OUTLIER -70.23 97.32 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.577 0 CA-C-N 114.0 -1.455 . . . . 0.0 110.731 -179.317 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.857 HG23 ' HB3' ' A' ' 50' ' ' ALA . 0.9 OUTLIER -36.99 -61.94 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 114.839 -1.073 . . . . 0.0 112.169 -179.245 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.765 ' SG ' HD12 ' A' ' 48' ' ' LEU . 28.0 p -163.9 164.85 23.23 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.116 0.484 . . . . 0.0 112.027 -179.621 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 4.1 ttm180 -122.45 127.46 49.65 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.634 179.804 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.623 HG11 ' HZ ' ' A' ' 68' ' ' PHE . 11.7 p -99.29 128.62 50.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.271 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.829 HG23 HG12 ' A' ' 45' ' ' ILE . 25.0 mt -127.08 108.31 18.44 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.601 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.735 ' SG ' HD23 ' A' ' 143' ' ' LEU . 0.1 OUTLIER -86.43 100.2 12.18 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 178.617 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.404 HG23 ' N ' ' A' ' 40' ' ' THR . 8.9 t -65.55 -40.66 93.12 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.416 0.524 . . . . 0.0 112.416 -178.637 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.404 ' N ' HG23 ' A' ' 39' ' ' THR . 0.2 OUTLIER -55.75 -33.97 64.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.867 0.365 . . . . 0.0 111.172 -179.345 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 114.36 0.21 23.6 Favored Glycine 0 CA--C 1.518 0.222 0 C-N-CA 120.553 -0.832 . . . . 0.0 113.575 179.217 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.76 ' HB3' HD12 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -61.39 -45.63 93.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.066 0.46 . . . . 0.0 110.86 179.904 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.76 HD12 ' HB3' ' A' ' 42' ' ' GLN . 4.3 mp -131.04 141.54 42.33 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.1 -179.644 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.628 ' HD2' HG23 ' A' ' 43' ' ' ILE . 96.3 Cg_endo -81.12 147.08 16.28 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 122.512 2.141 . . . . 0.0 111.591 179.451 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.829 HG12 HG23 ' A' ' 37' ' ' ILE . 40.4 mt -42.19 109.59 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.034 0.445 . . . . 0.0 111.78 -179.473 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.401 ' O ' HG12 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -115.01 132.34 56.63 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.843 179.513 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.4 ' HB3' ' CD1' ' A' ' 32' ' ' ILE . 3.7 m-20 -85.99 119.6 26.46 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.108 0.48 . . . . 0.0 111.609 -179.276 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.765 HD12 ' SG ' ' A' ' 34' ' ' CYS . 2.9 mt -96.43 125.85 41.22 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 178.615 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.527 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -132.64 161.86 32.85 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 113.874 1.064 . . . . 0.0 113.874 -178.045 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.857 ' HB3' HG23 ' A' ' 33' ' ' VAL . . . -151.52 164.98 35.62 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.02 -1.445 . . . . 0.0 110.806 178.867 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.436 ' CB ' ' HG3' ' A' ' 54' ' ' GLN . 0.5 OUTLIER -87.41 123.87 32.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.957 0.408 . . . . 0.0 111.325 -179.547 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.611 HD11 ' O ' ' A' ' 30' ' ' GLU . 18.0 mt -63.75 -36.88 78.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.338 179.751 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -56.18 -34.16 65.96 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.838 -179.267 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.436 ' HG3' ' CB ' ' A' ' 51' ' ' ASP . 0.7 OUTLIER -63.45 -37.15 86.19 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.564 179.974 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.648 HG11 HD21 ' A' ' 155' ' ' LEU . 13.7 t -66.92 -38.01 80.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.097 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.7 mp -61.5 -41.29 97.07 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.886 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.09 -43.76 18.99 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.713 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 57.14 164.91 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.227 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 2.5 tmtp? 65.47 -72.92 0.07 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.316 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.52 -41.38 93.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.383 -179.592 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.408 ' O ' ' HB ' ' A' ' 62' ' ' ILE . 4.7 m -124.54 99.34 6.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.242 -179.556 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.631 ' O ' HG23 ' A' ' 62' ' ' ILE . 8.7 tp 178.26 61.89 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.063 179.776 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 52.3 mttt -144.53 89.29 1.99 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.579 -179.709 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 4.9 ttpt -140.36 131.37 26.2 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.262 179.228 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.647 HG13 ' O ' ' A' ' 91' ' ' ILE . 18.4 t -137.46 137.95 45.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.174 0.511 . . . . 0.0 112.232 -178.752 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' TRP . . . . . 0.683 ' HB2' ' HB ' ' A' ' 91' ' ' ILE . 14.5 m-90 -99.78 140.48 33.93 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.372 178.719 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.627 HG23 ' HG2' ' A' ' 90' ' ' GLN . 33.6 m -128.44 137.18 51.71 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.554 0.692 . . . . 0.0 112.084 179.237 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.623 ' HZ ' HG11 ' A' ' 36' ' ' VAL . 13.0 m-85 -109.07 119.01 38.26 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.124 -0.944 . . . . 0.0 109.203 178.222 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.648 ' HA2' ' O ' ' A' ' 85' ' ' SER . . . 156.82 -152.81 24.16 Favored Glycine 0 CA--C 1.503 -0.66 0 C-N-CA 118.71 -1.71 . . . . 0.0 113.412 179.16 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.462 ' CG ' ' HA ' ' A' ' 80' ' ' ASN . 62.1 mtp180 -75.06 91.44 2.55 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-O 122.513 1.149 . . . . 0.0 108.615 -179.629 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -150.54 159.27 34.87 Favored Pre-proline 0 C--N 1.309 -1.183 0 CA-C-N 112.744 -2.026 . . . . 0.0 108.153 179.004 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.553 ' O ' ' HB2' ' A' ' 77' ' ' HIS . 34.7 Cg_endo -66.04 -7.08 15.98 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 120.79 0.993 . . . . 0.0 110.683 177.689 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.751 ' HB2' ' HB2' ' A' ' 77' ' ' HIS . . . 136.91 54.22 0.0 OUTLIER 'General case' 0 CA--C 1.488 -1.41 0 CA-C-N 114.338 -1.301 . . . . 0.0 108.887 178.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.528 ' HB3' ' HB ' ' A' ' 67' ' ' THR . 0.1 OUTLIER -52.46 -69.9 0.1 Allowed 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 105.58 -2.007 . . . . 0.0 105.58 179.826 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.592 ' HB2' ' N ' ' A' ' 67' ' ' THR . 62.0 t0 -96.04 -47.18 6.2 Favored 'General case' 0 N--CA 1.437 -1.103 0 N-CA-C 105.383 -2.08 . . . . 0.0 105.383 168.895 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.505 ' CE2' ' HB3' ' A' ' 78' ' ' LEU . 57.2 t80 -142.75 142.22 31.9 Favored 'General case' 0 C--N 1.35 0.599 0 CA-C-N 112.767 -2.015 . . . . 0.0 111.347 179.565 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.751 ' HB2' ' HB2' ' A' ' 73' ' ' ALA . 1.6 t60 -93.11 112.54 24.52 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 177.194 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.796 HD11 ' O ' ' A' ' 85' ' ' SER . 1.4 pp -129.02 173.5 10.38 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.03 0.443 . . . . 0.0 111.525 -179.524 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.562 ' O ' HD12 ' A' ' 78' ' ' LEU . . . -60.53 178.7 3.04 Favored Glycine 0 C--N 1.333 0.376 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.465 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.462 ' HA ' ' CG ' ' A' ' 70' ' ' ARG . 2.6 p-10 -111.84 99.39 8.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.848 0.356 . . . . 0.0 111.487 -179.762 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.596 ' HB ' ' HB2' ' A' ' 85' ' ' SER . 0.5 OUTLIER -114.83 121.27 66.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.163 -0.471 . . . . 0.0 109.835 178.871 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.4 t -53.81 -24.54 15.76 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -178.15 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.425 ' H ' HG23 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -89.94 -103.72 0.09 Allowed 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -179.071 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.431 ' O ' ' CB ' ' A' ' 85' ' ' SER . 0.0 OUTLIER -109.0 113.56 26.55 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-O 121.336 0.589 . . . . 0.0 109.432 179.681 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.796 ' O ' HD11 ' A' ' 78' ' ' LEU . 0.4 OUTLIER 162.02 -48.98 0.0 OUTLIER 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 114.769 -1.105 . . . . 0.0 109.317 -179.276 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.907 ' O ' ' N ' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -59.79 -162.84 0.01 OUTLIER 'General case' 0 CA--C 1.513 -0.465 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 177.717 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.69 ' HB3' HD11 ' A' ' 104' ' ' ILE . 13.3 mtmt -44.99 71.08 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 178.547 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 1.013 ' O ' ' O ' ' A' ' 104' ' ' ILE . 39.6 t60 -86.87 -15.92 37.62 Favored 'General case' 0 CA--C 1.513 -0.459 0 N-CA-C 113.956 1.095 . . . . 0.0 113.956 -176.466 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.592 ' HA ' ' H ' ' A' ' 104' ' ' ILE . 0.0 OUTLIER -175.97 159.53 2.19 Favored 'General case' 0 C--N 1.311 -1.07 0 C-N-CA 119.165 -1.014 . . . . 0.0 112.8 178.145 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.627 ' HG2' HG23 ' A' ' 67' ' ' THR . 42.3 mt-30 -138.73 160.23 40.16 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 113.734 1.013 . . . . 0.0 113.734 -178.336 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.683 ' HB ' ' HB2' ' A' ' 66' ' ' TRP . 4.8 mt -125.08 129.21 73.34 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.019 177.825 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.807 HD12 ' N ' ' A' ' 93' ' ' LEU . 0.3 OUTLIER -109.43 140.17 43.49 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.115 0.483 . . . . 0.0 111.82 -179.203 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.807 ' N ' HD12 ' A' ' 92' ' ' LEU . 6.6 tp -120.16 128.25 53.24 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.409 179.231 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.499 ' HA2' HD11 ' A' ' 62' ' ' ILE . . . 146.85 -155.17 26.41 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.55 179.74 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 63.18 78.85 0.28 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.879 0.371 . . . . 0.0 110.743 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 2.4 t70 69.01 17.82 8.52 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.331 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 93.58 -26.98 13.33 Favored Glycine 0 C--N 1.331 0.28 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.846 179.683 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -56.74 178.33 0.06 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.844 0.354 . . . . 0.0 111.107 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.611 ' O ' HD12 ' A' ' 100' ' ' LEU . 6.3 mp -116.97 148.91 41.01 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.826 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.718 HD23 ' HB3' ' A' ' 121' ' ' ASN . 2.5 mp -133.47 148.86 51.75 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.487 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.472 ' O ' ' N ' ' A' ' 122' ' ' GLN . 9.5 mp -112.66 129.02 56.54 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.503 ' O ' ' O ' ' A' ' 90' ' ' GLN . 28.7 t30 -110.39 111.94 23.55 Favored 'General case' 0 CA--C 1.508 -0.638 0 C-N-CA 119.735 -0.786 . . . . 0.0 109.838 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.773 ' HB3' HG21 ' A' ' 109' ' ' THR . 88.5 m-20 -84.04 111.22 19.1 Favored 'General case' 0 N--CA 1.439 -0.99 0 C-N-CA 119.572 -0.851 . . . . 0.0 109.564 179.755 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 1.013 ' O ' ' O ' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -123.07 107.9 20.17 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.968 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 177.22 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.435 ' HB3' ' CE1' ' A' ' 88' ' ' HIS . 50.8 m -135.23 167.32 21.22 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.485 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 18.4 m -69.5 -63.26 1.1 Allowed 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 119.109 -1.036 . . . . 0.0 111.749 -178.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -112.45 -32.64 6.42 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 115.065 1.506 . . . . 0.0 115.065 179.433 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -146.05 128.66 3.13 Favored Glycine 0 C--N 1.34 0.788 0 N-CA-C 117.216 1.646 . . . . 0.0 117.216 -177.692 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.773 HG21 ' HB3' ' A' ' 103' ' ' ASP . 6.1 m -121.35 138.14 54.39 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 174.353 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 0.74 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.8 m-90 -121.27 149.04 43.49 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 113.466 0.913 . . . . 0.0 113.466 -178.47 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.48 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -123.24 112.27 17.45 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 114.98 -1.009 . . . . 0.0 108.709 177.479 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ASN . . . . . 0.402 ' N ' HD12 ' A' ' 111' ' ' LEU . 71.5 m-20 45.42 43.88 9.01 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.104 -0.498 . . . . 0.0 112.061 -179.601 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 79.19 23.67 62.9 Favored Glycine 0 N--CA 1.444 -0.82 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.699 179.298 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 7.8 mt-30 -136.19 96.41 3.38 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.038 0.447 . . . . 0.0 110.828 179.69 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.74 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.0 OUTLIER -44.84 136.2 4.7 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.812 179.762 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.452 HG21 ' OD2' ' A' ' 103' ' ' ASP . 3.2 m -127.4 -179.89 3.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 121.023 0.44 . . . . 0.0 112.043 -178.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -83.51 142.36 30.96 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.439 -179.669 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.413 ' O ' ' C ' ' A' ' 119' ' ' ASN . 82.3 tttt -64.86 164.88 11.6 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.108 179.362 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.413 ' C ' ' O ' ' A' ' 118' ' ' LYS . 21.0 m-80 33.9 39.54 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 121.209 0.528 . . . . 0.0 111.193 -179.446 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 2.5 p -110.91 106.29 15.37 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.989 -179.489 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.718 ' HB3' HD23 ' A' ' 100' ' ' LEU . 72.9 m-20 -57.7 144.18 38.95 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.506 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' GLN . . . . . 0.667 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 76.9 mm-40 -129.39 149.27 51.24 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-O 121.063 0.458 . . . . 0.0 112.003 -179.473 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 62.9 tp -72.92 124.38 25.31 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.71 179.104 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.702 HD21 HG12 ' A' ' 147' ' ' ILE . 4.9 tp -50.73 141.48 12.88 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-O 122.026 0.917 . . . . 0.0 111.78 -178.88 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.617 ' O ' HD11 ' A' ' 147' ' ' ILE . 0.0 OUTLIER -127.14 153.06 46.51 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 113.836 -1.529 . . . . 0.0 109.936 179.421 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 1.8 mm100 -71.14 113.64 8.38 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 179.566 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 64.84 30.96 79.37 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.516 -179.481 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.411 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 27.0 t70 -55.71 159.53 2.98 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 120.906 0.384 . . . . 0.0 111.109 -179.763 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.656 ' HG3' HG22 ' A' ' 144' ' ' VAL . 13.0 tt0 -146.49 135.6 22.61 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.699 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.665 ' O ' HD12 ' A' ' 143' ' ' LEU . 8.2 mm -114.23 128.72 71.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 116.145 -0.48 . . . . 0.0 109.915 178.644 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.461 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 88.9 m -103.43 145.2 30.35 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.873 -179.431 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.513 HG11 ' CD2' ' A' ' 88' ' ' HIS . 6.0 m -141.2 158.38 22.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 -179.193 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' GLY . . . . . 0.429 ' CA ' HD13 ' A' ' 84' ' ' LEU . . . 69.49 44.23 65.39 Favored Glycine 0 N--CA 1.447 -0.595 0 CA-C-N 115.897 -0.592 . . . . 0.0 112.287 179.583 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.486 ' HA ' HG12 ' A' ' 140' ' ' ILE . 90.5 t -79.72 155.46 4.62 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.569 0 CA-C-O 121.373 0.606 . . . . 0.0 112.236 -179.166 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.43 ' N ' HG12 ' A' ' 134' ' ' VAL . . . 145.62 -46.5 0.77 Allowed Glycine 0 N--CA 1.441 -1.0 0 CA-C-N 114.908 -1.042 . . . . 0.0 110.571 -179.01 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.657 HG12 ' H ' ' A' ' 138' ' ' SER . 45.7 t -126.81 128.56 71.01 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 CA-C-N 115.241 -0.48 . . . . 0.0 109.795 178.54 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.488 ' HA ' HD12 ' A' ' 140' ' ' ILE . 7.3 mt-10 -51.06 -26.52 6.43 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.692 0.282 . . . . 0.0 111.376 -179.294 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' SER . . . . . 0.657 ' H ' HG12 ' A' ' 136' ' ' VAL . 0.1 OUTLIER -94.66 6.05 50.05 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 -179.268 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -131.29 23.4 4.82 Favored 'General case' 0 CA--C 1.523 -0.093 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 -179.449 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.603 ' C ' HD22 ' A' ' 141' ' ' LEU . 23.6 mt -97.65 141.16 16.37 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.249 179.06 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.603 HD22 ' C ' ' A' ' 140' ' ' ILE . 3.8 mm? -119.21 135.54 54.63 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 114.821 -1.081 . . . . 0.0 109.793 179.514 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 46.3 t -116.46 151.73 35.46 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.749 0.785 . . . . 0.0 113.011 -178.529 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.735 HD23 ' SG ' ' A' ' 38' ' ' CYS . 0.9 OUTLIER -134.0 132.24 39.87 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 114.554 -1.203 . . . . 0.0 109.679 179.2 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.656 HG22 ' HG3' ' A' ' 129' ' ' GLU . 25.1 t -128.11 140.46 49.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.914 0.387 . . . . 0.0 111.518 -178.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.483 HD11 HD11 ' A' ' 91' ' ' ILE . 0.0 OUTLIER -117.3 124.99 73.72 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.763 179.795 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 49.3 t80 -106.62 105.69 15.84 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.393 179.622 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.702 HG12 HD21 ' A' ' 124' ' ' LEU . 1.3 mp -84.97 133.39 29.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.483 -179.478 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -79.9 113.93 18.43 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.835 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -58.59 -21.03 52.0 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.256 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 32.1 mtmm -57.49 -42.67 83.16 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.957 0.408 . . . . 0.0 110.638 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -60.4 -44.31 95.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.75 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 1.3 mttt -64.26 -36.0 82.68 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.809 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 5.5 tt0 -63.28 -37.91 89.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.852 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 10.9 t -63.92 -45.26 90.07 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.939 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.648 HD21 HG11 ' A' ' 55' ' ' VAL . 0.8 OUTLIER -58.87 -39.65 82.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.892 179.975 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -65.2 -41.0 94.92 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.833 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -66.41 -22.45 66.23 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.147 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -116.0 63.09 0.7 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.854 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.26 161.71 30.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.97 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 11.5 m -92.28 132.39 36.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.017 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -172.61 157.39 3.86 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.881 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 20.0 mtp180 -141.96 38.56 1.62 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.837 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 21.4 mt -98.44 124.64 51.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.081 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 2.1 mmt85 . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.148 -0.929 . . . . 0.0 110.842 -179.968 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.265 0 N-CA-C 112.485 -0.246 . . . . 0.0 112.485 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -155.17 114.35 3.62 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.853 0.358 . . . . 0.0 110.929 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -129.39 151.59 49.86 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.907 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.654 ' N ' HD13 ' A' ' 4' ' ' ILE . 0.1 OUTLIER -136.77 134.69 48.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.06 -179.998 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 22.1 p -69.41 127.02 31.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.105 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.443 ' HA ' HE21 ' A' ' 6' ' ' GLN . 4.6 mm-40 -132.86 62.74 64.05 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.847 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -71.61 -35.16 8.24 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.605 2.203 . . . . 0.0 112.231 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 31.1 p -103.65 -22.31 13.6 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.273 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 61.69 -172.98 0.14 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.815 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -123.74 23.01 8.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.138 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 52.72 -168.5 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.843 0.354 . . . . 0.0 111.061 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -73.49 -36.87 65.84 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.032 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 11.8 mp0 -106.31 120.18 41.2 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.805 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -130.88 102.57 6.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.148 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -161.62 -55.26 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.13 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.9 -47.06 79.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.965 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 3.5 ttt85 -63.81 -37.37 87.13 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.078 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -67.01 -35.9 80.95 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.036 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.2 mp -63.42 -45.25 91.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.994 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 41.1 mm -62.15 -40.77 88.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.302 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -57.64 -47.14 83.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.108 -179.776 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -67.18 -28.67 68.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.044 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -59.25 -47.26 86.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.443 -179.726 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 78.6 p -65.33 -48.05 74.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.205 -179.684 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER 42.66 34.61 0.58 Allowed 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.365 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -62.57 131.21 48.32 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.223 -179.735 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -110.45 140.95 44.2 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.832 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 23.9 mm -86.62 139.61 17.08 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.347 0 CA-C-O 121.474 0.654 . . . . 0.0 111.789 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 102.3 -24.45 31.01 Favored Glycine 0 C--N 1.318 -0.443 0 CA-C-N 114.937 -1.029 . . . . 0.0 112.679 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -80.56 -23.93 39.59 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.612 0.244 . . . . 0.0 111.271 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.474 ' HA ' HD12 ' A' ' 52' ' ' ILE . 13.2 m120 -109.0 -14.65 14.51 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-O 121.911 0.863 . . . . 0.0 108.906 178.409 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.521 ' O ' HG22 ' A' ' 32' ' ' ILE . 0.1 OUTLIER -73.3 106.36 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.58 0 CA-C-N 113.968 -1.469 . . . . 0.0 111.094 -179.442 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 1.008 HG23 ' HB2' ' A' ' 50' ' ' ALA . 0.5 OUTLIER -38.87 -62.21 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.384 -0.826 . . . . 0.0 111.403 -179.664 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.602 ' N ' ' CG1' ' A' ' 33' ' ' VAL . 28.4 p -165.77 165.95 18.12 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.482 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 2.2 ttp180 -120.77 127.38 51.91 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.542 179.517 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.693 HG23 ' CD1' ' A' ' 48' ' ' LEU . 39.1 t -97.23 121.92 48.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.504 179.285 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.927 HG23 HG12 ' A' ' 45' ' ' ILE . 20.3 mt -125.29 109.02 20.96 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.824 -179.355 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 43.4 t -78.2 99.92 6.42 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 178.683 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 9.7 t -69.73 -33.27 72.24 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -178.667 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.415 ' OG1' ' O ' ' A' ' 142' ' ' SER . 0.0 OUTLIER -52.38 -29.32 23.46 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.914 0.388 . . . . 0.0 110.9 -179.658 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 90.46 49.78 3.13 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.866 -0.683 . . . . 0.0 113.003 179.205 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.887 ' OE1' HD21 ' A' ' 141' ' ' LEU . 2.3 mm-40 -126.55 -31.77 2.7 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.663 0.268 . . . . 0.0 111.368 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.537 HD12 HD11 ' A' ' 143' ' ' LEU . 19.0 mt -127.37 131.15 23.7 Favored Pre-proline 0 N--CA 1.452 -0.329 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.98 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.462 ' HD2' ' CE2' ' A' ' 76' ' ' TYR . 27.8 Cg_exo -59.85 146.82 94.73 Favored 'Trans proline' 0 C--N 1.343 0.263 0 C-N-CA 122.655 2.236 . . . . 0.0 112.046 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.927 HG12 HG23 ' A' ' 37' ' ' ILE . 78.8 mt -51.59 133.12 13.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.327 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -126.16 131.23 52.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.371 179.669 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.411 ' HB3' HD11 ' A' ' 32' ' ' ILE . 1.1 m-20 -96.17 119.95 35.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.043 0.449 . . . . 0.0 111.511 -179.525 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.944 HD21 HD13 ' A' ' 91' ' ' ILE . 1.8 mp -96.37 117.0 29.95 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 178.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.524 ' O ' ' CZ2' ' A' ' 66' ' ' TRP . 0.1 OUTLIER -112.24 162.17 15.78 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 122.077 0.942 . . . . 0.0 113.121 -178.715 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 1.008 ' HB2' HG23 ' A' ' 33' ' ' VAL . . . -125.97 165.9 17.93 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 114.718 -1.128 . . . . 0.0 111.4 179.401 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.75 ' O ' HG23 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -108.22 78.56 1.18 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.42 179.879 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.474 HD12 ' HA ' ' A' ' 31' ' ' ASN . 88.4 mt -64.06 -45.52 96.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.571 -179.581 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 37.8 t -61.27 -37.08 81.86 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.018 0.437 . . . . 0.0 110.812 -179.492 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.417 ' HG2' ' CB ' ' A' ' 51' ' ' ASP . 11.7 mm-40 -68.53 -40.41 80.76 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.033 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.75 HG23 ' O ' ' A' ' 51' ' ' ASP . 23.7 t -74.03 -38.45 49.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.24 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.99 -41.29 95.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.152 -179.608 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -90.73 -43.71 9.93 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.096 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -114.66 163.56 15.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.816 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.43 30.62 3.2 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.785 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -94.5 -36.18 11.97 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.994 -179.888 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.7 p -81.15 -97.24 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.918 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER 41.37 42.76 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.162 0 CA-C-O 121.064 0.459 . . . . 0.0 111.578 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 27.9 tttt -159.03 77.67 0.74 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.08 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.403 ' O ' ' HB3' ' A' ' 93' ' ' LEU . 0.8 OUTLIER -115.0 138.88 50.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.563 179.597 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.598 HG13 ' O ' ' A' ' 91' ' ' ILE . 13.9 t -136.73 136.92 47.89 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 CA-C-O 121.116 0.484 . . . . 0.0 112.003 -179.289 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' TRP . . . . . 0.661 ' HB2' ' HB ' ' A' ' 91' ' ' ILE . 15.2 m-90 -100.19 140.61 34.18 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.666 179.205 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.874 HG23 ' HG3' ' A' ' 90' ' ' GLN . 7.1 m -129.21 129.47 45.08 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.455 0.645 . . . . 0.0 112.337 179.653 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.578 ' CZ ' HG11 ' A' ' 36' ' ' VAL . 3.4 m-85 -103.43 118.69 37.34 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.051 -0.977 . . . . 0.0 108.716 177.578 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.647 ' HA2' ' O ' ' A' ' 85' ' ' SER . . . 157.06 -154.86 25.89 Favored Glycine 0 CA--C 1.505 -0.548 0 C-N-CA 118.58 -1.772 . . . . 0.0 113.468 179.346 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 4.1 mtp180 -75.27 91.83 2.7 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-O 122.543 1.163 . . . . 0.0 108.826 -179.416 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -150.05 159.41 35.52 Favored Pre-proline 0 C--N 1.307 -1.262 0 CA-C-N 112.782 -2.008 . . . . 0.0 107.85 178.786 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.552 ' O ' ' HB2' ' A' ' 77' ' ' HIS . 30.9 Cg_endo -64.4 -7.09 13.19 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 120.7 0.933 . . . . 0.0 110.758 177.714 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.742 ' HB2' ' HB2' ' A' ' 77' ' ' HIS . . . 136.71 53.62 0.0 OUTLIER 'General case' 0 CA--C 1.488 -1.406 0 CA-C-N 114.367 -1.288 . . . . 0.0 109.0 178.874 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.579 ' HB3' ' HB ' ' A' ' 67' ' ' THR . 0.1 OUTLIER -52.56 -70.07 0.1 Allowed 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 105.409 -2.071 . . . . 0.0 105.409 179.719 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.504 ' CG ' ' CE1' ' A' ' 68' ' ' PHE . 16.8 t70 -95.58 -47.56 6.18 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 105.781 -1.933 . . . . 0.0 105.781 169.114 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.499 ' CD2' HG23 ' A' ' 43' ' ' ILE . 19.4 t80 -143.08 141.95 31.4 Favored 'General case' 0 C--N 1.348 0.507 0 CA-C-N 112.775 -2.011 . . . . 0.0 111.458 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.742 ' HB2' ' HB2' ' A' ' 73' ' ' ALA . 1.7 t60 -96.1 107.28 19.58 Favored 'General case' 0 C--N 1.33 -0.261 0 O-C-N 122.114 -0.366 . . . . 0.0 110.222 177.26 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.817 HD11 ' O ' ' A' ' 85' ' ' SER . 0.6 OUTLIER -121.19 173.77 7.1 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.916 0.388 . . . . 0.0 111.506 -179.895 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -56.91 -173.39 0.21 Allowed Glycine 0 C--N 1.332 0.343 0 C-N-CA 121.014 -0.612 . . . . 0.0 112.475 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.421 ' HA ' ' OD1' ' A' ' 86' ' ' ASN . 9.2 p30 -111.81 98.34 7.32 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.82 0.343 . . . . 0.0 111.758 -179.671 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.79 HD12 ' OG ' ' A' ' 85' ' ' SER . 11.2 mt -114.91 113.79 44.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.436 178.574 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -55.65 -24.37 33.35 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 -179.352 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.441 ' H ' HG22 ' A' ' 81' ' ' ILE . 1.4 mtt180 -88.21 -106.11 0.08 Allowed 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -179.047 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.408 ' HB3' ' CE1' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -109.26 111.17 22.61 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-O 121.568 0.699 . . . . 0.0 110.158 179.976 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.817 ' O ' HD11 ' A' ' 78' ' ' LEU . 0.5 OUTLIER 162.11 -48.94 0.0 OUTLIER 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 114.378 -1.283 . . . . 0.0 109.261 -179.817 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.846 ' O ' ' N ' ' A' ' 88' ' ' HIS . 89.0 m-20 -63.32 -152.57 0.01 OUTLIER 'General case' 0 CA--C 1.522 -0.122 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 177.809 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.848 ' HB3' HD11 ' A' ' 104' ' ' ILE . 12.9 mttt -48.54 72.8 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 179.303 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.996 ' O ' ' O ' ' A' ' 104' ' ' ILE . 36.3 t60 -93.93 -17.76 22.64 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 114.103 1.149 . . . . 0.0 114.103 -176.86 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.62 ' HA ' ' H ' ' A' ' 104' ' ' ILE . 0.1 OUTLIER -175.83 155.69 1.7 Allowed 'General case' 0 C--N 1.313 -1.002 0 C-N-CA 118.96 -1.096 . . . . 0.0 113.073 177.982 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.874 ' HG3' HG23 ' A' ' 67' ' ' THR . 21.2 mt-30 -137.46 160.97 37.62 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.308 -1.314 . . . . 0.0 113.574 -177.898 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.944 HD13 HD21 ' A' ' 48' ' ' LEU . 2.7 mt -128.42 132.33 68.17 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.784 178.746 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.571 HD13 ' ND2' ' A' ' 121' ' ' ASN . 0.3 OUTLIER -109.52 146.12 35.15 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.142 0.496 . . . . 0.0 112.017 -179.126 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.637 HD22 ' N ' ' A' ' 94' ' ' GLY . 1.1 tm? -125.97 124.52 40.92 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.445 179.195 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.637 ' N ' HD22 ' A' ' 93' ' ' LEU . . . 128.21 -129.55 6.33 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.617 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 67.76 -70.4 0.12 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.779 0.323 . . . . 0.0 111.023 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -143.15 52.86 1.36 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.01 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 77.93 -60.18 3.82 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.562 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -57.67 -170.27 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.901 0.382 . . . . 0.0 110.991 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.956 HD21 HG13 ' A' ' 33' ' ' VAL . 4.9 mp -106.95 159.92 15.91 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.943 -180.0 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.938 HD23 ' HB3' ' A' ' 121' ' ' ASN . 4.6 mp -131.58 148.35 52.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.389 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.462 ' O ' ' N ' ' A' ' 122' ' ' GLN . 6.0 mt -118.23 128.78 55.02 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 179.823 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.515 ' O ' ' O ' ' A' ' 90' ' ' GLN . 29.4 t30 -111.21 111.38 22.41 Favored 'General case' 0 CA--C 1.507 -0.675 0 C-N-CA 119.907 -0.717 . . . . 0.0 109.685 179.606 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.758 ' HB3' HG21 ' A' ' 109' ' ' THR . 84.0 m-20 -85.8 111.56 20.28 Favored 'General case' 0 N--CA 1.44 -0.932 0 C-N-CA 119.596 -0.842 . . . . 0.0 109.535 179.697 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.996 ' O ' ' O ' ' A' ' 88' ' ' HIS . 0.1 OUTLIER -122.91 107.57 19.59 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.953 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 177.563 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.415 ' HG ' ' CE1' ' A' ' 88' ' ' HIS . 70.9 m -134.17 166.89 21.72 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-N 114.982 -1.008 . . . . 0.0 109.398 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 20.8 m -69.24 -62.81 1.23 Allowed 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 119.226 -0.99 . . . . 0.0 111.581 -179.074 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -112.12 -32.82 6.43 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 114.984 1.476 . . . . 0.0 114.984 179.443 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -146.35 127.95 2.9 Favored Glycine 0 C--N 1.339 0.749 0 N-CA-C 117.388 1.715 . . . . 0.0 117.388 -177.718 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.758 HG21 ' HB3' ' A' ' 103' ' ' ASP . 5.4 m -121.37 138.3 54.32 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 174.18 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 0.761 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.9 m-90 -121.24 148.91 43.65 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 113.318 0.859 . . . . 0.0 113.318 -178.506 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.463 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -121.6 112.05 17.98 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 115.12 -0.946 . . . . 0.0 108.509 177.424 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 43.97 44.44 6.02 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.038 -0.528 . . . . 0.0 112.126 -179.462 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 80.06 25.12 58.36 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.744 179.336 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' GLN . . . . . 0.434 ' O ' HG13 ' A' ' 116' ' ' VAL . 58.0 mt-30 -137.74 95.98 3.15 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.077 0.465 . . . . 0.0 110.841 179.677 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.761 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.0 OUTLIER -45.61 134.54 7.17 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.891 179.77 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.434 HG13 ' O ' ' A' ' 114' ' ' GLN . 27.3 m -126.05 -178.19 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.916 -179.029 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -85.84 142.1 29.15 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.229 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.457 ' HG3' ' HA ' ' A' ' 104' ' ' ILE . 71.4 tttt -64.49 163.21 13.82 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.155 179.28 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.42 ' N ' ' HG2' ' A' ' 118' ' ' LYS . 4.9 p-10 35.41 39.5 0.06 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.287 0.565 . . . . 0.0 111.17 -179.796 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 4.9 p -110.87 106.76 16.02 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.024 -179.448 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.938 ' HB3' HD23 ' A' ' 100' ' ' LEU . 1.6 m-20 -57.26 140.8 48.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.506 179.86 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' GLN . . . . . 0.691 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 59.9 mm-40 -129.63 147.86 51.47 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-O 121.109 0.481 . . . . 0.0 111.965 -179.542 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.3 tp -73.77 116.89 14.9 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.628 -0.715 . . . . 0.0 109.491 178.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.801 HD21 HD13 ' A' ' 147' ' ' ILE . 2.4 tt -47.54 144.53 3.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.85 0.833 . . . . 0.0 111.892 -178.759 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.441 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.6 OUTLIER -126.83 153.18 45.99 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 114.04 -1.436 . . . . 0.0 110.291 179.535 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 24.6 mm100 -71.67 113.93 9.22 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.002 0.429 . . . . 0.0 110.152 179.73 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 69.24 25.66 75.27 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.645 -179.711 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.441 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 27.0 t70 -58.5 159.99 5.85 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.045 0.45 . . . . 0.0 111.136 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.597 ' HG3' HG22 ' A' ' 144' ' ' VAL . 1.7 tt0 -146.56 135.37 22.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.411 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.466 ' CG2' ' O ' ' A' ' 110' ' ' TRP . 1.2 mp -110.46 128.5 66.7 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.157 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 178.685 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.577 HG23 ' CG2' ' A' ' 140' ' ' ILE . 23.3 m -103.13 144.79 30.84 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.451 -179.571 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.474 ' HB ' ' NE2' ' A' ' 88' ' ' HIS . 10.2 m -141.29 158.14 22.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -178.926 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 67.38 43.16 88.59 Favored Glycine 0 N--CA 1.447 -0.582 0 CA-C-N 115.667 -0.697 . . . . 0.0 112.281 179.477 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.485 ' HA ' HG12 ' A' ' 140' ' ' ILE . 85.2 t -77.84 156.48 5.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 121.406 0.622 . . . . 0.0 112.133 -179.245 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.448 ' N ' HG12 ' A' ' 134' ' ' VAL . . . 147.79 -42.06 0.89 Allowed Glycine 0 N--CA 1.441 -0.99 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.635 -179.061 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.528 HG12 ' H ' ' A' ' 138' ' ' SER . 43.8 t -126.65 130.14 71.63 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.684 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 178.73 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.29 -34.0 31.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.724 0.297 . . . . 0.0 111.405 -179.181 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' SER . . . . . 0.528 ' H ' HG12 ' A' ' 136' ' ' VAL . 4.0 p -94.28 6.39 48.81 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 -179.441 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -128.14 30.25 5.25 Favored 'General case' 0 CA--C 1.52 -0.197 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -179.274 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.577 ' CG2' HG23 ' A' ' 131' ' ' THR . 20.9 mt -103.66 141.12 20.03 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.361 179.183 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.887 HD21 ' OE1' ' A' ' 42' ' ' GLN . 3.4 mp -111.51 135.67 51.76 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.021 -0.991 . . . . 0.0 110.048 179.506 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.764 ' C ' HD22 ' A' ' 143' ' ' LEU . 47.3 t -116.82 152.02 35.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.865 0.841 . . . . 0.0 112.94 -178.916 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.764 HD22 ' C ' ' A' ' 142' ' ' SER . 3.9 mm? -136.24 127.06 27.45 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.526 -1.215 . . . . 0.0 109.166 178.906 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.597 HG22 ' HG3' ' A' ' 129' ' ' GLU . 18.7 t -120.2 140.61 43.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.017 0.437 . . . . 0.0 111.978 -178.879 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.499 ' CG1' HG22 ' A' ' 36' ' ' VAL . 0.2 OUTLIER -114.19 127.17 71.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.575 179.639 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 15.6 t80 -110.65 107.19 16.68 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.753 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.801 HD13 HD21 ' A' ' 124' ' ' LEU . 1.4 mp -99.76 133.41 42.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.393 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 14.7 p30 -82.05 134.79 35.37 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.926 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -64.63 -23.03 67.13 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.154 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 16.7 mtmt -57.31 -42.22 81.37 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.94 0.4 . . . . 0.0 110.687 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 37.3 t80 -59.38 -43.88 92.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.75 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 16.4 mttm -59.55 -42.8 93.19 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.95 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 72.5 mt-30 -63.75 -40.22 96.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.956 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 10.5 t -63.29 -45.07 93.09 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.949 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -68.51 -37.84 80.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.915 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -60.28 -39.32 86.47 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.983 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -88.85 -35.52 16.52 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.909 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 42.51 42.28 2.68 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.465 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 1.9 mttm -90.87 150.2 21.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.917 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 21.5 t -66.16 141.1 18.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.13 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -57.59 92.77 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.939 -179.888 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 5.6 ptm180 -138.13 -175.52 4.13 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.902 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 3.6 mt -77.92 113.77 17.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.025 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 48.0 ttp85 . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.282 -0.866 . . . . 0.0 110.91 -179.925 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.353 0 N-CA-C 112.546 -0.221 . . . . 0.0 112.546 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -64.36 130.82 45.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.843 0.354 . . . . 0.0 110.95 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -158.28 51.41 0.42 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.82 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 4.8 mt -121.33 -65.51 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.061 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 10.9 p -148.4 102.18 3.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.193 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.419 ' N ' ' CD ' ' A' ' 7' ' ' PRO . 0.0 OUTLIER -61.08 -52.24 73.21 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.968 179.91 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.419 ' CD ' ' N ' ' A' ' 6' ' ' GLN . 74.0 Cg_exo -48.49 113.89 1.0 Allowed 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.634 2.223 . . . . 0.0 112.41 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 12.9 m -61.04 126.91 29.09 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.144 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -134.95 85.79 2.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.895 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.19 -38.07 82.16 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.85 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -151.98 176.12 11.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.916 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -145.8 89.27 1.89 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.131 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -103.91 34.96 2.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.883 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -145.33 64.31 1.26 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.105 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -140.84 -48.69 0.42 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.147 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 10.1 tm0? -66.24 -37.29 85.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.868 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 2.5 mtt180 -61.68 -41.74 97.98 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.899 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -64.41 -36.01 82.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.869 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.7 tt -59.8 -42.22 92.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.931 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 34.5 mm -62.14 -40.57 88.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.108 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -57.68 -35.94 71.25 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.039 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.35 -33.51 74.85 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.942 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -61.73 -47.58 84.6 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.142 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 6.8 t -59.95 -46.98 87.64 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.824 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 22.4 mt-30 -146.15 154.62 41.99 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.838 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -98.02 155.52 17.07 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.869 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 21.1 tt0 -96.74 131.1 43.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.828 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.426 HG22 ' HB ' ' A' ' 32' ' ' ILE . 22.6 mm -82.04 139.5 17.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 121.463 0.649 . . . . 0.0 111.59 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -172.86 -37.95 0.04 OUTLIER Glycine 0 C--N 1.317 -0.521 0 CA-C-N 114.884 -1.053 . . . . 0.0 112.644 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -73.89 -23.69 59.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.701 0.286 . . . . 0.0 111.317 -179.798 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.417 ' HA ' HD12 ' A' ' 52' ' ' ILE . 12.2 m120 -109.06 -14.37 14.54 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-O 121.949 0.881 . . . . 0.0 108.746 178.574 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.555 ' O ' HG22 ' A' ' 32' ' ' ILE . 0.0 OUTLIER -74.31 101.53 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.522 0 CA-C-N 114.011 -1.449 . . . . 0.0 110.558 -179.769 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 1.022 HG23 ' HB2' ' A' ' 50' ' ' ALA . 0.5 OUTLIER -34.93 -61.73 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.249 -0.887 . . . . 0.0 112.297 -179.059 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.725 ' SG ' HG23 ' A' ' 147' ' ' ILE . 41.2 m -159.36 165.46 33.25 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.677 -179.178 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.513 HH11 HD11 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -128.46 115.12 17.68 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.828 179.367 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.629 HG11 ' HZ ' ' A' ' 68' ' ' PHE . 9.9 p -89.18 134.38 28.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.812 179.799 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.964 HG23 HG12 ' A' ' 45' ' ' ILE . 21.6 mt -132.68 107.86 12.55 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -179.373 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -89.23 106.56 18.52 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 177.604 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 10.1 t -99.11 -22.4 15.7 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 -177.855 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.772 HG21 ' CB ' ' A' ' 142' ' ' SER . 56.7 p -57.74 -20.7 36.51 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.656 0.265 . . . . 0.0 111.583 -179.556 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 104.86 71.75 0.84 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.561 -0.828 . . . . 0.0 112.627 179.658 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.788 ' HG2' HD12 ' A' ' 141' ' ' LEU . 0.0 OUTLIER -159.35 -66.95 0.08 Allowed 'General case' 0 C--N 1.328 -0.37 0 CA-C-O 120.893 0.377 . . . . 0.0 110.925 179.925 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.514 HG23 ' HD2' ' A' ' 44' ' ' PRO . 34.3 mt -103.5 138.97 19.69 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.257 -179.714 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.514 ' HD2' HG23 ' A' ' 43' ' ' ILE . 91.2 Cg_endo -81.73 146.79 15.09 Favored 'Trans proline' 0 N--CA 1.46 -0.458 0 C-N-CA 122.71 2.273 . . . . 0.0 111.706 179.51 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.964 HG12 HG23 ' A' ' 37' ' ' ILE . 55.8 mt -43.82 116.07 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.072 0.463 . . . . 0.0 111.622 -179.665 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.404 ' NE ' ' HA ' ' A' ' 46' ' ' ARG . 8.9 mmm180 -114.69 131.48 56.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.928 179.49 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.424 ' HB3' HD11 ' A' ' 32' ' ' ILE . 5.0 m-20 -88.11 119.6 28.64 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.063 0.459 . . . . 0.0 111.604 -179.306 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.592 HD22 ' CD1' ' A' ' 66' ' ' TRP . 1.0 OUTLIER -98.34 121.57 40.43 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 178.741 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.513 ' O ' ' HZ2' ' A' ' 66' ' ' TRP . 0.0 OUTLIER -120.81 162.05 20.44 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 122.133 0.968 . . . . 0.0 113.46 -178.371 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 1.022 ' HB2' HG23 ' A' ' 33' ' ' VAL . . . -116.96 166.28 12.36 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 114.343 -1.299 . . . . 0.0 110.958 179.685 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.909 ' O ' HG23 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -105.47 63.44 0.69 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.029 0.442 . . . . 0.0 110.837 -179.973 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.417 HD12 ' HA ' ' A' ' 31' ' ' ASN . 53.6 mt -63.18 -44.05 99.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.04 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.54 -39.23 88.47 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.04 0.448 . . . . 0.0 111.1 -179.497 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 16.8 mt-30 -65.79 -40.76 92.25 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.198 -179.701 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.909 HG23 ' O ' ' A' ' 51' ' ' ASP . 41.4 t -63.28 -40.37 88.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.136 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -61.63 -32.36 72.5 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.959 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.95 -27.74 16.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.079 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.59 -175.98 3.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.919 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.42 -48.88 4.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.833 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 6.6 mmt85 -115.87 -67.93 0.96 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.894 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.543 ' CB ' HG22 ' A' ' 55' ' ' VAL . 1.8 t 61.5 -163.44 0.26 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.827 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 22.0 mm 71.93 86.62 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.176 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 179.83 71.24 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.852 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.469 ' HB3' HD12 ' A' ' 93' ' ' LEU . 13.2 ttpt -130.41 136.68 49.3 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.625 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.635 HG13 ' O ' ' A' ' 91' ' ' ILE . 17.6 t -137.41 137.3 46.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.969 0.414 . . . . 0.0 112.008 -179.124 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' TRP . . . . . 0.675 ' HB2' ' HB ' ' A' ' 91' ' ' ILE . 13.8 m-90 -100.26 139.29 36.15 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.09 178.636 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.574 ' HB ' ' HB3' ' A' ' 74' ' ' CYS . 4.4 m -131.3 130.49 42.83 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.458 0.647 . . . . 0.0 112.57 179.747 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.629 ' HZ ' HG11 ' A' ' 36' ' ' VAL . 93.7 m-85 -101.73 118.57 37.2 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.303 178.006 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.62 ' HA2' ' O ' ' A' ' 85' ' ' SER . . . 157.34 -157.2 27.9 Favored Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 118.899 -1.619 . . . . 0.0 112.812 179.291 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.47 92.34 2.85 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-O 122.71 1.243 . . . . 0.0 108.738 -179.763 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -149.16 159.43 37.09 Favored Pre-proline 0 C--N 1.309 -1.169 0 CA-C-N 112.515 -2.129 . . . . 0.0 107.921 179.224 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.545 ' O ' ' CB ' ' A' ' 73' ' ' ALA . 28.8 Cg_endo -63.64 -7.43 12.75 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 120.842 1.028 . . . . 0.0 111.118 178.255 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.735 ' HB2' ' HB2' ' A' ' 77' ' ' HIS . . . 135.99 51.6 0.0 OUTLIER 'General case' 0 CA--C 1.49 -1.362 0 CA-C-N 114.527 -1.215 . . . . 0.0 109.455 178.84 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.574 ' HB3' ' HB ' ' A' ' 67' ' ' THR . 0.1 OUTLIER -52.88 -69.9 0.1 Allowed 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 105.63 -1.989 . . . . 0.0 105.63 179.491 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.551 ' N ' ' O ' ' A' ' 67' ' ' THR . 7.6 t0 -95.26 -47.14 6.45 Favored 'General case' 0 N--CA 1.435 -1.182 0 N-CA-C 106.0 -1.852 . . . . 0.0 106.0 169.594 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.496 ' C ' ' HA ' ' A' ' 73' ' ' ALA . 29.8 t80 -144.33 142.6 30.5 Favored 'General case' 0 C--N 1.347 0.465 0 CA-C-N 112.624 -2.08 . . . . 0.0 111.476 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.735 ' HB2' ' HB2' ' A' ' 73' ' ' ALA . 1.6 t60 -96.33 107.3 19.64 Favored 'General case' 0 C--N 1.33 -0.249 0 O-C-N 121.997 -0.439 . . . . 0.0 110.322 177.073 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.811 HD11 ' O ' ' A' ' 85' ' ' SER . 0.7 OUTLIER -124.24 175.22 7.19 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 120.916 0.388 . . . . 0.0 111.375 179.969 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -59.02 -174.18 0.57 Allowed Glycine 0 C--N 1.332 0.342 0 C-N-CA 120.981 -0.628 . . . . 0.0 112.704 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.436 ' HA ' ' OD1' ' A' ' 86' ' ' ASN . 0.4 OUTLIER -111.48 98.24 7.32 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.933 0.397 . . . . 0.0 111.634 -179.797 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.594 ' HB ' ' HB2' ' A' ' 85' ' ' SER . 4.0 mp -114.92 114.03 45.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.356 178.868 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 53.3 p -55.7 -24.62 35.54 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 -178.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.523 ' C ' HD13 ' A' ' 84' ' ' LEU . 0.6 OUTLIER -85.32 -110.13 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 -178.931 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.847 HD22 ' H ' ' A' ' 84' ' ' LEU . 0.0 OUTLIER -108.98 112.07 24.08 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-O 121.453 0.644 . . . . 0.0 109.573 179.679 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.811 ' O ' HD11 ' A' ' 78' ' ' LEU . 0.6 OUTLIER 161.86 -45.63 0.0 OUTLIER 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 114.671 -1.15 . . . . 0.0 109.433 -179.562 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.858 ' O ' ' N ' ' A' ' 88' ' ' HIS . 95.7 m-20 -64.68 -149.65 0.01 OUTLIER 'General case' 0 N--CA 1.456 -0.148 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 177.9 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.925 ' HB3' HD11 ' A' ' 104' ' ' ILE . 28.1 mttm -49.58 72.02 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 179.065 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.983 ' C ' ' O ' ' A' ' 104' ' ' ILE . 31.8 t60 -91.35 -15.93 28.26 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 113.846 1.054 . . . . 0.0 113.846 -176.853 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.631 ' HA ' ' H ' ' A' ' 104' ' ' ILE . 0.9 OUTLIER -175.31 152.83 1.45 Allowed 'General case' 0 C--N 1.31 -1.131 0 C-N-CA 119.436 -0.906 . . . . 0.0 112.291 177.972 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.508 ' HG2' HG12 ' A' ' 65' ' ' VAL . 20.5 tt0 -136.82 153.38 50.81 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 114.514 -1.221 . . . . 0.0 113.338 -177.664 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.675 ' HB ' ' HB2' ' A' ' 66' ' ' TRP . 32.4 mt -123.53 131.98 72.17 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.196 178.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.697 HD13 ' ND2' ' A' ' 121' ' ' ASN . 0.3 OUTLIER -108.64 144.05 36.89 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.055 0.455 . . . . 0.0 111.824 -179.56 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.797 HD22 ' N ' ' A' ' 94' ' ' GLY . 0.2 OUTLIER -125.77 122.66 36.86 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.28 179.26 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.797 ' N ' HD22 ' A' ' 93' ' ' LEU . . . 113.0 -136.27 13.32 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.375 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 57.75 88.59 0.06 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.788 0.328 . . . . 0.0 110.871 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 1.6 t70 60.93 29.9 19.29 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.851 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 80.55 174.82 48.52 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.593 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 34.0 m-80 61.66 176.6 0.12 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.843 0.354 . . . . 0.0 110.932 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.867 ' HB2' HD13 ' A' ' 124' ' ' LEU . 0.5 OUTLIER -107.08 155.58 19.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.893 179.849 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.54 ' HA ' ' O ' ' A' ' 122' ' ' GLN . 20.5 mt -133.61 147.98 51.53 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.432 179.758 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.516 HD13 ' HA ' ' A' ' 124' ' ' LEU . 4.8 mp -116.58 131.85 56.84 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.615 ' HB2' HD11 ' A' ' 92' ' ' LEU . 23.1 t30 -114.42 110.87 20.54 Favored 'General case' 0 CA--C 1.508 -0.661 0 C-N-CA 119.714 -0.795 . . . . 0.0 109.839 179.704 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.69 ' HB3' HG21 ' A' ' 109' ' ' THR . 70.1 m-20 -81.68 111.88 18.36 Favored 'General case' 0 N--CA 1.442 -0.865 0 C-N-CA 119.726 -0.79 . . . . 0.0 109.37 179.557 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.983 ' O ' ' C ' ' A' ' 88' ' ' HIS . 0.1 OUTLIER -123.45 107.98 20.1 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.937 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 177.71 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.456 ' HG ' ' CE1' ' A' ' 88' ' ' HIS . 69.8 m -130.91 169.83 15.25 Favored 'General case' 0 C--N 1.296 -1.742 0 CA-C-N 114.926 -1.034 . . . . 0.0 109.304 179.694 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 24.0 m -69.56 -62.68 1.28 Allowed 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 119.089 -1.044 . . . . 0.0 111.325 -179.302 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -111.75 -33.52 6.3 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 114.66 1.356 . . . . 0.0 114.66 179.195 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -146.99 130.37 3.58 Favored Glycine 0 C--N 1.34 0.786 0 N-CA-C 116.764 1.466 . . . . 0.0 116.764 -178.158 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.69 HG21 ' HB3' ' A' ' 103' ' ' ASP . 4.3 m -120.85 137.87 54.34 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 174.47 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 0.771 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.5 m-90 -120.37 148.96 43.08 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 -178.543 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.432 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.3 OUTLIER -122.49 112.09 17.62 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 114.931 -1.031 . . . . 0.0 108.514 177.421 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 67.4 m-20 48.02 42.82 17.34 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.08 -0.509 . . . . 0.0 112.12 -179.458 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 82.22 3.44 90.56 Favored Glycine 0 N--CA 1.445 -0.754 0 C-N-CA 120.785 -0.721 . . . . 0.0 113.134 179.125 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.07 100.07 7.3 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.062 0.458 . . . . 0.0 110.829 179.78 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.771 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.0 OUTLIER -44.86 139.17 3.17 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.018 179.919 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.456 HG21 ' OD2' ' A' ' 103' ' ' ASP . 28.1 m -126.98 178.92 3.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.103 0.478 . . . . 0.0 111.756 -179.103 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -84.01 139.09 32.75 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.755 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.451 ' O ' ' N ' ' A' ' 120' ' ' SER . 0.5 OUTLIER -61.94 169.46 2.6 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 179.348 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.444 ' C ' ' O ' ' A' ' 118' ' ' LYS . 6.7 p30 28.63 41.42 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.534 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.451 ' N ' ' O ' ' A' ' 118' ' ' LYS . 4.0 p -111.22 111.52 22.64 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.154 -179.113 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.697 ' ND2' HD13 ' A' ' 92' ' ' LEU . 1.9 m120 -62.95 133.77 55.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.124 179.51 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' GLN . . . . . 0.54 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 49.6 mm-40 -129.56 147.04 51.32 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 -179.425 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.8 tt -72.62 113.71 9.95 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.351 178.738 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.895 HD12 HG12 ' A' ' 147' ' ' ILE . 1.6 pt? -45.51 155.41 0.15 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.852 0.834 . . . . 0.0 112.362 -178.462 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.476 ' O ' HD13 ' A' ' 147' ' ' ILE . 0.0 OUTLIER -127.44 153.38 46.35 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 114.069 -1.423 . . . . 0.0 109.855 179.142 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 32.8 tp60 -70.72 113.82 8.18 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 179.659 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 69.13 27.93 73.34 Favored Glycine 0 N--CA 1.445 -0.7 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.131 -179.093 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.449 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 27.5 t70 -58.96 159.62 6.88 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.099 0.476 . . . . 0.0 111.53 -179.567 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.505 ' HB2' HG22 ' A' ' 144' ' ' VAL . 2.0 tt0 -146.54 135.35 22.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.941 179.704 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.692 ' O ' HD12 ' A' ' 143' ' ' LEU . 1.0 OUTLIER -108.74 129.17 63.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.13 179.157 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.529 HG23 ' CG2' ' A' ' 140' ' ' ILE . 32.0 m -102.77 143.16 32.75 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.86 0.362 . . . . 0.0 110.454 -179.665 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.47 ' HB ' ' NE2' ' A' ' 88' ' ' HIS . 5.3 m -141.13 158.26 22.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 -178.669 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 68.64 43.98 73.47 Favored Glycine 0 N--CA 1.447 -0.575 0 CA-C-N 115.705 -0.68 . . . . 0.0 112.219 179.351 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.497 ' HA ' HG12 ' A' ' 140' ' ' ILE . 93.0 t -79.35 154.22 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 CA-C-O 121.467 0.651 . . . . 0.0 112.242 -179.093 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.406 ' N ' HG12 ' A' ' 134' ' ' VAL . . . 151.39 -42.79 0.71 Allowed Glycine 0 N--CA 1.44 -1.04 0 CA-C-N 114.93 -1.032 . . . . 0.0 110.648 -179.068 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.547 HG12 ' H ' ' A' ' 138' ' ' SER . 44.8 t -126.66 132.19 70.42 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.751 0 CA-C-N 115.196 -0.502 . . . . 0.0 109.844 178.65 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 46.5 tp10 -51.42 -34.74 36.13 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.798 0.332 . . . . 0.0 111.405 -179.292 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' SER . . . . . 0.547 ' H ' HG12 ' A' ' 136' ' ' VAL . 40.9 t -94.31 6.45 48.65 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -179.318 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -126.94 30.16 5.51 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 -179.3 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.529 ' CG2' HG23 ' A' ' 131' ' ' THR . 13.3 mt -107.33 140.95 23.81 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.305 179.15 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.788 HD12 ' HG2' ' A' ' 42' ' ' GLN . 3.6 mm? -117.3 135.01 54.14 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 114.974 -1.012 . . . . 0.0 109.834 179.409 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.772 ' CB ' HG21 ' A' ' 40' ' ' THR . 0.9 OUTLIER -120.65 147.4 45.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.537 0.684 . . . . 0.0 112.701 -178.943 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.692 HD12 ' O ' ' A' ' 130' ' ' ILE . 3.5 mp -122.93 147.38 46.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 114.861 -1.063 . . . . 0.0 109.369 179.534 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.505 HG22 ' HB2' ' A' ' 129' ' ' GLU . 23.5 t -131.76 140.28 48.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 C-N-CA 120.769 -0.372 . . . . 0.0 111.657 -179.314 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.63 ' CG2' HD11 ' A' ' 147' ' ' ILE . 0.0 OUTLIER -115.4 139.85 39.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.809 179.64 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 39.2 t80 -117.51 105.06 11.69 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.904 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.895 HG12 HD12 ' A' ' 124' ' ' LEU . 3.5 mp -98.96 130.57 47.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.298 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 148' ' ' ASN . . . . . 0.413 ' ND2' ' O ' ' A' ' 32' ' ' ILE . 11.1 p30 -89.06 133.43 34.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.81 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -67.71 -20.06 65.23 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.264 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.46 -42.93 83.48 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.895 0.379 . . . . 0.0 110.591 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 151' ' ' PHE . . . . . 0.544 ' HE2' ' HB3' ' A' ' 50' ' ' ALA . 31.2 t80 -59.05 -43.23 91.68 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.754 179.804 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -60.59 -34.35 74.07 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.859 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 56.5 tt0 -62.91 -41.64 99.52 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.941 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 12.6 t -60.47 -45.54 93.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.909 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.92 -42.13 94.97 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.92 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -60.35 -41.0 92.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.839 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -67.91 -28.89 67.89 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.937 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -124.03 46.62 2.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.869 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 4.4 ttpt -70.12 131.73 44.73 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.971 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 25.8 t -66.29 121.9 16.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.079 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 33.8 m-20 -107.31 -30.47 8.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.843 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 1.3 ppt_? -164.33 150.64 10.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.894 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.505 ' H ' HD12 ' A' ' 163' ' ' ILE . 3.1 mp -100.77 131.98 47.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.088 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 1.8 mmt85 . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.173 -0.918 . . . . 0.0 111.048 -179.987 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.322 0 N-CA-C 112.463 -0.255 . . . . 0.0 112.463 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 60.04 62.95 1.53 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.066 0.46 . . . . 0.0 110.853 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 43.0 t-20 58.36 99.19 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.026 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 5.6 pt -120.86 51.15 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.053 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 64.75 131.84 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.222 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -112.32 78.07 2.42 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.809 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 147.8 63.62 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.657 2.238 . . . . 0.0 112.269 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -59.89 -40.06 87.47 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.058 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -178.05 93.12 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.88 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 -61.62 84.67 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.768 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 18.9 p -149.58 130.54 14.32 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.898 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.68 88.63 3.95 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.992 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -170.98 -64.42 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.816 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.74 112.6 3.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.228 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.442 HG23 ' N ' ' A' ' 16' ' ' GLN . 2.0 t -148.4 -51.21 0.17 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.103 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.442 ' N ' HG23 ' A' ' 15' ' ' THR . 28.0 pt20 -73.07 -35.41 66.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.92 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 5.5 ttm-85 -65.93 -36.8 84.36 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.974 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 64.5 t80 -57.45 -47.0 82.98 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.083 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 8.4 tt -59.59 -43.49 93.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.876 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 42.4 mm -71.26 -46.46 65.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.099 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -57.6 -44.72 85.64 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.077 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -59.24 -34.04 71.74 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.847 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -59.73 -47.63 84.89 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.211 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 19.5 p -66.96 -30.73 70.93 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.901 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 3.0 tt0 -77.51 116.58 18.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.874 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 13.9 pm0 -96.86 127.36 42.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.991 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.6 mm100 -76.49 120.98 22.46 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.706 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 21.3 mm -83.46 139.52 17.58 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.368 0 CA-C-O 121.502 0.668 . . . . 0.0 111.695 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -90.23 62.11 3.22 Favored Glycine 0 C--N 1.317 -0.474 0 CA-C-N 114.851 -1.068 . . . . 0.0 112.49 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -87.09 -23.13 25.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.787 0.327 . . . . 0.0 110.96 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.572 ' HA ' HD11 ' A' ' 52' ' ' ILE . 11.2 m-20 -108.23 -13.11 14.97 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-O 121.933 0.873 . . . . 0.0 108.979 178.626 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.835 HD13 ' O ' ' A' ' 48' ' ' LEU . 0.1 OUTLIER -70.78 103.46 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.518 0 CA-C-N 113.94 -1.482 . . . . 0.0 111.268 -179.274 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 1.076 HG23 ' HB2' ' A' ' 50' ' ' ALA . 0.4 OUTLIER -33.37 -62.8 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 CA-C-N 115.25 -0.886 . . . . 0.0 112.065 -179.297 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.631 ' N ' ' CG1' ' A' ' 33' ' ' VAL . 67.2 m -162.42 165.26 26.57 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.401 -179.299 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.39 114.96 18.23 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.669 179.125 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 1.035 HG12 HD21 ' A' ' 143' ' ' LEU . 1.8 t -89.16 129.08 40.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.427 179.711 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.928 HG23 HG12 ' A' ' 45' ' ' ILE . 26.0 mt -122.6 108.45 21.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -178.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.537 ' SG ' HD23 ' A' ' 143' ' ' LEU . 0.0 OUTLIER -102.5 107.86 18.97 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 177.783 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.6 t -113.92 -24.49 9.05 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 -178.143 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.592 HG21 ' HB3' ' A' ' 142' ' ' SER . 17.1 p -56.01 -26.16 47.5 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.765 0.316 . . . . 0.0 111.348 -179.489 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 124.53 66.84 0.19 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.642 -0.789 . . . . 0.0 112.674 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.648 ' CB ' HD12 ' A' ' 43' ' ' ILE . 21.9 mt-30 -141.13 -71.92 0.35 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.765 0.317 . . . . 0.0 110.666 179.752 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.648 HD12 ' CB ' ' A' ' 42' ' ' GLN . 3.9 mp -135.33 136.65 24.76 Favored Pre-proline 0 N--CA 1.452 -0.37 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.084 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.48 ' HD2' ' CZ ' ' A' ' 76' ' ' TYR . 31.3 Cg_exo -58.8 147.29 89.3 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.576 2.184 . . . . 0.0 111.739 179.508 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.928 HG12 HG23 ' A' ' 37' ' ' ILE . 48.8 mt -38.04 140.19 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 CA-C-O 121.004 0.43 . . . . 0.0 111.83 -179.503 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.435 ' HG2' ' O ' ' A' ' 75' ' ' ASP . 0.0 OUTLIER -137.26 130.42 30.86 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.318 179.864 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.548 ' C ' HD23 ' A' ' 48' ' ' LEU . 0.7 OUTLIER -94.7 120.27 34.66 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.028 0.442 . . . . 0.0 111.538 -179.339 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.835 ' O ' HD13 ' A' ' 32' ' ' ILE . 1.2 mt -100.35 129.84 46.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.821 179.295 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.479 ' HB3' HG12 ' A' ' 32' ' ' ILE . 0.1 OUTLIER -120.91 162.92 19.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 122.091 0.948 . . . . 0.0 113.364 -179.118 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 1.076 ' HB2' HG23 ' A' ' 33' ' ' VAL . . . -127.34 166.59 17.55 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.456 -1.247 . . . . 0.0 111.064 179.73 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.763 ' O ' HG23 ' A' ' 55' ' ' VAL . 0.3 OUTLIER -104.8 92.37 4.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.365 179.607 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.572 HD11 ' HA ' ' A' ' 31' ' ' ASN . 45.6 mt -64.07 -44.96 97.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.929 -179.363 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 11.4 m -58.44 -38.7 78.04 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.189 0.519 . . . . 0.0 110.76 -179.357 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.458 ' HG2' ' HB3' ' A' ' 51' ' ' ASP . 18.0 mm-40 -68.81 -37.31 79.15 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.485 -0.779 . . . . 0.0 111.032 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.763 HG23 ' O ' ' A' ' 51' ' ' ASP . 36.0 t -73.68 -37.7 49.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.12 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.7 tp -57.15 -39.11 74.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.729 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 8.0 mttm -95.61 -29.35 14.38 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.66 179.702 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 59.26 46.64 12.56 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.961 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.2 mtpt -112.26 -36.78 5.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.697 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -129.51 174.54 9.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.663 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.62 ' O ' HG22 ' A' ' 62' ' ' ILE . 3.5 m 61.38 -151.59 0.38 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.546 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.62 HG22 ' O ' ' A' ' 61' ' ' SER . 0.4 OUTLIER 87.92 14.89 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 C-N-CA 122.552 0.341 . . . . 0.0 111.359 -179.89 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 4.3 tptm -148.15 67.38 1.09 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.888 0.375 . . . . 0.0 110.77 179.754 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 16.6 ttpt -117.06 133.49 55.94 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.687 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.611 HG13 ' O ' ' A' ' 91' ' ' ILE . 23.9 t -136.9 139.25 44.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.181 0.515 . . . . 0.0 111.856 -179.497 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' TRP . . . . . 0.739 ' CD1' HD22 ' A' ' 48' ' ' LEU . 13.1 m-90 -100.36 137.73 38.38 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.472 179.03 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.615 HG23 ' CG ' ' A' ' 90' ' ' GLN . 17.6 m -132.38 129.09 38.92 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.586 0.707 . . . . 0.0 112.712 179.835 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.499 ' HE1' HD12 ' A' ' 91' ' ' ILE . 18.4 m-85 -101.32 118.87 37.85 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.02 -0.991 . . . . 0.0 108.76 177.399 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.594 ' HA2' ' O ' ' A' ' 85' ' ' SER . . . 157.99 -156.53 27.44 Favored Glycine 0 CA--C 1.503 -0.698 0 C-N-CA 118.723 -1.703 . . . . 0.0 113.261 179.491 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 2.1 mtp180 -74.97 91.84 2.53 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-O 122.496 1.141 . . . . 0.0 108.561 -179.686 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -149.76 159.31 36.25 Favored Pre-proline 0 C--N 1.308 -1.226 0 CA-C-N 112.764 -2.016 . . . . 0.0 108.036 179.148 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.549 ' O ' ' HB2' ' A' ' 77' ' ' HIS . 28.9 Cg_endo -64.33 -7.03 12.92 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 120.79 0.994 . . . . 0.0 110.845 178.006 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.71 ' HB2' ' HB2' ' A' ' 77' ' ' HIS . . . 136.43 52.38 0.0 OUTLIER 'General case' 0 CA--C 1.49 -1.36 0 CA-C-N 114.542 -1.208 . . . . 0.0 109.281 178.738 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.559 ' HB3' ' HB ' ' A' ' 67' ' ' THR . 0.1 OUTLIER -52.85 -69.48 0.11 Allowed 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 105.823 -1.918 . . . . 0.0 105.823 179.57 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.515 ' N ' ' O ' ' A' ' 67' ' ' THR . 6.1 t70 -95.06 -48.27 6.03 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 105.544 -2.021 . . . . 0.0 105.544 169.649 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.48 ' CZ ' ' HD2' ' A' ' 44' ' ' PRO . 29.0 t80 -144.74 142.61 30.16 Favored 'General case' 0 C--N 1.345 0.402 0 CA-C-N 112.527 -2.124 . . . . 0.0 111.779 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.71 ' HB2' ' HB2' ' A' ' 73' ' ' ALA . 2.0 t60 -97.82 106.96 19.34 Favored 'General case' 0 C--N 1.33 -0.244 0 O-C-N 122.091 -0.381 . . . . 0.0 110.043 176.863 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.445 HD21 ' HA2' ' A' ' 69' ' ' GLY . 0.7 OUTLIER -121.57 -176.48 3.32 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.899 0.38 . . . . 0.0 111.569 -179.841 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -62.21 -174.41 1.98 Allowed Glycine 0 C--N 1.332 0.344 0 C-N-CA 120.953 -0.642 . . . . 0.0 112.445 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -111.89 98.38 7.34 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.926 0.393 . . . . 0.0 111.772 -179.699 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.625 ' HB ' ' HB2' ' A' ' 85' ' ' SER . 1.4 mp -114.85 115.18 48.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.252 178.737 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -56.43 -24.26 43.99 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 -179.077 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -90.07 -105.34 0.09 Allowed 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -178.736 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.444 ' HB3' ' CE1' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -109.11 111.96 23.87 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-O 121.466 0.65 . . . . 0.0 110.132 -179.522 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.625 ' HB2' ' HB ' ' A' ' 81' ' ' ILE . 0.6 OUTLIER 160.17 -48.02 0.0 OUTLIER 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 114.396 -1.275 . . . . 0.0 109.209 -179.753 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.846 ' O ' ' N ' ' A' ' 88' ' ' HIS . 91.6 m-20 -64.92 -151.19 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.247 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 177.546 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.904 ' HB2' HD11 ' A' ' 104' ' ' ILE . 2.1 pttp -46.82 74.42 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.352 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.975 ' O ' ' O ' ' A' ' 104' ' ' ILE . 32.7 t60 -95.45 -18.76 20.42 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 114.047 1.129 . . . . 0.0 114.047 -176.763 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.638 ' HA ' ' H ' ' A' ' 104' ' ' ILE . 0.1 OUTLIER -174.57 154.79 2.1 Favored 'General case' 0 C--N 1.312 -1.046 0 C-N-CA 118.912 -1.115 . . . . 0.0 113.089 178.125 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.615 ' CG ' HG23 ' A' ' 67' ' ' THR . 31.7 mt-30 -137.05 158.4 44.55 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.397 -1.274 . . . . 0.0 113.858 -177.726 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.669 ' HB ' ' HB2' ' A' ' 66' ' ' TRP . 13.4 mt -129.92 127.67 64.08 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.204 178.708 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.891 HD13 ' OD1' ' A' ' 121' ' ' ASN . 0.3 OUTLIER -102.99 142.05 34.74 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.103 0.478 . . . . 0.0 111.874 -179.56 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.851 HD22 ' N ' ' A' ' 94' ' ' GLY . 0.4 OUTLIER -125.74 130.36 51.33 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.481 179.32 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.851 ' N ' HD22 ' A' ' 93' ' ' LEU . . . 88.34 -114.76 4.28 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.621 179.639 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 69.82 -64.94 0.33 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.784 0.326 . . . . 0.0 110.851 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -130.38 32.54 4.43 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.889 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 78.42 31.27 46.75 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.477 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.499 ' C ' HD23 ' A' ' 99' ' ' LEU . 25.0 p-10 -155.36 -178.76 7.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.867 0.365 . . . . 0.0 111.037 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 1.006 HD12 HD22 ' A' ' 124' ' ' LEU . 0.1 OUTLIER -106.87 138.06 43.75 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.742 179.897 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.571 HD23 ' O ' ' A' ' 122' ' ' GLN . 14.8 mt -133.61 148.38 51.56 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.523 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.43 ' O ' ' N ' ' A' ' 122' ' ' GLN . 5.5 mp -112.68 132.18 55.3 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 179.292 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.723 ' HB2' HD12 ' A' ' 92' ' ' LEU . 20.4 t30 -113.33 111.8 22.61 Favored 'General case' 0 CA--C 1.509 -0.607 0 C-N-CA 119.868 -0.733 . . . . 0.0 110.046 -179.773 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.703 ' HB3' HG21 ' A' ' 109' ' ' THR . 72.8 m-20 -84.81 112.26 20.36 Favored 'General case' 0 N--CA 1.442 -0.87 0 C-N-CA 119.835 -0.746 . . . . 0.0 109.452 179.476 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.975 ' O ' ' O ' ' A' ' 88' ' ' HIS . 0.1 OUTLIER -123.16 107.56 19.42 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.018 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 177.875 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.415 ' OG ' ' NE2' ' A' ' 88' ' ' HIS . 75.8 m -130.81 170.74 13.98 Favored 'General case' 0 C--N 1.294 -1.833 0 CA-C-N 114.95 -1.023 . . . . 0.0 109.372 179.646 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 25.1 m -69.39 -63.02 1.15 Allowed 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 118.965 -1.094 . . . . 0.0 111.234 -179.334 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -112.27 -33.21 6.28 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 114.551 1.315 . . . . 0.0 114.551 178.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -146.63 130.26 3.59 Favored Glycine 0 C--N 1.34 0.775 0 N-CA-C 116.976 1.55 . . . . 0.0 116.976 -177.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.703 HG21 ' HB3' ' A' ' 103' ' ' ASP . 6.3 m -121.06 138.23 54.28 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 174.262 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 0.688 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.4 m-90 -119.6 149.28 42.21 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 113.407 0.892 . . . . 0.0 113.407 -178.461 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.475 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -120.96 112.03 18.25 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 115.162 -0.926 . . . . 0.0 108.638 177.495 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 66.9 m-20 44.7 43.17 6.49 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.126 -0.488 . . . . 0.0 112.085 -179.484 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 79.74 26.81 55.56 Favored Glycine 0 N--CA 1.444 -0.813 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.743 179.349 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' GLN . . . . . 0.45 ' O ' HG13 ' A' ' 116' ' ' VAL . 38.6 tt0 -138.11 98.18 3.57 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.073 0.464 . . . . 0.0 110.929 179.728 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.688 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.0 OUTLIER -45.29 128.76 7.91 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.97 179.725 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.45 HG13 ' O ' ' A' ' 114' ' ' GLN . 28.3 m -121.12 -179.31 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.845 -179.329 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -85.65 141.83 29.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.921 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.431 ' HG3' ' HA ' ' A' ' 104' ' ' ILE . 86.7 tttt -66.38 163.14 18.86 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.226 179.471 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.411 ' C ' ' O ' ' A' ' 118' ' ' LYS . 8.1 m-80 34.24 39.05 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 121.203 0.525 . . . . 0.0 111.13 -179.4 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.409 ' OG ' ' NE2' ' A' ' 122' ' ' GLN . 14.8 p -111.13 115.25 29.09 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.991 -179.443 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.891 ' OD1' HD13 ' A' ' 92' ' ' LEU . 11.9 m-80 -59.63 138.52 57.71 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.534 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' GLN . . . . . 0.571 ' O ' HD23 ' A' ' 100' ' ' LEU . 31.5 mm-40 -129.07 144.91 51.35 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.163 0.506 . . . . 0.0 111.829 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.4 tp -72.39 127.03 31.31 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.976 179.503 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 1.006 HD22 HD12 ' A' ' 99' ' ' LEU . 4.7 tp -55.7 143.33 30.94 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.899 0.856 . . . . 0.0 111.763 -179.145 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.746 ' O ' HD11 ' A' ' 147' ' ' ILE . 0.6 OUTLIER -126.87 151.98 47.66 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 114.049 -1.432 . . . . 0.0 109.92 179.133 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 126' ' ' GLN . . . . . 0.473 ' HA ' HD12 ' A' ' 147' ' ' ILE . 0.0 OUTLIER -71.44 114.13 9.19 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.962 0.411 . . . . 0.0 109.988 179.752 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 69.66 25.83 75.1 Favored Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.333 -179.374 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -54.97 159.62 2.3 Favored 'General case' 0 C--N 1.334 -0.103 0 CA-C-O 121.001 0.429 . . . . 0.0 111.068 -179.796 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.471 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 1.1 tt0 -146.56 135.26 22.21 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.559 -179.823 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.698 HD13 ' OD1' ' A' ' 103' ' ' ASP . 3.5 mt -111.37 127.94 68.19 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.184 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 178.53 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.465 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 29.4 m -103.39 144.31 31.55 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.505 -179.531 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.488 ' O ' HD12 ' A' ' 141' ' ' LEU . 5.4 m -140.91 156.31 22.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -179.042 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 72.42 40.05 55.52 Favored Glycine 0 N--CA 1.446 -0.682 0 CA-C-N 115.891 -0.595 . . . . 0.0 112.366 179.599 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.462 HG12 ' N ' ' A' ' 135' ' ' GLY . 95.1 t -75.7 156.64 5.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 121.38 0.61 . . . . 0.0 112.06 -179.256 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.462 ' N ' HG12 ' A' ' 134' ' ' VAL . . . 153.74 -47.35 0.54 Allowed Glycine 0 N--CA 1.441 -0.971 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.8 -179.281 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.646 HG12 ' H ' ' A' ' 138' ' ' SER . 49.3 t -126.66 134.49 66.17 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 CA-C-N 115.216 -0.492 . . . . 0.0 109.908 178.714 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.418 ' HA ' HD12 ' A' ' 140' ' ' ILE . 14.2 pt-20 -51.29 -31.66 22.14 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.835 0.35 . . . . 0.0 111.263 -179.419 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 138' ' ' SER . . . . . 0.646 ' H ' HG12 ' A' ' 136' ' ' VAL . 0.6 OUTLIER -94.05 6.34 48.84 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.119 -0.491 . . . . 0.0 112.118 -179.538 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -129.79 29.62 4.98 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 112.543 0.571 . . . . 0.0 112.543 -179.343 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.465 ' CG2' ' CG2' ' A' ' 131' ' ' THR . 28.3 mt -104.99 141.24 20.8 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.073 179.22 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.488 HD12 ' O ' ' A' ' 132' ' ' VAL . 1.6 mp -118.63 134.94 54.74 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.492 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.592 ' HB3' HG21 ' A' ' 40' ' ' THR . 42.4 t -115.04 152.23 32.85 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.761 0.791 . . . . 0.0 112.686 -179.089 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 1.035 HD21 HG12 ' A' ' 36' ' ' VAL . 1.3 tm? -135.85 129.44 32.38 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 114.488 -1.233 . . . . 0.0 108.96 179.169 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.765 ' N ' HD22 ' A' ' 143' ' ' LEU . 21.4 t -119.78 140.21 44.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.934 0.397 . . . . 0.0 111.83 -178.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -110.56 139.67 33.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.851 179.558 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -115.23 118.71 34.08 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.586 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.762 HG12 HD21 ' A' ' 124' ' ' LEU . 1.7 mt -98.26 133.56 40.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.986 0.422 . . . . 0.0 111.775 -179.602 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 18.5 p-10 -77.94 124.39 27.95 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.738 179.516 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -66.16 -24.87 66.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.313 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 3.2 mptt -59.22 -44.33 92.31 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.991 0.424 . . . . 0.0 110.844 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 20.3 t80 -62.75 -44.35 96.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.093 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 46.1 tttp -58.94 -47.57 84.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.847 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -61.61 -36.94 82.16 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.888 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 11.6 t -62.34 -45.59 92.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.959 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.99 -46.73 67.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.037 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 72.4 mm-40 -58.88 -48.49 81.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.23 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -78.75 -37.07 42.12 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.13 -179.792 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 42.47 45.26 3.79 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.511 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.65 148.12 42.26 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.869 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 38.5 t -99.09 137.19 27.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.132 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 68.5 m-20 -116.47 141.57 48.0 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.791 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 23.2 tpp180 -105.03 106.82 17.49 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.944 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.455 HG23 ' O ' ' A' ' 163' ' ' ILE . 14.2 tt -92.95 123.09 44.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.998 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 2.1 ttt-85 . . . . . 0 C--O 1.25 1.086 0 CA-C-O 118.276 -0.868 . . . . 0.0 110.927 179.922 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.307 0 N-CA-C 112.542 -0.223 . . . . 0.0 112.542 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -124.05 31.74 5.74 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.826 0.346 . . . . 0.0 110.899 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -109.8 94.68 5.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.888 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.446 HG22 ' H ' ' A' ' 5' ' ' THR . 4.7 mt -140.38 164.44 22.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.003 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.446 ' H ' HG22 ' A' ' 4' ' ' ILE . 0.2 OUTLIER 72.4 54.5 0.16 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.176 179.948 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 57.59 79.08 0.34 Allowed Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.994 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -66.88 101.22 0.56 Allowed 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.577 2.185 . . . . 0.0 112.301 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.6 t -149.81 36.74 0.71 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.119 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -166.04 109.62 0.79 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.887 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -132.53 -70.16 0.56 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.883 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 63.0 p -127.71 179.53 5.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.872 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -131.23 -53.48 1.03 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.054 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 25.1 mm-40 -122.75 165.77 16.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.933 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -75.4 162.85 28.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.059 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 40.5 p -112.47 20.55 16.55 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.427 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -64.23 -47.6 79.07 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.932 0.396 . . . . 0.0 110.474 179.833 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 2.0 ptt85 -72.02 -36.35 69.66 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.406 179.363 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 4.1 m-30 -56.86 -39.28 74.0 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.619 179.822 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 14.9 tp -61.9 -32.28 72.65 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.453 179.566 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 7.9 mt -69.15 -42.33 81.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.725 179.729 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -57.69 -35.48 70.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.996 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.58 -36.92 84.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.878 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -58.94 -47.5 84.84 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.065 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 5.9 m -62.99 -35.92 81.83 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.861 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -157.62 89.93 1.06 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.904 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 63.7 tt0 -87.48 137.82 32.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.966 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -88.36 101.96 14.4 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.892 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 19.5 mm -93.12 139.32 18.31 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.308 0 CA-C-O 121.475 0.655 . . . . 0.0 112.048 -179.767 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.405 ' HA2' ' HB ' ' A' ' 32' ' ' ILE . . . 46.51 64.99 2.33 Favored Glycine 0 C--N 1.319 -0.398 0 CA-C-N 114.775 -1.102 . . . . 0.0 113.114 179.741 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -89.02 -32.03 17.79 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.737 0.303 . . . . 0.0 111.275 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -109.43 -13.81 14.52 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-O 121.856 0.836 . . . . 0.0 109.043 178.77 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.609 ' O ' ' CG2' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -70.97 95.46 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.534 0 CA-C-N 114.032 -1.44 . . . . 0.0 111.166 -179.08 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.62 ' CG2' ' HB2' ' A' ' 50' ' ' ALA . 0.4 OUTLIER -32.58 -62.13 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 CA-C-N 115.081 -0.963 . . . . 0.0 111.647 -179.946 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.604 ' N ' ' CG1' ' A' ' 33' ' ' VAL . 23.2 p -165.85 163.44 18.69 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.962 179.757 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 6.7 ttm180 -122.58 125.99 46.81 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.096 179.563 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.676 HG21 ' CZ ' ' A' ' 68' ' ' PHE . 12.3 m -93.67 137.0 23.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.993 -0.548 . . . . 0.0 111.169 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.857 HG23 HG12 ' A' ' 45' ' ' ILE . 19.0 mt -130.74 106.88 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 CA-C-O 120.954 0.406 . . . . 0.0 111.787 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.535 ' SG ' HD23 ' A' ' 143' ' ' LEU . 0.1 OUTLIER -99.78 99.73 10.58 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 177.949 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 9.5 t -108.62 26.7 10.22 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -178.322 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.885 HG21 ' HB2' ' A' ' 142' ' ' SER . 77.4 p -111.39 -6.35 14.49 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 111.679 0.252 . . . . 0.0 111.679 179.764 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 101.59 61.64 0.76 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.425 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.575 ' HB3' HD12 ' A' ' 43' ' ' ILE . 3.8 mt-30 -141.66 -69.5 0.37 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.708 0.29 . . . . 0.0 110.904 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.765 HG23 HD21 ' A' ' 78' ' ' LEU . 3.5 mp -135.06 129.92 19.19 Favored Pre-proline 0 N--CA 1.452 -0.36 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.091 179.764 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.435 ' HD2' ' CZ ' ' A' ' 76' ' ' TYR . 35.5 Cg_exo -59.36 147.0 93.12 Favored 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 122.702 2.268 . . . . 0.0 111.848 179.743 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.857 HG12 HG23 ' A' ' 37' ' ' ILE . 40.8 mt -44.73 127.5 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.076 -0.511 . . . . 0.0 112.044 -179.416 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.597 ' O ' HG22 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -130.36 130.25 44.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.92 179.124 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -86.86 119.54 27.19 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.079 0.466 . . . . 0.0 111.629 -179.19 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.987 HD22 ' CD1' ' A' ' 66' ' ' TRP . 9.1 mt -99.5 138.89 35.96 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.054 178.621 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.609 ' OG ' ' N ' ' A' ' 50' ' ' ALA . 45.5 t -131.49 -171.55 2.63 Favored 'General case' 0 CA--C 1.511 -0.536 0 CA-C-O 123.09 1.424 . . . . 0.0 113.971 -179.173 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.62 ' HB2' ' CG2' ' A' ' 33' ' ' VAL . . . -157.16 165.27 36.47 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 112.537 -2.119 . . . . 0.0 110.941 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.526 ' O ' HG23 ' A' ' 55' ' ' VAL . 3.3 m-20 -106.59 121.76 44.95 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.043 0.449 . . . . 0.0 110.785 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 7.5 mt -64.63 -34.65 71.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.889 -179.581 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.1 m -60.24 -43.74 95.84 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.606 -178.599 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.438 ' HG2' ' CB ' ' A' ' 51' ' ' ASP . 9.9 pt20 -68.58 -37.56 79.95 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.702 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.613 HG11 HD21 ' A' ' 155' ' ' LEU . 23.9 t -74.09 -37.87 47.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.06 179.734 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.3 tt -56.74 -36.26 69.55 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.749 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -99.88 -29.82 12.37 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.693 179.606 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 56.6 57.49 4.78 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.878 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.95 -47.32 0.16 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.771 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.73 120.21 24.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.847 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.48 ' O ' HG22 ' A' ' 62' ' ' ILE . 0.4 OUTLIER 62.5 -83.66 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.927 179.963 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.48 HG22 ' O ' ' A' ' 61' ' ' SER . 6.8 tp 43.54 34.61 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.173 0 CA-C-O 121.07 0.462 . . . . 0.0 111.322 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.65 79.12 1.15 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.938 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.403 ' O ' ' HB3' ' A' ' 93' ' ' LEU . 18.9 ttpt -117.43 131.11 56.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.472 179.609 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.593 HG13 ' O ' ' A' ' 91' ' ' ILE . 9.0 t -130.49 136.94 57.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.99 0.424 . . . . 0.0 111.654 -179.191 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' TRP . . . . . 0.987 ' CD1' HD22 ' A' ' 48' ' ' LEU . 16.0 m-90 -99.8 138.89 36.25 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.536 179.218 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.837 HG23 ' HG3' ' A' ' 90' ' ' GLN . 2.2 m -131.86 128.33 38.42 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.676 ' CZ ' HG21 ' A' ' 36' ' ' VAL . 81.4 m-85 -96.74 118.09 32.44 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 177.374 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.547 ' HA3' ' C ' ' A' ' 86' ' ' ASN . . . 157.73 -154.87 25.92 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 118.56 -1.781 . . . . 0.0 113.263 179.547 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.515 ' HG2' ' HA ' ' A' ' 80' ' ' ASN . 61.9 mtp180 -75.87 91.09 2.97 Favored 'General case' 0 N--CA 1.44 -0.931 0 CA-C-O 122.481 1.134 . . . . 0.0 108.196 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 29.2 m-80 -150.12 160.1 34.06 Favored Pre-proline 0 C--N 1.31 -1.143 0 CA-C-N 112.897 -1.956 . . . . 0.0 108.658 179.503 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.528 ' O ' ' CB ' ' A' ' 73' ' ' ALA . 35.6 Cg_endo -65.22 -9.66 22.81 Favored 'Trans proline' 0 N--CA 1.452 -0.931 0 C-N-CA 120.73 0.954 . . . . 0.0 110.564 177.257 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.792 ' HB2' ' HB2' ' A' ' 77' ' ' HIS . . . 138.92 52.47 0.0 OUTLIER 'General case' 0 CA--C 1.492 -1.288 0 CA-C-N 114.537 -1.211 . . . . 0.0 109.405 178.785 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.563 ' HB3' ' HB ' ' A' ' 67' ' ' THR . 0.1 OUTLIER -53.07 -69.87 0.1 Allowed 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 106.135 -1.802 . . . . 0.0 106.135 179.539 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.583 ' HB2' ' N ' ' A' ' 67' ' ' THR . 5.5 t70 -94.14 -47.49 6.63 Favored 'General case' 0 N--CA 1.436 -1.144 0 N-CA-C 105.577 -2.008 . . . . 0.0 105.577 169.837 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.543 ' C ' ' HA ' ' A' ' 73' ' ' ALA . 14.4 t80 -144.0 142.78 30.89 Favored 'General case' 0 C--N 1.343 0.315 0 CA-C-N 112.37 -2.195 . . . . 0.0 110.91 179.664 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.792 ' HB2' ' HB2' ' A' ' 73' ' ' ALA . 0.8 OUTLIER -84.83 107.12 16.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 118.41 0.55 . . . . 0.0 110.014 177.589 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.765 HD21 HG23 ' A' ' 43' ' ' ILE . 29.9 mt -111.96 156.63 21.81 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.849 0.357 . . . . 0.0 111.114 -179.662 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -60.26 -160.25 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.586 -0.816 . . . . 0.0 111.792 179.436 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.515 ' HA ' ' HG2' ' A' ' 70' ' ' ARG . 9.4 p30 -109.42 98.9 8.21 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 117.001 0.4 . . . . 0.0 111.112 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.499 ' HB ' ' HB2' ' A' ' 85' ' ' SER . 37.9 mm -113.72 154.61 15.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.567 179.387 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.417 ' N ' HG22 ' A' ' 81' ' ' ILE . 0.8 OUTLIER -67.48 -44.83 77.57 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 -178.922 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 1.6 mpp_? -122.81 -92.09 0.54 Allowed 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 113.658 0.985 . . . . 0.0 113.658 -177.753 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.487 ' O ' ' CB ' ' A' ' 85' ' ' SER . 0.0 OUTLIER -79.05 101.85 8.07 Favored 'General case' 0 CA--C 1.506 -0.724 0 CA-C-O 121.973 0.892 . . . . 0.0 110.961 -178.546 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.521 ' O ' ' HA2' ' A' ' 69' ' ' GLY . 0.4 OUTLIER 150.03 -28.59 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 113.155 -1.839 . . . . 0.0 108.834 -179.793 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.826 ' O ' ' N ' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -85.47 -164.66 1.04 Allowed 'General case' 0 CA--C 1.51 -0.589 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 177.465 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.923 ' HB2' HD11 ' A' ' 104' ' ' ILE . 2.5 ptmt -47.74 73.85 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 178.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.99 ' O ' ' O ' ' A' ' 104' ' ' ILE . 25.1 t60 -91.66 -17.35 25.63 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 114.243 1.201 . . . . 0.0 114.243 -176.779 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.624 ' HA ' ' H ' ' A' ' 104' ' ' ILE . 0.2 OUTLIER -173.56 155.3 2.73 Favored 'General case' 0 C--N 1.314 -0.938 0 C-N-CA 118.946 -1.102 . . . . 0.0 112.775 177.845 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.837 ' HG3' HG23 ' A' ' 67' ' ' THR . 0.5 OUTLIER -135.18 154.43 51.62 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.579 -1.191 . . . . 0.0 113.868 -177.67 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.666 ' HB ' ' HB2' ' A' ' 66' ' ' TRP . 49.3 mt -124.91 132.14 71.7 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.734 178.435 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.667 HD13 ' ND2' ' A' ' 121' ' ' ASN . 0.3 OUTLIER -108.6 140.57 41.78 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.139 0.495 . . . . 0.0 112.249 -179.168 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.87 HD22 ' N ' ' A' ' 94' ' ' GLY . 0.6 OUTLIER -125.54 135.07 51.87 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.173 179.129 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.87 ' N ' HD22 ' A' ' 93' ' ' LEU . . . 97.17 108.99 2.63 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.605 -0.807 . . . . 0.0 112.693 179.691 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 178.51 68.73 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.959 0.409 . . . . 0.0 110.574 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 60.73 31.03 20.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.659 -179.671 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 101.58 162.95 27.14 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.31 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 65.12 -173.35 0.18 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.841 0.353 . . . . 0.0 110.972 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.769 ' HB2' HD13 ' A' ' 124' ' ' LEU . 8.1 mp -123.99 160.77 26.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.878 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.654 HD23 ' HB3' ' A' ' 121' ' ' ASN . 7.9 mp -123.72 148.29 46.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.171 179.735 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.457 ' O ' ' N ' ' A' ' 122' ' ' GLN . 12.3 mt -118.1 130.5 56.17 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.813 -0.355 . . . . 0.0 110.263 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.517 ' HB2' HD11 ' A' ' 92' ' ' LEU . 24.8 t30 -113.32 111.58 22.25 Favored 'General case' 0 CA--C 1.512 -0.516 0 C-N-CA 120.017 -0.673 . . . . 0.0 109.686 179.611 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.687 ' HB3' HG21 ' A' ' 109' ' ' THR . 72.3 m-20 -84.96 111.93 20.13 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 119.826 -0.749 . . . . 0.0 110.13 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.99 ' O ' ' O ' ' A' ' 88' ' ' HIS . 0.1 OUTLIER -124.47 108.18 19.89 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.91 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 177.393 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 67.1 m -129.77 174.16 9.98 Favored 'General case' 0 C--N 1.296 -1.737 0 CA-C-N 115.285 -0.871 . . . . 0.0 109.312 179.353 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 23.3 m -69.25 -63.85 0.99 Allowed 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 118.998 -1.081 . . . . 0.0 111.435 -179.271 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 5.5 p30 -112.48 -32.91 6.33 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 114.181 1.178 . . . . 0.0 114.181 178.781 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -145.98 131.47 4.13 Favored Glycine 0 C--N 1.339 0.695 0 N-CA-C 116.558 1.383 . . . . 0.0 116.558 -178.133 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.687 HG21 ' HB3' ' A' ' 103' ' ' ASP . 5.8 m -121.19 138.29 54.28 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 174.697 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 0.769 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.4 m-90 -119.78 149.18 42.47 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 113.503 0.927 . . . . 0.0 113.503 -178.542 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.474 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -122.84 112.25 17.64 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 114.997 -1.001 . . . . 0.0 108.644 177.603 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 46.25 43.73 11.63 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.091 -0.504 . . . . 0.0 112.18 -179.546 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 79.49 17.41 75.91 Favored Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.913 179.257 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -130.39 97.85 4.53 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.053 0.454 . . . . 0.0 110.713 179.634 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.769 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.0 OUTLIER -44.75 134.3 5.62 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.059 179.886 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.552 HG22 ' N ' ' A' ' 117' ' ' GLU . 14.7 p -127.57 164.2 29.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.45 -179.163 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.552 ' N ' HG22 ' A' ' 116' ' ' VAL . 19.1 tt0 -70.13 141.83 52.63 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.975 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.469 ' HG3' ' HA ' ' A' ' 104' ' ' ILE . 36.3 tttm -65.23 163.69 14.76 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.217 179.552 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.4 ' N ' ' HG2' ' A' ' 118' ' ' LYS . 0.8 OUTLIER 36.16 39.13 0.08 Allowed 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 121.255 0.55 . . . . 0.0 110.747 -179.438 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 4.7 p -110.82 108.94 18.94 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.034 -179.305 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.667 ' ND2' HD13 ' A' ' 92' ' ' LEU . 1.6 m-20 -58.77 139.37 56.38 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.798 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' GLN . . . . . 0.651 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 44.0 mm-40 -129.85 147.42 51.62 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-O 120.964 0.412 . . . . 0.0 111.919 -179.651 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.1 tp -72.3 112.01 8.0 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 178.832 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.983 HD21 HD13 ' A' ' 147' ' ' ILE . 3.7 tt -44.0 145.91 0.68 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.726 0.774 . . . . 0.0 112.143 -178.716 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -126.4 153.15 45.38 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 114.225 -1.352 . . . . 0.0 110.33 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -71.56 113.78 8.95 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 179.51 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 70.33 26.5 74.1 Favored Glycine 0 N--CA 1.444 -0.787 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.338 -179.32 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -56.54 159.89 3.52 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.02 0.438 . . . . 0.0 111.198 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.623 ' HG3' HG22 ' A' ' 144' ' ' VAL . 5.1 tt0 -146.53 135.07 22.07 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.415 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.428 ' CG2' ' O ' ' A' ' 110' ' ' TRP . 7.8 mm -111.68 128.31 68.3 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.119 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 178.761 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.544 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 3.4 m -103.66 144.74 31.04 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.81 -179.493 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.467 HG11 ' NE2' ' A' ' 88' ' ' HIS . 4.4 m -141.28 158.39 22.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 112.462 0.542 . . . . 0.0 112.462 -178.801 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 70.26 43.99 61.23 Favored Glycine 0 N--CA 1.447 -0.586 0 CA-C-N 115.75 -0.659 . . . . 0.0 112.398 179.269 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.499 ' HA ' HG12 ' A' ' 140' ' ' ILE . 93.6 t -79.26 155.73 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 CA-C-O 121.436 0.636 . . . . 0.0 112.234 -179.13 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.436 ' N ' HG12 ' A' ' 134' ' ' VAL . . . 150.07 -43.88 0.72 Allowed Glycine 0 N--CA 1.442 -0.939 0 CA-C-N 114.908 -1.042 . . . . 0.0 110.529 -178.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.55 HG12 ' H ' ' A' ' 138' ' ' SER . 46.3 t -126.6 130.87 71.7 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.687 0 CA-C-N 115.08 -0.56 . . . . 0.0 109.753 178.583 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.442 ' HA ' HD12 ' A' ' 140' ' ' ILE . 7.5 tt0 -51.07 -33.9 27.73 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.731 0.3 . . . . 0.0 111.493 -179.198 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' SER . . . . . 0.55 ' H ' HG12 ' A' ' 136' ' ' VAL . 83.0 p -94.14 6.25 49.17 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.243 0.461 . . . . 0.0 112.243 -179.464 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -127.54 30.15 5.39 Favored 'General case' 0 CA--C 1.52 -0.206 0 N-CA-C 112.408 0.521 . . . . 0.0 112.408 -179.373 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.544 ' CG2' ' CG2' ' A' ' 131' ' ' THR . 14.9 mt -106.0 141.28 21.65 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.935 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.392 179.213 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.494 HD22 ' C ' ' A' ' 140' ' ' ILE . 3.6 mm? -115.64 135.67 53.83 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.052 -0.977 . . . . 0.0 110.51 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.885 ' HB2' HG21 ' A' ' 40' ' ' THR . 4.2 m -120.01 153.67 35.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.814 0.816 . . . . 0.0 112.669 -179.273 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.824 HD22 ' N ' ' A' ' 144' ' ' VAL . 1.2 tm? -135.45 135.38 40.49 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 114.49 -1.232 . . . . 0.0 108.835 179.451 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.824 ' N ' HD22 ' A' ' 143' ' ' LEU . 21.2 t -122.67 140.46 46.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 112.217 0.451 . . . . 0.0 112.217 -178.717 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.559 HG13 HG12 ' A' ' 36' ' ' VAL . 0.6 OUTLIER -108.45 138.79 33.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.43 179.378 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 18.3 t80 -121.23 104.17 9.54 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.783 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.983 HD13 HD21 ' A' ' 124' ' ' LEU . 1.6 mp -102.39 130.67 51.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.281 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 11.3 p30 -78.33 141.16 38.64 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.929 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -73.27 -22.62 60.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.182 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 28.0 mmtt -58.26 -43.87 88.12 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-O 120.898 0.38 . . . . 0.0 110.712 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 11.4 t80 -58.99 -44.58 91.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.831 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.53 -34.34 73.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.002 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -59.68 -46.22 89.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.913 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 12.0 t -59.65 -43.67 93.82 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.866 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.613 HD21 HG11 ' A' ' 55' ' ' VAL . 0.2 OUTLIER -67.06 -37.72 84.54 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.011 -179.917 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -60.35 -48.01 83.61 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.887 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.417 ' O ' ' N ' ' A' ' 159' ' ' LYS . 0.7 OUTLIER -83.42 -28.76 28.61 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.056 -179.919 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 43.68 -90.73 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.658 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 159' ' ' LYS . . . . . 0.417 ' N ' ' O ' ' A' ' 157' ' ' GLN . 4.8 tptt -108.33 149.93 28.02 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.839 0.352 . . . . 0.0 110.904 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.521 ' O ' HG13 ' A' ' 160' ' ' VAL . 12.0 p -70.23 118.08 14.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.104 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -165.75 148.88 7.7 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.764 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -174.37 99.45 0.1 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.903 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 3.3 pt -79.25 134.81 27.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.113 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.096 0 CA-C-O 118.277 -0.868 . . . . 0.0 110.938 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.29 0 N-CA-C 112.438 -0.265 . . . . 0.0 112.438 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -77.93 -38.89 44.42 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.775 0.321 . . . . 0.0 110.91 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -160.7 -57.15 0.05 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.88 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 52.6 mt 62.12 85.39 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.953 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.6 t -59.53 141.16 55.44 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.123 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -142.64 154.37 62.89 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.931 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -67.91 75.12 0.65 Allowed 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.517 2.145 . . . . 0.0 112.178 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.1 t -95.18 154.34 17.23 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.175 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 17.4 mt-30 -115.78 78.91 1.23 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.838 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -80.94 170.87 15.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.846 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -153.15 78.59 1.17 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.959 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.88 153.57 41.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.115 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 21.6 pt20 -76.55 113.08 13.78 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.909 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -173.43 115.64 0.25 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.063 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -143.6 -59.1 0.41 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.141 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.6 ' HA ' HD12 ' A' ' 19' ' ' LEU . 5.2 pt20 -59.94 -31.93 70.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.895 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.09 -40.27 71.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.84 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -61.08 -35.76 77.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.874 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.6 HD12 ' HA ' ' A' ' 16' ' ' GLN . 3.8 mt -57.36 -37.31 72.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.024 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 35.7 mm -68.43 -41.39 83.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.171 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -57.67 -39.49 77.21 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.126 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -64.26 -40.43 95.98 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.075 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -68.32 -47.5 67.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.182 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 13.4 p -62.72 -36.41 82.89 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.975 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 4.7 tp60 69.19 -66.2 0.26 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.985 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -62.97 124.04 20.08 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.872 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 3.2 tt0 -85.7 115.63 23.49 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.924 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 23.0 mm -82.33 139.45 17.85 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.347 0 CA-C-O 121.459 0.647 . . . . 0.0 111.737 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -100.94 72.07 0.4 Allowed Glycine 0 C--N 1.318 -0.465 0 CA-C-N 114.904 -1.044 . . . . 0.0 112.595 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -84.92 -24.95 28.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.733 0.301 . . . . 0.0 110.995 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -108.72 -13.82 14.72 Favored 'General case' 0 CA--C 1.516 -0.347 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 178.333 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.595 ' O ' ' CG2' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -70.77 96.33 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.635 0 CA-C-N 113.928 -1.487 . . . . 0.0 110.689 -179.48 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.906 HG23 ' HB3' ' A' ' 50' ' ' ALA . 0.8 OUTLIER -33.46 -62.51 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 114.996 -1.002 . . . . 0.0 112.244 -179.157 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.64 ' N ' HG12 ' A' ' 33' ' ' VAL . 22.4 m -160.7 164.85 31.36 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.092 0.472 . . . . 0.0 111.637 -179.487 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 3.1 tmm_? -132.72 114.34 14.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.445 179.469 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.923 HG23 ' CD2' ' A' ' 48' ' ' LEU . 40.0 t -90.27 136.08 24.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.612 179.767 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.932 HG23 HG12 ' A' ' 45' ' ' ILE . 21.5 mt -124.09 107.97 19.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -179.248 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.799 ' SG ' HD12 ' A' ' 143' ' ' LEU . 70.3 m -99.82 102.91 14.47 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 177.565 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.492 ' CG2' HG22 ' A' ' 37' ' ' ILE . 1.4 p -108.86 -21.54 12.61 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 113.509 0.929 . . . . 0.0 113.509 -176.866 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.73 HG21 ' HB2' ' A' ' 142' ' ' SER . 34.0 p -55.67 -20.67 14.92 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.745 0.307 . . . . 0.0 111.525 -179.428 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 113.53 62.87 0.43 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.285 179.705 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.666 ' HG3' HD12 ' A' ' 141' ' ' LEU . 3.2 mt-30 -144.18 -54.16 0.34 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.703 0.287 . . . . 0.0 111.361 -179.718 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.926 HG22 ' HD2' ' A' ' 44' ' ' PRO . 0.0 OUTLIER -134.76 154.62 79.54 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.33 -178.961 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.926 ' HD2' HG22 ' A' ' 43' ' ' ILE . 90.1 Cg_endo -83.78 146.86 11.94 Favored 'Trans proline' 0 N--CA 1.459 -0.511 0 C-N-CA 122.648 2.232 . . . . 0.0 111.569 179.402 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.932 HG12 HG23 ' A' ' 37' ' ' ILE . 40.8 mt -47.85 112.0 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 120.926 0.393 . . . . 0.0 111.728 -179.5 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 7.4 mmm180 -114.91 130.05 56.83 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.684 178.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -97.98 120.08 37.74 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.094 0.473 . . . . 0.0 111.928 -178.83 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.923 ' CD2' HG23 ' A' ' 36' ' ' VAL . 0.2 OUTLIER -92.59 137.21 32.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.238 178.641 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.534 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -135.79 163.16 30.83 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 113.258 0.836 . . . . 0.0 113.258 -178.601 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.906 ' HB3' HG23 ' A' ' 33' ' ' VAL . . . -157.48 142.16 16.58 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.626 -1.17 . . . . 0.0 111.195 179.111 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.408 ' CB ' ' HG3' ' A' ' 54' ' ' GLN . 0.1 OUTLIER -64.31 137.19 57.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.227 -179.9 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 12.4 mt -63.87 -38.19 81.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.994 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -56.42 -34.46 66.8 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.929 -179.565 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.408 ' HG3' ' CB ' ' A' ' 51' ' ' ASP . 0.6 OUTLIER -63.64 -43.61 96.28 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.613 179.974 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.462 HG21 ' CZ ' ' A' ' 151' ' ' PHE . 20.2 t -74.07 -38.17 48.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.206 179.781 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.3 mt -57.99 -37.38 74.14 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.856 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 8.4 mttm -88.64 -51.82 5.48 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.799 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 57.55 51.11 10.04 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.952 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -175.9 39.54 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.974 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 2.2 ttt-85 -163.65 -75.54 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.048 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 4.9 m -106.83 20.9 18.36 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.178 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.563 ' O ' HG23 ' A' ' 62' ' ' ILE . 0.8 OUTLIER -86.88 60.38 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.939 0.399 . . . . 0.0 111.107 179.974 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -154.32 80.97 1.12 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.916 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.41 ' O ' ' HB3' ' A' ' 93' ' ' LEU . 12.4 ttpt -134.32 134.44 41.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.585 179.813 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.621 HG13 ' O ' ' A' ' 91' ' ' ILE . 11.8 t -132.88 137.36 54.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.052 0.453 . . . . 0.0 111.763 -179.125 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' TRP . . . . . 0.839 ' CD1' HD12 ' A' ' 48' ' ' LEU . 14.9 m-90 -99.6 139.7 34.87 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.431 179.081 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.843 HG23 ' CG ' ' A' ' 90' ' ' GLN . 4.8 m -129.56 131.39 46.54 Favored 'General case' 0 CA--C 1.52 -0.194 0 CA-C-O 121.416 0.626 . . . . 0.0 112.46 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.503 ' CE2' ' CE2' ' A' ' 89' ' ' PHE . 90.1 m-85 -103.03 118.35 36.62 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.12 177.833 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.574 ' HA2' ' O ' ' A' ' 85' ' ' SER . . . 158.2 -156.12 27.09 Favored Glycine 0 CA--C 1.504 -0.656 0 C-N-CA 118.883 -1.627 . . . . 0.0 112.432 179.468 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.465 ' CD ' ' HB3' ' A' ' 86' ' ' ASN . 7.5 ptm180 -75.74 92.09 2.98 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-O 122.549 1.166 . . . . 0.0 108.377 179.703 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -149.18 159.81 36.21 Favored Pre-proline 0 C--N 1.311 -1.089 0 CA-C-N 112.783 -2.008 . . . . 0.0 108.46 179.511 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.556 ' O ' ' HB2' ' A' ' 77' ' ' HIS . 32.7 Cg_endo -64.96 -7.85 16.39 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 121.025 1.15 . . . . 0.0 111.095 178.295 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.774 ' HB2' ' HB2' ' A' ' 77' ' ' HIS . . . 136.18 50.89 0.0 OUTLIER 'General case' 0 CA--C 1.49 -1.331 0 CA-C-N 114.661 -1.154 . . . . 0.0 109.656 178.704 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.564 ' HB3' ' HB ' ' A' ' 67' ' ' THR . 0.1 OUTLIER -53.24 -69.74 0.11 Allowed 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 105.863 -1.903 . . . . 0.0 105.863 179.438 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.576 ' N ' ' O ' ' A' ' 67' ' ' THR . 11.2 t0 -95.33 -46.92 6.52 Favored 'General case' 0 N--CA 1.435 -1.196 0 N-CA-C 105.915 -1.883 . . . . 0.0 105.915 169.766 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.55 ' CD2' HG22 ' A' ' 43' ' ' ILE . 61.4 t80 -143.77 142.73 31.05 Favored 'General case' 0 C--N 1.346 0.453 0 CA-C-N 112.62 -2.082 . . . . 0.0 111.113 179.832 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.774 ' HB2' ' HB2' ' A' ' 73' ' ' ALA . 1.3 t60 -94.23 108.91 20.75 Favored 'General case' 0 C--N 1.328 -0.329 0 O-C-N 121.984 -0.447 . . . . 0.0 110.413 177.125 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.804 HD12 ' O ' ' A' ' 79' ' ' GLY . 3.9 pp -126.17 170.92 11.33 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.82 0.343 . . . . 0.0 110.735 179.48 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.804 ' O ' HD12 ' A' ' 78' ' ' LEU . . . -53.16 -176.3 0.06 OUTLIER Glycine 0 CA--C 1.518 0.245 0 C-N-CA 120.897 -0.668 . . . . 0.0 112.745 -179.754 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.541 ' C ' HD12 ' A' ' 81' ' ' ILE . 0.5 OUTLIER -108.25 102.25 11.39 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.85 0.357 . . . . 0.0 110.881 179.859 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.741 HD13 ' HB3' ' A' ' 85' ' ' SER . 2.0 mp -110.11 153.99 11.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.919 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 10.0 t -68.19 -45.31 73.76 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 113.72 1.007 . . . . 0.0 113.72 -178.717 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.778 ' HB3' HD13 ' A' ' 84' ' ' LEU . 3.1 mpt_? -120.4 -90.1 0.59 Allowed 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 113.74 1.015 . . . . 0.0 113.74 -177.338 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.778 HD13 ' HB3' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -84.72 103.51 13.88 Favored 'General case' 0 CA--C 1.506 -0.741 0 CA-C-O 122.014 0.912 . . . . 0.0 110.836 -178.622 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.741 ' HB3' HD13 ' A' ' 81' ' ' ILE . 0.4 OUTLIER 148.13 -35.8 0.01 OUTLIER 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 113.072 -1.876 . . . . 0.0 108.607 -179.812 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.809 ' O ' ' N ' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -70.42 -161.55 0.05 Allowed 'General case' 0 CA--C 1.513 -0.477 0 N-CA-C 107.586 -1.265 . . . . 0.0 107.586 177.492 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.831 ' HB2' HD11 ' A' ' 104' ' ' ILE . 9.6 pttt -51.54 72.82 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 178.129 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.93 ' O ' ' O ' ' A' ' 104' ' ' ILE . 32.9 t60 -84.51 -17.09 40.09 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 114.389 1.255 . . . . 0.0 114.389 -176.374 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.665 ' HA ' ' H ' ' A' ' 104' ' ' ILE . 0.1 OUTLIER -172.09 154.18 3.34 Favored 'General case' 0 C--N 1.31 -1.124 0 C-N-CA 119.124 -1.03 . . . . 0.0 112.48 177.867 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.843 ' CG ' HG23 ' A' ' 67' ' ' THR . 32.9 mt-30 -136.04 159.05 42.88 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 114.52 -1.218 . . . . 0.0 113.902 -177.294 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.733 HD11 HG21 ' A' ' 36' ' ' VAL . 7.1 mt -125.25 131.85 71.86 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 CA-C-N 114.949 -1.023 . . . . 0.0 109.703 178.607 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.662 HD22 ' ND2' ' A' ' 121' ' ' ASN . 0.3 OUTLIER -108.05 143.78 36.29 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.083 0.468 . . . . 0.0 112.111 -179.421 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.71 HD13 ' CG2' ' A' ' 33' ' ' VAL . 14.3 tp -125.6 122.68 37.15 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.349 179.038 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 120.44 -136.62 11.6 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.401 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.542 ' OE1' HD13 ' A' ' 100' ' ' LEU . 9.1 mt-10 57.69 81.43 0.15 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.835 0.35 . . . . 0.0 110.862 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 61.15 28.76 18.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.894 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 84.2 -177.94 51.85 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.55 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 22.1 m120 63.35 177.76 0.16 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.848 0.356 . . . . 0.0 110.984 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.412 HD22 ' SG ' ' A' ' 34' ' ' CYS . 1.2 mt -106.76 153.09 22.96 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.854 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.614 HD22 ' HB3' ' A' ' 121' ' ' ASN . 5.6 mt -133.79 148.46 51.35 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.434 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.447 ' O ' ' N ' ' A' ' 122' ' ' GLN . 38.0 mt -117.27 130.99 56.91 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 179.777 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.512 ' HB2' HD11 ' A' ' 92' ' ' LEU . 23.8 t30 -113.25 111.31 21.83 Favored 'General case' 0 CA--C 1.51 -0.581 0 C-N-CA 119.847 -0.741 . . . . 0.0 109.944 179.684 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.724 ' HB3' HG21 ' A' ' 109' ' ' THR . 70.7 m-20 -84.43 112.52 20.44 Favored 'General case' 0 N--CA 1.444 -0.773 0 C-N-CA 119.669 -0.812 . . . . 0.0 109.381 179.4 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.93 ' O ' ' O ' ' A' ' 88' ' ' HIS . 0.1 OUTLIER -122.91 107.61 19.67 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.876 0 CA-C-O 121.756 0.789 . . . . 0.0 108.96 178.136 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.439 ' OG ' ' NE2' ' A' ' 88' ' ' HIS . 66.8 m -132.39 171.49 13.67 Favored 'General case' 0 C--N 1.295 -1.77 0 CA-C-N 114.757 -1.11 . . . . 0.0 109.36 179.551 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 22.6 m -69.5 -63.8 1.0 Allowed 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 118.998 -1.081 . . . . 0.0 111.706 -178.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 5.5 p30 -112.6 -32.76 6.35 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 114.63 1.344 . . . . 0.0 114.63 179.203 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -146.13 129.17 3.28 Favored Glycine 0 C--N 1.339 0.719 0 N-CA-C 116.931 1.532 . . . . 0.0 116.931 -177.796 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.724 HG21 ' HB3' ' A' ' 103' ' ' ASP . 6.5 m -121.15 138.36 54.24 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 174.411 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 0.639 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.7 m-90 -120.45 149.2 42.76 Favored 'General case' 0 CA--C 1.515 -0.374 0 N-CA-C 113.283 0.846 . . . . 0.0 113.283 -178.447 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.469 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -121.64 111.85 17.71 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 115.001 -0.999 . . . . 0.0 108.563 177.44 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 44.74 43.79 7.06 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.125 -0.489 . . . . 0.0 112.114 -179.511 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 78.88 31.4 44.0 Favored Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.891 179.238 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -141.95 98.93 3.42 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.999 0.428 . . . . 0.0 110.832 179.648 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.639 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.2 OUTLIER -45.22 122.59 3.49 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.786 179.727 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.515 HG21 ' OD2' ' A' ' 103' ' ' ASP . 8.1 m -112.35 179.56 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.902 -179.047 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.431 ' HB3' ' HB3' ' A' ' 120' ' ' SER . 0.5 OUTLIER -88.13 136.96 32.73 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.809 179.89 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.405 ' HG2' ' N ' ' A' ' 119' ' ' ASN . 63.7 tttm -62.73 162.39 10.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.534 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.405 ' N ' ' HG2' ' A' ' 118' ' ' LYS . 4.9 p-10 34.46 38.54 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.364 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.431 ' HB3' ' HB3' ' A' ' 117' ' ' GLU . 9.0 p -111.28 114.23 27.28 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.055 -179.334 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.662 ' ND2' HD22 ' A' ' 92' ' ' LEU . 1.6 m120 -61.76 136.26 57.92 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.616 179.777 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' GLN . . . . . 0.608 ' C ' HD23 ' A' ' 100' ' ' LEU . 32.0 mm-40 -129.53 145.37 51.47 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.119 0.485 . . . . 0.0 112.161 -179.613 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.6 tp -72.62 120.03 17.67 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.562 178.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.567 HD22 ' C ' ' A' ' 124' ' ' LEU . 0.0 OUTLIER -47.6 149.22 1.23 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 122.026 0.917 . . . . 0.0 112.346 -178.661 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.435 ' O ' ' CD1' ' A' ' 147' ' ' ILE . 0.0 OUTLIER -126.42 152.56 46.2 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 114.102 -1.408 . . . . 0.0 109.661 179.195 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.62 113.75 8.03 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.07 0.462 . . . . 0.0 110.136 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 66.49 29.96 75.69 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.375 -179.469 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.452 ' OD2' HD13 ' A' ' 111' ' ' LEU . 9.8 t70 -58.31 161.05 4.61 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.98 0.419 . . . . 0.0 111.343 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -146.28 135.35 22.63 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.044 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.464 ' CD1' ' CE1' ' A' ' 89' ' ' PHE . 3.9 mt -109.91 128.53 65.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 120.831 0.348 . . . . 0.0 110.258 179.213 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.482 HG23 ' CG2' ' A' ' 140' ' ' ILE . 16.8 m -103.19 142.66 33.79 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.634 -179.57 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.5 HG11 ' CD2' ' A' ' 88' ' ' HIS . 4.4 m -140.72 154.09 21.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.298 -0.41 . . . . 0.0 112.008 -179.11 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 75.16 37.03 43.86 Favored Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 121.127 -0.559 . . . . 0.0 112.402 179.549 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.489 ' HA ' HG12 ' A' ' 140' ' ' ILE . 91.5 t -72.89 156.75 6.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 121.44 0.638 . . . . 0.0 112.081 -179.174 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.461 ' N ' HG12 ' A' ' 134' ' ' VAL . . . 153.59 -47.86 0.53 Allowed Glycine 0 N--CA 1.442 -0.957 0 N-CA-C 110.665 -0.974 . . . . 0.0 110.665 -179.297 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.65 HG12 ' H ' ' A' ' 138' ' ' SER . 56.1 t -126.71 134.61 65.87 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.682 0 CA-C-N 115.295 -0.453 . . . . 0.0 109.877 178.607 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.447 ' HA ' HD12 ' A' ' 140' ' ' ILE . 12.6 pt-20 -51.19 -32.06 22.3 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.841 0.353 . . . . 0.0 111.19 -179.36 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' SER . . . . . 0.65 ' H ' HG12 ' A' ' 136' ' ' VAL . 90.2 p -94.09 6.26 49.13 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 116.159 -0.473 . . . . 0.0 112.088 -179.657 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -129.31 29.14 5.16 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 112.376 0.51 . . . . 0.0 112.376 -179.487 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.489 HG12 ' HA ' ' A' ' 134' ' ' VAL . 23.6 mt -104.88 140.95 21.37 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 CA-C-N 115.668 -0.697 . . . . 0.0 111.154 179.157 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.666 HD12 ' HG3' ' A' ' 42' ' ' GLN . 4.6 mm? -117.23 135.22 53.96 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 114.925 -1.034 . . . . 0.0 110.06 179.489 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.764 ' O ' HD13 ' A' ' 143' ' ' LEU . 4.1 m -119.13 152.79 35.92 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.833 0.825 . . . . 0.0 112.581 -179.144 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.799 HD12 ' SG ' ' A' ' 38' ' ' CYS . 1.8 mm? -132.11 153.88 50.04 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 114.401 -1.272 . . . . 0.0 109.174 179.25 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 22.1 t -128.08 140.55 48.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 120.946 0.403 . . . . 0.0 111.777 -179.348 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.759 HG13 HG22 ' A' ' 36' ' ' VAL . 0.4 OUTLIER -113.88 126.58 71.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.333 179.61 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 7.7 t80 -108.84 119.52 39.79 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.054 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.454 HD13 HD23 ' A' ' 124' ' ' LEU . 2.7 mp -112.1 123.0 67.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.881 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 148' ' ' ASN . . . . . 0.409 ' ND2' ' O ' ' A' ' 32' ' ' ILE . 3.1 p30 -76.31 122.88 25.07 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.923 0.392 . . . . 0.0 111.087 -179.74 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -73.82 -19.44 60.75 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.078 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.82 -42.98 85.46 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 120.962 0.411 . . . . 0.0 110.732 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 151' ' ' PHE . . . . . 0.462 ' CZ ' HG21 ' A' ' 55' ' ' VAL . 4.7 t80 -59.5 -41.54 90.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.64 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 3.3 tptm -63.18 -34.16 77.04 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.807 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -68.14 -38.47 82.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.962 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 12.2 t -60.17 -45.53 92.81 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.823 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -68.95 -48.18 63.84 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.951 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -57.77 -46.9 83.91 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.177 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 15.2 tt0 -79.3 -37.01 38.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.046 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 44.36 -171.4 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.541 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 15.3 pttt -57.08 146.65 26.79 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.027 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 12.8 p -91.92 130.0 41.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.068 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -171.38 35.02 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.786 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 30.6 ttt180 -58.94 136.32 57.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.996 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 34.5 pt -105.86 135.68 43.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.141 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 3.6 tmt_? . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.231 -0.89 . . . . 0.0 110.88 179.974 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.353 0 N-CA-C 112.466 -0.253 . . . . 0.0 112.466 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -109.32 58.77 0.6 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.92 0.391 . . . . 0.0 110.936 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.487 ' O ' HG23 ' A' ' 4' ' ' ILE . 43.8 p30 -121.13 32.57 5.89 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.872 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.487 HG23 ' O ' ' A' ' 3' ' ' ASN . 6.1 pt -156.73 106.44 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.197 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 13.7 p -90.17 -43.02 10.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.224 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -141.56 79.21 17.4 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.874 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -71.17 63.57 2.65 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.59 2.194 . . . . 0.0 112.24 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.4 -40.09 6.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.099 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -98.69 41.65 1.13 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.831 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 2.3 mm-40 -122.39 37.52 4.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.832 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 7.9 p 62.4 122.39 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.873 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.425 HG23 ' N ' ' A' ' 13' ' ' GLN . 9.6 t -122.01 -42.15 2.4 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.252 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.425 ' N ' HG23 ' A' ' 12' ' ' THR . 28.4 mt-30 62.85 101.32 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.792 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -97.62 -169.88 1.91 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.153 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -124.56 -58.6 1.5 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.067 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -64.56 -46.12 84.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.943 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.82 -38.75 82.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.876 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -60.82 -41.3 95.44 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.975 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 91.8 mt -59.71 -39.03 83.28 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.098 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 45.6 mm -69.88 -37.34 72.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.217 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -57.56 -36.15 71.29 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.246 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -59.18 -29.76 67.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.049 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -65.68 -47.26 76.06 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.173 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.3 m -58.03 -47.19 83.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.95 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -90.93 172.34 8.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.88 179.87 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -80.24 128.97 34.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.992 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -81.18 110.74 16.96 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.767 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.3 mm -86.15 139.26 17.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.483 0.659 . . . . 0.0 111.761 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -123.63 72.15 0.42 Allowed Glycine 0 C--N 1.317 -0.481 0 CA-C-N 114.773 -1.103 . . . . 0.0 112.287 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -78.07 -24.81 47.52 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.642 0.258 . . . . 0.0 111.369 -179.637 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -109.42 -14.45 14.42 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-O 121.936 0.874 . . . . 0.0 108.681 178.463 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.587 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 0.1 OUTLIER -71.08 108.99 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.662 0 CA-C-N 113.949 -1.478 . . . . 0.0 111.121 -179.464 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.781 HG11 HD13 ' A' ' 93' ' ' LEU . 2.2 t -53.35 -67.19 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.834 0 CA-C-N 114.946 -1.025 . . . . 0.0 111.459 -179.576 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 18.3 p -155.23 165.08 37.79 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.022 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 1.5 ttm180 -129.33 115.48 17.63 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.402 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.913 HG12 HD21 ' A' ' 143' ' ' LEU . 66.6 t -89.05 130.09 38.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.149 -0.478 . . . . 0.0 109.901 179.183 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.976 HG23 HG12 ' A' ' 45' ' ' ILE . 28.0 mt -122.23 108.54 22.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -178.802 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.632 ' SG ' HD23 ' A' ' 143' ' ' LEU . 0.1 OUTLIER -95.92 101.65 13.35 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 177.599 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -111.47 2.32 17.42 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -178.049 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.86 HG21 ' HB2' ' A' ' 142' ' ' SER . 67.8 p -83.76 -16.35 45.1 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.784 -0.366 . . . . 0.0 111.402 179.646 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 113.71 58.83 0.4 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.587 179.768 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.47 ' HB2' HD12 ' A' ' 43' ' ' ILE . 20.9 mt-30 -134.6 -69.42 0.52 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.641 0.258 . . . . 0.0 111.134 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.47 HD12 ' HB2' ' A' ' 42' ' ' GLN . 3.7 mp -135.09 139.07 30.83 Favored Pre-proline 0 N--CA 1.452 -0.336 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.185 -179.88 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.541 ' HD2' ' CZ ' ' A' ' 76' ' ' TYR . 28.2 Cg_exo -59.26 147.32 91.38 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.718 2.278 . . . . 0.0 111.68 179.607 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.976 HG12 HG23 ' A' ' 37' ' ' ILE . 32.0 mt -46.33 148.72 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 121.008 0.432 . . . . 0.0 111.689 -179.633 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.1 130.28 13.61 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.187 179.445 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.421 ' HB3' HD11 ' A' ' 32' ' ' ILE . 1.8 m-20 -91.58 119.77 31.78 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.086 0.469 . . . . 0.0 111.168 -179.649 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.911 ' CD2' HG23 ' A' ' 36' ' ' VAL . 0.1 OUTLIER -92.5 123.34 35.74 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.479 179.129 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.687 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -132.99 155.98 48.16 Favored 'General case' 0 CA--C 1.515 -0.398 0 N-CA-C 114.04 1.126 . . . . 0.0 114.04 -178.979 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.58 ' N ' HG23 ' A' ' 33' ' ' VAL . . . -149.9 142.24 24.24 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 113.698 -1.592 . . . . 0.0 110.824 179.028 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.47 ' CB ' ' HG3' ' A' ' 54' ' ' GLN . 0.4 OUTLIER -66.46 110.22 3.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.982 0.42 . . . . 0.0 110.89 -179.845 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.668 HG23 HD23 ' A' ' 56' ' ' LEU . 10.7 mt -56.16 -34.53 39.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.1 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 9.6 t -56.86 -34.66 68.04 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.899 -179.574 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.47 ' HG3' ' CB ' ' A' ' 51' ' ' ASP . 0.0 OUTLIER -66.22 -44.74 82.97 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.768 -179.974 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.77 ' HA ' HD12 ' A' ' 62' ' ' ILE . 7.8 t -74.01 -40.66 52.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.208 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.668 HD23 HG23 ' A' ' 52' ' ' ILE . 0.9 OUTLIER -59.38 -37.97 79.3 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.973 -179.942 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 5.3 mmtm -92.81 -50.06 5.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.764 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.607 ' CD ' HD13 ' A' ' 62' ' ' ILE . 2.5 tt0 60.54 79.96 0.23 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.959 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 19.0 tttt -126.27 -64.66 1.02 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.819 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 23.9 mtp180 -136.57 38.53 2.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.785 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -175.01 103.22 0.09 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.986 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.77 HD12 ' HA ' ' A' ' 55' ' ' VAL . 0.9 OUTLIER -168.75 53.56 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.917 -179.963 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.1 pttp -160.4 70.0 0.4 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.084 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.503 ' HD2' ' HB2' ' A' ' 50' ' ' ALA . 29.2 ttmt -99.69 123.55 44.07 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.237 179.478 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.523 HG13 ' O ' ' A' ' 91' ' ' ILE . 4.7 t -126.11 133.32 69.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.141 0.496 . . . . 0.0 112.09 -178.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' TRP . . . . . 0.703 ' CD1' HD12 ' A' ' 48' ' ' LEU . 13.3 m-90 -99.34 139.9 34.3 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.229 178.827 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.569 ' HB ' ' CB ' ' A' ' 74' ' ' CYS . 2.8 m -131.37 129.34 41.23 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.447 0.642 . . . . 0.0 112.436 179.678 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.509 ' CD2' ' CD2' ' A' ' 89' ' ' PHE . 94.2 m-85 -100.13 117.6 34.71 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.415 -0.812 . . . . 0.0 109.091 177.832 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.608 ' C ' HD11 ' A' ' 78' ' ' LEU . . . 158.19 -157.83 28.64 Favored Glycine 0 CA--C 1.503 -0.695 0 C-N-CA 119.061 -1.542 . . . . 0.0 113.061 179.456 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -75.46 91.49 2.77 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-O 122.726 1.25 . . . . 0.0 108.43 -179.7 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.403 ' CG ' ' HB2' ' A' ' 74' ' ' CYS . 0.2 OUTLIER -150.39 155.26 36.61 Favored Pre-proline 0 C--N 1.309 -1.162 0 CA-C-N 112.617 -2.083 . . . . 0.0 108.44 179.34 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.56 ' O ' ' HB2' ' A' ' 77' ' ' HIS . 23.9 Cg_exo -56.9 -11.11 6.62 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 121.406 1.404 . . . . 0.0 111.606 178.254 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.744 ' HB2' ' HB2' ' A' ' 77' ' ' HIS . . . 136.16 51.78 0.0 OUTLIER 'General case' 0 CA--C 1.491 -1.315 0 CA-C-N 115.001 -1.0 . . . . 0.0 109.535 178.875 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.569 ' CB ' ' HB ' ' A' ' 67' ' ' THR . 0.1 OUTLIER -52.91 -69.55 0.11 Allowed 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 105.919 -1.882 . . . . 0.0 105.919 179.387 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.568 ' HB2' ' N ' ' A' ' 67' ' ' THR . 8.2 t0 -94.48 -47.73 6.43 Favored 'General case' 0 N--CA 1.434 -1.258 0 N-CA-C 105.772 -1.936 . . . . 0.0 105.772 169.784 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.541 ' CZ ' ' HD2' ' A' ' 44' ' ' PRO . 39.0 t80 -145.04 142.37 29.69 Favored 'General case' 0 C--N 1.347 0.473 0 CA-C-N 112.655 -2.066 . . . . 0.0 111.54 179.485 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.744 ' HB2' ' HB2' ' A' ' 73' ' ' ALA . 1.8 t60 -92.06 107.43 19.21 Favored 'General case' 0 C--N 1.331 -0.196 0 O-C-N 121.846 -0.534 . . . . 0.0 109.906 176.779 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.608 HD11 ' C ' ' A' ' 69' ' ' GLY . 2.6 pp -119.99 176.29 5.5 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.949 0.404 . . . . 0.0 111.48 -179.763 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.504 ' O ' HD12 ' A' ' 78' ' ' LEU . . . -64.1 -169.98 1.82 Allowed Glycine 0 C--N 1.332 0.324 0 C-N-CA 121.044 -0.598 . . . . 0.0 112.572 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 10.1 p-10 -111.71 98.82 7.68 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.957 0.408 . . . . 0.0 111.604 -179.686 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.602 ' HB ' ' HB2' ' A' ' 85' ' ' SER . 13.4 mm -113.72 112.1 38.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.302 179.018 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 8.0 t -55.01 -24.24 23.4 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.238 0.458 . . . . 0.0 112.238 -179.236 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -91.49 -109.51 0.1 Allowed 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 -179.027 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.455 ' HB3' ' CE1' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -108.01 112.41 24.96 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 121.619 0.723 . . . . 0.0 109.87 -179.915 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.602 ' HB2' ' HB ' ' A' ' 81' ' ' ILE . 0.4 OUTLIER 162.16 -43.93 0.0 OUTLIER 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 114.285 -1.325 . . . . 0.0 108.932 -179.422 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.843 ' O ' ' N ' ' A' ' 88' ' ' HIS . 96.9 m-20 -65.43 -149.46 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 177.522 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.95 ' HB2' HD11 ' A' ' 104' ' ' ILE . 0.0 OUTLIER -49.79 72.33 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 179.063 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.962 ' C ' ' O ' ' A' ' 104' ' ' ILE . 30.7 t60 -90.58 -16.17 29.23 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 113.813 1.042 . . . . 0.0 113.813 -176.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.639 ' HA ' ' H ' ' A' ' 104' ' ' ILE . 1.0 OUTLIER -174.8 152.66 1.61 Allowed 'General case' 0 C--N 1.311 -1.092 0 C-N-CA 119.484 -0.886 . . . . 0.0 112.257 178.052 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.482 ' O ' ' O ' ' A' ' 102' ' ' ASN . 3.2 tt0 -136.42 154.14 50.88 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 114.656 -1.156 . . . . 0.0 113.638 -177.422 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.71 HD11 HG21 ' A' ' 36' ' ' VAL . 16.4 mt -124.65 131.96 71.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.261 -0.882 . . . . 0.0 109.842 178.623 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.745 HD13 ' ND2' ' A' ' 121' ' ' ASN . 0.1 OUTLIER -113.32 140.23 48.18 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.975 0.417 . . . . 0.0 111.99 -179.378 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.781 HD13 HG11 ' A' ' 33' ' ' VAL . 27.1 tp -125.9 130.66 51.75 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.602 179.116 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 123.29 -167.26 15.56 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.415 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 62.39 118.76 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.93 0.395 . . . . 0.0 110.916 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 19.5 t0 59.98 20.23 9.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.117 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 54.13 60.03 9.07 Favored Glycine 0 C--N 1.332 0.314 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.691 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 -158.99 -179.21 7.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.84 0.352 . . . . 0.0 110.876 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.601 ' C ' HD22 ' A' ' 100' ' ' LEU . 67.8 tp -108.04 145.4 34.04 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.836 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.601 HD22 ' C ' ' A' ' 99' ' ' LEU . 3.8 mm? -133.48 147.84 51.68 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.547 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 1.064 HD21 HD13 ' A' ' 145' ' ' ILE . 8.0 mp -117.03 130.67 56.83 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 179.647 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.636 ' HB2' HD11 ' A' ' 92' ' ' LEU . 25.0 t30 -114.84 110.93 20.42 Favored 'General case' 0 CA--C 1.508 -0.64 0 C-N-CA 119.87 -0.732 . . . . 0.0 109.881 179.729 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.796 ' OD2' HG11 ' A' ' 116' ' ' VAL . 63.0 m-20 -82.9 111.85 19.15 Favored 'General case' 0 N--CA 1.442 -0.841 0 C-N-CA 119.63 -0.828 . . . . 0.0 109.326 179.5 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.962 ' O ' ' C ' ' A' ' 88' ' ' HIS . 0.1 OUTLIER -123.55 108.03 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.997 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 178.028 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.478 ' HG ' ' CE1' ' A' ' 88' ' ' HIS . 75.6 m -128.09 171.34 11.98 Favored 'General case' 0 C--N 1.297 -1.702 0 CA-C-N 114.914 -1.039 . . . . 0.0 109.275 179.673 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 26.6 m -69.24 -62.96 1.17 Allowed 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 119.099 -1.04 . . . . 0.0 111.074 -179.393 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 5.7 p30 -111.97 -33.66 6.21 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 114.216 1.191 . . . . 0.0 114.216 178.839 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -147.02 133.09 4.62 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 116.667 1.427 . . . . 0.0 116.667 -178.253 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.764 HG21 ' HB3' ' A' ' 103' ' ' ASP . 8.3 m -121.01 138.29 54.24 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 174.164 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 0.756 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.4 m-90 -119.3 149.15 42.27 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 -178.387 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.419 ' O ' ' HG ' ' A' ' 111' ' ' LEU . 0.2 OUTLIER -123.74 112.44 17.35 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 114.842 -1.072 . . . . 0.0 108.647 177.66 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 7.1 m-80 46.46 42.93 11.5 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.951 -0.568 . . . . 0.0 112.34 -179.511 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.04 -6.5 83.19 Favored Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 120.69 -0.767 . . . . 0.0 113.437 178.84 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 1.8 mm-40 -110.55 104.77 13.53 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.892 0.377 . . . . 0.0 110.963 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.756 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.0 OUTLIER -44.22 127.85 5.78 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.908 179.721 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.796 HG11 ' OD2' ' A' ' 103' ' ' ASP . 12.3 p -111.95 159.45 11.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.779 -179.049 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.509 ' N ' HG22 ' A' ' 116' ' ' VAL . 14.1 mp0 -70.7 136.86 49.29 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.95 179.773 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.408 ' O ' ' C ' ' A' ' 119' ' ' ASN . 78.7 tttt -63.09 163.86 9.34 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.296 179.594 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.408 ' C ' ' O ' ' A' ' 118' ' ' LYS . 10.5 m-80 34.43 40.61 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.24 -179.537 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 4.9 p -110.99 110.6 21.23 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.86 -179.629 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.745 ' ND2' HD13 ' A' ' 92' ' ' LEU . 1.9 m120 -62.69 133.97 55.63 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.554 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' GLN . . . . . 0.501 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 32.7 mm-40 -129.62 145.62 51.48 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.312 0.577 . . . . 0.0 112.357 -179.602 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.428 HD23 ' O ' ' A' ' 124' ' ' LEU . 2.7 tt -72.61 122.77 21.94 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.634 179.018 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.558 HD22 ' C ' ' A' ' 124' ' ' LEU . 0.0 OUTLIER -48.71 148.82 1.96 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 122.067 0.937 . . . . 0.0 112.041 -178.887 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -126.79 153.08 46.07 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 114.195 -1.366 . . . . 0.0 110.153 179.703 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 2.9 mm-40 -70.98 113.49 8.08 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 179.452 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 68.33 28.1 73.44 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.227 -179.096 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.454 ' HB3' HG22 ' A' ' 145' ' ' ILE . 28.2 t70 -53.86 160.09 1.51 Allowed 'General case' 0 C--O 1.231 0.123 0 CA-C-O 120.963 0.411 . . . . 0.0 111.224 -179.675 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.509 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 29.0 tt0 -146.66 134.9 21.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.587 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.452 HG21 ' OD1' ' A' ' 103' ' ' ASP . 7.1 mm -117.56 128.3 74.82 Favored 'Isoleucine or valine' 0 C--O 1.231 0.131 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 178.542 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.504 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 94.6 m -103.49 145.47 29.97 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.632 -179.658 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.506 ' HB ' ' NE2' ' A' ' 88' ' ' HIS . 6.2 m -140.9 157.97 23.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -178.885 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' GLY . . . . . 0.403 ' O ' ' O ' ' A' ' 139' ' ' ASP . . . 70.72 40.86 65.02 Favored Glycine 0 N--CA 1.446 -0.637 0 CA-C-N 115.728 -0.669 . . . . 0.0 112.648 179.292 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.484 HG12 ' N ' ' A' ' 135' ' ' GLY . 94.8 t -76.76 157.17 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 CA-C-O 121.409 0.624 . . . . 0.0 112.005 -179.297 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.484 ' N ' HG12 ' A' ' 134' ' ' VAL . . . 152.63 -44.68 0.61 Allowed Glycine 0 N--CA 1.44 -1.037 0 N-CA-C 110.652 -0.979 . . . . 0.0 110.652 -179.271 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.545 HG12 ' H ' ' A' ' 138' ' ' SER . 45.3 t -126.75 134.22 66.76 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.739 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 178.66 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 26.9 tp10 -50.87 -34.51 28.4 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.827 0.346 . . . . 0.0 111.464 -179.182 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' SER . . . . . 0.545 ' H ' HG12 ' A' ' 136' ' ' VAL . 37.7 t -93.78 6.23 49.05 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 116.204 -0.453 . . . . 0.0 112.141 -179.507 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 139' ' ' ASP . . . . . 0.403 ' O ' ' O ' ' A' ' 133' ' ' GLY . 2.3 t70 -125.77 29.25 5.98 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-O 121.124 0.488 . . . . 0.0 112.169 -179.484 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.504 ' CG2' ' CG2' ' A' ' 131' ' ' THR . 25.7 mt -107.17 141.45 22.34 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.328 179.394 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 12.1 mt -123.41 134.79 53.93 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.037 -0.983 . . . . 0.0 110.633 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.86 ' HB2' HG21 ' A' ' 40' ' ' THR . 4.8 m -114.94 153.5 30.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.756 0.788 . . . . 0.0 112.462 -179.352 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.913 HD21 HG12 ' A' ' 36' ' ' VAL . 1.8 tm? -133.83 136.84 44.7 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 114.55 -1.205 . . . . 0.0 109.396 179.701 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.73 ' H ' HD22 ' A' ' 143' ' ' LEU . 15.0 t -118.04 140.3 41.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.903 0.382 . . . . 0.0 111.801 -179.13 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 1.064 HD13 HD21 ' A' ' 101' ' ' LEU . 0.1 OUTLIER -108.01 140.3 26.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.776 179.592 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 37.5 t80 -118.4 122.87 43.86 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.96 -179.802 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 3.0 mp -115.32 130.23 70.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.11 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 23.6 p-10 -75.28 138.0 41.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.993 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -73.64 -30.24 62.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.934 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -57.44 -40.16 77.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.777 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 6.2 t80 -63.72 -38.73 92.22 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.917 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 19.7 tttm -64.86 -44.4 89.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.036 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 17.3 tt0 -58.99 -36.84 75.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.055 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 9.0 t -64.97 -43.46 92.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.737 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.429 HD22 ' HA ' ' A' ' 155' ' ' LEU . 0.2 OUTLIER -66.35 -35.67 80.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.822 179.873 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 59.5 tt0 -56.83 -41.08 77.21 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.807 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 3.4 tt0 -89.35 -34.08 16.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.838 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 44.62 -171.54 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.55 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 4.1 pttp -88.13 140.32 29.61 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.954 -179.782 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 29.3 m -67.36 125.48 24.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.167 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 28.9 p30 -114.16 -173.47 2.29 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.86 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -58.72 -26.82 64.31 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.963 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 27.8 mt -76.84 132.64 32.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.023 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.241 -0.885 . . . . 0.0 110.945 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.36 0 N-CA-C 112.521 -0.231 . . . . 0.0 112.521 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 59.52 36.98 23.01 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.769 0.319 . . . . 0.0 110.944 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.65 ' O ' HG23 ' A' ' 4' ' ' ILE . 0.1 OUTLIER -165.61 -73.68 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.81 -179.913 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.65 HG23 ' O ' ' A' ' 3' ' ' ASN . 5.9 pt -162.72 158.5 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.148 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.4 m -135.29 112.01 10.07 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.175 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 5.9 mm-40 -152.46 73.97 7.39 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.857 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -67.36 -165.51 0.11 Allowed 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.632 2.221 . . . . 0.0 112.304 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.8 p 62.68 158.59 0.07 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.174 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER 61.57 63.44 1.17 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.882 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -161.32 32.94 0.14 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.82 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -59.41 158.55 9.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.871 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -69.48 143.51 53.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.151 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.59 158.81 14.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.871 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -131.7 174.94 9.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.228 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 1.6 t -164.69 -42.05 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.021 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.67 -39.29 70.38 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.86 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 41.7 mtp85 -66.31 -46.34 77.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.906 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 -58.53 -35.71 72.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.973 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.07 -37.74 80.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.784 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 37.2 mm -65.1 -39.16 84.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.029 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.7 -37.54 73.67 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.984 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.69 -43.54 97.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.871 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -61.06 -47.65 85.38 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.042 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.9 m -65.29 -45.24 85.2 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.939 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -80.39 160.72 25.29 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.882 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -73.86 142.9 46.04 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.822 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 64.9 mt-30 -98.03 116.74 30.87 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.916 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 25.1 mm -82.03 139.73 17.49 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.345 0 CA-C-O 121.458 0.647 . . . . 0.0 111.574 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -140.55 80.95 0.26 Allowed Glycine 0 C--N 1.318 -0.443 0 CA-C-N 114.95 -1.023 . . . . 0.0 112.633 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -87.51 -25.58 23.61 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.757 0.313 . . . . 0.0 110.936 179.795 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.409 ' HA ' ' CD1' ' A' ' 52' ' ' ILE . 1.6 m-20 -109.02 -13.5 14.71 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-O 121.997 0.903 . . . . 0.0 108.626 178.353 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.783 HD13 ' O ' ' A' ' 48' ' ' LEU . 0.1 OUTLIER -70.7 95.57 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.556 0 CA-C-N 113.911 -1.495 . . . . 0.0 110.711 -179.41 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.572 ' CG1' ' N ' ' A' ' 34' ' ' CYS . 0.5 OUTLIER -32.45 -59.94 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 114.874 -1.057 . . . . 0.0 112.379 -179.127 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.707 ' SG ' HD12 ' A' ' 48' ' ' LEU . 31.7 p -164.29 164.88 22.26 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.529 -179.757 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 5.2 ttm180 -127.11 122.62 34.76 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.077 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.71 ' CG2' HD11 ' A' ' 48' ' ' LEU . 24.8 t -93.81 131.74 39.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.669 179.536 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.976 HG23 HG12 ' A' ' 45' ' ' ILE . 32.9 mt -121.18 108.38 22.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 N-CA-C 112.362 0.505 . . . . 0.0 112.362 -179.326 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -98.6 105.66 17.83 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 177.374 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 8.9 t -113.71 -21.22 10.84 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 113.328 0.862 . . . . 0.0 113.328 -177.496 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.813 HG21 ' CB ' ' A' ' 142' ' ' SER . 44.5 p -55.59 -22.22 21.14 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.874 0.369 . . . . 0.0 111.467 -179.475 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 120.73 64.76 0.25 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.353 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.2 mt-30 -141.75 -70.32 0.36 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.773 0.32 . . . . 0.0 111.205 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.56 HG22 ' HD2' ' A' ' 44' ' ' PRO . 0.7 OUTLIER -135.16 139.24 31.2 Favored Pre-proline 0 N--CA 1.453 -0.325 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.113 -179.566 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.56 ' HD2' HG22 ' A' ' 43' ' ' ILE . 26.6 Cg_exo -59.41 147.76 89.83 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.506 2.137 . . . . 0.0 111.379 179.223 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.976 HG12 HG23 ' A' ' 37' ' ' ILE . 43.1 mt -36.33 136.04 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 -179.398 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.48 ' CG ' ' CE2' ' A' ' 76' ' ' TYR . 0.0 OUTLIER -123.26 144.87 49.12 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.337 179.306 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -110.11 119.61 39.82 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.977 0.418 . . . . 0.0 111.259 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.794 HD11 HD13 ' A' ' 91' ' ' ILE . 5.4 mt -98.53 137.88 36.55 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 178.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.566 ' O ' ' HZ2' ' A' ' 66' ' ' TRP . 0.0 OUTLIER -137.8 163.31 31.69 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 113.55 0.944 . . . . 0.0 113.55 -178.646 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.528 ' HB3' HG23 ' A' ' 33' ' ' VAL . . . -138.27 166.03 25.23 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 114.41 -1.268 . . . . 0.0 110.888 179.292 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.421 ' CB ' ' HG3' ' A' ' 54' ' ' GLN . 1.4 m-20 -92.28 100.52 13.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.943 0.401 . . . . 0.0 111.187 -179.71 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.409 ' CD1' ' HA ' ' A' ' 31' ' ' ASN . 2.3 mt -63.76 -29.7 47.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.528 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -56.47 -34.84 67.28 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.017 -179.186 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.421 ' HG3' ' CB ' ' A' ' 51' ' ' ASP . 0.6 OUTLIER -66.07 -36.99 84.67 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.822 179.992 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.854 ' CG2' HD11 ' A' ' 62' ' ' ILE . 16.4 t -73.77 -42.21 54.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.242 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -61.57 -27.07 68.37 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.308 -179.678 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.5 tppp? -99.47 -32.4 11.15 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.784 0.326 . . . . 0.0 111.221 -179.821 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -135.14 117.97 16.18 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.031 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -58.02 -56.29 23.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.906 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -82.98 71.19 10.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.793 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 51.4 p -128.2 -161.48 1.1 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.847 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.854 HD11 ' CG2' ' A' ' 55' ' ' VAL . 23.9 mm 73.54 128.95 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-O 120.912 0.386 . . . . 0.0 111.335 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 4.5 tttt -169.51 64.02 0.05 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.707 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.448 ' O ' ' CZ3' ' A' ' 66' ' ' TRP . 29.9 ttpt -132.55 118.79 19.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.916 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.713 HG23 ' O ' ' A' ' 91' ' ' ILE . 7.9 p -108.61 140.13 28.39 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 CA-C-O 121.37 0.605 . . . . 0.0 112.428 -179.07 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' TRP . . . . . 0.713 ' CD1' HD22 ' A' ' 48' ' ' LEU . 14.3 m-90 -99.93 139.31 35.78 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.099 -0.955 . . . . 0.0 111.325 179.099 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.867 HG23 ' HG3' ' A' ' 90' ' ' GLN . 10.6 m -127.36 130.07 48.76 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.547 0.689 . . . . 0.0 111.951 179.113 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.646 ' CE2' HG11 ' A' ' 36' ' ' VAL . 11.2 m-85 -102.86 118.33 36.59 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.054 -0.976 . . . . 0.0 108.98 178.099 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.651 ' HA2' ' O ' ' A' ' 85' ' ' SER . . . 157.16 -153.95 25.12 Favored Glycine 0 CA--C 1.505 -0.561 0 C-N-CA 118.765 -1.683 . . . . 0.0 113.317 179.32 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 1.6 mtp180 -75.58 91.94 2.88 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-O 122.593 1.187 . . . . 0.0 108.873 -179.299 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 33.8 m-80 -150.07 159.62 35.06 Favored Pre-proline 0 C--N 1.308 -1.197 0 CA-C-N 112.761 -2.018 . . . . 0.0 108.102 178.708 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.549 ' O ' ' HB2' ' A' ' 77' ' ' HIS . 31.7 Cg_endo -64.85 -6.78 13.28 Favored 'Trans proline' 0 N--CA 1.453 -0.91 0 C-N-CA 120.637 0.891 . . . . 0.0 110.576 177.33 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.747 ' HB2' ' HB2' ' A' ' 77' ' ' HIS . . . 136.36 52.99 0.0 OUTLIER 'General case' 0 CA--C 1.49 -1.337 0 CA-C-N 114.359 -1.292 . . . . 0.0 109.052 178.856 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.574 ' HB3' ' HB ' ' A' ' 67' ' ' THR . 0.1 OUTLIER -52.7 -69.93 0.1 Allowed 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 105.497 -2.038 . . . . 0.0 105.497 179.491 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.638 ' HB2' ' N ' ' A' ' 67' ' ' THR . 60.7 t0 -95.85 -47.0 6.33 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 105.834 -1.913 . . . . 0.0 105.834 169.259 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.486 ' C ' ' HA ' ' A' ' 73' ' ' ALA . 0.1 OUTLIER -143.63 141.33 30.55 Favored 'General case' 0 C--N 1.348 0.531 0 CA-C-N 112.77 -2.014 . . . . 0.0 111.855 -179.712 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.747 ' HB2' ' HB2' ' A' ' 73' ' ' ALA . 1.8 t60 -97.21 106.15 18.42 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 176.306 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.756 HD11 ' O ' ' A' ' 85' ' ' SER . 1.1 pp -123.11 175.52 6.59 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.919 0.39 . . . . 0.0 111.512 -179.583 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -53.54 -179.76 0.12 Allowed Glycine 0 C--N 1.333 0.369 0 C-N-CA 121.015 -0.612 . . . . 0.0 112.573 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.449 ' HA ' ' OD1' ' A' ' 86' ' ' ASN . 5.0 p30 -111.61 98.47 7.45 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.785 0.326 . . . . 0.0 111.582 -179.708 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.703 ' HB ' ' HB2' ' A' ' 85' ' ' SER . 15.0 mm -114.7 117.52 55.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.701 178.886 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 43.4 t -54.97 -24.18 22.7 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 111.82 0.304 . . . . 0.0 111.82 -179.631 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.478 ' H ' HG22 ' A' ' 81' ' ' ILE . 3.3 mpt_? -92.44 -102.25 0.12 Allowed 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -179.095 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.422 ' O ' ' HB2' ' A' ' 85' ' ' SER . 0.0 OUTLIER -108.96 109.76 20.9 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-O 121.631 0.729 . . . . 0.0 110.512 -179.702 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.756 ' O ' HD11 ' A' ' 78' ' ' LEU . 0.3 OUTLIER 161.38 -46.0 0.0 OUTLIER 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 114.128 -1.397 . . . . 0.0 109.201 -179.92 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.814 ' O ' ' N ' ' A' ' 88' ' ' HIS . 88.3 m-20 -66.44 -153.44 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 177.658 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.844 ' HB2' HD11 ' A' ' 104' ' ' ILE . 17.2 pttm -49.37 73.64 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 179.095 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 1.053 ' O ' ' O ' ' A' ' 104' ' ' ILE . 36.9 t60 -95.0 -16.5 22.7 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 114.307 1.225 . . . . 0.0 114.307 -176.854 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.616 ' HA ' ' H ' ' A' ' 104' ' ' ILE . 0.2 OUTLIER -177.39 157.04 1.26 Allowed 'General case' 0 C--N 1.316 -0.881 0 C-N-CA 119.127 -1.029 . . . . 0.0 112.529 178.264 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.867 ' HG3' HG23 ' A' ' 67' ' ' THR . 17.4 mt-30 -137.74 161.81 35.54 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 -177.348 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.794 HD13 HD11 ' A' ' 48' ' ' LEU . 4.7 mt -128.33 132.66 67.99 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 CA-C-N 114.913 -1.039 . . . . 0.0 110.041 178.754 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.66 ' C ' HD22 ' A' ' 93' ' ' LEU . 0.0 OUTLIER -120.52 128.92 53.55 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.851 0.358 . . . . 0.0 111.963 -179.414 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.777 HD13 ' HA ' ' A' ' 99' ' ' LEU . 4.2 mm? -125.71 133.63 52.06 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.842 179.171 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 126.43 -139.31 11.26 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.425 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 58.23 84.33 0.1 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.844 0.354 . . . . 0.0 110.894 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 50.2 m-20 62.06 30.78 17.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.0 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 66.46 94.33 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.567 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -178.07 -175.24 0.47 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.872 0.368 . . . . 0.0 110.942 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.777 ' HA ' HD13 ' A' ' 93' ' ' LEU . 2.1 mp -132.94 130.86 40.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.807 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.776 HD22 ' C ' ' A' ' 99' ' ' LEU . 3.6 mm? -133.97 148.05 51.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.784 0.326 . . . . 0.0 111.029 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.556 ' CD1' HD13 ' A' ' 145' ' ' ILE . 3.0 mm? -112.79 131.71 55.57 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 179.203 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.506 ' HB2' HD11 ' A' ' 92' ' ' LEU . 9.7 t30 -109.06 111.96 23.88 Favored 'General case' 0 CA--C 1.508 -0.665 0 C-N-CA 119.742 -0.783 . . . . 0.0 109.963 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.767 ' HB3' HG21 ' A' ' 109' ' ' THR . 31.2 m-20 -86.24 110.65 19.77 Favored 'General case' 0 N--CA 1.44 -0.928 0 C-N-CA 119.319 -0.952 . . . . 0.0 109.231 179.274 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 1.053 ' O ' ' O ' ' A' ' 88' ' ' HIS . 0.1 OUTLIER -123.84 108.5 20.91 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.07 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 177.44 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.474 ' HG ' ' CE1' ' A' ' 88' ' ' HIS . 73.8 m -133.37 169.32 17.1 Favored 'General case' 0 C--N 1.293 -1.858 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.59 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 21.4 m -69.29 -63.05 1.14 Allowed 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 119.061 -1.056 . . . . 0.0 111.328 -179.149 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -112.12 -33.38 6.26 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 114.576 1.324 . . . . 0.0 114.576 179.078 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -146.94 132.64 4.45 Favored Glycine 0 C--N 1.34 0.795 0 N-CA-C 116.875 1.51 . . . . 0.0 116.875 -178.078 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.767 HG21 ' HB3' ' A' ' 103' ' ' ASP . 13.3 m -121.28 137.94 54.46 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 174.386 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 0.715 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 3.0 m-90 -121.61 148.82 44.04 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 113.599 0.963 . . . . 0.0 113.599 -178.506 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.415 ' O ' ' HG ' ' A' ' 111' ' ' LEU . 0.2 OUTLIER -123.26 112.33 17.51 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 114.969 -1.014 . . . . 0.0 108.637 177.61 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 71.6 m-20 44.71 44.28 7.38 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.032 -0.531 . . . . 0.0 112.213 -179.531 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 79.75 24.18 60.73 Favored Glycine 0 N--CA 1.445 -0.763 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.739 179.295 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -136.43 97.9 3.69 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.113 0.483 . . . . 0.0 110.819 179.655 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.715 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.0 OUTLIER -44.63 129.03 6.87 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.969 179.826 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.544 HG11 ' OD2' ' A' ' 103' ' ' ASP . 15.0 p -118.82 162.07 17.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.671 -178.833 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.533 ' N ' HG22 ' A' ' 116' ' ' VAL . 1.5 tp10 -70.47 142.05 51.97 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.068 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 49.2 tttm -65.42 162.93 16.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.396 179.525 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 35.55 37.44 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.313 0.578 . . . . 0.0 111.354 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 5.0 p -111.27 109.49 19.54 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.953 -179.488 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.586 ' ND2' HD22 ' A' ' 92' ' ' LEU . 1.7 m-20 -59.76 139.5 57.24 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.808 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' GLN . . . . . 0.633 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 5.8 mm100 -129.25 148.23 51.16 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.878 0.37 . . . . 0.0 111.925 -179.677 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -71.61 131.78 43.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.026 -0.534 . . . . 0.0 109.933 179.463 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.577 HD22 ' C ' ' A' ' 124' ' ' LEU . 0.0 OUTLIER -55.18 147.2 16.88 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 122.258 1.028 . . . . 0.0 112.248 -178.747 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.43 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.5 OUTLIER -127.16 153.38 46.12 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 113.79 -1.55 . . . . 0.0 109.898 179.143 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 4.8 mm-40 -70.81 113.12 7.56 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 179.623 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 63.05 31.87 82.19 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.019 -179.207 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.43 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 30.2 t70 -51.71 160.51 0.64 Allowed 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 121.015 0.436 . . . . 0.0 111.584 -179.571 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.904 ' HG2' HG22 ' A' ' 144' ' ' VAL . 2.5 mt-10 -146.47 135.43 22.48 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.17 179.779 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.627 HG21 ' OD1' ' A' ' 103' ' ' ASP . 2.6 mp -114.61 128.76 71.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-O 120.802 0.334 . . . . 0.0 110.396 179.151 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.464 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 59.9 m -102.93 145.05 30.42 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.341 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.479 ' HB ' ' NE2' ' A' ' 88' ' ' HIS . 4.8 m -141.01 158.3 23.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -178.582 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 67.11 43.21 90.79 Favored Glycine 0 N--CA 1.447 -0.59 0 CA-C-N 115.621 -0.718 . . . . 0.0 112.334 179.385 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.509 ' HA ' HG12 ' A' ' 140' ' ' ILE . 90.8 t -78.85 156.43 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 CA-C-O 121.49 0.662 . . . . 0.0 112.275 -179.163 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.462 ' N ' HG12 ' A' ' 134' ' ' VAL . . . 147.4 -42.89 0.87 Allowed Glycine 0 N--CA 1.441 -0.984 0 CA-C-N 114.843 -1.072 . . . . 0.0 110.553 -178.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.623 HG12 ' H ' ' A' ' 138' ' ' SER . 47.4 t -126.77 128.13 70.66 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.723 0 CA-C-N 115.157 -0.522 . . . . 0.0 109.796 178.634 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.515 ' HA ' HD12 ' A' ' 140' ' ' ILE . 8.6 tt0 -51.13 -30.14 15.59 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.802 0.334 . . . . 0.0 111.279 -179.342 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' SER . . . . . 0.623 ' H ' HG12 ' A' ' 136' ' ' VAL . 28.2 t -94.2 6.46 48.55 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -179.497 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -131.03 29.27 4.71 Favored 'General case' 0 CA--C 1.52 -0.182 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -179.346 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.515 HD12 ' HA ' ' A' ' 137' ' ' GLU . 18.9 mt -105.55 140.97 21.95 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.33 179.103 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 5.4 mp -121.49 134.67 55.07 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 114.971 -1.013 . . . . 0.0 109.846 179.297 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.813 ' CB ' HG21 ' A' ' 40' ' ' THR . 0.9 OUTLIER -119.1 149.73 41.2 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.676 0.751 . . . . 0.0 112.757 -178.721 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.485 HD12 ' N ' ' A' ' 143' ' ' LEU . 4.7 mp -125.34 150.68 46.94 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 114.843 -1.071 . . . . 0.0 109.193 179.372 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.904 HG22 ' HG2' ' A' ' 129' ' ' GLU . 12.1 t -126.87 141.09 47.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 120.904 0.383 . . . . 0.0 111.842 -179.276 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.556 HD13 ' CD1' ' A' ' 101' ' ' LEU . 0.1 OUTLIER -122.72 125.92 73.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.069 179.436 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -115.58 121.38 42.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.961 0.41 . . . . 0.0 111.248 -179.469 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.535 HD11 ' CG2' ' A' ' 145' ' ' ILE . 3.0 mm -104.04 130.03 55.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.788 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 148' ' ' ASN . . . . . 0.42 ' ND2' ' O ' ' A' ' 32' ' ' ILE . 6.2 p30 -77.42 130.75 37.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.85 0.357 . . . . 0.0 110.78 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -73.02 -22.96 60.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.398 -179.723 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 1.3 mptp? -57.34 -40.62 78.36 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.913 0.387 . . . . 0.0 110.699 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -60.65 -41.31 94.72 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.724 179.801 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.3 -34.38 73.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.745 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -62.48 -41.95 99.15 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.794 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 13.0 t -58.73 -45.44 89.6 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.954 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -68.06 -35.83 78.86 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.825 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -63.52 -41.19 98.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.884 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -80.92 -37.06 30.25 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.871 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 2.9 p30 42.41 89.3 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.451 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 10.5 tptm -60.05 120.75 10.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.948 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 28.7 m -66.17 138.86 22.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.076 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -158.36 44.06 0.29 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.88 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 6.9 mtt180 -106.55 -62.65 1.36 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.885 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 19.2 pt -100.01 133.64 42.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.197 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.232 -0.889 . . . . 0.0 110.911 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.303 0 N-CA-C 112.683 -0.167 . . . . 0.0 112.683 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 62.45 47.86 4.9 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.956 0.408 . . . . 0.0 110.844 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 36.4 m-80 -109.17 -26.4 10.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.112 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 20.6 mm 71.2 -66.89 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.229 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.8 m 61.91 151.05 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.189 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 56.97 84.7 0.2 Allowed Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.955 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -53.94 136.05 65.35 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.634 2.223 . . . . 0.0 112.345 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -126.3 179.9 5.06 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.964 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -122.39 -57.41 1.76 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.928 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -59.96 136.38 57.99 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.03 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -146.64 54.74 1.12 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.73 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.9 p -106.29 -17.59 14.25 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.482 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.83 147.27 7.05 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.882 0.372 . . . . 0.0 111.053 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -56.94 164.92 1.39 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.204 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 18.8 p -95.12 -46.57 6.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.051 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -59.69 -36.57 76.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.004 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.61 -38.43 70.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.898 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -59.08 -40.3 84.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.968 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 7.4 mp -60.34 -40.26 90.06 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.855 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 34.3 mm -68.34 -47.2 78.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.055 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -57.71 -35.37 70.56 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.002 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -60.31 -37.94 82.13 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.86 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -59.66 -47.53 85.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.093 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 35.4 p -76.95 -31.33 56.52 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.941 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -59.77 92.99 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.929 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.515 ' OE2' HD13 ' A' ' 28' ' ' ILE . 0.0 OUTLIER -91.35 146.23 23.98 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.933 179.97 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -64.88 128.71 36.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.831 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.515 HD13 ' OE2' ' A' ' 26' ' ' GLU . 19.0 mm -87.26 139.16 17.76 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.327 0 CA-C-O 121.589 0.709 . . . . 0.0 111.709 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.477 ' HA2' ' HB ' ' A' ' 32' ' ' ILE . . . -152.19 18.13 0.81 Allowed Glycine 0 C--N 1.318 -0.428 0 CA-C-N 114.773 -1.103 . . . . 0.0 112.885 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.479 ' OE2' HG23 ' A' ' 28' ' ' ILE . 8.3 pm0 -89.19 -23.62 22.36 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 111.687 0.254 . . . . 0.0 111.687 -179.715 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.659 ' HA ' HD12 ' A' ' 52' ' ' ILE . 8.2 m120 -108.75 -14.56 14.58 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-O 121.918 0.866 . . . . 0.0 109.017 178.926 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.542 HD13 ' O ' ' A' ' 48' ' ' LEU . 0.0 OUTLIER -74.08 105.91 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.533 0 CA-C-N 113.919 -1.491 . . . . 0.0 110.664 -179.6 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 1.027 ' CG2' ' HB2' ' A' ' 50' ' ' ALA . 0.5 OUTLIER -40.26 -62.65 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.712 -179.105 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.739 ' SG ' HD12 ' A' ' 48' ' ' LEU . 31.1 p -164.92 164.96 20.67 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.505 -179.78 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 12.0 ttm180 -126.78 122.4 34.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.842 0.353 . . . . 0.0 111.176 179.73 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.831 ' CG2' HD11 ' A' ' 48' ' ' LEU . 18.8 t -93.12 124.34 45.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.616 179.643 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.963 HG23 HG12 ' A' ' 45' ' ' ILE . 35.6 mt -121.51 108.49 22.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 112.254 0.464 . . . . 0.0 112.254 -179.178 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 14.6 t -80.28 103.92 10.48 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 177.793 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.9 p -99.34 22.18 10.98 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 112.454 0.538 . . . . 0.0 112.454 -178.347 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.691 HG21 ' HB2' ' A' ' 142' ' ' SER . 45.5 p -114.21 -13.14 12.4 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 111.657 0.244 . . . . 0.0 111.657 179.78 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 95.63 75.54 1.27 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.602 -0.808 . . . . 0.0 112.616 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.542 ' CG ' HD12 ' A' ' 141' ' ' LEU . 15.3 mt-30 -150.97 -55.68 0.15 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.774 0.321 . . . . 0.0 110.983 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 2.0 mt -134.71 131.14 20.04 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.833 -179.697 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.433 ' HD2' ' CZ ' ' A' ' 76' ' ' TYR . 37.3 Cg_exo -58.87 147.1 90.79 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.569 2.18 . . . . 0.0 111.682 179.721 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.963 HG12 HG23 ' A' ' 37' ' ' ILE . 51.9 mt -42.39 128.97 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 121.03 0.443 . . . . 0.0 112.064 -179.363 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.439 ' HG2' ' O ' ' A' ' 75' ' ' ASP . 0.9 OUTLIER -123.54 130.13 52.22 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.935 179.295 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -95.14 120.16 34.89 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.095 0.474 . . . . 0.0 111.664 -179.13 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.831 HD11 ' CG2' ' A' ' 36' ' ' VAL . 1.6 mt -94.63 126.73 40.12 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.387 178.821 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.494 ' O ' ' HZ2' ' A' ' 66' ' ' TRP . 0.0 OUTLIER -119.62 162.08 19.58 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 122.102 0.953 . . . . 0.0 113.171 -178.731 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 1.027 ' HB2' ' CG2' ' A' ' 33' ' ' VAL . . . -116.47 166.17 12.39 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 114.47 -1.241 . . . . 0.0 111.011 179.596 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.874 ' O ' HG23 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -103.99 57.97 0.72 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.098 0.475 . . . . 0.0 110.755 179.914 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.736 HD11 ' CE2' ' A' ' 151' ' ' PHE . 46.2 mt -60.08 -43.49 92.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.9 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 5.0 m -66.76 -38.73 87.17 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.112 -179.638 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.41 ' CG ' ' HB3' ' A' ' 51' ' ' ASP . 2.4 mm100 -68.11 -41.71 81.34 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.036 -179.781 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.874 HG23 ' O ' ' A' ' 51' ' ' ASP . 37.7 t -65.04 -41.96 93.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.034 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.467 HD23 ' HA ' ' A' ' 56' ' ' LEU . 4.4 mt -70.77 -41.13 72.13 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.913 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.2 mtpt -100.1 21.6 12.59 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.109 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 177.99 96.66 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.87 0.366 . . . . 0.0 110.834 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.07 105.03 0.36 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.02 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.13 15.53 2.07 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.273 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.2 t 53.33 101.27 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.769 0.319 . . . . 0.0 111.071 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.739 HD11 ' HB1' ' A' ' 50' ' ' ALA . 0.5 OUTLIER -49.54 116.43 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.06 179.789 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 10.1 ttmt -154.5 99.69 2.2 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.201 -179.732 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.404 ' HE3' ' O ' ' A' ' 49' ' ' SER . 3.7 ttpt -136.79 134.03 36.6 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.183 179.489 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.508 HG12 ' HG2' ' A' ' 90' ' ' GLN . 3.4 t -123.29 134.6 65.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.214 0.531 . . . . 0.0 112.01 -178.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' TRP . . . . . 0.786 ' CD1' HD22 ' A' ' 48' ' ' LEU . 12.3 m-90 -100.95 138.86 37.43 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.727 179.2 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.612 ' N ' ' HB2' ' A' ' 75' ' ' ASP . 1.3 m -131.75 127.71 37.36 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.31 0.576 . . . . 0.0 112.315 179.436 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.513 ' CE1' ' CE2' ' A' ' 89' ' ' PHE . 96.2 m-85 -98.32 117.83 33.61 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.423 178.011 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.67 ' HA2' ' O ' ' A' ' 85' ' ' SER . . . 158.9 -157.95 28.94 Favored Glycine 0 CA--C 1.503 -0.716 0 C-N-CA 119.001 -1.571 . . . . 0.0 112.683 179.1 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.407 ' HB3' ' HA ' ' A' ' 80' ' ' ASN . 7.8 ptm180 -76.13 91.92 3.18 Favored 'General case' 0 N--CA 1.441 -0.911 0 CA-C-O 122.614 1.197 . . . . 0.0 108.302 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -149.71 160.4 34.09 Favored Pre-proline 0 C--N 1.309 -1.188 0 CA-C-N 112.787 -2.006 . . . . 0.0 108.261 179.608 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.544 ' O ' ' CB ' ' A' ' 73' ' ' ALA . 29.3 Cg_endo -63.0 -11.04 22.75 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 120.869 1.046 . . . . 0.0 111.03 178.479 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.769 ' HB2' ' HB2' ' A' ' 77' ' ' HIS . . . 137.82 52.32 0.0 OUTLIER 'General case' 0 CA--C 1.491 -1.297 0 CA-C-N 114.743 -1.117 . . . . 0.0 109.685 178.548 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.566 ' CB ' ' HB ' ' A' ' 67' ' ' THR . 0.1 OUTLIER -53.12 -69.92 0.1 Allowed 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 105.957 -1.868 . . . . 0.0 105.957 179.347 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.612 ' HB2' ' N ' ' A' ' 67' ' ' THR . 5.8 t0 -94.26 -47.45 6.62 Favored 'General case' 0 N--CA 1.436 -1.153 0 N-CA-C 105.743 -1.947 . . . . 0.0 105.743 169.754 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.548 ' C ' ' HA ' ' A' ' 73' ' ' ALA . 10.6 t80 -143.37 143.12 31.52 Favored 'General case' 0 C--N 1.344 0.356 0 CA-C-N 112.386 -2.188 . . . . 0.0 110.728 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.769 ' HB2' ' HB2' ' A' ' 73' ' ' ALA . 0.8 OUTLIER -84.54 114.1 21.71 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.33 -0.548 . . . . 0.0 110.309 177.958 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 87.2 mt -126.58 166.19 17.76 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.869 0.366 . . . . 0.0 111.099 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -66.02 -166.71 2.06 Favored Glycine 0 C--N 1.33 0.228 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.212 179.763 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.41 ' O ' ' ND2' ' A' ' 80' ' ' ASN . 0.3 OUTLIER -111.35 99.1 7.96 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.932 0.396 . . . . 0.0 111.245 -179.875 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.535 ' HB ' ' HB2' ' A' ' 85' ' ' SER . 29.7 mm -113.84 133.63 59.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.811 179.34 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 5.7 p -66.6 -41.91 87.7 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.794 0.665 . . . . 0.0 112.794 -179.449 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.573 ' C ' HD13 ' A' ' 84' ' ' LEU . 2.2 mpt_? -83.12 -105.76 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 113.11 0.781 . . . . 0.0 113.11 -177.769 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.742 HD22 ' H ' ' A' ' 84' ' ' LEU . 0.0 OUTLIER -107.69 114.6 28.67 Favored 'General case' 0 CA--C 1.511 -0.554 0 CA-C-O 121.637 0.732 . . . . 0.0 109.179 -179.8 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.67 ' O ' ' HA2' ' A' ' 69' ' ' GLY . 0.5 OUTLIER 156.34 -36.25 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 114.054 -1.43 . . . . 0.0 107.885 -178.839 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.802 ' O ' ' N ' ' A' ' 88' ' ' HIS . 0.1 OUTLIER -61.85 -161.56 0.01 OUTLIER 'General case' 0 CA--C 1.51 -0.566 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 176.743 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.785 ' HB2' HD11 ' A' ' 104' ' ' ILE . 0.0 OUTLIER -53.63 72.53 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 177.091 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.928 ' O ' ' O ' ' A' ' 104' ' ' ILE . 28.3 t60 -77.66 -16.32 58.6 Favored 'General case' 0 CA--C 1.515 -0.376 0 N-CA-C 113.858 1.059 . . . . 0.0 113.858 -176.406 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.623 ' HA ' ' H ' ' A' ' 104' ' ' ILE . 0.2 OUTLIER -173.47 154.84 2.67 Favored 'General case' 0 C--N 1.308 -1.232 0 C-N-CA 119.307 -0.957 . . . . 0.0 112.549 177.914 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.508 ' HG2' HG12 ' A' ' 65' ' ' VAL . 2.8 tt0 -136.28 155.66 49.77 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.732 -1.122 . . . . 0.0 113.533 -177.448 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.644 ' HB ' ' HB2' ' A' ' 66' ' ' TRP . 25.4 mt -127.42 132.46 69.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 115.256 -0.883 . . . . 0.0 110.224 179.231 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.681 HD11 ' HB2' ' A' ' 102' ' ' ASN . 0.1 OUTLIER -117.29 125.35 50.94 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.946 0.403 . . . . 0.0 111.365 179.792 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.768 ' CD1' HD22 ' A' ' 99' ' ' LEU . 1.1 mm? -127.19 140.11 52.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.599 179.265 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 128.5 -124.27 4.62 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.529 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 62.93 43.06 7.05 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.892 0.377 . . . . 0.0 110.971 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 60.18 30.79 20.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.936 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 106.96 75.8 0.96 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.456 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.458 ' C ' HD23 ' A' ' 99' ' ' LEU . 0.2 OUTLIER -178.37 136.19 0.16 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.763 0.316 . . . . 0.0 110.758 -179.883 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.829 HD12 HD22 ' A' ' 124' ' ' LEU . 0.1 OUTLIER -108.1 130.84 55.08 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.552 179.957 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.642 ' HA ' ' O ' ' A' ' 122' ' ' GLN . 6.5 mt -133.76 148.5 51.4 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.028 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.455 ' O ' ' N ' ' A' ' 122' ' ' GLN . 41.3 mt -116.31 129.77 56.43 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 179.205 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.681 ' HB2' HD11 ' A' ' 92' ' ' LEU . 18.1 t30 -110.56 110.78 21.63 Favored 'General case' 0 CA--C 1.508 -0.637 0 C-N-CA 119.611 -0.836 . . . . 0.0 110.105 -179.793 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.764 ' HB3' HG21 ' A' ' 109' ' ' THR . 58.4 m-20 -83.57 111.11 18.8 Favored 'General case' 0 N--CA 1.441 -0.888 0 C-N-CA 119.647 -0.821 . . . . 0.0 108.883 179.157 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.928 ' O ' ' O ' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -124.08 107.69 19.16 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.9 0 CA-C-O 121.6 0.714 . . . . 0.0 109.188 178.203 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.426 ' HG ' ' CD2' ' A' ' 88' ' ' HIS . 43.4 m -131.33 172.28 12.36 Favored 'General case' 0 C--N 1.297 -1.706 0 CA-C-N 114.867 -1.061 . . . . 0.0 109.142 179.504 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 19.6 m -69.62 -63.63 1.03 Allowed 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 119.092 -1.043 . . . . 0.0 111.906 -178.899 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -112.41 -32.26 6.55 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 114.755 1.391 . . . . 0.0 114.755 179.421 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -145.57 126.55 2.59 Favored Glycine 0 C--N 1.338 0.685 0 N-CA-C 116.849 1.5 . . . . 0.0 116.849 -177.756 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.764 HG21 ' HB3' ' A' ' 103' ' ' ASP . 3.3 m -121.12 138.16 54.32 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 174.522 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 0.703 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 3.1 m-90 -121.76 149.37 43.39 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 113.393 0.886 . . . . 0.0 113.393 -178.231 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.701 HD12 HG11 ' A' ' 116' ' ' VAL . 1.2 mt -124.06 112.1 16.75 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.068 -0.969 . . . . 0.0 109.021 177.157 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 10.1 m-80 50.13 35.72 10.76 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.541 -179.223 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 82.57 26.09 48.01 Favored Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.64 179.419 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -133.08 96.83 3.85 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.009 0.433 . . . . 0.0 110.743 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.703 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.0 OUTLIER -46.52 134.61 9.18 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.01 179.82 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.701 HG11 HD12 ' A' ' 111' ' ' LEU . 12.6 p -135.14 165.45 30.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.227 -179.254 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.538 ' N ' HG22 ' A' ' 116' ' ' VAL . 0.3 OUTLIER -69.6 142.69 53.48 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.256 179.746 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.469 ' HG3' ' ND2' ' A' ' 119' ' ' ASN . 12.8 ptmt -68.42 169.68 10.32 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.792 0.329 . . . . 0.0 110.92 -179.65 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.469 ' ND2' ' HG3' ' A' ' 118' ' ' LYS . 21.8 p30 33.86 37.58 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.192 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.427 ' HB3' ' O ' ' A' ' 117' ' ' GLU . 0.1 OUTLIER -111.8 107.9 17.12 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.671 179.406 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.591 ' ND2' HD22 ' A' ' 92' ' ' LEU . 5.3 m120 -47.67 138.45 8.22 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 120.598 0.237 . . . . 0.0 110.951 -179.843 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' GLN . . . . . 0.642 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 11.1 mm100 -126.84 148.5 49.97 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-O 121.144 0.497 . . . . 0.0 111.857 -179.684 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.539 HD13 ' O ' ' A' ' 124' ' ' LEU . 3.0 tm? -73.98 112.08 9.75 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.585 178.916 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 1.104 HD21 HD13 ' A' ' 147' ' ' ILE . 6.6 tt -46.99 145.75 1.95 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.789 0.804 . . . . 0.0 112.06 -178.693 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -126.67 153.23 45.68 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 114.185 -1.37 . . . . 0.0 110.272 179.638 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 8.0 mm100 -71.24 113.68 8.52 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 179.35 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 68.47 28.38 73.25 Favored Glycine 0 N--CA 1.445 -0.72 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.18 -179.145 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -55.1 160.56 2.04 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.987 0.422 . . . . 0.0 111.434 -179.735 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.452 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 1.3 tm-20 -146.4 135.58 22.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.249 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.501 HG21 ' OD1' ' A' ' 103' ' ' ASP . 1.3 mp -112.38 129.05 68.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.415 179.047 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.566 HG23 ' CG2' ' A' ' 140' ' ' ILE . 16.0 m -103.02 142.26 34.4 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.835 -179.513 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.447 HG11 ' CD2' ' A' ' 88' ' ' HIS . 4.3 m -140.85 153.26 20.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.187 -0.461 . . . . 0.0 112.004 -179.021 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 75.52 35.8 45.9 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 121.111 -0.566 . . . . 0.0 112.367 179.442 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.45 ' HA ' HG12 ' A' ' 140' ' ' ILE . 78.9 t -71.68 155.61 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 CA-C-O 121.468 0.651 . . . . 0.0 112.127 -179.306 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.426 ' N ' HG12 ' A' ' 134' ' ' VAL . . . 153.44 -45.77 0.57 Allowed Glycine 0 N--CA 1.443 -0.863 0 CA-C-N 115.003 -0.998 . . . . 0.0 110.707 -179.164 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.61 HG12 ' H ' ' A' ' 138' ' ' SER . 62.0 t -126.71 134.85 65.32 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 CA-C-N 115.258 -0.471 . . . . 0.0 109.744 178.644 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 16.3 tm-20 -51.28 -34.38 32.72 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.83 0.347 . . . . 0.0 111.26 -179.293 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' SER . . . . . 0.61 ' H ' HG12 ' A' ' 136' ' ' VAL . 76.7 p -94.11 6.4 48.67 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 116.246 -0.434 . . . . 0.0 112.06 -179.595 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -126.38 30.66 5.54 Favored 'General case' 0 CA--C 1.518 -0.257 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -179.439 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.566 ' CG2' HG23 ' A' ' 131' ' ' THR . 20.9 mt -107.23 140.91 23.82 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.304 179.213 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.542 HD12 ' CG ' ' A' ' 42' ' ' GLN . 3.0 mm? -120.43 135.43 55.05 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 114.874 -1.057 . . . . 0.0 110.005 179.737 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.691 ' HB2' HG21 ' A' ' 40' ' ' THR . 4.2 m -125.13 152.35 44.53 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.848 0.833 . . . . 0.0 113.094 -178.86 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.634 HD12 ' O ' ' A' ' 142' ' ' SER . 6.5 mp -125.82 146.21 49.89 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.323 -1.308 . . . . 0.0 109.033 178.851 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 21.7 t -131.16 140.28 48.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 120.838 0.351 . . . . 0.0 111.793 -179.083 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.824 HG13 HG22 ' A' ' 36' ' ' VAL . 0.6 OUTLIER -111.04 139.64 34.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.743 179.552 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 47.4 t80 -119.14 104.24 10.26 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.689 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 1.104 HD13 HD21 ' A' ' 124' ' ' LEU . 1.2 mp -98.15 129.72 47.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.241 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 14.7 p30 -83.37 133.1 34.96 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.953 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -67.83 -20.65 65.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.13 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.71 -43.1 84.98 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.935 0.398 . . . . 0.0 110.61 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 151' ' ' PHE . . . . . 0.736 ' CE2' HD11 ' A' ' 52' ' ' ILE . 13.2 t80 -59.57 -44.51 93.29 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.816 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 50.0 tttm -59.43 -36.86 76.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.857 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 3.0 tp60 -66.09 -37.26 85.33 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.9 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 13.0 t -59.82 -45.6 91.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.863 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.0 -39.31 79.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.922 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -60.71 -48.46 81.68 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.096 -179.766 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -82.84 -32.5 27.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.996 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 42.5 65.03 0.98 Allowed 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.432 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 16.4 mmtm -85.01 120.36 26.44 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.941 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 18.8 t -85.0 124.04 39.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.025 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -49.97 -64.75 0.71 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.15 -179.884 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 3.1 tpt180 52.23 99.51 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.271 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 30.8 mm -103.57 114.46 43.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.119 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 20.7 mmt180 . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.254 -0.879 . . . . 0.0 110.877 -179.918 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.266 0 N-CA-C 112.49 -0.244 . . . . 0.0 112.49 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 57.2 31.87 20.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.821 0.343 . . . . 0.0 110.977 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 22.4 m-20 -107.21 41.61 1.45 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.908 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.8 tt -58.43 -22.37 20.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.316 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 69.72 140.86 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.086 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 9.2 tp60 -126.41 93.79 42.21 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.959 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -49.76 97.74 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.564 2.176 . . . . 0.0 112.326 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.614 HG23 ' H ' ' A' ' 10' ' ' GLN . 6.9 t -101.13 -26.61 13.62 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.29 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 62.86 30.58 16.58 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.871 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.614 ' H ' HG23 ' A' ' 8' ' ' THR . 4.9 mt-30 60.76 158.49 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.89 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -125.05 176.19 6.85 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.847 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.3 m -144.44 114.93 7.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.188 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -102.14 70.21 1.19 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.7 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -109.3 106.11 15.8 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.069 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 32.8 p -107.53 59.81 0.62 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.106 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -60.48 -34.22 73.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.688 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.99 -35.76 77.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.714 179.727 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -56.83 -41.43 77.86 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.981 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.74 -34.6 78.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.867 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 40.2 mm -73.48 -43.68 55.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.015 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -57.78 -33.96 69.1 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.048 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.12 -28.63 66.72 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.072 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -56.89 -47.59 80.15 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.032 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.28 -21.71 66.76 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.979 179.763 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 71.21 47.86 0.38 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.939 0.4 . . . . 0.0 110.86 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -75.03 153.21 38.56 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.892 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -110.39 110.64 21.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.024 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 22.3 mm -86.84 139.61 17.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.404 0.621 . . . . 0.0 111.716 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.12 -36.31 0.06 OUTLIER Glycine 0 C--N 1.319 -0.408 0 CA-C-N 114.914 -1.039 . . . . 0.0 112.616 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -72.7 -23.45 60.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.617 0.246 . . . . 0.0 111.39 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.576 ' HA ' HD12 ' A' ' 52' ' ' ILE . 43.6 m-20 -108.74 -14.53 14.58 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-O 121.904 0.859 . . . . 0.0 108.95 178.611 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.487 ' O ' HG22 ' A' ' 32' ' ' ILE . 0.1 OUTLIER -75.07 110.62 10.09 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.636 0 CA-C-N 113.991 -1.459 . . . . 0.0 111.088 -179.557 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 1.027 ' CG2' ' HB2' ' A' ' 50' ' ' ALA . 0.5 OUTLIER -41.18 -63.66 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.406 -179.49 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.626 ' N ' ' CG1' ' A' ' 33' ' ' VAL . 23.4 p -166.21 165.05 17.77 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.519 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 3.6 ttm180 -121.95 120.39 34.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.877 179.491 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.781 HG23 HD13 ' A' ' 48' ' ' LEU . 40.1 t -89.13 124.75 42.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.95 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.937 HG23 HG12 ' A' ' 45' ' ' ILE . 30.0 mt -124.58 108.12 19.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.65 -179.741 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.517 ' SG ' HD23 ' A' ' 143' ' ' LEU . 3.4 m -90.48 100.96 13.7 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 178.53 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 7.0 t -80.21 -27.19 38.85 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 -178.184 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.417 ' OG1' ' O ' ' A' ' 142' ' ' SER . 0.1 OUTLIER -51.54 -27.17 10.09 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.997 0.427 . . . . 0.0 111.023 -179.679 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 97.41 36.94 4.7 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.384 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 18.9 pt20 -106.0 -46.85 3.99 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.853 0.358 . . . . 0.0 110.908 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.439 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 7.1 mt -133.53 132.53 21.9 Favored Pre-proline 0 N--CA 1.451 -0.414 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.19 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.524 ' HD2' ' CZ ' ' A' ' 76' ' ' TYR . 27.3 Cg_exo -59.63 147.37 92.19 Favored 'Trans proline' 0 C--O 1.232 0.214 0 C-N-CA 122.763 2.309 . . . . 0.0 111.904 179.535 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.937 HG12 HG23 ' A' ' 37' ' ' ILE . 44.2 mt -43.6 139.0 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.83 -179.702 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.1 140.81 46.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.37 179.67 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -108.34 120.23 41.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.112 0.482 . . . . 0.0 111.632 -179.426 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 1.106 HD21 HD13 ' A' ' 91' ' ' ILE . 3.0 mp -98.82 125.2 44.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.156 178.796 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.518 ' O ' ' CZ2' ' A' ' 66' ' ' TRP . 0.0 OUTLIER -111.26 163.11 14.28 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 122.041 0.924 . . . . 0.0 113.338 -178.545 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 1.027 ' HB2' ' CG2' ' A' ' 33' ' ' VAL . . . -123.45 166.19 15.8 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 114.632 -1.167 . . . . 0.0 111.22 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.826 ' O ' HG23 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -111.21 71.69 0.75 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.287 179.477 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.637 HD11 ' CE2' ' A' ' 151' ' ' PHE . 92.3 mt -63.59 -45.77 96.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.401 -179.56 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -60.49 -36.89 79.39 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.083 0.468 . . . . 0.0 110.672 -179.762 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.406 ' CG ' ' HB3' ' A' ' 51' ' ' ASP . 37.7 mm-40 -68.55 -44.78 73.8 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.973 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.826 HG23 ' O ' ' A' ' 51' ' ' ASP . 23.7 t -62.18 -45.14 99.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.204 -179.867 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.5 tp -58.73 -33.13 69.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.991 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.04 -46.13 10.78 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.954 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -118.35 134.57 54.94 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.865 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.65 -31.41 52.67 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.824 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 13.5 ptm180 -68.3 -34.0 75.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.9 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.507 ' O ' HG22 ' A' ' 55' ' ' VAL . 5.8 m -61.22 95.88 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.947 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.569 ' O ' HG23 ' A' ' 62' ' ' ILE . 0.6 OUTLIER -178.28 65.56 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.119 -179.967 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 11.0 tttm -157.78 84.59 0.89 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.013 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.418 ' O ' ' HB3' ' A' ' 93' ' ' LEU . 17.0 ttpt -136.1 130.64 33.67 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.635 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.6 HG13 ' O ' ' A' ' 91' ' ' ILE . 15.3 t -135.2 137.93 49.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.113 0.482 . . . . 0.0 111.894 -179.29 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' TRP . . . . . 0.641 ' HB2' ' HB ' ' A' ' 91' ' ' ILE . 15.5 m-90 -100.61 140.15 35.28 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.607 179.175 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.86 HG23 ' HG3' ' A' ' 90' ' ' GLN . 7.8 m -125.78 127.41 46.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.544 0.687 . . . . 0.0 112.329 179.46 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.655 ' HE2' HD11 ' A' ' 91' ' ' ILE . 44.7 m-85 -101.03 118.57 37.25 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.114 -0.948 . . . . 0.0 108.927 177.808 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.604 ' HA2' ' O ' ' A' ' 85' ' ' SER . . . 160.0 -157.66 28.95 Favored Glycine 0 CA--C 1.503 -0.665 0 C-N-CA 119.117 -1.516 . . . . 0.0 112.419 179.499 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.423 ' N ' ' HA ' ' A' ' 86' ' ' ASN . 0.5 OUTLIER -76.74 92.17 3.54 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-O 122.554 1.168 . . . . 0.0 108.912 -179.712 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.409 ' C ' ' H ' ' A' ' 73' ' ' ALA . 6.1 m-80 -149.59 155.19 38.76 Favored Pre-proline 0 C--N 1.308 -1.197 0 CA-C-N 112.809 -1.996 . . . . 0.0 108.259 178.72 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.551 ' O ' ' CB ' ' A' ' 73' ' ' ALA . 24.5 Cg_exo -55.79 -10.23 3.72 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 121.277 1.318 . . . . 0.0 111.278 177.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.739 ' HB2' ' HB2' ' A' ' 77' ' ' HIS . . . 135.99 52.23 0.0 OUTLIER 'General case' 0 CA--C 1.49 -1.336 0 CA-C-N 114.999 -1.0 . . . . 0.0 109.375 178.792 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.567 ' HB3' ' HB ' ' A' ' 67' ' ' THR . 0.1 OUTLIER -52.97 -69.62 0.11 Allowed 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 105.867 -1.901 . . . . 0.0 105.867 179.524 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.592 ' HB2' ' N ' ' A' ' 67' ' ' THR . 40.1 t0 -94.93 -47.74 6.3 Favored 'General case' 0 N--CA 1.435 -1.211 0 N-CA-C 105.687 -1.968 . . . . 0.0 105.687 169.755 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.524 ' CZ ' ' HD2' ' A' ' 44' ' ' PRO . 33.0 t80 -145.01 142.7 30.01 Favored 'General case' 0 C--N 1.347 0.485 0 CA-C-N 112.573 -2.103 . . . . 0.0 111.473 179.366 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.739 ' HB2' ' HB2' ' A' ' 73' ' ' ALA . 1.9 t60 -93.79 107.28 19.19 Favored 'General case' 0 C--N 1.33 -0.249 0 O-C-N 122.014 -0.429 . . . . 0.0 109.968 176.836 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.841 HD12 ' O ' ' A' ' 79' ' ' GLY . 3.8 pp -121.82 172.61 8.04 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 120.96 0.409 . . . . 0.0 111.645 -179.691 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.841 ' O ' HD12 ' A' ' 78' ' ' LEU . . . -57.86 -172.65 0.3 Allowed Glycine 0 C--N 1.333 0.383 0 CA-C-N 115.916 -0.584 . . . . 0.0 112.595 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.456 ' HA ' ' OD1' ' A' ' 86' ' ' ASN . 0.3 OUTLIER -111.94 98.11 7.15 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -179.64 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.809 HD12 ' CB ' ' A' ' 85' ' ' SER . 16.7 mt -114.79 113.96 45.18 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.252 178.41 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 5.8 m -54.7 -24.12 20.6 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 112.587 0.588 . . . . 0.0 112.587 -178.825 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.448 ' H ' HG22 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -93.58 -102.22 0.13 Allowed 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 -178.743 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.416 ' O ' ' CB ' ' A' ' 85' ' ' SER . 0.0 OUTLIER -109.23 110.45 21.66 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-O 121.682 0.753 . . . . 0.0 110.537 -179.391 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.809 ' CB ' HD12 ' A' ' 81' ' ' ILE . 0.5 OUTLIER 160.43 -46.84 0.0 OUTLIER 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 114.205 -1.362 . . . . 0.0 109.489 179.875 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.817 ' O ' ' N ' ' A' ' 88' ' ' HIS . 93.9 m-20 -64.8 -153.99 0.01 OUTLIER 'General case' 0 CA--C 1.521 -0.165 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 178.128 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.89 ' HB2' HD11 ' A' ' 104' ' ' ILE . 7.9 ptmt -49.31 73.44 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 179.099 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.971 ' O ' ' O ' ' A' ' 104' ' ' ILE . 31.2 t60 -95.67 -18.64 20.35 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 114.299 1.222 . . . . 0.0 114.299 -176.517 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.656 ' HA ' ' H ' ' A' ' 104' ' ' ILE . 0.2 OUTLIER -172.98 153.24 2.53 Favored 'General case' 0 C--N 1.31 -1.115 0 C-N-CA 119.014 -1.074 . . . . 0.0 112.489 178.063 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.86 ' HG3' HG23 ' A' ' 67' ' ' THR . 20.1 mt-30 -134.1 159.23 41.48 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 114.38 -1.282 . . . . 0.0 113.483 -177.322 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 1.106 HD13 HD21 ' A' ' 48' ' ' LEU . 2.8 mt -124.71 131.88 72.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.113 -0.948 . . . . 0.0 110.213 179.013 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.652 HD13 ' ND2' ' A' ' 121' ' ' ASN . 0.3 OUTLIER -107.38 145.09 33.34 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.036 0.446 . . . . 0.0 111.935 -179.623 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.881 HD22 ' N ' ' A' ' 94' ' ' GLY . 0.3 OUTLIER -125.73 128.73 48.21 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.47 179.324 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.881 ' N ' HD22 ' A' ' 93' ' ' LEU . . . 158.32 -146.94 14.06 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.46 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 62.67 71.68 0.52 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.909 0.385 . . . . 0.0 110.936 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 63.47 -80.41 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.028 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.558 ' HA3' HD23 ' A' ' 155' ' ' LEU . . . -150.02 29.27 1.12 Allowed Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.593 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -114.68 -170.8 1.81 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.715 0.293 . . . . 0.0 110.897 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 1.014 HD22 HD13 ' A' ' 124' ' ' LEU . 9.7 tt -131.0 156.69 44.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.893 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.689 HD23 ' HB3' ' A' ' 121' ' ' ASN . 4.5 mp -133.4 149.25 51.82 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.53 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.607 HD11 HD13 ' A' ' 145' ' ' ILE . 4.9 mp -114.81 128.92 56.58 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.756 -0.378 . . . . 0.0 110.101 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.49 ' O ' ' O ' ' A' ' 90' ' ' GLN . 27.9 t30 -110.47 111.21 22.31 Favored 'General case' 0 CA--C 1.509 -0.619 0 C-N-CA 119.76 -0.776 . . . . 0.0 109.766 179.47 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.825 ' HB3' HG21 ' A' ' 109' ' ' THR . 83.7 m-20 -84.74 112.65 20.68 Favored 'General case' 0 N--CA 1.444 -0.772 0 C-N-CA 119.865 -0.734 . . . . 0.0 109.887 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.971 ' O ' ' O ' ' A' ' 88' ' ' HIS . 0.1 OUTLIER -122.91 107.5 19.44 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.925 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 177.473 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.44 ' HG ' ' CE1' ' A' ' 88' ' ' HIS . 55.7 m -134.79 164.53 27.34 Favored 'General case' 0 C--N 1.295 -1.797 0 CA-C-N 115.011 -0.995 . . . . 0.0 109.432 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 19.9 m -69.4 -62.69 1.28 Allowed 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 119.207 -0.997 . . . . 0.0 111.789 -178.903 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -111.79 -32.64 6.56 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 115.218 1.562 . . . . 0.0 115.218 179.698 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -146.18 127.64 2.83 Favored Glycine 0 C--N 1.339 0.747 0 N-CA-C 117.36 1.704 . . . . 0.0 117.36 -177.674 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.825 HG21 ' HB3' ' A' ' 103' ' ' ASP . 7.5 m -121.36 138.12 54.4 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 174.289 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 0.712 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 3.4 m-90 -122.89 149.21 44.51 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 113.532 0.938 . . . . 0.0 113.532 -178.552 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.41 ' O ' ' HG ' ' A' ' 111' ' ' LEU . 0.3 OUTLIER -123.95 112.18 16.91 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 114.917 -1.038 . . . . 0.0 108.451 177.5 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 15.9 m-20 44.37 44.46 6.84 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.065 -0.516 . . . . 0.0 112.109 -179.394 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 79.89 26.4 56.02 Favored Glycine 0 N--CA 1.444 -0.792 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.779 179.28 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -138.62 96.8 3.21 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.079 0.466 . . . . 0.0 110.78 179.737 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.712 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.0 OUTLIER -44.37 129.08 6.48 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.964 179.806 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.786 HG21 ' OD2' ' A' ' 103' ' ' ASP . 27.6 m -115.91 -178.74 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.133 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.971 -178.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -91.61 142.23 27.86 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.086 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.46 ' HG3' ' HA ' ' A' ' 104' ' ' ILE . 49.1 tttm -63.72 162.35 13.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.27 179.381 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.422 ' N ' ' HG2' ' A' ' 118' ' ' LYS . 4.8 p-10 34.58 39.13 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.268 0.556 . . . . 0.0 111.264 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 9.5 p -111.24 106.58 15.62 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.07 -179.4 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.689 ' HB3' HD23 ' A' ' 100' ' ' LEU . 1.6 m-20 -54.68 143.6 24.53 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.64 179.736 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' GLN . . . . . 0.633 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 30.9 mm-40 -129.74 145.62 51.54 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.98 0.419 . . . . 0.0 112.005 -179.467 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.8 tt -72.87 121.33 19.82 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.526 178.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 1.014 HD13 HD22 ' A' ' 99' ' ' LEU . 12.1 tp -47.76 142.39 4.74 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-O 122.027 0.918 . . . . 0.0 112.186 -178.806 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.444 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.3 OUTLIER -127.51 152.62 47.35 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 113.895 -1.502 . . . . 0.0 110.05 179.191 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 11.3 mm100 -71.61 113.82 9.04 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.898 0.38 . . . . 0.0 110.024 179.549 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 64.61 31.67 81.67 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.512 -179.619 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.444 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 17.2 t70 -58.31 159.42 6.13 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.959 0.409 . . . . 0.0 111.195 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.748 ' HG3' HG22 ' A' ' 144' ' ' VAL . 3.0 tt0 -146.6 135.71 22.59 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.531 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.447 ' CG2' ' O ' ' A' ' 110' ' ' TRP . 1.3 mp -111.84 128.69 68.25 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.168 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.117 178.851 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.472 HG23 ' CG2' ' A' ' 140' ' ' ILE . 95.2 m -103.24 145.05 30.52 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.512 -179.687 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.513 HG11 ' CD2' ' A' ' 88' ' ' HIS . 4.3 m -141.09 158.27 22.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 -178.879 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 68.8 41.26 83.67 Favored Glycine 0 N--CA 1.448 -0.533 0 CA-C-N 115.776 -0.647 . . . . 0.0 112.553 179.406 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.505 ' HA ' HG12 ' A' ' 140' ' ' ILE . 98.6 t -76.45 157.33 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.625 0 CA-C-O 121.38 0.609 . . . . 0.0 112.012 -179.343 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.452 ' N ' HG12 ' A' ' 134' ' ' VAL . . . 138.21 -43.46 1.19 Allowed Glycine 0 N--CA 1.441 -1.017 0 N-CA-C 110.36 -1.096 . . . . 0.0 110.36 -178.609 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.624 HG12 ' H ' ' A' ' 138' ' ' SER . 46.4 t -126.8 123.93 63.81 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.708 0 CA-C-N 115.022 -0.589 . . . . 0.0 109.63 178.423 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.506 ' HA ' HD12 ' A' ' 140' ' ' ILE . 6.9 mt-10 -51.05 -26.17 5.92 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.711 0.291 . . . . 0.0 111.355 -179.121 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' SER . . . . . 0.624 ' H ' HG12 ' A' ' 136' ' ' VAL . 6.4 t -94.4 6.4 48.85 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 112.3 0.481 . . . . 0.0 112.3 -179.463 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -131.54 24.31 4.75 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 -179.243 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.506 HD12 ' HA ' ' A' ' 137' ' ' GLU . 23.6 mt -98.89 141.1 17.05 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.305 179.04 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.412 ' HB2' ' CG2' ' A' ' 132' ' ' VAL . 8.7 mp -119.98 135.07 55.05 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.83 -1.077 . . . . 0.0 109.805 179.446 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.417 ' O ' ' OG1' ' A' ' 40' ' ' THR . 46.6 t -114.54 151.84 32.72 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.836 0.827 . . . . 0.0 112.765 -178.848 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.517 HD23 ' SG ' ' A' ' 38' ' ' CYS . 8.2 mt -136.18 129.76 32.17 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.554 -1.203 . . . . 0.0 109.251 178.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.748 HG22 ' HG3' ' A' ' 129' ' ' GLU . 21.4 t -124.09 140.95 45.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.917 0.389 . . . . 0.0 111.923 -178.728 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.67 HG13 HG22 ' A' ' 36' ' ' VAL . 0.3 OUTLIER -112.31 140.23 33.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.832 179.558 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -118.99 108.64 15.0 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.704 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.698 HG12 HD21 ' A' ' 124' ' ' LEU . 1.9 mp -101.21 128.66 53.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.436 -179.854 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 10.7 p30 -79.16 132.02 36.41 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.909 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -63.64 -21.36 66.33 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.128 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 2.1 mptm? -58.37 -44.35 88.82 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.967 0.413 . . . . 0.0 110.716 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' PHE . . . . . 0.637 ' CE2' HD11 ' A' ' 52' ' ' ILE . 17.9 t80 -58.9 -44.49 91.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.82 179.777 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 4.0 mttt -63.94 -36.85 85.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.784 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -62.76 -37.43 86.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.82 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 11.4 t -60.97 -44.02 97.95 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.893 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.679 ' O ' HD13 ' A' ' 155' ' ' LEU . 3.0 tm? -57.22 -38.9 74.45 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.93 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 12.9 tm-20 -59.69 -41.0 89.76 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.84 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 32.9 tt0 -72.59 -27.94 62.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.006 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -122.08 44.59 2.55 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.867 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.79 120.85 27.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.85 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 21.5 t -93.21 129.51 43.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.12 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -124.54 86.65 2.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.959 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.67 157.57 9.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.864 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.403 ' O ' HG23 ' A' ' 163' ' ' ILE . 2.7 tt -78.63 127.58 38.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.142 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.248 1.003 0 CA-C-O 118.292 -0.861 . . . . 0.0 110.934 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.367 0 N-CA-C 112.519 -0.232 . . . . 0.0 112.519 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -100.34 -165.48 1.22 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.763 0.316 . . . . 0.0 110.808 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 7.4 m120 70.6 67.64 0.19 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.926 0.393 . . . . 0.0 110.86 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 6.0 pt -95.55 116.28 36.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.934 179.808 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 4.0 m 69.9 -66.91 0.25 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.926 -179.719 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 3.3 tp60 49.06 80.11 0.31 Allowed Pre-proline 0 C--N 1.331 -0.223 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.238 179.746 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -53.99 121.7 10.08 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.545 2.164 . . . . 0.0 112.314 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 5.5 t -99.04 151.37 21.02 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.064 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 8.8 mt-30 -100.32 69.56 1.47 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.945 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 7.0 tp-100 -128.95 32.22 4.79 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.876 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.9 m -139.48 -64.19 0.5 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.967 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 73.6 p -74.52 77.75 1.95 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.112 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 61.7 mt-30 -102.3 38.2 1.73 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.94 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -124.76 113.39 17.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.03 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 4.9 m -124.93 -47.54 1.79 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.144 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -59.82 -41.94 92.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.998 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 19.0 mtt85 -71.48 -39.0 71.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.931 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 87.0 t80 -59.45 -39.8 84.75 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.929 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.95 -41.47 96.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.99 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 39.6 mm -64.77 -40.14 88.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.251 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -57.65 -46.93 83.56 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.992 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 10.6 ttpp -67.04 -35.63 80.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.86 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -65.78 -47.73 74.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.201 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -70.16 -43.8 70.1 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.999 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -142.38 137.12 30.24 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.085 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -95.6 158.64 15.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.758 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 12.0 mt-30 -106.25 101.59 11.06 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.898 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 22.7 mm -90.77 139.69 17.22 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.343 0 CA-C-O 121.458 0.647 . . . . 0.0 111.526 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.424 ' CA ' ' HB ' ' A' ' 32' ' ' ILE . . . -150.95 -43.47 0.02 OUTLIER Glycine 0 C--N 1.317 -0.483 0 CA-C-N 114.882 -1.054 . . . . 0.0 112.681 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.479 ' O ' HD11 ' A' ' 52' ' ' ILE . 25.1 mt-10 -71.82 -22.83 61.5 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.656 0.265 . . . . 0.0 111.403 -179.825 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 68.0 m-20 -108.83 -13.29 14.79 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-O 121.886 0.851 . . . . 0.0 109.117 178.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.575 ' O ' ' CG2' ' A' ' 32' ' ' ILE . 0.1 OUTLIER -70.41 96.77 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.618 0 CA-C-N 114.11 -1.405 . . . . 0.0 110.844 -179.145 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.809 HG23 ' HB3' ' A' ' 50' ' ' ALA . 0.9 OUTLIER -39.21 -61.5 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 114.54 -1.209 . . . . 0.0 112.651 -178.896 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.631 ' N ' HG12 ' A' ' 33' ' ' VAL . 49.6 t -162.93 162.85 26.38 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.853 0.359 . . . . 0.0 111.743 -178.795 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.448 ' HD3' ' CG2' ' A' ' 45' ' ' ILE . 1.8 ttm180 -128.93 115.37 17.73 Favored 'General case' 0 C--N 1.334 -0.104 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.678 179.817 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.901 HG23 ' CD2' ' A' ' 48' ' ' LEU . 92.4 t -89.07 129.64 39.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.559 179.858 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.983 HG23 HG12 ' A' ' 45' ' ' ILE . 29.0 mt -118.48 107.77 22.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 116.056 -0.52 . . . . 0.0 112.026 -179.309 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.491 ' HB2' ' O ' ' A' ' 43' ' ' ILE . 3.7 m -97.38 99.93 11.37 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 177.954 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 8.7 t -107.27 27.17 9.33 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 -178.097 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.741 HG21 ' HB2' ' A' ' 142' ' ' SER . 40.3 p -108.96 -3.31 17.61 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.761 0.315 . . . . 0.0 111.566 179.664 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 95.67 60.2 1.04 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.467 179.819 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.562 ' CG ' HD12 ' A' ' 141' ' ' LEU . 27.7 mt-30 -141.12 -60.58 0.49 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.762 0.315 . . . . 0.0 111.242 -179.83 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.491 ' O ' ' HB2' ' A' ' 38' ' ' CYS . 3.5 mp -135.24 132.36 20.04 Favored Pre-proline 0 N--CA 1.452 -0.339 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.371 -179.639 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.415 ' HB2' ' OH ' ' A' ' 76' ' ' TYR . 24.1 Cg_exo -60.14 146.8 95.43 Favored 'Trans proline' 0 N--CA 1.463 -0.307 0 C-N-CA 122.214 1.943 . . . . 0.0 111.054 178.942 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.983 HG12 HG23 ' A' ' 37' ' ' ILE . 29.9 mt -50.72 122.55 2.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.948 0.404 . . . . 0.0 111.791 -179.165 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.422 ' HB2' ' CD2' ' A' ' 76' ' ' TYR . 0.0 OUTLIER -124.85 141.76 51.9 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.032 179.241 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.403 ' HB3' ' CD1' ' A' ' 32' ' ' ILE . 0.7 OUTLIER -99.55 119.58 38.27 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.975 0.417 . . . . 0.0 111.689 -179.241 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.901 ' CD2' HG23 ' A' ' 36' ' ' VAL . 0.3 OUTLIER -89.63 136.47 33.02 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 178.48 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.601 ' O ' ' HZ2' ' A' ' 66' ' ' TRP . 0.0 OUTLIER -137.23 162.25 33.99 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 122.034 0.921 . . . . 0.0 113.398 -178.564 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.809 ' HB3' HG23 ' A' ' 33' ' ' VAL . . . -149.62 152.65 35.79 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 114.418 -1.265 . . . . 0.0 111.174 179.24 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.446 ' CB ' ' HG2' ' A' ' 54' ' ' GLN . 95.6 m-20 -80.27 111.26 16.48 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.121 -179.617 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.479 HD11 ' O ' ' A' ' 30' ' ' GLU . 11.6 mt -64.01 -35.36 73.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.733 -179.826 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 7.3 t -56.78 -34.48 67.68 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.994 -179.121 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.446 ' HG2' ' CB ' ' A' ' 51' ' ' ASP . 10.3 mm-40 -65.76 -36.85 84.74 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.93 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 10.1 t -72.03 -37.94 62.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.149 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.2 tt -58.97 -37.52 76.97 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.8 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 5.7 mttt -91.23 -55.63 3.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.849 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.429 ' HG3' HD13 ' A' ' 62' ' ' ILE . 7.9 tt0 57.3 72.65 0.5 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.948 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.6 18.58 1.67 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.267 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 174.64 -55.92 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.859 0.361 . . . . 0.0 110.774 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -97.73 117.75 32.73 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.863 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.433 ' O ' HG23 ' A' ' 62' ' ' ILE . 0.8 OUTLIER -178.08 46.85 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.947 -179.818 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -161.92 87.99 0.67 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.153 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.439 ' O ' ' HB3' ' A' ' 93' ' ' LEU . 2.1 ttpt -118.65 136.29 53.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.178 179.573 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.634 HG13 ' O ' ' A' ' 91' ' ' ILE . 14.1 t -136.26 135.91 49.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.143 0.497 . . . . 0.0 111.946 -179.215 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' TRP . . . . . 0.726 ' CD1' HD12 ' A' ' 48' ' ' LEU . 13.8 m-90 -99.74 140.06 34.49 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.59 179.052 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.858 HG23 ' CG ' ' A' ' 90' ' ' GLN . 4.3 m -130.3 126.79 38.08 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.404 0.621 . . . . 0.0 112.403 179.504 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.471 ' CD2' ' CD2' ' A' ' 89' ' ' PHE . 88.5 m-85 -98.01 118.39 34.51 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.171 177.89 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.641 ' HA3' ' N ' ' A' ' 87' ' ' LYS . . . 160.33 -158.97 30.4 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 118.978 -1.582 . . . . 0.0 112.936 179.473 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.508 ' CD ' ' HB3' ' A' ' 86' ' ' ASN . 0.4 OUTLIER -76.84 91.75 3.56 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-O 122.55 1.167 . . . . 0.0 108.456 -179.888 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.453 ' CG ' ' HB2' ' A' ' 74' ' ' CYS . 0.5 OUTLIER -149.83 160.78 33.16 Favored Pre-proline 0 C--N 1.308 -1.205 0 CA-C-N 112.755 -2.021 . . . . 0.0 108.027 179.326 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.559 ' O ' ' CB ' ' A' ' 73' ' ' ALA . 28.1 Cg_endo -63.14 -8.73 14.94 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 120.99 1.127 . . . . 0.0 111.439 178.697 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.739 ' HB2' ' HB2' ' A' ' 77' ' ' HIS . . . 135.98 51.85 0.0 OUTLIER 'General case' 0 CA--C 1.491 -1.309 0 CA-C-N 114.806 -1.088 . . . . 0.0 109.788 178.602 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.575 ' HB3' ' HB ' ' A' ' 67' ' ' THR . 0.1 OUTLIER -52.88 -69.45 0.11 Allowed 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 105.838 -1.912 . . . . 0.0 105.838 179.328 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.628 ' HB2' ' N ' ' A' ' 67' ' ' THR . 7.5 t0 -94.63 -47.76 6.38 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 105.734 -1.951 . . . . 0.0 105.734 169.732 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.487 ' C ' ' HA ' ' A' ' 73' ' ' ALA . 1.7 t80 -145.37 141.65 28.66 Favored 'General case' 0 C--N 1.346 0.454 0 CA-C-N 112.717 -2.038 . . . . 0.0 112.35 -179.76 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.739 ' HB2' ' HB2' ' A' ' 73' ' ' ALA . 1.9 t60 -94.91 107.2 19.23 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 176.276 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -135.67 -176.24 4.22 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.001 0.429 . . . . 0.0 111.7 -179.386 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -60.92 163.31 20.39 Favored Glycine 0 N--CA 1.451 -0.339 0 CA-C-N 115.819 -0.628 . . . . 0.0 112.582 -179.82 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 12.8 p-10 -111.97 100.57 8.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.823 0.345 . . . . 0.0 111.553 -179.649 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.654 ' HB ' ' HB2' ' A' ' 85' ' ' SER . 12.4 mm -112.76 120.48 62.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 178.67 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 3.5 m -51.09 -23.92 3.54 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -177.856 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -83.66 -106.7 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 120.971 -0.291 . . . . 0.0 111.084 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.468 ' N ' HD23 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -109.86 113.32 25.96 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-O 121.341 0.591 . . . . 0.0 109.598 179.236 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.654 ' HB2' ' HB ' ' A' ' 81' ' ' ILE . 1.5 m 166.6 -66.55 0.0 OUTLIER 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.041 -179.708 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.977 ' O ' ' N ' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -60.04 -166.18 0.01 OUTLIER 'General case' 0 CA--C 1.51 -0.575 0 N-CA-C 109.333 -0.618 . . . . 0.0 109.333 178.954 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.641 ' N ' ' HA3' ' A' ' 69' ' ' GLY . 2.8 mtmt -28.7 69.44 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 121.279 0.562 . . . . 0.0 109.704 -179.685 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.986 ' C ' ' O ' ' A' ' 104' ' ' ILE . 32.3 t60 -98.03 -17.44 19.15 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 113.559 0.948 . . . . 0.0 113.559 -176.765 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.677 ' HA ' ' H ' ' A' ' 104' ' ' ILE . 0.3 OUTLIER -173.08 153.33 2.5 Favored 'General case' 0 C--N 1.31 -1.135 0 C-N-CA 119.422 -0.911 . . . . 0.0 112.379 177.73 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.858 ' CG ' HG23 ' A' ' 67' ' ' THR . 31.9 mt-30 -135.83 157.92 45.67 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.455 -1.248 . . . . 0.0 113.674 -177.42 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.663 HD11 HG21 ' A' ' 36' ' ' VAL . 9.9 mt -125.14 131.62 72.22 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 CA-C-N 114.955 -1.021 . . . . 0.0 109.711 178.496 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.636 HD13 ' ND2' ' A' ' 121' ' ' ASN . 0.2 OUTLIER -109.37 141.45 41.72 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.098 0.475 . . . . 0.0 112.154 -179.298 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.709 HD13 ' CG2' ' A' ' 33' ' ' VAL . 6.4 tp -125.8 141.52 51.96 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.355 178.923 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 127.37 -135.89 9.01 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.542 179.787 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 58.74 80.09 0.2 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.815 0.341 . . . . 0.0 110.855 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 67.27 -72.68 0.09 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.956 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -172.94 54.52 0.16 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.421 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.476 ' C ' HD13 ' A' ' 99' ' ' LEU . 32.1 m-20 -148.81 -174.88 4.74 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.825 0.345 . . . . 0.0 110.953 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.662 HD22 ' N ' ' A' ' 99' ' ' LEU . 0.3 OUTLIER -119.47 148.32 43.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.751 179.918 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.665 HD22 ' HB3' ' A' ' 121' ' ' ASN . 0.4 OUTLIER -133.73 148.31 51.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.399 179.969 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.541 HD23 HD11 ' A' ' 130' ' ' ILE . 3.2 mp -114.82 131.33 56.86 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.978 -0.378 . . . . 0.0 109.978 179.855 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.499 ' HB2' HD11 ' A' ' 92' ' ' LEU . 23.4 t30 -113.16 111.32 21.89 Favored 'General case' 0 CA--C 1.511 -0.529 0 C-N-CA 119.851 -0.74 . . . . 0.0 110.032 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.787 ' HB3' HG21 ' A' ' 109' ' ' THR . 73.2 m-20 -84.37 112.17 20.1 Favored 'General case' 0 N--CA 1.444 -0.752 0 C-N-CA 119.738 -0.785 . . . . 0.0 109.641 179.519 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.986 ' O ' ' C ' ' A' ' 88' ' ' HIS . 0.1 OUTLIER -123.54 107.29 18.66 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.886 0 N-CA-C 108.752 -0.832 . . . . 0.0 108.752 177.614 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 67.3 m -129.72 169.14 15.48 Favored 'General case' 0 C--N 1.296 -1.74 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.435 179.617 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 23.7 m -69.35 -62.88 1.2 Allowed 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 119.121 -1.031 . . . . 0.0 111.281 -179.228 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -112.11 -33.09 6.35 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 114.658 1.355 . . . . 0.0 114.658 179.011 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -146.67 130.2 3.56 Favored Glycine 0 C--N 1.341 0.813 0 N-CA-C 116.97 1.548 . . . . 0.0 116.97 -177.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.787 HG21 ' HB3' ' A' ' 103' ' ' ASP . 5.6 m -121.18 138.32 54.26 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 174.396 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 0.666 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.6 m-90 -120.48 149.22 42.74 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 -178.639 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.474 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -122.17 112.04 17.7 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 114.915 -1.039 . . . . 0.0 108.601 177.579 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 44.9 44.36 7.84 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.983 -0.553 . . . . 0.0 112.155 -179.524 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 79.79 21.62 65.7 Favored Glycine 0 N--CA 1.444 -0.794 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.786 179.345 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -133.4 98.75 4.32 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.928 0.394 . . . . 0.0 110.664 179.779 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.666 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.1 OUTLIER -43.23 122.43 2.53 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.034 179.804 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.712 HG11 ' OD2' ' A' ' 103' ' ' ASP . 12.6 p -113.78 160.49 13.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.688 -178.859 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.515 ' N ' HG22 ' A' ' 116' ' ' VAL . 4.8 tt0 -70.96 141.61 51.06 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.104 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.407 ' O ' ' C ' ' A' ' 119' ' ' ASN . 88.6 tttt -65.39 164.24 14.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.076 179.325 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.407 ' C ' ' O ' ' A' ' 118' ' ' LYS . 4.3 m-80 35.47 39.01 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.249 0.547 . . . . 0.0 110.938 -179.402 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 5.3 p -111.04 108.46 18.18 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.997 -179.365 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.665 ' HB3' HD22 ' A' ' 100' ' ' LEU . 1.4 m-20 -58.59 140.59 54.11 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.737 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' GLN . . . . . 0.596 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 4.2 mm100 -129.82 145.21 51.58 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-O 121.039 0.447 . . . . 0.0 112.137 -179.567 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 22.3 tp -72.58 117.94 14.88 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.44 178.958 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.886 HD21 HG12 ' A' ' 147' ' ' ILE . 29.9 tp -45.24 144.05 1.49 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.875 0.845 . . . . 0.0 112.081 -178.713 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -127.02 152.79 46.78 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 114.037 -1.438 . . . . 0.0 110.252 179.585 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.72 113.88 9.22 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 179.414 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 67.06 29.12 74.12 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.281 -179.379 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -54.57 160.53 1.76 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.925 0.393 . . . . 0.0 111.203 -179.828 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.468 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 2.4 tt0 -146.05 135.32 22.87 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.529 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.674 HD13 ' OD1' ' A' ' 103' ' ' ASP . 5.4 mt -115.05 128.61 72.15 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 116.285 -0.416 . . . . 0.0 109.976 179.007 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.585 HG23 ' CG2' ' A' ' 140' ' ' ILE . 7.7 m -103.21 143.74 32.24 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.83 -179.374 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.452 ' HB ' ' NE2' ' A' ' 88' ' ' HIS . 4.6 m -141.21 155.26 21.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.317 -0.401 . . . . 0.0 112.039 -179.013 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 72.14 38.1 59.46 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 121.126 -0.559 . . . . 0.0 112.4 179.282 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.476 ' HA ' HG12 ' A' ' 140' ' ' ILE . 96.1 t -72.88 156.26 6.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 121.499 0.666 . . . . 0.0 112.129 -179.276 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.453 ' N ' HG12 ' A' ' 134' ' ' VAL . . . 153.26 -46.5 0.56 Allowed Glycine 0 N--CA 1.442 -0.96 0 CA-C-N 114.939 -1.028 . . . . 0.0 110.606 -179.234 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.567 HG12 ' H ' ' A' ' 138' ' ' SER . 46.7 t -126.78 135.83 62.56 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.65 0 CA-C-N 115.239 -0.48 . . . . 0.0 109.832 178.644 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.1 -35.13 33.6 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.818 0.342 . . . . 0.0 111.269 -179.337 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 138' ' ' SER . . . . . 0.567 ' H ' HG12 ' A' ' 136' ' ' VAL . 0.2 OUTLIER -94.04 6.14 49.47 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 116.273 -0.421 . . . . 0.0 112.13 -179.513 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -125.6 28.72 6.16 Favored 'General case' 0 CA--C 1.518 -0.261 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -179.398 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.585 ' CG2' HG23 ' A' ' 131' ' ' THR . 22.0 mt -105.29 141.28 20.99 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.373 179.342 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.562 HD12 ' CG ' ' A' ' 42' ' ' GLN . 3.1 mm? -114.85 135.0 54.67 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 114.906 -1.043 . . . . 0.0 109.92 179.344 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.741 ' HB2' HG21 ' A' ' 40' ' ' THR . 3.9 m -119.2 153.7 34.53 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.845 0.831 . . . . 0.0 112.48 -179.03 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.468 ' O ' ' HA ' ' A' ' 129' ' ' GLU . 13.7 mt -135.4 141.5 45.48 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.36 -1.291 . . . . 0.0 109.216 179.325 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 17.3 t -124.02 140.85 46.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.014 0.435 . . . . 0.0 112.123 -178.636 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.725 HG13 HG22 ' A' ' 36' ' ' VAL . 0.8 OUTLIER -108.63 125.99 65.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.105 179.257 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 8.5 t80 -111.98 118.36 35.24 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.277 -179.419 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.886 HG12 HD21 ' A' ' 124' ' ' LEU . 2.4 mp -95.34 134.57 32.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.655 179.628 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -73.87 122.66 22.85 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.994 -179.765 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -60.38 -41.7 94.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.798 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.17 -43.28 87.36 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.677 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 24.1 t80 -60.84 -44.41 96.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.761 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 54.7 tttm -60.24 -34.6 73.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.833 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 15.3 tt0 -58.98 -45.3 90.93 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.792 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 9.7 t -64.33 -44.31 91.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.83 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -68.73 -38.44 80.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.806 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -58.38 -40.17 81.6 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.938 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -91.65 -28.55 17.41 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.894 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 2.7 p30 42.6 88.23 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.484 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 20.3 mtmm -61.24 136.2 57.98 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.894 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.436 ' O ' HG23 ' A' ' 160' ' ' VAL . 27.6 m -102.9 123.34 56.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.151 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -66.6 139.75 57.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.892 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 1.3 mmm180 -98.4 -36.94 9.8 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.926 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.489 ' H ' HD12 ' A' ' 163' ' ' ILE . 3.7 mp -92.75 120.47 42.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.114 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 164' ' ' ARG . . . . . 0.427 ' HG3' HG22 ' A' ' 163' ' ' ILE . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.201 -0.904 . . . . 0.0 110.918 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.319 0 N-CA-C 112.485 -0.246 . . . . 0.0 112.485 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -108.55 -174.61 2.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.906 0.384 . . . . 0.0 110.85 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -150.7 87.58 1.44 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.76 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.49 ' O ' HG22 ' A' ' 4' ' ' ILE . 26.3 mt -144.36 47.82 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.151 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -93.76 -37.99 11.5 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.041 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -145.84 89.78 6.04 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.898 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -50.68 -53.45 7.12 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.579 2.186 . . . . 0.0 112.429 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 9.3 t -177.22 -176.24 0.63 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.246 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 14.6 mt-30 62.19 -89.99 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.045 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 45.43 32.44 1.07 Allowed 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 120.881 0.372 . . . . 0.0 111.329 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 59.7 p -62.13 -47.22 85.53 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.11 -179.797 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER 51.7 77.19 0.15 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.132 -179.849 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -86.63 -164.61 1.09 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.901 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 65.82 175.93 0.22 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.099 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.415 HG23 ' N ' ' A' ' 16' ' ' GLN . 3.2 t -172.95 -45.25 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.078 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.415 ' N ' HG23 ' A' ' 15' ' ' THR . 15.3 mt-30 -65.89 -47.09 75.98 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.902 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -71.65 -37.58 70.8 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.81 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -61.66 -38.19 86.85 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.865 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -60.64 -42.99 98.07 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.897 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 33.0 mm -63.03 -42.63 97.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.163 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -57.68 -34.12 69.08 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.018 -179.876 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -63.65 -31.01 72.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.868 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -59.18 -47.64 84.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.158 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 2.4 m -56.55 -32.12 64.83 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.103 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -110.11 81.03 1.37 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.926 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -70.89 149.87 46.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.933 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -68.53 123.61 21.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.894 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 22.4 mm -82.69 139.61 17.56 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.358 0 CA-C-O 121.507 0.67 . . . . 0.0 111.648 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.453 ' CA ' ' HB ' ' A' ' 32' ' ' ILE . . . -87.93 66.85 3.27 Favored Glycine 0 C--N 1.318 -0.453 0 CA-C-N 114.875 -1.057 . . . . 0.0 112.578 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -67.95 -22.75 65.02 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.648 0.261 . . . . 0.0 111.414 -179.819 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 26.6 m120 -109.23 -13.56 14.63 Favored 'General case' 0 CA--C 1.514 -0.422 0 CA-C-O 121.933 0.873 . . . . 0.0 109.131 178.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.585 ' O ' ' CG2' ' A' ' 32' ' ' ILE . 0.1 OUTLIER -70.47 96.83 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.619 0 CA-C-N 114.103 -1.408 . . . . 0.0 111.183 -178.983 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.858 HG23 ' HB3' ' A' ' 50' ' ' ALA . 0.9 OUTLIER -36.55 -60.77 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 CA-C-N 114.643 -1.162 . . . . 0.0 112.246 -179.403 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.625 ' N ' HG12 ' A' ' 33' ' ' VAL . 1.7 m -163.19 165.42 24.45 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.742 -179.466 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.429 ' CZ ' HD11 ' A' ' 37' ' ' ILE . 2.3 tmm_? -134.27 114.78 13.39 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.159 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.99 HG23 HD21 ' A' ' 48' ' ' LEU . 48.2 t -91.38 122.0 42.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.508 179.313 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.984 HG23 HG12 ' A' ' 45' ' ' ILE . 34.1 mt -109.55 108.06 24.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.636 -179.847 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.817 ' SG ' HD12 ' A' ' 143' ' ' LEU . 60.1 m -102.04 101.75 12.16 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 178.098 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 7.6 t -118.69 32.63 6.03 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -177.649 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.562 HG21 ' HB2' ' A' ' 142' ' ' SER . 34.8 p -112.45 15.89 20.05 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.976 0.417 . . . . 0.0 111.285 179.325 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 88.71 38.87 6.82 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.133 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.673 ' OE1' HD13 ' A' ' 141' ' ' LEU . 0.0 OUTLIER -117.23 -76.21 0.57 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.663 0.268 . . . . 0.0 111.465 -179.591 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.616 HD12 ' HB3' ' A' ' 42' ' ' GLN . 3.7 mp -135.18 141.59 38.55 Favored Pre-proline 0 N--CA 1.452 -0.348 0 CA-C-O 120.859 0.361 . . . . 0.0 111.527 -179.072 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.481 ' HD2' ' CZ ' ' A' ' 76' ' ' TYR . 25.6 Cg_exo -59.25 147.08 92.5 Favored 'Trans proline' 0 N--CA 1.465 -0.186 0 C-N-CA 122.338 2.025 . . . . 0.0 111.202 178.832 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.984 HG12 HG23 ' A' ' 37' ' ' ILE . 44.2 mt -43.38 128.6 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-O 121.046 0.451 . . . . 0.0 111.852 -179.401 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.424 ' HG2' ' O ' ' A' ' 75' ' ' ASP . 0.0 OUTLIER -123.27 130.38 52.66 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.255 179.58 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.426 ' C ' HD13 ' A' ' 48' ' ' LEU . 4.9 m-20 -100.83 119.72 39.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.021 0.439 . . . . 0.0 111.444 -179.54 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.99 HD21 HG23 ' A' ' 36' ' ' VAL . 0.2 OUTLIER -93.9 130.73 39.85 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.353 178.763 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.532 ' O ' ' HZ2' ' A' ' 66' ' ' TRP . 0.0 OUTLIER -133.41 161.66 33.93 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.972 0.891 . . . . 0.0 113.221 -178.809 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.858 ' HB3' HG23 ' A' ' 33' ' ' VAL . . . -156.87 141.94 17.17 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 114.441 -1.254 . . . . 0.0 110.937 179.017 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.444 ' CB ' ' HG3' ' A' ' 54' ' ' GLN . 0.2 OUTLIER -70.02 124.14 23.31 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.091 0.472 . . . . 0.0 111.231 -179.613 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 14.7 mt -63.69 -36.34 76.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 115.824 -0.626 . . . . 0.0 111.104 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.6 t -56.62 -34.28 67.08 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.899 -179.537 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.444 ' HG3' ' CB ' ' A' ' 51' ' ' ASP . 1.9 mt-30 -63.76 -37.72 88.42 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.67 -179.888 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.555 ' HA ' HD13 ' A' ' 62' ' ' ILE . 37.4 t -73.73 -46.6 46.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.149 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -59.45 -34.02 72.0 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.921 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.8 mmtp -89.54 -36.15 15.52 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.881 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 43.82 47.1 6.78 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.396 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 3.2 tmtm? -84.56 -67.72 0.77 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.009 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 6.2 ttp180 -160.42 51.12 0.29 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.884 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -158.43 29.46 0.24 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.96 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.589 ' O ' HG23 ' A' ' 62' ' ' ILE . 2.3 tp -110.64 61.62 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.876 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 3.0 mttp -165.65 71.45 0.15 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.999 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -108.16 132.73 53.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.35 179.587 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.563 HG13 ' O ' ' A' ' 91' ' ' ILE . 6.9 t -127.35 135.47 63.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.182 0.515 . . . . 0.0 111.959 -179.058 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' TRP . . . . . 0.83 ' CD1' HD12 ' A' ' 48' ' ' LEU . 14.7 m-90 -99.25 139.97 34.11 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.786 179.179 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.661 HG23 ' HG2' ' A' ' 90' ' ' GLN . 32.0 m -131.43 131.42 43.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.571 0.7 . . . . 0.0 112.048 179.491 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.49 ' CD2' ' CD2' ' A' ' 89' ' ' PHE . 94.0 m-85 -102.68 118.98 38.03 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.023 -0.99 . . . . 0.0 109.148 177.851 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.675 ' CA ' HD21 ' A' ' 78' ' ' LEU . . . 158.64 -156.87 27.87 Favored Glycine 0 CA--C 1.501 -0.804 0 C-N-CA 118.962 -1.59 . . . . 0.0 112.709 179.638 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -75.62 91.65 2.88 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-O 122.615 1.198 . . . . 0.0 108.679 -179.669 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.401 ' C ' ' H ' ' A' ' 73' ' ' ALA . 10.3 m120 -149.9 153.37 35.84 Favored Pre-proline 0 C--N 1.31 -1.119 0 CA-C-N 112.693 -2.049 . . . . 0.0 108.187 178.992 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.556 ' O ' ' HB2' ' A' ' 77' ' ' HIS . 26.6 Cg_exo -55.92 -10.84 4.57 Favored 'Trans proline' 0 N--CA 1.459 -0.525 0 C-N-CA 121.239 1.293 . . . . 0.0 111.318 178.101 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.742 ' HB2' ' HB2' ' A' ' 77' ' ' HIS . . . 137.99 52.03 0.0 OUTLIER 'General case' 0 CA--C 1.49 -1.365 0 CA-C-N 114.761 -1.109 . . . . 0.0 109.212 178.871 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.522 ' HB3' ' HB ' ' A' ' 67' ' ' THR . 0.1 OUTLIER -52.55 -69.45 0.11 Allowed 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 105.783 -1.932 . . . . 0.0 105.783 179.689 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.538 ' HB2' ' N ' ' A' ' 67' ' ' THR . 9.2 t0 -95.38 -47.73 6.17 Favored 'General case' 0 N--CA 1.435 -1.21 0 N-CA-C 105.671 -1.974 . . . . 0.0 105.671 169.513 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.508 ' C ' ' HA ' ' A' ' 73' ' ' ALA . 33.7 t80 -144.07 142.61 30.73 Favored 'General case' 0 C--N 1.347 0.5 0 CA-C-N 112.544 -2.116 . . . . 0.0 111.316 179.713 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.742 ' HB2' ' HB2' ' A' ' 73' ' ' ALA . 1.5 t60 -92.77 109.32 20.75 Favored 'General case' 0 C--N 1.33 -0.279 0 O-C-N 121.999 -0.438 . . . . 0.0 110.177 177.209 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.675 HD21 ' CA ' ' A' ' 69' ' ' GLY . 1.3 pp -123.45 175.28 6.85 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.911 0.386 . . . . 0.0 111.538 -179.824 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.503 ' O ' HD12 ' A' ' 78' ' ' LEU . . . -62.92 -170.85 1.35 Allowed Glycine 0 C--N 1.332 0.313 0 C-N-CA 120.985 -0.626 . . . . 0.0 112.525 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -111.76 98.64 7.54 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 121.025 0.44 . . . . 0.0 111.68 -179.666 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.875 HD13 ' HB3' ' A' ' 85' ' ' SER . 3.2 mp -114.13 111.77 37.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.404 178.775 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 46.9 t -55.35 -24.25 28.33 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 -179.247 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.514 ' C ' HD13 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -88.75 -109.53 0.07 Allowed 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 112.249 0.463 . . . . 0.0 112.249 -178.845 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.842 HD22 ' H ' ' A' ' 84' ' ' LEU . 0.0 OUTLIER -108.89 112.22 24.34 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-O 121.437 0.637 . . . . 0.0 109.666 179.87 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.875 ' HB3' HD13 ' A' ' 81' ' ' ILE . 0.6 OUTLIER 161.88 -45.11 0.0 OUTLIER 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 114.686 -1.143 . . . . 0.0 109.335 -179.628 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.858 ' O ' ' N ' ' A' ' 88' ' ' HIS . 97.1 m-20 -64.31 -149.47 0.01 OUTLIER 'General case' 0 CA--C 1.521 -0.138 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 177.726 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.815 ' HB3' HD11 ' A' ' 104' ' ' ILE . 9.3 mttt -49.47 72.34 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.073 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.977 ' C ' ' O ' ' A' ' 104' ' ' ILE . 32.8 t60 -90.89 -17.34 26.64 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 114.02 1.118 . . . . 0.0 114.02 -176.727 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.664 ' HA ' ' H ' ' A' ' 104' ' ' ILE . 0.5 OUTLIER -174.43 153.56 1.93 Allowed 'General case' 0 C--N 1.311 -1.089 0 C-N-CA 119.257 -0.977 . . . . 0.0 112.673 178.061 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.661 ' HG2' HG23 ' A' ' 67' ' ' THR . 34.9 mt-30 -136.64 158.49 44.33 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.523 -1.217 . . . . 0.0 113.72 -177.624 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.781 HD11 HG21 ' A' ' 36' ' ' VAL . 10.6 mt -127.72 131.7 69.68 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 CA-C-N 114.868 -1.06 . . . . 0.0 109.896 178.725 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.539 HD12 ' N ' ' A' ' 93' ' ' LEU . 0.5 OUTLIER -111.42 137.68 48.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.86 0.362 . . . . 0.0 110.945 -179.94 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.806 HD23 HD22 ' A' ' 99' ' ' LEU . 1.0 OUTLIER -124.06 129.14 50.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.779 179.789 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.792 ' N ' HD22 ' A' ' 93' ' ' LEU . . . 136.63 -128.61 4.52 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.399 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 60.17 66.71 0.93 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.825 0.345 . . . . 0.0 110.775 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 49.1 m-20 62.6 32.39 16.41 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.848 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 79.55 78.1 0.89 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.497 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.418 ' O ' HD22 ' A' ' 93' ' ' LEU . 5.4 t-20 -167.82 177.92 5.49 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.795 0.331 . . . . 0.0 110.897 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.806 HD22 HD23 ' A' ' 93' ' ' LEU . 2.4 mm? -119.85 130.76 55.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.809 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.729 HD13 ' O ' ' A' ' 122' ' ' GLN . 3.8 mm? -127.39 148.05 50.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.284 179.845 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.47 ' O ' ' N ' ' A' ' 122' ' ' GLN . 52.5 mt -115.93 129.66 56.49 Favored 'General case' 0 CA--C 1.518 -0.287 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.11 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.489 ' O ' ' O ' ' A' ' 90' ' ' GLN . 26.7 t30 -113.26 111.25 21.72 Favored 'General case' 0 CA--C 1.509 -0.598 0 C-N-CA 119.804 -0.758 . . . . 0.0 109.877 179.803 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.749 ' HB3' HG21 ' A' ' 109' ' ' THR . 72.6 m-20 -83.57 112.24 19.82 Favored 'General case' 0 N--CA 1.442 -0.853 0 C-N-CA 119.827 -0.749 . . . . 0.0 109.619 179.664 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.977 ' O ' ' C ' ' A' ' 88' ' ' HIS . 0.1 OUTLIER -123.13 107.84 20.0 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.949 0 N-CA-C 108.928 -0.768 . . . . 0.0 108.928 177.745 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.502 ' HG ' ' CE1' ' A' ' 88' ' ' HIS . 71.9 m -128.93 169.6 14.44 Favored 'General case' 0 C--N 1.295 -1.793 0 CA-C-N 114.974 -1.012 . . . . 0.0 109.286 179.473 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 29.2 m -69.11 -62.68 1.28 Allowed 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 119.074 -1.05 . . . . 0.0 111.061 -179.356 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -111.86 -33.42 6.31 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 114.326 1.232 . . . . 0.0 114.326 178.882 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -147.05 131.69 4.05 Favored Glycine 0 C--N 1.341 0.813 0 N-CA-C 116.886 1.514 . . . . 0.0 116.886 -178.181 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.749 HG21 ' HB3' ' A' ' 103' ' ' ASP . 7.2 m -121.08 138.18 54.31 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 174.259 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 0.751 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.4 m-90 -119.78 149.36 42.17 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 113.543 0.942 . . . . 0.0 113.543 -178.58 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.452 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -123.4 112.2 17.27 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 114.82 -1.082 . . . . 0.0 108.546 177.556 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 73.3 m-20 47.3 43.11 14.7 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.079 -0.509 . . . . 0.0 112.204 -179.496 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 84.06 -4.11 84.01 Favored Glycine 0 N--CA 1.445 -0.732 0 C-N-CA 120.759 -0.734 . . . . 0.0 113.25 179.168 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -111.47 102.3 10.67 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.917 0.389 . . . . 0.0 110.817 179.688 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.751 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.0 OUTLIER -44.01 136.49 3.72 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.939 179.846 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.63 HG11 ' OD2' ' A' ' 103' ' ' ASP . 14.9 p -124.35 163.39 24.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.693 -179.082 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.548 ' N ' HG22 ' A' ' 116' ' ' VAL . 29.7 tp10 -70.1 141.84 52.69 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.019 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.409 ' HG3' ' HA ' ' A' ' 104' ' ' ILE . 63.4 tttm -68.59 162.7 25.3 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.407 179.654 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.405 ' N ' ' HG2' ' A' ' 118' ' ' LYS . 4.9 p-10 35.21 38.04 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.349 0.595 . . . . 0.0 111.404 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 6.7 p -111.39 109.79 19.94 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.018 -179.453 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.431 ' HB3' HD12 ' A' ' 100' ' ' LEU . 72.1 m-80 -59.33 139.47 56.98 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.502 179.754 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' GLN . . . . . 0.729 ' O ' HD13 ' A' ' 100' ' ' LEU . 48.9 mm-40 -129.7 148.53 51.6 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-O 121.072 0.463 . . . . 0.0 112.121 -179.357 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.686 HD13 ' O ' ' A' ' 124' ' ' LEU . 3.5 tm? -72.31 112.08 8.07 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.456 179.172 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.686 ' O ' HD13 ' A' ' 123' ' ' LEU . 7.8 tt -43.23 147.22 0.38 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.728 0.775 . . . . 0.0 112.246 -178.645 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.43 ' O ' HD11 ' A' ' 147' ' ' ILE . 0.6 OUTLIER -126.64 153.15 45.74 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 114.322 -1.308 . . . . 0.0 110.43 179.752 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 126' ' ' GLN . . . . . 0.437 ' HA ' HD13 ' A' ' 147' ' ' ILE . 0.1 OUTLIER -71.61 113.86 9.08 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 179.414 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 68.25 27.32 73.78 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.201 -179.153 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -53.41 161.22 1.01 Allowed 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.928 0.394 . . . . 0.0 111.319 -179.744 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.403 ' HG2' ' O ' ' A' ' 143' ' ' LEU . 1.1 tt0 -146.21 134.85 22.2 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.204 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.636 HD13 ' OD1' ' A' ' 103' ' ' ASP . 3.7 mt -115.8 128.44 73.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 178.854 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.483 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 36.7 m -103.02 143.31 32.74 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.61 -179.742 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.474 ' HB ' ' NE2' ' A' ' 88' ' ' HIS . 6.3 m -140.75 158.21 23.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 -178.549 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 72.88 44.09 38.94 Favored Glycine 0 N--CA 1.445 -0.717 0 CA-C-N 115.679 -0.692 . . . . 0.0 112.275 179.39 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.504 ' HA ' HG12 ' A' ' 140' ' ' ILE . 85.4 t -81.64 153.94 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.616 0 CA-C-O 121.438 0.637 . . . . 0.0 112.161 -179.212 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.403 ' N ' HG12 ' A' ' 134' ' ' VAL . . . 152.68 -43.48 0.65 Allowed Glycine 0 N--CA 1.441 -1.0 0 CA-C-N 114.932 -1.031 . . . . 0.0 110.564 -179.113 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.53 HG12 ' H ' ' A' ' 138' ' ' SER . 44.0 t -126.71 132.82 69.74 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.675 0 CA-C-N 115.137 -0.531 . . . . 0.0 109.714 178.681 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 37.3 tp10 -51.28 -34.59 33.59 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.761 0.315 . . . . 0.0 111.449 -179.169 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' SER . . . . . 0.53 ' H ' HG12 ' A' ' 136' ' ' VAL . 48.2 t -94.34 6.52 48.46 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -179.413 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -126.13 29.64 5.81 Favored 'General case' 0 CA--C 1.52 -0.201 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -179.239 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.504 HG12 ' HA ' ' A' ' 134' ' ' VAL . 11.8 mt -107.6 141.14 23.58 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.367 179.162 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.673 HD13 ' OE1' ' A' ' 42' ' ' GLN . 1.2 mp -123.07 134.79 54.24 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.164 -0.926 . . . . 0.0 110.315 179.768 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.759 ' O ' HD13 ' A' ' 143' ' ' LEU . 0.8 OUTLIER -112.73 154.67 25.81 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.958 0.885 . . . . 0.0 112.758 -179.087 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.817 HD12 ' SG ' ' A' ' 38' ' ' CYS . 1.6 mm? -130.12 144.05 51.13 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 114.047 -1.433 . . . . 0.0 109.192 179.34 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.472 ' O ' ' N ' ' A' ' 37' ' ' ILE . 21.9 t -124.31 140.97 46.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.933 0.396 . . . . 0.0 111.939 -178.903 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.873 HG13 HG22 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -109.86 132.2 58.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.712 179.538 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -118.2 125.27 49.84 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.69 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.685 HG12 HD21 ' A' ' 124' ' ' LEU . 3.9 mp -109.58 133.61 54.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.472 -179.647 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 148' ' ' ASN . . . . . 0.48 ' N ' HD21 ' A' ' 148' ' ' ASN . 0.9 OUTLIER -78.62 117.95 20.27 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.957 179.935 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -65.15 -27.58 68.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.95 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.74 -46.01 90.44 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-O 121.065 0.459 . . . . 0.0 110.68 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 10.5 t80 -57.61 -44.48 85.51 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.008 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 4.8 mttm -61.38 -47.68 84.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.12 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 1.1 mm100 -58.96 -36.92 75.62 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.938 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 12.2 t -58.29 -44.67 88.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.963 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.26 -35.9 82.45 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.038 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -57.91 -48.39 80.03 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.0 -179.877 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 17.7 mm-40 -85.84 -30.5 22.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.933 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 42.64 68.54 0.47 Allowed 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.416 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.06 134.07 47.85 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.816 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 6.3 m -71.69 120.39 19.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.032 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -126.77 -67.51 0.85 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.184 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 17.2 ttm180 61.23 119.49 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.884 0.373 . . . . 0.0 111.052 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 17.8 mt -104.66 128.46 58.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.044 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.239 -0.886 . . . . 0.0 110.934 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.355 0 N-CA-C 112.552 -0.219 . . . . 0.0 112.552 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -107.92 121.42 44.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.769 0.319 . . . . 0.0 110.95 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -107.0 -168.89 1.46 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.847 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.7 tt -106.59 17.04 6.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.397 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER 48.13 92.73 0.01 OUTLIER 'General case' 0 C--O 1.231 0.106 0 CA-C-O 120.834 0.349 . . . . 0.0 111.344 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -87.04 119.95 71.26 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.868 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -52.3 101.29 0.06 OUTLIER 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.406 2.071 . . . . 0.0 112.331 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.18 138.32 36.45 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.137 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 11.2 tm0? -83.15 -32.22 26.76 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.874 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.536 ' O ' HG23 ' A' ' 12' ' ' THR . 7.6 mt-30 -61.19 -27.59 68.53 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.04 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.2 m -55.9 105.77 0.21 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.993 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.536 HG23 ' O ' ' A' ' 10' ' ' GLN . 69.5 p -108.16 76.16 1.03 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.167 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 2.6 tt0 -152.01 -176.75 5.78 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.816 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -75.96 105.75 7.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.183 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.482 HG23 ' N ' ' A' ' 16' ' ' GLN . 6.0 t -148.46 -46.52 0.15 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.03 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.482 ' N ' HG23 ' A' ' 15' ' ' THR . 31.9 tt0 -72.78 -47.06 49.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.92 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.4 ttt85 -63.36 -40.12 96.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.945 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -60.52 -35.86 76.98 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.889 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -62.75 -37.22 85.74 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.991 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 32.5 mm -70.49 -42.57 78.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.164 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -57.6 -43.83 84.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.987 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.58 -35.34 80.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.895 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -59.24 -47.58 84.83 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.115 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.3 p -64.65 -44.14 91.37 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.897 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 12.8 tt0 -150.66 150.86 31.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.06 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 -97.77 159.39 14.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.811 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 2.0 mm-40 -64.41 101.8 0.47 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.956 0.408 . . . . 0.0 110.774 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.549 HG22 ' H ' ' A' ' 30' ' ' GLU . 17.9 mm -92.78 140.04 16.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.438 0.637 . . . . 0.0 111.861 -179.785 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.481 ' HA2' ' HB ' ' A' ' 32' ' ' ILE . . . -85.16 13.73 53.23 Favored Glycine 0 C--N 1.318 -0.427 0 CA-C-N 114.893 -1.049 . . . . 0.0 112.817 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.549 ' H ' HG22 ' A' ' 28' ' ' ILE . 6.9 tt0 -88.96 -21.76 23.39 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 111.795 0.295 . . . . 0.0 111.795 -179.774 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.564 ' HA ' HD12 ' A' ' 52' ' ' ILE . 18.2 m-80 -107.99 -12.92 15.07 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-O 121.883 0.849 . . . . 0.0 109.107 179.345 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.616 ' O ' ' CG2' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -70.71 95.08 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.572 0 CA-C-N 113.961 -1.472 . . . . 0.0 111.198 -179.241 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.665 ' CG2' ' HB2' ' A' ' 50' ' ' ALA . 0.4 OUTLIER -32.81 -61.13 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-N 114.706 -1.134 . . . . 0.0 112.286 -179.567 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.844 ' SG ' HD12 ' A' ' 48' ' ' LEU . 20.9 p -165.11 164.83 20.25 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 112.516 0.561 . . . . 0.0 112.516 -179.47 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 2.8 ttm180 -119.44 125.15 48.26 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.62 179.47 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.947 HG13 HD11 ' A' ' 48' ' ' LEU . 3.5 m -92.96 124.39 45.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.896 0.379 . . . . 0.0 111.088 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.969 HG23 HG12 ' A' ' 45' ' ' ILE . 19.8 mt -132.27 108.6 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.911 -179.487 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.441 ' HB3' ' O ' ' A' ' 43' ' ' ILE . 38.9 t -78.9 127.77 32.45 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 178.291 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 48.4 p -110.77 28.65 8.49 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 112.576 0.584 . . . . 0.0 112.576 -178.442 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.435 ' OG1' ' O ' ' A' ' 142' ' ' SER . 0.0 OUTLIER -116.41 -37.41 3.75 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.778 0.323 . . . . 0.0 110.983 179.333 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 116.92 53.08 0.33 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.861 179.492 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.694 ' HG3' HD12 ' A' ' 141' ' ' LEU . 3.4 mt-30 -142.58 -42.71 0.32 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.612 0.244 . . . . 0.0 111.479 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.598 HD12 ' HB2' ' A' ' 42' ' ' GLN . 4.0 mp -115.04 138.96 23.74 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 120.779 0.323 . . . . 0.0 111.493 -179.385 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.489 ' CD ' ' CZ ' ' A' ' 76' ' ' TYR . 86.9 Cg_endo -82.43 146.79 13.92 Favored 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 122.76 2.307 . . . . 0.0 111.732 179.494 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.969 HG12 HG23 ' A' ' 37' ' ' ILE . 35.7 mt -53.2 111.86 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.995 0.426 . . . . 0.0 111.528 -179.688 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.437 ' O ' HG22 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -115.17 144.0 44.36 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.84 179.297 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -103.36 119.65 39.28 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.052 0.453 . . . . 0.0 111.599 -179.409 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.947 HD11 HG13 ' A' ' 36' ' ' VAL . 0.3 OUTLIER -100.47 138.65 37.25 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 178.504 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.641 ' C ' ' HB ' ' A' ' 33' ' ' VAL . 42.5 t -127.48 -170.82 2.29 Favored 'General case' 0 CA--C 1.511 -0.538 0 CA-C-O 122.941 1.353 . . . . 0.0 113.916 -178.944 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.665 ' HB2' ' CG2' ' A' ' 33' ' ' VAL . . . -157.52 145.02 18.61 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 112.699 -2.046 . . . . 0.0 110.809 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.484 ' CB ' ' HG3' ' A' ' 54' ' ' GLN . 13.2 m-20 -84.7 86.6 7.31 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.116 0.484 . . . . 0.0 110.705 179.826 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.619 HG23 HD23 ' A' ' 56' ' ' LEU . 5.8 mt -57.98 -31.55 41.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.687 -179.67 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -57.01 -34.84 68.56 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.982 -179.195 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.484 ' HG3' ' CB ' ' A' ' 51' ' ' ASP . 2.7 mm-40 -67.6 -42.93 81.64 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.961 -179.746 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 22.4 t -74.27 -37.75 46.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.238 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.619 HD23 HG23 ' A' ' 52' ' ' ILE . 0.5 OUTLIER -56.47 -33.26 65.76 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.967 0.413 . . . . 0.0 110.682 -179.965 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 25.5 mmtt -105.81 -24.76 12.41 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.603 179.48 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.437 ' N ' ' O ' ' A' ' 54' ' ' GLN . 15.9 tp10 60.09 95.86 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.873 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 26.1 mtpp -150.68 -60.02 0.18 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.832 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.94 -175.58 4.56 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.914 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.8 t 57.33 84.06 0.1 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.951 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.411 ' O ' HG23 ' A' ' 62' ' ' ILE . 1.5 tt -145.98 47.5 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.996 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -174.42 73.62 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.951 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 15.9 ttpt -113.29 131.48 55.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.693 179.72 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.622 HG13 ' O ' ' A' ' 91' ' ' ILE . 13.9 t -132.29 139.21 50.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.989 0.423 . . . . 0.0 111.696 -179.284 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' TRP . . . . . 0.64 ' HB2' ' HB ' ' A' ' 91' ' ' ILE . 17.3 m-90 -100.62 139.63 36.04 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.286 179.069 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.74 HG23 ' HG3' ' A' ' 90' ' ' GLN . 15.6 m -122.4 133.03 54.64 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.594 0.712 . . . . 0.0 112.286 179.829 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.518 ' CE1' ' CG ' ' A' ' 75' ' ' ASP . 10.8 m-85 -102.8 118.21 36.34 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.051 -0.977 . . . . 0.0 108.792 177.887 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.652 ' HA2' HD21 ' A' ' 78' ' ' LEU . . . 157.21 -153.92 25.09 Favored Glycine 0 CA--C 1.503 -0.663 0 C-N-CA 118.812 -1.661 . . . . 0.0 113.148 179.573 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.539 ' HB3' ' HA ' ' A' ' 80' ' ' ASN . 6.5 ptm180 -76.55 92.08 3.43 Favored 'General case' 0 N--CA 1.442 -0.861 0 CA-C-O 122.551 1.167 . . . . 0.0 108.985 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 25.3 m-80 -149.72 159.99 34.93 Favored Pre-proline 0 C--N 1.308 -1.225 0 CA-C-N 112.806 -1.997 . . . . 0.0 108.261 178.857 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.545 ' O ' ' HB2' ' A' ' 77' ' ' HIS . 30.2 Cg_endo -63.89 -8.37 15.69 Favored 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 120.606 0.87 . . . . 0.0 110.434 177.407 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.732 ' HB2' ' HB2' ' A' ' 77' ' ' HIS . . . 137.28 53.32 0.0 OUTLIER 'General case' 0 CA--C 1.49 -1.345 0 CA-C-N 114.482 -1.235 . . . . 0.0 109.14 178.814 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.564 ' HB3' ' HB ' ' A' ' 67' ' ' THR . 0.1 OUTLIER -52.96 -69.75 0.11 Allowed 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 105.859 -1.904 . . . . 0.0 105.859 179.713 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.577 ' HB2' ' N ' ' A' ' 67' ' ' THR . 55.5 t0 -95.09 -47.73 6.25 Favored 'General case' 0 N--CA 1.435 -1.197 0 N-CA-C 105.526 -2.027 . . . . 0.0 105.526 169.59 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.506 ' C ' ' HA ' ' A' ' 73' ' ' ALA . 13.9 t80 -144.05 142.38 30.62 Favored 'General case' 0 C--N 1.346 0.441 0 CA-C-N 112.603 -2.089 . . . . 0.0 110.984 179.262 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.732 ' HB2' ' HB2' ' A' ' 73' ' ' ALA . 1.6 t60 -89.33 108.51 19.67 Favored 'General case' 0 C--N 1.328 -0.338 0 O-C-N 121.961 -0.462 . . . . 0.0 109.902 177.038 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.652 HD21 ' HA2' ' A' ' 69' ' ' GLY . 0.5 OUTLIER -132.8 175.43 9.35 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.931 0.396 . . . . 0.0 111.546 -179.615 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -57.06 161.56 8.0 Favored Glycine 0 C--N 1.332 0.309 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.406 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.539 ' HA ' ' HB3' ' A' ' 70' ' ' ARG . 3.8 p30 -112.02 100.07 8.58 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.857 0.36 . . . . 0.0 111.79 -179.499 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.651 ' HB ' ' HB2' ' A' ' 85' ' ' SER . 14.2 mt -113.41 147.28 17.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.177 178.738 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.07 -24.27 67.41 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 -179.45 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.541 ' C ' HD13 ' A' ' 84' ' ' LEU . 41.8 mtp180 -95.78 -98.31 0.17 Allowed 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 112.077 0.399 . . . . 0.0 112.077 -178.962 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.793 HD22 ' H ' ' A' ' 84' ' ' LEU . 0.0 OUTLIER -108.46 110.71 22.3 Favored 'General case' 0 CA--C 1.512 -0.491 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 179.268 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.652 ' O ' ' HA2' ' A' ' 69' ' ' GLY . 0.5 OUTLIER 158.56 -35.95 0.0 OUTLIER 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 114.415 -1.266 . . . . 0.0 108.514 -179.068 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.783 ' O ' ' N ' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -66.17 -164.9 0.03 OUTLIER 'General case' 0 CA--C 1.507 -0.688 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 176.86 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.421 ' HA ' ' HA3' ' A' ' 69' ' ' GLY . 0.5 OUTLIER -55.52 70.39 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 177.411 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 1.061 ' O ' ' O ' ' A' ' 104' ' ' ILE . 44.6 t60 -73.3 -14.46 61.31 Favored 'General case' 0 CA--C 1.513 -0.449 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 -176.708 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.559 ' CD2' ' HA ' ' A' ' 103' ' ' ASP . 0.1 OUTLIER -177.67 159.81 1.49 Allowed 'General case' 0 C--N 1.313 -1.007 0 C-N-CA 119.577 -0.849 . . . . 0.0 112.101 178.423 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.74 ' HG3' HG23 ' A' ' 67' ' ' THR . 23.4 mt-30 -137.92 160.79 38.37 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 113.791 1.034 . . . . 0.0 113.791 -177.998 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.64 ' HB ' ' HB2' ' A' ' 66' ' ' TRP . 2.9 mt -122.81 132.02 72.12 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 CA-C-N 115.333 -0.848 . . . . 0.0 109.643 178.058 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.707 HD13 ' ND2' ' A' ' 121' ' ' ASN . 0.5 OUTLIER -106.69 142.79 35.76 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -179.391 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.857 HD22 ' N ' ' A' ' 94' ' ' GLY . 0.2 OUTLIER -126.36 127.78 46.03 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.389 179.04 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.857 ' N ' HD22 ' A' ' 93' ' ' LEU . . . 132.39 -121.56 3.02 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.6 -0.81 . . . . 0.0 112.801 179.647 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 70.55 -65.2 0.34 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.762 0.315 . . . . 0.0 110.868 -179.805 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 21.5 p-10 -167.74 54.98 0.07 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.909 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 72.45 27.21 70.06 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.508 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -135.42 -174.6 3.68 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.799 0.333 . . . . 0.0 110.954 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.642 ' O ' HD12 ' A' ' 100' ' ' LEU . 0.6 OUTLIER -113.73 146.95 39.1 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.909 179.983 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.68 ' HA ' ' O ' ' A' ' 122' ' ' GLN . 4.2 mp -133.8 149.06 51.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.294 179.819 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.452 ' O ' ' N ' ' A' ' 122' ' ' GLN . 1.1 mt -115.27 129.97 56.77 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 179.723 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.477 ' O ' ' O ' ' A' ' 90' ' ' GLN . 29.6 t30 -108.54 112.49 24.89 Favored 'General case' 0 CA--C 1.508 -0.636 0 C-N-CA 119.832 -0.747 . . . . 0.0 109.854 179.739 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.871 ' HB3' HG21 ' A' ' 109' ' ' THR . 44.3 m-20 -83.92 109.7 17.81 Favored 'General case' 0 N--CA 1.44 -0.926 0 C-N-CA 119.198 -1.001 . . . . 0.0 109.627 179.871 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 1.061 ' O ' ' O ' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -125.05 109.38 22.04 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.041 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 177.168 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.443 ' HB3' ' CE1' ' A' ' 88' ' ' HIS . 65.0 m -136.09 169.39 17.69 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.359 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 19.1 m -69.38 -63.34 1.09 Allowed 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 119.005 -1.078 . . . . 0.0 111.709 -179.009 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -112.29 -32.88 6.38 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 114.904 1.446 . . . . 0.0 114.904 179.301 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -146.03 131.49 4.13 Favored Glycine 0 C--N 1.34 0.759 0 N-CA-C 117.033 1.573 . . . . 0.0 117.033 -177.725 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.871 HG21 ' HB3' ' A' ' 103' ' ' ASP . 11.9 m -121.33 138.2 54.36 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 174.451 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 0.716 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 3.1 m-90 -121.69 149.27 43.48 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 113.648 0.981 . . . . 0.0 113.648 -178.411 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.487 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -123.85 112.22 17.02 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 114.979 -1.009 . . . . 0.0 108.711 177.512 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 44.66 43.94 7.03 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.013 -0.54 . . . . 0.0 112.127 -179.566 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 80.8 22.81 60.95 Favored Glycine 0 N--CA 1.445 -0.732 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.801 179.308 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.46 97.77 3.77 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.013 0.435 . . . . 0.0 110.661 179.749 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.716 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.0 OUTLIER -43.99 127.04 5.19 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.98 179.919 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.445 HG13 ' HB3' ' A' ' 111' ' ' LEU . 6.1 m -112.41 179.96 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.907 -179.008 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -90.66 142.2 28.0 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.143 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.415 ' O ' ' C ' ' A' ' 119' ' ' ASN . 54.4 tttm -63.51 163.78 10.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.113 179.429 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.415 ' C ' ' O ' ' A' ' 118' ' ' LYS . 19.4 m-80 33.72 39.85 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 121.28 0.562 . . . . 0.0 111.167 -179.39 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 7.1 p -111.04 105.05 13.68 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.038 -179.429 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.707 ' ND2' HD13 ' A' ' 92' ' ' LEU . 1.7 m120 -53.58 144.59 17.06 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.571 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' GLN . . . . . 0.68 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 35.4 mm-40 -129.5 146.02 51.38 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-O 120.976 0.417 . . . . 0.0 111.754 -179.625 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.673 HD13 ' N ' ' A' ' 124' ' ' LEU . 2.1 tm? -74.08 129.5 37.98 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.677 179.216 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.691 HD13 ' N ' ' A' ' 125' ' ' SER . 3.5 tm? -52.28 138.46 26.45 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-O 122.045 0.926 . . . . 0.0 111.587 -179.102 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.735 ' O ' HD11 ' A' ' 147' ' ' ILE . 0.6 OUTLIER -127.36 152.13 47.88 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 113.762 -1.563 . . . . 0.0 110.395 179.686 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 126' ' ' GLN . . . . . 0.437 ' HA ' HD13 ' A' ' 147' ' ' ILE . 14.0 mm100 -71.33 113.9 8.85 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.911 0.386 . . . . 0.0 109.973 179.412 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 62.95 32.12 82.93 Favored Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.336 -179.399 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.407 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 9.3 t70 -53.78 159.24 1.7 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.97 0.414 . . . . 0.0 111.011 -179.837 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.526 ' HB2' HG22 ' A' ' 144' ' ' VAL . 30.4 tt0 -146.66 135.1 21.94 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.883 -0.598 . . . . 0.0 111.642 -179.838 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.62 HG21 ' OD1' ' A' ' 103' ' ' ASP . 2.7 mp -116.03 129.0 73.14 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.045 178.597 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.569 HG23 ' CG2' ' A' ' 140' ' ' ILE . 12.9 m -102.75 145.41 29.78 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.884 0.373 . . . . 0.0 110.852 -179.266 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.499 ' HB ' ' NE2' ' A' ' 88' ' ' HIS . 5.8 m -141.2 158.39 22.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 112.327 0.491 . . . . 0.0 112.327 -179.113 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 67.17 43.03 90.75 Favored Glycine 0 N--CA 1.447 -0.601 0 CA-C-N 115.797 -0.638 . . . . 0.0 112.31 179.356 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.467 HG12 ' N ' ' A' ' 135' ' ' GLY . 93.6 t -78.44 157.25 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.613 0 CA-C-O 121.36 0.6 . . . . 0.0 112.076 -179.146 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.467 ' N ' HG12 ' A' ' 134' ' ' VAL . . . 149.0 -42.02 0.84 Allowed Glycine 0 N--CA 1.441 -1.012 0 N-CA-C 110.691 -0.964 . . . . 0.0 110.691 -179.193 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.569 HG12 ' H ' ' A' ' 138' ' ' SER . 48.1 t -126.6 131.33 71.36 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.715 0 CA-C-N 115.256 -0.472 . . . . 0.0 109.883 178.709 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.24 -33.9 30.04 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.772 0.32 . . . . 0.0 111.432 -179.247 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 138' ' ' SER . . . . . 0.569 ' H ' HG12 ' A' ' 136' ' ' VAL . 0.9 OUTLIER -94.31 6.5 48.48 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.214 0.45 . . . . 0.0 112.214 -179.397 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 12.0 t0 -127.74 30.92 5.23 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 112.648 0.61 . . . . 0.0 112.648 -179.259 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.569 ' CG2' HG23 ' A' ' 131' ' ' THR . 24.2 mt -105.53 141.11 21.6 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.978 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.353 179.238 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.694 HD12 ' HG3' ' A' ' 42' ' ' GLN . 2.8 mm? -116.49 135.92 53.42 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 114.938 -1.028 . . . . 0.0 110.358 179.822 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.435 ' O ' ' OG1' ' A' ' 40' ' ' THR . 43.5 t -120.96 152.59 38.35 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 -178.758 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.713 HD13 ' N ' ' A' ' 144' ' ' VAL . 3.3 tm? -135.41 136.99 41.83 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 114.841 -1.072 . . . . 0.0 109.21 179.04 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.713 ' N ' HD13 ' A' ' 143' ' ' LEU . 43.0 t -130.12 140.21 49.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 120.955 0.407 . . . . 0.0 111.842 -178.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.78 HG13 HG12 ' A' ' 36' ' ' VAL . 0.1 OUTLIER -111.41 126.44 68.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.612 179.493 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 15.5 t80 -106.08 108.63 20.24 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.687 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.735 HD11 ' O ' ' A' ' 125' ' ' SER . 1.7 mp -85.24 133.42 29.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.26 -179.797 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 148' ' ' ASN . . . . . 0.433 ' ND2' ' HB2' ' A' ' 151' ' ' PHE . 0.9 OUTLIER -83.77 116.52 22.74 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.798 179.841 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -58.08 -21.67 46.97 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.326 -179.822 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 4.7 mptt -57.54 -41.07 80.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.891 0.377 . . . . 0.0 110.717 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' PHE . . . . . 0.454 ' CE2' HD11 ' A' ' 52' ' ' ILE . 4.0 t80 -61.22 -44.56 97.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.76 179.781 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 8.0 tttt -59.48 -34.29 72.39 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.788 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -60.5 -43.73 96.72 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.918 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 10.6 t -62.46 -44.92 95.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.865 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.67 -38.13 83.87 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.81 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -59.37 -40.89 87.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.937 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 1.5 tp-100 -78.64 -31.79 47.02 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.871 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -124.99 68.97 1.12 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.896 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.29 134.31 42.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.858 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 14.0 p -77.55 133.65 30.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.171 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -175.95 149.6 0.93 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.951 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -89.7 99.69 12.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.889 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 38.5 mt -93.11 119.53 40.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.104 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.237 -0.887 . . . . 0.0 110.906 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.336 0 N-CA-C 112.513 -0.235 . . . . 0.0 112.513 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -122.23 -173.56 2.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.805 0.336 . . . . 0.0 110.832 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.721 ' O ' HD13 ' A' ' 4' ' ' ILE . 0.3 OUTLIER -97.08 27.52 4.04 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.022 179.923 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.721 HD13 ' O ' ' A' ' 3' ' ' ASN . 21.4 mm -143.12 122.69 8.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.121 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 7.5 m -150.4 133.91 16.49 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.108 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -80.21 165.98 43.19 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.857 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -52.25 179.03 0.04 OUTLIER 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.588 2.192 . . . . 0.0 112.237 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -64.54 104.75 0.84 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.05 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -72.83 -35.63 67.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.918 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 62.24 149.43 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.824 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -97.65 -172.79 2.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.972 -179.904 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 16.2 p -107.89 -167.24 1.22 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.134 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 69.6 144.44 0.05 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.897 0.379 . . . . 0.0 111.013 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.51 -23.98 67.24 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.298 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER 77.83 -58.54 0.47 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.272 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 4.5 tp-100 -59.44 -33.35 71.16 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.901 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 6.3 mtt85 -62.55 -37.61 86.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.846 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 17.3 t80 -68.0 -35.84 78.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.838 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -61.18 -39.24 89.43 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.949 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 34.2 mm -67.88 -39.45 81.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.118 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -57.73 -39.92 78.4 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.036 -179.868 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.69 -32.73 73.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.903 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -60.49 -47.52 85.79 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.084 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 44.4 t -59.03 -38.89 80.38 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.94 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER 60.52 62.69 1.48 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.856 -179.924 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -101.05 128.61 47.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.952 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -81.25 115.18 20.52 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.888 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 23.7 mm -82.76 139.5 17.71 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.359 0 CA-C-O 121.482 0.658 . . . . 0.0 111.703 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.411 ' O ' ' ND2' ' A' ' 148' ' ' ASN . . . 152.84 41.95 0.02 OUTLIER Glycine 0 C--N 1.318 -0.436 0 CA-C-N 114.841 -1.072 . . . . 0.0 112.514 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -89.46 -22.72 22.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.668 0.27 . . . . 0.0 111.631 -179.73 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 27.3 m120 -108.54 -13.27 14.86 Favored 'General case' 0 CA--C 1.513 -0.476 0 CA-C-O 121.913 0.863 . . . . 0.0 109.35 179.282 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.529 ' O ' ' CG2' ' A' ' 32' ' ' ILE . 0.1 OUTLIER -70.6 104.13 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.54 0 CA-C-N 114.085 -1.416 . . . . 0.0 111.035 -179.353 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 1.02 ' CG2' ' HB2' ' A' ' 50' ' ' ALA . 0.5 OUTLIER -37.5 -63.42 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 CA-C-N 115.133 -0.94 . . . . 0.0 112.037 -179.197 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.784 ' SG ' HD12 ' A' ' 48' ' ' LEU . 18.8 p -164.83 164.73 20.94 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.363 -179.406 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.4 ' HD3' ' CG2' ' A' ' 45' ' ' ILE . 0.9 OUTLIER -127.38 123.64 36.68 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.858 0.361 . . . . 0.0 111.245 179.629 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.863 ' CG2' HD11 ' A' ' 48' ' ' LEU . 2.4 t -93.75 122.22 45.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.478 179.531 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 1.044 HG23 HG12 ' A' ' 45' ' ' ILE . 22.4 mt -121.86 107.94 21.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -179.231 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 8.4 m -85.02 100.64 11.81 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 177.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.6 t -85.81 -27.43 25.14 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -178.398 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.45 ' OG1' ' O ' ' A' ' 142' ' ' SER . 0.1 OUTLIER -52.08 -26.43 11.04 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.986 0.422 . . . . 0.0 111.016 -179.899 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 97.08 68.42 0.96 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.28 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.732 ' HB3' HD22 ' A' ' 141' ' ' LEU . 16.9 pt20 -142.42 -46.87 0.33 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.825 0.345 . . . . 0.0 111.204 -179.622 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.477 HG23 ' CE2' ' A' ' 76' ' ' TYR . 10.7 mt -132.31 133.84 24.24 Favored Pre-proline 0 N--CA 1.452 -0.351 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.161 -179.684 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.493 ' HD2' ' CZ ' ' A' ' 76' ' ' TYR . 29.4 Cg_exo -59.36 147.14 92.5 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.754 2.303 . . . . 0.0 111.728 179.501 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 1.044 HG12 HG23 ' A' ' 37' ' ' ILE . 52.6 mt -47.24 143.5 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.994 0.426 . . . . 0.0 111.851 -179.607 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.06 130.38 33.38 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.123 179.422 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.453 ' C ' HD23 ' A' ' 48' ' ' LEU . 1.2 p30 -97.76 120.27 37.85 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.11 0.481 . . . . 0.0 111.512 -179.341 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.863 HD11 ' CG2' ' A' ' 36' ' ' VAL . 0.5 OUTLIER -96.78 125.18 41.05 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.393 179.032 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.492 ' O ' ' HZ2' ' A' ' 66' ' ' TRP . 0.0 OUTLIER -118.49 162.21 18.73 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 122.065 0.936 . . . . 0.0 113.274 -178.861 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 1.02 ' HB2' ' CG2' ' A' ' 33' ' ' VAL . . . -119.07 164.78 15.01 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.531 -1.213 . . . . 0.0 111.026 179.644 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.883 ' O ' HG23 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -116.06 71.24 0.77 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.021 0.439 . . . . 0.0 110.679 179.932 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.836 HD11 ' CE2' ' A' ' 151' ' ' PHE . 96.6 mt -63.83 -45.63 96.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.416 -179.803 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 11.2 t -66.17 -35.55 80.76 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.475 -179.274 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.423 ' CG ' ' HB3' ' A' ' 51' ' ' ASP . 42.6 mm-40 -67.94 -38.88 83.38 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.189 -179.535 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.883 HG23 ' O ' ' A' ' 51' ' ' ASP . 21.8 t -66.38 -38.02 80.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.381 -179.846 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.2 tp -68.74 -29.82 68.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.266 -179.704 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.5 -34.05 13.54 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.064 -179.76 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 11.9 mm-40 -72.82 166.65 22.51 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.931 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -89.71 77.23 7.14 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.861 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 63.27 88.21 0.1 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.854 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.654 ' O ' HG13 ' A' ' 55' ' ' VAL . 25.2 p -139.0 137.66 36.54 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.919 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.606 ' O ' HG23 ' A' ' 62' ' ' ILE . 1.0 OUTLIER -179.37 69.95 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.882 -179.943 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.2 tptm -142.36 79.74 1.67 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.166 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.443 ' HB3' HD12 ' A' ' 93' ' ' LEU . 17.7 ttpt -124.83 131.57 53.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.599 179.385 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.637 HG13 ' O ' ' A' ' 91' ' ' ILE . 19.2 t -136.0 139.26 46.2 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 CA-C-O 121.211 0.529 . . . . 0.0 111.94 -179.172 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' TRP . . . . . 0.678 ' HB2' ' HB ' ' A' ' 91' ' ' ILE . 15.0 m-90 -100.11 139.97 35.02 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.443 179.138 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.598 HG23 ' HG2' ' A' ' 90' ' ' GLN . 26.1 m -130.79 132.54 45.33 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.527 0.68 . . . . 0.0 112.149 179.719 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.486 ' CE1' ' CG ' ' A' ' 75' ' ' ASP . 3.6 m-85 -105.96 119.04 38.18 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 114.873 -1.058 . . . . 0.0 109.348 178.298 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.637 ' HA2' ' O ' ' A' ' 85' ' ' SER . . . 160.71 -157.85 29.32 Favored Glycine 0 CA--C 1.505 -0.538 0 C-N-CA 118.658 -1.734 . . . . 0.0 113.286 178.802 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.479 ' HD2' ' OD1' ' A' ' 86' ' ' ASN . 5.1 ptm180 -75.94 91.76 3.07 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-O 122.629 1.204 . . . . 0.0 108.165 179.887 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.414 ' CG ' ' HB2' ' A' ' 74' ' ' CYS . 0.2 OUTLIER -149.72 160.35 34.18 Favored Pre-proline 0 C--N 1.307 -1.263 0 CA-C-N 112.606 -2.088 . . . . 0.0 108.085 179.681 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.547 ' O ' ' CB ' ' A' ' 73' ' ' ALA . 30.1 Cg_endo -63.91 -8.74 16.69 Favored 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 120.84 1.027 . . . . 0.0 111.12 178.268 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.743 ' HB2' ' HB2' ' A' ' 77' ' ' HIS . . . 135.69 54.21 0.0 OUTLIER 'General case' 0 CA--C 1.49 -1.358 0 CA-C-N 114.706 -1.134 . . . . 0.0 109.361 178.724 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.55 ' HB3' ' HB ' ' A' ' 67' ' ' THR . 0.1 OUTLIER -52.59 -69.73 0.11 Allowed 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 105.546 -2.02 . . . . 0.0 105.546 179.46 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.504 ' N ' ' O ' ' A' ' 67' ' ' THR . 13.8 t70 -95.51 -47.74 6.12 Favored 'General case' 0 N--CA 1.435 -1.202 0 N-CA-C 105.446 -2.057 . . . . 0.0 105.446 169.137 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.518 ' C ' ' HA ' ' A' ' 73' ' ' ALA . 67.3 t80 -142.96 142.21 31.6 Favored 'General case' 0 C--N 1.347 0.492 0 CA-C-N 112.627 -2.079 . . . . 0.0 111.465 179.756 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.743 ' HB2' ' HB2' ' A' ' 73' ' ' ALA . 1.7 t60 -91.65 111.64 23.24 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 177.079 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.676 HD11 ' HA ' ' A' ' 85' ' ' SER . 0.5 OUTLIER -135.47 175.89 9.17 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.925 0.393 . . . . 0.0 111.604 -179.666 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -59.39 165.63 9.68 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.257 179.802 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.41 ' HB3' ' CB ' ' A' ' 70' ' ' ARG . 3.1 p30 -112.01 100.07 8.58 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.829 0.347 . . . . 0.0 111.76 -179.493 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.669 ' HB ' ' HB2' ' A' ' 85' ' ' SER . 19.1 mt -115.02 131.77 66.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 177.903 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.632 ' HA ' HD22 ' A' ' 86' ' ' ASN . 1.6 m -52.79 -24.01 8.03 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 111.789 0.292 . . . . 0.0 111.789 -178.779 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.503 ' C ' HD13 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -93.05 -94.85 0.15 Allowed 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 120.428 0.156 . . . . 0.0 111.419 -179.943 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.844 HD22 ' H ' ' A' ' 84' ' ' LEU . 0.0 OUTLIER -109.43 108.77 19.4 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 121.388 0.613 . . . . 0.0 109.402 178.918 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.676 ' HA ' HD11 ' A' ' 78' ' ' LEU . 1.8 m 158.7 -39.67 0.0 OUTLIER 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 114.589 -1.187 . . . . 0.0 109.369 -179.684 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.696 ' O ' ' N ' ' A' ' 88' ' ' HIS . 56.6 m-20 -65.76 -163.01 0.02 OUTLIER 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 177.188 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.845 ' HB2' HD11 ' A' ' 104' ' ' ILE . 4.1 pttp -58.08 72.82 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 177.435 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.976 ' O ' ' O ' ' A' ' 104' ' ' ILE . 31.2 t60 -77.79 -19.5 54.92 Favored 'General case' 0 CA--C 1.515 -0.382 0 N-CA-C 114.315 1.228 . . . . 0.0 114.315 -176.437 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.596 ' HA ' ' H ' ' A' ' 104' ' ' ILE . 0.0 OUTLIER -173.7 156.86 2.99 Favored 'General case' 0 C--N 1.314 -0.97 0 C-N-CA 118.834 -1.146 . . . . 0.0 113.012 177.944 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.598 ' HG2' HG23 ' A' ' 67' ' ' THR . 33.4 mt-30 -137.55 160.75 38.27 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 114.587 -1.188 . . . . 0.0 113.751 -177.861 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.68 HD13 HD11 ' A' ' 48' ' ' LEU . 3.5 mt -128.37 132.18 68.36 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 CA-C-N 115.076 -0.966 . . . . 0.0 109.49 178.486 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.771 HD13 ' ND2' ' A' ' 121' ' ' ASN . 0.3 OUTLIER -108.95 144.11 37.33 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.118 0.485 . . . . 0.0 112.219 -178.988 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.882 HD22 ' N ' ' A' ' 94' ' ' GLY . 0.3 OUTLIER -125.88 129.95 50.36 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.477 179.409 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.882 ' N ' HD22 ' A' ' 93' ' ' LEU . . . 136.47 100.68 0.59 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.509 179.733 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -176.88 -169.06 0.24 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.806 0.336 . . . . 0.0 110.768 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -68.4 73.05 0.22 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.716 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 60.23 29.92 69.73 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.327 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.431 ' C ' HD12 ' A' ' 99' ' ' LEU . 6.6 t-20 -138.27 165.65 26.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.891 0.377 . . . . 0.0 111.051 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.577 HD21 HG13 ' A' ' 33' ' ' VAL . 6.6 mp -112.16 160.69 17.32 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.769 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.852 HD13 ' O ' ' A' ' 122' ' ' GLN . 3.6 mm? -122.54 147.96 45.76 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.336 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.758 HD21 HD13 ' A' ' 145' ' ' ILE . 3.5 mp -118.79 127.44 53.53 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 179.502 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.491 ' O ' ' O ' ' A' ' 90' ' ' GLN . 26.1 t30 -111.98 111.48 22.44 Favored 'General case' 0 CA--C 1.506 -0.736 0 C-N-CA 119.641 -0.824 . . . . 0.0 109.944 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.923 ' OD1' HD13 ' A' ' 130' ' ' ILE . 81.6 m-20 -83.83 111.36 19.14 Favored 'General case' 0 N--CA 1.439 -1.016 0 C-N-CA 119.645 -0.822 . . . . 0.0 109.098 179.354 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.976 ' O ' ' O ' ' A' ' 88' ' ' HIS . 0.1 OUTLIER -122.8 107.74 20.0 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.073 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 177.964 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 59.1 m -133.89 169.12 17.56 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-N 114.86 -1.064 . . . . 0.0 109.187 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 20.0 m -69.44 -63.58 1.04 Allowed 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 119.04 -1.064 . . . . 0.0 111.689 -179.045 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -112.5 -32.45 6.47 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 114.858 1.429 . . . . 0.0 114.858 179.271 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -145.66 129.25 3.37 Favored Glycine 0 C--N 1.34 0.761 0 N-CA-C 117.151 1.62 . . . . 0.0 117.151 -177.712 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.772 HG21 ' HB3' ' A' ' 103' ' ' ASP . 6.8 m -121.61 138.54 54.28 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 174.392 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 0.758 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.4 m-90 -119.46 149.23 42.22 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 -178.393 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.468 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.3 OUTLIER -122.61 112.2 17.7 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 115.158 -0.928 . . . . 0.0 108.692 177.594 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 112' ' ' ASN . . . . . 0.406 ' N ' HD12 ' A' ' 111' ' ' LEU . 57.8 m-20 44.93 44.06 7.65 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.075 -0.511 . . . . 0.0 112.171 -179.595 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 79.02 23.71 63.19 Favored Glycine 0 N--CA 1.445 -0.745 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.787 179.362 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 -136.76 96.09 3.26 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.105 0.478 . . . . 0.0 110.752 179.642 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.758 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.0 OUTLIER -44.12 132.87 5.45 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.071 179.888 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 4.1 m -123.61 179.29 2.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.761 -179.184 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -82.95 139.34 33.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.971 180.0 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.437 ' O ' ' C ' ' A' ' 119' ' ' ASN . 9.3 tmtt? -63.03 167.78 4.58 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 179.312 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.437 ' C ' ' O ' ' A' ' 118' ' ' LYS . 6.0 p-10 31.22 40.74 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.331 -179.664 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 5.2 p -110.97 107.66 17.15 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.059 -179.187 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.771 ' ND2' HD13 ' A' ' 92' ' ' LEU . 1.5 m120 -56.54 140.46 46.3 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.436 179.741 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' GLN . . . . . 0.852 ' O ' HD13 ' A' ' 100' ' ' LEU . 68.6 mm-40 -129.63 147.07 51.38 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-O 121.115 0.483 . . . . 0.0 112.042 -179.714 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 7.3 tp -72.62 119.92 17.52 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.384 -0.825 . . . . 0.0 109.759 179.147 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.777 HD11 ' CD1' ' A' ' 147' ' ' ILE . 2.3 tp -48.06 142.41 5.18 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-O 121.854 0.835 . . . . 0.0 111.825 -178.881 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.422 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.0 OUTLIER -127.19 152.62 47.13 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 114.146 -1.388 . . . . 0.0 110.557 179.739 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 1.2 tp60 -72.34 113.71 9.66 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 179.162 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 68.75 27.24 74.01 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.466 -179.486 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.422 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 8.3 t70 -56.03 159.96 3.05 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-O 120.895 0.378 . . . . 0.0 111.232 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.446 ' HG3' HG22 ' A' ' 144' ' ' VAL . 2.0 tt0 -146.74 135.4 22.13 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.756 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.923 HD13 ' OD1' ' A' ' 103' ' ' ASP . 7.0 mt -116.27 128.14 73.67 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 178.586 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.498 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 98.6 m -103.2 145.82 29.35 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.856 0.36 . . . . 0.0 110.788 -179.404 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.54 ' HB ' ' NE2' ' A' ' 88' ' ' HIS . 7.8 m -141.12 158.42 22.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -178.786 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 69.94 44.13 62.87 Favored Glycine 0 N--CA 1.448 -0.567 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.451 179.2 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.473 ' HA ' HG12 ' A' ' 140' ' ' ILE . 93.8 t -80.43 156.49 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 CA-C-O 121.434 0.635 . . . . 0.0 112.192 -179.242 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.451 ' N ' HG12 ' A' ' 134' ' ' VAL . . . 149.62 -42.56 0.79 Allowed Glycine 0 N--CA 1.441 -0.972 0 N-CA-C 110.552 -1.019 . . . . 0.0 110.552 -179.129 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.565 HG12 ' H ' ' A' ' 138' ' ' SER . 51.9 t -126.85 131.95 70.53 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.69 0 CA-C-N 115.205 -0.497 . . . . 0.0 109.769 178.563 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -51.34 -34.52 34.05 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.725 0.298 . . . . 0.0 111.472 -179.266 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' SER . . . . . 0.565 ' H ' HG12 ' A' ' 136' ' ' VAL . 13.9 m -94.3 6.51 48.44 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.416 0.524 . . . . 0.0 112.416 -179.36 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 18.2 t0 -126.51 30.37 5.57 Favored 'General case' 0 CA--C 1.519 -0.249 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -179.313 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.498 ' CG2' ' CG2' ' A' ' 131' ' ' THR . 14.7 mt -107.29 141.23 23.01 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.437 179.348 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.732 HD22 ' HB3' ' A' ' 42' ' ' GLN . 28.3 mt -119.82 135.23 54.95 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 114.902 -1.045 . . . . 0.0 109.916 179.554 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.819 ' C ' HD12 ' A' ' 143' ' ' LEU . 47.3 t -116.92 151.89 35.69 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.912 0.863 . . . . 0.0 113.053 -178.806 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.819 HD12 ' C ' ' A' ' 142' ' ' SER . 5.5 mp -128.42 129.54 46.31 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.547 -1.206 . . . . 0.0 109.312 179.145 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.446 HG22 ' HG3' ' A' ' 129' ' ' GLU . 10.6 t -115.37 140.45 36.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 120.892 0.377 . . . . 0.0 111.641 -179.179 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.758 HD13 HD21 ' A' ' 101' ' ' LEU . 0.1 OUTLIER -116.23 126.26 73.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.766 179.957 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 9.8 t80 -109.62 121.89 46.22 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.782 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.777 ' CD1' HD11 ' A' ' 124' ' ' LEU . 5.9 mm -100.79 133.54 43.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.275 -179.835 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 148' ' ' ASN . . . . . 0.411 ' ND2' ' O ' ' A' ' 29' ' ' GLY . 7.9 p-10 -82.44 125.57 31.23 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.002 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -67.82 -22.66 65.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.024 179.828 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 9.8 mtmt -57.19 -40.23 76.95 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-O 120.939 0.399 . . . . 0.0 110.649 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' PHE . . . . . 0.836 ' CE2' HD11 ' A' ' 52' ' ' ILE . 19.5 t80 -60.57 -41.29 94.34 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.563 179.732 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 5.6 mttm -58.88 -35.48 73.08 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.717 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 5.0 mt-30 -68.45 -40.43 81.09 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.895 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 13.7 t -58.77 -45.73 89.12 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.824 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -68.44 -35.65 77.92 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.861 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -62.41 -36.87 83.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.992 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -92.13 -36.51 13.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.881 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 42.71 32.82 0.41 Allowed 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.501 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -124.8 156.09 38.34 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.85 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 4.3 m -102.63 124.18 56.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.174 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -168.0 -169.4 1.13 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.791 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.58 36.46 3.55 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.901 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 24.3 mm -95.57 131.69 41.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.093 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.206 -0.902 . . . . 0.0 110.939 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.352 0 N-CA-C 112.486 -0.245 . . . . 0.0 112.486 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -69.76 121.19 16.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.745 0.307 . . . . 0.0 110.845 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -158.68 -70.43 0.09 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.867 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 18.7 pt -114.53 157.92 15.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.084 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 5.5 m -87.68 -21.61 25.14 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.359 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 64.5 mt-30 -52.88 157.33 2.82 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.02 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -65.75 173.03 7.33 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.567 2.178 . . . . 0.0 112.234 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -127.03 131.89 50.85 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.203 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -131.09 122.24 26.35 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.739 179.893 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 4.5 mm100 64.54 69.01 0.52 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.765 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -102.98 36.85 2.1 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.951 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 3.3 t -165.21 128.59 2.27 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.155 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 38.3 tt0 -72.41 114.45 10.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.963 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -169.71 44.82 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.096 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.3 -57.94 2.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.23 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.571 ' HA ' HD23 ' A' ' 19' ' ' LEU . 7.2 mt-30 -68.21 -41.72 80.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.86 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.2 mtp180 -70.54 -35.88 73.38 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.954 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 15.7 t80 -56.84 -44.72 82.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.27 -179.758 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.571 HD23 ' HA ' ' A' ' 16' ' ' GLN . 1.1 pp -58.61 -32.39 68.95 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.881 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 33.3 mm -72.76 -41.27 61.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.04 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -57.77 -46.77 84.09 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.051 -179.865 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.81 -34.3 77.51 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.769 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -65.37 -47.48 76.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.063 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.9 t -59.9 -30.95 69.37 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.907 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER 60.49 163.16 0.06 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.845 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -68.72 135.63 51.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.807 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 9.9 mt-30 -76.69 135.05 39.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.913 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 23.8 mm -82.22 139.61 17.64 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.316 0 CA-C-O 121.426 0.632 . . . . 0.0 111.509 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -103.84 73.14 0.27 Allowed Glycine 0 C--N 1.316 -0.56 0 CA-C-N 114.884 -1.053 . . . . 0.0 112.585 -179.858 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -84.31 -27.49 27.76 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.727 0.299 . . . . 0.0 110.888 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.436 ' OD1' HD12 ' A' ' 52' ' ' ILE . 10.7 m-20 -109.0 -13.95 14.63 Favored 'General case' 0 CA--C 1.516 -0.345 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 178.244 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.594 ' O ' ' CG2' ' A' ' 32' ' ' ILE . 0.1 OUTLIER -70.74 95.46 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.581 0 CA-C-N 113.908 -1.497 . . . . 0.0 110.473 -179.685 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.743 HG23 ' HB3' ' A' ' 50' ' ' ALA . 0.8 OUTLIER -36.02 -63.08 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 114.813 -1.085 . . . . 0.0 112.593 -178.939 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.646 ' N ' HG12 ' A' ' 33' ' ' VAL . 98.3 m -154.31 164.8 38.03 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.152 0.501 . . . . 0.0 112.141 -179.009 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.19 114.84 20.82 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.264 179.241 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.601 HG12 HG13 ' A' ' 145' ' ' ILE . 5.7 m -88.98 126.93 42.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.663 -179.917 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.964 HG23 HG12 ' A' ' 45' ' ' ILE . 26.3 mt -126.07 108.82 20.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 112.464 0.542 . . . . 0.0 112.464 -179.035 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.49 ' SG ' HD23 ' A' ' 143' ' ' LEU . 0.0 OUTLIER -108.73 108.88 19.88 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 177.822 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.6 t -110.69 -23.22 11.19 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 -177.864 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.2 p -53.13 -25.21 12.5 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.917 0.389 . . . . 0.0 111.286 -179.433 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 119.98 47.74 0.34 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.494 179.765 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.752 ' HG2' HD22 ' A' ' 141' ' ' LEU . 2.8 mt-30 -120.06 -67.77 0.96 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.837 0.351 . . . . 0.0 110.886 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.486 HG21 ' CG ' ' A' ' 76' ' ' TYR . 0.6 OUTLIER -135.02 135.1 22.33 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.953 -179.804 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.432 ' HD2' ' CZ ' ' A' ' 76' ' ' TYR . 24.0 Cg_exo -59.37 147.69 89.99 Favored 'Trans proline' 0 C--N 1.342 0.234 0 C-N-CA 122.469 2.112 . . . . 0.0 111.563 179.451 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.964 HG12 HG23 ' A' ' 37' ' ' ILE . 32.8 mt -44.28 129.02 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.056 0.455 . . . . 0.0 111.99 -179.32 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.435 ' HB2' ' CD2' ' A' ' 76' ' ' TYR . 4.8 tpt180 -128.05 148.16 50.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.738 -0.664 . . . . 0.0 109.765 179.151 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -106.05 120.03 40.73 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.972 0.415 . . . . 0.0 111.797 -179.159 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.906 HD11 HD13 ' A' ' 91' ' ' ILE . 3.5 mt -93.64 131.84 38.56 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.282 178.716 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.525 ' O ' ' HZ2' ' A' ' 66' ' ' TRP . 0.0 OUTLIER -136.59 162.27 33.59 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 122.03 0.919 . . . . 0.0 113.406 -178.641 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.743 ' HB3' HG23 ' A' ' 33' ' ' VAL . . . -149.17 165.57 31.43 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.24 -1.346 . . . . 0.0 111.035 179.057 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.867 ' O ' HG23 ' A' ' 55' ' ' VAL . 32.3 m-20 -91.57 121.16 33.0 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.051 0.453 . . . . 0.0 111.303 -179.678 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.436 HD12 ' OD1' ' A' ' 31' ' ' ASN . 72.0 mt -64.65 -45.18 96.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.788 -0.642 . . . . 0.0 112.077 -179.759 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -63.93 -38.06 89.7 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.093 0.473 . . . . 0.0 111.135 -178.806 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.445 ' HG2' ' HB3' ' A' ' 51' ' ' ASP . 55.2 mm-40 -68.55 -38.37 80.72 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.042 -179.751 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.867 HG23 ' O ' ' A' ' 51' ' ' ASP . 32.6 t -73.63 -40.64 54.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.029 179.695 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.614 HD21 ' O ' ' A' ' 159' ' ' LYS . 5.6 tp -59.06 -37.82 77.96 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.945 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 3.7 tttt -78.07 -38.83 43.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.786 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 44.54 44.92 7.53 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.346 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.3 -60.51 1.51 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.763 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 4.2 ptm180 -143.2 36.53 1.37 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.922 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 68.6 m -163.23 54.51 0.18 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.822 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.679 HD13 HG13 ' A' ' 55' ' ' VAL . 7.3 tp -139.43 71.92 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.915 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 60.3 tttt -172.85 75.71 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.961 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.433 ' O ' ' HB3' ' A' ' 93' ' ' LEU . 6.3 ttpt -115.18 134.1 55.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.462 179.791 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.645 HG13 ' O ' ' A' ' 91' ' ' ILE . 16.8 t -137.1 137.72 46.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.116 0.484 . . . . 0.0 111.647 -179.292 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' TRP . . . . . 0.695 ' CD1' HD22 ' A' ' 48' ' ' LEU . 14.5 m-90 -99.89 139.67 35.21 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.199 179.128 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.709 HG23 ' CG ' ' A' ' 90' ' ' GLN . 8.8 m -127.57 129.63 47.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.505 0.669 . . . . 0.0 112.489 179.301 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.571 ' CE1' ' CG ' ' A' ' 75' ' ' ASP . 12.9 m-85 -100.91 118.49 37.05 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.14 -0.936 . . . . 0.0 108.961 177.735 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.639 ' HA2' ' O ' ' A' ' 85' ' ' SER . . . 160.46 -157.03 28.4 Favored Glycine 0 CA--C 1.505 -0.546 0 C-N-CA 119.045 -1.55 . . . . 0.0 113.057 179.236 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.442 ' H ' ' HA ' ' A' ' 86' ' ' ASN . 0.0 OUTLIER -76.78 92.42 3.59 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-O 122.663 1.22 . . . . 0.0 108.719 -179.685 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -149.42 159.45 36.58 Favored Pre-proline 0 C--N 1.306 -1.289 0 CA-C-N 112.68 -2.055 . . . . 0.0 108.06 179.15 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.544 ' O ' ' CB ' ' A' ' 73' ' ' ALA . 27.8 Cg_endo -63.61 -6.66 10.95 Favored 'Trans proline' 0 N--CA 1.452 -0.956 0 C-N-CA 120.64 0.893 . . . . 0.0 110.695 177.648 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.707 ' HB2' ' HB2' ' A' ' 77' ' ' HIS . . . 135.32 53.47 0.0 OUTLIER 'General case' 0 CA--C 1.491 -1.316 0 CA-C-N 114.447 -1.252 . . . . 0.0 109.227 178.814 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.579 ' HB3' ' HB ' ' A' ' 67' ' ' THR . 0.1 OUTLIER -52.48 -69.88 0.1 Allowed 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 105.443 -2.058 . . . . 0.0 105.443 179.617 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.701 ' HB2' ' N ' ' A' ' 67' ' ' THR . 57.0 t0 -95.45 -47.47 6.26 Favored 'General case' 0 N--CA 1.434 -1.232 0 N-CA-C 105.504 -2.036 . . . . 0.0 105.504 169.05 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.499 ' C ' ' HA ' ' A' ' 73' ' ' ALA . 1.7 t80 -143.72 142.72 31.08 Favored 'General case' 0 C--N 1.348 0.512 0 CA-C-N 112.602 -2.09 . . . . 0.0 112.019 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.707 ' HB2' ' HB2' ' A' ' 73' ' ' ALA . 2.0 t60 -96.43 108.02 20.5 Favored 'General case' 0 C--N 1.331 -0.218 0 O-C-N 122.166 -0.334 . . . . 0.0 110.101 176.977 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.694 ' N ' HD13 ' A' ' 78' ' ' LEU . 0.0 OUTLIER -136.94 179.93 6.08 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.891 0.377 . . . . 0.0 111.677 -179.754 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -52.23 157.75 3.54 Favored Glycine 0 C--N 1.333 0.383 0 CA-C-N 115.983 -0.553 . . . . 0.0 112.854 -179.736 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 5.9 p-10 -111.93 99.9 8.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.811 0.339 . . . . 0.0 111.814 -179.561 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.662 ' HB ' ' HB2' ' A' ' 85' ' ' SER . 14.1 mm -114.26 129.97 69.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.237 -0.438 . . . . 0.0 109.845 178.336 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.458 ' HA ' ' ND2' ' A' ' 86' ' ' ASN . 80.3 p -53.02 -23.7 8.07 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.788 -179.082 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.516 ' C ' HD13 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -93.97 -96.38 0.15 Allowed 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 111.669 0.248 . . . . 0.0 111.669 -179.509 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.816 HD22 ' H ' ' A' ' 84' ' ' LEU . 0.0 OUTLIER -109.82 109.93 20.74 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-O 121.295 0.569 . . . . 0.0 109.84 179.324 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.662 ' HB2' ' HB ' ' A' ' 81' ' ' ILE . 0.4 OUTLIER 157.24 -41.26 0.0 OUTLIER 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 114.781 -1.099 . . . . 0.0 109.469 -179.942 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.761 ' O ' ' N ' ' A' ' 88' ' ' HIS . 91.1 m-20 -67.71 -156.19 0.02 OUTLIER 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 177.69 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.937 ' HB2' HD11 ' A' ' 104' ' ' ILE . 8.7 pttp -54.03 72.23 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 178.397 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 1.023 ' O ' ' O ' ' A' ' 104' ' ' ILE . 42.8 t60 -81.92 -16.13 51.59 Favored 'General case' 0 CA--C 1.514 -0.419 0 N-CA-C 113.888 1.07 . . . . 0.0 113.888 -176.998 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.591 ' CE1' HG13 ' A' ' 91' ' ' ILE . 0.0 OUTLIER -177.54 159.99 1.55 Allowed 'General case' 0 C--N 1.314 -0.95 0 C-N-CA 119.301 -0.96 . . . . 0.0 112.457 178.161 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.709 ' CG ' HG23 ' A' ' 67' ' ' THR . 38.3 mt-30 -138.89 160.35 39.93 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 113.761 1.022 . . . . 0.0 113.761 -178.442 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.906 HD13 HD11 ' A' ' 48' ' ' LEU . 5.6 mt -124.57 131.54 72.58 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.345 177.714 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.642 HD13 ' ND2' ' A' ' 121' ' ' ASN . 0.2 OUTLIER -107.61 140.24 40.93 Favored 'General case' 0 N--CA 1.463 0.176 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 -179.129 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.916 HD22 ' N ' ' A' ' 94' ' ' GLY . 0.3 OUTLIER -126.34 131.18 51.87 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.445 179.068 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.916 ' N ' HD22 ' A' ' 93' ' ' LEU . . . 133.41 -142.49 14.0 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.661 179.694 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 63.15 75.08 0.41 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.903 0.382 . . . . 0.0 110.77 -179.852 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 7.5 t0 59.04 39.88 22.82 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.912 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 65.06 71.46 0.87 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.442 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -156.56 165.75 35.39 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.778 0.323 . . . . 0.0 110.864 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.699 ' O ' HD12 ' A' ' 100' ' ' LEU . 4.0 mm? -106.74 137.07 45.47 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.763 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.699 HD12 ' O ' ' A' ' 99' ' ' LEU . 3.8 mp -133.58 149.02 51.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.538 -179.794 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 1.028 HD22 HD13 ' A' ' 145' ' ' ILE . 0.5 OUTLIER -115.21 129.9 56.77 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 179.506 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.485 ' O ' ' O ' ' A' ' 90' ' ' GLN . 20.6 t30 -110.26 112.35 24.25 Favored 'General case' 0 CA--C 1.51 -0.588 0 C-N-CA 119.796 -0.762 . . . . 0.0 109.893 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.729 ' HB3' HG21 ' A' ' 109' ' ' THR . 87.0 m-20 -83.93 110.49 18.44 Favored 'General case' 0 N--CA 1.442 -0.848 0 C-N-CA 119.355 -0.938 . . . . 0.0 109.495 179.593 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 1.023 ' O ' ' O ' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -124.27 108.5 20.62 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.026 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 177.08 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.412 ' HG ' ' CE1' ' A' ' 88' ' ' HIS . 64.0 m -134.56 168.97 17.99 Favored 'General case' 0 C--N 1.296 -1.754 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.227 179.808 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 19.9 m -69.33 -63.14 1.12 Allowed 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 119.006 -1.078 . . . . 0.0 111.542 -179.042 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 63.9 m-80 -112.27 -32.39 6.54 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 114.934 1.457 . . . . 0.0 114.934 179.323 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -145.89 127.82 2.91 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 117.105 1.602 . . . . 0.0 117.105 -177.718 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.729 HG21 ' HB3' ' A' ' 103' ' ' ASP . 5.7 m -121.18 138.11 54.36 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 174.337 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 0.736 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.8 m-90 -120.7 148.98 43.21 Favored 'General case' 0 CA--C 1.515 -0.384 0 N-CA-C 113.462 0.912 . . . . 0.0 113.462 -178.515 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.462 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -122.65 112.08 17.53 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 115.026 -0.988 . . . . 0.0 108.621 177.532 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 39.7 m-20 45.57 43.76 9.42 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.085 -0.507 . . . . 0.0 112.118 -179.478 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 78.88 25.05 60.82 Favored Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.784 179.425 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' GLN . . . . . 0.435 ' O ' HG13 ' A' ' 116' ' ' VAL . 31.2 mt-30 -136.98 97.51 3.53 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.102 0.477 . . . . 0.0 110.802 179.69 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.736 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.0 OUTLIER -45.66 132.61 8.44 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.911 179.755 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.606 HG21 ' OD2' ' A' ' 103' ' ' ASP . 27.7 m -124.07 -178.84 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 121.069 0.461 . . . . 0.0 111.916 -179.041 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -85.5 142.29 29.3 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.111 -179.84 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.426 ' HG2' ' N ' ' A' ' 119' ' ' ASN . 33.7 tttm -64.26 163.73 12.34 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.197 179.422 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.426 ' N ' ' HG2' ' A' ' 118' ' ' LYS . 8.2 m-80 34.56 39.91 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 121.182 0.515 . . . . 0.0 111.062 -179.374 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 3.5 p -110.74 107.2 16.66 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.901 -179.537 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.642 ' ND2' HD13 ' A' ' 92' ' ' LEU . 2.0 m120 -53.12 146.75 10.87 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.771 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' GLN . . . . . 0.665 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 13.8 mm100 -129.28 152.11 49.2 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-O 121.149 0.499 . . . . 0.0 111.925 -179.514 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.596 HD13 ' O ' ' A' ' 124' ' ' LEU . 2.6 tm? -81.02 122.52 27.41 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.571 -0.741 . . . . 0.0 109.531 179.031 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.596 ' O ' HD13 ' A' ' 123' ' ' LEU . 0.0 OUTLIER -48.45 139.44 9.05 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-O 122.365 1.078 . . . . 0.0 112.241 -178.672 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.419 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.3 OUTLIER -127.68 152.56 47.55 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 113.593 -1.64 . . . . 0.0 110.196 179.485 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 7.2 tp-100 -71.86 113.44 8.9 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 179.27 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 64.8 30.79 78.92 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.366 -179.564 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.463 ' OD2' HD13 ' A' ' 101' ' ' LEU . 29.8 t70 -53.74 160.5 1.34 Allowed 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.884 0.373 . . . . 0.0 111.077 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.496 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 0.1 OUTLIER -146.6 135.48 22.37 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.755 -179.898 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.454 HG23 ' O ' ' A' ' 110' ' ' TRP . 7.3 mm -113.68 128.72 70.43 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.124 0 CA-C-N 116.167 -0.47 . . . . 0.0 109.922 178.659 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.536 HG23 ' CG2' ' A' ' 140' ' ' ILE . 18.7 m -103.42 144.31 31.55 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.785 -179.392 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.476 ' HB ' ' NE2' ' A' ' 88' ' ' HIS . 5.6 m -141.19 156.1 21.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.005 0.431 . . . . 0.0 112.159 -179.068 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 133' ' ' GLY . . . . . 0.405 ' O ' ' O ' ' A' ' 139' ' ' ASP . . . 70.34 39.54 70.45 Favored Glycine 0 N--CA 1.448 -0.562 0 CA-C-N 115.914 -0.585 . . . . 0.0 112.463 179.396 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.462 HG12 ' N ' ' A' ' 135' ' ' GLY . 90.2 t -74.39 156.86 6.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 121.447 0.641 . . . . 0.0 112.123 -179.247 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.462 ' N ' HG12 ' A' ' 134' ' ' VAL . . . 152.99 -46.21 0.57 Allowed Glycine 0 N--CA 1.441 -1.0 0 CA-C-N 114.981 -1.008 . . . . 0.0 110.749 -179.285 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.595 HG12 ' H ' ' A' ' 138' ' ' SER . 42.7 t -126.59 133.9 67.55 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.722 0 CA-C-N 115.222 -0.489 . . . . 0.0 109.904 178.597 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -51.01 -32.44 21.27 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.89 0.376 . . . . 0.0 111.207 -179.353 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' SER . . . . . 0.595 ' H ' HG12 ' A' ' 136' ' ' VAL . 46.7 m -94.39 6.22 49.39 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 116.164 -0.471 . . . . 0.0 112.132 -179.666 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 139' ' ' ASP . . . . . 0.405 ' O ' ' O ' ' A' ' 133' ' ' GLY . 25.4 t0 -128.34 30.26 5.21 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 -179.378 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.536 ' CG2' HG23 ' A' ' 131' ' ' THR . 27.5 mt -105.89 141.19 21.76 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.287 179.373 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.752 HD22 ' HG2' ' A' ' 42' ' ' GLN . 4.5 mt -116.79 135.27 53.88 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.869 -1.059 . . . . 0.0 110.291 179.675 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 29.8 t -120.31 152.42 37.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.694 0.759 . . . . 0.0 112.359 -179.17 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.872 HD22 ' N ' ' A' ' 144' ' ' VAL . 0.8 OUTLIER -135.7 131.28 35.44 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.625 -1.17 . . . . 0.0 108.992 179.357 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.872 ' N ' HD22 ' A' ' 143' ' ' LEU . 12.2 t -111.67 140.17 32.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.975 0.416 . . . . 0.0 111.908 -179.079 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 1.028 HD13 HD22 ' A' ' 101' ' ' LEU . 0.0 OUTLIER -116.91 126.63 74.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.215 179.575 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 16.0 t80 -106.97 125.48 51.06 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.057 -179.724 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 4.1 mm -103.53 133.3 47.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.999 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 35.5 p-10 -84.77 111.25 19.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.861 0.362 . . . . 0.0 110.718 179.796 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -56.28 -27.34 54.96 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.153 -179.861 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 2.2 tptt -57.2 -36.34 70.72 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.807 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -66.32 -41.88 89.05 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.777 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -62.05 -49.81 74.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.948 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 6.5 tm0? -59.22 -38.29 79.59 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.885 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 10.2 t -65.88 -45.15 83.15 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.886 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -68.64 -37.69 79.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.768 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -60.05 -39.83 87.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.876 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -86.43 -36.13 19.29 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.791 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 3.9 p30 42.6 90.76 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.466 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 159' ' ' LYS . . . . . 0.614 ' O ' HD21 ' A' ' 56' ' ' LEU . 13.8 pttp -75.37 117.72 17.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.975 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 14.3 t -91.53 132.49 35.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.01 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 24.0 p-10 -91.48 -31.8 15.83 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.043 -179.853 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 33.3 ttm180 -70.47 -77.96 0.08 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.942 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 16.9 pt -106.01 136.05 41.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.136 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 4.0 ppt_? . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.189 -0.91 . . . . 0.0 111.015 179.946 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.325 0 N-CA-C 112.502 -0.239 . . . . 0.0 112.502 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 6.2 pm0 -60.35 143.49 52.93 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.851 0.357 . . . . 0.0 110.936 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -124.52 42.32 3.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.748 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.0 mp 63.12 83.19 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.099 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -115.68 178.64 4.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.115 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 2.3 pm0 -112.38 90.84 15.09 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.835 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -68.01 122.94 10.08 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.511 2.14 . . . . 0.0 112.329 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.6 m 64.27 139.03 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.059 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 2.8 tp60 -122.57 33.7 5.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.943 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -145.47 141.79 28.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.924 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -171.47 86.23 0.09 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.907 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 23.4 m -161.33 -61.38 0.05 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.132 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -165.55 175.34 9.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.896 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 61.66 71.07 0.56 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.14 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 27.6 m -159.05 -70.0 0.08 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.097 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 4.3 mp0 -72.79 -45.4 58.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.878 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 23.1 ttt180 -61.3 -42.63 98.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.858 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 15.4 t80 -58.53 -38.91 78.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.997 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -62.37 -34.5 76.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.833 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 41.6 mm -73.05 -39.47 57.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.173 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.5 tm-20 -57.72 -46.49 84.33 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.139 -179.879 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 16.9 mmtm -60.68 -29.06 69.08 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.987 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -63.4 -47.65 81.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.208 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 85.7 p -58.44 -33.78 70.09 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.054 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -58.99 -31.54 68.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.922 -179.851 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -97.74 136.51 37.98 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.88 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -95.96 103.49 15.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.862 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.804 HG22 ' H ' ' A' ' 30' ' ' GLU . 19.7 mm -83.47 139.27 17.94 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.333 0 CA-C-O 121.521 0.677 . . . . 0.0 111.624 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.431 ' HA2' ' HB ' ' A' ' 32' ' ' ILE . . . -97.21 12.64 65.21 Favored Glycine 0 C--N 1.318 -0.469 0 CA-C-N 114.845 -1.07 . . . . 0.0 112.759 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.804 ' H ' HG22 ' A' ' 28' ' ' ILE . 6.2 tm-20 -88.98 -23.78 22.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.643 0.258 . . . . 0.0 111.508 -179.788 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 26.0 m-80 -109.56 -14.69 14.34 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-O 121.909 0.862 . . . . 0.0 109.28 178.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.487 ' O ' HG22 ' A' ' 32' ' ' ILE . 0.1 OUTLIER -74.1 111.14 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.571 0 CA-C-N 114.129 -1.396 . . . . 0.0 111.23 -179.168 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 1.043 ' CG2' ' HB2' ' A' ' 50' ' ' ALA . 0.5 OUTLIER -45.02 -64.12 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.211 -0.904 . . . . 0.0 111.381 -179.488 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.644 ' N ' HG12 ' A' ' 33' ' ' VAL . 30.2 p -165.4 164.93 19.61 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.039 0.447 . . . . 0.0 112.046 -179.644 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.412 ' HD3' HG23 ' A' ' 45' ' ' ILE . 1.0 OUTLIER -124.39 117.63 24.89 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.598 179.38 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.897 HG13 HD11 ' A' ' 143' ' ' LEU . 89.3 t -89.16 132.57 33.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.112 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.937 HG23 HG12 ' A' ' 45' ' ' ILE . 22.6 mt -129.86 108.14 15.84 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.693 -179.745 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.433 ' HB3' ' O ' ' A' ' 43' ' ' ILE . 2.5 t -86.66 105.98 17.29 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 178.18 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 11.4 t -90.71 -26.76 19.38 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 -178.41 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.454 HG21 ' H ' ' A' ' 142' ' ' SER . 26.1 p -59.64 -21.99 61.24 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 121.047 -0.261 . . . . 0.0 111.422 -179.429 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 103.65 72.39 0.9 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.571 -0.823 . . . . 0.0 113.033 179.384 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.508 ' OE1' HD23 ' A' ' 141' ' ' LEU . 1.8 mt-30 -151.1 -70.62 0.17 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.859 0.361 . . . . 0.0 110.941 179.534 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.554 HG23 ' HD2' ' A' ' 44' ' ' PRO . 16.7 mt -102.56 140.33 21.0 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.2 -179.565 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.554 ' HD2' HG23 ' A' ' 43' ' ' ILE . 74.3 Cg_endo -77.6 146.76 24.41 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 122.337 2.025 . . . . 0.0 111.724 179.566 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.937 HG12 HG23 ' A' ' 37' ' ' ILE . 35.5 mt -44.12 108.67 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.056 0.455 . . . . 0.0 111.779 -179.499 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.24 129.8 56.73 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.761 179.132 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.424 ' C ' HD13 ' A' ' 48' ' ' LEU . 3.6 p30 -96.4 119.38 34.78 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.986 0.422 . . . . 0.0 111.429 -179.305 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.876 HD12 ' CD1' ' A' ' 66' ' ' TRP . 0.2 OUTLIER -96.36 131.98 42.34 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 178.543 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.559 ' O ' ' CZ2' ' A' ' 66' ' ' TRP . 0.1 OUTLIER -113.15 164.02 14.03 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.84 0.828 . . . . 0.0 112.608 -178.598 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 1.043 ' HB2' ' CG2' ' A' ' 33' ' ' VAL . . . -111.46 166.42 11.14 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 114.915 -1.039 . . . . 0.0 110.864 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.679 ' O ' HG23 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -93.56 46.13 1.18 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.946 0.403 . . . . 0.0 110.942 179.919 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 14.1 mm -57.02 -40.59 73.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.099 0.476 . . . . 0.0 110.664 179.614 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -67.25 -38.45 85.17 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.968 -179.763 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.419 ' CG ' ' HB3' ' A' ' 51' ' ' ASP . 1.4 mm-40 -67.99 -41.71 81.89 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.92 -179.765 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.679 HG23 ' O ' ' A' ' 51' ' ' ASP . 39.1 t -64.08 -38.02 81.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.85 179.788 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.11 -25.82 64.59 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.936 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -93.45 -54.14 3.79 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.15 -179.795 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.58 -178.42 3.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.077 -179.763 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 8.9 pttt -100.11 -31.89 11.19 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.88 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 16.0 mtm180 -111.39 112.36 24.06 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.834 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -166.83 33.03 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.788 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.492 HG23 ' HA2' ' A' ' 94' ' ' GLY . 39.7 mm -117.47 91.07 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.017 -179.884 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.5 ttpt -179.27 68.49 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.776 179.891 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.427 ' O ' ' HB3' ' A' ' 93' ' ' LEU . 7.9 ttpt -126.92 131.21 51.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.685 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.561 HG13 ' O ' ' A' ' 91' ' ' ILE . 10.7 t -134.86 136.33 52.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 121.037 0.446 . . . . 0.0 111.588 -179.494 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' TRP . . . . . 0.876 ' CD1' HD12 ' A' ' 48' ' ' LEU . 16.0 m-90 -102.07 140.06 36.86 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.057 179.599 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.932 HG23 ' HG3' ' A' ' 90' ' ' GLN . 3.1 m -127.58 129.81 47.95 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.435 0.635 . . . . 0.0 112.14 179.51 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.54 ' HE2' HD11 ' A' ' 91' ' ' ILE . 64.7 m-85 -101.77 118.38 36.81 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.322 178.192 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.679 ' HA2' HD21 ' A' ' 78' ' ' LEU . . . 159.33 -157.6 28.72 Favored Glycine 0 CA--C 1.502 -0.755 0 C-N-CA 119.034 -1.555 . . . . 0.0 112.192 179.328 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.44 ' CD ' ' HB3' ' A' ' 86' ' ' ASN . 11.7 ptm180 -76.75 91.81 3.52 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-O 122.424 1.106 . . . . 0.0 108.297 179.538 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 6.3 m120 -149.08 154.63 39.63 Favored Pre-proline 0 C--N 1.311 -1.068 0 CA-C-N 112.985 -1.916 . . . . 0.0 108.506 179.269 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.573 ' O ' ' HB2' ' A' ' 77' ' ' HIS . 25.7 Cg_exo -56.1 -11.56 5.97 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 121.507 1.472 . . . . 0.0 111.571 178.45 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.787 ' HB2' ' HB2' ' A' ' 77' ' ' HIS . . . 137.27 50.97 0.0 OUTLIER 'General case' 0 CA--C 1.49 -1.336 0 CA-C-N 114.96 -1.018 . . . . 0.0 109.605 178.791 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.58 ' HB3' ' HB ' ' A' ' 67' ' ' THR . 0.1 OUTLIER -52.92 -69.9 0.1 Allowed 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 105.858 -1.904 . . . . 0.0 105.858 179.485 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.576 ' N ' ' O ' ' A' ' 67' ' ' THR . 12.2 t0 -94.78 -47.4 6.49 Favored 'General case' 0 N--CA 1.437 -1.112 0 N-CA-C 105.89 -1.893 . . . . 0.0 105.89 169.806 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.517 ' CD2' HG23 ' A' ' 43' ' ' ILE . 35.6 t80 -144.21 142.56 30.59 Favored 'General case' 0 C--N 1.347 0.473 0 CA-C-N 112.576 -2.102 . . . . 0.0 110.951 179.658 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.787 ' HB2' ' HB2' ' A' ' 73' ' ' ALA . 1.4 t60 -93.0 108.38 19.96 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 118.12 0.418 . . . . 0.0 110.442 177.323 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.781 HD11 ' O ' ' A' ' 85' ' ' SER . 2.2 pp -125.66 168.48 13.67 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.784 0.326 . . . . 0.0 111.103 179.698 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.677 ' O ' HD12 ' A' ' 78' ' ' LEU . . . -53.91 173.05 0.63 Allowed Glycine 0 C--N 1.33 0.209 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.777 -179.791 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.563 ' C ' HD12 ' A' ' 81' ' ' ILE . 12.8 p-10 -96.05 105.36 17.39 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.725 0.298 . . . . 0.0 110.965 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.673 HD13 ' HB3' ' A' ' 85' ' ' SER . 2.0 mp -111.53 152.65 13.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.772 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.23 -45.27 73.74 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 113.61 0.967 . . . . 0.0 113.61 -178.767 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 17.9 mtt180 -119.72 -91.16 0.56 Allowed 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 113.692 0.997 . . . . 0.0 113.692 -177.328 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.493 ' O ' ' CB ' ' A' ' 85' ' ' SER . 0.0 OUTLIER -84.9 103.26 13.8 Favored 'General case' 0 CA--C 1.507 -0.704 0 CA-C-O 121.948 0.88 . . . . 0.0 110.74 -178.606 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.781 ' O ' HD11 ' A' ' 78' ' ' LEU . 0.4 OUTLIER 148.62 -35.42 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 113.113 -1.858 . . . . 0.0 108.718 -179.745 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.803 ' O ' ' N ' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -68.44 -162.39 0.03 OUTLIER 'General case' 0 CA--C 1.514 -0.43 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 177.6 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.911 ' HB3' HD11 ' A' ' 104' ' ' ILE . 1.0 OUTLIER -53.14 72.18 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 177.822 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.959 ' O ' ' O ' ' A' ' 104' ' ' ILE . 29.6 t60 -83.73 -18.91 36.26 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 114.642 1.349 . . . . 0.0 114.642 -175.981 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.651 ' HA ' ' H ' ' A' ' 104' ' ' ILE . 0.0 OUTLIER -171.06 156.98 5.02 Favored 'General case' 0 C--N 1.31 -1.113 0 C-N-CA 118.824 -1.15 . . . . 0.0 112.632 177.864 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.932 ' HG3' HG23 ' A' ' 67' ' ' THR . 34.4 mt-30 -135.37 158.8 43.45 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.587 -1.188 . . . . 0.0 113.825 -177.197 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.646 ' HB ' ' HB2' ' A' ' 66' ' ' TRP . 7.9 mt -124.16 132.82 70.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 114.908 -1.042 . . . . 0.0 109.785 178.499 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.714 HD13 ' ND2' ' A' ' 121' ' ' ASN . 0.3 OUTLIER -108.99 144.03 37.5 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.01 0.433 . . . . 0.0 111.807 -179.557 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.645 HD22 ' N ' ' A' ' 94' ' ' GLY . 0.8 OUTLIER -125.58 122.69 37.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.485 179.442 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.645 ' N ' HD22 ' A' ' 93' ' ' LEU . . . 157.53 -125.71 1.61 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.594 -0.812 . . . . 0.0 112.678 179.806 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 61.68 -176.06 0.13 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.793 0.33 . . . . 0.0 110.786 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -76.73 67.86 2.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.944 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.579 ' HA2' HD21 ' A' ' 155' ' ' LEU . . . 71.4 68.47 1.61 Allowed Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.553 179.874 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -178.26 179.39 0.81 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.821 0.343 . . . . 0.0 110.782 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.74 ' O ' HD22 ' A' ' 100' ' ' LEU . 0.2 OUTLIER -113.26 154.78 26.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.783 179.937 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.777 HD13 ' O ' ' A' ' 122' ' ' GLN . 4.1 mm? -131.35 148.24 52.65 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.263 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.466 ' O ' ' N ' ' A' ' 122' ' ' GLN . 0.3 OUTLIER -117.03 129.99 56.38 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 179.869 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.497 ' O ' ' O ' ' A' ' 90' ' ' GLN . 28.0 t30 -111.35 111.41 22.43 Favored 'General case' 0 CA--C 1.508 -0.64 0 C-N-CA 119.79 -0.764 . . . . 0.0 109.781 179.611 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.745 ' HB3' HG21 ' A' ' 109' ' ' THR . 76.2 m-20 -85.54 112.01 20.55 Favored 'General case' 0 N--CA 1.442 -0.838 0 C-N-CA 119.643 -0.823 . . . . 0.0 109.543 179.507 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.959 ' O ' ' O ' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -123.0 107.63 19.66 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.975 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 177.849 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 50.1 m -134.49 168.95 18.02 Favored 'General case' 0 C--N 1.296 -1.732 0 CA-C-N 114.906 -1.043 . . . . 0.0 109.221 179.672 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 19.5 m -69.59 -63.34 1.09 Allowed 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 119.055 -1.058 . . . . 0.0 111.76 -178.904 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -112.26 -32.33 6.56 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 114.976 1.473 . . . . 0.0 114.976 179.436 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -145.72 126.46 2.55 Favored Glycine 0 C--N 1.339 0.725 0 N-CA-C 117.346 1.698 . . . . 0.0 117.346 -177.531 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.745 HG21 ' HB3' ' A' ' 103' ' ' ASP . 4.3 m -121.26 138.11 54.38 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 174.389 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 0.7 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.6 m-90 -120.67 148.94 43.25 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 -178.539 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.469 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -121.77 112.2 18.08 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 115.152 -0.931 . . . . 0.0 108.698 177.437 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 33.5 m-20 45.48 43.4 8.81 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.073 -0.512 . . . . 0.0 112.099 -179.439 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 78.83 27.87 55.78 Favored Glycine 0 N--CA 1.444 -0.798 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.761 179.247 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -139.19 96.73 3.15 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.099 0.476 . . . . 0.0 110.774 179.776 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.7 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.3 OUTLIER -44.57 128.96 6.76 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.019 179.775 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 3.7 m -121.99 -179.84 2.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.743 -179.208 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -85.57 142.1 29.37 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.186 -179.785 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.436 ' HG3' ' HA ' ' A' ' 104' ' ' ILE . 62.3 tttm -65.0 162.55 16.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.129 179.358 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.431 ' N ' ' HG2' ' A' ' 118' ' ' LYS . 4.9 p-10 35.88 38.19 0.05 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.215 0.531 . . . . 0.0 111.142 -179.799 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 9.6 p -111.18 110.95 21.69 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.929 -179.394 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.714 ' ND2' HD13 ' A' ' 92' ' ' LEU . 1.4 m120 -57.39 141.04 48.62 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.683 179.864 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' GLN . . . . . 0.777 ' O ' HD13 ' A' ' 100' ' ' LEU . 33.6 mm-40 -129.52 145.89 51.4 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-O 121.009 0.433 . . . . 0.0 111.861 -179.666 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -72.28 117.7 14.25 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.671 179.184 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.72 HD21 HG12 ' A' ' 147' ' ' ILE . 0.7 OUTLIER -47.42 143.79 3.34 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.9 0.857 . . . . 0.0 112.029 -178.943 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.46 ' N ' ' HG ' ' A' ' 124' ' ' LEU . 0.3 OUTLIER -126.84 152.78 46.53 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 114.045 -1.434 . . . . 0.0 110.124 179.263 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -71.59 113.99 9.21 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.981 -0.378 . . . . 0.0 109.981 179.633 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 67.99 27.62 73.62 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.852 -0.689 . . . . 0.0 112.266 -179.411 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.402 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 8.3 t70 -55.04 160.42 2.05 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.01 0.433 . . . . 0.0 111.185 -179.82 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.776 ' CG ' HG22 ' A' ' 144' ' ' VAL . 4.2 mt-10 -146.01 135.38 22.98 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.447 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.454 HG23 ' O ' ' A' ' 110' ' ' TRP . 7.0 mm -111.51 128.22 68.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 178.908 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.589 HG23 ' CG2' ' A' ' 140' ' ' ILE . 41.9 m -103.73 144.94 30.81 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.73 -179.538 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.561 HG11 ' CD2' ' A' ' 88' ' ' HIS . 4.1 m -141.46 158.42 21.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -178.781 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 66.17 42.17 94.49 Favored Glycine 0 N--CA 1.447 -0.574 0 CA-C-N 115.83 -0.623 . . . . 0.0 112.355 179.359 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.454 ' HA ' HG12 ' A' ' 140' ' ' ILE . 88.9 t -76.89 157.04 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 CA-C-O 121.467 0.651 . . . . 0.0 112.193 -179.125 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.446 ' N ' HG12 ' A' ' 134' ' ' VAL . . . 144.65 -43.08 0.98 Allowed Glycine 0 N--CA 1.44 -1.062 0 N-CA-C 110.447 -1.061 . . . . 0.0 110.447 -178.814 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.632 HG12 ' H ' ' A' ' 138' ' ' SER . 47.5 t -126.87 126.09 67.88 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 CA-C-N 114.984 -0.608 . . . . 0.0 109.705 178.589 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.525 ' HA ' HD12 ' A' ' 140' ' ' ILE . 0.8 OUTLIER -51.17 -28.23 10.66 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.774 0.321 . . . . 0.0 111.186 -179.342 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 138' ' ' SER . . . . . 0.632 ' H ' HG12 ' A' ' 136' ' ' VAL . 0.9 OUTLIER -94.36 6.49 48.56 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 116.224 -0.443 . . . . 0.0 112.114 -179.598 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -130.94 27.55 4.88 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 -179.427 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.589 ' CG2' HG23 ' A' ' 131' ' ' THR . 23.9 mt -102.73 140.86 19.94 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.312 179.169 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.508 HD23 ' OE1' ' A' ' 42' ' ' GLN . 4.9 mp -124.07 135.39 53.53 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 114.808 -1.087 . . . . 0.0 109.734 179.511 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.454 ' H ' HG21 ' A' ' 40' ' ' THR . 38.9 t -127.65 151.92 48.33 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -178.966 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.897 HD11 HG13 ' A' ' 36' ' ' VAL . 3.2 tm? -122.96 138.09 54.77 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 114.424 -1.262 . . . . 0.0 109.155 179.184 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.776 HG22 ' CG ' ' A' ' 129' ' ' GLU . 3.8 t -119.17 141.03 41.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.8 0.333 . . . . 0.0 111.724 -178.811 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.741 HG13 HG22 ' A' ' 36' ' ' VAL . 0.2 OUTLIER -111.02 140.34 30.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.161 179.564 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -119.76 106.57 12.25 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.556 179.79 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.72 HG12 HD21 ' A' ' 124' ' ' LEU . 2.0 mp -99.38 133.38 42.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.483 -179.781 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 -78.82 140.23 38.24 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.236 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -73.8 -18.44 60.95 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.196 178.771 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.408 ' HB3' ' HA ' ' A' ' 30' ' ' GLU . 0.0 OUTLIER -65.5 -45.21 84.44 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.648 179.779 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 151' ' ' PHE . . . . . 0.523 ' HE2' ' HB3' ' A' ' 50' ' ' ALA . 26.1 t80 -57.25 -42.41 81.44 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.681 179.844 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.78 -38.14 72.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.73 179.749 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 7.8 mm100 -64.61 -36.54 84.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.882 179.891 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 13.0 t -58.0 -45.13 87.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.958 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.579 HD21 ' HA2' ' A' ' 97' ' ' GLY . 0.1 OUTLIER -66.47 -38.15 86.67 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.905 -179.969 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -60.42 -40.7 91.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.901 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 6.5 mt-30 -86.75 -36.62 18.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.899 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 44.83 -172.76 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.635 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 4.8 ttpp -82.54 145.92 29.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.013 -179.812 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 13.7 t -97.43 129.63 47.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.017 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -79.43 157.54 27.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.007 -179.872 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 6.2 ptm180 -133.35 27.06 4.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.901 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 2.1 mt -105.85 130.01 58.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.051 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.252 -0.88 . . . . 0.0 110.895 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.344 0 N-CA-C 112.487 -0.245 . . . . 0.0 112.487 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 -142.69 156.12 44.99 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.844 0.354 . . . . 0.0 110.92 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -62.82 -177.05 0.13 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.88 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.648 ' N ' HD13 ' A' ' 4' ' ' ILE . 0.1 OUTLIER -125.53 129.08 72.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.026 179.963 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -156.89 135.31 11.38 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.1 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -171.94 136.23 0.91 Allowed Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.811 179.873 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -74.91 83.73 1.76 Allowed 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.499 2.133 . . . . 0.0 112.33 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 11.0 m -62.36 -50.71 70.52 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.108 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -175.34 116.7 0.16 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.893 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -74.57 141.69 44.74 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.914 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 13.4 m -127.3 88.09 2.74 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.835 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -124.82 30.98 5.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.033 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -58.8 -32.11 69.04 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.923 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.8 81.13 0.19 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.157 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.418 ' O ' HD13 ' A' ' 19' ' ' LEU . 18.2 m -152.52 -48.03 0.1 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.224 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -62.74 -42.45 99.67 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.965 -179.87 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.8 mtm-85 -60.03 -39.9 87.5 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.995 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -65.24 -36.55 84.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.964 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.418 HD13 ' O ' ' A' ' 15' ' ' THR . 6.9 mp -62.2 -43.17 99.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.016 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 37.5 mm -62.87 -44.04 99.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.167 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -57.66 -40.96 80.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.019 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -65.23 -29.51 70.31 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.014 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -57.92 -47.5 82.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.282 -179.894 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -57.5 -41.06 80.0 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.98 -179.892 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 8.4 mm-40 -86.51 -174.07 4.83 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.968 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -62.52 140.52 58.62 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.876 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -80.22 114.93 19.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.893 -179.876 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 21.7 mm -82.12 139.67 17.56 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.329 0 CA-C-O 121.388 0.613 . . . . 0.0 111.476 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.419 ' O ' ' ND2' ' A' ' 148' ' ' ASN . . . -91.6 36.57 3.6 Favored Glycine 0 C--N 1.317 -0.506 0 CA-C-N 114.978 -1.01 . . . . 0.0 112.755 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -89.79 -39.23 13.25 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.73 0.3 . . . . 0.0 111.326 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 73.2 m-20 -110.1 -13.34 14.39 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-O 121.829 0.823 . . . . 0.0 109.07 178.965 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.589 ' O ' ' CG2' ' A' ' 32' ' ' ILE . 0.1 OUTLIER -70.07 97.32 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.605 0 CA-C-N 114.216 -1.356 . . . . 0.0 111.266 -178.839 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.88 HG23 ' HB3' ' A' ' 50' ' ' ALA . 0.6 OUTLIER -34.15 -59.06 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 114.795 -1.093 . . . . 0.0 112.159 -179.578 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.617 ' N ' HG12 ' A' ' 33' ' ' VAL . 3.2 t -163.5 164.98 24.18 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.747 -179.27 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 1.8 ttm180 -125.47 115.17 19.81 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.026 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.639 HG21 ' CZ ' ' A' ' 68' ' ' PHE . 14.4 p -89.92 137.17 22.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.076 179.799 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.899 HG23 HG12 ' A' ' 45' ' ' ILE . 23.6 mt -129.51 107.42 15.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -179.673 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.453 ' HB2' ' O ' ' A' ' 43' ' ' ILE . 67.1 m -92.74 101.03 13.41 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 177.211 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.2 t -105.82 -18.21 14.13 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 113.469 0.915 . . . . 0.0 113.469 -177.256 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.768 HG21 ' CB ' ' A' ' 142' ' ' SER . 26.1 p -57.81 -19.35 27.95 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.924 -0.31 . . . . 0.0 111.534 -179.564 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 111.12 67.64 0.55 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.558 -0.83 . . . . 0.0 112.425 179.837 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.735 ' C ' HD13 ' A' ' 43' ' ' ILE . 10.9 mt-30 -151.15 -54.49 0.14 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.737 0.303 . . . . 0.0 111.138 -179.739 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.927 HG22 ' HD2' ' A' ' 44' ' ' PRO . 0.0 OUTLIER -134.63 151.5 76.02 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.158 -179.299 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.927 ' HD2' HG22 ' A' ' 43' ' ' ILE . 87.0 Cg_endo -80.42 147.3 17.86 Favored 'Trans proline' 0 N--CA 1.461 -0.433 0 C-N-CA 122.403 2.069 . . . . 0.0 111.562 179.352 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.899 HG12 HG23 ' A' ' 37' ' ' ILE . 23.2 mt -37.73 124.58 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 CA-C-O 121.043 0.449 . . . . 0.0 111.844 -179.517 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.568 ' HD2' ' HB3' ' A' ' 76' ' ' TYR . 0.0 OUTLIER -115.28 153.94 30.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.266 179.698 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 15.9 p-10 -116.22 119.83 37.03 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.187 0.517 . . . . 0.0 111.674 -179.605 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.934 HD22 ' CD1' ' A' ' 66' ' ' TRP . 6.9 mt -96.72 123.25 40.36 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.251 178.829 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.526 ' O ' ' HZ2' ' A' ' 66' ' ' TRP . 0.0 OUTLIER -127.52 160.88 30.17 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 -178.76 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.88 ' HB3' HG23 ' A' ' 33' ' ' VAL . . . -157.71 142.31 16.4 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 114.287 -1.324 . . . . 0.0 110.998 178.991 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.458 ' CB ' ' HG3' ' A' ' 54' ' ' GLN . 0.5 OUTLIER -68.87 129.89 41.22 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.969 0.414 . . . . 0.0 111.083 -179.771 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 33.9 mt -62.15 -38.84 81.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.197 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 31.4 p -56.74 -34.08 67.18 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.031 -179.43 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.458 ' HG3' ' CB ' ' A' ' 51' ' ' ASP . 0.3 OUTLIER -63.5 -44.77 93.37 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.934 -179.66 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.415 ' HA ' HD12 ' A' ' 62' ' ' ILE . 16.8 t -74.04 -42.62 52.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.24 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -58.75 -35.54 72.9 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.996 -179.896 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 14.2 tptp -93.93 -44.62 7.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.823 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 57.66 69.69 0.72 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.841 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -175.02 -40.64 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.828 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 7.2 tpp180 -62.85 -71.66 0.16 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.833 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 58.1 m -144.04 68.27 1.27 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.903 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.415 HD12 ' HA ' ' A' ' 55' ' ' VAL . 1.2 tt -95.22 42.39 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.974 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 34.0 mtmt -139.23 71.11 1.38 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.128 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.569 ' HB3' HD12 ' A' ' 93' ' ' LEU . 5.5 ttpt -112.96 130.78 56.0 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.409 179.557 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.729 HG22 HD23 ' A' ' 92' ' ' LEU . 21.4 t -137.47 139.45 43.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.164 0.507 . . . . 0.0 112.176 -179.098 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' TRP . . . . . 0.934 ' CD1' HD22 ' A' ' 48' ' ' LEU . 12.5 m-90 -100.08 139.23 36.04 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.06 178.607 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.628 HG23 ' HG2' ' A' ' 90' ' ' GLN . 33.9 m -131.68 130.64 42.29 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.554 0.692 . . . . 0.0 111.793 179.329 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.639 ' CZ ' HG21 ' A' ' 36' ' ' VAL . 1.3 m-85 -102.26 119.36 38.67 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 114.886 -1.052 . . . . 0.0 109.093 178.462 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.65 ' HA2' ' O ' ' A' ' 85' ' ' SER . . . 156.35 -160.7 30.37 Favored Glycine 0 CA--C 1.505 -0.542 0 C-N-CA 118.537 -1.792 . . . . 0.0 113.225 179.041 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.421 ' H ' ' HA ' ' A' ' 86' ' ' ASN . 12.5 ptm180 -76.84 93.15 3.69 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-O 122.686 1.231 . . . . 0.0 108.918 -179.874 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.454 ' C ' ' N ' ' A' ' 73' ' ' ALA . 4.7 m-80 -148.45 156.53 42.37 Favored Pre-proline 0 C--N 1.307 -1.275 0 CA-C-N 112.857 -1.974 . . . . 0.0 107.936 178.812 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.546 ' O ' ' CB ' ' A' ' 73' ' ' ALA . 47.0 Cg_exo -50.37 -13.76 0.83 Allowed 'Trans proline' 0 N--CA 1.459 -0.553 0 C-N-CA 121.384 1.389 . . . . 0.0 111.315 178.276 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.557 ' HB2' ' HB2' ' A' ' 77' ' ' HIS . . . 135.85 53.63 0.0 OUTLIER 'General case' 0 CA--C 1.489 -1.385 0 CA-C-N 114.504 -1.226 . . . . 0.0 108.582 178.731 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.555 ' HB3' ' HB ' ' A' ' 67' ' ' THR . 0.0 OUTLIER -52.07 -69.28 0.12 Allowed 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 -179.846 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.559 ' N ' ' O ' ' A' ' 67' ' ' THR . 29.9 t70 -92.76 -51.2 5.2 Favored 'General case' 0 N--CA 1.433 -1.29 0 N-CA-C 104.388 -2.449 . . . . 0.0 104.388 169.861 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.834 ' CE2' HG21 ' A' ' 43' ' ' ILE . 1.3 p90 -148.26 143.87 27.25 Favored 'General case' 0 C--N 1.345 0.389 0 CA-C-N 112.815 -1.993 . . . . 0.0 111.011 176.227 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.557 ' HB2' ' HB2' ' A' ' 73' ' ' ALA . 5.8 t60 -90.09 105.81 18.06 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 177.454 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.631 HD21 ' O ' ' A' ' 85' ' ' SER . 1.4 pt? -127.63 178.78 5.89 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.922 0.391 . . . . 0.0 111.336 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -51.1 158.43 2.24 Favored Glycine 0 C--N 1.333 0.373 0 C-N-CA 120.991 -0.623 . . . . 0.0 112.694 -179.792 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.436 ' ND2' ' O ' ' A' ' 80' ' ' ASN . 0.8 OUTLIER -111.71 99.38 8.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.762 0.315 . . . . 0.0 111.579 -179.697 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.64 ' HB ' ' HB2' ' A' ' 85' ' ' SER . 17.3 mt -114.93 131.66 66.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 178.175 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.423 ' HA ' ' ND2' ' A' ' 86' ' ' ASN . 0.5 OUTLIER -52.81 -24.09 8.24 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 111.697 0.258 . . . . 0.0 111.697 -179.016 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.445 ' H ' HG22 ' A' ' 81' ' ' ILE . 2.2 mtt-85 -92.3 -95.05 0.14 Allowed 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 116.841 -0.163 . . . . 0.0 111.256 179.869 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.491 ' N ' HD23 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -109.48 109.45 20.28 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-O 121.359 0.599 . . . . 0.0 109.761 179.191 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.65 ' O ' ' HA2' ' A' ' 69' ' ' GLY . 1.5 m 157.19 -42.37 0.0 OUTLIER 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 114.592 -1.186 . . . . 0.0 109.55 -179.698 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.669 ' O ' ' N ' ' A' ' 88' ' ' HIS . 30.3 m-20 -65.41 -160.71 0.02 OUTLIER 'General case' 0 CA--C 1.516 -0.354 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 177.514 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.845 ' HB3' HD11 ' A' ' 104' ' ' ILE . 0.0 OUTLIER -58.64 75.18 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 177.791 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.969 ' O ' ' O ' ' A' ' 104' ' ' ILE . 30.6 t60 -79.53 -18.64 51.4 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 114.182 1.179 . . . . 0.0 114.182 -176.685 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.611 ' CZ ' HD11 ' A' ' 91' ' ' ILE . 0.0 OUTLIER -174.98 156.84 2.25 Favored 'General case' 0 C--N 1.312 -1.052 0 C-N-CA 119.038 -1.065 . . . . 0.0 112.88 177.961 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.628 ' HG2' HG23 ' A' ' 67' ' ' THR . 35.2 mt-30 -138.09 160.75 38.57 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 114.677 -1.147 . . . . 0.0 113.758 -177.779 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.672 ' HB ' ' HB2' ' A' ' 66' ' ' TRP . 3.4 mt -130.24 129.81 65.31 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.004 178.617 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.729 HD23 HG22 ' A' ' 65' ' ' VAL . 0.4 OUTLIER -103.93 143.86 32.3 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -179.22 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.78 HD22 ' N ' ' A' ' 94' ' ' GLY . 0.2 OUTLIER -126.43 122.81 36.36 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.188 178.965 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.78 ' N ' HD22 ' A' ' 93' ' ' LEU . . . 119.11 -114.8 2.89 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.563 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 17.5 tp10 66.07 -72.98 0.07 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.843 0.354 . . . . 0.0 111.033 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -175.88 65.15 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.841 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 93.26 136.8 8.0 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.4 -179.823 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 6.2 m-20 63.74 -173.36 0.16 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.766 0.317 . . . . 0.0 110.803 -179.802 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.789 HD11 HG22 ' A' ' 33' ' ' VAL . 0.2 OUTLIER -106.85 160.11 15.75 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.936 -179.998 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.577 ' HA ' ' O ' ' A' ' 122' ' ' GLN . 0.8 OUTLIER -121.07 148.01 44.74 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.083 179.625 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.441 ' O ' ' N ' ' A' ' 122' ' ' GLN . 4.4 mp -116.94 127.38 54.17 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 179.614 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.484 ' O ' ' O ' ' A' ' 90' ' ' GLN . 27.8 t30 -113.9 111.49 21.8 Favored 'General case' 0 CA--C 1.507 -0.706 0 C-N-CA 119.74 -0.784 . . . . 0.0 109.928 -179.92 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.698 ' HB3' HG21 ' A' ' 109' ' ' THR . 74.8 m-20 -84.11 111.51 19.39 Favored 'General case' 0 N--CA 1.44 -0.972 0 C-N-CA 119.647 -0.821 . . . . 0.0 109.227 179.57 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.969 ' O ' ' O ' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -123.38 107.76 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.007 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 177.837 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.465 ' HG ' ' CE1' ' A' ' 88' ' ' HIS . 71.1 m -132.96 171.48 13.9 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-N 114.939 -1.028 . . . . 0.0 109.328 179.754 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 23.4 m -69.58 -63.56 1.05 Allowed 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 119.093 -1.043 . . . . 0.0 111.545 -179.156 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -112.65 -32.85 6.31 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 114.687 1.366 . . . . 0.0 114.687 179.162 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -145.97 129.08 3.27 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 116.996 1.558 . . . . 0.0 116.996 -177.84 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.698 HG21 ' HB3' ' A' ' 103' ' ' ASP . 5.8 m -121.17 138.15 54.34 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 174.478 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 0.776 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.5 m-90 -120.09 148.85 43.09 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 113.14 0.793 . . . . 0.0 113.14 -178.653 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -123.59 112.3 17.27 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 115.123 -0.944 . . . . 0.0 108.755 177.714 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 13.4 m-80 45.23 44.68 9.08 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.933 -0.576 . . . . 0.0 112.116 -179.531 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 77.53 26.14 61.75 Favored Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.75 179.249 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' GLN . . . . . 0.413 ' O ' HG13 ' A' ' 116' ' ' VAL . 0.6 OUTLIER -138.74 95.3 2.95 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.077 0.465 . . . . 0.0 110.739 179.703 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.776 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.1 OUTLIER -44.98 133.64 6.25 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.931 179.763 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.495 HG21 ' OD2' ' A' ' 103' ' ' ASP . 31.2 m -124.44 -179.66 2.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.83 -179.113 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 29.3 mm-40 -84.9 141.57 30.31 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.005 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.427 ' HG2' ' N ' ' A' ' 119' ' ' ASN . 88.4 tttt -65.31 163.2 15.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.056 179.443 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.427 ' N ' ' HG2' ' A' ' 118' ' ' LYS . 13.5 m-80 33.63 40.04 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.164 0.507 . . . . 0.0 111.152 -179.461 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 19.5 p -110.48 117.08 32.59 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.967 -179.397 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.403 ' HB3' ' CD2' ' A' ' 100' ' ' LEU . 66.9 m-20 -57.97 138.98 55.38 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.778 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' GLN . . . . . 0.577 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 45.0 mm-40 -129.49 146.33 51.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.117 0.484 . . . . 0.0 111.787 -179.849 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 12.3 tp -78.74 120.24 23.1 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.545 178.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.813 HD21 HG12 ' A' ' 147' ' ' ILE . 13.3 tp -46.88 144.33 2.48 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.773 0.797 . . . . 0.0 111.965 -178.905 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.757 ' O ' HD11 ' A' ' 147' ' ' ILE . 0.6 OUTLIER -126.83 152.34 47.11 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 114.22 -1.354 . . . . 0.0 110.26 179.542 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 126' ' ' GLN . . . . . 0.447 ' HA ' HD12 ' A' ' 147' ' ' ILE . 4.1 mm100 -71.41 114.15 9.18 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 179.584 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 65.67 30.29 77.01 Favored Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.172 -179.364 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.405 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 18.6 t0 -55.76 160.24 2.7 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.987 0.423 . . . . 0.0 111.39 -179.705 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.409 ' CG ' ' O ' ' A' ' 143' ' ' LEU . 1.2 tt0 -146.15 134.94 22.38 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.004 179.925 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.446 ' CG2' ' O ' ' A' ' 110' ' ' TRP . 1.1 mp -113.41 127.15 70.86 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.202 0 CA-C-O 120.799 0.333 . . . . 0.0 110.112 178.958 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.492 ' HB ' ' HB2' ' A' ' 110' ' ' TRP . 18.3 m -104.04 145.6 29.93 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.52 -179.754 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.49 HG11 ' CD2' ' A' ' 88' ' ' HIS . 5.5 m -141.21 158.09 22.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -178.669 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 133' ' ' GLY . . . . . 0.404 ' O ' ' O ' ' A' ' 139' ' ' ASP . . . 69.06 41.33 81.61 Favored Glycine 0 N--CA 1.447 -0.612 0 CA-C-N 115.682 -0.69 . . . . 0.0 112.509 179.25 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.465 ' HA ' HG12 ' A' ' 140' ' ' ILE . 85.9 t -77.55 153.87 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.636 0 CA-C-O 121.398 0.618 . . . . 0.0 112.14 -179.284 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 145.13 -39.61 1.17 Allowed Glycine 0 N--CA 1.441 -0.999 0 CA-C-N 115.015 -0.993 . . . . 0.0 110.7 -179.004 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.541 HG12 ' H ' ' A' ' 138' ' ' SER . 48.3 t -126.67 129.35 71.59 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.65 0 CA-C-N 115.231 -0.485 . . . . 0.0 109.837 178.874 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -51.25 -34.43 32.54 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.784 0.326 . . . . 0.0 111.618 -179.235 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 138' ' ' SER . . . . . 0.541 ' H ' HG12 ' A' ' 136' ' ' VAL . 2.6 t -94.06 6.48 48.41 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 -179.326 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 139' ' ' ASP . . . . . 0.404 ' O ' ' O ' ' A' ' 133' ' ' GLY . 14.6 t0 -126.77 26.94 6.13 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -179.319 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.5 ' C ' HD22 ' A' ' 141' ' ' LEU . 26.6 mt -102.52 141.35 18.77 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.34 179.194 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.539 HD12 ' CD ' ' A' ' 42' ' ' GLN . 4.1 mm? -121.26 135.45 55.12 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 114.885 -1.052 . . . . 0.0 110.176 179.594 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.807 ' C ' HD12 ' A' ' 143' ' ' LEU . 0.9 OUTLIER -122.27 147.39 46.28 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.551 0.691 . . . . 0.0 112.648 -178.898 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.807 HD12 ' C ' ' A' ' 142' ' ' SER . 5.7 mp -127.14 146.27 50.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.028 -0.987 . . . . 0.0 109.086 179.399 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 21.5 t -129.42 141.01 47.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.918 0.39 . . . . 0.0 112.009 -178.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.4 HD13 HD11 ' A' ' 101' ' ' LEU . 0.2 OUTLIER -116.08 127.88 73.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.786 179.771 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 9.7 t80 -111.27 120.21 41.48 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.49 179.855 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.813 HG12 HD21 ' A' ' 124' ' ' LEU . 1.3 mt -100.47 133.8 42.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.998 0.427 . . . . 0.0 111.86 -179.458 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 148' ' ' ASN . . . . . 0.419 ' ND2' ' O ' ' A' ' 29' ' ' GLY . 0.7 OUTLIER -84.37 114.99 22.27 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.558 179.423 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -59.97 -19.28 51.39 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.442 -179.694 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 9.4 mtmm -57.9 -43.29 86.07 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.947 0.403 . . . . 0.0 110.801 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 32.4 t80 -61.27 -44.66 96.87 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.968 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.11 -39.97 88.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.926 -179.844 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -59.86 -39.5 85.43 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.943 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 9.3 t -66.68 -45.55 78.48 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.885 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.658 ' O ' HD13 ' A' ' 155' ' ' LEU . 3.1 tm? -67.41 -40.4 85.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.902 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -57.27 -38.89 74.58 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.928 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 3.3 mm-40 -89.58 -32.21 17.22 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.766 179.871 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 3.6 p30 42.33 79.62 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.497 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -120.49 115.87 24.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.885 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 22.2 t -84.08 133.05 30.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.1 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -117.43 123.97 47.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.932 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -99.1 126.14 44.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.798 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 2.9 tt -105.51 129.77 57.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.101 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 35.8 ptt180 . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.259 -0.877 . . . . 0.0 110.91 179.937 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.323 0 N-CA-C 112.397 -0.281 . . . . 0.0 112.397 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -165.69 111.96 0.9 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.764 0.316 . . . . 0.0 110.969 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 31.3 m120 -90.11 123.64 34.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.863 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 8.6 pt -131.98 101.05 4.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.205 -179.889 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.4 t 175.38 -35.36 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.278 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.409 ' CB ' ' HD3' ' A' ' 7' ' ' PRO . 0.0 OUTLIER -52.69 -53.26 56.09 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.155 -179.803 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.409 ' HD3' ' CB ' ' A' ' 6' ' ' GLN . 50.5 Cg_exo -53.56 99.1 0.05 OUTLIER 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.515 2.143 . . . . 0.0 112.282 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.86 -68.36 0.78 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.126 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 56.15 37.24 28.64 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.103 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -153.08 144.73 23.45 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.885 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 72.1 p -126.46 84.81 2.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.865 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 37.1 p -65.02 80.56 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.111 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 1.7 tm0? -131.64 108.55 9.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.939 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.543 ' HB1' ' HE ' ' A' ' 17' ' ' ARG . . . 59.1 80.46 0.19 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.087 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -139.03 -49.96 0.52 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.049 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.2 mm-40 -66.33 -36.53 83.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.896 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.543 ' HE ' ' HB1' ' A' ' 14' ' ' ALA . 0.6 OUTLIER -61.56 -37.72 84.84 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.89 179.909 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -63.8 -36.97 85.65 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.87 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.6 mt -59.4 -38.74 81.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.891 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 31.3 mm -64.24 -40.56 89.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.025 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -57.85 -43.92 86.22 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.959 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -64.79 -37.32 87.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.991 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -64.29 -47.47 79.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.086 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 2.3 m -64.62 -38.15 90.02 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.951 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 10.8 tp60 -62.1 120.03 10.09 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.934 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.85 129.48 39.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.834 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 20.9 mt-30 -89.37 102.07 14.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.996 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 21.4 mm -88.15 139.27 17.62 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.345 0 CA-C-O 121.421 0.629 . . . . 0.0 111.58 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.406 ' HA2' ' HB ' ' A' ' 32' ' ' ILE . . . 90.94 -24.4 18.42 Favored Glycine 0 C--N 1.317 -0.48 0 CA-C-N 114.938 -1.028 . . . . 0.0 112.868 179.916 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -78.03 -23.22 48.27 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.596 0.236 . . . . 0.0 111.474 -179.698 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.597 ' HA ' HD12 ' A' ' 52' ' ' ILE . 10.4 m120 -108.55 -14.02 14.72 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-O 121.843 0.83 . . . . 0.0 109.048 178.797 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.528 HD13 ' O ' ' A' ' 48' ' ' LEU . 0.1 OUTLIER -73.58 111.6 8.8 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.568 0 CA-C-N 114.066 -1.424 . . . . 0.0 111.433 -179.355 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 1.05 ' CG2' ' HB2' ' A' ' 50' ' ' ALA . 0.5 OUTLIER -42.27 -64.57 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.47 -179.653 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.631 ' N ' ' CG1' ' A' ' 33' ' ' VAL . 22.6 p -166.31 165.85 17.05 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.712 -179.686 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 11.7 ttm180 -119.21 126.27 51.15 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.385 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 1.011 HG12 HD21 ' A' ' 143' ' ' LEU . 14.8 t -95.59 137.09 24.6 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.19 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.349 179.226 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.936 HG23 HG12 ' A' ' 45' ' ' ILE . 21.8 mt -129.3 108.6 17.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 -178.985 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.757 ' SG ' HD23 ' A' ' 143' ' ' LEU . 0.7 OUTLIER -103.38 102.02 11.94 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 177.413 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.61 ' CG2' HG22 ' A' ' 37' ' ' ILE . 1.7 p -112.42 -23.16 10.48 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 113.664 0.987 . . . . 0.0 113.664 -177.112 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.528 HG21 ' HB3' ' A' ' 142' ' ' SER . 5.3 p -54.16 -23.33 13.9 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.874 -0.33 . . . . 0.0 111.452 -179.241 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 124.26 70.64 0.22 Allowed Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.642 -0.79 . . . . 0.0 112.402 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.497 ' NE2' ' HB3' ' A' ' 141' ' ' LEU . 0.6 OUTLIER -151.05 -70.77 0.17 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.74 0.305 . . . . 0.0 110.944 -179.893 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.762 HG12 HD13 ' A' ' 78' ' ' LEU . 2.1 mp -134.64 133.13 21.07 Favored Pre-proline 0 N--CA 1.453 -0.319 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.15 -179.826 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.476 ' HD2' ' CZ ' ' A' ' 76' ' ' TYR . 35.6 Cg_exo -58.58 147.44 86.84 Favored 'Trans proline' 0 C--N 1.342 0.236 0 C-N-CA 122.474 2.116 . . . . 0.0 111.611 179.497 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.936 HG12 HG23 ' A' ' 37' ' ' ILE . 45.7 mt -33.68 145.57 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -179.24 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.404 ' HD3' ' CD2' ' A' ' 76' ' ' TYR . 9.8 tpt180 -139.88 149.46 43.42 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.045 179.47 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -120.54 119.91 34.31 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.888 0.375 . . . . 0.0 111.635 -179.441 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.864 HD11 HD13 ' A' ' 91' ' ' ILE . 0.3 OUTLIER -99.26 133.39 43.62 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 178.367 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.567 ' O ' ' CZ2' ' A' ' 66' ' ' TRP . 0.1 OUTLIER -113.42 164.73 13.23 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.794 0.807 . . . . 0.0 112.658 -179.131 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 1.05 ' HB2' ' CG2' ' A' ' 33' ' ' VAL . . . -119.77 166.16 13.61 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.116 -0.947 . . . . 0.0 111.428 -179.895 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.429 ' CB ' ' CG ' ' A' ' 54' ' ' GLN . 0.0 OUTLIER -105.72 76.02 1.17 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.384 179.642 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.597 HD12 ' HA ' ' A' ' 31' ' ' ASN . 19.0 mt -61.55 -41.24 89.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.484 -179.53 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 19.3 t -57.51 -36.61 71.77 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.174 0.511 . . . . 0.0 110.506 -179.525 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.429 ' CG ' ' CB ' ' A' ' 51' ' ' ASP . 3.3 mm-40 -68.75 -40.48 79.8 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.742 179.736 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 39.6 t -72.66 -37.65 56.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.748 179.728 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 22.0 mt -56.67 -35.29 68.25 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.49 179.765 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.45 -30.09 13.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.526 179.513 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER 59.6 111.76 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.01 179.783 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.8 tttt -176.68 -53.55 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.908 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 12.2 mtt180 -152.67 -176.95 5.95 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.814 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 62.15 30.0 17.65 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.874 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -103.06 42.26 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 121.018 0.437 . . . . 0.0 111.044 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.6 ptpt -160.62 82.89 0.67 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.995 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.457 ' O ' ' HB3' ' A' ' 93' ' ' LEU . 14.0 ttpt -115.19 130.84 57.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.532 179.8 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.484 HG13 ' O ' ' A' ' 91' ' ' ILE . 5.5 t -133.36 134.08 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 CA-C-O 121.028 0.442 . . . . 0.0 111.554 -179.503 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' TRP . . . . . 0.666 ' HB2' ' HB ' ' A' ' 91' ' ' ILE . 17.2 m-90 -100.61 140.27 35.12 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.854 179.395 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.73 HG23 ' HG2' ' A' ' 90' ' ' GLN . 21.6 m -127.34 130.44 49.46 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.53 0.681 . . . . 0.0 112.262 179.515 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.52 ' HE2' HD11 ' A' ' 91' ' ' ILE . 43.6 m-85 -101.66 118.04 36.12 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.089 -0.959 . . . . 0.0 108.739 177.768 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.686 ' HA2' ' O ' ' A' ' 85' ' ' SER . . . 158.29 -151.93 23.06 Favored Glycine 0 CA--C 1.505 -0.558 0 C-N-CA 119.054 -1.546 . . . . 0.0 113.055 179.828 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.44 ' HD2' ' HB2' ' A' ' 80' ' ' ASN . 35.5 mtp180 -75.49 91.08 2.76 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-O 122.348 1.071 . . . . 0.0 108.49 -179.853 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.427 ' CB ' ' HB2' ' A' ' 74' ' ' CYS . 20.6 m120 -150.82 159.32 34.26 Favored Pre-proline 0 C--N 1.308 -1.212 0 CA-C-N 113.18 -1.827 . . . . 0.0 108.688 178.917 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.558 ' O ' ' HB2' ' A' ' 77' ' ' HIS . 36.3 Cg_endo -66.73 -6.22 15.04 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 120.874 1.05 . . . . 0.0 110.777 177.591 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.73 ' HB2' ' HB2' ' A' ' 77' ' ' HIS . . . 137.03 51.57 0.0 OUTLIER 'General case' 0 CA--C 1.491 -1.32 0 CA-C-N 114.452 -1.249 . . . . 0.0 109.269 178.867 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.548 ' HB3' ' HB ' ' A' ' 67' ' ' THR . 0.1 OUTLIER -52.78 -69.43 0.11 Allowed 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 105.709 -1.959 . . . . 0.0 105.709 179.537 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.655 ' HB2' ' N ' ' A' ' 67' ' ' THR . 36.9 t0 -95.56 -47.56 6.19 Favored 'General case' 0 N--CA 1.433 -1.319 0 N-CA-C 105.872 -1.899 . . . . 0.0 105.872 169.638 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.5 ' CG ' HG21 ' A' ' 43' ' ' ILE . 7.5 t80 -145.12 142.14 29.4 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 112.501 -2.136 . . . . 0.0 112.102 -179.609 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.73 ' HB2' ' HB2' ' A' ' 73' ' ' ALA . 1.9 t60 -100.89 106.7 18.07 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 176.392 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.814 HD11 ' HA ' ' A' ' 85' ' ' SER . 0.9 OUTLIER -133.07 -174.65 3.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.057 0.456 . . . . 0.0 111.773 -179.282 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -56.73 170.71 2.73 Favored Glycine 0 C--N 1.332 0.355 0 CA-C-N 115.75 -0.659 . . . . 0.0 112.471 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.44 ' HB2' ' HD2' ' A' ' 70' ' ' ARG . 0.8 OUTLIER -112.12 98.49 7.37 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 -179.438 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.661 ' HB ' ' HB2' ' A' ' 85' ' ' SER . 15.3 mm -115.3 129.81 70.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 177.964 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.42 ' HA ' ' ND2' ' A' ' 86' ' ' ASN . 18.8 m -53.09 -23.86 8.81 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 111.617 0.229 . . . . 0.0 111.617 -179.267 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.54 ' H ' HG22 ' A' ' 81' ' ' ILE . 3.1 mpt_? -98.01 -88.6 0.31 Allowed 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 111.608 0.225 . . . . 0.0 111.608 -179.82 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.462 HD23 ' HB3' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -109.41 108.8 19.46 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 121.455 0.645 . . . . 0.0 110.541 179.812 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.814 ' HA ' HD11 ' A' ' 78' ' ' LEU . 3.1 m 155.23 -42.93 0.01 OUTLIER 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 114.247 -1.342 . . . . 0.0 109.437 179.793 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.655 ' O ' ' N ' ' A' ' 88' ' ' HIS . 38.0 m-20 -77.21 -164.5 0.47 Allowed 'General case' 0 CA--C 1.512 -0.498 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 177.679 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.505 ' HB2' HD11 ' A' ' 104' ' ' ILE . 0.0 OUTLIER -49.51 83.12 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 178.961 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 1.071 ' O ' ' O ' ' A' ' 104' ' ' ILE . 36.3 t60 -102.74 -19.32 14.78 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 114.624 1.342 . . . . 0.0 114.624 -177.002 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.571 ' CD2' ' HA ' ' A' ' 103' ' ' ASP . 0.1 OUTLIER -176.55 159.44 1.9 Allowed 'General case' 0 C--N 1.317 -0.811 0 C-N-CA 119.332 -0.947 . . . . 0.0 111.869 178.338 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.73 ' HG2' HG23 ' A' ' 67' ' ' THR . 27.4 mt-30 -137.89 161.09 37.56 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 113.767 1.025 . . . . 0.0 113.767 -177.673 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.864 HD13 HD11 ' A' ' 48' ' ' LEU . 2.9 mt -124.97 133.11 70.31 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 CA-C-N 115.092 -0.958 . . . . 0.0 109.588 178.267 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.718 HD13 ' ND2' ' A' ' 121' ' ' ASN . 0.2 OUTLIER -110.47 141.92 42.93 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 121.01 0.434 . . . . 0.0 112.166 -179.168 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.853 HD13 ' CG2' ' A' ' 33' ' ' VAL . 19.0 tp -125.65 137.96 53.89 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.298 178.843 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 132.0 -145.09 16.88 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.416 179.777 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 57.01 74.18 0.42 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.913 0.387 . . . . 0.0 110.84 -179.865 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 2.9 t0 71.07 17.45 6.13 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.218 -179.887 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 94.37 -23.61 31.15 Favored Glycine 0 C--N 1.331 0.288 0 C-N-CA 120.69 -0.766 . . . . 0.0 112.804 179.711 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.466 ' C ' HD12 ' A' ' 99' ' ' LEU . 58.0 m-20 -58.96 -178.8 0.06 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.968 0.413 . . . . 0.0 111.02 -179.884 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.466 HD12 ' C ' ' A' ' 98' ' ' ASN . 10.5 mp -119.56 147.32 44.61 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.658 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.916 HD22 ' HB3' ' A' ' 121' ' ' ASN . 1.0 OUTLIER -133.68 148.72 51.5 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.627 -179.965 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.459 ' O ' ' N ' ' A' ' 122' ' ' GLN . 5.4 mp -116.22 129.69 56.42 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.681 -0.488 . . . . 0.0 109.681 179.638 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.467 ' HB3' ' HB2' ' A' ' 90' ' ' GLN . 24.5 t30 -110.31 112.39 24.31 Favored 'General case' 0 CA--C 1.508 -0.652 0 C-N-CA 119.706 -0.798 . . . . 0.0 110.031 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.768 ' OD2' HG11 ' A' ' 116' ' ' VAL . 33.5 m-20 -83.78 110.23 18.16 Favored 'General case' 0 N--CA 1.441 -0.924 0 C-N-CA 119.428 -0.909 . . . . 0.0 109.662 179.846 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 1.071 ' O ' ' O ' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -125.04 108.91 20.9 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.061 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 177.07 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 68.7 m -131.48 173.5 11.03 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.452 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 25.8 m -69.34 -63.86 0.98 Allowed 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 119.038 -1.065 . . . . 0.0 111.084 -179.358 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 6.1 m-80 -112.68 -33.23 6.18 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 114.234 1.198 . . . . 0.0 114.234 178.629 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -146.71 133.94 5.06 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 116.536 1.374 . . . . 0.0 116.536 -178.093 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.756 HG21 ' HB3' ' A' ' 103' ' ' ASP . 16.7 m -121.06 138.01 54.38 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 174.417 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 0.719 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.9 m-90 -120.89 149.14 43.07 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 113.65 0.981 . . . . 0.0 113.65 -178.357 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.474 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -122.92 111.99 17.3 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 115.004 -0.998 . . . . 0.0 108.66 177.536 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 44.21 44.6 6.61 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.998 -0.546 . . . . 0.0 112.191 -179.457 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 80.72 21.77 63.16 Favored Glycine 0 N--CA 1.445 -0.765 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.837 179.437 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -134.29 98.34 4.08 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.968 0.413 . . . . 0.0 110.7 179.608 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.719 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.3 OUTLIER -44.06 124.93 4.12 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.084 179.936 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.768 HG11 ' OD2' ' A' ' 103' ' ' ASP . 14.7 p -112.15 160.22 11.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.722 -179.074 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.511 ' N ' HG22 ' A' ' 116' ' ' VAL . 9.8 tt0 -71.01 142.05 50.95 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.995 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.419 ' HG3' ' HA ' ' A' ' 104' ' ' ILE . 81.6 tttt -65.17 162.55 16.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.293 179.432 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.463 ' ND2' ' O ' ' A' ' 119' ' ' ASN . 1.7 p-10 34.67 39.09 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.265 0.555 . . . . 0.0 111.305 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 8.6 p -111.09 109.5 19.61 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.9 -179.473 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.916 ' HB3' HD22 ' A' ' 100' ' ' LEU . 1.6 m120 -57.69 140.91 50.16 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.771 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 122' ' ' GLN . . . . . 0.651 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 3.6 mm100 -129.64 143.43 50.82 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-O 121.055 0.455 . . . . 0.0 111.844 -179.707 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.509 HD13 ' N ' ' A' ' 124' ' ' LEU . 2.7 tm? -72.57 122.83 22.02 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.512 178.942 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.68 HD11 HG12 ' A' ' 147' ' ' ILE . 0.9 OUTLIER -47.71 143.53 3.85 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-O 121.854 0.835 . . . . 0.0 111.941 -178.799 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.448 ' N ' ' HG ' ' A' ' 124' ' ' LEU . 0.3 OUTLIER -126.72 152.84 46.27 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 114.166 -1.379 . . . . 0.0 110.242 179.535 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -71.72 113.99 9.33 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.882 0.372 . . . . 0.0 110.058 179.615 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 65.9 30.3 76.82 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.917 -0.658 . . . . 0.0 112.577 -179.588 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.418 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 29.2 t70 -57.87 159.5 5.41 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.96 0.41 . . . . 0.0 111.142 -179.851 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.638 ' HB2' HG22 ' A' ' 144' ' ' VAL . 0.6 OUTLIER -146.55 135.79 22.72 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.377 -179.932 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.631 HG21 ' OD1' ' A' ' 103' ' ' ASP . 10.4 mm -113.31 128.86 69.91 Favored 'Isoleucine or valine' 0 C--O 1.232 0.132 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.3 178.815 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.49 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 53.8 m -103.17 144.65 31.04 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.477 -179.804 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.476 ' HB ' ' NE2' ' A' ' 88' ' ' HIS . 9.7 m -140.57 157.7 24.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.039 0.447 . . . . 0.0 112.18 -178.927 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 70.43 42.19 65.16 Favored Glycine 0 N--CA 1.446 -0.65 0 CA-C-N 115.725 -0.67 . . . . 0.0 112.404 179.436 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.462 HG12 ' N ' ' A' ' 135' ' ' GLY . 94.6 t -78.13 156.81 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 CA-C-O 121.394 0.616 . . . . 0.0 112.032 -179.256 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.462 ' N ' HG12 ' A' ' 134' ' ' VAL . . . 149.82 -42.68 0.78 Allowed Glycine 0 N--CA 1.443 -0.896 0 N-CA-C 110.627 -0.989 . . . . 0.0 110.627 -179.248 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.587 HG12 ' H ' ' A' ' 138' ' ' SER . 48.0 t -126.66 131.3 71.34 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 CA-C-N 115.271 -0.464 . . . . 0.0 109.89 178.791 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.07 -33.67 26.81 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.769 0.319 . . . . 0.0 111.257 -179.425 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 138' ' ' SER . . . . . 0.587 ' H ' HG12 ' A' ' 136' ' ' VAL . 2.0 p -94.16 6.24 49.22 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 112.251 0.464 . . . . 0.0 112.251 -179.535 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -128.1 29.91 5.31 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-O 121.137 0.494 . . . . 0.0 112.265 -179.467 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.49 ' CG2' ' CG2' ' A' ' 131' ' ' THR . 26.9 mt -104.71 141.34 20.38 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.268 179.22 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.497 ' HB3' ' NE2' ' A' ' 42' ' ' GLN . 5.8 mp -118.88 135.19 54.69 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.015 -0.993 . . . . 0.0 110.633 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.528 ' HB3' HG21 ' A' ' 40' ' ' THR . 46.9 t -118.76 152.4 36.25 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.691 0.758 . . . . 0.0 112.547 -179.178 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 1.011 HD21 HG12 ' A' ' 36' ' ' VAL . 1.5 tm? -134.72 137.55 43.6 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 114.589 -1.187 . . . . 0.0 109.019 179.427 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.756 ' N ' HD22 ' A' ' 143' ' ' LEU . 25.5 t -128.4 140.01 50.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 C-N-CA 120.75 -0.38 . . . . 0.0 111.858 -179.062 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.493 HG13 HG22 ' A' ' 36' ' ' VAL . 1.1 tt -109.08 139.84 30.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.725 179.461 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 16.8 t80 -118.1 103.85 10.28 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.777 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.68 HG12 HD11 ' A' ' 124' ' ' LEU . 2.5 mp -92.56 129.37 43.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.175 179.9 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 12.2 p30 -78.6 132.08 36.97 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.017 -179.738 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 50.2 m-20 -64.49 -21.38 66.65 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.095 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 3.1 mmpt? -57.49 -43.66 84.33 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-O 120.953 0.406 . . . . 0.0 110.564 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 151' ' ' PHE . . . . . 0.575 ' HE2' ' HB3' ' A' ' 50' ' ' ALA . 19.0 t80 -58.96 -44.62 91.5 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.67 179.731 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 1.7 mttt -65.0 -35.55 81.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.807 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 11.7 tt0 -63.14 -39.98 96.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.907 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 11.8 t -61.22 -44.96 96.43 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.94 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -58.82 -45.45 89.92 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.872 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -60.87 -40.74 94.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.832 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -66.94 -25.76 66.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.992 179.845 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -115.16 31.61 6.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.9 -179.874 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.97 115.41 20.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.872 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.444 ' O ' HG23 ' A' ' 160' ' ' VAL . 25.2 m -77.82 120.16 27.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.143 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -111.76 -164.84 0.94 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.805 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 31.8 mtm180 -49.3 132.7 20.04 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.194 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 20.5 mm -78.56 110.04 13.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.137 -179.804 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.196 -0.907 . . . . 0.0 111.07 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.356 0 N-CA-C 112.479 -0.248 . . . . 0.0 112.479 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -117.85 81.43 1.66 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.915 0.388 . . . . 0.0 110.884 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -171.7 151.73 2.95 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.843 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 21.9 mm -102.9 136.15 36.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.122 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 18.8 p -135.7 157.64 46.38 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.239 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -114.67 115.31 44.14 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.849 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_exo -51.01 108.92 0.26 Allowed 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.446 2.097 . . . . 0.0 112.372 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -115.34 -9.01 12.23 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.541 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 69.53 -66.93 0.24 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.74 0.305 . . . . 0.0 111.035 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -168.95 107.36 0.44 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.981 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 32.3 t -148.61 161.77 41.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.953 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 9.5 t -125.59 176.24 7.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.075 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 72.0 mt-30 -106.04 101.58 11.06 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.887 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -168.14 -53.81 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.089 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 10.8 p 55.78 29.99 14.91 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.264 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 5.7 tp60 -62.06 -46.91 87.05 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.832 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 2.9 ttm180 -67.08 -36.78 82.74 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.876 179.86 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -61.55 -35.76 78.69 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.762 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 36.6 mt -64.84 -42.22 95.1 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.864 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 31.6 mm -62.51 -42.0 94.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.977 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -57.84 -46.63 84.46 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.155 -179.874 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.72 -33.66 76.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.013 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -59.01 -47.81 83.85 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.126 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 20.5 p -57.16 -31.37 65.32 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.905 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 22.1 tm0? -88.41 -31.86 18.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.803 179.841 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -84.46 121.28 27.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.807 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -98.87 142.58 30.2 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.934 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 24.8 mm -82.0 139.51 17.82 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.337 0 CA-C-O 121.393 0.616 . . . . 0.0 111.707 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.432 ' HA2' ' CG2' ' A' ' 32' ' ' ILE . . . 111.89 17.88 8.19 Favored Glycine 0 C--N 1.316 -0.528 0 CA-C-N 114.936 -1.029 . . . . 0.0 112.733 179.907 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -89.36 -32.64 17.21 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.695 0.283 . . . . 0.0 111.484 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 23.5 m120 -109.39 -14.27 14.46 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-O 121.946 0.879 . . . . 0.0 109.018 178.767 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.592 ' O ' ' CG2' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -71.06 98.41 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.581 0 CA-C-N 113.935 -1.484 . . . . 0.0 110.922 -179.285 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.778 HG23 ' HB3' ' A' ' 50' ' ' ALA . 0.5 OUTLIER -34.39 -60.62 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 114.96 -1.018 . . . . 0.0 112.058 -179.432 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.601 ' N ' HG12 ' A' ' 33' ' ' VAL . 19.7 m -159.81 149.36 18.12 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.454 -179.434 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.0 114.62 24.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.763 179.506 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.84 ' CG2' HD11 ' A' ' 48' ' ' LEU . 26.7 t -90.29 124.64 43.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.686 179.712 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 1.009 HG23 HG12 ' A' ' 45' ' ' ILE . 31.2 mt -123.12 108.33 21.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.138 -0.483 . . . . 0.0 112.033 -179.35 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.474 ' SG ' ' HG ' ' A' ' 143' ' ' LEU . 0.8 OUTLIER -78.81 99.73 6.84 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 177.984 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.436 HG22 ' CG2' ' A' ' 144' ' ' VAL . 9.6 t -87.34 -28.65 22.1 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 -178.007 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.749 HG21 ' H ' ' A' ' 142' ' ' SER . 66.0 p -58.72 -18.27 29.96 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.678 0.275 . . . . 0.0 111.655 -179.552 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 90.88 71.46 1.22 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.554 -0.831 . . . . 0.0 112.555 179.735 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -142.99 -48.08 0.32 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.69 0.281 . . . . 0.0 111.151 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.41 ' O ' ' HB2' ' A' ' 38' ' ' CYS . 14.8 mt -134.53 138.05 29.13 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.04 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.485 ' HD2' ' CZ ' ' A' ' 76' ' ' TYR . 33.4 Cg_exo -58.46 146.69 89.43 Favored 'Trans proline' 0 N--CA 1.465 -0.186 0 C-N-CA 122.445 2.097 . . . . 0.0 111.5 179.53 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 1.009 HG12 HG23 ' A' ' 37' ' ' ILE . 45.6 mt -45.46 129.93 2.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 112.376 0.51 . . . . 0.0 112.376 -179.096 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 6.3 tpt180 -120.31 130.61 54.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.646 178.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 8.7 p30 -105.83 122.27 45.76 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.346 0.499 . . . . 0.0 112.346 -178.798 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.84 HD11 ' CG2' ' A' ' 36' ' ' VAL . 0.3 OUTLIER -97.52 133.63 41.84 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 178.384 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.519 ' HB3' HG12 ' A' ' 32' ' ' ILE . 0.0 OUTLIER -134.27 164.44 27.39 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 113.67 0.989 . . . . 0.0 113.67 -178.333 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.778 ' HB3' HG23 ' A' ' 33' ' ' VAL . . . -151.33 166.23 31.61 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 114.484 -1.234 . . . . 0.0 110.667 179.041 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.452 ' CB ' ' HG2' ' A' ' 54' ' ' GLN . 1.4 m-20 -106.04 136.34 45.89 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.08 0.467 . . . . 0.0 111.29 -179.679 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 18.5 mm -63.86 -38.93 83.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.483 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.7 t -56.09 -33.48 65.1 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.14 -179.244 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.452 ' HG2' ' CB ' ' A' ' 51' ' ' ASP . 9.8 mm100 -62.62 -36.79 83.91 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.025 -179.581 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 40.9 t -68.53 -48.67 71.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.997 179.81 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.0 tt -57.71 -33.37 68.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.876 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 24.2 ttmt -84.9 -59.02 2.47 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.777 179.864 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 52.52 89.68 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.274 179.838 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.8 mtmm -164.02 -76.84 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.75 179.809 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 7.0 mtt180 -85.29 -73.94 0.42 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.704 179.842 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -84.78 97.01 9.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.612 179.737 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.741 HD13 ' O ' ' A' ' 62' ' ' ILE . 0.0 OUTLIER -145.62 -42.73 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.386 -179.679 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.438 ' N ' HG23 ' A' ' 62' ' ' ILE . 0.0 OUTLIER -88.82 84.69 6.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.236 -179.659 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.419 ' O ' ' HB3' ' A' ' 93' ' ' LEU . 22.9 ttpt -104.09 131.66 51.13 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.19 179.335 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.565 HG13 ' O ' ' A' ' 91' ' ' ILE . 5.8 t -131.1 135.92 58.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.044 0.45 . . . . 0.0 111.916 -179.036 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' TRP . . . . . 0.685 ' CG ' HD22 ' A' ' 48' ' ' LEU . 14.6 m-90 -99.7 139.85 34.76 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.692 -0.686 . . . . 0.0 111.25 178.932 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.815 HG23 ' HG3' ' A' ' 90' ' ' GLN . 12.0 m -123.57 129.07 50.63 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.541 0.686 . . . . 0.0 112.162 179.445 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.6 ' CE2' HG11 ' A' ' 36' ' ' VAL . 13.8 m-85 -100.37 118.1 35.92 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.069 -0.969 . . . . 0.0 109.104 178.077 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.614 ' HA2' ' O ' ' A' ' 85' ' ' SER . . . 159.21 -159.6 30.55 Favored Glycine 0 N--CA 1.444 -0.793 0 C-N-CA 119.287 -1.435 . . . . 0.0 112.708 179.459 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.42 ' N ' ' HA ' ' A' ' 86' ' ' ASN . 0.0 OUTLIER -76.13 92.27 3.21 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-O 122.612 1.196 . . . . 0.0 109.05 -179.402 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.462 ' C ' ' H ' ' A' ' 73' ' ' ALA . 6.0 m-80 -149.19 155.38 39.86 Favored Pre-proline 0 C--N 1.309 -1.175 0 CA-C-N 112.681 -2.054 . . . . 0.0 107.989 178.646 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.564 ' O ' ' CB ' ' A' ' 73' ' ' ALA . 25.2 Cg_exo -55.76 -7.87 1.79 Allowed 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 121.271 1.314 . . . . 0.0 111.32 177.979 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.708 ' HB2' ' HB2' ' A' ' 77' ' ' HIS . . . 132.99 52.7 0.0 OUTLIER 'General case' 0 CA--C 1.489 -1.379 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.223 178.765 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.564 ' HB3' ' HB ' ' A' ' 67' ' ' THR . 0.1 OUTLIER -52.81 -69.52 0.11 Allowed 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 105.565 -2.013 . . . . 0.0 105.565 179.499 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.612 ' HB2' ' N ' ' A' ' 67' ' ' THR . 51.3 t0 -95.32 -47.81 6.15 Favored 'General case' 0 N--CA 1.433 -1.302 0 N-CA-C 105.776 -1.935 . . . . 0.0 105.776 169.65 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.504 ' C ' ' HA ' ' A' ' 73' ' ' ALA . 9.4 t80 -144.52 142.68 30.4 Favored 'General case' 0 C--N 1.346 0.424 0 CA-C-N 112.51 -2.132 . . . . 0.0 111.354 179.66 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.708 ' HB2' ' HB2' ' A' ' 73' ' ' ALA . 2.3 t60 -97.16 106.91 19.32 Favored 'General case' 0 CA--C 1.531 0.238 0 O-C-N 121.921 -0.487 . . . . 0.0 110.157 176.971 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.576 HD21 ' C ' ' A' ' 69' ' ' GLY . 0.0 OUTLIER -120.67 171.83 8.31 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 120.824 0.345 . . . . 0.0 111.692 179.749 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -55.03 -167.86 0.04 OUTLIER Glycine 0 C--N 1.333 0.405 0 CA-C-N 116.022 -0.535 . . . . 0.0 113.126 -179.499 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.459 ' C ' HD12 ' A' ' 81' ' ' ILE . 5.4 p30 -112.06 97.77 6.89 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.927 0.394 . . . . 0.0 111.768 -179.752 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.655 ' HB ' ' HB2' ' A' ' 85' ' ' SER . 3.2 mp -114.86 112.72 41.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.104 178.542 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 68.5 m -56.69 -24.16 47.05 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 -179.002 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.407 ' H ' HG22 ' A' ' 81' ' ' ILE . 3.7 mtt180 -93.47 -102.15 0.13 Allowed 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 -178.487 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.434 ' O ' ' CB ' ' A' ' 85' ' ' SER . 0.0 OUTLIER -109.02 110.83 22.21 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-O 121.52 0.676 . . . . 0.0 110.691 -179.262 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.655 ' HB2' ' HB ' ' A' ' 81' ' ' ILE . 0.6 OUTLIER 158.99 -48.39 0.0 OUTLIER 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 114.247 -1.342 . . . . 0.0 109.478 179.796 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.792 ' O ' ' N ' ' A' ' 88' ' ' HIS . 94.1 m-20 -65.34 -153.45 0.01 OUTLIER 'General case' 0 CA--C 1.521 -0.151 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 177.779 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.42 ' HB2' HD11 ' A' ' 104' ' ' ILE . 0.0 OUTLIER -47.55 76.71 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 179.105 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 1.071 ' O ' ' O ' ' A' ' 104' ' ' ILE . 36.3 t60 -101.58 -15.89 16.93 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 114.622 1.341 . . . . 0.0 114.622 -176.346 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.559 ' HA ' ' H ' ' A' ' 104' ' ' ILE . 0.1 OUTLIER -178.1 160.37 1.39 Allowed 'General case' 0 C--N 1.317 -0.848 0 C-N-CA 119.333 -0.947 . . . . 0.0 112.125 178.334 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.815 ' HG3' HG23 ' A' ' 67' ' ' THR . 14.7 mt-30 -137.45 160.82 38.03 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 113.694 0.998 . . . . 0.0 113.694 -178.031 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.732 HG12 HD11 ' A' ' 145' ' ' ILE . 2.5 mt -122.27 132.14 71.7 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 CA-C-N 115.109 -0.95 . . . . 0.0 108.998 177.981 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.773 HD13 ' ND2' ' A' ' 121' ' ' ASN . 1.9 mt -110.06 135.31 51.07 Favored 'General case' 0 N--CA 1.464 0.233 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 -178.732 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.779 HD22 ' N ' ' A' ' 94' ' ' GLY . 1.2 tm? -126.42 136.64 52.92 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.245 178.752 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.779 ' N ' HD22 ' A' ' 93' ' ' LEU . . . 125.7 -161.75 20.07 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.601 179.819 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 57.27 76.61 0.31 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.808 0.337 . . . . 0.0 110.506 -179.748 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 67.87 163.6 0.21 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.617 -179.545 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -59.48 86.41 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.488 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -179.59 159.42 0.88 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.822 0.344 . . . . 0.0 111.061 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.669 HD23 HD23 ' A' ' 93' ' ' LEU . 0.6 OUTLIER -109.98 155.04 22.31 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.653 179.769 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.764 HD22 ' HB3' ' A' ' 121' ' ' ASN . 4.4 mt -133.66 148.62 51.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.81 -179.813 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.44 ' O ' ' N ' ' A' ' 122' ' ' GLN . 1.6 mt -113.38 130.87 56.18 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 179.529 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.684 ' CG ' HD11 ' A' ' 92' ' ' LEU . 7.4 t30 -107.18 112.56 25.5 Favored 'General case' 0 CA--C 1.51 -0.59 0 C-N-CA 119.976 -0.69 . . . . 0.0 109.776 179.863 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.758 ' HB3' HG21 ' A' ' 109' ' ' THR . 29.1 m-20 -87.4 108.94 19.23 Favored 'General case' 0 N--CA 1.442 -0.872 0 C-N-CA 119.076 -1.05 . . . . 0.0 109.789 179.691 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 1.071 ' O ' ' O ' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -126.48 109.32 20.83 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.164 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 176.854 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 70.5 m -129.38 174.66 9.42 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.868 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 28.0 m -69.76 -63.29 1.1 Allowed 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 118.98 -1.088 . . . . 0.0 110.862 -179.557 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -112.52 -33.46 6.15 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 114.253 1.205 . . . . 0.0 114.253 178.593 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -147.1 136.71 6.26 Favored Glycine 0 C--N 1.34 0.795 0 N-CA-C 116.422 1.329 . . . . 0.0 116.422 -178.339 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.758 HG21 ' HB3' ' A' ' 103' ' ' ASP . 14.8 m -121.06 137.96 54.41 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 174.738 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 0.74 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 3.0 m-90 -122.36 149.25 44.04 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 113.436 0.902 . . . . 0.0 113.436 -178.517 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.459 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -122.46 112.07 17.61 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 115.182 -0.917 . . . . 0.0 108.62 177.24 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 3.7 m120 46.14 43.93 11.46 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.104 -0.498 . . . . 0.0 112.167 -179.573 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 79.91 20.92 66.89 Favored Glycine 0 N--CA 1.445 -0.76 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.93 179.153 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 13.6 mt-30 -133.82 97.79 4.0 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.039 0.447 . . . . 0.0 110.624 179.674 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.74 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.3 OUTLIER -44.92 134.17 5.89 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.843 179.856 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 15.0 m -121.25 177.25 3.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.141 0.496 . . . . 0.0 111.969 -178.876 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.433 ' HB3' ' HB3' ' A' ' 120' ' ' SER . 0.0 OUTLIER -82.83 141.13 32.51 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.676 179.799 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.401 ' O ' ' C ' ' A' ' 119' ' ' ASN . 0.0 OUTLIER -66.25 163.75 17.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.731 0.3 . . . . 0.0 110.537 179.711 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.401 ' C ' ' O ' ' A' ' 118' ' ' LYS . 0.6 OUTLIER 34.88 37.52 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.995 -179.639 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.433 ' HB3' ' HB3' ' A' ' 117' ' ' GLU . 10.1 p -111.3 105.16 13.73 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.858 -179.281 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.773 ' ND2' HD13 ' A' ' 92' ' ' LEU . 1.3 m120 -50.22 142.46 9.87 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.803 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 122' ' ' GLN . . . . . 0.575 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 30.1 mm-40 -128.75 144.15 51.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.207 0.527 . . . . 0.0 112.057 -179.662 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 16.6 tp -74.36 120.62 20.17 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.718 178.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.621 ' HG ' HD12 ' A' ' 99' ' ' LEU . 0.0 OUTLIER -51.73 144.65 10.67 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 122.193 0.997 . . . . 0.0 112.202 -178.857 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.442 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.6 OUTLIER -127.15 153.15 46.41 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 113.871 -1.513 . . . . 0.0 110.022 179.499 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 34.9 tp60 -70.62 113.5 7.79 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 179.647 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 68.35 28.6 73.19 Favored Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.394 -179.359 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.442 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 9.7 t70 -58.85 158.86 7.61 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.984 0.421 . . . . 0.0 111.308 -179.719 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.425 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 0.4 OUTLIER -147.12 135.71 21.96 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.565 179.871 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.669 HG21 ' OD1' ' A' ' 103' ' ' ASP . 2.0 mp -108.86 129.12 64.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.299 -0.41 . . . . 0.0 109.994 178.559 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.524 HG23 ' CG2' ' A' ' 140' ' ' ILE . 69.5 m -102.31 142.37 33.64 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.0 0.428 . . . . 0.0 110.519 -179.53 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.478 HG11 ' NE2' ' A' ' 88' ' ' HIS . 5.2 m -141.24 158.37 22.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.132 -0.485 . . . . 0.0 112.21 -178.592 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 133' ' ' GLY . . . . . 0.403 ' HA3' ' CD2' ' A' ' 84' ' ' LEU . . . 69.87 44.43 62.1 Favored Glycine 0 N--CA 1.446 -0.645 0 CA-C-N 115.911 -0.586 . . . . 0.0 112.086 179.545 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.489 ' HA ' HG12 ' A' ' 140' ' ' ILE . 81.8 t -80.18 153.1 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 CA-C-O 121.526 0.679 . . . . 0.0 112.261 -178.964 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 148.14 -44.52 0.77 Allowed Glycine 0 N--CA 1.44 -1.075 0 N-CA-C 110.374 -1.09 . . . . 0.0 110.374 -178.925 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.593 HG12 ' H ' ' A' ' 138' ' ' SER . 41.3 t -126.8 127.83 70.35 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.764 0 CA-C-N 115.103 -0.549 . . . . 0.0 109.641 178.499 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.536 ' HA ' HD12 ' A' ' 140' ' ' ILE . 3.1 tt0 -51.07 -29.61 13.47 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.789 0.328 . . . . 0.0 111.308 -179.202 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 138' ' ' SER . . . . . 0.593 ' H ' HG12 ' A' ' 136' ' ' VAL . 0.5 OUTLIER -94.31 6.48 48.56 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -179.56 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -128.77 25.61 5.64 Favored 'General case' 0 CA--C 1.519 -0.223 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 -179.402 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.536 HD12 ' HA ' ' A' ' 137' ' ' GLU . 13.4 mt -103.13 140.67 20.74 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.003 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.447 179.233 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.46 HD22 ' C ' ' A' ' 140' ' ' ILE . 3.8 mm? -124.24 134.53 53.22 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.017 -0.992 . . . . 0.0 109.798 179.196 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.749 ' H ' HG21 ' A' ' 40' ' ' THR . 0.9 OUTLIER -119.33 150.95 39.29 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.408 0.623 . . . . 0.0 112.504 -178.78 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.712 HD12 ' C ' ' A' ' 142' ' ' SER . 5.7 mp -122.77 132.99 54.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.325 179.342 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.436 ' CG2' HG22 ' A' ' 39' ' ' THR . 4.7 t -114.15 140.28 35.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 120.872 0.368 . . . . 0.0 111.426 -179.432 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.749 ' CG1' HG22 ' A' ' 36' ' ' VAL . 0.2 OUTLIER -120.66 127.68 75.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.821 179.893 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 18.6 t80 -105.08 103.78 13.39 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.54 179.786 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 2.7 mp -87.91 128.45 40.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.053 -179.776 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 25.9 p-10 -78.3 120.7 23.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.003 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -71.35 -24.67 62.14 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.957 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 4.2 mttt -57.38 -40.53 78.35 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.947 0.403 . . . . 0.0 110.595 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 19.9 t80 -59.99 -40.17 88.27 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.613 179.746 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.17 -37.91 87.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.885 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -61.02 -38.4 85.98 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.842 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 9.8 t -65.88 -43.82 87.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.827 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -58.0 -44.17 87.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.9 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -60.75 -34.08 73.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.847 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.81 -22.71 62.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.141 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -109.64 27.81 9.19 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.057 -179.718 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 1.1 mtmm -125.63 121.4 33.43 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.909 179.863 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 31.5 t -90.23 124.05 42.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.079 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -88.55 -29.94 19.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.796 179.788 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 11.3 ttt180 -172.36 155.65 3.57 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.738 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 23.1 pt -76.89 138.01 21.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.161 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.023 0 CA-C-O 118.198 -0.906 . . . . 0.0 110.843 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.375 0 N-CA-C 112.529 -0.228 . . . . 0.0 112.529 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -84.46 -45.93 12.17 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.754 0.311 . . . . 0.0 110.847 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 6.2 p-10 -102.96 169.19 8.73 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.853 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.588 HG23 ' O ' ' A' ' 4' ' ' ILE . 8.4 tp -78.65 110.73 14.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.101 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.9 t -147.2 166.61 26.48 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.926 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 59.23 64.89 2.91 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.823 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_exo -51.86 177.6 0.05 OUTLIER 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.607 2.205 . . . . 0.0 112.389 -179.92 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 25.8 p -119.42 -176.37 3.13 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.087 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 69.0 tp60 -115.18 151.78 33.81 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.936 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -62.75 109.19 1.35 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.855 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 60.6 p -75.84 -168.68 0.93 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.983 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -57.63 138.69 55.06 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.189 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -135.87 152.22 50.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.944 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -162.12 -168.3 1.86 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.968 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 56.6 p -73.84 64.26 0.95 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.073 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.547 ' HA ' HD12 ' A' ' 19' ' ' LEU . 7.2 pt20 -62.3 -44.42 96.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.918 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.68 -36.57 81.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.918 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 57.5 t80 -57.45 -35.83 70.62 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.912 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.547 HD12 ' HA ' ' A' ' 16' ' ' GLN . 10.7 mt -61.26 -40.43 94.05 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.79 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 34.7 mm -70.45 -36.74 67.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.044 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -57.66 -43.0 84.66 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.075 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 2.6 mtpt -62.03 -41.97 98.67 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.917 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -63.5 -47.76 80.4 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.021 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -66.02 -21.52 66.4 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.133 179.826 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 76.2 161.13 0.23 Allowed 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.839 -179.875 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -62.31 131.33 48.98 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.965 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 11.7 pm0 -101.36 135.22 43.21 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.85 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 24.6 mm -83.14 139.61 17.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.457 0.646 . . . . 0.0 111.581 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -102.6 63.36 0.45 Allowed Glycine 0 C--N 1.317 -0.477 0 CA-C-N 114.952 -1.022 . . . . 0.0 112.617 -179.865 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.554 ' O ' HD12 ' A' ' 52' ' ' ILE . 0.8 OUTLIER -88.45 -23.82 23.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.716 0.293 . . . . 0.0 111.119 179.928 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.432 ' HA ' HD12 ' A' ' 52' ' ' ILE . 34.8 m-20 -109.17 -14.08 14.56 Favored 'General case' 0 CA--C 1.514 -0.409 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 178.405 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.558 HG12 ' HB3' ' A' ' 49' ' ' SER . 0.1 OUTLIER -71.15 108.44 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.66 0 CA-C-N 113.888 -1.505 . . . . 0.0 110.933 -179.499 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.89 HG12 ' CD2' ' A' ' 99' ' ' LEU . 2.3 t -48.21 -66.3 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.769 0 CA-C-N 115.19 -0.914 . . . . 0.0 111.364 -179.498 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 31.9 p -162.98 164.59 25.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.676 179.856 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.665 HH11 HD11 ' A' ' 37' ' ' ILE . 8.1 ttm180 -122.98 123.76 41.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.189 -179.808 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.867 ' CG2' HD11 ' A' ' 48' ' ' LEU . 3.3 t -91.58 122.13 42.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.754 179.666 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.849 HG23 HG12 ' A' ' 45' ' ' ILE . 26.7 mt -121.61 107.81 20.9 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 CA-C-N 116.263 -0.426 . . . . 0.0 112.006 -179.547 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 88.8 m -81.86 102.2 10.7 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 178.076 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.0 p -89.79 2.96 54.26 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 -178.076 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.736 HG21 ' CB ' ' A' ' 142' ' ' SER . 77.2 p -94.59 -6.78 42.75 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.038 0.384 . . . . 0.0 112.038 -179.769 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 85.91 91.58 0.88 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.606 179.88 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.519 ' HG3' HD12 ' A' ' 43' ' ' ILE . 17.4 pt20 -172.41 -45.86 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.108 0.48 . . . . 0.0 110.516 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.59 HG23 ' HD2' ' A' ' 44' ' ' PRO . 5.1 mt -131.87 140.43 38.17 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.718 179.899 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.59 ' HD2' HG23 ' A' ' 43' ' ' ILE . 74.2 Cg_endo -78.46 147.01 22.28 Favored 'Trans proline' 0 N--CA 1.462 -0.377 0 C-N-CA 122.324 2.016 . . . . 0.0 112.141 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.849 HG12 HG23 ' A' ' 37' ' ' ILE . 27.3 mt -43.12 122.21 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 121.222 0.534 . . . . 0.0 111.827 -179.493 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.438 ' HG2' ' O ' ' A' ' 75' ' ' ASP . 0.0 OUTLIER -121.49 130.21 53.41 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.099 179.463 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.461 ' HB2' HD11 ' A' ' 32' ' ' ILE . 3.8 p30 -93.14 120.11 33.07 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.06 0.457 . . . . 0.0 111.413 -179.302 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.867 HD11 ' CG2' ' A' ' 36' ' ' VAL . 0.8 OUTLIER -94.36 121.73 36.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.642 179.249 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.686 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -130.98 154.56 48.03 Favored 'General case' 0 CA--C 1.517 -0.323 0 N-CA-C 114.295 1.22 . . . . 0.0 114.295 -179.205 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.583 ' N ' HG23 ' A' ' 33' ' ' VAL . . . -133.22 166.07 23.32 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 113.587 -1.642 . . . . 0.0 110.832 178.753 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.469 ' CB ' ' HG3' ' A' ' 54' ' ' GLN . 60.6 m-20 -91.08 97.26 11.05 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.065 0.46 . . . . 0.0 111.014 -179.815 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.554 HD12 ' O ' ' A' ' 30' ' ' GLU . 4.4 mt -63.81 -31.15 52.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.704 -179.701 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 27.8 t -56.44 -35.01 67.38 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.218 -179.027 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.469 ' HG3' ' CB ' ' A' ' 51' ' ' ASP . 6.7 mt-30 -68.12 -36.96 80.56 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.806 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.709 HG22 HD11 ' A' ' 62' ' ' ILE . 6.0 t -67.37 -44.88 86.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.082 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -69.16 -28.9 66.83 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.002 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.89 -50.96 8.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.979 -179.919 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -104.61 141.83 35.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.003 -179.861 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 3.0 ttpm? -58.94 -30.92 68.23 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.988 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 41.6 ttt-85 -159.38 107.63 1.8 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.928 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 21.1 t -152.7 51.35 0.76 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.894 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.709 HD11 HG22 ' A' ' 55' ' ' VAL . 7.1 mm -106.03 134.27 48.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.011 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.6 68.29 0.07 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.012 0.435 . . . . 0.0 111.058 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 7.8 ttpt -138.01 132.09 31.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.667 179.752 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.665 HG13 ' O ' ' A' ' 91' ' ' ILE . 21.5 t -135.35 138.82 47.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.14 0.495 . . . . 0.0 111.707 -179.407 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' TRP . . . . . 0.656 ' HB2' ' HB ' ' A' ' 91' ' ' ILE . 14.7 m-90 -99.91 139.95 34.83 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.6 179.297 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.641 HG23 ' HG2' ' A' ' 90' ' ' GLN . 30.5 m -131.39 131.85 43.95 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.53 0.681 . . . . 0.0 112.162 179.744 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.609 ' HE1' HD12 ' A' ' 91' ' ' ILE . 7.3 m-85 -103.24 119.06 38.16 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 114.897 -1.047 . . . . 0.0 109.086 177.873 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.713 ' HA2' HD21 ' A' ' 78' ' ' LEU . . . 158.7 -155.96 26.99 Favored Glycine 0 CA--C 1.503 -0.706 0 C-N-CA 118.832 -1.652 . . . . 0.0 113.098 179.389 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.42 ' HG3' ' O ' ' A' ' 70' ' ' ARG . 3.1 ptm180 -76.37 91.77 3.3 Favored 'General case' 0 N--CA 1.441 -0.888 0 CA-C-O 122.587 1.184 . . . . 0.0 108.747 -179.614 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.442 ' C ' ' H ' ' A' ' 73' ' ' ALA . 13.1 m120 -149.98 154.53 37.09 Favored Pre-proline 0 C--N 1.308 -1.218 0 CA-C-N 112.857 -1.974 . . . . 0.0 108.337 178.758 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.548 ' O ' ' CB ' ' A' ' 73' ' ' ALA . 21.8 Cg_exo -57.18 -8.25 3.35 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 121.115 1.21 . . . . 0.0 110.934 177.679 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.729 ' HB2' ' HB2' ' A' ' 77' ' ' HIS . . . 135.04 53.45 0.0 OUTLIER 'General case' 0 CA--C 1.489 -1.402 0 CA-C-N 114.901 -1.045 . . . . 0.0 109.08 179.041 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.525 ' HB3' ' HB ' ' A' ' 67' ' ' THR . 0.1 OUTLIER -52.28 -69.6 0.11 Allowed 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 105.599 -2.0 . . . . 0.0 105.599 179.708 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.474 ' N ' ' O ' ' A' ' 67' ' ' THR . 4.9 t70 -95.45 -47.87 6.09 Favored 'General case' 0 N--CA 1.436 -1.174 0 N-CA-C 105.426 -2.064 . . . . 0.0 105.426 169.085 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.519 ' C ' ' HA ' ' A' ' 73' ' ' ALA . 73.3 t80 -143.26 142.1 31.26 Favored 'General case' 0 C--N 1.347 0.493 0 CA-C-N 112.512 -2.131 . . . . 0.0 111.334 179.825 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.729 ' HB2' ' HB2' ' A' ' 73' ' ' ALA . 1.9 t60 -91.78 110.23 21.57 Favored 'General case' 0 C--N 1.33 -0.247 0 O-C-N 122.027 -0.421 . . . . 0.0 110.013 177.327 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.845 HD11 ' O ' ' A' ' 85' ' ' SER . 1.1 pp -129.57 174.6 9.51 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.969 0.414 . . . . 0.0 111.494 -179.642 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.424 ' O ' HD12 ' A' ' 78' ' ' LEU . . . -58.6 175.33 2.63 Favored Glycine 0 C--N 1.333 0.41 0 C-N-CA 120.939 -0.648 . . . . 0.0 112.311 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 15.5 p-10 -112.04 99.28 7.95 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.902 0.382 . . . . 0.0 111.847 -179.628 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.719 ' HB ' ' HB2' ' A' ' 85' ' ' SER . 16.5 mm -113.91 118.39 58.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.036 178.45 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -53.46 -24.03 11.76 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 111.807 0.299 . . . . 0.0 111.807 -179.056 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.545 ' C ' HD13 ' A' ' 84' ' ' LEU . 6.2 mpt_? -86.72 -106.85 0.06 Allowed 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 121.222 -0.191 . . . . 0.0 111.378 -179.661 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.812 HD22 ' H ' ' A' ' 84' ' ' LEU . 0.0 OUTLIER -109.36 110.22 21.31 Favored 'General case' 0 CA--C 1.512 -0.482 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 179.036 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.845 ' O ' HD11 ' A' ' 78' ' ' LEU . 0.4 OUTLIER 162.25 -40.66 0.0 OUTLIER 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 114.709 -1.132 . . . . 0.0 109.427 -179.525 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.802 ' O ' ' N ' ' A' ' 88' ' ' HIS . 95.1 m-20 -64.25 -153.81 0.01 OUTLIER 'General case' 0 CA--C 1.52 -0.191 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 177.597 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.858 ' HB2' HD11 ' A' ' 104' ' ' ILE . 0.0 OUTLIER -54.05 71.28 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 178.313 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.964 ' O ' ' O ' ' A' ' 104' ' ' ILE . 36.2 t60 -80.82 -17.6 50.28 Favored 'General case' 0 CA--C 1.514 -0.412 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 -176.789 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.605 ' HA ' ' H ' ' A' ' 104' ' ' ILE . 0.0 OUTLIER -174.57 156.3 2.38 Favored 'General case' 0 C--N 1.31 -1.111 0 C-N-CA 119.23 -0.988 . . . . 0.0 112.981 178.024 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.641 ' HG2' HG23 ' A' ' 67' ' ' THR . 36.6 mt-30 -138.1 161.02 37.86 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.502 -1.226 . . . . 0.0 113.958 -177.829 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.759 HD13 ' CD1' ' A' ' 48' ' ' LEU . 6.2 mt -127.84 126.6 67.01 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-N 115.006 -0.997 . . . . 0.0 109.13 178.037 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.85 HD12 ' N ' ' A' ' 93' ' ' LEU . 0.3 OUTLIER -107.4 142.41 37.28 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.961 0.41 . . . . 0.0 111.974 -178.781 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.85 ' N ' HD12 ' A' ' 92' ' ' LEU . 0.5 OUTLIER -125.78 125.41 42.9 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.693 179.356 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 137.61 89.06 0.22 Allowed Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.59 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -176.98 84.93 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.868 0.366 . . . . 0.0 110.904 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 50.5 m-20 58.66 44.46 17.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.899 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 59.97 59.51 10.33 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.418 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.534 ' O ' HD13 ' A' ' 93' ' ' LEU . 2.1 m-80 -152.09 178.54 9.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.802 0.334 . . . . 0.0 110.864 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.948 HD13 HD22 ' A' ' 124' ' ' LEU . 2.3 mp -112.09 151.65 29.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.761 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.613 ' HA ' ' O ' ' A' ' 122' ' ' GLN . 0.8 OUTLIER -132.47 147.96 52.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.107 179.987 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.512 HD21 HD12 ' A' ' 124' ' ' LEU . 1.0 OUTLIER -116.04 126.28 53.57 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 120.623 -0.431 . . . . 0.0 110.363 -179.81 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.497 ' O ' ' O ' ' A' ' 90' ' ' GLN . 33.5 t30 -111.57 111.47 22.49 Favored 'General case' 0 CA--C 1.51 -0.58 0 C-N-CA 119.988 -0.685 . . . . 0.0 109.448 179.539 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.692 ' HB3' HG21 ' A' ' 109' ' ' THR . 74.4 m-20 -83.37 111.5 19.06 Favored 'General case' 0 N--CA 1.442 -0.857 0 C-N-CA 119.623 -0.831 . . . . 0.0 109.603 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.964 ' O ' ' O ' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -123.35 107.95 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.969 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 177.533 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.417 ' HG ' ' CE1' ' A' ' 88' ' ' HIS . 63.7 m -132.17 171.12 14.06 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 115.05 -0.977 . . . . 0.0 109.331 179.778 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 25.1 m -69.52 -63.36 1.08 Allowed 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 119.143 -1.023 . . . . 0.0 111.541 -179.157 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -112.5 -32.75 6.37 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 114.63 1.345 . . . . 0.0 114.63 179.015 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -146.04 128.16 2.99 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 116.988 1.555 . . . . 0.0 116.988 -177.814 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.692 HG21 ' HB3' ' A' ' 103' ' ' ASP . 3.4 m -121.1 138.29 54.26 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 174.483 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 0.685 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.3 m-90 -119.35 149.24 42.15 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 -178.535 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.459 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -120.9 112.08 18.33 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 115.177 -0.92 . . . . 0.0 108.691 177.483 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 39.7 m-20 45.24 43.29 7.93 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.074 -0.512 . . . . 0.0 112.24 -179.522 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 80.35 23.37 60.94 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.947 179.13 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 42.3 mt-30 -135.61 99.07 4.1 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.017 0.437 . . . . 0.0 110.861 179.647 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.685 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.0 OUTLIER -43.98 123.64 3.41 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.08 179.87 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.495 HG21 ' OD2' ' A' ' 103' ' ' ASP . 5.4 m -114.92 -179.74 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.7 -179.218 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -87.29 140.13 29.85 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.824 -0.626 . . . . 0.0 111.011 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.432 ' HG3' ' HA ' ' A' ' 104' ' ' ILE . 54.2 tttm -63.63 162.69 12.58 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.25 179.518 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.427 ' N ' ' HG2' ' A' ' 118' ' ' LYS . 4.9 p-10 34.85 38.87 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.228 0.537 . . . . 0.0 111.372 -179.865 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 6.9 p -111.04 108.71 18.52 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.973 -179.533 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.461 ' CG ' HD23 ' A' ' 92' ' ' LEU . 81.1 m-20 -54.91 144.66 22.21 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.633 179.882 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 122' ' ' GLN . . . . . 0.613 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 65.8 mm-40 -129.88 149.39 51.63 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.04 0.448 . . . . 0.0 112.084 -179.346 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.636 HD23 ' O ' ' A' ' 124' ' ' LEU . 9.8 tt -77.27 120.5 22.4 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.357 178.849 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.948 HD22 HD13 ' A' ' 99' ' ' LEU . 8.2 tp -46.39 141.98 3.26 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 122.06 0.933 . . . . 0.0 112.022 -178.549 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.43 ' O ' HD11 ' A' ' 147' ' ' ILE . 0.0 OUTLIER -127.29 152.85 46.89 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 113.811 -1.541 . . . . 0.0 110.215 179.567 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 4.7 tp-100 -71.79 113.67 9.07 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 179.301 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 64.87 31.58 81.39 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.323 -179.351 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.402 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 8.4 t70 -54.9 160.13 2.07 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.978 0.418 . . . . 0.0 111.207 -179.758 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.529 ' HG3' HG22 ' A' ' 144' ' ' VAL . 13.8 tt0 -146.48 135.35 22.39 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.642 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.437 HG21 ' OD1' ' A' ' 103' ' ' ASP . 1.1 mp -112.94 128.47 69.66 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.121 0 CA-C-N 116.363 -0.38 . . . . 0.0 109.986 178.987 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.611 HG23 ' CG2' ' A' ' 140' ' ' ILE . 16.0 m -103.16 144.77 30.88 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.478 -179.748 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.474 ' HB ' ' NE2' ' A' ' 88' ' ' HIS . 5.4 m -141.37 158.16 22.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 112.581 0.586 . . . . 0.0 112.581 -178.715 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 67.04 42.81 92.06 Favored Glycine 0 N--CA 1.449 -0.494 0 CA-C-N 115.595 -0.729 . . . . 0.0 112.312 179.253 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.546 ' HA ' HG12 ' A' ' 140' ' ' ILE . 89.8 t -76.79 153.3 5.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-O 121.479 0.656 . . . . 0.0 112.268 -179.176 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 148.65 -42.03 0.85 Allowed Glycine 0 N--CA 1.441 -0.99 0 CA-C-N 114.888 -1.051 . . . . 0.0 110.655 -178.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.548 HG12 ' H ' ' A' ' 138' ' ' SER . 47.6 t -126.62 131.4 71.28 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 CA-C-N 115.172 -0.514 . . . . 0.0 109.743 178.698 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -51.3 -34.61 34.01 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.737 0.303 . . . . 0.0 111.445 -179.229 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 138' ' ' SER . . . . . 0.548 ' H ' HG12 ' A' ' 136' ' ' VAL . 0.7 OUTLIER -94.17 6.32 48.96 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 112.343 0.497 . . . . 0.0 112.343 -179.288 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 139' ' ' ASP . . . . . 0.405 ' CB ' ' HB ' ' A' ' 136' ' ' VAL . 10.1 t70 -125.65 26.72 6.64 Favored 'General case' 0 CA--C 1.518 -0.252 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 -179.367 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.611 ' CG2' HG23 ' A' ' 131' ' ' THR . 14.9 mt -105.5 140.81 22.4 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.967 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.267 179.069 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.439 HD23 ' OE1' ' A' ' 42' ' ' GLN . 1.0 OUTLIER -117.73 130.01 56.06 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.901 179.327 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.736 ' CB ' HG21 ' A' ' 40' ' ' THR . 0.8 OUTLIER -116.37 139.06 50.81 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.417 0.627 . . . . 0.0 112.397 -178.845 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.545 HD12 ' N ' ' A' ' 143' ' ' LEU . 4.8 mp -118.25 138.98 51.98 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.14 -0.937 . . . . 0.0 109.331 179.083 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.529 HG22 ' HG3' ' A' ' 129' ' ' GLU . 21.7 t -123.41 140.5 46.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 120.809 0.338 . . . . 0.0 111.816 -179.034 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.604 HG13 HG13 ' A' ' 36' ' ' VAL . 0.1 OUTLIER -113.63 126.7 71.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.554 179.657 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 80.0 t80 -111.27 123.78 50.89 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.948 -179.846 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.809 HG12 HD21 ' A' ' 124' ' ' LEU . 2.8 mp -106.27 132.24 53.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.111 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 148' ' ' ASN . . . . . 0.456 ' ND2' HG22 ' A' ' 32' ' ' ILE . 8.9 p30 -81.65 141.7 33.41 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.104 -179.795 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -73.93 -19.45 60.68 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.375 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 12.7 mptt -58.19 -44.83 88.28 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.958 0.408 . . . . 0.0 110.815 -179.835 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 151' ' ' PHE . . . . . 0.459 ' CE2' HD11 ' A' ' 52' ' ' ILE . 14.0 t80 -59.58 -43.61 93.58 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.886 -179.933 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 14.8 tttt -64.57 -34.24 77.79 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.953 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -59.1 -46.05 89.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.917 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 12.1 t -61.16 -45.42 94.7 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.78 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -66.39 -35.78 81.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.835 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 79.8 tt0 -59.44 -36.44 75.92 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.916 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 13.6 mm-40 -76.31 -32.12 58.56 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.875 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -122.4 80.22 1.7 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.899 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 2.3 tttt -125.19 136.59 53.73 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.931 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 12.4 p -96.44 134.57 33.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.109 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -110.48 -69.18 0.88 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.881 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 6.4 ttt180 68.48 -68.28 0.18 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.032 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 10.3 mt -86.18 130.26 36.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.059 -179.899 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.148 -0.93 . . . . 0.0 110.936 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.611 ' O ' HD11 ' A' ' 52' ' ' ILE . 0.7 OUTLIER . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.742 0.305 . . . . 0.0 111.071 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 13.8 m-20 -109.15 -13.42 14.68 Favored 'General case' 0 CA--C 1.514 -0.422 0 CA-C-O 121.983 0.897 . . . . 0.0 108.742 178.631 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.58 ' CG2' ' O ' ' A' ' 32' ' ' ILE . 0.1 OUTLIER -70.23 97.32 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.577 0 CA-C-N 114.0 -1.455 . . . . 0.0 110.731 -179.317 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.857 HG23 ' HB3' ' A' ' 50' ' ' ALA . 0.9 OUTLIER -36.99 -61.94 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 114.839 -1.073 . . . . 0.0 112.169 -179.245 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.765 ' SG ' HD12 ' A' ' 48' ' ' LEU . 28.0 p -163.9 164.85 23.23 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.116 0.484 . . . . 0.0 112.027 -179.621 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 4.1 ttm180 -122.45 127.46 49.65 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.634 179.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.623 HG11 ' HZ ' ' A' ' 68' ' ' PHE . 11.7 p -99.29 128.62 50.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.271 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.829 HG23 HG12 ' A' ' 45' ' ' ILE . 25.0 mt -127.08 108.31 18.44 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.601 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.735 ' SG ' HD23 ' A' ' 143' ' ' LEU . 0.1 OUTLIER -86.43 100.2 12.18 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 178.617 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.404 HG23 ' N ' ' A' ' 40' ' ' THR . 8.9 t -65.55 -40.66 93.12 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.416 0.524 . . . . 0.0 112.416 -178.637 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.404 ' N ' HG23 ' A' ' 39' ' ' THR . 0.2 OUTLIER -55.75 -33.97 64.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.867 0.365 . . . . 0.0 111.172 -179.345 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 114.36 0.21 23.6 Favored Glycine 0 CA--C 1.518 0.222 0 C-N-CA 120.553 -0.832 . . . . 0.0 113.575 179.217 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.76 ' HB3' HD12 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -61.39 -45.63 93.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.066 0.46 . . . . 0.0 110.86 179.904 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.76 HD12 ' HB3' ' A' ' 42' ' ' GLN . 4.3 mp -131.04 141.54 42.33 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.1 -179.644 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.628 ' HD2' HG23 ' A' ' 43' ' ' ILE . 96.3 Cg_endo -81.12 147.08 16.28 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 122.512 2.141 . . . . 0.0 111.591 179.451 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.829 HG12 HG23 ' A' ' 37' ' ' ILE . 40.4 mt -42.19 109.59 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.034 0.445 . . . . 0.0 111.78 -179.473 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.401 ' O ' HG12 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -115.01 132.34 56.63 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.843 179.513 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.4 ' HB3' ' CD1' ' A' ' 32' ' ' ILE . 3.7 m-20 -85.99 119.6 26.46 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.108 0.48 . . . . 0.0 111.609 -179.276 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.765 HD12 ' SG ' ' A' ' 34' ' ' CYS . 2.9 mt -96.43 125.85 41.22 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 178.615 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.527 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -132.64 161.86 32.85 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 113.874 1.064 . . . . 0.0 113.874 -178.045 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.857 ' HB3' HG23 ' A' ' 33' ' ' VAL . . . -151.52 164.98 35.62 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.02 -1.445 . . . . 0.0 110.806 178.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -87.41 123.87 32.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.957 0.408 . . . . 0.0 111.325 -179.547 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.611 HD11 ' O ' ' A' ' 30' ' ' GLU . 18.0 mt . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.338 179.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 52.3 mttt . . . . . 0 N--CA 1.457 -0.102 0 CA-C-O 120.897 0.379 . . . . 0.0 111.579 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 4.9 ttpt -140.36 131.37 26.2 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.262 179.228 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.647 HG13 ' O ' ' A' ' 91' ' ' ILE . 18.4 t -137.46 137.95 45.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.174 0.511 . . . . 0.0 112.232 -178.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . 0.683 ' HB2' ' HB ' ' A' ' 91' ' ' ILE . 14.5 m-90 -99.78 140.48 33.93 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.372 178.719 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.627 HG23 ' HG2' ' A' ' 90' ' ' GLN . 33.6 m -128.44 137.18 51.71 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.554 0.692 . . . . 0.0 112.084 179.237 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.623 ' HZ ' HG11 ' A' ' 36' ' ' VAL . 13.0 m-85 -109.07 119.01 38.26 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.124 -0.944 . . . . 0.0 109.203 178.222 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.648 ' HA2' ' O ' ' A' ' 85' ' ' SER . . . 156.82 -152.81 24.16 Favored Glycine 0 CA--C 1.503 -0.66 0 C-N-CA 118.71 -1.71 . . . . 0.0 113.412 179.16 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.462 ' CG ' ' HA ' ' A' ' 80' ' ' ASN . 62.1 mtp180 -75.06 91.44 2.55 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-O 122.513 1.149 . . . . 0.0 108.615 -179.629 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.477 ' O ' ' CD2' ' A' ' 77' ' ' HIS . 13.8 m120 -150.54 159.27 34.87 Favored Pre-proline 0 C--N 1.309 -1.183 0 CA-C-N 112.744 -2.026 . . . . 0.0 108.153 179.004 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.553 ' O ' ' HB2' ' A' ' 77' ' ' HIS . 34.7 Cg_endo -66.04 -7.08 15.98 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 120.79 0.993 . . . . 0.0 110.683 177.689 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.751 ' HB2' ' HB2' ' A' ' 77' ' ' HIS . . . 136.91 54.22 0.0 OUTLIER 'General case' 0 CA--C 1.488 -1.41 0 CA-C-N 114.338 -1.301 . . . . 0.0 108.887 178.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.528 ' HB3' ' HB ' ' A' ' 67' ' ' THR . 0.1 OUTLIER -52.46 -69.9 0.1 Allowed 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 105.58 -2.007 . . . . 0.0 105.58 179.826 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.592 ' HB2' ' N ' ' A' ' 67' ' ' THR . 62.0 t0 -96.04 -47.18 6.2 Favored 'General case' 0 N--CA 1.437 -1.103 0 N-CA-C 105.383 -2.08 . . . . 0.0 105.383 168.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.505 ' CE2' ' HB3' ' A' ' 78' ' ' LEU . 57.2 t80 -142.75 142.22 31.9 Favored 'General case' 0 C--N 1.35 0.599 0 CA-C-N 112.767 -2.015 . . . . 0.0 111.347 179.565 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . 0.751 ' HB2' ' HB2' ' A' ' 73' ' ' ALA . 23.7 t-160 -93.11 112.54 24.52 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 177.194 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.796 HD11 ' O ' ' A' ' 85' ' ' SER . 1.4 pp -129.02 173.5 10.38 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.03 0.443 . . . . 0.0 111.525 -179.524 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.562 ' O ' HD12 ' A' ' 78' ' ' LEU . . . -60.53 178.7 3.04 Favored Glycine 0 C--N 1.333 0.376 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.465 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.462 ' HA ' ' CG ' ' A' ' 70' ' ' ARG . 0.8 OUTLIER -111.84 99.39 8.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.848 0.356 . . . . 0.0 111.487 -179.762 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.596 ' HB ' ' HB2' ' A' ' 85' ' ' SER . 0.5 OUTLIER -114.83 121.27 66.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.163 -0.471 . . . . 0.0 109.835 178.871 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.4 t -53.81 -24.54 15.76 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -178.15 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.425 ' H ' HG23 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -89.94 -103.72 0.09 Allowed 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -179.071 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.431 ' O ' ' CB ' ' A' ' 85' ' ' SER . 0.0 OUTLIER -109.0 113.56 26.55 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-O 121.336 0.589 . . . . 0.0 109.432 179.681 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.796 ' O ' HD11 ' A' ' 78' ' ' LEU . 0.4 OUTLIER 162.02 -48.98 0.0 OUTLIER 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 114.769 -1.105 . . . . 0.0 109.317 -179.276 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.907 ' O ' ' N ' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -59.79 -162.84 0.01 OUTLIER 'General case' 0 CA--C 1.513 -0.465 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 177.717 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.69 ' HB3' HD11 ' A' ' 104' ' ' ILE . 13.3 mtmt -44.99 71.08 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 178.547 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 1.013 ' O ' ' O ' ' A' ' 104' ' ' ILE . 39.6 t60 -86.87 -15.92 37.62 Favored 'General case' 0 CA--C 1.513 -0.459 0 N-CA-C 113.956 1.095 . . . . 0.0 113.956 -176.466 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.592 ' HA ' ' H ' ' A' ' 104' ' ' ILE . 0.0 OUTLIER -175.97 159.53 2.19 Favored 'General case' 0 C--N 1.311 -1.07 0 C-N-CA 119.165 -1.014 . . . . 0.0 112.8 178.145 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.627 ' HG2' HG23 ' A' ' 67' ' ' THR . 42.3 mt-30 -138.73 160.23 40.16 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 113.734 1.013 . . . . 0.0 113.734 -178.336 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.683 ' HB ' ' HB2' ' A' ' 66' ' ' TRP . 4.8 mt -125.08 129.21 73.34 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.019 177.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.807 HD12 ' N ' ' A' ' 93' ' ' LEU . 0.3 OUTLIER -109.43 140.17 43.49 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.115 0.483 . . . . 0.0 111.82 -179.203 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.807 ' N ' HD12 ' A' ' 92' ' ' LEU . 6.6 tp -120.16 128.25 53.24 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.409 179.231 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.436 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.55 179.74 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.611 ' O ' HD12 ' A' ' 100' ' ' LEU . 6.3 mp . . . . . 0 C--O 1.23 0.06 0 CA-C-O 120.763 0.316 . . . . 0.0 110.826 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.718 HD23 ' HB3' ' A' ' 121' ' ' ASN . 2.5 mp -133.47 148.86 51.75 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.487 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.472 ' O ' ' N ' ' A' ' 122' ' ' GLN . 9.5 mp -112.66 129.02 56.54 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.503 ' O ' ' O ' ' A' ' 90' ' ' GLN . 28.7 t30 -110.39 111.94 23.55 Favored 'General case' 0 CA--C 1.508 -0.638 0 C-N-CA 119.735 -0.786 . . . . 0.0 109.838 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.773 ' HB3' HG21 ' A' ' 109' ' ' THR . 88.5 m-20 -84.04 111.22 19.1 Favored 'General case' 0 N--CA 1.439 -0.99 0 C-N-CA 119.572 -0.851 . . . . 0.0 109.564 179.755 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 1.013 ' O ' ' O ' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -123.07 107.9 20.17 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.968 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 177.22 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.435 ' HB3' ' CE1' ' A' ' 88' ' ' HIS . 50.8 m -135.23 167.32 21.22 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.485 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 18.4 m -69.5 -63.26 1.1 Allowed 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 119.109 -1.036 . . . . 0.0 111.749 -178.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -112.45 -32.64 6.42 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 115.065 1.506 . . . . 0.0 115.065 179.433 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -146.05 128.66 3.13 Favored Glycine 0 C--N 1.34 0.788 0 N-CA-C 117.216 1.646 . . . . 0.0 117.216 -177.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.773 HG21 ' HB3' ' A' ' 103' ' ' ASP . 6.1 m -121.35 138.14 54.39 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 174.353 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . 0.74 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.8 m-90 -121.27 149.04 43.49 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 113.466 0.913 . . . . 0.0 113.466 -178.47 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.48 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -123.24 112.27 17.45 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 114.98 -1.009 . . . . 0.0 108.709 177.479 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . 0.402 ' N ' HD12 ' A' ' 111' ' ' LEU . 71.5 m-20 45.42 43.88 9.01 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.104 -0.498 . . . . 0.0 112.061 -179.601 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 79.19 23.67 62.9 Favored Glycine 0 N--CA 1.444 -0.82 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.699 179.298 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 7.8 mt-30 -136.19 96.41 3.38 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.038 0.447 . . . . 0.0 110.828 179.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.74 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.0 OUTLIER -44.84 136.2 4.7 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.812 179.762 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.452 HG21 ' OD2' ' A' ' 103' ' ' ASP . 3.2 m -127.4 -179.89 3.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 121.023 0.44 . . . . 0.0 112.043 -178.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -83.51 142.36 30.96 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.439 -179.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.413 ' O ' ' C ' ' A' ' 119' ' ' ASN . 82.3 tttt -64.86 164.88 11.6 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.108 179.362 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.413 ' C ' ' O ' ' A' ' 118' ' ' LYS . 21.0 m-80 33.9 39.54 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 121.209 0.528 . . . . 0.0 111.193 -179.446 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 2.5 p -110.91 106.29 15.37 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.989 -179.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.718 ' HB3' HD23 ' A' ' 100' ' ' LEU . 22.7 m120 -57.7 144.18 38.95 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.506 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . 0.667 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 76.9 mm-40 -129.39 149.27 51.24 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-O 121.063 0.458 . . . . 0.0 112.003 -179.473 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 62.9 tp -72.92 124.38 25.31 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.71 179.104 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.702 HD21 HG12 ' A' ' 147' ' ' ILE . 4.9 tp -50.73 141.48 12.88 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-O 122.026 0.917 . . . . 0.0 111.78 -178.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.617 ' O ' HD11 ' A' ' 147' ' ' ILE . 0.0 OUTLIER -127.14 153.06 46.51 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 113.836 -1.529 . . . . 0.0 109.936 179.421 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 1.7 mm-40 -71.14 113.64 8.38 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 179.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 64.84 30.96 79.37 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.516 -179.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.411 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 27.0 t70 -55.71 159.53 2.98 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 120.906 0.384 . . . . 0.0 111.109 -179.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.656 ' HG3' HG22 ' A' ' 144' ' ' VAL . 13.0 tt0 -146.49 135.6 22.61 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.699 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.665 ' O ' HD12 ' A' ' 143' ' ' LEU . 8.2 mm -114.23 128.72 71.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 116.145 -0.48 . . . . 0.0 109.915 178.644 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.461 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 88.9 m -103.43 145.2 30.35 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.873 -179.431 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.513 HG11 ' CD2' ' A' ' 88' ' ' HIS . 6.0 m -141.2 158.38 22.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 -179.193 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . 0.429 ' CA ' HD13 ' A' ' 84' ' ' LEU . . . 69.49 44.23 65.39 Favored Glycine 0 N--CA 1.447 -0.595 0 CA-C-N 115.897 -0.592 . . . . 0.0 112.287 179.583 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.486 ' HA ' HG12 ' A' ' 140' ' ' ILE . 90.5 t -79.72 155.46 4.62 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.569 0 CA-C-O 121.373 0.606 . . . . 0.0 112.236 -179.166 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . 0.43 ' N ' HG12 ' A' ' 134' ' ' VAL . . . 145.62 -46.5 0.77 Allowed Glycine 0 N--CA 1.441 -1.0 0 CA-C-N 114.908 -1.042 . . . . 0.0 110.571 -179.01 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.657 HG12 ' H ' ' A' ' 138' ' ' SER . 45.7 t -126.81 128.56 71.01 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 CA-C-N 115.241 -0.48 . . . . 0.0 109.795 178.54 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.488 ' HA ' HD12 ' A' ' 140' ' ' ILE . 7.3 mt-10 -51.06 -26.52 6.43 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.692 0.282 . . . . 0.0 111.376 -179.294 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . 0.657 ' H ' HG12 ' A' ' 136' ' ' VAL . 0.1 OUTLIER -94.66 6.05 50.05 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 -179.268 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -131.29 23.4 4.82 Favored 'General case' 0 CA--C 1.523 -0.093 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 -179.449 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.603 ' C ' HD22 ' A' ' 141' ' ' LEU . 23.6 mt -97.65 141.16 16.37 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.249 179.06 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.603 HD22 ' C ' ' A' ' 140' ' ' ILE . 3.8 mm? -119.21 135.54 54.63 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 114.821 -1.081 . . . . 0.0 109.793 179.514 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 46.3 t -116.46 151.73 35.46 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.749 0.785 . . . . 0.0 113.011 -178.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.735 HD23 ' SG ' ' A' ' 38' ' ' CYS . 0.9 OUTLIER -134.0 132.24 39.87 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 114.554 -1.203 . . . . 0.0 109.679 179.2 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.656 HG22 ' HG3' ' A' ' 129' ' ' GLU . 25.1 t -128.11 140.46 49.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.914 0.387 . . . . 0.0 111.518 -178.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.483 HD11 HD11 ' A' ' 91' ' ' ILE . 0.0 OUTLIER -117.3 124.99 73.72 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.763 179.795 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 49.3 t80 -106.62 105.69 15.84 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.393 179.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.702 HG12 HD21 ' A' ' 124' ' ' LEU . 1.3 mp -84.97 133.39 29.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.483 -179.478 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -79.9 113.93 18.43 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.835 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -58.59 -21.03 52.0 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.256 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 32.1 mtmm -57.49 -42.67 83.16 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.957 0.408 . . . . 0.0 110.638 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 5.7 t80 . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.75 179.873 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.612 0.244 . . . . 0.0 111.271 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.474 ' HA ' HD12 ' A' ' 52' ' ' ILE . 13.2 m120 -109.0 -14.65 14.51 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-O 121.911 0.863 . . . . 0.0 108.906 178.409 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.521 ' O ' HG22 ' A' ' 32' ' ' ILE . 0.1 OUTLIER -73.3 106.36 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.58 0 CA-C-N 113.968 -1.469 . . . . 0.0 111.094 -179.442 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 1.008 HG23 ' HB2' ' A' ' 50' ' ' ALA . 0.5 OUTLIER -38.87 -62.21 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.384 -0.826 . . . . 0.0 111.403 -179.664 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.602 ' N ' ' CG1' ' A' ' 33' ' ' VAL . 28.4 p -165.77 165.95 18.12 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.482 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 2.2 ttp180 -120.77 127.38 51.91 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.542 179.517 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.693 HG23 ' CD1' ' A' ' 48' ' ' LEU . 39.1 t -97.23 121.92 48.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.504 179.285 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.927 HG23 HG12 ' A' ' 45' ' ' ILE . 20.3 mt -125.29 109.02 20.96 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.824 -179.355 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 43.4 t -78.2 99.92 6.42 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 178.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 9.7 t -69.73 -33.27 72.24 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -178.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.415 ' OG1' ' O ' ' A' ' 142' ' ' SER . 0.0 OUTLIER -52.38 -29.32 23.46 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.914 0.388 . . . . 0.0 110.9 -179.658 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 90.46 49.78 3.13 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.866 -0.683 . . . . 0.0 113.003 179.205 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.887 ' OE1' HD21 ' A' ' 141' ' ' LEU . 2.3 mm-40 -126.55 -31.77 2.7 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.663 0.268 . . . . 0.0 111.368 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.537 HD12 HD11 ' A' ' 143' ' ' LEU . 19.0 mt -127.37 131.15 23.7 Favored Pre-proline 0 N--CA 1.452 -0.329 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.98 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.462 ' HD2' ' CE2' ' A' ' 76' ' ' TYR . 27.8 Cg_exo -59.85 146.82 94.73 Favored 'Trans proline' 0 C--N 1.343 0.263 0 C-N-CA 122.655 2.236 . . . . 0.0 112.046 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.927 HG12 HG23 ' A' ' 37' ' ' ILE . 78.8 mt -51.59 133.12 13.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.327 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -126.16 131.23 52.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.371 179.669 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.411 ' HB3' HD11 ' A' ' 32' ' ' ILE . 1.1 m-20 -96.17 119.95 35.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.043 0.449 . . . . 0.0 111.511 -179.525 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.944 HD21 HD13 ' A' ' 91' ' ' ILE . 1.8 mp -96.37 117.0 29.95 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 178.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.524 ' O ' ' CZ2' ' A' ' 66' ' ' TRP . 0.1 OUTLIER -112.24 162.17 15.78 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 122.077 0.942 . . . . 0.0 113.121 -178.715 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 1.008 ' HB2' HG23 ' A' ' 33' ' ' VAL . . . -125.97 165.9 17.93 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 114.718 -1.128 . . . . 0.0 111.4 179.401 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -108.22 78.56 1.18 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.42 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.474 HD12 ' HA ' ' A' ' 31' ' ' ASN . 88.4 mt . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.571 -179.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 27.9 tttt . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.827 0.346 . . . . 0.0 111.08 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.403 ' O ' ' HB3' ' A' ' 93' ' ' LEU . 0.8 OUTLIER -115.0 138.88 50.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.563 179.597 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.598 HG13 ' O ' ' A' ' 91' ' ' ILE . 13.9 t -136.73 136.92 47.89 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 CA-C-O 121.116 0.484 . . . . 0.0 112.003 -179.289 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . 0.661 ' HB2' ' HB ' ' A' ' 91' ' ' ILE . 15.2 m-90 -100.19 140.61 34.18 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.666 179.205 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.874 HG23 ' HG3' ' A' ' 90' ' ' GLN . 7.1 m -129.21 129.47 45.08 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.455 0.645 . . . . 0.0 112.337 179.653 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.578 ' CZ ' HG11 ' A' ' 36' ' ' VAL . 3.4 m-85 -103.43 118.69 37.34 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.051 -0.977 . . . . 0.0 108.716 177.578 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.647 ' HA2' ' O ' ' A' ' 85' ' ' SER . . . 157.06 -154.86 25.89 Favored Glycine 0 CA--C 1.505 -0.548 0 C-N-CA 118.58 -1.772 . . . . 0.0 113.468 179.346 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 4.1 mtp180 -75.27 91.83 2.7 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-O 122.543 1.163 . . . . 0.0 108.826 -179.416 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.518 ' O ' ' CD2' ' A' ' 77' ' ' HIS . 16.1 m120 -150.05 159.41 35.52 Favored Pre-proline 0 C--N 1.307 -1.262 0 CA-C-N 112.782 -2.008 . . . . 0.0 107.85 178.786 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.552 ' O ' ' HB2' ' A' ' 77' ' ' HIS . 30.9 Cg_endo -64.4 -7.09 13.19 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 120.7 0.933 . . . . 0.0 110.758 177.714 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.742 ' HB2' ' HB2' ' A' ' 77' ' ' HIS . . . 136.71 53.62 0.0 OUTLIER 'General case' 0 CA--C 1.488 -1.406 0 CA-C-N 114.367 -1.288 . . . . 0.0 109.0 178.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.579 ' HB3' ' HB ' ' A' ' 67' ' ' THR . 0.1 OUTLIER -52.56 -70.07 0.1 Allowed 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 105.409 -2.071 . . . . 0.0 105.409 179.719 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.504 ' CG ' ' CE1' ' A' ' 68' ' ' PHE . 16.8 t70 -95.58 -47.56 6.18 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 105.781 -1.933 . . . . 0.0 105.781 169.114 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.499 ' CD2' HG23 ' A' ' 43' ' ' ILE . 19.4 t80 -143.08 141.95 31.4 Favored 'General case' 0 C--N 1.348 0.507 0 CA-C-N 112.775 -2.011 . . . . 0.0 111.458 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . 0.742 ' HB2' ' HB2' ' A' ' 73' ' ' ALA . 23.7 t-160 -96.1 107.28 19.58 Favored 'General case' 0 C--N 1.33 -0.261 0 O-C-N 122.114 -0.366 . . . . 0.0 110.222 177.26 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.817 HD11 ' O ' ' A' ' 85' ' ' SER . 0.6 OUTLIER -121.19 173.77 7.1 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.916 0.388 . . . . 0.0 111.506 -179.895 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -56.91 -173.39 0.21 Allowed Glycine 0 C--N 1.332 0.343 0 C-N-CA 121.014 -0.612 . . . . 0.0 112.475 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.421 ' HA ' ' OD1' ' A' ' 86' ' ' ASN . 9.2 p30 -111.81 98.34 7.32 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.82 0.343 . . . . 0.0 111.758 -179.671 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.79 HD12 ' OG ' ' A' ' 85' ' ' SER . 11.2 mt -114.91 113.79 44.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.436 178.574 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -55.65 -24.37 33.35 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 -179.352 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.441 ' H ' HG22 ' A' ' 81' ' ' ILE . 1.4 mtt180 -88.21 -106.11 0.08 Allowed 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -179.047 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.408 ' HB3' ' CE1' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -109.26 111.17 22.61 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-O 121.568 0.699 . . . . 0.0 110.158 179.976 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.817 ' O ' HD11 ' A' ' 78' ' ' LEU . 0.5 OUTLIER 162.11 -48.94 0.0 OUTLIER 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 114.378 -1.283 . . . . 0.0 109.261 -179.817 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.846 ' O ' ' N ' ' A' ' 88' ' ' HIS . 89.0 m-20 -63.32 -152.57 0.01 OUTLIER 'General case' 0 CA--C 1.522 -0.122 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 177.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.848 ' HB3' HD11 ' A' ' 104' ' ' ILE . 12.9 mttt -48.54 72.8 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 179.303 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.996 ' O ' ' O ' ' A' ' 104' ' ' ILE . 36.3 t60 -93.93 -17.76 22.64 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 114.103 1.149 . . . . 0.0 114.103 -176.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.62 ' HA ' ' H ' ' A' ' 104' ' ' ILE . 0.1 OUTLIER -175.83 155.69 1.7 Allowed 'General case' 0 C--N 1.313 -1.002 0 C-N-CA 118.96 -1.096 . . . . 0.0 113.073 177.982 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.874 ' HG3' HG23 ' A' ' 67' ' ' THR . 21.2 mt-30 -137.46 160.97 37.62 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.308 -1.314 . . . . 0.0 113.574 -177.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.944 HD13 HD21 ' A' ' 48' ' ' LEU . 2.7 mt -128.42 132.33 68.17 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.784 178.746 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.571 HD13 ' ND2' ' A' ' 121' ' ' ASN . 0.3 OUTLIER -109.52 146.12 35.15 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.142 0.496 . . . . 0.0 112.017 -179.126 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.637 HD22 ' N ' ' A' ' 94' ' ' GLY . 1.1 tm? -125.97 124.52 40.92 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.445 179.195 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.637 ' N ' HD22 ' A' ' 93' ' ' LEU . . . . . . . . 0 N--CA 1.451 -0.337 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.617 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.956 HD21 HG13 ' A' ' 33' ' ' VAL . 4.9 mp . . . . . 0 N--CA 1.457 -0.094 0 CA-C-O 120.842 0.353 . . . . 0.0 110.943 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.938 HD23 ' HB3' ' A' ' 121' ' ' ASN . 4.6 mp -131.58 148.35 52.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.389 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.462 ' O ' ' N ' ' A' ' 122' ' ' GLN . 6.0 mt -118.23 128.78 55.02 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 179.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.515 ' O ' ' O ' ' A' ' 90' ' ' GLN . 29.4 t30 -111.21 111.38 22.41 Favored 'General case' 0 CA--C 1.507 -0.675 0 C-N-CA 119.907 -0.717 . . . . 0.0 109.685 179.606 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.758 ' HB3' HG21 ' A' ' 109' ' ' THR . 84.0 m-20 -85.8 111.56 20.28 Favored 'General case' 0 N--CA 1.44 -0.932 0 C-N-CA 119.596 -0.842 . . . . 0.0 109.535 179.697 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.996 ' O ' ' O ' ' A' ' 88' ' ' HIS . 0.1 OUTLIER -122.91 107.57 19.59 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.953 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 177.563 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.415 ' HG ' ' CE1' ' A' ' 88' ' ' HIS . 70.9 m -134.17 166.89 21.72 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-N 114.982 -1.008 . . . . 0.0 109.398 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 20.8 m -69.24 -62.81 1.23 Allowed 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 119.226 -0.99 . . . . 0.0 111.581 -179.074 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -112.12 -32.82 6.43 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 114.984 1.476 . . . . 0.0 114.984 179.443 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -146.35 127.95 2.9 Favored Glycine 0 C--N 1.339 0.749 0 N-CA-C 117.388 1.715 . . . . 0.0 117.388 -177.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.758 HG21 ' HB3' ' A' ' 103' ' ' ASP . 5.4 m -121.37 138.3 54.32 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 174.18 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . 0.761 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.9 m-90 -121.24 148.91 43.65 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 113.318 0.859 . . . . 0.0 113.318 -178.506 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.463 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -121.6 112.05 17.98 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 115.12 -0.946 . . . . 0.0 108.509 177.424 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 43.97 44.44 6.02 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.038 -0.528 . . . . 0.0 112.126 -179.462 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 80.06 25.12 58.36 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.744 179.336 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . 0.434 ' O ' HG13 ' A' ' 116' ' ' VAL . 58.0 mt-30 -137.74 95.98 3.15 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.077 0.465 . . . . 0.0 110.841 179.677 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.761 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.0 OUTLIER -45.61 134.54 7.17 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.891 179.77 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.434 HG13 ' O ' ' A' ' 114' ' ' GLN . 27.3 m -126.05 -178.19 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.916 -179.029 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -85.84 142.1 29.15 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.229 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.457 ' HG3' ' HA ' ' A' ' 104' ' ' ILE . 71.4 tttt -64.49 163.21 13.82 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.155 179.28 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.42 ' N ' ' HG2' ' A' ' 118' ' ' LYS . 4.2 p30 35.41 39.5 0.06 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.287 0.565 . . . . 0.0 111.17 -179.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 4.9 p -110.87 106.76 16.02 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.024 -179.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.938 ' HB3' HD23 ' A' ' 100' ' ' LEU . 1.6 m-20 -57.26 140.8 48.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.506 179.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . 0.691 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 59.9 mm-40 -129.63 147.86 51.47 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-O 121.109 0.481 . . . . 0.0 111.965 -179.542 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.3 tp -73.77 116.89 14.9 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.628 -0.715 . . . . 0.0 109.491 178.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.801 HD21 HD13 ' A' ' 147' ' ' ILE . 2.4 tt -47.54 144.53 3.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.85 0.833 . . . . 0.0 111.892 -178.759 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.441 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.6 OUTLIER -126.83 153.18 45.99 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 114.04 -1.436 . . . . 0.0 110.291 179.535 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 24.6 mm100 -71.67 113.93 9.22 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.002 0.429 . . . . 0.0 110.152 179.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 69.24 25.66 75.27 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.645 -179.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.441 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 27.0 t70 -58.5 159.99 5.85 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.045 0.45 . . . . 0.0 111.136 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.597 ' HG3' HG22 ' A' ' 144' ' ' VAL . 1.7 tt0 -146.56 135.37 22.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.411 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.466 ' CG2' ' O ' ' A' ' 110' ' ' TRP . 1.2 mp -110.46 128.5 66.7 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.157 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 178.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.577 HG23 ' CG2' ' A' ' 140' ' ' ILE . 23.3 m -103.13 144.79 30.84 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.451 -179.571 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.474 ' HB ' ' NE2' ' A' ' 88' ' ' HIS . 10.2 m -141.29 158.14 22.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -178.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 67.38 43.16 88.59 Favored Glycine 0 N--CA 1.447 -0.582 0 CA-C-N 115.667 -0.697 . . . . 0.0 112.281 179.477 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.485 ' HA ' HG12 ' A' ' 140' ' ' ILE . 85.2 t -77.84 156.48 5.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 121.406 0.622 . . . . 0.0 112.133 -179.245 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . 0.448 ' N ' HG12 ' A' ' 134' ' ' VAL . . . 147.79 -42.06 0.89 Allowed Glycine 0 N--CA 1.441 -0.99 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.635 -179.061 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.528 HG12 ' H ' ' A' ' 138' ' ' SER . 43.8 t -126.65 130.14 71.63 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.684 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 178.73 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.29 -34.0 31.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.724 0.297 . . . . 0.0 111.405 -179.181 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . 0.528 ' H ' HG12 ' A' ' 136' ' ' VAL . 4.0 p -94.28 6.39 48.81 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 -179.441 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -128.14 30.25 5.25 Favored 'General case' 0 CA--C 1.52 -0.197 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -179.274 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.577 ' CG2' HG23 ' A' ' 131' ' ' THR . 20.9 mt -103.66 141.12 20.03 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.361 179.183 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.887 HD21 ' OE1' ' A' ' 42' ' ' GLN . 3.4 mp -111.51 135.67 51.76 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.021 -0.991 . . . . 0.0 110.048 179.506 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . 0.764 ' C ' HD22 ' A' ' 143' ' ' LEU . 47.3 t -116.82 152.02 35.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.865 0.841 . . . . 0.0 112.94 -178.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.764 HD22 ' C ' ' A' ' 142' ' ' SER . 3.9 mm? -136.24 127.06 27.45 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.526 -1.215 . . . . 0.0 109.166 178.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.597 HG22 ' HG3' ' A' ' 129' ' ' GLU . 18.7 t -120.2 140.61 43.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.017 0.437 . . . . 0.0 111.978 -178.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.499 ' CG1' HG22 ' A' ' 36' ' ' VAL . 0.2 OUTLIER -114.19 127.17 71.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.575 179.639 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 15.6 t80 -110.65 107.19 16.68 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.753 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.801 HD13 HD21 ' A' ' 124' ' ' LEU . 1.4 mp -99.76 133.41 42.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.393 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 14.7 p30 -82.05 134.79 35.37 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.926 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -64.63 -23.03 67.13 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.154 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 16.7 mtmt -57.31 -42.22 81.37 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.94 0.4 . . . . 0.0 110.687 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 37.3 t80 . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.75 179.766 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.701 0.286 . . . . 0.0 111.317 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.417 ' HA ' HD12 ' A' ' 52' ' ' ILE . 12.2 m120 -109.06 -14.37 14.54 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-O 121.949 0.881 . . . . 0.0 108.746 178.574 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.555 ' O ' HG22 ' A' ' 32' ' ' ILE . 0.0 OUTLIER -74.31 101.53 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.522 0 CA-C-N 114.011 -1.449 . . . . 0.0 110.558 -179.769 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 1.022 HG23 ' HB2' ' A' ' 50' ' ' ALA . 0.5 OUTLIER -34.93 -61.73 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.249 -0.887 . . . . 0.0 112.297 -179.059 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.725 ' SG ' HG23 ' A' ' 147' ' ' ILE . 41.2 m -159.36 165.46 33.25 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.677 -179.178 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.513 HH11 HD11 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -128.46 115.12 17.68 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.828 179.367 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.629 HG11 ' HZ ' ' A' ' 68' ' ' PHE . 9.9 p -89.18 134.38 28.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.812 179.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.964 HG23 HG12 ' A' ' 45' ' ' ILE . 21.6 mt -132.68 107.86 12.55 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -179.373 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -89.23 106.56 18.52 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 177.604 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 10.1 t -99.11 -22.4 15.7 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 -177.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.772 HG21 ' CB ' ' A' ' 142' ' ' SER . 56.7 p -57.74 -20.7 36.51 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.656 0.265 . . . . 0.0 111.583 -179.556 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 104.86 71.75 0.84 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.561 -0.828 . . . . 0.0 112.627 179.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.788 ' HG2' HD12 ' A' ' 141' ' ' LEU . 0.0 OUTLIER -159.35 -66.95 0.08 Allowed 'General case' 0 C--N 1.328 -0.37 0 CA-C-O 120.893 0.377 . . . . 0.0 110.925 179.925 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.514 HG23 ' HD2' ' A' ' 44' ' ' PRO . 34.3 mt -103.5 138.97 19.69 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.257 -179.714 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.514 ' HD2' HG23 ' A' ' 43' ' ' ILE . 91.2 Cg_endo -81.73 146.79 15.09 Favored 'Trans proline' 0 N--CA 1.46 -0.458 0 C-N-CA 122.71 2.273 . . . . 0.0 111.706 179.51 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.964 HG12 HG23 ' A' ' 37' ' ' ILE . 55.8 mt -43.82 116.07 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.072 0.463 . . . . 0.0 111.622 -179.665 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.404 ' NE ' ' HA ' ' A' ' 46' ' ' ARG . 8.9 mmm180 -114.69 131.48 56.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.928 179.49 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.424 ' HB3' HD11 ' A' ' 32' ' ' ILE . 5.0 m-20 -88.11 119.6 28.64 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.063 0.459 . . . . 0.0 111.604 -179.306 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.592 HD22 ' CD1' ' A' ' 66' ' ' TRP . 1.0 OUTLIER -98.34 121.57 40.43 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 178.741 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.513 ' O ' ' HZ2' ' A' ' 66' ' ' TRP . 0.0 OUTLIER -120.81 162.05 20.44 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 122.133 0.968 . . . . 0.0 113.46 -178.371 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 1.022 ' HB2' HG23 ' A' ' 33' ' ' VAL . . . -116.96 166.28 12.36 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 114.343 -1.299 . . . . 0.0 110.958 179.685 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -105.47 63.44 0.69 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.029 0.442 . . . . 0.0 110.837 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.417 HD12 ' HA ' ' A' ' 31' ' ' ASN . 53.6 mt . . . . . 0 C--N 1.326 -0.428 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.04 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.461 0.078 0 CA-C-O 120.868 0.366 . . . . 0.0 110.852 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.469 ' HB3' HD12 ' A' ' 93' ' ' LEU . 13.2 ttpt -130.41 136.68 49.3 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.625 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.635 HG13 ' O ' ' A' ' 91' ' ' ILE . 17.6 t -137.41 137.3 46.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.969 0.414 . . . . 0.0 112.008 -179.124 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . 0.675 ' HB2' ' HB ' ' A' ' 91' ' ' ILE . 13.8 m-90 -100.26 139.29 36.15 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.09 178.636 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.574 ' HB ' ' HB3' ' A' ' 74' ' ' CYS . 4.4 m -131.3 130.49 42.83 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.458 0.647 . . . . 0.0 112.57 179.747 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.629 ' HZ ' HG11 ' A' ' 36' ' ' VAL . 93.7 m-85 -101.73 118.57 37.2 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.303 178.006 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.62 ' HA2' ' O ' ' A' ' 85' ' ' SER . . . 157.34 -157.2 27.9 Favored Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 118.899 -1.619 . . . . 0.0 112.812 179.291 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.47 92.34 2.85 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-O 122.71 1.243 . . . . 0.0 108.738 -179.763 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.536 ' O ' ' CD2' ' A' ' 77' ' ' HIS . 19.3 m120 -149.16 159.43 37.09 Favored Pre-proline 0 C--N 1.309 -1.169 0 CA-C-N 112.515 -2.129 . . . . 0.0 107.921 179.224 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.545 ' O ' ' CB ' ' A' ' 73' ' ' ALA . 28.8 Cg_endo -63.64 -7.43 12.75 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 120.842 1.028 . . . . 0.0 111.118 178.255 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.735 ' HB2' ' HB2' ' A' ' 77' ' ' HIS . . . 135.99 51.6 0.0 OUTLIER 'General case' 0 CA--C 1.49 -1.362 0 CA-C-N 114.527 -1.215 . . . . 0.0 109.455 178.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.574 ' HB3' ' HB ' ' A' ' 67' ' ' THR . 0.1 OUTLIER -52.88 -69.9 0.1 Allowed 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 105.63 -1.989 . . . . 0.0 105.63 179.491 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.551 ' N ' ' O ' ' A' ' 67' ' ' THR . 7.6 t0 -95.26 -47.14 6.45 Favored 'General case' 0 N--CA 1.435 -1.182 0 N-CA-C 106.0 -1.852 . . . . 0.0 106.0 169.594 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.496 ' C ' ' HA ' ' A' ' 73' ' ' ALA . 29.8 t80 -144.33 142.6 30.5 Favored 'General case' 0 C--N 1.347 0.465 0 CA-C-N 112.624 -2.08 . . . . 0.0 111.476 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . 0.735 ' HB2' ' HB2' ' A' ' 73' ' ' ALA . 23.7 t-160 -96.33 107.3 19.64 Favored 'General case' 0 C--N 1.33 -0.249 0 O-C-N 121.997 -0.439 . . . . 0.0 110.322 177.073 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.811 HD11 ' O ' ' A' ' 85' ' ' SER . 0.7 OUTLIER -124.24 175.22 7.19 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 120.916 0.388 . . . . 0.0 111.375 179.969 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -59.02 -174.18 0.57 Allowed Glycine 0 C--N 1.332 0.342 0 C-N-CA 120.981 -0.628 . . . . 0.0 112.704 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.436 ' HA ' ' OD1' ' A' ' 86' ' ' ASN . 8.0 p30 -111.48 98.24 7.32 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.933 0.397 . . . . 0.0 111.634 -179.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.594 ' HB ' ' HB2' ' A' ' 85' ' ' SER . 4.0 mp -114.92 114.03 45.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.356 178.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 53.3 p -55.7 -24.62 35.54 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 -178.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.523 ' C ' HD13 ' A' ' 84' ' ' LEU . 0.6 OUTLIER -85.32 -110.13 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 -178.931 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.847 ' H ' HD22 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -108.98 112.07 24.08 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-O 121.453 0.644 . . . . 0.0 109.573 179.679 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.811 ' O ' HD11 ' A' ' 78' ' ' LEU . 0.6 OUTLIER 161.86 -45.63 0.0 OUTLIER 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 114.671 -1.15 . . . . 0.0 109.433 -179.562 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.858 ' O ' ' N ' ' A' ' 88' ' ' HIS . 95.7 m-20 -64.68 -149.65 0.01 OUTLIER 'General case' 0 N--CA 1.456 -0.148 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 177.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.925 ' HB3' HD11 ' A' ' 104' ' ' ILE . 28.1 mttm -49.58 72.02 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 179.065 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.983 ' C ' ' O ' ' A' ' 104' ' ' ILE . 31.8 t60 -91.35 -15.93 28.26 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 113.846 1.054 . . . . 0.0 113.846 -176.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.631 ' HA ' ' H ' ' A' ' 104' ' ' ILE . 0.9 OUTLIER -175.31 152.83 1.45 Allowed 'General case' 0 C--N 1.31 -1.131 0 C-N-CA 119.436 -0.906 . . . . 0.0 112.291 177.972 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.508 ' HG2' HG12 ' A' ' 65' ' ' VAL . 20.5 tt0 -136.82 153.38 50.81 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 114.514 -1.221 . . . . 0.0 113.338 -177.664 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.675 ' HB ' ' HB2' ' A' ' 66' ' ' TRP . 32.4 mt -123.53 131.98 72.17 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.196 178.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.697 HD13 ' ND2' ' A' ' 121' ' ' ASN . 0.3 OUTLIER -108.64 144.05 36.89 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.055 0.455 . . . . 0.0 111.824 -179.56 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.797 HD22 ' N ' ' A' ' 94' ' ' GLY . 0.2 OUTLIER -125.77 122.66 36.86 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.28 179.26 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.797 ' N ' HD22 ' A' ' 93' ' ' LEU . . . . . . . . 0 N--CA 1.452 -0.287 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.375 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.867 ' HB2' HD13 ' A' ' 124' ' ' LEU . 0.5 OUTLIER . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.805 0.336 . . . . 0.0 110.893 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.54 ' HA ' ' O ' ' A' ' 122' ' ' GLN . 20.5 mt -133.61 147.98 51.53 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.432 179.758 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.516 HD13 ' HA ' ' A' ' 124' ' ' LEU . 4.8 mp -116.58 131.85 56.84 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.615 ' HB2' HD11 ' A' ' 92' ' ' LEU . 23.1 t30 -114.42 110.87 20.54 Favored 'General case' 0 CA--C 1.508 -0.661 0 C-N-CA 119.714 -0.795 . . . . 0.0 109.839 179.704 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.69 ' HB3' HG21 ' A' ' 109' ' ' THR . 70.1 m-20 -81.68 111.88 18.36 Favored 'General case' 0 N--CA 1.442 -0.865 0 C-N-CA 119.726 -0.79 . . . . 0.0 109.37 179.557 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.983 ' O ' ' C ' ' A' ' 88' ' ' HIS . 0.1 OUTLIER -123.45 107.98 20.1 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.937 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 177.71 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.456 ' HG ' ' CE1' ' A' ' 88' ' ' HIS . 69.8 m -130.91 169.83 15.25 Favored 'General case' 0 C--N 1.296 -1.742 0 CA-C-N 114.926 -1.034 . . . . 0.0 109.304 179.694 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 24.0 m -69.56 -62.68 1.28 Allowed 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 119.089 -1.044 . . . . 0.0 111.325 -179.302 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -111.75 -33.52 6.3 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 114.66 1.356 . . . . 0.0 114.66 179.195 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -146.99 130.37 3.58 Favored Glycine 0 C--N 1.34 0.786 0 N-CA-C 116.764 1.466 . . . . 0.0 116.764 -178.158 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.69 HG21 ' HB3' ' A' ' 103' ' ' ASP . 4.3 m -120.85 137.87 54.34 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 174.47 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . 0.771 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.5 m-90 -120.37 148.96 43.08 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 -178.543 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.432 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.3 OUTLIER -122.49 112.09 17.62 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 114.931 -1.031 . . . . 0.0 108.514 177.421 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 67.4 m-20 48.02 42.82 17.34 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.08 -0.509 . . . . 0.0 112.12 -179.458 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 82.22 3.44 90.56 Favored Glycine 0 N--CA 1.445 -0.754 0 C-N-CA 120.785 -0.721 . . . . 0.0 113.134 179.125 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.07 100.07 7.3 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.062 0.458 . . . . 0.0 110.829 179.78 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.771 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.0 OUTLIER -44.86 139.17 3.17 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.018 179.919 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.456 HG21 ' OD2' ' A' ' 103' ' ' ASP . 28.1 m -126.98 178.92 3.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.103 0.478 . . . . 0.0 111.756 -179.103 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -84.01 139.09 32.75 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.755 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.451 ' O ' ' N ' ' A' ' 120' ' ' SER . 0.5 OUTLIER -61.94 169.46 2.6 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 179.348 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.444 ' C ' ' O ' ' A' ' 118' ' ' LYS . 6.7 p30 28.63 41.42 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.534 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.451 ' N ' ' O ' ' A' ' 118' ' ' LYS . 4.0 p -111.22 111.52 22.64 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.154 -179.113 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.697 ' ND2' HD13 ' A' ' 92' ' ' LEU . 1.9 m120 -62.95 133.77 55.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.124 179.51 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . 0.54 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 49.6 mm-40 -129.56 147.04 51.32 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 -179.425 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.8 tt -72.62 113.71 9.95 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.351 178.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.895 HD12 HG12 ' A' ' 147' ' ' ILE . 1.6 pt? -45.51 155.41 0.15 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.852 0.834 . . . . 0.0 112.362 -178.462 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.476 ' O ' HD13 ' A' ' 147' ' ' ILE . 0.0 OUTLIER -127.44 153.38 46.35 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 114.069 -1.423 . . . . 0.0 109.855 179.142 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 5.6 tp-100 -70.72 113.82 8.18 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 179.659 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 69.13 27.93 73.34 Favored Glycine 0 N--CA 1.445 -0.7 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.131 -179.093 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.449 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 27.5 t70 -58.96 159.62 6.88 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.099 0.476 . . . . 0.0 111.53 -179.567 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.505 ' HB2' HG22 ' A' ' 144' ' ' VAL . 2.0 tt0 -146.54 135.35 22.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.941 179.704 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.692 ' O ' HD12 ' A' ' 143' ' ' LEU . 1.0 OUTLIER -108.74 129.17 63.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.13 179.157 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.529 HG23 ' CG2' ' A' ' 140' ' ' ILE . 32.0 m -102.77 143.16 32.75 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.86 0.362 . . . . 0.0 110.454 -179.665 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.47 ' HB ' ' NE2' ' A' ' 88' ' ' HIS . 5.3 m -141.13 158.26 22.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 -178.669 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 68.64 43.98 73.47 Favored Glycine 0 N--CA 1.447 -0.575 0 CA-C-N 115.705 -0.68 . . . . 0.0 112.219 179.351 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.497 ' HA ' HG12 ' A' ' 140' ' ' ILE . 93.0 t -79.35 154.22 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 CA-C-O 121.467 0.651 . . . . 0.0 112.242 -179.093 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . 0.406 ' N ' HG12 ' A' ' 134' ' ' VAL . . . 151.39 -42.79 0.71 Allowed Glycine 0 N--CA 1.44 -1.04 0 CA-C-N 114.93 -1.032 . . . . 0.0 110.648 -179.068 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.547 HG12 ' H ' ' A' ' 138' ' ' SER . 44.8 t -126.66 132.19 70.42 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.751 0 CA-C-N 115.196 -0.502 . . . . 0.0 109.844 178.65 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 46.5 tp10 -51.42 -34.74 36.13 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.798 0.332 . . . . 0.0 111.405 -179.292 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . 0.547 ' H ' HG12 ' A' ' 136' ' ' VAL . 40.9 t -94.31 6.45 48.65 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -179.318 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -126.94 30.16 5.51 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 -179.3 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.529 ' CG2' HG23 ' A' ' 131' ' ' THR . 13.3 mt -107.33 140.95 23.81 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.305 179.15 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.788 HD12 ' HG2' ' A' ' 42' ' ' GLN . 3.6 mm? -117.3 135.01 54.14 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 114.974 -1.012 . . . . 0.0 109.834 179.409 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . 0.772 ' CB ' HG21 ' A' ' 40' ' ' THR . 0.9 OUTLIER -120.65 147.4 45.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.537 0.684 . . . . 0.0 112.701 -178.943 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.692 HD12 ' O ' ' A' ' 130' ' ' ILE . 3.5 mp -122.93 147.38 46.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 114.861 -1.063 . . . . 0.0 109.369 179.534 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.505 HG22 ' HB2' ' A' ' 129' ' ' GLU . 23.5 t -131.76 140.28 48.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 C-N-CA 120.769 -0.372 . . . . 0.0 111.657 -179.314 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.63 ' CG2' HD11 ' A' ' 147' ' ' ILE . 0.0 OUTLIER -115.4 139.85 39.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.809 179.64 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 39.2 t80 -117.51 105.06 11.69 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.904 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.895 HG12 HD12 ' A' ' 124' ' ' LEU . 3.5 mp -98.96 130.57 47.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.298 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . 0.413 ' ND2' ' O ' ' A' ' 32' ' ' ILE . 11.1 p30 -89.06 133.43 34.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.81 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -67.71 -20.06 65.23 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.264 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.46 -42.93 83.48 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.895 0.379 . . . . 0.0 110.591 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . 0.544 ' HE2' ' HB3' ' A' ' 50' ' ' ALA . 31.2 t80 . . . . . 0 C--N 1.327 -0.383 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.754 179.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 . . . . . 0 C--O 1.232 0.152 0 CA-C-O 120.787 0.327 . . . . 0.0 110.96 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.572 ' HA ' HD11 ' A' ' 52' ' ' ILE . 11.2 m-20 -108.23 -13.11 14.97 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-O 121.933 0.873 . . . . 0.0 108.979 178.626 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.835 HD13 ' O ' ' A' ' 48' ' ' LEU . 0.1 OUTLIER -70.78 103.46 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.518 0 CA-C-N 113.94 -1.482 . . . . 0.0 111.268 -179.274 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 1.076 HG23 ' HB2' ' A' ' 50' ' ' ALA . 0.4 OUTLIER -33.37 -62.8 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 CA-C-N 115.25 -0.886 . . . . 0.0 112.065 -179.297 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.631 ' N ' ' CG1' ' A' ' 33' ' ' VAL . 67.2 m -162.42 165.26 26.57 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.401 -179.299 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.39 114.96 18.23 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.669 179.125 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 1.035 HG12 HD21 ' A' ' 143' ' ' LEU . 1.8 t -89.16 129.08 40.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.427 179.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.928 HG23 HG12 ' A' ' 45' ' ' ILE . 26.0 mt -122.6 108.45 21.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -178.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.537 ' SG ' HD23 ' A' ' 143' ' ' LEU . 0.0 OUTLIER -102.5 107.86 18.97 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 177.783 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.6 t -113.92 -24.49 9.05 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 -178.143 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.592 HG21 ' HB3' ' A' ' 142' ' ' SER . 17.1 p -56.01 -26.16 47.5 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.765 0.316 . . . . 0.0 111.348 -179.489 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 124.53 66.84 0.19 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.642 -0.789 . . . . 0.0 112.674 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.648 ' CB ' HD12 ' A' ' 43' ' ' ILE . 21.9 mt-30 -141.13 -71.92 0.35 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.765 0.317 . . . . 0.0 110.666 179.752 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.648 HD12 ' CB ' ' A' ' 42' ' ' GLN . 3.9 mp -135.33 136.65 24.76 Favored Pre-proline 0 N--CA 1.452 -0.37 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.084 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.48 ' HD2' ' CZ ' ' A' ' 76' ' ' TYR . 31.3 Cg_exo -58.8 147.29 89.3 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.576 2.184 . . . . 0.0 111.739 179.508 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.928 HG12 HG23 ' A' ' 37' ' ' ILE . 48.8 mt -38.04 140.19 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 CA-C-O 121.004 0.43 . . . . 0.0 111.83 -179.503 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.435 ' HG2' ' O ' ' A' ' 75' ' ' ASP . 0.0 OUTLIER -137.26 130.42 30.86 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.318 179.864 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.548 ' C ' HD23 ' A' ' 48' ' ' LEU . 0.7 OUTLIER -94.7 120.27 34.66 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.028 0.442 . . . . 0.0 111.538 -179.339 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.835 ' O ' HD13 ' A' ' 32' ' ' ILE . 1.2 mt -100.35 129.84 46.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.821 179.295 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.479 ' HB3' HG12 ' A' ' 32' ' ' ILE . 0.1 OUTLIER -120.91 162.92 19.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 122.091 0.948 . . . . 0.0 113.364 -179.118 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 1.076 ' HB2' HG23 ' A' ' 33' ' ' VAL . . . -127.34 166.59 17.55 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.456 -1.247 . . . . 0.0 111.064 179.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -104.8 92.37 4.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.365 179.607 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.572 HD11 ' HA ' ' A' ' 31' ' ' ASN . 45.6 mt . . . . . 0 C--N 1.33 -0.242 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.929 -179.363 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 4.3 tptm . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.888 0.375 . . . . 0.0 110.77 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 16.6 ttpt -117.06 133.49 55.94 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.687 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.611 HG13 ' O ' ' A' ' 91' ' ' ILE . 23.9 t -136.9 139.25 44.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.181 0.515 . . . . 0.0 111.856 -179.497 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . 0.739 ' CD1' HD22 ' A' ' 48' ' ' LEU . 13.1 m-90 -100.36 137.73 38.38 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.472 179.03 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.615 HG23 ' CG ' ' A' ' 90' ' ' GLN . 17.6 m -132.38 129.09 38.92 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.586 0.707 . . . . 0.0 112.712 179.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.499 ' HE1' HD12 ' A' ' 91' ' ' ILE . 18.4 m-85 -101.32 118.87 37.85 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.02 -0.991 . . . . 0.0 108.76 177.399 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.594 ' HA2' ' O ' ' A' ' 85' ' ' SER . . . 157.99 -156.53 27.44 Favored Glycine 0 CA--C 1.503 -0.698 0 C-N-CA 118.723 -1.703 . . . . 0.0 113.261 179.491 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 2.1 mtp180 -74.97 91.84 2.53 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-O 122.496 1.141 . . . . 0.0 108.561 -179.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.52 ' O ' ' CD2' ' A' ' 77' ' ' HIS . 17.5 m120 -149.76 159.31 36.25 Favored Pre-proline 0 C--N 1.308 -1.226 0 CA-C-N 112.764 -2.016 . . . . 0.0 108.036 179.148 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.549 ' O ' ' HB2' ' A' ' 77' ' ' HIS . 28.9 Cg_endo -64.33 -7.03 12.92 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 120.79 0.994 . . . . 0.0 110.845 178.006 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.71 ' HB2' ' HB2' ' A' ' 77' ' ' HIS . . . 136.43 52.38 0.0 OUTLIER 'General case' 0 CA--C 1.49 -1.36 0 CA-C-N 114.542 -1.208 . . . . 0.0 109.281 178.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.559 ' HB3' ' HB ' ' A' ' 67' ' ' THR . 0.1 OUTLIER -52.85 -69.48 0.11 Allowed 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 105.823 -1.918 . . . . 0.0 105.823 179.57 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.515 ' N ' ' O ' ' A' ' 67' ' ' THR . 6.1 t70 -95.06 -48.27 6.03 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 105.544 -2.021 . . . . 0.0 105.544 169.649 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.48 ' CZ ' ' HD2' ' A' ' 44' ' ' PRO . 29.0 t80 -144.74 142.61 30.16 Favored 'General case' 0 C--N 1.345 0.402 0 CA-C-N 112.527 -2.124 . . . . 0.0 111.779 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . 0.71 ' HB2' ' HB2' ' A' ' 73' ' ' ALA . 23.4 t-160 -97.82 106.96 19.34 Favored 'General case' 0 C--N 1.33 -0.244 0 O-C-N 122.091 -0.381 . . . . 0.0 110.043 176.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.445 HD21 ' HA2' ' A' ' 69' ' ' GLY . 0.7 OUTLIER -121.57 -176.48 3.32 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.899 0.38 . . . . 0.0 111.569 -179.841 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -62.21 -174.41 1.98 Allowed Glycine 0 C--N 1.332 0.344 0 C-N-CA 120.953 -0.642 . . . . 0.0 112.445 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -111.89 98.38 7.34 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.926 0.393 . . . . 0.0 111.772 -179.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.625 ' HB ' ' HB2' ' A' ' 85' ' ' SER . 1.4 mp -114.85 115.18 48.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.252 178.737 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -56.43 -24.26 43.99 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 -179.077 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -90.07 -105.34 0.09 Allowed 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -178.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.444 ' HB3' ' CE1' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -109.11 111.96 23.87 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-O 121.466 0.65 . . . . 0.0 110.132 -179.522 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.625 ' HB2' ' HB ' ' A' ' 81' ' ' ILE . 0.6 OUTLIER 160.17 -48.02 0.0 OUTLIER 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 114.396 -1.275 . . . . 0.0 109.209 -179.753 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.846 ' O ' ' N ' ' A' ' 88' ' ' HIS . 91.6 m-20 -64.92 -151.19 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.247 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 177.546 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.904 ' HB2' HD11 ' A' ' 104' ' ' ILE . 2.1 pttp -46.82 74.42 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.352 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.975 ' O ' ' O ' ' A' ' 104' ' ' ILE . 32.7 t60 -95.45 -18.76 20.42 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 114.047 1.129 . . . . 0.0 114.047 -176.763 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.638 ' HA ' ' H ' ' A' ' 104' ' ' ILE . 0.1 OUTLIER -174.57 154.79 2.1 Favored 'General case' 0 C--N 1.312 -1.046 0 C-N-CA 118.912 -1.115 . . . . 0.0 113.089 178.125 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.615 ' CG ' HG23 ' A' ' 67' ' ' THR . 31.7 mt-30 -137.05 158.4 44.55 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.397 -1.274 . . . . 0.0 113.858 -177.726 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.669 ' HB ' ' HB2' ' A' ' 66' ' ' TRP . 13.4 mt -129.92 127.67 64.08 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.204 178.708 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.891 HD13 ' OD1' ' A' ' 121' ' ' ASN . 0.3 OUTLIER -102.99 142.05 34.74 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.103 0.478 . . . . 0.0 111.874 -179.56 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.851 HD22 ' N ' ' A' ' 94' ' ' GLY . 0.4 OUTLIER -125.74 130.36 51.33 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.481 179.32 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.851 ' N ' HD22 ' A' ' 93' ' ' LEU . . . . . . . . 0 N--CA 1.45 -0.384 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.621 179.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 1.006 HD12 HD22 ' A' ' 124' ' ' LEU . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.18 0 CA-C-O 120.713 0.292 . . . . 0.0 110.742 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.571 HD23 ' O ' ' A' ' 122' ' ' GLN . 14.8 mt -133.61 148.38 51.56 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.523 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.43 ' O ' ' N ' ' A' ' 122' ' ' GLN . 5.5 mp -112.68 132.18 55.3 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 179.292 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.723 ' HB2' HD12 ' A' ' 92' ' ' LEU . 20.4 t30 -113.33 111.8 22.61 Favored 'General case' 0 CA--C 1.509 -0.607 0 C-N-CA 119.868 -0.733 . . . . 0.0 110.046 -179.773 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.703 ' HB3' HG21 ' A' ' 109' ' ' THR . 72.8 m-20 -84.81 112.26 20.36 Favored 'General case' 0 N--CA 1.442 -0.87 0 C-N-CA 119.835 -0.746 . . . . 0.0 109.452 179.476 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.975 ' O ' ' O ' ' A' ' 88' ' ' HIS . 0.1 OUTLIER -123.16 107.56 19.42 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.018 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 177.875 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.415 ' OG ' ' NE2' ' A' ' 88' ' ' HIS . 75.8 m -130.81 170.74 13.98 Favored 'General case' 0 C--N 1.294 -1.833 0 CA-C-N 114.95 -1.023 . . . . 0.0 109.372 179.646 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 25.1 m -69.39 -63.02 1.15 Allowed 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 118.965 -1.094 . . . . 0.0 111.234 -179.334 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -112.27 -33.21 6.28 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 114.551 1.315 . . . . 0.0 114.551 178.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -146.63 130.26 3.59 Favored Glycine 0 C--N 1.34 0.775 0 N-CA-C 116.976 1.55 . . . . 0.0 116.976 -177.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.703 HG21 ' HB3' ' A' ' 103' ' ' ASP . 6.3 m -121.06 138.23 54.28 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 174.262 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . 0.688 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.4 m-90 -119.6 149.28 42.21 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 113.407 0.892 . . . . 0.0 113.407 -178.461 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.475 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -120.96 112.03 18.25 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 115.162 -0.926 . . . . 0.0 108.638 177.495 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 66.9 m-20 44.7 43.17 6.49 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.126 -0.488 . . . . 0.0 112.085 -179.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 79.74 26.81 55.56 Favored Glycine 0 N--CA 1.444 -0.813 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.743 179.349 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . 0.45 ' O ' HG13 ' A' ' 116' ' ' VAL . 38.6 tt0 -138.11 98.18 3.57 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.073 0.464 . . . . 0.0 110.929 179.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.688 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.0 OUTLIER -45.29 128.76 7.91 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.97 179.725 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.45 HG13 ' O ' ' A' ' 114' ' ' GLN . 28.3 m -121.12 -179.31 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.845 -179.329 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -85.65 141.83 29.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.921 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.431 ' HG3' ' HA ' ' A' ' 104' ' ' ILE . 86.7 tttt -66.38 163.14 18.86 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.226 179.471 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.411 ' C ' ' O ' ' A' ' 118' ' ' LYS . 8.1 m-80 34.24 39.05 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 121.203 0.525 . . . . 0.0 111.13 -179.4 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.409 ' OG ' ' NE2' ' A' ' 122' ' ' GLN . 14.8 p -111.13 115.25 29.09 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.991 -179.443 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.891 ' OD1' HD13 ' A' ' 92' ' ' LEU . 11.9 m-80 -59.63 138.52 57.71 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.534 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . 0.571 ' O ' HD23 ' A' ' 100' ' ' LEU . 31.5 mm-40 -129.07 144.91 51.35 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.163 0.506 . . . . 0.0 111.829 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.4 tp -72.39 127.03 31.31 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.976 179.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 1.006 HD22 HD12 ' A' ' 99' ' ' LEU . 4.7 tp -55.7 143.33 30.94 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.899 0.856 . . . . 0.0 111.763 -179.145 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.746 ' O ' HD11 ' A' ' 147' ' ' ILE . 0.6 OUTLIER -126.87 151.98 47.66 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 114.049 -1.432 . . . . 0.0 109.92 179.133 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . 0.473 ' HA ' HD12 ' A' ' 147' ' ' ILE . 0.0 OUTLIER -71.44 114.13 9.19 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.962 0.411 . . . . 0.0 109.988 179.752 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 69.66 25.83 75.1 Favored Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.333 -179.374 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -54.97 159.62 2.3 Favored 'General case' 0 C--N 1.334 -0.103 0 CA-C-O 121.001 0.429 . . . . 0.0 111.068 -179.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.471 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 1.1 tt0 -146.56 135.26 22.21 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.559 -179.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.698 HD13 ' OD1' ' A' ' 103' ' ' ASP . 3.5 mt -111.37 127.94 68.19 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.184 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 178.53 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.465 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 29.4 m -103.39 144.31 31.55 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.505 -179.531 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.488 ' O ' HD12 ' A' ' 141' ' ' LEU . 5.4 m -140.91 156.31 22.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -179.042 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 72.42 40.05 55.52 Favored Glycine 0 N--CA 1.446 -0.682 0 CA-C-N 115.891 -0.595 . . . . 0.0 112.366 179.599 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.462 HG12 ' N ' ' A' ' 135' ' ' GLY . 95.1 t -75.7 156.64 5.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 121.38 0.61 . . . . 0.0 112.06 -179.256 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . 0.462 ' N ' HG12 ' A' ' 134' ' ' VAL . . . 153.74 -47.35 0.54 Allowed Glycine 0 N--CA 1.441 -0.971 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.8 -179.281 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.646 HG12 ' H ' ' A' ' 138' ' ' SER . 49.3 t -126.66 134.49 66.17 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 CA-C-N 115.216 -0.492 . . . . 0.0 109.908 178.714 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.418 ' HA ' HD12 ' A' ' 140' ' ' ILE . 14.2 pt-20 -51.29 -31.66 22.14 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.835 0.35 . . . . 0.0 111.263 -179.419 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . 0.646 ' H ' HG12 ' A' ' 136' ' ' VAL . 0.6 OUTLIER -94.05 6.34 48.84 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.119 -0.491 . . . . 0.0 112.118 -179.538 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -129.79 29.62 4.98 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 112.543 0.571 . . . . 0.0 112.543 -179.343 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.465 ' CG2' ' CG2' ' A' ' 131' ' ' THR . 28.3 mt -104.99 141.24 20.8 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.073 179.22 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.488 HD12 ' O ' ' A' ' 132' ' ' VAL . 1.6 mp -118.63 134.94 54.74 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.492 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . 0.592 ' HB3' HG21 ' A' ' 40' ' ' THR . 42.4 t -115.04 152.23 32.85 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.761 0.791 . . . . 0.0 112.686 -179.089 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 1.035 HD21 HG12 ' A' ' 36' ' ' VAL . 1.3 tm? -135.85 129.44 32.38 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 114.488 -1.233 . . . . 0.0 108.96 179.169 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.765 ' N ' HD22 ' A' ' 143' ' ' LEU . 21.4 t -119.78 140.21 44.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.934 0.397 . . . . 0.0 111.83 -178.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -110.56 139.67 33.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.851 179.558 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -115.23 118.71 34.08 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.586 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.762 HG12 HD21 ' A' ' 124' ' ' LEU . 1.7 mt -98.26 133.56 40.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.986 0.422 . . . . 0.0 111.775 -179.602 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 18.5 p-10 -77.94 124.39 27.95 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.738 179.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -66.16 -24.87 66.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.313 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 3.2 mptt -59.22 -44.33 92.31 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.991 0.424 . . . . 0.0 110.844 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 20.3 t80 . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.093 -179.855 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 . . . . . 0 C--O 1.23 0.07 0 CA-C-O 120.737 0.303 . . . . 0.0 111.275 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -109.43 -13.81 14.52 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-O 121.856 0.836 . . . . 0.0 109.043 178.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.609 ' CG2' ' O ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -70.97 95.46 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.534 0 CA-C-N 114.032 -1.44 . . . . 0.0 111.166 -179.08 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.62 ' CG2' ' HB2' ' A' ' 50' ' ' ALA . 0.4 OUTLIER -32.58 -62.13 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 CA-C-N 115.081 -0.963 . . . . 0.0 111.647 -179.946 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.604 ' N ' ' CG1' ' A' ' 33' ' ' VAL . 23.2 p -165.85 163.44 18.69 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.962 179.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 6.7 ttm180 -122.58 125.99 46.81 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.096 179.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.676 HG21 ' CZ ' ' A' ' 68' ' ' PHE . 12.3 m -93.67 137.0 23.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.993 -0.548 . . . . 0.0 111.169 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.857 HG23 HG12 ' A' ' 45' ' ' ILE . 19.0 mt -130.74 106.88 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 CA-C-O 120.954 0.406 . . . . 0.0 111.787 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.535 ' SG ' HD23 ' A' ' 143' ' ' LEU . 0.1 OUTLIER -99.78 99.73 10.58 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 177.949 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 9.5 t -108.62 26.7 10.22 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -178.322 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.885 HG21 ' HB2' ' A' ' 142' ' ' SER . 77.4 p -111.39 -6.35 14.49 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 111.679 0.252 . . . . 0.0 111.679 179.764 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 101.59 61.64 0.76 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.425 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.575 ' HB3' HD12 ' A' ' 43' ' ' ILE . 3.8 mt-30 -141.66 -69.5 0.37 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.708 0.29 . . . . 0.0 110.904 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.765 HG23 HD21 ' A' ' 78' ' ' LEU . 3.5 mp -135.06 129.92 19.19 Favored Pre-proline 0 N--CA 1.452 -0.36 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.091 179.764 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.435 ' HD2' ' CZ ' ' A' ' 76' ' ' TYR . 35.5 Cg_exo -59.36 147.0 93.12 Favored 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 122.702 2.268 . . . . 0.0 111.848 179.743 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.857 HG12 HG23 ' A' ' 37' ' ' ILE . 40.8 mt -44.73 127.5 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.076 -0.511 . . . . 0.0 112.044 -179.416 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.597 ' O ' HG22 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -130.36 130.25 44.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.92 179.124 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -86.86 119.54 27.19 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.079 0.466 . . . . 0.0 111.629 -179.19 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.987 HD22 ' CD1' ' A' ' 66' ' ' TRP . 9.1 mt -99.5 138.89 35.96 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.054 178.621 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.609 ' OG ' ' N ' ' A' ' 50' ' ' ALA . 45.5 t -131.49 -171.55 2.63 Favored 'General case' 0 CA--C 1.511 -0.536 0 CA-C-O 123.09 1.424 . . . . 0.0 113.971 -179.173 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.62 ' HB2' ' CG2' ' A' ' 33' ' ' VAL . . . -157.16 165.27 36.47 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 112.537 -2.119 . . . . 0.0 110.941 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -106.59 121.76 44.95 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.043 0.449 . . . . 0.0 110.785 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 7.5 mt . . . . . 0 C--N 1.326 -0.432 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.889 -179.581 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.902 0.382 . . . . 0.0 110.938 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.403 ' O ' ' HB3' ' A' ' 93' ' ' LEU . 18.9 ttpt -117.43 131.11 56.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.472 179.609 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.593 HG13 ' O ' ' A' ' 91' ' ' ILE . 9.0 t -130.49 136.94 57.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.99 0.424 . . . . 0.0 111.654 -179.191 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . 0.987 ' CD1' HD22 ' A' ' 48' ' ' LEU . 16.0 m-90 -99.8 138.89 36.25 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.536 179.218 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.837 HG23 ' HG3' ' A' ' 90' ' ' GLN . 2.2 m -131.86 128.33 38.42 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.676 ' CZ ' HG21 ' A' ' 36' ' ' VAL . 81.4 m-85 -96.74 118.09 32.44 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 177.374 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.547 ' HA3' ' C ' ' A' ' 86' ' ' ASN . . . 157.73 -154.87 25.92 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 118.56 -1.781 . . . . 0.0 113.263 179.547 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.515 ' HG2' ' HA ' ' A' ' 80' ' ' ASN . 61.9 mtp180 -75.87 91.09 2.97 Favored 'General case' 0 N--CA 1.44 -0.931 0 CA-C-O 122.481 1.134 . . . . 0.0 108.196 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.465 ' O ' ' CD2' ' A' ' 77' ' ' HIS . 29.2 m-80 -150.12 160.1 34.06 Favored Pre-proline 0 C--N 1.31 -1.143 0 CA-C-N 112.897 -1.956 . . . . 0.0 108.658 179.503 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.528 ' O ' ' CB ' ' A' ' 73' ' ' ALA . 35.6 Cg_endo -65.22 -9.66 22.81 Favored 'Trans proline' 0 N--CA 1.452 -0.931 0 C-N-CA 120.73 0.954 . . . . 0.0 110.564 177.257 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.792 ' HB2' ' HB2' ' A' ' 77' ' ' HIS . . . 138.92 52.47 0.0 OUTLIER 'General case' 0 CA--C 1.492 -1.288 0 CA-C-N 114.537 -1.211 . . . . 0.0 109.405 178.785 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.563 ' HB3' ' HB ' ' A' ' 67' ' ' THR . 0.1 OUTLIER -53.07 -69.87 0.1 Allowed 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 106.135 -1.802 . . . . 0.0 106.135 179.539 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.583 ' HB2' ' N ' ' A' ' 67' ' ' THR . 5.5 t70 -94.14 -47.49 6.63 Favored 'General case' 0 N--CA 1.436 -1.144 0 N-CA-C 105.577 -2.008 . . . . 0.0 105.577 169.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.543 ' C ' ' HA ' ' A' ' 73' ' ' ALA . 14.4 t80 -144.0 142.78 30.89 Favored 'General case' 0 C--N 1.343 0.315 0 CA-C-N 112.37 -2.195 . . . . 0.0 110.91 179.664 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . 0.792 ' HB2' ' HB2' ' A' ' 73' ' ' ALA . 18.7 t-160 -84.83 107.12 16.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 118.41 0.55 . . . . 0.0 110.014 177.589 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.765 HD21 HG23 ' A' ' 43' ' ' ILE . 29.9 mt -111.96 156.63 21.81 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.849 0.357 . . . . 0.0 111.114 -179.662 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -60.26 -160.25 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.586 -0.816 . . . . 0.0 111.792 179.436 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.515 ' HA ' ' HG2' ' A' ' 70' ' ' ARG . 9.4 p30 -109.42 98.9 8.21 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 117.001 0.4 . . . . 0.0 111.112 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.499 ' HB ' ' HB2' ' A' ' 85' ' ' SER . 37.9 mm -113.72 154.61 15.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.567 179.387 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.417 ' N ' HG22 ' A' ' 81' ' ' ILE . 0.8 OUTLIER -67.48 -44.83 77.57 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 -178.922 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 1.6 mpp_? -122.81 -92.09 0.54 Allowed 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 113.658 0.985 . . . . 0.0 113.658 -177.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.487 ' O ' ' CB ' ' A' ' 85' ' ' SER . 0.0 OUTLIER -79.05 101.85 8.07 Favored 'General case' 0 CA--C 1.506 -0.724 0 CA-C-O 121.973 0.892 . . . . 0.0 110.961 -178.546 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.521 ' O ' ' HA2' ' A' ' 69' ' ' GLY . 0.4 OUTLIER 150.03 -28.59 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 113.155 -1.839 . . . . 0.0 108.834 -179.793 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.826 ' O ' ' N ' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -85.47 -164.66 1.04 Allowed 'General case' 0 CA--C 1.51 -0.589 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 177.465 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.923 ' HB2' HD11 ' A' ' 104' ' ' ILE . 2.5 ptmt -47.74 73.85 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 178.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.99 ' O ' ' O ' ' A' ' 104' ' ' ILE . 25.1 t60 -91.66 -17.35 25.63 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 114.243 1.201 . . . . 0.0 114.243 -176.779 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.624 ' HA ' ' H ' ' A' ' 104' ' ' ILE . 0.2 OUTLIER -173.56 155.3 2.73 Favored 'General case' 0 C--N 1.314 -0.938 0 C-N-CA 118.946 -1.102 . . . . 0.0 112.775 177.845 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.837 ' HG3' HG23 ' A' ' 67' ' ' THR . 0.5 OUTLIER -135.18 154.43 51.62 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.579 -1.191 . . . . 0.0 113.868 -177.67 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.666 ' HB ' ' HB2' ' A' ' 66' ' ' TRP . 49.3 mt -124.91 132.14 71.7 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.734 178.435 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.667 HD13 ' ND2' ' A' ' 121' ' ' ASN . 0.3 OUTLIER -108.6 140.57 41.78 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.139 0.495 . . . . 0.0 112.249 -179.168 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.87 HD22 ' N ' ' A' ' 94' ' ' GLY . 0.6 OUTLIER -125.54 135.07 51.87 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.173 179.129 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.87 ' N ' HD22 ' A' ' 93' ' ' LEU . . . . . . . . 0 N--CA 1.45 -0.413 0 C-N-CA 120.605 -0.807 . . . . 0.0 112.693 179.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.769 ' HB2' HD13 ' A' ' 124' ' ' LEU . 8.1 mp . . . . . 0 C--O 1.23 0.076 0 CA-C-O 120.914 0.388 . . . . 0.0 110.878 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.654 HD23 ' HB3' ' A' ' 121' ' ' ASN . 7.9 mp -123.72 148.29 46.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.171 179.735 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.457 ' O ' ' N ' ' A' ' 122' ' ' GLN . 12.3 mt -118.1 130.5 56.17 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.813 -0.355 . . . . 0.0 110.263 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.517 ' HB2' HD11 ' A' ' 92' ' ' LEU . 24.8 t30 -113.32 111.58 22.25 Favored 'General case' 0 CA--C 1.512 -0.516 0 C-N-CA 120.017 -0.673 . . . . 0.0 109.686 179.611 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.687 ' HB3' HG21 ' A' ' 109' ' ' THR . 72.3 m-20 -84.96 111.93 20.13 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 119.826 -0.749 . . . . 0.0 110.13 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.99 ' O ' ' O ' ' A' ' 88' ' ' HIS . 0.1 OUTLIER -124.47 108.18 19.89 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.91 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 177.393 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 67.1 m -129.77 174.16 9.98 Favored 'General case' 0 C--N 1.296 -1.737 0 CA-C-N 115.285 -0.871 . . . . 0.0 109.312 179.353 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 23.3 m -69.25 -63.85 0.99 Allowed 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 118.998 -1.081 . . . . 0.0 111.435 -179.271 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 5.5 p30 -112.48 -32.91 6.33 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 114.181 1.178 . . . . 0.0 114.181 178.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -145.98 131.47 4.13 Favored Glycine 0 C--N 1.339 0.695 0 N-CA-C 116.558 1.383 . . . . 0.0 116.558 -178.133 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.687 HG21 ' HB3' ' A' ' 103' ' ' ASP . 5.8 m -121.19 138.29 54.28 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 174.697 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . 0.769 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.4 m-90 -119.78 149.18 42.47 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 113.503 0.927 . . . . 0.0 113.503 -178.542 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.474 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -122.84 112.25 17.64 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 114.997 -1.001 . . . . 0.0 108.644 177.603 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 46.25 43.73 11.63 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.091 -0.504 . . . . 0.0 112.18 -179.546 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 79.49 17.41 75.91 Favored Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.913 179.257 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -130.39 97.85 4.53 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.053 0.454 . . . . 0.0 110.713 179.634 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.769 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.0 OUTLIER -44.75 134.3 5.62 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.059 179.886 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.552 HG22 ' N ' ' A' ' 117' ' ' GLU . 14.7 p -127.57 164.2 29.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.45 -179.163 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.552 ' N ' HG22 ' A' ' 116' ' ' VAL . 19.1 tt0 -70.13 141.83 52.63 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.975 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.469 ' HG3' ' HA ' ' A' ' 104' ' ' ILE . 36.3 tttm -65.23 163.69 14.76 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.217 179.552 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.4 ' N ' ' HG2' ' A' ' 118' ' ' LYS . 0.8 OUTLIER 36.16 39.13 0.08 Allowed 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 121.255 0.55 . . . . 0.0 110.747 -179.438 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 4.7 p -110.82 108.94 18.94 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.034 -179.305 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.667 ' ND2' HD13 ' A' ' 92' ' ' LEU . 1.6 m-20 -58.77 139.37 56.38 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.798 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . 0.651 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 44.0 mm-40 -129.85 147.42 51.62 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-O 120.964 0.412 . . . . 0.0 111.919 -179.651 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.1 tp -72.3 112.01 8.0 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 178.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.983 HD21 HD13 ' A' ' 147' ' ' ILE . 3.7 tt -44.0 145.91 0.68 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.726 0.774 . . . . 0.0 112.143 -178.716 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -126.4 153.15 45.38 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 114.225 -1.352 . . . . 0.0 110.33 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.56 113.78 8.95 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 179.51 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 70.33 26.5 74.1 Favored Glycine 0 N--CA 1.444 -0.787 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.338 -179.32 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -56.54 159.89 3.52 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.02 0.438 . . . . 0.0 111.198 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.623 ' HG3' HG22 ' A' ' 144' ' ' VAL . 5.1 tt0 -146.53 135.07 22.07 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.415 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.428 ' CG2' ' O ' ' A' ' 110' ' ' TRP . 7.8 mm -111.68 128.31 68.3 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.119 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 178.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.544 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 3.4 m -103.66 144.74 31.04 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.81 -179.493 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.467 HG11 ' NE2' ' A' ' 88' ' ' HIS . 4.4 m -141.28 158.39 22.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 112.462 0.542 . . . . 0.0 112.462 -178.801 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 70.26 43.99 61.23 Favored Glycine 0 N--CA 1.447 -0.586 0 CA-C-N 115.75 -0.659 . . . . 0.0 112.398 179.269 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.499 ' HA ' HG12 ' A' ' 140' ' ' ILE . 93.6 t -79.26 155.73 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 CA-C-O 121.436 0.636 . . . . 0.0 112.234 -179.13 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . 0.436 ' N ' HG12 ' A' ' 134' ' ' VAL . . . 150.07 -43.88 0.72 Allowed Glycine 0 N--CA 1.442 -0.939 0 CA-C-N 114.908 -1.042 . . . . 0.0 110.529 -178.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.55 HG12 ' H ' ' A' ' 138' ' ' SER . 46.3 t -126.6 130.87 71.7 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.687 0 CA-C-N 115.08 -0.56 . . . . 0.0 109.753 178.583 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.442 ' HA ' HD12 ' A' ' 140' ' ' ILE . 7.5 tt0 -51.07 -33.9 27.73 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.731 0.3 . . . . 0.0 111.493 -179.198 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . 0.55 ' H ' HG12 ' A' ' 136' ' ' VAL . 83.0 p -94.14 6.25 49.17 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.243 0.461 . . . . 0.0 112.243 -179.464 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -127.54 30.15 5.39 Favored 'General case' 0 CA--C 1.52 -0.206 0 N-CA-C 112.408 0.521 . . . . 0.0 112.408 -179.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.544 ' CG2' ' CG2' ' A' ' 131' ' ' THR . 14.9 mt -106.0 141.28 21.65 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.935 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.392 179.213 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.494 HD22 ' C ' ' A' ' 140' ' ' ILE . 3.6 mm? -115.64 135.67 53.83 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.052 -0.977 . . . . 0.0 110.51 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . 0.885 ' HB2' HG21 ' A' ' 40' ' ' THR . 4.2 m -120.01 153.67 35.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.814 0.816 . . . . 0.0 112.669 -179.273 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.824 HD22 ' N ' ' A' ' 144' ' ' VAL . 1.2 tm? -135.45 135.38 40.49 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 114.49 -1.232 . . . . 0.0 108.835 179.451 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.824 ' N ' HD22 ' A' ' 143' ' ' LEU . 21.2 t -122.67 140.46 46.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 112.217 0.451 . . . . 0.0 112.217 -178.717 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.559 HG13 HG12 ' A' ' 36' ' ' VAL . 0.6 OUTLIER -108.45 138.79 33.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.43 179.378 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 18.3 t80 -121.23 104.17 9.54 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.783 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.983 HD13 HD21 ' A' ' 124' ' ' LEU . 1.6 mp -102.39 130.67 51.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.281 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 11.3 p30 -78.33 141.16 38.64 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.929 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -73.27 -22.62 60.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.182 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 28.0 mmtt -58.26 -43.87 88.12 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-O 120.898 0.38 . . . . 0.0 110.712 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 11.4 t80 . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.831 179.827 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.733 0.301 . . . . 0.0 110.995 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -108.72 -13.82 14.72 Favored 'General case' 0 CA--C 1.516 -0.347 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 178.333 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.595 ' CG2' ' O ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -70.77 96.33 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.635 0 CA-C-N 113.928 -1.487 . . . . 0.0 110.689 -179.48 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.906 HG23 ' HB3' ' A' ' 50' ' ' ALA . 0.8 OUTLIER -33.46 -62.51 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 114.996 -1.002 . . . . 0.0 112.244 -179.157 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.64 ' N ' HG12 ' A' ' 33' ' ' VAL . 22.4 m -160.7 164.85 31.36 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.092 0.472 . . . . 0.0 111.637 -179.487 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 3.1 tmm_? -132.72 114.34 14.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.445 179.469 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.923 HG23 ' CD2' ' A' ' 48' ' ' LEU . 40.0 t -90.27 136.08 24.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.612 179.767 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.932 HG23 HG12 ' A' ' 45' ' ' ILE . 21.5 mt -124.09 107.97 19.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -179.248 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.799 ' SG ' HD12 ' A' ' 143' ' ' LEU . 70.3 m -99.82 102.91 14.47 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 177.565 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.492 ' CG2' HG22 ' A' ' 37' ' ' ILE . 1.4 p -108.86 -21.54 12.61 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 113.509 0.929 . . . . 0.0 113.509 -176.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.73 HG21 ' HB2' ' A' ' 142' ' ' SER . 34.0 p -55.67 -20.67 14.92 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.745 0.307 . . . . 0.0 111.525 -179.428 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 113.53 62.87 0.43 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.285 179.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.666 ' HG3' HD12 ' A' ' 141' ' ' LEU . 3.2 mt-30 -144.18 -54.16 0.34 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.703 0.287 . . . . 0.0 111.361 -179.718 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.926 HG22 ' HD2' ' A' ' 44' ' ' PRO . 0.0 OUTLIER -134.76 154.62 79.54 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.33 -178.961 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.926 ' HD2' HG22 ' A' ' 43' ' ' ILE . 90.1 Cg_endo -83.78 146.86 11.94 Favored 'Trans proline' 0 N--CA 1.459 -0.511 0 C-N-CA 122.648 2.232 . . . . 0.0 111.569 179.402 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.932 HG12 HG23 ' A' ' 37' ' ' ILE . 40.8 mt -47.85 112.0 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 120.926 0.393 . . . . 0.0 111.728 -179.5 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 7.4 mmm180 -114.91 130.05 56.83 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.684 178.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -97.98 120.08 37.74 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.094 0.473 . . . . 0.0 111.928 -178.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.923 ' CD2' HG23 ' A' ' 36' ' ' VAL . 0.2 OUTLIER -92.59 137.21 32.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.238 178.641 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.534 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -135.79 163.16 30.83 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 113.258 0.836 . . . . 0.0 113.258 -178.601 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.906 ' HB3' HG23 ' A' ' 33' ' ' VAL . . . -157.48 142.16 16.58 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.626 -1.17 . . . . 0.0 111.195 179.111 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -64.31 137.19 57.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.227 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 12.4 mt . . . . . 0 C--N 1.33 -0.271 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.994 179.804 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.232 0.152 0 CA-C-O 120.809 0.337 . . . . 0.0 110.916 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.41 ' O ' ' HB3' ' A' ' 93' ' ' LEU . 12.4 ttpt -134.32 134.44 41.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.585 179.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.621 HG13 ' O ' ' A' ' 91' ' ' ILE . 11.8 t -132.88 137.36 54.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.052 0.453 . . . . 0.0 111.763 -179.125 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . 0.839 ' CD1' HD12 ' A' ' 48' ' ' LEU . 14.9 m-90 -99.6 139.7 34.87 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.431 179.081 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.843 HG23 ' CG ' ' A' ' 90' ' ' GLN . 4.8 m -129.56 131.39 46.54 Favored 'General case' 0 CA--C 1.52 -0.194 0 CA-C-O 121.416 0.626 . . . . 0.0 112.46 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.503 ' CE2' ' CE2' ' A' ' 89' ' ' PHE . 90.1 m-85 -103.03 118.35 36.62 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.12 177.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.574 ' HA2' ' O ' ' A' ' 85' ' ' SER . . . 158.2 -156.12 27.09 Favored Glycine 0 CA--C 1.504 -0.656 0 C-N-CA 118.883 -1.627 . . . . 0.0 112.432 179.468 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.465 ' CD ' ' HB3' ' A' ' 86' ' ' ASN . 7.5 ptm180 -75.74 92.09 2.98 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-O 122.549 1.166 . . . . 0.0 108.377 179.703 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.513 ' O ' ' CD2' ' A' ' 77' ' ' HIS . 17.1 m120 -149.18 159.81 36.21 Favored Pre-proline 0 C--N 1.311 -1.089 0 CA-C-N 112.783 -2.008 . . . . 0.0 108.46 179.511 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.556 ' O ' ' HB2' ' A' ' 77' ' ' HIS . 32.7 Cg_endo -64.96 -7.85 16.39 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 121.025 1.15 . . . . 0.0 111.095 178.295 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.774 ' HB2' ' HB2' ' A' ' 77' ' ' HIS . . . 136.18 50.89 0.0 OUTLIER 'General case' 0 CA--C 1.49 -1.331 0 CA-C-N 114.661 -1.154 . . . . 0.0 109.656 178.704 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.564 ' HB3' ' HB ' ' A' ' 67' ' ' THR . 0.1 OUTLIER -53.24 -69.74 0.11 Allowed 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 105.863 -1.903 . . . . 0.0 105.863 179.438 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.576 ' N ' ' O ' ' A' ' 67' ' ' THR . 11.2 t0 -95.33 -46.92 6.52 Favored 'General case' 0 N--CA 1.435 -1.196 0 N-CA-C 105.915 -1.883 . . . . 0.0 105.915 169.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.55 ' CD2' HG22 ' A' ' 43' ' ' ILE . 61.4 t80 -143.77 142.73 31.05 Favored 'General case' 0 C--N 1.346 0.453 0 CA-C-N 112.62 -2.082 . . . . 0.0 111.113 179.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . 0.774 ' HB2' ' HB2' ' A' ' 73' ' ' ALA . 23.1 t-160 -94.23 108.91 20.75 Favored 'General case' 0 C--N 1.328 -0.329 0 O-C-N 121.984 -0.447 . . . . 0.0 110.413 177.125 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.804 HD12 ' O ' ' A' ' 79' ' ' GLY . 3.9 pp -126.17 170.92 11.33 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.82 0.343 . . . . 0.0 110.735 179.48 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.804 ' O ' HD12 ' A' ' 78' ' ' LEU . . . -53.16 -176.3 0.06 OUTLIER Glycine 0 CA--C 1.518 0.245 0 C-N-CA 120.897 -0.668 . . . . 0.0 112.745 -179.754 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.541 ' C ' HD12 ' A' ' 81' ' ' ILE . 0.5 OUTLIER -108.25 102.25 11.39 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.85 0.357 . . . . 0.0 110.881 179.859 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.741 HD13 ' HB3' ' A' ' 85' ' ' SER . 2.0 mp -110.11 153.99 11.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.919 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 10.0 t -68.19 -45.31 73.76 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 113.72 1.007 . . . . 0.0 113.72 -178.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.778 ' HB3' HD13 ' A' ' 84' ' ' LEU . 3.1 mpt_? -120.4 -90.1 0.59 Allowed 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 113.74 1.015 . . . . 0.0 113.74 -177.338 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.778 HD13 ' HB3' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -84.72 103.51 13.88 Favored 'General case' 0 CA--C 1.506 -0.741 0 CA-C-O 122.014 0.912 . . . . 0.0 110.836 -178.622 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.741 ' HB3' HD13 ' A' ' 81' ' ' ILE . 0.4 OUTLIER 148.13 -35.8 0.01 OUTLIER 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 113.072 -1.876 . . . . 0.0 108.607 -179.812 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.809 ' O ' ' N ' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -70.42 -161.55 0.05 Allowed 'General case' 0 CA--C 1.513 -0.477 0 N-CA-C 107.586 -1.265 . . . . 0.0 107.586 177.492 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.831 ' HB2' HD11 ' A' ' 104' ' ' ILE . 9.6 pttt -51.54 72.82 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 178.129 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.93 ' O ' ' O ' ' A' ' 104' ' ' ILE . 32.9 t60 -84.51 -17.09 40.09 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 114.389 1.255 . . . . 0.0 114.389 -176.374 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.665 ' HA ' ' H ' ' A' ' 104' ' ' ILE . 0.1 OUTLIER -172.09 154.18 3.34 Favored 'General case' 0 C--N 1.31 -1.124 0 C-N-CA 119.124 -1.03 . . . . 0.0 112.48 177.867 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.843 ' CG ' HG23 ' A' ' 67' ' ' THR . 32.9 mt-30 -136.04 159.05 42.88 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 114.52 -1.218 . . . . 0.0 113.902 -177.294 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.733 HD11 HG21 ' A' ' 36' ' ' VAL . 7.1 mt -125.25 131.85 71.86 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 CA-C-N 114.949 -1.023 . . . . 0.0 109.703 178.607 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.662 HD22 ' ND2' ' A' ' 121' ' ' ASN . 0.3 OUTLIER -108.05 143.78 36.29 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.083 0.468 . . . . 0.0 112.111 -179.421 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.71 HD13 ' CG2' ' A' ' 33' ' ' VAL . 14.3 tp -125.6 122.68 37.15 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.349 179.038 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.353 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.401 179.951 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.412 HD22 ' SG ' ' A' ' 34' ' ' CYS . 1.2 mt . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.708 0.29 . . . . 0.0 110.854 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.614 HD22 ' HB3' ' A' ' 121' ' ' ASN . 5.6 mt -133.79 148.46 51.35 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.434 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.447 ' O ' ' N ' ' A' ' 122' ' ' GLN . 38.0 mt -117.27 130.99 56.91 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 179.777 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.512 ' HB2' HD11 ' A' ' 92' ' ' LEU . 23.8 t30 -113.25 111.31 21.83 Favored 'General case' 0 CA--C 1.51 -0.581 0 C-N-CA 119.847 -0.741 . . . . 0.0 109.944 179.684 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.724 ' HB3' HG21 ' A' ' 109' ' ' THR . 70.7 m-20 -84.43 112.52 20.44 Favored 'General case' 0 N--CA 1.444 -0.773 0 C-N-CA 119.669 -0.812 . . . . 0.0 109.381 179.4 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.93 ' O ' ' O ' ' A' ' 88' ' ' HIS . 0.1 OUTLIER -122.91 107.61 19.67 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.876 0 CA-C-O 121.756 0.789 . . . . 0.0 108.96 178.136 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.439 ' OG ' ' NE2' ' A' ' 88' ' ' HIS . 66.8 m -132.39 171.49 13.67 Favored 'General case' 0 C--N 1.295 -1.77 0 CA-C-N 114.757 -1.11 . . . . 0.0 109.36 179.551 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 22.6 m -69.5 -63.8 1.0 Allowed 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 118.998 -1.081 . . . . 0.0 111.706 -178.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 5.5 p30 -112.6 -32.76 6.35 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 114.63 1.344 . . . . 0.0 114.63 179.203 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -146.13 129.17 3.28 Favored Glycine 0 C--N 1.339 0.719 0 N-CA-C 116.931 1.532 . . . . 0.0 116.931 -177.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.724 HG21 ' HB3' ' A' ' 103' ' ' ASP . 6.5 m -121.15 138.36 54.24 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 174.411 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . 0.639 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.7 m-90 -120.45 149.2 42.76 Favored 'General case' 0 CA--C 1.515 -0.374 0 N-CA-C 113.283 0.846 . . . . 0.0 113.283 -178.447 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.469 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -121.64 111.85 17.71 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 115.001 -0.999 . . . . 0.0 108.563 177.44 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 44.74 43.79 7.06 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.125 -0.489 . . . . 0.0 112.114 -179.511 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 78.88 31.4 44.0 Favored Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.891 179.238 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -141.95 98.93 3.42 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.999 0.428 . . . . 0.0 110.832 179.648 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.639 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.2 OUTLIER -45.22 122.59 3.49 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.786 179.727 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.515 HG21 ' OD2' ' A' ' 103' ' ' ASP . 8.1 m -112.35 179.56 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.902 -179.047 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.431 ' HB3' ' HB3' ' A' ' 120' ' ' SER . 0.5 OUTLIER -88.13 136.96 32.73 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.809 179.89 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.405 ' HG2' ' N ' ' A' ' 119' ' ' ASN . 63.7 tttm -62.73 162.39 10.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.534 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.405 ' N ' ' HG2' ' A' ' 118' ' ' LYS . 4.0 p30 34.46 38.54 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.364 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.431 ' HB3' ' HB3' ' A' ' 117' ' ' GLU . 9.0 p -111.28 114.23 27.28 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.055 -179.334 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.662 ' ND2' HD22 ' A' ' 92' ' ' LEU . 1.6 m120 -61.76 136.26 57.92 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.616 179.777 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . 0.608 ' C ' HD23 ' A' ' 100' ' ' LEU . 32.0 mm-40 -129.53 145.37 51.47 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.119 0.485 . . . . 0.0 112.161 -179.613 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.6 tp -72.62 120.03 17.67 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.562 178.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.567 ' C ' HD22 ' A' ' 124' ' ' LEU . 0.0 OUTLIER -47.6 149.22 1.23 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 122.026 0.917 . . . . 0.0 112.346 -178.661 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.435 ' O ' ' CD1' ' A' ' 147' ' ' ILE . 0.0 OUTLIER -126.42 152.56 46.2 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 114.102 -1.408 . . . . 0.0 109.661 179.195 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.62 113.75 8.03 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.07 0.462 . . . . 0.0 110.136 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 66.49 29.96 75.69 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.375 -179.469 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.452 ' OD2' HD13 ' A' ' 111' ' ' LEU . 9.8 t70 -58.31 161.05 4.61 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.98 0.419 . . . . 0.0 111.343 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -146.28 135.35 22.63 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.044 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.464 ' CD1' ' CE1' ' A' ' 89' ' ' PHE . 3.9 mt -109.91 128.53 65.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 120.831 0.348 . . . . 0.0 110.258 179.213 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.482 HG23 ' CG2' ' A' ' 140' ' ' ILE . 16.8 m -103.19 142.66 33.79 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.634 -179.57 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.5 HG11 ' CD2' ' A' ' 88' ' ' HIS . 4.4 m -140.72 154.09 21.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.298 -0.41 . . . . 0.0 112.008 -179.11 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 75.16 37.03 43.86 Favored Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 121.127 -0.559 . . . . 0.0 112.402 179.549 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.489 ' HA ' HG12 ' A' ' 140' ' ' ILE . 91.5 t -72.89 156.75 6.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 121.44 0.638 . . . . 0.0 112.081 -179.174 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . 0.461 ' N ' HG12 ' A' ' 134' ' ' VAL . . . 153.59 -47.86 0.53 Allowed Glycine 0 N--CA 1.442 -0.957 0 N-CA-C 110.665 -0.974 . . . . 0.0 110.665 -179.297 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.65 HG12 ' H ' ' A' ' 138' ' ' SER . 56.1 t -126.71 134.61 65.87 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.682 0 CA-C-N 115.295 -0.453 . . . . 0.0 109.877 178.607 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.447 ' HA ' HD12 ' A' ' 140' ' ' ILE . 12.6 pt-20 -51.19 -32.06 22.3 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.841 0.353 . . . . 0.0 111.19 -179.36 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . 0.65 ' H ' HG12 ' A' ' 136' ' ' VAL . 90.2 p -94.09 6.26 49.13 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 116.159 -0.473 . . . . 0.0 112.088 -179.657 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -129.31 29.14 5.16 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 112.376 0.51 . . . . 0.0 112.376 -179.487 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.489 HG12 ' HA ' ' A' ' 134' ' ' VAL . 23.6 mt -104.88 140.95 21.37 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 CA-C-N 115.668 -0.697 . . . . 0.0 111.154 179.157 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.666 HD12 ' HG3' ' A' ' 42' ' ' GLN . 4.6 mm? -117.23 135.22 53.96 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 114.925 -1.034 . . . . 0.0 110.06 179.489 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . 0.764 ' O ' HD13 ' A' ' 143' ' ' LEU . 4.1 m -119.13 152.79 35.92 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.833 0.825 . . . . 0.0 112.581 -179.144 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.799 HD12 ' SG ' ' A' ' 38' ' ' CYS . 1.8 mm? -132.11 153.88 50.04 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 114.401 -1.272 . . . . 0.0 109.174 179.25 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 22.1 t -128.08 140.55 48.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 120.946 0.403 . . . . 0.0 111.777 -179.348 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.759 HG13 HG22 ' A' ' 36' ' ' VAL . 0.4 OUTLIER -113.88 126.58 71.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.333 179.61 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 7.7 t80 -108.84 119.52 39.79 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.054 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.454 HD13 HD23 ' A' ' 124' ' ' LEU . 2.7 mp -112.1 123.0 67.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.881 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . 0.409 ' ND2' ' O ' ' A' ' 32' ' ' ILE . 3.1 p30 -76.31 122.88 25.07 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.923 0.392 . . . . 0.0 111.087 -179.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -73.82 -19.44 60.75 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.078 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.82 -42.98 85.46 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 120.962 0.411 . . . . 0.0 110.732 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 4.7 t80 . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.64 179.861 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 . . . . . 0 CA--C 1.527 0.094 0 CA-C-O 120.642 0.258 . . . . 0.0 111.369 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -109.42 -14.45 14.42 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-O 121.936 0.874 . . . . 0.0 108.681 178.463 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.587 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 0.1 OUTLIER -71.08 108.99 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.662 0 CA-C-N 113.949 -1.478 . . . . 0.0 111.121 -179.464 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.781 HG11 HD13 ' A' ' 93' ' ' LEU . 2.2 t -53.35 -67.19 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.834 0 CA-C-N 114.946 -1.025 . . . . 0.0 111.459 -179.576 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 18.3 p -155.23 165.08 37.79 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.022 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 1.5 ttm180 -129.33 115.48 17.63 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.402 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.913 HG12 HD21 ' A' ' 143' ' ' LEU . 66.6 t -89.05 130.09 38.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.149 -0.478 . . . . 0.0 109.901 179.183 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.976 HG23 HG12 ' A' ' 45' ' ' ILE . 28.0 mt -122.23 108.54 22.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -178.802 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.632 ' SG ' HD23 ' A' ' 143' ' ' LEU . 0.1 OUTLIER -95.92 101.65 13.35 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 177.599 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -111.47 2.32 17.42 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -178.049 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.86 HG21 ' HB2' ' A' ' 142' ' ' SER . 67.8 p -83.76 -16.35 45.1 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.784 -0.366 . . . . 0.0 111.402 179.646 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 113.71 58.83 0.4 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.587 179.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.47 ' HB2' HD12 ' A' ' 43' ' ' ILE . 6.1 mt-30 -134.6 -69.42 0.52 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.641 0.258 . . . . 0.0 111.134 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.47 HD12 ' HB2' ' A' ' 42' ' ' GLN . 3.7 mp -135.09 139.07 30.83 Favored Pre-proline 0 N--CA 1.452 -0.336 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.185 -179.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.541 ' HD2' ' CZ ' ' A' ' 76' ' ' TYR . 28.2 Cg_exo -59.26 147.32 91.38 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.718 2.278 . . . . 0.0 111.68 179.607 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.976 HG12 HG23 ' A' ' 37' ' ' ILE . 32.0 mt -46.33 148.72 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 121.008 0.432 . . . . 0.0 111.689 -179.633 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.1 130.28 13.61 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.187 179.445 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.421 ' HB3' HD11 ' A' ' 32' ' ' ILE . 1.8 m-20 -91.58 119.77 31.78 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.086 0.469 . . . . 0.0 111.168 -179.649 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.911 ' CD2' HG23 ' A' ' 36' ' ' VAL . 0.1 OUTLIER -92.5 123.34 35.74 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.479 179.129 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.687 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -132.99 155.98 48.16 Favored 'General case' 0 CA--C 1.515 -0.398 0 N-CA-C 114.04 1.126 . . . . 0.0 114.04 -178.979 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.58 ' N ' HG23 ' A' ' 33' ' ' VAL . . . -149.9 142.24 24.24 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 113.698 -1.592 . . . . 0.0 110.824 179.028 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -66.46 110.22 3.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.982 0.42 . . . . 0.0 110.89 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 10.7 mt . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.1 179.956 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.1 pttp . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.851 0.358 . . . . 0.0 111.084 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.503 ' HD2' ' HB2' ' A' ' 50' ' ' ALA . 29.2 ttmt -99.69 123.55 44.07 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.237 179.478 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.523 HG13 ' O ' ' A' ' 91' ' ' ILE . 4.7 t -126.11 133.32 69.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.141 0.496 . . . . 0.0 112.09 -178.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . 0.703 ' CD1' HD12 ' A' ' 48' ' ' LEU . 13.3 m-90 -99.34 139.9 34.3 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.229 178.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.569 ' HB ' ' CB ' ' A' ' 74' ' ' CYS . 2.8 m -131.37 129.34 41.23 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.447 0.642 . . . . 0.0 112.436 179.678 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.509 ' CD2' ' CD2' ' A' ' 89' ' ' PHE . 94.2 m-85 -100.13 117.6 34.71 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.415 -0.812 . . . . 0.0 109.091 177.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.608 ' C ' HD11 ' A' ' 78' ' ' LEU . . . 158.19 -157.83 28.64 Favored Glycine 0 CA--C 1.503 -0.695 0 C-N-CA 119.061 -1.542 . . . . 0.0 113.061 179.456 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -75.46 91.49 2.77 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-O 122.726 1.25 . . . . 0.0 108.43 -179.7 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.485 ' O ' ' CD2' ' A' ' 77' ' ' HIS . 0.2 OUTLIER -150.39 155.26 36.61 Favored Pre-proline 0 C--N 1.309 -1.162 0 CA-C-N 112.617 -2.083 . . . . 0.0 108.44 179.34 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.56 ' O ' ' HB2' ' A' ' 77' ' ' HIS . 23.9 Cg_exo -56.9 -11.11 6.62 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 121.406 1.404 . . . . 0.0 111.606 178.254 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.744 ' HB2' ' HB2' ' A' ' 77' ' ' HIS . . . 136.16 51.78 0.0 OUTLIER 'General case' 0 CA--C 1.491 -1.315 0 CA-C-N 115.001 -1.0 . . . . 0.0 109.535 178.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.569 ' CB ' ' HB ' ' A' ' 67' ' ' THR . 0.1 OUTLIER -52.91 -69.55 0.11 Allowed 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 105.919 -1.882 . . . . 0.0 105.919 179.387 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.568 ' HB2' ' N ' ' A' ' 67' ' ' THR . 8.2 t0 -94.48 -47.73 6.43 Favored 'General case' 0 N--CA 1.434 -1.258 0 N-CA-C 105.772 -1.936 . . . . 0.0 105.772 169.784 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.541 ' CZ ' ' HD2' ' A' ' 44' ' ' PRO . 39.0 t80 -145.04 142.37 29.69 Favored 'General case' 0 C--N 1.347 0.473 0 CA-C-N 112.655 -2.066 . . . . 0.0 111.54 179.485 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . 0.744 ' HB2' ' HB2' ' A' ' 73' ' ' ALA . 23.8 t-160 -92.06 107.43 19.21 Favored 'General case' 0 C--N 1.331 -0.196 0 O-C-N 121.846 -0.534 . . . . 0.0 109.906 176.779 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.608 HD11 ' C ' ' A' ' 69' ' ' GLY . 2.6 pp -119.99 176.29 5.5 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.949 0.404 . . . . 0.0 111.48 -179.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.504 ' O ' HD12 ' A' ' 78' ' ' LEU . . . -64.1 -169.98 1.82 Allowed Glycine 0 C--N 1.332 0.324 0 C-N-CA 121.044 -0.598 . . . . 0.0 112.572 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 10.1 p-10 -111.71 98.82 7.68 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.957 0.408 . . . . 0.0 111.604 -179.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.602 ' HB ' ' HB2' ' A' ' 85' ' ' SER . 13.4 mm -113.72 112.1 38.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.302 179.018 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 8.0 t -55.01 -24.24 23.4 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.238 0.458 . . . . 0.0 112.238 -179.236 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -91.49 -109.51 0.1 Allowed 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 -179.027 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.455 ' HB3' ' CE1' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -108.01 112.41 24.96 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 121.619 0.723 . . . . 0.0 109.87 -179.915 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.602 ' HB2' ' HB ' ' A' ' 81' ' ' ILE . 0.4 OUTLIER 162.16 -43.93 0.0 OUTLIER 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 114.285 -1.325 . . . . 0.0 108.932 -179.422 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.843 ' O ' ' N ' ' A' ' 88' ' ' HIS . 96.9 m-20 -65.43 -149.46 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 177.522 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.95 ' HB2' HD11 ' A' ' 104' ' ' ILE . 0.0 OUTLIER -49.79 72.33 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 179.063 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.962 ' C ' ' O ' ' A' ' 104' ' ' ILE . 30.7 t60 -90.58 -16.17 29.23 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 113.813 1.042 . . . . 0.0 113.813 -176.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.639 ' HA ' ' H ' ' A' ' 104' ' ' ILE . 1.0 OUTLIER -174.8 152.66 1.61 Allowed 'General case' 0 C--N 1.311 -1.092 0 C-N-CA 119.484 -0.886 . . . . 0.0 112.257 178.052 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.482 ' O ' ' O ' ' A' ' 102' ' ' ASN . 3.2 tt0 -136.42 154.14 50.88 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 114.656 -1.156 . . . . 0.0 113.638 -177.422 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.71 HD11 HG21 ' A' ' 36' ' ' VAL . 16.4 mt -124.65 131.96 71.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.261 -0.882 . . . . 0.0 109.842 178.623 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.745 HD13 ' ND2' ' A' ' 121' ' ' ASN . 0.1 OUTLIER -113.32 140.23 48.18 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.975 0.417 . . . . 0.0 111.99 -179.378 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.781 HD13 HG11 ' A' ' 33' ' ' VAL . 27.1 tp -125.9 130.66 51.75 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.602 179.116 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.344 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.415 -179.959 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.601 ' C ' HD22 ' A' ' 100' ' ' LEU . 67.8 tp . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.744 0.307 . . . . 0.0 110.836 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.601 HD22 ' C ' ' A' ' 99' ' ' LEU . 3.8 mm? -133.48 147.84 51.68 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.547 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 1.064 HD21 HD13 ' A' ' 145' ' ' ILE . 8.0 mp -117.03 130.67 56.83 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 179.647 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.636 ' HB2' HD11 ' A' ' 92' ' ' LEU . 25.0 t30 -114.84 110.93 20.42 Favored 'General case' 0 CA--C 1.508 -0.64 0 C-N-CA 119.87 -0.732 . . . . 0.0 109.881 179.729 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.796 ' OD2' HG11 ' A' ' 116' ' ' VAL . 63.0 m-20 -82.9 111.85 19.15 Favored 'General case' 0 N--CA 1.442 -0.841 0 C-N-CA 119.63 -0.828 . . . . 0.0 109.326 179.5 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.962 ' O ' ' C ' ' A' ' 88' ' ' HIS . 0.1 OUTLIER -123.55 108.03 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.997 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 178.028 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.478 ' HG ' ' CE1' ' A' ' 88' ' ' HIS . 75.6 m -128.09 171.34 11.98 Favored 'General case' 0 C--N 1.297 -1.702 0 CA-C-N 114.914 -1.039 . . . . 0.0 109.275 179.673 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 26.6 m -69.24 -62.96 1.17 Allowed 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 119.099 -1.04 . . . . 0.0 111.074 -179.393 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 5.7 p30 -111.97 -33.66 6.21 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 114.216 1.191 . . . . 0.0 114.216 178.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -147.02 133.09 4.62 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 116.667 1.427 . . . . 0.0 116.667 -178.253 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.764 HG21 ' HB3' ' A' ' 103' ' ' ASP . 8.3 m -121.01 138.29 54.24 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 174.164 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . 0.756 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.4 m-90 -119.3 149.15 42.27 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 -178.387 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.419 ' O ' ' HG ' ' A' ' 111' ' ' LEU . 0.2 OUTLIER -123.74 112.44 17.35 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 114.842 -1.072 . . . . 0.0 108.647 177.66 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 7.1 m-80 46.46 42.93 11.5 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.951 -0.568 . . . . 0.0 112.34 -179.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.04 -6.5 83.19 Favored Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 120.69 -0.767 . . . . 0.0 113.437 178.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 1.8 mm-40 -110.55 104.77 13.53 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.892 0.377 . . . . 0.0 110.963 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.756 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.0 OUTLIER -44.22 127.85 5.78 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.908 179.721 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.796 HG11 ' OD2' ' A' ' 103' ' ' ASP . 12.3 p -111.95 159.45 11.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.779 -179.049 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.509 ' N ' HG22 ' A' ' 116' ' ' VAL . 14.1 mp0 -70.7 136.86 49.29 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.95 179.773 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.408 ' O ' ' C ' ' A' ' 119' ' ' ASN . 78.7 tttt -63.09 163.86 9.34 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.296 179.594 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.408 ' C ' ' O ' ' A' ' 118' ' ' LYS . 10.5 m-80 34.43 40.61 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.24 -179.537 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 4.9 p -110.99 110.6 21.23 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.86 -179.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.745 ' ND2' HD13 ' A' ' 92' ' ' LEU . 1.9 m120 -62.69 133.97 55.63 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.554 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . 0.501 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 32.7 mm-40 -129.62 145.62 51.48 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.312 0.577 . . . . 0.0 112.357 -179.602 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.428 HD23 ' O ' ' A' ' 124' ' ' LEU . 2.7 tt -72.61 122.77 21.94 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.634 179.018 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.558 ' C ' HD22 ' A' ' 124' ' ' LEU . 0.0 OUTLIER -48.71 148.82 1.96 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 122.067 0.937 . . . . 0.0 112.041 -178.887 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -126.79 153.08 46.07 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 114.195 -1.366 . . . . 0.0 110.153 179.703 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 1.3 mm100 -70.98 113.49 8.08 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 179.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 68.33 28.1 73.44 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.227 -179.096 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.454 ' HB3' HG22 ' A' ' 145' ' ' ILE . 28.2 t70 -53.86 160.09 1.51 Allowed 'General case' 0 C--O 1.231 0.123 0 CA-C-O 120.963 0.411 . . . . 0.0 111.224 -179.675 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.509 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 29.0 tt0 -146.66 134.9 21.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.587 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.452 HG21 ' OD1' ' A' ' 103' ' ' ASP . 7.1 mm -117.56 128.3 74.82 Favored 'Isoleucine or valine' 0 C--O 1.231 0.131 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 178.542 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.504 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 94.6 m -103.49 145.47 29.97 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.632 -179.658 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.506 ' HB ' ' NE2' ' A' ' 88' ' ' HIS . 6.2 m -140.9 157.97 23.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -178.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . 0.403 ' O ' ' O ' ' A' ' 139' ' ' ASP . . . 70.72 40.86 65.02 Favored Glycine 0 N--CA 1.446 -0.637 0 CA-C-N 115.728 -0.669 . . . . 0.0 112.648 179.292 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.484 HG12 ' N ' ' A' ' 135' ' ' GLY . 94.8 t -76.76 157.17 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 CA-C-O 121.409 0.624 . . . . 0.0 112.005 -179.297 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . 0.484 ' N ' HG12 ' A' ' 134' ' ' VAL . . . 152.63 -44.68 0.61 Allowed Glycine 0 N--CA 1.44 -1.037 0 N-CA-C 110.652 -0.979 . . . . 0.0 110.652 -179.271 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.545 HG12 ' H ' ' A' ' 138' ' ' SER . 45.3 t -126.75 134.22 66.76 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.739 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 178.66 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 26.9 tp10 -50.87 -34.51 28.4 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.827 0.346 . . . . 0.0 111.464 -179.182 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . 0.545 ' H ' HG12 ' A' ' 136' ' ' VAL . 37.7 t -93.78 6.23 49.05 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 116.204 -0.453 . . . . 0.0 112.141 -179.507 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . 0.403 ' O ' ' O ' ' A' ' 133' ' ' GLY . 2.3 t70 -125.77 29.25 5.98 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-O 121.124 0.488 . . . . 0.0 112.169 -179.484 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.504 ' CG2' ' CG2' ' A' ' 131' ' ' THR . 25.7 mt -107.17 141.45 22.34 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.328 179.394 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 12.1 mt -123.41 134.79 53.93 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.037 -0.983 . . . . 0.0 110.633 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . 0.86 ' HB2' HG21 ' A' ' 40' ' ' THR . 4.8 m -114.94 153.5 30.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.756 0.788 . . . . 0.0 112.462 -179.352 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.913 HD21 HG12 ' A' ' 36' ' ' VAL . 1.8 tm? -133.83 136.84 44.7 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 114.55 -1.205 . . . . 0.0 109.396 179.701 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.73 ' H ' HD22 ' A' ' 143' ' ' LEU . 15.0 t -118.04 140.3 41.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.903 0.382 . . . . 0.0 111.801 -179.13 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 1.064 HD13 HD21 ' A' ' 101' ' ' LEU . 0.1 OUTLIER -108.01 140.3 26.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.776 179.592 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 37.5 t80 -118.4 122.87 43.86 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.96 -179.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 3.0 mp -115.32 130.23 70.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.11 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 23.6 p-10 -75.28 138.0 41.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.993 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -73.64 -30.24 62.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.934 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -57.44 -40.16 77.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.777 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 6.2 t80 . . . . . 0 N--CA 1.451 -0.393 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.917 -179.942 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.757 0.313 . . . . 0.0 110.936 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.409 ' HA ' ' CD1' ' A' ' 52' ' ' ILE . 1.6 m-20 -109.02 -13.5 14.71 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-O 121.997 0.903 . . . . 0.0 108.626 178.353 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.783 HD13 ' O ' ' A' ' 48' ' ' LEU . 0.1 OUTLIER -70.7 95.57 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.556 0 CA-C-N 113.911 -1.495 . . . . 0.0 110.711 -179.41 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.572 ' CG1' ' N ' ' A' ' 34' ' ' CYS . 0.5 OUTLIER -32.45 -59.94 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 114.874 -1.057 . . . . 0.0 112.379 -179.127 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.707 ' SG ' HD12 ' A' ' 48' ' ' LEU . 31.7 p -164.29 164.88 22.26 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.529 -179.757 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 5.2 ttm180 -127.11 122.62 34.76 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.077 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.71 ' CG2' HD11 ' A' ' 48' ' ' LEU . 24.8 t -93.81 131.74 39.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.669 179.536 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.976 HG23 HG12 ' A' ' 45' ' ' ILE . 32.9 mt -121.18 108.38 22.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 N-CA-C 112.362 0.505 . . . . 0.0 112.362 -179.326 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -98.6 105.66 17.83 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 177.374 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 8.9 t -113.71 -21.22 10.84 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 113.328 0.862 . . . . 0.0 113.328 -177.496 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.813 HG21 ' CB ' ' A' ' 142' ' ' SER . 44.5 p -55.59 -22.22 21.14 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.874 0.369 . . . . 0.0 111.467 -179.475 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 120.73 64.76 0.25 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.353 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.2 mt-30 -141.75 -70.32 0.36 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.773 0.32 . . . . 0.0 111.205 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.56 HG22 ' HD2' ' A' ' 44' ' ' PRO . 0.7 OUTLIER -135.16 139.24 31.2 Favored Pre-proline 0 N--CA 1.453 -0.325 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.113 -179.566 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.56 ' HD2' HG22 ' A' ' 43' ' ' ILE . 26.6 Cg_exo -59.41 147.76 89.83 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.506 2.137 . . . . 0.0 111.379 179.223 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.976 HG12 HG23 ' A' ' 37' ' ' ILE . 43.1 mt -36.33 136.04 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 -179.398 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.48 ' CG ' ' CE2' ' A' ' 76' ' ' TYR . 0.0 OUTLIER -123.26 144.87 49.12 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.337 179.306 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -110.11 119.61 39.82 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.977 0.418 . . . . 0.0 111.259 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.794 HD11 HD13 ' A' ' 91' ' ' ILE . 5.4 mt -98.53 137.88 36.55 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 178.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.566 ' O ' ' HZ2' ' A' ' 66' ' ' TRP . 0.0 OUTLIER -137.8 163.31 31.69 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 113.55 0.944 . . . . 0.0 113.55 -178.646 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.528 ' HB3' HG23 ' A' ' 33' ' ' VAL . . . -138.27 166.03 25.23 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 114.41 -1.268 . . . . 0.0 110.888 179.292 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -92.28 100.52 13.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.943 0.401 . . . . 0.0 111.187 -179.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.409 ' CD1' ' HA ' ' A' ' 31' ' ' ASN . 2.3 mt . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.528 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 4.5 tttt . . . . . 0 C--O 1.232 0.169 0 CA-C-O 120.922 0.392 . . . . 0.0 110.707 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.448 ' O ' ' CZ3' ' A' ' 66' ' ' TRP . 29.9 ttpt -132.55 118.79 19.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.916 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.713 HG23 ' O ' ' A' ' 91' ' ' ILE . 7.9 p -108.61 140.13 28.39 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 CA-C-O 121.37 0.605 . . . . 0.0 112.428 -179.07 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . 0.713 ' CD1' HD22 ' A' ' 48' ' ' LEU . 14.3 m-90 -99.93 139.31 35.78 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.099 -0.955 . . . . 0.0 111.325 179.099 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.867 HG23 ' HG3' ' A' ' 90' ' ' GLN . 10.6 m -127.36 130.07 48.76 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.547 0.689 . . . . 0.0 111.951 179.113 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.646 ' CE2' HG11 ' A' ' 36' ' ' VAL . 11.2 m-85 -102.86 118.33 36.59 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.054 -0.976 . . . . 0.0 108.98 178.099 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.651 ' HA2' ' O ' ' A' ' 85' ' ' SER . . . 157.16 -153.95 25.12 Favored Glycine 0 CA--C 1.505 -0.561 0 C-N-CA 118.765 -1.683 . . . . 0.0 113.317 179.32 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 1.6 mtp180 -75.58 91.94 2.88 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-O 122.593 1.187 . . . . 0.0 108.873 -179.299 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.519 ' O ' ' CD2' ' A' ' 77' ' ' HIS . 33.8 m-80 -150.07 159.62 35.06 Favored Pre-proline 0 C--N 1.308 -1.197 0 CA-C-N 112.761 -2.018 . . . . 0.0 108.102 178.708 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.549 ' O ' ' HB2' ' A' ' 77' ' ' HIS . 31.7 Cg_endo -64.85 -6.78 13.28 Favored 'Trans proline' 0 N--CA 1.453 -0.91 0 C-N-CA 120.637 0.891 . . . . 0.0 110.576 177.33 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.747 ' HB2' ' HB2' ' A' ' 77' ' ' HIS . . . 136.36 52.99 0.0 OUTLIER 'General case' 0 CA--C 1.49 -1.337 0 CA-C-N 114.359 -1.292 . . . . 0.0 109.052 178.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.574 ' HB3' ' HB ' ' A' ' 67' ' ' THR . 0.1 OUTLIER -52.7 -69.93 0.1 Allowed 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 105.497 -2.038 . . . . 0.0 105.497 179.491 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.638 ' HB2' ' N ' ' A' ' 67' ' ' THR . 60.7 t0 -95.85 -47.0 6.33 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 105.834 -1.913 . . . . 0.0 105.834 169.259 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.486 ' C ' ' HA ' ' A' ' 73' ' ' ALA . 0.1 OUTLIER -143.63 141.33 30.55 Favored 'General case' 0 C--N 1.348 0.531 0 CA-C-N 112.77 -2.014 . . . . 0.0 111.855 -179.712 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . 0.747 ' HB2' ' HB2' ' A' ' 73' ' ' ALA . 23.7 t-160 -97.21 106.15 18.42 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 176.306 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.756 HD11 ' O ' ' A' ' 85' ' ' SER . 1.1 pp -123.11 175.52 6.59 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.919 0.39 . . . . 0.0 111.512 -179.583 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -53.54 -179.76 0.12 Allowed Glycine 0 C--N 1.333 0.369 0 C-N-CA 121.015 -0.612 . . . . 0.0 112.573 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.449 ' HA ' ' OD1' ' A' ' 86' ' ' ASN . 5.0 p30 -111.61 98.47 7.45 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.785 0.326 . . . . 0.0 111.582 -179.708 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.703 ' HB ' ' HB2' ' A' ' 85' ' ' SER . 15.0 mm -114.7 117.52 55.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.701 178.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 43.4 t -54.97 -24.18 22.7 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 111.82 0.304 . . . . 0.0 111.82 -179.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.478 ' H ' HG22 ' A' ' 81' ' ' ILE . 3.3 mpt_? -92.44 -102.25 0.12 Allowed 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -179.095 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.422 ' O ' ' HB2' ' A' ' 85' ' ' SER . 0.0 OUTLIER -108.96 109.76 20.9 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-O 121.631 0.729 . . . . 0.0 110.512 -179.702 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.756 ' O ' HD11 ' A' ' 78' ' ' LEU . 0.3 OUTLIER 161.38 -46.0 0.0 OUTLIER 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 114.128 -1.397 . . . . 0.0 109.201 -179.92 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.814 ' O ' ' N ' ' A' ' 88' ' ' HIS . 88.3 m-20 -66.44 -153.44 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 177.658 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.844 ' HB2' HD11 ' A' ' 104' ' ' ILE . 17.2 pttm -49.37 73.64 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 179.095 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 1.053 ' O ' ' O ' ' A' ' 104' ' ' ILE . 36.9 t60 -95.0 -16.5 22.7 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 114.307 1.225 . . . . 0.0 114.307 -176.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.616 ' HA ' ' H ' ' A' ' 104' ' ' ILE . 0.2 OUTLIER -177.39 157.04 1.26 Allowed 'General case' 0 C--N 1.316 -0.881 0 C-N-CA 119.127 -1.029 . . . . 0.0 112.529 178.264 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.867 ' HG3' HG23 ' A' ' 67' ' ' THR . 17.4 mt-30 -137.74 161.81 35.54 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 -177.348 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.794 HD13 HD11 ' A' ' 48' ' ' LEU . 4.7 mt -128.33 132.66 67.99 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 CA-C-N 114.913 -1.039 . . . . 0.0 110.041 178.754 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.66 ' C ' HD22 ' A' ' 93' ' ' LEU . 0.0 OUTLIER -120.52 128.92 53.55 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.851 0.358 . . . . 0.0 111.963 -179.414 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.777 HD13 ' HA ' ' A' ' 99' ' ' LEU . 4.2 mm? -125.71 133.63 52.06 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.842 179.171 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.269 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.425 179.965 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.777 ' HA ' HD13 ' A' ' 93' ' ' LEU . 2.1 mp . . . . . 0 N--CA 1.456 -0.13 0 CA-C-O 120.655 0.264 . . . . 0.0 110.807 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.776 HD22 ' C ' ' A' ' 99' ' ' LEU . 3.6 mm? -133.97 148.05 51.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.784 0.326 . . . . 0.0 111.029 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.556 ' CD1' HD13 ' A' ' 145' ' ' ILE . 3.0 mm? -112.79 131.71 55.57 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 179.203 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.506 ' HB2' HD11 ' A' ' 92' ' ' LEU . 9.7 t30 -109.06 111.96 23.88 Favored 'General case' 0 CA--C 1.508 -0.665 0 C-N-CA 119.742 -0.783 . . . . 0.0 109.963 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.767 ' HB3' HG21 ' A' ' 109' ' ' THR . 31.2 m-20 -86.24 110.65 19.77 Favored 'General case' 0 N--CA 1.44 -0.928 0 C-N-CA 119.319 -0.952 . . . . 0.0 109.231 179.274 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 1.053 ' O ' ' O ' ' A' ' 88' ' ' HIS . 0.1 OUTLIER -123.84 108.5 20.91 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.07 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 177.44 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.474 ' HG ' ' CE1' ' A' ' 88' ' ' HIS . 73.8 m -133.37 169.32 17.1 Favored 'General case' 0 C--N 1.293 -1.858 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.59 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 21.4 m -69.29 -63.05 1.14 Allowed 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 119.061 -1.056 . . . . 0.0 111.328 -179.149 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -112.12 -33.38 6.26 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 114.576 1.324 . . . . 0.0 114.576 179.078 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -146.94 132.64 4.45 Favored Glycine 0 C--N 1.34 0.795 0 N-CA-C 116.875 1.51 . . . . 0.0 116.875 -178.078 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.767 HG21 ' HB3' ' A' ' 103' ' ' ASP . 13.3 m -121.28 137.94 54.46 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 174.386 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . 0.715 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 3.0 m-90 -121.61 148.82 44.04 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 113.599 0.963 . . . . 0.0 113.599 -178.506 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.415 ' O ' ' HG ' ' A' ' 111' ' ' LEU . 0.2 OUTLIER -123.26 112.33 17.51 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 114.969 -1.014 . . . . 0.0 108.637 177.61 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 71.6 m-20 44.71 44.28 7.38 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.032 -0.531 . . . . 0.0 112.213 -179.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 79.75 24.18 60.73 Favored Glycine 0 N--CA 1.445 -0.763 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.739 179.295 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -136.43 97.9 3.69 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.113 0.483 . . . . 0.0 110.819 179.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.715 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.0 OUTLIER -44.63 129.03 6.87 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.969 179.826 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.544 HG11 ' OD2' ' A' ' 103' ' ' ASP . 15.0 p -118.82 162.07 17.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.671 -178.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.533 ' N ' HG22 ' A' ' 116' ' ' VAL . 1.5 tp10 -70.47 142.05 51.97 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.068 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 49.2 tttm -65.42 162.93 16.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.396 179.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 4.1 p30 35.55 37.44 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.313 0.578 . . . . 0.0 111.354 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 5.0 p -111.27 109.49 19.54 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.953 -179.488 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.586 ' ND2' HD22 ' A' ' 92' ' ' LEU . 1.7 m-20 -59.76 139.5 57.24 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.808 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . 0.633 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 29.9 mm-40 -129.25 148.23 51.16 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.878 0.37 . . . . 0.0 111.925 -179.677 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -71.61 131.78 43.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.026 -0.534 . . . . 0.0 109.933 179.463 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.577 ' C ' HD22 ' A' ' 124' ' ' LEU . 0.0 OUTLIER -55.18 147.2 16.88 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 122.258 1.028 . . . . 0.0 112.248 -178.747 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.43 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.5 OUTLIER -127.16 153.38 46.12 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 113.79 -1.55 . . . . 0.0 109.898 179.143 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 4.8 mm-40 -70.81 113.12 7.56 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 179.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 63.05 31.87 82.19 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.019 -179.207 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.43 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 30.2 t70 -51.71 160.51 0.64 Allowed 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 121.015 0.436 . . . . 0.0 111.584 -179.571 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.904 ' HG2' HG22 ' A' ' 144' ' ' VAL . 2.5 mt-10 -146.47 135.43 22.48 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.17 179.779 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.627 HG21 ' OD1' ' A' ' 103' ' ' ASP . 2.6 mp -114.61 128.76 71.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-O 120.802 0.334 . . . . 0.0 110.396 179.151 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.464 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 59.9 m -102.93 145.05 30.42 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.341 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.479 ' HB ' ' NE2' ' A' ' 88' ' ' HIS . 4.8 m -141.01 158.3 23.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -178.582 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 67.11 43.21 90.79 Favored Glycine 0 N--CA 1.447 -0.59 0 CA-C-N 115.621 -0.718 . . . . 0.0 112.334 179.385 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.509 ' HA ' HG12 ' A' ' 140' ' ' ILE . 90.8 t -78.85 156.43 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 CA-C-O 121.49 0.662 . . . . 0.0 112.275 -179.163 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . 0.462 ' N ' HG12 ' A' ' 134' ' ' VAL . . . 147.4 -42.89 0.87 Allowed Glycine 0 N--CA 1.441 -0.984 0 CA-C-N 114.843 -1.072 . . . . 0.0 110.553 -178.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.623 HG12 ' H ' ' A' ' 138' ' ' SER . 47.4 t -126.77 128.13 70.66 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.723 0 CA-C-N 115.157 -0.522 . . . . 0.0 109.796 178.634 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.515 ' HA ' HD12 ' A' ' 140' ' ' ILE . 8.6 tt0 -51.13 -30.14 15.59 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.802 0.334 . . . . 0.0 111.279 -179.342 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . 0.623 ' H ' HG12 ' A' ' 136' ' ' VAL . 28.2 t -94.2 6.46 48.55 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -179.497 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -131.03 29.27 4.71 Favored 'General case' 0 CA--C 1.52 -0.182 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -179.346 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.515 HD12 ' HA ' ' A' ' 137' ' ' GLU . 18.9 mt -105.55 140.97 21.95 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.33 179.103 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 5.4 mp -121.49 134.67 55.07 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 114.971 -1.013 . . . . 0.0 109.846 179.297 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . 0.813 ' CB ' HG21 ' A' ' 40' ' ' THR . 0.9 OUTLIER -119.1 149.73 41.2 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.676 0.751 . . . . 0.0 112.757 -178.721 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.485 ' N ' HD12 ' A' ' 143' ' ' LEU . 4.7 mp -125.34 150.68 46.94 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 114.843 -1.071 . . . . 0.0 109.193 179.372 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.904 HG22 ' HG2' ' A' ' 129' ' ' GLU . 12.1 t -126.87 141.09 47.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 120.904 0.383 . . . . 0.0 111.842 -179.276 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.556 HD13 ' CD1' ' A' ' 101' ' ' LEU . 0.1 OUTLIER -122.72 125.92 73.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.069 179.436 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -115.58 121.38 42.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.961 0.41 . . . . 0.0 111.248 -179.469 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.535 HD11 ' CG2' ' A' ' 145' ' ' ILE . 3.0 mm -104.04 130.03 55.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.788 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . 0.42 ' ND2' ' O ' ' A' ' 32' ' ' ILE . 6.2 p30 -77.42 130.75 37.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.85 0.357 . . . . 0.0 110.78 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -73.02 -22.96 60.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.398 -179.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 1.3 mptp? -57.34 -40.62 78.36 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.913 0.387 . . . . 0.0 110.699 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 4.1 t80 . . . . . 0 N--CA 1.452 -0.345 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.724 179.801 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 8.3 pm0 . . . . . 0 CA--C 1.529 0.142 0 N-CA-C 111.687 0.254 . . . . 0.0 111.687 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.659 ' HA ' HD12 ' A' ' 52' ' ' ILE . 11.3 m-80 -108.75 -14.56 14.58 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-O 121.918 0.866 . . . . 0.0 109.017 178.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.542 HD13 ' O ' ' A' ' 48' ' ' LEU . 0.0 OUTLIER -74.08 105.91 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.533 0 CA-C-N 113.919 -1.491 . . . . 0.0 110.664 -179.6 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 1.027 ' CG2' ' HB2' ' A' ' 50' ' ' ALA . 0.5 OUTLIER -40.26 -62.65 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.712 -179.105 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.739 ' SG ' HD12 ' A' ' 48' ' ' LEU . 31.1 p -164.92 164.96 20.67 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.505 -179.78 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 12.0 ttm180 -126.78 122.4 34.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.842 0.353 . . . . 0.0 111.176 179.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.831 ' CG2' HD11 ' A' ' 48' ' ' LEU . 18.8 t -93.12 124.34 45.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.616 179.643 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.963 HG23 HG12 ' A' ' 45' ' ' ILE . 35.6 mt -121.51 108.49 22.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 112.254 0.464 . . . . 0.0 112.254 -179.178 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 14.6 t -80.28 103.92 10.48 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 177.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.9 p -99.34 22.18 10.98 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 112.454 0.538 . . . . 0.0 112.454 -178.347 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.691 HG21 ' HB2' ' A' ' 142' ' ' SER . 45.5 p -114.21 -13.14 12.4 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 111.657 0.244 . . . . 0.0 111.657 179.78 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 95.63 75.54 1.27 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.602 -0.808 . . . . 0.0 112.616 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.542 ' CG ' HD12 ' A' ' 141' ' ' LEU . 4.8 mt-30 -150.97 -55.68 0.15 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.774 0.321 . . . . 0.0 110.983 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 2.0 mt -134.71 131.14 20.04 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.833 -179.697 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.433 ' HD2' ' CZ ' ' A' ' 76' ' ' TYR . 37.3 Cg_exo -58.87 147.1 90.79 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.569 2.18 . . . . 0.0 111.682 179.721 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.963 HG12 HG23 ' A' ' 37' ' ' ILE . 51.9 mt -42.39 128.97 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 121.03 0.443 . . . . 0.0 112.064 -179.363 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.439 ' HG2' ' O ' ' A' ' 75' ' ' ASP . 0.9 OUTLIER -123.54 130.13 52.22 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.935 179.295 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -95.14 120.16 34.89 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.095 0.474 . . . . 0.0 111.664 -179.13 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.831 HD11 ' CG2' ' A' ' 36' ' ' VAL . 1.6 mt -94.63 126.73 40.12 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.387 178.821 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.494 ' O ' ' HZ2' ' A' ' 66' ' ' TRP . 0.0 OUTLIER -119.62 162.08 19.58 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 122.102 0.953 . . . . 0.0 113.171 -178.731 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 1.027 ' HB2' ' CG2' ' A' ' 33' ' ' VAL . . . -116.47 166.17 12.39 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 114.47 -1.241 . . . . 0.0 111.011 179.596 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -103.99 57.97 0.72 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.098 0.475 . . . . 0.0 110.755 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.736 HD11 ' CE2' ' A' ' 151' ' ' PHE . 46.2 mt . . . . . 0 C--N 1.327 -0.395 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.9 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 10.1 ttmt . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.837 0.351 . . . . 0.0 111.201 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.404 ' HE3' ' O ' ' A' ' 49' ' ' SER . 3.7 ttpt -136.79 134.03 36.6 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.183 179.489 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.508 HG12 ' HG2' ' A' ' 90' ' ' GLN . 3.4 t -123.29 134.6 65.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.214 0.531 . . . . 0.0 112.01 -178.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . 0.786 ' CD1' HD22 ' A' ' 48' ' ' LEU . 12.3 m-90 -100.95 138.86 37.43 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.727 179.2 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.612 ' N ' ' HB2' ' A' ' 75' ' ' ASP . 1.3 m -131.75 127.71 37.36 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.31 0.576 . . . . 0.0 112.315 179.436 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.513 ' CE1' ' CE2' ' A' ' 89' ' ' PHE . 96.2 m-85 -98.32 117.83 33.61 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.423 178.011 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.67 ' HA2' ' O ' ' A' ' 85' ' ' SER . . . 158.9 -157.95 28.94 Favored Glycine 0 CA--C 1.503 -0.716 0 C-N-CA 119.001 -1.571 . . . . 0.0 112.683 179.1 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.407 ' HB3' ' HA ' ' A' ' 80' ' ' ASN . 7.8 ptm180 -76.13 91.92 3.18 Favored 'General case' 0 N--CA 1.441 -0.911 0 CA-C-O 122.614 1.197 . . . . 0.0 108.302 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.483 ' O ' ' CD2' ' A' ' 77' ' ' HIS . 0.1 OUTLIER -149.71 160.4 34.09 Favored Pre-proline 0 C--N 1.309 -1.188 0 CA-C-N 112.787 -2.006 . . . . 0.0 108.261 179.608 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.544 ' O ' ' CB ' ' A' ' 73' ' ' ALA . 29.3 Cg_endo -63.0 -11.04 22.75 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 120.869 1.046 . . . . 0.0 111.03 178.479 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.769 ' HB2' ' HB2' ' A' ' 77' ' ' HIS . . . 137.82 52.32 0.0 OUTLIER 'General case' 0 CA--C 1.491 -1.297 0 CA-C-N 114.743 -1.117 . . . . 0.0 109.685 178.548 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.566 ' CB ' ' HB ' ' A' ' 67' ' ' THR . 0.1 OUTLIER -53.12 -69.92 0.1 Allowed 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 105.957 -1.868 . . . . 0.0 105.957 179.347 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.612 ' HB2' ' N ' ' A' ' 67' ' ' THR . 5.8 t0 -94.26 -47.45 6.62 Favored 'General case' 0 N--CA 1.436 -1.153 0 N-CA-C 105.743 -1.947 . . . . 0.0 105.743 169.754 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.548 ' C ' ' HA ' ' A' ' 73' ' ' ALA . 10.6 t80 -143.37 143.12 31.52 Favored 'General case' 0 C--N 1.344 0.356 0 CA-C-N 112.386 -2.188 . . . . 0.0 110.728 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . 0.769 ' HB2' ' HB2' ' A' ' 73' ' ' ALA . 19.4 t-160 -84.54 114.1 21.71 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.33 -0.548 . . . . 0.0 110.309 177.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 87.2 mt -126.58 166.19 17.76 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.869 0.366 . . . . 0.0 111.099 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -66.02 -166.71 2.06 Favored Glycine 0 C--N 1.33 0.228 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.212 179.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.407 ' HA ' ' HB3' ' A' ' 70' ' ' ARG . 8.6 p30 -111.35 99.1 7.96 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.932 0.396 . . . . 0.0 111.245 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.535 ' HB ' ' HB2' ' A' ' 85' ' ' SER . 29.7 mm -113.84 133.63 59.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.811 179.34 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 5.7 p -66.6 -41.91 87.7 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.794 0.665 . . . . 0.0 112.794 -179.449 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.573 ' C ' HD13 ' A' ' 84' ' ' LEU . 2.2 mpt_? -83.12 -105.76 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 113.11 0.781 . . . . 0.0 113.11 -177.769 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.742 ' H ' HD22 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -107.69 114.6 28.67 Favored 'General case' 0 CA--C 1.511 -0.554 0 CA-C-O 121.637 0.732 . . . . 0.0 109.179 -179.8 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.67 ' O ' ' HA2' ' A' ' 69' ' ' GLY . 0.5 OUTLIER 156.34 -36.25 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 114.054 -1.43 . . . . 0.0 107.885 -178.839 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.802 ' O ' ' N ' ' A' ' 88' ' ' HIS . 0.1 OUTLIER -61.85 -161.56 0.01 OUTLIER 'General case' 0 CA--C 1.51 -0.566 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 176.743 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.785 ' HB2' HD11 ' A' ' 104' ' ' ILE . 0.0 OUTLIER -53.63 72.53 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 177.091 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.928 ' O ' ' O ' ' A' ' 104' ' ' ILE . 28.3 t60 -77.66 -16.32 58.6 Favored 'General case' 0 CA--C 1.515 -0.376 0 N-CA-C 113.858 1.059 . . . . 0.0 113.858 -176.406 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.623 ' HA ' ' H ' ' A' ' 104' ' ' ILE . 0.2 OUTLIER -173.47 154.84 2.67 Favored 'General case' 0 C--N 1.308 -1.232 0 C-N-CA 119.307 -0.957 . . . . 0.0 112.549 177.914 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.508 ' HG2' HG12 ' A' ' 65' ' ' VAL . 2.8 tt0 -136.28 155.66 49.77 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.732 -1.122 . . . . 0.0 113.533 -177.448 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.644 ' HB ' ' HB2' ' A' ' 66' ' ' TRP . 25.4 mt -127.42 132.46 69.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 115.256 -0.883 . . . . 0.0 110.224 179.231 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.681 HD11 ' HB2' ' A' ' 102' ' ' ASN . 0.1 OUTLIER -117.29 125.35 50.94 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.946 0.403 . . . . 0.0 111.365 179.792 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.768 ' CD1' HD22 ' A' ' 99' ' ' LEU . 1.1 mm? -127.19 140.11 52.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.599 179.265 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.31 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.529 -179.98 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.829 HD12 HD22 ' A' ' 124' ' ' LEU . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.703 0.287 . . . . 0.0 110.552 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.642 ' HA ' ' O ' ' A' ' 122' ' ' GLN . 6.5 mt -133.76 148.5 51.4 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.028 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.455 ' O ' ' N ' ' A' ' 122' ' ' GLN . 41.3 mt -116.31 129.77 56.43 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 179.205 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.681 ' HB2' HD11 ' A' ' 92' ' ' LEU . 18.1 t30 -110.56 110.78 21.63 Favored 'General case' 0 CA--C 1.508 -0.637 0 C-N-CA 119.611 -0.836 . . . . 0.0 110.105 -179.793 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.764 ' HB3' HG21 ' A' ' 109' ' ' THR . 58.4 m-20 -83.57 111.11 18.8 Favored 'General case' 0 N--CA 1.441 -0.888 0 C-N-CA 119.647 -0.821 . . . . 0.0 108.883 179.157 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.928 ' O ' ' O ' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -124.08 107.69 19.16 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.9 0 CA-C-O 121.6 0.714 . . . . 0.0 109.188 178.203 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.426 ' HG ' ' CD2' ' A' ' 88' ' ' HIS . 43.4 m -131.33 172.28 12.36 Favored 'General case' 0 C--N 1.297 -1.706 0 CA-C-N 114.867 -1.061 . . . . 0.0 109.142 179.504 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 19.6 m -69.62 -63.63 1.03 Allowed 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 119.092 -1.043 . . . . 0.0 111.906 -178.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -112.41 -32.26 6.55 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 114.755 1.391 . . . . 0.0 114.755 179.421 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -145.57 126.55 2.59 Favored Glycine 0 C--N 1.338 0.685 0 N-CA-C 116.849 1.5 . . . . 0.0 116.849 -177.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.764 HG21 ' HB3' ' A' ' 103' ' ' ASP . 3.3 m -121.12 138.16 54.32 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 174.522 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . 0.703 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 3.1 m-90 -121.76 149.37 43.39 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 113.393 0.886 . . . . 0.0 113.393 -178.231 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.701 HD12 HG11 ' A' ' 116' ' ' VAL . 1.2 mt -124.06 112.1 16.75 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.068 -0.969 . . . . 0.0 109.021 177.157 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 10.1 m-80 50.13 35.72 10.76 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.541 -179.223 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 82.57 26.09 48.01 Favored Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.64 179.419 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -133.08 96.83 3.85 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.009 0.433 . . . . 0.0 110.743 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.703 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.0 OUTLIER -46.52 134.61 9.18 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.01 179.82 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.701 HG11 HD12 ' A' ' 111' ' ' LEU . 12.6 p -135.14 165.45 30.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.227 -179.254 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.538 ' N ' HG22 ' A' ' 116' ' ' VAL . 0.3 OUTLIER -69.6 142.69 53.48 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.256 179.746 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.469 ' HG3' ' ND2' ' A' ' 119' ' ' ASN . 12.8 ptmt -68.42 169.68 10.32 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.792 0.329 . . . . 0.0 110.92 -179.65 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.469 ' ND2' ' HG3' ' A' ' 118' ' ' LYS . 21.8 p30 33.86 37.58 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.192 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.427 ' HB3' ' O ' ' A' ' 117' ' ' GLU . 0.1 OUTLIER -111.8 107.9 17.12 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.671 179.406 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.591 ' ND2' HD22 ' A' ' 92' ' ' LEU . 5.3 m120 -47.67 138.45 8.22 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 120.598 0.237 . . . . 0.0 110.951 -179.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . 0.642 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 71.9 mm-40 -126.84 148.5 49.97 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-O 121.144 0.497 . . . . 0.0 111.857 -179.684 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.539 HD13 ' O ' ' A' ' 124' ' ' LEU . 3.0 tm? -73.98 112.08 9.75 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.585 178.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 1.104 HD21 HD13 ' A' ' 147' ' ' ILE . 6.6 tt -46.99 145.75 1.95 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.789 0.804 . . . . 0.0 112.06 -178.693 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -126.67 153.23 45.68 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 114.185 -1.37 . . . . 0.0 110.272 179.638 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 8.0 mm100 -71.24 113.68 8.52 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 179.35 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 68.47 28.38 73.25 Favored Glycine 0 N--CA 1.445 -0.72 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.18 -179.145 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -55.1 160.56 2.04 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.987 0.422 . . . . 0.0 111.434 -179.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.452 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 1.3 tm-20 -146.4 135.58 22.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.249 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.501 HG21 ' OD1' ' A' ' 103' ' ' ASP . 1.3 mp -112.38 129.05 68.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.415 179.047 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.566 HG23 ' CG2' ' A' ' 140' ' ' ILE . 16.0 m -103.02 142.26 34.4 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.835 -179.513 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.447 HG11 ' CD2' ' A' ' 88' ' ' HIS . 4.3 m -140.85 153.26 20.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.187 -0.461 . . . . 0.0 112.004 -179.021 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 75.52 35.8 45.9 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 121.111 -0.566 . . . . 0.0 112.367 179.442 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.45 ' HA ' HG12 ' A' ' 140' ' ' ILE . 78.9 t -71.68 155.61 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 CA-C-O 121.468 0.651 . . . . 0.0 112.127 -179.306 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . 0.426 ' N ' HG12 ' A' ' 134' ' ' VAL . . . 153.44 -45.77 0.57 Allowed Glycine 0 N--CA 1.443 -0.863 0 CA-C-N 115.003 -0.998 . . . . 0.0 110.707 -179.164 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.61 HG12 ' H ' ' A' ' 138' ' ' SER . 62.0 t -126.71 134.85 65.32 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 CA-C-N 115.258 -0.471 . . . . 0.0 109.744 178.644 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 16.3 tm-20 -51.28 -34.38 32.72 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.83 0.347 . . . . 0.0 111.26 -179.293 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . 0.61 ' H ' HG12 ' A' ' 136' ' ' VAL . 76.7 p -94.11 6.4 48.67 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 116.246 -0.434 . . . . 0.0 112.06 -179.595 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -126.38 30.66 5.54 Favored 'General case' 0 CA--C 1.518 -0.257 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -179.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.566 ' CG2' HG23 ' A' ' 131' ' ' THR . 20.9 mt -107.23 140.91 23.82 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.304 179.213 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.542 HD12 ' CG ' ' A' ' 42' ' ' GLN . 3.0 mm? -120.43 135.43 55.05 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 114.874 -1.057 . . . . 0.0 110.005 179.737 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . 0.691 ' HB2' HG21 ' A' ' 40' ' ' THR . 4.2 m -125.13 152.35 44.53 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.848 0.833 . . . . 0.0 113.094 -178.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.634 HD12 ' O ' ' A' ' 142' ' ' SER . 6.5 mp -125.82 146.21 49.89 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.323 -1.308 . . . . 0.0 109.033 178.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 21.7 t -131.16 140.28 48.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 120.838 0.351 . . . . 0.0 111.793 -179.083 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.824 HG13 HG22 ' A' ' 36' ' ' VAL . 0.6 OUTLIER -111.04 139.64 34.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.743 179.552 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 47.4 t80 -119.14 104.24 10.26 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.689 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 1.104 HD13 HD21 ' A' ' 124' ' ' LEU . 1.2 mp -98.15 129.72 47.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.241 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 14.7 p30 -83.37 133.1 34.96 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.953 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -67.83 -20.65 65.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.13 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.71 -43.1 84.98 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.935 0.398 . . . . 0.0 110.61 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . 0.736 ' CE2' HD11 ' A' ' 52' ' ' ILE . 13.2 t80 . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.816 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 . . . . . 0 CA--C 1.527 0.088 0 CA-C-O 120.617 0.246 . . . . 0.0 111.39 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.576 ' HA ' HD12 ' A' ' 52' ' ' ILE . 43.6 m-20 -108.74 -14.53 14.58 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-O 121.904 0.859 . . . . 0.0 108.95 178.611 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.487 ' O ' HG22 ' A' ' 32' ' ' ILE . 0.1 OUTLIER -75.07 110.62 10.09 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.636 0 CA-C-N 113.991 -1.459 . . . . 0.0 111.088 -179.557 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 1.027 ' CG2' ' HB2' ' A' ' 50' ' ' ALA . 0.5 OUTLIER -41.18 -63.66 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.406 -179.49 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.626 ' N ' ' CG1' ' A' ' 33' ' ' VAL . 23.4 p -166.21 165.05 17.77 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.519 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 3.6 ttm180 -121.95 120.39 34.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.877 179.491 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.781 HG23 HD13 ' A' ' 48' ' ' LEU . 40.1 t -89.13 124.75 42.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.95 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.937 HG23 HG12 ' A' ' 45' ' ' ILE . 30.0 mt -124.58 108.12 19.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.65 -179.741 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.517 ' SG ' HD23 ' A' ' 143' ' ' LEU . 3.4 m -90.48 100.96 13.7 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 178.53 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 7.0 t -80.21 -27.19 38.85 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 -178.184 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.417 ' OG1' ' O ' ' A' ' 142' ' ' SER . 0.1 OUTLIER -51.54 -27.17 10.09 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.997 0.427 . . . . 0.0 111.023 -179.679 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 97.41 36.94 4.7 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.384 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 18.9 pt20 -106.0 -46.85 3.99 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.853 0.358 . . . . 0.0 110.908 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.439 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 7.1 mt -133.53 132.53 21.9 Favored Pre-proline 0 N--CA 1.451 -0.414 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.19 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.524 ' HD2' ' CZ ' ' A' ' 76' ' ' TYR . 27.3 Cg_exo -59.63 147.37 92.19 Favored 'Trans proline' 0 C--O 1.232 0.214 0 C-N-CA 122.763 2.309 . . . . 0.0 111.904 179.535 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.937 HG12 HG23 ' A' ' 37' ' ' ILE . 44.2 mt -43.6 139.0 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.83 -179.702 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.1 140.81 46.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.37 179.67 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -108.34 120.23 41.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.112 0.482 . . . . 0.0 111.632 -179.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 1.106 HD21 HD13 ' A' ' 91' ' ' ILE . 3.0 mp -98.82 125.2 44.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.156 178.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.518 ' O ' ' CZ2' ' A' ' 66' ' ' TRP . 0.0 OUTLIER -111.26 163.11 14.28 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 122.041 0.924 . . . . 0.0 113.338 -178.545 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 1.027 ' HB2' ' CG2' ' A' ' 33' ' ' VAL . . . -123.45 166.19 15.8 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 114.632 -1.167 . . . . 0.0 111.22 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -111.21 71.69 0.75 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.287 179.477 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.637 HD11 ' CD2' ' A' ' 151' ' ' PHE . 92.3 mt . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.401 -179.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 11.0 tttm . . . . . 0 C--O 1.23 0.036 0 CA-C-O 120.902 0.382 . . . . 0.0 111.013 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.418 ' O ' ' HB3' ' A' ' 93' ' ' LEU . 17.0 ttpt -136.1 130.64 33.67 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.635 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.6 HG13 ' O ' ' A' ' 91' ' ' ILE . 15.3 t -135.2 137.93 49.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.113 0.482 . . . . 0.0 111.894 -179.29 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . 0.641 ' HB2' ' HB ' ' A' ' 91' ' ' ILE . 15.5 m-90 -100.61 140.15 35.28 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.607 179.175 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.86 HG23 ' HG3' ' A' ' 90' ' ' GLN . 7.8 m -125.78 127.41 46.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.544 0.687 . . . . 0.0 112.329 179.46 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.655 ' HE2' HD11 ' A' ' 91' ' ' ILE . 44.7 m-85 -101.03 118.57 37.25 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.114 -0.948 . . . . 0.0 108.927 177.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.604 ' HA2' ' O ' ' A' ' 85' ' ' SER . . . 160.0 -157.66 28.95 Favored Glycine 0 CA--C 1.503 -0.665 0 C-N-CA 119.117 -1.516 . . . . 0.0 112.419 179.499 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.423 ' N ' ' HA ' ' A' ' 86' ' ' ASN . 0.5 OUTLIER -76.74 92.17 3.54 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-O 122.554 1.168 . . . . 0.0 108.912 -179.712 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.524 ' O ' ' CD2' ' A' ' 77' ' ' HIS . 6.1 m-80 -149.59 155.19 38.76 Favored Pre-proline 0 C--N 1.308 -1.197 0 CA-C-N 112.809 -1.996 . . . . 0.0 108.259 178.72 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.551 ' O ' ' CB ' ' A' ' 73' ' ' ALA . 24.5 Cg_exo -55.79 -10.23 3.72 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 121.277 1.318 . . . . 0.0 111.278 177.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.739 ' HB2' ' HB2' ' A' ' 77' ' ' HIS . . . 135.99 52.23 0.0 OUTLIER 'General case' 0 CA--C 1.49 -1.336 0 CA-C-N 114.999 -1.0 . . . . 0.0 109.375 178.792 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.567 ' HB3' ' HB ' ' A' ' 67' ' ' THR . 0.1 OUTLIER -52.97 -69.62 0.11 Allowed 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 105.867 -1.901 . . . . 0.0 105.867 179.524 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.592 ' HB2' ' N ' ' A' ' 67' ' ' THR . 40.1 t0 -94.93 -47.74 6.3 Favored 'General case' 0 N--CA 1.435 -1.211 0 N-CA-C 105.687 -1.968 . . . . 0.0 105.687 169.755 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.524 ' CZ ' ' HD2' ' A' ' 44' ' ' PRO . 33.0 t80 -145.01 142.7 30.01 Favored 'General case' 0 C--N 1.347 0.485 0 CA-C-N 112.573 -2.103 . . . . 0.0 111.473 179.366 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . 0.739 ' HB2' ' HB2' ' A' ' 73' ' ' ALA . 23.7 t-160 -93.79 107.28 19.19 Favored 'General case' 0 C--N 1.33 -0.249 0 O-C-N 122.014 -0.429 . . . . 0.0 109.968 176.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.841 HD12 ' O ' ' A' ' 79' ' ' GLY . 3.8 pp -121.82 172.61 8.04 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 120.96 0.409 . . . . 0.0 111.645 -179.691 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.841 ' O ' HD12 ' A' ' 78' ' ' LEU . . . -57.86 -172.65 0.3 Allowed Glycine 0 C--N 1.333 0.383 0 CA-C-N 115.916 -0.584 . . . . 0.0 112.595 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.456 ' HA ' ' OD1' ' A' ' 86' ' ' ASN . 0.3 OUTLIER -111.94 98.11 7.15 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -179.64 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.809 HD12 ' CB ' ' A' ' 85' ' ' SER . 16.7 mt -114.79 113.96 45.18 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.252 178.41 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 5.8 m -54.7 -24.12 20.6 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 112.587 0.588 . . . . 0.0 112.587 -178.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.448 ' H ' HG22 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -93.58 -102.22 0.13 Allowed 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 -178.743 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.416 ' O ' ' CB ' ' A' ' 85' ' ' SER . 0.0 OUTLIER -109.23 110.45 21.66 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-O 121.682 0.753 . . . . 0.0 110.537 -179.391 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.809 ' CB ' HD12 ' A' ' 81' ' ' ILE . 0.5 OUTLIER 160.43 -46.84 0.0 OUTLIER 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 114.205 -1.362 . . . . 0.0 109.489 179.875 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.817 ' O ' ' N ' ' A' ' 88' ' ' HIS . 93.9 m-20 -64.8 -153.99 0.01 OUTLIER 'General case' 0 CA--C 1.521 -0.165 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 178.128 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.89 ' HB2' HD11 ' A' ' 104' ' ' ILE . 7.9 ptmt -49.31 73.44 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 179.099 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.971 ' O ' ' O ' ' A' ' 104' ' ' ILE . 31.2 t60 -95.67 -18.64 20.35 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 114.299 1.222 . . . . 0.0 114.299 -176.517 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.656 ' HA ' ' H ' ' A' ' 104' ' ' ILE . 0.2 OUTLIER -172.98 153.24 2.53 Favored 'General case' 0 C--N 1.31 -1.115 0 C-N-CA 119.014 -1.074 . . . . 0.0 112.489 178.063 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.86 ' HG3' HG23 ' A' ' 67' ' ' THR . 20.1 mt-30 -134.1 159.23 41.48 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 114.38 -1.282 . . . . 0.0 113.483 -177.322 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 1.106 HD13 HD21 ' A' ' 48' ' ' LEU . 2.8 mt -124.71 131.88 72.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.113 -0.948 . . . . 0.0 110.213 179.013 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.652 HD13 ' ND2' ' A' ' 121' ' ' ASN . 0.3 OUTLIER -107.38 145.09 33.34 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.036 0.446 . . . . 0.0 111.935 -179.623 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.881 HD22 ' N ' ' A' ' 94' ' ' GLY . 0.3 OUTLIER -125.73 128.73 48.21 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.47 179.324 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.881 ' N ' HD22 ' A' ' 93' ' ' LEU . . . . . . . . 0 N--CA 1.452 -0.299 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.46 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 1.014 HD22 HD13 ' A' ' 124' ' ' LEU . 9.7 tt . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.839 0.352 . . . . 0.0 110.893 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.689 HD23 ' HB3' ' A' ' 121' ' ' ASN . 4.5 mp -133.4 149.25 51.82 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.53 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.607 HD11 HD13 ' A' ' 145' ' ' ILE . 4.9 mp -114.81 128.92 56.58 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.756 -0.378 . . . . 0.0 110.101 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.49 ' O ' ' O ' ' A' ' 90' ' ' GLN . 27.9 t30 -110.47 111.21 22.31 Favored 'General case' 0 CA--C 1.509 -0.619 0 C-N-CA 119.76 -0.776 . . . . 0.0 109.766 179.47 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.825 ' HB3' HG21 ' A' ' 109' ' ' THR . 83.7 m-20 -84.74 112.65 20.68 Favored 'General case' 0 N--CA 1.444 -0.772 0 C-N-CA 119.865 -0.734 . . . . 0.0 109.887 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.971 ' O ' ' O ' ' A' ' 88' ' ' HIS . 0.1 OUTLIER -122.91 107.5 19.44 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.925 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 177.473 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.44 ' HG ' ' CE1' ' A' ' 88' ' ' HIS . 55.7 m -134.79 164.53 27.34 Favored 'General case' 0 C--N 1.295 -1.797 0 CA-C-N 115.011 -0.995 . . . . 0.0 109.432 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 19.9 m -69.4 -62.69 1.28 Allowed 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 119.207 -0.997 . . . . 0.0 111.789 -178.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -111.79 -32.64 6.56 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 115.218 1.562 . . . . 0.0 115.218 179.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -146.18 127.64 2.83 Favored Glycine 0 C--N 1.339 0.747 0 N-CA-C 117.36 1.704 . . . . 0.0 117.36 -177.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.825 HG21 ' HB3' ' A' ' 103' ' ' ASP . 7.5 m -121.36 138.12 54.4 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 174.289 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . 0.712 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 3.4 m-90 -122.89 149.21 44.51 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 113.532 0.938 . . . . 0.0 113.532 -178.552 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.41 ' O ' ' HG ' ' A' ' 111' ' ' LEU . 0.3 OUTLIER -123.95 112.18 16.91 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 114.917 -1.038 . . . . 0.0 108.451 177.5 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 15.9 m-20 44.37 44.46 6.84 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.065 -0.516 . . . . 0.0 112.109 -179.394 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 79.89 26.4 56.02 Favored Glycine 0 N--CA 1.444 -0.792 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.779 179.28 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -138.62 96.8 3.21 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.079 0.466 . . . . 0.0 110.78 179.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.712 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.0 OUTLIER -44.37 129.08 6.48 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.964 179.806 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.786 HG21 ' OD2' ' A' ' 103' ' ' ASP . 27.6 m -115.91 -178.74 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.133 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.971 -178.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -91.61 142.23 27.86 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.086 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.46 ' HG3' ' HA ' ' A' ' 104' ' ' ILE . 49.1 tttm -63.72 162.35 13.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.27 179.381 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.422 ' N ' ' HG2' ' A' ' 118' ' ' LYS . 4.3 p30 34.58 39.13 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.268 0.556 . . . . 0.0 111.264 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 9.5 p -111.24 106.58 15.62 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.07 -179.4 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.689 ' HB3' HD23 ' A' ' 100' ' ' LEU . 1.6 m-20 -54.68 143.6 24.53 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.64 179.736 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . 0.633 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 30.9 mm-40 -129.74 145.62 51.54 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.98 0.419 . . . . 0.0 112.005 -179.467 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.8 tt -72.87 121.33 19.82 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.526 178.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 1.014 HD13 HD22 ' A' ' 99' ' ' LEU . 12.1 tp -47.76 142.39 4.74 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-O 122.027 0.918 . . . . 0.0 112.186 -178.806 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.444 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.3 OUTLIER -127.51 152.62 47.35 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 113.895 -1.502 . . . . 0.0 110.05 179.191 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 11.3 mm100 -71.61 113.82 9.04 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.898 0.38 . . . . 0.0 110.024 179.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 64.61 31.67 81.67 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.512 -179.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.444 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 17.2 t70 -58.31 159.42 6.13 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.959 0.409 . . . . 0.0 111.195 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.748 ' HG3' HG22 ' A' ' 144' ' ' VAL . 3.0 tt0 -146.6 135.71 22.59 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.531 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.447 ' CG2' ' O ' ' A' ' 110' ' ' TRP . 1.3 mp -111.84 128.69 68.25 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.168 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.117 178.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.472 HG23 ' CG2' ' A' ' 140' ' ' ILE . 95.2 m -103.24 145.05 30.52 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.512 -179.687 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.513 HG11 ' CD2' ' A' ' 88' ' ' HIS . 4.3 m -141.09 158.27 22.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 -178.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 68.8 41.26 83.67 Favored Glycine 0 N--CA 1.448 -0.533 0 CA-C-N 115.776 -0.647 . . . . 0.0 112.553 179.406 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.505 ' HA ' HG12 ' A' ' 140' ' ' ILE . 98.6 t -76.45 157.33 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.625 0 CA-C-O 121.38 0.609 . . . . 0.0 112.012 -179.343 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . 0.452 ' N ' HG12 ' A' ' 134' ' ' VAL . . . 138.21 -43.46 1.19 Allowed Glycine 0 N--CA 1.441 -1.017 0 N-CA-C 110.36 -1.096 . . . . 0.0 110.36 -178.609 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.624 HG12 ' H ' ' A' ' 138' ' ' SER . 46.4 t -126.8 123.93 63.81 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.708 0 CA-C-N 115.022 -0.589 . . . . 0.0 109.63 178.423 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.506 ' HA ' HD12 ' A' ' 140' ' ' ILE . 6.9 mt-10 -51.05 -26.17 5.92 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.711 0.291 . . . . 0.0 111.355 -179.121 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . 0.624 ' H ' HG12 ' A' ' 136' ' ' VAL . 6.4 t -94.4 6.4 48.85 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 112.3 0.481 . . . . 0.0 112.3 -179.463 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -131.54 24.31 4.75 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 -179.243 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.506 HD12 ' HA ' ' A' ' 137' ' ' GLU . 23.6 mt -98.89 141.1 17.05 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.305 179.04 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.412 ' HB2' ' CG2' ' A' ' 132' ' ' VAL . 8.7 mp -119.98 135.07 55.05 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.83 -1.077 . . . . 0.0 109.805 179.446 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . 0.417 ' O ' ' OG1' ' A' ' 40' ' ' THR . 46.6 t -114.54 151.84 32.72 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.836 0.827 . . . . 0.0 112.765 -178.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.517 HD23 ' SG ' ' A' ' 38' ' ' CYS . 8.2 mt -136.18 129.76 32.17 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.554 -1.203 . . . . 0.0 109.251 178.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.748 HG22 ' HG3' ' A' ' 129' ' ' GLU . 21.4 t -124.09 140.95 45.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.917 0.389 . . . . 0.0 111.923 -178.728 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.67 HG13 HG22 ' A' ' 36' ' ' VAL . 0.3 OUTLIER -112.31 140.23 33.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.832 179.558 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -118.99 108.64 15.0 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.704 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.698 HG12 HD21 ' A' ' 124' ' ' LEU . 1.9 mp -101.21 128.66 53.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.436 -179.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 10.7 p30 -79.16 132.02 36.41 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.909 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -63.64 -21.36 66.33 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.128 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 2.1 mptm? -58.37 -44.35 88.82 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.967 0.413 . . . . 0.0 110.716 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . 0.637 ' CD2' HD11 ' A' ' 52' ' ' ILE . 17.9 t80 . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.82 179.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.479 ' O ' HD11 ' A' ' 52' ' ' ILE . 25.1 mt-10 . . . . . 0 C--O 1.232 0.157 0 CA-C-O 120.656 0.265 . . . . 0.0 111.403 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 68.0 m-20 -108.83 -13.29 14.79 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-O 121.886 0.851 . . . . 0.0 109.117 178.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.575 ' CG2' ' O ' ' A' ' 32' ' ' ILE . 0.1 OUTLIER -70.41 96.77 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.618 0 CA-C-N 114.11 -1.405 . . . . 0.0 110.844 -179.145 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.809 HG23 ' HB3' ' A' ' 50' ' ' ALA . 0.9 OUTLIER -39.21 -61.5 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 114.54 -1.209 . . . . 0.0 112.651 -178.896 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.631 ' N ' HG12 ' A' ' 33' ' ' VAL . 49.6 t -162.93 162.85 26.38 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.853 0.359 . . . . 0.0 111.743 -178.795 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.448 ' HD3' ' CG2' ' A' ' 45' ' ' ILE . 1.8 ttm180 -128.93 115.37 17.73 Favored 'General case' 0 C--N 1.334 -0.104 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.678 179.817 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.901 HG23 ' CD2' ' A' ' 48' ' ' LEU . 92.4 t -89.07 129.64 39.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.559 179.858 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.983 HG23 HG12 ' A' ' 45' ' ' ILE . 29.0 mt -118.48 107.77 22.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 116.056 -0.52 . . . . 0.0 112.026 -179.309 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.491 ' HB2' ' O ' ' A' ' 43' ' ' ILE . 3.7 m -97.38 99.93 11.37 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 177.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 8.7 t -107.27 27.17 9.33 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 -178.097 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.741 HG21 ' HB2' ' A' ' 142' ' ' SER . 40.3 p -108.96 -3.31 17.61 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.761 0.315 . . . . 0.0 111.566 179.664 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 95.67 60.2 1.04 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.467 179.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.562 ' CG ' HD12 ' A' ' 141' ' ' LEU . 27.7 mt-30 -141.12 -60.58 0.49 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.762 0.315 . . . . 0.0 111.242 -179.83 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.491 ' O ' ' HB2' ' A' ' 38' ' ' CYS . 3.5 mp -135.24 132.36 20.04 Favored Pre-proline 0 N--CA 1.452 -0.339 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.371 -179.639 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.415 ' HB2' ' OH ' ' A' ' 76' ' ' TYR . 24.1 Cg_exo -60.14 146.8 95.43 Favored 'Trans proline' 0 N--CA 1.463 -0.307 0 C-N-CA 122.214 1.943 . . . . 0.0 111.054 178.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.983 HG12 HG23 ' A' ' 37' ' ' ILE . 29.9 mt -50.72 122.55 2.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.948 0.404 . . . . 0.0 111.791 -179.165 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.422 ' HB2' ' CD2' ' A' ' 76' ' ' TYR . 0.0 OUTLIER -124.85 141.76 51.9 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.032 179.241 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.403 ' HB3' ' CD1' ' A' ' 32' ' ' ILE . 0.7 OUTLIER -99.55 119.58 38.27 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.975 0.417 . . . . 0.0 111.689 -179.241 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.901 ' CD2' HG23 ' A' ' 36' ' ' VAL . 0.3 OUTLIER -89.63 136.47 33.02 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 178.48 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.601 ' O ' ' HZ2' ' A' ' 66' ' ' TRP . 0.0 OUTLIER -137.23 162.25 33.99 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 122.034 0.921 . . . . 0.0 113.398 -178.564 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.809 ' HB3' HG23 ' A' ' 33' ' ' VAL . . . -149.62 152.65 35.79 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 114.418 -1.265 . . . . 0.0 111.174 179.24 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -80.27 111.26 16.48 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.121 -179.617 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.479 HD11 ' O ' ' A' ' 30' ' ' GLU . 11.6 mt . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.733 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.915 0.388 . . . . 0.0 111.153 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.439 ' O ' ' HB3' ' A' ' 93' ' ' LEU . 2.1 ttpt -118.65 136.29 53.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.178 179.573 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.634 HG13 ' O ' ' A' ' 91' ' ' ILE . 14.1 t -136.26 135.91 49.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.143 0.497 . . . . 0.0 111.946 -179.215 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . 0.726 ' CD1' HD12 ' A' ' 48' ' ' LEU . 13.8 m-90 -99.74 140.06 34.49 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.59 179.052 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.858 HG23 ' CG ' ' A' ' 90' ' ' GLN . 4.3 m -130.3 126.79 38.08 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.404 0.621 . . . . 0.0 112.403 179.504 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.471 ' CD2' ' CD2' ' A' ' 89' ' ' PHE . 88.5 m-85 -98.01 118.39 34.51 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.171 177.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.641 ' HA3' ' N ' ' A' ' 87' ' ' LYS . . . 160.33 -158.97 30.4 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 118.978 -1.582 . . . . 0.0 112.936 179.473 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.508 ' CD ' ' HB3' ' A' ' 86' ' ' ASN . 0.4 OUTLIER -76.84 91.75 3.56 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-O 122.55 1.167 . . . . 0.0 108.456 -179.888 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.493 ' O ' ' CD2' ' A' ' 77' ' ' HIS . 0.2 OUTLIER -149.83 160.78 33.16 Favored Pre-proline 0 C--N 1.308 -1.205 0 CA-C-N 112.755 -2.021 . . . . 0.0 108.027 179.326 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.559 ' O ' ' CB ' ' A' ' 73' ' ' ALA . 28.1 Cg_endo -63.14 -8.73 14.94 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 120.99 1.127 . . . . 0.0 111.439 178.697 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.739 ' HB2' ' HB2' ' A' ' 77' ' ' HIS . . . 135.98 51.85 0.0 OUTLIER 'General case' 0 CA--C 1.491 -1.309 0 CA-C-N 114.806 -1.088 . . . . 0.0 109.788 178.602 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.575 ' HB3' ' HB ' ' A' ' 67' ' ' THR . 0.1 OUTLIER -52.88 -69.45 0.11 Allowed 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 105.838 -1.912 . . . . 0.0 105.838 179.328 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.628 ' HB2' ' N ' ' A' ' 67' ' ' THR . 7.5 t0 -94.63 -47.76 6.38 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 105.734 -1.951 . . . . 0.0 105.734 169.732 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.487 ' C ' ' HA ' ' A' ' 73' ' ' ALA . 1.7 t80 -145.37 141.65 28.66 Favored 'General case' 0 C--N 1.346 0.454 0 CA-C-N 112.717 -2.038 . . . . 0.0 112.35 -179.76 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . 0.739 ' HB2' ' HB2' ' A' ' 73' ' ' ALA . 23.5 t-160 -94.91 107.2 19.23 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 176.276 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -135.67 -176.24 4.22 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.001 0.429 . . . . 0.0 111.7 -179.386 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -60.92 163.31 20.39 Favored Glycine 0 N--CA 1.451 -0.339 0 CA-C-N 115.819 -0.628 . . . . 0.0 112.582 -179.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 12.8 p-10 -111.97 100.57 8.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.823 0.345 . . . . 0.0 111.553 -179.649 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.654 ' HB ' ' HB2' ' A' ' 85' ' ' SER . 12.4 mm -112.76 120.48 62.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 178.67 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 3.5 m -51.09 -23.92 3.54 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -177.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -83.66 -106.7 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 120.971 -0.291 . . . . 0.0 111.084 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.468 HD23 ' N ' ' A' ' 84' ' ' LEU . 0.0 OUTLIER -109.86 113.32 25.96 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-O 121.341 0.591 . . . . 0.0 109.598 179.236 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.654 ' HB2' ' HB ' ' A' ' 81' ' ' ILE . 1.5 m 166.6 -66.55 0.0 OUTLIER 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.041 -179.708 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.977 ' O ' ' N ' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -60.04 -166.18 0.01 OUTLIER 'General case' 0 CA--C 1.51 -0.575 0 N-CA-C 109.333 -0.618 . . . . 0.0 109.333 178.954 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.641 ' N ' ' HA3' ' A' ' 69' ' ' GLY . 2.8 mtmt -28.7 69.44 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 121.279 0.562 . . . . 0.0 109.704 -179.685 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.986 ' C ' ' O ' ' A' ' 104' ' ' ILE . 32.3 t60 -98.03 -17.44 19.15 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 113.559 0.948 . . . . 0.0 113.559 -176.765 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.677 ' HA ' ' H ' ' A' ' 104' ' ' ILE . 0.3 OUTLIER -173.08 153.33 2.5 Favored 'General case' 0 C--N 1.31 -1.135 0 C-N-CA 119.422 -0.911 . . . . 0.0 112.379 177.73 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.858 ' CG ' HG23 ' A' ' 67' ' ' THR . 31.9 mt-30 -135.83 157.92 45.67 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.455 -1.248 . . . . 0.0 113.674 -177.42 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.663 HD11 HG21 ' A' ' 36' ' ' VAL . 9.9 mt -125.14 131.62 72.22 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 CA-C-N 114.955 -1.021 . . . . 0.0 109.711 178.496 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.636 HD13 ' ND2' ' A' ' 121' ' ' ASN . 0.2 OUTLIER -109.37 141.45 41.72 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.098 0.475 . . . . 0.0 112.154 -179.298 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.709 HD13 ' CG2' ' A' ' 33' ' ' VAL . 6.4 tp -125.8 141.52 51.96 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.355 178.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.305 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.542 179.787 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.662 HD22 ' N ' ' A' ' 99' ' ' LEU . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.845 0.355 . . . . 0.0 110.751 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.665 HD22 ' HB3' ' A' ' 121' ' ' ASN . 0.4 OUTLIER -133.73 148.31 51.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.399 179.969 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.541 HD23 HD11 ' A' ' 130' ' ' ILE . 3.2 mp -114.82 131.33 56.86 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.978 -0.378 . . . . 0.0 109.978 179.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.499 ' HB2' HD11 ' A' ' 92' ' ' LEU . 23.4 t30 -113.16 111.32 21.89 Favored 'General case' 0 CA--C 1.511 -0.529 0 C-N-CA 119.851 -0.74 . . . . 0.0 110.032 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.787 ' HB3' HG21 ' A' ' 109' ' ' THR . 73.2 m-20 -84.37 112.17 20.1 Favored 'General case' 0 N--CA 1.444 -0.752 0 C-N-CA 119.738 -0.785 . . . . 0.0 109.641 179.519 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.986 ' O ' ' C ' ' A' ' 88' ' ' HIS . 0.1 OUTLIER -123.54 107.29 18.66 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.886 0 N-CA-C 108.752 -0.832 . . . . 0.0 108.752 177.614 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 67.3 m -129.72 169.14 15.48 Favored 'General case' 0 C--N 1.296 -1.74 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.435 179.617 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 23.7 m -69.35 -62.88 1.2 Allowed 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 119.121 -1.031 . . . . 0.0 111.281 -179.228 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -112.11 -33.09 6.35 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 114.658 1.355 . . . . 0.0 114.658 179.011 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -146.67 130.2 3.56 Favored Glycine 0 C--N 1.341 0.813 0 N-CA-C 116.97 1.548 . . . . 0.0 116.97 -177.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.787 HG21 ' HB3' ' A' ' 103' ' ' ASP . 5.6 m -121.18 138.32 54.26 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 174.396 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . 0.666 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.6 m-90 -120.48 149.22 42.74 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 -178.639 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.474 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -122.17 112.04 17.7 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 114.915 -1.039 . . . . 0.0 108.601 177.579 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 44.9 44.36 7.84 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.983 -0.553 . . . . 0.0 112.155 -179.524 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 79.79 21.62 65.7 Favored Glycine 0 N--CA 1.444 -0.794 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.786 179.345 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -133.4 98.75 4.32 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.928 0.394 . . . . 0.0 110.664 179.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.666 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.1 OUTLIER -43.23 122.43 2.53 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.034 179.804 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.712 HG11 ' OD2' ' A' ' 103' ' ' ASP . 12.6 p -113.78 160.49 13.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.688 -178.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.515 ' N ' HG22 ' A' ' 116' ' ' VAL . 4.8 tt0 -70.96 141.61 51.06 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.104 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.407 ' O ' ' C ' ' A' ' 119' ' ' ASN . 88.6 tttt -65.39 164.24 14.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.076 179.325 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.407 ' C ' ' O ' ' A' ' 118' ' ' LYS . 4.3 m-80 35.47 39.01 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.249 0.547 . . . . 0.0 110.938 -179.402 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.403 ' OG ' ' NE2' ' A' ' 122' ' ' GLN . 5.3 p -111.04 108.46 18.18 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.997 -179.365 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.665 ' HB3' HD22 ' A' ' 100' ' ' LEU . 1.4 m-20 -58.59 140.59 54.11 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.737 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . 0.596 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 22.4 mm-40 -129.82 145.21 51.58 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-O 121.039 0.447 . . . . 0.0 112.137 -179.567 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 22.3 tp -72.58 117.94 14.88 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.44 178.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.886 HD21 HG12 ' A' ' 147' ' ' ILE . 29.9 tp -45.24 144.05 1.49 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.875 0.845 . . . . 0.0 112.081 -178.713 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -127.02 152.79 46.78 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 114.037 -1.438 . . . . 0.0 110.252 179.585 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.72 113.88 9.22 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 179.414 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 67.06 29.12 74.12 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.281 -179.379 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -54.57 160.53 1.76 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.925 0.393 . . . . 0.0 111.203 -179.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.468 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 2.4 tt0 -146.05 135.32 22.87 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.529 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.674 HD13 ' OD1' ' A' ' 103' ' ' ASP . 5.4 mt -115.05 128.61 72.15 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 116.285 -0.416 . . . . 0.0 109.976 179.007 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.585 HG23 ' CG2' ' A' ' 140' ' ' ILE . 7.7 m -103.21 143.74 32.24 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.83 -179.374 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.452 ' HB ' ' NE2' ' A' ' 88' ' ' HIS . 4.6 m -141.21 155.26 21.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.317 -0.401 . . . . 0.0 112.039 -179.013 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 72.14 38.1 59.46 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 121.126 -0.559 . . . . 0.0 112.4 179.282 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.476 ' HA ' HG12 ' A' ' 140' ' ' ILE . 96.1 t -72.88 156.26 6.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 121.499 0.666 . . . . 0.0 112.129 -179.276 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . 0.453 ' N ' HG12 ' A' ' 134' ' ' VAL . . . 153.26 -46.5 0.56 Allowed Glycine 0 N--CA 1.442 -0.96 0 CA-C-N 114.939 -1.028 . . . . 0.0 110.606 -179.234 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.567 HG12 ' H ' ' A' ' 138' ' ' SER . 46.7 t -126.78 135.83 62.56 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.65 0 CA-C-N 115.239 -0.48 . . . . 0.0 109.832 178.644 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.1 -35.13 33.6 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.818 0.342 . . . . 0.0 111.269 -179.337 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . 0.567 ' H ' HG12 ' A' ' 136' ' ' VAL . 0.2 OUTLIER -94.04 6.14 49.47 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 116.273 -0.421 . . . . 0.0 112.13 -179.513 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -125.6 28.72 6.16 Favored 'General case' 0 CA--C 1.518 -0.261 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -179.398 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.585 ' CG2' HG23 ' A' ' 131' ' ' THR . 22.0 mt -105.29 141.28 20.99 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.373 179.342 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.562 HD12 ' CG ' ' A' ' 42' ' ' GLN . 3.1 mm? -114.85 135.0 54.67 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 114.906 -1.043 . . . . 0.0 109.92 179.344 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . 0.741 ' HB2' HG21 ' A' ' 40' ' ' THR . 3.9 m -119.2 153.7 34.53 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.845 0.831 . . . . 0.0 112.48 -179.03 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.468 ' O ' ' HA ' ' A' ' 129' ' ' GLU . 13.7 mt -135.4 141.5 45.48 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.36 -1.291 . . . . 0.0 109.216 179.325 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 17.3 t -124.02 140.85 46.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.014 0.435 . . . . 0.0 112.123 -178.636 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.725 HG13 HG22 ' A' ' 36' ' ' VAL . 0.8 OUTLIER -108.63 125.99 65.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.105 179.257 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 8.5 t80 -111.98 118.36 35.24 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.277 -179.419 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.886 HG12 HD21 ' A' ' 124' ' ' LEU . 2.4 mp -95.34 134.57 32.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.655 179.628 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -73.87 122.66 22.85 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.994 -179.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -60.38 -41.7 94.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.798 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.17 -43.28 87.36 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.677 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 24.1 t80 . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.761 179.784 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.648 0.261 . . . . 0.0 111.414 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 26.6 m120 -109.23 -13.56 14.63 Favored 'General case' 0 CA--C 1.514 -0.422 0 CA-C-O 121.933 0.873 . . . . 0.0 109.131 178.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.585 ' CG2' ' O ' ' A' ' 32' ' ' ILE . 0.1 OUTLIER -70.47 96.83 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.619 0 CA-C-N 114.103 -1.408 . . . . 0.0 111.183 -178.983 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.858 HG23 ' HB3' ' A' ' 50' ' ' ALA . 0.9 OUTLIER -36.55 -60.77 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 CA-C-N 114.643 -1.162 . . . . 0.0 112.246 -179.403 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.625 ' N ' HG12 ' A' ' 33' ' ' VAL . 1.7 m -163.19 165.42 24.45 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.742 -179.466 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.429 ' CZ ' HD11 ' A' ' 37' ' ' ILE . 2.3 tmm_? -134.27 114.78 13.39 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.159 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.99 HG23 HD21 ' A' ' 48' ' ' LEU . 48.2 t -91.38 122.0 42.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.508 179.313 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.984 HG23 HG12 ' A' ' 45' ' ' ILE . 34.1 mt -109.55 108.06 24.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.636 -179.847 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.817 ' SG ' HD12 ' A' ' 143' ' ' LEU . 60.1 m -102.04 101.75 12.16 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 178.098 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 7.6 t -118.69 32.63 6.03 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -177.649 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.562 HG21 ' HB2' ' A' ' 142' ' ' SER . 34.8 p -112.45 15.89 20.05 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.976 0.417 . . . . 0.0 111.285 179.325 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 88.71 38.87 6.82 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.133 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.673 ' OE1' HD13 ' A' ' 141' ' ' LEU . 0.0 OUTLIER -117.23 -76.21 0.57 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.663 0.268 . . . . 0.0 111.465 -179.591 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.616 HD12 ' HB3' ' A' ' 42' ' ' GLN . 3.7 mp -135.18 141.59 38.55 Favored Pre-proline 0 N--CA 1.452 -0.348 0 CA-C-O 120.859 0.361 . . . . 0.0 111.527 -179.072 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.481 ' HD2' ' CZ ' ' A' ' 76' ' ' TYR . 25.6 Cg_exo -59.25 147.08 92.5 Favored 'Trans proline' 0 N--CA 1.465 -0.186 0 C-N-CA 122.338 2.025 . . . . 0.0 111.202 178.832 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.984 HG12 HG23 ' A' ' 37' ' ' ILE . 44.2 mt -43.38 128.6 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-O 121.046 0.451 . . . . 0.0 111.852 -179.401 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.424 ' HG2' ' O ' ' A' ' 75' ' ' ASP . 0.0 OUTLIER -123.27 130.38 52.66 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.255 179.58 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.426 ' C ' HD13 ' A' ' 48' ' ' LEU . 4.9 m-20 -100.83 119.72 39.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.021 0.439 . . . . 0.0 111.444 -179.54 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.99 HD21 HG23 ' A' ' 36' ' ' VAL . 0.2 OUTLIER -93.9 130.73 39.85 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.353 178.763 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.532 ' O ' ' HZ2' ' A' ' 66' ' ' TRP . 0.0 OUTLIER -133.41 161.66 33.93 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.972 0.891 . . . . 0.0 113.221 -178.809 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.858 ' HB3' HG23 ' A' ' 33' ' ' VAL . . . -156.87 141.94 17.17 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 114.441 -1.254 . . . . 0.0 110.937 179.017 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -70.02 124.14 23.31 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.091 0.472 . . . . 0.0 111.231 -179.613 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 14.7 mt . . . . . 0 C--N 1.33 -0.283 0 CA-C-N 115.824 -0.626 . . . . 0.0 111.104 179.92 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 3.0 mttp . . . . . 0 CA--C 1.528 0.097 0 CA-C-O 120.947 0.403 . . . . 0.0 110.999 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -108.16 132.73 53.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.35 179.587 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.563 HG13 ' O ' ' A' ' 91' ' ' ILE . 6.9 t -127.35 135.47 63.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.182 0.515 . . . . 0.0 111.959 -179.058 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . 0.83 ' CD1' HD12 ' A' ' 48' ' ' LEU . 14.7 m-90 -99.25 139.97 34.11 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.786 179.179 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.661 HG23 ' HG2' ' A' ' 90' ' ' GLN . 32.0 m -131.43 131.42 43.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.571 0.7 . . . . 0.0 112.048 179.491 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.49 ' CD2' ' CD2' ' A' ' 89' ' ' PHE . 94.0 m-85 -102.68 118.98 38.03 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.023 -0.99 . . . . 0.0 109.148 177.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.675 ' CA ' HD21 ' A' ' 78' ' ' LEU . . . 158.64 -156.87 27.87 Favored Glycine 0 CA--C 1.501 -0.804 0 C-N-CA 118.962 -1.59 . . . . 0.0 112.709 179.638 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -75.62 91.65 2.88 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-O 122.615 1.198 . . . . 0.0 108.679 -179.669 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.511 ' O ' ' CD2' ' A' ' 77' ' ' HIS . 10.3 m120 -149.9 153.37 35.84 Favored Pre-proline 0 C--N 1.31 -1.119 0 CA-C-N 112.693 -2.049 . . . . 0.0 108.187 178.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.556 ' O ' ' HB2' ' A' ' 77' ' ' HIS . 26.6 Cg_exo -55.92 -10.84 4.57 Favored 'Trans proline' 0 N--CA 1.459 -0.525 0 C-N-CA 121.239 1.293 . . . . 0.0 111.318 178.101 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.742 ' HB2' ' HB2' ' A' ' 77' ' ' HIS . . . 137.99 52.03 0.0 OUTLIER 'General case' 0 CA--C 1.49 -1.365 0 CA-C-N 114.761 -1.109 . . . . 0.0 109.212 178.871 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.522 ' HB3' ' HB ' ' A' ' 67' ' ' THR . 0.1 OUTLIER -52.55 -69.45 0.11 Allowed 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 105.783 -1.932 . . . . 0.0 105.783 179.689 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.538 ' HB2' ' N ' ' A' ' 67' ' ' THR . 9.2 t0 -95.38 -47.73 6.17 Favored 'General case' 0 N--CA 1.435 -1.21 0 N-CA-C 105.671 -1.974 . . . . 0.0 105.671 169.513 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.508 ' C ' ' HA ' ' A' ' 73' ' ' ALA . 33.7 t80 -144.07 142.61 30.73 Favored 'General case' 0 C--N 1.347 0.5 0 CA-C-N 112.544 -2.116 . . . . 0.0 111.316 179.713 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . 0.742 ' HB2' ' HB2' ' A' ' 73' ' ' ALA . 23.6 t-160 -92.77 109.32 20.75 Favored 'General case' 0 C--N 1.33 -0.279 0 O-C-N 121.999 -0.438 . . . . 0.0 110.177 177.209 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.675 HD21 ' CA ' ' A' ' 69' ' ' GLY . 1.3 pp -123.45 175.28 6.85 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.911 0.386 . . . . 0.0 111.538 -179.824 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.503 ' O ' HD12 ' A' ' 78' ' ' LEU . . . -62.92 -170.85 1.35 Allowed Glycine 0 C--N 1.332 0.313 0 C-N-CA 120.985 -0.626 . . . . 0.0 112.525 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -111.76 98.64 7.54 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 121.025 0.44 . . . . 0.0 111.68 -179.666 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.875 HD13 ' HB3' ' A' ' 85' ' ' SER . 3.2 mp -114.13 111.77 37.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.404 178.775 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 46.9 t -55.35 -24.25 28.33 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 -179.247 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.514 ' C ' HD13 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -88.75 -109.53 0.07 Allowed 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 112.249 0.463 . . . . 0.0 112.249 -178.845 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.842 ' H ' HD22 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -108.89 112.22 24.34 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-O 121.437 0.637 . . . . 0.0 109.666 179.87 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.875 ' HB3' HD13 ' A' ' 81' ' ' ILE . 0.6 OUTLIER 161.88 -45.11 0.0 OUTLIER 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 114.686 -1.143 . . . . 0.0 109.335 -179.628 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.858 ' O ' ' N ' ' A' ' 88' ' ' HIS . 97.1 m-20 -64.31 -149.47 0.01 OUTLIER 'General case' 0 CA--C 1.521 -0.138 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 177.726 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.815 ' HB3' HD11 ' A' ' 104' ' ' ILE . 9.3 mttt -49.47 72.34 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.073 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.977 ' C ' ' O ' ' A' ' 104' ' ' ILE . 32.8 t60 -90.89 -17.34 26.64 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 114.02 1.118 . . . . 0.0 114.02 -176.727 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.664 ' HA ' ' H ' ' A' ' 104' ' ' ILE . 0.5 OUTLIER -174.43 153.56 1.93 Allowed 'General case' 0 C--N 1.311 -1.089 0 C-N-CA 119.257 -0.977 . . . . 0.0 112.673 178.061 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.661 ' HG2' HG23 ' A' ' 67' ' ' THR . 34.9 mt-30 -136.64 158.49 44.33 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.523 -1.217 . . . . 0.0 113.72 -177.624 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.781 HD11 HG21 ' A' ' 36' ' ' VAL . 10.6 mt -127.72 131.7 69.68 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 CA-C-N 114.868 -1.06 . . . . 0.0 109.896 178.725 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.539 HD12 ' N ' ' A' ' 93' ' ' LEU . 0.5 OUTLIER -111.42 137.68 48.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.86 0.362 . . . . 0.0 110.945 -179.94 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.806 HD23 HD22 ' A' ' 99' ' ' LEU . 1.0 OUTLIER -124.06 129.14 50.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.779 179.789 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.792 ' N ' HD22 ' A' ' 93' ' ' LEU . . . . . . . . 0 N--CA 1.451 -0.306 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.399 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.806 HD22 HD23 ' A' ' 93' ' ' LEU . 2.4 mm? . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.826 0.346 . . . . 0.0 110.809 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.729 HD13 ' O ' ' A' ' 122' ' ' GLN . 3.8 mm? -127.39 148.05 50.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.284 179.845 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.47 ' O ' ' N ' ' A' ' 122' ' ' GLN . 52.5 mt -115.93 129.66 56.49 Favored 'General case' 0 CA--C 1.518 -0.287 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.11 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.489 ' O ' ' O ' ' A' ' 90' ' ' GLN . 26.7 t30 -113.26 111.25 21.72 Favored 'General case' 0 CA--C 1.509 -0.598 0 C-N-CA 119.804 -0.758 . . . . 0.0 109.877 179.803 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.749 ' HB3' HG21 ' A' ' 109' ' ' THR . 72.6 m-20 -83.57 112.24 19.82 Favored 'General case' 0 N--CA 1.442 -0.853 0 C-N-CA 119.827 -0.749 . . . . 0.0 109.619 179.664 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.977 ' O ' ' C ' ' A' ' 88' ' ' HIS . 0.1 OUTLIER -123.13 107.84 20.0 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.949 0 N-CA-C 108.928 -0.768 . . . . 0.0 108.928 177.745 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.502 ' HG ' ' CE1' ' A' ' 88' ' ' HIS . 71.9 m -128.93 169.6 14.44 Favored 'General case' 0 C--N 1.295 -1.793 0 CA-C-N 114.974 -1.012 . . . . 0.0 109.286 179.473 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 29.2 m -69.11 -62.68 1.28 Allowed 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 119.074 -1.05 . . . . 0.0 111.061 -179.356 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -111.86 -33.42 6.31 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 114.326 1.232 . . . . 0.0 114.326 178.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -147.05 131.69 4.05 Favored Glycine 0 C--N 1.341 0.813 0 N-CA-C 116.886 1.514 . . . . 0.0 116.886 -178.181 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.749 HG21 ' HB3' ' A' ' 103' ' ' ASP . 7.2 m -121.08 138.18 54.31 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 174.259 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . 0.751 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.4 m-90 -119.78 149.36 42.17 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 113.543 0.942 . . . . 0.0 113.543 -178.58 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.452 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -123.4 112.2 17.27 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 114.82 -1.082 . . . . 0.0 108.546 177.556 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 73.3 m-20 47.3 43.11 14.7 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.079 -0.509 . . . . 0.0 112.204 -179.496 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 84.06 -4.11 84.01 Favored Glycine 0 N--CA 1.445 -0.732 0 C-N-CA 120.759 -0.734 . . . . 0.0 113.25 179.168 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -111.47 102.3 10.67 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.917 0.389 . . . . 0.0 110.817 179.688 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.751 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.0 OUTLIER -44.01 136.49 3.72 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.939 179.846 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.63 HG11 ' OD2' ' A' ' 103' ' ' ASP . 14.9 p -124.35 163.39 24.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.693 -179.082 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.548 ' N ' HG22 ' A' ' 116' ' ' VAL . 29.7 tp10 -70.1 141.84 52.69 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.019 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.409 ' HG3' ' HA ' ' A' ' 104' ' ' ILE . 63.4 tttm -68.59 162.7 25.3 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.407 179.654 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.405 ' N ' ' HG2' ' A' ' 118' ' ' LYS . 4.1 p30 35.21 38.04 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.349 0.595 . . . . 0.0 111.404 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 6.7 p -111.39 109.79 19.94 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.018 -179.453 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.431 ' HB3' HD12 ' A' ' 100' ' ' LEU . 29.5 m120 -59.33 139.47 56.98 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.502 179.754 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . 0.729 ' O ' HD13 ' A' ' 100' ' ' LEU . 48.9 mm-40 -129.7 148.53 51.6 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-O 121.072 0.463 . . . . 0.0 112.121 -179.357 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.686 HD13 ' O ' ' A' ' 124' ' ' LEU . 3.5 tm? -72.31 112.08 8.07 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.456 179.172 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.686 ' O ' HD13 ' A' ' 123' ' ' LEU . 7.8 tt -43.23 147.22 0.38 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.728 0.775 . . . . 0.0 112.246 -178.645 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.43 ' O ' HD11 ' A' ' 147' ' ' ILE . 0.6 OUTLIER -126.64 153.15 45.74 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 114.322 -1.308 . . . . 0.0 110.43 179.752 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . 0.437 ' HA ' HD13 ' A' ' 147' ' ' ILE . 0.0 OUTLIER -71.61 113.86 9.08 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 179.414 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 68.25 27.32 73.78 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.201 -179.153 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -53.41 161.22 1.01 Allowed 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.928 0.394 . . . . 0.0 111.319 -179.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.403 ' HG2' ' O ' ' A' ' 143' ' ' LEU . 1.1 tt0 -146.21 134.85 22.2 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.204 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.636 HD13 ' OD1' ' A' ' 103' ' ' ASP . 3.7 mt -115.8 128.44 73.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 178.854 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.483 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 36.7 m -103.02 143.31 32.74 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.61 -179.742 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.474 ' HB ' ' NE2' ' A' ' 88' ' ' HIS . 6.3 m -140.75 158.21 23.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 -178.549 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 72.88 44.09 38.94 Favored Glycine 0 N--CA 1.445 -0.717 0 CA-C-N 115.679 -0.692 . . . . 0.0 112.275 179.39 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.504 ' HA ' HG12 ' A' ' 140' ' ' ILE . 85.4 t -81.64 153.94 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.616 0 CA-C-O 121.438 0.637 . . . . 0.0 112.161 -179.212 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . 0.403 ' N ' HG12 ' A' ' 134' ' ' VAL . . . 152.68 -43.48 0.65 Allowed Glycine 0 N--CA 1.441 -1.0 0 CA-C-N 114.932 -1.031 . . . . 0.0 110.564 -179.113 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.53 HG12 ' H ' ' A' ' 138' ' ' SER . 44.0 t -126.71 132.82 69.74 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.675 0 CA-C-N 115.137 -0.531 . . . . 0.0 109.714 178.681 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 37.3 tp10 -51.28 -34.59 33.59 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.761 0.315 . . . . 0.0 111.449 -179.169 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . 0.53 ' H ' HG12 ' A' ' 136' ' ' VAL . 48.2 t -94.34 6.52 48.46 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -179.413 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -126.13 29.64 5.81 Favored 'General case' 0 CA--C 1.52 -0.201 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -179.239 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.504 HG12 ' HA ' ' A' ' 134' ' ' VAL . 11.8 mt -107.6 141.14 23.58 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.367 179.162 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.673 HD13 ' OE1' ' A' ' 42' ' ' GLN . 1.2 mp -123.07 134.79 54.24 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.164 -0.926 . . . . 0.0 110.315 179.768 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . 0.759 ' O ' HD13 ' A' ' 143' ' ' LEU . 0.8 OUTLIER -112.73 154.67 25.81 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.958 0.885 . . . . 0.0 112.758 -179.087 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.817 HD12 ' SG ' ' A' ' 38' ' ' CYS . 1.6 mm? -130.12 144.05 51.13 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 114.047 -1.433 . . . . 0.0 109.192 179.34 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.472 ' O ' ' N ' ' A' ' 37' ' ' ILE . 21.9 t -124.31 140.97 46.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.933 0.396 . . . . 0.0 111.939 -178.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.873 HG13 HG22 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -109.86 132.2 58.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.712 179.538 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -118.2 125.27 49.84 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.69 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.685 HG12 HD21 ' A' ' 124' ' ' LEU . 3.9 mp -109.58 133.61 54.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.472 -179.647 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -78.62 117.95 20.27 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.957 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -65.15 -27.58 68.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.95 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.74 -46.01 90.44 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-O 121.065 0.459 . . . . 0.0 110.68 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 10.5 t80 . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.008 179.897 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 . . . . . 0 C--O 1.231 0.111 0 N-CA-C 111.795 0.295 . . . . 0.0 111.795 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.564 ' HA ' HD12 ' A' ' 52' ' ' ILE . 18.2 m-80 -107.99 -12.92 15.07 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-O 121.883 0.849 . . . . 0.0 109.107 179.345 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.616 ' CG2' ' O ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -70.71 95.08 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.572 0 CA-C-N 113.961 -1.472 . . . . 0.0 111.198 -179.241 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.665 ' CG2' ' HB2' ' A' ' 50' ' ' ALA . 0.4 OUTLIER -32.81 -61.13 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-N 114.706 -1.134 . . . . 0.0 112.286 -179.567 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.844 ' SG ' HD12 ' A' ' 48' ' ' LEU . 20.9 p -165.11 164.83 20.25 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 112.516 0.561 . . . . 0.0 112.516 -179.47 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 2.8 ttm180 -119.44 125.15 48.26 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.62 179.47 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.947 HG13 HD11 ' A' ' 48' ' ' LEU . 3.5 m -92.96 124.39 45.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.896 0.379 . . . . 0.0 111.088 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.969 HG23 HG12 ' A' ' 45' ' ' ILE . 19.8 mt -132.27 108.6 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.911 -179.487 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.441 ' HB3' ' O ' ' A' ' 43' ' ' ILE . 38.9 t -78.9 127.77 32.45 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 178.291 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 48.4 p -110.77 28.65 8.49 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 112.576 0.584 . . . . 0.0 112.576 -178.442 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.435 ' OG1' ' O ' ' A' ' 142' ' ' SER . 0.0 OUTLIER -116.41 -37.41 3.75 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.778 0.323 . . . . 0.0 110.983 179.333 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 116.92 53.08 0.33 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.861 179.492 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.694 ' HG3' HD12 ' A' ' 141' ' ' LEU . 3.4 mt-30 -142.58 -42.71 0.32 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.612 0.244 . . . . 0.0 111.479 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.598 HD12 ' HB2' ' A' ' 42' ' ' GLN . 4.0 mp -115.04 138.96 23.74 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 120.779 0.323 . . . . 0.0 111.493 -179.385 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.489 ' CD ' ' CZ ' ' A' ' 76' ' ' TYR . 86.9 Cg_endo -82.43 146.79 13.92 Favored 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 122.76 2.307 . . . . 0.0 111.732 179.494 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.969 HG12 HG23 ' A' ' 37' ' ' ILE . 35.7 mt -53.2 111.86 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.995 0.426 . . . . 0.0 111.528 -179.688 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.437 ' O ' HG22 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -115.17 144.0 44.36 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.84 179.297 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -103.36 119.65 39.28 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.052 0.453 . . . . 0.0 111.599 -179.409 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.947 HD11 HG13 ' A' ' 36' ' ' VAL . 0.3 OUTLIER -100.47 138.65 37.25 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 178.504 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.641 ' C ' ' HB ' ' A' ' 33' ' ' VAL . 42.5 t -127.48 -170.82 2.29 Favored 'General case' 0 CA--C 1.511 -0.538 0 CA-C-O 122.941 1.353 . . . . 0.0 113.916 -178.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.665 ' HB2' ' CG2' ' A' ' 33' ' ' VAL . . . -157.52 145.02 18.61 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 112.699 -2.046 . . . . 0.0 110.809 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -84.7 86.6 7.31 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.116 0.484 . . . . 0.0 110.705 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.564 HD12 ' HA ' ' A' ' 31' ' ' ASN . 5.8 mt . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.687 -179.67 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.88 0.371 . . . . 0.0 110.951 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 15.9 ttpt -113.29 131.48 55.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.693 179.72 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.622 HG13 ' O ' ' A' ' 91' ' ' ILE . 13.9 t -132.29 139.21 50.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.989 0.423 . . . . 0.0 111.696 -179.284 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . 0.64 ' HB2' ' HB ' ' A' ' 91' ' ' ILE . 17.3 m-90 -100.62 139.63 36.04 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.286 179.069 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.74 HG23 ' HG3' ' A' ' 90' ' ' GLN . 15.6 m -122.4 133.03 54.64 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.594 0.712 . . . . 0.0 112.286 179.829 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.518 ' CE1' ' CG ' ' A' ' 75' ' ' ASP . 10.8 m-85 -102.8 118.21 36.34 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.051 -0.977 . . . . 0.0 108.792 177.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.652 ' HA2' HD21 ' A' ' 78' ' ' LEU . . . 157.21 -153.92 25.09 Favored Glycine 0 CA--C 1.503 -0.663 0 C-N-CA 118.812 -1.661 . . . . 0.0 113.148 179.573 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.539 ' HB3' ' HA ' ' A' ' 80' ' ' ASN . 6.5 ptm180 -76.55 92.08 3.43 Favored 'General case' 0 N--CA 1.442 -0.861 0 CA-C-O 122.551 1.167 . . . . 0.0 108.985 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.491 ' O ' ' CD2' ' A' ' 77' ' ' HIS . 25.3 m-80 -149.72 159.99 34.93 Favored Pre-proline 0 C--N 1.308 -1.225 0 CA-C-N 112.806 -1.997 . . . . 0.0 108.261 178.857 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.545 ' O ' ' HB2' ' A' ' 77' ' ' HIS . 30.2 Cg_endo -63.89 -8.37 15.69 Favored 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 120.606 0.87 . . . . 0.0 110.434 177.407 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.732 ' HB2' ' HB2' ' A' ' 77' ' ' HIS . . . 137.28 53.32 0.0 OUTLIER 'General case' 0 CA--C 1.49 -1.345 0 CA-C-N 114.482 -1.235 . . . . 0.0 109.14 178.814 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.564 ' HB3' ' HB ' ' A' ' 67' ' ' THR . 0.1 OUTLIER -52.96 -69.75 0.11 Allowed 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 105.859 -1.904 . . . . 0.0 105.859 179.713 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.577 ' HB2' ' N ' ' A' ' 67' ' ' THR . 55.5 t0 -95.09 -47.73 6.25 Favored 'General case' 0 N--CA 1.435 -1.197 0 N-CA-C 105.526 -2.027 . . . . 0.0 105.526 169.59 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.506 ' C ' ' HA ' ' A' ' 73' ' ' ALA . 13.9 t80 -144.05 142.38 30.62 Favored 'General case' 0 C--N 1.346 0.441 0 CA-C-N 112.603 -2.089 . . . . 0.0 110.984 179.262 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . 0.732 ' HB2' ' HB2' ' A' ' 73' ' ' ALA . 23.8 t-160 -89.33 108.51 19.67 Favored 'General case' 0 C--N 1.328 -0.338 0 O-C-N 121.961 -0.462 . . . . 0.0 109.902 177.038 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.652 HD21 ' HA2' ' A' ' 69' ' ' GLY . 0.5 OUTLIER -132.8 175.43 9.35 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.931 0.396 . . . . 0.0 111.546 -179.615 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -57.06 161.56 8.0 Favored Glycine 0 C--N 1.332 0.309 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.406 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.539 ' HA ' ' HB3' ' A' ' 70' ' ' ARG . 3.6 p-10 -112.02 100.07 8.58 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.857 0.36 . . . . 0.0 111.79 -179.499 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.651 ' HB ' ' HB2' ' A' ' 85' ' ' SER . 14.2 mt -113.41 147.28 17.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.177 178.738 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.07 -24.27 67.41 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 -179.45 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.541 ' C ' HD13 ' A' ' 84' ' ' LEU . 41.8 mtp180 -95.78 -98.31 0.17 Allowed 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 112.077 0.399 . . . . 0.0 112.077 -178.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.793 ' H ' HD22 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -108.46 110.71 22.3 Favored 'General case' 0 CA--C 1.512 -0.491 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 179.268 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.652 ' O ' ' HA2' ' A' ' 69' ' ' GLY . 0.5 OUTLIER 158.56 -35.95 0.0 OUTLIER 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 114.415 -1.266 . . . . 0.0 108.514 -179.068 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.783 ' O ' ' N ' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -66.17 -164.9 0.03 OUTLIER 'General case' 0 CA--C 1.507 -0.688 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 176.86 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.421 ' HA ' ' HA3' ' A' ' 69' ' ' GLY . 0.5 OUTLIER -55.52 70.39 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 177.411 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 1.061 ' O ' ' O ' ' A' ' 104' ' ' ILE . 44.6 t60 -73.3 -14.46 61.31 Favored 'General case' 0 CA--C 1.513 -0.449 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 -176.708 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.559 ' CD2' ' HA ' ' A' ' 103' ' ' ASP . 0.1 OUTLIER -177.67 159.81 1.49 Allowed 'General case' 0 C--N 1.313 -1.007 0 C-N-CA 119.577 -0.849 . . . . 0.0 112.101 178.423 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.74 ' HG3' HG23 ' A' ' 67' ' ' THR . 23.4 mt-30 -137.92 160.79 38.37 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 113.791 1.034 . . . . 0.0 113.791 -177.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.64 ' HB ' ' HB2' ' A' ' 66' ' ' TRP . 2.9 mt -122.81 132.02 72.12 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 CA-C-N 115.333 -0.848 . . . . 0.0 109.643 178.058 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.707 HD13 ' ND2' ' A' ' 121' ' ' ASN . 0.5 OUTLIER -106.69 142.79 35.76 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -179.391 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.857 HD22 ' N ' ' A' ' 94' ' ' GLY . 0.2 OUTLIER -126.36 127.78 46.03 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.389 179.04 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.857 ' N ' HD22 ' A' ' 93' ' ' LEU . . . . . . . . 0 N--CA 1.451 -0.31 0 C-N-CA 120.6 -0.81 . . . . 0.0 112.801 179.647 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.642 ' O ' HD12 ' A' ' 100' ' ' LEU . 0.6 OUTLIER . . . . . 0 C--O 1.23 0.065 0 CA-C-O 120.875 0.369 . . . . 0.0 110.909 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.68 ' HA ' ' O ' ' A' ' 122' ' ' GLN . 4.2 mp -133.8 149.06 51.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.294 179.819 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.452 ' O ' ' N ' ' A' ' 122' ' ' GLN . 1.1 mt -115.27 129.97 56.77 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 179.723 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.477 ' O ' ' O ' ' A' ' 90' ' ' GLN . 29.6 t30 -108.54 112.49 24.89 Favored 'General case' 0 CA--C 1.508 -0.636 0 C-N-CA 119.832 -0.747 . . . . 0.0 109.854 179.739 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.871 ' HB3' HG21 ' A' ' 109' ' ' THR . 44.3 m-20 -83.92 109.7 17.81 Favored 'General case' 0 N--CA 1.44 -0.926 0 C-N-CA 119.198 -1.001 . . . . 0.0 109.627 179.871 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 1.061 ' O ' ' O ' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -125.05 109.38 22.04 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.041 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 177.168 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.443 ' HB3' ' CE1' ' A' ' 88' ' ' HIS . 65.0 m -136.09 169.39 17.69 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.359 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 19.1 m -69.38 -63.34 1.09 Allowed 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 119.005 -1.078 . . . . 0.0 111.709 -179.009 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -112.29 -32.88 6.38 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 114.904 1.446 . . . . 0.0 114.904 179.301 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -146.03 131.49 4.13 Favored Glycine 0 C--N 1.34 0.759 0 N-CA-C 117.033 1.573 . . . . 0.0 117.033 -177.725 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.871 HG21 ' HB3' ' A' ' 103' ' ' ASP . 11.9 m -121.33 138.2 54.36 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 174.451 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . 0.716 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 3.1 m-90 -121.69 149.27 43.48 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 113.648 0.981 . . . . 0.0 113.648 -178.411 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.487 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -123.85 112.22 17.02 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 114.979 -1.009 . . . . 0.0 108.711 177.512 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 44.66 43.94 7.03 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.013 -0.54 . . . . 0.0 112.127 -179.566 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 80.8 22.81 60.95 Favored Glycine 0 N--CA 1.445 -0.732 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.801 179.308 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.46 97.77 3.77 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.013 0.435 . . . . 0.0 110.661 179.749 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.716 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.0 OUTLIER -43.99 127.04 5.19 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.98 179.919 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.445 HG13 ' HB3' ' A' ' 111' ' ' LEU . 6.1 m -112.41 179.96 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.907 -179.008 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -90.66 142.2 28.0 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.143 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.415 ' HG2' ' N ' ' A' ' 119' ' ' ASN . 54.4 tttm -63.51 163.78 10.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.113 179.429 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.415 ' N ' ' HG2' ' A' ' 118' ' ' LYS . 19.4 m-80 33.72 39.85 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 121.28 0.562 . . . . 0.0 111.167 -179.39 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 7.1 p -111.04 105.05 13.68 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.038 -179.429 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.707 ' ND2' HD13 ' A' ' 92' ' ' LEU . 1.7 m120 -53.58 144.59 17.06 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.571 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . 0.68 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 35.4 mm-40 -129.5 146.02 51.38 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-O 120.976 0.417 . . . . 0.0 111.754 -179.625 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.673 HD13 ' N ' ' A' ' 124' ' ' LEU . 2.1 tm? -74.08 129.5 37.98 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.677 179.216 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.691 HD13 ' N ' ' A' ' 125' ' ' SER . 3.5 tm? -52.28 138.46 26.45 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-O 122.045 0.926 . . . . 0.0 111.587 -179.102 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.735 ' O ' HD11 ' A' ' 147' ' ' ILE . 0.6 OUTLIER -127.36 152.13 47.88 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 113.762 -1.563 . . . . 0.0 110.395 179.686 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . 0.437 ' HA ' HD13 ' A' ' 147' ' ' ILE . 14.0 mm100 -71.33 113.9 8.85 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.911 0.386 . . . . 0.0 109.973 179.412 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 62.95 32.12 82.93 Favored Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.336 -179.399 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.407 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 9.3 t70 -53.78 159.24 1.7 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.97 0.414 . . . . 0.0 111.011 -179.837 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.526 ' HB2' HG22 ' A' ' 144' ' ' VAL . 30.4 tt0 -146.66 135.1 21.94 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.883 -0.598 . . . . 0.0 111.642 -179.838 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.62 HG21 ' OD1' ' A' ' 103' ' ' ASP . 2.7 mp -116.03 129.0 73.14 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.045 178.597 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.569 HG23 ' CG2' ' A' ' 140' ' ' ILE . 12.9 m -102.75 145.41 29.78 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.884 0.373 . . . . 0.0 110.852 -179.266 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.499 ' HB ' ' NE2' ' A' ' 88' ' ' HIS . 5.8 m -141.2 158.39 22.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 112.327 0.491 . . . . 0.0 112.327 -179.113 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 67.17 43.03 90.75 Favored Glycine 0 N--CA 1.447 -0.601 0 CA-C-N 115.797 -0.638 . . . . 0.0 112.31 179.356 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.467 HG12 ' N ' ' A' ' 135' ' ' GLY . 93.6 t -78.44 157.25 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.613 0 CA-C-O 121.36 0.6 . . . . 0.0 112.076 -179.146 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . 0.467 ' N ' HG12 ' A' ' 134' ' ' VAL . . . 149.0 -42.02 0.84 Allowed Glycine 0 N--CA 1.441 -1.012 0 N-CA-C 110.691 -0.964 . . . . 0.0 110.691 -179.193 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.569 HG12 ' H ' ' A' ' 138' ' ' SER . 48.1 t -126.6 131.33 71.36 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.715 0 CA-C-N 115.256 -0.472 . . . . 0.0 109.883 178.709 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.24 -33.9 30.04 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.772 0.32 . . . . 0.0 111.432 -179.247 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . 0.569 ' H ' HG12 ' A' ' 136' ' ' VAL . 0.9 OUTLIER -94.31 6.5 48.48 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.214 0.45 . . . . 0.0 112.214 -179.397 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 12.0 t0 -127.74 30.92 5.23 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 112.648 0.61 . . . . 0.0 112.648 -179.259 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.569 ' CG2' HG23 ' A' ' 131' ' ' THR . 24.2 mt -105.53 141.11 21.6 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.978 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.353 179.238 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.694 HD12 ' HG3' ' A' ' 42' ' ' GLN . 2.8 mm? -116.49 135.92 53.42 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 114.938 -1.028 . . . . 0.0 110.358 179.822 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . 0.435 ' O ' ' OG1' ' A' ' 40' ' ' THR . 43.5 t -120.96 152.59 38.35 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 -178.758 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.713 HD13 ' N ' ' A' ' 144' ' ' VAL . 3.3 tm? -135.41 136.99 41.83 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 114.841 -1.072 . . . . 0.0 109.21 179.04 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.713 ' N ' HD13 ' A' ' 143' ' ' LEU . 43.0 t -130.12 140.21 49.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 120.955 0.407 . . . . 0.0 111.842 -178.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.78 HG13 HG12 ' A' ' 36' ' ' VAL . 0.1 OUTLIER -111.41 126.44 68.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.612 179.493 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 15.5 t80 -106.08 108.63 20.24 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.687 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.735 HD11 ' O ' ' A' ' 125' ' ' SER . 1.7 mp -85.24 133.42 29.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.26 -179.797 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . 0.433 ' ND2' ' HB2' ' A' ' 151' ' ' PHE . 0.9 OUTLIER -83.77 116.52 22.74 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.798 179.841 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -58.08 -21.67 46.97 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.326 -179.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 4.7 mptt -57.54 -41.07 80.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.891 0.377 . . . . 0.0 110.717 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . 0.454 ' CE2' HD11 ' A' ' 52' ' ' ILE . 4.0 t80 . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.76 179.781 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.528 0.122 0 CA-C-O 120.668 0.27 . . . . 0.0 111.631 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 27.3 m120 -108.54 -13.27 14.86 Favored 'General case' 0 CA--C 1.513 -0.476 0 CA-C-O 121.913 0.863 . . . . 0.0 109.35 179.282 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.529 ' CG2' ' O ' ' A' ' 32' ' ' ILE . 0.1 OUTLIER -70.6 104.13 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.54 0 CA-C-N 114.085 -1.416 . . . . 0.0 111.035 -179.353 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 1.02 ' CG2' ' HB2' ' A' ' 50' ' ' ALA . 0.5 OUTLIER -37.5 -63.42 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 CA-C-N 115.133 -0.94 . . . . 0.0 112.037 -179.197 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.784 ' SG ' HD12 ' A' ' 48' ' ' LEU . 18.8 p -164.83 164.73 20.94 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.363 -179.406 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.4 ' HD3' ' CG2' ' A' ' 45' ' ' ILE . 0.9 OUTLIER -127.38 123.64 36.68 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.858 0.361 . . . . 0.0 111.245 179.629 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.863 ' CG2' HD11 ' A' ' 48' ' ' LEU . 2.4 t -93.75 122.22 45.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.478 179.531 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 1.044 HG23 HG12 ' A' ' 45' ' ' ILE . 22.4 mt -121.86 107.94 21.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -179.231 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 8.4 m -85.02 100.64 11.81 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 177.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.6 t -85.81 -27.43 25.14 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -178.398 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.45 ' OG1' ' O ' ' A' ' 142' ' ' SER . 0.1 OUTLIER -52.08 -26.43 11.04 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.986 0.422 . . . . 0.0 111.016 -179.899 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 97.08 68.42 0.96 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.28 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.732 ' HB3' HD22 ' A' ' 141' ' ' LEU . 16.9 pt20 -142.42 -46.87 0.33 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.825 0.345 . . . . 0.0 111.204 -179.622 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.477 HG23 ' CE2' ' A' ' 76' ' ' TYR . 10.7 mt -132.31 133.84 24.24 Favored Pre-proline 0 N--CA 1.452 -0.351 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.161 -179.684 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.493 ' HD2' ' CZ ' ' A' ' 76' ' ' TYR . 29.4 Cg_exo -59.36 147.14 92.5 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.754 2.303 . . . . 0.0 111.728 179.501 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 1.044 HG12 HG23 ' A' ' 37' ' ' ILE . 52.6 mt -47.24 143.5 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.994 0.426 . . . . 0.0 111.851 -179.607 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.06 130.38 33.38 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.123 179.422 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.453 ' C ' HD23 ' A' ' 48' ' ' LEU . 1.2 p30 -97.76 120.27 37.85 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.11 0.481 . . . . 0.0 111.512 -179.341 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.863 HD11 ' CG2' ' A' ' 36' ' ' VAL . 0.5 OUTLIER -96.78 125.18 41.05 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.393 179.032 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.492 ' O ' ' HZ2' ' A' ' 66' ' ' TRP . 0.0 OUTLIER -118.49 162.21 18.73 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 122.065 0.936 . . . . 0.0 113.274 -178.861 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 1.02 ' HB2' ' CG2' ' A' ' 33' ' ' VAL . . . -119.07 164.78 15.01 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.531 -1.213 . . . . 0.0 111.026 179.644 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -116.06 71.24 0.77 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.021 0.439 . . . . 0.0 110.679 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.836 HD11 ' CE2' ' A' ' 151' ' ' PHE . 96.6 mt . . . . . 0 C--N 1.328 -0.356 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.416 -179.803 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.2 tptm . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.822 0.344 . . . . 0.0 111.166 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.443 ' HB3' HD12 ' A' ' 93' ' ' LEU . 17.7 ttpt -124.83 131.57 53.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.599 179.385 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.637 HG13 ' O ' ' A' ' 91' ' ' ILE . 19.2 t -136.0 139.26 46.2 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 CA-C-O 121.211 0.529 . . . . 0.0 111.94 -179.172 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . 0.678 ' HB2' ' HB ' ' A' ' 91' ' ' ILE . 15.0 m-90 -100.11 139.97 35.02 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.443 179.138 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.598 HG23 ' HG2' ' A' ' 90' ' ' GLN . 26.1 m -130.79 132.54 45.33 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.527 0.68 . . . . 0.0 112.149 179.719 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.486 ' CE1' ' CG ' ' A' ' 75' ' ' ASP . 3.6 m-85 -105.96 119.04 38.18 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 114.873 -1.058 . . . . 0.0 109.348 178.298 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.637 ' HA2' ' O ' ' A' ' 85' ' ' SER . . . 160.71 -157.85 29.32 Favored Glycine 0 CA--C 1.505 -0.538 0 C-N-CA 118.658 -1.734 . . . . 0.0 113.286 178.802 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.629 ' HD2' ' ND2' ' A' ' 86' ' ' ASN . 5.1 ptm180 -75.94 91.76 3.07 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-O 122.629 1.204 . . . . 0.0 108.165 179.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.506 ' O ' ' CD2' ' A' ' 77' ' ' HIS . 0.2 OUTLIER -149.72 160.35 34.18 Favored Pre-proline 0 C--N 1.307 -1.263 0 CA-C-N 112.606 -2.088 . . . . 0.0 108.085 179.681 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.547 ' O ' ' CB ' ' A' ' 73' ' ' ALA . 30.1 Cg_endo -63.91 -8.74 16.69 Favored 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 120.84 1.027 . . . . 0.0 111.12 178.268 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.743 ' HB2' ' HB2' ' A' ' 77' ' ' HIS . . . 135.69 54.21 0.0 OUTLIER 'General case' 0 CA--C 1.49 -1.358 0 CA-C-N 114.706 -1.134 . . . . 0.0 109.361 178.724 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.55 ' HB3' ' HB ' ' A' ' 67' ' ' THR . 0.1 OUTLIER -52.59 -69.73 0.11 Allowed 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 105.546 -2.02 . . . . 0.0 105.546 179.46 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.504 ' N ' ' O ' ' A' ' 67' ' ' THR . 13.8 t70 -95.51 -47.74 6.12 Favored 'General case' 0 N--CA 1.435 -1.202 0 N-CA-C 105.446 -2.057 . . . . 0.0 105.446 169.137 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.518 ' C ' ' HA ' ' A' ' 73' ' ' ALA . 67.3 t80 -142.96 142.21 31.6 Favored 'General case' 0 C--N 1.347 0.492 0 CA-C-N 112.627 -2.079 . . . . 0.0 111.465 179.756 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . 0.743 ' HB2' ' HB2' ' A' ' 73' ' ' ALA . 23.6 t-160 -91.65 111.64 23.24 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 177.079 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.676 HD11 ' HA ' ' A' ' 85' ' ' SER . 0.5 OUTLIER -135.47 175.89 9.17 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.925 0.393 . . . . 0.0 111.604 -179.666 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -59.39 165.63 9.68 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.257 179.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.41 ' HB3' ' CB ' ' A' ' 70' ' ' ARG . 2.4 p-10 -112.01 100.07 8.58 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.829 0.347 . . . . 0.0 111.76 -179.493 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.669 ' HB ' ' HB2' ' A' ' 85' ' ' SER . 19.1 mt -115.02 131.77 66.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 177.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.446 ' HA ' ' OD1' ' A' ' 86' ' ' ASN . 1.6 m -52.79 -24.01 8.03 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 111.789 0.292 . . . . 0.0 111.789 -178.779 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.503 ' C ' HD13 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -93.05 -94.85 0.15 Allowed 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 120.428 0.156 . . . . 0.0 111.419 -179.943 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.844 ' H ' HD22 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -109.43 108.77 19.4 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 121.388 0.613 . . . . 0.0 109.402 178.918 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.676 ' HA ' HD11 ' A' ' 78' ' ' LEU . 1.8 m 158.7 -39.67 0.0 OUTLIER 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 114.589 -1.187 . . . . 0.0 109.369 -179.684 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.696 ' O ' ' N ' ' A' ' 88' ' ' HIS . 6.7 m120 -65.76 -163.01 0.02 OUTLIER 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 177.188 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.845 ' HB2' HD11 ' A' ' 104' ' ' ILE . 4.1 pttp -58.08 72.82 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 177.435 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.976 ' O ' ' O ' ' A' ' 104' ' ' ILE . 31.2 t60 -77.79 -19.5 54.92 Favored 'General case' 0 CA--C 1.515 -0.382 0 N-CA-C 114.315 1.228 . . . . 0.0 114.315 -176.437 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.596 ' HA ' ' H ' ' A' ' 104' ' ' ILE . 0.0 OUTLIER -173.7 156.86 2.99 Favored 'General case' 0 C--N 1.314 -0.97 0 C-N-CA 118.834 -1.146 . . . . 0.0 113.012 177.944 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.598 ' HG2' HG23 ' A' ' 67' ' ' THR . 33.4 mt-30 -137.55 160.75 38.27 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 114.587 -1.188 . . . . 0.0 113.751 -177.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.68 HD13 HD11 ' A' ' 48' ' ' LEU . 3.5 mt -128.37 132.18 68.36 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 CA-C-N 115.076 -0.966 . . . . 0.0 109.49 178.486 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.771 HD13 ' ND2' ' A' ' 121' ' ' ASN . 0.3 OUTLIER -108.95 144.11 37.33 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.118 0.485 . . . . 0.0 112.219 -178.988 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.882 HD22 ' N ' ' A' ' 94' ' ' GLY . 0.3 OUTLIER -125.88 129.95 50.36 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.477 179.409 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.882 ' N ' HD22 ' A' ' 93' ' ' LEU . . . . . . . . 0 N--CA 1.451 -0.312 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.509 179.733 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.577 HD21 HG13 ' A' ' 33' ' ' VAL . 6.6 mp . . . . . 0 CA--C 1.523 -0.092 0 CA-C-O 120.762 0.315 . . . . 0.0 110.769 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.852 HD13 ' O ' ' A' ' 122' ' ' GLN . 3.6 mm? -122.54 147.96 45.76 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.336 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.758 HD21 HD13 ' A' ' 145' ' ' ILE . 3.5 mp -118.79 127.44 53.53 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 179.502 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.491 ' O ' ' O ' ' A' ' 90' ' ' GLN . 26.1 t30 -111.98 111.48 22.44 Favored 'General case' 0 CA--C 1.506 -0.736 0 C-N-CA 119.641 -0.824 . . . . 0.0 109.944 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.923 ' OD1' HD13 ' A' ' 130' ' ' ILE . 81.6 m-20 -83.83 111.36 19.14 Favored 'General case' 0 N--CA 1.439 -1.016 0 C-N-CA 119.645 -0.822 . . . . 0.0 109.098 179.354 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.976 ' O ' ' O ' ' A' ' 88' ' ' HIS . 0.1 OUTLIER -122.8 107.74 20.0 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.073 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 177.964 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 59.1 m -133.89 169.12 17.56 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-N 114.86 -1.064 . . . . 0.0 109.187 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 20.0 m -69.44 -63.58 1.04 Allowed 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 119.04 -1.064 . . . . 0.0 111.689 -179.045 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -112.5 -32.45 6.47 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 114.858 1.429 . . . . 0.0 114.858 179.271 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -145.66 129.25 3.37 Favored Glycine 0 C--N 1.34 0.761 0 N-CA-C 117.151 1.62 . . . . 0.0 117.151 -177.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.772 HG21 ' HB3' ' A' ' 103' ' ' ASP . 6.8 m -121.61 138.54 54.28 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 174.392 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . 0.758 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.4 m-90 -119.46 149.23 42.22 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 -178.393 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.468 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.3 OUTLIER -122.61 112.2 17.7 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 115.158 -0.928 . . . . 0.0 108.692 177.594 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . 0.406 ' N ' HD12 ' A' ' 111' ' ' LEU . 57.8 m-20 44.93 44.06 7.65 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.075 -0.511 . . . . 0.0 112.171 -179.595 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 79.02 23.71 63.19 Favored Glycine 0 N--CA 1.445 -0.745 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.787 179.362 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 -136.76 96.09 3.26 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.105 0.478 . . . . 0.0 110.752 179.642 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.758 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.0 OUTLIER -44.12 132.87 5.45 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.071 179.888 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 4.1 m -123.61 179.29 2.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.761 -179.184 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -82.95 139.34 33.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.971 180.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.437 ' O ' ' C ' ' A' ' 119' ' ' ASN . 9.3 tmtt? -63.03 167.78 4.58 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 179.312 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.437 ' C ' ' O ' ' A' ' 118' ' ' LYS . 3.7 p30 31.22 40.74 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.331 -179.664 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 5.2 p -110.97 107.66 17.15 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.059 -179.187 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.771 ' ND2' HD13 ' A' ' 92' ' ' LEU . 1.5 m120 -56.54 140.46 46.3 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.436 179.741 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . 0.852 ' O ' HD13 ' A' ' 100' ' ' LEU . 68.6 mm-40 -129.63 147.07 51.38 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-O 121.115 0.483 . . . . 0.0 112.042 -179.714 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 7.3 tp -72.62 119.92 17.52 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.384 -0.825 . . . . 0.0 109.759 179.147 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.777 HD11 ' CD1' ' A' ' 147' ' ' ILE . 2.3 tp -48.06 142.41 5.18 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-O 121.854 0.835 . . . . 0.0 111.825 -178.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.422 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.0 OUTLIER -127.19 152.62 47.13 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 114.146 -1.388 . . . . 0.0 110.557 179.739 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 1.2 tp60 -72.34 113.71 9.66 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 179.162 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 68.75 27.24 74.01 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.466 -179.486 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.422 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 8.3 t70 -56.03 159.96 3.05 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-O 120.895 0.378 . . . . 0.0 111.232 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.446 ' HG3' HG22 ' A' ' 144' ' ' VAL . 2.0 tt0 -146.74 135.4 22.13 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.756 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.923 HD13 ' OD1' ' A' ' 103' ' ' ASP . 7.0 mt -116.27 128.14 73.67 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 178.586 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.498 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 98.6 m -103.2 145.82 29.35 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.856 0.36 . . . . 0.0 110.788 -179.404 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.54 ' HB ' ' NE2' ' A' ' 88' ' ' HIS . 7.8 m -141.12 158.42 22.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -178.786 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 69.94 44.13 62.87 Favored Glycine 0 N--CA 1.448 -0.567 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.451 179.2 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.473 ' HA ' HG12 ' A' ' 140' ' ' ILE . 93.8 t -80.43 156.49 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 CA-C-O 121.434 0.635 . . . . 0.0 112.192 -179.242 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . 0.451 ' N ' HG12 ' A' ' 134' ' ' VAL . . . 149.62 -42.56 0.79 Allowed Glycine 0 N--CA 1.441 -0.972 0 N-CA-C 110.552 -1.019 . . . . 0.0 110.552 -179.129 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.565 HG12 ' H ' ' A' ' 138' ' ' SER . 51.9 t -126.85 131.95 70.53 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.69 0 CA-C-N 115.205 -0.497 . . . . 0.0 109.769 178.563 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -51.34 -34.52 34.05 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.725 0.298 . . . . 0.0 111.472 -179.266 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . 0.565 ' H ' HG12 ' A' ' 136' ' ' VAL . 13.9 m -94.3 6.51 48.44 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.416 0.524 . . . . 0.0 112.416 -179.36 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 18.2 t0 -126.51 30.37 5.57 Favored 'General case' 0 CA--C 1.519 -0.249 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -179.313 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.498 ' CG2' ' CG2' ' A' ' 131' ' ' THR . 14.7 mt -107.29 141.23 23.01 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.437 179.348 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.732 HD22 ' HB3' ' A' ' 42' ' ' GLN . 28.3 mt -119.82 135.23 54.95 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 114.902 -1.045 . . . . 0.0 109.916 179.554 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . 0.819 ' C ' HD12 ' A' ' 143' ' ' LEU . 47.3 t -116.92 151.89 35.69 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.912 0.863 . . . . 0.0 113.053 -178.806 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.819 HD12 ' C ' ' A' ' 142' ' ' SER . 5.5 mp -128.42 129.54 46.31 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.547 -1.206 . . . . 0.0 109.312 179.145 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.446 HG22 ' HG3' ' A' ' 129' ' ' GLU . 10.6 t -115.37 140.45 36.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 120.892 0.377 . . . . 0.0 111.641 -179.179 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.758 HD13 HD21 ' A' ' 101' ' ' LEU . 0.1 OUTLIER -116.23 126.26 73.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.766 179.957 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 9.8 t80 -109.62 121.89 46.22 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.782 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.777 ' CD1' HD11 ' A' ' 124' ' ' LEU . 5.9 mm -100.79 133.54 43.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.275 -179.835 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 7.9 p-10 -82.44 125.57 31.23 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.002 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -67.82 -22.66 65.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.024 179.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 9.8 mtmt -57.19 -40.23 76.95 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-O 120.939 0.399 . . . . 0.0 110.649 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . 0.836 ' CE2' HD11 ' A' ' 52' ' ' ILE . 19.5 t80 . . . . . 0 C--N 1.328 -0.348 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.563 179.732 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.727 0.299 . . . . 0.0 110.888 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.436 ' OD1' HD12 ' A' ' 52' ' ' ILE . 10.7 m-20 -109.0 -13.95 14.63 Favored 'General case' 0 CA--C 1.516 -0.345 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 178.244 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.594 ' CG2' ' O ' ' A' ' 32' ' ' ILE . 0.1 OUTLIER -70.74 95.46 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.581 0 CA-C-N 113.908 -1.497 . . . . 0.0 110.473 -179.685 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.743 HG23 ' HB3' ' A' ' 50' ' ' ALA . 0.8 OUTLIER -36.02 -63.08 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 114.813 -1.085 . . . . 0.0 112.593 -178.939 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.646 ' N ' HG12 ' A' ' 33' ' ' VAL . 98.3 m -154.31 164.8 38.03 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.152 0.501 . . . . 0.0 112.141 -179.009 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.19 114.84 20.82 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.264 179.241 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.601 HG12 HG13 ' A' ' 145' ' ' ILE . 5.7 m -88.98 126.93 42.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.663 -179.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.964 HG23 HG12 ' A' ' 45' ' ' ILE . 26.3 mt -126.07 108.82 20.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 112.464 0.542 . . . . 0.0 112.464 -179.035 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.49 ' SG ' HD23 ' A' ' 143' ' ' LEU . 0.0 OUTLIER -108.73 108.88 19.88 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 177.822 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.6 t -110.69 -23.22 11.19 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 -177.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.2 p -53.13 -25.21 12.5 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.917 0.389 . . . . 0.0 111.286 -179.433 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 119.98 47.74 0.34 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.494 179.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.752 ' HG2' HD22 ' A' ' 141' ' ' LEU . 2.8 mt-30 -120.06 -67.77 0.96 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.837 0.351 . . . . 0.0 110.886 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.486 HG21 ' CG ' ' A' ' 76' ' ' TYR . 0.6 OUTLIER -135.02 135.1 22.33 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.953 -179.804 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.432 ' HD2' ' CZ ' ' A' ' 76' ' ' TYR . 24.0 Cg_exo -59.37 147.69 89.99 Favored 'Trans proline' 0 C--N 1.342 0.234 0 C-N-CA 122.469 2.112 . . . . 0.0 111.563 179.451 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.964 HG12 HG23 ' A' ' 37' ' ' ILE . 32.8 mt -44.28 129.02 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.056 0.455 . . . . 0.0 111.99 -179.32 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.435 ' HB2' ' CD2' ' A' ' 76' ' ' TYR . 4.8 tpt180 -128.05 148.16 50.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.738 -0.664 . . . . 0.0 109.765 179.151 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -106.05 120.03 40.73 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.972 0.415 . . . . 0.0 111.797 -179.159 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.906 HD11 HD13 ' A' ' 91' ' ' ILE . 3.5 mt -93.64 131.84 38.56 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.282 178.716 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.525 ' O ' ' HZ2' ' A' ' 66' ' ' TRP . 0.0 OUTLIER -136.59 162.27 33.59 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 122.03 0.919 . . . . 0.0 113.406 -178.641 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.743 ' HB3' HG23 ' A' ' 33' ' ' VAL . . . -149.17 165.57 31.43 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.24 -1.346 . . . . 0.0 111.035 179.057 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 32.3 m-20 -91.57 121.16 33.0 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.051 0.453 . . . . 0.0 111.303 -179.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.436 HD12 ' OD1' ' A' ' 31' ' ' ASN . 72.0 mt . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 115.788 -0.642 . . . . 0.0 112.077 -179.759 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 60.3 tttt . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.842 0.353 . . . . 0.0 110.961 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.433 ' O ' ' HB3' ' A' ' 93' ' ' LEU . 6.3 ttpt -115.18 134.1 55.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.462 179.791 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.645 HG13 ' O ' ' A' ' 91' ' ' ILE . 16.8 t -137.1 137.72 46.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.116 0.484 . . . . 0.0 111.647 -179.292 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . 0.695 ' CD1' HD22 ' A' ' 48' ' ' LEU . 14.5 m-90 -99.89 139.67 35.21 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.199 179.128 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.709 HG23 ' CG ' ' A' ' 90' ' ' GLN . 8.8 m -127.57 129.63 47.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.505 0.669 . . . . 0.0 112.489 179.301 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.571 ' CE1' ' CG ' ' A' ' 75' ' ' ASP . 12.9 m-85 -100.91 118.49 37.05 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.14 -0.936 . . . . 0.0 108.961 177.735 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.639 ' HA2' ' O ' ' A' ' 85' ' ' SER . . . 160.46 -157.03 28.4 Favored Glycine 0 CA--C 1.505 -0.546 0 C-N-CA 119.045 -1.55 . . . . 0.0 113.057 179.236 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.442 ' H ' ' HA ' ' A' ' 86' ' ' ASN . 0.0 OUTLIER -76.78 92.42 3.59 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-O 122.663 1.22 . . . . 0.0 108.719 -179.685 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.502 ' O ' ' CD2' ' A' ' 77' ' ' HIS . 17.7 m-80 -149.42 159.45 36.58 Favored Pre-proline 0 C--N 1.306 -1.289 0 CA-C-N 112.68 -2.055 . . . . 0.0 108.06 179.15 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.544 ' O ' ' CB ' ' A' ' 73' ' ' ALA . 27.8 Cg_endo -63.61 -6.66 10.95 Favored 'Trans proline' 0 N--CA 1.452 -0.956 0 C-N-CA 120.64 0.893 . . . . 0.0 110.695 177.648 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.707 ' HB2' ' HB2' ' A' ' 77' ' ' HIS . . . 135.32 53.47 0.0 OUTLIER 'General case' 0 CA--C 1.491 -1.316 0 CA-C-N 114.447 -1.252 . . . . 0.0 109.227 178.814 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.579 ' HB3' ' HB ' ' A' ' 67' ' ' THR . 0.1 OUTLIER -52.48 -69.88 0.1 Allowed 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 105.443 -2.058 . . . . 0.0 105.443 179.617 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.701 ' HB2' ' N ' ' A' ' 67' ' ' THR . 57.0 t0 -95.45 -47.47 6.26 Favored 'General case' 0 N--CA 1.434 -1.232 0 N-CA-C 105.504 -2.036 . . . . 0.0 105.504 169.05 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.499 ' C ' ' HA ' ' A' ' 73' ' ' ALA . 1.7 t80 -143.72 142.72 31.08 Favored 'General case' 0 C--N 1.348 0.512 0 CA-C-N 112.602 -2.09 . . . . 0.0 112.019 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . 0.707 ' HB2' ' HB2' ' A' ' 73' ' ' ALA . 23.3 t-160 -96.43 108.02 20.5 Favored 'General case' 0 C--N 1.331 -0.218 0 O-C-N 122.166 -0.334 . . . . 0.0 110.101 176.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.694 HD13 ' N ' ' A' ' 78' ' ' LEU . 0.0 OUTLIER -136.94 179.93 6.08 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.891 0.377 . . . . 0.0 111.677 -179.754 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -52.23 157.75 3.54 Favored Glycine 0 C--N 1.333 0.383 0 CA-C-N 115.983 -0.553 . . . . 0.0 112.854 -179.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 5.9 p-10 -111.93 99.9 8.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.811 0.339 . . . . 0.0 111.814 -179.561 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.662 ' HB ' ' HB2' ' A' ' 85' ' ' SER . 14.1 mm -114.26 129.97 69.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.237 -0.438 . . . . 0.0 109.845 178.336 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.458 ' HA ' ' ND2' ' A' ' 86' ' ' ASN . 80.3 p -53.02 -23.7 8.07 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.788 -179.082 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.516 ' C ' HD13 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -93.97 -96.38 0.15 Allowed 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 111.669 0.248 . . . . 0.0 111.669 -179.509 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.816 ' H ' HD22 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -109.82 109.93 20.74 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-O 121.295 0.569 . . . . 0.0 109.84 179.324 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.662 ' HB2' ' HB ' ' A' ' 81' ' ' ILE . 0.4 OUTLIER 157.24 -41.26 0.0 OUTLIER 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 114.781 -1.099 . . . . 0.0 109.469 -179.942 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.761 ' O ' ' N ' ' A' ' 88' ' ' HIS . 91.1 m-20 -67.71 -156.19 0.02 OUTLIER 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 177.69 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.937 ' HB2' HD11 ' A' ' 104' ' ' ILE . 8.7 pttp -54.03 72.23 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 178.397 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 1.023 ' O ' ' O ' ' A' ' 104' ' ' ILE . 42.8 t60 -81.92 -16.13 51.59 Favored 'General case' 0 CA--C 1.514 -0.419 0 N-CA-C 113.888 1.07 . . . . 0.0 113.888 -176.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.591 ' CE1' HG13 ' A' ' 91' ' ' ILE . 0.0 OUTLIER -177.54 159.99 1.55 Allowed 'General case' 0 C--N 1.314 -0.95 0 C-N-CA 119.301 -0.96 . . . . 0.0 112.457 178.161 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.709 ' CG ' HG23 ' A' ' 67' ' ' THR . 38.3 mt-30 -138.89 160.35 39.93 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 113.761 1.022 . . . . 0.0 113.761 -178.442 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.906 HD13 HD11 ' A' ' 48' ' ' LEU . 5.6 mt -124.57 131.54 72.58 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.345 177.714 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.642 HD13 ' ND2' ' A' ' 121' ' ' ASN . 0.2 OUTLIER -107.61 140.24 40.93 Favored 'General case' 0 N--CA 1.463 0.176 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 -179.129 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.916 HD22 ' N ' ' A' ' 94' ' ' GLY . 0.3 OUTLIER -126.34 131.18 51.87 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.445 179.068 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.916 ' N ' HD22 ' A' ' 93' ' ' LEU . . . . . . . . 0 N--CA 1.451 -0.328 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.661 179.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.699 ' O ' HD12 ' A' ' 100' ' ' LEU . 4.0 mm? . . . . . 0 C--O 1.23 0.072 0 CA-C-O 120.836 0.351 . . . . 0.0 110.763 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.699 HD12 ' O ' ' A' ' 99' ' ' LEU . 3.8 mp -133.58 149.02 51.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.538 -179.794 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 1.028 HD22 HD13 ' A' ' 145' ' ' ILE . 0.5 OUTLIER -115.21 129.9 56.77 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 179.506 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.485 ' O ' ' O ' ' A' ' 90' ' ' GLN . 20.6 t30 -110.26 112.35 24.25 Favored 'General case' 0 CA--C 1.51 -0.588 0 C-N-CA 119.796 -0.762 . . . . 0.0 109.893 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.729 ' HB3' HG21 ' A' ' 109' ' ' THR . 87.0 m-20 -83.93 110.49 18.44 Favored 'General case' 0 N--CA 1.442 -0.848 0 C-N-CA 119.355 -0.938 . . . . 0.0 109.495 179.593 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 1.023 ' O ' ' O ' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -124.27 108.5 20.62 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.026 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 177.08 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.412 ' HG ' ' CE1' ' A' ' 88' ' ' HIS . 64.0 m -134.56 168.97 17.99 Favored 'General case' 0 C--N 1.296 -1.754 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.227 179.808 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 19.9 m -69.33 -63.14 1.12 Allowed 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 119.006 -1.078 . . . . 0.0 111.542 -179.042 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 63.9 m-80 -112.27 -32.39 6.54 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 114.934 1.457 . . . . 0.0 114.934 179.323 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -145.89 127.82 2.91 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 117.105 1.602 . . . . 0.0 117.105 -177.718 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.729 HG21 ' HB3' ' A' ' 103' ' ' ASP . 5.7 m -121.18 138.11 54.36 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 174.337 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . 0.736 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.8 m-90 -120.7 148.98 43.21 Favored 'General case' 0 CA--C 1.515 -0.384 0 N-CA-C 113.462 0.912 . . . . 0.0 113.462 -178.515 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.462 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -122.65 112.08 17.53 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 115.026 -0.988 . . . . 0.0 108.621 177.532 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 39.7 m-20 45.57 43.76 9.42 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.085 -0.507 . . . . 0.0 112.118 -179.478 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 78.88 25.05 60.82 Favored Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.784 179.425 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . 0.435 ' O ' HG13 ' A' ' 116' ' ' VAL . 31.2 mt-30 -136.98 97.51 3.53 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.102 0.477 . . . . 0.0 110.802 179.69 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.736 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.0 OUTLIER -45.66 132.61 8.44 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.911 179.755 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.606 HG21 ' OD2' ' A' ' 103' ' ' ASP . 27.7 m -124.07 -178.84 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 121.069 0.461 . . . . 0.0 111.916 -179.041 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -85.5 142.29 29.3 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.111 -179.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.426 ' HG2' ' N ' ' A' ' 119' ' ' ASN . 33.7 tttm -64.26 163.73 12.34 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.197 179.422 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.426 ' N ' ' HG2' ' A' ' 118' ' ' LYS . 8.2 m-80 34.56 39.91 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 121.182 0.515 . . . . 0.0 111.062 -179.374 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 3.5 p -110.74 107.2 16.66 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.901 -179.537 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.642 ' ND2' HD13 ' A' ' 92' ' ' LEU . 2.0 m120 -53.12 146.75 10.87 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.771 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . 0.665 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 80.7 mm-40 -129.28 152.11 49.2 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-O 121.149 0.499 . . . . 0.0 111.925 -179.514 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.596 HD13 ' O ' ' A' ' 124' ' ' LEU . 2.6 tm? -81.02 122.52 27.41 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.571 -0.741 . . . . 0.0 109.531 179.031 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.596 ' O ' HD13 ' A' ' 123' ' ' LEU . 0.0 OUTLIER -48.45 139.44 9.05 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-O 122.365 1.078 . . . . 0.0 112.241 -178.672 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.419 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.3 OUTLIER -127.68 152.56 47.55 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 113.593 -1.64 . . . . 0.0 110.196 179.485 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 7.2 tp-100 -71.86 113.44 8.9 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 179.27 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 64.8 30.79 78.92 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.366 -179.564 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.463 ' OD2' HD13 ' A' ' 101' ' ' LEU . 29.8 t70 -53.74 160.5 1.34 Allowed 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.884 0.373 . . . . 0.0 111.077 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.496 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 0.1 OUTLIER -146.6 135.48 22.37 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.755 -179.898 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.454 HG23 ' O ' ' A' ' 110' ' ' TRP . 7.3 mm -113.68 128.72 70.43 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.124 0 CA-C-N 116.167 -0.47 . . . . 0.0 109.922 178.659 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.536 HG23 ' CG2' ' A' ' 140' ' ' ILE . 18.7 m -103.42 144.31 31.55 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.785 -179.392 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.476 ' HB ' ' NE2' ' A' ' 88' ' ' HIS . 5.6 m -141.19 156.1 21.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.005 0.431 . . . . 0.0 112.159 -179.068 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . 0.405 ' O ' ' O ' ' A' ' 139' ' ' ASP . . . 70.34 39.54 70.45 Favored Glycine 0 N--CA 1.448 -0.562 0 CA-C-N 115.914 -0.585 . . . . 0.0 112.463 179.396 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.462 HG12 ' N ' ' A' ' 135' ' ' GLY . 90.2 t -74.39 156.86 6.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 121.447 0.641 . . . . 0.0 112.123 -179.247 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . 0.462 ' N ' HG12 ' A' ' 134' ' ' VAL . . . 152.99 -46.21 0.57 Allowed Glycine 0 N--CA 1.441 -1.0 0 CA-C-N 114.981 -1.008 . . . . 0.0 110.749 -179.285 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.595 HG12 ' H ' ' A' ' 138' ' ' SER . 42.7 t -126.59 133.9 67.55 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.722 0 CA-C-N 115.222 -0.489 . . . . 0.0 109.904 178.597 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -51.01 -32.44 21.27 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.89 0.376 . . . . 0.0 111.207 -179.353 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . 0.595 ' H ' HG12 ' A' ' 136' ' ' VAL . 46.7 m -94.39 6.22 49.39 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 116.164 -0.471 . . . . 0.0 112.132 -179.666 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . 0.405 ' O ' ' O ' ' A' ' 133' ' ' GLY . 25.4 t0 -128.34 30.26 5.21 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 -179.378 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.536 ' CG2' HG23 ' A' ' 131' ' ' THR . 27.5 mt -105.89 141.19 21.76 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.287 179.373 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.752 HD22 ' HG2' ' A' ' 42' ' ' GLN . 4.5 mt -116.79 135.27 53.88 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.869 -1.059 . . . . 0.0 110.291 179.675 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 29.8 t -120.31 152.42 37.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.694 0.759 . . . . 0.0 112.359 -179.17 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.872 HD22 ' N ' ' A' ' 144' ' ' VAL . 0.8 OUTLIER -135.7 131.28 35.44 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.625 -1.17 . . . . 0.0 108.992 179.357 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.872 ' N ' HD22 ' A' ' 143' ' ' LEU . 12.2 t -111.67 140.17 32.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.975 0.416 . . . . 0.0 111.908 -179.079 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 1.028 HD13 HD22 ' A' ' 101' ' ' LEU . 0.0 OUTLIER -116.91 126.63 74.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.215 179.575 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 16.0 t80 -106.97 125.48 51.06 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.057 -179.724 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 4.1 mm -103.53 133.3 47.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.999 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 35.5 p-10 -84.77 111.25 19.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.861 0.362 . . . . 0.0 110.718 179.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -56.28 -27.34 54.96 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.153 -179.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 2.2 tptt -57.2 -36.34 70.72 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.807 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 4.2 t80 . . . . . 0 N--CA 1.451 -0.381 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.777 179.998 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.408 ' HA ' ' HB3' ' A' ' 150' ' ' LYS . 6.2 tm-20 . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.643 0.258 . . . . 0.0 111.508 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 26.0 m-80 -109.56 -14.69 14.34 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-O 121.909 0.862 . . . . 0.0 109.28 178.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.487 ' O ' HG22 ' A' ' 32' ' ' ILE . 0.1 OUTLIER -74.1 111.14 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.571 0 CA-C-N 114.129 -1.396 . . . . 0.0 111.23 -179.168 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 1.043 ' CG2' ' HB2' ' A' ' 50' ' ' ALA . 0.5 OUTLIER -45.02 -64.12 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.211 -0.904 . . . . 0.0 111.381 -179.488 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.644 ' N ' HG12 ' A' ' 33' ' ' VAL . 30.2 p -165.4 164.93 19.61 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.039 0.447 . . . . 0.0 112.046 -179.644 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.412 ' HD3' HG23 ' A' ' 45' ' ' ILE . 1.0 OUTLIER -124.39 117.63 24.89 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.598 179.38 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.897 HG13 HD11 ' A' ' 143' ' ' LEU . 89.3 t -89.16 132.57 33.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.112 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.937 HG23 HG12 ' A' ' 45' ' ' ILE . 22.6 mt -129.86 108.14 15.84 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.693 -179.745 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.433 ' HB3' ' O ' ' A' ' 43' ' ' ILE . 2.5 t -86.66 105.98 17.29 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 178.18 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 11.4 t -90.71 -26.76 19.38 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 -178.41 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.454 HG21 ' H ' ' A' ' 142' ' ' SER . 26.1 p -59.64 -21.99 61.24 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 121.047 -0.261 . . . . 0.0 111.422 -179.429 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 103.65 72.39 0.9 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.571 -0.823 . . . . 0.0 113.033 179.384 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.658 ' NE2' HD23 ' A' ' 141' ' ' LEU . 0.0 OUTLIER -151.1 -70.62 0.17 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.859 0.361 . . . . 0.0 110.941 179.534 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.554 HG23 ' HD2' ' A' ' 44' ' ' PRO . 16.7 mt -102.56 140.33 21.0 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.2 -179.565 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.554 ' HD2' HG23 ' A' ' 43' ' ' ILE . 74.3 Cg_endo -77.6 146.76 24.41 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 122.337 2.025 . . . . 0.0 111.724 179.566 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.937 HG12 HG23 ' A' ' 37' ' ' ILE . 35.5 mt -44.12 108.67 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.056 0.455 . . . . 0.0 111.779 -179.499 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.24 129.8 56.73 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.761 179.132 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.424 ' C ' HD13 ' A' ' 48' ' ' LEU . 3.6 p30 -96.4 119.38 34.78 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.986 0.422 . . . . 0.0 111.429 -179.305 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.876 HD12 ' CD1' ' A' ' 66' ' ' TRP . 0.2 OUTLIER -96.36 131.98 42.34 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 178.543 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.559 ' O ' ' CZ2' ' A' ' 66' ' ' TRP . 0.1 OUTLIER -113.15 164.02 14.03 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.84 0.828 . . . . 0.0 112.608 -178.598 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 1.043 ' HB2' ' CG2' ' A' ' 33' ' ' VAL . . . -111.46 166.42 11.14 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 114.915 -1.039 . . . . 0.0 110.864 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -93.56 46.13 1.18 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.946 0.403 . . . . 0.0 110.942 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 14.1 mm . . . . . 0 C--N 1.328 -0.368 0 CA-C-O 121.099 0.476 . . . . 0.0 110.664 179.614 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.5 ttpt . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.99 0.424 . . . . 0.0 110.776 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.427 ' O ' ' HB3' ' A' ' 93' ' ' LEU . 7.9 ttpt -126.92 131.21 51.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.685 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.561 HG13 ' O ' ' A' ' 91' ' ' ILE . 10.7 t -134.86 136.33 52.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 121.037 0.446 . . . . 0.0 111.588 -179.494 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . 0.876 ' CD1' HD12 ' A' ' 48' ' ' LEU . 16.0 m-90 -102.07 140.06 36.86 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.057 179.599 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.932 HG23 ' HG3' ' A' ' 90' ' ' GLN . 3.1 m -127.58 129.81 47.95 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.435 0.635 . . . . 0.0 112.14 179.51 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.54 ' HE2' HD11 ' A' ' 91' ' ' ILE . 64.7 m-85 -101.77 118.38 36.81 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.322 178.192 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.679 ' HA2' HD21 ' A' ' 78' ' ' LEU . . . 159.33 -157.6 28.72 Favored Glycine 0 CA--C 1.502 -0.755 0 C-N-CA 119.034 -1.555 . . . . 0.0 112.192 179.328 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.44 ' CD ' ' HB3' ' A' ' 86' ' ' ASN . 11.7 ptm180 -76.75 91.81 3.52 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-O 122.424 1.106 . . . . 0.0 108.297 179.538 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.542 ' O ' ' CD2' ' A' ' 77' ' ' HIS . 6.3 m120 -149.08 154.63 39.63 Favored Pre-proline 0 C--N 1.311 -1.068 0 CA-C-N 112.985 -1.916 . . . . 0.0 108.506 179.269 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.573 ' O ' ' HB2' ' A' ' 77' ' ' HIS . 25.7 Cg_exo -56.1 -11.56 5.97 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 121.507 1.472 . . . . 0.0 111.571 178.45 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.787 ' HB2' ' HB2' ' A' ' 77' ' ' HIS . . . 137.27 50.97 0.0 OUTLIER 'General case' 0 CA--C 1.49 -1.336 0 CA-C-N 114.96 -1.018 . . . . 0.0 109.605 178.791 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.58 ' HB3' ' HB ' ' A' ' 67' ' ' THR . 0.1 OUTLIER -52.92 -69.9 0.1 Allowed 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 105.858 -1.904 . . . . 0.0 105.858 179.485 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.576 ' N ' ' O ' ' A' ' 67' ' ' THR . 12.2 t0 -94.78 -47.4 6.49 Favored 'General case' 0 N--CA 1.437 -1.112 0 N-CA-C 105.89 -1.893 . . . . 0.0 105.89 169.806 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.517 ' CD2' HG23 ' A' ' 43' ' ' ILE . 35.6 t80 -144.21 142.56 30.59 Favored 'General case' 0 C--N 1.347 0.473 0 CA-C-N 112.576 -2.102 . . . . 0.0 110.951 179.658 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . 0.787 ' HB2' ' HB2' ' A' ' 73' ' ' ALA . 23.3 t-160 -93.0 108.38 19.96 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 118.12 0.418 . . . . 0.0 110.442 177.323 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.781 HD11 ' O ' ' A' ' 85' ' ' SER . 2.2 pp -125.66 168.48 13.67 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.784 0.326 . . . . 0.0 111.103 179.698 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.677 ' O ' HD12 ' A' ' 78' ' ' LEU . . . -53.91 173.05 0.63 Allowed Glycine 0 C--N 1.33 0.209 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.777 -179.791 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.563 ' C ' HD12 ' A' ' 81' ' ' ILE . 12.8 p-10 -96.05 105.36 17.39 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.725 0.298 . . . . 0.0 110.965 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.673 HD13 ' HB3' ' A' ' 85' ' ' SER . 2.0 mp -111.53 152.65 13.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.772 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.23 -45.27 73.74 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 113.61 0.967 . . . . 0.0 113.61 -178.767 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 17.9 mtt180 -119.72 -91.16 0.56 Allowed 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 113.692 0.997 . . . . 0.0 113.692 -177.328 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.493 ' O ' ' CB ' ' A' ' 85' ' ' SER . 0.0 OUTLIER -84.9 103.26 13.8 Favored 'General case' 0 CA--C 1.507 -0.704 0 CA-C-O 121.948 0.88 . . . . 0.0 110.74 -178.606 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.781 ' O ' HD11 ' A' ' 78' ' ' LEU . 0.4 OUTLIER 148.62 -35.42 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 113.113 -1.858 . . . . 0.0 108.718 -179.745 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.803 ' O ' ' N ' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -68.44 -162.39 0.03 OUTLIER 'General case' 0 CA--C 1.514 -0.43 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 177.6 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.911 ' HB3' HD11 ' A' ' 104' ' ' ILE . 1.0 OUTLIER -53.14 72.18 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 177.822 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.959 ' O ' ' O ' ' A' ' 104' ' ' ILE . 29.6 t60 -83.73 -18.91 36.26 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 114.642 1.349 . . . . 0.0 114.642 -175.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.651 ' HA ' ' H ' ' A' ' 104' ' ' ILE . 0.0 OUTLIER -171.06 156.98 5.02 Favored 'General case' 0 C--N 1.31 -1.113 0 C-N-CA 118.824 -1.15 . . . . 0.0 112.632 177.864 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.932 ' HG3' HG23 ' A' ' 67' ' ' THR . 34.4 mt-30 -135.37 158.8 43.45 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.587 -1.188 . . . . 0.0 113.825 -177.197 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.646 ' HB ' ' HB2' ' A' ' 66' ' ' TRP . 7.9 mt -124.16 132.82 70.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 114.908 -1.042 . . . . 0.0 109.785 178.499 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.714 HD13 ' ND2' ' A' ' 121' ' ' ASN . 0.3 OUTLIER -108.99 144.03 37.5 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.01 0.433 . . . . 0.0 111.807 -179.557 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.645 HD22 ' N ' ' A' ' 94' ' ' GLY . 0.8 OUTLIER -125.58 122.69 37.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.485 179.442 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.645 ' N ' HD22 ' A' ' 93' ' ' LEU . . . . . . . . 0 N--CA 1.45 -0.379 0 C-N-CA 120.594 -0.812 . . . . 0.0 112.678 179.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.74 ' O ' HD22 ' A' ' 100' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.797 0.332 . . . . 0.0 110.783 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.777 HD13 ' O ' ' A' ' 122' ' ' GLN . 4.1 mm? -131.35 148.24 52.65 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.263 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.466 ' O ' ' N ' ' A' ' 122' ' ' GLN . 0.3 OUTLIER -117.03 129.99 56.38 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 179.869 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.497 ' O ' ' O ' ' A' ' 90' ' ' GLN . 28.0 t30 -111.35 111.41 22.43 Favored 'General case' 0 CA--C 1.508 -0.64 0 C-N-CA 119.79 -0.764 . . . . 0.0 109.781 179.611 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.745 ' HB3' HG21 ' A' ' 109' ' ' THR . 76.2 m-20 -85.54 112.01 20.55 Favored 'General case' 0 N--CA 1.442 -0.838 0 C-N-CA 119.643 -0.823 . . . . 0.0 109.543 179.507 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.959 ' O ' ' O ' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -123.0 107.63 19.66 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.975 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 177.849 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 50.1 m -134.49 168.95 18.02 Favored 'General case' 0 C--N 1.296 -1.732 0 CA-C-N 114.906 -1.043 . . . . 0.0 109.221 179.672 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 19.5 m -69.59 -63.34 1.09 Allowed 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 119.055 -1.058 . . . . 0.0 111.76 -178.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -112.26 -32.33 6.56 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 114.976 1.473 . . . . 0.0 114.976 179.436 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -145.72 126.46 2.55 Favored Glycine 0 C--N 1.339 0.725 0 N-CA-C 117.346 1.698 . . . . 0.0 117.346 -177.531 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.745 HG21 ' HB3' ' A' ' 103' ' ' ASP . 4.3 m -121.26 138.11 54.38 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 174.389 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . 0.7 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.6 m-90 -120.67 148.94 43.25 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 -178.539 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.469 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -121.77 112.2 18.08 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 115.152 -0.931 . . . . 0.0 108.698 177.437 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 33.5 m-20 45.48 43.4 8.81 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.073 -0.512 . . . . 0.0 112.099 -179.439 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 78.83 27.87 55.78 Favored Glycine 0 N--CA 1.444 -0.798 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.761 179.247 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -139.19 96.73 3.15 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.099 0.476 . . . . 0.0 110.774 179.776 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.7 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.3 OUTLIER -44.57 128.96 6.76 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.019 179.775 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 3.7 m -121.99 -179.84 2.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.743 -179.208 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -85.57 142.1 29.37 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.186 -179.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.436 ' HG3' ' HA ' ' A' ' 104' ' ' ILE . 62.3 tttm -65.0 162.55 16.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.129 179.358 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.431 ' N ' ' HG2' ' A' ' 118' ' ' LYS . 4.4 p30 35.88 38.19 0.05 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.215 0.531 . . . . 0.0 111.142 -179.799 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 9.6 p -111.18 110.95 21.69 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.929 -179.394 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.714 ' ND2' HD13 ' A' ' 92' ' ' LEU . 1.4 m120 -57.39 141.04 48.62 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.683 179.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . 0.777 ' O ' HD13 ' A' ' 100' ' ' LEU . 33.6 mm-40 -129.52 145.89 51.4 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-O 121.009 0.433 . . . . 0.0 111.861 -179.666 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -72.28 117.7 14.25 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.671 179.184 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.72 HD21 HG12 ' A' ' 147' ' ' ILE . 0.7 OUTLIER -47.42 143.79 3.34 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.9 0.857 . . . . 0.0 112.029 -178.943 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.46 ' N ' ' HG ' ' A' ' 124' ' ' LEU . 0.3 OUTLIER -126.84 152.78 46.53 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 114.045 -1.434 . . . . 0.0 110.124 179.263 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.59 113.99 9.21 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.981 -0.378 . . . . 0.0 109.981 179.633 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 67.99 27.62 73.62 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.852 -0.689 . . . . 0.0 112.266 -179.411 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.402 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 8.3 t70 -55.04 160.42 2.05 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.01 0.433 . . . . 0.0 111.185 -179.82 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.776 ' CG ' HG22 ' A' ' 144' ' ' VAL . 4.2 mt-10 -146.01 135.38 22.98 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.447 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.454 HG23 ' O ' ' A' ' 110' ' ' TRP . 7.0 mm -111.51 128.22 68.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 178.908 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.589 HG23 ' CG2' ' A' ' 140' ' ' ILE . 41.9 m -103.73 144.94 30.81 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.73 -179.538 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.561 HG11 ' CD2' ' A' ' 88' ' ' HIS . 4.1 m -141.46 158.42 21.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -178.781 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 66.17 42.17 94.49 Favored Glycine 0 N--CA 1.447 -0.574 0 CA-C-N 115.83 -0.623 . . . . 0.0 112.355 179.359 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.454 ' HA ' HG12 ' A' ' 140' ' ' ILE . 88.9 t -76.89 157.04 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 CA-C-O 121.467 0.651 . . . . 0.0 112.193 -179.125 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . 0.446 ' N ' HG12 ' A' ' 134' ' ' VAL . . . 144.65 -43.08 0.98 Allowed Glycine 0 N--CA 1.44 -1.062 0 N-CA-C 110.447 -1.061 . . . . 0.0 110.447 -178.814 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.632 HG12 ' H ' ' A' ' 138' ' ' SER . 47.5 t -126.87 126.09 67.88 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 CA-C-N 114.984 -0.608 . . . . 0.0 109.705 178.589 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.525 ' HA ' HD12 ' A' ' 140' ' ' ILE . 0.8 OUTLIER -51.17 -28.23 10.66 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.774 0.321 . . . . 0.0 111.186 -179.342 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . 0.632 ' H ' HG12 ' A' ' 136' ' ' VAL . 0.9 OUTLIER -94.36 6.49 48.56 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 116.224 -0.443 . . . . 0.0 112.114 -179.598 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -130.94 27.55 4.88 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 -179.427 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.589 ' CG2' HG23 ' A' ' 131' ' ' THR . 23.9 mt -102.73 140.86 19.94 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.312 179.169 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.658 HD23 ' NE2' ' A' ' 42' ' ' GLN . 4.9 mp -124.07 135.39 53.53 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 114.808 -1.087 . . . . 0.0 109.734 179.511 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . 0.454 ' H ' HG21 ' A' ' 40' ' ' THR . 38.9 t -127.65 151.92 48.33 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -178.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.897 HD11 HG13 ' A' ' 36' ' ' VAL . 3.2 tm? -122.96 138.09 54.77 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 114.424 -1.262 . . . . 0.0 109.155 179.184 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.776 HG22 ' CG ' ' A' ' 129' ' ' GLU . 3.8 t -119.17 141.03 41.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.8 0.333 . . . . 0.0 111.724 -178.811 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.741 HG13 HG22 ' A' ' 36' ' ' VAL . 0.2 OUTLIER -111.02 140.34 30.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.161 179.564 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -119.76 106.57 12.25 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.556 179.79 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.72 HG12 HD21 ' A' ' 124' ' ' LEU . 2.0 mp -99.38 133.38 42.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.483 -179.781 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 -78.82 140.23 38.24 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.236 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -73.8 -18.44 60.95 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.196 178.771 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . 0.408 ' HB3' ' HA ' ' A' ' 30' ' ' GLU . 0.0 OUTLIER -65.5 -45.21 84.44 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.648 179.779 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . 0.523 ' HE2' ' HB3' ' A' ' 50' ' ' ALA . 26.1 t80 . . . . . 0 C--N 1.331 -0.227 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.681 179.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 . . . . . 0 CA--C 1.528 0.109 0 CA-C-O 120.73 0.3 . . . . 0.0 111.326 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 73.2 m-20 -110.1 -13.34 14.39 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-O 121.829 0.823 . . . . 0.0 109.07 178.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.589 ' CG2' ' O ' ' A' ' 32' ' ' ILE . 0.1 OUTLIER -70.07 97.32 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.605 0 CA-C-N 114.216 -1.356 . . . . 0.0 111.266 -178.839 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.88 HG23 ' HB3' ' A' ' 50' ' ' ALA . 0.6 OUTLIER -34.15 -59.06 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 114.795 -1.093 . . . . 0.0 112.159 -179.578 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.617 ' N ' HG12 ' A' ' 33' ' ' VAL . 3.2 t -163.5 164.98 24.18 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.747 -179.27 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 1.8 ttm180 -125.47 115.17 19.81 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.026 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.639 HG21 ' CZ ' ' A' ' 68' ' ' PHE . 14.4 p -89.92 137.17 22.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.076 179.799 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.899 HG23 HG12 ' A' ' 45' ' ' ILE . 23.6 mt -129.51 107.42 15.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -179.673 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.453 ' HB2' ' O ' ' A' ' 43' ' ' ILE . 67.1 m -92.74 101.03 13.41 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 177.211 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.2 t -105.82 -18.21 14.13 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 113.469 0.915 . . . . 0.0 113.469 -177.256 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.768 HG21 ' CB ' ' A' ' 142' ' ' SER . 26.1 p -57.81 -19.35 27.95 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.924 -0.31 . . . . 0.0 111.534 -179.564 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 111.12 67.64 0.55 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.558 -0.83 . . . . 0.0 112.425 179.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.735 ' C ' HD13 ' A' ' 43' ' ' ILE . 4.4 mt-30 -151.15 -54.49 0.14 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.737 0.303 . . . . 0.0 111.138 -179.739 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.927 HG22 ' HD2' ' A' ' 44' ' ' PRO . 0.0 OUTLIER -134.63 151.5 76.02 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.158 -179.299 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.927 ' HD2' HG22 ' A' ' 43' ' ' ILE . 87.0 Cg_endo -80.42 147.3 17.86 Favored 'Trans proline' 0 N--CA 1.461 -0.433 0 C-N-CA 122.403 2.069 . . . . 0.0 111.562 179.352 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.899 HG12 HG23 ' A' ' 37' ' ' ILE . 23.2 mt -37.73 124.58 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 CA-C-O 121.043 0.449 . . . . 0.0 111.844 -179.517 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.568 ' HD2' ' HB3' ' A' ' 76' ' ' TYR . 0.0 OUTLIER -115.28 153.94 30.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.266 179.698 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 15.9 p-10 -116.22 119.83 37.03 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.187 0.517 . . . . 0.0 111.674 -179.605 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.934 HD22 ' CD1' ' A' ' 66' ' ' TRP . 6.9 mt -96.72 123.25 40.36 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.251 178.829 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.526 ' O ' ' HZ2' ' A' ' 66' ' ' TRP . 0.0 OUTLIER -127.52 160.88 30.17 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 -178.76 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.88 ' HB3' HG23 ' A' ' 33' ' ' VAL . . . -157.71 142.31 16.4 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 114.287 -1.324 . . . . 0.0 110.998 178.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -68.87 129.89 41.22 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.969 0.414 . . . . 0.0 111.083 -179.771 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 33.9 mt . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.197 -179.992 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 34.0 mtmt . . . . . 0 C--O 1.232 0.16 0 CA-C-O 120.807 0.337 . . . . 0.0 111.128 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.569 ' HB3' HD12 ' A' ' 93' ' ' LEU . 5.5 ttpt -112.96 130.78 56.0 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.409 179.557 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.729 HG22 HD23 ' A' ' 92' ' ' LEU . 21.4 t -137.47 139.45 43.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.164 0.507 . . . . 0.0 112.176 -179.098 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . 0.934 ' CD1' HD22 ' A' ' 48' ' ' LEU . 12.5 m-90 -100.08 139.23 36.04 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.06 178.607 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.628 HG23 ' HG2' ' A' ' 90' ' ' GLN . 33.9 m -131.68 130.64 42.29 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.554 0.692 . . . . 0.0 111.793 179.329 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.639 ' CZ ' HG21 ' A' ' 36' ' ' VAL . 1.3 m-85 -102.26 119.36 38.67 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 114.886 -1.052 . . . . 0.0 109.093 178.462 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.65 ' HA2' ' O ' ' A' ' 85' ' ' SER . . . 156.35 -160.7 30.37 Favored Glycine 0 CA--C 1.505 -0.542 0 C-N-CA 118.537 -1.792 . . . . 0.0 113.225 179.041 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.421 ' H ' ' HA ' ' A' ' 86' ' ' ASN . 12.5 ptm180 -76.84 93.15 3.69 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-O 122.686 1.231 . . . . 0.0 108.918 -179.874 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.591 ' O ' ' CD2' ' A' ' 77' ' ' HIS . 6.7 m120 -148.45 156.53 42.37 Favored Pre-proline 0 C--N 1.307 -1.275 0 CA-C-N 112.857 -1.974 . . . . 0.0 107.936 178.812 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.546 ' O ' ' CB ' ' A' ' 73' ' ' ALA . 47.0 Cg_exo -50.37 -13.76 0.83 Allowed 'Trans proline' 0 N--CA 1.459 -0.553 0 C-N-CA 121.384 1.389 . . . . 0.0 111.315 178.276 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.557 ' HB2' ' HB2' ' A' ' 77' ' ' HIS . . . 135.85 53.63 0.0 OUTLIER 'General case' 0 CA--C 1.489 -1.385 0 CA-C-N 114.504 -1.226 . . . . 0.0 108.582 178.731 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.555 ' HB3' ' HB ' ' A' ' 67' ' ' THR . 0.0 OUTLIER -52.07 -69.28 0.12 Allowed 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 -179.846 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.559 ' N ' ' O ' ' A' ' 67' ' ' THR . 29.9 t70 -92.76 -51.2 5.2 Favored 'General case' 0 N--CA 1.433 -1.29 0 N-CA-C 104.388 -2.449 . . . . 0.0 104.388 169.861 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.834 ' CE2' HG21 ' A' ' 43' ' ' ILE . 1.3 p90 -148.26 143.87 27.25 Favored 'General case' 0 C--N 1.345 0.389 0 CA-C-N 112.815 -1.993 . . . . 0.0 111.011 176.227 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . 0.591 ' CD2' ' O ' ' A' ' 71' ' ' ASN . 15.4 t-160 -90.09 105.81 18.06 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 177.454 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.631 HD21 ' O ' ' A' ' 85' ' ' SER . 1.4 pt? -127.63 178.78 5.89 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.922 0.391 . . . . 0.0 111.336 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -51.1 158.43 2.24 Favored Glycine 0 C--N 1.333 0.373 0 C-N-CA 120.991 -0.623 . . . . 0.0 112.694 -179.792 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 5.0 p30 -111.71 99.38 8.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.762 0.315 . . . . 0.0 111.579 -179.697 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.64 ' HB ' ' HB2' ' A' ' 85' ' ' SER . 17.3 mt -114.93 131.66 66.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 178.175 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.423 ' HA ' ' ND2' ' A' ' 86' ' ' ASN . 0.5 OUTLIER -52.81 -24.09 8.24 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 111.697 0.258 . . . . 0.0 111.697 -179.016 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.445 ' H ' HG22 ' A' ' 81' ' ' ILE . 2.2 mtt-85 -92.3 -95.05 0.14 Allowed 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 116.841 -0.163 . . . . 0.0 111.256 179.869 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.491 HD23 ' N ' ' A' ' 84' ' ' LEU . 0.0 OUTLIER -109.48 109.45 20.28 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-O 121.359 0.599 . . . . 0.0 109.761 179.191 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.65 ' O ' ' HA2' ' A' ' 69' ' ' GLY . 1.5 m 157.19 -42.37 0.0 OUTLIER 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 114.592 -1.186 . . . . 0.0 109.55 -179.698 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.669 ' O ' ' N ' ' A' ' 88' ' ' HIS . 30.3 m-20 -65.41 -160.71 0.02 OUTLIER 'General case' 0 CA--C 1.516 -0.354 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 177.514 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.845 ' HB3' HD11 ' A' ' 104' ' ' ILE . 0.0 OUTLIER -58.64 75.18 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 177.791 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.969 ' O ' ' O ' ' A' ' 104' ' ' ILE . 30.6 t60 -79.53 -18.64 51.4 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 114.182 1.179 . . . . 0.0 114.182 -176.685 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.611 ' CZ ' HD11 ' A' ' 91' ' ' ILE . 0.0 OUTLIER -174.98 156.84 2.25 Favored 'General case' 0 C--N 1.312 -1.052 0 C-N-CA 119.038 -1.065 . . . . 0.0 112.88 177.961 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.628 ' HG2' HG23 ' A' ' 67' ' ' THR . 35.2 mt-30 -138.09 160.75 38.57 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 114.677 -1.147 . . . . 0.0 113.758 -177.779 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.672 ' HB ' ' HB2' ' A' ' 66' ' ' TRP . 3.4 mt -130.24 129.81 65.31 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.004 178.617 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.729 HD23 HG22 ' A' ' 65' ' ' VAL . 0.4 OUTLIER -103.93 143.86 32.3 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -179.22 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.78 HD22 ' N ' ' A' ' 94' ' ' GLY . 0.2 OUTLIER -126.43 122.81 36.36 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.188 178.965 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.78 ' N ' HD22 ' A' ' 93' ' ' LEU . . . . . . . . 0 N--CA 1.452 -0.247 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.563 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.789 HD11 HG22 ' A' ' 33' ' ' VAL . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.796 0.332 . . . . 0.0 110.936 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.577 ' HA ' ' O ' ' A' ' 122' ' ' GLN . 0.8 OUTLIER -121.07 148.01 44.74 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.083 179.625 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.441 ' O ' ' N ' ' A' ' 122' ' ' GLN . 4.4 mp -116.94 127.38 54.17 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 179.614 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.484 ' O ' ' O ' ' A' ' 90' ' ' GLN . 27.8 t30 -113.9 111.49 21.8 Favored 'General case' 0 CA--C 1.507 -0.706 0 C-N-CA 119.74 -0.784 . . . . 0.0 109.928 -179.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.698 ' HB3' HG21 ' A' ' 109' ' ' THR . 74.8 m-20 -84.11 111.51 19.39 Favored 'General case' 0 N--CA 1.44 -0.972 0 C-N-CA 119.647 -0.821 . . . . 0.0 109.227 179.57 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.969 ' O ' ' O ' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -123.38 107.76 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.007 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 177.837 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.465 ' HG ' ' CE1' ' A' ' 88' ' ' HIS . 71.1 m -132.96 171.48 13.9 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-N 114.939 -1.028 . . . . 0.0 109.328 179.754 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 23.4 m -69.58 -63.56 1.05 Allowed 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 119.093 -1.043 . . . . 0.0 111.545 -179.156 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -112.65 -32.85 6.31 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 114.687 1.366 . . . . 0.0 114.687 179.162 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -145.97 129.08 3.27 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 116.996 1.558 . . . . 0.0 116.996 -177.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.698 HG21 ' HB3' ' A' ' 103' ' ' ASP . 5.8 m -121.17 138.15 54.34 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 174.478 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . 0.776 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.5 m-90 -120.09 148.85 43.09 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 113.14 0.793 . . . . 0.0 113.14 -178.653 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -123.59 112.3 17.27 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 115.123 -0.944 . . . . 0.0 108.755 177.714 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 13.4 m-80 45.23 44.68 9.08 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.933 -0.576 . . . . 0.0 112.116 -179.531 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 77.53 26.14 61.75 Favored Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.75 179.249 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . 0.413 ' O ' HG13 ' A' ' 116' ' ' VAL . 0.6 OUTLIER -138.74 95.3 2.95 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.077 0.465 . . . . 0.0 110.739 179.703 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.776 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.1 OUTLIER -44.98 133.64 6.25 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.931 179.763 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.495 HG21 ' OD2' ' A' ' 103' ' ' ASP . 31.2 m -124.44 -179.66 2.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.83 -179.113 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 29.3 mm-40 -84.9 141.57 30.31 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.005 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.427 ' HG2' ' N ' ' A' ' 119' ' ' ASN . 88.4 tttt -65.31 163.2 15.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.056 179.443 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.427 ' N ' ' HG2' ' A' ' 118' ' ' LYS . 13.5 m-80 33.63 40.04 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.164 0.507 . . . . 0.0 111.152 -179.461 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 19.5 p -110.48 117.08 32.59 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.967 -179.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.427 ' ND2' ' CD1' ' A' ' 92' ' ' LEU . 15.8 m120 -57.97 138.98 55.38 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.778 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . 0.577 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 45.0 mm-40 -129.49 146.33 51.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.117 0.484 . . . . 0.0 111.787 -179.849 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 12.3 tp -78.74 120.24 23.1 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.545 178.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.813 HD21 HG12 ' A' ' 147' ' ' ILE . 13.3 tp -46.88 144.33 2.48 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.773 0.797 . . . . 0.0 111.965 -178.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.757 ' O ' HD11 ' A' ' 147' ' ' ILE . 0.6 OUTLIER -126.83 152.34 47.11 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 114.22 -1.354 . . . . 0.0 110.26 179.542 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . 0.447 ' HA ' HD12 ' A' ' 147' ' ' ILE . 4.1 mm100 -71.41 114.15 9.18 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 179.584 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 65.67 30.29 77.01 Favored Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.172 -179.364 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.405 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 18.6 t0 -55.76 160.24 2.7 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.987 0.423 . . . . 0.0 111.39 -179.705 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.409 ' CG ' ' O ' ' A' ' 143' ' ' LEU . 1.2 tt0 -146.15 134.94 22.38 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.004 179.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.446 ' CG2' ' O ' ' A' ' 110' ' ' TRP . 1.1 mp -113.41 127.15 70.86 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.202 0 CA-C-O 120.799 0.333 . . . . 0.0 110.112 178.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.492 ' HB ' ' HB2' ' A' ' 110' ' ' TRP . 18.3 m -104.04 145.6 29.93 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.52 -179.754 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.49 HG11 ' CD2' ' A' ' 88' ' ' HIS . 5.5 m -141.21 158.09 22.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -178.669 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . 0.404 ' O ' ' O ' ' A' ' 139' ' ' ASP . . . 69.06 41.33 81.61 Favored Glycine 0 N--CA 1.447 -0.612 0 CA-C-N 115.682 -0.69 . . . . 0.0 112.509 179.25 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.465 ' HA ' HG12 ' A' ' 140' ' ' ILE . 85.9 t -77.55 153.87 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.636 0 CA-C-O 121.398 0.618 . . . . 0.0 112.14 -179.284 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 145.13 -39.61 1.17 Allowed Glycine 0 N--CA 1.441 -0.999 0 CA-C-N 115.015 -0.993 . . . . 0.0 110.7 -179.004 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.541 HG12 ' H ' ' A' ' 138' ' ' SER . 48.3 t -126.67 129.35 71.59 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.65 0 CA-C-N 115.231 -0.485 . . . . 0.0 109.837 178.874 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -51.25 -34.43 32.54 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.784 0.326 . . . . 0.0 111.618 -179.235 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . 0.541 ' H ' HG12 ' A' ' 136' ' ' VAL . 2.6 t -94.06 6.48 48.41 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 -179.326 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . 0.404 ' O ' ' O ' ' A' ' 133' ' ' GLY . 14.6 t0 -126.77 26.94 6.13 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -179.319 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.5 ' C ' HD22 ' A' ' 141' ' ' LEU . 26.6 mt -102.52 141.35 18.77 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.34 179.194 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.539 HD12 ' CD ' ' A' ' 42' ' ' GLN . 4.1 mm? -121.26 135.45 55.12 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 114.885 -1.052 . . . . 0.0 110.176 179.594 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . 0.807 ' C ' HD12 ' A' ' 143' ' ' LEU . 0.9 OUTLIER -122.27 147.39 46.28 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.551 0.691 . . . . 0.0 112.648 -178.898 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.807 HD12 ' C ' ' A' ' 142' ' ' SER . 5.7 mp -127.14 146.27 50.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.028 -0.987 . . . . 0.0 109.086 179.399 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 21.5 t -129.42 141.01 47.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.918 0.39 . . . . 0.0 112.009 -178.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.4 HD13 HD11 ' A' ' 101' ' ' LEU . 0.2 OUTLIER -116.08 127.88 73.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.786 179.771 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 9.7 t80 -111.27 120.21 41.48 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.49 179.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.813 HG12 HD21 ' A' ' 124' ' ' LEU . 1.3 mt -100.47 133.8 42.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.998 0.427 . . . . 0.0 111.86 -179.458 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . 0.414 ' ND2' ' O ' ' A' ' 32' ' ' ILE . 0.7 OUTLIER -84.37 114.99 22.27 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.558 179.423 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -59.97 -19.28 51.39 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.442 -179.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 9.4 mtmm -57.9 -43.29 86.07 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.947 0.403 . . . . 0.0 110.801 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 32.4 t80 . . . . . 0 C--N 1.328 -0.36 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.968 179.987 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.527 0.09 0 CA-C-O 120.596 0.236 . . . . 0.0 111.474 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.597 ' HA ' HD12 ' A' ' 52' ' ' ILE . 10.4 m120 -108.55 -14.02 14.72 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-O 121.843 0.83 . . . . 0.0 109.048 178.797 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.528 HD13 ' O ' ' A' ' 48' ' ' LEU . 0.1 OUTLIER -73.58 111.6 8.8 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.568 0 CA-C-N 114.066 -1.424 . . . . 0.0 111.433 -179.355 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 1.05 ' CG2' ' HB2' ' A' ' 50' ' ' ALA . 0.5 OUTLIER -42.27 -64.57 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.47 -179.653 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.631 ' N ' ' CG1' ' A' ' 33' ' ' VAL . 22.6 p -166.31 165.85 17.05 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.712 -179.686 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 11.7 ttm180 -119.21 126.27 51.15 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.385 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 1.011 HG12 HD21 ' A' ' 143' ' ' LEU . 14.8 t -95.59 137.09 24.6 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.19 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.349 179.226 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.936 HG23 HG12 ' A' ' 45' ' ' ILE . 21.8 mt -129.3 108.6 17.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 -178.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.757 ' SG ' HD23 ' A' ' 143' ' ' LEU . 0.7 OUTLIER -103.38 102.02 11.94 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 177.413 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.61 ' CG2' HG22 ' A' ' 37' ' ' ILE . 1.7 p -112.42 -23.16 10.48 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 113.664 0.987 . . . . 0.0 113.664 -177.112 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.528 HG21 ' HB3' ' A' ' 142' ' ' SER . 5.3 p -54.16 -23.33 13.9 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.874 -0.33 . . . . 0.0 111.452 -179.241 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 124.26 70.64 0.22 Allowed Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.642 -0.79 . . . . 0.0 112.402 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -151.05 -70.77 0.17 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.74 0.305 . . . . 0.0 110.944 -179.893 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.762 HG12 HD13 ' A' ' 78' ' ' LEU . 2.1 mp -134.64 133.13 21.07 Favored Pre-proline 0 N--CA 1.453 -0.319 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.15 -179.826 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.476 ' HD2' ' CZ ' ' A' ' 76' ' ' TYR . 35.6 Cg_exo -58.58 147.44 86.84 Favored 'Trans proline' 0 C--N 1.342 0.236 0 C-N-CA 122.474 2.116 . . . . 0.0 111.611 179.497 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.936 HG12 HG23 ' A' ' 37' ' ' ILE . 45.7 mt -33.68 145.57 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -179.24 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.404 ' HD3' ' CD2' ' A' ' 76' ' ' TYR . 9.8 tpt180 -139.88 149.46 43.42 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.045 179.47 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -120.54 119.91 34.31 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.888 0.375 . . . . 0.0 111.635 -179.441 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.864 HD11 HD13 ' A' ' 91' ' ' ILE . 0.3 OUTLIER -99.26 133.39 43.62 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 178.367 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.567 ' O ' ' CZ2' ' A' ' 66' ' ' TRP . 0.1 OUTLIER -113.42 164.73 13.23 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.794 0.807 . . . . 0.0 112.658 -179.131 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 1.05 ' HB2' ' CG2' ' A' ' 33' ' ' VAL . . . -119.77 166.16 13.61 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.116 -0.947 . . . . 0.0 111.428 -179.895 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -105.72 76.02 1.17 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.384 179.642 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.597 HD12 ' HA ' ' A' ' 31' ' ' ASN . 19.0 mt . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.484 -179.53 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.6 ptpt . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.806 0.336 . . . . 0.0 110.995 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.457 ' O ' ' HB3' ' A' ' 93' ' ' LEU . 14.0 ttpt -115.19 130.84 57.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.532 179.8 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.484 HG13 ' O ' ' A' ' 91' ' ' ILE . 5.5 t -133.36 134.08 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 CA-C-O 121.028 0.442 . . . . 0.0 111.554 -179.503 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . 0.666 ' HB2' ' HB ' ' A' ' 91' ' ' ILE . 17.2 m-90 -100.61 140.27 35.12 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.854 179.395 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.73 HG23 ' HG2' ' A' ' 90' ' ' GLN . 21.6 m -127.34 130.44 49.46 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.53 0.681 . . . . 0.0 112.262 179.515 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.52 ' HE2' HD11 ' A' ' 91' ' ' ILE . 43.6 m-85 -101.66 118.04 36.12 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.089 -0.959 . . . . 0.0 108.739 177.768 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.686 ' HA2' ' O ' ' A' ' 85' ' ' SER . . . 158.29 -151.93 23.06 Favored Glycine 0 CA--C 1.505 -0.558 0 C-N-CA 119.054 -1.546 . . . . 0.0 113.055 179.828 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.44 ' HD2' ' HB2' ' A' ' 80' ' ' ASN . 35.5 mtp180 -75.49 91.08 2.76 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-O 122.348 1.071 . . . . 0.0 108.49 -179.853 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.505 ' O ' ' CD2' ' A' ' 77' ' ' HIS . 20.6 m120 -150.82 159.32 34.26 Favored Pre-proline 0 C--N 1.308 -1.212 0 CA-C-N 113.18 -1.827 . . . . 0.0 108.688 178.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.558 ' O ' ' HB2' ' A' ' 77' ' ' HIS . 36.3 Cg_endo -66.73 -6.22 15.04 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 120.874 1.05 . . . . 0.0 110.777 177.591 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.73 ' HB2' ' HB2' ' A' ' 77' ' ' HIS . . . 137.03 51.57 0.0 OUTLIER 'General case' 0 CA--C 1.491 -1.32 0 CA-C-N 114.452 -1.249 . . . . 0.0 109.269 178.867 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.548 ' HB3' ' HB ' ' A' ' 67' ' ' THR . 0.1 OUTLIER -52.78 -69.43 0.11 Allowed 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 105.709 -1.959 . . . . 0.0 105.709 179.537 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.655 ' HB2' ' N ' ' A' ' 67' ' ' THR . 36.9 t0 -95.56 -47.56 6.19 Favored 'General case' 0 N--CA 1.433 -1.319 0 N-CA-C 105.872 -1.899 . . . . 0.0 105.872 169.638 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.5 ' CG ' HG21 ' A' ' 43' ' ' ILE . 7.5 t80 -145.12 142.14 29.4 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 112.501 -2.136 . . . . 0.0 112.102 -179.609 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . 0.73 ' HB2' ' HB2' ' A' ' 73' ' ' ALA . 23.6 t-160 -100.89 106.7 18.07 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 176.392 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.814 HD11 ' HA ' ' A' ' 85' ' ' SER . 0.9 OUTLIER -133.07 -174.65 3.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.057 0.456 . . . . 0.0 111.773 -179.282 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -56.73 170.71 2.73 Favored Glycine 0 C--N 1.332 0.355 0 CA-C-N 115.75 -0.659 . . . . 0.0 112.471 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.44 ' HB2' ' HD2' ' A' ' 70' ' ' ARG . 3.4 p30 -112.12 98.49 7.37 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 -179.438 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.661 ' HB ' ' HB2' ' A' ' 85' ' ' SER . 15.3 mm -115.3 129.81 70.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 177.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.42 ' HA ' ' ND2' ' A' ' 86' ' ' ASN . 18.8 m -53.09 -23.86 8.81 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 111.617 0.229 . . . . 0.0 111.617 -179.267 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.54 ' H ' HG22 ' A' ' 81' ' ' ILE . 3.1 mpt_? -98.01 -88.6 0.31 Allowed 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 111.608 0.225 . . . . 0.0 111.608 -179.82 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.462 HD23 ' HB3' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -109.41 108.8 19.46 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 121.455 0.645 . . . . 0.0 110.541 179.812 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.814 ' HA ' HD11 ' A' ' 78' ' ' LEU . 3.1 m 155.23 -42.93 0.01 OUTLIER 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 114.247 -1.342 . . . . 0.0 109.437 179.793 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.655 ' O ' ' N ' ' A' ' 88' ' ' HIS . 38.0 m-20 -77.21 -164.5 0.47 Allowed 'General case' 0 CA--C 1.512 -0.498 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 177.679 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.505 ' HB2' HD11 ' A' ' 104' ' ' ILE . 0.0 OUTLIER -49.51 83.12 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 178.961 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 1.071 ' O ' ' O ' ' A' ' 104' ' ' ILE . 36.3 t60 -102.74 -19.32 14.78 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 114.624 1.342 . . . . 0.0 114.624 -177.002 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.571 ' CD2' ' HA ' ' A' ' 103' ' ' ASP . 0.1 OUTLIER -176.55 159.44 1.9 Allowed 'General case' 0 C--N 1.317 -0.811 0 C-N-CA 119.332 -0.947 . . . . 0.0 111.869 178.338 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.73 ' HG2' HG23 ' A' ' 67' ' ' THR . 27.4 mt-30 -137.89 161.09 37.56 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 113.767 1.025 . . . . 0.0 113.767 -177.673 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.864 HD13 HD11 ' A' ' 48' ' ' LEU . 2.9 mt -124.97 133.11 70.31 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 CA-C-N 115.092 -0.958 . . . . 0.0 109.588 178.267 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.718 HD13 ' ND2' ' A' ' 121' ' ' ASN . 0.2 OUTLIER -110.47 141.92 42.93 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 121.01 0.434 . . . . 0.0 112.166 -179.168 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.853 HD13 ' CG2' ' A' ' 33' ' ' VAL . 19.0 tp -125.65 137.96 53.89 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.298 178.843 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.322 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.416 179.777 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 10.5 mp . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.794 0.33 . . . . 0.0 110.658 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.916 HD22 ' HB3' ' A' ' 121' ' ' ASN . 1.0 OUTLIER -133.68 148.72 51.5 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.627 -179.965 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.459 ' O ' ' N ' ' A' ' 122' ' ' GLN . 5.4 mp -116.22 129.69 56.42 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.681 -0.488 . . . . 0.0 109.681 179.638 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.467 ' HB3' ' HB2' ' A' ' 90' ' ' GLN . 24.5 t30 -110.31 112.39 24.31 Favored 'General case' 0 CA--C 1.508 -0.652 0 C-N-CA 119.706 -0.798 . . . . 0.0 110.031 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.768 ' OD2' HG11 ' A' ' 116' ' ' VAL . 33.5 m-20 -83.78 110.23 18.16 Favored 'General case' 0 N--CA 1.441 -0.924 0 C-N-CA 119.428 -0.909 . . . . 0.0 109.662 179.846 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 1.071 ' O ' ' O ' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -125.04 108.91 20.9 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.061 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 177.07 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 68.7 m -131.48 173.5 11.03 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.452 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 25.8 m -69.34 -63.86 0.98 Allowed 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 119.038 -1.065 . . . . 0.0 111.084 -179.358 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 6.1 m-80 -112.68 -33.23 6.18 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 114.234 1.198 . . . . 0.0 114.234 178.629 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -146.71 133.94 5.06 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 116.536 1.374 . . . . 0.0 116.536 -178.093 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.756 HG21 ' HB3' ' A' ' 103' ' ' ASP . 16.7 m -121.06 138.01 54.38 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 174.417 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . 0.719 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.9 m-90 -120.89 149.14 43.07 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 113.65 0.981 . . . . 0.0 113.65 -178.357 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.474 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -122.92 111.99 17.3 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 115.004 -0.998 . . . . 0.0 108.66 177.536 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 44.21 44.6 6.61 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.998 -0.546 . . . . 0.0 112.191 -179.457 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 80.72 21.77 63.16 Favored Glycine 0 N--CA 1.445 -0.765 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.837 179.437 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -134.29 98.34 4.08 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.968 0.413 . . . . 0.0 110.7 179.608 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.719 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.3 OUTLIER -44.06 124.93 4.12 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.084 179.936 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.768 HG11 ' OD2' ' A' ' 103' ' ' ASP . 14.7 p -112.15 160.22 11.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.722 -179.074 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.511 ' N ' HG22 ' A' ' 116' ' ' VAL . 9.8 tt0 -71.01 142.05 50.95 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.995 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.419 ' HG3' ' HA ' ' A' ' 104' ' ' ILE . 81.6 tttt -65.17 162.55 16.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.293 179.432 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.415 ' N ' ' HG2' ' A' ' 118' ' ' LYS . 12.1 p30 34.67 39.09 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.265 0.555 . . . . 0.0 111.305 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 8.6 p -111.09 109.5 19.61 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.9 -179.473 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.916 ' HB3' HD22 ' A' ' 100' ' ' LEU . 1.6 m120 -57.69 140.91 50.16 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.771 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . 0.651 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 18.4 mm-40 -129.64 143.43 50.82 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-O 121.055 0.455 . . . . 0.0 111.844 -179.707 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.509 HD13 ' N ' ' A' ' 124' ' ' LEU . 2.7 tm? -72.57 122.83 22.02 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.512 178.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.68 HD11 HG12 ' A' ' 147' ' ' ILE . 0.9 OUTLIER -47.71 143.53 3.85 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-O 121.854 0.835 . . . . 0.0 111.941 -178.799 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.448 ' N ' ' HG ' ' A' ' 124' ' ' LEU . 0.3 OUTLIER -126.72 152.84 46.27 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 114.166 -1.379 . . . . 0.0 110.242 179.535 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -71.72 113.99 9.33 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.882 0.372 . . . . 0.0 110.058 179.615 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 65.9 30.3 76.82 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.917 -0.658 . . . . 0.0 112.577 -179.588 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.418 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 29.2 t70 -57.87 159.5 5.41 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.96 0.41 . . . . 0.0 111.142 -179.851 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.638 ' HB2' HG22 ' A' ' 144' ' ' VAL . 0.6 OUTLIER -146.55 135.79 22.72 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.377 -179.932 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.631 HG21 ' OD1' ' A' ' 103' ' ' ASP . 10.4 mm -113.31 128.86 69.91 Favored 'Isoleucine or valine' 0 C--O 1.232 0.132 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.3 178.815 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.49 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 53.8 m -103.17 144.65 31.04 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.477 -179.804 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.476 ' HB ' ' NE2' ' A' ' 88' ' ' HIS . 9.7 m -140.57 157.7 24.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.039 0.447 . . . . 0.0 112.18 -178.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 70.43 42.19 65.16 Favored Glycine 0 N--CA 1.446 -0.65 0 CA-C-N 115.725 -0.67 . . . . 0.0 112.404 179.436 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.462 HG12 ' N ' ' A' ' 135' ' ' GLY . 94.6 t -78.13 156.81 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 CA-C-O 121.394 0.616 . . . . 0.0 112.032 -179.256 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . 0.462 ' N ' HG12 ' A' ' 134' ' ' VAL . . . 149.82 -42.68 0.78 Allowed Glycine 0 N--CA 1.443 -0.896 0 N-CA-C 110.627 -0.989 . . . . 0.0 110.627 -179.248 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.587 HG12 ' H ' ' A' ' 138' ' ' SER . 48.0 t -126.66 131.3 71.34 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 CA-C-N 115.271 -0.464 . . . . 0.0 109.89 178.791 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.07 -33.67 26.81 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.769 0.319 . . . . 0.0 111.257 -179.425 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . 0.587 ' H ' HG12 ' A' ' 136' ' ' VAL . 2.0 p -94.16 6.24 49.22 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 112.251 0.464 . . . . 0.0 112.251 -179.535 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -128.1 29.91 5.31 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-O 121.137 0.494 . . . . 0.0 112.265 -179.467 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.49 ' CG2' ' CG2' ' A' ' 131' ' ' THR . 26.9 mt -104.71 141.34 20.38 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.268 179.22 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 5.8 mp -118.88 135.19 54.69 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.015 -0.993 . . . . 0.0 110.633 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . 0.528 ' HB3' HG21 ' A' ' 40' ' ' THR . 46.9 t -118.76 152.4 36.25 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.691 0.758 . . . . 0.0 112.547 -179.178 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 1.011 HD21 HG12 ' A' ' 36' ' ' VAL . 1.5 tm? -134.72 137.55 43.6 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 114.589 -1.187 . . . . 0.0 109.019 179.427 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.756 ' N ' HD22 ' A' ' 143' ' ' LEU . 25.5 t -128.4 140.01 50.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 C-N-CA 120.75 -0.38 . . . . 0.0 111.858 -179.062 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.493 HG13 HG22 ' A' ' 36' ' ' VAL . 1.1 tt -109.08 139.84 30.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.725 179.461 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 16.8 t80 -118.1 103.85 10.28 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.777 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.68 HG12 HD11 ' A' ' 124' ' ' LEU . 2.5 mp -92.56 129.37 43.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.175 179.9 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 12.2 p30 -78.6 132.08 36.97 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.017 -179.738 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 50.2 m-20 -64.49 -21.38 66.65 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.095 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 3.1 mmpt? -57.49 -43.66 84.33 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-O 120.953 0.406 . . . . 0.0 110.564 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . 0.575 ' HE2' ' HB3' ' A' ' 50' ' ' ALA . 19.0 t80 . . . . . 0 C--N 1.328 -0.354 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.67 179.731 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 . . . . . 0 CA--C 1.528 0.098 0 CA-C-O 120.695 0.283 . . . . 0.0 111.484 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 38.1 m-80 -109.39 -14.27 14.46 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-O 121.946 0.879 . . . . 0.0 109.018 178.767 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.592 ' CG2' ' O ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -71.06 98.41 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.581 0 CA-C-N 113.935 -1.484 . . . . 0.0 110.922 -179.285 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.778 HG23 ' HB3' ' A' ' 50' ' ' ALA . 0.5 OUTLIER -34.39 -60.62 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 114.96 -1.018 . . . . 0.0 112.058 -179.432 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.601 ' N ' HG12 ' A' ' 33' ' ' VAL . 19.7 m -159.81 149.36 18.12 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.454 -179.434 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.0 114.62 24.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.763 179.506 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.84 ' CG2' HD11 ' A' ' 48' ' ' LEU . 26.7 t -90.29 124.64 43.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.686 179.712 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 1.009 HG23 HG12 ' A' ' 45' ' ' ILE . 31.2 mt -123.12 108.33 21.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.138 -0.483 . . . . 0.0 112.033 -179.35 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.474 ' SG ' ' HG ' ' A' ' 143' ' ' LEU . 0.8 OUTLIER -78.81 99.73 6.84 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 177.984 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.436 HG22 ' CG2' ' A' ' 144' ' ' VAL . 9.6 t -87.34 -28.65 22.1 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 -178.007 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.749 HG21 ' H ' ' A' ' 142' ' ' SER . 66.0 p -58.72 -18.27 29.96 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.678 0.275 . . . . 0.0 111.655 -179.552 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 90.88 71.46 1.22 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.554 -0.831 . . . . 0.0 112.555 179.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.521 HE22 HD11 ' A' ' 143' ' ' LEU . 16.8 pt20 -142.99 -48.08 0.32 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.69 0.281 . . . . 0.0 111.151 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.41 ' O ' ' HB2' ' A' ' 38' ' ' CYS . 14.8 mt -134.53 138.05 29.13 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.04 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.485 ' HD2' ' CZ ' ' A' ' 76' ' ' TYR . 33.4 Cg_exo -58.46 146.69 89.43 Favored 'Trans proline' 0 N--CA 1.465 -0.186 0 C-N-CA 122.445 2.097 . . . . 0.0 111.5 179.53 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 1.009 HG12 HG23 ' A' ' 37' ' ' ILE . 45.6 mt -45.46 129.93 2.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 112.376 0.51 . . . . 0.0 112.376 -179.096 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 6.3 tpt180 -120.31 130.61 54.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.646 178.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 8.7 p30 -105.83 122.27 45.76 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.346 0.499 . . . . 0.0 112.346 -178.798 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.84 HD11 ' CG2' ' A' ' 36' ' ' VAL . 0.3 OUTLIER -97.52 133.63 41.84 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 178.384 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.519 ' HB3' HG12 ' A' ' 32' ' ' ILE . 0.0 OUTLIER -134.27 164.44 27.39 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 113.67 0.989 . . . . 0.0 113.67 -178.333 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.778 ' HB3' HG23 ' A' ' 33' ' ' VAL . . . -151.33 166.23 31.61 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 114.484 -1.234 . . . . 0.0 110.667 179.041 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -106.04 136.34 45.89 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.08 0.467 . . . . 0.0 111.29 -179.679 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 18.5 mm . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.483 -179.915 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.528 0.111 0 CA-C-O 120.853 0.359 . . . . 0.0 111.236 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.419 ' O ' ' HB3' ' A' ' 93' ' ' LEU . 22.9 ttpt -104.09 131.66 51.13 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.19 179.335 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.565 HG13 ' O ' ' A' ' 91' ' ' ILE . 5.8 t -131.1 135.92 58.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.044 0.45 . . . . 0.0 111.916 -179.036 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . 0.685 ' CG ' HD22 ' A' ' 48' ' ' LEU . 14.6 m-90 -99.7 139.85 34.76 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.692 -0.686 . . . . 0.0 111.25 178.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.815 HG23 ' HG3' ' A' ' 90' ' ' GLN . 12.0 m -123.57 129.07 50.63 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.541 0.686 . . . . 0.0 112.162 179.445 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.6 ' CE2' HG11 ' A' ' 36' ' ' VAL . 13.8 m-85 -100.37 118.1 35.92 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.069 -0.969 . . . . 0.0 109.104 178.077 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.614 ' HA2' ' O ' ' A' ' 85' ' ' SER . . . 159.21 -159.6 30.55 Favored Glycine 0 N--CA 1.444 -0.793 0 C-N-CA 119.287 -1.435 . . . . 0.0 112.708 179.459 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.42 ' N ' ' HA ' ' A' ' 86' ' ' ASN . 0.0 OUTLIER -76.13 92.27 3.21 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-O 122.612 1.196 . . . . 0.0 109.05 -179.402 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.54 ' O ' ' CD2' ' A' ' 77' ' ' HIS . 6.0 m-80 -149.19 155.38 39.86 Favored Pre-proline 0 C--N 1.309 -1.175 0 CA-C-N 112.681 -2.054 . . . . 0.0 107.989 178.646 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.564 ' O ' ' CB ' ' A' ' 73' ' ' ALA . 25.2 Cg_exo -55.76 -7.87 1.79 Allowed 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 121.271 1.314 . . . . 0.0 111.32 177.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.708 ' HB2' ' HB2' ' A' ' 77' ' ' HIS . . . 132.99 52.7 0.0 OUTLIER 'General case' 0 CA--C 1.489 -1.379 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.223 178.765 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.564 ' HB3' ' HB ' ' A' ' 67' ' ' THR . 0.1 OUTLIER -52.81 -69.52 0.11 Allowed 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 105.565 -2.013 . . . . 0.0 105.565 179.499 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.612 ' HB2' ' N ' ' A' ' 67' ' ' THR . 51.3 t0 -95.32 -47.81 6.15 Favored 'General case' 0 N--CA 1.433 -1.302 0 N-CA-C 105.776 -1.935 . . . . 0.0 105.776 169.65 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.504 ' C ' ' HA ' ' A' ' 73' ' ' ALA . 9.4 t80 -144.52 142.68 30.4 Favored 'General case' 0 C--N 1.346 0.424 0 CA-C-N 112.51 -2.132 . . . . 0.0 111.354 179.66 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . 0.708 ' HB2' ' HB2' ' A' ' 73' ' ' ALA . 22.4 t-160 -97.16 106.91 19.32 Favored 'General case' 0 CA--C 1.531 0.238 0 O-C-N 121.921 -0.487 . . . . 0.0 110.157 176.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.576 HD21 ' C ' ' A' ' 69' ' ' GLY . 0.0 OUTLIER -120.67 171.83 8.31 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 120.824 0.345 . . . . 0.0 111.692 179.749 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -55.03 -167.86 0.04 OUTLIER Glycine 0 C--N 1.333 0.405 0 CA-C-N 116.022 -0.535 . . . . 0.0 113.126 -179.499 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.459 ' C ' HD12 ' A' ' 81' ' ' ILE . 5.4 p30 -112.06 97.77 6.89 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.927 0.394 . . . . 0.0 111.768 -179.752 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.655 ' HB ' ' HB2' ' A' ' 85' ' ' SER . 3.2 mp -114.86 112.72 41.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.104 178.542 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 68.5 m -56.69 -24.16 47.05 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 -179.002 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.407 ' H ' HG22 ' A' ' 81' ' ' ILE . 3.7 mtt180 -93.47 -102.15 0.13 Allowed 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 -178.487 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.434 ' O ' ' CB ' ' A' ' 85' ' ' SER . 0.0 OUTLIER -109.02 110.83 22.21 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-O 121.52 0.676 . . . . 0.0 110.691 -179.262 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.655 ' HB2' ' HB ' ' A' ' 81' ' ' ILE . 0.6 OUTLIER 158.99 -48.39 0.0 OUTLIER 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 114.247 -1.342 . . . . 0.0 109.478 179.796 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.792 ' O ' ' N ' ' A' ' 88' ' ' HIS . 94.1 m-20 -65.34 -153.45 0.01 OUTLIER 'General case' 0 CA--C 1.521 -0.151 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 177.779 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.42 ' HB2' HD11 ' A' ' 104' ' ' ILE . 0.0 OUTLIER -47.55 76.71 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 179.105 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 1.071 ' O ' ' O ' ' A' ' 104' ' ' ILE . 36.3 t60 -101.58 -15.89 16.93 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 114.622 1.341 . . . . 0.0 114.622 -176.346 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.559 ' HA ' ' H ' ' A' ' 104' ' ' ILE . 0.1 OUTLIER -178.1 160.37 1.39 Allowed 'General case' 0 C--N 1.317 -0.848 0 C-N-CA 119.333 -0.947 . . . . 0.0 112.125 178.334 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.815 ' HG3' HG23 ' A' ' 67' ' ' THR . 14.7 mt-30 -137.45 160.82 38.03 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 113.694 0.998 . . . . 0.0 113.694 -178.031 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.732 HG12 HD11 ' A' ' 145' ' ' ILE . 2.5 mt -122.27 132.14 71.7 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 CA-C-N 115.109 -0.95 . . . . 0.0 108.998 177.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.773 HD13 ' ND2' ' A' ' 121' ' ' ASN . 1.9 mt -110.06 135.31 51.07 Favored 'General case' 0 N--CA 1.464 0.233 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 -178.732 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.779 HD22 ' N ' ' A' ' 94' ' ' GLY . 1.2 tm? -126.42 136.64 52.92 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.245 178.752 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.779 ' N ' HD22 ' A' ' 93' ' ' LEU . . . . . . . . 0 N--CA 1.452 -0.294 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.601 179.819 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.669 HD23 HD23 ' A' ' 93' ' ' LEU . 0.6 OUTLIER . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.569 0.224 . . . . 0.0 110.653 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.764 HD22 ' HB3' ' A' ' 121' ' ' ASN . 4.4 mt -133.66 148.62 51.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.81 -179.813 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.44 ' O ' ' N ' ' A' ' 122' ' ' GLN . 1.6 mt -113.38 130.87 56.18 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 179.529 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.684 ' CG ' HD11 ' A' ' 92' ' ' LEU . 7.4 t30 -107.18 112.56 25.5 Favored 'General case' 0 CA--C 1.51 -0.59 0 C-N-CA 119.976 -0.69 . . . . 0.0 109.776 179.863 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.758 ' HB3' HG21 ' A' ' 109' ' ' THR . 29.1 m-20 -87.4 108.94 19.23 Favored 'General case' 0 N--CA 1.442 -0.872 0 C-N-CA 119.076 -1.05 . . . . 0.0 109.789 179.691 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 1.071 ' O ' ' O ' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -126.48 109.32 20.83 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.164 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 176.854 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 70.5 m -129.38 174.66 9.42 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.868 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 28.0 m -69.76 -63.29 1.1 Allowed 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 118.98 -1.088 . . . . 0.0 110.862 -179.557 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -112.52 -33.46 6.15 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 114.253 1.205 . . . . 0.0 114.253 178.593 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -147.1 136.71 6.26 Favored Glycine 0 C--N 1.34 0.795 0 N-CA-C 116.422 1.329 . . . . 0.0 116.422 -178.339 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.758 HG21 ' HB3' ' A' ' 103' ' ' ASP . 14.8 m -121.06 137.96 54.41 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 174.738 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . 0.74 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 3.0 m-90 -122.36 149.25 44.04 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 113.436 0.902 . . . . 0.0 113.436 -178.517 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.459 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -122.46 112.07 17.61 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 115.182 -0.917 . . . . 0.0 108.62 177.24 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 46.14 43.93 11.46 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.104 -0.498 . . . . 0.0 112.167 -179.573 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 79.91 20.92 66.89 Favored Glycine 0 N--CA 1.445 -0.76 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.93 179.153 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 13.6 mt-30 -133.82 97.79 4.0 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.039 0.447 . . . . 0.0 110.624 179.674 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.74 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.3 OUTLIER -44.92 134.17 5.89 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.843 179.856 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 15.0 m -121.25 177.25 3.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.141 0.496 . . . . 0.0 111.969 -178.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.433 ' HB3' ' HB3' ' A' ' 120' ' ' SER . 0.0 OUTLIER -82.83 141.13 32.51 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.676 179.799 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.401 ' O ' ' C ' ' A' ' 119' ' ' ASN . 0.0 OUTLIER -66.25 163.75 17.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.731 0.3 . . . . 0.0 110.537 179.711 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.401 ' C ' ' O ' ' A' ' 118' ' ' LYS . 0.5 OUTLIER 34.88 37.52 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.995 -179.639 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.433 ' HB3' ' HB3' ' A' ' 117' ' ' GLU . 10.1 p -111.3 105.16 13.73 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.858 -179.281 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.773 ' ND2' HD13 ' A' ' 92' ' ' LEU . 1.3 m120 -50.22 142.46 9.87 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.803 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . 0.575 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 30.1 mm-40 -128.75 144.15 51.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.207 0.527 . . . . 0.0 112.057 -179.662 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 16.6 tp -74.36 120.62 20.17 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.718 178.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.621 ' HG ' HD12 ' A' ' 99' ' ' LEU . 0.0 OUTLIER -51.73 144.65 10.67 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 122.193 0.997 . . . . 0.0 112.202 -178.857 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.442 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.6 OUTLIER -127.15 153.15 46.41 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 113.871 -1.513 . . . . 0.0 110.022 179.499 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 5.7 tp-100 -70.62 113.5 7.79 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 179.647 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 68.35 28.6 73.19 Favored Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.394 -179.359 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.442 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 9.7 t70 -58.85 158.86 7.61 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.984 0.421 . . . . 0.0 111.308 -179.719 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.425 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 0.4 OUTLIER -147.12 135.71 21.96 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.565 179.871 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.669 HG21 ' OD1' ' A' ' 103' ' ' ASP . 2.0 mp -108.86 129.12 64.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.299 -0.41 . . . . 0.0 109.994 178.559 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.524 HG23 ' CG2' ' A' ' 140' ' ' ILE . 69.5 m -102.31 142.37 33.64 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.0 0.428 . . . . 0.0 110.519 -179.53 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.478 HG11 ' NE2' ' A' ' 88' ' ' HIS . 5.2 m -141.24 158.37 22.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.132 -0.485 . . . . 0.0 112.21 -178.592 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . 0.403 ' HA3' ' CD2' ' A' ' 84' ' ' LEU . . . 69.87 44.43 62.1 Favored Glycine 0 N--CA 1.446 -0.645 0 CA-C-N 115.911 -0.586 . . . . 0.0 112.086 179.545 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.489 ' HA ' HG12 ' A' ' 140' ' ' ILE . 81.8 t -80.18 153.1 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 CA-C-O 121.526 0.679 . . . . 0.0 112.261 -178.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 148.14 -44.52 0.77 Allowed Glycine 0 N--CA 1.44 -1.075 0 N-CA-C 110.374 -1.09 . . . . 0.0 110.374 -178.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.593 HG12 ' H ' ' A' ' 138' ' ' SER . 41.3 t -126.8 127.83 70.35 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.764 0 CA-C-N 115.103 -0.549 . . . . 0.0 109.641 178.499 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.536 ' HA ' HD12 ' A' ' 140' ' ' ILE . 3.1 tt0 -51.07 -29.61 13.47 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.789 0.328 . . . . 0.0 111.308 -179.202 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . 0.593 ' H ' HG12 ' A' ' 136' ' ' VAL . 0.5 OUTLIER -94.31 6.48 48.56 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -179.56 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -128.77 25.61 5.64 Favored 'General case' 0 CA--C 1.519 -0.223 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 -179.402 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.536 HD12 ' HA ' ' A' ' 137' ' ' GLU . 13.4 mt -103.13 140.67 20.74 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.003 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.447 179.233 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.46 HD22 ' C ' ' A' ' 140' ' ' ILE . 3.8 mm? -124.24 134.53 53.22 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.017 -0.992 . . . . 0.0 109.798 179.196 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . 0.749 ' H ' HG21 ' A' ' 40' ' ' THR . 0.9 OUTLIER -119.33 150.95 39.29 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.408 0.623 . . . . 0.0 112.504 -178.78 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.712 HD12 ' C ' ' A' ' 142' ' ' SER . 5.7 mp -122.77 132.99 54.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.325 179.342 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.436 ' CG2' HG22 ' A' ' 39' ' ' THR . 4.7 t -114.15 140.28 35.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 120.872 0.368 . . . . 0.0 111.426 -179.432 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.749 ' CG1' HG22 ' A' ' 36' ' ' VAL . 0.2 OUTLIER -120.66 127.68 75.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.821 179.893 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 18.6 t80 -105.08 103.78 13.39 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.54 179.786 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 2.7 mp -87.91 128.45 40.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.053 -179.776 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 25.9 p-10 -78.3 120.7 23.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.003 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -71.35 -24.67 62.14 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.957 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 4.2 mttt -57.38 -40.53 78.35 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.947 0.403 . . . . 0.0 110.595 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 19.9 t80 . . . . . 0 C--N 1.328 -0.364 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.613 179.746 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.554 ' O ' HD12 ' A' ' 52' ' ' ILE . 0.8 OUTLIER . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.716 0.293 . . . . 0.0 111.119 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.432 ' HA ' HD12 ' A' ' 52' ' ' ILE . 8.8 m120 -109.17 -14.08 14.56 Favored 'General case' 0 CA--C 1.514 -0.409 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 178.405 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.558 HG12 ' HB3' ' A' ' 49' ' ' SER . 0.1 OUTLIER -71.15 108.44 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.66 0 CA-C-N 113.888 -1.505 . . . . 0.0 110.933 -179.499 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.89 HG12 ' CD2' ' A' ' 99' ' ' LEU . 2.3 t -48.21 -66.3 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.769 0 CA-C-N 115.19 -0.914 . . . . 0.0 111.364 -179.498 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 31.9 p -162.98 164.59 25.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.676 179.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.665 HH11 HD11 ' A' ' 37' ' ' ILE . 8.1 ttm180 -122.98 123.76 41.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.189 -179.808 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.867 ' CG2' HD11 ' A' ' 48' ' ' LEU . 3.3 t -91.58 122.13 42.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.754 179.666 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.849 HG23 HG12 ' A' ' 45' ' ' ILE . 26.7 mt -121.61 107.81 20.9 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 CA-C-N 116.263 -0.426 . . . . 0.0 112.006 -179.547 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 88.8 m -81.86 102.2 10.7 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 178.076 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.0 p -89.79 2.96 54.26 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 -178.076 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.736 HG21 ' CB ' ' A' ' 142' ' ' SER . 77.2 p -94.59 -6.78 42.75 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.038 0.384 . . . . 0.0 112.038 -179.769 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 85.91 91.58 0.88 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.606 179.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.595 ' NE2' HD23 ' A' ' 141' ' ' LEU . 16.3 pt20 -172.41 -45.86 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.108 0.48 . . . . 0.0 110.516 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.59 HG23 ' HD2' ' A' ' 44' ' ' PRO . 5.1 mt -131.87 140.43 38.17 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.718 179.899 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.59 ' HD2' HG23 ' A' ' 43' ' ' ILE . 74.2 Cg_endo -78.46 147.01 22.28 Favored 'Trans proline' 0 N--CA 1.462 -0.377 0 C-N-CA 122.324 2.016 . . . . 0.0 112.141 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.849 HG12 HG23 ' A' ' 37' ' ' ILE . 27.3 mt -43.12 122.21 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 121.222 0.534 . . . . 0.0 111.827 -179.493 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.438 ' HG2' ' O ' ' A' ' 75' ' ' ASP . 0.0 OUTLIER -121.49 130.21 53.41 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.099 179.463 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.461 ' HB2' HD11 ' A' ' 32' ' ' ILE . 3.8 p30 -93.14 120.11 33.07 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.06 0.457 . . . . 0.0 111.413 -179.302 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.867 HD11 ' CG2' ' A' ' 36' ' ' VAL . 0.8 OUTLIER -94.36 121.73 36.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.642 179.249 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.686 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -130.98 154.56 48.03 Favored 'General case' 0 CA--C 1.517 -0.323 0 N-CA-C 114.295 1.22 . . . . 0.0 114.295 -179.205 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.583 ' N ' HG23 ' A' ' 33' ' ' VAL . . . -133.22 166.07 23.32 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 113.587 -1.642 . . . . 0.0 110.832 178.753 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 60.6 m-20 -91.08 97.26 11.05 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.065 0.46 . . . . 0.0 111.014 -179.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.554 HD12 ' O ' ' A' ' 30' ' ' GLU . 4.4 mt . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.704 -179.701 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.528 0.114 0 CA-C-O 121.012 0.435 . . . . 0.0 111.058 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 7.8 ttpt -138.01 132.09 31.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.667 179.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.665 HG13 ' O ' ' A' ' 91' ' ' ILE . 21.5 t -135.35 138.82 47.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.14 0.495 . . . . 0.0 111.707 -179.407 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . 0.656 ' HB2' ' HB ' ' A' ' 91' ' ' ILE . 14.7 m-90 -99.91 139.95 34.83 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.6 179.297 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.641 HG23 ' HG2' ' A' ' 90' ' ' GLN . 30.5 m -131.39 131.85 43.95 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.53 0.681 . . . . 0.0 112.162 179.744 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.609 ' HE1' HD12 ' A' ' 91' ' ' ILE . 7.3 m-85 -103.24 119.06 38.16 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 114.897 -1.047 . . . . 0.0 109.086 177.873 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.713 ' HA2' HD21 ' A' ' 78' ' ' LEU . . . 158.7 -155.96 26.99 Favored Glycine 0 CA--C 1.503 -0.706 0 C-N-CA 118.832 -1.652 . . . . 0.0 113.098 179.389 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.42 ' O ' ' HG3' ' A' ' 70' ' ' ARG . 3.1 ptm180 -76.37 91.77 3.3 Favored 'General case' 0 N--CA 1.441 -0.888 0 CA-C-O 122.587 1.184 . . . . 0.0 108.747 -179.614 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.502 ' O ' ' CD2' ' A' ' 77' ' ' HIS . 15.7 m-80 -149.98 154.53 37.09 Favored Pre-proline 0 C--N 1.308 -1.218 0 CA-C-N 112.857 -1.974 . . . . 0.0 108.337 178.758 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.548 ' O ' ' CB ' ' A' ' 73' ' ' ALA . 21.8 Cg_exo -57.18 -8.25 3.35 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 121.115 1.21 . . . . 0.0 110.934 177.679 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.729 ' HB2' ' HB2' ' A' ' 77' ' ' HIS . . . 135.04 53.45 0.0 OUTLIER 'General case' 0 CA--C 1.489 -1.402 0 CA-C-N 114.901 -1.045 . . . . 0.0 109.08 179.041 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.525 ' HB3' ' HB ' ' A' ' 67' ' ' THR . 0.1 OUTLIER -52.28 -69.6 0.11 Allowed 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 105.599 -2.0 . . . . 0.0 105.599 179.708 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.474 ' N ' ' O ' ' A' ' 67' ' ' THR . 4.9 t70 -95.45 -47.87 6.09 Favored 'General case' 0 N--CA 1.436 -1.174 0 N-CA-C 105.426 -2.064 . . . . 0.0 105.426 169.085 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.519 ' C ' ' HA ' ' A' ' 73' ' ' ALA . 73.3 t80 -143.26 142.1 31.26 Favored 'General case' 0 C--N 1.347 0.493 0 CA-C-N 112.512 -2.131 . . . . 0.0 111.334 179.825 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . 0.729 ' HB2' ' HB2' ' A' ' 73' ' ' ALA . 23.8 t-160 -91.78 110.23 21.57 Favored 'General case' 0 C--N 1.33 -0.247 0 O-C-N 122.027 -0.421 . . . . 0.0 110.013 177.327 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.845 HD11 ' O ' ' A' ' 85' ' ' SER . 1.1 pp -129.57 174.6 9.51 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.969 0.414 . . . . 0.0 111.494 -179.642 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.424 ' O ' HD12 ' A' ' 78' ' ' LEU . . . -58.6 175.33 2.63 Favored Glycine 0 C--N 1.333 0.41 0 C-N-CA 120.939 -0.648 . . . . 0.0 112.311 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 15.5 p-10 -112.04 99.28 7.95 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.902 0.382 . . . . 0.0 111.847 -179.628 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.719 ' HB ' ' HB2' ' A' ' 85' ' ' SER . 16.5 mm -113.91 118.39 58.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.036 178.45 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -53.46 -24.03 11.76 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 111.807 0.299 . . . . 0.0 111.807 -179.056 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.545 ' C ' HD13 ' A' ' 84' ' ' LEU . 6.2 mpt_? -86.72 -106.85 0.06 Allowed 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 121.222 -0.191 . . . . 0.0 111.378 -179.661 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.812 ' H ' HD22 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -109.36 110.22 21.31 Favored 'General case' 0 CA--C 1.512 -0.482 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 179.036 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.845 ' O ' HD11 ' A' ' 78' ' ' LEU . 0.4 OUTLIER 162.25 -40.66 0.0 OUTLIER 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 114.709 -1.132 . . . . 0.0 109.427 -179.525 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.802 ' O ' ' N ' ' A' ' 88' ' ' HIS . 95.1 m-20 -64.25 -153.81 0.01 OUTLIER 'General case' 0 CA--C 1.52 -0.191 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 177.597 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.858 ' HB2' HD11 ' A' ' 104' ' ' ILE . 0.0 OUTLIER -54.05 71.28 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 178.313 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.964 ' O ' ' O ' ' A' ' 104' ' ' ILE . 36.2 t60 -80.82 -17.6 50.28 Favored 'General case' 0 CA--C 1.514 -0.412 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 -176.789 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.605 ' HA ' ' H ' ' A' ' 104' ' ' ILE . 0.0 OUTLIER -174.57 156.3 2.38 Favored 'General case' 0 C--N 1.31 -1.111 0 C-N-CA 119.23 -0.988 . . . . 0.0 112.981 178.024 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.641 ' HG2' HG23 ' A' ' 67' ' ' THR . 36.6 mt-30 -138.1 161.02 37.86 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.502 -1.226 . . . . 0.0 113.958 -177.829 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.759 HD13 ' CD1' ' A' ' 48' ' ' LEU . 6.2 mt -127.84 126.6 67.01 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-N 115.006 -0.997 . . . . 0.0 109.13 178.037 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.85 HD12 ' N ' ' A' ' 93' ' ' LEU . 0.3 OUTLIER -107.4 142.41 37.28 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.961 0.41 . . . . 0.0 111.974 -178.781 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.85 ' N ' HD12 ' A' ' 92' ' ' LEU . 0.5 OUTLIER -125.78 125.41 42.9 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.693 179.356 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.382 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.59 179.923 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.948 HD13 HD22 ' A' ' 124' ' ' LEU . 2.3 mp . . . . . 0 CA--C 1.528 0.122 0 CA-C-O 120.765 0.317 . . . . 0.0 110.761 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.613 ' HA ' ' O ' ' A' ' 122' ' ' GLN . 0.8 OUTLIER -132.47 147.96 52.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.107 179.987 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.512 HD21 HD12 ' A' ' 124' ' ' LEU . 1.0 OUTLIER -116.04 126.28 53.57 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 120.623 -0.431 . . . . 0.0 110.363 -179.81 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.497 ' O ' ' O ' ' A' ' 90' ' ' GLN . 33.5 t30 -111.57 111.47 22.49 Favored 'General case' 0 CA--C 1.51 -0.58 0 C-N-CA 119.988 -0.685 . . . . 0.0 109.448 179.539 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.692 ' HB3' HG21 ' A' ' 109' ' ' THR . 74.4 m-20 -83.37 111.5 19.06 Favored 'General case' 0 N--CA 1.442 -0.857 0 C-N-CA 119.623 -0.831 . . . . 0.0 109.603 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.964 ' O ' ' O ' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -123.35 107.95 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.969 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 177.533 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.417 ' HG ' ' CE1' ' A' ' 88' ' ' HIS . 63.7 m -132.17 171.12 14.06 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 115.05 -0.977 . . . . 0.0 109.331 179.778 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 25.1 m -69.52 -63.36 1.08 Allowed 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 119.143 -1.023 . . . . 0.0 111.541 -179.157 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -112.5 -32.75 6.37 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 114.63 1.345 . . . . 0.0 114.63 179.015 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -146.04 128.16 2.99 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 116.988 1.555 . . . . 0.0 116.988 -177.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.692 HG21 ' HB3' ' A' ' 103' ' ' ASP . 3.4 m -121.1 138.29 54.26 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 174.483 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . 0.685 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.3 m-90 -119.35 149.24 42.15 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 -178.535 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.459 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -120.9 112.08 18.33 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 115.177 -0.92 . . . . 0.0 108.691 177.483 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 39.7 m-20 45.24 43.29 7.93 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.074 -0.512 . . . . 0.0 112.24 -179.522 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 80.35 23.37 60.94 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.947 179.13 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 42.3 mt-30 -135.61 99.07 4.1 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.017 0.437 . . . . 0.0 110.861 179.647 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.685 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.0 OUTLIER -43.98 123.64 3.41 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.08 179.87 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.495 HG21 ' OD2' ' A' ' 103' ' ' ASP . 5.4 m -114.92 -179.74 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.7 -179.218 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -87.29 140.13 29.85 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.824 -0.626 . . . . 0.0 111.011 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.432 ' HG3' ' HA ' ' A' ' 104' ' ' ILE . 54.2 tttm -63.63 162.69 12.58 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.25 179.518 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.427 ' N ' ' HG2' ' A' ' 118' ' ' LYS . 4.1 p30 34.85 38.87 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.228 0.537 . . . . 0.0 111.372 -179.865 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 6.9 p -111.04 108.71 18.52 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.973 -179.533 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.591 ' ND2' HD23 ' A' ' 92' ' ' LEU . 27.9 m120 -54.91 144.66 22.21 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.633 179.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . 0.613 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 65.8 mm-40 -129.88 149.39 51.63 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.04 0.448 . . . . 0.0 112.084 -179.346 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.636 HD23 ' O ' ' A' ' 124' ' ' LEU . 9.8 tt -77.27 120.5 22.4 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.357 178.849 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.948 HD22 HD13 ' A' ' 99' ' ' LEU . 8.2 tp -46.39 141.98 3.26 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 122.06 0.933 . . . . 0.0 112.022 -178.549 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.43 ' O ' HD11 ' A' ' 147' ' ' ILE . 0.0 OUTLIER -127.29 152.85 46.89 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 113.811 -1.541 . . . . 0.0 110.215 179.567 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 9.6 tp60 -71.79 113.67 9.07 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 179.301 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 64.87 31.58 81.39 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.323 -179.351 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.402 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 8.4 t70 -54.9 160.13 2.07 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.978 0.418 . . . . 0.0 111.207 -179.758 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.529 ' HG3' HG22 ' A' ' 144' ' ' VAL . 13.8 tt0 -146.48 135.35 22.39 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.642 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.437 HG21 ' OD1' ' A' ' 103' ' ' ASP . 1.1 mp -112.94 128.47 69.66 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.121 0 CA-C-N 116.363 -0.38 . . . . 0.0 109.986 178.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.611 HG23 ' CG2' ' A' ' 140' ' ' ILE . 16.0 m -103.16 144.77 30.88 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.478 -179.748 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.474 ' HB ' ' NE2' ' A' ' 88' ' ' HIS . 5.4 m -141.37 158.16 22.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 112.581 0.586 . . . . 0.0 112.581 -178.715 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 67.04 42.81 92.06 Favored Glycine 0 N--CA 1.449 -0.494 0 CA-C-N 115.595 -0.729 . . . . 0.0 112.312 179.253 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.546 ' HA ' HG12 ' A' ' 140' ' ' ILE . 89.8 t -76.79 153.3 5.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-O 121.479 0.656 . . . . 0.0 112.268 -179.176 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 148.65 -42.03 0.85 Allowed Glycine 0 N--CA 1.441 -0.99 0 CA-C-N 114.888 -1.051 . . . . 0.0 110.655 -178.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.548 HG12 ' H ' ' A' ' 138' ' ' SER . 47.6 t -126.62 131.4 71.28 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 CA-C-N 115.172 -0.514 . . . . 0.0 109.743 178.698 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -51.3 -34.61 34.01 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.737 0.303 . . . . 0.0 111.445 -179.229 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . 0.548 ' H ' HG12 ' A' ' 136' ' ' VAL . 0.7 OUTLIER -94.17 6.32 48.96 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 112.343 0.497 . . . . 0.0 112.343 -179.288 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . 0.405 ' CB ' ' HB ' ' A' ' 136' ' ' VAL . 10.1 t70 -125.65 26.72 6.64 Favored 'General case' 0 CA--C 1.518 -0.252 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 -179.367 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.611 ' CG2' HG23 ' A' ' 131' ' ' THR . 14.9 mt -105.5 140.81 22.4 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.967 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.267 179.069 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.595 HD23 ' NE2' ' A' ' 42' ' ' GLN . 1.0 OUTLIER -117.73 130.01 56.06 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.901 179.327 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . 0.736 ' CB ' HG21 ' A' ' 40' ' ' THR . 0.8 OUTLIER -116.37 139.06 50.81 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.417 0.627 . . . . 0.0 112.397 -178.845 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.545 ' N ' HD12 ' A' ' 143' ' ' LEU . 4.8 mp -118.25 138.98 51.98 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.14 -0.937 . . . . 0.0 109.331 179.083 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.529 HG22 ' HG3' ' A' ' 129' ' ' GLU . 21.7 t -123.41 140.5 46.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 120.809 0.338 . . . . 0.0 111.816 -179.034 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.604 HG13 HG13 ' A' ' 36' ' ' VAL . 0.1 OUTLIER -113.63 126.7 71.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.554 179.657 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 80.0 t80 -111.27 123.78 50.89 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.948 -179.846 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.809 HG12 HD21 ' A' ' 124' ' ' LEU . 2.8 mp -106.27 132.24 53.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.111 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . 0.456 ' ND2' HG22 ' A' ' 32' ' ' ILE . 8.9 p30 -81.65 141.7 33.41 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.104 -179.795 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -73.93 -19.45 60.68 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.375 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 12.7 mptt -58.19 -44.83 88.28 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.958 0.408 . . . . 0.0 110.815 -179.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . 0.459 ' CE2' HD11 ' A' ' 52' ' ' ILE . 14.0 t80 . . . . . 0 C--N 1.328 -0.355 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.886 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.377 0 N-CA-C 112.582 -0.207 . . . . 0.0 112.582 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 -106.65 -39.61 5.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.785 0.326 . . . . 0.0 110.803 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -88.71 -174.17 4.43 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.775 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 11.5 mt -118.07 137.11 53.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.139 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.6 t -166.45 134.75 2.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.112 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 59.52 69.91 1.2 Allowed Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.925 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -72.18 139.93 33.27 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.568 2.179 . . . . 0.0 112.298 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 41.1 p -97.59 162.64 13.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.202 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.53 113.33 2.62 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.856 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -146.19 -73.7 0.22 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.854 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.8 p -142.32 131.61 23.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.903 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 6.8 m -117.84 138.8 51.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.078 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -170.6 147.8 2.94 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.915 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -133.62 31.99 3.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.057 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.75 -65.96 0.97 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.149 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 21.8 mm-40 -63.01 -35.68 81.04 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.925 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 8.1 tmm_? -64.62 -36.65 84.92 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.922 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 15.6 t80 -60.8 -42.17 97.1 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.86 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 57.0 mt -60.2 -39.4 86.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.011 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 43.1 mm -65.32 -40.76 89.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.177 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -57.64 -43.58 84.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.086 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 2.0 ttpt -64.35 -37.57 87.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.999 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -60.98 -47.57 85.83 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.19 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 31.2 t -71.19 -28.69 64.41 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.016 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.36 95.22 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.984 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -81.4 124.09 29.12 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.833 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 41.9 mt-30 -101.36 142.65 32.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.995 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.7 mm -82.47 139.35 17.98 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.333 0 CA-C-O 121.512 0.672 . . . . 0.0 111.427 179.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -123.9 67.11 0.5 Allowed Glycine 0 C--N 1.318 -0.427 0 CA-C-N 114.907 -1.042 . . . . 0.0 112.72 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.611 ' O ' HD11 ' A' ' 52' ' ' ILE . 0.7 OUTLIER -88.96 -23.79 22.58 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.742 0.305 . . . . 0.0 111.071 179.855 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 13.8 m-20 -109.15 -13.42 14.68 Favored 'General case' 0 CA--C 1.514 -0.422 0 CA-C-O 121.983 0.897 . . . . 0.0 108.742 178.631 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.58 ' CG2' ' O ' ' A' ' 32' ' ' ILE . 0.1 OUTLIER -70.23 97.32 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.577 0 CA-C-N 114.0 -1.455 . . . . 0.0 110.731 -179.317 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.857 HG23 ' HB3' ' A' ' 50' ' ' ALA . 0.9 OUTLIER -36.99 -61.94 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 114.839 -1.073 . . . . 0.0 112.169 -179.245 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.765 ' SG ' HD12 ' A' ' 48' ' ' LEU . 28.0 p -163.9 164.85 23.23 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.116 0.484 . . . . 0.0 112.027 -179.621 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 4.1 ttm180 -122.45 127.46 49.65 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.634 179.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.623 HG11 ' HZ ' ' A' ' 68' ' ' PHE . 11.7 p -99.29 128.62 50.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.271 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.829 HG23 HG12 ' A' ' 45' ' ' ILE . 25.0 mt -127.08 108.31 18.44 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.601 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.735 ' SG ' HD23 ' A' ' 143' ' ' LEU . 0.1 OUTLIER -86.43 100.2 12.18 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 178.617 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.404 HG23 ' N ' ' A' ' 40' ' ' THR . 8.9 t -65.55 -40.66 93.12 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.416 0.524 . . . . 0.0 112.416 -178.637 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.404 ' N ' HG23 ' A' ' 39' ' ' THR . 0.2 OUTLIER -55.75 -33.97 64.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.867 0.365 . . . . 0.0 111.172 -179.345 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 114.36 0.21 23.6 Favored Glycine 0 CA--C 1.518 0.222 0 C-N-CA 120.553 -0.832 . . . . 0.0 113.575 179.217 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.76 ' HB3' HD12 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -61.39 -45.63 93.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.066 0.46 . . . . 0.0 110.86 179.904 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.76 HD12 ' HB3' ' A' ' 42' ' ' GLN . 4.3 mp -131.04 141.54 42.33 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.1 -179.644 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.628 ' HD2' HG23 ' A' ' 43' ' ' ILE . 96.3 Cg_endo -81.12 147.08 16.28 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 122.512 2.141 . . . . 0.0 111.591 179.451 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.829 HG12 HG23 ' A' ' 37' ' ' ILE . 40.4 mt -42.19 109.59 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.034 0.445 . . . . 0.0 111.78 -179.473 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.401 ' O ' HG12 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -115.01 132.34 56.63 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.843 179.513 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.4 ' HB3' ' CD1' ' A' ' 32' ' ' ILE . 3.7 m-20 -85.99 119.6 26.46 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.108 0.48 . . . . 0.0 111.609 -179.276 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.765 HD12 ' SG ' ' A' ' 34' ' ' CYS . 2.9 mt -96.43 125.85 41.22 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 178.615 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.527 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -132.64 161.86 32.85 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 113.874 1.064 . . . . 0.0 113.874 -178.045 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.857 ' HB3' HG23 ' A' ' 33' ' ' VAL . . . -151.52 164.98 35.62 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.02 -1.445 . . . . 0.0 110.806 178.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.436 ' CB ' ' HG3' ' A' ' 54' ' ' GLN . 0.5 OUTLIER -87.41 123.87 32.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.957 0.408 . . . . 0.0 111.325 -179.547 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.611 HD11 ' O ' ' A' ' 30' ' ' GLU . 18.0 mt -63.75 -36.88 78.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.338 179.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -56.18 -34.16 65.96 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.838 -179.267 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.436 ' HG3' ' CB ' ' A' ' 51' ' ' ASP . 0.1 OUTLIER -63.45 -37.15 86.19 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.564 179.974 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.648 HG11 HD21 ' A' ' 155' ' ' LEU . 13.7 t -66.92 -38.01 80.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.097 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.7 mp -61.5 -41.29 97.07 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.886 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.09 -43.76 18.99 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.713 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 57.14 164.91 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.227 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 2.5 tmtp? 65.47 -72.92 0.07 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.316 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.52 -41.38 93.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.383 -179.592 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.408 ' O ' ' HB ' ' A' ' 62' ' ' ILE . 4.7 m -124.54 99.34 6.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.242 -179.556 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.631 HG23 ' O ' ' A' ' 62' ' ' ILE . 8.7 tp 178.26 61.89 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.063 179.776 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 52.3 mttt -144.53 89.29 1.99 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.579 -179.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 4.9 ttpt -140.36 131.37 26.2 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.262 179.228 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.647 HG13 ' O ' ' A' ' 91' ' ' ILE . 18.4 t -137.46 137.95 45.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.174 0.511 . . . . 0.0 112.232 -178.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . 0.683 ' HB2' ' HB ' ' A' ' 91' ' ' ILE . 14.5 m-90 -99.78 140.48 33.93 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.372 178.719 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.627 HG23 ' HG2' ' A' ' 90' ' ' GLN . 33.6 m -128.44 137.18 51.71 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.554 0.692 . . . . 0.0 112.084 179.237 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.623 ' HZ ' HG11 ' A' ' 36' ' ' VAL . 13.0 m-85 -109.07 119.01 38.26 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.124 -0.944 . . . . 0.0 109.203 178.222 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.648 ' HA2' ' O ' ' A' ' 85' ' ' SER . . . 156.82 -152.81 24.16 Favored Glycine 0 CA--C 1.503 -0.66 0 C-N-CA 118.71 -1.71 . . . . 0.0 113.412 179.16 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.462 ' CG ' ' HA ' ' A' ' 80' ' ' ASN . 62.1 mtp180 -75.06 91.44 2.55 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-O 122.513 1.149 . . . . 0.0 108.615 -179.629 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.477 ' O ' ' CD2' ' A' ' 77' ' ' HIS . 13.8 m120 -150.54 159.27 34.87 Favored Pre-proline 0 C--N 1.309 -1.183 0 CA-C-N 112.744 -2.026 . . . . 0.0 108.153 179.004 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.553 ' O ' ' HB2' ' A' ' 77' ' ' HIS . 34.7 Cg_endo -66.04 -7.08 15.98 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 120.79 0.993 . . . . 0.0 110.683 177.689 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.751 ' HB2' ' HB2' ' A' ' 77' ' ' HIS . . . 136.91 54.22 0.0 OUTLIER 'General case' 0 CA--C 1.488 -1.41 0 CA-C-N 114.338 -1.301 . . . . 0.0 108.887 178.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.528 ' HB3' ' HB ' ' A' ' 67' ' ' THR . 0.1 OUTLIER -52.46 -69.9 0.1 Allowed 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 105.58 -2.007 . . . . 0.0 105.58 179.826 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.592 ' HB2' ' N ' ' A' ' 67' ' ' THR . 62.0 t0 -96.04 -47.18 6.2 Favored 'General case' 0 N--CA 1.437 -1.103 0 N-CA-C 105.383 -2.08 . . . . 0.0 105.383 168.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.505 ' CE2' ' HB3' ' A' ' 78' ' ' LEU . 57.2 t80 -142.75 142.22 31.9 Favored 'General case' 0 C--N 1.35 0.599 0 CA-C-N 112.767 -2.015 . . . . 0.0 111.347 179.565 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.751 ' HB2' ' HB2' ' A' ' 73' ' ' ALA . 23.7 t-160 -93.11 112.54 24.52 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 177.194 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.796 HD11 ' O ' ' A' ' 85' ' ' SER . 1.4 pp -129.02 173.5 10.38 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.03 0.443 . . . . 0.0 111.525 -179.524 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.562 ' O ' HD12 ' A' ' 78' ' ' LEU . . . -60.53 178.7 3.04 Favored Glycine 0 C--N 1.333 0.376 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.465 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.462 ' HA ' ' CG ' ' A' ' 70' ' ' ARG . 0.8 OUTLIER -111.84 99.39 8.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.848 0.356 . . . . 0.0 111.487 -179.762 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.596 ' HB ' ' HB2' ' A' ' 85' ' ' SER . 0.5 OUTLIER -114.83 121.27 66.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.163 -0.471 . . . . 0.0 109.835 178.871 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.4 t -53.81 -24.54 15.76 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -178.15 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.425 ' H ' HG23 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -89.94 -103.72 0.09 Allowed 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -179.071 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.431 ' O ' ' CB ' ' A' ' 85' ' ' SER . 0.0 OUTLIER -109.0 113.56 26.55 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-O 121.336 0.589 . . . . 0.0 109.432 179.681 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.796 ' O ' HD11 ' A' ' 78' ' ' LEU . 0.4 OUTLIER 162.02 -48.98 0.0 OUTLIER 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 114.769 -1.105 . . . . 0.0 109.317 -179.276 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.907 ' O ' ' N ' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -59.79 -162.84 0.01 OUTLIER 'General case' 0 CA--C 1.513 -0.465 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 177.717 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.69 ' HB3' HD11 ' A' ' 104' ' ' ILE . 13.3 mtmt -44.99 71.08 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 178.547 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 1.013 ' O ' ' O ' ' A' ' 104' ' ' ILE . 39.6 t60 -86.87 -15.92 37.62 Favored 'General case' 0 CA--C 1.513 -0.459 0 N-CA-C 113.956 1.095 . . . . 0.0 113.956 -176.466 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.592 ' HA ' ' H ' ' A' ' 104' ' ' ILE . 0.0 OUTLIER -175.97 159.53 2.19 Favored 'General case' 0 C--N 1.311 -1.07 0 C-N-CA 119.165 -1.014 . . . . 0.0 112.8 178.145 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.627 ' HG2' HG23 ' A' ' 67' ' ' THR . 42.3 mt-30 -138.73 160.23 40.16 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 113.734 1.013 . . . . 0.0 113.734 -178.336 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.683 ' HB ' ' HB2' ' A' ' 66' ' ' TRP . 4.8 mt -125.08 129.21 73.34 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.019 177.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.807 HD12 ' N ' ' A' ' 93' ' ' LEU . 0.3 OUTLIER -109.43 140.17 43.49 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.115 0.483 . . . . 0.0 111.82 -179.203 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.807 ' N ' HD12 ' A' ' 92' ' ' LEU . 6.6 tp -120.16 128.25 53.24 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.409 179.231 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.499 ' HA2' HD11 ' A' ' 62' ' ' ILE . . . 146.85 -155.17 26.41 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.55 179.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 63.18 78.85 0.28 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.879 0.371 . . . . 0.0 110.743 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 2.4 t70 69.01 17.82 8.52 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.331 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 93.58 -26.98 13.33 Favored Glycine 0 C--N 1.331 0.28 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.846 179.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -56.74 178.33 0.06 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.844 0.354 . . . . 0.0 111.107 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.611 ' O ' HD12 ' A' ' 100' ' ' LEU . 6.3 mp -116.97 148.91 41.01 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.826 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.718 HD23 ' HB3' ' A' ' 121' ' ' ASN . 2.5 mp -133.47 148.86 51.75 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.487 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.472 ' O ' ' N ' ' A' ' 122' ' ' GLN . 9.5 mp -112.66 129.02 56.54 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.503 ' O ' ' O ' ' A' ' 90' ' ' GLN . 28.7 t30 -110.39 111.94 23.55 Favored 'General case' 0 CA--C 1.508 -0.638 0 C-N-CA 119.735 -0.786 . . . . 0.0 109.838 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.773 ' HB3' HG21 ' A' ' 109' ' ' THR . 88.5 m-20 -84.04 111.22 19.1 Favored 'General case' 0 N--CA 1.439 -0.99 0 C-N-CA 119.572 -0.851 . . . . 0.0 109.564 179.755 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 1.013 ' O ' ' O ' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -123.07 107.9 20.17 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.968 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 177.22 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.435 ' HB3' ' CE1' ' A' ' 88' ' ' HIS . 50.8 m -135.23 167.32 21.22 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.485 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 18.4 m -69.5 -63.26 1.1 Allowed 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 119.109 -1.036 . . . . 0.0 111.749 -178.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -112.45 -32.64 6.42 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 115.065 1.506 . . . . 0.0 115.065 179.433 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -146.05 128.66 3.13 Favored Glycine 0 C--N 1.34 0.788 0 N-CA-C 117.216 1.646 . . . . 0.0 117.216 -177.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.773 HG21 ' HB3' ' A' ' 103' ' ' ASP . 6.1 m -121.35 138.14 54.39 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 174.353 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 0.74 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.8 m-90 -121.27 149.04 43.49 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 113.466 0.913 . . . . 0.0 113.466 -178.47 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.48 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -123.24 112.27 17.45 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 114.98 -1.009 . . . . 0.0 108.709 177.479 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.402 ' N ' HD12 ' A' ' 111' ' ' LEU . 71.5 m-20 45.42 43.88 9.01 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.104 -0.498 . . . . 0.0 112.061 -179.601 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 79.19 23.67 62.9 Favored Glycine 0 N--CA 1.444 -0.82 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.699 179.298 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 7.8 mt-30 -136.19 96.41 3.38 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.038 0.447 . . . . 0.0 110.828 179.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.74 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.0 OUTLIER -44.84 136.2 4.7 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.812 179.762 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.452 HG21 ' OD2' ' A' ' 103' ' ' ASP . 3.2 m -127.4 -179.89 3.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 121.023 0.44 . . . . 0.0 112.043 -178.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -83.51 142.36 30.96 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.439 -179.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.413 ' O ' ' C ' ' A' ' 119' ' ' ASN . 82.3 tttt -64.86 164.88 11.6 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.108 179.362 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.413 ' C ' ' O ' ' A' ' 118' ' ' LYS . 21.0 m-80 33.9 39.54 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 121.209 0.528 . . . . 0.0 111.193 -179.446 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 2.5 p -110.91 106.29 15.37 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.989 -179.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.718 ' HB3' HD23 ' A' ' 100' ' ' LEU . 22.7 m120 -57.7 144.18 38.95 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.506 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . 0.667 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 76.9 mm-40 -129.39 149.27 51.24 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-O 121.063 0.458 . . . . 0.0 112.003 -179.473 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 62.9 tp -72.92 124.38 25.31 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.71 179.104 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.702 HD21 HG12 ' A' ' 147' ' ' ILE . 4.9 tp -50.73 141.48 12.88 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-O 122.026 0.917 . . . . 0.0 111.78 -178.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.617 ' O ' HD11 ' A' ' 147' ' ' ILE . 0.0 OUTLIER -127.14 153.06 46.51 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 113.836 -1.529 . . . . 0.0 109.936 179.421 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 1.7 mm-40 -71.14 113.64 8.38 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 179.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 64.84 30.96 79.37 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.516 -179.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.411 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 27.0 t70 -55.71 159.53 2.98 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 120.906 0.384 . . . . 0.0 111.109 -179.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.656 ' HG3' HG22 ' A' ' 144' ' ' VAL . 13.0 tt0 -146.49 135.6 22.61 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.699 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.665 ' O ' HD12 ' A' ' 143' ' ' LEU . 8.2 mm -114.23 128.72 71.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 116.145 -0.48 . . . . 0.0 109.915 178.644 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.461 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 88.9 m -103.43 145.2 30.35 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.873 -179.431 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.513 HG11 ' CD2' ' A' ' 88' ' ' HIS . 6.0 m -141.2 158.38 22.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 -179.193 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . 0.429 ' CA ' HD13 ' A' ' 84' ' ' LEU . . . 69.49 44.23 65.39 Favored Glycine 0 N--CA 1.447 -0.595 0 CA-C-N 115.897 -0.592 . . . . 0.0 112.287 179.583 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.486 ' HA ' HG12 ' A' ' 140' ' ' ILE . 90.5 t -79.72 155.46 4.62 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.569 0 CA-C-O 121.373 0.606 . . . . 0.0 112.236 -179.166 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.43 ' N ' HG12 ' A' ' 134' ' ' VAL . . . 145.62 -46.5 0.77 Allowed Glycine 0 N--CA 1.441 -1.0 0 CA-C-N 114.908 -1.042 . . . . 0.0 110.571 -179.01 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.657 HG12 ' H ' ' A' ' 138' ' ' SER . 45.7 t -126.81 128.56 71.01 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 CA-C-N 115.241 -0.48 . . . . 0.0 109.795 178.54 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.488 ' HA ' HD12 ' A' ' 140' ' ' ILE . 7.3 mt-10 -51.06 -26.52 6.43 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.692 0.282 . . . . 0.0 111.376 -179.294 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . 0.657 ' H ' HG12 ' A' ' 136' ' ' VAL . 0.1 OUTLIER -94.66 6.05 50.05 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 -179.268 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -131.29 23.4 4.82 Favored 'General case' 0 CA--C 1.523 -0.093 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 -179.449 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.603 ' C ' HD22 ' A' ' 141' ' ' LEU . 23.6 mt -97.65 141.16 16.37 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.249 179.06 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.603 HD22 ' C ' ' A' ' 140' ' ' ILE . 3.8 mm? -119.21 135.54 54.63 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 114.821 -1.081 . . . . 0.0 109.793 179.514 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 46.3 t -116.46 151.73 35.46 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.749 0.785 . . . . 0.0 113.011 -178.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.735 HD23 ' SG ' ' A' ' 38' ' ' CYS . 0.9 OUTLIER -134.0 132.24 39.87 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 114.554 -1.203 . . . . 0.0 109.679 179.2 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.656 HG22 ' HG3' ' A' ' 129' ' ' GLU . 25.1 t -128.11 140.46 49.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.914 0.387 . . . . 0.0 111.518 -178.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.483 HD11 HD11 ' A' ' 91' ' ' ILE . 0.0 OUTLIER -117.3 124.99 73.72 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.763 179.795 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 49.3 t80 -106.62 105.69 15.84 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.393 179.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.702 HG12 HD21 ' A' ' 124' ' ' LEU . 1.3 mp -84.97 133.39 29.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.483 -179.478 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -79.9 113.93 18.43 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.835 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -58.59 -21.03 52.0 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.256 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 32.1 mtmm -57.49 -42.67 83.16 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.957 0.408 . . . . 0.0 110.638 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -60.4 -44.31 95.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.75 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 1.3 mttt -64.26 -36.0 82.68 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.809 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 5.5 tt0 -63.28 -37.91 89.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.852 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 10.9 t -63.92 -45.26 90.07 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.939 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.648 HD21 HG11 ' A' ' 55' ' ' VAL . 0.8 OUTLIER -58.87 -39.65 82.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.892 179.975 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -65.2 -41.0 94.92 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.833 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -66.41 -22.45 66.23 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.147 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -116.0 63.09 0.7 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.854 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.26 161.71 30.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.97 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 11.5 m -92.28 132.39 36.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.017 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -172.61 157.39 3.86 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.881 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 20.0 mtp180 -141.96 38.56 1.62 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.837 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 21.4 mt -98.44 124.64 51.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.081 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 2.1 mmt85 . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.148 -0.929 . . . . 0.0 110.842 -179.968 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.265 0 N-CA-C 112.485 -0.246 . . . . 0.0 112.485 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -155.17 114.35 3.62 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.853 0.358 . . . . 0.0 110.929 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -129.39 151.59 49.86 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.907 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.654 ' N ' HD13 ' A' ' 4' ' ' ILE . 0.1 OUTLIER -136.77 134.69 48.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.06 -179.998 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 22.1 p -69.41 127.02 31.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.105 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -132.86 62.74 64.05 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.847 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -71.61 -35.16 8.24 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.605 2.203 . . . . 0.0 112.231 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 31.1 p -103.65 -22.31 13.6 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.273 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 61.69 -172.98 0.14 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.815 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 3.1 pm0 -123.74 23.01 8.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.138 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 52.72 -168.5 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.843 0.354 . . . . 0.0 111.061 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -73.49 -36.87 65.84 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.032 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 11.8 mp0 -106.31 120.18 41.2 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.805 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -130.88 102.57 6.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.148 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -161.62 -55.26 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.13 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.9 -47.06 79.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.965 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 3.5 ttt85 -63.81 -37.37 87.13 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.078 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -67.01 -35.9 80.95 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.036 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.2 mp -63.42 -45.25 91.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.994 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 41.1 mm -62.15 -40.77 88.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.302 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -57.64 -47.14 83.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.108 -179.776 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -67.18 -28.67 68.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.044 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -59.25 -47.26 86.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.443 -179.726 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 78.6 p -65.33 -48.05 74.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.205 -179.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 42.66 34.61 0.58 Allowed 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.365 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -62.57 131.21 48.32 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.223 -179.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -110.45 140.95 44.2 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.832 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 23.9 mm -86.62 139.61 17.08 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.347 0 CA-C-O 121.474 0.654 . . . . 0.0 111.789 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 102.3 -24.45 31.01 Favored Glycine 0 C--N 1.318 -0.443 0 CA-C-N 114.937 -1.029 . . . . 0.0 112.679 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -80.56 -23.93 39.59 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.612 0.244 . . . . 0.0 111.271 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.474 ' HA ' HD12 ' A' ' 52' ' ' ILE . 13.2 m120 -109.0 -14.65 14.51 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-O 121.911 0.863 . . . . 0.0 108.906 178.409 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.521 ' O ' HG22 ' A' ' 32' ' ' ILE . 0.1 OUTLIER -73.3 106.36 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.58 0 CA-C-N 113.968 -1.469 . . . . 0.0 111.094 -179.442 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 1.008 HG23 ' HB2' ' A' ' 50' ' ' ALA . 0.5 OUTLIER -38.87 -62.21 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.384 -0.826 . . . . 0.0 111.403 -179.664 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.602 ' N ' ' CG1' ' A' ' 33' ' ' VAL . 28.4 p -165.77 165.95 18.12 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.482 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 2.2 ttp180 -120.77 127.38 51.91 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.542 179.517 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.693 HG23 ' CD1' ' A' ' 48' ' ' LEU . 39.1 t -97.23 121.92 48.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.504 179.285 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.927 HG23 HG12 ' A' ' 45' ' ' ILE . 20.3 mt -125.29 109.02 20.96 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.824 -179.355 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 43.4 t -78.2 99.92 6.42 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 178.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 9.7 t -69.73 -33.27 72.24 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -178.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.415 ' OG1' ' O ' ' A' ' 142' ' ' SER . 0.0 OUTLIER -52.38 -29.32 23.46 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.914 0.388 . . . . 0.0 110.9 -179.658 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 90.46 49.78 3.13 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.866 -0.683 . . . . 0.0 113.003 179.205 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.887 ' OE1' HD21 ' A' ' 141' ' ' LEU . 2.3 mm-40 -126.55 -31.77 2.7 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.663 0.268 . . . . 0.0 111.368 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.537 HD12 HD11 ' A' ' 143' ' ' LEU . 19.0 mt -127.37 131.15 23.7 Favored Pre-proline 0 N--CA 1.452 -0.329 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.98 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.462 ' HD2' ' CE2' ' A' ' 76' ' ' TYR . 27.8 Cg_exo -59.85 146.82 94.73 Favored 'Trans proline' 0 C--N 1.343 0.263 0 C-N-CA 122.655 2.236 . . . . 0.0 112.046 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.927 HG12 HG23 ' A' ' 37' ' ' ILE . 78.8 mt -51.59 133.12 13.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.327 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -126.16 131.23 52.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.371 179.669 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.411 ' HB3' HD11 ' A' ' 32' ' ' ILE . 1.1 m-20 -96.17 119.95 35.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.043 0.449 . . . . 0.0 111.511 -179.525 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.944 HD21 HD13 ' A' ' 91' ' ' ILE . 1.8 mp -96.37 117.0 29.95 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 178.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.524 ' O ' ' CZ2' ' A' ' 66' ' ' TRP . 0.1 OUTLIER -112.24 162.17 15.78 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 122.077 0.942 . . . . 0.0 113.121 -178.715 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 1.008 ' HB2' HG23 ' A' ' 33' ' ' VAL . . . -125.97 165.9 17.93 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 114.718 -1.128 . . . . 0.0 111.4 179.401 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.75 ' O ' HG23 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -108.22 78.56 1.18 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.42 179.879 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.474 HD12 ' HA ' ' A' ' 31' ' ' ASN . 88.4 mt -64.06 -45.52 96.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.571 -179.581 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 37.8 t -61.27 -37.08 81.86 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.018 0.437 . . . . 0.0 110.812 -179.492 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.417 ' HG2' ' CB ' ' A' ' 51' ' ' ASP . 11.7 mm-40 -68.53 -40.41 80.76 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.033 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.75 HG23 ' O ' ' A' ' 51' ' ' ASP . 23.7 t -74.03 -38.45 49.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.24 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.99 -41.29 95.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.152 -179.608 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -90.73 -43.71 9.93 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.096 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -114.66 163.56 15.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.816 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.43 30.62 3.2 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.785 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -94.5 -36.18 11.97 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.994 -179.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.7 p -81.15 -97.24 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.918 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER 41.37 42.76 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.162 0 CA-C-O 121.064 0.459 . . . . 0.0 111.578 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 27.9 tttt -159.03 77.67 0.74 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.08 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.403 ' O ' ' HB3' ' A' ' 93' ' ' LEU . 0.8 OUTLIER -115.0 138.88 50.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.563 179.597 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.598 HG13 ' O ' ' A' ' 91' ' ' ILE . 13.9 t -136.73 136.92 47.89 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 CA-C-O 121.116 0.484 . . . . 0.0 112.003 -179.289 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . 0.661 ' HB2' ' HB ' ' A' ' 91' ' ' ILE . 15.2 m-90 -100.19 140.61 34.18 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.666 179.205 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.874 HG23 ' HG3' ' A' ' 90' ' ' GLN . 7.1 m -129.21 129.47 45.08 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.455 0.645 . . . . 0.0 112.337 179.653 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.578 ' CZ ' HG11 ' A' ' 36' ' ' VAL . 3.4 m-85 -103.43 118.69 37.34 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.051 -0.977 . . . . 0.0 108.716 177.578 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.647 ' HA2' ' O ' ' A' ' 85' ' ' SER . . . 157.06 -154.86 25.89 Favored Glycine 0 CA--C 1.505 -0.548 0 C-N-CA 118.58 -1.772 . . . . 0.0 113.468 179.346 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 4.1 mtp180 -75.27 91.83 2.7 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-O 122.543 1.163 . . . . 0.0 108.826 -179.416 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.518 ' O ' ' CD2' ' A' ' 77' ' ' HIS . 16.1 m120 -150.05 159.41 35.52 Favored Pre-proline 0 C--N 1.307 -1.262 0 CA-C-N 112.782 -2.008 . . . . 0.0 107.85 178.786 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.552 ' O ' ' HB2' ' A' ' 77' ' ' HIS . 30.9 Cg_endo -64.4 -7.09 13.19 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 120.7 0.933 . . . . 0.0 110.758 177.714 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.742 ' HB2' ' HB2' ' A' ' 77' ' ' HIS . . . 136.71 53.62 0.0 OUTLIER 'General case' 0 CA--C 1.488 -1.406 0 CA-C-N 114.367 -1.288 . . . . 0.0 109.0 178.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.579 ' HB3' ' HB ' ' A' ' 67' ' ' THR . 0.1 OUTLIER -52.56 -70.07 0.1 Allowed 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 105.409 -2.071 . . . . 0.0 105.409 179.719 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.504 ' CG ' ' CE1' ' A' ' 68' ' ' PHE . 16.8 t70 -95.58 -47.56 6.18 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 105.781 -1.933 . . . . 0.0 105.781 169.114 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.499 ' CD2' HG23 ' A' ' 43' ' ' ILE . 19.4 t80 -143.08 141.95 31.4 Favored 'General case' 0 C--N 1.348 0.507 0 CA-C-N 112.775 -2.011 . . . . 0.0 111.458 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.742 ' HB2' ' HB2' ' A' ' 73' ' ' ALA . 23.7 t-160 -96.1 107.28 19.58 Favored 'General case' 0 C--N 1.33 -0.261 0 O-C-N 122.114 -0.366 . . . . 0.0 110.222 177.26 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.817 HD11 ' O ' ' A' ' 85' ' ' SER . 0.6 OUTLIER -121.19 173.77 7.1 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.916 0.388 . . . . 0.0 111.506 -179.895 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -56.91 -173.39 0.21 Allowed Glycine 0 C--N 1.332 0.343 0 C-N-CA 121.014 -0.612 . . . . 0.0 112.475 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.421 ' HA ' ' OD1' ' A' ' 86' ' ' ASN . 9.2 p30 -111.81 98.34 7.32 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.82 0.343 . . . . 0.0 111.758 -179.671 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.79 HD12 ' OG ' ' A' ' 85' ' ' SER . 11.2 mt -114.91 113.79 44.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.436 178.574 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -55.65 -24.37 33.35 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 -179.352 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.441 ' H ' HG22 ' A' ' 81' ' ' ILE . 1.4 mtt180 -88.21 -106.11 0.08 Allowed 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -179.047 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.408 ' HB3' ' CE1' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -109.26 111.17 22.61 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-O 121.568 0.699 . . . . 0.0 110.158 179.976 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.817 ' O ' HD11 ' A' ' 78' ' ' LEU . 0.5 OUTLIER 162.11 -48.94 0.0 OUTLIER 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 114.378 -1.283 . . . . 0.0 109.261 -179.817 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.846 ' O ' ' N ' ' A' ' 88' ' ' HIS . 89.0 m-20 -63.32 -152.57 0.01 OUTLIER 'General case' 0 CA--C 1.522 -0.122 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 177.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.848 ' HB3' HD11 ' A' ' 104' ' ' ILE . 12.9 mttt -48.54 72.8 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 179.303 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.996 ' O ' ' O ' ' A' ' 104' ' ' ILE . 36.3 t60 -93.93 -17.76 22.64 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 114.103 1.149 . . . . 0.0 114.103 -176.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.62 ' HA ' ' H ' ' A' ' 104' ' ' ILE . 0.1 OUTLIER -175.83 155.69 1.7 Allowed 'General case' 0 C--N 1.313 -1.002 0 C-N-CA 118.96 -1.096 . . . . 0.0 113.073 177.982 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.874 ' HG3' HG23 ' A' ' 67' ' ' THR . 21.2 mt-30 -137.46 160.97 37.62 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.308 -1.314 . . . . 0.0 113.574 -177.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.944 HD13 HD21 ' A' ' 48' ' ' LEU . 2.7 mt -128.42 132.33 68.17 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.784 178.746 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.571 HD13 ' ND2' ' A' ' 121' ' ' ASN . 0.3 OUTLIER -109.52 146.12 35.15 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.142 0.496 . . . . 0.0 112.017 -179.126 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.637 HD22 ' N ' ' A' ' 94' ' ' GLY . 1.1 tm? -125.97 124.52 40.92 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.445 179.195 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.637 ' N ' HD22 ' A' ' 93' ' ' LEU . . . 128.21 -129.55 6.33 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.617 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 67.76 -70.4 0.12 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.779 0.323 . . . . 0.0 111.023 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -143.15 52.86 1.36 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.01 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 77.93 -60.18 3.82 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.562 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -57.67 -170.27 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.901 0.382 . . . . 0.0 110.991 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.956 HD21 HG13 ' A' ' 33' ' ' VAL . 4.9 mp -106.95 159.92 15.91 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.943 -180.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.938 HD23 ' HB3' ' A' ' 121' ' ' ASN . 4.6 mp -131.58 148.35 52.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.389 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.462 ' O ' ' N ' ' A' ' 122' ' ' GLN . 6.0 mt -118.23 128.78 55.02 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 179.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.515 ' O ' ' O ' ' A' ' 90' ' ' GLN . 29.4 t30 -111.21 111.38 22.41 Favored 'General case' 0 CA--C 1.507 -0.675 0 C-N-CA 119.907 -0.717 . . . . 0.0 109.685 179.606 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.758 ' HB3' HG21 ' A' ' 109' ' ' THR . 84.0 m-20 -85.8 111.56 20.28 Favored 'General case' 0 N--CA 1.44 -0.932 0 C-N-CA 119.596 -0.842 . . . . 0.0 109.535 179.697 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.996 ' O ' ' O ' ' A' ' 88' ' ' HIS . 0.1 OUTLIER -122.91 107.57 19.59 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.953 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 177.563 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.415 ' HG ' ' CE1' ' A' ' 88' ' ' HIS . 70.9 m -134.17 166.89 21.72 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-N 114.982 -1.008 . . . . 0.0 109.398 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 20.8 m -69.24 -62.81 1.23 Allowed 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 119.226 -0.99 . . . . 0.0 111.581 -179.074 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -112.12 -32.82 6.43 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 114.984 1.476 . . . . 0.0 114.984 179.443 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -146.35 127.95 2.9 Favored Glycine 0 C--N 1.339 0.749 0 N-CA-C 117.388 1.715 . . . . 0.0 117.388 -177.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.758 HG21 ' HB3' ' A' ' 103' ' ' ASP . 5.4 m -121.37 138.3 54.32 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 174.18 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 0.761 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.9 m-90 -121.24 148.91 43.65 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 113.318 0.859 . . . . 0.0 113.318 -178.506 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.463 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -121.6 112.05 17.98 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 115.12 -0.946 . . . . 0.0 108.509 177.424 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 43.97 44.44 6.02 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.038 -0.528 . . . . 0.0 112.126 -179.462 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 80.06 25.12 58.36 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.744 179.336 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . 0.434 ' O ' HG13 ' A' ' 116' ' ' VAL . 58.0 mt-30 -137.74 95.98 3.15 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.077 0.465 . . . . 0.0 110.841 179.677 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.761 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.0 OUTLIER -45.61 134.54 7.17 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.891 179.77 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.434 HG13 ' O ' ' A' ' 114' ' ' GLN . 27.3 m -126.05 -178.19 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.916 -179.029 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -85.84 142.1 29.15 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.229 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.457 ' HG3' ' HA ' ' A' ' 104' ' ' ILE . 71.4 tttt -64.49 163.21 13.82 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.155 179.28 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.42 ' N ' ' HG2' ' A' ' 118' ' ' LYS . 4.2 p30 35.41 39.5 0.06 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.287 0.565 . . . . 0.0 111.17 -179.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 4.9 p -110.87 106.76 16.02 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.024 -179.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.938 ' HB3' HD23 ' A' ' 100' ' ' LEU . 1.6 m-20 -57.26 140.8 48.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.506 179.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . 0.691 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 59.9 mm-40 -129.63 147.86 51.47 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-O 121.109 0.481 . . . . 0.0 111.965 -179.542 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.3 tp -73.77 116.89 14.9 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.628 -0.715 . . . . 0.0 109.491 178.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.801 HD21 HD13 ' A' ' 147' ' ' ILE . 2.4 tt -47.54 144.53 3.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.85 0.833 . . . . 0.0 111.892 -178.759 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.441 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.6 OUTLIER -126.83 153.18 45.99 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 114.04 -1.436 . . . . 0.0 110.291 179.535 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 24.6 mm100 -71.67 113.93 9.22 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.002 0.429 . . . . 0.0 110.152 179.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 69.24 25.66 75.27 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.645 -179.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.441 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 27.0 t70 -58.5 159.99 5.85 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.045 0.45 . . . . 0.0 111.136 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.597 ' HG3' HG22 ' A' ' 144' ' ' VAL . 1.7 tt0 -146.56 135.37 22.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.411 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.466 ' CG2' ' O ' ' A' ' 110' ' ' TRP . 1.2 mp -110.46 128.5 66.7 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.157 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 178.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.577 HG23 ' CG2' ' A' ' 140' ' ' ILE . 23.3 m -103.13 144.79 30.84 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.451 -179.571 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.474 ' HB ' ' NE2' ' A' ' 88' ' ' HIS . 10.2 m -141.29 158.14 22.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -178.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 67.38 43.16 88.59 Favored Glycine 0 N--CA 1.447 -0.582 0 CA-C-N 115.667 -0.697 . . . . 0.0 112.281 179.477 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.485 ' HA ' HG12 ' A' ' 140' ' ' ILE . 85.2 t -77.84 156.48 5.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 121.406 0.622 . . . . 0.0 112.133 -179.245 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.448 ' N ' HG12 ' A' ' 134' ' ' VAL . . . 147.79 -42.06 0.89 Allowed Glycine 0 N--CA 1.441 -0.99 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.635 -179.061 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.528 HG12 ' H ' ' A' ' 138' ' ' SER . 43.8 t -126.65 130.14 71.63 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.684 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 178.73 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.29 -34.0 31.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.724 0.297 . . . . 0.0 111.405 -179.181 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . 0.528 ' H ' HG12 ' A' ' 136' ' ' VAL . 4.0 p -94.28 6.39 48.81 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 -179.441 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -128.14 30.25 5.25 Favored 'General case' 0 CA--C 1.52 -0.197 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -179.274 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.577 ' CG2' HG23 ' A' ' 131' ' ' THR . 20.9 mt -103.66 141.12 20.03 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.361 179.183 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.887 HD21 ' OE1' ' A' ' 42' ' ' GLN . 3.4 mp -111.51 135.67 51.76 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.021 -0.991 . . . . 0.0 110.048 179.506 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.764 ' C ' HD22 ' A' ' 143' ' ' LEU . 47.3 t -116.82 152.02 35.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.865 0.841 . . . . 0.0 112.94 -178.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.764 HD22 ' C ' ' A' ' 142' ' ' SER . 3.9 mm? -136.24 127.06 27.45 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.526 -1.215 . . . . 0.0 109.166 178.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.597 HG22 ' HG3' ' A' ' 129' ' ' GLU . 18.7 t -120.2 140.61 43.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.017 0.437 . . . . 0.0 111.978 -178.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.499 ' CG1' HG22 ' A' ' 36' ' ' VAL . 0.2 OUTLIER -114.19 127.17 71.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.575 179.639 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 15.6 t80 -110.65 107.19 16.68 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.753 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.801 HD13 HD21 ' A' ' 124' ' ' LEU . 1.4 mp -99.76 133.41 42.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.393 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 14.7 p30 -82.05 134.79 35.37 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.926 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -64.63 -23.03 67.13 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.154 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 16.7 mtmt -57.31 -42.22 81.37 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.94 0.4 . . . . 0.0 110.687 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 37.3 t80 -59.38 -43.88 92.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.75 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 16.4 mttm -59.55 -42.8 93.19 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.95 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 72.5 mt-30 -63.75 -40.22 96.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.956 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 10.5 t -63.29 -45.07 93.09 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.949 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -68.51 -37.84 80.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.915 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -60.28 -39.32 86.47 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.983 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -88.85 -35.52 16.52 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.909 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 4.6 p30 42.51 42.28 2.68 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.465 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 1.9 mttm -90.87 150.2 21.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.917 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 21.5 t -66.16 141.1 18.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.13 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -57.59 92.77 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.939 -179.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 5.6 ptm180 -138.13 -175.52 4.13 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.902 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 3.6 mt -77.92 113.77 17.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.025 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 48.0 ttp85 . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.282 -0.866 . . . . 0.0 110.91 -179.925 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.353 0 N-CA-C 112.546 -0.221 . . . . 0.0 112.546 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -64.36 130.82 45.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.843 0.354 . . . . 0.0 110.95 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -158.28 51.41 0.42 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.82 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 4.8 mt -121.33 -65.51 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.061 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 10.9 p -148.4 102.18 3.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.193 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.419 ' N ' ' CD ' ' A' ' 7' ' ' PRO . 0.0 OUTLIER -61.08 -52.24 73.21 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.968 179.91 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.419 ' CD ' ' N ' ' A' ' 6' ' ' GLN . 74.0 Cg_exo -48.49 113.89 1.0 Allowed 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.634 2.223 . . . . 0.0 112.41 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 12.9 m -61.04 126.91 29.09 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.144 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -134.95 85.79 2.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.895 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.19 -38.07 82.16 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.85 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -151.98 176.12 11.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.916 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -145.8 89.27 1.89 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.131 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -103.91 34.96 2.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.883 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -145.33 64.31 1.26 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.105 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -140.84 -48.69 0.42 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.147 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 10.1 tm0? -66.24 -37.29 85.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.868 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 2.5 mtt180 -61.68 -41.74 97.98 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.899 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -64.41 -36.01 82.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.869 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.7 tt -59.8 -42.22 92.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.931 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 34.5 mm -62.14 -40.57 88.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.108 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -57.68 -35.94 71.25 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.039 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.35 -33.51 74.85 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.942 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -61.73 -47.58 84.6 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.142 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 6.8 t -59.95 -46.98 87.64 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.824 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 22.4 mt-30 -146.15 154.62 41.99 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.838 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -98.02 155.52 17.07 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.869 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 21.1 tt0 -96.74 131.1 43.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.828 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.426 HG22 ' HB ' ' A' ' 32' ' ' ILE . 22.6 mm -82.04 139.5 17.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 121.463 0.649 . . . . 0.0 111.59 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -172.86 -37.95 0.04 OUTLIER Glycine 0 C--N 1.317 -0.521 0 CA-C-N 114.884 -1.053 . . . . 0.0 112.644 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -73.89 -23.69 59.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.701 0.286 . . . . 0.0 111.317 -179.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.417 ' HA ' HD12 ' A' ' 52' ' ' ILE . 12.2 m120 -109.06 -14.37 14.54 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-O 121.949 0.881 . . . . 0.0 108.746 178.574 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.555 ' O ' HG22 ' A' ' 32' ' ' ILE . 0.0 OUTLIER -74.31 101.53 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.522 0 CA-C-N 114.011 -1.449 . . . . 0.0 110.558 -179.769 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 1.022 HG23 ' HB2' ' A' ' 50' ' ' ALA . 0.5 OUTLIER -34.93 -61.73 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.249 -0.887 . . . . 0.0 112.297 -179.059 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.725 ' SG ' HG23 ' A' ' 147' ' ' ILE . 41.2 m -159.36 165.46 33.25 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.677 -179.178 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.513 HH11 HD11 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -128.46 115.12 17.68 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.828 179.367 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.629 HG11 ' HZ ' ' A' ' 68' ' ' PHE . 9.9 p -89.18 134.38 28.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.812 179.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.964 HG23 HG12 ' A' ' 45' ' ' ILE . 21.6 mt -132.68 107.86 12.55 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -179.373 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -89.23 106.56 18.52 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 177.604 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 10.1 t -99.11 -22.4 15.7 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 -177.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.772 HG21 ' CB ' ' A' ' 142' ' ' SER . 56.7 p -57.74 -20.7 36.51 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.656 0.265 . . . . 0.0 111.583 -179.556 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 104.86 71.75 0.84 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.561 -0.828 . . . . 0.0 112.627 179.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.788 ' HG2' HD12 ' A' ' 141' ' ' LEU . 0.0 OUTLIER -159.35 -66.95 0.08 Allowed 'General case' 0 C--N 1.328 -0.37 0 CA-C-O 120.893 0.377 . . . . 0.0 110.925 179.925 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.514 HG23 ' HD2' ' A' ' 44' ' ' PRO . 34.3 mt -103.5 138.97 19.69 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.257 -179.714 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.514 ' HD2' HG23 ' A' ' 43' ' ' ILE . 91.2 Cg_endo -81.73 146.79 15.09 Favored 'Trans proline' 0 N--CA 1.46 -0.458 0 C-N-CA 122.71 2.273 . . . . 0.0 111.706 179.51 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.964 HG12 HG23 ' A' ' 37' ' ' ILE . 55.8 mt -43.82 116.07 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.072 0.463 . . . . 0.0 111.622 -179.665 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.404 ' NE ' ' HA ' ' A' ' 46' ' ' ARG . 8.9 mmm180 -114.69 131.48 56.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.928 179.49 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.424 ' HB3' HD11 ' A' ' 32' ' ' ILE . 5.0 m-20 -88.11 119.6 28.64 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.063 0.459 . . . . 0.0 111.604 -179.306 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.592 HD22 ' CD1' ' A' ' 66' ' ' TRP . 1.0 OUTLIER -98.34 121.57 40.43 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 178.741 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.513 ' O ' ' HZ2' ' A' ' 66' ' ' TRP . 0.0 OUTLIER -120.81 162.05 20.44 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 122.133 0.968 . . . . 0.0 113.46 -178.371 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 1.022 ' HB2' HG23 ' A' ' 33' ' ' VAL . . . -116.96 166.28 12.36 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 114.343 -1.299 . . . . 0.0 110.958 179.685 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.909 ' O ' HG23 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -105.47 63.44 0.69 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.029 0.442 . . . . 0.0 110.837 -179.973 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.417 HD12 ' HA ' ' A' ' 31' ' ' ASN . 53.6 mt -63.18 -44.05 99.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.04 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.54 -39.23 88.47 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.04 0.448 . . . . 0.0 111.1 -179.497 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 16.8 mt-30 -65.79 -40.76 92.25 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.198 -179.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.909 HG23 ' O ' ' A' ' 51' ' ' ASP . 41.4 t -63.28 -40.37 88.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.136 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -61.63 -32.36 72.5 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.959 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.95 -27.74 16.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.079 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.59 -175.98 3.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.919 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.42 -48.88 4.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.833 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 6.6 mmt85 -115.87 -67.93 0.96 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.894 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.543 ' CB ' HG22 ' A' ' 55' ' ' VAL . 1.8 t 61.5 -163.44 0.26 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.827 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 22.0 mm 71.93 86.62 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.176 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 179.83 71.24 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.852 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.469 ' HB3' HD12 ' A' ' 93' ' ' LEU . 13.2 ttpt -130.41 136.68 49.3 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.625 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.635 HG13 ' O ' ' A' ' 91' ' ' ILE . 17.6 t -137.41 137.3 46.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.969 0.414 . . . . 0.0 112.008 -179.124 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . 0.675 ' HB2' ' HB ' ' A' ' 91' ' ' ILE . 13.8 m-90 -100.26 139.29 36.15 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.09 178.636 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.574 ' HB ' ' HB3' ' A' ' 74' ' ' CYS . 4.4 m -131.3 130.49 42.83 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.458 0.647 . . . . 0.0 112.57 179.747 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.629 ' HZ ' HG11 ' A' ' 36' ' ' VAL . 93.7 m-85 -101.73 118.57 37.2 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.303 178.006 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.62 ' HA2' ' O ' ' A' ' 85' ' ' SER . . . 157.34 -157.2 27.9 Favored Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 118.899 -1.619 . . . . 0.0 112.812 179.291 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.47 92.34 2.85 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-O 122.71 1.243 . . . . 0.0 108.738 -179.763 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.536 ' O ' ' CD2' ' A' ' 77' ' ' HIS . 19.3 m120 -149.16 159.43 37.09 Favored Pre-proline 0 C--N 1.309 -1.169 0 CA-C-N 112.515 -2.129 . . . . 0.0 107.921 179.224 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.545 ' O ' ' CB ' ' A' ' 73' ' ' ALA . 28.8 Cg_endo -63.64 -7.43 12.75 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 120.842 1.028 . . . . 0.0 111.118 178.255 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.735 ' HB2' ' HB2' ' A' ' 77' ' ' HIS . . . 135.99 51.6 0.0 OUTLIER 'General case' 0 CA--C 1.49 -1.362 0 CA-C-N 114.527 -1.215 . . . . 0.0 109.455 178.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.574 ' HB3' ' HB ' ' A' ' 67' ' ' THR . 0.1 OUTLIER -52.88 -69.9 0.1 Allowed 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 105.63 -1.989 . . . . 0.0 105.63 179.491 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.551 ' N ' ' O ' ' A' ' 67' ' ' THR . 7.6 t0 -95.26 -47.14 6.45 Favored 'General case' 0 N--CA 1.435 -1.182 0 N-CA-C 106.0 -1.852 . . . . 0.0 106.0 169.594 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.496 ' C ' ' HA ' ' A' ' 73' ' ' ALA . 29.8 t80 -144.33 142.6 30.5 Favored 'General case' 0 C--N 1.347 0.465 0 CA-C-N 112.624 -2.08 . . . . 0.0 111.476 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.735 ' HB2' ' HB2' ' A' ' 73' ' ' ALA . 23.7 t-160 -96.33 107.3 19.64 Favored 'General case' 0 C--N 1.33 -0.249 0 O-C-N 121.997 -0.439 . . . . 0.0 110.322 177.073 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.811 HD11 ' O ' ' A' ' 85' ' ' SER . 0.7 OUTLIER -124.24 175.22 7.19 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 120.916 0.388 . . . . 0.0 111.375 179.969 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -59.02 -174.18 0.57 Allowed Glycine 0 C--N 1.332 0.342 0 C-N-CA 120.981 -0.628 . . . . 0.0 112.704 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.436 ' HA ' ' OD1' ' A' ' 86' ' ' ASN . 8.0 p30 -111.48 98.24 7.32 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.933 0.397 . . . . 0.0 111.634 -179.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.594 ' HB ' ' HB2' ' A' ' 85' ' ' SER . 4.0 mp -114.92 114.03 45.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.356 178.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 53.3 p -55.7 -24.62 35.54 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 -178.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.523 ' C ' HD13 ' A' ' 84' ' ' LEU . 0.6 OUTLIER -85.32 -110.13 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 -178.931 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.847 ' H ' HD22 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -108.98 112.07 24.08 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-O 121.453 0.644 . . . . 0.0 109.573 179.679 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.811 ' O ' HD11 ' A' ' 78' ' ' LEU . 0.6 OUTLIER 161.86 -45.63 0.0 OUTLIER 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 114.671 -1.15 . . . . 0.0 109.433 -179.562 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.858 ' O ' ' N ' ' A' ' 88' ' ' HIS . 95.7 m-20 -64.68 -149.65 0.01 OUTLIER 'General case' 0 N--CA 1.456 -0.148 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 177.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.925 ' HB3' HD11 ' A' ' 104' ' ' ILE . 28.1 mttm -49.58 72.02 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 179.065 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.983 ' C ' ' O ' ' A' ' 104' ' ' ILE . 31.8 t60 -91.35 -15.93 28.26 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 113.846 1.054 . . . . 0.0 113.846 -176.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.631 ' HA ' ' H ' ' A' ' 104' ' ' ILE . 0.9 OUTLIER -175.31 152.83 1.45 Allowed 'General case' 0 C--N 1.31 -1.131 0 C-N-CA 119.436 -0.906 . . . . 0.0 112.291 177.972 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.508 ' HG2' HG12 ' A' ' 65' ' ' VAL . 20.5 tt0 -136.82 153.38 50.81 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 114.514 -1.221 . . . . 0.0 113.338 -177.664 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.675 ' HB ' ' HB2' ' A' ' 66' ' ' TRP . 32.4 mt -123.53 131.98 72.17 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.196 178.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.697 HD13 ' ND2' ' A' ' 121' ' ' ASN . 0.3 OUTLIER -108.64 144.05 36.89 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.055 0.455 . . . . 0.0 111.824 -179.56 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.797 HD22 ' N ' ' A' ' 94' ' ' GLY . 0.2 OUTLIER -125.77 122.66 36.86 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.28 179.26 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.797 ' N ' HD22 ' A' ' 93' ' ' LEU . . . 113.0 -136.27 13.32 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.375 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 57.75 88.59 0.06 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.788 0.328 . . . . 0.0 110.871 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 1.6 t70 60.93 29.9 19.29 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.851 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 80.55 174.82 48.52 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.593 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 34.0 m-80 61.66 176.6 0.12 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.843 0.354 . . . . 0.0 110.932 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.867 ' HB2' HD13 ' A' ' 124' ' ' LEU . 0.5 OUTLIER -107.08 155.58 19.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.893 179.849 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.54 ' HA ' ' O ' ' A' ' 122' ' ' GLN . 20.5 mt -133.61 147.98 51.53 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.432 179.758 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.516 HD13 ' HA ' ' A' ' 124' ' ' LEU . 4.8 mp -116.58 131.85 56.84 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.615 ' HB2' HD11 ' A' ' 92' ' ' LEU . 23.1 t30 -114.42 110.87 20.54 Favored 'General case' 0 CA--C 1.508 -0.661 0 C-N-CA 119.714 -0.795 . . . . 0.0 109.839 179.704 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.69 ' HB3' HG21 ' A' ' 109' ' ' THR . 70.1 m-20 -81.68 111.88 18.36 Favored 'General case' 0 N--CA 1.442 -0.865 0 C-N-CA 119.726 -0.79 . . . . 0.0 109.37 179.557 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.983 ' O ' ' C ' ' A' ' 88' ' ' HIS . 0.1 OUTLIER -123.45 107.98 20.1 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.937 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 177.71 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.456 ' HG ' ' CE1' ' A' ' 88' ' ' HIS . 69.8 m -130.91 169.83 15.25 Favored 'General case' 0 C--N 1.296 -1.742 0 CA-C-N 114.926 -1.034 . . . . 0.0 109.304 179.694 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 24.0 m -69.56 -62.68 1.28 Allowed 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 119.089 -1.044 . . . . 0.0 111.325 -179.302 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -111.75 -33.52 6.3 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 114.66 1.356 . . . . 0.0 114.66 179.195 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -146.99 130.37 3.58 Favored Glycine 0 C--N 1.34 0.786 0 N-CA-C 116.764 1.466 . . . . 0.0 116.764 -178.158 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.69 HG21 ' HB3' ' A' ' 103' ' ' ASP . 4.3 m -120.85 137.87 54.34 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 174.47 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 0.771 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.5 m-90 -120.37 148.96 43.08 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 -178.543 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.432 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.3 OUTLIER -122.49 112.09 17.62 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 114.931 -1.031 . . . . 0.0 108.514 177.421 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 67.4 m-20 48.02 42.82 17.34 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.08 -0.509 . . . . 0.0 112.12 -179.458 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 82.22 3.44 90.56 Favored Glycine 0 N--CA 1.445 -0.754 0 C-N-CA 120.785 -0.721 . . . . 0.0 113.134 179.125 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.07 100.07 7.3 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.062 0.458 . . . . 0.0 110.829 179.78 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.771 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.0 OUTLIER -44.86 139.17 3.17 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.018 179.919 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.456 HG21 ' OD2' ' A' ' 103' ' ' ASP . 28.1 m -126.98 178.92 3.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.103 0.478 . . . . 0.0 111.756 -179.103 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -84.01 139.09 32.75 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.755 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.451 ' O ' ' N ' ' A' ' 120' ' ' SER . 0.5 OUTLIER -61.94 169.46 2.6 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 179.348 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.444 ' C ' ' O ' ' A' ' 118' ' ' LYS . 6.7 p30 28.63 41.42 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.534 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.451 ' N ' ' O ' ' A' ' 118' ' ' LYS . 4.0 p -111.22 111.52 22.64 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.154 -179.113 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.697 ' ND2' HD13 ' A' ' 92' ' ' LEU . 1.9 m120 -62.95 133.77 55.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.124 179.51 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . 0.54 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 49.6 mm-40 -129.56 147.04 51.32 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 -179.425 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.8 tt -72.62 113.71 9.95 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.351 178.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.895 HD12 HG12 ' A' ' 147' ' ' ILE . 1.6 pt? -45.51 155.41 0.15 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.852 0.834 . . . . 0.0 112.362 -178.462 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.476 ' O ' HD13 ' A' ' 147' ' ' ILE . 0.0 OUTLIER -127.44 153.38 46.35 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 114.069 -1.423 . . . . 0.0 109.855 179.142 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 5.6 tp-100 -70.72 113.82 8.18 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 179.659 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 69.13 27.93 73.34 Favored Glycine 0 N--CA 1.445 -0.7 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.131 -179.093 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.449 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 27.5 t70 -58.96 159.62 6.88 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.099 0.476 . . . . 0.0 111.53 -179.567 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.505 ' HB2' HG22 ' A' ' 144' ' ' VAL . 2.0 tt0 -146.54 135.35 22.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.941 179.704 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.692 ' O ' HD12 ' A' ' 143' ' ' LEU . 1.0 OUTLIER -108.74 129.17 63.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.13 179.157 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.529 HG23 ' CG2' ' A' ' 140' ' ' ILE . 32.0 m -102.77 143.16 32.75 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.86 0.362 . . . . 0.0 110.454 -179.665 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.47 ' HB ' ' NE2' ' A' ' 88' ' ' HIS . 5.3 m -141.13 158.26 22.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 -178.669 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 68.64 43.98 73.47 Favored Glycine 0 N--CA 1.447 -0.575 0 CA-C-N 115.705 -0.68 . . . . 0.0 112.219 179.351 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.497 ' HA ' HG12 ' A' ' 140' ' ' ILE . 93.0 t -79.35 154.22 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 CA-C-O 121.467 0.651 . . . . 0.0 112.242 -179.093 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.406 ' N ' HG12 ' A' ' 134' ' ' VAL . . . 151.39 -42.79 0.71 Allowed Glycine 0 N--CA 1.44 -1.04 0 CA-C-N 114.93 -1.032 . . . . 0.0 110.648 -179.068 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.547 HG12 ' H ' ' A' ' 138' ' ' SER . 44.8 t -126.66 132.19 70.42 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.751 0 CA-C-N 115.196 -0.502 . . . . 0.0 109.844 178.65 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 46.5 tp10 -51.42 -34.74 36.13 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.798 0.332 . . . . 0.0 111.405 -179.292 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . 0.547 ' H ' HG12 ' A' ' 136' ' ' VAL . 40.9 t -94.31 6.45 48.65 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -179.318 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -126.94 30.16 5.51 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 -179.3 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.529 ' CG2' HG23 ' A' ' 131' ' ' THR . 13.3 mt -107.33 140.95 23.81 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.305 179.15 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.788 HD12 ' HG2' ' A' ' 42' ' ' GLN . 3.6 mm? -117.3 135.01 54.14 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 114.974 -1.012 . . . . 0.0 109.834 179.409 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.772 ' CB ' HG21 ' A' ' 40' ' ' THR . 0.9 OUTLIER -120.65 147.4 45.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.537 0.684 . . . . 0.0 112.701 -178.943 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.692 HD12 ' O ' ' A' ' 130' ' ' ILE . 3.5 mp -122.93 147.38 46.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 114.861 -1.063 . . . . 0.0 109.369 179.534 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.505 HG22 ' HB2' ' A' ' 129' ' ' GLU . 23.5 t -131.76 140.28 48.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 C-N-CA 120.769 -0.372 . . . . 0.0 111.657 -179.314 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.63 ' CG2' HD11 ' A' ' 147' ' ' ILE . 0.0 OUTLIER -115.4 139.85 39.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.809 179.64 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 39.2 t80 -117.51 105.06 11.69 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.904 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.895 HG12 HD12 ' A' ' 124' ' ' LEU . 3.5 mp -98.96 130.57 47.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.298 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . 0.413 ' ND2' ' O ' ' A' ' 32' ' ' ILE . 11.1 p30 -89.06 133.43 34.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.81 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -67.71 -20.06 65.23 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.264 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.46 -42.93 83.48 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.895 0.379 . . . . 0.0 110.591 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . 0.544 ' HE2' ' HB3' ' A' ' 50' ' ' ALA . 31.2 t80 -59.05 -43.23 91.68 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.754 179.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -60.59 -34.35 74.07 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.859 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 56.5 tt0 -62.91 -41.64 99.52 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.941 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 12.6 t -60.47 -45.54 93.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.909 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.92 -42.13 94.97 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.92 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -60.35 -41.0 92.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.839 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -67.91 -28.89 67.89 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.937 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -124.03 46.62 2.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.869 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 4.4 ttpt -70.12 131.73 44.73 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.971 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 25.8 t -66.29 121.9 16.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.079 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 33.8 m-20 -107.31 -30.47 8.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.843 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 1.3 ppt_? -164.33 150.64 10.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.894 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.505 ' H ' HD12 ' A' ' 163' ' ' ILE . 3.1 mp -100.77 131.98 47.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.088 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 1.8 mmt85 . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.173 -0.918 . . . . 0.0 111.048 -179.987 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.322 0 N-CA-C 112.463 -0.255 . . . . 0.0 112.463 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 60.04 62.95 1.53 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.066 0.46 . . . . 0.0 110.853 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 43.0 t-20 58.36 99.19 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.026 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 5.6 pt -120.86 51.15 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.053 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 64.75 131.84 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.222 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -112.32 78.07 2.42 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.809 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 147.8 63.62 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.657 2.238 . . . . 0.0 112.269 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -59.89 -40.06 87.47 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.058 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -178.05 93.12 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.88 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 -61.62 84.67 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.768 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 18.9 p -149.58 130.54 14.32 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.898 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.68 88.63 3.95 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.992 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -170.98 -64.42 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.816 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.74 112.6 3.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.228 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.442 HG23 ' N ' ' A' ' 16' ' ' GLN . 2.0 t -148.4 -51.21 0.17 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.103 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.442 ' N ' HG23 ' A' ' 15' ' ' THR . 28.0 pt20 -73.07 -35.41 66.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.92 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 5.5 ttm-85 -65.93 -36.8 84.36 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.974 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 64.5 t80 -57.45 -47.0 82.98 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.083 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 8.4 tt -59.59 -43.49 93.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.876 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 42.4 mm -71.26 -46.46 65.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.099 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -57.6 -44.72 85.64 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.077 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -59.24 -34.04 71.74 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.847 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -59.73 -47.63 84.89 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.211 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 19.5 p -66.96 -30.73 70.93 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.901 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 3.0 tt0 -77.51 116.58 18.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.874 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 13.9 pm0 -96.86 127.36 42.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.991 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.6 mm100 -76.49 120.98 22.46 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.706 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 21.3 mm -83.46 139.52 17.58 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.368 0 CA-C-O 121.502 0.668 . . . . 0.0 111.695 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -90.23 62.11 3.22 Favored Glycine 0 C--N 1.317 -0.474 0 CA-C-N 114.851 -1.068 . . . . 0.0 112.49 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -87.09 -23.13 25.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.787 0.327 . . . . 0.0 110.96 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.572 ' HA ' HD11 ' A' ' 52' ' ' ILE . 11.2 m-20 -108.23 -13.11 14.97 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-O 121.933 0.873 . . . . 0.0 108.979 178.626 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.835 HD13 ' O ' ' A' ' 48' ' ' LEU . 0.1 OUTLIER -70.78 103.46 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.518 0 CA-C-N 113.94 -1.482 . . . . 0.0 111.268 -179.274 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 1.076 HG23 ' HB2' ' A' ' 50' ' ' ALA . 0.4 OUTLIER -33.37 -62.8 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 CA-C-N 115.25 -0.886 . . . . 0.0 112.065 -179.297 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.631 ' N ' ' CG1' ' A' ' 33' ' ' VAL . 67.2 m -162.42 165.26 26.57 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.401 -179.299 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.39 114.96 18.23 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.669 179.125 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 1.035 HG12 HD21 ' A' ' 143' ' ' LEU . 1.8 t -89.16 129.08 40.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.427 179.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.928 HG23 HG12 ' A' ' 45' ' ' ILE . 26.0 mt -122.6 108.45 21.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -178.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.537 ' SG ' HD23 ' A' ' 143' ' ' LEU . 0.0 OUTLIER -102.5 107.86 18.97 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 177.783 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.6 t -113.92 -24.49 9.05 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 -178.143 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.592 HG21 ' HB3' ' A' ' 142' ' ' SER . 17.1 p -56.01 -26.16 47.5 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.765 0.316 . . . . 0.0 111.348 -179.489 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 124.53 66.84 0.19 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.642 -0.789 . . . . 0.0 112.674 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.648 ' CB ' HD12 ' A' ' 43' ' ' ILE . 21.9 mt-30 -141.13 -71.92 0.35 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.765 0.317 . . . . 0.0 110.666 179.752 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.648 HD12 ' CB ' ' A' ' 42' ' ' GLN . 3.9 mp -135.33 136.65 24.76 Favored Pre-proline 0 N--CA 1.452 -0.37 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.084 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.48 ' HD2' ' CZ ' ' A' ' 76' ' ' TYR . 31.3 Cg_exo -58.8 147.29 89.3 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.576 2.184 . . . . 0.0 111.739 179.508 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.928 HG12 HG23 ' A' ' 37' ' ' ILE . 48.8 mt -38.04 140.19 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 CA-C-O 121.004 0.43 . . . . 0.0 111.83 -179.503 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.435 ' HG2' ' O ' ' A' ' 75' ' ' ASP . 0.0 OUTLIER -137.26 130.42 30.86 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.318 179.864 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.548 ' C ' HD23 ' A' ' 48' ' ' LEU . 0.7 OUTLIER -94.7 120.27 34.66 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.028 0.442 . . . . 0.0 111.538 -179.339 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.835 ' O ' HD13 ' A' ' 32' ' ' ILE . 1.2 mt -100.35 129.84 46.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.821 179.295 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.479 ' HB3' HG12 ' A' ' 32' ' ' ILE . 0.1 OUTLIER -120.91 162.92 19.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 122.091 0.948 . . . . 0.0 113.364 -179.118 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 1.076 ' HB2' HG23 ' A' ' 33' ' ' VAL . . . -127.34 166.59 17.55 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.456 -1.247 . . . . 0.0 111.064 179.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.763 ' O ' HG23 ' A' ' 55' ' ' VAL . 0.3 OUTLIER -104.8 92.37 4.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.365 179.607 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.572 HD11 ' HA ' ' A' ' 31' ' ' ASN . 45.6 mt -64.07 -44.96 97.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.929 -179.363 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 11.4 m -58.44 -38.7 78.04 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.189 0.519 . . . . 0.0 110.76 -179.357 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.458 ' HG2' ' HB3' ' A' ' 51' ' ' ASP . 18.0 mm-40 -68.81 -37.31 79.15 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.485 -0.779 . . . . 0.0 111.032 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.763 HG23 ' O ' ' A' ' 51' ' ' ASP . 36.0 t -73.68 -37.7 49.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.12 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.7 tp -57.15 -39.11 74.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.729 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 8.0 mttm -95.61 -29.35 14.38 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.66 179.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 59.26 46.64 12.56 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.961 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.2 mtpt -112.26 -36.78 5.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.697 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -129.51 174.54 9.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.663 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.62 ' O ' HG22 ' A' ' 62' ' ' ILE . 3.5 m 61.38 -151.59 0.38 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.546 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.62 HG22 ' O ' ' A' ' 61' ' ' SER . 0.4 OUTLIER 87.92 14.89 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 C-N-CA 122.552 0.341 . . . . 0.0 111.359 -179.89 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 4.3 tptm -148.15 67.38 1.09 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.888 0.375 . . . . 0.0 110.77 179.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 16.6 ttpt -117.06 133.49 55.94 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.687 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.611 HG13 ' O ' ' A' ' 91' ' ' ILE . 23.9 t -136.9 139.25 44.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.181 0.515 . . . . 0.0 111.856 -179.497 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . 0.739 ' CD1' HD22 ' A' ' 48' ' ' LEU . 13.1 m-90 -100.36 137.73 38.38 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.472 179.03 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.615 HG23 ' CG ' ' A' ' 90' ' ' GLN . 17.6 m -132.38 129.09 38.92 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.586 0.707 . . . . 0.0 112.712 179.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.499 ' HE1' HD12 ' A' ' 91' ' ' ILE . 18.4 m-85 -101.32 118.87 37.85 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.02 -0.991 . . . . 0.0 108.76 177.399 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.594 ' HA2' ' O ' ' A' ' 85' ' ' SER . . . 157.99 -156.53 27.44 Favored Glycine 0 CA--C 1.503 -0.698 0 C-N-CA 118.723 -1.703 . . . . 0.0 113.261 179.491 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 2.1 mtp180 -74.97 91.84 2.53 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-O 122.496 1.141 . . . . 0.0 108.561 -179.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.52 ' O ' ' CD2' ' A' ' 77' ' ' HIS . 17.5 m120 -149.76 159.31 36.25 Favored Pre-proline 0 C--N 1.308 -1.226 0 CA-C-N 112.764 -2.016 . . . . 0.0 108.036 179.148 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.549 ' O ' ' HB2' ' A' ' 77' ' ' HIS . 28.9 Cg_endo -64.33 -7.03 12.92 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 120.79 0.994 . . . . 0.0 110.845 178.006 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.71 ' HB2' ' HB2' ' A' ' 77' ' ' HIS . . . 136.43 52.38 0.0 OUTLIER 'General case' 0 CA--C 1.49 -1.36 0 CA-C-N 114.542 -1.208 . . . . 0.0 109.281 178.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.559 ' HB3' ' HB ' ' A' ' 67' ' ' THR . 0.1 OUTLIER -52.85 -69.48 0.11 Allowed 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 105.823 -1.918 . . . . 0.0 105.823 179.57 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.515 ' N ' ' O ' ' A' ' 67' ' ' THR . 6.1 t70 -95.06 -48.27 6.03 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 105.544 -2.021 . . . . 0.0 105.544 169.649 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.48 ' CZ ' ' HD2' ' A' ' 44' ' ' PRO . 29.0 t80 -144.74 142.61 30.16 Favored 'General case' 0 C--N 1.345 0.402 0 CA-C-N 112.527 -2.124 . . . . 0.0 111.779 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.71 ' HB2' ' HB2' ' A' ' 73' ' ' ALA . 23.4 t-160 -97.82 106.96 19.34 Favored 'General case' 0 C--N 1.33 -0.244 0 O-C-N 122.091 -0.381 . . . . 0.0 110.043 176.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.445 HD21 ' HA2' ' A' ' 69' ' ' GLY . 0.7 OUTLIER -121.57 -176.48 3.32 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.899 0.38 . . . . 0.0 111.569 -179.841 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -62.21 -174.41 1.98 Allowed Glycine 0 C--N 1.332 0.344 0 C-N-CA 120.953 -0.642 . . . . 0.0 112.445 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -111.89 98.38 7.34 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.926 0.393 . . . . 0.0 111.772 -179.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.625 ' HB ' ' HB2' ' A' ' 85' ' ' SER . 1.4 mp -114.85 115.18 48.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.252 178.737 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -56.43 -24.26 43.99 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 -179.077 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -90.07 -105.34 0.09 Allowed 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -178.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.444 ' HB3' ' CE1' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -109.11 111.96 23.87 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-O 121.466 0.65 . . . . 0.0 110.132 -179.522 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.625 ' HB2' ' HB ' ' A' ' 81' ' ' ILE . 0.6 OUTLIER 160.17 -48.02 0.0 OUTLIER 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 114.396 -1.275 . . . . 0.0 109.209 -179.753 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.846 ' O ' ' N ' ' A' ' 88' ' ' HIS . 91.6 m-20 -64.92 -151.19 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.247 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 177.546 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.904 ' HB2' HD11 ' A' ' 104' ' ' ILE . 2.1 pttp -46.82 74.42 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.352 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.975 ' O ' ' O ' ' A' ' 104' ' ' ILE . 32.7 t60 -95.45 -18.76 20.42 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 114.047 1.129 . . . . 0.0 114.047 -176.763 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.638 ' HA ' ' H ' ' A' ' 104' ' ' ILE . 0.1 OUTLIER -174.57 154.79 2.1 Favored 'General case' 0 C--N 1.312 -1.046 0 C-N-CA 118.912 -1.115 . . . . 0.0 113.089 178.125 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.615 ' CG ' HG23 ' A' ' 67' ' ' THR . 31.7 mt-30 -137.05 158.4 44.55 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.397 -1.274 . . . . 0.0 113.858 -177.726 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.669 ' HB ' ' HB2' ' A' ' 66' ' ' TRP . 13.4 mt -129.92 127.67 64.08 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.204 178.708 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.891 HD13 ' OD1' ' A' ' 121' ' ' ASN . 0.3 OUTLIER -102.99 142.05 34.74 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.103 0.478 . . . . 0.0 111.874 -179.56 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.851 HD22 ' N ' ' A' ' 94' ' ' GLY . 0.4 OUTLIER -125.74 130.36 51.33 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.481 179.32 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.851 ' N ' HD22 ' A' ' 93' ' ' LEU . . . 88.34 -114.76 4.28 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.621 179.639 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 69.82 -64.94 0.33 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.784 0.326 . . . . 0.0 110.851 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -130.38 32.54 4.43 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.889 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 78.42 31.27 46.75 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.477 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.499 ' C ' HD23 ' A' ' 99' ' ' LEU . 25.0 p-10 -155.36 -178.76 7.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.867 0.365 . . . . 0.0 111.037 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 1.006 HD12 HD22 ' A' ' 124' ' ' LEU . 0.1 OUTLIER -106.87 138.06 43.75 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.742 179.897 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.571 HD23 ' O ' ' A' ' 122' ' ' GLN . 14.8 mt -133.61 148.38 51.56 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.523 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.43 ' O ' ' N ' ' A' ' 122' ' ' GLN . 5.5 mp -112.68 132.18 55.3 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 179.292 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.723 ' HB2' HD12 ' A' ' 92' ' ' LEU . 20.4 t30 -113.33 111.8 22.61 Favored 'General case' 0 CA--C 1.509 -0.607 0 C-N-CA 119.868 -0.733 . . . . 0.0 110.046 -179.773 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.703 ' HB3' HG21 ' A' ' 109' ' ' THR . 72.8 m-20 -84.81 112.26 20.36 Favored 'General case' 0 N--CA 1.442 -0.87 0 C-N-CA 119.835 -0.746 . . . . 0.0 109.452 179.476 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.975 ' O ' ' O ' ' A' ' 88' ' ' HIS . 0.1 OUTLIER -123.16 107.56 19.42 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.018 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 177.875 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.415 ' OG ' ' NE2' ' A' ' 88' ' ' HIS . 75.8 m -130.81 170.74 13.98 Favored 'General case' 0 C--N 1.294 -1.833 0 CA-C-N 114.95 -1.023 . . . . 0.0 109.372 179.646 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 25.1 m -69.39 -63.02 1.15 Allowed 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 118.965 -1.094 . . . . 0.0 111.234 -179.334 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -112.27 -33.21 6.28 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 114.551 1.315 . . . . 0.0 114.551 178.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -146.63 130.26 3.59 Favored Glycine 0 C--N 1.34 0.775 0 N-CA-C 116.976 1.55 . . . . 0.0 116.976 -177.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.703 HG21 ' HB3' ' A' ' 103' ' ' ASP . 6.3 m -121.06 138.23 54.28 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 174.262 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 0.688 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.4 m-90 -119.6 149.28 42.21 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 113.407 0.892 . . . . 0.0 113.407 -178.461 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.475 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -120.96 112.03 18.25 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 115.162 -0.926 . . . . 0.0 108.638 177.495 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 66.9 m-20 44.7 43.17 6.49 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.126 -0.488 . . . . 0.0 112.085 -179.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 79.74 26.81 55.56 Favored Glycine 0 N--CA 1.444 -0.813 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.743 179.349 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . 0.45 ' O ' HG13 ' A' ' 116' ' ' VAL . 38.6 tt0 -138.11 98.18 3.57 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.073 0.464 . . . . 0.0 110.929 179.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.688 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.0 OUTLIER -45.29 128.76 7.91 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.97 179.725 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.45 HG13 ' O ' ' A' ' 114' ' ' GLN . 28.3 m -121.12 -179.31 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.845 -179.329 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -85.65 141.83 29.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.921 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.431 ' HG3' ' HA ' ' A' ' 104' ' ' ILE . 86.7 tttt -66.38 163.14 18.86 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.226 179.471 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.411 ' C ' ' O ' ' A' ' 118' ' ' LYS . 8.1 m-80 34.24 39.05 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 121.203 0.525 . . . . 0.0 111.13 -179.4 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.409 ' OG ' ' NE2' ' A' ' 122' ' ' GLN . 14.8 p -111.13 115.25 29.09 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.991 -179.443 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.891 ' OD1' HD13 ' A' ' 92' ' ' LEU . 11.9 m-80 -59.63 138.52 57.71 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.534 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . 0.571 ' O ' HD23 ' A' ' 100' ' ' LEU . 31.5 mm-40 -129.07 144.91 51.35 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.163 0.506 . . . . 0.0 111.829 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.4 tp -72.39 127.03 31.31 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.976 179.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 1.006 HD22 HD12 ' A' ' 99' ' ' LEU . 4.7 tp -55.7 143.33 30.94 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.899 0.856 . . . . 0.0 111.763 -179.145 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.746 ' O ' HD11 ' A' ' 147' ' ' ILE . 0.6 OUTLIER -126.87 151.98 47.66 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 114.049 -1.432 . . . . 0.0 109.92 179.133 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . 0.473 ' HA ' HD12 ' A' ' 147' ' ' ILE . 0.0 OUTLIER -71.44 114.13 9.19 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.962 0.411 . . . . 0.0 109.988 179.752 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 69.66 25.83 75.1 Favored Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.333 -179.374 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -54.97 159.62 2.3 Favored 'General case' 0 C--N 1.334 -0.103 0 CA-C-O 121.001 0.429 . . . . 0.0 111.068 -179.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.471 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 1.1 tt0 -146.56 135.26 22.21 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.559 -179.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.698 HD13 ' OD1' ' A' ' 103' ' ' ASP . 3.5 mt -111.37 127.94 68.19 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.184 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 178.53 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.465 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 29.4 m -103.39 144.31 31.55 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.505 -179.531 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.488 ' O ' HD12 ' A' ' 141' ' ' LEU . 5.4 m -140.91 156.31 22.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -179.042 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 72.42 40.05 55.52 Favored Glycine 0 N--CA 1.446 -0.682 0 CA-C-N 115.891 -0.595 . . . . 0.0 112.366 179.599 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.462 HG12 ' N ' ' A' ' 135' ' ' GLY . 95.1 t -75.7 156.64 5.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 121.38 0.61 . . . . 0.0 112.06 -179.256 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.462 ' N ' HG12 ' A' ' 134' ' ' VAL . . . 153.74 -47.35 0.54 Allowed Glycine 0 N--CA 1.441 -0.971 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.8 -179.281 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.646 HG12 ' H ' ' A' ' 138' ' ' SER . 49.3 t -126.66 134.49 66.17 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 CA-C-N 115.216 -0.492 . . . . 0.0 109.908 178.714 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.418 ' HA ' HD12 ' A' ' 140' ' ' ILE . 14.2 pt-20 -51.29 -31.66 22.14 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.835 0.35 . . . . 0.0 111.263 -179.419 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . 0.646 ' H ' HG12 ' A' ' 136' ' ' VAL . 0.6 OUTLIER -94.05 6.34 48.84 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.119 -0.491 . . . . 0.0 112.118 -179.538 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -129.79 29.62 4.98 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 112.543 0.571 . . . . 0.0 112.543 -179.343 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.465 ' CG2' ' CG2' ' A' ' 131' ' ' THR . 28.3 mt -104.99 141.24 20.8 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.073 179.22 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.488 HD12 ' O ' ' A' ' 132' ' ' VAL . 1.6 mp -118.63 134.94 54.74 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.492 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.592 ' HB3' HG21 ' A' ' 40' ' ' THR . 42.4 t -115.04 152.23 32.85 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.761 0.791 . . . . 0.0 112.686 -179.089 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 1.035 HD21 HG12 ' A' ' 36' ' ' VAL . 1.3 tm? -135.85 129.44 32.38 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 114.488 -1.233 . . . . 0.0 108.96 179.169 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.765 ' N ' HD22 ' A' ' 143' ' ' LEU . 21.4 t -119.78 140.21 44.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.934 0.397 . . . . 0.0 111.83 -178.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -110.56 139.67 33.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.851 179.558 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -115.23 118.71 34.08 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.586 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.762 HG12 HD21 ' A' ' 124' ' ' LEU . 1.7 mt -98.26 133.56 40.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.986 0.422 . . . . 0.0 111.775 -179.602 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 18.5 p-10 -77.94 124.39 27.95 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.738 179.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -66.16 -24.87 66.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.313 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 3.2 mptt -59.22 -44.33 92.31 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.991 0.424 . . . . 0.0 110.844 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 20.3 t80 -62.75 -44.35 96.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.093 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 46.1 tttp -58.94 -47.57 84.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.847 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -61.61 -36.94 82.16 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.888 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 11.6 t -62.34 -45.59 92.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.959 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.99 -46.73 67.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.037 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 72.4 mm-40 -58.88 -48.49 81.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.23 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -78.75 -37.07 42.12 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.13 -179.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 3.9 p30 42.47 45.26 3.79 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.511 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.65 148.12 42.26 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.869 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 38.5 t -99.09 137.19 27.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.132 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 68.5 m-20 -116.47 141.57 48.0 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.791 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 23.2 tpp180 -105.03 106.82 17.49 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.944 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.455 HG23 ' O ' ' A' ' 163' ' ' ILE . 14.2 tt -92.95 123.09 44.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.998 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 2.1 ttt-85 . . . . . 0 C--O 1.25 1.086 0 CA-C-O 118.276 -0.868 . . . . 0.0 110.927 179.922 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.307 0 N-CA-C 112.542 -0.223 . . . . 0.0 112.542 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -124.05 31.74 5.74 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.826 0.346 . . . . 0.0 110.899 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -109.8 94.68 5.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.888 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.446 HG22 ' H ' ' A' ' 5' ' ' THR . 4.7 mt -140.38 164.44 22.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.003 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.446 ' H ' HG22 ' A' ' 4' ' ' ILE . 0.2 OUTLIER 72.4 54.5 0.16 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.176 179.948 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 57.59 79.08 0.34 Allowed Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.994 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -66.88 101.22 0.56 Allowed 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.577 2.185 . . . . 0.0 112.301 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.6 t -149.81 36.74 0.71 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.119 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -166.04 109.62 0.79 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.887 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -132.53 -70.16 0.56 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.883 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 63.0 p -127.71 179.53 5.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.872 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -131.23 -53.48 1.03 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.054 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 25.1 mm-40 -122.75 165.77 16.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.933 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -75.4 162.85 28.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.059 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 40.5 p -112.47 20.55 16.55 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.427 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -64.23 -47.6 79.07 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.932 0.396 . . . . 0.0 110.474 179.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 2.0 ptt85 -72.02 -36.35 69.66 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.406 179.363 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 4.1 m-30 -56.86 -39.28 74.0 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.619 179.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 14.9 tp -61.9 -32.28 72.65 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.453 179.566 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 7.9 mt -69.15 -42.33 81.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.725 179.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -57.69 -35.48 70.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.996 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.58 -36.92 84.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.878 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -58.94 -47.5 84.84 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.065 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 5.9 m -62.99 -35.92 81.83 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.861 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -157.62 89.93 1.06 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.904 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 63.7 tt0 -87.48 137.82 32.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.966 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -88.36 101.96 14.4 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.892 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 19.5 mm -93.12 139.32 18.31 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.308 0 CA-C-O 121.475 0.655 . . . . 0.0 112.048 -179.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.405 ' HA2' ' HB ' ' A' ' 32' ' ' ILE . . . 46.51 64.99 2.33 Favored Glycine 0 C--N 1.319 -0.398 0 CA-C-N 114.775 -1.102 . . . . 0.0 113.114 179.741 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -89.02 -32.03 17.79 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.737 0.303 . . . . 0.0 111.275 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -109.43 -13.81 14.52 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-O 121.856 0.836 . . . . 0.0 109.043 178.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.609 ' CG2' ' O ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -70.97 95.46 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.534 0 CA-C-N 114.032 -1.44 . . . . 0.0 111.166 -179.08 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.62 ' CG2' ' HB2' ' A' ' 50' ' ' ALA . 0.4 OUTLIER -32.58 -62.13 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 CA-C-N 115.081 -0.963 . . . . 0.0 111.647 -179.946 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.604 ' N ' ' CG1' ' A' ' 33' ' ' VAL . 23.2 p -165.85 163.44 18.69 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.962 179.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 6.7 ttm180 -122.58 125.99 46.81 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.096 179.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.676 HG21 ' CZ ' ' A' ' 68' ' ' PHE . 12.3 m -93.67 137.0 23.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.993 -0.548 . . . . 0.0 111.169 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.857 HG23 HG12 ' A' ' 45' ' ' ILE . 19.0 mt -130.74 106.88 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 CA-C-O 120.954 0.406 . . . . 0.0 111.787 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.535 ' SG ' HD23 ' A' ' 143' ' ' LEU . 0.1 OUTLIER -99.78 99.73 10.58 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 177.949 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 9.5 t -108.62 26.7 10.22 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -178.322 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.885 HG21 ' HB2' ' A' ' 142' ' ' SER . 77.4 p -111.39 -6.35 14.49 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 111.679 0.252 . . . . 0.0 111.679 179.764 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 101.59 61.64 0.76 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.425 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.575 ' HB3' HD12 ' A' ' 43' ' ' ILE . 3.8 mt-30 -141.66 -69.5 0.37 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.708 0.29 . . . . 0.0 110.904 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.765 HG23 HD21 ' A' ' 78' ' ' LEU . 3.5 mp -135.06 129.92 19.19 Favored Pre-proline 0 N--CA 1.452 -0.36 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.091 179.764 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.435 ' HD2' ' CZ ' ' A' ' 76' ' ' TYR . 35.5 Cg_exo -59.36 147.0 93.12 Favored 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 122.702 2.268 . . . . 0.0 111.848 179.743 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.857 HG12 HG23 ' A' ' 37' ' ' ILE . 40.8 mt -44.73 127.5 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.076 -0.511 . . . . 0.0 112.044 -179.416 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.597 ' O ' HG22 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -130.36 130.25 44.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.92 179.124 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -86.86 119.54 27.19 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.079 0.466 . . . . 0.0 111.629 -179.19 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.987 HD22 ' CD1' ' A' ' 66' ' ' TRP . 9.1 mt -99.5 138.89 35.96 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.054 178.621 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.609 ' OG ' ' N ' ' A' ' 50' ' ' ALA . 45.5 t -131.49 -171.55 2.63 Favored 'General case' 0 CA--C 1.511 -0.536 0 CA-C-O 123.09 1.424 . . . . 0.0 113.971 -179.173 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.62 ' HB2' ' CG2' ' A' ' 33' ' ' VAL . . . -157.16 165.27 36.47 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 112.537 -2.119 . . . . 0.0 110.941 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.526 ' O ' HG23 ' A' ' 55' ' ' VAL . 3.3 m-20 -106.59 121.76 44.95 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.043 0.449 . . . . 0.0 110.785 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 7.5 mt -64.63 -34.65 71.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.889 -179.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.1 m -60.24 -43.74 95.84 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.606 -178.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.438 ' HG2' ' CB ' ' A' ' 51' ' ' ASP . 9.9 pt20 -68.58 -37.56 79.95 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.702 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.613 HG11 HD21 ' A' ' 155' ' ' LEU . 23.9 t -74.09 -37.87 47.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.06 179.734 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.3 tt -56.74 -36.26 69.55 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.749 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -99.88 -29.82 12.37 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.693 179.606 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 56.6 57.49 4.78 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.878 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.95 -47.32 0.16 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.771 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.73 120.21 24.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.847 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.48 ' O ' HG22 ' A' ' 62' ' ' ILE . 0.4 OUTLIER 62.5 -83.66 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.927 179.963 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.48 HG22 ' O ' ' A' ' 61' ' ' SER . 6.8 tp 43.54 34.61 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.173 0 CA-C-O 121.07 0.462 . . . . 0.0 111.322 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.65 79.12 1.15 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.938 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.403 ' O ' ' HB3' ' A' ' 93' ' ' LEU . 18.9 ttpt -117.43 131.11 56.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.472 179.609 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.593 HG13 ' O ' ' A' ' 91' ' ' ILE . 9.0 t -130.49 136.94 57.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.99 0.424 . . . . 0.0 111.654 -179.191 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . 0.987 ' CD1' HD22 ' A' ' 48' ' ' LEU . 16.0 m-90 -99.8 138.89 36.25 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.536 179.218 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.837 HG23 ' HG3' ' A' ' 90' ' ' GLN . 2.2 m -131.86 128.33 38.42 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.676 ' CZ ' HG21 ' A' ' 36' ' ' VAL . 81.4 m-85 -96.74 118.09 32.44 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 177.374 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.547 ' HA3' ' C ' ' A' ' 86' ' ' ASN . . . 157.73 -154.87 25.92 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 118.56 -1.781 . . . . 0.0 113.263 179.547 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.515 ' HG2' ' HA ' ' A' ' 80' ' ' ASN . 61.9 mtp180 -75.87 91.09 2.97 Favored 'General case' 0 N--CA 1.44 -0.931 0 CA-C-O 122.481 1.134 . . . . 0.0 108.196 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.465 ' O ' ' CD2' ' A' ' 77' ' ' HIS . 29.2 m-80 -150.12 160.1 34.06 Favored Pre-proline 0 C--N 1.31 -1.143 0 CA-C-N 112.897 -1.956 . . . . 0.0 108.658 179.503 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.528 ' O ' ' CB ' ' A' ' 73' ' ' ALA . 35.6 Cg_endo -65.22 -9.66 22.81 Favored 'Trans proline' 0 N--CA 1.452 -0.931 0 C-N-CA 120.73 0.954 . . . . 0.0 110.564 177.257 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.792 ' HB2' ' HB2' ' A' ' 77' ' ' HIS . . . 138.92 52.47 0.0 OUTLIER 'General case' 0 CA--C 1.492 -1.288 0 CA-C-N 114.537 -1.211 . . . . 0.0 109.405 178.785 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.563 ' HB3' ' HB ' ' A' ' 67' ' ' THR . 0.1 OUTLIER -53.07 -69.87 0.1 Allowed 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 106.135 -1.802 . . . . 0.0 106.135 179.539 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.583 ' HB2' ' N ' ' A' ' 67' ' ' THR . 5.5 t70 -94.14 -47.49 6.63 Favored 'General case' 0 N--CA 1.436 -1.144 0 N-CA-C 105.577 -2.008 . . . . 0.0 105.577 169.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.543 ' C ' ' HA ' ' A' ' 73' ' ' ALA . 14.4 t80 -144.0 142.78 30.89 Favored 'General case' 0 C--N 1.343 0.315 0 CA-C-N 112.37 -2.195 . . . . 0.0 110.91 179.664 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.792 ' HB2' ' HB2' ' A' ' 73' ' ' ALA . 18.7 t-160 -84.83 107.12 16.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 118.41 0.55 . . . . 0.0 110.014 177.589 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.765 HD21 HG23 ' A' ' 43' ' ' ILE . 29.9 mt -111.96 156.63 21.81 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.849 0.357 . . . . 0.0 111.114 -179.662 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -60.26 -160.25 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.586 -0.816 . . . . 0.0 111.792 179.436 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.515 ' HA ' ' HG2' ' A' ' 70' ' ' ARG . 9.4 p30 -109.42 98.9 8.21 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 117.001 0.4 . . . . 0.0 111.112 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.499 ' HB ' ' HB2' ' A' ' 85' ' ' SER . 37.9 mm -113.72 154.61 15.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.567 179.387 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.417 ' N ' HG22 ' A' ' 81' ' ' ILE . 0.8 OUTLIER -67.48 -44.83 77.57 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 -178.922 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 1.6 mpp_? -122.81 -92.09 0.54 Allowed 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 113.658 0.985 . . . . 0.0 113.658 -177.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.487 ' O ' ' CB ' ' A' ' 85' ' ' SER . 0.0 OUTLIER -79.05 101.85 8.07 Favored 'General case' 0 CA--C 1.506 -0.724 0 CA-C-O 121.973 0.892 . . . . 0.0 110.961 -178.546 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.521 ' O ' ' HA2' ' A' ' 69' ' ' GLY . 0.4 OUTLIER 150.03 -28.59 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 113.155 -1.839 . . . . 0.0 108.834 -179.793 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.826 ' O ' ' N ' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -85.47 -164.66 1.04 Allowed 'General case' 0 CA--C 1.51 -0.589 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 177.465 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.923 ' HB2' HD11 ' A' ' 104' ' ' ILE . 2.5 ptmt -47.74 73.85 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 178.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.99 ' O ' ' O ' ' A' ' 104' ' ' ILE . 25.1 t60 -91.66 -17.35 25.63 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 114.243 1.201 . . . . 0.0 114.243 -176.779 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.624 ' HA ' ' H ' ' A' ' 104' ' ' ILE . 0.2 OUTLIER -173.56 155.3 2.73 Favored 'General case' 0 C--N 1.314 -0.938 0 C-N-CA 118.946 -1.102 . . . . 0.0 112.775 177.845 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.837 ' HG3' HG23 ' A' ' 67' ' ' THR . 0.5 OUTLIER -135.18 154.43 51.62 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.579 -1.191 . . . . 0.0 113.868 -177.67 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.666 ' HB ' ' HB2' ' A' ' 66' ' ' TRP . 49.3 mt -124.91 132.14 71.7 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.734 178.435 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.667 HD13 ' ND2' ' A' ' 121' ' ' ASN . 0.3 OUTLIER -108.6 140.57 41.78 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.139 0.495 . . . . 0.0 112.249 -179.168 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.87 HD22 ' N ' ' A' ' 94' ' ' GLY . 0.6 OUTLIER -125.54 135.07 51.87 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.173 179.129 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.87 ' N ' HD22 ' A' ' 93' ' ' LEU . . . 97.17 108.99 2.63 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.605 -0.807 . . . . 0.0 112.693 179.691 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 178.51 68.73 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.959 0.409 . . . . 0.0 110.574 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 60.73 31.03 20.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.659 -179.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 101.58 162.95 27.14 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.31 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 65.12 -173.35 0.18 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.841 0.353 . . . . 0.0 110.972 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.769 ' HB2' HD13 ' A' ' 124' ' ' LEU . 8.1 mp -123.99 160.77 26.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.878 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.654 HD23 ' HB3' ' A' ' 121' ' ' ASN . 7.9 mp -123.72 148.29 46.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.171 179.735 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.457 ' O ' ' N ' ' A' ' 122' ' ' GLN . 12.3 mt -118.1 130.5 56.17 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.813 -0.355 . . . . 0.0 110.263 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.517 ' HB2' HD11 ' A' ' 92' ' ' LEU . 24.8 t30 -113.32 111.58 22.25 Favored 'General case' 0 CA--C 1.512 -0.516 0 C-N-CA 120.017 -0.673 . . . . 0.0 109.686 179.611 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.687 ' HB3' HG21 ' A' ' 109' ' ' THR . 72.3 m-20 -84.96 111.93 20.13 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 119.826 -0.749 . . . . 0.0 110.13 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.99 ' O ' ' O ' ' A' ' 88' ' ' HIS . 0.1 OUTLIER -124.47 108.18 19.89 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.91 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 177.393 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 67.1 m -129.77 174.16 9.98 Favored 'General case' 0 C--N 1.296 -1.737 0 CA-C-N 115.285 -0.871 . . . . 0.0 109.312 179.353 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 23.3 m -69.25 -63.85 0.99 Allowed 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 118.998 -1.081 . . . . 0.0 111.435 -179.271 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 5.5 p30 -112.48 -32.91 6.33 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 114.181 1.178 . . . . 0.0 114.181 178.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -145.98 131.47 4.13 Favored Glycine 0 C--N 1.339 0.695 0 N-CA-C 116.558 1.383 . . . . 0.0 116.558 -178.133 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.687 HG21 ' HB3' ' A' ' 103' ' ' ASP . 5.8 m -121.19 138.29 54.28 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 174.697 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 0.769 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.4 m-90 -119.78 149.18 42.47 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 113.503 0.927 . . . . 0.0 113.503 -178.542 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.474 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -122.84 112.25 17.64 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 114.997 -1.001 . . . . 0.0 108.644 177.603 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 46.25 43.73 11.63 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.091 -0.504 . . . . 0.0 112.18 -179.546 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 79.49 17.41 75.91 Favored Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.913 179.257 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -130.39 97.85 4.53 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.053 0.454 . . . . 0.0 110.713 179.634 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.769 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.0 OUTLIER -44.75 134.3 5.62 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.059 179.886 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.552 HG22 ' N ' ' A' ' 117' ' ' GLU . 14.7 p -127.57 164.2 29.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.45 -179.163 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.552 ' N ' HG22 ' A' ' 116' ' ' VAL . 19.1 tt0 -70.13 141.83 52.63 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.975 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.469 ' HG3' ' HA ' ' A' ' 104' ' ' ILE . 36.3 tttm -65.23 163.69 14.76 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.217 179.552 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.4 ' N ' ' HG2' ' A' ' 118' ' ' LYS . 0.8 OUTLIER 36.16 39.13 0.08 Allowed 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 121.255 0.55 . . . . 0.0 110.747 -179.438 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 4.7 p -110.82 108.94 18.94 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.034 -179.305 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.667 ' ND2' HD13 ' A' ' 92' ' ' LEU . 1.6 m-20 -58.77 139.37 56.38 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.798 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . 0.651 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 44.0 mm-40 -129.85 147.42 51.62 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-O 120.964 0.412 . . . . 0.0 111.919 -179.651 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.1 tp -72.3 112.01 8.0 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 178.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.983 HD21 HD13 ' A' ' 147' ' ' ILE . 3.7 tt -44.0 145.91 0.68 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.726 0.774 . . . . 0.0 112.143 -178.716 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -126.4 153.15 45.38 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 114.225 -1.352 . . . . 0.0 110.33 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.56 113.78 8.95 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 179.51 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 70.33 26.5 74.1 Favored Glycine 0 N--CA 1.444 -0.787 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.338 -179.32 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -56.54 159.89 3.52 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.02 0.438 . . . . 0.0 111.198 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.623 ' HG3' HG22 ' A' ' 144' ' ' VAL . 5.1 tt0 -146.53 135.07 22.07 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.415 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.428 ' CG2' ' O ' ' A' ' 110' ' ' TRP . 7.8 mm -111.68 128.31 68.3 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.119 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 178.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.544 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 3.4 m -103.66 144.74 31.04 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.81 -179.493 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.467 HG11 ' NE2' ' A' ' 88' ' ' HIS . 4.4 m -141.28 158.39 22.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 112.462 0.542 . . . . 0.0 112.462 -178.801 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 70.26 43.99 61.23 Favored Glycine 0 N--CA 1.447 -0.586 0 CA-C-N 115.75 -0.659 . . . . 0.0 112.398 179.269 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.499 ' HA ' HG12 ' A' ' 140' ' ' ILE . 93.6 t -79.26 155.73 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 CA-C-O 121.436 0.636 . . . . 0.0 112.234 -179.13 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.436 ' N ' HG12 ' A' ' 134' ' ' VAL . . . 150.07 -43.88 0.72 Allowed Glycine 0 N--CA 1.442 -0.939 0 CA-C-N 114.908 -1.042 . . . . 0.0 110.529 -178.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.55 HG12 ' H ' ' A' ' 138' ' ' SER . 46.3 t -126.6 130.87 71.7 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.687 0 CA-C-N 115.08 -0.56 . . . . 0.0 109.753 178.583 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.442 ' HA ' HD12 ' A' ' 140' ' ' ILE . 7.5 tt0 -51.07 -33.9 27.73 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.731 0.3 . . . . 0.0 111.493 -179.198 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . 0.55 ' H ' HG12 ' A' ' 136' ' ' VAL . 83.0 p -94.14 6.25 49.17 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.243 0.461 . . . . 0.0 112.243 -179.464 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -127.54 30.15 5.39 Favored 'General case' 0 CA--C 1.52 -0.206 0 N-CA-C 112.408 0.521 . . . . 0.0 112.408 -179.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.544 ' CG2' ' CG2' ' A' ' 131' ' ' THR . 14.9 mt -106.0 141.28 21.65 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.935 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.392 179.213 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.494 HD22 ' C ' ' A' ' 140' ' ' ILE . 3.6 mm? -115.64 135.67 53.83 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.052 -0.977 . . . . 0.0 110.51 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.885 ' HB2' HG21 ' A' ' 40' ' ' THR . 4.2 m -120.01 153.67 35.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.814 0.816 . . . . 0.0 112.669 -179.273 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.824 HD22 ' N ' ' A' ' 144' ' ' VAL . 1.2 tm? -135.45 135.38 40.49 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 114.49 -1.232 . . . . 0.0 108.835 179.451 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.824 ' N ' HD22 ' A' ' 143' ' ' LEU . 21.2 t -122.67 140.46 46.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 112.217 0.451 . . . . 0.0 112.217 -178.717 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.559 HG13 HG12 ' A' ' 36' ' ' VAL . 0.6 OUTLIER -108.45 138.79 33.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.43 179.378 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 18.3 t80 -121.23 104.17 9.54 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.783 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.983 HD13 HD21 ' A' ' 124' ' ' LEU . 1.6 mp -102.39 130.67 51.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.281 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 11.3 p30 -78.33 141.16 38.64 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.929 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -73.27 -22.62 60.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.182 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 28.0 mmtt -58.26 -43.87 88.12 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-O 120.898 0.38 . . . . 0.0 110.712 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 11.4 t80 -58.99 -44.58 91.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.831 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.53 -34.34 73.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.002 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -59.68 -46.22 89.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.913 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 12.0 t -59.65 -43.67 93.82 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.866 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.613 HD21 HG11 ' A' ' 55' ' ' VAL . 0.2 OUTLIER -67.06 -37.72 84.54 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.011 -179.917 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -60.35 -48.01 83.61 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.887 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.417 ' O ' ' N ' ' A' ' 159' ' ' LYS . 0.7 OUTLIER -83.42 -28.76 28.61 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.056 -179.919 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 43.68 -90.73 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.658 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . 0.417 ' N ' ' O ' ' A' ' 157' ' ' GLN . 4.8 tptt -108.33 149.93 28.02 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.839 0.352 . . . . 0.0 110.904 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.521 ' O ' HG13 ' A' ' 160' ' ' VAL . 12.0 p -70.23 118.08 14.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.104 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -165.75 148.88 7.7 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.764 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -174.37 99.45 0.1 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.903 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 3.3 pt -79.25 134.81 27.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.113 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.096 0 CA-C-O 118.277 -0.868 . . . . 0.0 110.938 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.29 0 N-CA-C 112.438 -0.265 . . . . 0.0 112.438 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -77.93 -38.89 44.42 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.775 0.321 . . . . 0.0 110.91 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -160.7 -57.15 0.05 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.88 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 52.6 mt 62.12 85.39 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.953 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.6 t -59.53 141.16 55.44 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.123 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -142.64 154.37 62.89 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.931 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -67.91 75.12 0.65 Allowed 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.517 2.145 . . . . 0.0 112.178 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.1 t -95.18 154.34 17.23 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.175 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 17.4 mt-30 -115.78 78.91 1.23 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.838 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -80.94 170.87 15.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.846 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -153.15 78.59 1.17 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.959 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.88 153.57 41.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.115 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 21.6 pt20 -76.55 113.08 13.78 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.909 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -173.43 115.64 0.25 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.063 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -143.6 -59.1 0.41 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.141 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.6 ' HA ' HD12 ' A' ' 19' ' ' LEU . 5.2 pt20 -59.94 -31.93 70.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.895 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.09 -40.27 71.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.84 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -61.08 -35.76 77.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.874 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.6 HD12 ' HA ' ' A' ' 16' ' ' GLN . 3.8 mt -57.36 -37.31 72.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.024 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 35.7 mm -68.43 -41.39 83.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.171 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -57.67 -39.49 77.21 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.126 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -64.26 -40.43 95.98 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.075 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -68.32 -47.5 67.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.182 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 13.4 p -62.72 -36.41 82.89 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.975 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 4.7 tp60 69.19 -66.2 0.26 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.985 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -62.97 124.04 20.08 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.872 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 3.2 tt0 -85.7 115.63 23.49 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.924 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 23.0 mm -82.33 139.45 17.85 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.347 0 CA-C-O 121.459 0.647 . . . . 0.0 111.737 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -100.94 72.07 0.4 Allowed Glycine 0 C--N 1.318 -0.465 0 CA-C-N 114.904 -1.044 . . . . 0.0 112.595 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -84.92 -24.95 28.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.733 0.301 . . . . 0.0 110.995 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -108.72 -13.82 14.72 Favored 'General case' 0 CA--C 1.516 -0.347 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 178.333 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.595 ' CG2' ' O ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -70.77 96.33 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.635 0 CA-C-N 113.928 -1.487 . . . . 0.0 110.689 -179.48 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.906 HG23 ' HB3' ' A' ' 50' ' ' ALA . 0.8 OUTLIER -33.46 -62.51 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 114.996 -1.002 . . . . 0.0 112.244 -179.157 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.64 ' N ' HG12 ' A' ' 33' ' ' VAL . 22.4 m -160.7 164.85 31.36 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.092 0.472 . . . . 0.0 111.637 -179.487 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 3.1 tmm_? -132.72 114.34 14.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.445 179.469 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.923 HG23 ' CD2' ' A' ' 48' ' ' LEU . 40.0 t -90.27 136.08 24.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.612 179.767 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.932 HG23 HG12 ' A' ' 45' ' ' ILE . 21.5 mt -124.09 107.97 19.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -179.248 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.799 ' SG ' HD12 ' A' ' 143' ' ' LEU . 70.3 m -99.82 102.91 14.47 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 177.565 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.492 ' CG2' HG22 ' A' ' 37' ' ' ILE . 1.4 p -108.86 -21.54 12.61 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 113.509 0.929 . . . . 0.0 113.509 -176.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.73 HG21 ' HB2' ' A' ' 142' ' ' SER . 34.0 p -55.67 -20.67 14.92 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.745 0.307 . . . . 0.0 111.525 -179.428 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 113.53 62.87 0.43 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.285 179.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.666 ' HG3' HD12 ' A' ' 141' ' ' LEU . 3.2 mt-30 -144.18 -54.16 0.34 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.703 0.287 . . . . 0.0 111.361 -179.718 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.926 HG22 ' HD2' ' A' ' 44' ' ' PRO . 0.0 OUTLIER -134.76 154.62 79.54 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.33 -178.961 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.926 ' HD2' HG22 ' A' ' 43' ' ' ILE . 90.1 Cg_endo -83.78 146.86 11.94 Favored 'Trans proline' 0 N--CA 1.459 -0.511 0 C-N-CA 122.648 2.232 . . . . 0.0 111.569 179.402 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.932 HG12 HG23 ' A' ' 37' ' ' ILE . 40.8 mt -47.85 112.0 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 120.926 0.393 . . . . 0.0 111.728 -179.5 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 7.4 mmm180 -114.91 130.05 56.83 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.684 178.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -97.98 120.08 37.74 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.094 0.473 . . . . 0.0 111.928 -178.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.923 ' CD2' HG23 ' A' ' 36' ' ' VAL . 0.2 OUTLIER -92.59 137.21 32.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.238 178.641 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.534 ' HB3' ' HA ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -135.79 163.16 30.83 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 113.258 0.836 . . . . 0.0 113.258 -178.601 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.906 ' HB3' HG23 ' A' ' 33' ' ' VAL . . . -157.48 142.16 16.58 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.626 -1.17 . . . . 0.0 111.195 179.111 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.408 ' CB ' ' HG3' ' A' ' 54' ' ' GLN . 0.1 OUTLIER -64.31 137.19 57.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.227 -179.9 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 12.4 mt -63.87 -38.19 81.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.994 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -56.42 -34.46 66.8 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.929 -179.565 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.408 ' HG3' ' CB ' ' A' ' 51' ' ' ASP . 0.6 OUTLIER -63.64 -43.61 96.28 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.613 179.974 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.462 HG21 ' CZ ' ' A' ' 151' ' ' PHE . 20.2 t -74.07 -38.17 48.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.206 179.781 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.3 mt -57.99 -37.38 74.14 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.856 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 8.4 mttm -88.64 -51.82 5.48 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.799 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 57.55 51.11 10.04 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.952 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -175.9 39.54 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.974 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 2.2 ttt-85 -163.65 -75.54 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.048 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 4.9 m -106.83 20.9 18.36 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.178 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.563 HG23 ' O ' ' A' ' 62' ' ' ILE . 0.8 OUTLIER -86.88 60.38 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.939 0.399 . . . . 0.0 111.107 179.974 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -154.32 80.97 1.12 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.916 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.41 ' O ' ' HB3' ' A' ' 93' ' ' LEU . 12.4 ttpt -134.32 134.44 41.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.585 179.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.621 HG13 ' O ' ' A' ' 91' ' ' ILE . 11.8 t -132.88 137.36 54.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.052 0.453 . . . . 0.0 111.763 -179.125 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . 0.839 ' CD1' HD12 ' A' ' 48' ' ' LEU . 14.9 m-90 -99.6 139.7 34.87 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.431 179.081 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.843 HG23 ' CG ' ' A' ' 90' ' ' GLN . 4.8 m -129.56 131.39 46.54 Favored 'General case' 0 CA--C 1.52 -0.194 0 CA-C-O 121.416 0.626 . . . . 0.0 112.46 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.503 ' CE2' ' CE2' ' A' ' 89' ' ' PHE . 90.1 m-85 -103.03 118.35 36.62 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.12 177.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.574 ' HA2' ' O ' ' A' ' 85' ' ' SER . . . 158.2 -156.12 27.09 Favored Glycine 0 CA--C 1.504 -0.656 0 C-N-CA 118.883 -1.627 . . . . 0.0 112.432 179.468 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.465 ' CD ' ' HB3' ' A' ' 86' ' ' ASN . 7.5 ptm180 -75.74 92.09 2.98 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-O 122.549 1.166 . . . . 0.0 108.377 179.703 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.513 ' O ' ' CD2' ' A' ' 77' ' ' HIS . 17.1 m120 -149.18 159.81 36.21 Favored Pre-proline 0 C--N 1.311 -1.089 0 CA-C-N 112.783 -2.008 . . . . 0.0 108.46 179.511 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.556 ' O ' ' HB2' ' A' ' 77' ' ' HIS . 32.7 Cg_endo -64.96 -7.85 16.39 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 121.025 1.15 . . . . 0.0 111.095 178.295 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.774 ' HB2' ' HB2' ' A' ' 77' ' ' HIS . . . 136.18 50.89 0.0 OUTLIER 'General case' 0 CA--C 1.49 -1.331 0 CA-C-N 114.661 -1.154 . . . . 0.0 109.656 178.704 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.564 ' HB3' ' HB ' ' A' ' 67' ' ' THR . 0.1 OUTLIER -53.24 -69.74 0.11 Allowed 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 105.863 -1.903 . . . . 0.0 105.863 179.438 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.576 ' N ' ' O ' ' A' ' 67' ' ' THR . 11.2 t0 -95.33 -46.92 6.52 Favored 'General case' 0 N--CA 1.435 -1.196 0 N-CA-C 105.915 -1.883 . . . . 0.0 105.915 169.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.55 ' CD2' HG22 ' A' ' 43' ' ' ILE . 61.4 t80 -143.77 142.73 31.05 Favored 'General case' 0 C--N 1.346 0.453 0 CA-C-N 112.62 -2.082 . . . . 0.0 111.113 179.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.774 ' HB2' ' HB2' ' A' ' 73' ' ' ALA . 23.1 t-160 -94.23 108.91 20.75 Favored 'General case' 0 C--N 1.328 -0.329 0 O-C-N 121.984 -0.447 . . . . 0.0 110.413 177.125 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.804 HD12 ' O ' ' A' ' 79' ' ' GLY . 3.9 pp -126.17 170.92 11.33 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.82 0.343 . . . . 0.0 110.735 179.48 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.804 ' O ' HD12 ' A' ' 78' ' ' LEU . . . -53.16 -176.3 0.06 OUTLIER Glycine 0 CA--C 1.518 0.245 0 C-N-CA 120.897 -0.668 . . . . 0.0 112.745 -179.754 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.541 ' C ' HD12 ' A' ' 81' ' ' ILE . 0.5 OUTLIER -108.25 102.25 11.39 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.85 0.357 . . . . 0.0 110.881 179.859 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.741 HD13 ' HB3' ' A' ' 85' ' ' SER . 2.0 mp -110.11 153.99 11.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.919 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 10.0 t -68.19 -45.31 73.76 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 113.72 1.007 . . . . 0.0 113.72 -178.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.778 ' HB3' HD13 ' A' ' 84' ' ' LEU . 3.1 mpt_? -120.4 -90.1 0.59 Allowed 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 113.74 1.015 . . . . 0.0 113.74 -177.338 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.778 HD13 ' HB3' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -84.72 103.51 13.88 Favored 'General case' 0 CA--C 1.506 -0.741 0 CA-C-O 122.014 0.912 . . . . 0.0 110.836 -178.622 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.741 ' HB3' HD13 ' A' ' 81' ' ' ILE . 0.4 OUTLIER 148.13 -35.8 0.01 OUTLIER 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 113.072 -1.876 . . . . 0.0 108.607 -179.812 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.809 ' O ' ' N ' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -70.42 -161.55 0.05 Allowed 'General case' 0 CA--C 1.513 -0.477 0 N-CA-C 107.586 -1.265 . . . . 0.0 107.586 177.492 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.831 ' HB2' HD11 ' A' ' 104' ' ' ILE . 9.6 pttt -51.54 72.82 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 178.129 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.93 ' O ' ' O ' ' A' ' 104' ' ' ILE . 32.9 t60 -84.51 -17.09 40.09 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 114.389 1.255 . . . . 0.0 114.389 -176.374 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.665 ' HA ' ' H ' ' A' ' 104' ' ' ILE . 0.1 OUTLIER -172.09 154.18 3.34 Favored 'General case' 0 C--N 1.31 -1.124 0 C-N-CA 119.124 -1.03 . . . . 0.0 112.48 177.867 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.843 ' CG ' HG23 ' A' ' 67' ' ' THR . 32.9 mt-30 -136.04 159.05 42.88 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 114.52 -1.218 . . . . 0.0 113.902 -177.294 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.733 HD11 HG21 ' A' ' 36' ' ' VAL . 7.1 mt -125.25 131.85 71.86 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 CA-C-N 114.949 -1.023 . . . . 0.0 109.703 178.607 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.662 HD22 ' ND2' ' A' ' 121' ' ' ASN . 0.3 OUTLIER -108.05 143.78 36.29 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.083 0.468 . . . . 0.0 112.111 -179.421 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.71 HD13 ' CG2' ' A' ' 33' ' ' VAL . 14.3 tp -125.6 122.68 37.15 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.349 179.038 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 120.44 -136.62 11.6 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.401 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.542 ' OE1' HD13 ' A' ' 100' ' ' LEU . 9.1 mt-10 57.69 81.43 0.15 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.835 0.35 . . . . 0.0 110.862 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 61.15 28.76 18.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.894 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 84.2 -177.94 51.85 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.55 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 22.1 m120 63.35 177.76 0.16 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.848 0.356 . . . . 0.0 110.984 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.412 HD22 ' SG ' ' A' ' 34' ' ' CYS . 1.2 mt -106.76 153.09 22.96 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.854 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.614 HD22 ' HB3' ' A' ' 121' ' ' ASN . 5.6 mt -133.79 148.46 51.35 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.434 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.447 ' O ' ' N ' ' A' ' 122' ' ' GLN . 38.0 mt -117.27 130.99 56.91 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 179.777 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.512 ' HB2' HD11 ' A' ' 92' ' ' LEU . 23.8 t30 -113.25 111.31 21.83 Favored 'General case' 0 CA--C 1.51 -0.581 0 C-N-CA 119.847 -0.741 . . . . 0.0 109.944 179.684 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.724 ' HB3' HG21 ' A' ' 109' ' ' THR . 70.7 m-20 -84.43 112.52 20.44 Favored 'General case' 0 N--CA 1.444 -0.773 0 C-N-CA 119.669 -0.812 . . . . 0.0 109.381 179.4 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.93 ' O ' ' O ' ' A' ' 88' ' ' HIS . 0.1 OUTLIER -122.91 107.61 19.67 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.876 0 CA-C-O 121.756 0.789 . . . . 0.0 108.96 178.136 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.439 ' OG ' ' NE2' ' A' ' 88' ' ' HIS . 66.8 m -132.39 171.49 13.67 Favored 'General case' 0 C--N 1.295 -1.77 0 CA-C-N 114.757 -1.11 . . . . 0.0 109.36 179.551 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 22.6 m -69.5 -63.8 1.0 Allowed 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 118.998 -1.081 . . . . 0.0 111.706 -178.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 5.5 p30 -112.6 -32.76 6.35 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 114.63 1.344 . . . . 0.0 114.63 179.203 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -146.13 129.17 3.28 Favored Glycine 0 C--N 1.339 0.719 0 N-CA-C 116.931 1.532 . . . . 0.0 116.931 -177.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.724 HG21 ' HB3' ' A' ' 103' ' ' ASP . 6.5 m -121.15 138.36 54.24 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 174.411 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 0.639 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.7 m-90 -120.45 149.2 42.76 Favored 'General case' 0 CA--C 1.515 -0.374 0 N-CA-C 113.283 0.846 . . . . 0.0 113.283 -178.447 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.469 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -121.64 111.85 17.71 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 115.001 -0.999 . . . . 0.0 108.563 177.44 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 44.74 43.79 7.06 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.125 -0.489 . . . . 0.0 112.114 -179.511 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 78.88 31.4 44.0 Favored Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.891 179.238 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -141.95 98.93 3.42 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.999 0.428 . . . . 0.0 110.832 179.648 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.639 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.2 OUTLIER -45.22 122.59 3.49 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.786 179.727 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.515 HG21 ' OD2' ' A' ' 103' ' ' ASP . 8.1 m -112.35 179.56 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.902 -179.047 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.431 ' HB3' ' HB3' ' A' ' 120' ' ' SER . 0.5 OUTLIER -88.13 136.96 32.73 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.809 179.89 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.405 ' HG2' ' N ' ' A' ' 119' ' ' ASN . 63.7 tttm -62.73 162.39 10.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.534 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.405 ' N ' ' HG2' ' A' ' 118' ' ' LYS . 4.0 p30 34.46 38.54 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.364 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.431 ' HB3' ' HB3' ' A' ' 117' ' ' GLU . 9.0 p -111.28 114.23 27.28 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.055 -179.334 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.662 ' ND2' HD22 ' A' ' 92' ' ' LEU . 1.6 m120 -61.76 136.26 57.92 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.616 179.777 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . 0.608 ' C ' HD23 ' A' ' 100' ' ' LEU . 32.0 mm-40 -129.53 145.37 51.47 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.119 0.485 . . . . 0.0 112.161 -179.613 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.6 tp -72.62 120.03 17.67 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.562 178.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.567 ' C ' HD22 ' A' ' 124' ' ' LEU . 0.0 OUTLIER -47.6 149.22 1.23 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 122.026 0.917 . . . . 0.0 112.346 -178.661 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.435 ' O ' ' CD1' ' A' ' 147' ' ' ILE . 0.0 OUTLIER -126.42 152.56 46.2 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 114.102 -1.408 . . . . 0.0 109.661 179.195 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.62 113.75 8.03 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.07 0.462 . . . . 0.0 110.136 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 66.49 29.96 75.69 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.375 -179.469 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.452 ' OD2' HD13 ' A' ' 111' ' ' LEU . 9.8 t70 -58.31 161.05 4.61 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.98 0.419 . . . . 0.0 111.343 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -146.28 135.35 22.63 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.044 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.464 ' CD1' ' CE1' ' A' ' 89' ' ' PHE . 3.9 mt -109.91 128.53 65.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 120.831 0.348 . . . . 0.0 110.258 179.213 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.482 HG23 ' CG2' ' A' ' 140' ' ' ILE . 16.8 m -103.19 142.66 33.79 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.634 -179.57 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.5 HG11 ' CD2' ' A' ' 88' ' ' HIS . 4.4 m -140.72 154.09 21.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.298 -0.41 . . . . 0.0 112.008 -179.11 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 75.16 37.03 43.86 Favored Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 121.127 -0.559 . . . . 0.0 112.402 179.549 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.489 ' HA ' HG12 ' A' ' 140' ' ' ILE . 91.5 t -72.89 156.75 6.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 121.44 0.638 . . . . 0.0 112.081 -179.174 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.461 ' N ' HG12 ' A' ' 134' ' ' VAL . . . 153.59 -47.86 0.53 Allowed Glycine 0 N--CA 1.442 -0.957 0 N-CA-C 110.665 -0.974 . . . . 0.0 110.665 -179.297 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.65 HG12 ' H ' ' A' ' 138' ' ' SER . 56.1 t -126.71 134.61 65.87 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.682 0 CA-C-N 115.295 -0.453 . . . . 0.0 109.877 178.607 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.447 ' HA ' HD12 ' A' ' 140' ' ' ILE . 12.6 pt-20 -51.19 -32.06 22.3 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.841 0.353 . . . . 0.0 111.19 -179.36 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . 0.65 ' H ' HG12 ' A' ' 136' ' ' VAL . 90.2 p -94.09 6.26 49.13 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 116.159 -0.473 . . . . 0.0 112.088 -179.657 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -129.31 29.14 5.16 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 112.376 0.51 . . . . 0.0 112.376 -179.487 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.489 HG12 ' HA ' ' A' ' 134' ' ' VAL . 23.6 mt -104.88 140.95 21.37 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 CA-C-N 115.668 -0.697 . . . . 0.0 111.154 179.157 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.666 HD12 ' HG3' ' A' ' 42' ' ' GLN . 4.6 mm? -117.23 135.22 53.96 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 114.925 -1.034 . . . . 0.0 110.06 179.489 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.764 ' O ' HD13 ' A' ' 143' ' ' LEU . 4.1 m -119.13 152.79 35.92 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.833 0.825 . . . . 0.0 112.581 -179.144 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.799 HD12 ' SG ' ' A' ' 38' ' ' CYS . 1.8 mm? -132.11 153.88 50.04 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 114.401 -1.272 . . . . 0.0 109.174 179.25 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 22.1 t -128.08 140.55 48.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 120.946 0.403 . . . . 0.0 111.777 -179.348 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.759 HG13 HG22 ' A' ' 36' ' ' VAL . 0.4 OUTLIER -113.88 126.58 71.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.333 179.61 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 7.7 t80 -108.84 119.52 39.79 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.054 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.454 HD13 HD23 ' A' ' 124' ' ' LEU . 2.7 mp -112.1 123.0 67.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.881 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . 0.409 ' ND2' ' O ' ' A' ' 32' ' ' ILE . 3.1 p30 -76.31 122.88 25.07 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.923 0.392 . . . . 0.0 111.087 -179.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -73.82 -19.44 60.75 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.078 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.82 -42.98 85.46 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 120.962 0.411 . . . . 0.0 110.732 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . 0.462 ' CZ ' HG21 ' A' ' 55' ' ' VAL . 4.7 t80 -59.5 -41.54 90.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.64 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 3.3 tptm -63.18 -34.16 77.04 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.807 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -68.14 -38.47 82.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.962 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 12.2 t -60.17 -45.53 92.81 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.823 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -68.95 -48.18 63.84 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.951 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -57.77 -46.9 83.91 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.177 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 15.2 tt0 -79.3 -37.01 38.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.046 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 3.7 p30 44.36 -171.4 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.541 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 15.3 pttt -57.08 146.65 26.79 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.027 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 12.8 p -91.92 130.0 41.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.068 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -171.38 35.02 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.786 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 30.6 ttt180 -58.94 136.32 57.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.996 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 34.5 pt -105.86 135.68 43.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.141 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 3.6 tmt_? . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.231 -0.89 . . . . 0.0 110.88 179.974 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.353 0 N-CA-C 112.466 -0.253 . . . . 0.0 112.466 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -109.32 58.77 0.6 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.92 0.391 . . . . 0.0 110.936 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.487 ' O ' HG23 ' A' ' 4' ' ' ILE . 43.8 p30 -121.13 32.57 5.89 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.872 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.487 HG23 ' O ' ' A' ' 3' ' ' ASN . 6.1 pt -156.73 106.44 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.197 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 13.7 p -90.17 -43.02 10.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.224 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -141.56 79.21 17.4 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.874 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -71.17 63.57 2.65 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.59 2.194 . . . . 0.0 112.24 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.4 -40.09 6.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.099 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -98.69 41.65 1.13 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.831 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 2.3 mm-40 -122.39 37.52 4.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.832 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 7.9 p 62.4 122.39 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.873 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.425 HG23 ' N ' ' A' ' 13' ' ' GLN . 9.6 t -122.01 -42.15 2.4 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.252 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.425 ' N ' HG23 ' A' ' 12' ' ' THR . 28.4 mt-30 62.85 101.32 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.792 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -97.62 -169.88 1.91 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.153 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -124.56 -58.6 1.5 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.067 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -64.56 -46.12 84.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.943 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.82 -38.75 82.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.876 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -60.82 -41.3 95.44 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.975 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 91.8 mt -59.71 -39.03 83.28 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.098 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 45.6 mm -69.88 -37.34 72.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.217 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -57.56 -36.15 71.29 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.246 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -59.18 -29.76 67.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.049 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -65.68 -47.26 76.06 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.173 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.3 m -58.03 -47.19 83.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.95 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -90.93 172.34 8.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.88 179.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -80.24 128.97 34.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.992 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -81.18 110.74 16.96 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.767 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.3 mm -86.15 139.26 17.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.483 0.659 . . . . 0.0 111.761 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -123.63 72.15 0.42 Allowed Glycine 0 C--N 1.317 -0.481 0 CA-C-N 114.773 -1.103 . . . . 0.0 112.287 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -78.07 -24.81 47.52 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.642 0.258 . . . . 0.0 111.369 -179.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -109.42 -14.45 14.42 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-O 121.936 0.874 . . . . 0.0 108.681 178.463 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.587 ' HA ' ' HB3' ' A' ' 49' ' ' SER . 0.1 OUTLIER -71.08 108.99 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.662 0 CA-C-N 113.949 -1.478 . . . . 0.0 111.121 -179.464 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.781 HG11 HD13 ' A' ' 93' ' ' LEU . 2.2 t -53.35 -67.19 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.834 0 CA-C-N 114.946 -1.025 . . . . 0.0 111.459 -179.576 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 18.3 p -155.23 165.08 37.79 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.022 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 1.5 ttm180 -129.33 115.48 17.63 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.402 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.913 HG12 HD21 ' A' ' 143' ' ' LEU . 66.6 t -89.05 130.09 38.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.149 -0.478 . . . . 0.0 109.901 179.183 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.976 HG23 HG12 ' A' ' 45' ' ' ILE . 28.0 mt -122.23 108.54 22.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -178.802 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.632 ' SG ' HD23 ' A' ' 143' ' ' LEU . 0.1 OUTLIER -95.92 101.65 13.35 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 177.599 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -111.47 2.32 17.42 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -178.049 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.86 HG21 ' HB2' ' A' ' 142' ' ' SER . 67.8 p -83.76 -16.35 45.1 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.784 -0.366 . . . . 0.0 111.402 179.646 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 113.71 58.83 0.4 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.587 179.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.47 ' HB2' HD12 ' A' ' 43' ' ' ILE . 6.1 mt-30 -134.6 -69.42 0.52 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.641 0.258 . . . . 0.0 111.134 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.47 HD12 ' HB2' ' A' ' 42' ' ' GLN . 3.7 mp -135.09 139.07 30.83 Favored Pre-proline 0 N--CA 1.452 -0.336 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.185 -179.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.541 ' HD2' ' CZ ' ' A' ' 76' ' ' TYR . 28.2 Cg_exo -59.26 147.32 91.38 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.718 2.278 . . . . 0.0 111.68 179.607 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.976 HG12 HG23 ' A' ' 37' ' ' ILE . 32.0 mt -46.33 148.72 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 121.008 0.432 . . . . 0.0 111.689 -179.633 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.1 130.28 13.61 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.187 179.445 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.421 ' HB3' HD11 ' A' ' 32' ' ' ILE . 1.8 m-20 -91.58 119.77 31.78 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.086 0.469 . . . . 0.0 111.168 -179.649 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.911 ' CD2' HG23 ' A' ' 36' ' ' VAL . 0.1 OUTLIER -92.5 123.34 35.74 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.479 179.129 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.687 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -132.99 155.98 48.16 Favored 'General case' 0 CA--C 1.515 -0.398 0 N-CA-C 114.04 1.126 . . . . 0.0 114.04 -178.979 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.58 ' N ' HG23 ' A' ' 33' ' ' VAL . . . -149.9 142.24 24.24 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 113.698 -1.592 . . . . 0.0 110.824 179.028 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.47 ' CB ' ' HG3' ' A' ' 54' ' ' GLN . 0.4 OUTLIER -66.46 110.22 3.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.982 0.42 . . . . 0.0 110.89 -179.845 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.668 HG23 HD23 ' A' ' 56' ' ' LEU . 10.7 mt -56.16 -34.53 39.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.1 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 9.6 t -56.86 -34.66 68.04 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.899 -179.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.47 ' HG3' ' CB ' ' A' ' 51' ' ' ASP . 0.0 OUTLIER -66.22 -44.74 82.97 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.768 -179.974 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.77 ' HA ' HD12 ' A' ' 62' ' ' ILE . 7.8 t -74.01 -40.66 52.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.208 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.668 HD23 HG23 ' A' ' 52' ' ' ILE . 0.9 OUTLIER -59.38 -37.97 79.3 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.973 -179.942 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 5.3 mmtm -92.81 -50.06 5.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.764 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.607 ' CD ' HD13 ' A' ' 62' ' ' ILE . 2.5 tt0 60.54 79.96 0.23 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.959 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 19.0 tttt -126.27 -64.66 1.02 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.819 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 23.9 mtp180 -136.57 38.53 2.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.785 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -175.01 103.22 0.09 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.986 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.77 HD12 ' HA ' ' A' ' 55' ' ' VAL . 0.9 OUTLIER -168.75 53.56 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.917 -179.963 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.1 pttp -160.4 70.0 0.4 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.084 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.503 ' HD2' ' HB2' ' A' ' 50' ' ' ALA . 29.2 ttmt -99.69 123.55 44.07 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.237 179.478 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.523 HG13 ' O ' ' A' ' 91' ' ' ILE . 4.7 t -126.11 133.32 69.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.141 0.496 . . . . 0.0 112.09 -178.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . 0.703 ' CD1' HD12 ' A' ' 48' ' ' LEU . 13.3 m-90 -99.34 139.9 34.3 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.229 178.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.569 ' HB ' ' CB ' ' A' ' 74' ' ' CYS . 2.8 m -131.37 129.34 41.23 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.447 0.642 . . . . 0.0 112.436 179.678 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.509 ' CD2' ' CD2' ' A' ' 89' ' ' PHE . 94.2 m-85 -100.13 117.6 34.71 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.415 -0.812 . . . . 0.0 109.091 177.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.608 ' C ' HD11 ' A' ' 78' ' ' LEU . . . 158.19 -157.83 28.64 Favored Glycine 0 CA--C 1.503 -0.695 0 C-N-CA 119.061 -1.542 . . . . 0.0 113.061 179.456 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -75.46 91.49 2.77 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-O 122.726 1.25 . . . . 0.0 108.43 -179.7 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.485 ' O ' ' CD2' ' A' ' 77' ' ' HIS . 0.2 OUTLIER -150.39 155.26 36.61 Favored Pre-proline 0 C--N 1.309 -1.162 0 CA-C-N 112.617 -2.083 . . . . 0.0 108.44 179.34 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.56 ' O ' ' HB2' ' A' ' 77' ' ' HIS . 23.9 Cg_exo -56.9 -11.11 6.62 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 121.406 1.404 . . . . 0.0 111.606 178.254 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.744 ' HB2' ' HB2' ' A' ' 77' ' ' HIS . . . 136.16 51.78 0.0 OUTLIER 'General case' 0 CA--C 1.491 -1.315 0 CA-C-N 115.001 -1.0 . . . . 0.0 109.535 178.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.569 ' CB ' ' HB ' ' A' ' 67' ' ' THR . 0.1 OUTLIER -52.91 -69.55 0.11 Allowed 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 105.919 -1.882 . . . . 0.0 105.919 179.387 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.568 ' HB2' ' N ' ' A' ' 67' ' ' THR . 8.2 t0 -94.48 -47.73 6.43 Favored 'General case' 0 N--CA 1.434 -1.258 0 N-CA-C 105.772 -1.936 . . . . 0.0 105.772 169.784 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.541 ' CZ ' ' HD2' ' A' ' 44' ' ' PRO . 39.0 t80 -145.04 142.37 29.69 Favored 'General case' 0 C--N 1.347 0.473 0 CA-C-N 112.655 -2.066 . . . . 0.0 111.54 179.485 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.744 ' HB2' ' HB2' ' A' ' 73' ' ' ALA . 23.8 t-160 -92.06 107.43 19.21 Favored 'General case' 0 C--N 1.331 -0.196 0 O-C-N 121.846 -0.534 . . . . 0.0 109.906 176.779 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.608 HD11 ' C ' ' A' ' 69' ' ' GLY . 2.6 pp -119.99 176.29 5.5 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.949 0.404 . . . . 0.0 111.48 -179.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.504 ' O ' HD12 ' A' ' 78' ' ' LEU . . . -64.1 -169.98 1.82 Allowed Glycine 0 C--N 1.332 0.324 0 C-N-CA 121.044 -0.598 . . . . 0.0 112.572 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 10.1 p-10 -111.71 98.82 7.68 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.957 0.408 . . . . 0.0 111.604 -179.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.602 ' HB ' ' HB2' ' A' ' 85' ' ' SER . 13.4 mm -113.72 112.1 38.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.302 179.018 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 8.0 t -55.01 -24.24 23.4 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.238 0.458 . . . . 0.0 112.238 -179.236 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -91.49 -109.51 0.1 Allowed 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 -179.027 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.455 ' HB3' ' CE1' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -108.01 112.41 24.96 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 121.619 0.723 . . . . 0.0 109.87 -179.915 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.602 ' HB2' ' HB ' ' A' ' 81' ' ' ILE . 0.4 OUTLIER 162.16 -43.93 0.0 OUTLIER 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 114.285 -1.325 . . . . 0.0 108.932 -179.422 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.843 ' O ' ' N ' ' A' ' 88' ' ' HIS . 96.9 m-20 -65.43 -149.46 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 177.522 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.95 ' HB2' HD11 ' A' ' 104' ' ' ILE . 0.0 OUTLIER -49.79 72.33 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 179.063 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.962 ' C ' ' O ' ' A' ' 104' ' ' ILE . 30.7 t60 -90.58 -16.17 29.23 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 113.813 1.042 . . . . 0.0 113.813 -176.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.639 ' HA ' ' H ' ' A' ' 104' ' ' ILE . 1.0 OUTLIER -174.8 152.66 1.61 Allowed 'General case' 0 C--N 1.311 -1.092 0 C-N-CA 119.484 -0.886 . . . . 0.0 112.257 178.052 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.482 ' O ' ' O ' ' A' ' 102' ' ' ASN . 3.2 tt0 -136.42 154.14 50.88 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 114.656 -1.156 . . . . 0.0 113.638 -177.422 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.71 HD11 HG21 ' A' ' 36' ' ' VAL . 16.4 mt -124.65 131.96 71.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.261 -0.882 . . . . 0.0 109.842 178.623 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.745 HD13 ' ND2' ' A' ' 121' ' ' ASN . 0.1 OUTLIER -113.32 140.23 48.18 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.975 0.417 . . . . 0.0 111.99 -179.378 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.781 HD13 HG11 ' A' ' 33' ' ' VAL . 27.1 tp -125.9 130.66 51.75 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.602 179.116 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 123.29 -167.26 15.56 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.415 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 62.39 118.76 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.93 0.395 . . . . 0.0 110.916 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 19.5 t0 59.98 20.23 9.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.117 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 54.13 60.03 9.07 Favored Glycine 0 C--N 1.332 0.314 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.691 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 -158.99 -179.21 7.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.84 0.352 . . . . 0.0 110.876 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.601 ' C ' HD22 ' A' ' 100' ' ' LEU . 67.8 tp -108.04 145.4 34.04 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.836 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.601 HD22 ' C ' ' A' ' 99' ' ' LEU . 3.8 mm? -133.48 147.84 51.68 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.547 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 1.064 HD21 HD13 ' A' ' 145' ' ' ILE . 8.0 mp -117.03 130.67 56.83 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 179.647 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.636 ' HB2' HD11 ' A' ' 92' ' ' LEU . 25.0 t30 -114.84 110.93 20.42 Favored 'General case' 0 CA--C 1.508 -0.64 0 C-N-CA 119.87 -0.732 . . . . 0.0 109.881 179.729 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.796 ' OD2' HG11 ' A' ' 116' ' ' VAL . 63.0 m-20 -82.9 111.85 19.15 Favored 'General case' 0 N--CA 1.442 -0.841 0 C-N-CA 119.63 -0.828 . . . . 0.0 109.326 179.5 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.962 ' O ' ' C ' ' A' ' 88' ' ' HIS . 0.1 OUTLIER -123.55 108.03 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.997 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 178.028 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.478 ' HG ' ' CE1' ' A' ' 88' ' ' HIS . 75.6 m -128.09 171.34 11.98 Favored 'General case' 0 C--N 1.297 -1.702 0 CA-C-N 114.914 -1.039 . . . . 0.0 109.275 179.673 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 26.6 m -69.24 -62.96 1.17 Allowed 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 119.099 -1.04 . . . . 0.0 111.074 -179.393 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 5.7 p30 -111.97 -33.66 6.21 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 114.216 1.191 . . . . 0.0 114.216 178.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -147.02 133.09 4.62 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 116.667 1.427 . . . . 0.0 116.667 -178.253 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.764 HG21 ' HB3' ' A' ' 103' ' ' ASP . 8.3 m -121.01 138.29 54.24 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 174.164 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 0.756 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.4 m-90 -119.3 149.15 42.27 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 -178.387 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.419 ' O ' ' HG ' ' A' ' 111' ' ' LEU . 0.2 OUTLIER -123.74 112.44 17.35 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 114.842 -1.072 . . . . 0.0 108.647 177.66 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 7.1 m-80 46.46 42.93 11.5 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.951 -0.568 . . . . 0.0 112.34 -179.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.04 -6.5 83.19 Favored Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 120.69 -0.767 . . . . 0.0 113.437 178.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 1.8 mm-40 -110.55 104.77 13.53 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.892 0.377 . . . . 0.0 110.963 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.756 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.0 OUTLIER -44.22 127.85 5.78 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.908 179.721 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.796 HG11 ' OD2' ' A' ' 103' ' ' ASP . 12.3 p -111.95 159.45 11.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.779 -179.049 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.509 ' N ' HG22 ' A' ' 116' ' ' VAL . 14.1 mp0 -70.7 136.86 49.29 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.95 179.773 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.408 ' O ' ' C ' ' A' ' 119' ' ' ASN . 78.7 tttt -63.09 163.86 9.34 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.296 179.594 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.408 ' C ' ' O ' ' A' ' 118' ' ' LYS . 10.5 m-80 34.43 40.61 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.24 -179.537 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 4.9 p -110.99 110.6 21.23 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.86 -179.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.745 ' ND2' HD13 ' A' ' 92' ' ' LEU . 1.9 m120 -62.69 133.97 55.63 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.554 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . 0.501 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 32.7 mm-40 -129.62 145.62 51.48 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.312 0.577 . . . . 0.0 112.357 -179.602 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.428 HD23 ' O ' ' A' ' 124' ' ' LEU . 2.7 tt -72.61 122.77 21.94 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.634 179.018 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.558 ' C ' HD22 ' A' ' 124' ' ' LEU . 0.0 OUTLIER -48.71 148.82 1.96 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 122.067 0.937 . . . . 0.0 112.041 -178.887 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -126.79 153.08 46.07 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 114.195 -1.366 . . . . 0.0 110.153 179.703 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 1.3 mm100 -70.98 113.49 8.08 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 179.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 68.33 28.1 73.44 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.227 -179.096 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.454 ' HB3' HG22 ' A' ' 145' ' ' ILE . 28.2 t70 -53.86 160.09 1.51 Allowed 'General case' 0 C--O 1.231 0.123 0 CA-C-O 120.963 0.411 . . . . 0.0 111.224 -179.675 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.509 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 29.0 tt0 -146.66 134.9 21.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.587 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.452 HG21 ' OD1' ' A' ' 103' ' ' ASP . 7.1 mm -117.56 128.3 74.82 Favored 'Isoleucine or valine' 0 C--O 1.231 0.131 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 178.542 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.504 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 94.6 m -103.49 145.47 29.97 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.632 -179.658 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.506 ' HB ' ' NE2' ' A' ' 88' ' ' HIS . 6.2 m -140.9 157.97 23.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -178.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . 0.403 ' O ' ' O ' ' A' ' 139' ' ' ASP . . . 70.72 40.86 65.02 Favored Glycine 0 N--CA 1.446 -0.637 0 CA-C-N 115.728 -0.669 . . . . 0.0 112.648 179.292 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.484 HG12 ' N ' ' A' ' 135' ' ' GLY . 94.8 t -76.76 157.17 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 CA-C-O 121.409 0.624 . . . . 0.0 112.005 -179.297 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.484 ' N ' HG12 ' A' ' 134' ' ' VAL . . . 152.63 -44.68 0.61 Allowed Glycine 0 N--CA 1.44 -1.037 0 N-CA-C 110.652 -0.979 . . . . 0.0 110.652 -179.271 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.545 HG12 ' H ' ' A' ' 138' ' ' SER . 45.3 t -126.75 134.22 66.76 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.739 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 178.66 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 26.9 tp10 -50.87 -34.51 28.4 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.827 0.346 . . . . 0.0 111.464 -179.182 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . 0.545 ' H ' HG12 ' A' ' 136' ' ' VAL . 37.7 t -93.78 6.23 49.05 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 116.204 -0.453 . . . . 0.0 112.141 -179.507 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . 0.403 ' O ' ' O ' ' A' ' 133' ' ' GLY . 2.3 t70 -125.77 29.25 5.98 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-O 121.124 0.488 . . . . 0.0 112.169 -179.484 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.504 ' CG2' ' CG2' ' A' ' 131' ' ' THR . 25.7 mt -107.17 141.45 22.34 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.328 179.394 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 12.1 mt -123.41 134.79 53.93 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.037 -0.983 . . . . 0.0 110.633 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.86 ' HB2' HG21 ' A' ' 40' ' ' THR . 4.8 m -114.94 153.5 30.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.756 0.788 . . . . 0.0 112.462 -179.352 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.913 HD21 HG12 ' A' ' 36' ' ' VAL . 1.8 tm? -133.83 136.84 44.7 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 114.55 -1.205 . . . . 0.0 109.396 179.701 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.73 ' H ' HD22 ' A' ' 143' ' ' LEU . 15.0 t -118.04 140.3 41.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.903 0.382 . . . . 0.0 111.801 -179.13 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 1.064 HD13 HD21 ' A' ' 101' ' ' LEU . 0.1 OUTLIER -108.01 140.3 26.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.776 179.592 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 37.5 t80 -118.4 122.87 43.86 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.96 -179.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 3.0 mp -115.32 130.23 70.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.11 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 23.6 p-10 -75.28 138.0 41.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.993 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -73.64 -30.24 62.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.934 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -57.44 -40.16 77.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.777 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 6.2 t80 -63.72 -38.73 92.22 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.917 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 19.7 tttm -64.86 -44.4 89.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.036 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 17.3 tt0 -58.99 -36.84 75.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.055 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 9.0 t -64.97 -43.46 92.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.737 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.429 HD22 ' HA ' ' A' ' 155' ' ' LEU . 0.2 OUTLIER -66.35 -35.67 80.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.822 179.873 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 59.5 tt0 -56.83 -41.08 77.21 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.807 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 3.4 tt0 -89.35 -34.08 16.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.838 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 4.9 p30 44.62 -171.54 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.55 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 4.1 pttp -88.13 140.32 29.61 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.954 -179.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 29.3 m -67.36 125.48 24.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.167 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 28.9 p30 -114.16 -173.47 2.29 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.86 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -58.72 -26.82 64.31 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.963 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 27.8 mt -76.84 132.64 32.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.023 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.241 -0.885 . . . . 0.0 110.945 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.36 0 N-CA-C 112.521 -0.231 . . . . 0.0 112.521 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 59.52 36.98 23.01 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.769 0.319 . . . . 0.0 110.944 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.65 ' O ' HG23 ' A' ' 4' ' ' ILE . 0.1 OUTLIER -165.61 -73.68 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.81 -179.913 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.65 HG23 ' O ' ' A' ' 3' ' ' ASN . 5.9 pt -162.72 158.5 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.148 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.4 m -135.29 112.01 10.07 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.175 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 5.9 mm-40 -152.46 73.97 7.39 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.857 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -67.36 -165.51 0.11 Allowed 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.632 2.221 . . . . 0.0 112.304 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.8 p 62.68 158.59 0.07 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.174 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER 61.57 63.44 1.17 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.882 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -161.32 32.94 0.14 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.82 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -59.41 158.55 9.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.871 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -69.48 143.51 53.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.151 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.59 158.81 14.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.871 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -131.7 174.94 9.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.228 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 1.6 t -164.69 -42.05 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.021 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -71.67 -39.29 70.38 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.86 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 41.7 mtp85 -66.31 -46.34 77.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.906 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 -58.53 -35.71 72.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.973 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.07 -37.74 80.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.784 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 37.2 mm -65.1 -39.16 84.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.029 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.7 -37.54 73.67 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.984 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.69 -43.54 97.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.871 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -61.06 -47.65 85.38 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.042 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.9 m -65.29 -45.24 85.2 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.939 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -80.39 160.72 25.29 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.882 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -73.86 142.9 46.04 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.822 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 64.9 mt-30 -98.03 116.74 30.87 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.916 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 25.1 mm -82.03 139.73 17.49 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.345 0 CA-C-O 121.458 0.647 . . . . 0.0 111.574 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -140.55 80.95 0.26 Allowed Glycine 0 C--N 1.318 -0.443 0 CA-C-N 114.95 -1.023 . . . . 0.0 112.633 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -87.51 -25.58 23.61 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.757 0.313 . . . . 0.0 110.936 179.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.409 ' HA ' ' CD1' ' A' ' 52' ' ' ILE . 1.6 m-20 -109.02 -13.5 14.71 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-O 121.997 0.903 . . . . 0.0 108.626 178.353 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.783 HD13 ' O ' ' A' ' 48' ' ' LEU . 0.1 OUTLIER -70.7 95.57 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.556 0 CA-C-N 113.911 -1.495 . . . . 0.0 110.711 -179.41 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.572 ' CG1' ' N ' ' A' ' 34' ' ' CYS . 0.5 OUTLIER -32.45 -59.94 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 114.874 -1.057 . . . . 0.0 112.379 -179.127 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.707 ' SG ' HD12 ' A' ' 48' ' ' LEU . 31.7 p -164.29 164.88 22.26 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.529 -179.757 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 5.2 ttm180 -127.11 122.62 34.76 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.077 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.71 ' CG2' HD11 ' A' ' 48' ' ' LEU . 24.8 t -93.81 131.74 39.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.669 179.536 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.976 HG23 HG12 ' A' ' 45' ' ' ILE . 32.9 mt -121.18 108.38 22.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 N-CA-C 112.362 0.505 . . . . 0.0 112.362 -179.326 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -98.6 105.66 17.83 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 177.374 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 8.9 t -113.71 -21.22 10.84 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 113.328 0.862 . . . . 0.0 113.328 -177.496 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.813 HG21 ' CB ' ' A' ' 142' ' ' SER . 44.5 p -55.59 -22.22 21.14 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.874 0.369 . . . . 0.0 111.467 -179.475 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 120.73 64.76 0.25 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.353 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.2 mt-30 -141.75 -70.32 0.36 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.773 0.32 . . . . 0.0 111.205 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.56 HG22 ' HD2' ' A' ' 44' ' ' PRO . 0.7 OUTLIER -135.16 139.24 31.2 Favored Pre-proline 0 N--CA 1.453 -0.325 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.113 -179.566 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.56 ' HD2' HG22 ' A' ' 43' ' ' ILE . 26.6 Cg_exo -59.41 147.76 89.83 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.506 2.137 . . . . 0.0 111.379 179.223 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.976 HG12 HG23 ' A' ' 37' ' ' ILE . 43.1 mt -36.33 136.04 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 -179.398 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.48 ' CG ' ' CE2' ' A' ' 76' ' ' TYR . 0.0 OUTLIER -123.26 144.87 49.12 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.337 179.306 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -110.11 119.61 39.82 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.977 0.418 . . . . 0.0 111.259 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.794 HD11 HD13 ' A' ' 91' ' ' ILE . 5.4 mt -98.53 137.88 36.55 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 178.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.566 ' O ' ' HZ2' ' A' ' 66' ' ' TRP . 0.0 OUTLIER -137.8 163.31 31.69 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 113.55 0.944 . . . . 0.0 113.55 -178.646 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.528 ' HB3' HG23 ' A' ' 33' ' ' VAL . . . -138.27 166.03 25.23 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 114.41 -1.268 . . . . 0.0 110.888 179.292 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.421 ' CB ' ' HG3' ' A' ' 54' ' ' GLN . 1.4 m-20 -92.28 100.52 13.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.943 0.401 . . . . 0.0 111.187 -179.71 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.409 ' CD1' ' HA ' ' A' ' 31' ' ' ASN . 2.3 mt -63.76 -29.7 47.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.528 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -56.47 -34.84 67.28 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.017 -179.186 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.421 ' HG3' ' CB ' ' A' ' 51' ' ' ASP . 0.6 OUTLIER -66.07 -36.99 84.67 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.822 179.992 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.854 ' CG2' HD11 ' A' ' 62' ' ' ILE . 16.4 t -73.77 -42.21 54.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.242 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -61.57 -27.07 68.37 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.308 -179.678 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.5 tppp? -99.47 -32.4 11.15 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.784 0.326 . . . . 0.0 111.221 -179.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -135.14 117.97 16.18 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.031 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -58.02 -56.29 23.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.906 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -82.98 71.19 10.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.793 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 51.4 p -128.2 -161.48 1.1 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.847 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.854 HD11 ' CG2' ' A' ' 55' ' ' VAL . 23.9 mm 73.54 128.95 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-O 120.912 0.386 . . . . 0.0 111.335 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 4.5 tttt -169.51 64.02 0.05 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.707 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.448 ' O ' ' CZ3' ' A' ' 66' ' ' TRP . 29.9 ttpt -132.55 118.79 19.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.916 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.713 HG23 ' O ' ' A' ' 91' ' ' ILE . 7.9 p -108.61 140.13 28.39 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 CA-C-O 121.37 0.605 . . . . 0.0 112.428 -179.07 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . 0.713 ' CD1' HD22 ' A' ' 48' ' ' LEU . 14.3 m-90 -99.93 139.31 35.78 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.099 -0.955 . . . . 0.0 111.325 179.099 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.867 HG23 ' HG3' ' A' ' 90' ' ' GLN . 10.6 m -127.36 130.07 48.76 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.547 0.689 . . . . 0.0 111.951 179.113 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.646 ' CE2' HG11 ' A' ' 36' ' ' VAL . 11.2 m-85 -102.86 118.33 36.59 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.054 -0.976 . . . . 0.0 108.98 178.099 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.651 ' HA2' ' O ' ' A' ' 85' ' ' SER . . . 157.16 -153.95 25.12 Favored Glycine 0 CA--C 1.505 -0.561 0 C-N-CA 118.765 -1.683 . . . . 0.0 113.317 179.32 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 1.6 mtp180 -75.58 91.94 2.88 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-O 122.593 1.187 . . . . 0.0 108.873 -179.299 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.519 ' O ' ' CD2' ' A' ' 77' ' ' HIS . 33.8 m-80 -150.07 159.62 35.06 Favored Pre-proline 0 C--N 1.308 -1.197 0 CA-C-N 112.761 -2.018 . . . . 0.0 108.102 178.708 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.549 ' O ' ' HB2' ' A' ' 77' ' ' HIS . 31.7 Cg_endo -64.85 -6.78 13.28 Favored 'Trans proline' 0 N--CA 1.453 -0.91 0 C-N-CA 120.637 0.891 . . . . 0.0 110.576 177.33 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.747 ' HB2' ' HB2' ' A' ' 77' ' ' HIS . . . 136.36 52.99 0.0 OUTLIER 'General case' 0 CA--C 1.49 -1.337 0 CA-C-N 114.359 -1.292 . . . . 0.0 109.052 178.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.574 ' HB3' ' HB ' ' A' ' 67' ' ' THR . 0.1 OUTLIER -52.7 -69.93 0.1 Allowed 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 105.497 -2.038 . . . . 0.0 105.497 179.491 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.638 ' HB2' ' N ' ' A' ' 67' ' ' THR . 60.7 t0 -95.85 -47.0 6.33 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 105.834 -1.913 . . . . 0.0 105.834 169.259 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.486 ' C ' ' HA ' ' A' ' 73' ' ' ALA . 0.1 OUTLIER -143.63 141.33 30.55 Favored 'General case' 0 C--N 1.348 0.531 0 CA-C-N 112.77 -2.014 . . . . 0.0 111.855 -179.712 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.747 ' HB2' ' HB2' ' A' ' 73' ' ' ALA . 23.7 t-160 -97.21 106.15 18.42 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 176.306 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.756 HD11 ' O ' ' A' ' 85' ' ' SER . 1.1 pp -123.11 175.52 6.59 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.919 0.39 . . . . 0.0 111.512 -179.583 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -53.54 -179.76 0.12 Allowed Glycine 0 C--N 1.333 0.369 0 C-N-CA 121.015 -0.612 . . . . 0.0 112.573 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.449 ' HA ' ' OD1' ' A' ' 86' ' ' ASN . 5.0 p30 -111.61 98.47 7.45 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.785 0.326 . . . . 0.0 111.582 -179.708 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.703 ' HB ' ' HB2' ' A' ' 85' ' ' SER . 15.0 mm -114.7 117.52 55.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.701 178.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 43.4 t -54.97 -24.18 22.7 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 111.82 0.304 . . . . 0.0 111.82 -179.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.478 ' H ' HG22 ' A' ' 81' ' ' ILE . 3.3 mpt_? -92.44 -102.25 0.12 Allowed 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -179.095 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.422 ' O ' ' HB2' ' A' ' 85' ' ' SER . 0.0 OUTLIER -108.96 109.76 20.9 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-O 121.631 0.729 . . . . 0.0 110.512 -179.702 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.756 ' O ' HD11 ' A' ' 78' ' ' LEU . 0.3 OUTLIER 161.38 -46.0 0.0 OUTLIER 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 114.128 -1.397 . . . . 0.0 109.201 -179.92 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.814 ' O ' ' N ' ' A' ' 88' ' ' HIS . 88.3 m-20 -66.44 -153.44 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 177.658 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.844 ' HB2' HD11 ' A' ' 104' ' ' ILE . 17.2 pttm -49.37 73.64 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 179.095 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 1.053 ' O ' ' O ' ' A' ' 104' ' ' ILE . 36.9 t60 -95.0 -16.5 22.7 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 114.307 1.225 . . . . 0.0 114.307 -176.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.616 ' HA ' ' H ' ' A' ' 104' ' ' ILE . 0.2 OUTLIER -177.39 157.04 1.26 Allowed 'General case' 0 C--N 1.316 -0.881 0 C-N-CA 119.127 -1.029 . . . . 0.0 112.529 178.264 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.867 ' HG3' HG23 ' A' ' 67' ' ' THR . 17.4 mt-30 -137.74 161.81 35.54 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 -177.348 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.794 HD13 HD11 ' A' ' 48' ' ' LEU . 4.7 mt -128.33 132.66 67.99 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 CA-C-N 114.913 -1.039 . . . . 0.0 110.041 178.754 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.66 ' C ' HD22 ' A' ' 93' ' ' LEU . 0.0 OUTLIER -120.52 128.92 53.55 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.851 0.358 . . . . 0.0 111.963 -179.414 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.777 HD13 ' HA ' ' A' ' 99' ' ' LEU . 4.2 mm? -125.71 133.63 52.06 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.842 179.171 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 126.43 -139.31 11.26 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.425 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 58.23 84.33 0.1 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.844 0.354 . . . . 0.0 110.894 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 50.2 m-20 62.06 30.78 17.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.0 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 66.46 94.33 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.567 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -178.07 -175.24 0.47 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.872 0.368 . . . . 0.0 110.942 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.777 ' HA ' HD13 ' A' ' 93' ' ' LEU . 2.1 mp -132.94 130.86 40.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.807 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.776 HD22 ' C ' ' A' ' 99' ' ' LEU . 3.6 mm? -133.97 148.05 51.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.784 0.326 . . . . 0.0 111.029 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.556 ' CD1' HD13 ' A' ' 145' ' ' ILE . 3.0 mm? -112.79 131.71 55.57 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 179.203 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.506 ' HB2' HD11 ' A' ' 92' ' ' LEU . 9.7 t30 -109.06 111.96 23.88 Favored 'General case' 0 CA--C 1.508 -0.665 0 C-N-CA 119.742 -0.783 . . . . 0.0 109.963 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.767 ' HB3' HG21 ' A' ' 109' ' ' THR . 31.2 m-20 -86.24 110.65 19.77 Favored 'General case' 0 N--CA 1.44 -0.928 0 C-N-CA 119.319 -0.952 . . . . 0.0 109.231 179.274 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 1.053 ' O ' ' O ' ' A' ' 88' ' ' HIS . 0.1 OUTLIER -123.84 108.5 20.91 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.07 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 177.44 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.474 ' HG ' ' CE1' ' A' ' 88' ' ' HIS . 73.8 m -133.37 169.32 17.1 Favored 'General case' 0 C--N 1.293 -1.858 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.59 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 21.4 m -69.29 -63.05 1.14 Allowed 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 119.061 -1.056 . . . . 0.0 111.328 -179.149 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -112.12 -33.38 6.26 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 114.576 1.324 . . . . 0.0 114.576 179.078 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -146.94 132.64 4.45 Favored Glycine 0 C--N 1.34 0.795 0 N-CA-C 116.875 1.51 . . . . 0.0 116.875 -178.078 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.767 HG21 ' HB3' ' A' ' 103' ' ' ASP . 13.3 m -121.28 137.94 54.46 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 174.386 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 0.715 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 3.0 m-90 -121.61 148.82 44.04 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 113.599 0.963 . . . . 0.0 113.599 -178.506 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.415 ' O ' ' HG ' ' A' ' 111' ' ' LEU . 0.2 OUTLIER -123.26 112.33 17.51 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 114.969 -1.014 . . . . 0.0 108.637 177.61 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 71.6 m-20 44.71 44.28 7.38 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.032 -0.531 . . . . 0.0 112.213 -179.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 79.75 24.18 60.73 Favored Glycine 0 N--CA 1.445 -0.763 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.739 179.295 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -136.43 97.9 3.69 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.113 0.483 . . . . 0.0 110.819 179.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.715 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.0 OUTLIER -44.63 129.03 6.87 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.969 179.826 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.544 HG11 ' OD2' ' A' ' 103' ' ' ASP . 15.0 p -118.82 162.07 17.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.671 -178.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.533 ' N ' HG22 ' A' ' 116' ' ' VAL . 1.5 tp10 -70.47 142.05 51.97 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.068 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 49.2 tttm -65.42 162.93 16.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.396 179.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 4.1 p30 35.55 37.44 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.313 0.578 . . . . 0.0 111.354 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 5.0 p -111.27 109.49 19.54 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.953 -179.488 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.586 ' ND2' HD22 ' A' ' 92' ' ' LEU . 1.7 m-20 -59.76 139.5 57.24 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.808 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . 0.633 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 29.9 mm-40 -129.25 148.23 51.16 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.878 0.37 . . . . 0.0 111.925 -179.677 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -71.61 131.78 43.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.026 -0.534 . . . . 0.0 109.933 179.463 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.577 ' C ' HD22 ' A' ' 124' ' ' LEU . 0.0 OUTLIER -55.18 147.2 16.88 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 122.258 1.028 . . . . 0.0 112.248 -178.747 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.43 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.5 OUTLIER -127.16 153.38 46.12 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 113.79 -1.55 . . . . 0.0 109.898 179.143 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 4.8 mm-40 -70.81 113.12 7.56 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 179.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 63.05 31.87 82.19 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.019 -179.207 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.43 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 30.2 t70 -51.71 160.51 0.64 Allowed 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 121.015 0.436 . . . . 0.0 111.584 -179.571 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.904 ' HG2' HG22 ' A' ' 144' ' ' VAL . 2.5 mt-10 -146.47 135.43 22.48 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.17 179.779 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.627 HG21 ' OD1' ' A' ' 103' ' ' ASP . 2.6 mp -114.61 128.76 71.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-O 120.802 0.334 . . . . 0.0 110.396 179.151 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.464 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 59.9 m -102.93 145.05 30.42 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.341 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.479 ' HB ' ' NE2' ' A' ' 88' ' ' HIS . 4.8 m -141.01 158.3 23.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -178.582 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 67.11 43.21 90.79 Favored Glycine 0 N--CA 1.447 -0.59 0 CA-C-N 115.621 -0.718 . . . . 0.0 112.334 179.385 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.509 ' HA ' HG12 ' A' ' 140' ' ' ILE . 90.8 t -78.85 156.43 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 CA-C-O 121.49 0.662 . . . . 0.0 112.275 -179.163 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.462 ' N ' HG12 ' A' ' 134' ' ' VAL . . . 147.4 -42.89 0.87 Allowed Glycine 0 N--CA 1.441 -0.984 0 CA-C-N 114.843 -1.072 . . . . 0.0 110.553 -178.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.623 HG12 ' H ' ' A' ' 138' ' ' SER . 47.4 t -126.77 128.13 70.66 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.723 0 CA-C-N 115.157 -0.522 . . . . 0.0 109.796 178.634 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.515 ' HA ' HD12 ' A' ' 140' ' ' ILE . 8.6 tt0 -51.13 -30.14 15.59 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.802 0.334 . . . . 0.0 111.279 -179.342 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . 0.623 ' H ' HG12 ' A' ' 136' ' ' VAL . 28.2 t -94.2 6.46 48.55 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -179.497 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -131.03 29.27 4.71 Favored 'General case' 0 CA--C 1.52 -0.182 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -179.346 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.515 HD12 ' HA ' ' A' ' 137' ' ' GLU . 18.9 mt -105.55 140.97 21.95 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.33 179.103 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 5.4 mp -121.49 134.67 55.07 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 114.971 -1.013 . . . . 0.0 109.846 179.297 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.813 ' CB ' HG21 ' A' ' 40' ' ' THR . 0.9 OUTLIER -119.1 149.73 41.2 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.676 0.751 . . . . 0.0 112.757 -178.721 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.485 ' N ' HD12 ' A' ' 143' ' ' LEU . 4.7 mp -125.34 150.68 46.94 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 114.843 -1.071 . . . . 0.0 109.193 179.372 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.904 HG22 ' HG2' ' A' ' 129' ' ' GLU . 12.1 t -126.87 141.09 47.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 120.904 0.383 . . . . 0.0 111.842 -179.276 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.556 HD13 ' CD1' ' A' ' 101' ' ' LEU . 0.1 OUTLIER -122.72 125.92 73.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.069 179.436 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -115.58 121.38 42.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.961 0.41 . . . . 0.0 111.248 -179.469 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.535 HD11 ' CG2' ' A' ' 145' ' ' ILE . 3.0 mm -104.04 130.03 55.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.788 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . 0.42 ' ND2' ' O ' ' A' ' 32' ' ' ILE . 6.2 p30 -77.42 130.75 37.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.85 0.357 . . . . 0.0 110.78 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -73.02 -22.96 60.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.398 -179.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 1.3 mptp? -57.34 -40.62 78.36 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.913 0.387 . . . . 0.0 110.699 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -60.65 -41.31 94.72 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.724 179.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.3 -34.38 73.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.745 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -62.48 -41.95 99.15 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.794 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 13.0 t -58.73 -45.44 89.6 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.954 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -68.06 -35.83 78.86 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.825 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -63.52 -41.19 98.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.884 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -80.92 -37.06 30.25 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.871 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 2.9 p30 42.41 89.3 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.451 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 10.5 tptm -60.05 120.75 10.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.948 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 28.7 m -66.17 138.86 22.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.076 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -158.36 44.06 0.29 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.88 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 6.9 mtt180 -106.55 -62.65 1.36 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.885 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 19.2 pt -100.01 133.64 42.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.197 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.232 -0.889 . . . . 0.0 110.911 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.303 0 N-CA-C 112.683 -0.167 . . . . 0.0 112.683 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 62.45 47.86 4.9 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.956 0.408 . . . . 0.0 110.844 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 36.4 m-80 -109.17 -26.4 10.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.112 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 20.6 mm 71.2 -66.89 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.229 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.8 m 61.91 151.05 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.189 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 56.97 84.7 0.2 Allowed Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.955 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -53.94 136.05 65.35 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.634 2.223 . . . . 0.0 112.345 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -126.3 179.9 5.06 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.964 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -122.39 -57.41 1.76 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.928 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -59.96 136.38 57.99 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.03 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -146.64 54.74 1.12 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.73 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.9 p -106.29 -17.59 14.25 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.482 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.83 147.27 7.05 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.882 0.372 . . . . 0.0 111.053 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -56.94 164.92 1.39 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.204 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 18.8 p -95.12 -46.57 6.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.051 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -59.69 -36.57 76.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.004 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.61 -38.43 70.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.898 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -59.08 -40.3 84.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.968 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 7.4 mp -60.34 -40.26 90.06 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.855 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 34.3 mm -68.34 -47.2 78.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.055 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -57.71 -35.37 70.56 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.002 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -60.31 -37.94 82.13 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.86 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -59.66 -47.53 85.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.093 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 35.4 p -76.95 -31.33 56.52 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.941 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -59.77 92.99 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.929 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.515 ' OE2' HD13 ' A' ' 28' ' ' ILE . 0.0 OUTLIER -91.35 146.23 23.98 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.933 179.97 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -64.88 128.71 36.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.831 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.515 HD13 ' OE2' ' A' ' 26' ' ' GLU . 19.0 mm -87.26 139.16 17.76 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.327 0 CA-C-O 121.589 0.709 . . . . 0.0 111.709 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.477 ' HA2' ' HB ' ' A' ' 32' ' ' ILE . . . -152.19 18.13 0.81 Allowed Glycine 0 C--N 1.318 -0.428 0 CA-C-N 114.773 -1.103 . . . . 0.0 112.885 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.479 ' OE2' HG23 ' A' ' 28' ' ' ILE . 8.3 pm0 -89.19 -23.62 22.36 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 111.687 0.254 . . . . 0.0 111.687 -179.715 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.659 ' HA ' HD12 ' A' ' 52' ' ' ILE . 11.3 m-80 -108.75 -14.56 14.58 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-O 121.918 0.866 . . . . 0.0 109.017 178.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.542 HD13 ' O ' ' A' ' 48' ' ' LEU . 0.0 OUTLIER -74.08 105.91 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.533 0 CA-C-N 113.919 -1.491 . . . . 0.0 110.664 -179.6 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 1.027 ' CG2' ' HB2' ' A' ' 50' ' ' ALA . 0.5 OUTLIER -40.26 -62.65 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.712 -179.105 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.739 ' SG ' HD12 ' A' ' 48' ' ' LEU . 31.1 p -164.92 164.96 20.67 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.505 -179.78 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 12.0 ttm180 -126.78 122.4 34.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.842 0.353 . . . . 0.0 111.176 179.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.831 ' CG2' HD11 ' A' ' 48' ' ' LEU . 18.8 t -93.12 124.34 45.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.616 179.643 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.963 HG23 HG12 ' A' ' 45' ' ' ILE . 35.6 mt -121.51 108.49 22.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 112.254 0.464 . . . . 0.0 112.254 -179.178 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 14.6 t -80.28 103.92 10.48 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 177.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.9 p -99.34 22.18 10.98 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 112.454 0.538 . . . . 0.0 112.454 -178.347 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.691 HG21 ' HB2' ' A' ' 142' ' ' SER . 45.5 p -114.21 -13.14 12.4 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 111.657 0.244 . . . . 0.0 111.657 179.78 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 95.63 75.54 1.27 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.602 -0.808 . . . . 0.0 112.616 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.542 ' CG ' HD12 ' A' ' 141' ' ' LEU . 4.8 mt-30 -150.97 -55.68 0.15 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.774 0.321 . . . . 0.0 110.983 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 2.0 mt -134.71 131.14 20.04 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.833 -179.697 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.433 ' HD2' ' CZ ' ' A' ' 76' ' ' TYR . 37.3 Cg_exo -58.87 147.1 90.79 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.569 2.18 . . . . 0.0 111.682 179.721 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.963 HG12 HG23 ' A' ' 37' ' ' ILE . 51.9 mt -42.39 128.97 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 121.03 0.443 . . . . 0.0 112.064 -179.363 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.439 ' HG2' ' O ' ' A' ' 75' ' ' ASP . 0.9 OUTLIER -123.54 130.13 52.22 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.935 179.295 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -95.14 120.16 34.89 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.095 0.474 . . . . 0.0 111.664 -179.13 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.831 HD11 ' CG2' ' A' ' 36' ' ' VAL . 1.6 mt -94.63 126.73 40.12 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.387 178.821 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.494 ' O ' ' HZ2' ' A' ' 66' ' ' TRP . 0.0 OUTLIER -119.62 162.08 19.58 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 122.102 0.953 . . . . 0.0 113.171 -178.731 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 1.027 ' HB2' ' CG2' ' A' ' 33' ' ' VAL . . . -116.47 166.17 12.39 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 114.47 -1.241 . . . . 0.0 111.011 179.596 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.874 ' O ' HG23 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -103.99 57.97 0.72 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.098 0.475 . . . . 0.0 110.755 179.914 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.736 HD11 ' CE2' ' A' ' 151' ' ' PHE . 46.2 mt -60.08 -43.49 92.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.9 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 5.0 m -66.76 -38.73 87.17 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.112 -179.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.41 ' CG ' ' HB3' ' A' ' 51' ' ' ASP . 2.4 mm100 -68.11 -41.71 81.34 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.036 -179.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.874 HG23 ' O ' ' A' ' 51' ' ' ASP . 37.7 t -65.04 -41.96 93.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.034 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.467 HD23 ' HA ' ' A' ' 56' ' ' LEU . 4.4 mt -70.77 -41.13 72.13 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.913 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.2 mtpt -100.1 21.6 12.59 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.109 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 177.99 96.66 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.87 0.366 . . . . 0.0 110.834 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.07 105.03 0.36 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.02 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.13 15.53 2.07 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.273 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.2 t 53.33 101.27 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.769 0.319 . . . . 0.0 111.071 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.739 HD11 ' HB1' ' A' ' 50' ' ' ALA . 0.5 OUTLIER -49.54 116.43 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.06 179.789 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 10.1 ttmt -154.5 99.69 2.2 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.201 -179.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.404 ' HE3' ' O ' ' A' ' 49' ' ' SER . 3.7 ttpt -136.79 134.03 36.6 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.183 179.489 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.508 HG12 ' HG2' ' A' ' 90' ' ' GLN . 3.4 t -123.29 134.6 65.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.214 0.531 . . . . 0.0 112.01 -178.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . 0.786 ' CD1' HD22 ' A' ' 48' ' ' LEU . 12.3 m-90 -100.95 138.86 37.43 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.727 179.2 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.612 ' N ' ' HB2' ' A' ' 75' ' ' ASP . 1.3 m -131.75 127.71 37.36 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.31 0.576 . . . . 0.0 112.315 179.436 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.513 ' CE1' ' CE2' ' A' ' 89' ' ' PHE . 96.2 m-85 -98.32 117.83 33.61 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.423 178.011 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.67 ' HA2' ' O ' ' A' ' 85' ' ' SER . . . 158.9 -157.95 28.94 Favored Glycine 0 CA--C 1.503 -0.716 0 C-N-CA 119.001 -1.571 . . . . 0.0 112.683 179.1 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.407 ' HB3' ' HA ' ' A' ' 80' ' ' ASN . 7.8 ptm180 -76.13 91.92 3.18 Favored 'General case' 0 N--CA 1.441 -0.911 0 CA-C-O 122.614 1.197 . . . . 0.0 108.302 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.483 ' O ' ' CD2' ' A' ' 77' ' ' HIS . 0.1 OUTLIER -149.71 160.4 34.09 Favored Pre-proline 0 C--N 1.309 -1.188 0 CA-C-N 112.787 -2.006 . . . . 0.0 108.261 179.608 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.544 ' O ' ' CB ' ' A' ' 73' ' ' ALA . 29.3 Cg_endo -63.0 -11.04 22.75 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 120.869 1.046 . . . . 0.0 111.03 178.479 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.769 ' HB2' ' HB2' ' A' ' 77' ' ' HIS . . . 137.82 52.32 0.0 OUTLIER 'General case' 0 CA--C 1.491 -1.297 0 CA-C-N 114.743 -1.117 . . . . 0.0 109.685 178.548 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.566 ' CB ' ' HB ' ' A' ' 67' ' ' THR . 0.1 OUTLIER -53.12 -69.92 0.1 Allowed 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 105.957 -1.868 . . . . 0.0 105.957 179.347 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.612 ' HB2' ' N ' ' A' ' 67' ' ' THR . 5.8 t0 -94.26 -47.45 6.62 Favored 'General case' 0 N--CA 1.436 -1.153 0 N-CA-C 105.743 -1.947 . . . . 0.0 105.743 169.754 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.548 ' C ' ' HA ' ' A' ' 73' ' ' ALA . 10.6 t80 -143.37 143.12 31.52 Favored 'General case' 0 C--N 1.344 0.356 0 CA-C-N 112.386 -2.188 . . . . 0.0 110.728 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.769 ' HB2' ' HB2' ' A' ' 73' ' ' ALA . 19.4 t-160 -84.54 114.1 21.71 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.33 -0.548 . . . . 0.0 110.309 177.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 87.2 mt -126.58 166.19 17.76 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.869 0.366 . . . . 0.0 111.099 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -66.02 -166.71 2.06 Favored Glycine 0 C--N 1.33 0.228 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.212 179.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.407 ' HA ' ' HB3' ' A' ' 70' ' ' ARG . 8.6 p30 -111.35 99.1 7.96 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.932 0.396 . . . . 0.0 111.245 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.535 ' HB ' ' HB2' ' A' ' 85' ' ' SER . 29.7 mm -113.84 133.63 59.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.811 179.34 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 5.7 p -66.6 -41.91 87.7 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.794 0.665 . . . . 0.0 112.794 -179.449 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.573 ' C ' HD13 ' A' ' 84' ' ' LEU . 2.2 mpt_? -83.12 -105.76 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 113.11 0.781 . . . . 0.0 113.11 -177.769 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.742 ' H ' HD22 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -107.69 114.6 28.67 Favored 'General case' 0 CA--C 1.511 -0.554 0 CA-C-O 121.637 0.732 . . . . 0.0 109.179 -179.8 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.67 ' O ' ' HA2' ' A' ' 69' ' ' GLY . 0.5 OUTLIER 156.34 -36.25 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 114.054 -1.43 . . . . 0.0 107.885 -178.839 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.802 ' O ' ' N ' ' A' ' 88' ' ' HIS . 0.1 OUTLIER -61.85 -161.56 0.01 OUTLIER 'General case' 0 CA--C 1.51 -0.566 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 176.743 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.785 ' HB2' HD11 ' A' ' 104' ' ' ILE . 0.0 OUTLIER -53.63 72.53 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 177.091 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.928 ' O ' ' O ' ' A' ' 104' ' ' ILE . 28.3 t60 -77.66 -16.32 58.6 Favored 'General case' 0 CA--C 1.515 -0.376 0 N-CA-C 113.858 1.059 . . . . 0.0 113.858 -176.406 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.623 ' HA ' ' H ' ' A' ' 104' ' ' ILE . 0.2 OUTLIER -173.47 154.84 2.67 Favored 'General case' 0 C--N 1.308 -1.232 0 C-N-CA 119.307 -0.957 . . . . 0.0 112.549 177.914 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.508 ' HG2' HG12 ' A' ' 65' ' ' VAL . 2.8 tt0 -136.28 155.66 49.77 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.732 -1.122 . . . . 0.0 113.533 -177.448 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.644 ' HB ' ' HB2' ' A' ' 66' ' ' TRP . 25.4 mt -127.42 132.46 69.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 115.256 -0.883 . . . . 0.0 110.224 179.231 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.681 HD11 ' HB2' ' A' ' 102' ' ' ASN . 0.1 OUTLIER -117.29 125.35 50.94 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.946 0.403 . . . . 0.0 111.365 179.792 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.768 ' CD1' HD22 ' A' ' 99' ' ' LEU . 1.1 mm? -127.19 140.11 52.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.599 179.265 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 128.5 -124.27 4.62 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.529 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 62.93 43.06 7.05 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.892 0.377 . . . . 0.0 110.971 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 60.18 30.79 20.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.936 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 106.96 75.8 0.96 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.456 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.458 ' C ' HD23 ' A' ' 99' ' ' LEU . 0.2 OUTLIER -178.37 136.19 0.16 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.763 0.316 . . . . 0.0 110.758 -179.883 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.829 HD12 HD22 ' A' ' 124' ' ' LEU . 0.1 OUTLIER -108.1 130.84 55.08 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.552 179.957 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.642 ' HA ' ' O ' ' A' ' 122' ' ' GLN . 6.5 mt -133.76 148.5 51.4 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.028 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.455 ' O ' ' N ' ' A' ' 122' ' ' GLN . 41.3 mt -116.31 129.77 56.43 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 179.205 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.681 ' HB2' HD11 ' A' ' 92' ' ' LEU . 18.1 t30 -110.56 110.78 21.63 Favored 'General case' 0 CA--C 1.508 -0.637 0 C-N-CA 119.611 -0.836 . . . . 0.0 110.105 -179.793 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.764 ' HB3' HG21 ' A' ' 109' ' ' THR . 58.4 m-20 -83.57 111.11 18.8 Favored 'General case' 0 N--CA 1.441 -0.888 0 C-N-CA 119.647 -0.821 . . . . 0.0 108.883 179.157 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.928 ' O ' ' O ' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -124.08 107.69 19.16 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.9 0 CA-C-O 121.6 0.714 . . . . 0.0 109.188 178.203 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.426 ' HG ' ' CD2' ' A' ' 88' ' ' HIS . 43.4 m -131.33 172.28 12.36 Favored 'General case' 0 C--N 1.297 -1.706 0 CA-C-N 114.867 -1.061 . . . . 0.0 109.142 179.504 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 19.6 m -69.62 -63.63 1.03 Allowed 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 119.092 -1.043 . . . . 0.0 111.906 -178.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -112.41 -32.26 6.55 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 114.755 1.391 . . . . 0.0 114.755 179.421 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -145.57 126.55 2.59 Favored Glycine 0 C--N 1.338 0.685 0 N-CA-C 116.849 1.5 . . . . 0.0 116.849 -177.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.764 HG21 ' HB3' ' A' ' 103' ' ' ASP . 3.3 m -121.12 138.16 54.32 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 174.522 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 0.703 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 3.1 m-90 -121.76 149.37 43.39 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 113.393 0.886 . . . . 0.0 113.393 -178.231 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.701 HD12 HG11 ' A' ' 116' ' ' VAL . 1.2 mt -124.06 112.1 16.75 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.068 -0.969 . . . . 0.0 109.021 177.157 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 10.1 m-80 50.13 35.72 10.76 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.541 -179.223 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 82.57 26.09 48.01 Favored Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.64 179.419 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -133.08 96.83 3.85 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.009 0.433 . . . . 0.0 110.743 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.703 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.0 OUTLIER -46.52 134.61 9.18 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.01 179.82 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.701 HG11 HD12 ' A' ' 111' ' ' LEU . 12.6 p -135.14 165.45 30.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.227 -179.254 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.538 ' N ' HG22 ' A' ' 116' ' ' VAL . 0.3 OUTLIER -69.6 142.69 53.48 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.256 179.746 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.469 ' HG3' ' ND2' ' A' ' 119' ' ' ASN . 12.8 ptmt -68.42 169.68 10.32 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.792 0.329 . . . . 0.0 110.92 -179.65 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.469 ' ND2' ' HG3' ' A' ' 118' ' ' LYS . 21.8 p30 33.86 37.58 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.192 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.427 ' HB3' ' O ' ' A' ' 117' ' ' GLU . 0.1 OUTLIER -111.8 107.9 17.12 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.671 179.406 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.591 ' ND2' HD22 ' A' ' 92' ' ' LEU . 5.3 m120 -47.67 138.45 8.22 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 120.598 0.237 . . . . 0.0 110.951 -179.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . 0.642 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 71.9 mm-40 -126.84 148.5 49.97 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-O 121.144 0.497 . . . . 0.0 111.857 -179.684 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.539 HD13 ' O ' ' A' ' 124' ' ' LEU . 3.0 tm? -73.98 112.08 9.75 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.585 178.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 1.104 HD21 HD13 ' A' ' 147' ' ' ILE . 6.6 tt -46.99 145.75 1.95 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.789 0.804 . . . . 0.0 112.06 -178.693 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -126.67 153.23 45.68 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 114.185 -1.37 . . . . 0.0 110.272 179.638 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 8.0 mm100 -71.24 113.68 8.52 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 179.35 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 68.47 28.38 73.25 Favored Glycine 0 N--CA 1.445 -0.72 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.18 -179.145 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -55.1 160.56 2.04 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.987 0.422 . . . . 0.0 111.434 -179.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.452 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 1.3 tm-20 -146.4 135.58 22.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.249 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.501 HG21 ' OD1' ' A' ' 103' ' ' ASP . 1.3 mp -112.38 129.05 68.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.415 179.047 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.566 HG23 ' CG2' ' A' ' 140' ' ' ILE . 16.0 m -103.02 142.26 34.4 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.835 -179.513 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.447 HG11 ' CD2' ' A' ' 88' ' ' HIS . 4.3 m -140.85 153.26 20.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.187 -0.461 . . . . 0.0 112.004 -179.021 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 75.52 35.8 45.9 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 121.111 -0.566 . . . . 0.0 112.367 179.442 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.45 ' HA ' HG12 ' A' ' 140' ' ' ILE . 78.9 t -71.68 155.61 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 CA-C-O 121.468 0.651 . . . . 0.0 112.127 -179.306 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.426 ' N ' HG12 ' A' ' 134' ' ' VAL . . . 153.44 -45.77 0.57 Allowed Glycine 0 N--CA 1.443 -0.863 0 CA-C-N 115.003 -0.998 . . . . 0.0 110.707 -179.164 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.61 HG12 ' H ' ' A' ' 138' ' ' SER . 62.0 t -126.71 134.85 65.32 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 CA-C-N 115.258 -0.471 . . . . 0.0 109.744 178.644 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 16.3 tm-20 -51.28 -34.38 32.72 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.83 0.347 . . . . 0.0 111.26 -179.293 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . 0.61 ' H ' HG12 ' A' ' 136' ' ' VAL . 76.7 p -94.11 6.4 48.67 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 116.246 -0.434 . . . . 0.0 112.06 -179.595 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -126.38 30.66 5.54 Favored 'General case' 0 CA--C 1.518 -0.257 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -179.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.566 ' CG2' HG23 ' A' ' 131' ' ' THR . 20.9 mt -107.23 140.91 23.82 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.304 179.213 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.542 HD12 ' CG ' ' A' ' 42' ' ' GLN . 3.0 mm? -120.43 135.43 55.05 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 114.874 -1.057 . . . . 0.0 110.005 179.737 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.691 ' HB2' HG21 ' A' ' 40' ' ' THR . 4.2 m -125.13 152.35 44.53 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.848 0.833 . . . . 0.0 113.094 -178.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.634 HD12 ' O ' ' A' ' 142' ' ' SER . 6.5 mp -125.82 146.21 49.89 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.323 -1.308 . . . . 0.0 109.033 178.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 21.7 t -131.16 140.28 48.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 120.838 0.351 . . . . 0.0 111.793 -179.083 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.824 HG13 HG22 ' A' ' 36' ' ' VAL . 0.6 OUTLIER -111.04 139.64 34.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.743 179.552 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 47.4 t80 -119.14 104.24 10.26 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.689 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 1.104 HD13 HD21 ' A' ' 124' ' ' LEU . 1.2 mp -98.15 129.72 47.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.241 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 14.7 p30 -83.37 133.1 34.96 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.953 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -67.83 -20.65 65.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.13 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.71 -43.1 84.98 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.935 0.398 . . . . 0.0 110.61 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . 0.736 ' CE2' HD11 ' A' ' 52' ' ' ILE . 13.2 t80 -59.57 -44.51 93.29 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.816 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 50.0 tttm -59.43 -36.86 76.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.857 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 3.0 tp60 -66.09 -37.26 85.33 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.9 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 13.0 t -59.82 -45.6 91.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.863 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.0 -39.31 79.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.922 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -60.71 -48.46 81.68 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.096 -179.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -82.84 -32.5 27.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.996 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 3.6 p30 42.5 65.03 0.98 Allowed 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.432 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 16.4 mmtm -85.01 120.36 26.44 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.941 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 18.8 t -85.0 124.04 39.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.025 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -49.97 -64.75 0.71 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.15 -179.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 3.1 tpt180 52.23 99.51 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.271 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 30.8 mm -103.57 114.46 43.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.119 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 20.7 mmt180 . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.254 -0.879 . . . . 0.0 110.877 -179.918 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.266 0 N-CA-C 112.49 -0.244 . . . . 0.0 112.49 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 57.2 31.87 20.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.821 0.343 . . . . 0.0 110.977 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 22.4 m-20 -107.21 41.61 1.45 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.908 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.8 tt -58.43 -22.37 20.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.316 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 69.72 140.86 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.086 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 9.2 tp60 -126.41 93.79 42.21 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.959 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -49.76 97.74 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.564 2.176 . . . . 0.0 112.326 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.614 HG23 ' H ' ' A' ' 10' ' ' GLN . 6.9 t -101.13 -26.61 13.62 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.29 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 62.86 30.58 16.58 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.871 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.614 ' H ' HG23 ' A' ' 8' ' ' THR . 4.9 mt-30 60.76 158.49 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.89 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -125.05 176.19 6.85 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.847 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.3 m -144.44 114.93 7.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.188 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -102.14 70.21 1.19 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.7 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -109.3 106.11 15.8 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.069 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 32.8 p -107.53 59.81 0.62 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.106 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -60.48 -34.22 73.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.688 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.99 -35.76 77.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.714 179.727 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -56.83 -41.43 77.86 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.981 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.74 -34.6 78.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.867 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 40.2 mm -73.48 -43.68 55.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.015 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -57.78 -33.96 69.1 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.048 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.12 -28.63 66.72 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.072 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -56.89 -47.59 80.15 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.032 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.28 -21.71 66.76 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.979 179.763 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 71.21 47.86 0.38 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.939 0.4 . . . . 0.0 110.86 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -75.03 153.21 38.56 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.892 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -110.39 110.64 21.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.024 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 22.3 mm -86.84 139.61 17.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.404 0.621 . . . . 0.0 111.716 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.12 -36.31 0.06 OUTLIER Glycine 0 C--N 1.319 -0.408 0 CA-C-N 114.914 -1.039 . . . . 0.0 112.616 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -72.7 -23.45 60.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.617 0.246 . . . . 0.0 111.39 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.576 ' HA ' HD12 ' A' ' 52' ' ' ILE . 43.6 m-20 -108.74 -14.53 14.58 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-O 121.904 0.859 . . . . 0.0 108.95 178.611 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.487 ' O ' HG22 ' A' ' 32' ' ' ILE . 0.1 OUTLIER -75.07 110.62 10.09 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.636 0 CA-C-N 113.991 -1.459 . . . . 0.0 111.088 -179.557 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 1.027 ' CG2' ' HB2' ' A' ' 50' ' ' ALA . 0.5 OUTLIER -41.18 -63.66 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.406 -179.49 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.626 ' N ' ' CG1' ' A' ' 33' ' ' VAL . 23.4 p -166.21 165.05 17.77 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.519 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 3.6 ttm180 -121.95 120.39 34.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.877 179.491 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.781 HG23 HD13 ' A' ' 48' ' ' LEU . 40.1 t -89.13 124.75 42.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.95 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.937 HG23 HG12 ' A' ' 45' ' ' ILE . 30.0 mt -124.58 108.12 19.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.65 -179.741 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.517 ' SG ' HD23 ' A' ' 143' ' ' LEU . 3.4 m -90.48 100.96 13.7 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 178.53 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 7.0 t -80.21 -27.19 38.85 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 -178.184 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.417 ' OG1' ' O ' ' A' ' 142' ' ' SER . 0.1 OUTLIER -51.54 -27.17 10.09 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.997 0.427 . . . . 0.0 111.023 -179.679 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 97.41 36.94 4.7 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.384 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 18.9 pt20 -106.0 -46.85 3.99 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.853 0.358 . . . . 0.0 110.908 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.439 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 7.1 mt -133.53 132.53 21.9 Favored Pre-proline 0 N--CA 1.451 -0.414 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.19 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.524 ' HD2' ' CZ ' ' A' ' 76' ' ' TYR . 27.3 Cg_exo -59.63 147.37 92.19 Favored 'Trans proline' 0 C--O 1.232 0.214 0 C-N-CA 122.763 2.309 . . . . 0.0 111.904 179.535 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.937 HG12 HG23 ' A' ' 37' ' ' ILE . 44.2 mt -43.6 139.0 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.83 -179.702 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.1 140.81 46.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.37 179.67 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -108.34 120.23 41.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.112 0.482 . . . . 0.0 111.632 -179.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 1.106 HD21 HD13 ' A' ' 91' ' ' ILE . 3.0 mp -98.82 125.2 44.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.156 178.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.518 ' O ' ' CZ2' ' A' ' 66' ' ' TRP . 0.0 OUTLIER -111.26 163.11 14.28 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 122.041 0.924 . . . . 0.0 113.338 -178.545 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 1.027 ' HB2' ' CG2' ' A' ' 33' ' ' VAL . . . -123.45 166.19 15.8 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 114.632 -1.167 . . . . 0.0 111.22 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.826 ' O ' HG23 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -111.21 71.69 0.75 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.287 179.477 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.637 HD11 ' CD2' ' A' ' 151' ' ' PHE . 92.3 mt -63.59 -45.77 96.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.401 -179.56 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -60.49 -36.89 79.39 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.083 0.468 . . . . 0.0 110.672 -179.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.406 ' CG ' ' HB3' ' A' ' 51' ' ' ASP . 37.7 mm-40 -68.55 -44.78 73.8 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.973 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.826 HG23 ' O ' ' A' ' 51' ' ' ASP . 23.7 t -62.18 -45.14 99.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.204 -179.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.5 tp -58.73 -33.13 69.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.991 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.04 -46.13 10.78 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.954 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -118.35 134.57 54.94 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.865 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.65 -31.41 52.67 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.824 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 13.5 ptm180 -68.3 -34.0 75.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.9 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.507 ' O ' HG22 ' A' ' 55' ' ' VAL . 5.8 m -61.22 95.88 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.947 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.569 HG23 ' O ' ' A' ' 62' ' ' ILE . 0.6 OUTLIER -178.28 65.56 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.119 -179.967 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 11.0 tttm -157.78 84.59 0.89 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.013 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.418 ' O ' ' HB3' ' A' ' 93' ' ' LEU . 17.0 ttpt -136.1 130.64 33.67 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.635 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.6 HG13 ' O ' ' A' ' 91' ' ' ILE . 15.3 t -135.2 137.93 49.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.113 0.482 . . . . 0.0 111.894 -179.29 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . 0.641 ' HB2' ' HB ' ' A' ' 91' ' ' ILE . 15.5 m-90 -100.61 140.15 35.28 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.607 179.175 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.86 HG23 ' HG3' ' A' ' 90' ' ' GLN . 7.8 m -125.78 127.41 46.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.544 0.687 . . . . 0.0 112.329 179.46 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.655 ' HE2' HD11 ' A' ' 91' ' ' ILE . 44.7 m-85 -101.03 118.57 37.25 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.114 -0.948 . . . . 0.0 108.927 177.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.604 ' HA2' ' O ' ' A' ' 85' ' ' SER . . . 160.0 -157.66 28.95 Favored Glycine 0 CA--C 1.503 -0.665 0 C-N-CA 119.117 -1.516 . . . . 0.0 112.419 179.499 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.423 ' N ' ' HA ' ' A' ' 86' ' ' ASN . 0.5 OUTLIER -76.74 92.17 3.54 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-O 122.554 1.168 . . . . 0.0 108.912 -179.712 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.524 ' O ' ' CD2' ' A' ' 77' ' ' HIS . 6.1 m-80 -149.59 155.19 38.76 Favored Pre-proline 0 C--N 1.308 -1.197 0 CA-C-N 112.809 -1.996 . . . . 0.0 108.259 178.72 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.551 ' O ' ' CB ' ' A' ' 73' ' ' ALA . 24.5 Cg_exo -55.79 -10.23 3.72 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 121.277 1.318 . . . . 0.0 111.278 177.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.739 ' HB2' ' HB2' ' A' ' 77' ' ' HIS . . . 135.99 52.23 0.0 OUTLIER 'General case' 0 CA--C 1.49 -1.336 0 CA-C-N 114.999 -1.0 . . . . 0.0 109.375 178.792 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.567 ' HB3' ' HB ' ' A' ' 67' ' ' THR . 0.1 OUTLIER -52.97 -69.62 0.11 Allowed 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 105.867 -1.901 . . . . 0.0 105.867 179.524 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.592 ' HB2' ' N ' ' A' ' 67' ' ' THR . 40.1 t0 -94.93 -47.74 6.3 Favored 'General case' 0 N--CA 1.435 -1.211 0 N-CA-C 105.687 -1.968 . . . . 0.0 105.687 169.755 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.524 ' CZ ' ' HD2' ' A' ' 44' ' ' PRO . 33.0 t80 -145.01 142.7 30.01 Favored 'General case' 0 C--N 1.347 0.485 0 CA-C-N 112.573 -2.103 . . . . 0.0 111.473 179.366 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.739 ' HB2' ' HB2' ' A' ' 73' ' ' ALA . 23.7 t-160 -93.79 107.28 19.19 Favored 'General case' 0 C--N 1.33 -0.249 0 O-C-N 122.014 -0.429 . . . . 0.0 109.968 176.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.841 HD12 ' O ' ' A' ' 79' ' ' GLY . 3.8 pp -121.82 172.61 8.04 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 120.96 0.409 . . . . 0.0 111.645 -179.691 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.841 ' O ' HD12 ' A' ' 78' ' ' LEU . . . -57.86 -172.65 0.3 Allowed Glycine 0 C--N 1.333 0.383 0 CA-C-N 115.916 -0.584 . . . . 0.0 112.595 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.456 ' HA ' ' OD1' ' A' ' 86' ' ' ASN . 0.3 OUTLIER -111.94 98.11 7.15 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -179.64 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.809 HD12 ' CB ' ' A' ' 85' ' ' SER . 16.7 mt -114.79 113.96 45.18 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.252 178.41 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 5.8 m -54.7 -24.12 20.6 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 112.587 0.588 . . . . 0.0 112.587 -178.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.448 ' H ' HG22 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -93.58 -102.22 0.13 Allowed 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 -178.743 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.416 ' O ' ' CB ' ' A' ' 85' ' ' SER . 0.0 OUTLIER -109.23 110.45 21.66 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-O 121.682 0.753 . . . . 0.0 110.537 -179.391 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.809 ' CB ' HD12 ' A' ' 81' ' ' ILE . 0.5 OUTLIER 160.43 -46.84 0.0 OUTLIER 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 114.205 -1.362 . . . . 0.0 109.489 179.875 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.817 ' O ' ' N ' ' A' ' 88' ' ' HIS . 93.9 m-20 -64.8 -153.99 0.01 OUTLIER 'General case' 0 CA--C 1.521 -0.165 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 178.128 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.89 ' HB2' HD11 ' A' ' 104' ' ' ILE . 7.9 ptmt -49.31 73.44 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 179.099 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.971 ' O ' ' O ' ' A' ' 104' ' ' ILE . 31.2 t60 -95.67 -18.64 20.35 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 114.299 1.222 . . . . 0.0 114.299 -176.517 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.656 ' HA ' ' H ' ' A' ' 104' ' ' ILE . 0.2 OUTLIER -172.98 153.24 2.53 Favored 'General case' 0 C--N 1.31 -1.115 0 C-N-CA 119.014 -1.074 . . . . 0.0 112.489 178.063 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.86 ' HG3' HG23 ' A' ' 67' ' ' THR . 20.1 mt-30 -134.1 159.23 41.48 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 114.38 -1.282 . . . . 0.0 113.483 -177.322 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 1.106 HD13 HD21 ' A' ' 48' ' ' LEU . 2.8 mt -124.71 131.88 72.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.113 -0.948 . . . . 0.0 110.213 179.013 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.652 HD13 ' ND2' ' A' ' 121' ' ' ASN . 0.3 OUTLIER -107.38 145.09 33.34 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.036 0.446 . . . . 0.0 111.935 -179.623 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.881 HD22 ' N ' ' A' ' 94' ' ' GLY . 0.3 OUTLIER -125.73 128.73 48.21 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.47 179.324 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.881 ' N ' HD22 ' A' ' 93' ' ' LEU . . . 158.32 -146.94 14.06 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.46 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 62.67 71.68 0.52 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.909 0.385 . . . . 0.0 110.936 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 63.47 -80.41 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.028 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.558 ' HA3' HD23 ' A' ' 155' ' ' LEU . . . -150.02 29.27 1.12 Allowed Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.593 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -114.68 -170.8 1.81 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.715 0.293 . . . . 0.0 110.897 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 1.014 HD22 HD13 ' A' ' 124' ' ' LEU . 9.7 tt -131.0 156.69 44.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.893 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.689 HD23 ' HB3' ' A' ' 121' ' ' ASN . 4.5 mp -133.4 149.25 51.82 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.53 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.607 HD11 HD13 ' A' ' 145' ' ' ILE . 4.9 mp -114.81 128.92 56.58 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.756 -0.378 . . . . 0.0 110.101 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.49 ' O ' ' O ' ' A' ' 90' ' ' GLN . 27.9 t30 -110.47 111.21 22.31 Favored 'General case' 0 CA--C 1.509 -0.619 0 C-N-CA 119.76 -0.776 . . . . 0.0 109.766 179.47 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.825 ' HB3' HG21 ' A' ' 109' ' ' THR . 83.7 m-20 -84.74 112.65 20.68 Favored 'General case' 0 N--CA 1.444 -0.772 0 C-N-CA 119.865 -0.734 . . . . 0.0 109.887 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.971 ' O ' ' O ' ' A' ' 88' ' ' HIS . 0.1 OUTLIER -122.91 107.5 19.44 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.925 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 177.473 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.44 ' HG ' ' CE1' ' A' ' 88' ' ' HIS . 55.7 m -134.79 164.53 27.34 Favored 'General case' 0 C--N 1.295 -1.797 0 CA-C-N 115.011 -0.995 . . . . 0.0 109.432 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 19.9 m -69.4 -62.69 1.28 Allowed 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 119.207 -0.997 . . . . 0.0 111.789 -178.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -111.79 -32.64 6.56 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 115.218 1.562 . . . . 0.0 115.218 179.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -146.18 127.64 2.83 Favored Glycine 0 C--N 1.339 0.747 0 N-CA-C 117.36 1.704 . . . . 0.0 117.36 -177.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.825 HG21 ' HB3' ' A' ' 103' ' ' ASP . 7.5 m -121.36 138.12 54.4 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 174.289 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 0.712 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 3.4 m-90 -122.89 149.21 44.51 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 113.532 0.938 . . . . 0.0 113.532 -178.552 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.41 ' O ' ' HG ' ' A' ' 111' ' ' LEU . 0.3 OUTLIER -123.95 112.18 16.91 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 114.917 -1.038 . . . . 0.0 108.451 177.5 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 15.9 m-20 44.37 44.46 6.84 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.065 -0.516 . . . . 0.0 112.109 -179.394 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 79.89 26.4 56.02 Favored Glycine 0 N--CA 1.444 -0.792 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.779 179.28 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -138.62 96.8 3.21 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.079 0.466 . . . . 0.0 110.78 179.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.712 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.0 OUTLIER -44.37 129.08 6.48 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.964 179.806 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.786 HG21 ' OD2' ' A' ' 103' ' ' ASP . 27.6 m -115.91 -178.74 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.133 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.971 -178.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -91.61 142.23 27.86 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.086 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.46 ' HG3' ' HA ' ' A' ' 104' ' ' ILE . 49.1 tttm -63.72 162.35 13.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.27 179.381 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.422 ' N ' ' HG2' ' A' ' 118' ' ' LYS . 4.3 p30 34.58 39.13 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.268 0.556 . . . . 0.0 111.264 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 9.5 p -111.24 106.58 15.62 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.07 -179.4 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.689 ' HB3' HD23 ' A' ' 100' ' ' LEU . 1.6 m-20 -54.68 143.6 24.53 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.64 179.736 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . 0.633 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 30.9 mm-40 -129.74 145.62 51.54 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.98 0.419 . . . . 0.0 112.005 -179.467 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.8 tt -72.87 121.33 19.82 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.526 178.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 1.014 HD13 HD22 ' A' ' 99' ' ' LEU . 12.1 tp -47.76 142.39 4.74 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-O 122.027 0.918 . . . . 0.0 112.186 -178.806 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.444 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.3 OUTLIER -127.51 152.62 47.35 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 113.895 -1.502 . . . . 0.0 110.05 179.191 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 11.3 mm100 -71.61 113.82 9.04 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.898 0.38 . . . . 0.0 110.024 179.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 64.61 31.67 81.67 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.512 -179.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.444 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 17.2 t70 -58.31 159.42 6.13 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.959 0.409 . . . . 0.0 111.195 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.748 ' HG3' HG22 ' A' ' 144' ' ' VAL . 3.0 tt0 -146.6 135.71 22.59 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.531 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.447 ' CG2' ' O ' ' A' ' 110' ' ' TRP . 1.3 mp -111.84 128.69 68.25 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.168 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.117 178.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.472 HG23 ' CG2' ' A' ' 140' ' ' ILE . 95.2 m -103.24 145.05 30.52 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.512 -179.687 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.513 HG11 ' CD2' ' A' ' 88' ' ' HIS . 4.3 m -141.09 158.27 22.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 -178.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 68.8 41.26 83.67 Favored Glycine 0 N--CA 1.448 -0.533 0 CA-C-N 115.776 -0.647 . . . . 0.0 112.553 179.406 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.505 ' HA ' HG12 ' A' ' 140' ' ' ILE . 98.6 t -76.45 157.33 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.625 0 CA-C-O 121.38 0.609 . . . . 0.0 112.012 -179.343 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.452 ' N ' HG12 ' A' ' 134' ' ' VAL . . . 138.21 -43.46 1.19 Allowed Glycine 0 N--CA 1.441 -1.017 0 N-CA-C 110.36 -1.096 . . . . 0.0 110.36 -178.609 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.624 HG12 ' H ' ' A' ' 138' ' ' SER . 46.4 t -126.8 123.93 63.81 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.708 0 CA-C-N 115.022 -0.589 . . . . 0.0 109.63 178.423 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.506 ' HA ' HD12 ' A' ' 140' ' ' ILE . 6.9 mt-10 -51.05 -26.17 5.92 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.711 0.291 . . . . 0.0 111.355 -179.121 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . 0.624 ' H ' HG12 ' A' ' 136' ' ' VAL . 6.4 t -94.4 6.4 48.85 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 112.3 0.481 . . . . 0.0 112.3 -179.463 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -131.54 24.31 4.75 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 -179.243 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.506 HD12 ' HA ' ' A' ' 137' ' ' GLU . 23.6 mt -98.89 141.1 17.05 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.305 179.04 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.412 ' HB2' ' CG2' ' A' ' 132' ' ' VAL . 8.7 mp -119.98 135.07 55.05 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.83 -1.077 . . . . 0.0 109.805 179.446 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.417 ' O ' ' OG1' ' A' ' 40' ' ' THR . 46.6 t -114.54 151.84 32.72 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.836 0.827 . . . . 0.0 112.765 -178.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.517 HD23 ' SG ' ' A' ' 38' ' ' CYS . 8.2 mt -136.18 129.76 32.17 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.554 -1.203 . . . . 0.0 109.251 178.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.748 HG22 ' HG3' ' A' ' 129' ' ' GLU . 21.4 t -124.09 140.95 45.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.917 0.389 . . . . 0.0 111.923 -178.728 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.67 HG13 HG22 ' A' ' 36' ' ' VAL . 0.3 OUTLIER -112.31 140.23 33.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.832 179.558 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -118.99 108.64 15.0 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.704 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.698 HG12 HD21 ' A' ' 124' ' ' LEU . 1.9 mp -101.21 128.66 53.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.436 -179.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 10.7 p30 -79.16 132.02 36.41 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.909 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -63.64 -21.36 66.33 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.128 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 2.1 mptm? -58.37 -44.35 88.82 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.967 0.413 . . . . 0.0 110.716 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . 0.637 ' CD2' HD11 ' A' ' 52' ' ' ILE . 17.9 t80 -58.9 -44.49 91.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.82 179.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 4.0 mttt -63.94 -36.85 85.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.784 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -62.76 -37.43 86.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.82 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 11.4 t -60.97 -44.02 97.95 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.893 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.679 HD13 ' O ' ' A' ' 155' ' ' LEU . 3.0 tm? -57.22 -38.9 74.45 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.93 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 12.9 tm-20 -59.69 -41.0 89.76 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.84 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 32.9 tt0 -72.59 -27.94 62.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.006 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -122.08 44.59 2.55 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.867 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.79 120.85 27.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.85 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 21.5 t -93.21 129.51 43.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.12 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -124.54 86.65 2.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.959 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.67 157.57 9.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.864 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.403 ' O ' HG23 ' A' ' 163' ' ' ILE . 2.7 tt -78.63 127.58 38.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.142 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.248 1.003 0 CA-C-O 118.292 -0.861 . . . . 0.0 110.934 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.367 0 N-CA-C 112.519 -0.232 . . . . 0.0 112.519 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -100.34 -165.48 1.22 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.763 0.316 . . . . 0.0 110.808 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 7.4 m120 70.6 67.64 0.19 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.926 0.393 . . . . 0.0 110.86 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 6.0 pt -95.55 116.28 36.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.934 179.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 4.0 m 69.9 -66.91 0.25 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.926 -179.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 3.3 tp60 49.06 80.11 0.31 Allowed Pre-proline 0 C--N 1.331 -0.223 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.238 179.746 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -53.99 121.7 10.08 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.545 2.164 . . . . 0.0 112.314 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 5.5 t -99.04 151.37 21.02 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.064 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 8.8 mt-30 -100.32 69.56 1.47 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.945 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 36.4 tp60 -128.95 32.22 4.79 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.876 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.9 m -139.48 -64.19 0.5 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.967 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 73.6 p -74.52 77.75 1.95 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.112 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 61.7 mt-30 -102.3 38.2 1.73 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.94 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -124.76 113.39 17.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.03 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 4.9 m -124.93 -47.54 1.79 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.144 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -59.82 -41.94 92.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.998 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 19.0 mtt85 -71.48 -39.0 71.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.931 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 87.0 t80 -59.45 -39.8 84.75 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.929 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.95 -41.47 96.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.99 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 39.6 mm -64.77 -40.14 88.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.251 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -57.65 -46.93 83.56 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.992 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 10.6 ttpp -67.04 -35.63 80.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.86 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -65.78 -47.73 74.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.201 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -70.16 -43.8 70.1 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.999 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -142.38 137.12 30.24 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.085 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -95.6 158.64 15.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.758 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 12.0 mt-30 -106.25 101.59 11.06 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.898 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 22.7 mm -90.77 139.69 17.22 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.343 0 CA-C-O 121.458 0.647 . . . . 0.0 111.526 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.436 ' HA2' ' ND2' ' A' ' 148' ' ' ASN . . . -150.95 -43.47 0.02 OUTLIER Glycine 0 C--N 1.317 -0.483 0 CA-C-N 114.882 -1.054 . . . . 0.0 112.681 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.479 ' O ' HD11 ' A' ' 52' ' ' ILE . 25.1 mt-10 -71.82 -22.83 61.5 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.656 0.265 . . . . 0.0 111.403 -179.825 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 68.0 m-20 -108.83 -13.29 14.79 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-O 121.886 0.851 . . . . 0.0 109.117 178.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.575 ' CG2' ' O ' ' A' ' 32' ' ' ILE . 0.1 OUTLIER -70.41 96.77 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.618 0 CA-C-N 114.11 -1.405 . . . . 0.0 110.844 -179.145 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.809 HG23 ' HB3' ' A' ' 50' ' ' ALA . 0.9 OUTLIER -39.21 -61.5 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 114.54 -1.209 . . . . 0.0 112.651 -178.896 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.631 ' N ' HG12 ' A' ' 33' ' ' VAL . 49.6 t -162.93 162.85 26.38 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.853 0.359 . . . . 0.0 111.743 -178.795 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.448 ' HD3' ' CG2' ' A' ' 45' ' ' ILE . 1.8 ttm180 -128.93 115.37 17.73 Favored 'General case' 0 C--N 1.334 -0.104 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.678 179.817 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.901 HG23 ' CD2' ' A' ' 48' ' ' LEU . 92.4 t -89.07 129.64 39.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.559 179.858 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.983 HG23 HG12 ' A' ' 45' ' ' ILE . 29.0 mt -118.48 107.77 22.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 116.056 -0.52 . . . . 0.0 112.026 -179.309 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.491 ' HB2' ' O ' ' A' ' 43' ' ' ILE . 3.7 m -97.38 99.93 11.37 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 177.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 8.7 t -107.27 27.17 9.33 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 -178.097 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.741 HG21 ' HB2' ' A' ' 142' ' ' SER . 40.3 p -108.96 -3.31 17.61 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.761 0.315 . . . . 0.0 111.566 179.664 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 95.67 60.2 1.04 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.467 179.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.562 ' CG ' HD12 ' A' ' 141' ' ' LEU . 27.7 mt-30 -141.12 -60.58 0.49 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.762 0.315 . . . . 0.0 111.242 -179.83 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.491 ' O ' ' HB2' ' A' ' 38' ' ' CYS . 3.5 mp -135.24 132.36 20.04 Favored Pre-proline 0 N--CA 1.452 -0.339 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.371 -179.639 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.415 ' HB2' ' OH ' ' A' ' 76' ' ' TYR . 24.1 Cg_exo -60.14 146.8 95.43 Favored 'Trans proline' 0 N--CA 1.463 -0.307 0 C-N-CA 122.214 1.943 . . . . 0.0 111.054 178.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.983 HG12 HG23 ' A' ' 37' ' ' ILE . 29.9 mt -50.72 122.55 2.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.948 0.404 . . . . 0.0 111.791 -179.165 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.422 ' HB2' ' CD2' ' A' ' 76' ' ' TYR . 0.0 OUTLIER -124.85 141.76 51.9 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.032 179.241 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.403 ' HB3' ' CD1' ' A' ' 32' ' ' ILE . 0.7 OUTLIER -99.55 119.58 38.27 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.975 0.417 . . . . 0.0 111.689 -179.241 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.901 ' CD2' HG23 ' A' ' 36' ' ' VAL . 0.3 OUTLIER -89.63 136.47 33.02 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 178.48 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.601 ' O ' ' HZ2' ' A' ' 66' ' ' TRP . 0.0 OUTLIER -137.23 162.25 33.99 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 122.034 0.921 . . . . 0.0 113.398 -178.564 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.809 ' HB3' HG23 ' A' ' 33' ' ' VAL . . . -149.62 152.65 35.79 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 114.418 -1.265 . . . . 0.0 111.174 179.24 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.446 ' CB ' ' HG2' ' A' ' 54' ' ' GLN . 95.6 m-20 -80.27 111.26 16.48 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.121 -179.617 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.479 HD11 ' O ' ' A' ' 30' ' ' GLU . 11.6 mt -64.01 -35.36 73.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.733 -179.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 7.3 t -56.78 -34.48 67.68 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.994 -179.121 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.446 ' HG2' ' CB ' ' A' ' 51' ' ' ASP . 10.3 mm-40 -65.76 -36.85 84.74 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.93 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 10.1 t -72.03 -37.94 62.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.149 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.2 tt -58.97 -37.52 76.97 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.8 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 5.7 mttt -91.23 -55.63 3.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.849 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.429 ' HG3' HD13 ' A' ' 62' ' ' ILE . 7.9 tt0 57.3 72.65 0.5 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.948 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.6 18.58 1.67 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.267 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 174.64 -55.92 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.859 0.361 . . . . 0.0 110.774 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -97.73 117.75 32.73 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.863 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.433 HG23 ' O ' ' A' ' 62' ' ' ILE . 0.8 OUTLIER -178.08 46.85 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.947 -179.818 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -161.92 87.99 0.67 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.153 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.439 ' O ' ' HB3' ' A' ' 93' ' ' LEU . 2.1 ttpt -118.65 136.29 53.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.178 179.573 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.634 HG13 ' O ' ' A' ' 91' ' ' ILE . 14.1 t -136.26 135.91 49.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.143 0.497 . . . . 0.0 111.946 -179.215 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . 0.726 ' CD1' HD12 ' A' ' 48' ' ' LEU . 13.8 m-90 -99.74 140.06 34.49 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.59 179.052 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.858 HG23 ' CG ' ' A' ' 90' ' ' GLN . 4.3 m -130.3 126.79 38.08 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.404 0.621 . . . . 0.0 112.403 179.504 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.471 ' CD2' ' CD2' ' A' ' 89' ' ' PHE . 88.5 m-85 -98.01 118.39 34.51 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.171 177.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.641 ' HA3' ' N ' ' A' ' 87' ' ' LYS . . . 160.33 -158.97 30.4 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 118.978 -1.582 . . . . 0.0 112.936 179.473 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.508 ' CD ' ' HB3' ' A' ' 86' ' ' ASN . 0.4 OUTLIER -76.84 91.75 3.56 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-O 122.55 1.167 . . . . 0.0 108.456 -179.888 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.493 ' O ' ' CD2' ' A' ' 77' ' ' HIS . 0.2 OUTLIER -149.83 160.78 33.16 Favored Pre-proline 0 C--N 1.308 -1.205 0 CA-C-N 112.755 -2.021 . . . . 0.0 108.027 179.326 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.559 ' O ' ' CB ' ' A' ' 73' ' ' ALA . 28.1 Cg_endo -63.14 -8.73 14.94 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 120.99 1.127 . . . . 0.0 111.439 178.697 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.739 ' HB2' ' HB2' ' A' ' 77' ' ' HIS . . . 135.98 51.85 0.0 OUTLIER 'General case' 0 CA--C 1.491 -1.309 0 CA-C-N 114.806 -1.088 . . . . 0.0 109.788 178.602 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.575 ' HB3' ' HB ' ' A' ' 67' ' ' THR . 0.1 OUTLIER -52.88 -69.45 0.11 Allowed 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 105.838 -1.912 . . . . 0.0 105.838 179.328 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.628 ' HB2' ' N ' ' A' ' 67' ' ' THR . 7.5 t0 -94.63 -47.76 6.38 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 105.734 -1.951 . . . . 0.0 105.734 169.732 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.487 ' C ' ' HA ' ' A' ' 73' ' ' ALA . 1.7 t80 -145.37 141.65 28.66 Favored 'General case' 0 C--N 1.346 0.454 0 CA-C-N 112.717 -2.038 . . . . 0.0 112.35 -179.76 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.739 ' HB2' ' HB2' ' A' ' 73' ' ' ALA . 23.5 t-160 -94.91 107.2 19.23 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 176.276 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -135.67 -176.24 4.22 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.001 0.429 . . . . 0.0 111.7 -179.386 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -60.92 163.31 20.39 Favored Glycine 0 N--CA 1.451 -0.339 0 CA-C-N 115.819 -0.628 . . . . 0.0 112.582 -179.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 12.8 p-10 -111.97 100.57 8.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.823 0.345 . . . . 0.0 111.553 -179.649 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.654 ' HB ' ' HB2' ' A' ' 85' ' ' SER . 12.4 mm -112.76 120.48 62.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 178.67 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 3.5 m -51.09 -23.92 3.54 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -177.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -83.66 -106.7 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 120.971 -0.291 . . . . 0.0 111.084 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.468 HD23 ' N ' ' A' ' 84' ' ' LEU . 0.0 OUTLIER -109.86 113.32 25.96 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-O 121.341 0.591 . . . . 0.0 109.598 179.236 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.654 ' HB2' ' HB ' ' A' ' 81' ' ' ILE . 1.5 m 166.6 -66.55 0.0 OUTLIER 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.041 -179.708 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.977 ' O ' ' N ' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -60.04 -166.18 0.01 OUTLIER 'General case' 0 CA--C 1.51 -0.575 0 N-CA-C 109.333 -0.618 . . . . 0.0 109.333 178.954 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.641 ' N ' ' HA3' ' A' ' 69' ' ' GLY . 2.8 mtmt -28.7 69.44 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 121.279 0.562 . . . . 0.0 109.704 -179.685 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.986 ' C ' ' O ' ' A' ' 104' ' ' ILE . 32.3 t60 -98.03 -17.44 19.15 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 113.559 0.948 . . . . 0.0 113.559 -176.765 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.677 ' HA ' ' H ' ' A' ' 104' ' ' ILE . 0.3 OUTLIER -173.08 153.33 2.5 Favored 'General case' 0 C--N 1.31 -1.135 0 C-N-CA 119.422 -0.911 . . . . 0.0 112.379 177.73 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.858 ' CG ' HG23 ' A' ' 67' ' ' THR . 31.9 mt-30 -135.83 157.92 45.67 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.455 -1.248 . . . . 0.0 113.674 -177.42 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.663 HD11 HG21 ' A' ' 36' ' ' VAL . 9.9 mt -125.14 131.62 72.22 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 CA-C-N 114.955 -1.021 . . . . 0.0 109.711 178.496 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.636 HD13 ' ND2' ' A' ' 121' ' ' ASN . 0.2 OUTLIER -109.37 141.45 41.72 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.098 0.475 . . . . 0.0 112.154 -179.298 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.709 HD13 ' CG2' ' A' ' 33' ' ' VAL . 6.4 tp -125.8 141.52 51.96 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.355 178.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 127.37 -135.89 9.01 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.542 179.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 58.74 80.09 0.2 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.815 0.341 . . . . 0.0 110.855 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 67.27 -72.68 0.09 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.956 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -172.94 54.52 0.16 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.421 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.476 ' C ' HD13 ' A' ' 99' ' ' LEU . 32.1 m-20 -148.81 -174.88 4.74 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.825 0.345 . . . . 0.0 110.953 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.662 HD22 ' N ' ' A' ' 99' ' ' LEU . 0.3 OUTLIER -119.47 148.32 43.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.751 179.918 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.665 HD22 ' HB3' ' A' ' 121' ' ' ASN . 0.4 OUTLIER -133.73 148.31 51.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.399 179.969 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.541 HD23 HD11 ' A' ' 130' ' ' ILE . 3.2 mp -114.82 131.33 56.86 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.978 -0.378 . . . . 0.0 109.978 179.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.499 ' HB2' HD11 ' A' ' 92' ' ' LEU . 23.4 t30 -113.16 111.32 21.89 Favored 'General case' 0 CA--C 1.511 -0.529 0 C-N-CA 119.851 -0.74 . . . . 0.0 110.032 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.787 ' HB3' HG21 ' A' ' 109' ' ' THR . 73.2 m-20 -84.37 112.17 20.1 Favored 'General case' 0 N--CA 1.444 -0.752 0 C-N-CA 119.738 -0.785 . . . . 0.0 109.641 179.519 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.986 ' O ' ' C ' ' A' ' 88' ' ' HIS . 0.1 OUTLIER -123.54 107.29 18.66 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.886 0 N-CA-C 108.752 -0.832 . . . . 0.0 108.752 177.614 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 67.3 m -129.72 169.14 15.48 Favored 'General case' 0 C--N 1.296 -1.74 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.435 179.617 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 23.7 m -69.35 -62.88 1.2 Allowed 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 119.121 -1.031 . . . . 0.0 111.281 -179.228 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -112.11 -33.09 6.35 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 114.658 1.355 . . . . 0.0 114.658 179.011 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -146.67 130.2 3.56 Favored Glycine 0 C--N 1.341 0.813 0 N-CA-C 116.97 1.548 . . . . 0.0 116.97 -177.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.787 HG21 ' HB3' ' A' ' 103' ' ' ASP . 5.6 m -121.18 138.32 54.26 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 174.396 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 0.666 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.6 m-90 -120.48 149.22 42.74 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 -178.639 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.474 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -122.17 112.04 17.7 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 114.915 -1.039 . . . . 0.0 108.601 177.579 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 44.9 44.36 7.84 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.983 -0.553 . . . . 0.0 112.155 -179.524 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 79.79 21.62 65.7 Favored Glycine 0 N--CA 1.444 -0.794 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.786 179.345 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -133.4 98.75 4.32 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.928 0.394 . . . . 0.0 110.664 179.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.666 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.1 OUTLIER -43.23 122.43 2.53 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.034 179.804 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.712 HG11 ' OD2' ' A' ' 103' ' ' ASP . 12.6 p -113.78 160.49 13.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.688 -178.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.515 ' N ' HG22 ' A' ' 116' ' ' VAL . 4.8 tt0 -70.96 141.61 51.06 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.104 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.407 ' O ' ' C ' ' A' ' 119' ' ' ASN . 88.6 tttt -65.39 164.24 14.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.076 179.325 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.407 ' C ' ' O ' ' A' ' 118' ' ' LYS . 4.3 m-80 35.47 39.01 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.249 0.547 . . . . 0.0 110.938 -179.402 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.403 ' OG ' ' NE2' ' A' ' 122' ' ' GLN . 5.3 p -111.04 108.46 18.18 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.997 -179.365 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.665 ' HB3' HD22 ' A' ' 100' ' ' LEU . 1.4 m-20 -58.59 140.59 54.11 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.737 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . 0.596 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 22.4 mm-40 -129.82 145.21 51.58 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-O 121.039 0.447 . . . . 0.0 112.137 -179.567 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 22.3 tp -72.58 117.94 14.88 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.44 178.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.886 HD21 HG12 ' A' ' 147' ' ' ILE . 29.9 tp -45.24 144.05 1.49 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.875 0.845 . . . . 0.0 112.081 -178.713 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -127.02 152.79 46.78 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 114.037 -1.438 . . . . 0.0 110.252 179.585 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.72 113.88 9.22 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 179.414 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 67.06 29.12 74.12 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.281 -179.379 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -54.57 160.53 1.76 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.925 0.393 . . . . 0.0 111.203 -179.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.468 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 2.4 tt0 -146.05 135.32 22.87 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.529 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.674 HD13 ' OD1' ' A' ' 103' ' ' ASP . 5.4 mt -115.05 128.61 72.15 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 116.285 -0.416 . . . . 0.0 109.976 179.007 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.585 HG23 ' CG2' ' A' ' 140' ' ' ILE . 7.7 m -103.21 143.74 32.24 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.83 -179.374 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.452 ' HB ' ' NE2' ' A' ' 88' ' ' HIS . 4.6 m -141.21 155.26 21.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.317 -0.401 . . . . 0.0 112.039 -179.013 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 72.14 38.1 59.46 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 121.126 -0.559 . . . . 0.0 112.4 179.282 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.476 ' HA ' HG12 ' A' ' 140' ' ' ILE . 96.1 t -72.88 156.26 6.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 121.499 0.666 . . . . 0.0 112.129 -179.276 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.453 ' N ' HG12 ' A' ' 134' ' ' VAL . . . 153.26 -46.5 0.56 Allowed Glycine 0 N--CA 1.442 -0.96 0 CA-C-N 114.939 -1.028 . . . . 0.0 110.606 -179.234 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.567 HG12 ' H ' ' A' ' 138' ' ' SER . 46.7 t -126.78 135.83 62.56 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.65 0 CA-C-N 115.239 -0.48 . . . . 0.0 109.832 178.644 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.1 -35.13 33.6 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.818 0.342 . . . . 0.0 111.269 -179.337 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . 0.567 ' H ' HG12 ' A' ' 136' ' ' VAL . 0.2 OUTLIER -94.04 6.14 49.47 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 116.273 -0.421 . . . . 0.0 112.13 -179.513 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -125.6 28.72 6.16 Favored 'General case' 0 CA--C 1.518 -0.261 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -179.398 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.585 ' CG2' HG23 ' A' ' 131' ' ' THR . 22.0 mt -105.29 141.28 20.99 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.373 179.342 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.562 HD12 ' CG ' ' A' ' 42' ' ' GLN . 3.1 mm? -114.85 135.0 54.67 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 114.906 -1.043 . . . . 0.0 109.92 179.344 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.741 ' HB2' HG21 ' A' ' 40' ' ' THR . 3.9 m -119.2 153.7 34.53 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.845 0.831 . . . . 0.0 112.48 -179.03 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.468 ' O ' ' HA ' ' A' ' 129' ' ' GLU . 13.7 mt -135.4 141.5 45.48 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.36 -1.291 . . . . 0.0 109.216 179.325 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 17.3 t -124.02 140.85 46.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.014 0.435 . . . . 0.0 112.123 -178.636 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.725 HG13 HG22 ' A' ' 36' ' ' VAL . 0.8 OUTLIER -108.63 125.99 65.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.105 179.257 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 8.5 t80 -111.98 118.36 35.24 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.277 -179.419 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.886 HG12 HD21 ' A' ' 124' ' ' LEU . 2.4 mp -95.34 134.57 32.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.655 179.628 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . 0.436 ' ND2' ' HA2' ' A' ' 29' ' ' GLY . 2.7 m120 -73.87 122.66 22.85 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.994 -179.765 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -60.38 -41.7 94.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.798 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.17 -43.28 87.36 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.677 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 24.1 t80 -60.84 -44.41 96.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.761 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 54.7 tttm -60.24 -34.6 73.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.833 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 15.3 tt0 -58.98 -45.3 90.93 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.792 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 9.7 t -64.33 -44.31 91.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.83 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -68.73 -38.44 80.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.806 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -58.38 -40.17 81.6 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.938 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -91.65 -28.55 17.41 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.894 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 2.7 p30 42.6 88.23 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.484 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 20.3 mtmm -61.24 136.2 57.98 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.894 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.436 HG23 ' O ' ' A' ' 160' ' ' VAL . 27.6 m -102.9 123.34 56.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.151 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -66.6 139.75 57.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.892 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 1.3 mmm180 -98.4 -36.94 9.8 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.926 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.489 ' H ' HD12 ' A' ' 163' ' ' ILE . 3.7 mp -92.75 120.47 42.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.114 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . 0.427 ' HG3' HG22 ' A' ' 163' ' ' ILE . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.201 -0.904 . . . . 0.0 110.918 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.319 0 N-CA-C 112.485 -0.246 . . . . 0.0 112.485 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -108.55 -174.61 2.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.906 0.384 . . . . 0.0 110.85 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -150.7 87.58 1.44 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.76 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.49 HG22 ' O ' ' A' ' 4' ' ' ILE . 26.3 mt -144.36 47.82 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.151 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -93.76 -37.99 11.5 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.041 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -145.84 89.78 6.04 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.898 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -50.68 -53.45 7.12 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.579 2.186 . . . . 0.0 112.429 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 9.3 t -177.22 -176.24 0.63 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.246 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 14.6 mt-30 62.19 -89.99 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.045 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 45.43 32.44 1.07 Allowed 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 120.881 0.372 . . . . 0.0 111.329 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 59.7 p -62.13 -47.22 85.53 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.11 -179.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER 51.7 77.19 0.15 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.132 -179.849 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -86.63 -164.61 1.09 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.901 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 65.82 175.93 0.22 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.099 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.415 HG23 ' N ' ' A' ' 16' ' ' GLN . 3.2 t -172.95 -45.25 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.078 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.415 ' N ' HG23 ' A' ' 15' ' ' THR . 15.3 mt-30 -65.89 -47.09 75.98 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.902 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -71.65 -37.58 70.8 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.81 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -61.66 -38.19 86.85 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.865 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -60.64 -42.99 98.07 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.897 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 33.0 mm -63.03 -42.63 97.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.163 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -57.68 -34.12 69.08 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.018 -179.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -63.65 -31.01 72.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.868 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -59.18 -47.64 84.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.158 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 2.4 m -56.55 -32.12 64.83 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.103 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -110.11 81.03 1.37 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.926 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -70.89 149.87 46.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.933 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -68.53 123.61 21.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.894 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 22.4 mm -82.69 139.61 17.56 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.358 0 CA-C-O 121.507 0.67 . . . . 0.0 111.648 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.453 ' CA ' ' HB ' ' A' ' 32' ' ' ILE . . . -87.93 66.85 3.27 Favored Glycine 0 C--N 1.318 -0.453 0 CA-C-N 114.875 -1.057 . . . . 0.0 112.578 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -67.95 -22.75 65.02 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.648 0.261 . . . . 0.0 111.414 -179.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 26.6 m120 -109.23 -13.56 14.63 Favored 'General case' 0 CA--C 1.514 -0.422 0 CA-C-O 121.933 0.873 . . . . 0.0 109.131 178.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.585 ' CG2' ' O ' ' A' ' 32' ' ' ILE . 0.1 OUTLIER -70.47 96.83 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.619 0 CA-C-N 114.103 -1.408 . . . . 0.0 111.183 -178.983 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.858 HG23 ' HB3' ' A' ' 50' ' ' ALA . 0.9 OUTLIER -36.55 -60.77 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 CA-C-N 114.643 -1.162 . . . . 0.0 112.246 -179.403 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.625 ' N ' HG12 ' A' ' 33' ' ' VAL . 1.7 m -163.19 165.42 24.45 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.742 -179.466 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.429 ' CZ ' HD11 ' A' ' 37' ' ' ILE . 2.3 tmm_? -134.27 114.78 13.39 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.159 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.99 HG23 HD21 ' A' ' 48' ' ' LEU . 48.2 t -91.38 122.0 42.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.508 179.313 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.984 HG23 HG12 ' A' ' 45' ' ' ILE . 34.1 mt -109.55 108.06 24.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.636 -179.847 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.817 ' SG ' HD12 ' A' ' 143' ' ' LEU . 60.1 m -102.04 101.75 12.16 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 178.098 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 7.6 t -118.69 32.63 6.03 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -177.649 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.562 HG21 ' HB2' ' A' ' 142' ' ' SER . 34.8 p -112.45 15.89 20.05 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.976 0.417 . . . . 0.0 111.285 179.325 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 88.71 38.87 6.82 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.133 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.673 ' OE1' HD13 ' A' ' 141' ' ' LEU . 0.0 OUTLIER -117.23 -76.21 0.57 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.663 0.268 . . . . 0.0 111.465 -179.591 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.616 HD12 ' HB3' ' A' ' 42' ' ' GLN . 3.7 mp -135.18 141.59 38.55 Favored Pre-proline 0 N--CA 1.452 -0.348 0 CA-C-O 120.859 0.361 . . . . 0.0 111.527 -179.072 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.481 ' HD2' ' CZ ' ' A' ' 76' ' ' TYR . 25.6 Cg_exo -59.25 147.08 92.5 Favored 'Trans proline' 0 N--CA 1.465 -0.186 0 C-N-CA 122.338 2.025 . . . . 0.0 111.202 178.832 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.984 HG12 HG23 ' A' ' 37' ' ' ILE . 44.2 mt -43.38 128.6 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-O 121.046 0.451 . . . . 0.0 111.852 -179.401 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.424 ' HG2' ' O ' ' A' ' 75' ' ' ASP . 0.0 OUTLIER -123.27 130.38 52.66 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.255 179.58 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.426 ' C ' HD13 ' A' ' 48' ' ' LEU . 4.9 m-20 -100.83 119.72 39.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.021 0.439 . . . . 0.0 111.444 -179.54 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.99 HD21 HG23 ' A' ' 36' ' ' VAL . 0.2 OUTLIER -93.9 130.73 39.85 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.353 178.763 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.532 ' O ' ' HZ2' ' A' ' 66' ' ' TRP . 0.0 OUTLIER -133.41 161.66 33.93 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.972 0.891 . . . . 0.0 113.221 -178.809 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.858 ' HB3' HG23 ' A' ' 33' ' ' VAL . . . -156.87 141.94 17.17 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 114.441 -1.254 . . . . 0.0 110.937 179.017 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.444 ' CB ' ' HG3' ' A' ' 54' ' ' GLN . 0.2 OUTLIER -70.02 124.14 23.31 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.091 0.472 . . . . 0.0 111.231 -179.613 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 14.7 mt -63.69 -36.34 76.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 115.824 -0.626 . . . . 0.0 111.104 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.6 t -56.62 -34.28 67.08 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.899 -179.537 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.444 ' HG3' ' CB ' ' A' ' 51' ' ' ASP . 1.9 mt-30 -63.76 -37.72 88.42 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.67 -179.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.555 ' HA ' HD13 ' A' ' 62' ' ' ILE . 37.4 t -73.73 -46.6 46.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.149 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -59.45 -34.02 72.0 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.921 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.8 mmtp -89.54 -36.15 15.52 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.881 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 43.82 47.1 6.78 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.396 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 3.2 tmtm? -84.56 -67.72 0.77 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.009 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 6.2 ttp180 -160.42 51.12 0.29 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.884 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -158.43 29.46 0.24 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.96 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.589 HG23 ' O ' ' A' ' 62' ' ' ILE . 2.3 tp -110.64 61.62 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.876 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 3.0 mttp -165.65 71.45 0.15 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.999 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -108.16 132.73 53.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.35 179.587 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.563 HG13 ' O ' ' A' ' 91' ' ' ILE . 6.9 t -127.35 135.47 63.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.182 0.515 . . . . 0.0 111.959 -179.058 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . 0.83 ' CD1' HD12 ' A' ' 48' ' ' LEU . 14.7 m-90 -99.25 139.97 34.11 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.786 179.179 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.661 HG23 ' HG2' ' A' ' 90' ' ' GLN . 32.0 m -131.43 131.42 43.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.571 0.7 . . . . 0.0 112.048 179.491 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.49 ' CD2' ' CD2' ' A' ' 89' ' ' PHE . 94.0 m-85 -102.68 118.98 38.03 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.023 -0.99 . . . . 0.0 109.148 177.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.675 ' CA ' HD21 ' A' ' 78' ' ' LEU . . . 158.64 -156.87 27.87 Favored Glycine 0 CA--C 1.501 -0.804 0 C-N-CA 118.962 -1.59 . . . . 0.0 112.709 179.638 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -75.62 91.65 2.88 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-O 122.615 1.198 . . . . 0.0 108.679 -179.669 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.511 ' O ' ' CD2' ' A' ' 77' ' ' HIS . 10.3 m120 -149.9 153.37 35.84 Favored Pre-proline 0 C--N 1.31 -1.119 0 CA-C-N 112.693 -2.049 . . . . 0.0 108.187 178.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.556 ' O ' ' HB2' ' A' ' 77' ' ' HIS . 26.6 Cg_exo -55.92 -10.84 4.57 Favored 'Trans proline' 0 N--CA 1.459 -0.525 0 C-N-CA 121.239 1.293 . . . . 0.0 111.318 178.101 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.742 ' HB2' ' HB2' ' A' ' 77' ' ' HIS . . . 137.99 52.03 0.0 OUTLIER 'General case' 0 CA--C 1.49 -1.365 0 CA-C-N 114.761 -1.109 . . . . 0.0 109.212 178.871 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.522 ' HB3' ' HB ' ' A' ' 67' ' ' THR . 0.1 OUTLIER -52.55 -69.45 0.11 Allowed 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 105.783 -1.932 . . . . 0.0 105.783 179.689 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.538 ' HB2' ' N ' ' A' ' 67' ' ' THR . 9.2 t0 -95.38 -47.73 6.17 Favored 'General case' 0 N--CA 1.435 -1.21 0 N-CA-C 105.671 -1.974 . . . . 0.0 105.671 169.513 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.508 ' C ' ' HA ' ' A' ' 73' ' ' ALA . 33.7 t80 -144.07 142.61 30.73 Favored 'General case' 0 C--N 1.347 0.5 0 CA-C-N 112.544 -2.116 . . . . 0.0 111.316 179.713 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.742 ' HB2' ' HB2' ' A' ' 73' ' ' ALA . 23.6 t-160 -92.77 109.32 20.75 Favored 'General case' 0 C--N 1.33 -0.279 0 O-C-N 121.999 -0.438 . . . . 0.0 110.177 177.209 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.675 HD21 ' CA ' ' A' ' 69' ' ' GLY . 1.3 pp -123.45 175.28 6.85 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.911 0.386 . . . . 0.0 111.538 -179.824 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.503 ' O ' HD12 ' A' ' 78' ' ' LEU . . . -62.92 -170.85 1.35 Allowed Glycine 0 C--N 1.332 0.313 0 C-N-CA 120.985 -0.626 . . . . 0.0 112.525 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -111.76 98.64 7.54 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 121.025 0.44 . . . . 0.0 111.68 -179.666 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.875 HD13 ' HB3' ' A' ' 85' ' ' SER . 3.2 mp -114.13 111.77 37.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.404 178.775 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 46.9 t -55.35 -24.25 28.33 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 -179.247 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.514 ' C ' HD13 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -88.75 -109.53 0.07 Allowed 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 112.249 0.463 . . . . 0.0 112.249 -178.845 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.842 ' H ' HD22 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -108.89 112.22 24.34 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-O 121.437 0.637 . . . . 0.0 109.666 179.87 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.875 ' HB3' HD13 ' A' ' 81' ' ' ILE . 0.6 OUTLIER 161.88 -45.11 0.0 OUTLIER 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 114.686 -1.143 . . . . 0.0 109.335 -179.628 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.858 ' O ' ' N ' ' A' ' 88' ' ' HIS . 97.1 m-20 -64.31 -149.47 0.01 OUTLIER 'General case' 0 CA--C 1.521 -0.138 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 177.726 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.815 ' HB3' HD11 ' A' ' 104' ' ' ILE . 9.3 mttt -49.47 72.34 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.073 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.977 ' C ' ' O ' ' A' ' 104' ' ' ILE . 32.8 t60 -90.89 -17.34 26.64 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 114.02 1.118 . . . . 0.0 114.02 -176.727 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.664 ' HA ' ' H ' ' A' ' 104' ' ' ILE . 0.5 OUTLIER -174.43 153.56 1.93 Allowed 'General case' 0 C--N 1.311 -1.089 0 C-N-CA 119.257 -0.977 . . . . 0.0 112.673 178.061 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.661 ' HG2' HG23 ' A' ' 67' ' ' THR . 34.9 mt-30 -136.64 158.49 44.33 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.523 -1.217 . . . . 0.0 113.72 -177.624 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.781 HD11 HG21 ' A' ' 36' ' ' VAL . 10.6 mt -127.72 131.7 69.68 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 CA-C-N 114.868 -1.06 . . . . 0.0 109.896 178.725 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.539 HD12 ' N ' ' A' ' 93' ' ' LEU . 0.5 OUTLIER -111.42 137.68 48.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.86 0.362 . . . . 0.0 110.945 -179.94 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.806 HD23 HD22 ' A' ' 99' ' ' LEU . 1.0 OUTLIER -124.06 129.14 50.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.779 179.789 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.792 ' N ' HD22 ' A' ' 93' ' ' LEU . . . 136.63 -128.61 4.52 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.399 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 60.17 66.71 0.93 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.825 0.345 . . . . 0.0 110.775 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 49.1 m-20 62.6 32.39 16.41 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.848 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 79.55 78.1 0.89 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.497 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.418 ' O ' HD22 ' A' ' 93' ' ' LEU . 5.4 t-20 -167.82 177.92 5.49 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.795 0.331 . . . . 0.0 110.897 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.806 HD22 HD23 ' A' ' 93' ' ' LEU . 2.4 mm? -119.85 130.76 55.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.809 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.729 HD13 ' O ' ' A' ' 122' ' ' GLN . 3.8 mm? -127.39 148.05 50.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.284 179.845 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.47 ' O ' ' N ' ' A' ' 122' ' ' GLN . 52.5 mt -115.93 129.66 56.49 Favored 'General case' 0 CA--C 1.518 -0.287 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.11 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.489 ' O ' ' O ' ' A' ' 90' ' ' GLN . 26.7 t30 -113.26 111.25 21.72 Favored 'General case' 0 CA--C 1.509 -0.598 0 C-N-CA 119.804 -0.758 . . . . 0.0 109.877 179.803 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.749 ' HB3' HG21 ' A' ' 109' ' ' THR . 72.6 m-20 -83.57 112.24 19.82 Favored 'General case' 0 N--CA 1.442 -0.853 0 C-N-CA 119.827 -0.749 . . . . 0.0 109.619 179.664 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.977 ' O ' ' C ' ' A' ' 88' ' ' HIS . 0.1 OUTLIER -123.13 107.84 20.0 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.949 0 N-CA-C 108.928 -0.768 . . . . 0.0 108.928 177.745 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.502 ' HG ' ' CE1' ' A' ' 88' ' ' HIS . 71.9 m -128.93 169.6 14.44 Favored 'General case' 0 C--N 1.295 -1.793 0 CA-C-N 114.974 -1.012 . . . . 0.0 109.286 179.473 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 29.2 m -69.11 -62.68 1.28 Allowed 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 119.074 -1.05 . . . . 0.0 111.061 -179.356 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -111.86 -33.42 6.31 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 114.326 1.232 . . . . 0.0 114.326 178.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -147.05 131.69 4.05 Favored Glycine 0 C--N 1.341 0.813 0 N-CA-C 116.886 1.514 . . . . 0.0 116.886 -178.181 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.749 HG21 ' HB3' ' A' ' 103' ' ' ASP . 7.2 m -121.08 138.18 54.31 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 174.259 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 0.751 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.4 m-90 -119.78 149.36 42.17 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 113.543 0.942 . . . . 0.0 113.543 -178.58 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.452 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -123.4 112.2 17.27 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 114.82 -1.082 . . . . 0.0 108.546 177.556 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 73.3 m-20 47.3 43.11 14.7 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.079 -0.509 . . . . 0.0 112.204 -179.496 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 84.06 -4.11 84.01 Favored Glycine 0 N--CA 1.445 -0.732 0 C-N-CA 120.759 -0.734 . . . . 0.0 113.25 179.168 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -111.47 102.3 10.67 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.917 0.389 . . . . 0.0 110.817 179.688 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.751 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.0 OUTLIER -44.01 136.49 3.72 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.939 179.846 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.63 HG11 ' OD2' ' A' ' 103' ' ' ASP . 14.9 p -124.35 163.39 24.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.693 -179.082 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.548 ' N ' HG22 ' A' ' 116' ' ' VAL . 29.7 tp10 -70.1 141.84 52.69 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.019 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.409 ' HG3' ' HA ' ' A' ' 104' ' ' ILE . 63.4 tttm -68.59 162.7 25.3 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.407 179.654 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.405 ' N ' ' HG2' ' A' ' 118' ' ' LYS . 4.1 p30 35.21 38.04 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.349 0.595 . . . . 0.0 111.404 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 6.7 p -111.39 109.79 19.94 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.018 -179.453 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.431 ' HB3' HD12 ' A' ' 100' ' ' LEU . 29.5 m120 -59.33 139.47 56.98 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.502 179.754 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . 0.729 ' O ' HD13 ' A' ' 100' ' ' LEU . 48.9 mm-40 -129.7 148.53 51.6 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-O 121.072 0.463 . . . . 0.0 112.121 -179.357 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.686 HD13 ' O ' ' A' ' 124' ' ' LEU . 3.5 tm? -72.31 112.08 8.07 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.456 179.172 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.686 ' O ' HD13 ' A' ' 123' ' ' LEU . 7.8 tt -43.23 147.22 0.38 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.728 0.775 . . . . 0.0 112.246 -178.645 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.43 ' O ' HD11 ' A' ' 147' ' ' ILE . 0.6 OUTLIER -126.64 153.15 45.74 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 114.322 -1.308 . . . . 0.0 110.43 179.752 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . 0.437 ' HA ' HD13 ' A' ' 147' ' ' ILE . 0.0 OUTLIER -71.61 113.86 9.08 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 179.414 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 68.25 27.32 73.78 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.201 -179.153 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -53.41 161.22 1.01 Allowed 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.928 0.394 . . . . 0.0 111.319 -179.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.403 ' HG2' ' O ' ' A' ' 143' ' ' LEU . 1.1 tt0 -146.21 134.85 22.2 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.204 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.636 HD13 ' OD1' ' A' ' 103' ' ' ASP . 3.7 mt -115.8 128.44 73.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 178.854 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.483 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 36.7 m -103.02 143.31 32.74 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.61 -179.742 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.474 ' HB ' ' NE2' ' A' ' 88' ' ' HIS . 6.3 m -140.75 158.21 23.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 -178.549 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 72.88 44.09 38.94 Favored Glycine 0 N--CA 1.445 -0.717 0 CA-C-N 115.679 -0.692 . . . . 0.0 112.275 179.39 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.504 ' HA ' HG12 ' A' ' 140' ' ' ILE . 85.4 t -81.64 153.94 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.616 0 CA-C-O 121.438 0.637 . . . . 0.0 112.161 -179.212 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.403 ' N ' HG12 ' A' ' 134' ' ' VAL . . . 152.68 -43.48 0.65 Allowed Glycine 0 N--CA 1.441 -1.0 0 CA-C-N 114.932 -1.031 . . . . 0.0 110.564 -179.113 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.53 HG12 ' H ' ' A' ' 138' ' ' SER . 44.0 t -126.71 132.82 69.74 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.675 0 CA-C-N 115.137 -0.531 . . . . 0.0 109.714 178.681 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 37.3 tp10 -51.28 -34.59 33.59 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.761 0.315 . . . . 0.0 111.449 -179.169 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . 0.53 ' H ' HG12 ' A' ' 136' ' ' VAL . 48.2 t -94.34 6.52 48.46 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -179.413 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -126.13 29.64 5.81 Favored 'General case' 0 CA--C 1.52 -0.201 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -179.239 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.504 HG12 ' HA ' ' A' ' 134' ' ' VAL . 11.8 mt -107.6 141.14 23.58 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.367 179.162 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.673 HD13 ' OE1' ' A' ' 42' ' ' GLN . 1.2 mp -123.07 134.79 54.24 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.164 -0.926 . . . . 0.0 110.315 179.768 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.759 ' O ' HD13 ' A' ' 143' ' ' LEU . 0.8 OUTLIER -112.73 154.67 25.81 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.958 0.885 . . . . 0.0 112.758 -179.087 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.817 HD12 ' SG ' ' A' ' 38' ' ' CYS . 1.6 mm? -130.12 144.05 51.13 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 114.047 -1.433 . . . . 0.0 109.192 179.34 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.472 ' O ' ' N ' ' A' ' 37' ' ' ILE . 21.9 t -124.31 140.97 46.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.933 0.396 . . . . 0.0 111.939 -178.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.873 HG13 HG22 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -109.86 132.2 58.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.712 179.538 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -118.2 125.27 49.84 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.69 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.685 HG12 HD21 ' A' ' 124' ' ' LEU . 3.9 mp -109.58 133.61 54.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.472 -179.647 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -78.62 117.95 20.27 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.957 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -65.15 -27.58 68.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.95 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.74 -46.01 90.44 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-O 121.065 0.459 . . . . 0.0 110.68 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 10.5 t80 -57.61 -44.48 85.51 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.008 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 4.8 mttm -61.38 -47.68 84.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.12 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 1.1 mm100 -58.96 -36.92 75.62 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.938 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 12.2 t -58.29 -44.67 88.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.963 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.26 -35.9 82.45 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.038 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -57.91 -48.39 80.03 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.0 -179.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 17.7 mm-40 -85.84 -30.5 22.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.933 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 4.1 p30 42.64 68.54 0.47 Allowed 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.416 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.06 134.07 47.85 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.816 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 6.3 m -71.69 120.39 19.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.032 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -126.77 -67.51 0.85 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.184 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 17.2 ttm180 61.23 119.49 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.884 0.373 . . . . 0.0 111.052 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 17.8 mt -104.66 128.46 58.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.044 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.239 -0.886 . . . . 0.0 110.934 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.355 0 N-CA-C 112.552 -0.219 . . . . 0.0 112.552 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -107.92 121.42 44.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.769 0.319 . . . . 0.0 110.95 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -107.0 -168.89 1.46 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.847 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.7 tt -106.59 17.04 6.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.397 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER 48.13 92.73 0.01 OUTLIER 'General case' 0 C--O 1.231 0.106 0 CA-C-O 120.834 0.349 . . . . 0.0 111.344 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -87.04 119.95 71.26 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.868 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -52.3 101.29 0.06 OUTLIER 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.406 2.071 . . . . 0.0 112.331 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.18 138.32 36.45 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.137 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 11.2 tm0? -83.15 -32.22 26.76 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.874 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.536 ' O ' HG23 ' A' ' 12' ' ' THR . 7.6 mt-30 -61.19 -27.59 68.53 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.04 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.2 m -55.9 105.77 0.21 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.993 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.536 HG23 ' O ' ' A' ' 10' ' ' GLN . 69.5 p -108.16 76.16 1.03 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.167 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 2.6 tt0 -152.01 -176.75 5.78 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.816 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -75.96 105.75 7.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.183 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.482 HG23 ' N ' ' A' ' 16' ' ' GLN . 6.0 t -148.46 -46.52 0.15 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.03 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.482 ' N ' HG23 ' A' ' 15' ' ' THR . 31.9 tt0 -72.78 -47.06 49.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.92 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.4 ttt85 -63.36 -40.12 96.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.945 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -60.52 -35.86 76.98 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.889 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -62.75 -37.22 85.74 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.991 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 32.5 mm -70.49 -42.57 78.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.164 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -57.6 -43.83 84.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.987 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.58 -35.34 80.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.895 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -59.24 -47.58 84.83 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.115 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.3 p -64.65 -44.14 91.37 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.897 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 12.8 tt0 -150.66 150.86 31.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.06 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 -97.77 159.39 14.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.811 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 2.0 mm-40 -64.41 101.8 0.47 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.956 0.408 . . . . 0.0 110.774 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.549 HG22 ' H ' ' A' ' 30' ' ' GLU . 17.9 mm -92.78 140.04 16.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.438 0.637 . . . . 0.0 111.861 -179.785 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.481 ' HA2' ' HB ' ' A' ' 32' ' ' ILE . . . -85.16 13.73 53.23 Favored Glycine 0 C--N 1.318 -0.427 0 CA-C-N 114.893 -1.049 . . . . 0.0 112.817 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.549 ' H ' HG22 ' A' ' 28' ' ' ILE . 6.9 tt0 -88.96 -21.76 23.39 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 111.795 0.295 . . . . 0.0 111.795 -179.774 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.564 ' HA ' HD12 ' A' ' 52' ' ' ILE . 18.2 m-80 -107.99 -12.92 15.07 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-O 121.883 0.849 . . . . 0.0 109.107 179.345 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.616 ' CG2' ' O ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -70.71 95.08 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.572 0 CA-C-N 113.961 -1.472 . . . . 0.0 111.198 -179.241 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.665 ' CG2' ' HB2' ' A' ' 50' ' ' ALA . 0.4 OUTLIER -32.81 -61.13 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-N 114.706 -1.134 . . . . 0.0 112.286 -179.567 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.844 ' SG ' HD12 ' A' ' 48' ' ' LEU . 20.9 p -165.11 164.83 20.25 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 112.516 0.561 . . . . 0.0 112.516 -179.47 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 2.8 ttm180 -119.44 125.15 48.26 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.62 179.47 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.947 HG13 HD11 ' A' ' 48' ' ' LEU . 3.5 m -92.96 124.39 45.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.896 0.379 . . . . 0.0 111.088 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.969 HG23 HG12 ' A' ' 45' ' ' ILE . 19.8 mt -132.27 108.6 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.911 -179.487 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.441 ' HB3' ' O ' ' A' ' 43' ' ' ILE . 38.9 t -78.9 127.77 32.45 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 178.291 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 48.4 p -110.77 28.65 8.49 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 112.576 0.584 . . . . 0.0 112.576 -178.442 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.435 ' OG1' ' O ' ' A' ' 142' ' ' SER . 0.0 OUTLIER -116.41 -37.41 3.75 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.778 0.323 . . . . 0.0 110.983 179.333 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 116.92 53.08 0.33 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.861 179.492 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.694 ' HG3' HD12 ' A' ' 141' ' ' LEU . 3.4 mt-30 -142.58 -42.71 0.32 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.612 0.244 . . . . 0.0 111.479 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.598 HD12 ' HB2' ' A' ' 42' ' ' GLN . 4.0 mp -115.04 138.96 23.74 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 120.779 0.323 . . . . 0.0 111.493 -179.385 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.489 ' CD ' ' CZ ' ' A' ' 76' ' ' TYR . 86.9 Cg_endo -82.43 146.79 13.92 Favored 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 122.76 2.307 . . . . 0.0 111.732 179.494 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.969 HG12 HG23 ' A' ' 37' ' ' ILE . 35.7 mt -53.2 111.86 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.995 0.426 . . . . 0.0 111.528 -179.688 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.437 ' O ' HG22 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -115.17 144.0 44.36 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.84 179.297 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -103.36 119.65 39.28 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.052 0.453 . . . . 0.0 111.599 -179.409 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.947 HD11 HG13 ' A' ' 36' ' ' VAL . 0.3 OUTLIER -100.47 138.65 37.25 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 178.504 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.641 ' C ' ' HB ' ' A' ' 33' ' ' VAL . 42.5 t -127.48 -170.82 2.29 Favored 'General case' 0 CA--C 1.511 -0.538 0 CA-C-O 122.941 1.353 . . . . 0.0 113.916 -178.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.665 ' HB2' ' CG2' ' A' ' 33' ' ' VAL . . . -157.52 145.02 18.61 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 112.699 -2.046 . . . . 0.0 110.809 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.484 ' CB ' ' HG3' ' A' ' 54' ' ' GLN . 13.2 m-20 -84.7 86.6 7.31 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.116 0.484 . . . . 0.0 110.705 179.826 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.619 HG23 HD23 ' A' ' 56' ' ' LEU . 5.8 mt -57.98 -31.55 41.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.687 -179.67 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -57.01 -34.84 68.56 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.982 -179.195 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.484 ' HG3' ' CB ' ' A' ' 51' ' ' ASP . 2.7 mm-40 -67.6 -42.93 81.64 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.961 -179.746 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 22.4 t -74.27 -37.75 46.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.238 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.619 HD23 HG23 ' A' ' 52' ' ' ILE . 0.5 OUTLIER -56.47 -33.26 65.76 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.967 0.413 . . . . 0.0 110.682 -179.965 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 25.5 mmtt -105.81 -24.76 12.41 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.603 179.48 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.437 ' N ' ' O ' ' A' ' 54' ' ' GLN . 15.9 tp10 60.09 95.86 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.873 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 26.1 mtpp -150.68 -60.02 0.18 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.832 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.94 -175.58 4.56 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.914 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.8 t 57.33 84.06 0.1 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.951 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.411 HG23 ' O ' ' A' ' 62' ' ' ILE . 1.5 tt -145.98 47.5 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.996 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -174.42 73.62 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.951 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 15.9 ttpt -113.29 131.48 55.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.693 179.72 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.622 HG13 ' O ' ' A' ' 91' ' ' ILE . 13.9 t -132.29 139.21 50.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.989 0.423 . . . . 0.0 111.696 -179.284 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . 0.64 ' HB2' ' HB ' ' A' ' 91' ' ' ILE . 17.3 m-90 -100.62 139.63 36.04 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.286 179.069 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.74 HG23 ' HG3' ' A' ' 90' ' ' GLN . 15.6 m -122.4 133.03 54.64 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.594 0.712 . . . . 0.0 112.286 179.829 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.518 ' CE1' ' CG ' ' A' ' 75' ' ' ASP . 10.8 m-85 -102.8 118.21 36.34 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.051 -0.977 . . . . 0.0 108.792 177.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.652 ' HA2' HD21 ' A' ' 78' ' ' LEU . . . 157.21 -153.92 25.09 Favored Glycine 0 CA--C 1.503 -0.663 0 C-N-CA 118.812 -1.661 . . . . 0.0 113.148 179.573 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.539 ' HB3' ' HA ' ' A' ' 80' ' ' ASN . 6.5 ptm180 -76.55 92.08 3.43 Favored 'General case' 0 N--CA 1.442 -0.861 0 CA-C-O 122.551 1.167 . . . . 0.0 108.985 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.491 ' O ' ' CD2' ' A' ' 77' ' ' HIS . 25.3 m-80 -149.72 159.99 34.93 Favored Pre-proline 0 C--N 1.308 -1.225 0 CA-C-N 112.806 -1.997 . . . . 0.0 108.261 178.857 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.545 ' O ' ' HB2' ' A' ' 77' ' ' HIS . 30.2 Cg_endo -63.89 -8.37 15.69 Favored 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 120.606 0.87 . . . . 0.0 110.434 177.407 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.732 ' HB2' ' HB2' ' A' ' 77' ' ' HIS . . . 137.28 53.32 0.0 OUTLIER 'General case' 0 CA--C 1.49 -1.345 0 CA-C-N 114.482 -1.235 . . . . 0.0 109.14 178.814 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.564 ' HB3' ' HB ' ' A' ' 67' ' ' THR . 0.1 OUTLIER -52.96 -69.75 0.11 Allowed 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 105.859 -1.904 . . . . 0.0 105.859 179.713 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.577 ' HB2' ' N ' ' A' ' 67' ' ' THR . 55.5 t0 -95.09 -47.73 6.25 Favored 'General case' 0 N--CA 1.435 -1.197 0 N-CA-C 105.526 -2.027 . . . . 0.0 105.526 169.59 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.506 ' C ' ' HA ' ' A' ' 73' ' ' ALA . 13.9 t80 -144.05 142.38 30.62 Favored 'General case' 0 C--N 1.346 0.441 0 CA-C-N 112.603 -2.089 . . . . 0.0 110.984 179.262 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.732 ' HB2' ' HB2' ' A' ' 73' ' ' ALA . 23.8 t-160 -89.33 108.51 19.67 Favored 'General case' 0 C--N 1.328 -0.338 0 O-C-N 121.961 -0.462 . . . . 0.0 109.902 177.038 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.652 HD21 ' HA2' ' A' ' 69' ' ' GLY . 0.5 OUTLIER -132.8 175.43 9.35 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.931 0.396 . . . . 0.0 111.546 -179.615 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -57.06 161.56 8.0 Favored Glycine 0 C--N 1.332 0.309 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.406 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.539 ' HA ' ' HB3' ' A' ' 70' ' ' ARG . 3.6 p-10 -112.02 100.07 8.58 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.857 0.36 . . . . 0.0 111.79 -179.499 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.651 ' HB ' ' HB2' ' A' ' 85' ' ' SER . 14.2 mt -113.41 147.28 17.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.177 178.738 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.07 -24.27 67.41 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 -179.45 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.541 ' C ' HD13 ' A' ' 84' ' ' LEU . 41.8 mtp180 -95.78 -98.31 0.17 Allowed 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 112.077 0.399 . . . . 0.0 112.077 -178.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.793 ' H ' HD22 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -108.46 110.71 22.3 Favored 'General case' 0 CA--C 1.512 -0.491 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 179.268 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.652 ' O ' ' HA2' ' A' ' 69' ' ' GLY . 0.5 OUTLIER 158.56 -35.95 0.0 OUTLIER 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 114.415 -1.266 . . . . 0.0 108.514 -179.068 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.783 ' O ' ' N ' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -66.17 -164.9 0.03 OUTLIER 'General case' 0 CA--C 1.507 -0.688 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 176.86 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.421 ' HA ' ' HA3' ' A' ' 69' ' ' GLY . 0.5 OUTLIER -55.52 70.39 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 177.411 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 1.061 ' O ' ' O ' ' A' ' 104' ' ' ILE . 44.6 t60 -73.3 -14.46 61.31 Favored 'General case' 0 CA--C 1.513 -0.449 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 -176.708 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.559 ' CD2' ' HA ' ' A' ' 103' ' ' ASP . 0.1 OUTLIER -177.67 159.81 1.49 Allowed 'General case' 0 C--N 1.313 -1.007 0 C-N-CA 119.577 -0.849 . . . . 0.0 112.101 178.423 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.74 ' HG3' HG23 ' A' ' 67' ' ' THR . 23.4 mt-30 -137.92 160.79 38.37 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 113.791 1.034 . . . . 0.0 113.791 -177.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.64 ' HB ' ' HB2' ' A' ' 66' ' ' TRP . 2.9 mt -122.81 132.02 72.12 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 CA-C-N 115.333 -0.848 . . . . 0.0 109.643 178.058 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.707 HD13 ' ND2' ' A' ' 121' ' ' ASN . 0.5 OUTLIER -106.69 142.79 35.76 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -179.391 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.857 HD22 ' N ' ' A' ' 94' ' ' GLY . 0.2 OUTLIER -126.36 127.78 46.03 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.389 179.04 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.857 ' N ' HD22 ' A' ' 93' ' ' LEU . . . 132.39 -121.56 3.02 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.6 -0.81 . . . . 0.0 112.801 179.647 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 70.55 -65.2 0.34 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.762 0.315 . . . . 0.0 110.868 -179.805 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 21.5 p-10 -167.74 54.98 0.07 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.909 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 72.45 27.21 70.06 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.508 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -135.42 -174.6 3.68 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.799 0.333 . . . . 0.0 110.954 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.642 ' O ' HD12 ' A' ' 100' ' ' LEU . 0.6 OUTLIER -113.73 146.95 39.1 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.909 179.983 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.68 ' HA ' ' O ' ' A' ' 122' ' ' GLN . 4.2 mp -133.8 149.06 51.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.294 179.819 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.452 ' O ' ' N ' ' A' ' 122' ' ' GLN . 1.1 mt -115.27 129.97 56.77 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 179.723 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.477 ' O ' ' O ' ' A' ' 90' ' ' GLN . 29.6 t30 -108.54 112.49 24.89 Favored 'General case' 0 CA--C 1.508 -0.636 0 C-N-CA 119.832 -0.747 . . . . 0.0 109.854 179.739 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.871 ' HB3' HG21 ' A' ' 109' ' ' THR . 44.3 m-20 -83.92 109.7 17.81 Favored 'General case' 0 N--CA 1.44 -0.926 0 C-N-CA 119.198 -1.001 . . . . 0.0 109.627 179.871 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 1.061 ' O ' ' O ' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -125.05 109.38 22.04 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.041 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 177.168 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.443 ' HB3' ' CE1' ' A' ' 88' ' ' HIS . 65.0 m -136.09 169.39 17.69 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.359 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 19.1 m -69.38 -63.34 1.09 Allowed 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 119.005 -1.078 . . . . 0.0 111.709 -179.009 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -112.29 -32.88 6.38 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 114.904 1.446 . . . . 0.0 114.904 179.301 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -146.03 131.49 4.13 Favored Glycine 0 C--N 1.34 0.759 0 N-CA-C 117.033 1.573 . . . . 0.0 117.033 -177.725 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.871 HG21 ' HB3' ' A' ' 103' ' ' ASP . 11.9 m -121.33 138.2 54.36 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 174.451 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 0.716 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 3.1 m-90 -121.69 149.27 43.48 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 113.648 0.981 . . . . 0.0 113.648 -178.411 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.487 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -123.85 112.22 17.02 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 114.979 -1.009 . . . . 0.0 108.711 177.512 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 44.66 43.94 7.03 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.013 -0.54 . . . . 0.0 112.127 -179.566 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 80.8 22.81 60.95 Favored Glycine 0 N--CA 1.445 -0.732 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.801 179.308 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.46 97.77 3.77 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.013 0.435 . . . . 0.0 110.661 179.749 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.716 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.0 OUTLIER -43.99 127.04 5.19 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.98 179.919 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.445 HG13 ' HB3' ' A' ' 111' ' ' LEU . 6.1 m -112.41 179.96 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.907 -179.008 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -90.66 142.2 28.0 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.143 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.415 ' HG2' ' N ' ' A' ' 119' ' ' ASN . 54.4 tttm -63.51 163.78 10.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.113 179.429 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.415 ' N ' ' HG2' ' A' ' 118' ' ' LYS . 19.4 m-80 33.72 39.85 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 121.28 0.562 . . . . 0.0 111.167 -179.39 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 7.1 p -111.04 105.05 13.68 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.038 -179.429 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.707 ' ND2' HD13 ' A' ' 92' ' ' LEU . 1.7 m120 -53.58 144.59 17.06 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.571 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . 0.68 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 35.4 mm-40 -129.5 146.02 51.38 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-O 120.976 0.417 . . . . 0.0 111.754 -179.625 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.673 HD13 ' N ' ' A' ' 124' ' ' LEU . 2.1 tm? -74.08 129.5 37.98 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.677 179.216 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.691 HD13 ' N ' ' A' ' 125' ' ' SER . 3.5 tm? -52.28 138.46 26.45 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-O 122.045 0.926 . . . . 0.0 111.587 -179.102 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.735 ' O ' HD11 ' A' ' 147' ' ' ILE . 0.6 OUTLIER -127.36 152.13 47.88 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 113.762 -1.563 . . . . 0.0 110.395 179.686 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . 0.437 ' HA ' HD13 ' A' ' 147' ' ' ILE . 14.0 mm100 -71.33 113.9 8.85 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.911 0.386 . . . . 0.0 109.973 179.412 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 62.95 32.12 82.93 Favored Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.336 -179.399 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.407 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 9.3 t70 -53.78 159.24 1.7 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.97 0.414 . . . . 0.0 111.011 -179.837 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.526 ' HB2' HG22 ' A' ' 144' ' ' VAL . 30.4 tt0 -146.66 135.1 21.94 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.883 -0.598 . . . . 0.0 111.642 -179.838 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.62 HG21 ' OD1' ' A' ' 103' ' ' ASP . 2.7 mp -116.03 129.0 73.14 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.045 178.597 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.569 HG23 ' CG2' ' A' ' 140' ' ' ILE . 12.9 m -102.75 145.41 29.78 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.884 0.373 . . . . 0.0 110.852 -179.266 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.499 ' HB ' ' NE2' ' A' ' 88' ' ' HIS . 5.8 m -141.2 158.39 22.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 112.327 0.491 . . . . 0.0 112.327 -179.113 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 67.17 43.03 90.75 Favored Glycine 0 N--CA 1.447 -0.601 0 CA-C-N 115.797 -0.638 . . . . 0.0 112.31 179.356 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.467 HG12 ' N ' ' A' ' 135' ' ' GLY . 93.6 t -78.44 157.25 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.613 0 CA-C-O 121.36 0.6 . . . . 0.0 112.076 -179.146 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.467 ' N ' HG12 ' A' ' 134' ' ' VAL . . . 149.0 -42.02 0.84 Allowed Glycine 0 N--CA 1.441 -1.012 0 N-CA-C 110.691 -0.964 . . . . 0.0 110.691 -179.193 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.569 HG12 ' H ' ' A' ' 138' ' ' SER . 48.1 t -126.6 131.33 71.36 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.715 0 CA-C-N 115.256 -0.472 . . . . 0.0 109.883 178.709 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.24 -33.9 30.04 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.772 0.32 . . . . 0.0 111.432 -179.247 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . 0.569 ' H ' HG12 ' A' ' 136' ' ' VAL . 0.9 OUTLIER -94.31 6.5 48.48 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.214 0.45 . . . . 0.0 112.214 -179.397 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 12.0 t0 -127.74 30.92 5.23 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 112.648 0.61 . . . . 0.0 112.648 -179.259 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.569 ' CG2' HG23 ' A' ' 131' ' ' THR . 24.2 mt -105.53 141.11 21.6 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.978 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.353 179.238 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.694 HD12 ' HG3' ' A' ' 42' ' ' GLN . 2.8 mm? -116.49 135.92 53.42 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 114.938 -1.028 . . . . 0.0 110.358 179.822 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.435 ' O ' ' OG1' ' A' ' 40' ' ' THR . 43.5 t -120.96 152.59 38.35 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 -178.758 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.713 HD13 ' N ' ' A' ' 144' ' ' VAL . 3.3 tm? -135.41 136.99 41.83 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 114.841 -1.072 . . . . 0.0 109.21 179.04 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.713 ' N ' HD13 ' A' ' 143' ' ' LEU . 43.0 t -130.12 140.21 49.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 120.955 0.407 . . . . 0.0 111.842 -178.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.78 HG13 HG12 ' A' ' 36' ' ' VAL . 0.1 OUTLIER -111.41 126.44 68.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.612 179.493 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 15.5 t80 -106.08 108.63 20.24 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.687 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.735 HD11 ' O ' ' A' ' 125' ' ' SER . 1.7 mp -85.24 133.42 29.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.26 -179.797 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . 0.433 ' ND2' ' HB2' ' A' ' 151' ' ' PHE . 0.9 OUTLIER -83.77 116.52 22.74 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.798 179.841 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -58.08 -21.67 46.97 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.326 -179.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 4.7 mptt -57.54 -41.07 80.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.891 0.377 . . . . 0.0 110.717 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . 0.454 ' CE2' HD11 ' A' ' 52' ' ' ILE . 4.0 t80 -61.22 -44.56 97.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.76 179.781 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 8.0 tttt -59.48 -34.29 72.39 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.788 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -60.5 -43.73 96.72 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.918 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 10.6 t -62.46 -44.92 95.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.865 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.67 -38.13 83.87 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.81 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -59.37 -40.89 87.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.937 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 1.5 tp-100 -78.64 -31.79 47.02 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.871 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -124.99 68.97 1.12 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.896 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.29 134.31 42.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.858 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 14.0 p -77.55 133.65 30.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.171 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -175.95 149.6 0.93 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.951 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -89.7 99.69 12.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.889 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 38.5 mt -93.11 119.53 40.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.104 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.237 -0.887 . . . . 0.0 110.906 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.336 0 N-CA-C 112.513 -0.235 . . . . 0.0 112.513 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -122.23 -173.56 2.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.805 0.336 . . . . 0.0 110.832 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.721 ' O ' HD13 ' A' ' 4' ' ' ILE . 0.3 OUTLIER -97.08 27.52 4.04 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.022 179.923 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.721 HD13 ' O ' ' A' ' 3' ' ' ASN . 21.4 mm -143.12 122.69 8.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.121 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 7.5 m -150.4 133.91 16.49 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.108 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -80.21 165.98 43.19 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.857 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -52.25 179.03 0.04 OUTLIER 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.588 2.192 . . . . 0.0 112.237 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -64.54 104.75 0.84 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.05 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -72.83 -35.63 67.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.918 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 62.24 149.43 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.824 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -97.65 -172.79 2.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.972 -179.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 16.2 p -107.89 -167.24 1.22 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.134 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 69.6 144.44 0.05 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.897 0.379 . . . . 0.0 111.013 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.51 -23.98 67.24 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.298 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER 77.83 -58.54 0.47 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.272 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 4.5 tp-100 -59.44 -33.35 71.16 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.901 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 6.3 mtt85 -62.55 -37.61 86.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.846 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 17.3 t80 -68.0 -35.84 78.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.838 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -61.18 -39.24 89.43 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.949 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 34.2 mm -67.88 -39.45 81.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.118 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -57.73 -39.92 78.4 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.036 -179.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.69 -32.73 73.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.903 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -60.49 -47.52 85.79 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.084 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 44.4 t -59.03 -38.89 80.38 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.94 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER 60.52 62.69 1.48 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.856 -179.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -101.05 128.61 47.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.952 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -81.25 115.18 20.52 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.888 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 23.7 mm -82.76 139.5 17.71 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.359 0 CA-C-O 121.482 0.658 . . . . 0.0 111.703 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.411 ' O ' ' ND2' ' A' ' 148' ' ' ASN . . . 152.84 41.95 0.02 OUTLIER Glycine 0 C--N 1.318 -0.436 0 CA-C-N 114.841 -1.072 . . . . 0.0 112.514 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -89.46 -22.72 22.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.668 0.27 . . . . 0.0 111.631 -179.73 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 27.3 m120 -108.54 -13.27 14.86 Favored 'General case' 0 CA--C 1.513 -0.476 0 CA-C-O 121.913 0.863 . . . . 0.0 109.35 179.282 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.529 ' CG2' ' O ' ' A' ' 32' ' ' ILE . 0.1 OUTLIER -70.6 104.13 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.54 0 CA-C-N 114.085 -1.416 . . . . 0.0 111.035 -179.353 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 1.02 ' CG2' ' HB2' ' A' ' 50' ' ' ALA . 0.5 OUTLIER -37.5 -63.42 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 CA-C-N 115.133 -0.94 . . . . 0.0 112.037 -179.197 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.784 ' SG ' HD12 ' A' ' 48' ' ' LEU . 18.8 p -164.83 164.73 20.94 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.363 -179.406 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.4 ' HD3' ' CG2' ' A' ' 45' ' ' ILE . 0.9 OUTLIER -127.38 123.64 36.68 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.858 0.361 . . . . 0.0 111.245 179.629 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.863 ' CG2' HD11 ' A' ' 48' ' ' LEU . 2.4 t -93.75 122.22 45.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.478 179.531 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 1.044 HG23 HG12 ' A' ' 45' ' ' ILE . 22.4 mt -121.86 107.94 21.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -179.231 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 8.4 m -85.02 100.64 11.81 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 177.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.6 t -85.81 -27.43 25.14 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -178.398 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.45 ' OG1' ' O ' ' A' ' 142' ' ' SER . 0.1 OUTLIER -52.08 -26.43 11.04 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.986 0.422 . . . . 0.0 111.016 -179.899 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 97.08 68.42 0.96 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.28 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.732 ' HB3' HD22 ' A' ' 141' ' ' LEU . 16.9 pt20 -142.42 -46.87 0.33 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.825 0.345 . . . . 0.0 111.204 -179.622 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.477 HG23 ' CE2' ' A' ' 76' ' ' TYR . 10.7 mt -132.31 133.84 24.24 Favored Pre-proline 0 N--CA 1.452 -0.351 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.161 -179.684 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.493 ' HD2' ' CZ ' ' A' ' 76' ' ' TYR . 29.4 Cg_exo -59.36 147.14 92.5 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.754 2.303 . . . . 0.0 111.728 179.501 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 1.044 HG12 HG23 ' A' ' 37' ' ' ILE . 52.6 mt -47.24 143.5 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.994 0.426 . . . . 0.0 111.851 -179.607 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.06 130.38 33.38 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.123 179.422 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.453 ' C ' HD23 ' A' ' 48' ' ' LEU . 1.2 p30 -97.76 120.27 37.85 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.11 0.481 . . . . 0.0 111.512 -179.341 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.863 HD11 ' CG2' ' A' ' 36' ' ' VAL . 0.5 OUTLIER -96.78 125.18 41.05 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.393 179.032 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.492 ' O ' ' HZ2' ' A' ' 66' ' ' TRP . 0.0 OUTLIER -118.49 162.21 18.73 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 122.065 0.936 . . . . 0.0 113.274 -178.861 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 1.02 ' HB2' ' CG2' ' A' ' 33' ' ' VAL . . . -119.07 164.78 15.01 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.531 -1.213 . . . . 0.0 111.026 179.644 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.883 ' O ' HG23 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -116.06 71.24 0.77 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.021 0.439 . . . . 0.0 110.679 179.932 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.836 HD11 ' CE2' ' A' ' 151' ' ' PHE . 96.6 mt -63.83 -45.63 96.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.416 -179.803 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 11.2 t -66.17 -35.55 80.76 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.475 -179.274 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.423 ' CG ' ' HB3' ' A' ' 51' ' ' ASP . 42.6 mm-40 -67.94 -38.88 83.38 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.189 -179.535 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.883 HG23 ' O ' ' A' ' 51' ' ' ASP . 21.8 t -66.38 -38.02 80.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.381 -179.846 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.2 tp -68.74 -29.82 68.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.266 -179.704 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.5 -34.05 13.54 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.064 -179.76 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 11.9 mm-40 -72.82 166.65 22.51 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.931 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -89.71 77.23 7.14 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.861 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 63.27 88.21 0.1 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.854 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.654 ' O ' HG13 ' A' ' 55' ' ' VAL . 25.2 p -139.0 137.66 36.54 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.919 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.606 HG23 ' O ' ' A' ' 62' ' ' ILE . 1.0 OUTLIER -179.37 69.95 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.882 -179.943 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.2 tptm -142.36 79.74 1.67 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.166 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.443 ' HB3' HD12 ' A' ' 93' ' ' LEU . 17.7 ttpt -124.83 131.57 53.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.599 179.385 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.637 HG13 ' O ' ' A' ' 91' ' ' ILE . 19.2 t -136.0 139.26 46.2 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 CA-C-O 121.211 0.529 . . . . 0.0 111.94 -179.172 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . 0.678 ' HB2' ' HB ' ' A' ' 91' ' ' ILE . 15.0 m-90 -100.11 139.97 35.02 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.443 179.138 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.598 HG23 ' HG2' ' A' ' 90' ' ' GLN . 26.1 m -130.79 132.54 45.33 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.527 0.68 . . . . 0.0 112.149 179.719 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.486 ' CE1' ' CG ' ' A' ' 75' ' ' ASP . 3.6 m-85 -105.96 119.04 38.18 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 114.873 -1.058 . . . . 0.0 109.348 178.298 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.637 ' HA2' ' O ' ' A' ' 85' ' ' SER . . . 160.71 -157.85 29.32 Favored Glycine 0 CA--C 1.505 -0.538 0 C-N-CA 118.658 -1.734 . . . . 0.0 113.286 178.802 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.629 ' HD2' ' ND2' ' A' ' 86' ' ' ASN . 5.1 ptm180 -75.94 91.76 3.07 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-O 122.629 1.204 . . . . 0.0 108.165 179.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.506 ' O ' ' CD2' ' A' ' 77' ' ' HIS . 0.2 OUTLIER -149.72 160.35 34.18 Favored Pre-proline 0 C--N 1.307 -1.263 0 CA-C-N 112.606 -2.088 . . . . 0.0 108.085 179.681 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.547 ' O ' ' CB ' ' A' ' 73' ' ' ALA . 30.1 Cg_endo -63.91 -8.74 16.69 Favored 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 120.84 1.027 . . . . 0.0 111.12 178.268 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.743 ' HB2' ' HB2' ' A' ' 77' ' ' HIS . . . 135.69 54.21 0.0 OUTLIER 'General case' 0 CA--C 1.49 -1.358 0 CA-C-N 114.706 -1.134 . . . . 0.0 109.361 178.724 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.55 ' HB3' ' HB ' ' A' ' 67' ' ' THR . 0.1 OUTLIER -52.59 -69.73 0.11 Allowed 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 105.546 -2.02 . . . . 0.0 105.546 179.46 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.504 ' N ' ' O ' ' A' ' 67' ' ' THR . 13.8 t70 -95.51 -47.74 6.12 Favored 'General case' 0 N--CA 1.435 -1.202 0 N-CA-C 105.446 -2.057 . . . . 0.0 105.446 169.137 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.518 ' C ' ' HA ' ' A' ' 73' ' ' ALA . 67.3 t80 -142.96 142.21 31.6 Favored 'General case' 0 C--N 1.347 0.492 0 CA-C-N 112.627 -2.079 . . . . 0.0 111.465 179.756 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.743 ' HB2' ' HB2' ' A' ' 73' ' ' ALA . 23.6 t-160 -91.65 111.64 23.24 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 177.079 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.676 HD11 ' HA ' ' A' ' 85' ' ' SER . 0.5 OUTLIER -135.47 175.89 9.17 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.925 0.393 . . . . 0.0 111.604 -179.666 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -59.39 165.63 9.68 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.257 179.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.41 ' HB3' ' CB ' ' A' ' 70' ' ' ARG . 2.4 p-10 -112.01 100.07 8.58 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.829 0.347 . . . . 0.0 111.76 -179.493 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.669 ' HB ' ' HB2' ' A' ' 85' ' ' SER . 19.1 mt -115.02 131.77 66.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 177.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.446 ' HA ' ' OD1' ' A' ' 86' ' ' ASN . 1.6 m -52.79 -24.01 8.03 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 111.789 0.292 . . . . 0.0 111.789 -178.779 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.503 ' C ' HD13 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -93.05 -94.85 0.15 Allowed 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 120.428 0.156 . . . . 0.0 111.419 -179.943 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.844 ' H ' HD22 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -109.43 108.77 19.4 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 121.388 0.613 . . . . 0.0 109.402 178.918 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.676 ' HA ' HD11 ' A' ' 78' ' ' LEU . 1.8 m 158.7 -39.67 0.0 OUTLIER 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 114.589 -1.187 . . . . 0.0 109.369 -179.684 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.696 ' O ' ' N ' ' A' ' 88' ' ' HIS . 6.7 m120 -65.76 -163.01 0.02 OUTLIER 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 177.188 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.845 ' HB2' HD11 ' A' ' 104' ' ' ILE . 4.1 pttp -58.08 72.82 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 177.435 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.976 ' O ' ' O ' ' A' ' 104' ' ' ILE . 31.2 t60 -77.79 -19.5 54.92 Favored 'General case' 0 CA--C 1.515 -0.382 0 N-CA-C 114.315 1.228 . . . . 0.0 114.315 -176.437 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.596 ' HA ' ' H ' ' A' ' 104' ' ' ILE . 0.0 OUTLIER -173.7 156.86 2.99 Favored 'General case' 0 C--N 1.314 -0.97 0 C-N-CA 118.834 -1.146 . . . . 0.0 113.012 177.944 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.598 ' HG2' HG23 ' A' ' 67' ' ' THR . 33.4 mt-30 -137.55 160.75 38.27 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 114.587 -1.188 . . . . 0.0 113.751 -177.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.68 HD13 HD11 ' A' ' 48' ' ' LEU . 3.5 mt -128.37 132.18 68.36 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 CA-C-N 115.076 -0.966 . . . . 0.0 109.49 178.486 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.771 HD13 ' ND2' ' A' ' 121' ' ' ASN . 0.3 OUTLIER -108.95 144.11 37.33 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.118 0.485 . . . . 0.0 112.219 -178.988 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.882 HD22 ' N ' ' A' ' 94' ' ' GLY . 0.3 OUTLIER -125.88 129.95 50.36 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.477 179.409 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.882 ' N ' HD22 ' A' ' 93' ' ' LEU . . . 136.47 100.68 0.59 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.509 179.733 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -176.88 -169.06 0.24 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.806 0.336 . . . . 0.0 110.768 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -68.4 73.05 0.22 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.716 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 60.23 29.92 69.73 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.327 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.431 ' C ' HD12 ' A' ' 99' ' ' LEU . 6.6 t-20 -138.27 165.65 26.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.891 0.377 . . . . 0.0 111.051 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.577 HD21 HG13 ' A' ' 33' ' ' VAL . 6.6 mp -112.16 160.69 17.32 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.769 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.852 HD13 ' O ' ' A' ' 122' ' ' GLN . 3.6 mm? -122.54 147.96 45.76 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.336 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.758 HD21 HD13 ' A' ' 145' ' ' ILE . 3.5 mp -118.79 127.44 53.53 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 179.502 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.491 ' O ' ' O ' ' A' ' 90' ' ' GLN . 26.1 t30 -111.98 111.48 22.44 Favored 'General case' 0 CA--C 1.506 -0.736 0 C-N-CA 119.641 -0.824 . . . . 0.0 109.944 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.923 ' OD1' HD13 ' A' ' 130' ' ' ILE . 81.6 m-20 -83.83 111.36 19.14 Favored 'General case' 0 N--CA 1.439 -1.016 0 C-N-CA 119.645 -0.822 . . . . 0.0 109.098 179.354 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.976 ' O ' ' O ' ' A' ' 88' ' ' HIS . 0.1 OUTLIER -122.8 107.74 20.0 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.073 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 177.964 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 59.1 m -133.89 169.12 17.56 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-N 114.86 -1.064 . . . . 0.0 109.187 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 20.0 m -69.44 -63.58 1.04 Allowed 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 119.04 -1.064 . . . . 0.0 111.689 -179.045 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -112.5 -32.45 6.47 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 114.858 1.429 . . . . 0.0 114.858 179.271 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -145.66 129.25 3.37 Favored Glycine 0 C--N 1.34 0.761 0 N-CA-C 117.151 1.62 . . . . 0.0 117.151 -177.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.772 HG21 ' HB3' ' A' ' 103' ' ' ASP . 6.8 m -121.61 138.54 54.28 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 174.392 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 0.758 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.4 m-90 -119.46 149.23 42.22 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 -178.393 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.468 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.3 OUTLIER -122.61 112.2 17.7 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 115.158 -0.928 . . . . 0.0 108.692 177.594 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.406 ' N ' HD12 ' A' ' 111' ' ' LEU . 57.8 m-20 44.93 44.06 7.65 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.075 -0.511 . . . . 0.0 112.171 -179.595 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 79.02 23.71 63.19 Favored Glycine 0 N--CA 1.445 -0.745 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.787 179.362 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 -136.76 96.09 3.26 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.105 0.478 . . . . 0.0 110.752 179.642 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.758 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.0 OUTLIER -44.12 132.87 5.45 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.071 179.888 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 4.1 m -123.61 179.29 2.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.761 -179.184 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -82.95 139.34 33.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.971 180.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.437 ' O ' ' C ' ' A' ' 119' ' ' ASN . 9.3 tmtt? -63.03 167.78 4.58 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 179.312 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.437 ' C ' ' O ' ' A' ' 118' ' ' LYS . 3.7 p30 31.22 40.74 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.331 -179.664 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 5.2 p -110.97 107.66 17.15 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.059 -179.187 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.771 ' ND2' HD13 ' A' ' 92' ' ' LEU . 1.5 m120 -56.54 140.46 46.3 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.436 179.741 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . 0.852 ' O ' HD13 ' A' ' 100' ' ' LEU . 68.6 mm-40 -129.63 147.07 51.38 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-O 121.115 0.483 . . . . 0.0 112.042 -179.714 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 7.3 tp -72.62 119.92 17.52 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.384 -0.825 . . . . 0.0 109.759 179.147 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.777 HD11 ' CD1' ' A' ' 147' ' ' ILE . 2.3 tp -48.06 142.41 5.18 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-O 121.854 0.835 . . . . 0.0 111.825 -178.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.422 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.0 OUTLIER -127.19 152.62 47.13 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 114.146 -1.388 . . . . 0.0 110.557 179.739 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 1.2 tp60 -72.34 113.71 9.66 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 179.162 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 68.75 27.24 74.01 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.466 -179.486 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.422 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 8.3 t70 -56.03 159.96 3.05 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-O 120.895 0.378 . . . . 0.0 111.232 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.446 ' HG3' HG22 ' A' ' 144' ' ' VAL . 2.0 tt0 -146.74 135.4 22.13 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.756 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.923 HD13 ' OD1' ' A' ' 103' ' ' ASP . 7.0 mt -116.27 128.14 73.67 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 178.586 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.498 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 98.6 m -103.2 145.82 29.35 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.856 0.36 . . . . 0.0 110.788 -179.404 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.54 ' HB ' ' NE2' ' A' ' 88' ' ' HIS . 7.8 m -141.12 158.42 22.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -178.786 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 69.94 44.13 62.87 Favored Glycine 0 N--CA 1.448 -0.567 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.451 179.2 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.473 ' HA ' HG12 ' A' ' 140' ' ' ILE . 93.8 t -80.43 156.49 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 CA-C-O 121.434 0.635 . . . . 0.0 112.192 -179.242 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.451 ' N ' HG12 ' A' ' 134' ' ' VAL . . . 149.62 -42.56 0.79 Allowed Glycine 0 N--CA 1.441 -0.972 0 N-CA-C 110.552 -1.019 . . . . 0.0 110.552 -179.129 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.565 HG12 ' H ' ' A' ' 138' ' ' SER . 51.9 t -126.85 131.95 70.53 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.69 0 CA-C-N 115.205 -0.497 . . . . 0.0 109.769 178.563 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -51.34 -34.52 34.05 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.725 0.298 . . . . 0.0 111.472 -179.266 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . 0.565 ' H ' HG12 ' A' ' 136' ' ' VAL . 13.9 m -94.3 6.51 48.44 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.416 0.524 . . . . 0.0 112.416 -179.36 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 18.2 t0 -126.51 30.37 5.57 Favored 'General case' 0 CA--C 1.519 -0.249 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -179.313 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.498 ' CG2' ' CG2' ' A' ' 131' ' ' THR . 14.7 mt -107.29 141.23 23.01 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.437 179.348 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.732 HD22 ' HB3' ' A' ' 42' ' ' GLN . 28.3 mt -119.82 135.23 54.95 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 114.902 -1.045 . . . . 0.0 109.916 179.554 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.819 ' C ' HD12 ' A' ' 143' ' ' LEU . 47.3 t -116.92 151.89 35.69 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.912 0.863 . . . . 0.0 113.053 -178.806 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.819 HD12 ' C ' ' A' ' 142' ' ' SER . 5.5 mp -128.42 129.54 46.31 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.547 -1.206 . . . . 0.0 109.312 179.145 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.446 HG22 ' HG3' ' A' ' 129' ' ' GLU . 10.6 t -115.37 140.45 36.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 120.892 0.377 . . . . 0.0 111.641 -179.179 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.758 HD13 HD21 ' A' ' 101' ' ' LEU . 0.1 OUTLIER -116.23 126.26 73.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.766 179.957 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 9.8 t80 -109.62 121.89 46.22 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.782 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.777 ' CD1' HD11 ' A' ' 124' ' ' LEU . 5.9 mm -100.79 133.54 43.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.275 -179.835 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . 0.411 ' ND2' ' O ' ' A' ' 29' ' ' GLY . 7.9 p-10 -82.44 125.57 31.23 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.002 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -67.82 -22.66 65.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.024 179.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 9.8 mtmt -57.19 -40.23 76.95 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-O 120.939 0.399 . . . . 0.0 110.649 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . 0.836 ' CE2' HD11 ' A' ' 52' ' ' ILE . 19.5 t80 -60.57 -41.29 94.34 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.563 179.732 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 5.6 mttm -58.88 -35.48 73.08 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.717 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 5.0 mt-30 -68.45 -40.43 81.09 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.895 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 13.7 t -58.77 -45.73 89.12 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.824 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -68.44 -35.65 77.92 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.861 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -62.41 -36.87 83.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.992 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -92.13 -36.51 13.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.881 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 5.0 p30 42.71 32.82 0.41 Allowed 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.501 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -124.8 156.09 38.34 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.85 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 4.3 m -102.63 124.18 56.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.174 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -168.0 -169.4 1.13 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.791 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.58 36.46 3.55 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.901 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 24.3 mm -95.57 131.69 41.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.093 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.206 -0.902 . . . . 0.0 110.939 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.352 0 N-CA-C 112.486 -0.245 . . . . 0.0 112.486 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -69.76 121.19 16.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.745 0.307 . . . . 0.0 110.845 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -158.68 -70.43 0.09 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.867 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 18.7 pt -114.53 157.92 15.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.084 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 5.5 m -87.68 -21.61 25.14 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.359 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 64.5 mt-30 -52.88 157.33 2.82 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.02 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -65.75 173.03 7.33 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.567 2.178 . . . . 0.0 112.234 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -127.03 131.89 50.85 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.203 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -131.09 122.24 26.35 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.739 179.893 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 4.5 mm100 64.54 69.01 0.52 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.765 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -102.98 36.85 2.1 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.951 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 3.3 t -165.21 128.59 2.27 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.155 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 38.3 tt0 -72.41 114.45 10.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.963 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -169.71 44.82 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.096 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.3 -57.94 2.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.23 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.571 ' HA ' HD23 ' A' ' 19' ' ' LEU . 7.2 mt-30 -68.21 -41.72 80.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.86 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.2 mtp180 -70.54 -35.88 73.38 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.954 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 15.7 t80 -56.84 -44.72 82.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.27 -179.758 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.571 HD23 ' HA ' ' A' ' 16' ' ' GLN . 1.1 pp -58.61 -32.39 68.95 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.881 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 33.3 mm -72.76 -41.27 61.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.04 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -57.77 -46.77 84.09 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.051 -179.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.81 -34.3 77.51 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.769 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -65.37 -47.48 76.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.063 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.9 t -59.9 -30.95 69.37 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.907 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER 60.49 163.16 0.06 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.845 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -68.72 135.63 51.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.807 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 9.9 mt-30 -76.69 135.05 39.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.913 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 23.8 mm -82.22 139.61 17.64 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.316 0 CA-C-O 121.426 0.632 . . . . 0.0 111.509 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -103.84 73.14 0.27 Allowed Glycine 0 C--N 1.316 -0.56 0 CA-C-N 114.884 -1.053 . . . . 0.0 112.585 -179.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -84.31 -27.49 27.76 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.727 0.299 . . . . 0.0 110.888 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.436 ' OD1' HD12 ' A' ' 52' ' ' ILE . 10.7 m-20 -109.0 -13.95 14.63 Favored 'General case' 0 CA--C 1.516 -0.345 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 178.244 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.594 ' CG2' ' O ' ' A' ' 32' ' ' ILE . 0.1 OUTLIER -70.74 95.46 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.581 0 CA-C-N 113.908 -1.497 . . . . 0.0 110.473 -179.685 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.743 HG23 ' HB3' ' A' ' 50' ' ' ALA . 0.8 OUTLIER -36.02 -63.08 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 114.813 -1.085 . . . . 0.0 112.593 -178.939 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.646 ' N ' HG12 ' A' ' 33' ' ' VAL . 98.3 m -154.31 164.8 38.03 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.152 0.501 . . . . 0.0 112.141 -179.009 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.19 114.84 20.82 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.264 179.241 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.601 HG12 HG13 ' A' ' 145' ' ' ILE . 5.7 m -88.98 126.93 42.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.663 -179.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.964 HG23 HG12 ' A' ' 45' ' ' ILE . 26.3 mt -126.07 108.82 20.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 112.464 0.542 . . . . 0.0 112.464 -179.035 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.49 ' SG ' HD23 ' A' ' 143' ' ' LEU . 0.0 OUTLIER -108.73 108.88 19.88 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 177.822 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.6 t -110.69 -23.22 11.19 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 -177.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.2 p -53.13 -25.21 12.5 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.917 0.389 . . . . 0.0 111.286 -179.433 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 119.98 47.74 0.34 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.494 179.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.752 ' HG2' HD22 ' A' ' 141' ' ' LEU . 2.8 mt-30 -120.06 -67.77 0.96 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.837 0.351 . . . . 0.0 110.886 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.486 HG21 ' CG ' ' A' ' 76' ' ' TYR . 0.6 OUTLIER -135.02 135.1 22.33 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.953 -179.804 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.432 ' HD2' ' CZ ' ' A' ' 76' ' ' TYR . 24.0 Cg_exo -59.37 147.69 89.99 Favored 'Trans proline' 0 C--N 1.342 0.234 0 C-N-CA 122.469 2.112 . . . . 0.0 111.563 179.451 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.964 HG12 HG23 ' A' ' 37' ' ' ILE . 32.8 mt -44.28 129.02 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.056 0.455 . . . . 0.0 111.99 -179.32 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.435 ' HB2' ' CD2' ' A' ' 76' ' ' TYR . 4.8 tpt180 -128.05 148.16 50.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.738 -0.664 . . . . 0.0 109.765 179.151 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -106.05 120.03 40.73 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.972 0.415 . . . . 0.0 111.797 -179.159 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.906 HD11 HD13 ' A' ' 91' ' ' ILE . 3.5 mt -93.64 131.84 38.56 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.282 178.716 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.525 ' O ' ' HZ2' ' A' ' 66' ' ' TRP . 0.0 OUTLIER -136.59 162.27 33.59 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 122.03 0.919 . . . . 0.0 113.406 -178.641 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.743 ' HB3' HG23 ' A' ' 33' ' ' VAL . . . -149.17 165.57 31.43 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.24 -1.346 . . . . 0.0 111.035 179.057 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.867 ' O ' HG23 ' A' ' 55' ' ' VAL . 32.3 m-20 -91.57 121.16 33.0 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.051 0.453 . . . . 0.0 111.303 -179.678 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.436 HD12 ' OD1' ' A' ' 31' ' ' ASN . 72.0 mt -64.65 -45.18 96.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.788 -0.642 . . . . 0.0 112.077 -179.759 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -63.93 -38.06 89.7 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.093 0.473 . . . . 0.0 111.135 -178.806 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.445 ' HG2' ' HB3' ' A' ' 51' ' ' ASP . 55.2 mm-40 -68.55 -38.37 80.72 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.042 -179.751 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.867 HG23 ' O ' ' A' ' 51' ' ' ASP . 32.6 t -73.63 -40.64 54.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.029 179.695 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.614 HD21 ' O ' ' A' ' 159' ' ' LYS . 5.6 tp -59.06 -37.82 77.96 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.945 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 3.7 tttt -78.07 -38.83 43.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.786 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 44.54 44.92 7.53 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.346 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.3 -60.51 1.51 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.763 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 4.2 ptm180 -143.2 36.53 1.37 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.922 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 68.6 m -163.23 54.51 0.18 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.822 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.679 HD13 HG13 ' A' ' 55' ' ' VAL . 7.3 tp -139.43 71.92 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.915 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 60.3 tttt -172.85 75.71 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.961 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.433 ' O ' ' HB3' ' A' ' 93' ' ' LEU . 6.3 ttpt -115.18 134.1 55.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.462 179.791 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.645 HG13 ' O ' ' A' ' 91' ' ' ILE . 16.8 t -137.1 137.72 46.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.116 0.484 . . . . 0.0 111.647 -179.292 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . 0.695 ' CD1' HD22 ' A' ' 48' ' ' LEU . 14.5 m-90 -99.89 139.67 35.21 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.199 179.128 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.709 HG23 ' CG ' ' A' ' 90' ' ' GLN . 8.8 m -127.57 129.63 47.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.505 0.669 . . . . 0.0 112.489 179.301 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.571 ' CE1' ' CG ' ' A' ' 75' ' ' ASP . 12.9 m-85 -100.91 118.49 37.05 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.14 -0.936 . . . . 0.0 108.961 177.735 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.639 ' HA2' ' O ' ' A' ' 85' ' ' SER . . . 160.46 -157.03 28.4 Favored Glycine 0 CA--C 1.505 -0.546 0 C-N-CA 119.045 -1.55 . . . . 0.0 113.057 179.236 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.442 ' H ' ' HA ' ' A' ' 86' ' ' ASN . 0.0 OUTLIER -76.78 92.42 3.59 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-O 122.663 1.22 . . . . 0.0 108.719 -179.685 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.502 ' O ' ' CD2' ' A' ' 77' ' ' HIS . 17.7 m-80 -149.42 159.45 36.58 Favored Pre-proline 0 C--N 1.306 -1.289 0 CA-C-N 112.68 -2.055 . . . . 0.0 108.06 179.15 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.544 ' O ' ' CB ' ' A' ' 73' ' ' ALA . 27.8 Cg_endo -63.61 -6.66 10.95 Favored 'Trans proline' 0 N--CA 1.452 -0.956 0 C-N-CA 120.64 0.893 . . . . 0.0 110.695 177.648 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.707 ' HB2' ' HB2' ' A' ' 77' ' ' HIS . . . 135.32 53.47 0.0 OUTLIER 'General case' 0 CA--C 1.491 -1.316 0 CA-C-N 114.447 -1.252 . . . . 0.0 109.227 178.814 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.579 ' HB3' ' HB ' ' A' ' 67' ' ' THR . 0.1 OUTLIER -52.48 -69.88 0.1 Allowed 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 105.443 -2.058 . . . . 0.0 105.443 179.617 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.701 ' HB2' ' N ' ' A' ' 67' ' ' THR . 57.0 t0 -95.45 -47.47 6.26 Favored 'General case' 0 N--CA 1.434 -1.232 0 N-CA-C 105.504 -2.036 . . . . 0.0 105.504 169.05 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.499 ' C ' ' HA ' ' A' ' 73' ' ' ALA . 1.7 t80 -143.72 142.72 31.08 Favored 'General case' 0 C--N 1.348 0.512 0 CA-C-N 112.602 -2.09 . . . . 0.0 112.019 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.707 ' HB2' ' HB2' ' A' ' 73' ' ' ALA . 23.3 t-160 -96.43 108.02 20.5 Favored 'General case' 0 C--N 1.331 -0.218 0 O-C-N 122.166 -0.334 . . . . 0.0 110.101 176.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.694 HD13 ' N ' ' A' ' 78' ' ' LEU . 0.0 OUTLIER -136.94 179.93 6.08 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.891 0.377 . . . . 0.0 111.677 -179.754 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -52.23 157.75 3.54 Favored Glycine 0 C--N 1.333 0.383 0 CA-C-N 115.983 -0.553 . . . . 0.0 112.854 -179.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 5.9 p-10 -111.93 99.9 8.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.811 0.339 . . . . 0.0 111.814 -179.561 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.662 ' HB ' ' HB2' ' A' ' 85' ' ' SER . 14.1 mm -114.26 129.97 69.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.237 -0.438 . . . . 0.0 109.845 178.336 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.458 ' HA ' ' ND2' ' A' ' 86' ' ' ASN . 80.3 p -53.02 -23.7 8.07 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.788 -179.082 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.516 ' C ' HD13 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -93.97 -96.38 0.15 Allowed 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 111.669 0.248 . . . . 0.0 111.669 -179.509 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.816 ' H ' HD22 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -109.82 109.93 20.74 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-O 121.295 0.569 . . . . 0.0 109.84 179.324 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.662 ' HB2' ' HB ' ' A' ' 81' ' ' ILE . 0.4 OUTLIER 157.24 -41.26 0.0 OUTLIER 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 114.781 -1.099 . . . . 0.0 109.469 -179.942 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.761 ' O ' ' N ' ' A' ' 88' ' ' HIS . 91.1 m-20 -67.71 -156.19 0.02 OUTLIER 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 177.69 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.937 ' HB2' HD11 ' A' ' 104' ' ' ILE . 8.7 pttp -54.03 72.23 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 178.397 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 1.023 ' O ' ' O ' ' A' ' 104' ' ' ILE . 42.8 t60 -81.92 -16.13 51.59 Favored 'General case' 0 CA--C 1.514 -0.419 0 N-CA-C 113.888 1.07 . . . . 0.0 113.888 -176.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.591 ' CE1' HG13 ' A' ' 91' ' ' ILE . 0.0 OUTLIER -177.54 159.99 1.55 Allowed 'General case' 0 C--N 1.314 -0.95 0 C-N-CA 119.301 -0.96 . . . . 0.0 112.457 178.161 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.709 ' CG ' HG23 ' A' ' 67' ' ' THR . 38.3 mt-30 -138.89 160.35 39.93 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 113.761 1.022 . . . . 0.0 113.761 -178.442 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.906 HD13 HD11 ' A' ' 48' ' ' LEU . 5.6 mt -124.57 131.54 72.58 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.345 177.714 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.642 HD13 ' ND2' ' A' ' 121' ' ' ASN . 0.2 OUTLIER -107.61 140.24 40.93 Favored 'General case' 0 N--CA 1.463 0.176 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 -179.129 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.916 HD22 ' N ' ' A' ' 94' ' ' GLY . 0.3 OUTLIER -126.34 131.18 51.87 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.445 179.068 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.916 ' N ' HD22 ' A' ' 93' ' ' LEU . . . 133.41 -142.49 14.0 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.661 179.694 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 63.15 75.08 0.41 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.903 0.382 . . . . 0.0 110.77 -179.852 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 7.5 t0 59.04 39.88 22.82 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.912 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 65.06 71.46 0.87 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.442 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -156.56 165.75 35.39 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.778 0.323 . . . . 0.0 110.864 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.699 ' O ' HD12 ' A' ' 100' ' ' LEU . 4.0 mm? -106.74 137.07 45.47 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.763 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.699 HD12 ' O ' ' A' ' 99' ' ' LEU . 3.8 mp -133.58 149.02 51.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.538 -179.794 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 1.028 HD22 HD13 ' A' ' 145' ' ' ILE . 0.5 OUTLIER -115.21 129.9 56.77 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 179.506 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.485 ' O ' ' O ' ' A' ' 90' ' ' GLN . 20.6 t30 -110.26 112.35 24.25 Favored 'General case' 0 CA--C 1.51 -0.588 0 C-N-CA 119.796 -0.762 . . . . 0.0 109.893 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.729 ' HB3' HG21 ' A' ' 109' ' ' THR . 87.0 m-20 -83.93 110.49 18.44 Favored 'General case' 0 N--CA 1.442 -0.848 0 C-N-CA 119.355 -0.938 . . . . 0.0 109.495 179.593 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 1.023 ' O ' ' O ' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -124.27 108.5 20.62 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.026 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 177.08 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.412 ' HG ' ' CE1' ' A' ' 88' ' ' HIS . 64.0 m -134.56 168.97 17.99 Favored 'General case' 0 C--N 1.296 -1.754 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.227 179.808 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 19.9 m -69.33 -63.14 1.12 Allowed 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 119.006 -1.078 . . . . 0.0 111.542 -179.042 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 63.9 m-80 -112.27 -32.39 6.54 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 114.934 1.457 . . . . 0.0 114.934 179.323 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -145.89 127.82 2.91 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 117.105 1.602 . . . . 0.0 117.105 -177.718 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.729 HG21 ' HB3' ' A' ' 103' ' ' ASP . 5.7 m -121.18 138.11 54.36 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 174.337 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 0.736 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.8 m-90 -120.7 148.98 43.21 Favored 'General case' 0 CA--C 1.515 -0.384 0 N-CA-C 113.462 0.912 . . . . 0.0 113.462 -178.515 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.462 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -122.65 112.08 17.53 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 115.026 -0.988 . . . . 0.0 108.621 177.532 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 39.7 m-20 45.57 43.76 9.42 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.085 -0.507 . . . . 0.0 112.118 -179.478 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 78.88 25.05 60.82 Favored Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.784 179.425 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . 0.435 ' O ' HG13 ' A' ' 116' ' ' VAL . 31.2 mt-30 -136.98 97.51 3.53 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.102 0.477 . . . . 0.0 110.802 179.69 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.736 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.0 OUTLIER -45.66 132.61 8.44 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.911 179.755 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.606 HG21 ' OD2' ' A' ' 103' ' ' ASP . 27.7 m -124.07 -178.84 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 121.069 0.461 . . . . 0.0 111.916 -179.041 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -85.5 142.29 29.3 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.111 -179.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.426 ' HG2' ' N ' ' A' ' 119' ' ' ASN . 33.7 tttm -64.26 163.73 12.34 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.197 179.422 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.426 ' N ' ' HG2' ' A' ' 118' ' ' LYS . 8.2 m-80 34.56 39.91 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 121.182 0.515 . . . . 0.0 111.062 -179.374 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 3.5 p -110.74 107.2 16.66 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.901 -179.537 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.642 ' ND2' HD13 ' A' ' 92' ' ' LEU . 2.0 m120 -53.12 146.75 10.87 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.771 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . 0.665 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 80.7 mm-40 -129.28 152.11 49.2 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-O 121.149 0.499 . . . . 0.0 111.925 -179.514 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.596 HD13 ' O ' ' A' ' 124' ' ' LEU . 2.6 tm? -81.02 122.52 27.41 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.571 -0.741 . . . . 0.0 109.531 179.031 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.596 ' O ' HD13 ' A' ' 123' ' ' LEU . 0.0 OUTLIER -48.45 139.44 9.05 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-O 122.365 1.078 . . . . 0.0 112.241 -178.672 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.419 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.3 OUTLIER -127.68 152.56 47.55 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 113.593 -1.64 . . . . 0.0 110.196 179.485 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 7.2 tp-100 -71.86 113.44 8.9 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 179.27 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 64.8 30.79 78.92 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.366 -179.564 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.463 ' OD2' HD13 ' A' ' 101' ' ' LEU . 29.8 t70 -53.74 160.5 1.34 Allowed 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.884 0.373 . . . . 0.0 111.077 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.496 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 0.1 OUTLIER -146.6 135.48 22.37 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.755 -179.898 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.454 HG23 ' O ' ' A' ' 110' ' ' TRP . 7.3 mm -113.68 128.72 70.43 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.124 0 CA-C-N 116.167 -0.47 . . . . 0.0 109.922 178.659 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.536 HG23 ' CG2' ' A' ' 140' ' ' ILE . 18.7 m -103.42 144.31 31.55 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.785 -179.392 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.476 ' HB ' ' NE2' ' A' ' 88' ' ' HIS . 5.6 m -141.19 156.1 21.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.005 0.431 . . . . 0.0 112.159 -179.068 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . 0.405 ' O ' ' O ' ' A' ' 139' ' ' ASP . . . 70.34 39.54 70.45 Favored Glycine 0 N--CA 1.448 -0.562 0 CA-C-N 115.914 -0.585 . . . . 0.0 112.463 179.396 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.462 HG12 ' N ' ' A' ' 135' ' ' GLY . 90.2 t -74.39 156.86 6.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 121.447 0.641 . . . . 0.0 112.123 -179.247 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.462 ' N ' HG12 ' A' ' 134' ' ' VAL . . . 152.99 -46.21 0.57 Allowed Glycine 0 N--CA 1.441 -1.0 0 CA-C-N 114.981 -1.008 . . . . 0.0 110.749 -179.285 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.595 HG12 ' H ' ' A' ' 138' ' ' SER . 42.7 t -126.59 133.9 67.55 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.722 0 CA-C-N 115.222 -0.489 . . . . 0.0 109.904 178.597 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -51.01 -32.44 21.27 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.89 0.376 . . . . 0.0 111.207 -179.353 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . 0.595 ' H ' HG12 ' A' ' 136' ' ' VAL . 46.7 m -94.39 6.22 49.39 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 116.164 -0.471 . . . . 0.0 112.132 -179.666 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . 0.405 ' O ' ' O ' ' A' ' 133' ' ' GLY . 25.4 t0 -128.34 30.26 5.21 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 -179.378 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.536 ' CG2' HG23 ' A' ' 131' ' ' THR . 27.5 mt -105.89 141.19 21.76 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.287 179.373 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.752 HD22 ' HG2' ' A' ' 42' ' ' GLN . 4.5 mt -116.79 135.27 53.88 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.869 -1.059 . . . . 0.0 110.291 179.675 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 29.8 t -120.31 152.42 37.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.694 0.759 . . . . 0.0 112.359 -179.17 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.872 HD22 ' N ' ' A' ' 144' ' ' VAL . 0.8 OUTLIER -135.7 131.28 35.44 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.625 -1.17 . . . . 0.0 108.992 179.357 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.872 ' N ' HD22 ' A' ' 143' ' ' LEU . 12.2 t -111.67 140.17 32.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.975 0.416 . . . . 0.0 111.908 -179.079 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 1.028 HD13 HD22 ' A' ' 101' ' ' LEU . 0.0 OUTLIER -116.91 126.63 74.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.215 179.575 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 16.0 t80 -106.97 125.48 51.06 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.057 -179.724 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 4.1 mm -103.53 133.3 47.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.999 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 35.5 p-10 -84.77 111.25 19.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.861 0.362 . . . . 0.0 110.718 179.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -56.28 -27.34 54.96 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.153 -179.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 2.2 tptt -57.2 -36.34 70.72 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.807 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -66.32 -41.88 89.05 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.777 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -62.05 -49.81 74.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.948 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 6.5 tm0? -59.22 -38.29 79.59 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.885 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 10.2 t -65.88 -45.15 83.15 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.886 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -68.64 -37.69 79.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.768 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -60.05 -39.83 87.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.876 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -86.43 -36.13 19.29 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.791 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 3.9 p30 42.6 90.76 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.466 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . 0.614 ' O ' HD21 ' A' ' 56' ' ' LEU . 13.8 pttp -75.37 117.72 17.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.975 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 14.3 t -91.53 132.49 35.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.01 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 24.0 p-10 -91.48 -31.8 15.83 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.043 -179.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 33.3 ttm180 -70.47 -77.96 0.08 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.942 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 16.9 pt -106.01 136.05 41.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.136 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 4.0 ppt_? . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.189 -0.91 . . . . 0.0 111.015 179.946 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.325 0 N-CA-C 112.502 -0.239 . . . . 0.0 112.502 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 6.2 pm0 -60.35 143.49 52.93 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.851 0.357 . . . . 0.0 110.936 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -124.52 42.32 3.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.748 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.0 mp 63.12 83.19 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.099 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -115.68 178.64 4.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.115 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 2.3 pm0 -112.38 90.84 15.09 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.835 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -68.01 122.94 10.08 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.511 2.14 . . . . 0.0 112.329 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.6 m 64.27 139.03 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.059 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 2.8 tp60 -122.57 33.7 5.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.943 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -145.47 141.79 28.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.924 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -171.47 86.23 0.09 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.907 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 23.4 m -161.33 -61.38 0.05 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.132 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -165.55 175.34 9.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.896 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 61.66 71.07 0.56 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.14 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 27.6 m -159.05 -70.0 0.08 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.097 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 4.3 mp0 -72.79 -45.4 58.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.878 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 23.1 ttt180 -61.3 -42.63 98.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.858 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 15.4 t80 -58.53 -38.91 78.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.997 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -62.37 -34.5 76.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.833 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 41.6 mm -73.05 -39.47 57.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.173 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.5 tm-20 -57.72 -46.49 84.33 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.139 -179.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 16.9 mmtm -60.68 -29.06 69.08 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.987 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -63.4 -47.65 81.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.208 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 85.7 p -58.44 -33.78 70.09 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.054 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -58.99 -31.54 68.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.922 -179.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -97.74 136.51 37.98 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.88 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -95.96 103.49 15.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.862 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.804 HG22 ' H ' ' A' ' 30' ' ' GLU . 19.7 mm -83.47 139.27 17.94 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.333 0 CA-C-O 121.521 0.677 . . . . 0.0 111.624 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.431 ' HA2' ' HB ' ' A' ' 32' ' ' ILE . . . -97.21 12.64 65.21 Favored Glycine 0 C--N 1.318 -0.469 0 CA-C-N 114.845 -1.07 . . . . 0.0 112.759 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.804 ' H ' HG22 ' A' ' 28' ' ' ILE . 6.2 tm-20 -88.98 -23.78 22.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.643 0.258 . . . . 0.0 111.508 -179.788 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 26.0 m-80 -109.56 -14.69 14.34 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-O 121.909 0.862 . . . . 0.0 109.28 178.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.487 ' O ' HG22 ' A' ' 32' ' ' ILE . 0.1 OUTLIER -74.1 111.14 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.571 0 CA-C-N 114.129 -1.396 . . . . 0.0 111.23 -179.168 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 1.043 ' CG2' ' HB2' ' A' ' 50' ' ' ALA . 0.5 OUTLIER -45.02 -64.12 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.211 -0.904 . . . . 0.0 111.381 -179.488 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.644 ' N ' HG12 ' A' ' 33' ' ' VAL . 30.2 p -165.4 164.93 19.61 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.039 0.447 . . . . 0.0 112.046 -179.644 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.412 ' HD3' HG23 ' A' ' 45' ' ' ILE . 1.0 OUTLIER -124.39 117.63 24.89 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.598 179.38 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.897 HG13 HD11 ' A' ' 143' ' ' LEU . 89.3 t -89.16 132.57 33.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.112 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.937 HG23 HG12 ' A' ' 45' ' ' ILE . 22.6 mt -129.86 108.14 15.84 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.693 -179.745 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.433 ' HB3' ' O ' ' A' ' 43' ' ' ILE . 2.5 t -86.66 105.98 17.29 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 178.18 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 11.4 t -90.71 -26.76 19.38 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 -178.41 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.454 HG21 ' H ' ' A' ' 142' ' ' SER . 26.1 p -59.64 -21.99 61.24 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 121.047 -0.261 . . . . 0.0 111.422 -179.429 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 103.65 72.39 0.9 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.571 -0.823 . . . . 0.0 113.033 179.384 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.658 ' NE2' HD23 ' A' ' 141' ' ' LEU . 0.0 OUTLIER -151.1 -70.62 0.17 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.859 0.361 . . . . 0.0 110.941 179.534 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.554 HG23 ' HD2' ' A' ' 44' ' ' PRO . 16.7 mt -102.56 140.33 21.0 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.2 -179.565 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.554 ' HD2' HG23 ' A' ' 43' ' ' ILE . 74.3 Cg_endo -77.6 146.76 24.41 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 122.337 2.025 . . . . 0.0 111.724 179.566 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.937 HG12 HG23 ' A' ' 37' ' ' ILE . 35.5 mt -44.12 108.67 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.056 0.455 . . . . 0.0 111.779 -179.499 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.24 129.8 56.73 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.761 179.132 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.424 ' C ' HD13 ' A' ' 48' ' ' LEU . 3.6 p30 -96.4 119.38 34.78 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.986 0.422 . . . . 0.0 111.429 -179.305 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.876 HD12 ' CD1' ' A' ' 66' ' ' TRP . 0.2 OUTLIER -96.36 131.98 42.34 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 178.543 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.559 ' O ' ' CZ2' ' A' ' 66' ' ' TRP . 0.1 OUTLIER -113.15 164.02 14.03 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.84 0.828 . . . . 0.0 112.608 -178.598 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 1.043 ' HB2' ' CG2' ' A' ' 33' ' ' VAL . . . -111.46 166.42 11.14 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 114.915 -1.039 . . . . 0.0 110.864 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.679 ' O ' HG23 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -93.56 46.13 1.18 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.946 0.403 . . . . 0.0 110.942 179.919 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 14.1 mm -57.02 -40.59 73.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.099 0.476 . . . . 0.0 110.664 179.614 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -67.25 -38.45 85.17 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.968 -179.763 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.419 ' CG ' ' HB3' ' A' ' 51' ' ' ASP . 1.4 mm-40 -67.99 -41.71 81.89 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.92 -179.765 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.679 HG23 ' O ' ' A' ' 51' ' ' ASP . 39.1 t -64.08 -38.02 81.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.85 179.788 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.11 -25.82 64.59 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.936 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -93.45 -54.14 3.79 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.15 -179.795 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.58 -178.42 3.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.077 -179.763 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 8.9 pttt -100.11 -31.89 11.19 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.88 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 16.0 mtm180 -111.39 112.36 24.06 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.834 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -166.83 33.03 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.788 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.492 HG23 ' HA2' ' A' ' 94' ' ' GLY . 39.7 mm -117.47 91.07 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.017 -179.884 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.5 ttpt -179.27 68.49 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.776 179.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.427 ' O ' ' HB3' ' A' ' 93' ' ' LEU . 7.9 ttpt -126.92 131.21 51.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.685 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.561 HG13 ' O ' ' A' ' 91' ' ' ILE . 10.7 t -134.86 136.33 52.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 121.037 0.446 . . . . 0.0 111.588 -179.494 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . 0.876 ' CD1' HD12 ' A' ' 48' ' ' LEU . 16.0 m-90 -102.07 140.06 36.86 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.057 179.599 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.932 HG23 ' HG3' ' A' ' 90' ' ' GLN . 3.1 m -127.58 129.81 47.95 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.435 0.635 . . . . 0.0 112.14 179.51 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.54 ' HE2' HD11 ' A' ' 91' ' ' ILE . 64.7 m-85 -101.77 118.38 36.81 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.322 178.192 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.679 ' HA2' HD21 ' A' ' 78' ' ' LEU . . . 159.33 -157.6 28.72 Favored Glycine 0 CA--C 1.502 -0.755 0 C-N-CA 119.034 -1.555 . . . . 0.0 112.192 179.328 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.44 ' CD ' ' HB3' ' A' ' 86' ' ' ASN . 11.7 ptm180 -76.75 91.81 3.52 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-O 122.424 1.106 . . . . 0.0 108.297 179.538 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.542 ' O ' ' CD2' ' A' ' 77' ' ' HIS . 6.3 m120 -149.08 154.63 39.63 Favored Pre-proline 0 C--N 1.311 -1.068 0 CA-C-N 112.985 -1.916 . . . . 0.0 108.506 179.269 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.573 ' O ' ' HB2' ' A' ' 77' ' ' HIS . 25.7 Cg_exo -56.1 -11.56 5.97 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 121.507 1.472 . . . . 0.0 111.571 178.45 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.787 ' HB2' ' HB2' ' A' ' 77' ' ' HIS . . . 137.27 50.97 0.0 OUTLIER 'General case' 0 CA--C 1.49 -1.336 0 CA-C-N 114.96 -1.018 . . . . 0.0 109.605 178.791 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.58 ' HB3' ' HB ' ' A' ' 67' ' ' THR . 0.1 OUTLIER -52.92 -69.9 0.1 Allowed 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 105.858 -1.904 . . . . 0.0 105.858 179.485 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.576 ' N ' ' O ' ' A' ' 67' ' ' THR . 12.2 t0 -94.78 -47.4 6.49 Favored 'General case' 0 N--CA 1.437 -1.112 0 N-CA-C 105.89 -1.893 . . . . 0.0 105.89 169.806 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.517 ' CD2' HG23 ' A' ' 43' ' ' ILE . 35.6 t80 -144.21 142.56 30.59 Favored 'General case' 0 C--N 1.347 0.473 0 CA-C-N 112.576 -2.102 . . . . 0.0 110.951 179.658 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.787 ' HB2' ' HB2' ' A' ' 73' ' ' ALA . 23.3 t-160 -93.0 108.38 19.96 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 118.12 0.418 . . . . 0.0 110.442 177.323 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.781 HD11 ' O ' ' A' ' 85' ' ' SER . 2.2 pp -125.66 168.48 13.67 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.784 0.326 . . . . 0.0 111.103 179.698 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.677 ' O ' HD12 ' A' ' 78' ' ' LEU . . . -53.91 173.05 0.63 Allowed Glycine 0 C--N 1.33 0.209 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.777 -179.791 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.563 ' C ' HD12 ' A' ' 81' ' ' ILE . 12.8 p-10 -96.05 105.36 17.39 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.725 0.298 . . . . 0.0 110.965 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.673 HD13 ' HB3' ' A' ' 85' ' ' SER . 2.0 mp -111.53 152.65 13.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.772 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.23 -45.27 73.74 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 113.61 0.967 . . . . 0.0 113.61 -178.767 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 17.9 mtt180 -119.72 -91.16 0.56 Allowed 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 113.692 0.997 . . . . 0.0 113.692 -177.328 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.493 ' O ' ' CB ' ' A' ' 85' ' ' SER . 0.0 OUTLIER -84.9 103.26 13.8 Favored 'General case' 0 CA--C 1.507 -0.704 0 CA-C-O 121.948 0.88 . . . . 0.0 110.74 -178.606 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.781 ' O ' HD11 ' A' ' 78' ' ' LEU . 0.4 OUTLIER 148.62 -35.42 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 113.113 -1.858 . . . . 0.0 108.718 -179.745 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.803 ' O ' ' N ' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -68.44 -162.39 0.03 OUTLIER 'General case' 0 CA--C 1.514 -0.43 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 177.6 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.911 ' HB3' HD11 ' A' ' 104' ' ' ILE . 1.0 OUTLIER -53.14 72.18 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 177.822 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.959 ' O ' ' O ' ' A' ' 104' ' ' ILE . 29.6 t60 -83.73 -18.91 36.26 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 114.642 1.349 . . . . 0.0 114.642 -175.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.651 ' HA ' ' H ' ' A' ' 104' ' ' ILE . 0.0 OUTLIER -171.06 156.98 5.02 Favored 'General case' 0 C--N 1.31 -1.113 0 C-N-CA 118.824 -1.15 . . . . 0.0 112.632 177.864 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.932 ' HG3' HG23 ' A' ' 67' ' ' THR . 34.4 mt-30 -135.37 158.8 43.45 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.587 -1.188 . . . . 0.0 113.825 -177.197 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.646 ' HB ' ' HB2' ' A' ' 66' ' ' TRP . 7.9 mt -124.16 132.82 70.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 114.908 -1.042 . . . . 0.0 109.785 178.499 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.714 HD13 ' ND2' ' A' ' 121' ' ' ASN . 0.3 OUTLIER -108.99 144.03 37.5 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.01 0.433 . . . . 0.0 111.807 -179.557 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.645 HD22 ' N ' ' A' ' 94' ' ' GLY . 0.8 OUTLIER -125.58 122.69 37.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.485 179.442 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.645 ' N ' HD22 ' A' ' 93' ' ' LEU . . . 157.53 -125.71 1.61 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.594 -0.812 . . . . 0.0 112.678 179.806 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 61.68 -176.06 0.13 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.793 0.33 . . . . 0.0 110.786 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -76.73 67.86 2.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.944 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.579 ' HA2' HD21 ' A' ' 155' ' ' LEU . . . 71.4 68.47 1.61 Allowed Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.553 179.874 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -178.26 179.39 0.81 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.821 0.343 . . . . 0.0 110.782 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.74 ' O ' HD22 ' A' ' 100' ' ' LEU . 0.2 OUTLIER -113.26 154.78 26.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.783 179.937 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.777 HD13 ' O ' ' A' ' 122' ' ' GLN . 4.1 mm? -131.35 148.24 52.65 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.263 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.466 ' O ' ' N ' ' A' ' 122' ' ' GLN . 0.3 OUTLIER -117.03 129.99 56.38 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 179.869 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.497 ' O ' ' O ' ' A' ' 90' ' ' GLN . 28.0 t30 -111.35 111.41 22.43 Favored 'General case' 0 CA--C 1.508 -0.64 0 C-N-CA 119.79 -0.764 . . . . 0.0 109.781 179.611 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.745 ' HB3' HG21 ' A' ' 109' ' ' THR . 76.2 m-20 -85.54 112.01 20.55 Favored 'General case' 0 N--CA 1.442 -0.838 0 C-N-CA 119.643 -0.823 . . . . 0.0 109.543 179.507 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.959 ' O ' ' O ' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -123.0 107.63 19.66 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.975 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 177.849 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 50.1 m -134.49 168.95 18.02 Favored 'General case' 0 C--N 1.296 -1.732 0 CA-C-N 114.906 -1.043 . . . . 0.0 109.221 179.672 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 19.5 m -69.59 -63.34 1.09 Allowed 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 119.055 -1.058 . . . . 0.0 111.76 -178.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -112.26 -32.33 6.56 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 114.976 1.473 . . . . 0.0 114.976 179.436 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -145.72 126.46 2.55 Favored Glycine 0 C--N 1.339 0.725 0 N-CA-C 117.346 1.698 . . . . 0.0 117.346 -177.531 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.745 HG21 ' HB3' ' A' ' 103' ' ' ASP . 4.3 m -121.26 138.11 54.38 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 174.389 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 0.7 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.6 m-90 -120.67 148.94 43.25 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 -178.539 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.469 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -121.77 112.2 18.08 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 115.152 -0.931 . . . . 0.0 108.698 177.437 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 33.5 m-20 45.48 43.4 8.81 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.073 -0.512 . . . . 0.0 112.099 -179.439 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 78.83 27.87 55.78 Favored Glycine 0 N--CA 1.444 -0.798 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.761 179.247 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -139.19 96.73 3.15 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.099 0.476 . . . . 0.0 110.774 179.776 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.7 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.3 OUTLIER -44.57 128.96 6.76 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.019 179.775 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 3.7 m -121.99 -179.84 2.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.743 -179.208 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -85.57 142.1 29.37 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.186 -179.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.436 ' HG3' ' HA ' ' A' ' 104' ' ' ILE . 62.3 tttm -65.0 162.55 16.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.129 179.358 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.431 ' N ' ' HG2' ' A' ' 118' ' ' LYS . 4.4 p30 35.88 38.19 0.05 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.215 0.531 . . . . 0.0 111.142 -179.799 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 9.6 p -111.18 110.95 21.69 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.929 -179.394 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.714 ' ND2' HD13 ' A' ' 92' ' ' LEU . 1.4 m120 -57.39 141.04 48.62 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.683 179.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . 0.777 ' O ' HD13 ' A' ' 100' ' ' LEU . 33.6 mm-40 -129.52 145.89 51.4 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-O 121.009 0.433 . . . . 0.0 111.861 -179.666 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -72.28 117.7 14.25 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.671 179.184 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.72 HD21 HG12 ' A' ' 147' ' ' ILE . 0.7 OUTLIER -47.42 143.79 3.34 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.9 0.857 . . . . 0.0 112.029 -178.943 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.46 ' N ' ' HG ' ' A' ' 124' ' ' LEU . 0.3 OUTLIER -126.84 152.78 46.53 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 114.045 -1.434 . . . . 0.0 110.124 179.263 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.59 113.99 9.21 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.981 -0.378 . . . . 0.0 109.981 179.633 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 67.99 27.62 73.62 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.852 -0.689 . . . . 0.0 112.266 -179.411 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.402 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 8.3 t70 -55.04 160.42 2.05 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.01 0.433 . . . . 0.0 111.185 -179.82 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.776 ' CG ' HG22 ' A' ' 144' ' ' VAL . 4.2 mt-10 -146.01 135.38 22.98 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.447 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.454 HG23 ' O ' ' A' ' 110' ' ' TRP . 7.0 mm -111.51 128.22 68.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 178.908 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.589 HG23 ' CG2' ' A' ' 140' ' ' ILE . 41.9 m -103.73 144.94 30.81 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.73 -179.538 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.561 HG11 ' CD2' ' A' ' 88' ' ' HIS . 4.1 m -141.46 158.42 21.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -178.781 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 66.17 42.17 94.49 Favored Glycine 0 N--CA 1.447 -0.574 0 CA-C-N 115.83 -0.623 . . . . 0.0 112.355 179.359 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.454 ' HA ' HG12 ' A' ' 140' ' ' ILE . 88.9 t -76.89 157.04 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 CA-C-O 121.467 0.651 . . . . 0.0 112.193 -179.125 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.446 ' N ' HG12 ' A' ' 134' ' ' VAL . . . 144.65 -43.08 0.98 Allowed Glycine 0 N--CA 1.44 -1.062 0 N-CA-C 110.447 -1.061 . . . . 0.0 110.447 -178.814 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.632 HG12 ' H ' ' A' ' 138' ' ' SER . 47.5 t -126.87 126.09 67.88 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 CA-C-N 114.984 -0.608 . . . . 0.0 109.705 178.589 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.525 ' HA ' HD12 ' A' ' 140' ' ' ILE . 0.8 OUTLIER -51.17 -28.23 10.66 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.774 0.321 . . . . 0.0 111.186 -179.342 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . 0.632 ' H ' HG12 ' A' ' 136' ' ' VAL . 0.9 OUTLIER -94.36 6.49 48.56 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 116.224 -0.443 . . . . 0.0 112.114 -179.598 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -130.94 27.55 4.88 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 -179.427 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.589 ' CG2' HG23 ' A' ' 131' ' ' THR . 23.9 mt -102.73 140.86 19.94 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.312 179.169 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.658 HD23 ' NE2' ' A' ' 42' ' ' GLN . 4.9 mp -124.07 135.39 53.53 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 114.808 -1.087 . . . . 0.0 109.734 179.511 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.454 ' H ' HG21 ' A' ' 40' ' ' THR . 38.9 t -127.65 151.92 48.33 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -178.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.897 HD11 HG13 ' A' ' 36' ' ' VAL . 3.2 tm? -122.96 138.09 54.77 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 114.424 -1.262 . . . . 0.0 109.155 179.184 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.776 HG22 ' CG ' ' A' ' 129' ' ' GLU . 3.8 t -119.17 141.03 41.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.8 0.333 . . . . 0.0 111.724 -178.811 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.741 HG13 HG22 ' A' ' 36' ' ' VAL . 0.2 OUTLIER -111.02 140.34 30.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.161 179.564 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -119.76 106.57 12.25 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.556 179.79 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.72 HG12 HD21 ' A' ' 124' ' ' LEU . 2.0 mp -99.38 133.38 42.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.483 -179.781 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 -78.82 140.23 38.24 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.236 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -73.8 -18.44 60.95 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.196 178.771 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.408 ' HB3' ' HA ' ' A' ' 30' ' ' GLU . 0.0 OUTLIER -65.5 -45.21 84.44 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.648 179.779 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . 0.523 ' HE2' ' HB3' ' A' ' 50' ' ' ALA . 26.1 t80 -57.25 -42.41 81.44 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.681 179.844 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.78 -38.14 72.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.73 179.749 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 7.8 mm100 -64.61 -36.54 84.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.882 179.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 13.0 t -58.0 -45.13 87.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.958 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.579 HD21 ' HA2' ' A' ' 97' ' ' GLY . 0.1 OUTLIER -66.47 -38.15 86.67 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.905 -179.969 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -60.42 -40.7 91.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.901 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 6.5 mt-30 -86.75 -36.62 18.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.899 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 4.9 p30 44.83 -172.76 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.635 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 4.8 ttpp -82.54 145.92 29.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.013 -179.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 13.7 t -97.43 129.63 47.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.017 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -79.43 157.54 27.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.007 -179.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 6.2 ptm180 -133.35 27.06 4.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.901 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 2.1 mt -105.85 130.01 58.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.051 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.252 -0.88 . . . . 0.0 110.895 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.344 0 N-CA-C 112.487 -0.245 . . . . 0.0 112.487 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 -142.69 156.12 44.99 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.844 0.354 . . . . 0.0 110.92 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -62.82 -177.05 0.13 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.88 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.648 ' N ' HD13 ' A' ' 4' ' ' ILE . 0.1 OUTLIER -125.53 129.08 72.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.026 179.963 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -156.89 135.31 11.38 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.1 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -171.94 136.23 0.91 Allowed Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.811 179.873 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -74.91 83.73 1.76 Allowed 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.499 2.133 . . . . 0.0 112.33 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 11.0 m -62.36 -50.71 70.52 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.108 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -175.34 116.7 0.16 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.893 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -74.57 141.69 44.74 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.914 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 13.4 m -127.3 88.09 2.74 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.835 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -124.82 30.98 5.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.033 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -58.8 -32.11 69.04 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.923 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.8 81.13 0.19 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.157 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.418 ' O ' HD13 ' A' ' 19' ' ' LEU . 18.2 m -152.52 -48.03 0.1 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.224 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -62.74 -42.45 99.67 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.965 -179.87 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.8 mtm-85 -60.03 -39.9 87.5 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.995 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -65.24 -36.55 84.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.964 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.418 HD13 ' O ' ' A' ' 15' ' ' THR . 6.9 mp -62.2 -43.17 99.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.016 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 37.5 mm -62.87 -44.04 99.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.167 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -57.66 -40.96 80.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.019 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -65.23 -29.51 70.31 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.014 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -57.92 -47.5 82.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.282 -179.894 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -57.5 -41.06 80.0 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.98 -179.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 8.4 mm-40 -86.51 -174.07 4.83 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.968 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -62.52 140.52 58.62 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.876 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -80.22 114.93 19.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.893 -179.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 21.7 mm -82.12 139.67 17.56 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.329 0 CA-C-O 121.388 0.613 . . . . 0.0 111.476 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.419 ' O ' ' ND2' ' A' ' 148' ' ' ASN . . . -91.6 36.57 3.6 Favored Glycine 0 C--N 1.317 -0.506 0 CA-C-N 114.978 -1.01 . . . . 0.0 112.755 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -89.79 -39.23 13.25 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.73 0.3 . . . . 0.0 111.326 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 73.2 m-20 -110.1 -13.34 14.39 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-O 121.829 0.823 . . . . 0.0 109.07 178.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.589 ' CG2' ' O ' ' A' ' 32' ' ' ILE . 0.1 OUTLIER -70.07 97.32 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.605 0 CA-C-N 114.216 -1.356 . . . . 0.0 111.266 -178.839 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.88 HG23 ' HB3' ' A' ' 50' ' ' ALA . 0.6 OUTLIER -34.15 -59.06 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 114.795 -1.093 . . . . 0.0 112.159 -179.578 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.617 ' N ' HG12 ' A' ' 33' ' ' VAL . 3.2 t -163.5 164.98 24.18 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.747 -179.27 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 1.8 ttm180 -125.47 115.17 19.81 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.026 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.639 HG21 ' CZ ' ' A' ' 68' ' ' PHE . 14.4 p -89.92 137.17 22.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.076 179.799 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.899 HG23 HG12 ' A' ' 45' ' ' ILE . 23.6 mt -129.51 107.42 15.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -179.673 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.453 ' HB2' ' O ' ' A' ' 43' ' ' ILE . 67.1 m -92.74 101.03 13.41 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 177.211 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.2 t -105.82 -18.21 14.13 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 113.469 0.915 . . . . 0.0 113.469 -177.256 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.768 HG21 ' CB ' ' A' ' 142' ' ' SER . 26.1 p -57.81 -19.35 27.95 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.924 -0.31 . . . . 0.0 111.534 -179.564 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 111.12 67.64 0.55 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.558 -0.83 . . . . 0.0 112.425 179.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.735 ' C ' HD13 ' A' ' 43' ' ' ILE . 4.4 mt-30 -151.15 -54.49 0.14 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.737 0.303 . . . . 0.0 111.138 -179.739 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.927 HG22 ' HD2' ' A' ' 44' ' ' PRO . 0.0 OUTLIER -134.63 151.5 76.02 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.158 -179.299 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.927 ' HD2' HG22 ' A' ' 43' ' ' ILE . 87.0 Cg_endo -80.42 147.3 17.86 Favored 'Trans proline' 0 N--CA 1.461 -0.433 0 C-N-CA 122.403 2.069 . . . . 0.0 111.562 179.352 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.899 HG12 HG23 ' A' ' 37' ' ' ILE . 23.2 mt -37.73 124.58 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 CA-C-O 121.043 0.449 . . . . 0.0 111.844 -179.517 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.568 ' HD2' ' HB3' ' A' ' 76' ' ' TYR . 0.0 OUTLIER -115.28 153.94 30.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.266 179.698 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 15.9 p-10 -116.22 119.83 37.03 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.187 0.517 . . . . 0.0 111.674 -179.605 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.934 HD22 ' CD1' ' A' ' 66' ' ' TRP . 6.9 mt -96.72 123.25 40.36 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.251 178.829 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.526 ' O ' ' HZ2' ' A' ' 66' ' ' TRP . 0.0 OUTLIER -127.52 160.88 30.17 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 -178.76 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.88 ' HB3' HG23 ' A' ' 33' ' ' VAL . . . -157.71 142.31 16.4 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 114.287 -1.324 . . . . 0.0 110.998 178.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.458 ' CB ' ' HG3' ' A' ' 54' ' ' GLN . 0.5 OUTLIER -68.87 129.89 41.22 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.969 0.414 . . . . 0.0 111.083 -179.771 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 33.9 mt -62.15 -38.84 81.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.197 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 31.4 p -56.74 -34.08 67.18 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.031 -179.43 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.458 ' HG3' ' CB ' ' A' ' 51' ' ' ASP . 0.3 OUTLIER -63.5 -44.77 93.37 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.934 -179.66 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.415 ' HA ' HD12 ' A' ' 62' ' ' ILE . 16.8 t -74.04 -42.62 52.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.24 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -58.75 -35.54 72.9 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.996 -179.896 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 14.2 tptp -93.93 -44.62 7.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.823 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 57.66 69.69 0.72 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.841 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -175.02 -40.64 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.828 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 7.2 tpp180 -62.85 -71.66 0.16 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.833 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 58.1 m -144.04 68.27 1.27 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.903 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.415 HD12 ' HA ' ' A' ' 55' ' ' VAL . 1.2 tt -95.22 42.39 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.974 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 34.0 mtmt -139.23 71.11 1.38 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.128 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.569 ' HB3' HD12 ' A' ' 93' ' ' LEU . 5.5 ttpt -112.96 130.78 56.0 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.409 179.557 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.729 HG22 HD23 ' A' ' 92' ' ' LEU . 21.4 t -137.47 139.45 43.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.164 0.507 . . . . 0.0 112.176 -179.098 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . 0.934 ' CD1' HD22 ' A' ' 48' ' ' LEU . 12.5 m-90 -100.08 139.23 36.04 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.06 178.607 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.628 HG23 ' HG2' ' A' ' 90' ' ' GLN . 33.9 m -131.68 130.64 42.29 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.554 0.692 . . . . 0.0 111.793 179.329 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.639 ' CZ ' HG21 ' A' ' 36' ' ' VAL . 1.3 m-85 -102.26 119.36 38.67 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 114.886 -1.052 . . . . 0.0 109.093 178.462 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.65 ' HA2' ' O ' ' A' ' 85' ' ' SER . . . 156.35 -160.7 30.37 Favored Glycine 0 CA--C 1.505 -0.542 0 C-N-CA 118.537 -1.792 . . . . 0.0 113.225 179.041 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.421 ' H ' ' HA ' ' A' ' 86' ' ' ASN . 12.5 ptm180 -76.84 93.15 3.69 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-O 122.686 1.231 . . . . 0.0 108.918 -179.874 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.591 ' O ' ' CD2' ' A' ' 77' ' ' HIS . 6.7 m120 -148.45 156.53 42.37 Favored Pre-proline 0 C--N 1.307 -1.275 0 CA-C-N 112.857 -1.974 . . . . 0.0 107.936 178.812 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.546 ' O ' ' CB ' ' A' ' 73' ' ' ALA . 47.0 Cg_exo -50.37 -13.76 0.83 Allowed 'Trans proline' 0 N--CA 1.459 -0.553 0 C-N-CA 121.384 1.389 . . . . 0.0 111.315 178.276 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.557 ' HB2' ' HB2' ' A' ' 77' ' ' HIS . . . 135.85 53.63 0.0 OUTLIER 'General case' 0 CA--C 1.489 -1.385 0 CA-C-N 114.504 -1.226 . . . . 0.0 108.582 178.731 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.555 ' HB3' ' HB ' ' A' ' 67' ' ' THR . 0.0 OUTLIER -52.07 -69.28 0.12 Allowed 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 -179.846 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.559 ' N ' ' O ' ' A' ' 67' ' ' THR . 29.9 t70 -92.76 -51.2 5.2 Favored 'General case' 0 N--CA 1.433 -1.29 0 N-CA-C 104.388 -2.449 . . . . 0.0 104.388 169.861 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.834 ' CE2' HG21 ' A' ' 43' ' ' ILE . 1.3 p90 -148.26 143.87 27.25 Favored 'General case' 0 C--N 1.345 0.389 0 CA-C-N 112.815 -1.993 . . . . 0.0 111.011 176.227 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.591 ' CD2' ' O ' ' A' ' 71' ' ' ASN . 15.4 t-160 -90.09 105.81 18.06 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 177.454 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.631 HD21 ' O ' ' A' ' 85' ' ' SER . 1.4 pt? -127.63 178.78 5.89 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.922 0.391 . . . . 0.0 111.336 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -51.1 158.43 2.24 Favored Glycine 0 C--N 1.333 0.373 0 C-N-CA 120.991 -0.623 . . . . 0.0 112.694 -179.792 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 5.0 p30 -111.71 99.38 8.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.762 0.315 . . . . 0.0 111.579 -179.697 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.64 ' HB ' ' HB2' ' A' ' 85' ' ' SER . 17.3 mt -114.93 131.66 66.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 178.175 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.423 ' HA ' ' ND2' ' A' ' 86' ' ' ASN . 0.5 OUTLIER -52.81 -24.09 8.24 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 111.697 0.258 . . . . 0.0 111.697 -179.016 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.445 ' H ' HG22 ' A' ' 81' ' ' ILE . 2.2 mtt-85 -92.3 -95.05 0.14 Allowed 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 116.841 -0.163 . . . . 0.0 111.256 179.869 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.491 HD23 ' N ' ' A' ' 84' ' ' LEU . 0.0 OUTLIER -109.48 109.45 20.28 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-O 121.359 0.599 . . . . 0.0 109.761 179.191 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.65 ' O ' ' HA2' ' A' ' 69' ' ' GLY . 1.5 m 157.19 -42.37 0.0 OUTLIER 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 114.592 -1.186 . . . . 0.0 109.55 -179.698 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.669 ' O ' ' N ' ' A' ' 88' ' ' HIS . 30.3 m-20 -65.41 -160.71 0.02 OUTLIER 'General case' 0 CA--C 1.516 -0.354 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 177.514 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.845 ' HB3' HD11 ' A' ' 104' ' ' ILE . 0.0 OUTLIER -58.64 75.18 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 177.791 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.969 ' O ' ' O ' ' A' ' 104' ' ' ILE . 30.6 t60 -79.53 -18.64 51.4 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 114.182 1.179 . . . . 0.0 114.182 -176.685 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.611 ' CZ ' HD11 ' A' ' 91' ' ' ILE . 0.0 OUTLIER -174.98 156.84 2.25 Favored 'General case' 0 C--N 1.312 -1.052 0 C-N-CA 119.038 -1.065 . . . . 0.0 112.88 177.961 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.628 ' HG2' HG23 ' A' ' 67' ' ' THR . 35.2 mt-30 -138.09 160.75 38.57 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 114.677 -1.147 . . . . 0.0 113.758 -177.779 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.672 ' HB ' ' HB2' ' A' ' 66' ' ' TRP . 3.4 mt -130.24 129.81 65.31 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.004 178.617 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.729 HD23 HG22 ' A' ' 65' ' ' VAL . 0.4 OUTLIER -103.93 143.86 32.3 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -179.22 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.78 HD22 ' N ' ' A' ' 94' ' ' GLY . 0.2 OUTLIER -126.43 122.81 36.36 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.188 178.965 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.78 ' N ' HD22 ' A' ' 93' ' ' LEU . . . 119.11 -114.8 2.89 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.563 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 17.5 tp10 66.07 -72.98 0.07 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.843 0.354 . . . . 0.0 111.033 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -175.88 65.15 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.841 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 93.26 136.8 8.0 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.4 -179.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 6.2 m-20 63.74 -173.36 0.16 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.766 0.317 . . . . 0.0 110.803 -179.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.789 HD11 HG22 ' A' ' 33' ' ' VAL . 0.2 OUTLIER -106.85 160.11 15.75 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.936 -179.998 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.577 ' HA ' ' O ' ' A' ' 122' ' ' GLN . 0.8 OUTLIER -121.07 148.01 44.74 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.083 179.625 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.441 ' O ' ' N ' ' A' ' 122' ' ' GLN . 4.4 mp -116.94 127.38 54.17 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 179.614 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.484 ' O ' ' O ' ' A' ' 90' ' ' GLN . 27.8 t30 -113.9 111.49 21.8 Favored 'General case' 0 CA--C 1.507 -0.706 0 C-N-CA 119.74 -0.784 . . . . 0.0 109.928 -179.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.698 ' HB3' HG21 ' A' ' 109' ' ' THR . 74.8 m-20 -84.11 111.51 19.39 Favored 'General case' 0 N--CA 1.44 -0.972 0 C-N-CA 119.647 -0.821 . . . . 0.0 109.227 179.57 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.969 ' O ' ' O ' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -123.38 107.76 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.007 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 177.837 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.465 ' HG ' ' CE1' ' A' ' 88' ' ' HIS . 71.1 m -132.96 171.48 13.9 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-N 114.939 -1.028 . . . . 0.0 109.328 179.754 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 23.4 m -69.58 -63.56 1.05 Allowed 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 119.093 -1.043 . . . . 0.0 111.545 -179.156 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -112.65 -32.85 6.31 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 114.687 1.366 . . . . 0.0 114.687 179.162 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -145.97 129.08 3.27 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 116.996 1.558 . . . . 0.0 116.996 -177.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.698 HG21 ' HB3' ' A' ' 103' ' ' ASP . 5.8 m -121.17 138.15 54.34 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 174.478 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 0.776 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.5 m-90 -120.09 148.85 43.09 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 113.14 0.793 . . . . 0.0 113.14 -178.653 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -123.59 112.3 17.27 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 115.123 -0.944 . . . . 0.0 108.755 177.714 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 13.4 m-80 45.23 44.68 9.08 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.933 -0.576 . . . . 0.0 112.116 -179.531 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 77.53 26.14 61.75 Favored Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.75 179.249 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . 0.413 ' O ' HG13 ' A' ' 116' ' ' VAL . 0.6 OUTLIER -138.74 95.3 2.95 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.077 0.465 . . . . 0.0 110.739 179.703 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.776 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.1 OUTLIER -44.98 133.64 6.25 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.931 179.763 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.495 HG21 ' OD2' ' A' ' 103' ' ' ASP . 31.2 m -124.44 -179.66 2.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.83 -179.113 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 29.3 mm-40 -84.9 141.57 30.31 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.005 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.427 ' HG2' ' N ' ' A' ' 119' ' ' ASN . 88.4 tttt -65.31 163.2 15.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.056 179.443 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.427 ' N ' ' HG2' ' A' ' 118' ' ' LYS . 13.5 m-80 33.63 40.04 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.164 0.507 . . . . 0.0 111.152 -179.461 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 19.5 p -110.48 117.08 32.59 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.967 -179.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.427 ' ND2' ' CD1' ' A' ' 92' ' ' LEU . 15.8 m120 -57.97 138.98 55.38 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.778 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . 0.577 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 45.0 mm-40 -129.49 146.33 51.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.117 0.484 . . . . 0.0 111.787 -179.849 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 12.3 tp -78.74 120.24 23.1 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.545 178.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.813 HD21 HG12 ' A' ' 147' ' ' ILE . 13.3 tp -46.88 144.33 2.48 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.773 0.797 . . . . 0.0 111.965 -178.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.757 ' O ' HD11 ' A' ' 147' ' ' ILE . 0.6 OUTLIER -126.83 152.34 47.11 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 114.22 -1.354 . . . . 0.0 110.26 179.542 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . 0.447 ' HA ' HD12 ' A' ' 147' ' ' ILE . 4.1 mm100 -71.41 114.15 9.18 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 179.584 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 65.67 30.29 77.01 Favored Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.172 -179.364 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.405 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 18.6 t0 -55.76 160.24 2.7 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.987 0.423 . . . . 0.0 111.39 -179.705 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.409 ' CG ' ' O ' ' A' ' 143' ' ' LEU . 1.2 tt0 -146.15 134.94 22.38 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.004 179.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.446 ' CG2' ' O ' ' A' ' 110' ' ' TRP . 1.1 mp -113.41 127.15 70.86 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.202 0 CA-C-O 120.799 0.333 . . . . 0.0 110.112 178.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.492 ' HB ' ' HB2' ' A' ' 110' ' ' TRP . 18.3 m -104.04 145.6 29.93 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.52 -179.754 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.49 HG11 ' CD2' ' A' ' 88' ' ' HIS . 5.5 m -141.21 158.09 22.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -178.669 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . 0.404 ' O ' ' O ' ' A' ' 139' ' ' ASP . . . 69.06 41.33 81.61 Favored Glycine 0 N--CA 1.447 -0.612 0 CA-C-N 115.682 -0.69 . . . . 0.0 112.509 179.25 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.465 ' HA ' HG12 ' A' ' 140' ' ' ILE . 85.9 t -77.55 153.87 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.636 0 CA-C-O 121.398 0.618 . . . . 0.0 112.14 -179.284 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 145.13 -39.61 1.17 Allowed Glycine 0 N--CA 1.441 -0.999 0 CA-C-N 115.015 -0.993 . . . . 0.0 110.7 -179.004 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.541 HG12 ' H ' ' A' ' 138' ' ' SER . 48.3 t -126.67 129.35 71.59 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.65 0 CA-C-N 115.231 -0.485 . . . . 0.0 109.837 178.874 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -51.25 -34.43 32.54 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.784 0.326 . . . . 0.0 111.618 -179.235 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . 0.541 ' H ' HG12 ' A' ' 136' ' ' VAL . 2.6 t -94.06 6.48 48.41 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 -179.326 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . 0.404 ' O ' ' O ' ' A' ' 133' ' ' GLY . 14.6 t0 -126.77 26.94 6.13 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -179.319 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.5 ' C ' HD22 ' A' ' 141' ' ' LEU . 26.6 mt -102.52 141.35 18.77 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.34 179.194 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.539 HD12 ' CD ' ' A' ' 42' ' ' GLN . 4.1 mm? -121.26 135.45 55.12 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 114.885 -1.052 . . . . 0.0 110.176 179.594 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.807 ' C ' HD12 ' A' ' 143' ' ' LEU . 0.9 OUTLIER -122.27 147.39 46.28 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.551 0.691 . . . . 0.0 112.648 -178.898 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.807 HD12 ' C ' ' A' ' 142' ' ' SER . 5.7 mp -127.14 146.27 50.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.028 -0.987 . . . . 0.0 109.086 179.399 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 21.5 t -129.42 141.01 47.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.918 0.39 . . . . 0.0 112.009 -178.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.4 HD13 HD11 ' A' ' 101' ' ' LEU . 0.2 OUTLIER -116.08 127.88 73.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.786 179.771 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 9.7 t80 -111.27 120.21 41.48 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.49 179.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.813 HG12 HD21 ' A' ' 124' ' ' LEU . 1.3 mt -100.47 133.8 42.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.998 0.427 . . . . 0.0 111.86 -179.458 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . 0.419 ' ND2' ' O ' ' A' ' 29' ' ' GLY . 0.7 OUTLIER -84.37 114.99 22.27 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.558 179.423 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -59.97 -19.28 51.39 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.442 -179.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 9.4 mtmm -57.9 -43.29 86.07 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.947 0.403 . . . . 0.0 110.801 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 32.4 t80 -61.27 -44.66 96.87 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.968 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.11 -39.97 88.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.926 -179.844 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -59.86 -39.5 85.43 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.943 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 9.3 t -66.68 -45.55 78.48 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.885 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.658 HD13 ' O ' ' A' ' 155' ' ' LEU . 3.1 tm? -67.41 -40.4 85.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.902 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -57.27 -38.89 74.58 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.928 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 3.3 mm-40 -89.58 -32.21 17.22 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.766 179.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 3.6 p30 42.33 79.62 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.497 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -120.49 115.87 24.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.885 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 22.2 t -84.08 133.05 30.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.1 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -117.43 123.97 47.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.932 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -99.1 126.14 44.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.798 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 2.9 tt -105.51 129.77 57.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.101 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 35.8 ptt180 . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.259 -0.877 . . . . 0.0 110.91 179.937 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.323 0 N-CA-C 112.397 -0.281 . . . . 0.0 112.397 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -165.69 111.96 0.9 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.764 0.316 . . . . 0.0 110.969 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 31.3 m120 -90.11 123.64 34.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.863 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 8.6 pt -131.98 101.05 4.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.205 -179.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.4 t 175.38 -35.36 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.278 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.409 ' CB ' ' HD3' ' A' ' 7' ' ' PRO . 0.0 OUTLIER -52.69 -53.26 56.09 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.155 -179.803 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.409 ' HD3' ' CB ' ' A' ' 6' ' ' GLN . 50.5 Cg_exo -53.56 99.1 0.05 OUTLIER 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.515 2.143 . . . . 0.0 112.282 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.86 -68.36 0.78 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.126 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 56.15 37.24 28.64 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.103 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -153.08 144.73 23.45 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.885 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 72.1 p -126.46 84.81 2.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.865 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 37.1 p -65.02 80.56 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.111 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 1.7 tm0? -131.64 108.55 9.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.939 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.543 ' HB1' ' HE ' ' A' ' 17' ' ' ARG . . . 59.1 80.46 0.19 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.087 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -139.03 -49.96 0.52 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.049 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.2 mm-40 -66.33 -36.53 83.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.896 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.543 ' HE ' ' HB1' ' A' ' 14' ' ' ALA . 0.6 OUTLIER -61.56 -37.72 84.84 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.89 179.909 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -63.8 -36.97 85.65 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.87 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.6 mt -59.4 -38.74 81.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.891 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 31.3 mm -64.24 -40.56 89.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.025 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -57.85 -43.92 86.22 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.959 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -64.79 -37.32 87.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.991 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -64.29 -47.47 79.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.086 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 2.3 m -64.62 -38.15 90.02 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.951 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 10.8 tp60 -62.1 120.03 10.09 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.934 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.85 129.48 39.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.834 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 20.9 mt-30 -89.37 102.07 14.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.996 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 21.4 mm -88.15 139.27 17.62 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.345 0 CA-C-O 121.421 0.629 . . . . 0.0 111.58 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.406 ' HA2' ' HB ' ' A' ' 32' ' ' ILE . . . 90.94 -24.4 18.42 Favored Glycine 0 C--N 1.317 -0.48 0 CA-C-N 114.938 -1.028 . . . . 0.0 112.868 179.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -78.03 -23.22 48.27 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.596 0.236 . . . . 0.0 111.474 -179.698 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.597 ' HA ' HD12 ' A' ' 52' ' ' ILE . 10.4 m120 -108.55 -14.02 14.72 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-O 121.843 0.83 . . . . 0.0 109.048 178.797 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.528 HD13 ' O ' ' A' ' 48' ' ' LEU . 0.1 OUTLIER -73.58 111.6 8.8 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.568 0 CA-C-N 114.066 -1.424 . . . . 0.0 111.433 -179.355 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 1.05 ' CG2' ' HB2' ' A' ' 50' ' ' ALA . 0.5 OUTLIER -42.27 -64.57 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.47 -179.653 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.631 ' N ' ' CG1' ' A' ' 33' ' ' VAL . 22.6 p -166.31 165.85 17.05 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.712 -179.686 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 11.7 ttm180 -119.21 126.27 51.15 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.385 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 1.011 HG12 HD21 ' A' ' 143' ' ' LEU . 14.8 t -95.59 137.09 24.6 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.19 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.349 179.226 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.936 HG23 HG12 ' A' ' 45' ' ' ILE . 21.8 mt -129.3 108.6 17.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 -178.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.757 ' SG ' HD23 ' A' ' 143' ' ' LEU . 0.7 OUTLIER -103.38 102.02 11.94 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 177.413 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.61 ' CG2' HG22 ' A' ' 37' ' ' ILE . 1.7 p -112.42 -23.16 10.48 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 113.664 0.987 . . . . 0.0 113.664 -177.112 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.528 HG21 ' HB3' ' A' ' 142' ' ' SER . 5.3 p -54.16 -23.33 13.9 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.874 -0.33 . . . . 0.0 111.452 -179.241 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 124.26 70.64 0.22 Allowed Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.642 -0.79 . . . . 0.0 112.402 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -151.05 -70.77 0.17 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.74 0.305 . . . . 0.0 110.944 -179.893 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.762 HG12 HD13 ' A' ' 78' ' ' LEU . 2.1 mp -134.64 133.13 21.07 Favored Pre-proline 0 N--CA 1.453 -0.319 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.15 -179.826 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.476 ' HD2' ' CZ ' ' A' ' 76' ' ' TYR . 35.6 Cg_exo -58.58 147.44 86.84 Favored 'Trans proline' 0 C--N 1.342 0.236 0 C-N-CA 122.474 2.116 . . . . 0.0 111.611 179.497 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.936 HG12 HG23 ' A' ' 37' ' ' ILE . 45.7 mt -33.68 145.57 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -179.24 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.404 ' HD3' ' CD2' ' A' ' 76' ' ' TYR . 9.8 tpt180 -139.88 149.46 43.42 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.045 179.47 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -120.54 119.91 34.31 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.888 0.375 . . . . 0.0 111.635 -179.441 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.864 HD11 HD13 ' A' ' 91' ' ' ILE . 0.3 OUTLIER -99.26 133.39 43.62 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 178.367 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.567 ' O ' ' CZ2' ' A' ' 66' ' ' TRP . 0.1 OUTLIER -113.42 164.73 13.23 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.794 0.807 . . . . 0.0 112.658 -179.131 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 1.05 ' HB2' ' CG2' ' A' ' 33' ' ' VAL . . . -119.77 166.16 13.61 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.116 -0.947 . . . . 0.0 111.428 -179.895 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.429 ' CB ' ' CG ' ' A' ' 54' ' ' GLN . 0.0 OUTLIER -105.72 76.02 1.17 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.384 179.642 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.597 HD12 ' HA ' ' A' ' 31' ' ' ASN . 19.0 mt -61.55 -41.24 89.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.484 -179.53 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 19.3 t -57.51 -36.61 71.77 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.174 0.511 . . . . 0.0 110.506 -179.525 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.429 ' CG ' ' CB ' ' A' ' 51' ' ' ASP . 3.3 mm-40 -68.75 -40.48 79.8 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.742 179.736 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 39.6 t -72.66 -37.65 56.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.748 179.728 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 22.0 mt -56.67 -35.29 68.25 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.49 179.765 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.45 -30.09 13.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.526 179.513 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER 59.6 111.76 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.01 179.783 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.8 tttt -176.68 -53.55 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.908 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 12.2 mtt180 -152.67 -176.95 5.95 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.814 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 62.15 30.0 17.65 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.874 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -103.06 42.26 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 121.018 0.437 . . . . 0.0 111.044 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.6 ptpt -160.62 82.89 0.67 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.995 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.457 ' O ' ' HB3' ' A' ' 93' ' ' LEU . 14.0 ttpt -115.19 130.84 57.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.532 179.8 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.484 HG13 ' O ' ' A' ' 91' ' ' ILE . 5.5 t -133.36 134.08 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 CA-C-O 121.028 0.442 . . . . 0.0 111.554 -179.503 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . 0.666 ' HB2' ' HB ' ' A' ' 91' ' ' ILE . 17.2 m-90 -100.61 140.27 35.12 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.854 179.395 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.73 HG23 ' HG2' ' A' ' 90' ' ' GLN . 21.6 m -127.34 130.44 49.46 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.53 0.681 . . . . 0.0 112.262 179.515 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.52 ' HE2' HD11 ' A' ' 91' ' ' ILE . 43.6 m-85 -101.66 118.04 36.12 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.089 -0.959 . . . . 0.0 108.739 177.768 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.686 ' HA2' ' O ' ' A' ' 85' ' ' SER . . . 158.29 -151.93 23.06 Favored Glycine 0 CA--C 1.505 -0.558 0 C-N-CA 119.054 -1.546 . . . . 0.0 113.055 179.828 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.44 ' HD2' ' HB2' ' A' ' 80' ' ' ASN . 35.5 mtp180 -75.49 91.08 2.76 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-O 122.348 1.071 . . . . 0.0 108.49 -179.853 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.505 ' O ' ' CD2' ' A' ' 77' ' ' HIS . 20.6 m120 -150.82 159.32 34.26 Favored Pre-proline 0 C--N 1.308 -1.212 0 CA-C-N 113.18 -1.827 . . . . 0.0 108.688 178.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.558 ' O ' ' HB2' ' A' ' 77' ' ' HIS . 36.3 Cg_endo -66.73 -6.22 15.04 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 120.874 1.05 . . . . 0.0 110.777 177.591 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.73 ' HB2' ' HB2' ' A' ' 77' ' ' HIS . . . 137.03 51.57 0.0 OUTLIER 'General case' 0 CA--C 1.491 -1.32 0 CA-C-N 114.452 -1.249 . . . . 0.0 109.269 178.867 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.548 ' HB3' ' HB ' ' A' ' 67' ' ' THR . 0.1 OUTLIER -52.78 -69.43 0.11 Allowed 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 105.709 -1.959 . . . . 0.0 105.709 179.537 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.655 ' HB2' ' N ' ' A' ' 67' ' ' THR . 36.9 t0 -95.56 -47.56 6.19 Favored 'General case' 0 N--CA 1.433 -1.319 0 N-CA-C 105.872 -1.899 . . . . 0.0 105.872 169.638 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.5 ' CG ' HG21 ' A' ' 43' ' ' ILE . 7.5 t80 -145.12 142.14 29.4 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 112.501 -2.136 . . . . 0.0 112.102 -179.609 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.73 ' HB2' ' HB2' ' A' ' 73' ' ' ALA . 23.6 t-160 -100.89 106.7 18.07 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 176.392 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.814 HD11 ' HA ' ' A' ' 85' ' ' SER . 0.9 OUTLIER -133.07 -174.65 3.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.057 0.456 . . . . 0.0 111.773 -179.282 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -56.73 170.71 2.73 Favored Glycine 0 C--N 1.332 0.355 0 CA-C-N 115.75 -0.659 . . . . 0.0 112.471 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.44 ' HB2' ' HD2' ' A' ' 70' ' ' ARG . 3.4 p30 -112.12 98.49 7.37 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 -179.438 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.661 ' HB ' ' HB2' ' A' ' 85' ' ' SER . 15.3 mm -115.3 129.81 70.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 177.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.42 ' HA ' ' ND2' ' A' ' 86' ' ' ASN . 18.8 m -53.09 -23.86 8.81 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 111.617 0.229 . . . . 0.0 111.617 -179.267 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.54 ' H ' HG22 ' A' ' 81' ' ' ILE . 3.1 mpt_? -98.01 -88.6 0.31 Allowed 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 111.608 0.225 . . . . 0.0 111.608 -179.82 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.462 HD23 ' HB3' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -109.41 108.8 19.46 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 121.455 0.645 . . . . 0.0 110.541 179.812 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.814 ' HA ' HD11 ' A' ' 78' ' ' LEU . 3.1 m 155.23 -42.93 0.01 OUTLIER 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 114.247 -1.342 . . . . 0.0 109.437 179.793 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.655 ' O ' ' N ' ' A' ' 88' ' ' HIS . 38.0 m-20 -77.21 -164.5 0.47 Allowed 'General case' 0 CA--C 1.512 -0.498 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 177.679 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.505 ' HB2' HD11 ' A' ' 104' ' ' ILE . 0.0 OUTLIER -49.51 83.12 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 178.961 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 1.071 ' O ' ' O ' ' A' ' 104' ' ' ILE . 36.3 t60 -102.74 -19.32 14.78 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 114.624 1.342 . . . . 0.0 114.624 -177.002 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.571 ' CD2' ' HA ' ' A' ' 103' ' ' ASP . 0.1 OUTLIER -176.55 159.44 1.9 Allowed 'General case' 0 C--N 1.317 -0.811 0 C-N-CA 119.332 -0.947 . . . . 0.0 111.869 178.338 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.73 ' HG2' HG23 ' A' ' 67' ' ' THR . 27.4 mt-30 -137.89 161.09 37.56 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 113.767 1.025 . . . . 0.0 113.767 -177.673 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.864 HD13 HD11 ' A' ' 48' ' ' LEU . 2.9 mt -124.97 133.11 70.31 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 CA-C-N 115.092 -0.958 . . . . 0.0 109.588 178.267 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.718 HD13 ' ND2' ' A' ' 121' ' ' ASN . 0.2 OUTLIER -110.47 141.92 42.93 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 121.01 0.434 . . . . 0.0 112.166 -179.168 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.853 HD13 ' CG2' ' A' ' 33' ' ' VAL . 19.0 tp -125.65 137.96 53.89 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.298 178.843 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 132.0 -145.09 16.88 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.416 179.777 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 57.01 74.18 0.42 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.913 0.387 . . . . 0.0 110.84 -179.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 2.9 t0 71.07 17.45 6.13 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.218 -179.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 94.37 -23.61 31.15 Favored Glycine 0 C--N 1.331 0.288 0 C-N-CA 120.69 -0.766 . . . . 0.0 112.804 179.711 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.466 ' C ' HD12 ' A' ' 99' ' ' LEU . 58.0 m-20 -58.96 -178.8 0.06 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.968 0.413 . . . . 0.0 111.02 -179.884 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.466 HD12 ' C ' ' A' ' 98' ' ' ASN . 10.5 mp -119.56 147.32 44.61 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.658 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.916 HD22 ' HB3' ' A' ' 121' ' ' ASN . 1.0 OUTLIER -133.68 148.72 51.5 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.627 -179.965 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.459 ' O ' ' N ' ' A' ' 122' ' ' GLN . 5.4 mp -116.22 129.69 56.42 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.681 -0.488 . . . . 0.0 109.681 179.638 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.467 ' HB3' ' HB2' ' A' ' 90' ' ' GLN . 24.5 t30 -110.31 112.39 24.31 Favored 'General case' 0 CA--C 1.508 -0.652 0 C-N-CA 119.706 -0.798 . . . . 0.0 110.031 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.768 ' OD2' HG11 ' A' ' 116' ' ' VAL . 33.5 m-20 -83.78 110.23 18.16 Favored 'General case' 0 N--CA 1.441 -0.924 0 C-N-CA 119.428 -0.909 . . . . 0.0 109.662 179.846 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 1.071 ' O ' ' O ' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -125.04 108.91 20.9 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.061 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 177.07 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 68.7 m -131.48 173.5 11.03 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.452 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 25.8 m -69.34 -63.86 0.98 Allowed 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 119.038 -1.065 . . . . 0.0 111.084 -179.358 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 6.1 m-80 -112.68 -33.23 6.18 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 114.234 1.198 . . . . 0.0 114.234 178.629 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -146.71 133.94 5.06 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 116.536 1.374 . . . . 0.0 116.536 -178.093 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.756 HG21 ' HB3' ' A' ' 103' ' ' ASP . 16.7 m -121.06 138.01 54.38 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 174.417 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 0.719 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.9 m-90 -120.89 149.14 43.07 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 113.65 0.981 . . . . 0.0 113.65 -178.357 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.474 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -122.92 111.99 17.3 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 115.004 -0.998 . . . . 0.0 108.66 177.536 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 44.21 44.6 6.61 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.998 -0.546 . . . . 0.0 112.191 -179.457 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 80.72 21.77 63.16 Favored Glycine 0 N--CA 1.445 -0.765 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.837 179.437 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -134.29 98.34 4.08 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.968 0.413 . . . . 0.0 110.7 179.608 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.719 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.3 OUTLIER -44.06 124.93 4.12 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.084 179.936 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.768 HG11 ' OD2' ' A' ' 103' ' ' ASP . 14.7 p -112.15 160.22 11.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.722 -179.074 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.511 ' N ' HG22 ' A' ' 116' ' ' VAL . 9.8 tt0 -71.01 142.05 50.95 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.995 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.419 ' HG3' ' HA ' ' A' ' 104' ' ' ILE . 81.6 tttt -65.17 162.55 16.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.293 179.432 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.415 ' N ' ' HG2' ' A' ' 118' ' ' LYS . 12.1 p30 34.67 39.09 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.265 0.555 . . . . 0.0 111.305 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 8.6 p -111.09 109.5 19.61 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.9 -179.473 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.916 ' HB3' HD22 ' A' ' 100' ' ' LEU . 1.6 m120 -57.69 140.91 50.16 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.771 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . 0.651 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 18.4 mm-40 -129.64 143.43 50.82 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-O 121.055 0.455 . . . . 0.0 111.844 -179.707 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.509 HD13 ' N ' ' A' ' 124' ' ' LEU . 2.7 tm? -72.57 122.83 22.02 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.512 178.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.68 HD11 HG12 ' A' ' 147' ' ' ILE . 0.9 OUTLIER -47.71 143.53 3.85 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-O 121.854 0.835 . . . . 0.0 111.941 -178.799 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.448 ' N ' ' HG ' ' A' ' 124' ' ' LEU . 0.3 OUTLIER -126.72 152.84 46.27 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 114.166 -1.379 . . . . 0.0 110.242 179.535 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -71.72 113.99 9.33 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.882 0.372 . . . . 0.0 110.058 179.615 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 65.9 30.3 76.82 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.917 -0.658 . . . . 0.0 112.577 -179.588 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.418 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 29.2 t70 -57.87 159.5 5.41 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.96 0.41 . . . . 0.0 111.142 -179.851 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.638 ' HB2' HG22 ' A' ' 144' ' ' VAL . 0.6 OUTLIER -146.55 135.79 22.72 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.377 -179.932 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.631 HG21 ' OD1' ' A' ' 103' ' ' ASP . 10.4 mm -113.31 128.86 69.91 Favored 'Isoleucine or valine' 0 C--O 1.232 0.132 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.3 178.815 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.49 ' CG2' ' CG2' ' A' ' 140' ' ' ILE . 53.8 m -103.17 144.65 31.04 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.477 -179.804 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.476 ' HB ' ' NE2' ' A' ' 88' ' ' HIS . 9.7 m -140.57 157.7 24.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.039 0.447 . . . . 0.0 112.18 -178.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 70.43 42.19 65.16 Favored Glycine 0 N--CA 1.446 -0.65 0 CA-C-N 115.725 -0.67 . . . . 0.0 112.404 179.436 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.462 HG12 ' N ' ' A' ' 135' ' ' GLY . 94.6 t -78.13 156.81 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 CA-C-O 121.394 0.616 . . . . 0.0 112.032 -179.256 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.462 ' N ' HG12 ' A' ' 134' ' ' VAL . . . 149.82 -42.68 0.78 Allowed Glycine 0 N--CA 1.443 -0.896 0 N-CA-C 110.627 -0.989 . . . . 0.0 110.627 -179.248 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.587 HG12 ' H ' ' A' ' 138' ' ' SER . 48.0 t -126.66 131.3 71.34 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 CA-C-N 115.271 -0.464 . . . . 0.0 109.89 178.791 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.07 -33.67 26.81 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.769 0.319 . . . . 0.0 111.257 -179.425 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . 0.587 ' H ' HG12 ' A' ' 136' ' ' VAL . 2.0 p -94.16 6.24 49.22 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 112.251 0.464 . . . . 0.0 112.251 -179.535 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -128.1 29.91 5.31 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-O 121.137 0.494 . . . . 0.0 112.265 -179.467 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.49 ' CG2' ' CG2' ' A' ' 131' ' ' THR . 26.9 mt -104.71 141.34 20.38 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.268 179.22 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 5.8 mp -118.88 135.19 54.69 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.015 -0.993 . . . . 0.0 110.633 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.528 ' HB3' HG21 ' A' ' 40' ' ' THR . 46.9 t -118.76 152.4 36.25 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.691 0.758 . . . . 0.0 112.547 -179.178 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 1.011 HD21 HG12 ' A' ' 36' ' ' VAL . 1.5 tm? -134.72 137.55 43.6 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 114.589 -1.187 . . . . 0.0 109.019 179.427 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.756 ' N ' HD22 ' A' ' 143' ' ' LEU . 25.5 t -128.4 140.01 50.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 C-N-CA 120.75 -0.38 . . . . 0.0 111.858 -179.062 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.493 HG13 HG22 ' A' ' 36' ' ' VAL . 1.1 tt -109.08 139.84 30.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.725 179.461 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 16.8 t80 -118.1 103.85 10.28 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.777 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.68 HG12 HD11 ' A' ' 124' ' ' LEU . 2.5 mp -92.56 129.37 43.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.175 179.9 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 12.2 p30 -78.6 132.08 36.97 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.017 -179.738 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 50.2 m-20 -64.49 -21.38 66.65 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.095 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 3.1 mmpt? -57.49 -43.66 84.33 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-O 120.953 0.406 . . . . 0.0 110.564 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . 0.575 ' HE2' ' HB3' ' A' ' 50' ' ' ALA . 19.0 t80 -58.96 -44.62 91.5 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.67 179.731 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 1.7 mttt -65.0 -35.55 81.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.807 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 11.7 tt0 -63.14 -39.98 96.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.907 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 11.8 t -61.22 -44.96 96.43 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.94 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -58.82 -45.45 89.92 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.872 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -60.87 -40.74 94.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.832 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -66.94 -25.76 66.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.992 179.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -115.16 31.61 6.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.9 -179.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.97 115.41 20.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.872 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.444 HG23 ' O ' ' A' ' 160' ' ' VAL . 25.2 m -77.82 120.16 27.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.143 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -111.76 -164.84 0.94 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.805 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 31.8 mtm180 -49.3 132.7 20.04 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.194 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 20.5 mm -78.56 110.04 13.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.137 -179.804 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.196 -0.907 . . . . 0.0 111.07 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.356 0 N-CA-C 112.479 -0.248 . . . . 0.0 112.479 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -117.85 81.43 1.66 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.915 0.388 . . . . 0.0 110.884 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -171.7 151.73 2.95 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.843 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 21.9 mm -102.9 136.15 36.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.122 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 18.8 p -135.7 157.64 46.38 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.239 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -114.67 115.31 44.14 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.849 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_exo -51.01 108.92 0.26 Allowed 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.446 2.097 . . . . 0.0 112.372 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -115.34 -9.01 12.23 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.541 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 69.53 -66.93 0.24 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.74 0.305 . . . . 0.0 111.035 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -168.95 107.36 0.44 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.981 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 32.3 t -148.61 161.77 41.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.953 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 9.5 t -125.59 176.24 7.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.075 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 72.0 mt-30 -106.04 101.58 11.06 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.887 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -168.14 -53.81 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.089 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 10.8 p 55.78 29.99 14.91 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.264 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 5.7 tp60 -62.06 -46.91 87.05 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.832 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 2.9 ttm180 -67.08 -36.78 82.74 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.876 179.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -61.55 -35.76 78.69 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.762 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 36.6 mt -64.84 -42.22 95.1 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.864 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 31.6 mm -62.51 -42.0 94.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.977 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -57.84 -46.63 84.46 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.155 -179.874 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.72 -33.66 76.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.013 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -59.01 -47.81 83.85 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.126 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 20.5 p -57.16 -31.37 65.32 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.905 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 22.1 tm0? -88.41 -31.86 18.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.803 179.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -84.46 121.28 27.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.807 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -98.87 142.58 30.2 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.934 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 24.8 mm -82.0 139.51 17.82 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.337 0 CA-C-O 121.393 0.616 . . . . 0.0 111.707 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.432 ' HA2' ' CG2' ' A' ' 32' ' ' ILE . . . 111.89 17.88 8.19 Favored Glycine 0 C--N 1.316 -0.528 0 CA-C-N 114.936 -1.029 . . . . 0.0 112.733 179.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -89.36 -32.64 17.21 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.695 0.283 . . . . 0.0 111.484 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 38.1 m-80 -109.39 -14.27 14.46 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-O 121.946 0.879 . . . . 0.0 109.018 178.767 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.592 ' CG2' ' O ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -71.06 98.41 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.581 0 CA-C-N 113.935 -1.484 . . . . 0.0 110.922 -179.285 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.778 HG23 ' HB3' ' A' ' 50' ' ' ALA . 0.5 OUTLIER -34.39 -60.62 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 114.96 -1.018 . . . . 0.0 112.058 -179.432 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.601 ' N ' HG12 ' A' ' 33' ' ' VAL . 19.7 m -159.81 149.36 18.12 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.454 -179.434 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.0 114.62 24.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.763 179.506 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.84 ' CG2' HD11 ' A' ' 48' ' ' LEU . 26.7 t -90.29 124.64 43.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.686 179.712 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 1.009 HG23 HG12 ' A' ' 45' ' ' ILE . 31.2 mt -123.12 108.33 21.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.138 -0.483 . . . . 0.0 112.033 -179.35 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.474 ' SG ' ' HG ' ' A' ' 143' ' ' LEU . 0.8 OUTLIER -78.81 99.73 6.84 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 177.984 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.436 HG22 ' CG2' ' A' ' 144' ' ' VAL . 9.6 t -87.34 -28.65 22.1 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 -178.007 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.749 HG21 ' H ' ' A' ' 142' ' ' SER . 66.0 p -58.72 -18.27 29.96 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.678 0.275 . . . . 0.0 111.655 -179.552 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 90.88 71.46 1.22 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.554 -0.831 . . . . 0.0 112.555 179.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.521 HE22 HD11 ' A' ' 143' ' ' LEU . 16.8 pt20 -142.99 -48.08 0.32 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.69 0.281 . . . . 0.0 111.151 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.41 ' O ' ' HB2' ' A' ' 38' ' ' CYS . 14.8 mt -134.53 138.05 29.13 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.04 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.485 ' HD2' ' CZ ' ' A' ' 76' ' ' TYR . 33.4 Cg_exo -58.46 146.69 89.43 Favored 'Trans proline' 0 N--CA 1.465 -0.186 0 C-N-CA 122.445 2.097 . . . . 0.0 111.5 179.53 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 1.009 HG12 HG23 ' A' ' 37' ' ' ILE . 45.6 mt -45.46 129.93 2.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 112.376 0.51 . . . . 0.0 112.376 -179.096 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 6.3 tpt180 -120.31 130.61 54.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.646 178.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 8.7 p30 -105.83 122.27 45.76 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.346 0.499 . . . . 0.0 112.346 -178.798 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.84 HD11 ' CG2' ' A' ' 36' ' ' VAL . 0.3 OUTLIER -97.52 133.63 41.84 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 178.384 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.519 ' HB3' HG12 ' A' ' 32' ' ' ILE . 0.0 OUTLIER -134.27 164.44 27.39 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 113.67 0.989 . . . . 0.0 113.67 -178.333 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.778 ' HB3' HG23 ' A' ' 33' ' ' VAL . . . -151.33 166.23 31.61 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 114.484 -1.234 . . . . 0.0 110.667 179.041 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.452 ' CB ' ' HG2' ' A' ' 54' ' ' GLN . 1.4 m-20 -106.04 136.34 45.89 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.08 0.467 . . . . 0.0 111.29 -179.679 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 18.5 mm -63.86 -38.93 83.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.483 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.7 t -56.09 -33.48 65.1 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.14 -179.244 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.452 ' HG2' ' CB ' ' A' ' 51' ' ' ASP . 9.8 mm100 -62.62 -36.79 83.91 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.025 -179.581 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 40.9 t -68.53 -48.67 71.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.997 179.81 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.0 tt -57.71 -33.37 68.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.876 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 24.2 ttmt -84.9 -59.02 2.47 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.777 179.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 52.52 89.68 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.274 179.838 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.8 mtmm -164.02 -76.84 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.75 179.809 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 7.0 mtt180 -85.29 -73.94 0.42 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.704 179.842 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -84.78 97.01 9.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.612 179.737 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.741 HD13 ' O ' ' A' ' 62' ' ' ILE . 0.0 OUTLIER -145.62 -42.73 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.386 -179.679 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.438 ' N ' HG23 ' A' ' 62' ' ' ILE . 0.0 OUTLIER -88.82 84.69 6.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.236 -179.659 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.419 ' O ' ' HB3' ' A' ' 93' ' ' LEU . 22.9 ttpt -104.09 131.66 51.13 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.19 179.335 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.565 HG13 ' O ' ' A' ' 91' ' ' ILE . 5.8 t -131.1 135.92 58.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.044 0.45 . . . . 0.0 111.916 -179.036 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . 0.685 ' CG ' HD22 ' A' ' 48' ' ' LEU . 14.6 m-90 -99.7 139.85 34.76 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.692 -0.686 . . . . 0.0 111.25 178.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.815 HG23 ' HG3' ' A' ' 90' ' ' GLN . 12.0 m -123.57 129.07 50.63 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.541 0.686 . . . . 0.0 112.162 179.445 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.6 ' CE2' HG11 ' A' ' 36' ' ' VAL . 13.8 m-85 -100.37 118.1 35.92 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.069 -0.969 . . . . 0.0 109.104 178.077 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.614 ' HA2' ' O ' ' A' ' 85' ' ' SER . . . 159.21 -159.6 30.55 Favored Glycine 0 N--CA 1.444 -0.793 0 C-N-CA 119.287 -1.435 . . . . 0.0 112.708 179.459 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.42 ' N ' ' HA ' ' A' ' 86' ' ' ASN . 0.0 OUTLIER -76.13 92.27 3.21 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-O 122.612 1.196 . . . . 0.0 109.05 -179.402 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.54 ' O ' ' CD2' ' A' ' 77' ' ' HIS . 6.0 m-80 -149.19 155.38 39.86 Favored Pre-proline 0 C--N 1.309 -1.175 0 CA-C-N 112.681 -2.054 . . . . 0.0 107.989 178.646 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.564 ' O ' ' CB ' ' A' ' 73' ' ' ALA . 25.2 Cg_exo -55.76 -7.87 1.79 Allowed 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 121.271 1.314 . . . . 0.0 111.32 177.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.708 ' HB2' ' HB2' ' A' ' 77' ' ' HIS . . . 132.99 52.7 0.0 OUTLIER 'General case' 0 CA--C 1.489 -1.379 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.223 178.765 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.564 ' HB3' ' HB ' ' A' ' 67' ' ' THR . 0.1 OUTLIER -52.81 -69.52 0.11 Allowed 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 105.565 -2.013 . . . . 0.0 105.565 179.499 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.612 ' HB2' ' N ' ' A' ' 67' ' ' THR . 51.3 t0 -95.32 -47.81 6.15 Favored 'General case' 0 N--CA 1.433 -1.302 0 N-CA-C 105.776 -1.935 . . . . 0.0 105.776 169.65 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.504 ' C ' ' HA ' ' A' ' 73' ' ' ALA . 9.4 t80 -144.52 142.68 30.4 Favored 'General case' 0 C--N 1.346 0.424 0 CA-C-N 112.51 -2.132 . . . . 0.0 111.354 179.66 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.708 ' HB2' ' HB2' ' A' ' 73' ' ' ALA . 22.4 t-160 -97.16 106.91 19.32 Favored 'General case' 0 CA--C 1.531 0.238 0 O-C-N 121.921 -0.487 . . . . 0.0 110.157 176.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.576 HD21 ' C ' ' A' ' 69' ' ' GLY . 0.0 OUTLIER -120.67 171.83 8.31 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 120.824 0.345 . . . . 0.0 111.692 179.749 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -55.03 -167.86 0.04 OUTLIER Glycine 0 C--N 1.333 0.405 0 CA-C-N 116.022 -0.535 . . . . 0.0 113.126 -179.499 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.459 ' C ' HD12 ' A' ' 81' ' ' ILE . 5.4 p30 -112.06 97.77 6.89 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.927 0.394 . . . . 0.0 111.768 -179.752 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.655 ' HB ' ' HB2' ' A' ' 85' ' ' SER . 3.2 mp -114.86 112.72 41.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.104 178.542 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 68.5 m -56.69 -24.16 47.05 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 -179.002 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.407 ' H ' HG22 ' A' ' 81' ' ' ILE . 3.7 mtt180 -93.47 -102.15 0.13 Allowed 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 -178.487 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.434 ' O ' ' CB ' ' A' ' 85' ' ' SER . 0.0 OUTLIER -109.02 110.83 22.21 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-O 121.52 0.676 . . . . 0.0 110.691 -179.262 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.655 ' HB2' ' HB ' ' A' ' 81' ' ' ILE . 0.6 OUTLIER 158.99 -48.39 0.0 OUTLIER 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 114.247 -1.342 . . . . 0.0 109.478 179.796 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.792 ' O ' ' N ' ' A' ' 88' ' ' HIS . 94.1 m-20 -65.34 -153.45 0.01 OUTLIER 'General case' 0 CA--C 1.521 -0.151 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 177.779 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.42 ' HB2' HD11 ' A' ' 104' ' ' ILE . 0.0 OUTLIER -47.55 76.71 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 179.105 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 1.071 ' O ' ' O ' ' A' ' 104' ' ' ILE . 36.3 t60 -101.58 -15.89 16.93 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 114.622 1.341 . . . . 0.0 114.622 -176.346 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.559 ' HA ' ' H ' ' A' ' 104' ' ' ILE . 0.1 OUTLIER -178.1 160.37 1.39 Allowed 'General case' 0 C--N 1.317 -0.848 0 C-N-CA 119.333 -0.947 . . . . 0.0 112.125 178.334 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.815 ' HG3' HG23 ' A' ' 67' ' ' THR . 14.7 mt-30 -137.45 160.82 38.03 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 113.694 0.998 . . . . 0.0 113.694 -178.031 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.732 HG12 HD11 ' A' ' 145' ' ' ILE . 2.5 mt -122.27 132.14 71.7 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 CA-C-N 115.109 -0.95 . . . . 0.0 108.998 177.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.773 HD13 ' ND2' ' A' ' 121' ' ' ASN . 1.9 mt -110.06 135.31 51.07 Favored 'General case' 0 N--CA 1.464 0.233 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 -178.732 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.779 HD22 ' N ' ' A' ' 94' ' ' GLY . 1.2 tm? -126.42 136.64 52.92 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.245 178.752 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.779 ' N ' HD22 ' A' ' 93' ' ' LEU . . . 125.7 -161.75 20.07 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.601 179.819 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 57.27 76.61 0.31 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.808 0.337 . . . . 0.0 110.506 -179.748 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 67.87 163.6 0.21 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.617 -179.545 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -59.48 86.41 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.488 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -179.59 159.42 0.88 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.822 0.344 . . . . 0.0 111.061 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.669 HD23 HD23 ' A' ' 93' ' ' LEU . 0.6 OUTLIER -109.98 155.04 22.31 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.653 179.769 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.764 HD22 ' HB3' ' A' ' 121' ' ' ASN . 4.4 mt -133.66 148.62 51.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.81 -179.813 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.44 ' O ' ' N ' ' A' ' 122' ' ' GLN . 1.6 mt -113.38 130.87 56.18 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 179.529 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.684 ' CG ' HD11 ' A' ' 92' ' ' LEU . 7.4 t30 -107.18 112.56 25.5 Favored 'General case' 0 CA--C 1.51 -0.59 0 C-N-CA 119.976 -0.69 . . . . 0.0 109.776 179.863 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.758 ' HB3' HG21 ' A' ' 109' ' ' THR . 29.1 m-20 -87.4 108.94 19.23 Favored 'General case' 0 N--CA 1.442 -0.872 0 C-N-CA 119.076 -1.05 . . . . 0.0 109.789 179.691 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 1.071 ' O ' ' O ' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -126.48 109.32 20.83 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.164 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 176.854 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 70.5 m -129.38 174.66 9.42 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.868 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 28.0 m -69.76 -63.29 1.1 Allowed 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 118.98 -1.088 . . . . 0.0 110.862 -179.557 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -112.52 -33.46 6.15 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 114.253 1.205 . . . . 0.0 114.253 178.593 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -147.1 136.71 6.26 Favored Glycine 0 C--N 1.34 0.795 0 N-CA-C 116.422 1.329 . . . . 0.0 116.422 -178.339 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.758 HG21 ' HB3' ' A' ' 103' ' ' ASP . 14.8 m -121.06 137.96 54.41 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 174.738 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 0.74 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 3.0 m-90 -122.36 149.25 44.04 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 113.436 0.902 . . . . 0.0 113.436 -178.517 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.459 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -122.46 112.07 17.61 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 115.182 -0.917 . . . . 0.0 108.62 177.24 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 46.14 43.93 11.46 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.104 -0.498 . . . . 0.0 112.167 -179.573 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 79.91 20.92 66.89 Favored Glycine 0 N--CA 1.445 -0.76 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.93 179.153 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 13.6 mt-30 -133.82 97.79 4.0 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.039 0.447 . . . . 0.0 110.624 179.674 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.74 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.3 OUTLIER -44.92 134.17 5.89 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.843 179.856 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 15.0 m -121.25 177.25 3.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.141 0.496 . . . . 0.0 111.969 -178.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.433 ' HB3' ' HB3' ' A' ' 120' ' ' SER . 0.0 OUTLIER -82.83 141.13 32.51 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.676 179.799 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.401 ' O ' ' C ' ' A' ' 119' ' ' ASN . 0.0 OUTLIER -66.25 163.75 17.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.731 0.3 . . . . 0.0 110.537 179.711 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.401 ' C ' ' O ' ' A' ' 118' ' ' LYS . 0.5 OUTLIER 34.88 37.52 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.995 -179.639 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.433 ' HB3' ' HB3' ' A' ' 117' ' ' GLU . 10.1 p -111.3 105.16 13.73 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.858 -179.281 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.773 ' ND2' HD13 ' A' ' 92' ' ' LEU . 1.3 m120 -50.22 142.46 9.87 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.803 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . 0.575 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 30.1 mm-40 -128.75 144.15 51.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.207 0.527 . . . . 0.0 112.057 -179.662 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 16.6 tp -74.36 120.62 20.17 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.718 178.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.621 ' HG ' HD12 ' A' ' 99' ' ' LEU . 0.0 OUTLIER -51.73 144.65 10.67 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 122.193 0.997 . . . . 0.0 112.202 -178.857 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.442 ' CB ' ' HB2' ' A' ' 128' ' ' ASP . 0.6 OUTLIER -127.15 153.15 46.41 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 113.871 -1.513 . . . . 0.0 110.022 179.499 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 5.7 tp-100 -70.62 113.5 7.79 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 179.647 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 68.35 28.6 73.19 Favored Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.394 -179.359 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.442 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 9.7 t70 -58.85 158.86 7.61 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.984 0.421 . . . . 0.0 111.308 -179.719 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.425 ' HA ' ' O ' ' A' ' 143' ' ' LEU . 0.4 OUTLIER -147.12 135.71 21.96 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.565 179.871 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.669 HG21 ' OD1' ' A' ' 103' ' ' ASP . 2.0 mp -108.86 129.12 64.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.299 -0.41 . . . . 0.0 109.994 178.559 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.524 HG23 ' CG2' ' A' ' 140' ' ' ILE . 69.5 m -102.31 142.37 33.64 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.0 0.428 . . . . 0.0 110.519 -179.53 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.478 HG11 ' NE2' ' A' ' 88' ' ' HIS . 5.2 m -141.24 158.37 22.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.132 -0.485 . . . . 0.0 112.21 -178.592 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . 0.403 ' HA3' ' CD2' ' A' ' 84' ' ' LEU . . . 69.87 44.43 62.1 Favored Glycine 0 N--CA 1.446 -0.645 0 CA-C-N 115.911 -0.586 . . . . 0.0 112.086 179.545 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.489 ' HA ' HG12 ' A' ' 140' ' ' ILE . 81.8 t -80.18 153.1 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 CA-C-O 121.526 0.679 . . . . 0.0 112.261 -178.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 148.14 -44.52 0.77 Allowed Glycine 0 N--CA 1.44 -1.075 0 N-CA-C 110.374 -1.09 . . . . 0.0 110.374 -178.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.593 HG12 ' H ' ' A' ' 138' ' ' SER . 41.3 t -126.8 127.83 70.35 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.764 0 CA-C-N 115.103 -0.549 . . . . 0.0 109.641 178.499 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.536 ' HA ' HD12 ' A' ' 140' ' ' ILE . 3.1 tt0 -51.07 -29.61 13.47 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.789 0.328 . . . . 0.0 111.308 -179.202 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . 0.593 ' H ' HG12 ' A' ' 136' ' ' VAL . 0.5 OUTLIER -94.31 6.48 48.56 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -179.56 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -128.77 25.61 5.64 Favored 'General case' 0 CA--C 1.519 -0.223 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 -179.402 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.536 HD12 ' HA ' ' A' ' 137' ' ' GLU . 13.4 mt -103.13 140.67 20.74 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.003 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.447 179.233 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.46 HD22 ' C ' ' A' ' 140' ' ' ILE . 3.8 mm? -124.24 134.53 53.22 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.017 -0.992 . . . . 0.0 109.798 179.196 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.749 ' H ' HG21 ' A' ' 40' ' ' THR . 0.9 OUTLIER -119.33 150.95 39.29 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.408 0.623 . . . . 0.0 112.504 -178.78 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.712 HD12 ' C ' ' A' ' 142' ' ' SER . 5.7 mp -122.77 132.99 54.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.325 179.342 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.436 ' CG2' HG22 ' A' ' 39' ' ' THR . 4.7 t -114.15 140.28 35.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 120.872 0.368 . . . . 0.0 111.426 -179.432 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.749 ' CG1' HG22 ' A' ' 36' ' ' VAL . 0.2 OUTLIER -120.66 127.68 75.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.821 179.893 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 18.6 t80 -105.08 103.78 13.39 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.54 179.786 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 2.7 mp -87.91 128.45 40.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.053 -179.776 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 25.9 p-10 -78.3 120.7 23.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.003 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -71.35 -24.67 62.14 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.957 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 4.2 mttt -57.38 -40.53 78.35 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.947 0.403 . . . . 0.0 110.595 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 19.9 t80 -59.99 -40.17 88.27 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.613 179.746 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.17 -37.91 87.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.885 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -61.02 -38.4 85.98 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.842 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 9.8 t -65.88 -43.82 87.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.827 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -58.0 -44.17 87.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.9 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -60.75 -34.08 73.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.847 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.81 -22.71 62.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.141 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -109.64 27.81 9.19 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.057 -179.718 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 1.1 mtmm -125.63 121.4 33.43 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.909 179.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 31.5 t -90.23 124.05 42.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.079 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -88.55 -29.94 19.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.796 179.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 11.3 ttt180 -172.36 155.65 3.57 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.738 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 23.1 pt -76.89 138.01 21.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.161 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.023 0 CA-C-O 118.198 -0.906 . . . . 0.0 110.843 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.375 0 N-CA-C 112.529 -0.228 . . . . 0.0 112.529 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -84.46 -45.93 12.17 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.754 0.311 . . . . 0.0 110.847 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 5.0 p30 -102.96 169.19 8.73 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.853 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.588 HG23 ' O ' ' A' ' 4' ' ' ILE . 8.4 tp -78.65 110.73 14.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.101 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.9 t -147.2 166.61 26.48 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.926 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 59.23 64.89 2.91 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.823 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_exo -51.86 177.6 0.05 OUTLIER 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.607 2.205 . . . . 0.0 112.389 -179.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 25.8 p -119.42 -176.37 3.13 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.087 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 69.0 tp60 -115.18 151.78 33.81 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.936 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -62.75 109.19 1.35 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.855 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 60.6 p -75.84 -168.68 0.93 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.983 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -57.63 138.69 55.06 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.189 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -135.87 152.22 50.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.944 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -162.12 -168.3 1.86 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.968 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 56.6 p -73.84 64.26 0.95 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.073 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.547 ' HA ' HD12 ' A' ' 19' ' ' LEU . 7.2 pt20 -62.3 -44.42 96.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.918 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.68 -36.57 81.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.918 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 57.5 t80 -57.45 -35.83 70.62 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.912 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.547 HD12 ' HA ' ' A' ' 16' ' ' GLN . 10.7 mt -61.26 -40.43 94.05 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.79 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 34.7 mm -70.45 -36.74 67.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.044 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -57.66 -43.0 84.66 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.075 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 2.6 mtpt -62.03 -41.97 98.67 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.917 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -63.5 -47.76 80.4 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.021 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -66.02 -21.52 66.4 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.133 179.826 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 76.2 161.13 0.23 Allowed 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.839 -179.875 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -62.31 131.33 48.98 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.965 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 11.7 pm0 -101.36 135.22 43.21 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.85 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 24.6 mm -83.14 139.61 17.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.457 0.646 . . . . 0.0 111.581 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -102.6 63.36 0.45 Allowed Glycine 0 C--N 1.317 -0.477 0 CA-C-N 114.952 -1.022 . . . . 0.0 112.617 -179.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.554 ' O ' HD12 ' A' ' 52' ' ' ILE . 0.8 OUTLIER -88.45 -23.82 23.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.716 0.293 . . . . 0.0 111.119 179.928 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.432 ' HA ' HD12 ' A' ' 52' ' ' ILE . 8.8 m120 -109.17 -14.08 14.56 Favored 'General case' 0 CA--C 1.514 -0.409 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 178.405 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.558 HG12 ' HB3' ' A' ' 49' ' ' SER . 0.1 OUTLIER -71.15 108.44 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.66 0 CA-C-N 113.888 -1.505 . . . . 0.0 110.933 -179.499 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.89 HG12 ' CD2' ' A' ' 99' ' ' LEU . 2.3 t -48.21 -66.3 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.769 0 CA-C-N 115.19 -0.914 . . . . 0.0 111.364 -179.498 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 31.9 p -162.98 164.59 25.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.676 179.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.665 HH11 HD11 ' A' ' 37' ' ' ILE . 8.1 ttm180 -122.98 123.76 41.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.189 -179.808 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.867 ' CG2' HD11 ' A' ' 48' ' ' LEU . 3.3 t -91.58 122.13 42.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.754 179.666 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.849 HG23 HG12 ' A' ' 45' ' ' ILE . 26.7 mt -121.61 107.81 20.9 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 CA-C-N 116.263 -0.426 . . . . 0.0 112.006 -179.547 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 88.8 m -81.86 102.2 10.7 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 178.076 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.0 p -89.79 2.96 54.26 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 -178.076 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.736 HG21 ' CB ' ' A' ' 142' ' ' SER . 77.2 p -94.59 -6.78 42.75 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.038 0.384 . . . . 0.0 112.038 -179.769 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 85.91 91.58 0.88 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.606 179.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.595 ' NE2' HD23 ' A' ' 141' ' ' LEU . 16.3 pt20 -172.41 -45.86 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.108 0.48 . . . . 0.0 110.516 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.59 HG23 ' HD2' ' A' ' 44' ' ' PRO . 5.1 mt -131.87 140.43 38.17 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.718 179.899 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.59 ' HD2' HG23 ' A' ' 43' ' ' ILE . 74.2 Cg_endo -78.46 147.01 22.28 Favored 'Trans proline' 0 N--CA 1.462 -0.377 0 C-N-CA 122.324 2.016 . . . . 0.0 112.141 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.849 HG12 HG23 ' A' ' 37' ' ' ILE . 27.3 mt -43.12 122.21 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 121.222 0.534 . . . . 0.0 111.827 -179.493 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.438 ' HG2' ' O ' ' A' ' 75' ' ' ASP . 0.0 OUTLIER -121.49 130.21 53.41 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.099 179.463 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.461 ' HB2' HD11 ' A' ' 32' ' ' ILE . 3.8 p30 -93.14 120.11 33.07 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.06 0.457 . . . . 0.0 111.413 -179.302 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.867 HD11 ' CG2' ' A' ' 36' ' ' VAL . 0.8 OUTLIER -94.36 121.73 36.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.642 179.249 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.686 ' HA ' HG23 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -130.98 154.56 48.03 Favored 'General case' 0 CA--C 1.517 -0.323 0 N-CA-C 114.295 1.22 . . . . 0.0 114.295 -179.205 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.583 ' N ' HG23 ' A' ' 33' ' ' VAL . . . -133.22 166.07 23.32 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 113.587 -1.642 . . . . 0.0 110.832 178.753 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.469 ' CB ' ' HG3' ' A' ' 54' ' ' GLN . 60.6 m-20 -91.08 97.26 11.05 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.065 0.46 . . . . 0.0 111.014 -179.815 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.554 HD12 ' O ' ' A' ' 30' ' ' GLU . 4.4 mt -63.81 -31.15 52.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.704 -179.701 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 27.8 t -56.44 -35.01 67.38 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.218 -179.027 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.469 ' HG3' ' CB ' ' A' ' 51' ' ' ASP . 6.7 mt-30 -68.12 -36.96 80.56 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.806 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.709 HG22 HD11 ' A' ' 62' ' ' ILE . 6.0 t -67.37 -44.88 86.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.082 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -69.16 -28.9 66.83 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.002 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.89 -50.96 8.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.979 -179.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -104.61 141.83 35.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.003 -179.861 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 3.0 ttpm? -58.94 -30.92 68.23 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.988 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 41.6 ttt-85 -159.38 107.63 1.8 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.928 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 21.1 t -152.7 51.35 0.76 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.894 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.709 HD11 HG22 ' A' ' 55' ' ' VAL . 7.1 mm -106.03 134.27 48.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.011 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.6 68.29 0.07 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.012 0.435 . . . . 0.0 111.058 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 7.8 ttpt -138.01 132.09 31.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.667 179.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.665 HG13 ' O ' ' A' ' 91' ' ' ILE . 21.5 t -135.35 138.82 47.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.14 0.495 . . . . 0.0 111.707 -179.407 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . 0.656 ' HB2' ' HB ' ' A' ' 91' ' ' ILE . 14.7 m-90 -99.91 139.95 34.83 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.6 179.297 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.641 HG23 ' HG2' ' A' ' 90' ' ' GLN . 30.5 m -131.39 131.85 43.95 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.53 0.681 . . . . 0.0 112.162 179.744 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.609 ' HE1' HD12 ' A' ' 91' ' ' ILE . 7.3 m-85 -103.24 119.06 38.16 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 114.897 -1.047 . . . . 0.0 109.086 177.873 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.713 ' HA2' HD21 ' A' ' 78' ' ' LEU . . . 158.7 -155.96 26.99 Favored Glycine 0 CA--C 1.503 -0.706 0 C-N-CA 118.832 -1.652 . . . . 0.0 113.098 179.389 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.42 ' O ' ' HG3' ' A' ' 70' ' ' ARG . 3.1 ptm180 -76.37 91.77 3.3 Favored 'General case' 0 N--CA 1.441 -0.888 0 CA-C-O 122.587 1.184 . . . . 0.0 108.747 -179.614 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.502 ' O ' ' CD2' ' A' ' 77' ' ' HIS . 15.7 m-80 -149.98 154.53 37.09 Favored Pre-proline 0 C--N 1.308 -1.218 0 CA-C-N 112.857 -1.974 . . . . 0.0 108.337 178.758 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.548 ' O ' ' CB ' ' A' ' 73' ' ' ALA . 21.8 Cg_exo -57.18 -8.25 3.35 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 121.115 1.21 . . . . 0.0 110.934 177.679 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.729 ' HB2' ' HB2' ' A' ' 77' ' ' HIS . . . 135.04 53.45 0.0 OUTLIER 'General case' 0 CA--C 1.489 -1.402 0 CA-C-N 114.901 -1.045 . . . . 0.0 109.08 179.041 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.525 ' HB3' ' HB ' ' A' ' 67' ' ' THR . 0.1 OUTLIER -52.28 -69.6 0.11 Allowed 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 105.599 -2.0 . . . . 0.0 105.599 179.708 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.474 ' N ' ' O ' ' A' ' 67' ' ' THR . 4.9 t70 -95.45 -47.87 6.09 Favored 'General case' 0 N--CA 1.436 -1.174 0 N-CA-C 105.426 -2.064 . . . . 0.0 105.426 169.085 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.519 ' C ' ' HA ' ' A' ' 73' ' ' ALA . 73.3 t80 -143.26 142.1 31.26 Favored 'General case' 0 C--N 1.347 0.493 0 CA-C-N 112.512 -2.131 . . . . 0.0 111.334 179.825 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.729 ' HB2' ' HB2' ' A' ' 73' ' ' ALA . 23.8 t-160 -91.78 110.23 21.57 Favored 'General case' 0 C--N 1.33 -0.247 0 O-C-N 122.027 -0.421 . . . . 0.0 110.013 177.327 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.845 HD11 ' O ' ' A' ' 85' ' ' SER . 1.1 pp -129.57 174.6 9.51 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.969 0.414 . . . . 0.0 111.494 -179.642 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.424 ' O ' HD12 ' A' ' 78' ' ' LEU . . . -58.6 175.33 2.63 Favored Glycine 0 C--N 1.333 0.41 0 C-N-CA 120.939 -0.648 . . . . 0.0 112.311 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 15.5 p-10 -112.04 99.28 7.95 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.902 0.382 . . . . 0.0 111.847 -179.628 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.719 ' HB ' ' HB2' ' A' ' 85' ' ' SER . 16.5 mm -113.91 118.39 58.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.036 178.45 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -53.46 -24.03 11.76 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 111.807 0.299 . . . . 0.0 111.807 -179.056 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.545 ' C ' HD13 ' A' ' 84' ' ' LEU . 6.2 mpt_? -86.72 -106.85 0.06 Allowed 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 121.222 -0.191 . . . . 0.0 111.378 -179.661 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.812 ' H ' HD22 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -109.36 110.22 21.31 Favored 'General case' 0 CA--C 1.512 -0.482 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 179.036 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.845 ' O ' HD11 ' A' ' 78' ' ' LEU . 0.4 OUTLIER 162.25 -40.66 0.0 OUTLIER 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 114.709 -1.132 . . . . 0.0 109.427 -179.525 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.802 ' O ' ' N ' ' A' ' 88' ' ' HIS . 95.1 m-20 -64.25 -153.81 0.01 OUTLIER 'General case' 0 CA--C 1.52 -0.191 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 177.597 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.858 ' HB2' HD11 ' A' ' 104' ' ' ILE . 0.0 OUTLIER -54.05 71.28 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 178.313 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.964 ' O ' ' O ' ' A' ' 104' ' ' ILE . 36.2 t60 -80.82 -17.6 50.28 Favored 'General case' 0 CA--C 1.514 -0.412 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 -176.789 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.605 ' HA ' ' H ' ' A' ' 104' ' ' ILE . 0.0 OUTLIER -174.57 156.3 2.38 Favored 'General case' 0 C--N 1.31 -1.111 0 C-N-CA 119.23 -0.988 . . . . 0.0 112.981 178.024 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.641 ' HG2' HG23 ' A' ' 67' ' ' THR . 36.6 mt-30 -138.1 161.02 37.86 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.502 -1.226 . . . . 0.0 113.958 -177.829 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.759 HD13 ' CD1' ' A' ' 48' ' ' LEU . 6.2 mt -127.84 126.6 67.01 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-N 115.006 -0.997 . . . . 0.0 109.13 178.037 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.85 HD12 ' N ' ' A' ' 93' ' ' LEU . 0.3 OUTLIER -107.4 142.41 37.28 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.961 0.41 . . . . 0.0 111.974 -178.781 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.85 ' N ' HD12 ' A' ' 92' ' ' LEU . 0.5 OUTLIER -125.78 125.41 42.9 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.693 179.356 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 137.61 89.06 0.22 Allowed Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.59 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -176.98 84.93 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.868 0.366 . . . . 0.0 110.904 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 50.5 m-20 58.66 44.46 17.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.899 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 59.97 59.51 10.33 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.418 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.534 ' O ' HD13 ' A' ' 93' ' ' LEU . 2.1 m-80 -152.09 178.54 9.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.802 0.334 . . . . 0.0 110.864 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.948 HD13 HD22 ' A' ' 124' ' ' LEU . 2.3 mp -112.09 151.65 29.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.761 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.613 ' HA ' ' O ' ' A' ' 122' ' ' GLN . 0.8 OUTLIER -132.47 147.96 52.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.107 179.987 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.512 HD21 HD12 ' A' ' 124' ' ' LEU . 1.0 OUTLIER -116.04 126.28 53.57 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 120.623 -0.431 . . . . 0.0 110.363 -179.81 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.497 ' O ' ' O ' ' A' ' 90' ' ' GLN . 33.5 t30 -111.57 111.47 22.49 Favored 'General case' 0 CA--C 1.51 -0.58 0 C-N-CA 119.988 -0.685 . . . . 0.0 109.448 179.539 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.692 ' HB3' HG21 ' A' ' 109' ' ' THR . 74.4 m-20 -83.37 111.5 19.06 Favored 'General case' 0 N--CA 1.442 -0.857 0 C-N-CA 119.623 -0.831 . . . . 0.0 109.603 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.964 ' O ' ' O ' ' A' ' 88' ' ' HIS . 0.0 OUTLIER -123.35 107.95 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.969 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 177.533 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.417 ' HG ' ' CE1' ' A' ' 88' ' ' HIS . 63.7 m -132.17 171.12 14.06 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 115.05 -0.977 . . . . 0.0 109.331 179.778 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 25.1 m -69.52 -63.36 1.08 Allowed 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 119.143 -1.023 . . . . 0.0 111.541 -179.157 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -112.5 -32.75 6.37 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 114.63 1.345 . . . . 0.0 114.63 179.015 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -146.04 128.16 2.99 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 116.988 1.555 . . . . 0.0 116.988 -177.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.692 HG21 ' HB3' ' A' ' 103' ' ' ASP . 3.4 m -121.1 138.29 54.26 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 174.483 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 0.685 ' CE2' ' HB2' ' A' ' 115' ' ' LYS . 2.3 m-90 -119.35 149.24 42.15 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 -178.535 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.459 ' C ' HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -120.9 112.08 18.33 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 115.177 -0.92 . . . . 0.0 108.691 177.483 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 39.7 m-20 45.24 43.29 7.93 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.074 -0.512 . . . . 0.0 112.24 -179.522 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 80.35 23.37 60.94 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.947 179.13 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 42.3 mt-30 -135.61 99.07 4.1 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.017 0.437 . . . . 0.0 110.861 179.647 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.685 ' HB2' ' CE2' ' A' ' 110' ' ' TRP . 0.0 OUTLIER -43.98 123.64 3.41 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.08 179.87 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.495 HG21 ' OD2' ' A' ' 103' ' ' ASP . 5.4 m -114.92 -179.74 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.7 -179.218 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -87.29 140.13 29.85 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.824 -0.626 . . . . 0.0 111.011 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.432 ' HG3' ' HA ' ' A' ' 104' ' ' ILE . 54.2 tttm -63.63 162.69 12.58 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.25 179.518 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.427 ' N ' ' HG2' ' A' ' 118' ' ' LYS . 4.1 p30 34.85 38.87 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.228 0.537 . . . . 0.0 111.372 -179.865 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 6.9 p -111.04 108.71 18.52 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.973 -179.533 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.591 ' ND2' HD23 ' A' ' 92' ' ' LEU . 27.9 m120 -54.91 144.66 22.21 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.633 179.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . 0.613 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 65.8 mm-40 -129.88 149.39 51.63 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.04 0.448 . . . . 0.0 112.084 -179.346 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.636 HD23 ' O ' ' A' ' 124' ' ' LEU . 9.8 tt -77.27 120.5 22.4 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.357 178.849 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.948 HD22 HD13 ' A' ' 99' ' ' LEU . 8.2 tp -46.39 141.98 3.26 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 122.06 0.933 . . . . 0.0 112.022 -178.549 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.43 ' O ' HD11 ' A' ' 147' ' ' ILE . 0.0 OUTLIER -127.29 152.85 46.89 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 113.811 -1.541 . . . . 0.0 110.215 179.567 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 9.6 tp60 -71.79 113.67 9.07 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 179.301 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 64.87 31.58 81.39 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.323 -179.351 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.402 ' HB2' ' CB ' ' A' ' 125' ' ' SER . 8.4 t70 -54.9 160.13 2.07 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.978 0.418 . . . . 0.0 111.207 -179.758 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.529 ' HG3' HG22 ' A' ' 144' ' ' VAL . 13.8 tt0 -146.48 135.35 22.39 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.642 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.437 HG21 ' OD1' ' A' ' 103' ' ' ASP . 1.1 mp -112.94 128.47 69.66 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.121 0 CA-C-N 116.363 -0.38 . . . . 0.0 109.986 178.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.611 HG23 ' CG2' ' A' ' 140' ' ' ILE . 16.0 m -103.16 144.77 30.88 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.478 -179.748 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.474 ' HB ' ' NE2' ' A' ' 88' ' ' HIS . 5.4 m -141.37 158.16 22.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 112.581 0.586 . . . . 0.0 112.581 -178.715 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 67.04 42.81 92.06 Favored Glycine 0 N--CA 1.449 -0.494 0 CA-C-N 115.595 -0.729 . . . . 0.0 112.312 179.253 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.546 ' HA ' HG12 ' A' ' 140' ' ' ILE . 89.8 t -76.79 153.3 5.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-O 121.479 0.656 . . . . 0.0 112.268 -179.176 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 148.65 -42.03 0.85 Allowed Glycine 0 N--CA 1.441 -0.99 0 CA-C-N 114.888 -1.051 . . . . 0.0 110.655 -178.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.548 HG12 ' H ' ' A' ' 138' ' ' SER . 47.6 t -126.62 131.4 71.28 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 CA-C-N 115.172 -0.514 . . . . 0.0 109.743 178.698 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -51.3 -34.61 34.01 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.737 0.303 . . . . 0.0 111.445 -179.229 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . 0.548 ' H ' HG12 ' A' ' 136' ' ' VAL . 0.7 OUTLIER -94.17 6.32 48.96 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 112.343 0.497 . . . . 0.0 112.343 -179.288 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . 0.405 ' CB ' ' HB ' ' A' ' 136' ' ' VAL . 10.1 t70 -125.65 26.72 6.64 Favored 'General case' 0 CA--C 1.518 -0.252 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 -179.367 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.611 ' CG2' HG23 ' A' ' 131' ' ' THR . 14.9 mt -105.5 140.81 22.4 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.967 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.267 179.069 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.595 HD23 ' NE2' ' A' ' 42' ' ' GLN . 1.0 OUTLIER -117.73 130.01 56.06 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.901 179.327 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.736 ' CB ' HG21 ' A' ' 40' ' ' THR . 0.8 OUTLIER -116.37 139.06 50.81 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.417 0.627 . . . . 0.0 112.397 -178.845 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.545 ' N ' HD12 ' A' ' 143' ' ' LEU . 4.8 mp -118.25 138.98 51.98 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.14 -0.937 . . . . 0.0 109.331 179.083 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.529 HG22 ' HG3' ' A' ' 129' ' ' GLU . 21.7 t -123.41 140.5 46.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 120.809 0.338 . . . . 0.0 111.816 -179.034 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.604 HG13 HG13 ' A' ' 36' ' ' VAL . 0.1 OUTLIER -113.63 126.7 71.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.554 179.657 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 80.0 t80 -111.27 123.78 50.89 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.948 -179.846 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.809 HG12 HD21 ' A' ' 124' ' ' LEU . 2.8 mp -106.27 132.24 53.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.111 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . 0.456 ' ND2' HG22 ' A' ' 32' ' ' ILE . 8.9 p30 -81.65 141.7 33.41 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.104 -179.795 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -73.93 -19.45 60.68 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.375 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 12.7 mptt -58.19 -44.83 88.28 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.958 0.408 . . . . 0.0 110.815 -179.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . 0.459 ' CE2' HD11 ' A' ' 52' ' ' ILE . 14.0 t80 -59.58 -43.61 93.58 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.886 -179.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 14.8 tttt -64.57 -34.24 77.79 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.953 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -59.1 -46.05 89.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.917 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 12.1 t -61.16 -45.42 94.7 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.78 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -66.39 -35.78 81.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.835 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 79.8 tt0 -59.44 -36.44 75.92 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.916 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 13.6 mm-40 -76.31 -32.12 58.56 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.875 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -122.4 80.22 1.7 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.899 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 2.3 tttt -125.19 136.59 53.73 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.931 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 12.4 p -96.44 134.57 33.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.109 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -110.48 -69.18 0.88 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.881 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 6.4 ttt180 68.48 -68.28 0.18 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.032 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 10.3 mt -86.18 130.26 36.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.059 -179.899 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.148 -0.93 . . . . 0.0 110.936 -179.979 . . . . . . . . 1 1 . 1 stop_ save_